assay_id,doc_id,description,assay_type,assay_test_type,assay_category,assay_organism,assay_tax_id,assay_strain,assay_tissue,assay_cell_type,assay_subcellular_fraction,tid,relationship_type,confidence_score,curated_by,src_id,src_assay_id,chembl_id,cell_id,bao_format,tissue_id,variant_id
1,11087,The compound was tested for the in vitro inhibition of platelet 12-lipoxygenase at a concentration of 30 uM,B,,,,,,,,,12052,H,8,Autocuration,1,,CHEMBL615117,,BAO_0000019,,
2,684,Compound was evaluated for its ability to mobilize calcium in 1321NI cells,F,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL615118,,BAO_0000219,,
3,15453,,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL615119,,BAO_0000019,,
4,17841,Binding affinity against A2 adenosine receptor in bovine striatal membranes using [3H]CGS-21680,B,,,Bos taurus,9913.0,,,,,104729,H,4,Autocuration,1,,CHEMBL615120,,BAO_0000249,,
5,17430,In vitro cell cytotoxicity against 143-B cell lines (Human osteosarcoma cell line),F,,,Homo sapiens,9606.0,,,143B,,80001,N,1,Intermediate,1,,CHEMBL615121,163.0,BAO_0000219,,
6,17430,In vitro cell cytotoxicity against 143-B cell lines (Human osteosarcoma cell line),F,,,Homo sapiens,9606.0,,,143B,,80001,N,1,Intermediate,1,,CHEMBL615122,163.0,BAO_0000219,,
7,13799,Cytotoxic Activity was evaluated against 143B (TK-) tumor cells,F,,,Mus musculus,10090.0,,,143B,,80001,N,1,Intermediate,1,,CHEMBL615123,163.0,BAO_0000219,,
8,17774,In vitro cell cytotoxicity was determined against 143B cell line,F,,,Homo sapiens,9606.0,,,143B,,80001,N,1,Expert,1,,CHEMBL615124,163.0,BAO_0000219,,
9,3801,Inhibitory activity against tumor osteosarcoma cell line 143B after 72 hr continuous exposure to compound,F,,,Homo sapiens,9606.0,,,143B,,80001,N,1,Intermediate,1,,CHEMBL615125,163.0,BAO_0000219,,
10,17430,In vitro cell cytotoxicity against 143B-LTK cell lines expressed in HSV-1 TK,F,,,Homo sapiens,9606.0,,,143B,,80001,N,1,Intermediate,1,,CHEMBL615126,163.0,BAO_0000219,,
11,17430,In vitro cell cytotoxicity against 143B-LTK cell lines expressed in HSV-1 TK,F,,,Homo sapiens,9606.0,,,143B,,80001,N,1,Intermediate,1,,CHEMBL615127,163.0,BAO_0000219,,
12,17774,In vitro cell cytotoxicity was determined against 143B-LTK cell line,F,,,Homo sapiens,9606.0,,,143B,,80001,N,1,Expert,1,,CHEMBL615128,163.0,BAO_0000219,,
13,11324,"The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus",F,,,Staphylococcus aureus,1280.0,,,,,50185,N,1,Intermediate,1,,CHEMBL857900,,BAO_0000218,,
14,11324,"The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus",F,,,Staphylococcus aureus,1280.0,,,,,50185,N,1,Intermediate,1,,CHEMBL615129,,BAO_0000218,,
15,11324,"The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus",F,,,Staphylococcus aureus,1280.0,,,,,50185,N,1,Intermediate,1,,CHEMBL615130,,BAO_0000218,,
16,11324,"The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus",F,,,Staphylococcus aureus,1280.0,,,,,50185,N,1,Intermediate,1,,CHEMBL615131,,BAO_0000218,,
17,11347,Inhibition of cytochrome P450 progesterone 15-alpha hydroxylase,A,,,Rattus norvegicus,10116.0,,,,,100122,D,9,Expert,1,,CHEMBL884521,,BAO_0000357,,
18,16474,Concentration that cause 50% activation of human reticulocyte 15-lipoxygenase (15-HLO),B,,,,,,,,,12054,H,8,Autocuration,1,,CHEMBL615132,,BAO_0000357,,
19,10091,Inhibition of partially purified 15-lipoxygenase from human leukocytes,B,,,,,,,,,12054,H,8,Autocuration,1,,CHEMBL615133,,BAO_0000019,,
20,16474,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO),B,,,,,,,,,12054,H,8,Autocuration,1,,CHEMBL615134,,BAO_0000357,,
21,16474,Compound was evaluated for the percent increase in activation concentration of human reticulocyte 15-lipoxygenase (15-HLO),B,,,,,,,,,12054,H,8,Autocuration,1,,CHEMBL615135,,BAO_0000357,,
22,16474,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO),B,,,,,,,,,12054,H,8,Autocuration,1,,CHEMBL615136,,BAO_0000357,,
23,16474,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO); NI is no inhibition,B,,,,,,,,,12054,H,8,Autocuration,1,,CHEMBL615137,,BAO_0000357,,
24,16474,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO); NI is no inhibition,B,,,,,,,,,12054,H,8,Autocuration,1,,CHEMBL615138,,BAO_0000357,,
25,14352,"Inhibitory concentration against 15-lipoxygenase, by inhibiting 15-HETE production by human umbilical vein endothelial cells (HUVEC) stimulated by calcium ionophore A 23187 at concentration of 10e-5 M.",B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL836324,,BAO_0000219,,
26,5646,In vitro inhibitory activity of compound on rabbit reticulocyte 15-lipoxygenase,B,,,Oryctolagus cuniculus,9986.0,,,,,12054,H,8,Autocuration,1,,CHEMBL615139,,BAO_0000357,,
27,5646,Inhibition of rabbit reticulocyte 15-lipoxygenase by compound (30 uM),B,,,Oryctolagus cuniculus,9986.0,,,,,12054,H,8,Autocuration,1,,CHEMBL615140,,BAO_0000357,,
28,10997,Inhibitory activity against 15-lipoxygenase in rat polymorphonuclear leukocytes,B,,,,,,,,,12426,H,8,Autocuration,1,,CHEMBL615141,,BAO_0000219,,
29,6309,Inhibitory activity against 15-lipoxygenase was determined obtained from soya bean,B,,,soya bean,3847.0,,,,,12054,H,8,Autocuration,1,,CHEMBL615142,,BAO_0000357,,
30,167,Inhibitory activity against soybean 15-lipoxygenase was evaluated,B,,,Glycine max,3847.0,,,,,12054,H,8,Autocuration,1,,CHEMBL615143,,BAO_0000357,,
31,167,Inhibitory activity against soybean 15-lipoxygenase was evaluated at 100 uM,B,,,Glycine max,3847.0,,,,,12054,H,8,Autocuration,1,,CHEMBL615144,,BAO_0000357,,
32,11087,The compound was tested for the in vitro inhibition of 15-lipoxygenase of soybean at a concentration of 10 uM,B,,,Glycine max,3847.0,,,,,12054,H,8,Autocuration,1,,CHEMBL872867,,BAO_0000357,,
33,11087,The compound was tested for the in vitro inhibition of 15-lipoxygenase of soybean at a concentration of 100 uM,B,,,Glycine max,3847.0,,,,,12054,H,8,Autocuration,1,,CHEMBL615145,,BAO_0000357,,
34,13622,Compound was tested in vitro for inhibition of 15-lipoxygenase soybean,B,,,Glycine max,3847.0,,,,,12054,H,8,Autocuration,1,,CHEMBL615146,,BAO_0000357,,
35,13622,Compound at 100 uM was tested in vitro for inhibition of 15-lipoxygenase soybean,B,,,Glycine max,3847.0,,,,,12054,H,8,Autocuration,1,,CHEMBL615147,,BAO_0000357,,
36,11347,Inhibition of cytochrome P450 progesterone 16-alpha hydroxylase,A,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615148,,BAO_0000019,,
37,5926,Binding affinity against bacterial 16S rRNA using mass spectrometry based assay,B,,,Escherichia coli,562.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615149,,BAO_0000019,,
38,4567,Dissociation constant with dimeric 16S rRNA RNA construct B,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL615150,,BAO_0000019,,
39,3782,Dissociation constant towards 16S rRNA construct A,B,,,,,,,,,22222,M,3,Intermediate,1,,CHEMBL615151,,BAO_0000225,,
40,3782,Dissociation constant towards 16S rRNA construct B,B,,,,,,,,,22222,M,3,Intermediate,1,,CHEMBL615152,,BAO_0000225,,
41,4466,Binding affinity of aminoglycoside to 16S ribosomal RNA A-site in Escherichia coli,B,,,Escherichia coli,562.0,,,,,100263,M,3,Expert,1,,CHEMBL615153,,BAO_0000225,,
42,6592,Binding affinity for the 16S ribosomal RNA A-site of Escherichia coli,B,,,Escherichia coli,562.0,,,,,100263,M,3,Expert,1,,CHEMBL615154,,BAO_0000225,,
43,898,Inhibitory activity against human placenta 17-beta-hydroxysteroid dehydrogenase type 2 (17-beta-HSD type 2),B,,,,,,,,,13053,H,8,Autocuration,1,,CHEMBL615155,,BAO_0000019,,
44,898,Inhibitory constant against human placenta 17-beta-hydroxysteroid dehydrogenase type 2 (17-beta-HSD type 2),B,,,,,,,,,13053,H,8,Autocuration,1,,CHEMBL615156,,BAO_0000019,,
45,13163,The compound was tested at a concentration of 1 uM for inhibitory activity against 17 beta-hydroxysteroid dehydrogenase from human placental microsomes,B,,,Homo sapiens,9606.0,,,,,20001,H,8,Autocuration,1,,CHEMBL615157,,BAO_0000019,,
46,13163,The compound was tested at a concentration of 1 uM for inhibitory activity against 17 beta-hydroxysteroid dehydrogenase from human placental microsomes,B,,,Homo sapiens,9606.0,,,,,20001,H,8,Autocuration,1,,CHEMBL615158,,BAO_0000019,,
47,10691,"Inhibition of 17-alpha-hydroxylase/17,20 lyase from rat testes microsomal preparation",B,,,Rattus norvegicus,10116.0,,,,,12971,D,9,Expert,1,,CHEMBL615159,,BAO_0000019,,
48,10691,"Inhibition of 17-alpha-hydroxylase/17,20 lyase from rat testes microsomal preparation",B,,,Rattus norvegicus,10116.0,,,,,12971,D,9,Expert,1,,CHEMBL615172,,BAO_0000019,,
49,10691,"Percent inhibition of 17-alpha-hydroxylase/17,20 lyase of rat testes microsomes at 100 uM",B,,,Rattus norvegicus,10116.0,,,,,12971,D,9,Expert,1,,CHEMBL615173,,BAO_0000019,,
50,10691,"Percent inhibition of Steroid 17-alpha-hydroxylase/17,20 lyase of rat testes microsomes at 100 uM",B,,,Rattus norvegicus,10116.0,,,,,12971,D,9,Expert,1,,CHEMBL615174,,BAO_0000019,,
51,898,Inhibitory activity against human placenta 17-beta-hydroxysteroid dehydrogenase type 2 (17-beta-HSD type 2),B,,,,,,,,,13053,H,8,Autocuration,1,,CHEMBL884518,,BAO_0000019,,
52,912,Compound was tested for the inhibition of 17-beta-hydroxysteroid dehydrogenase type 1(17-beta-HSD type 1),B,,,,,,,,,11512,H,8,Autocuration,1,,CHEMBL615175,,BAO_0000357,,
53,912,Compound was tested for the inhibition of 17-beta-hydroxysteroid dehydrogenase type 1(17-beta-HSD type 1) at 1 uM concentration,B,,,,,,,,,11512,H,8,Autocuration,1,,CHEMBL615176,,BAO_0000357,,
54,912,Compound was tested for the inhibition of 17-beta-hydroxysteroid dehydrogenase type 1(17-beta-HSD type 1) at 10 uM concentration,B,,,,,,,,,11512,H,8,Autocuration,1,,CHEMBL615177,,BAO_0000357,,
55,15103,Selectivity ratio of binding affinity towards mu to delta receptors of rat brain membranes,B,,,Rattus norvegicus,10116.0,,,,Membranes,104740,D,5,Autocuration,1,,CHEMBL615178,,BAO_0000249,,
56,5116,Cytotoxicity against ovarian cancer cell line (1A-9) of humans was determined,F,,,Homo sapiens,9606.0,,,1A9,,80002,N,1,Intermediate,1,,CHEMBL615179,506.0,BAO_0000219,,
57,14578,Functional antagonism by electrical assays in Xenopus oocytes expressing 1A/2A NMDA receptor subtype,F,,,Rattus norvegicus,10116.0,,,Oocytes,,104835,D,7,Autocuration,1,,CHEMBL615180,,BAO_0000219,,
58,14578,Functional antagonism by electrical assays in Xenopus oocytes expressing the 1A/2B NMDA receptor,F,,,Rattus norvegicus,10116.0,,,Oocytes,,104821,D,7,Autocuration,1,,CHEMBL615181,,BAO_0000219,,
59,14578,Functional antagonism by electrical assays in Xenopus oocytes expressing the 1A/2C NMDA receptor,F,,,Rattus norvegicus,10116.0,,,Oocytes,,104848,D,7,Autocuration,1,,CHEMBL615182,,BAO_0000219,,
60,4787,In vitro effective concentration required to reduce the number of human ovarian cancer (1A9) after 3-day incubation,F,,,Homo sapiens,9606.0,,,1A9,,80002,N,1,Expert,1,,CHEMBL615183,506.0,BAO_0000219,,
61,4787,In vitro effective concentration required to reduce the number of human ovarian cancer cells (1A9) after 3-day incubation,F,,,Homo sapiens,9606.0,,,1A9,,80002,N,1,Intermediate,1,,CHEMBL615184,506.0,BAO_0000219,,
62,3547,Cytotoxic activity against human ovarian cancer (1A9) cell line,F,,,Homo sapiens,9606.0,,,1A9,,80002,N,1,Intermediate,1,,CHEMBL615185,506.0,BAO_0000219,,
63,3547,Cytotoxic activity against human ovarian cancer (1A9) cell line; ND=Not determined,F,,,Homo sapiens,9606.0,,,1A9,,80002,N,1,Intermediate,1,,CHEMBL615186,506.0,BAO_0000219,,
64,6726,Effective dose of compound against replication of 1A9 cell line was evaluated,F,,,Homo sapiens,9606.0,,,1A9,,80002,N,1,Intermediate,1,,CHEMBL615187,506.0,BAO_0000219,,
65,3455,In vitro cytotoxic activity was determined against ovarian cancer (1A9) cell line,F,,,Homo sapiens,9606.0,,,1A9,,80002,N,1,Expert,1,,CHEMBL885343,506.0,BAO_0000219,,
66,5726,In vitro cytotoxicity evaluated against human ovarian cancer (1A9 cell line),F,,,Homo sapiens,9606.0,,,1A9,,80002,N,1,Intermediate,1,,CHEMBL615188,506.0,BAO_0000219,,
67,5726,In vitro cytotoxicity evaluated against human ovarian cancer (1A9 cell line); NA is not active,F,,,Homo sapiens,9606.0,,,1A9,,80002,N,1,Intermediate,1,,CHEMBL615189,506.0,BAO_0000219,,
68,5726,In vitro percent inhibition evaluated against human ovarian cancer (1A9 cell line) at >20 ug/mL,F,,,Homo sapiens,9606.0,,,1A9,,80002,N,1,Intermediate,1,,CHEMBL615190,506.0,BAO_0000219,,
69,3395,Inhibitory activity against Taxol resistant 1A9 cell lines,F,,,Homo sapiens,9606.0,,,1A9,,80002,N,1,Intermediate,1,,CHEMBL615191,506.0,BAO_0000219,,
70,3415,Cytotoxicity against human ovarian cancer (1A9) cell lines.,F,,,Homo sapiens,9606.0,,,1A9,,80002,N,1,Expert,1,,CHEMBL615192,506.0,BAO_0000219,,
71,3415,Percentage inhibition of human ovarian cancer (1A9) cell lines.,F,,,Homo sapiens,9606.0,,,1A9,,80002,N,1,Expert,1,,CHEMBL827083,506.0,BAO_0000219,,
72,17099,Effective dose required for inhibitory activity against 1A9 human tumor cell line.,F,,,Homo sapiens,9606.0,,,1A9,,80002,N,1,Expert,1,,CHEMBL615193,506.0,BAO_0000219,,
73,17099,Percent inhibition against 1A9 human tumor cell line at 0.10 ug/mL,F,,,Homo sapiens,9606.0,,,1A9,,80002,N,1,Intermediate,1,,CHEMBL615194,506.0,BAO_0000219,,
74,17099,Percent inhibition against 1A9 human tumor cell line at <0.00008 ug/mL,F,,,Homo sapiens,9606.0,,,1A9,,80002,N,1,Intermediate,1,,CHEMBL615195,506.0,BAO_0000219,,
75,17099,Percent inhibition against 1A9 human tumor cell line at >10 ug/mL,F,,,Homo sapiens,9606.0,,,1A9,,80002,N,1,Intermediate,1,,CHEMBL615196,506.0,BAO_0000219,,
76,17721,Inhibitory concentration against Jurkat cells,F,,,Homo sapiens,9606.0,,,Jurkat,,81072,N,1,Intermediate,1,,CHEMBL615197,503.0,BAO_0000219,,
77,1229,In vitro anticancer activity against 2 NCI SCLC cell lines; inactive,F,,,,,,,,,22226,U,0,Intermediate,1,,CHEMBL615198,,BAO_0000019,,
78,11347,Inhibition of cytochrome P450 progesterone 2-alpha-hydroxylase,A,,,Rattus norvegicus,10116.0,,,,,100121,D,9,Expert,1,,CHEMBL615199,,BAO_0000357,,
79,17117,"In vitro inhibition of human 2,3-oxidosqualene cyclase.",B,,,,,,,,,11231,H,8,Expert,1,,CHEMBL615200,,BAO_0000357,,
80,17117,"In vitro inhibition of human 2,3-oxidosqualene cyclase.",B,,,,,,,,,11231,H,8,Expert,1,,CHEMBL615201,,BAO_0000357,,
81,17117,"In vitro inhibition of human 2,3-oxidosqualene cyclase at 100 nM.",B,,,,,,,,,11231,H,8,Expert,1,,CHEMBL615202,,BAO_0000357,,
82,11375,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene cyclase in Candida albicans microsomes",B,,,Candida albicans,5476.0,,,,Microsomes,11231,H,8,Autocuration,1,,CHEMBL615203,,BAO_0000251,,
83,11375,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in Candida albicans microsomes",B,,,Candida albicans,5476.0,,,,Microsomes,11231,H,8,Autocuration,1,,CHEMBL615204,,BAO_0000251,,
84,11375,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene cyclase in Saccharomyces cerevisiae microsomes",B,,,Saccharomyces cerevisiae,4932.0,,,,Microsomes,11231,H,8,Autocuration,1,,CHEMBL615205,,BAO_0000251,,
85,11375,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in Saccharomyces cerevisiae microsomes",B,,,Saccharomyces cerevisiae,4932.0,,,,Microsomes,11231,H,8,Autocuration,1,,CHEMBL615206,,BAO_0000251,,
86,11375,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in pig liver microsomes",B,,,Sus scrofa,9823.0,,Liver,,Microsomes,12083,H,8,Autocuration,1,,CHEMBL615207,,BAO_0000251,2107.0,
87,791,"Concentration required to inhibit rat liver 2,3-oxidosqualene-lanosterol cyclase",B,,,Rattus norvegicus,10116.0,,,,,11231,H,8,Autocuration,1,,CHEMBL827084,,BAO_0000019,,
88,791,"Concentration required to inhibit rat liver 2,3-oxidosqualene-lanosterol cyclase (OSC)",B,,,Rattus norvegicus,10116.0,,,,,11231,H,8,Autocuration,1,,CHEMBL615208,,BAO_0000019,,
89,791,"Evaluated for its activity to inhibit rat liver 2,3-oxidosqualene-lanosterol cyclase, activity expressed as Ki",B,,,Rattus norvegicus,10116.0,,,,,11231,H,8,Autocuration,1,,CHEMBL615209,,BAO_0000019,,
90,11375,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene cyclase in rat liver microsomes",B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,12083,D,9,Autocuration,1,,CHEMBL615210,,BAO_0000251,2107.0,
91,11375,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in rat liver microsomes",B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,12083,D,9,Autocuration,1,,CHEMBL615211,,BAO_0000251,2107.0,
92,153,"Compound was evaluated for inhibitory activity against 2,3-oxidosqualene-lanosterol cyclase in rat liver microsomes",B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,12083,D,9,Autocuration,1,,CHEMBL615212,,BAO_0000251,2107.0,
93,8269,Molar concentration needed to give 50% prevention of 2-5A (Adenosine dependent endoribonuclease),B,,,,,,,,,11377,H,8,Expert,1,,CHEMBL615213,,BAO_0000357,,
94,8269,Molar concentration required to displace 50% of the radiolabeled probe from 2-5A (Adenosine dependent endoribonuclease) in endonuclease-nitrocellulose complex,B,,,,,,,,,11377,H,8,Expert,1,,CHEMBL615273,,BAO_0000357,,
95,17653,In vitro cytotoxic concentration required to inhibit hepatitisB virus (HBV) replication in 2.2.15 cell line,F,,,Homo sapiens,9606.0,,,HepG2,,81020,N,1,Expert,1,,CHEMBL615274,726.0,BAO_0000219,,
96,14277,50% Effective concentration of compound required for inhibiting intracellular viral replicative intermediate DNA in HBV-transfected 2.2.15 cell line.,F,,,Homo sapiens,9606.0,,,HepG2,,81020,N,1,Intermediate,1,,CHEMBL615275,726.0,BAO_0000219,,
97,1717,Antiviral activity against Hepatitis B virus in 2.2.15 cell line,F,,,Homo sapiens,9606.0,,,HepG2,,81020,N,1,Intermediate,1,,CHEMBL615276,726.0,BAO_0000219,,
98,14091,In vitro effective concentration against hepatitis B virus was determined in 2.2.15 cells,F,,,Homo sapiens,9606.0,,,HepG2,,81020,N,1,Intermediate,1,,CHEMBL615277,726.0,BAO_0000219,,
99,14091,In vitro effective concentration against hepatitis B virus was determined in 2.2.15 cells; Not determined,F,,,Homo sapiens,9606.0,,,HepG2,,81020,N,1,Intermediate,1,,CHEMBL615326,726.0,BAO_0000219,,
100,17653,In vitro effective concentration required to inhibit hepatitisB virus (HBV) replication in 2.2.15 cell line,F,,,Hepatitis B virus,10407.0,,,,,50606,N,1,Expert,1,,CHEMBL883130,,BAO_0000218,,
101,13105,Ability to inhibit the episomal HBV-DNA in 2.2.15 cells.,F,,,Homo sapiens,9606.0,,,HepG2,,81020,N,1,Intermediate,1,,CHEMBL884519,726.0,BAO_0000219,,
102,1717,Concentration required to inhibit 50% of 2.2.15 cell line,F,,,Homo sapiens,9606.0,,,HepG2,,81020,N,1,Intermediate,1,,CHEMBL615327,726.0,BAO_0000219,,
103,13105,Anti viral activity against 2.2.15 cells (concentration required to reduce the log phase cell growth by 50%).,A,,,Homo sapiens,9606.0,,,HepG2,,81020,N,1,Intermediate,1,,CHEMBL615328,726.0,BAO_0000219,,
104,13600,Cytotoxic activity of compound against uninfected 2.2.15 cells.,F,,,Homo sapiens,9606.0,,,2.2.15,,50587,N,1,Intermediate,1,,CHEMBL615329,,BAO_0000218,,
105,13467,Anti hepatitis-B virus activity was evaluated in 2.2.15 cells.,F,,,Homo sapiens,9606.0,,,2.2.15,,50587,N,1,Intermediate,1,,CHEMBL615330,,BAO_0000218,,
106,17477,"Inhibition of the replication of HBV in 2.2.15 cells, by DNA hybridization assay",F,,,Hepatitis B virus,10407.0,,,2.2.15,,50606,N,1,Expert,1,,CHEMBL615331,,BAO_0000218,,
107,1593,In vitro anti-HBV activity in 2.2.15 cells,F,,,Homo sapiens,9606.0,,,2.2.15,,50587,N,1,Intermediate,1,,CHEMBL615332,,BAO_0000218,,
108,1593,In vitro anti-HBV activity in 2.2.15 cells; Not determined,F,,,Homo sapiens,9606.0,,,2.2.15,,50587,N,1,Intermediate,1,,CHEMBL615333,,BAO_0000218,,
109,15089,The compound was tested in vitro for the anti-HBV activity against 2.2.15 cells,F,,,Homo sapiens,9606.0,,,2.2.15,,50587,N,1,Intermediate,1,,CHEMBL615334,,BAO_0000218,,
110,15089,The compound was tested in vitro for the anti-HBV activity in 2.2.15 cells,F,,,Homo sapiens,9606.0,,,2.2.15,,50587,N,1,Intermediate,1,,CHEMBL615335,,BAO_0000218,,
111,1593,Cytotoxicity in 2.2.15 cells,F,,,Homo sapiens,9606.0,,,2.2.15,,50587,N,1,Intermediate,1,,CHEMBL615336,,BAO_0000218,,
112,1593,Cytotoxicity in 2.2.15 cells; Not determined,F,,,Homo sapiens,9606.0,,,2.2.15,,50587,N,1,Intermediate,1,,CHEMBL615337,,BAO_0000218,,
113,13600,Inhibitory activity of compound against hepatitis B virus (HBV) in growing cultures of 2.2.15 cells,F,,,Homo sapiens,9606.0,,,2.2.15,,50587,N,1,Intermediate,1,,CHEMBL615338,,BAO_0000218,,
114,13467,The growth inhibition activity for the compound was evaluated in 2.2.15 cells.,F,,,Homo sapiens,9606.0,,,2.2.15,,50587,N,1,Intermediate,1,,CHEMBL615339,,BAO_0000218,,
115,13467,Selectivity index was determined from the ratio of IC50 to the EC50 values evaluated in 2.2.15 cells.,F,,,Homo sapiens,9606.0,,,2.2.15,,50587,N,1,Intermediate,1,,CHEMBL615340,,BAO_0000218,,
116,14764,Antiviral activity against HBV was determined in 2.215 cell line,F,,,Homo sapiens,9606.0,,,HepG2,,81020,N,1,Intermediate,1,,CHEMBL615341,726.0,BAO_0000219,,
117,6531,Inhibition of 20-HETE synthesis in human renal microsomes,B,,,Homo sapiens,9606.0,,,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL615342,,BAO_0000251,,
118,17322,Inhibitory activity against 20-HETE production from arachidonic acid using human renal microsome 20-HETE synthase.,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL615343,,BAO_0000019,,
119,17072,Inhibitory concentration against 2008 (ovarian) cells,F,,,Homo sapiens,9606.0,,,2008,,80612,N,1,Intermediate,1,,CHEMBL615344,388.0,BAO_0000219,,
120,16936,50% Growth inhibitory concentration( GI 50 ) by using 2008 human ovarian carcinoma cell lines.,F,,,Homo sapiens,9606.0,,,2008,,80612,N,1,Intermediate,1,,CHEMBL615345,388.0,BAO_0000219,,
121,16936,Compound was tested for 50% growth inhibitory concentration by using human ovarian carcinoma cell lines (2008),F,,,Homo sapiens,9606.0,,,2008,,80612,N,1,Intermediate,1,,CHEMBL615346,388.0,BAO_0000219,,
122,17146,Direct cytotoxicity against the selected tumor cell line 2008 was determined especially on ovarian adenocarcinoma derived cells,F,,,Homo sapiens,9606.0,,,2008,,80612,N,1,Intermediate,1,,CHEMBL615347,388.0,BAO_0000219,,
123,17146,Direct cytotoxicity against the selected tumor cell line 2008 was determined especially on ovarian adenocarcinoma derived cells; not detected,F,,,Homo sapiens,9606.0,,,2008,,80612,N,1,Intermediate,1,,CHEMBL615348,388.0,BAO_0000219,,
124,10797,In vitro inhibition of 2008/R ovarian cancer cell line,F,,,Homo sapiens,9606.0,,,2008/R,,80613,N,1,Intermediate,1,,CHEMBL827085,561.0,BAO_0000219,,
125,10797,In vitro inhibition of 2008/R ovarian cancer cell line; NA= Not achievable,F,,,Homo sapiens,9606.0,,,2008/R,,80613,N,1,Intermediate,1,,CHEMBL615349,561.0,BAO_0000219,,
126,10797,In vitro inhibition of 2008/S ovarian cancer cell line,F,,,Homo sapiens,9606.0,,,2008/S,,80614,N,1,Intermediate,1,,CHEMBL615350,389.0,BAO_0000219,,
127,10797,In vitro inhibition of 2008/S ovarian cancer cell line; NA= Not achievable,F,,,Homo sapiens,9606.0,,,2008/S,,80614,N,1,Intermediate,1,,CHEMBL615351,389.0,BAO_0000219,,
128,4823,Tested in vitro for inhibition of chymotrypsin like activity of purified human 20S proteasome,B,,,Homo sapiens,9606.0,,,,,100256,S,2,Expert,1,,CHEMBL615352,,BAO_0000220,,
129,12912,Compound was evaluated for inhibitory activity against 20S proteasome from human liver and brain,B,,,Homo sapiens,9606.0,,,,,100256,S,2,Intermediate,1,,CHEMBL615353,,BAO_0000220,,
130,2957,Inhibition of chymotrypsin-like activity of 20S proteasome,B,,,,,,,,,100256,S,2,Expert,1,,CHEMBL615354,,BAO_0000220,,
131,2957,Inhibition of chymotrypsin-like activity of 20S proteasome; value ranges from 10-20 uM,B,,,,,,,,,100256,S,2,Expert,1,,CHEMBL615355,,BAO_0000220,,
132,3260,Inhibitory activity against 20S proteosome,B,,,,,,,,,100256,S,2,Intermediate,1,,CHEMBL615356,,BAO_0000220,,
133,3451,Compound was tested for inhibitory activity against tryptase,B,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615357,,BAO_0000019,,
134,13885,Concentration required to inhibit 50% of extracellular circular replication of HBV DNA using 2215 cell line,F,,,Homo sapiens,9606.0,,,HepG2,,81020,N,1,Intermediate,1,,CHEMBL615358,726.0,BAO_0000219,,
135,13885,Concentration required to inhibit 50% of intracellular circular replication of HBV DNA using 2215 cell line,F,,,Homo sapiens,9606.0,,,HepG2,,81020,N,1,Intermediate,1,,CHEMBL827086,726.0,BAO_0000219,,
136,3676,Compound was tested for the inhibition of Alpha-glucosidase,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL615359,,BAO_0000019,,
137,6043,Inhibitory concentration against human neutrophil elastase (HNE),B,,,,,,,,,235,H,8,Autocuration,1,,CHEMBL615360,,BAO_0000357,,
138,11140,Change in heart rate was expressed in percent at at a dose 0.002 mg/kg iv in anesthetized rat,F,,,Rattus norvegicus,10116.0,,Heart,,,22226,U,0,Autocuration,1,,CHEMBL615361,,BAO_0000218,948.0,
139,10543,90% inhibition of the 20 Mycobacterium avium complex (MAC) clinical isolates,F,,,,,,,,,19640,H,8,Autocuration,1,,CHEMBL615362,,BAO_0000019,,
140,10543,Minimum inhibitory concentration of compound against 20 Mycobacterium avium complex (MAC) clinical isolates,F,,,,,,,,,19640,H,8,Expert,1,,CHEMBL615363,,BAO_0000019,,
141,10543,Minimum inhibitory concentration of compound against 20 Mycobacterium avium complex (MAC) clinical isolates,B,,,,,,,,,19640,H,8,Autocuration,1,,CHEMBL615364,,BAO_0000357,,
142,10543,90% inhibition of the 20 Mycobacterium avium complex (MAC) clinical isolates,F,,,,,,,,,19640,H,8,Expert,1,,CHEMBL615365,,BAO_0000019,,
143,11365,In Vitro evaluation for the growth inhibition of Subline (P388/AMSA) Leukemia cell lines,F,,,Mus musculus,10090.0,,,P338,,80360,N,1,Intermediate,1,,CHEMBL615366,524.0,BAO_0000219,,
144,11365,In Vitro evaluation for the growth inhibition of Subline (P388/CP) Leukemia cell lines,F,,,Mus musculus,10090.0,,,P338,,80360,N,1,Intermediate,1,,CHEMBL615367,524.0,BAO_0000219,,
145,11803,Compound was evaluated for the inhibition of cell replication human peripheral blood lymphocytes (PBL's).,F,,,Homo sapiens,9606.0,,,PBL,,80384,N,1,Intermediate,1,,CHEMBL615368,554.0,BAO_0000219,,
146,11803,Compound was evaluated for the inhibition of cell replication sheep choroid plexus (SCP) cells,F,,,Ovis aries,9940.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615369,,BAO_0000019,,
147,11803,Compound was evaluated for the inhibition of cell replication sheep choroid plexus (SCP) cells.,F,,,Ovis aries,9940.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615370,,BAO_0000019,,
148,12278,Compound is evaluated in vitro for the inhibition single mutant of HIV-1 RT (Y181C),B,,,,,,,,,191,H,8,Autocuration,1,,CHEMBL615673,,BAO_0000357,,
149,8249,Compound was evaluated for its inhibitory effect on thymidine [3H]dThd) incorporation into DNA of CEM/MTX cells in culture at conc. 10e-5,F,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615674,,BAO_0000019,,
150,8249,Compound was evaluated for its inhibitory effect on thymidine [3H]-dThd) incorporation into DNA of CEM/MTX cells in culture at conc. 10e-6,F,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615675,,BAO_0000019,,
151,8249,Compound was evaluated for its inhibitory effect on thymidine ([3H]dThd) incorporation into DNA of CEM cells in at conc. 10e-7,F,,,Homo sapiens,9606.0,,,CCRF-CEM,,22226,U,0,Autocuration,1,,CHEMBL615676,635.0,BAO_0000219,,
152,8249,Compound was evaluated for its inhibitory effect on thymidine ([3H]-dThd) incorporation into DNA of CEM cells in culture at conc. 10e-4,F,,,Homo sapiens,9606.0,,,CCRF-CEM,,22226,U,0,Autocuration,1,,CHEMBL615677,635.0,BAO_0000219,,
153,8249,Compound was evaluated for its inhibitory effect on thymidine ([3H]dThd) incorporation into DNA of CEM cells in culture at conc. 10e-5,F,,,Homo sapiens,9606.0,,,CCRF-CEM,,22226,U,0,Autocuration,1,,CHEMBL615678,635.0,BAO_0000219,,
154,8249,Compound was evaluated for its inhibitory effect on thymidine ([3H]dThd) incorporation into DNA of CEM cells in culture at conc. 10e-6,F,,,Homo sapiens,9606.0,,,CCRF-CEM,,22226,U,0,Autocuration,1,,CHEMBL615679,635.0,BAO_0000219,,
155,8249,Compound was evaluated for its inhibitory effect on thymidine ([3H]-dThd) incorporation into DNA of CEM/MTX cells in at conc. 10e-7.,F,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615680,,BAO_0000019,,
156,8249,Compound was evaluated for its inhibitory effect on thymidine ([3H]dThd) incorporation into DNA of CEM/MTX cells in culture at conc. 10e-4,F,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615681,,BAO_0000019,,
157,16992,In vitro binding affinity towards (alpha-4)2(beta-2)3 neuronal nicotinic acetylcholine receptor in P2 membrane fractions of rat forebrain,B,,,,,,,,,104290,H,6,Autocuration,1,,CHEMBL857972,,BAO_0000249,,
158,10543,Minimum inhibitory concentration of compound against Streptococcus pyogenus septicemia in the mouse,F,,,Streptococcus pyogenes,1314.0,,,,,50264,N,1,Intermediate,1,,CHEMBL857899,,BAO_0000218,,
159,17833,Antiviral activity against 07/1 strain of thymidine kinase negative (TK-) Varicella-Zoster Virus (VZV),F,,,Human herpesvirus 3,10335.0,,,,,50527,N,1,Intermediate,1,,CHEMBL615371,,BAO_0000218,,
160,17290,Antiviral activity against 07/1 strain of VZV in HEL (human erythroleukemia) cells.,F,,,vericilla zoster virus,10335.0,,,HEL,,50527,N,1,Expert,1,,CHEMBL615372,468.0,BAO_0000218,,
161,17290,Antiviral activity against 07/1 strain of VZV; ND: No data,F,,,vericilla zoster virus,10335.0,,,,,50527,N,1,Intermediate,1,,CHEMBL615373,,BAO_0000218,,
162,17290,Antiviral activity against 07/1 strain of VZV; ND=No data,F,,,vericilla zoster virus,10335.0,,,,,50527,N,1,Intermediate,1,,CHEMBL615374,,BAO_0000218,,
163,10932,"Antibacterial activity was determined against gram negative organism, Enterobacter cloacae (MA2646)",F,,,escherichia cloac,561.0,,,,,50145,N,1,Intermediate,1,,CHEMBL615375,,BAO_0000218,,
164,9707,Ratio of Ki at A2 to Ki at A1 receptors,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL615376,,BAO_0000019,,
165,2346,"In vitro inhibition of 1,3-beta-glucan synthase in Candida albicans membrane assay.",B,,,Candida albicans,5476.0,,,,,11143,H,8,Expert,1,,CHEMBL615377,,BAO_0000249,,
166,2205,"Inhibition of 1,3-beta-glucan synthase",B,,,Candida glabrata CBS 138,284593.0,,,,,18077,H,8,Expert,1,,CHEMBL615378,,BAO_0000357,,
167,11900,Inhibition of growth of 1-87 human tumor cell line,F,,,Homo sapiens,9606.0,,,1-87 tumor cell line,,80609,N,1,Intermediate,1,,CHEMBL615379,832.0,BAO_0000219,,
168,14864,Inhibition of 1-lipoxygenase (LOX)in RBL cells,B,,,Rattus norvegicus,10116.0,,,,,12166,D,9,Expert,1,,CHEMBL615380,,BAO_0000219,,
169,16474,Inhibitory activity against soybean 1-lipoxygenase (SLO),B,,,Glycine max,3847.0,,,,,100171,D,9,Autocuration,1,,CHEMBL615381,,BAO_0000357,,
170,16474,Inhibitory activity against soybean 1-lipoxygenase (SLO); no effect,B,,,Glycine max,3847.0,,,,,100171,D,9,Autocuration,1,,CHEMBL615382,,BAO_0000357,,
171,16474,% inhibition against soybean 1-lipoxygenase (SLO),B,,,Glycine max,3847.0,,,,,100171,D,9,Autocuration,1,,CHEMBL615383,,BAO_0000357,,
172,16474,percent inhibition against soybean 1-lipoxygenase (SLO);NI is no inhibition,B,,,Glycine max,3847.0,,,,,100171,D,9,Autocuration,1,,CHEMBL615384,,BAO_0000357,,
173,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 10:90,B,,,Glycine max,3847.0,,,,,100171,D,9,Autocuration,1,,CHEMBL615385,,BAO_0000357,,
174,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 1:99,B,,,Glycine max,3847.0,,,,,100171,D,9,Autocuration,1,,CHEMBL615386,,BAO_0000357,,
175,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 25:75,B,,,Glycine max,3847.0,,,,,100171,D,9,Autocuration,1,,CHEMBL615387,,BAO_0000357,,
176,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 35:65,B,,,Glycine max,3847.0,,,,,100171,D,9,Autocuration,1,,CHEMBL615388,,BAO_0000357,,
177,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 50:50,B,,,Glycine max,3847.0,,,,,100171,D,9,Autocuration,1,,CHEMBL615214,,BAO_0000357,,
178,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 76:24,B,,,Glycine max,3847.0,,,,,100171,D,9,Autocuration,1,,CHEMBL827087,,BAO_0000357,,
179,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 87:13,B,,,Glycine max,3847.0,,,,,100171,D,9,Autocuration,1,,CHEMBL615215,,BAO_0000357,,
180,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 89:11,B,,,Glycine max,3847.0,,,,,100171,D,9,Autocuration,1,,CHEMBL615216,,BAO_0000357,,
181,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 95:5,B,,,Glycine max,3847.0,,,,,100171,D,9,Autocuration,1,,CHEMBL615217,,BAO_0000357,,
182,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 97:3,B,,,Glycine max,3847.0,,,,,100171,D,9,Autocuration,1,,CHEMBL615218,,BAO_0000357,,
183,3094,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 99:1,B,,,Glycine max,3847.0,,,,,100171,D,9,Autocuration,1,,CHEMBL615219,,BAO_0000357,,
184,10413,Evaluated for inhibitory activity on 10-formyltetrahydrofolate synthetase(L cell) at folate substrate concentration of 100 uM,B,,,Mus musculus,10090.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615220,,BAO_0000019,,
185,16929,Cells were harvested and were assayed for luciferase and -galactosidase activities (Transcriptional activity),F,,,Mus musculus,10090.0,,,C3H 10T1/2,,80049,N,1,Intermediate,1,,CHEMBL615221,294.0,BAO_0000219,,
186,1229,In vitro anticancer activity against 11 NCI NSCLC cell lines; inactive,F,,,,,,,,,22226,U,0,Intermediate,1,,CHEMBL615222,,BAO_0000019,,
187,16587,In vitro inhibitory activity against human 11 beta hydroxysteroid dehydrogenase type 1 using scintillation proximity assay (SPA),B,,,,,,,,,11489,H,8,Autocuration,1,,CHEMBL615223,,BAO_0000357,,
188,16587,In vitro inhibitory activity against mouse 11 beta hydroxysteroid dehydrogenase type 1 using scintillation proximity assay (SPA),B,,,,,,,,,11862,H,8,Autocuration,1,,CHEMBL615224,,BAO_0000357,,
189,16587,In vitro inhibitory activity against mouse 11 beta hydroxysteroid dehydrogenase type 1 using scintillation proximity assay (SPA).,B,,,,,,,,,11862,H,8,Autocuration,1,,CHEMBL615225,,BAO_0000357,,
190,16587,Ability to convert [3H]cortisol to the tritium labeled cortisone in the presence of human 11 beta hydroxysteroid dehydrogenase type 2,B,,,,,,,,,11489,H,8,Autocuration,1,,CHEMBL615226,,BAO_0000357,,
191,16587,Inhibitory activity against mouse 11 beta hydroxysteroid dehydrogenase type 2 at a concentration of 0.2 mM; NI means no inhibition,B,,,,,,,,,11862,H,8,Autocuration,1,,CHEMBL615227,,BAO_0000357,,
192,8058,Evaluated for inhibition of bovine adrenal cortical mitochondrial 11 beta-hydroxylase,F,,,Bos taurus,9913.0,,,,,12347,D,9,Expert,1,,CHEMBL615228,,BAO_0000019,,
193,9065,Effect on adrenal 11-beta-hydroxylase activity at 10e-4 M; No significant effect,B,,,Rattus norvegicus,10116.0,,,,,100120,D,9,Expert,1,,CHEMBL615229,,BAO_0000357,,
194,8865,Inhibition of 11 beta-hydroxylase from rat adrenal gland,B,,,Rattus norvegicus,10116.0,,Adrenal gland,,,100120,D,9,Expert,1,,CHEMBL615230,,BAO_0000357,2369.0,
195,9066,Inhibition of rat adrenal 11-beta-hydroxylase,B,,,Rattus norvegicus,10116.0,,,,,100120,D,9,Expert,1,,CHEMBL615231,,BAO_0000357,,
196,8394,Inhibition of rat adrenal 11-beta-hydroxylase,B,,,Rattus norvegicus,10116.0,,,,,100120,D,9,Expert,1,,CHEMBL884520,,BAO_0000357,,
197,8394,Inhibition of rat adrenal 11-beta-hydroxylase at 10e-5 M,B,,,Rattus norvegicus,10116.0,,,,,100120,D,9,Expert,1,,CHEMBL615232,,BAO_0000357,,
198,6431,Percent inhibition against 11-beta-hydroxysteroid dehydrogenase 1 of wistar rat liver cytosol at 10 uM was determined using [3H]cortisone,B,,,,,,,,,10328,H,8,Autocuration,1,,CHEMBL615233,,BAO_0000019,,
199,6431,Percent inhibition against 11-beta-hydroxysteroid dehydrogenase 2 of wistar rat kidney at 10 uM was determined using [3H]cortisol,B,,,,,,,,,11490,H,8,Autocuration,1,,CHEMBL827088,,BAO_0000357,,
200,6431,Percent inhibition against 11-beta-hydroxysteroid dehydrogenase 2 of wistar rat kidney at 10 uM was determined using [3H]cortisol,B,,,,,,,,,11490,H,8,Autocuration,1,,CHEMBL615234,,BAO_0000357,,
201,9295,Compound was tested for the percent of inhibition against 12-LO at 10 uM,F,,,,,,,,,11134,H,8,Autocuration,1,,CHEMBL615235,,BAO_0000019,,
202,10193,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 10 uM,B,,,,,,,,,12052,H,8,Autocuration,1,,CHEMBL615236,,BAO_0000019,,
203,13622,Compound was tested in vitro for inhibition of 12-LO human platelet,B,,,,,,,,,11134,H,8,Autocuration,1,,CHEMBL615237,,BAO_0000019,,
204,12079,Inhibitory concentration against human platelet 12-lipoxygenase,F,,,,,,,,,11134,H,8,Autocuration,1,,CHEMBL615238,,BAO_0000019,,
205,13622,Compound at 100 uM was tested in vitro for inhibition of 12-LO human platelet,B,,,,,,,,,11134,H,8,Autocuration,1,,CHEMBL615239,,BAO_0000019,,
206,12079,Inhibitory concentration against human platelet 12-lipoxygenase,F,,,Homo sapiens,9606.0,,,,,11134,D,9,Autocuration,1,,CHEMBL615240,,BAO_0000019,,
207,13500,Tested for inhibition of 12-LO (12-lipoxygenase) as an inhibitor of 12(S)-HETE biosynthesis in mouse epidermal homogenates,B,,,,,,,,,11835,H,8,Expert,1,,CHEMBL615241,,BAO_0000019,,
208,13723,Inhibitory activity against conversion of [1-14C]arachidonic acid to 12-HPETE and its reduction product 12-HETE by porcine leukocyte type 12-lipoxygenase,B,,,,,,,,,11601,H,8,Expert,1,,CHEMBL615242,,BAO_0000357,,
209,16474,Inhibitory activity against human platelet 12-lipoxygenase (12-HLO),B,,,,,,,,,11134,H,8,Autocuration,1,,CHEMBL615243,,BAO_0000019,,
210,1630,Inhibitory activity against human platelet 12-lipoxygenase,B,,,,,,,,,11134,H,8,Autocuration,1,,CHEMBL615244,,BAO_0000019,,
211,167,Inhibitory activity against human platelet 12-lipoxygenase was evaluated,B,,,,,,,,,11134,H,8,Autocuration,1,,CHEMBL615245,,BAO_0000019,,
212,16474,% inhibition against human platelet 12-lipoxygenase (12-HLO),B,,,,,,,,,11134,H,8,Autocuration,1,,CHEMBL615246,,BAO_0000019,,
213,167,Inhibitory activity against human platelet 12-lipoxygenase was evaluated at 100 uM,B,,,,,,,,,11134,H,8,Autocuration,1,,CHEMBL615247,,BAO_0000019,,
214,16474,percent inhibition against human platelet 12-lipoxygenase (12-HLO); NI is no inhibition,B,,,,,,,,,11134,H,8,Autocuration,1,,CHEMBL615248,,BAO_0000019,,
215,10091,Inhibitory activity towards porcine 12-lipoxygenase,B,,,,,,,,,11601,H,8,Autocuration,1,,CHEMBL615249,,BAO_0000357,,
216,11966,Tested for inhibition against porcine 12-LO,B,,,,,,,,,11601,H,8,Autocuration,1,,CHEMBL615250,,BAO_0000357,,
217,951,Inhibition of 12-lipoxygenase was evaluated in rat platelets stimulated by thrombin up to a concentration of 10 uM; NE means No effect,B,,,,,,,,,12052,H,8,Autocuration,1,,CHEMBL615251,,BAO_0000019,,
218,10997,Inhibitory activity against 12-lipoxygenase in rat platelet rich plasma,B,,,,,,,,,12052,H,8,Autocuration,1,,CHEMBL615252,,BAO_0000019,,
219,10193,In vitro inhibition of rat platelet 12-lipoxygenase,B,,,,,,,,,12052,H,8,Expert,1,,CHEMBL828340,,BAO_0000019,,
220,10193,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 10 uM,B,,,,,,,,,12052,H,8,Autocuration,1,,CHEMBL615253,,BAO_0000019,,
221,10193,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 100 uM,B,,,,,,,,,12052,H,8,Autocuration,1,,CHEMBL615254,,BAO_0000019,,
222,10193,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 30 uM,B,,,,,,,,,12052,H,8,Autocuration,1,,CHEMBL615255,,BAO_0000019,,
223,10193,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 10 uM,B,,,,,,,,,12052,H,8,Autocuration,1,,CHEMBL615256,,BAO_0000019,,
224,10193,In vitro inhibitory activity against rat platelet 12-lipoxygenase,B,,,,,,,,,12052,H,8,Autocuration,1,,CHEMBL615257,,BAO_0000019,,
225,11087,The compound was tested for the in vitro inhibition of platelet 12-lipoxygenase at a concentration of 100 uM,B,,,,,,,,,12052,H,8,Autocuration,1,,CHEMBL615258,,BAO_0000019,,
226,15569,Cytotoxic activity in a panel of Human ovarian tumor 41M cell line after 96h of drug exposure,F,,,Homo sapiens,9606.0,,,41M,,80007,N,1,Intermediate,1,,CHEMBL615259,621.0,BAO_0000219,,
227,12989,In vitro antitumor activity against 41M cell line.,F,,,Homo sapiens,9606.0,,,41M,,80007,N,1,Expert,1,,CHEMBL615260,621.0,BAO_0000219,,
228,16745,cytotoxicity against 41M cells incubated for 24 hr in MTT assay.,F,,,Homo sapiens,9606.0,,,41M,,80007,N,1,Intermediate,1,,CHEMBL615261,621.0,BAO_0000219,,
229,15569,Cytotoxic activity in a panel of Human ovarian tumor 41M/CDDP cell line after 96h of drug exposure,F,,,Homo sapiens,9606.0,,,41M,,80007,N,1,Intermediate,1,,CHEMBL615262,621.0,BAO_0000219,,
230,12989,In vitro antitumor activity against 41McisR cell line.,F,,,Homo sapiens,9606.0,,,41M,,80007,N,1,Expert,1,,CHEMBL615263,621.0,BAO_0000219,,
231,12989,Resistant factor was determined between IC50 of cisplatin-resistant human tumor cell lines to that of 41McisR cell line,F,,,Homo sapiens,9606.0,,,41M,,80007,N,1,Expert,1,,CHEMBL838393,621.0,BAO_0000219,,
232,16745,cytotoxicity against 41McisR cells incubated for 24 hr in MTT assay,F,,,Homo sapiens,9606.0,,,41M,,80007,N,1,Intermediate,1,,CHEMBL615264,621.0,BAO_0000219,,
233,6210,Inhibition of 5'-inosine monophosphate dehydrogenase type I (IMPDH I),B,,,Homo sapiens,9606.0,,,,,84,D,9,Expert,1,,CHEMBL615265,,BAO_0000357,,
234,6210,Inhibition of 5'-inosine monophosphate dehydrogenase type II (IMPDH II),B,,,Homo sapiens,9606.0,,,,,68,D,9,Expert,1,,CHEMBL615266,,BAO_0000357,,
235,6226,Inhibitory activity against inosine 5'-inosine monophosphate dehydrogenase type II (IMPDH II),B,,,,,,,,,68,H,8,Expert,1,,CHEMBL615267,,BAO_0000357,,
236,17855,Equilibrium dissociation constant towards human 5'-methylthioadenosine phosphorylase,B,,,,,,,,,10201,H,8,Expert,1,,CHEMBL615268,,BAO_0000357,,
237,17855,Equilibrium dissociation constant towards human 5'-methylthioadenosine phosphorylase; nd = Not determined,B,,,,,,,,,10201,H,8,Expert,1,,CHEMBL615269,,BAO_0000357,,
238,17855,Initial dissociation constant towards human 5'-methylthioadenosine phosphorylase,B,,,,,,,,,10201,H,8,Expert,1,,CHEMBL615270,,BAO_0000357,,
239,10413,"Evaluated for inhibitory activity on 5,10-Methenyl Tetrahydrofolate Cyclohydrolase(L cell) at folate substrate concentration of 100 uM",B,,,,,,,,,12220,H,8,Autocuration,1,,CHEMBL615271,,BAO_0000357,,
240,10413,"Inhibitory activity against 5,10-methylenetetrahydrofolate dehydrogenase from Escherichia coli at a concentration of 0.1 mM; NT=Not tested",B,,,Escherichia coli,562.0,,,,,11303,H,8,Autocuration,1,,CHEMBL615272,,BAO_0000357,,
241,10413,"Inhibitory activity against 5,10-Methylene Tetrahydrofolate Cyclohydrolase from Escherichia coli at a concentration of 0.1 mM; NT=Not tested",B,,,Escherichia coli,562.0,,,,,11303,H,8,Autocuration,1,,CHEMBL615103,,BAO_0000357,,
242,10413,"Inhibitory activity against 5,10-Methylene Tetrahydrofolate Cyclohydrolase from Escherichia coli at a concentration of 0.1 mM;NT=Not tested",B,,,Escherichia coli,562.0,,,,,11303,H,8,Autocuration,1,,CHEMBL615104,,BAO_0000357,,
243,10413,"Evaluated for inhibitory activity on 5,10-Methylene Tetrahydrofolate Cyclohydrolase(L cell) at folate substrate concentration of 100 uM",B,,,,,,,,,12220,H,8,Autocuration,1,,CHEMBL615105,,BAO_0000357,,
244,10413,"Evaluated for inhibitory activity on 5,10-methylenetetrahydrofolate dehydrogenase(L cell) at folate substrate concentration of 100 uM",B,,,,,,,,,12220,H,8,Autocuration,1,,CHEMBL872866,,BAO_0000357,,
245,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-6 M inhibitory concentration",B,,,Sus scrofa,9823.0,,,,,11303,H,8,Autocuration,1,,CHEMBL615106,,BAO_0000357,,
246,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (A,porcine liver) enzyme.",B,,,Sus scrofa,9823.0,,,,,11303,H,8,Autocuration,1,,CHEMBL615107,,BAO_0000019,,
247,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-4 M inhibitory concentration",B,,,Sus scrofa,9823.0,,,,,11303,H,8,Autocuration,1,,CHEMBL615108,,BAO_0000357,,
248,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-5 M inhibitory concentration",B,,,Sus scrofa,9823.0,,,,,11303,H,8,Autocuration,1,,CHEMBL615109,,BAO_0000357,,
249,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-6 M inhibitory concentration",B,,,Sus scrofa,9823.0,,,,,11303,H,8,Autocuration,1,,CHEMBL615110,,BAO_0000357,,
250,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-4 M inhibitory concentration",B,,,Sus scrofa,9823.0,,,,,11303,H,8,Autocuration,1,,CHEMBL840105,,BAO_0000019,,
251,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-5 M inhibitory concentration",B,,,Sus scrofa,9823.0,,,,,11303,H,8,Autocuration,1,,CHEMBL615111,,BAO_0000019,,
252,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-6 M inhibitory concentration",B,,,Sus scrofa,9823.0,,,,,11303,H,8,Autocuration,1,,CHEMBL615112,,BAO_0000019,,
253,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-7 M inhibitory concentration",B,,,Sus scrofa,9823.0,,,,,11303,H,8,Autocuration,1,,CHEMBL615113,,BAO_0000019,,
254,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme.",B,,,Sus scrofa,9823.0,,,,,11303,H,8,Autocuration,1,,CHEMBL615114,,BAO_0000019,,
255,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-6 M inhibitory concentration",B,,,Sus scrofa,9823.0,,,,,11303,H,8,Autocuration,1,,CHEMBL615115,,BAO_0000357,,
256,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-4 M inhibitory concentration",B,,,Sus scrofa,9823.0,,,,,11303,H,8,Autocuration,1,,CHEMBL615116,,BAO_0000019,,
257,7323,"Compound was tested for in vitro inhibition of 5,10-Methylene Tetrahydrofolate Cyclohydrolase, competitive against (+)-L-5,10-methenyltetrahydrofolate",B,,,,,,,,,11303,H,8,Autocuration,1,,CHEMBL615698,,BAO_0000357,,
258,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Reductase (porcine kidney) enzyme at 10E-4 M inhibitory concentration",B,,,Sus scrofa,9823.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615699,,BAO_0000019,,
259,7587,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Reductase (porcine kidney) enzyme.",B,,,Sus scrofa,9823.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615700,,BAO_0000019,,
260,13750,Inhibition of 5-Desaturase involved in ergosterol biosynthesis,B,,,Saccharomyces cerevisiae,4932.0,,,,,100249,H,8,Expert,1,,CHEMBL615701,,BAO_0000357,,
261,7662,Ability for reversible inhibition of Walker 256 5-Fluoro-2'-deoxyuridine Phosphorylase,B,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615702,,BAO_0000019,,
262,7662,Ability for reversible inhibition of Walker 256 5-Fluoro-2'-deoxyuridine Phosphorylase,B,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615703,,BAO_0000019,,
263,7662,"Irreversible inhibition of Walker 256 FUDR phosphorylase; expressed as Vo/Vi, velocity without inhibitor to that of velocity with inhibitor",B,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615704,,BAO_0000019,,
264,12211,"Tested for 5-HT 3 receptor antagonist potency by ability to inhibit the reflex bradycardia, the Bezold-Jarisch reflex in the rat",F,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL615705,,BAO_0000019,,
265,12211,"Compound was tested for its 5-HT 3 receptor antagonist potency by their ability to inhibit the reflex bradycardia, the Bezold-Jarisch reflex in the rat",F,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL615706,,BAO_0000019,,
266,12211,Relative ability to increase cholinergically mediated contractions in isolated ileum of guinea pig,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL615707,,BAO_0000221,2116.0,
267,12211,Stimulatory activity of intragastric pressure was tested in the rat,F,,,,,,,,,10623,H,8,Expert,1,,CHEMBL615708,,BAO_0000019,,
268,15453,% Decrease of 5-HT carrier-receptor -bound radioactivity using paroxetine as a radioligand.,B,,,,,,,,,121,H,8,Autocuration,1,,CHEMBL615709,,BAO_0000357,,
269,11884,Dose to reduce neuronal firing against 5-HT cells in rats (iv),F,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615710,,BAO_0000218,,
270,7185,Antagonistic activity of corresponding methoxy compound against serotonin 5-HT receptor,F,,,,,,,,,12688,H,8,Autocuration,1,,CHEMBL615711,,BAO_0000019,,
271,6876,Binding affinity at 5-HT reuptake site labeled with [3H]paroxetine,B,,,Homo sapiens,9606.0,,,,,121,D,9,Expert,1,,CHEMBL615712,,BAO_0000357,,
272,6876,Binding affinity at 5-HT reuptake site labeled with [3H]paroxetine; No data,B,,,Homo sapiens,9606.0,,,,,121,D,9,Expert,1,,CHEMBL836325,,BAO_0000357,,
273,11863,Inhibition of high affinity 5-HT uptake at concentration of 1 uM,F,,,,,,,,,12198,H,8,Autocuration,1,,CHEMBL615713,,BAO_0000019,,
274,11863,Inhibition constant of high-affinity 5-HT uptake,B,,,,,,,,,12198,H,8,Autocuration,1,,CHEMBL615714,,BAO_0000357,,
275,11863,Michaelis-Menten constant was reported for high affinity transport of 5-HT,F,,,,,,,,,12198,H,8,Autocuration,1,,CHEMBL615715,,BAO_0000019,,
276,11863,Maximum rate was determined for high affinity transport of 5-HT,F,,,,,,,,,12198,H,8,Autocuration,1,,CHEMBL615716,,BAO_0000019,,
277,4639,Compound was tested for agonistic activity against 5-HT uptake,F,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL615717,,BAO_0000019,,
278,15796,Inhibition affinity against 5-HT-1B receptor in rat frontal cortex using radio binding assay,B,,,,,,,,,10577,H,8,Expert,1,,CHEMBL881818,,BAO_0000019,,
279,15796,Inhibition affinity against 5-HT-1D receptor in bovine caudate nucleus using radio binding assay,B,,,Bos taurus,9913.0,,,,,105,H,8,Expert,1,,CHEMBL884540,,BAO_0000357,,
280,12801,Binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT as radioligand,B,,,Rattus norvegicus,10116.0,,,,,104744,D,5,Autocuration,1,,CHEMBL615718,,BAO_0000224,,
281,12801,The compound was evaluated for the binding affinity towards 5-hydroxytryptamine 1 using [3H]5-HT as radioligand,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615719,,BAO_0000224,,
282,12120,Percent inhibition of binding of 3.0 nM [3H]5-HT to 5-hydroxytryptamine 1 receptor in rat caudate membranes at 10 e -5 M,B,,,,,,,,Membranes,104744,H,4,Autocuration,1,,CHEMBL615720,,BAO_0000249,,
283,12120,Percent inhibition of binding of 3.0 nM [3H]5-HT to 5-hydroxytryptamine 1 receptor in rat caudate membranes at 10 e -5 M.,B,,,,,,,,Membranes,104744,H,4,Autocuration,1,,CHEMBL615721,,BAO_0000249,,
284,11963,Displacement of binding of [3H]-5-HT to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615722,,BAO_0000019,,
285,11701,Dose required to reduce neuronal firing of 5-HT1A cells by 50%,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615723,,BAO_0000019,,
286,9995,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615724,,BAO_0000221,10000000.0,
287,9995,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-HT1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615725,,BAO_0000221,10000000.0,
288,9995,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615726,,BAO_0000221,10000000.0,
289,16394,Antagonistic activity at postsynaptic 5-HT1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (.26-3.52),F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615727,,BAO_0000218,,
290,11574,Effect on forskolin stimulated adenylate cyclase activity at 5-HT1D receptor of guinea pig substantia nigra.,F,,,Cavia porcellus,10141.0,,,,,105570,D,9,Intermediate,1,,CHEMBL615728,,BAO_0000019,,
291,15779,Binding affinity towards 5-HT1F (human cloned receptor) in CHO cells using [3H]5-HT as radioligand.,B,,,,,,,CHO,,279,H,8,Autocuration,1,,CHEMBL857971,449.0,BAO_0000219,,
292,15363,Compound was tested for the displacement of [125I]DOI from clone human 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL615729,,BAO_0000357,,
293,15363,Efficacy against 5-hydroxytryptamine 2A receptor,F,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL615730,,BAO_0000019,,
294,15329,Intrinsic activity towards 5-HT2A receptor of rat tail artery,F,,,,,,,,,12687,H,8,Expert,1,,CHEMBL615731,,BAO_0000019,,
295,15329,Relative potency towards 5-HT2A receptor of rat tail artery,F,,,,,,,,,12687,H,8,Expert,1,,CHEMBL615732,,BAO_0000019,,
296,15329,Blocking 5-HT2A receptor-mediated contractions of rat tail artery,F,,,,,,,,,12687,H,8,Expert,1,,CHEMBL615733,,BAO_0000019,,
297,15329,Partial agonism at 5-HT2A receptor was evaluated in presence of ketanserin (3-10 nM) in isolated rat tail artery,F,,,,,,,,,12687,H,8,Expert,1,,CHEMBL615734,,BAO_0000019,,
298,15329,Compound was tested for the intrinsic activity against 5-HT2A receptors of rat tail artery.,F,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL615735,,BAO_0000019,,
299,15329,Effectiveness in blocking 5-HT2A receptor-mediated contractions of rat tail artery,F,,,,,,,,,12687,H,8,Expert,1,,CHEMBL615736,,BAO_0000019,,
300,273,Evaluated for the agonistic activity against 5-HT4 receptor in non-electrically stimulated guinea-pig ileum.,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL615737,,BAO_0000221,2116.0,
301,273,Agonistic activity against Serotonin 5-HT4 receptor in low frequency field stimulation of guinea-pig ileum (FSGPI),F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL615738,,BAO_0000221,2116.0,
302,273,Evaluated for the agonistic activity against Serotonin 5-HT4 receptor in non-electrically stimulated guinea-pig ileum.,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL615739,,BAO_0000221,2116.0,
303,12092,The binding affinity was measured on 5-hydroxytryptamine 4 receptor using [3H]- GR-113808 as radioligand.,B,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL615278,,BAO_0000357,,
304,1317,Antagonist activity against 5-HT4 receptor mediated relaxation of rat carbachol contracted esophageal muscularis mucosae,F,,,Rattus norvegicus,10116.0,,,,,10623,D,9,Expert,1,,CHEMBL615279,,BAO_0000019,,
305,12409,Binding affinity against 5-hydroxytryptamine 4 receptor,B,,,,,,,,,168,H,8,Expert,1,,CHEMBL615280,,BAO_0000357,,
306,11126,Relative competitive index values for binding to 25-OH-D3-1-hydroxylase of chick intestine,B,,,Gallus gallus,9031.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615281,,BAO_0000019,,
307,11126,Inhibitory effect (10e-6 M) on the 25-OH-D3-1-hydroxylase activity,F,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615282,,BAO_0000019,,
308,11126,25-OH-D3-1-hydroxylase activity (10e-6 M) was measured as %control,F,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615283,,BAO_0000019,,
309,11126,Relative competitive index values for binding to 25-OH-D3-1-hydroxylase of human HL-60 cells,B,,,Homo sapiens,9606.0,,,HL-60,,80156,N,1,Autocuration,1,,CHEMBL615284,649.0,BAO_0000219,,
310,11126,Inhibitory effect (10e-6 M) on the 25-hydroxyvitamin D3-1-hydroxylase activity,B,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615285,,BAO_0000019,,
311,11126,25-hydroxyvitamin D3-1-hydroxylase activity (10e-6 M) was measured as %control,B,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615286,,BAO_0000019,,
312,17807,Displacement of [3H]-Ro- 15-1788 from human GABA-A alpha-1-beta-3-gamma-2 receptor subunits expressed in Xenopus oocytes,B,,,Homo sapiens,9606.0,,,Oocytes,,104703,D,7,Autocuration,1,,CHEMBL615287,,BAO_0000219,,
313,16575,Chymotryptic inhibitory activity against 26S proteasome,F,,,,,,,,,100256,S,2,Intermediate,1,,CHEMBL615288,,BAO_0000220,,
314,15407,Inhibitory activity against 26S proteasome degradation of IkB,B,,,,,,,,,100256,S,2,Intermediate,1,,CHEMBL615289,,BAO_0000220,,
315,10797,In vitro inhibition of 2780/DOX ovarian cancer cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL615290,478.0,BAO_0000219,,
316,10797,In vitro inhibition of 2780/S ovarian cancer cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL884522,478.0,BAO_0000219,,
317,3469,Relative activity on the cellular accumulation of vincristine in multidrug-resistant (MDR) human ovarian cancer 2780AD cells,F,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615291,,BAO_0000019,,
318,16037,Association constant for binding to AATT 28-mer AATT hairpin,B,,,,,,,,,22222,M,3,Intermediate,1,,CHEMBL615292,,BAO_0000225,,
319,16037,Kinetically Defined Association Constant for 28-mer AATT hairpin.,B,,,,,,,,,22222,M,3,Intermediate,1,,CHEMBL615293,,BAO_0000225,,
320,16037,Reaction Rate Parameter for 28-mer AATT hairpin,B,,,,,,,,,22222,M,3,Intermediate,1,,CHEMBL615294,,BAO_0000225,,
321,16037,Reaction Rate Parameter for 28-mer AATT hairpin,B,,,,,,,,,22222,M,3,Intermediate,1,,CHEMBL615295,,BAO_0000225,,
322,16524,Antiviral activity against envelope deficient HIV-1 in a single cycle replication assay (experiment 1),F,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL825021,,BAO_0000019,,
323,16524,Antiviral activity against envelope deficient HIV-1 in a single cycle replication assay (experiment 2),F,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615296,,BAO_0000019,,
324,16524,Inhibitory concentration by single cycle replication assay using envelope deficient HIV-1,F,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615297,,BAO_0000019,,
325,16758,Cytotoxicity against cell line 2SC/20 determined by MTT test,F,,,Cricetulus griseus,10029.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615298,,BAO_0000019,,
326,16758,Cytotoxicity against cell line 2SC/20 of hamster determined by MTT test,F,,,Cricetulus griseus,10029.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615299,,BAO_0000019,,
327,16758,Inhibitory concentration against the growth of 2SC/20 cell line after 72 hr of drug exposure by MTT test,F,,,Cricetulus griseus,10029.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615300,,BAO_0000019,,
328,14360,Binding affinity on 3 beta-hydroxysteroid dehydrogenase,B,,,,,,,,,241,H,8,Autocuration,1,,CHEMBL615301,,BAO_0000357,,
329,14360,Binding affinity for 3-beta-hydroxysteroid dehydrogenase,B,,,Homo sapiens,9606.0,,,,,241,D,9,Expert,1,,CHEMBL615302,,BAO_0000357,,
330,9964,Selectivity ratio of ID50 in liver and heart,B,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615303,,BAO_0000019,,
331,9964,"Selectivity, ratio of relative ID50 in liver and heart",B,,,,,,,,,12132,H,8,Autocuration,1,,CHEMBL615304,,BAO_0000019,,
332,9964,Binding affinity to the receptor was determined in isolated nuclei of heart(In vitro) relative to T3,B,,,,,,,,,12132,H,8,Autocuration,1,,CHEMBL615305,,BAO_0000019,,
333,9964,"Binding affinity to the receptor was determined in nuclei of heart In vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",B,,,,,,,,,12132,H,8,Autocuration,1,,CHEMBL615306,,BAO_0000218,,
334,9964,"Binding affinity to the receptor was determined in nuclei of liver In vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",B,,,,,,,,,12132,H,8,Autocuration,1,,CHEMBL615307,,BAO_0000218,,
335,9964,"Binding affinity to the receptor was determined in nuclei of liver in vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",B,In vivo,,,,,,,,12132,H,8,Autocuration,1,,CHEMBL615308,,BAO_0000218,,
336,9964,"Binding affinity to the receptor was determined in nuclei of liver in vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",F,In vivo,,,,,,,,12132,H,8,Autocuration,1,,CHEMBL615309,,BAO_0000218,,
337,9964,"Binding affinity to the thyroid hormone receptor was determined in vitro in isolated nuclei of rat liver relative to 3,5,3' triiodothyronine",B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL615310,,BAO_0000019,,
338,9964,Binding affinity to the receptor was determined in vitro in isolated nuclei of rat liver relative to T3,B,,,,,,,,,12132,H,8,Autocuration,1,,CHEMBL615311,,BAO_0000019,,
339,9964,"Binding affinity to thyroid hormone receptor beta, relative to 3,5,3' triiodothyronine receptor, in isolated nuclei of heart",B,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615312,,BAO_0000019,,
340,9964,In vitro binding affinity to the receptor was determined in isolated nuclei of heart relative to T3,B,,,,,,,,,12132,H,8,Autocuration,1,,CHEMBL615313,,BAO_0000019,,
341,9964,In vitro binding affinity to the receptor was determined in isolated nuclei of heart relative to T3,F,,,,,,,,,12132,H,8,Autocuration,1,,CHEMBL615314,,BAO_0000019,,
342,9964,"Binding affinity to the receptor was determined in isolated nuclei of heart(In vitro) relative to 3,5,3' triiodothyronine receptor",B,,,,,,,,,12132,H,8,Autocuration,1,,CHEMBL615315,,BAO_0000019,,
343,9964,"In vivo binding affinity for 3,5,3'' triiodothyronine receptor of heart nuclei 1 hr after intravenous administration",B,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615316,,BAO_0000218,,
344,9964,Binding affinity to the receptor was determined in nuclei of heart in vivo 1 hour after intravenous administration relative to T3,B,In vivo,,,,,,,,12132,H,8,Autocuration,1,,CHEMBL615317,,BAO_0000218,,
345,9964,"Binding affinity to the receptor was determined in nuclei of liver In vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",B,,,,,,,,,12132,H,8,Autocuration,1,,CHEMBL615318,,BAO_0000218,,
346,9964,"In vivo binding affinity for 3,5,3' triiodothyronine receptor of liver nuclei 1 hour after intravenous administration",B,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615319,,BAO_0000218,,
347,9964,"In vitro binding affinity to the receptor was determined in isolated nuclei of heart relative to 3,5,3' triiodothyronine receptor",B,,,,,,,,,12132,H,8,Autocuration,1,,CHEMBL615320,,BAO_0000019,,
348,9964,"In vitro binding affinity to the receptor was determined in isolated nuclei of heart relative to 3,5,3' triiodothyronine receptor",F,,,,,,,,,12132,H,8,Autocuration,1,,CHEMBL615321,,BAO_0000019,,
349,3796,"Inhibition of [125I]L-T3 binding to rat hepatic 3,5,3''-triiodo-L-thyronine receptor",B,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615322,,BAO_0000019,,
350,4251,Inhibition constant for binding to Co2+ form of 3-dehydroquinate synthase (DHQ) purified from Escherichia coli,B,,,Escherichia coli,562.0,,,,,19690,H,8,Autocuration,1,,CHEMBL615323,,BAO_0000357,,
351,4251,Inhibition constant for binding to Zn2+ form of 3-dehydroquinate synthase (DHQ) purified from Escherichia coli,B,,,Escherichia coli,562.0,,,,,19690,H,8,Autocuration,1,,CHEMBL615407,,BAO_0000357,,
352,4251,Kinetics expressed as Michaelis-Menten constant against Co2+ form of 3-dehydroquinate synthase purified from Escherichia coli,B,,,Escherichia coli,562.0,,,,,19690,H,8,Autocuration,1,,CHEMBL857267,,BAO_0000357,,
353,4251,Kinetics expressed as Michaelis-Menten constant against Zn2+ form of 3-dehydroquinate synthase purified from Escherichia coli,B,,,Escherichia coli,562.0,,,,,19690,H,8,Autocuration,1,,CHEMBL615408,,BAO_0000357,,
354,166,Type of inhibition of 3-dehydroquinate synthase was determined; R - Slowly reversible,B,,,,,,,,,19690,H,8,Autocuration,1,,CHEMBL615409,,BAO_0000357,,
355,17861,Compound was evaluated for its inhibitory constant against 3-dehydroquinate synthase,B,,,,,,,,,19690,H,8,Autocuration,1,,CHEMBL615410,,BAO_0000357,,
356,166,Inhibition constant against 3-dehydroquinate synthase,B,,,,,,,,,19690,H,8,Autocuration,1,,CHEMBL615411,,BAO_0000357,,
357,166,Association rate constant against 3-dehydroquinate synthase,B,,,,,,,,,19690,H,8,Autocuration,1,,CHEMBL615412,,BAO_0000357,,
358,166,Rate constant against 3-dehydroquinate synthase,B,,,,,,,,,19690,H,8,Autocuration,1,,CHEMBL615413,,BAO_0000357,,
359,3548,Inhibitory activity against fuc-TVII,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL615414,,BAO_0000019,,
360,9877,Ability of compound (2.5 uM) to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,12236,D,9,Autocuration,1,,CHEMBL615415,,BAO_0000251,2107.0,
361,9877,Ability of compound (2500 uM) to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,12236,D,9,Autocuration,1,,CHEMBL615416,,BAO_0000251,2107.0,
362,9877,Ability of compound (250 uM) to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,12236,D,9,Autocuration,1,,CHEMBL615417,,BAO_0000251,2107.0,
363,9877,Ability of compound (25 uM) to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,12236,D,9,Autocuration,1,,CHEMBL615418,,BAO_0000251,2107.0,
364,9877,Ability of compound at 0 uM to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,12236,D,9,Autocuration,1,,CHEMBL615419,,BAO_0000251,2107.0,
365,9877,Ability of compound to inhibit the activity of 3-hydroxy-3-methylglutarylcoenzyme A(HMGR) reductase in rat liver microsomes,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,12236,D,9,Autocuration,1,,CHEMBL615420,,BAO_0000251,2107.0,
366,9877,Percentage inhibition of 3-hydroxy-3-methyl glutaryl coenzyme A reductase in rat liver microsomes at 250 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,12236,D,9,Autocuration,1,,CHEMBL615421,,BAO_0000251,2107.0,
367,9877,Percentage inhibition of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 0 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,12236,D,9,Autocuration,1,,CHEMBL615422,,BAO_0000251,2107.0,
368,9877,Percentage inhibition of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 2.5 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,12236,D,9,Autocuration,1,,CHEMBL615423,,BAO_0000251,2107.0,
369,9877,Percentage inhibition of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 2500 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,12236,D,9,Autocuration,1,,CHEMBL872868,,BAO_0000251,2107.0,
370,9877,Percentage inhibition of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 25 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,12236,D,9,Autocuration,1,,CHEMBL615424,,BAO_0000251,2107.0,
371,3003,Inhibitory activity against 3-phosphoglycerate kinase.,B,,,,,,,,,104832,H,4,Autocuration,1,,CHEMBL825022,,BAO_0000224,,
372,3003,Binding affinity was evaluated towards 3-phosphoglycerate kinase at 37 degrees Celsius in 0.1 m NaCl pH 7.1,B,,,,,,,,,104832,H,4,Autocuration,1,,CHEMBL615425,,BAO_0000224,,
373,3003,"Michaelis-Menten constant with 1,3-bisphosphoglyceric acid (1,3-BPG) against 3-phosphoglycerate kinase",B,,,,,,,,,104832,H,4,Autocuration,1,,CHEMBL615426,,BAO_0000224,,
374,17185,Inhibition of human 3-phosphoinositide-dependent protein kinase 1 at 10 uM,B,,,Homo sapiens,9606.0,,,,,10612,D,9,Expert,1,,CHEMBL615427,,BAO_0000357,,
375,6072,Cytotoxicity on 3677 melanoma cells,F,,,Homo sapiens,9606.0,,,3677 melanoma cell line,,80616,N,1,Intermediate,1,,CHEMBL615428,844.0,BAO_0000219,,
376,6072,Cytotoxicity on 3677 melanoma cells in combination with L-49-sFv-bL,F,,,Homo sapiens,9606.0,,,3677 melanoma cell line,,80616,N,1,Intermediate,1,,CHEMBL615429,844.0,BAO_0000219,,
377,5018,Antitumor activity against Mouse colon 38 at 500 ug/disk in disk diffusion assay,F,,,Mus musculus,10090.0,,,MC-38,,80617,N,1,Intermediate,1,,CHEMBL615430,700.0,BAO_0000219,,
378,2852,Compound was evaluated for inhibition of tumor cell growth using sulforhodamine-B assay in 38 human cell lines,F,,,Homo sapiens,9606.0,,,,,22226,U,0,Intermediate,1,,CHEMBL615431,,BAO_0000019,,
379,8663,In vivo antitumor activity against 3B131 intraperitoneally implanted B16 melanoma cells; NT= Not tested,F,,,,,,,B16,,22226,U,0,Autocuration,1,,CHEMBL615432,798.0,BAO_0000218,,
380,8663,In vivo antitumor activity against 3B131 intraperitoneally implanted B16 melanoma cells; reproducible significant activity.,F,,,,,,,B16,,22226,U,0,Autocuration,1,,CHEMBL615433,798.0,BAO_0000218,,
381,3245,Inhibitory activity against Human RhinoVirus serotype-14 3C Protease,F,,,Human rhinovirus 14,12131.0,,,,,12464,D,9,Expert,1,,CHEMBL615434,,BAO_0000019,,
382,3245,Inhibitory activity against Human RhinoVirus serotype-14 3C Protease; NI means No inhibition to 50 uM,F,,,Human rhinovirus sp.,169066.0,,,,,50085,N,1,Intermediate,1,,CHEMBL615435,,BAO_0000218,,
383,3877,Compound was evaluated for the inactivation of HRV 14 3C protease activity expressed as KI,F,,,human rhinovirus type 14,169066.0,,,,,50679,N,1,Intermediate,1,,CHEMBL615436,,BAO_0000218,,
384,3877,Compound was evaluated for the inactivation of HRV 14 3C protease activity expressed as kinact,F,,,human rhinovirus type 14,169066.0,,,,,50679,N,1,Intermediate,1,,CHEMBL615437,,BAO_0000218,,
385,5861,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay,F,,,Human rhinovirus 14,12131.0,,,,,12464,D,9,Expert,1,,CHEMBL615438,,BAO_0000019,,
386,5861,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay,F,,,Human rhinovirus 14,12131.0,,,,,12464,D,9,Expert,1,,CHEMBL615439,,BAO_0000019,,
387,5861,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay,F,,,Human rhinovirus 14,12131.0,,,,,12464,D,9,Expert,1,,CHEMBL615440,,BAO_0000019,,
388,5861,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay; inactive,F,,,Human rhinovirus 14,12131.0,,,,,12464,D,9,Expert,1,,CHEMBL615441,,BAO_0000019,,
389,13748,Compound was tested for the inhibitory activity of compound towards human rhinovirus 3C protease,F,,,Enterovirus,12059.0,,,,,50665,N,1,Intermediate,1,,CHEMBL615641,,BAO_0000218,,
390,13748,Compound was tested for the inhibitory activity of compound towards human rhinovirus-16 3C protease,F,,,Enterovirus,12059.0,,,,,50665,N,1,Intermediate,1,,CHEMBL872065,,BAO_0000218,,
391,13748,Compound was tested for the inhibitory activity of compound towards human rhinovirus-2 3C protease,F,,,Enterovirus,12059.0,,,,,50665,N,1,Intermediate,1,,CHEMBL825023,,BAO_0000218,,
392,13748,Compound was tested for the inhibitory activity of compound towards human rhinovirus-89 3C protease,F,,,Enterovirus,12059.0,,,,,50665,N,1,Intermediate,1,,CHEMBL615642,,BAO_0000218,,
393,13748,Inhibition of human rhinovirus 3C protease,B,,,Human rhinovirus B,147712.0,,,,,12464,H,8,Expert,1,,CHEMBL615643,,BAO_0000357,,
394,17699,Compound was tested for inhibition of a proteinase 3CL pro of human coronavirus; Inhibited,B,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615644,,BAO_0000019,,
395,7145,Compound tested for activity against 3EM 37 mouse ependymoblastoma after single ip injection on day 1 at optimal dose of 100 mg/kg (Dose range 200-12.5),F,,,Mus musculus,10090.0,,,3EM 37,,80619,N,1,Intermediate,1,,CHEMBL615645,833.0,BAO_0000218,,
396,7145,Compound tested for activity against 3EM 37 mouse ependymoblastoma after single ip injection on day 1 at optimal dose of 128 mg/kg (Dose range 256-16),F,,,Mus musculus,10090.0,,,3EM 37,,80619,N,1,Intermediate,1,,CHEMBL615646,833.0,BAO_0000218,,
397,7145,Compound tested for toxicity against 3EM 37 Mouse Ependymoblastoma after single ip injection on day 1 at optimal dose (OD) of 100 mg/kg on the 5th day after the injection of the compound; (10/10),F,,,Mus musculus,10090.0,,,3EM 37,,80619,N,1,Intermediate,1,,CHEMBL615647,833.0,BAO_0000218,,
398,7145,Compound tested for toxicity against 3EM 37 mouse ependymoblastoma after single ip injection on day 1 at optimal dose (OD) of 100 mg/kg on the 5th day after the injection of the compound; (6/6),F,,,Mus musculus,10090.0,,,3EM 37,,80619,N,1,Intermediate,1,,CHEMBL615648,833.0,BAO_0000218,,
399,7145,Effect of compound on 3EM 37 mouse ependymoblastoma after single ip injection on day 1 recorded as animal weight difference of the treated and the control (T-C) at OD of 100 mg/kg,F,,,Mus musculus,10090.0,,,3EM 37,,80619,N,1,Intermediate,1,,CHEMBL615649,833.0,BAO_0000218,,
400,7145,Effect of compound on 3EM 37 mouse ependymoblastoma after single ip injection on day 1 recorded as percentage of cured animals at OD of 100 mg/kg,F,,,Mus musculus,10090.0,,,3EM 37,,80619,N,1,Intermediate,1,,CHEMBL615650,833.0,BAO_0000218,,
401,5325,In vivo anti-tumor and anti-metastatic activity was measured after oral dosing 15 mg/kg b.i.d. to B6D2F1 mice bearing metastatic 3LL Lewis lung tumor,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615651,847.0,BAO_0000218,,
402,5325,In vivo anti-tumor and anti-metastatic activity was measured after oral dosing b.i.d. to B6D2F1 mice bearing metastatic 3LL Lewis lung tumor,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615652,847.0,BAO_0000218,,
403,5325,In vivo anti-tumor and anti-metastatic activity following p.o. administration b.i.d. to B6D2F1 mice bearing metastatic 3LL Lewis lung tumor; Not tested.,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Expert,1,,CHEMBL615653,847.0,BAO_0000218,,
404,16169,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 1 uM dose,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615654,847.0,BAO_0000219,,
405,16169,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 10 uM dose,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615655,847.0,BAO_0000219,,
406,16169,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 250 uM dose,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL825024,847.0,BAO_0000219,,
407,16169,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 50 uM dose,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615656,847.0,BAO_0000219,,
408,16169,accumulation of compound in 3LL cells was measured with DFMO by ICP-AES at 50 uM dose,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615657,847.0,BAO_0000219,,
409,16169,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 1 uM dose,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615658,847.0,BAO_0000219,,
410,16169,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 10 uM dose,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615659,847.0,BAO_0000219,,
411,16169,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 250 uM dose,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615660,847.0,BAO_0000219,,
412,16169,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 50 uM dose,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615661,847.0,BAO_0000219,,
413,16169,accumulation of compound in 3LL cells was measured without DFMO by ICP-AES at 50 uM dose,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615662,847.0,BAO_0000219,,
414,16169,Effect on the growth of 3LL cells by DFMO pretreatment at 48 hr incubation,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615663,847.0,BAO_0000219,,
415,16169,Effect on the growth of 3LL cells was evaluated using an MTT assay at 48 hour incubation,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615664,847.0,BAO_0000219,,
416,16169,Effect on the growth of 3LL cells was evaluated using an MTT assay at 72 hour incubation,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615665,847.0,BAO_0000219,,
417,16169,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 50 uM dose,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615666,847.0,BAO_0000219,,
418,16169,putrescine levels in 3LL cells after the treatment of 1 uM of Compound,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615667,847.0,BAO_0000219,,
419,16169,putrescine levels in 3LL cells after the treatment of 10 uM of Compound,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615668,847.0,BAO_0000219,,
420,16169,putrescine levels in 3LL cells after the treatment of 250 uM of Compound,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615669,847.0,BAO_0000219,,
421,16169,putrescine levels in 3LL cells after the treatment of 50 uM of Compound,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615670,847.0,BAO_0000219,,
422,16169,spermidine levels in 3LL cells after the treatment of 1 uM of Compound,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL836739,847.0,BAO_0000219,,
423,16169,spermidine levels in 3LL cells after the treatment of 10 uM of Compound,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615671,847.0,BAO_0000219,,
424,16169,spermidine levels in 3LL cells after the treatment of 250 uM of Compound,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615672,847.0,BAO_0000219,,
425,16169,spermidine levels in 3LL cells after the treatment of 50 uM of Compound,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615791,847.0,BAO_0000219,,
426,16169,spermine levels in 3LL cells after the treatment of 1 uM of Compound,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615792,847.0,BAO_0000219,,
427,16169,spermine levels in 3LL cells after the treatment of 10 uM of Compound,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615793,847.0,BAO_0000219,,
428,16169,spermine levels in 3LL cells after the treatment of 250 uM of Compound,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615794,847.0,BAO_0000219,,
429,16169,spermine levels in 3LL cells after the treatment of 50 uM of Compound,F,,,Mus musculus,10090.0,,,3LL cell line,,80620,N,1,Intermediate,1,,CHEMBL615795,847.0,BAO_0000219,,
430,15547,Concentration required to inhibit the colony formation of lung carcinoma (3LLD122) cell lines by 50%,F,,,Homo sapiens,9606.0,,,3LLD122,,80621,N,1,Intermediate,1,,CHEMBL615590,971.0,BAO_0000219,,
431,8663,In vivo antitumor activity against 3M531 is the sarcoma M5076; reproducible minimal activity,F,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL615591,,BAO_0000218,,
432,8663,In vivo antitumor activity against 3M531 is the sarcoma M5076; reproducible significant activity.,F,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL615592,,BAO_0000218,,
433,8663,In vivo antitumor activity against 3MBG5 subrenal capsule mammary carcinoma MX-1 xenograft; NT= Not tested,F,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL615593,,BAO_0000218,,
434,8663,In vivo antitumor activity against 3MBG5 subrenal capsule mammary carcinoma MX-1 xenograft; reproducible significant activity.,F,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL615594,,BAO_0000218,,
435,4504,Effective dose required against Trypanosoma cruzi amastigotes in 3T3 Fibroblasts,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615595,723.0,BAO_0000219,,
436,4504,Effective dose required against Trypanosoma cruzi amastigotes in 3T3 Fibroblasts,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615596,723.0,BAO_0000219,,
437,12695,Inhibition of 6 nM bombesin induced [3H]thymidine incorporation measured in swiss 3T3 cells using a mitogenicity assay,F,,,,,,,NIH3T3,,11169,H,8,Expert,1,,CHEMBL615597,723.0,BAO_0000219,,
438,12695,Ability of the peptide to inhibit 6 nM bombesin induced [3H]thymidine incorporation was measured in swiss 3T3 cells using mitogenicity assay; na=Not active,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615598,723.0,BAO_0000219,,
439,12695,Ability of the peptide to inhibit 6 nM bombesin induced [3H]thymidine incorporation was measured in swiss 3T3 cells using mitogenicity assay; nt=Not tested,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615599,723.0,BAO_0000219,,
440,17642,Effective dose against murine 3T3 fibroblasts cells,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Expert,1,,CHEMBL615600,723.0,BAO_0000219,,
441,17642,Dose required against murine 3T3 fibroblasts cells; 1-10 uM,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Expert,1,,CHEMBL615601,723.0,BAO_0000219,,
442,12340,Cytotoxic effect on 3T3 cells,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Expert,1,,CHEMBL615602,723.0,BAO_0000219,,
443,12340,Cytotoxic effect on 3T3 cells,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Expert,1,,CHEMBL615603,723.0,BAO_0000219,,
444,12716,Compound was tested for the concentration necessary to inhibit swiss 3T3 Mouse Fibroblast cell growth rate by 50%.,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615604,723.0,BAO_0000219,,
445,6277,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line in the presence of compound was determined using NR coloration,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615605,723.0,BAO_0000219,,
446,6277,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line in the presence of compound was determined using NR coloration; nd=No data,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615606,723.0,BAO_0000219,,
447,6277,In vitro cytotoxic concentration against mouse fibroblasts (3T3) cell line using MTT coloration,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Expert,1,,CHEMBL884526,723.0,BAO_0000219,,
448,6277,In vitro cytotoxic concentration against mouse fibroblasts (3T3) cell line using MTT coloration; n.d.=no data,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Expert,1,,CHEMBL615607,723.0,BAO_0000219,,
449,6277,In vitro cytotoxic concentration against mouse fibroblasts (3T3) cell line using MTT coloration; n.t.=not tested,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615608,723.0,BAO_0000219,,
450,6277,In vitro inhibitory activity against mouse fibroblasts (3T3) cell line using CV coloration,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Expert,1,,CHEMBL615609,723.0,BAO_0000219,,
451,6277,In vitro inhibitory activity against mouse fibroblasts (3T3) cell line using CV coloration; n.d.=no data,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Expert,1,,CHEMBL615682,723.0,BAO_0000219,,
452,6277,In vitro inhibitory activity against mouse fibroblasts (3T3) cell line using CV coloration; n.t.=not tested,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615683,723.0,BAO_0000219,,
453,17780,In vivo inhibition of H-ras-transformed 3T3 fibroblasts in nude mouse tumor models,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Expert,1,,CHEMBL615684,723.0,BAO_0000218,,
454,12751,Inhibition of PDGF-dependent autophosphorylation of PDGF-R in mouse BALB/c3T3 cells,F,,,Mus musculus,10090.0,,,,,104860,D,7,Autocuration,1,,CHEMBL615685,,BAO_0000219,,
455,12380,Inhibition of Swiss 3T3 Mouse fibroblast proliferation,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Expert,1,,CHEMBL615686,723.0,BAO_0000219,,
456,14892,Inhibitory activity against 3T3 cell line,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615687,723.0,BAO_0000219,,
457,12695,The ability of the peptide to inhibit the binding of 10 pM [125I]gastrin releasing peptide to S-3T3 cell membrane was measured,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL884523,723.0,BAO_0000219,,
458,12695,Ability of peptide to inhibit binding of 10 pM [125I]gastrin releasing peptide to S-3T3 cell membrane.,F,,,,,,,,,11169,H,8,Expert,1,,CHEMBL615688,,BAO_0000019,,
459,12695,The ability of the peptide to inhibit the binding of 10 pM [125I]gastrin releasing peptide to S-3T3 cell membrane was measured; nt=Not tested,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615689,723.0,BAO_0000219,,
460,12695,The ability of the peptide to inhibit the binding of 50 pM [125I]gastrin releasing peptide to intact S-3T3 cells was measured,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615690,723.0,BAO_0000219,,
461,12695,The ability of the peptide to inhibit the binding of 50 pM [125I]gastrin releasing peptide to intact S-3T3 cells,F,,,,,,,,,11169,H,8,Expert,1,,CHEMBL615691,,BAO_0000019,,
462,12695,The ability of the peptide to inhibit the binding of 50 pM [125I]gastrin releasing peptide to intact S-3T3 cells; nt=Not tested,F,,,,,,,,,11169,H,8,Expert,1,,CHEMBL615692,,BAO_0000019,,
463,6277,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line in the presence of compound was determined using NR coloration,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615693,723.0,BAO_0000219,,
464,6277,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line was determined using NR coloration; n.d.=no data,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Expert,1,,CHEMBL615324,723.0,BAO_0000219,,
465,4959,Inhibition of ligand-induced proliferation in human EGF-R Kinase expressing 3T3 cells,F,,,Homo sapiens,9606.0,,,NIH3T3,,9,D,9,Expert,1,,CHEMBL615325,723.0,BAO_0000219,,
466,4959,Inhibition of ligand-induced proliferation in human EGF-R Kinase expressing 3T3 cells (Not tested),F,,,Homo sapiens,9606.0,,,NIH3T3,,9,D,9,Expert,1,,CHEMBL615490,723.0,BAO_0000219,,
467,4959,Inhibition of ligand induced proliferation in human Her-2 (p185erbB) tyrosine kinase expressing 3T3 cells,F,,,Homo sapiens,9606.0,,,NIH3T3,,188,D,9,Expert,1,,CHEMBL615491,723.0,BAO_0000219,,
468,4959,Inhibition of ligand-induced proliferation in human Her-2 (p185erbB) tyrosine kinase expressing 3T3 cells (Not tested),F,,,Homo sapiens,9606.0,,,NIH3T3,,188,D,9,Expert,1,,CHEMBL615492,723.0,BAO_0000219,,
469,12082,Inhibitory concentration of compound rwas calculated on 3T3 cells by [3H]Thd incorporation,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615493,723.0,BAO_0000219,,
470,12082,Inhibitory concentration of compound was calculated on 3T3 cells by [14C]Leu incorporation,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615494,723.0,BAO_0000219,,
471,12082,Inhibitory concentration of compound was calculated on 3T3 cells by using clonal assay,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615495,723.0,BAO_0000219,,
472,12082,Inhibitory concentration was calculated on 3T3 cells by using growth assay,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615496,723.0,BAO_0000219,,
473,2643,In vitro cytotoxicity was evaluated in mouse embryo BALB/c 3T3 cells,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615497,723.0,BAO_0000219,,
474,11926,Inhibition of Swiss 3T3 mouse fibroblast proliferation,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Expert,1,,CHEMBL615498,723.0,BAO_0000219,,
475,15204,The compound was tested for cytotoxicity against 3T3 fibroblast murine cell line.,A,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615499,723.0,BAO_0000219,,
476,15992,Effective concentration required to inhibit the growth of murine 3T3 fibroblasts,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Expert,1,,CHEMBL835522,723.0,BAO_0000219,,
477,16279,Cytotoxicity on 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014); Not tested,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615500,723.0,BAO_0000219,,
478,16279,Cytotoxicity against 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615501,723.0,BAO_0000219,,
479,16279,Cytotoxicity on 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615502,723.0,BAO_0000219,,
480,16279,cytotoxicity on 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615503,723.0,BAO_0000219,,
481,16279,Cytotoxicity on 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615504,723.0,BAO_0000219,,
482,16279,Cytotoxicity against 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615505,723.0,BAO_0000219,,
483,12831,Inhibition of swiss 3T3 mouse fibroblast proliferation,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Expert,1,,CHEMBL615506,723.0,BAO_0000219,,
484,13497,Compound was tested for sublethal concentrations in 3T3 mouse fibroblast lysis.,F,,,Mus musculus,10090.0,,,NIH3T3,,80951,N,1,Intermediate,1,,CHEMBL615507,723.0,BAO_0000219,,
485,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 30 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615508,620.0,BAO_0000218,,
486,13618,Concentration required to stimulate glucose uptake in 3T3-L1 adipocytes after 48 hr incubation,F,,,Mus musculus,10090.0,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615509,620.0,BAO_0000219,,
487,11902,Effect on GLUT 1 glucose transporter expression in 3T3-L1 adipocytes at dose of 0.3 uM,F,,,Mus musculus,10090.0,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615510,620.0,BAO_0000219,,
488,11902,Effect on GLUT 1 glucose transporter expression in 3T3-L1 adipocytes at dose of 3 uM,F,,,Mus musculus,10090.0,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615511,620.0,BAO_0000219,,
489,11902,Effect on GLUT 1 glucose transporter expression in 3T3-L1 adipocytes at dose of 30 uM,F,,,Mus musculus,10090.0,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615512,620.0,BAO_0000219,,
490,14840,"In vitro ability to stimulate glucose transport in 3T3-L1 adipocytes, given at 100 mg/kg in mouse, after 24 hr",F,,,Mus musculus,10090.0,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615513,620.0,BAO_0000218,,
491,14840,"In vitro ability to stimulate glucose transport in 3T3-L1 adipocytes, given at 100 mg/kg in mouse, after 3 hr",F,,,Mus musculus,10090.0,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615514,620.0,BAO_0000218,,
492,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615515,620.0,BAO_0000219,,
493,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 10 micro M,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615516,620.0,BAO_0000219,,
494,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 3 micro M,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615517,620.0,BAO_0000219,,
495,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 30 micro M,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615518,620.0,BAO_0000219,,
496,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 3 micro M,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615519,620.0,BAO_0000219,,
497,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 0.3 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615520,620.0,BAO_0000218,,
498,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 0.5 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615521,620.0,BAO_0000218,,
499,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 1 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615522,620.0,BAO_0000218,,
500,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 10 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615523,620.0,BAO_0000218,,
501,13715,In vitro measurements 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 100 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Expert,1,,CHEMBL615524,620.0,BAO_0000218,,
502,13715,Acute effects in vitro by measuring 2-deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 10 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Expert,1,,CHEMBL615525,620.0,BAO_0000218,,
503,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 1 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615526,620.0,BAO_0000218,,
504,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 3 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615527,620.0,BAO_0000218,,
505,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 300 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615528,620.0,BAO_0000218,,
506,13715,Acute effects in vitro by measuring 2-deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 30 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Expert,1,,CHEMBL615529,620.0,BAO_0000218,,
507,13715,In vitro by measurements of 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 3 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Expert,1,,CHEMBL615530,620.0,BAO_0000218,,
508,13715,In vitro measurements of 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 60 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Expert,1,,CHEMBL615531,620.0,BAO_0000218,,
509,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 10 micro M,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615532,620.0,BAO_0000219,,
510,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 3 micro M,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615533,620.0,BAO_0000219,,
511,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 30 micro M,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615534,620.0,BAO_0000219,,
512,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 100 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615535,620.0,BAO_0000218,,
513,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 10 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615536,620.0,BAO_0000218,,
514,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 30 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615537,620.0,BAO_0000218,,
515,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 3 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615538,620.0,BAO_0000218,,
516,13715,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 60 uM dose.,F,,,,,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL836166,620.0,BAO_0000218,,
517,6411,Inhibition of forskolin-stimulated lipolysis in differentiated 3T3-L1 cells,F,,,,,,,3T3-L1,,11214,H,8,Expert,1,,CHEMBL615539,620.0,BAO_0000219,,
518,6411,Evaluated for the inhibition of forskolin-stimulated lipolysis in differentiated 3T3-L1 cells; ND = No data,F,,,Mus musculus,10090.0,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615540,620.0,BAO_0000219,,
519,6411,Evaluated for the inhibition of forskolin-stimulated lipolysis in differentiated 3T3-L1 cells; Na = Not active,F,,,,,,,3T3-L1,,11214,H,8,Expert,1,,CHEMBL615541,620.0,BAO_0000219,,
520,3966,Insulin-sensitizing activity; triglyceride accumulation from insulin regulated differentiation of 3T3-L1 cells at 1 uM expressed as percent activity of pioglitazone,F,,,Mus musculus,10090.0,,,3T3-L1,,80006,N,1,Expert,1,,CHEMBL615542,620.0,BAO_0000219,,
521,3966,Compound was tested for insulin-sensitizing activity by measuring triglyceride accumulation from insulin regulated differentiation of 3T3-L1 cells at 10 uM expressed as percent activity of pioglitazone,F,,,Mus musculus,10090.0,,,3T3-L1,,80006,N,1,Intermediate,1,,CHEMBL615543,620.0,BAO_0000219,,
522,15556,Stimulation of adipogenesis in 3T3-L1 cells is expressed as concentration equivalent to the [ 1-14C] uptake counts after treatment with 0.2 ug/mL troglitazone,F,,,Mus musculus,10090.0,,,3T3-L1,,80006,N,1,Expert,1,,CHEMBL615544,620.0,BAO_0000219,,
523,5845,Effective concentration for enhancement of insulin-induced triglyceride accumulation in 3T3-L1 cells,F,,,Mus musculus,10090.0,,,3T3-L1,,80006,N,1,Expert,1,,CHEMBL615545,620.0,BAO_0000219,,
524,14422,Effective concentration for 50% enhancement of insulin-induced triglyceride accumulation in 3T3-L1 cells,F,,,Mus musculus,10090.0,,,3T3-L1,,80006,N,1,Expert,1,,CHEMBL615546,620.0,BAO_0000219,,
525,5845,Percentage of rosiglitazone response for insulin-sensitizing activity at 1 uM concentration in 3T3-L1 cells,F,,,Mus musculus,10090.0,,,3T3-L1,,80006,N,1,Expert,1,,CHEMBL615547,620.0,BAO_0000219,,
526,14508,In vitro glucose transport activity in 3T3-LI adipocytes at 10 uM concentration.,F,,,Mus musculus,10090.0,,,3T3-L1,,80006,N,1,Expert,1,,CHEMBL615548,620.0,BAO_0000219,,
527,14508,In vitro glucose transport activity in 3T3-LI adipocytes at 3 uM concentration.,F,,,Mus musculus,10090.0,,,3T3-L1,,80006,N,1,Expert,1,,CHEMBL615549,620.0,BAO_0000219,,
528,14508,In vitro glucose transport activity in 3T3-LI adipocytes at 30 uM concentration.,F,,,Mus musculus,10090.0,,,3T3-L1,,80006,N,1,Expert,1,,CHEMBL615550,620.0,BAO_0000219,,
529,6349,Inhibitory activity against rat fibroblast (3Y1) cell line,F,,,Rattus norvegicus,10116.0,,,3Y1 cell line,,80622,N,1,Intermediate,1,,CHEMBL615551,1118.0,BAO_0000219,,
530,15899,Mean concentration causing inhibition of cell growth in 3Y1 cells.,F,,,Rattus norvegicus,10116.0,,,3Y1 cell line,,80622,N,1,Expert,1,,CHEMBL615552,1118.0,BAO_0000219,,
531,15899,Cytotoxicity in 3Y1 cells.,F,,,Rattus norvegicus,10116.0,,,3Y1 cell line,,80622,N,1,Expert,1,,CHEMBL615553,1118.0,BAO_0000219,,
532,15899,Cytostatic effect in 3Y1 cells.,F,,,Rattus norvegicus,10116.0,,,3Y1 cell line,,80622,N,1,Expert,1,,CHEMBL615554,1118.0,BAO_0000219,,
533,15899,"Mean averaged concentration for total growth inhibition, which signifies cytostatic effect",F,,,Rattus norvegicus,10116.0,,,3Y1 cell line,,80622,N,1,Intermediate,1,,CHEMBL615555,1118.0,BAO_0000219,,
534,17038,Concentration to inhibit growth of normal rat fibroblast cells (3Y1-B cells) after 72 h exposure,F,,,Rattus norvegicus,10116.0,,,3Y1 cell line,,80622,N,1,Expert,1,,CHEMBL615556,1118.0,BAO_0000219,,
535,12421,In vitro inhibitory activity against human adrenal 3-beta hydroxy-delta 5-teroid isomerase,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL615557,,BAO_0000019,,
536,12947,Inhibition of recombinant human adrenal 3-beta-hydroxy-delta-5-steroid dehydrogenase,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL615558,,BAO_0000019,,
537,12947,Inhibition of recombinant rat adrenal 3-beta-hydroxy-delta-5-steroid dehydrogenase,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL872066,,BAO_0000019,,
538,4896,In vitro inhibition against of 4-Hydroxyphenylpyruvate dioxygenase (4-HPPD) from pig liver by the enol borate method,B,,,Sus scrofa,9823.0,,,,,11607,D,9,Expert,1,,CHEMBL615559,,BAO_0000019,,
539,6148,In vitro inhibitory concentration required against 4-hydroxyphenylpyruvate dioxygenase (4-HPPD) taken from pig liver,B,,,,,,,,,11607,H,8,Autocuration,1,,CHEMBL615560,,BAO_0000019,,
540,16432,Inhibition of pig liver 4-Hydroxyphenylpyruvate dioxygenase (4-HPPD) enzyme,B,,,,,,,,,11607,H,8,Autocuration,1,,CHEMBL615561,,BAO_0000019,,
541,4978,Concentration required to achieve 50% inhibition against 4-Hydroxyphenylpyruvate dioxygenase (HPPD) from pig liver,B,,,,,,,,,11607,H,8,Expert,1,,CHEMBL857062,,BAO_0000019,,
542,4978,Concentration required to achieve 50% inhibition against 4-Hydroxyphenylpyruvate dioxygenase (HPPD) from pig liver; (observed value),B,,,,,,,,,11607,H,8,Expert,1,,CHEMBL615562,,BAO_0000019,,
543,3723,In vitro inhibitory activity against HPPD(4-hydroxyphenylpyruvate Dioxygenase) from pig liver using enol borate assay method,B,,,,,,,,,11607,H,8,Autocuration,1,,CHEMBL615563,,BAO_0000019,,
544,3518,Compound was evaluated for complete competitive inhibition of 4-hydroxyphenylpyruvate dioxygenase (HPPD),B,,,,,,,,,11607,H,8,Autocuration,1,,CHEMBL615564,,BAO_0000357,,
545,4164,In vitro inhibition of 4-hydroxyphenylpyruvate dioxygenase obtained from purified pig liver by enol-borate method,B,,,,,,,,,11607,H,8,Autocuration,1,,CHEMBL615565,,BAO_0000019,,
546,3518,Inhibitory activity on pig liver 4-hydroxyphenylpyruvate dioxygenase (HPPD) was evaluated,B,,,,,,,,,11607,H,8,Autocuration,1,,CHEMBL615566,,BAO_0000019,,
547,4164,Inhibition of 4-hydroxyphenylpyruvate dioxygenase of purified pig liver by enol-borate method,B,,,Sus scrofa,9823.0,,,,,11607,D,9,Expert,1,,CHEMBL615567,,BAO_0000019,,
548,3518,The inhibitory activity on pig liver 4-hydroxyphenylpyruvate dioxygenase (HPPD) was evaluated.,B,,,,,,,,,11607,H,8,Autocuration,1,,CHEMBL615568,,BAO_0000019,,
549,3518,Compound was evaluated for competitive inhibition of 4-hydroxyphenylpyruvate dioxygenase (HPPD) (complete inhibition was observed at a concentration of 0.5-1.0 mM),B,,,,,,,,,11607,H,8,Autocuration,1,,CHEMBL615569,,BAO_0000357,,
550,4978,Concentration required to achieve 50% inhibition against 4-hydroxyphenylpyruvate dioxygenase from pig liver,B,,,,,,,,,11607,H,8,Autocuration,1,,CHEMBL615570,,BAO_0000019,,
551,4978,Concentration required to achieve 50% inhibition against 4-hydroxyphenylpyruvate dioxygenase from pig liver; (observed value),B,,,,,,,,,11607,H,8,Autocuration,1,,CHEMBL615571,,BAO_0000019,,
552,6455,Binding affinity against melatonin (MT1) receptor (pC1),B,,,,,,,,,104733,H,4,Autocuration,1,,CHEMBL615572,,BAO_0000224,,
553,2222,Compound was tested for inhibitory activity against 5-hydroxytryptamine 1 receptor,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL615573,,BAO_0000019,,
554,13020,Inhibition of [3H]- 5-HT binding to 5-hydroxytryptamine 1 receptor at 10e-5 M,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL615574,,BAO_0000019,,
555,13021,Inhibition of [3H]5-HT binding to 5-hydroxytryptamine 1 receptor of central nervous system,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL615575,,BAO_0000019,,
556,14532,Inhibitory activity against 5-hydroxytryptamine 1 receptor using [3H]5-HT as radioligand at 10e-5 M concentration,B,,,,,,,,,10619,H,8,Autocuration,1,,CHEMBL615576,,BAO_0000357,,
557,14118,Binding affinity against 5-hydroxytryptamine 1 receptor using [3H]5-HT as radioligand,B,,,,,,,,,10619,H,8,Autocuration,1,,CHEMBL615577,,BAO_0000357,,
558,11884,Binding affinity at 5-hydroxytryptamine 1A receptor in bovine hippocampal preparation using [3H]8-OH-DPAT,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615578,,BAO_0000221,10000000.0,
559,13969,Binding affinity against 5-hydroxytryptamine 1A receptor was measured using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL615579,,BAO_0000357,,
560,13392,Binding affinity for 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL615580,,BAO_0000357,,
561,14430,Affinity towards 5-hydroxytryptamine 1A receptor in membranes from bovine hippocampus using [3H]OH-DPAT,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL615581,,BAO_0000019,,
562,12248,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615582,,BAO_0000221,10000000.0,
563,12249,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615583,,BAO_0000221,10000000.0,
564,9995,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-HT1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615584,,BAO_0000221,10000000.0,
565,9995,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL833691,,BAO_0000221,10000000.0,
566,9995,In vitro inhibition of azido-[125I]-IPAPP (0.25 nM) binding to 5-HT1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615585,,BAO_0000221,10000000.0,
567,9995,In vitro inhibition of [125I]IPAPP (0.25 nM) binding to 5-HT1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615586,,BAO_0000221,10000000.0,
568,9995,In vitro inhibition of [125I]IPAPP (2.5 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL884524,,BAO_0000221,10000000.0,
569,12249,Inhibitory concentration against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615587,,BAO_0000221,10000000.0,
570,11799,"Compound was tested for binding affinity against 5-hydroxytryptamine 1A receptor from bovine hippocampus, used [3H]8-OH-DPAT as radioligand",B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615588,,BAO_0000221,10000000.0,
571,14331,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat hippocampal membranes,B,,,Rattus norvegicus,10116.0,,,,Membranes,10576,D,9,Expert,1,,CHEMBL615589,,BAO_0000249,,
572,11884,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of bovine hippocampus.,B,,,Bos taurus,9913.0,,Hippocampus,,,51,H,8,Expert,1,,CHEMBL615442,,BAO_0000221,10000000.0,
573,14331,Binding affinity of compound towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT (0.5 nM) ligand in hippocampus + frontal bovine was determined,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615443,,BAO_0000221,10000000.0,
574,11701,Compound was evaluated for its ability to displace [3H]DPAT from 5-HT1A receptor in homogenates of bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615444,,BAO_0000221,10000000.0,
575,11701,Ability to displace [3H]-DPAT from 5-hydroxytryptamine 1A receptor in homogenates of bovine hippocampus.,B,,,,,,Hippocampus,,,51,H,8,Expert,1,,CHEMBL615445,,BAO_0000221,10000000.0,
576,12248,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor in bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615446,,BAO_0000221,10000000.0,
577,12248,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in CHO cells,B,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615447,449.0,BAO_0000219,,
578,12248,Binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Expert,1,,CHEMBL615448,,BAO_0000221,10000000.0,
579,12249,Binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Expert,1,,CHEMBL615449,,BAO_0000221,10000000.0,
580,12248,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,B,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615450,449.0,BAO_0000219,,
581,11799,"Binding affinity against 5-hydroxytryptamine 1A receptor from bovine hippocampus, used [3H]8-OH-DPAT as radioligand",B,,,,,,Hippocampus,,,51,H,8,Expert,1,,CHEMBL615451,,BAO_0000221,10000000.0,
582,634,Compound was tested for its binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615452,,BAO_0000357,,
583,9995,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-HT1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615453,,BAO_0000221,10000000.0,
584,9995,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615454,,BAO_0000221,10000000.0,
585,9995,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-HT1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615455,,BAO_0000221,10000000.0,
586,9995,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615456,,BAO_0000221,10000000.0,
587,9995,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-HT1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615457,,BAO_0000221,10000000.0,
588,12210,In vivo binding affinity towards [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus.,B,,,,,,Hippocampus,,,51,H,8,Expert,1,,CHEMBL615458,,BAO_0000218,10000000.0,
589,13311,Tested for activity against 5-hydroxytryptamine 1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Expert,1,,CHEMBL615459,,BAO_0000221,10000000.0,
590,2331,"Tested in vitro for the inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor, expressed in cloned CHO cells.",B,,,Homo sapiens,9606.0,,,CHO,,51,D,9,Expert,1,,CHEMBL615460,449.0,BAO_0000219,,
591,1375,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1A receptor in guinea pig,F,,,Cavia porcellus,10141.0,,,,,51,H,8,Autocuration,1,,CHEMBL615461,,BAO_0000019,,
592,1375,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1A receptor in guinea pig; NT means not tested,F,,,Cavia porcellus,10141.0,,,,,51,H,8,Autocuration,1,,CHEMBL615462,,BAO_0000019,,
593,11574,Effect on forskolin stimulated adenylate cyclase activity at 5-hydroxytryptamine 1A receptor of guinea pig hippocampus.,F,,,Cavia porcellus,10141.0,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL615463,,BAO_0000221,10000000.0,
594,12867,Ability to antagonize Acetylcholine induced contractile responses in Guinea pig ileum for 5-HT1A receptor.,B,,,Cavia porcellus,10141.0,,Ileum,,,51,H,8,Autocuration,1,,CHEMBL615464,,BAO_0000221,2116.0,
595,12867,Ability to antagonize Acetylcholine induced contractile responses in Guinea pig ileum for 5-HT1A receptor. Inactive at dose level of 1.0 uM,B,,,Cavia porcellus,10141.0,,Ileum,,,51,H,8,Autocuration,1,,CHEMBL615465,,BAO_0000221,2116.0,
596,12867,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5-HT1A receptor.,B,,,Cavia porcellus,10141.0,,Ileum,,,51,H,8,Autocuration,1,,CHEMBL615466,,BAO_0000221,2116.0,
597,12867,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5-HT1A receptor. Inactive at dose level of 1.0 uM,B,,,Cavia porcellus,10141.0,,Ileum,,,51,H,8,Autocuration,1,,CHEMBL615467,,BAO_0000221,2116.0,
598,12867,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5-HT1A receptor. Inactive at dose level of 1.0 uM,B,,,Cavia porcellus,10141.0,,Ileum,,,51,H,8,Autocuration,1,,CHEMBL615468,,BAO_0000221,2116.0,
599,12867,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5-HT1A receptor; Inactive at dose level of 1.0 uM,B,,,Cavia porcellus,10141.0,,Ileum,,,51,H,8,Autocuration,1,,CHEMBL615469,,BAO_0000221,2116.0,
600,11574,Binding affinity against 5-hydroxytryptamine 1A receptor,B,,,Cavia porcellus,10141.0,,,,,51,H,8,Autocuration,1,,CHEMBL615470,,BAO_0000357,,
601,13114,Compound is evaluated for in vitro receptor binding affinity against 5-hydroxytryptamine 1A receptor,B,,,Cavia porcellus,10141.0,,,,,51,H,8,Autocuration,1,,CHEMBL615471,,BAO_0000357,,
602,13181,Binding affinity was determined against 5-hydroxytryptamine 1A receptor,B,,,Cavia porcellus,10141.0,,,,,51,H,8,Autocuration,1,,CHEMBL615472,,BAO_0000357,,
603,10639,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1A receptor of guinea pig hippocampus,B,,,Cavia porcellus,10141.0,,Hippocampus,,,106,H,8,Autocuration,1,,CHEMBL883242,,BAO_0000221,10000000.0,
604,10639,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1A receptor of guinea pig hippocampus,F,,,Cavia porcellus,10141.0,,Hippocampus,,,106,H,8,Autocuration,1,,CHEMBL615473,,BAO_0000221,10000000.0,
605,11883,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand in CHO cells (sc),B,,,Cricetulus griseus,10029.0,,,CHO,,11863,H,8,Autocuration,1,,CHEMBL615474,449.0,BAO_0000218,,
606,17785,Fraction involved in salt bridge interactions with Asp3:11 part of the 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615475,,BAO_0000357,,
607,1558,Compound was tested for its ability to inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-HT 1A receptor in HeLa cells; value ranges from 85-370,F,,,,,,,HeLa,,51,H,8,Autocuration,1,,CHEMBL615476,308.0,BAO_0000219,,
608,1558,Compound was tested for its ability to inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1A receptor in HeLa cells; value ranges from 95-320,F,,,,,,,HeLa,,51,H,8,Autocuration,1,,CHEMBL615477,308.0,BAO_0000219,,
609,15740,EC50 for inhibition of 50 uM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615478,,BAO_0000019,,
610,17624,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing human 5-hydroxytryptamine 1A receptor,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615160,449.0,BAO_0000219,,
611,17624,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing human 5-hydroxytryptamine 1A receptor,F,,,,,,,CHO,,51,H,8,Expert,1,,CHEMBL615161,449.0,BAO_0000219,,
612,17624,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing human 5-hydroxytryptamine 1A receptor; nd=Not determined,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615162,449.0,BAO_0000219,,
613,17624,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing human 5-hydroxytryptamine 1A receptor; nd=not determined,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615163,449.0,BAO_0000219,,
614,17624,Effective concentration against human 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,B,,,,,,,CHO,,51,H,8,Expert,1,,CHEMBL615164,449.0,BAO_0000219,,
615,17624,Effective concentration against human 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,B,,,,,,,CHO,,51,H,8,Expert,1,,CHEMBL615165,449.0,BAO_0000219,,
616,17624,Effective concentration against human 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells; nd=not determined,B,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615166,449.0,BAO_0000219,,
617,14256,In vitro potency at human 5-hydroxytryptamine 1A receptor in inhibiting forskolin-stimulated accumulation of intracellular cAMP,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615167,,BAO_0000219,,
618,3445,Stimulation of [35S]- GIPyS binding to cloned human 5-hydroxytryptamine 1A receptor stably expressed in HeLa cells,B,,,Homo sapiens,9606.0,,,HeLa,,51,D,9,Expert,1,,CHEMBL615168,308.0,BAO_0000219,,
619,3445,Stimulation of [35S]- GIPyS binding to cloned human 5-hydroxytryptamine 1A receptor stably expressed in HeLa cells; Inverse,B,,,Homo sapiens,9606.0,,,HeLa,,51,D,9,Expert,1,,CHEMBL615169,308.0,BAO_0000219,,
620,17200,Tested for functional response on CHO cells expressing cloned human 5-hydroxytryptamine 1A receptor,B,,,Homo sapiens,9606.0,,,CHO,,51,D,9,Expert,1,,CHEMBL615170,449.0,BAO_0000219,,
621,17200,Tested for functional response on CHO cells expressing cloned human 5-hydroxytryptamine 1A receptor; Not determined,B,,,Homo sapiens,9606.0,,,CHO,,51,D,9,Expert,1,,CHEMBL615171,449.0,BAO_0000219,,
622,15180,Eudisimic ratio(ER) is the antilog of the defference between the pKb and pD2 values against 5-hydroxytryptamine 1A receptor,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615694,,BAO_0000019,,
623,15180,Eudisimic ratio(ER) is the antilog of the difference between the pKb and pD2 values against 5-hydroxytryptamine 1A receptor,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615695,,BAO_0000019,,
624,16026,"Percent of maximum effect on binding of [35S]GTP-gamma-S, to HeLa cell membranes expressing the human 5-hydroxytryptamine 1A receptor",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615696,,BAO_0000019,,
625,2759,Agonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615697,449.0,BAO_0000219,,
626,2759,Agonistic efficacy as adenylyl cyclase assay in CHO cells expressing human 5-HT1A receptor (experiment 1),F,,,Homo sapiens,9606.0,,,CHO,,51,D,9,Expert,1,,CHEMBL859410,449.0,BAO_0000219,,
627,2759,Agonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor (experiment 2),F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615841,449.0,BAO_0000219,,
628,2759,Agonistic efficacy in adenylyl cyclase assay in CHO cells expressing human 5-HT1A receptor (experiment 2),F,,,Homo sapiens,9606.0,,,CHO,,51,D,9,Expert,1,,CHEMBL615842,449.0,BAO_0000219,,
629,2759,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL835003,449.0,BAO_0000219,,
630,2759,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor (experiment 1),F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615843,449.0,BAO_0000219,,
631,2759,Antagonistic efficacy as adenylyl cyclase assay in CHO cells expressing human 5-HT1A receptor (experiment 1),F,,,Homo sapiens,9606.0,,,CHO,,51,D,9,Expert,1,,CHEMBL615979,449.0,BAO_0000219,,
632,2759,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor (experiment 2),F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615980,449.0,BAO_0000219,,
633,2759,Antagonistic efficacy as adenylyl cyclase assay in CHO cells expressing human 5-HT1A receptor (experiment 2),F,,,Homo sapiens,9606.0,,,CHO,,51,D,9,Expert,1,,CHEMBL615981,449.0,BAO_0000219,,
634,3445,Percent efficacy against cloned human 5-hydroxytryptamine 1A receptor normalized to the maximal 5-HT response,F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL615982,,BAO_0000019,,
635,5272,"Agonist activity at the 5-hydroxytryptamine 1A receptor was determined in vitro using a [35S]GTP-gamma-S,",F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL615983,,BAO_0000019,,
636,5272,"Agonist activity at the 5-hydroxytryptamine 1A receptor in vitro using a [35S]GTP-gamma-S, No data",F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL615984,,BAO_0000019,,
637,5272,"Agonist activity at the 5-hydroxytryptamine 1A receptor determined in vitro using a [35S]GTP-gamma-S,",F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL615985,,BAO_0000019,,
638,17624,Agonistic effect against 5-HT1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615986,449.0,BAO_0000219,,
639,17624,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615987,449.0,BAO_0000219,,
640,17624,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells; nd=Not determined,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615988,449.0,BAO_0000219,,
641,17624,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells,F,,,,,,,CHO,,51,H,8,Expert,1,,CHEMBL615989,449.0,BAO_0000219,,
642,17624,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells; nd=Not determined,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615990,449.0,BAO_0000219,,
643,17624,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells; nd=not determined,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615991,449.0,BAO_0000219,,
644,17624,Agonistic effect against 5-HT 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615992,449.0,BAO_0000219,,
645,17624,Agonistic effect against 5-HT 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT; nd=Not determined,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615993,449.0,BAO_0000219,,
646,17624,Agonistic effect against 5-hydroxytryptamine 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT,F,,,,,,,CHO,,51,H,8,Expert,1,,CHEMBL615994,449.0,BAO_0000219,,
647,17624,Agonistic effect against 5-hydroxytryptamine 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT; nd=not determined,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615995,449.0,BAO_0000219,,
648,17624,Agonistic effect against 5-hydroxytryptamine 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615996,449.0,BAO_0000219,,
649,17624,Agonistic effect against 5-hydroxytryptamine 1A receptor using [35]GTPgammaS as radioligand in CHO cells relative to 5-HT; nd=Not determined,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615997,449.0,BAO_0000219,,
650,6563,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615998,,BAO_0000019,,
651,6563,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615999,,BAO_0000019,,
652,6563,Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by forskolin stimulated cAMP assay,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616000,,BAO_0000019,,
653,17296,Binding affinity against human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,F,,,,,,,HEK293,,51,H,8,Autocuration,1,,CHEMBL616001,722.0,BAO_0000219,,
654,6876,"Evaluated for stimulation at 1 uM concentration expressed as percent of the maximal [35S]GTP-gamma-S, binding induced by 5-hydroxytryptamine",F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616002,,BAO_0000019,,
655,6876,"Stimulation of percent maximal [35S]GTP-gamma-S, binding induced by 5-hydroxytryptamine at 1 uM; nd = not determined",F,,,,,,,,,51,H,8,Expert,1,,CHEMBL616003,,BAO_0000019,,
656,5272,In vitro agonist activity at the 5-hydroxytryptamine 1A receptor,F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616004,,BAO_0000019,,
657,5272,In vitro agonist activity at the 5-hydroxytryptamine 1A receptor; No data,F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616005,,BAO_0000019,,
658,5548,"Maximal response as a result of 5-HT1A receptor-mediated stimulation of [35S]GTP-gamma-S, binding; Not determined",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616006,,BAO_0000019,,
659,5548,"Maximal response as a result of 5-hydroxytryptamine 1A receptor-mediated stimulation of [35S]GTP-gamma-S, binding",F,,,,,,,,,51,H,8,Expert,1,,CHEMBL616007,,BAO_0000019,,
660,5548,"Maximal response as a result of 5-hydroxytryptamine 1A receptor-mediated stimulation of [35S]GTP-gamma-S, binding; Not determined",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616008,,BAO_0000019,,
661,5548,"Maximal response as a result of 5-hydroxytryptamine 1A receptor-mediated stimulation of [35S]GTP-gamma-S, binding; Not determined",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616009,,BAO_0000019,,
662,5929,"Maximal stimulation of expressed human 5-hydroxytryptamine 1A receptor assayed by [35S]GTP-gamma-S, binding",F,,,,,,,,,51,H,8,Expert,1,,CHEMBL616010,,BAO_0000019,,
663,5929,"Maximal response towards 5-hydroxytryptamine 1A receptor in human using [35S]GTP-gamma-S, as radioligand; ND means not determined",F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616011,,BAO_0000019,,
664,5929,"Maximal response towards 5-hydroxytryptamine 1A receptor in human using [35S]GTP-gamma-S, as radioligand; ND=Not determined",F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL615740,,BAO_0000019,,
665,16245,"Maximal stimulation was expressed as percentage of the maximal 5-HT response in the [35S]GTP-gamma-S, binding assay on 5-hydroxytryptamine 1A receptor",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615741,,BAO_0000019,,
666,5640,"Inhibition of 5-HT induced [35S]GTP-gamma-S, binding at human cloned 5-HT 1A receptors.",F,,,,,,,,,51,H,8,Expert,1,,CHEMBL615742,,BAO_0000019,,
667,5640,"5-hydroxytryptamine 1A receptor antagonism was evaluated by the ability to inhibit [35S]GTP-gamma-S, binding that was induced by 5-HT; Emin (%): not determined",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615743,,BAO_0000019,,
668,14509,Antagonist activity was measured against CHO cells expressing the human 5-hydroxytryptamine 1A receptor in a forskolin stimulated adenylate cyclase (FSC) assay,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615744,449.0,BAO_0000219,,
669,14509,Antagonist activity against CHO cells expressing the human 5-hydroxytryptamine 1A receptor in a forskolin stimulated adenylate cyclase (FSC) assay.,F,,,,,,,CHO,,51,H,8,Expert,1,,CHEMBL615745,449.0,BAO_0000219,,
670,15331,Affinity of compound towards 5-hydroxytryptamine 1A receptor was evaluated using radioligand binding technique,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615746,,BAO_0000357,,
671,15331,Affinity of compound towards 5-hydroxytryptamine 1A receptor was evaluated using radioligand binding technique,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615747,,BAO_0000357,,
672,6563,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615748,,BAO_0000019,,
673,6563,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay; NA indicates not available",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615749,,BAO_0000019,,
674,6563,Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by forskolin stimulated cAMP assay,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615750,,BAO_0000019,,
675,6563,Forskolin stimulated cAMP assessment of agonist activity for 5-hydroxytryptamine 1A receptor,F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616259,,BAO_0000019,,
676,6563,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616260,,BAO_0000019,,
677,5272,Antagonism of 5-hydroxytryptamine 1A receptor determined in vitro,F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616261,,BAO_0000019,,
678,5272,"Antagonism of 5-hydroxytryptamine 1A receptor was determined in vitro using a [35S]GTP-gamma-S,",F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616262,,BAO_0000019,,
679,5272,"Antagonism at the 5-hydroxytryptamine 1A receptor determined in vitro using a [35S]GTP-gamma-S, No data",F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616263,,BAO_0000019,,
680,5272,Antagonism at the 5-hydroxytryptamine 1A receptor was determined in vitro; No data,F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616264,,BAO_0000019,,
681,5272,Antagonism at the 5-hydroxytryptamine 1A receptor in vitro,F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616265,,BAO_0000019,,
682,5272,"Antagonism at the 5-hydroxytryptamine 1A receptor was determined in vitro using a [35S]GTP-gamma-S,",F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616266,,BAO_0000019,,
683,5272,"Antagonism at the 5-hydroxytryptamine 1A receptor determined in vitro using a [35S]GTP-gamma-S, No data",F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616267,,BAO_0000019,,
684,5272,Antagonism at the 5-hydroxytryptamine 1A receptor determined in vitro; No data,F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616268,,BAO_0000019,,
685,16146,Inhibition of human 5-hydroxytryptamine 1A receptor,B,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616269,,BAO_0000357,,
686,17624,Binding affinity against 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,B,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL884528,449.0,BAO_0000219,,
687,13706,Displacement of [3H]-5-HT from human 5-hydroxytryptamine 1D receptor alpha expressed in HEK 293 cells,B,,,,,,,HEK293,,105,D,9,Expert,1,,CHEMBL616270,722.0,BAO_0000219,,
688,15250,Compound was tested for the displacement of [3H]5-HT binding to cloned 5-hydroxytryptamine 1A receptor stably expressed in CHO cells,B,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL616271,449.0,BAO_0000219,,
689,17624,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing 5-hydroxytryptamine 1A receptor,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL616272,449.0,BAO_0000219,,
690,6861,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in human CYP3A4 assay,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL616273,,BAO_0000357,,
691,17200,In vitro inhibitory concentration required against [3H]8-OH-DPAT binding to cloned human 5-hydroxytryptamine 1A receptor,B,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616274,,BAO_0000357,,
692,17624,Inhibition concentration against 5-HT 1A receptor using cAMP as radioligand in CHO cells,B,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL616275,449.0,BAO_0000219,,
693,17624,Inhibition concentration against 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,B,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL616276,449.0,BAO_0000219,,
694,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by po administration,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL616277,,BAO_0000218,,
695,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by po administration; Inactive,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL616278,,BAO_0000218,,
696,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL616279,,BAO_0000218,,
697,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration; Inactive,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL616280,,BAO_0000218,,
698,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration; Partial response at the highest dose tested,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL616281,,BAO_0000218,,
699,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration; Inactive,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL616282,,BAO_0000218,,
700,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by po administration,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL616283,,BAO_0000218,,
701,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by po administration; Inactive,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL616284,,BAO_0000218,,
702,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by sc administration,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL616285,,BAO_0000218,,
703,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by sc administration; Inactive,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL616286,,BAO_0000218,,
704,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by sc administration; partial response at the highest dose tested,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL616287,,BAO_0000218,,
705,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by po administration,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL616288,,BAO_0000218,,
706,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by po administration; Inactive,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL616289,,BAO_0000218,,
707,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by po administration; Partial response at the highest dose tested,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615610,,BAO_0000218,,
708,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615611,,BAO_0000218,,
709,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration; Inactive,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615612,,BAO_0000218,,
710,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration; Partial response at the highest dose tested,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615613,,BAO_0000218,,
711,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration; partial response at the highest dose tested,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615614,,BAO_0000218,,
712,12058,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by po administration,F,In vivo,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615615,,BAO_0000218,,
713,11440,Affinity in displacing [125I](R)-DOI from rat cortical homogenate 5-HT2 receptor.,B,,,,,,,,,105093,H,4,Autocuration,1,,CHEMBL615616,,BAO_0000019,,
714,6238,Binding affinity towards 5-HT 7 receptor in rat hypothalamus membranes using [3H]5-CT as radioligand,B,,,,,,Hypothalamus,,,11923,H,8,Autocuration,1,,CHEMBL615617,,BAO_0000249,1898.0,
715,10046,Inhibitory activity against 5-HT1B receptor of rat striatal membrane homogenate using [3H]5-HT as the radioligand; nd is No Data,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL615618,,BAO_0000019,,
716,10046,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat striatal membrane homogenate using [3H]5-HT as the radioligand; nd is No Data.,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL615619,,BAO_0000019,,
717,10046,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat striatal membrane homogenate using [3H]5-HT as the radioligand.,B,,,,,,,,,10577,H,8,Expert,1,,CHEMBL615620,,BAO_0000019,,
718,167,"Inhibitory activity against human whole blood, LTB4 5-lipoxygenase was evaluated",B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL615621,,BAO_0000357,,
719,167,"Inhibitory activity against intact human PMNL, LTB4 5-lipoxygenase was evaluated",B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL615622,,BAO_0000357,,
720,11520,Compound was evaluated for the inhibition of 5-LO (lipoxygenase),F,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL615623,,BAO_0000019,,
721,11520,Compound was evaluated for the inhibition of 5-LO (5-lipoxygenase).,F,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL615624,,BAO_0000019,,
722,11520,Compound was evaluated for the inhibition of 5-LO (5-lipoxygenase).,F,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL615625,,BAO_0000019,,
723,11520,Compound was evaluated for the inhibition of 5-LO (5-lipoxygenase).,F,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL767045,,BAO_0000019,,
724,135,Inhibition of [14C]arachidonic acid conversion to 5-HETE by broken cell 5-LO isolated from guinea pig PMN,F,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL615626,,BAO_0000019,,
725,135,Inhibition of [14C]arachidonic acid conversion to 5-HETE by broken cell 5-LO isolated from guinea pig PMN; not active at the highest concentration (3 ug/mL) tested; No activity,F,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL615627,,BAO_0000019,,
726,11311,The compound was tested for inhibitory activity against 5-Lipoxygenase in guinea pig polymorphonuclear leukocytes,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL615628,,BAO_0000019,,
727,10193,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase using guinea pig supernatant at 10 uM,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL615629,,BAO_0000357,,
728,12281,Inhibitory concentration against 5-lipoxygenase from human whole blood,B,,,Homo sapiens,9606.0,,,,,55,D,9,Expert,1,,CHEMBL615630,,BAO_0000357,,
729,11311,The compound was tested for inhibitory activity against 5-Lipoxygenase in human polymorphonuclear leukocytes[PMNS],B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL615631,,BAO_0000219,,
730,12576,In vivo inhibition of 5-lipoxygenase (LTC4) in the mouse zymosan peritonitis assay at an oral dose of 30 mg/Kg,F,,,,,,,,,17087,H,8,Autocuration,1,,CHEMBL615632,,BAO_0000218,,
731,12281,Inhibitory concentration against 5-lipoxygenase from mouse macrophage,B,,,,,,,,,17087,H,8,Autocuration,1,,CHEMBL615633,,BAO_0000357,,
732,12576,In vivo inhibition of 5-lipoxygenase (LTC4) in the mouse zymosan peritonitis assay at an oral dose of 30 mg/Kg,F,,,,,,,,,17087,H,8,Autocuration,1,,CHEMBL615634,,BAO_0000218,,
733,11089,Inhibition of arachidonate 5-lipoxygenase purified from porcine leukocytes.,B,,,Sus scrofa,9823.0,,,,,55,H,8,Expert,1,,CHEMBL615635,,BAO_0000019,,
734,11006,In vitro inhibition of rat 5-Lipoxygenase,B,,,,,,,,,12166,H,8,Expert,1,,CHEMBL615636,,BAO_0000357,,
735,11481,Inhibitory activity against 5-Lipoxygenase,B,,,Rattus norvegicus,10116.0,,,,,12166,D,9,Expert,1,,CHEMBL615637,,BAO_0000357,,
736,10864,Inhibitory activity against 5-lipoxygenase in rat basophilic leukemia cells,B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL615638,702.0,BAO_0000219,,
737,3595,Inhibitory activity against 5-lipoxygenase (5-LO) in intact rat barophilic leukemia cells (RBL-1),B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL615639,702.0,BAO_0000219,,
738,11311,The compound was tested for inhibitory activity against 5-Lipoxygenase in rat RBL-1,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL615640,702.0,BAO_0000219,,
739,11311,The compound was tested for inhibitory activity against 5-Lipoxygenase in rat blood,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL615796,,BAO_0000019,,
740,11311,The compound was tested for inhibitory activity against 5-Lipoxygenase receptor in rat polymorphonuclear leukocytes[PMNS],B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL615845,,BAO_0000219,,
741,11006,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) in vitro at 1 uM,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL615846,,BAO_0000357,,
742,3595,Inhibitory activity against 5-lipoxygenase (5-LO) using broken rat barophilic leukemia cells (RBL-1)at 10 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL615847,702.0,BAO_0000219,,
743,11311,The compound was tested for inhibition of isolated 5-Lipoxygenase,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL615848,,BAO_0000357,,
744,11481,Ratio of IC50 against 5-LO and COX,B,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615849,,BAO_0000019,,
745,11006,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) in vitro at 1 uM,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL615850,,BAO_0000357,,
746,11006,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) in vitro at 1 uM; range is 20-35%,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL615851,,BAO_0000357,,
747,11311,The compound was tested for inhibition against 5-Lipoxygenase in rat polymorphonuclear leukocytes at 10 uM concentration,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL615852,,BAO_0000219,,
748,11006,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) ex vivo,F,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL615853,,BAO_0000019,,
749,4288,Compound was tested for the inhibition of type 2 5-alpha-reductase of human prostates,B,,,,,,Prostate gland,,,120,H,8,Autocuration,1,,CHEMBL884527,,BAO_0000357,2367.0,
750,7587,Percent inhibition was measured against 5-amino-4-imidazolecarboxamide ribotide transformylase(pigeon liver) enzyme at 10E-4 M inhibitory concentration,B,,,Columba livia,8932.0,,,,,22226,U,0,Autocuration,1,,CHEMBL872871,,BAO_0000019,,
751,7587,Percent inhibition was measured against 5-amino-4-imidazolecarboxamide ribotide transformylase(pigeon liver) enzyme at 10E-5 M inhibitory concentration,B,,,Columba livia,8932.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615854,,BAO_0000019,,
752,7587,Percent inhibition was measured against 5-amino-4-imidazolecarboxamide ribotide transformylase(pigeon liver) enzyme.,B,,,Columba livia,8932.0,,,,,22226,U,0,Autocuration,1,,CHEMBL767046,,BAO_0000019,,
753,11249,Compound was evaluated for the inhibition of 5-aminoimidazole-4-carboxamide ribonucleotide transformylase obtained from human at 100 uM,B,,,,,,,,,10732,H,8,Autocuration,1,,CHEMBL615855,,BAO_0000357,,
754,8003,Effect on synaptosomal uptake inhibition of 5-hydroxytryptamine (5-HT); NT = Not Tested,F,,,Rattus norvegicus,10116.0,,,,,12198,D,9,Expert,1,,CHEMBL615856,,BAO_0000019,,
755,8003,Effect on synaptosomal uptake inhibition of 5-hydroxytryptamine (5-HT),F,,,Rattus norvegicus,10116.0,,,,,12198,D,9,Expert,1,,CHEMBL615857,,BAO_0000019,,
756,8003,Effect on synaptosomal uptake inhibition of 5-hydroxytryptamine (5-HT),F,,,Rattus norvegicus,10116.0,,,,,12198,D,9,Expert,1,,CHEMBL615858,,BAO_0000019,,
757,12416,In vitro affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL615859,,BAO_0000221,10000000.0,
758,16293,Binding affinity towards human 5-hydroxytryptamine 1 receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615860,,BAO_0000357,,
759,13047,Intrinsic activity against 5-hydroxytryptamine 1 receptor using rabbit saphenous vein assay.,B,,,Oryctolagus cuniculus,9986.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615861,,BAO_0000019,,
760,13047,Binding affinity against 5-hydroxytryptamine 1 receptor using rabbit saphenous vein assay.,B,,,Oryctolagus cuniculus,9986.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615862,,BAO_0000019,,
761,13047,Binding affinity against 5-hydroxytryptamine 1D receptor using rabbit saphenous vein assay.,B,,,Oryctolagus cuniculus,9986.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615863,,BAO_0000019,,
762,13047,Binding affinity against 5-hydroxytryptamine 4 receptor using rabbit saphenous vein assay.,B,,,Oryctolagus cuniculus,9986.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615864,,BAO_0000019,,
763,10085,Ability to bind at 5-hydroxytryptamine 1 receptor of rat hippocampus by displacing [3H]5-HT,B,,,,,,Hippocampus,,,104744,H,4,Autocuration,1,,CHEMBL615865,,BAO_0000221,10000000.0,
764,10085,Ability to bind at 5-hydroxytryptamine 1 receptor of rat hippocampus by displacing [3H]5-HT,B,,,,,,Hippocampus,,,104744,H,4,Autocuration,1,,CHEMBL615866,,BAO_0000221,10000000.0,
765,10085,Ability to bind at serotonin 5-hydroxytryptamine 1 receptor of rat hippocampus by displacing [3H]5-HT,B,,,,,,Hippocampus,,,104744,H,4,Autocuration,1,,CHEMBL615867,,BAO_0000221,10000000.0,
766,9841,Ability to inhibit binding of titreated serotonin to the 5-hydroxytryptamine 1 receptor in rat brain frontal cortex membranes,B,,,,,,,,Membranes,104744,H,4,Autocuration,1,,CHEMBL615868,,BAO_0000249,,
767,8822,Binding affinity towards 5-hydroxytryptamine 1 receptor in brain cortical membranes of rat,B,,,Rattus norvegicus,10116.0,,,,,104744,D,5,Autocuration,1,,CHEMBL615869,,BAO_0000249,,
768,9806,Binding affinity towards 5-hydroxytryptamine 1 receptor in rat frontal cortex homogenates using [3H]5-HT as a radioligand,B,,,Rattus norvegicus,10116.0,,,,,104744,D,5,Autocuration,1,,CHEMBL615870,,BAO_0000019,,
769,9806,Binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT as a radioligand from rat frontal cortex homogenates,B,,,Rattus norvegicus,10116.0,,,,,104744,D,5,Autocuration,1,,CHEMBL615871,,BAO_0000019,,
770,8868,Binding affinity towards 5-hydroxytryptamine 1 receptor was measured using radioligand ([3H]5-HT) binding assay,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615872,,BAO_0000224,,
771,9036,Binding affinity towards hippocampus 5-hydroxytryptamine 1 receptor was measured using radioligand [3H]5-HT,B,,,,,,Hippocampus,,,104744,H,4,Autocuration,1,,CHEMBL833492,,BAO_0000221,10000000.0,
772,11374,Compound was evaluated for the inhibition of [3H]5-HT (concentration of 12 nM) specific binding to rat hippocampus,B,,,,,,Hippocampus,,,104744,H,4,Autocuration,1,,CHEMBL615873,,BAO_0000221,10000000.0,
773,10881,Inhibitory activity against 5-hydroxytryptamine 1 receptor by 3H ligand binding experiments.,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615479,,BAO_0000224,,
774,8822,Tested for its binding affinity towards 5-hydroxytryptamine 1 receptor in rat,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615480,,BAO_0000019,,
775,9806,Tested for its binding affinity towards 5-hydroxytryptamine 1 receptor in rat cortical membrane homogenates using radioligand ([3H]5-HT) binding assay.,B,,,Rattus norvegicus,10116.0,,,,,104744,D,5,Autocuration,1,,CHEMBL615481,,BAO_0000249,,
776,15463,Compound at 1 uM was tested for the inhibition of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL872869,,BAO_0000019,,
777,15463,Compound at 1 uM was tested for the inhibition of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615482,,BAO_0000019,,
778,14542,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT in rat brain cortex at 10 uM,B,,,,,,Brain,,,104744,H,4,Autocuration,1,,CHEMBL615483,,BAO_0000221,955.0,
779,14542,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT in rat brain cortex at 10 uM,B,,,,,,Brain,,,104744,H,4,Autocuration,1,,CHEMBL615484,,BAO_0000221,955.0,
780,8569,Percent inhibition of 5-hydroxytryptamine 1 receptor from rat cortex membrane using [3H]- serotonin as radioligand at 33 uM,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615485,,BAO_0000019,,
781,10062,Inhibition of [3H]5-HT radioligand binding against 5-hydroxytryptamine 1 receptor,B,,,Rattus norvegicus,10116.0,,,,,104744,D,5,Autocuration,1,,CHEMBL615486,,BAO_0000224,,
782,4771,Ancillary Binding affinity towards rat 5-hydroxytryptamine 1 receptor,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615487,,BAO_0000224,,
783,10062,Binding affinity determined in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1 receptor,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615488,,BAO_0000224,,
784,10062,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1 receptor,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615489,,BAO_0000224,,
785,10062,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1 receptor,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615389,,BAO_0000224,,
786,15463,Binding affinity towards 5-hydroxytryptamine 1 receptor was determined in rat cerebral cortex using [3H]5-HT as radioligand,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615390,,BAO_0000019,,
787,15463,Binding affinity towards central 5-hydroxytryptamine 1 receptor was determined in rat cerebral cortex using [3H]5-HT as radioligand,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615391,,BAO_0000019,,
788,9098,Binding affinity towards 5-hydroxytryptamine 1 receptor was determined,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615392,,BAO_0000224,,
789,3070,Affinity for 5-hydroxytryptamine 1 receptor,B,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615393,,BAO_0000019,,
790,14542,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT in rat brain cortex,B,,,,,,Brain,,,104744,H,4,Autocuration,1,,CHEMBL615394,,BAO_0000221,955.0,
791,14542,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT in rat brain cortex at 10 uM,B,,,,,,Brain,,,104744,H,4,Autocuration,1,,CHEMBL615395,,BAO_0000221,955.0,
792,6398,Compound was evaluated for 5-hydroxytryptamine 1 receptor binding,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615396,,BAO_0000224,,
793,1344,Compound was evaluated for its binding affinity to 5-hydroxytryptamine 1 receptor in rat brain using [3H]HT radioligand assay,B,,,,,,Brain,,,104744,H,4,Autocuration,1,,CHEMBL615397,,BAO_0000221,955.0,
794,11963,Displacement of binding of [3H]5-HT to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615398,,BAO_0000019,,
795,8908,Displacement of [3H]spiperone from 5-hydroxytryptamine 1 receptor of rat cortex,B,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615399,,BAO_0000019,,
796,9098,Evaluated for binding affinity towards rat cortical membranes at 5-hydroxytryptamine 1 receptor binding site by using [3H]-5-HT as a radioligand.,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615400,,BAO_0000019,,
797,8841,Binding affinity for 5-hydroxytryptamine 1 receptor of rat prefrontal cortex,B,,,Rattus norvegicus,10116.0,,,,,104744,D,5,Autocuration,1,,CHEMBL615401,,BAO_0000019,,
798,8814,Displacement of [3H]5-HT from 5-hydroxytryptamine 1 receptor of rat cortical membrane homogenates,B,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL615402,,BAO_0000019,,
799,11752,The ability to inhibit [3H]5-HT binding to 5-hydroxytryptamine 1 receptor in rat cortex,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615403,,BAO_0000019,,
800,11642,The binding affinity was measured on serotonin 5-hydroxytryptamine 1 receptor in rat brain tissue,B,,,,,,Brain,,,104744,H,4,Autocuration,1,,CHEMBL615404,,BAO_0000221,955.0,
801,11642,The compound was tested for its binding affinity towards 5-hydroxytryptamine 1 receptor by displacing [3H]5-HT radioligand in rat cerebral cortex,B,,,,,,,,,104744,H,4,Autocuration,1,,CHEMBL615781,,BAO_0000019,,
802,9231,Tested for 5-hydroxytryptamine 1 receptor binding ability by displacement of [3H]5-HT from rat brain synaptosomes,B,,,,,,Brain,,,104744,H,4,Autocuration,1,,CHEMBL615782,,BAO_0000220,955.0,
803,11351,Inhibition constant (1 uM) was measured on 5-hydroxytryptamine 1 receptor/uptake using [3H]- serotonin as radioligand in rat brain cortex.,B,,,,,,Brain,,,104744,H,4,Autocuration,1,,CHEMBL615783,,BAO_0000221,955.0,
804,4639,Compound was tested for binding affinity against 5-HT1 receptor,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL873481,,BAO_0000019,,
805,1205,Inhibitory concentration against 5-hydroxytryptamine 1 receptor,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL615784,,BAO_0000019,,
806,10025,Concentration necessary to achieve half maximal inhibition of [3H]8-Hydroxy-2-(di-n-propylamino)tetralin binding to 5-hydroxytryptamine 1A receptor at 1 uM,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615785,,BAO_0000357,,
807,13241,"Ability to inhibit 5-HT sensitive,forskolin-stimulated adenylyl cyclase(FSC) activity in rat hippocampal membranes mediated through 5-hydroxytryptamine 1A receptor",F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615786,,BAO_0000249,,
808,16245,Agonistic activity (induction of forepaw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while iv administration,F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615787,,BAO_0000218,,
809,16245,Agonistic activity (induction of forepaw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while subcutaneous administration,F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615788,,BAO_0000218,,
810,12438,Inhibition of forskolin stimulated adenylate cyclase at 5-hydroxytryptamine 1A receptor,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL767044,,BAO_0000019,,
811,16245,Agonistic activity (induction of forepaw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while iv administration,F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615789,,BAO_0000218,,
812,16245,Agonistic activity (induction of forepaw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while subcutaneous administration,F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615790,,BAO_0000218,,
813,15740,Evaluated for the 5-hydroxytryptamine 1A receptor agonist activity in LY-293284 trained rats,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615813,,BAO_0000019,,
814,15535,Percent of maximum response by 5-HT when tested for inhibition of vasoactive intestinal polypeptide-induced (VIP-induced) cAMP formation assessed in GH4ZD10 cells at 10 uM concentration,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615814,,BAO_0000219,,
815,15535,Percent inhibition of vasoactive intestinal polypeptide-induced (VIP-induced) cAMP formation in GH4ZD10 cells expressing 5-HT1A receptor at 50 uM relative to 5-HT,F,,,,,,,,,51,H,8,Expert,1,,CHEMBL615815,,BAO_0000219,,
816,15535,Percent of maximum response by 5-HT when tested for inhibition of vasoactive intestinal polypeptide-induced (VIP-induced) cAMP formation assessed in GH4ZD10 cells at 50 uM concentration; No effect,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615816,,BAO_0000219,,
817,9888,Binding affinity at [3H]8-OH-DPAT-Labeled 5-hydroxytryptamine 1A receptor sites in rat brain hippocampal membranes expressed as Hill values,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615817,,BAO_0000249,,
818,10085,Ability to bind at 5-hydroxytryptamine 1A receptor of rat hippocampus by displacing [3H]8-OH-DPAT,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615818,,BAO_0000221,10000000.0,
819,10085,Ability to bind at serotonin 5-hydroxytryptamine 1A receptors of rat hippocampus by displacing [3H]8-OH-DPAT,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615819,,BAO_0000221,10000000.0,
820,17331,Binding affinity against 5-hydroxytryptamine 1A receptor (5-HT1A) by displacement of [3H]8-OH-DPAT from rat hippocampus membranes,B,,,,,,,,Membranes,10576,H,8,Expert,1,,CHEMBL615820,,BAO_0000249,,
821,10845,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue with [3H]8-OH-DPAT,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL615821,,BAO_0000221,10000000.0,
822,10845,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue with [3H]5-HT,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL615822,,BAO_0000221,10000000.0,
823,10845,Binding affinity against 5-hydroxytryptamine 1A receptor using in rat hippocampal tissue using [3H]8-OH-DPAT as radioligand,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL615823,,BAO_0000221,10000000.0,
824,10845,Displacement of [3H]8-OH-DPAT from rat hippocampal 5-hydroxytryptamine 1A receptor; IA-Inactive,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL615824,,BAO_0000221,10000000.0,
825,10845,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue with [3H]5-HT,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL615825,,BAO_0000221,10000000.0,
826,13730,Binding affinity towards rat 5-hydroxytryptamine 1A receptor was evaluated using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615826,,BAO_0000357,,
827,13508,Binding affinity against 5-hydroxytryptamine 1A receptor in rat hippocampus membranes using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615827,,BAO_0000249,,
828,13508,Binding affinity against serotonin 5-hydroxytryptamine 1A receptor in rat hippocampus membrane using [3H]8-OH-DPAT as radioligand,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL615828,,BAO_0000249,10000000.0,
829,12073,Binding affinity by measuring displacement of [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL615829,,BAO_0000221,10000000.0,
830,4671,Binding affinity to 5-hydroxytryptamine 1A receptor of rat hippocampus with [3H]8-OH-DPAT as radioligand,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615830,,BAO_0000221,10000000.0,
831,13631,Binding affinity towards serotonin 5-HT1A receptor was determined in rat hippocampus using [3H]8-OH-DPAT as ligand,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL615831,,BAO_0000221,10000000.0,
832,12438,Binding affinity was measured against serotonin 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615832,,BAO_0000357,,
833,10483,Binding affinity to 5-hydroxytryptamine 1A receptor in rat cortex using [3H]-8-OH- DPAT as radioligand,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615833,,BAO_0000019,,
834,10483,Binding affinity to 5-hydroxytryptamine 1A receptor in rat hippocampus using [3H]-8-OH- DPAT as radioligand,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615834,,BAO_0000221,10000000.0,
835,12352,Binding affinity against 5-hydroxytryptamine 1A (5-HT1A) receptor in rat hippocampus membranes,B,,,,,,,,,10576,H,8,Intermediate,1,,CHEMBL615835,,BAO_0000249,,
836,14732,Binding affinity was measured at the serotonin 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in rat hippocampal membrane.,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615836,,BAO_0000249,10000000.0,
837,11049,Binding affinity to 5-hydroxytryptamine 1A receptor in the rat brain using [3H]8-hydroxy-2-(di-n-propylamine)tetralin as radioligand.,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL615837,,BAO_0000019,,
838,11049,Binding affinity to 5-hydroxytryptamine 1A receptor in the rat brain using [3H]8-hydroxy-2-(di-n-propylamine)tetralin as radioligand; ND-Not determined,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL615838,,BAO_0000019,,
839,13657,"Binding affinity to 5-hydroxytryptamine 1A receptor in rat hippocampus membranes,3H-8-OH-DPAT and buspirone for nonspecific binding (NSB)",B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615839,,BAO_0000249,,
840,11473,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 1A receptor in rat cortex using [3H]-8-OH-DPAT as radioligand,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL884525,,BAO_0000019,,
841,2014,Compound was evaluated for its ability to displace [3H]8-OH-DPAT from serotonin 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615840,,BAO_0000249,,
842,3086,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL615405,,BAO_0000221,10000000.0,
843,15854,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat frontal cortex using [125I]iodocyanopindolol as radio-ligand.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615406,,BAO_0000019,,
844,10922,Affinity for 5-hydroxytryptamine 1A receptor labeled with [3H]8-OH-DPAT radioligand in hippocampus tissue,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL615900,,BAO_0000221,10000000.0,
845,13346,Inhibition of [3H]8-OH-DPAT binding at serotonin 5-hydroxytryptamine 1A receptor from rat hippocampus tissue.,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL615901,,BAO_0000221,10000000.0,
846,15311,In vitro inhibition of [3H]8-OH-DPAT binding to rat 5-HT 1a receptors.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615902,,BAO_0000357,,
847,10922,Compound was measured for affinity at 5-hydroxytryptamine 1A receptor labeled with [3H]8-OH-DPAT radioligand in hippocampus tissue,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615903,,BAO_0000221,10000000.0,
848,10025,Concentration necessary to achieve half maximal inhibition of [3H]8-Hydroxy-2-(di-n-propylamino)tetralin binding to 5-hydroxytryptamine 1A receptor<br>at 1 uM,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615904,,BAO_0000357,,
849,10025,Concentration necessary to achieve half maximal inhibition of [3H]8-Hydroxy-2-(di-n-propylamino)tetralin binding to 5-hydroxytryptamine 1A receptor at 1 uM,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615905,,BAO_0000357,,
850,9742,In vitro Inhibitory activity tested at 5-hydroxytryptamine 1A receptor binding site in rat,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615906,,BAO_0000019,,
851,9742,In vitro Inhibitory activity tested at 5-hydroxytryptamine 1A receptor binding site in rat,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615907,,BAO_0000019,,
852,12304,In vitro ability to inhibit binding of radioligand [3H]8-OH-DPAT to 5-hydroxytryptamine 1A receptor in rat cerebral cortex,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615908,,BAO_0000019,,
853,15789,In vitro affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT in rat hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615909,,BAO_0000221,10000000.0,
854,9912,"In vitro binding activity against 5-hydroxytryptamine 1A receptor from homogenized rat brain, using [3H]-8-OH-DPAT as the radioligand",B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615910,,BAO_0000019,,
855,9912,"In vitro binding activity against 5-hydroxytryptamine 1A receptor from homogenized rat brain, using [3H]8-OH-DPAT as the radioligand.",B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615911,,BAO_0000019,,
856,9912,"In vitro binding activity against 5-hydroxytryptamine 1A receptor from homogenized rat brain, using [3H]8-OH-DPAT as the radioligand",B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615912,,BAO_0000019,,
857,16693,In vitro binding affinity for serotonin 5-hydroxytryptamine 1A receptor fof rat cerebral cortex using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615913,,BAO_0000019,,
858,13276,In vitro binding affinity measured on serotonin 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615914,,BAO_0000357,,
859,12678,In vitro binding affinity to 5-hydroxytryptamine 1A receptor using [125I](R)-(+)-trans-8-OH-PIPAT as radioligand in rat hippocampal homogenate,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615915,,BAO_0000221,10000000.0,
860,11825,In vitro binding affinity towards the 5-hydroxytryptamine 1A receptor was evaluated,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615916,,BAO_0000357,,
861,12443,In vitro binding affinity was measured on serotonergic 5-hydroxytryptamine 1A receptor by displacement of [3H]- tetralin,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615917,,BAO_0000357,,
862,13830,In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615918,,BAO_0000357,,
863,14286,In vitro inhibitory concentration against radioligand [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat hippocampal membrane.,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL615919,,BAO_0000249,10000000.0,
864,14356,In vitro radioligand binding assay on 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in rat hippocampus,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL615920,,BAO_0000221,10000000.0,
865,15306,Inhibition concentration against 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615921,,BAO_0000357,,
866,15306,Inhibitory concentration against 5-hydroxytryptamine 1A receptor (Inactive at >1000 nM concentration),B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615922,,BAO_0000357,,
867,16616,"Inhibition of (+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor in hippocampal membranes",F,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL881290,,BAO_0000249,,
868,3651,"Inhibition of [3H]8-hydroxy-2-dipropylamino-1,2,3,4-tetrahydronaphthalene binding to 5-hydroxytryptamine 1A receptor in hippocampus region of rat brain; Residual radioligand binding higher than 50%",B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615923,,BAO_0000221,10000000.0,
869,14331,Inhibition of forskolin-activated adenylate cyclase (cAMP) activity at 5-hydroxytryptamine 1A receptor in rat hippocampus,F,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615924,,BAO_0000221,10000000.0,
870,14331,Inhibition of forskolin-activated adenylate cyclase (cAMP) activity at 5-hydroxytryptamine 1A receptor in rat hippocampus,F,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615925,,BAO_0000221,10000000.0,
871,14178,Inhibition of radiolabeled [3H]-8-OH-DPAT ligand binding to 5-hydroxytryptamine 1A receptor,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL615926,,BAO_0000357,,
872,10639,Displacement of [3H]8-OH-DPAT from rat cortex 5-hydroxytryptamine 1A receptor,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL615927,,BAO_0000019,,
873,12306,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615928,,BAO_0000221,10000000.0,
874,1348,Inhibitory activity against 5-hydroxytryptamine 1A receptor subtype,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL615929,,BAO_0000357,,
875,13605,Inhibitory activity against [3H]DPAT binding to 5-HT1A receptor in rat hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615930,,BAO_0000221,10000000.0,
876,17624,Inhibition concentration against 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,B,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615931,449.0,BAO_0000219,,
877,17624,Inhibition concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing 5-hydroxytryptamine 1A receptor,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615932,449.0,BAO_0000219,,
878,17624,Inhibition concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing 5-hydroxytryptamine 1A receptor,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615933,449.0,BAO_0000219,,
879,15267,Inhibition of [3H]- 8-OH-DAPT binding against human recombinant 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615934,,BAO_0000357,,
880,16532,The binding affinity at the 5-hydroxytryptamine 1A receptor determined using [3H]5-CT; Not tested,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615935,,BAO_0000357,,
881,6563,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615936,,BAO_0000019,,
882,4751,Ability to displace [3H]-8-OH-DPAT from CHO cells stably transfected with human 5-hydroxytryptamine 1A receptor at a concentration of 1 uM,B,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615937,449.0,BAO_0000219,,
883,15463,Compound at 1 uM was tested for the inhibition of radioligand [3H]8-OH-DPAT binding to recombinant human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615938,,BAO_0000357,,
884,3805,In vitro binding affinity against human 5-hydroxytryptamine 1A receptor at a concentration of 100 (nM),B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615797,,BAO_0000357,,
885,5640,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615798,,BAO_0000357,,
886,6563,Inhibition of [3H]8-OH-DPAT binding to human 5-hydroxytryptamine 1A receptor at 1000 nM compound concentration,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL872870,,BAO_0000357,,
887,5548,Inhibitory activity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand at 100 nM concentration,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615799,,BAO_0000357,,
888,6347,Percent binding affinity against 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615800,,BAO_0000357,,
889,17296,Intrinsic activity for human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,F,,,,,,,HEK293,,51,H,8,Autocuration,1,,CHEMBL615801,722.0,BAO_0000219,,
890,13047,Binding affinity against 5-hydroxytryptamine 1 receptor using rabbit jugular vein assay in the absence of endothelium,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615802,,BAO_0000019,,
891,15740,Dissociation constant against human 5-hydroxytryptamine 1A receptor receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615803,,BAO_0000357,,
892,5640,"Inhibition of 5-HT induced [35S]GTP-gamma-S, binding at human cloned 5-HT 1A receptors.",F,,,,,,,,,51,H,8,Expert,1,,CHEMBL835002,,BAO_0000019,,
893,5640,"5-hydroxytryptamine 1A receptor antagonism was evaluated by the ability to inhibit [35S]GTP-gamma-S, binding that was induced by 5-HT; Ki (nM): not determined",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615804,,BAO_0000019,,
894,17211,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor,B,,,,,,,HeLa,,51,H,8,Expert,1,,CHEMBL615805,308.0,BAO_0000219,,
895,4751,Ability to displace [3H]8-OH-DPAT from CHO cells stably transfected with human 5-hydroxytryptamine 1A receptor,B,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615806,449.0,BAO_0000219,,
896,6491,Affinity towards human 5-hydroxytryptamine 1A serotonin receptor,B,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL615807,,BAO_0000357,,
897,4707,Binding affinity towards human 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT-as radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615808,,BAO_0000357,,
898,13910,Binding affinity against 5-hydroxytryptamine 1A receptor,B,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL615809,,BAO_0000357,,
899,16190,Binding affinity against 5-hydroxytryptamine 1A receptor in HeLa cells was determined using [3H]5-HT,B,,,,,,,HeLa,,51,H,8,Autocuration,1,,CHEMBL615810,308.0,BAO_0000219,,
900,16633,Binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615811,,BAO_0000357,,
901,11898,Binding affinity against [3H]- -8-OH-DPAT -labeled 5-hydroxytryptamine 1A sites in cloned CHO cells,B,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615812,449.0,BAO_0000219,,
902,11898,Binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,B,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615751,449.0,BAO_0000219,,
903,14331,Binding affinity against human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615752,,BAO_0000357,,
904,17624,Binding affinity against human 5-hydroxytryptamine 1A receptor in CHO cells labeled with [3H]8-OH-DPAT radioligand,B,,,,,,,CHO,,51,H,8,Expert,1,,CHEMBL615753,449.0,BAO_0000219,,
905,17624,Binding affinity against human 5-hydroxytryptamine 1A receptor in CHO cells labeled with [3H]8-OH-DPAT radioligand; nd=not determined,B,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL615754,449.0,BAO_0000219,,
906,3307,Binding affinity of compound to human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615755,,BAO_0000357,,
907,6563,Displacement of [3H]8-OH-DPAT from human 5-hydroxytryptamine 1A receptor expressed in CHO cells,B,,,Homo sapiens,9606.0,,,CHO,,51,D,9,Expert,1,,CHEMBL615756,449.0,BAO_0000219,,
908,14165,Binding affinity for 5-hydroxytryptamine 1A receptor in HeLa transfected cell type using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615757,,BAO_0000019,,
909,5732,Binding affinity towards cloned human 5-hydroxytryptamine 1A receptor was determined,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615758,,BAO_0000357,,
910,13366,In vitro affinity at human cloned 5-hydroxytryptamine 1A receptor by [3H]8-OH-DPAT displacement.,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL615759,,BAO_0000357,,
911,17626,Binding affinity towards human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615760,,BAO_0000357,,
912,6588,Binding affinity towards human 5-hydroxytryptamine 1A receptor by the displacement of [3H]5-HT radioligand from the cloned receptor expressed in HeLa cells,B,,,,,,,HeLa,,51,H,8,Expert,1,,CHEMBL615761,308.0,BAO_0000219,,
913,16209,Binding affinity towards human 5-hydroxytryptamine 1A receptor was determined using [3H]-5-HT as radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL872104,,BAO_0000357,,
914,15463,Binding affinity towards recombinant human 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615762,,BAO_0000357,,
915,15463,Binding affinity towards recombinant human Compound at 1 uM was tested for the inhibition of radioligand [3H]8-OH-DPAT binding to recombinant human 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615763,,BAO_0000357,,
916,14770,Binding affinity for recombinant human 5-hydroxytryptamine 1A receptor using [3H]5-HT as radioligand.,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615764,,BAO_0000357,,
917,16245,Binding affinity on human cloned 5-hydroxytryptamine 1A receptor transfected in human cell lines (He La),B,,,,,,,Cell line,,51,H,8,Autocuration,1,,CHEMBL615765,1167.0,BAO_0000219,,
918,16245,Binding affinity on human cloned 5-hydroxytryptamine 1A receptor transfected in human cell lines(He La),B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615766,,BAO_0000019,,
919,5548,Binding affinity towards 5-HT1A receptor using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615767,,BAO_0000357,,
920,5548,Binding affinity was determined towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL615768,,BAO_0000357,,
921,5548,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615769,,BAO_0000357,,
922,6876,Binding affinity was evaluated at 5-hydroxytryptamine 1A receptor labeled with [3H]-8-OH-DPAT,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL615770,,BAO_0000357,,
923,2598,Binding affinity was evaluated at human recombinant 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615771,,BAO_0000357,,
924,17785,Binding affinity to human 5-hydroxytryptamine 1A receptor was measured using [3H]-8-hydroxy-2-(di-n-propylamine) tetraline [3H]8-OH-DPAT) as radioligand,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL615772,,BAO_0000357,,
925,6013,Binding affinity towards 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615773,,BAO_0000357,,
926,5929,Binding affinity towards 5-hydroxytryptamine 1A receptor in human using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL615774,,BAO_0000357,,
927,16633,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615775,,BAO_0000357,,
928,1558,Binding affinity towards cloned human 5-hydroxytryptamine 1A receptor was determined,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615776,,BAO_0000357,,
929,16026,Binding affinity towards human cloned 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL615777,,BAO_0000357,,
930,12469,Binding affinity was measured on 5-hydroxytryptamine 1A receptor in AK cells transfected with human 5-HT1A gene labeled with [3H]-8-OH-DPAT,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615778,,BAO_0000219,,
931,15874,Binding affinity was measured on cloned Human 5-hydroxytryptamine 1A receptor which is labeled by [3H]8-OH-DPAT,B,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL615779,,BAO_0000357,,
932,15874,Binding affinity was measured on cloned human 5-hydroxytryptamine 1A receptor which is labeled by [3H]8-OH-DPAT,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL615780,,BAO_0000357,,
933,3935,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616298,,BAO_0000357,,
934,15818,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616299,,BAO_0000357,,
935,13706,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1A receptor expressed in CHO-K1 cells.,B,,,,,,,CHO-K1,,51,H,8,Autocuration,1,,CHEMBL616300,485.0,BAO_0000219,,
936,13729,Ability to inhibit the forskolin-stimulated c-AMP formation mediated by human 5-hydroxytryptamine 1A receptor in CHO-K1 cells,F,,,,,,,CHO-K1,,51,H,8,Expert,1,,CHEMBL616301,485.0,BAO_0000219,,
937,15413,In vitro inhibition of [3H]- 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616302,,BAO_0000019,,
938,15413,In vitro inhibition of [3H]- 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor (Experiment 1),B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616117,,BAO_0000019,,
939,15413,In vitro inhibition of [3H]- 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor (Experiment 2),B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616118,,BAO_0000019,,
940,15413,In vitro inhibition of [3H]- 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor by Panlabs assay,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616119,,BAO_0000019,,
941,3445,Displacement of specific [3H]- 5-HT binding to cloned human 5-hydroxytryptamine 1A receptor stably expressed in HeLa cells,B,,,Homo sapiens,9606.0,,,HeLa,,51,D,9,Expert,1,,CHEMBL616120,308.0,BAO_0000219,,
942,15740,Evaluated for the binding constant at [3H]8-OH-DPAT-labeled human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616121,,BAO_0000357,,
943,15740,Evaluated for the binding constant at [3H]8-OH-DPAT-labeled human 5-hydroxytryptamine 1A receptor receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616122,,BAO_0000357,,
944,17626,In vitro binding affinity tested on human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616123,,BAO_0000357,,
945,4234,In vitro binding affinity to human 5-hydroxytryptamine 1A receptor,B,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616124,,BAO_0000357,,
946,5640,In vitro binding affinity at 5-hydroxytryptamine 1A receptor by [3H]8-OH-DPAT displacement.,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL616125,,BAO_0000357,,
947,5272,In vitro binding affinity towards Human 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT,B,,,Rattus norvegicus,10116.0,,,,,51,H,8,Expert,1,,CHEMBL616126,,BAO_0000357,,
948,4622,In vitro binding affinity towards cloned human 5-hydroxytryptamine 1A receptor expressed in Chinese hamster ovary (CHO) cells using [3H]8-OH-DPAT as radioligand,B,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL616127,449.0,BAO_0000219,,
949,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL616128,,BAO_0000019,,
950,3025,In vitro binding affinity was determined towards cloned human 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616129,,BAO_0000357,,
951,15315,In vitro receptor binding affinity for cloned human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL616130,,BAO_0000357,,
952,15267,Inhibition of [3H]- OH-DPAT binding against 5-hydroxytryptamine 1A receptor from human recombinant,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616131,,BAO_0000357,,
953,17158,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor serotonergic receptor in human HeLa cells,B,,,,,,,HeLa,,51,H,8,Autocuration,1,,CHEMBL616132,308.0,BAO_0000219,,
954,14214,Receptor binding affinity for cloned human 5-hydroxytryptamine 1A receptor in HeLa cells,B,,,Homo sapiens,9606.0,,,HeLa,,51,D,9,Expert,1,,CHEMBL616133,308.0,BAO_0000219,,
955,17133,Tested in vitro for its ability to bind to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616134,,BAO_0000357,,
956,16532,The binding affinity at the 5-hydroxytryptamine 1A receptor determined using [3H]5-CT,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616135,,BAO_0000357,,
957,2391,Affinity for 5-hydroxytryptamine 1A receptor subtype,B,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616136,,BAO_0000357,,
958,14447,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1A receptor from cloned Human membranes,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616137,,BAO_0000019,,
959,14447,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1A receptor from cloned Human membranes.,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL872105,,BAO_0000019,,
960,15086,The compound was tested for binding affinity against 5-hydroxytryptamine 1A receptor receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616138,,BAO_0000357,,
961,13051,Binding affinity for cloned human 5-hydroxytryptamine 1A receptor,B,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616139,,BAO_0000357,,
962,16026,"Ability to influence the binding of [35S]GTP-gamma-S, to HeLa cell membranes expressing the human 5-hydroxytryptamine 1A receptor; Not active",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616140,,BAO_0000019,,
963,17085,In vitro binding affinity was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1A receptor; ND means not determined,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL616141,,BAO_0000019,,
964,17133,Tested in vitro for its ability to bind to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616142,,BAO_0000357,,
965,17133,Tested in vitro for its ability to bind to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand; ND means Not determined,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616143,,BAO_0000357,,
966,17211,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT denotes not tested,B,,,,,,,HeLa,,51,H,8,Autocuration,1,,CHEMBL616144,308.0,BAO_0000219,,
967,17211,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT=not tested,B,,,,,,,HeLa,,51,H,8,Autocuration,1,,CHEMBL616145,308.0,BAO_0000219,,
968,17211,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT denotes not tested,B,,,,,,,HeLa,,51,H,8,Autocuration,1,,CHEMBL616012,308.0,BAO_0000219,,
969,17211,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT denotes not tested,B,,,,,,,HeLa,,51,H,8,Autocuration,1,,CHEMBL616013,308.0,BAO_0000219,,
970,16394,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared with 5-HT.; NT is not tested",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616014,,BAO_0000019,,
971,16394,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared with 5-HT.; NT is not tested",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616015,,BAO_0000019,,
972,16394,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared with 5-HT.; NT is not tested",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616016,,BAO_0000019,,
973,16394,Antagonist induction of hypothermia by 8-OH-DPAT in 5-hydroxytryptamine 1A receptor after subcutaneous administration; NT is not tested,F,In vivo,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616017,,BAO_0000218,,
974,16394,Binding affinity at human 5-hydroxytryptamine 1A receptor by inhibition of [3H]-8-OH-DPAT binding in Chinese hamster ovary cell line; NT is not tested,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616018,,BAO_0000019,,
975,15740,EC50 for inhibition of 50 uM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor receptor; Not tested,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616019,,BAO_0000019,,
976,15740,EC50 for inhibition of 50 uM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor; Not tested,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616020,,BAO_0000019,,
977,15740,Evaluated for the binding constant at [3H]8-OH-DPAT-labeled human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL858018,,BAO_0000357,,
978,17296,Binding affinity against human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,F,,,,,,,HEK293,,51,H,8,Autocuration,1,,CHEMBL616021,722.0,BAO_0000219,,
979,5640,"Stimulation of binding of [35S]GTP-gamma-S, to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at 1 uM.",F,,,,,,,,,51,H,8,Expert,1,,CHEMBL616022,,BAO_0000019,,
980,5640,"Stimulation of binding of [35S]GTP-gamma-S, to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at a concentration of 1 uM; ND means Not determined",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616023,,BAO_0000019,,
981,5640,"Stimulation of binding of [35S]GTP-gamma-S, to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at a concentration of 1 uM; ND means not determined",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616024,,BAO_0000019,,
982,5640,"Stimulation of binding of [35S]GTP-gamma-S, to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at a concentration of 1 uM; Not determined",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616025,,BAO_0000019,,
983,2759,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL616026,449.0,BAO_0000219,,
984,16394,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared with 5-HT",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616027,,BAO_0000019,,
985,16394,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared to 5-HT",F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616028,,BAO_0000019,,
986,3445,Percent efficacy against human 5-hydroxytryptamine 1A receptor relative to maximal 5-HT response,F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616029,,BAO_0000019,,
987,4316,Binding affinity for 5-hydroxytryptamine 1A receptor was determined by incubating human 5-hydroxytryptamine 1A receptor transfected CHO cells with [3H]8-OH-DPAT,B,,,,,,,CHO,,51,H,8,Expert,1,,CHEMBL616030,449.0,BAO_0000219,,
988,4316,In vitro inhibition of [3H]8-OH-DPAT binding to human cloned 5-hydroxytryptamine 1A receptor on CHO cell membranes.,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL616031,,BAO_0000019,,
989,15180,Agonist efficacy on 5-hydroxytryptamine 1A receptor subtype,F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616032,,BAO_0000019,,
990,15180,Agonist efficacy on 5-hydroxytryptamine 1A receptor subtype,F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616033,,BAO_0000019,,
991,15042,Maximum binding affinity was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616034,,BAO_0000019,,
992,15042,Maximum binding affinity was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616035,,BAO_0000019,,
993,15042,Maximum binding affinity was evaluated as ([35S]GTP binding on cloned human 5-hydroxytryptamine 1A receptor,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616036,,BAO_0000019,,
994,15042,Agonist efficacy was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616037,,BAO_0000019,,
995,15042,Agonist efficacy was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616038,,BAO_0000019,,
996,15042,Agonist efficacy was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616039,,BAO_0000019,,
997,15042,Agonist efficacy was evaluated as [35S]GTP binding on cloned human 5-hydroxytryptamine 1A receptor,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616040,,BAO_0000019,,
998,15180,Concentration required to obtain 50% maximal stimulation of [35S]GTP gamma-S binding to human cloned 5-HT1A receptors of cell membranes from HeLa cells,F,,,Homo sapiens,9606.0,,,HeLa,,51,D,9,Expert,1,,CHEMBL616041,308.0,BAO_0000219,,
999,15180,Negative logarithm of concentration required to obtain 50% maximal stimulation of [35S]GTP gamma-S binding to human cloned 5-HT1A receptors of cell membranes from HeLa cells,F,,,Homo sapiens,9606.0,,,HeLa,,51,D,9,Expert,1,,CHEMBL616042,308.0,BAO_0000219,,
1000,15180,Negative logarithm of concentration required to obtain 50% maximal stimulation of [35S]GTP gamma-S binding to human cloned 5-HT1A receptors of cell membranes from HeLa cells,F,,,Homo sapiens,9606.0,,,HeLa,,51,D,9,Expert,1,,CHEMBL616043,308.0,BAO_0000219,,
1001,16245,"Potency (pD2) for the stimulation of [35S]GTP-gamma-S, binding on 5-hydroxytryptamine 1A receptor",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616044,,BAO_0000019,,
1002,16026,"Ability to influence the binding of [35S]GTP-gamma-S, to HeLa cell membranes expressing the human 5-hydroxytryptamine 1A receptor",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616045,,BAO_0000019,,
1003,17296,Binding affinity against human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,F,,,,,,,HEK293,,51,H,8,Autocuration,1,,CHEMBL616046,722.0,BAO_0000219,,
1004,2759,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor expressed in CHO cells (experiment 2),F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL616047,449.0,BAO_0000219,,
1005,2759,Compound was tested for its potency against human 5-hydroxytryptamine 1A receptor expressed in CHO cells,F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL616048,449.0,BAO_0000219,,
1006,2759,Potency against human 5-hydroxytryptamine 1A receptor expressed in CHO cells (experiment 1),F,,,Homo sapiens,9606.0,,,CHO,,51,D,9,Expert,1,,CHEMBL616049,449.0,BAO_0000219,,
1007,2759,Compound was tested for its potency against human 5-hydroxytryptamine 1A receptor expressed in CHO cells (experiment 2),F,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL616050,449.0,BAO_0000219,,
1008,15419,In vitro effective concentration required to inhibit forskolin-stimulated cAMP levels in HA7 cells expressing human 5-HT1A receptor,F,,,,,,,,,51,H,8,Expert,1,,CHEMBL616051,,BAO_0000219,,
1009,15419,In vitro effective concentration required to inhibit forskolin-stimulated cAMP levels in HA7 cells expressing human 5-HT1A receptor; Not tested,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616212,,BAO_0000219,,
1010,16026,"ability to influence the binding of [35S]GTP-gamma-S, to HeLa cell membranes expressing the human 5-hydroxytryptamine 1A receptor",F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616213,,BAO_0000019,,
1011,1414,Ability to bind to 5-hydroxytryptamine 1A receptor from cloned human expressed in Ha7 cells,B,In vitro,,,,,,,,51,H,8,Expert,1,,CHEMBL616214,,BAO_0000219,,
1012,1414,Ability to bind to 5-hydroxytryptamine 1A receptor subtype from cloned human expressed in Ha7 cells,B,In vitro,,,,,,,,51,H,8,Expert,1,,CHEMBL616215,,BAO_0000219,,
1013,12861,Binding activity radioligand.,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616216,,BAO_0000357,,
1014,12861,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand.,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616217,,BAO_0000019,,
1015,5104,Binding affinity for human cloned 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616218,,BAO_0000357,,
1016,5105,Binding affinity for human cloned 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616219,,BAO_0000357,,
1017,16312,binding affinity towards human recombinant 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616220,,BAO_0000357,,
1018,15180,Displacement of [3H]8-hydroxy-2-(di-n-propylamino)tetralin from human 5-hydroxytryptamine 1A receptor,B,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL833493,,BAO_0000357,,
1019,5033,Ability to displace the radioligand [3H]-8-OH-DPAT from human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616221,,BAO_0000357,,
1020,16909,Affinity constant on CHO cells expressing Human recombinant 5-hydroxytryptamine receptor 1A,B,,,Homo sapiens,9606.0,,,CHO,,51,D,9,Expert,1,,CHEMBL616222,449.0,BAO_0000219,,
1021,2590,Antagonistic affinity against cloned human 5-hydroxytryptamine 1A receptor,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616223,,BAO_0000019,,
1022,2590,Antagonistic affinity against cloned human 5-hydroxytryptamine 1A receptor; Not determined,F,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616224,,BAO_0000019,,
1023,16394,Binding affinity at human 5-hydroxytryptamine 1A receptor by inhibition of [3H]8-OH-DPAT binding in Chinese hamster ovary cell line,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL616225,,BAO_0000019,,
1024,4540,Binding affinity to human cloned 5-hydroxytryptamine 1A receptor in HEK 293 cells using [3H]-8-OH- DPAT as radioligand,B,,,Homo sapiens,9606.0,,,HEK293,,51,D,9,Expert,1,,CHEMBL616226,722.0,BAO_0000219,,
1025,17296,Binding affinity against 5-hydroxytryptamine 1A human cloned receptors in HEK293 cells,B,,,,,,,HEK293,,51,H,8,Autocuration,1,,CHEMBL616227,722.0,BAO_0000219,,
1026,17296,Binding affinity against 5-hydroxytryptamine 1A human cloned receptors in HEK293 cells using [3H]8-OH-DPAT as radioligand,B,,,,,,,HEK293,,51,H,8,Autocuration,1,,CHEMBL616228,722.0,BAO_0000219,,
1027,15779,Binding affinity towards 5-hydroxytryptamine 1A receptor (human cloned receptor) in HEK293 cells using [3H]8-OH-DPAT as radioligand;,B,,,,,,,HEK293,,51,H,8,Autocuration,1,,CHEMBL616229,722.0,BAO_0000219,,
1028,15779,Binding affinity towards 5-hydroxytryptamine 1A receptor (human cloned receptor) in HEK293 cells using [3H]8-OH-DPAT as radioligand; ND means no data,B,,,,,,,HEK293,,51,H,8,Autocuration,1,,CHEMBL616230,722.0,BAO_0000219,,
1029,15779,Binding affinity towards 5-hydroxytryptamine 1A receptor (human cloned receptor) in HEK293 cells using [3H]8-OH-DPAT as radioligand;ND means no data.,B,,,,,,,HEK293,,51,H,8,Autocuration,1,,CHEMBL616231,722.0,BAO_0000219,,
1030,6166,Binding affinity towards 5-hydroxytryptamine 1A receptor in human using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616232,,BAO_0000357,,
1031,15779,Binding affinity towards 5-hydroxytryptamine 1A receptor (human cloned receptor) in HEK293 cells using [3H]8-OH-DPAT as radioligand;,B,,,,,,,HEK293,,51,H,8,Autocuration,1,,CHEMBL616233,722.0,BAO_0000219,,
1032,4199,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1A receptor in HEK 293 cells using [3H]8-OH-DPAT as the radioligand,B,,,,,,,HEK293,,51,H,8,Autocuration,1,,CHEMBL857973,722.0,BAO_0000219,,
1033,15316,Compound was evaluated for its ability to displace [3H]8-OH-DPAT binding from human 5-hydroxytryptamine 1A receptor in mammalian cells,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616234,,BAO_0000219,,
1034,14875,Compound was tested for binding affinity against human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616235,,BAO_0000357,,
1035,14727,Binding affinity at human cloned 5-hydroxytryptamine 1A receptor expressed in HeLa cells by [3H]8-hydroxy-2-(di-n-propylamino)tetraline displacement.,B,,,,,,,HeLa,,51,H,8,Expert,1,,CHEMBL616236,308.0,BAO_0000219,,
1036,14727,Binding affinity at native 5-hydroxytryptamine 1A receptor in rat by [3H]8-hydroxy-2-(di-n-propylamino)tetraline displacement.,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL616237,,BAO_0000019,,
1037,15146,Compound was tested for its binding affinity against 5-hydroxytryptamine 1A receptor in human cloned receptors in HEK 293 cells using [3H]8-OH-DPAT,B,,,,,,,HEK293,,51,H,8,Autocuration,1,,CHEMBL616238,722.0,BAO_0000219,,
1038,5213,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1A receptor in HEK 293 using [3H]5-CT as a radioligand,B,,,,,,,HEK293,,51,H,8,Autocuration,1,,CHEMBL616239,722.0,BAO_0000219,,
1039,16429,In vitro binding affinity at human recombinant 5-hydroxytryptamine 1A receptor in mammalian cells using 3[H]8-OH-DPAT as the radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616240,,BAO_0000219,,
1040,15042,The binding affinity was evaluated on cloned human 5-hydroxytryptamine 1A receptor expressed in HeLa cells by using DPAT as radioligand.,B,,,Homo sapiens,9606.0,,,HeLa,,51,D,9,Expert,1,,CHEMBL616241,308.0,BAO_0000219,,
1041,14818,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1A receptor in HEK 293 cells using [3H]8-OH-DPAT.,B,,,,,,,HEK293,,51,H,8,Autocuration,1,,CHEMBL616242,722.0,BAO_0000219,,
1042,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1A receptor in HEK293 cells, using [3H]8-OH-DPAT as radioligand",B,,,,,,,HEK293,,51,H,8,Autocuration,1,,CHEMBL616243,722.0,BAO_0000219,,
1043,17200,In vitro inhibitory concentration required against [3H]8-OH-DPAT binding to cloned human 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,D,9,Expert,1,,CHEMBL616244,,BAO_0000357,,
1044,13051,The compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1A receptor,B,,,Homo sapiens,9606.0,,,,,51,D,9,Autocuration,1,,CHEMBL616245,,BAO_0000357,,
1045,5486,Binding affinity towards 5-HT1B receptor by the displacement of [3H]-5-CT] in human recombinant receptors in mammalian cell,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616246,,BAO_0000357,,
1046,5254,Binding affinity against 5-HT1D receptor,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616247,,BAO_0000357,,
1047,5254,Binding affinity against 5-hydroxytryptamine 1A receptor,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616248,,BAO_0000357,,
1048,15331,Affinity of compound towards 5-hydroxytryptamine 1A receptor was evaluated using radioligand binding technique,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL616249,,BAO_0000357,,
1049,13506,Binding affinity against serotonin 5-hydroxytryptamine 1A receptor using radioligand [3H]8-OH-DPAT binding assay,B,,,Homo sapiens,9606.0,,,,,10576,H,8,Autocuration,1,,CHEMBL616250,,BAO_0000357,,
1050,15267,Inhibition of [3H]- 8-OH-DAPT binding against human recombinant 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616251,,BAO_0000357,,
1051,16616,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice 15 min after administration of the compound,F,In vivo,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616252,,BAO_0000218,,
1052,16616,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice 30 min after administration of the compound,F,In vivo,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616253,,BAO_0000218,,
1053,16616,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice 60 min after administration of the compound,F,In vivo,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616254,,BAO_0000218,,
1054,16616,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 10 mg/kg after 15 min,F,,,Mus musculus,10090.0,,,,,11863,D,9,Expert,1,,CHEMBL616255,,BAO_0000218,,
1055,16616,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 10 mg/kg after 30 min,F,,,Mus musculus,10090.0,,,,,11863,D,9,Expert,1,,CHEMBL832872,,BAO_0000218,,
1056,16616,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 10 mg/kg after 60 min,F,,,Mus musculus,10090.0,,,,,11863,D,9,Expert,1,,CHEMBL616256,,BAO_0000218,,
1057,16616,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 1 mg/kg after 15 min,F,,,Mus musculus,10090.0,,,,,11863,D,9,Expert,1,,CHEMBL616257,,BAO_0000218,,
1058,16616,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 1 mg/kg after 30 min,F,,,Mus musculus,10090.0,,,,,11863,D,9,Expert,1,,CHEMBL616258,,BAO_0000218,,
1059,16616,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 1 mg/kg after 60 min,F,,,Mus musculus,10090.0,,,,,11863,D,9,Expert,1,,CHEMBL616384,,BAO_0000218,,
1060,10297,Hill number was determined for inhibition of of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in mouse hippocampus,B,,,,,,Hippocampus,,,11863,H,8,Autocuration,1,,CHEMBL616385,,BAO_0000221,10000000.0,
1061,13704,Inhibitory activity against serotonin 5-hydroxytryptamine 1A receptor from mice.,B,,,,,,,,,11863,H,8,Expert,1,,CHEMBL616386,,BAO_0000357,,
1062,10297,Inhibitory activity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in mouse hippocampus,B,,,Mus musculus,10090.0,,Hippocampus,,,11863,D,9,Expert,1,,CHEMBL616387,,BAO_0000221,10000000.0,
1063,10297,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in mouse hippocampus; Not determined,B,,,,,,Hippocampus,,,11863,H,8,Autocuration,1,,CHEMBL616388,,BAO_0000221,10000000.0,
1064,10297,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in mouse hippocampus,B,,,Mus musculus,10090.0,,Hippocampus,,,11863,D,9,Expert,1,,CHEMBL616389,,BAO_0000221,10000000.0,
1065,10297,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in mouse hippocampus; Not determined,B,,,,,,Hippocampus,,,11863,H,8,Autocuration,1,,CHEMBL616390,,BAO_0000221,10000000.0,
1066,217,Compound was tested for binding affinity to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as a radioligand,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616391,,BAO_0000357,,
1067,10297,Hill number was determined for inhibition of of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in mouse hippocampus,B,,,Mus musculus,10090.0,,Hippocampus,,,11863,D,9,Expert,1,,CHEMBL616392,,BAO_0000221,10000000.0,
1068,4921,Ability to displace [3H]8-OH-DPAT radioligand from porcine 5-hydroxytryptamine 1A receptor,B,,,Sus scrofa,9823.0,,,,,51,H,8,Autocuration,1,,CHEMBL616393,,BAO_0000357,,
1069,4921,Ability to displace [3H]8-OH-DPAT radioligand from porcine 5-hydroxytryptamine 1A receptor; ND denotes not determined,B,,,Sus scrofa,9823.0,,,,,51,H,8,Autocuration,1,,CHEMBL616394,,BAO_0000357,,
1070,4996,Binding affinity of compound measured for 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT-labeled porcine brain homogenates,B,,,Sus scrofa,9823.0,,,,,51,H,8,Autocuration,1,,CHEMBL616395,,BAO_0000019,,
1071,12918,Compound was evaluated for the binding affinity at 5- HT1A receptor,B,,,Sus scrofa,9823.0,,,,,51,H,8,Autocuration,1,,CHEMBL616396,,BAO_0000357,,
1072,5333,Compound was tested in vitro for its ability to compete with [3H]8-OH-DPAT at 5-hydroxytryptamine 1A receptor in porcine brain homogenate,B,,,Sus scrofa,9823.0,,,,,51,H,8,Autocuration,1,,CHEMBL872907,,BAO_0000019,,
1073,4437,In vitro for its ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in porcine brain homogenate,B,,,Sus scrofa,9823.0,,,,,51,H,8,Autocuration,1,,CHEMBL616397,,BAO_0000019,,
1074,1742,Compound was tested for its ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in pig cortex,B,,,Sus scrofa,9823.0,,,,,51,H,8,Autocuration,1,,CHEMBL616398,,BAO_0000019,,
1075,16688,Displacement of [3H]- 8-OH-DPAT from porcine 5-hydroxytryptamine 1A receptor,B,,,Sus scrofa,9823.0,,,,,51,H,8,Expert,1,,CHEMBL616399,,BAO_0000357,,
1076,12861,Binding activity radioligand.,B,,,Sus scrofa,9823.0,,,,,51,H,8,Autocuration,1,,CHEMBL857065,,BAO_0000357,,
1077,12861,Binding activity against 5-hydroxytryptamine 1A receptor from pig cortex membrane using [3H]8-OH-DPAT-HT as radioligand.,B,,,Sus scrofa,9823.0,,,,,51,H,8,Expert,1,,CHEMBL616400,,BAO_0000019,,
1078,12861,Binding activity against 5-hydroxytryptamine 1A receptor from pig cortex membrane using [3H]8-OH-DPAT-HT as radioligand.,B,,,Sus scrofa,9823.0,,,,,51,H,8,Autocuration,1,,CHEMBL616401,,BAO_0000019,,
1079,12490,Displacement of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor from pig cortex,B,,,,,,,,,10624,H,8,Expert,1,,CHEMBL616402,,BAO_0000019,,
1080,11828,Displacement of [3H]8-OH-DPAT from pig cortex 5-hydroxytryptamine 1A receptor,B,,,Sus scrofa,9823.0,,,,,51,H,8,Expert,1,,CHEMBL616403,,BAO_0000019,,
1081,11866,Binding affinity for 5-hydroxytryptamine 1A receptor in piglet hippocampus using [3H]8-OH-DPAT,B,,,Sus scrofa,9823.0,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL616404,,BAO_0000221,10000000.0,
1082,12827,Binding affinity towards 5-hydroxytryptamine 1A receptor in pig frontal cortex membranes using [8H]-OH-DPAT,B,,,Sus scrofa,9823.0,,,,,51,H,8,Autocuration,1,,CHEMBL616405,,BAO_0000249,,
1083,12918,Binding affinity was evaluated by 5-hydroxytryptamine 1A receptor agonism in the pig cortex by displacing 8-OH-DPAT,B,,,Sus scrofa,9823.0,,,,,51,H,8,Autocuration,1,,CHEMBL616406,,BAO_0000019,,
1084,12919,Agonistic activity against 5-hydroxytryptamine 1A receptor in pig cortex using [3H]8-OH-DPAT,F,,,Sus scrofa,9823.0,,,,,51,H,8,Expert,1,,CHEMBL616407,,BAO_0000019,,
1085,13047,Binding affinity against 5-hydroxytryptamine 1 receptor using rabbit jugular vein assay in the presence of endothelium,B,,,Oryctolagus cuniculus,9986.0,,,,,51,H,8,Autocuration,1,,CHEMBL616408,,BAO_0000019,,
1086,15796,Inhibition activity against 5-hydroxytryptamine 1A receptor in rat hippocampus membranes using radio binding assays,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL616409,,BAO_0000249,,
1087,3651,"Inhibition of [3H]8-hydroxy-2-dipropylamino-1,2,3,4-tetrahydronaphthalene binding to 5-hydroxytryptamine 1A receptor in hippocampus region of rat brain; Less active",B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL616410,,BAO_0000221,10000000.0,
1088,188,Tested for the effect on binding at 5-hydroxytryptamine 1A receptor; No activity,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616411,,BAO_0000357,,
1089,16616,"Antagonist activity to stimulate binding of [35S]GTP-gamma-S, to 5-hydroxytryptamine 1A receptor in isolated rat hippocampal membranes",F,,,Rattus norvegicus,10116.0,,,,Membranes,10576,D,9,Expert,1,,CHEMBL616412,,BAO_0000249,,
1090,16616,"Inhibition of (+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding in rat hippocampal membranes",F,,,Rattus norvegicus,10116.0,,Hippocampus,,Membranes,10576,D,9,Expert,1,,CHEMBL616413,,BAO_0000249,10000000.0,
1091,12306,The binding of [125I]MPPI ligand to 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616414,,BAO_0000221,10000000.0,
1092,17167,Binding affinity for rat hippocampus 5-hydroxytryptamine 1A receptor by inhibition of [3H]8-OH-DPAT binding,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL616415,,BAO_0000221,10000000.0,
1093,14776,Binding affinity measured at the 5-hydroxytryptamine 1A receptor by the inhibition of [3H]8-OH-DPAT binding to rat cortex using unlabeled buspirone for nonspecific binding.,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616416,,BAO_0000019,,
1094,12158,Binding affinity of 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616417,,BAO_0000357,,
1095,13481,Binding affinity of [3H]- -8-OH-DPAT labelled towards Rat Hippocampal 5-hydroxytryptamine 1A receptor using radioligand binding assay,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616418,,BAO_0000357,,
1096,13427,Binding affinity of [3H]-8-OH-DPAT towards 5-hydroxytryptamine 1A receptor in cloned mammalian receptor expressed in cultured cells or from rat whole brain.,B,In vitro,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616419,,BAO_0000219,,
1097,10210,Binding affinity of compound against 5-hydroxytryptamine 1A receptor binding site using radioligand [3H]8-OH-DPAT,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616420,,BAO_0000357,,
1098,10205,Binding affinity of compound towards 5-HT 1A receptor by measuring ability to displace [3H]OH-DPAT from 5-hydroxytryptamine 1A receptor in rat striatal membranes,B,,,,,,,,Membranes,10576,H,8,Autocuration,1,,CHEMBL616421,,BAO_0000249,,
1099,10205,Binding affinity of compound towards 5-HT 1A receptor by measuring ability to displace [3H]OH-DPAT from 5-hydroxytryptamine 1A receptor in rat striatal membranes,B,,,,,,,,Membranes,10576,H,8,Autocuration,1,,CHEMBL616422,,BAO_0000249,,
1100,10205,Binding affinity of compound towards 5-hydroxytryptamine 1A receptor in rat striatal membranes by [3H]OH-DPAT displacement.,B,,,,,,,,Membranes,10576,H,8,Expert,1,,CHEMBL616423,,BAO_0000249,,
1101,12280,Binding affinity for 5-hydroxytryptamine 1A receptor with [3H]5-HT,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL616424,,BAO_0000357,,
1102,17386,Binding affinity to the rat 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616425,,BAO_0000357,,
1103,13654,Binding affinity was tested on 5-hydroxytryptamine 1A receptor using radioligand [3H]5-HT binding assay.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616426,,BAO_0000357,,
1104,14423,Binding affinity against 5-hydroxytryptamine 1A receptor from rat hippocampus using [3H]8-OH-DPAT as the radioligand.,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616427,,BAO_0000221,10000000.0,
1105,15412,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampus tissue.,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616428,,BAO_0000221,10000000.0,
1106,12073,Binding affinity by measuring displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616290,,BAO_0000221,10000000.0,
1107,4101,Displacement of [3H]8-OH-DPAT from rat striata 5-hydroxytryptamine 1A receptor,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL616052,,BAO_0000357,,
1108,10062,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616053,,BAO_0000357,,
1109,6238,Binding affinity towards 5-HT 1A receptor in rat cerebral cortex membranes using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616054,,BAO_0000249,,
1110,16273,Binding affinity towards 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616055,,BAO_0000357,,
1111,11139,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in competitive binding assay,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616056,,BAO_0000357,,
1112,16796,Binding affinity towards 5-hydroxytryptamine 1A receptor from rat hippocampal membranes,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616057,,BAO_0000019,,
1113,9548,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat brain,B,,,Rattus norvegicus,10116.0,,Brain,,,10576,D,9,Expert,1,,CHEMBL616058,,BAO_0000221,955.0,
1114,10381,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat brain,B,,,,,,Brain,,,10576,H,8,Autocuration,1,,CHEMBL616059,,BAO_0000221,955.0,
1115,13408,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat hypocampus membrane using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616060,,BAO_0000249,,
1116,13825,Binding affinity towards 5-hydroxytryptamine 1A receptor in the rat brain (hippocampus) using [3H]8-OH-DPAT,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL616061,,BAO_0000221,10000000.0,
1117,11147,Binding affinity towards 5-hydroxytryptamine 1A receptor of rat hippocampus using [3H]-8-hydroxy-2-(di-n-propylamine) tetralin (8-OH-DPAT) as a radioligand,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616062,,BAO_0000221,10000000.0,
1118,10552,Binding affinity towards 5-hydroxytryptamine 1A receptor sites in cortical membranes using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616063,,BAO_0000249,,
1119,10552,"Binding affinity towards 5-hydroxytryptamine 1A receptor sites, in rat striatum membranes using [3H]- sandoz 205-501 as radioligand",B,,,,,,Striatum,,,10576,H,8,Autocuration,1,,CHEMBL616064,,BAO_0000249,2435.0,
1120,17136,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat cortex membranes,B,,,Rattus norvegicus,10116.0,,,,Membranes,10576,D,9,Expert,1,,CHEMBL616065,,BAO_0000249,,
1121,5778,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat cerebral cortex membranes,B,,,Rattus norvegicus,10116.0,,,,Membranes,10576,D,9,Expert,1,,CHEMBL616066,,BAO_0000249,,
1122,13481,Binding affinity towards rat hippocampal 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616067,,BAO_0000221,10000000.0,
1123,13481,Binding affinity towards rat hippocampal 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand; Not tested,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616068,,BAO_0000221,10000000.0,
1124,13630,Binding affinity against rat hippocampal 5-hydroxytryptamine 1A (5-HT1A) receptor determined using [3H]8-OH-DPAT as radioligand,B,,,,,,Hippocampus,,,10576,H,8,Intermediate,1,,CHEMBL616069,,BAO_0000221,10000000.0,
1125,16245,Binding was determined on 5-hydroxytryptamine 1A receptor in rat hippocampal membranes,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616070,,BAO_0000249,,
1126,14509,Binding affinity was evaluated against 5-hydroxytryptamine 1A receptor on rat hippocampus using [3H]8-OH-DPAT as radioligand,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616071,,BAO_0000221,10000000.0,
1127,14509,Binding affinity against 5-hydroxytryptamine 1A receptor on rat hippocampus using [3H]8-OH-DPAT as radioligand.,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616072,,BAO_0000221,10000000.0,
1128,14509,Binding affinity was evaluated against 5-hydroxytryptamine 1A receptor on rat hippocampus using [3H]8-OH-DPAT as radioligand.; ND = Not determined,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616073,,BAO_0000221,10000000.0,
1129,14509,Binding affinity was evaluated against 5-hydroxytryptamine 1A receptor on rat hippocampus using [3H]8-OH-DPAT as radioligand; ND = Not determined,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616074,,BAO_0000221,10000000.0,
1130,14256,Binding affinity was evaluated by determining in vitro displacement of [3H]8-OH-DPAT from the central 5-hydroxytryptamine 1A receptor recognition site in rat frontal cortex homogenate.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616075,,BAO_0000019,,
1131,11139,Binding affinity was evaluated by using [3H]8-OH-DPAT radioligand by using competitive binding assay on 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616076,,BAO_0000357,,
1132,11047,Binding affinity for 5-HT1A measured by displacing [3H]8-OH-DPAT from rat cortical membranes; Not determined,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL616077,,BAO_0000019,,
1133,11047,Binding affinity for 5-hydroxytryptamine 1A receptor measured by displacing [3H]8-OH-DPAT from rat cortical membranes,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL616078,,BAO_0000019,,
1134,11047,Binding affinity for 5-hydroxytryptamine 1A receptor measured by displacing [3H]8-OH-DPAT from rat cortical membranes;ND-Not determined,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL616079,,BAO_0000019,,
1135,2395,Binding affinity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor expressed in CHO-K1 cells,B,,,Rattus norvegicus,10116.0,,,CHO-K1,,10576,D,9,Expert,1,,CHEMBL616080,485.0,BAO_0000219,,
1136,9699,Binding affinity towards 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616081,,BAO_0000357,,
1137,12028,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [125I]trans-8-OH-PIPAT in membrane homogenates of hippocampal tissue of rat brain,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL616082,,BAO_0000221,10000000.0,
1138,12028,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in membrane homogenates of hippocampal tissue of rat brain,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616083,,BAO_0000221,10000000.0,
1139,5815,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat cerebral cortex,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616084,,BAO_0000019,,
1140,16616,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenates,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616085,,BAO_0000019,,
1141,5815,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat cerebral cortex using [3H]-8-OH-DPAT,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616086,,BAO_0000019,,
1142,2761,"Binding affinity towards 5-hydroxytryptamine 1A receptor using 0.1 nM [3H]-8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)tet-ralin), from rat hippocampal homogenate",B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616087,,BAO_0000221,10000000.0,
1143,13133,Binding affinity was determined against 5-hydroxytryptamine 1A receptor using [3H]WB-4101,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616088,,BAO_0000357,,
1144,10444,Binding affinity was determined against 5-hydroxytryptamine 1A receptor was determined in male Sprague-Dawley rat brain.,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616089,,BAO_0000019,,
1145,13278,Binding affinity was measured against 5-hydroxytryptamine 1A receptor by displacement of [3H]8-OH-DPAT by lysergic acid amides,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL616090,,BAO_0000357,,
1146,15874,Binding affinity was measured on cloned rat 5-hydroxytryptamine 1A receptor which is labeled by [3H]8-OH-DPAT,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616091,,BAO_0000357,,
1147,10552,"Binding affinity of the compound towards 5-hydroxytryptamine 1A receptor sites, in rat striatum membranes using [3H]- sandoz 205-501 as radioligand",B,,,,,,Striatum,,Membranes,10576,H,8,Autocuration,1,,CHEMBL616092,,BAO_0000249,2435.0,
1148,11130,Binding constant against 5-hydroxytryptamine 1A receptor (in vitro),B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616093,,BAO_0000357,,
1149,11130,Binding constant against 5-hydroxytryptamine 1A receptor (in vivo),B,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616094,,BAO_0000218,,
1150,14542,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]-8-OH- -DPAT in rat brain cortex,B,,,,,,Brain,,,10576,H,8,Autocuration,1,,CHEMBL616095,,BAO_0000221,955.0,
1151,13670,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL616096,,BAO_0000357,,
1152,9888,Binding affinity at [3H]8-OH-DPAT-Labeled 5-hydroxytryptamine 1A receptor sites in rat brain hippocampal membranes,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616097,,BAO_0000249,,
1153,3678,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat hippocampus membranes,B,,,Rattus norvegicus,10116.0,,,,Membranes,10576,D,9,Expert,1,,CHEMBL616098,,BAO_0000249,,
1154,11332,Compound was evaluated for in vitro binding affinity towards 5-hydroxytryptamine 1A receptor in rat hippocampus using [3H]8-OH-DPAT as radioligand,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616099,,BAO_0000221,10000000.0,
1155,11332,Compound was evaluated for in vitro binding affinity towards serotonin 5-hydroxytryptamine 1A receptor receptor in rat hippocampus using [3H]8-OH-DPAT as radioligand,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616100,,BAO_0000221,10000000.0,
1156,1185,Ability to displace [3H]-8-OH-DPAT from serotonergic 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616101,,BAO_0000357,,
1157,2014,Binding affinity at 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes by [3H]8-OH-DPAT displacement.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616102,,BAO_0000249,,
1158,1185,Compound was evaluated for its ability to displace [3H]8-OH-DPAT from serotonergic 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616103,,BAO_0000357,,
1159,14429,Compound was evaluated for its binding affinity against 5-hydroxytryptamine 1A receptor from rat cerebral cortex,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616104,,BAO_0000019,,
1160,16288,"Binding affinity to 5-hydroxytryptamine 1A receptor (5-HT 1A receptor, serotonin receptor) from rat cortex using [3H]8-OH-DPAT as radioligand",B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616105,,BAO_0000019,,
1161,5432,Displacement of [3H]prazosin from rat cortex membrane 5-hydroxytryptamine 1A receptor,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL616106,,BAO_0000019,,
1162,14429,Compound was evaluated for its binding affinity with 5-hydroxytryptamine 1A receptor using membranes prepared from rat cerebral cortex,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616107,,BAO_0000019,,
1163,13672,Binding affinity towards rat 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT radioligand.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616108,,BAO_0000357,,
1164,11296,In vitro ability to displace [3H]8-hydroxy-2-(di-n-propylamino) tetralin binding from 5-hydroxytryptamine 1A receptor site in rat brain hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616109,,BAO_0000221,10000000.0,
1165,11296,In vitro ability to displace [3H]8-hydroxy-2-(di-n-propylamino) tetralin binding from 5-hydroxytryptamine 1A receptor site.,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616110,,BAO_0000357,,
1166,14749,Binding affinity against rat 5-hydroxytryptamine 1A receptor in CHO cells.,B,,,,,,,CHO,,10576,H,8,Expert,1,,CHEMBL616111,449.0,BAO_0000219,,
1167,15086,Binding affinity towards 5-hydroxytryptamine 1A receptor from rat brain using [3H]-8-OH-DPAT as radioligand,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616112,,BAO_0000019,,
1168,13462,Compound was tested for the Binding affinity against rat hippocampal 5-hydroxytryptamine 1A receptor by Radio ligand [3H]8-OH-DPAT binding assay.,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616113,,BAO_0000221,10000000.0,
1169,15363,Compound was tested for the displacement of [3H]-8-OH- DPAT from rat brain 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616114,,BAO_0000019,,
1170,15363,Compound was tested for the displacement of [3H]-8-OH- DPAT from rat brain 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616115,,BAO_0000019,,
1171,10796,Compound was tested in vitro for binding affinity for 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616116,,BAO_0000357,,
1172,12816,Binding affinity for 5-hydroxytryptamine 1A receptor in rat brain tissue using [3H]8-OH-DPAT as radioligand,B,,,,,,Brain,,,10576,H,8,Expert,1,,CHEMBL615844,,BAO_0000221,955.0,
1173,13542,In vitro displacement of [3H]8-OH-DPAT binding to rat hippocampal 5-hydroxytryptamine 1A receptor,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL615939,,BAO_0000221,10000000.0,
1174,13308,In vitro ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor sites of rat brain cortex.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615940,,BAO_0000019,,
1175,13541,In vitro affinity at 5-hydroxytryptamine 1A receptor of rat hippocampus by [3H]8-OH-DPAT displacement.,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL615941,,BAO_0000221,10000000.0,
1176,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-HT1A receptor of rat hippocampus and the value ranges from 9 - 12,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615942,,BAO_0000221,10000000.0,
1177,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615943,,BAO_0000221,10000000.0,
1178,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus (94%CI) from 12 to 17,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615944,,BAO_0000221,10000000.0,
1179,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus (94%CI) from 391-841,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615945,,BAO_0000221,10000000.0,
1180,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 12 to 17.,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615946,,BAO_0000221,10000000.0,
1181,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 12 to 20.,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615947,,BAO_0000221,10000000.0,
1182,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 245 to 736,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615948,,BAO_0000221,10000000.0,
1183,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 25 - 84,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615949,,BAO_0000221,10000000.0,
1184,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 48 to 59,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615950,,BAO_0000221,10000000.0,
1185,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 3 -5,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615951,,BAO_0000221,10000000.0,
1186,10058,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and value ranges from 15 - 31,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615952,,BAO_0000221,10000000.0,
1187,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and value ranges from 27 - 42,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615953,,BAO_0000221,10000000.0,
1188,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and value ranges from 6 - 13,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615954,,BAO_0000221,10000000.0,
1189,10058,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL615955,,BAO_0000221,10000000.0,
1190,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus.; ND is No Data.,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615956,,BAO_0000221,10000000.0,
1191,10058,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus. and the value ranges from 16 - 27,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL615957,,BAO_0000221,10000000.0,
1192,12879,Displacement of [3H]2-(di-N-propylamino)-8-hydroxytetralin from central 5-hydroxytryptamine 1A receptor recognition sites in rat frontal cortex homogenates.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615958,,BAO_0000019,,
1193,11964,Displacement of radioligand [3H]2-(di-N-propylamino)-8-hydroxytetralin from 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenate,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615959,,BAO_0000019,,
1194,11964,Displacement of radioligand [3H]2-(di-N-propylamino)-8-hydroxytetralin from 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenate (experiment 1),B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615960,,BAO_0000019,,
1195,11964,Displacement of radioligand [3H]2-(di-N-propylamino)-8-hydroxytetralin from 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenate (experiment 2),B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615961,,BAO_0000019,,
1196,9548,Evaluated for binding affinity towards 5-hydroxytryptamine 1A receptor in rat brain,B,,,,,,Brain,,,10576,H,8,Expert,1,,CHEMBL615962,,BAO_0000221,955.0,
1197,9098,Evaluated for the binding affinity to hippocampus striatal membranes at 5-hydroxytryptamine 1A receptor binding site by using [3H]-8-OH- DPAT as a radioligand.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615963,,BAO_0000019,,
1198,9098,Evaluated for the binding affinity to hippocampus striatal membranes at 5-hydroxytryptamine 1A receptor binding site by using [3H]-8-OH- DPAT as a radioligand; ND is no data.,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615964,,BAO_0000019,,
1199,9098,Evaluated for the binding affinity to hippocampus striatal membranes at 5-hydroxytryptamine 1A receptor binding site by using [3H]-8-OH- DPAT as a radioligand;ND means no data,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615965,,BAO_0000019,,
1200,13248,In vitro displacement of radioactively labeled ligand [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor site in CHO cells,B,,,,,,,CHO,,10576,H,8,Expert,1,,CHEMBL615966,449.0,BAO_0000219,,
1201,3147,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat cortical membranes,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615967,,BAO_0000249,,
1202,13949,In vitro binding affinity against 5-hydroxytryptamine 1A receptor of rat cerebral cortex using [3H]8-OH-DPAT as radioligand.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615968,,BAO_0000019,,
1203,11883,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand in CHO cells (sc),B,,,,,,,CHO,,10576,H,8,Autocuration,1,,CHEMBL615969,449.0,BAO_0000218,,
1204,11883,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT (agonist) as radioligand (sc),B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615970,,BAO_0000218,,
1205,11883,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL615971,,BAO_0000357,,
1206,15535,In vitro binding affinity at 5-HT1A receptors assayed by displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampal membranes,B,,,,,,,,Membranes,10576,H,8,Expert,1,,CHEMBL615972,,BAO_0000249,,
1207,15535,In vitro binding affinity at 5-HT1A receptor by measuring its ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampal membranes + cortex,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615973,,BAO_0000249,,
1208,15535,In vitro binding affinity at 5-HT1A receptor by measuring its ability to displace [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampal membranes+cortex,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615974,,BAO_0000249,,
1209,16372,Displacement of [3H]8-OH-DPAT from human 5-hydroxytryptamine 1A receptor expressed in CHO cells,B,,,Homo sapiens,9606.0,,,CHO,,51,D,9,Expert,1,,CHEMBL615975,449.0,BAO_0000219,,
1210,14608,In vitro binding affinity for 5-hydroxytryptamine 1A receptor in rat hippocampal membranes by [125I]-labeled agonist displacement.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615976,,BAO_0000249,,
1211,4795,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat hippocampus,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL872106,,BAO_0000221,10000000.0,
1212,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615977,,BAO_0000357,,
1213,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=100-230,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615978,,BAO_0000357,,
1214,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=12-14,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616166,,BAO_0000357,,
1215,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=16-20,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616167,,BAO_0000357,,
1216,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=160-430,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616168,,BAO_0000357,,
1217,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=174-224,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616169,,BAO_0000357,,
1218,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=184-503,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616170,,BAO_0000357,,
1219,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=19-23,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616171,,BAO_0000357,,
1220,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT as radioligand; range=2.2-3.2,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616172,,BAO_0000357,,
1221,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=2.7-3.6,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616173,,BAO_0000357,,
1222,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=20-23,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616174,,BAO_0000357,,
1223,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT as radioligand; range=21-28,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616175,,BAO_0000357,,
1224,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=240-760,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616176,,BAO_0000357,,
1225,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT as radioligand; range=39-87,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616177,,BAO_0000357,,
1226,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=4.6-5.2,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616178,,BAO_0000357,,
1227,9742,Inhibitory activity tested in vitro at 5-hydroxytryptamine 1A receptor binding site in rat,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616179,,BAO_0000019,,
1228,12073,Inhibitory concentration against 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616180,,BAO_0000357,,
1229,4101,Inhibitory concentration against binding of 5-hydroxytryptamine 1A receptor from striata of male Wistar rats by displacement of [3H]8-OH-DPAT,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616181,,BAO_0000357,,
1230,15360,Inhibitory concentration against radioligand [3H]hydroxy-2-(di-n-propylamino)-tetralin binding to 5-hydroxytryptamine 1A receptor in rat,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616182,,BAO_0000019,,
1231,11576,Inhibitory concentration against radioligand [3H]8-OH-DPAT binding to rat hippocampal 5-hydroxytryptamine 1A receptor,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616183,,BAO_0000221,10000000.0,
1232,5834,Inhibition of the 5-hydroxytryptamine 1A receptor in rat dorsal raphe,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615874,,BAO_0000019,,
1233,2395,Inhibitory concentration against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor expressed in CHO-K1 cells,B,,,Rattus norvegicus,10116.0,,,CHO-K1,,10576,D,9,Expert,1,,CHEMBL615875,485.0,BAO_0000219,,
1234,1375,Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1A receptor in rat cortex using [3H]OH-DPAT radioligand,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615876,,BAO_0000019,,
1235,1375,Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1A receptor in rat cortex using [3H]OH-DPAT radioligand; NT means not tested,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615877,,BAO_0000019,,
1236,3967,The compound was evaluated for the ability to displace [3H]- 8-OH -DPAT from 5-hydroxytryptamine 1A receptor ( striata of male wistar rats),B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615878,,BAO_0000357,,
1237,12884,Binding affinity towards 5-hydroxytryptamine 1A receptor binding site using [3H]8-OH-DPAT. ,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615879,,BAO_0000357,,
1238,2343,Binding affinity towards 5-hydroxytryptamine 1A receptor using receptor binding assay,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL615880,,BAO_0000357,,
1239,11511,"The compound was tested in vitro for inhibitory activity against 5-HT1A receptor in rats, using [3H]8-OH-DPAT as radioligand",B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615881,,BAO_0000019,,
1240,11511,"Inhibitory activity against 5-hydroxytryptamine 1A receptor in rats, using [3H]8-OH-DPAT as radioligand",B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL615882,,BAO_0000019,,
1241,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat,F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615883,,BAO_0000218,,
1242,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.10-6.20),F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615884,,BAO_0000218,,
1243,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.20-1.60),F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615885,,BAO_0000218,,
1244,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.20-1.80),F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615886,,BAO_0000218,,
1245,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.37-4.27),F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615887,,BAO_0000218,,
1246,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.40-2.70),F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615888,,BAO_0000218,,
1247,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.40-4),F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615889,,BAO_0000218,,
1248,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.45-4.51),F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615890,,BAO_0000218,,
1249,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.50-5.30),F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615891,,BAO_0000218,,
1250,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.60-1.60),F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615892,,BAO_0000218,,
1251,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.72-2.87),F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615893,,BAO_0000218,,
1252,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.80-5.80),F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615894,,BAO_0000218,,
1253,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (1.50-16.5),F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615895,,BAO_0000218,,
1254,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (2.20-30.5),F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615896,,BAO_0000218,,
1255,16394,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges is not computable,F,In vivo,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615897,,BAO_0000218,,
1256,16616,"Percent increase of R(+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor in isolated rat hippocampal membranes",F,,,Rattus norvegicus,10116.0,,,,Membranes,10576,D,9,Expert,1,,CHEMBL615898,,BAO_0000249,,
1257,16796,% inhibition towards 5-HT1A receptor from rat hippocampal membranes,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL615899,,BAO_0000019,,
1258,16796,% inhibition towards 5-hydroxytryptamine 1A receptor from rat hippocampal membranes,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616291,,BAO_0000019,,
1259,15629,Tested in vitro for % inhibition against (serotonin)5-HT 1A receptor.,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616292,,BAO_0000357,,
1260,13241,"Ability to inhibit 5-HT sensitive,forskolin-stimulated adenylyl cyclase(FSC) activity in rat hippocampal membranes mediated through 5-hydroxytryptamine 1A receptor",F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616293,,BAO_0000249,,
1261,12073,Measurement of binding affinity by displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616294,,BAO_0000221,10000000.0,
1262,14286,Compound at 10E-5 M was tested in vitro for the inhibition of radioligand [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat hippocampal membrane,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616295,,BAO_0000249,10000000.0,
1263,14542,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]-8-OH- -DPAT in rat brain cortex at 10 uM,B,,,,,,Brain,,,10576,H,8,Autocuration,1,,CHEMBL616296,,BAO_0000221,955.0,
1264,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM + 10 uM 5-HT.,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616297,,BAO_0000019,,
1265,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0+ 1 uM 5-HT.,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616605,,BAO_0000019,,
1266,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.01 uM+ 1 uM 5-HT.,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616606,,BAO_0000019,,
1267,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.05 uM,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616607,,BAO_0000019,,
1268,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.05 uM,F,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616608,,BAO_0000019,,
1269,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.05 uM+ 1 uM 5-HT.,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616609,,BAO_0000019,,
1270,13630,Effect against 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at 0.1 uM dose,F,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL616610,,BAO_0000019,,
1271,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM + 10 uM 5-HT.,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616611,,BAO_0000019,,
1272,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM + 1 uM 5-HT.,F,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616612,,BAO_0000019,,
1273,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM + 0.1 uM 5-HT.,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616613,,BAO_0000019,,
1274,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 10 uM,F,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616614,,BAO_0000019,,
1275,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 10 uM+ 10 uM 5-HT.,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616615,,BAO_0000019,,
1276,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM,F,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616616,,BAO_0000019,,
1277,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 0.1 uM 5-HT.,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616617,,BAO_0000019,,
1278,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 10 uM 5-HT.,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616618,,BAO_0000019,,
1279,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 1 uM 5-HT.,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616619,,BAO_0000019,,
1280,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 3 uM 5-HT.,F,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616620,,BAO_0000019,,
1281,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 50 uM 5-HT.,F,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616621,,BAO_0000019,,
1282,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 30 uM,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616622,,BAO_0000019,,
1283,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 50 uM,F,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616146,,BAO_0000019,,
1284,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 50 uM+ 50 uM 5-HT.,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL832873,,BAO_0000019,,
1285,13630,Effect on 5-hydroxytryptamine 1A receptor-mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616147,,BAO_0000019,,
1286,13630,Effect on 5-hydroxytryptamine 1A receptor-mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 10 uM 5-HT.,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL872872,,BAO_0000019,,
1287,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616148,,BAO_0000019,,
1288,9783,In vitro inhibition of [3H]spiperone binding to 5-hydroxytryptamine 1A receptor from rat hippocampal tissue,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616149,,BAO_0000221,10000000.0,
1289,9783,In vitro inhibition of [3H]spiperone binding to 5-hydroxytryptamine 1A receptor from rat hippocampal tissue at 1 uM,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616150,,BAO_0000221,10000000.0,
1290,14331,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat hippocampal membranes at 10e-7 M,B,,,Rattus norvegicus,10116.0,,,,Membranes,10576,D,9,Expert,1,,CHEMBL616151,,BAO_0000249,,
1291,15260,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue at 1 uM,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL872873,,BAO_0000221,10000000.0,
1292,15260,Inhibitory activity against rat hippocampal tissue 5-hydroxytryptamine 1A receptor at 0.1 uM concentration,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616670,,BAO_0000221,10000000.0,
1293,15260,Inhibitory activity against rat hippocampal tissue 5-hydroxytryptamine 1A receptor at 1 uM concentration,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616671,,BAO_0000221,10000000.0,
1294,16616,"Percent inhibition of (+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor in hippocampal membranes",F,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL884861,,BAO_0000249,,
1295,15629,Tested in vitro for % inhibition against (serotonin)5-HT 1A receptor,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616672,,BAO_0000357,,
1296,15086,The compound was tested binding affinity against 5-hydroxytryptamine 1A receptor from rat brain using [3H]8-OH-DPAT as radioligand at 10e-6 M.,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616673,,BAO_0000019,,
1297,5717,Antagonistic activity against 5-hydroxytryptamine 1A receptor in rat cerebral cortex using [3H]8-OH-DPAT as radioligand.,F,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616674,,BAO_0000019,,
1298,12652,Binding affinity against the site labelled by the 5-hydroxytryptamine 1A receptor agonist [3H]- 8-OH-DPAT,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616675,,BAO_0000357,,
1299,14608,In vitro binding affinity for 5-hydroxytryptamine 1A receptor was determined by measuring specific inhibition of [125I]-binding to rat hippocampal membrane preparations,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616676,,BAO_0000221,10000000.0,
1300,12306,Inhibition of binding of [125I]-8-OH-PIPAT ligand to 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616677,,BAO_0000221,10000000.0,
1301,12306,The binding of [125I]MPPI ligand to 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616678,,BAO_0000221,10000000.0,
1302,15247,Ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL616679,,BAO_0000357,,
1303,17529,Ability to bind to central serotonin 5-hydroxytryptamine 1A receptor in vitro in hippocampus of the rat brain using [3H]8-OH-DPAT radioligand,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616680,,BAO_0000221,10000000.0,
1304,14826,Ability to displace [3H]- -OH-DPAT bound to 5-hydroxytryptamine 1A receptor in rat hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616681,,BAO_0000221,10000000.0,
1305,14826,Ability to displace [3H]- -(OH)-DPAT bound to 5-hydroxytryptamine 1A receptor in rat hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616682,,BAO_0000221,10000000.0,
1306,13241,Ability to displace [3H]8-OH-DPAT binding to rat hippocampal 5-hydroxytryptamine 1A receptor,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616683,,BAO_0000221,10000000.0,
1307,14093,Ability to displace [3H]-8-OH-DPAT from rat hippocampal homogenate 5-hydroxytryptamine 1A receptor,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616684,,BAO_0000221,10000000.0,
1308,14093,Ability to displace [3H]-8-OH-DPAT from rat hippocampal homogenate 5-hydroxytryptamine 1A receptor; Not tested,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616685,,BAO_0000221,10000000.0,
1309,14442,Affinity at [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor in rat brain homogenate was determined,B,,,,,,Brain,,,10576,H,8,Autocuration,1,,CHEMBL616686,,BAO_0000221,955.0,
1310,9919,Affinity for 5-hydroxytryptamine 1A receptor site,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616687,,BAO_0000357,,
1311,9919,Affinity for 5-hydroxytryptamine 1A receptor site,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616688,,BAO_0000357,,
1312,11440,Affinity in displacing [3H]8-OH-DPAT from rat hippocampal 5-HT1A receptor.,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616689,,BAO_0000221,10000000.0,
1313,11257,Affinity on 5-hydroxytryptamine 1A receptor labeled by [3H]8-OH-DPAT,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616690,,BAO_0000357,,
1314,10330,Binding affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616691,,BAO_0000357,,
1315,17331,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat hippocampus mambranes,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL616692,,BAO_0000221,10000000.0,
1316,16567,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616693,,BAO_0000249,,
1317,12058,"Binding affinity against 5-hydroxytryptamine 1A receptor in homogenated rat brain tissue, using by [3H]8-OH-DPAT as radioligand",B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL616694,,BAO_0000019,,
1318,9699,Binding affinity against 5-hydroxytryptamine 1A receptor in rat hippocampal tissue,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616695,,BAO_0000221,10000000.0,
1319,9547,Binding affinity against 5-hydroxytryptamine 1A receptor of rat was determined using [3H]8-OH-DPAT in binding assay,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616696,,BAO_0000357,,
1320,10330,Binding affinity against 5-hydroxytryptamine 1A receptor using [3H]DOB as radioligand,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616697,,BAO_0000357,,
1321,14331,Binding affinity against rat 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616698,,BAO_0000357,,
1322,14060,Binding affinity against rat brain 5-hydroxytryptamine 1A receptor,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL616949,,BAO_0000019,,
1323,14744,Binding affinity against the 5-hydroxytryptamine 1A receptor labelled with [3H]8-OH-DPAT in rat hippocampal homogenates,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616950,,BAO_0000221,10000000.0,
1324,13506,Binding affinity against serotonin 5-hydroxytryptamine 1A receptor using radioligand [3H]8-OH-DPAT binding assay,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL832875,,BAO_0000357,,
1325,10862,Binding affinity at 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in rat brain.,B,,,,,,Brain,,,10576,H,8,Expert,1,,CHEMBL616951,,BAO_0000221,955.0,
1326,10862,Binding affinity at 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in rat brain.,B,,,,,,Brain,,,10576,H,8,Expert,1,,CHEMBL616952,,BAO_0000221,955.0,
1327,10062,Binding affinity at rat 5-hydroxytryptamine 1A receptor by [3H]WB-4101 displacement.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616953,,BAO_0000357,,
1328,12073,Binding affinity for 5-hydroxytryptamine 1A receptor by use of [3H]8-OH-DPAT in male rat,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616954,,BAO_0000357,,
1329,14875,GTPgammaS radioligand binding assay,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616955,,BAO_0000357,,
1330,2391,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; Not determined,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616956,,BAO_0000357,,
1331,2391,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; Partial agonist,F,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616957,,BAO_0000019,,
1332,2391,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; Slient antagonist,F,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616958,,BAO_0000019,,
1333,2391,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616959,,BAO_0000357,,
1334,2391,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; Not determined,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616960,,BAO_0000357,,
1335,2391,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; silent antagonist,F,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616961,,BAO_0000019,,
1336,17211,Ability to displace [3H]5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor,B,,,,,,,HeLa,,106,H,8,Expert,1,,CHEMBL616962,308.0,BAO_0000219,,
1337,17211,Ability to displace [3H]5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor receptor,B,,,,,,,HeLa,,106,H,8,Autocuration,1,,CHEMBL616963,308.0,BAO_0000219,,
1338,6491,Affinity towards human 5-hydroxytryptamine 1B serotonin receptor,B,,,Homo sapiens,9606.0,,,,,106,D,9,Expert,1,,CHEMBL616524,,BAO_0000357,,
1339,16190,Binding affinity against 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT as radioligand,B,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616525,449.0,BAO_0000219,,
1340,14165,Binding affinity for 5-hydroxytryptamine 1B receptor in C6-glial transfected cell type using [3H]5-CT as radioligand,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL872908,,BAO_0000019,,
1341,14165,Binding affinity for 5-hydroxytryptamine 1B receptor in C6-glial transfected cell type using [3H]GR-125743 as radioligand,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616526,,BAO_0000019,,
1342,4234,Binding affinity to cloned human 5-hydroxytryptamine 1B receptor,B,,,Homo sapiens,9606.0,,,,,106,D,9,Expert,1,,CHEMBL616527,,BAO_0000357,,
1343,6328,Binding affinity towards human 5-hydroxytryptamine 1B receptor in L-M(tk-) cells using [3H]GR-125743 as radioligand,B,,,,,,,,,106,H,8,Expert,1,,CHEMBL616528,,BAO_0000219,,
1344,14770,Binding affinity for recombinant human 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand.,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616529,,BAO_0000357,,
1345,2598,Binding affinity was evaluated at human recombinant 5-hydroxytryptamine 1B receptor using [3H]5-CT as radioligand,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616530,,BAO_0000357,,
1346,6897,Binding affinity was evaluated at the cloned human 5-hydroxytryptamine 1B receptor,B,,,,,,,,,106,H,8,Expert,1,,CHEMBL616531,,BAO_0000357,,
1347,6897,Binding affinity was evaluated at the cloned human 5-hydroxytryptamine 1B receptor,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616532,,BAO_0000357,,
1348,6013,Binding affinity towards 5-hydroxytryptamine 1B receptor,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616533,,BAO_0000357,,
1349,5843,Binding affinity towards cloned human 5-hydroxytryptamine 1B receptor,B,,,,,,,,,106,H,8,Expert,1,,CHEMBL616534,,BAO_0000357,,
1350,14454,Binding affinity towards human 5-hydroxytryptamine 1B receptor using [3H]5-HT trifluoroacetate as radioligand,B,,,,,,,,,106,H,8,Expert,1,,CHEMBL616535,,BAO_0000357,,
1351,16209,Binding affinity towards human 5-hydroxytryptamine 1B receptor using [3H]5-HT radioligand,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616536,,BAO_0000357,,
1352,3935,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 1B receptor,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616537,,BAO_0000357,,
1353,13729,Ability to inhibit the forskolin-stimulated c-AMP formation mediated by human 5-hydroxytryptamine 1B receptor in CHO-K1 cells,F,,,,,,,CHO-K1,,106,H,8,Expert,1,,CHEMBL616538,485.0,BAO_0000219,,
1354,14251,Agonist activity to the human recombinant 5-hydroxytryptamine 1B receptor,F,,,,,,,,,106,H,8,Expert,1,,CHEMBL616539,,BAO_0000019,,
1355,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1B receptor,B,,,,,,,,,106,H,8,Expert,1,,CHEMBL616540,,BAO_0000019,,
1356,3025,In vitro binding affinity was determined towards cloned human 5-hydroxytryptamine 1B receptor using [3H]5-CT radioligand,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616429,,BAO_0000357,,
1357,15315,In vitro receptor binding affinity for cloned human 5-hydroxytryptamine 1B receptor,B,,,,,,,,,106,H,8,Expert,1,,CHEMBL616430,,BAO_0000357,,
1358,14214,Receptor binding affinity for cloned human 5-hydroxytryptamine 1B receptor in Cos-7 cells,B,,,Homo sapiens,9606.0,,,,,106,D,9,Expert,1,,CHEMBL616431,,BAO_0000219,,
1359,3804,Binding affinity towards cloned human 5-hydroxytryptamine 1B receptor,B,,,Homo sapiens,9606.0,,,,,106,D,9,Expert,1,,CHEMBL616432,,BAO_0000357,,
1360,2391,Affinity for 5-hydroxytryptamine 1B receptor subtype,B,,,Homo sapiens,9606.0,,,,,106,D,9,Expert,1,,CHEMBL616433,,BAO_0000357,,
1361,4175,Binding affinity for human 5-hydroxytryptamine 1B receptor,B,,,Homo sapiens,9606.0,,,,,106,D,9,Expert,1,,CHEMBL616434,,BAO_0000357,,
1362,17296,Binding affinity against cloned human 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-CT as radioligand; Not determined,B,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616435,449.0,BAO_0000219,,
1363,17085,In vitro binding affinity was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1B receptor; ND means not determined,B,,,,,,,,,106,H,8,Expert,1,,CHEMBL616436,,BAO_0000019,,
1364,17211,Ability to displace [3H]5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor; NT denotes not tested,B,,,,,,,HeLa,,106,H,8,Autocuration,1,,CHEMBL616437,308.0,BAO_0000219,,
1365,17211,Ability to displace [3H]5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor; NT=not tested,B,,,,,,,HeLa,,106,H,8,Autocuration,1,,CHEMBL616438,308.0,BAO_0000219,,
1366,17211,Ability to displace [3H]-5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor; NT denotes not tested,B,,,,,,,HeLa,,106,H,8,Autocuration,1,,CHEMBL616439,308.0,BAO_0000219,,
1367,15926,Binding activity against human 5-hydroxytryptamine 1B receptor; NT means not tested,B,,,Homo sapiens,9606.0,,,,,106,D,9,Expert,1,,CHEMBL616440,,BAO_0000357,,
1368,16312,Binding affinity in CHO-K1 cells transfected with human recombinant 5-hydroxytryptamine 1B receptor; not tested,B,,,,,,,CHO-K1,,106,H,8,Autocuration,1,,CHEMBL616441,485.0,BAO_0000219,,
1369,5843,Selectivity ratio against cloned human 5-HT1B receptor to that of h5-HT1D receptor,B,,,,,,,,,106,H,8,Expert,1,,CHEMBL616442,,BAO_0000357,,
1370,5843,Selectivity ratio against cloned human 5-hydroxytryptamine 1B receptor to that of human 5-hydroxytryptamine 1D receptor,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616443,,BAO_0000357,,
1371,16312,Binding affinity in CHO-K1 cells transfected with human recombinant 5-hydroxytryptamine 1B receptor,B,,,,,,,CHO-K1,,106,H,8,Expert,1,,CHEMBL616444,485.0,BAO_0000219,,
1372,15926,Binding activity against human 5-hydroxytryptamine 1B receptor,B,,,Homo sapiens,9606.0,,,,,106,D,9,Expert,1,,CHEMBL616445,,BAO_0000357,,
1373,15926,Binding activity against human 5-hydroxytryptamine 1B receptor,B,,,Homo sapiens,9606.0,,,,,106,D,9,Expert,1,,CHEMBL616446,,BAO_0000357,,
1374,4540,Binding affinity to human cloned 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT as radioligand,B,,,Homo sapiens,9606.0,,,CHO,,106,D,9,Expert,1,,CHEMBL616447,449.0,BAO_0000219,,
1375,6166,Binding affinity towards cloned human 5-hydroxytryptamine 1B receptor was determined,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616448,,BAO_0000357,,
1376,17296,Binding affinity against cloned human 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-CT as radioligand,B,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616449,449.0,BAO_0000219,,
1377,17296,Binding affinity against human 5-hydroxytryptamine 1B receptor cloned receptors in CHO cells,B,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616450,449.0,BAO_0000219,,
1378,17296,Binding affinity against human 5-hydroxytryptamine 1B receptor cloned receptors in CHO cells using [3H]5-CT as radioligand,B,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL857974,449.0,BAO_0000219,,
1379,15779,Binding affinity towards 5-hydroxytryptamine 1B (human cloned receptor) in CHO cells using [3H]5-HT as radioligand,B,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616451,449.0,BAO_0000219,,
1380,15779,Binding affinity towards 5-hydroxytryptamine 1B receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand,B,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616452,449.0,BAO_0000219,,
1381,15779,Binding affinity towards 5-hydroxytryptamine 1B receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand;ND means no data.,B,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616453,449.0,BAO_0000219,,
1382,4199,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT as the radioligand,B,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616454,449.0,BAO_0000219,,
1383,14875,Binding affinity for human 5-hydroxytryptamine 1B receptor,B,,,Homo sapiens,9606.0,,,,,106,D,9,Expert,1,,CHEMBL616455,,BAO_0000357,,
1384,15146,Compound was tested for its binding affinity against human cloned 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT,B,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616456,449.0,BAO_0000219,,
1385,5213,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1B receptor in CHO using [3H]5-HT as a radioligand,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616457,,BAO_0000357,,
1386,14818,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT,B,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616458,449.0,BAO_0000219,,
1387,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1B receptor in CHO cells, using [3H]5-HT as radioligand",B,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616459,449.0,BAO_0000219,,
1388,14454,Adenyl cyclase activity was expressed as percent forskolin response against 5-hydroxytryptamine 1B receptor at concentration 1 uM,F,,,,,,,,,106,H,8,Expert,1,,CHEMBL616460,,BAO_0000019,,
1389,14454,Adenyl cyclase activity was expressed as percent forskolin response against 5-hydroxytryptamine 1B receptor at concentration 10 uM,F,,,,,,,,,106,H,8,Expert,1,,CHEMBL616461,,BAO_0000019,,
1390,14875,"Effect of compound on [35S]GTP-gamma-S, radioligand binding CHO cells expressing human 5-hydroxytryptamine 1B receptor",F,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616462,449.0,BAO_0000219,,
1391,14875,"Effect of compound on [35S]GTP-gamma-S, radioligand binding in CHO cells expressing human 5-hydroxytryptamine 1B receptor",F,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616463,449.0,BAO_0000219,,
1392,15250,"Compound was tested for maximum stimulation of [35S]GTP-gamma-S, binding expressed relative to the maximal effect produced by 5-HT.",F,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616464,,BAO_0000019,,
1393,15250,Compound was tested for the displacement of [3H]5-HT binding to cloned 5-hydroxytryptamine 1D receptor stably expressed in CHO cells.,B,,,,,,,CHO,,105,H,8,Autocuration,1,,CHEMBL616465,449.0,BAO_0000219,,
1394,15086,The compound was tested for binding affinity against 5-hydroxytryptamine 1B receptor,B,,,,,,,,,17105,H,8,Autocuration,1,,CHEMBL832874,,BAO_0000357,,
1395,3025,5-hydroxytryptamine 1B receptor agonist potency determined in rabbit saphenous vein contraction model,F,,,Oryctolagus cuniculus,9986.0,,,,,106,H,8,Autocuration,1,,CHEMBL616184,,BAO_0000019,,
1396,14998,The vascular 5-hydroxytryptamine 1B receptor affinity was assessed using ring preparations of rabbit saphenous vein (RbSV).,B,,,Oryctolagus cuniculus,9986.0,,,,,106,H,8,Autocuration,1,,CHEMBL616185,,BAO_0000019,,
1397,14998,"Binding affinity against vascular 5-hydroxytryptamine 1B receptor, measured using ring preparations of rabbit saphenous vein (RbSV)",B,,,Oryctolagus cuniculus,9986.0,,,,,106,H,8,Intermediate,1,,CHEMBL616186,,BAO_0000019,,
1398,14998,The vascular 5-hydroxytryptamine 1B receptor affinity was assessed using ring preparations of rabbit saphenous vein(RbSV).,B,,,Oryctolagus cuniculus,9986.0,,,,,106,H,8,Autocuration,1,,CHEMBL616187,,BAO_0000019,,
1399,13969,Binding affinity towards 5-hydroxytryptamine 1B receptor was measured using [3H]5-HT as radioligand,B,,,,,,,,,10577,H,8,Expert,1,,CHEMBL616188,,BAO_0000357,,
1400,13392,Binding affinity for 5-hydroxytryptamine 1B receptor,B,,,,,,,,,10577,D,9,Intermediate,1,,CHEMBL873475,,BAO_0000357,,
1401,3651,Inhibition of [3H]5-HT binding to 5-hydroxytryptamine 1B receptor in rat striatum; Less active,B,,,Rattus norvegicus,10116.0,,Striatum,,,10577,D,9,Expert,1,,CHEMBL616189,,BAO_0000019,2435.0,
1402,10025,Concentration necessary to achieve half maximal inhibition of [125I]- Iodocyanopindolol binding to 5-hydroxytryptamine 1B receptor at 1 uM,B,,,,,,,,,10577,H,8,Expert,1,,CHEMBL616190,,BAO_0000357,,
1403,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT as radioligand; range=48-77,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616191,,BAO_0000357,,
1404,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=63-95,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616192,,BAO_0000357,,
1405,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=710-980,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616193,,BAO_0000357,,
1406,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=78-140,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616194,,BAO_0000357,,
1407,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=85-130,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616195,,BAO_0000357,,
1408,13863,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=89-280,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616196,,BAO_0000357,,
1409,4622,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in rat hippocampus membrane.,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616197,,BAO_0000249,10000000.0,
1410,14911,Binding affinity at 5-hydroxytryptamine 1A (5-HT1A) receptor in rat cerebral cortex using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,10576,H,8,Intermediate,1,,CHEMBL616198,,BAO_0000019,,
1411,12678,In vitro binding affinity to 5-hydroxytryptamine 1A receptor using [125I](R)-(+)-trans-8-OH-PIPAT as radioligand in rat hippocampal homogenate,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616199,,BAO_0000221,10000000.0,
1412,12678,In vitro binding affinity to 5-hydroxytryptamine 1A receptor in rat hippocampal homogenate by [125I](R)-(+)-trans-8-OH-PIPAT displacement.,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616200,,BAO_0000221,10000000.0,
1413,14235,In vitro binding affinity to rat hippocampal 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616201,,BAO_0000221,10000000.0,
1414,14949,In vitro binding affinity towards 5-hydroxytryptamine 1A r receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616202,,BAO_0000221,10000000.0,
1415,14949,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616203,,BAO_0000221,10000000.0,
1416,14949,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates; ND=not determined,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616204,,BAO_0000221,10000000.0,
1417,14949,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates; Not determined,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616205,,BAO_0000221,10000000.0,
1418,14949,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates; not determined,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616206,,BAO_0000221,10000000.0,
1419,16118,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616207,,BAO_0000249,,
1420,3268,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand in rat cerebral cortex membranes,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616208,,BAO_0000249,,
1421,3268,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand in rat cerebral cortex membranes; Inactive,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616209,,BAO_0000249,,
1422,16117,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor was determined using radioligand [3H]-8-OH-DPAT,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616210,,BAO_0000357,,
1423,9783,In vitro inhibition of [3H]spiperone binding to 5-hydroxytryptamine 1A receptor from rat hippocampal tissue.,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616211,,BAO_0000221,10000000.0,
1424,9783,In vitro inhibition of [3H]spiperone binding to 5-hydroxytryptamine 1A receptor from rat hippocampal tissue; NT=Not tested,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616504,,BAO_0000221,10000000.0,
1425,14356,Displacement of [3H]8-OH-DPAT from rat hippocampal 5-hydroxytryptamine 1A receptor,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL616505,,BAO_0000221,10000000.0,
1426,15740,Inhibition constant of 50 uM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616506,,BAO_0000019,,
1427,12306,Inhibition of binding of [125I]8-OH-PIPAT ligand to 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL872107,,BAO_0000221,10000000.0,
1428,13348,Displacement of [3H]5-HT from rat hippocampal 5-hydroxytryptamine 1A receptor with 10e-6 M ketanserin,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL616507,,BAO_0000221,10000000.0,
1429,10394,Inhibitory activity against 5-hydroxytryptamine 1A receptor in rat cortical membranes using [3H]8-OH-DPAT as a radioligand,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616303,,BAO_0000249,,
1430,15260,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616304,,BAO_0000221,10000000.0,
1431,10046,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue using [3H]OH-DPAT as radioligand.,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616305,,BAO_0000221,10000000.0,
1432,15260,Antagonist activity against rat hippocampal tissue 5-hydroxytryptamine 1A receptor,F,,,,,,Hippocampus,,,10576,H,8,Intermediate,1,,CHEMBL616306,,BAO_0000221,10000000.0,
1433,12851,Inhibitory affinity constant against 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616307,,BAO_0000357,,
1434,2148,Displacement of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat brain hippocampus,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL881829,,BAO_0000221,10000000.0,
1435,13134,Affinity against the 5-hydroxytryptamine receptor 1A using [3H]WB-4101.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616308,,BAO_0000357,,
1436,12462,Tested for affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in homogenized rat brain,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616309,,BAO_0000019,,
1437,12462,Tested for affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in homogenized rat brain tissue,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616310,,BAO_0000019,,
1438,12462,Tested for affinity against 5-hydroxytryptamine 1A receptors using [3H]8-OH-DPAT in homogenized rat cloned CHO cells,B,,,,,,,CHO,,10576,H,8,Autocuration,1,,CHEMBL616311,449.0,BAO_0000219,,
1439,11933,Tested for binding affinity against 5-hydroxytryptamine 1A receptor from rat frontal cortical regions using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616312,,BAO_0000357,,
1440,11933,Tested for binding affinity against 5-hydroxytryptamine 1A receptor from rat frontal cortical regions using [3H]8-OH-DPAT as radioligand; ND is Not Determined,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616313,,BAO_0000357,,
1441,403,Displacement of [3H]8-OH-DPAT from rat hippocampal 5-hydroxytryptamine 1A receptor,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL616314,,BAO_0000221,10000000.0,
1442,15538,Tested for binding affinity by measuring displacement of [3H]8-OH-DPAT from rat serotonin 5-hydroxytryptamine 1A receptor in rat hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616315,,BAO_0000221,10000000.0,
1443,15538,Tested for binding affinity by measuring displacement of [3H]8-OH-DPAT from rat serotonin 5-hydroxytryptamine 1A receptor in rat hippocampus; NA means Not Active,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616567,,BAO_0000221,10000000.0,
1444,15538,Tested for binding affinity by measuring displacement of [3H]-8-OH-DPAT from rat serotonin 5-hydroxytryptamine 1A receptor in rat hippocampus; ND means Not Determined,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616568,,BAO_0000221,10000000.0,
1445,12464,Binding affinity to displace [3H]2-(di-N-propylamino)-8-hydroxy-tetralin from 5-hydroxytryptamine 1A (5-HT1A) receptor in rat frontal cortex homogenates,B,,,,,,,,,10576,H,8,Intermediate,1,,CHEMBL616569,,BAO_0000019,,
1446,1455,Binding affinity to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT radioligand assay.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616570,,BAO_0000357,,
1447,12652,Tested for the binding affinity against the site labelled by the 5-hydroxytryptamine 1A receptor agonist [3H]- 8-OH-DPAT,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616571,,BAO_0000357,,
1448,12639,Tested for the inhibitory activity against 5-hydroxytryptamine 1A receptor in rat hippocampal,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616572,,BAO_0000221,10000000.0,
1449,13949,Tested in vitro for binding affinity by measuring its ability to inhibit [3H]8-OH-DPAT binding at 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616573,,BAO_0000249,,
1450,12463,Tested in vitro for receptor binding affinity against 5-hydroxytryptamine 1A receptor using radioligand [3H]8-OH-DPAT,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL616574,,BAO_0000357,,
1451,14829,The binding affinity by measuring its ability to displace [3H]8-OH-DPAT radioligand in 5-hydroxytryptamine 1A receptor on rat hippocampal preparation,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616575,,BAO_0000221,10000000.0,
1452,14829,The binding affinity by measuring its ability to displace [3H]8-OH-DPAT radioligand in 5-hydroxytryptamine 1A receptor on rat hippocampal preparation; ND=not determined,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL872108,,BAO_0000221,10000000.0,
1453,12092,The binding affinity was measured on 5-hydroxytryptamine 1A receptor using [3H]- 8-OH-DPAT as radioligand.,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616576,,BAO_0000357,,
1454,403,The compound was evaluated for binding affinity against 5-hydroxytryptamine 1A receptor in rat hippocampal membranes using [3H]8-OH-DPAT as radioligand in the presence of 1 mM of MnCl2,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616577,,BAO_0000249,,
1455,403,The compound was evaluated for binding affinity against 5-hydroxytryptamine 1A receptor in rat hippocampal membranes using [3H]8-OH-DPAT as radioligand in the presence of 3*10e-5 M GTP gamma S,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616578,,BAO_0000249,,
1456,3967,Binding affinity at 5-hydroxytryptamine 1A receptor from striata of wistar rats by [3H]- 8-OH -DPAT displacement.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616579,,BAO_0000357,,
1457,12771,Binding affinity towards 5-hydroxytryptamine 1A receptor of rat brain synaptosomal preparations,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL616580,,BAO_0000019,,
1458,15086,The compound was tested binding affinity against 5-hydroxytryptamine 1A receptor from rat brain using [3H]8-OH-DPAT as radioligand at 10e-6 M.,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616581,,BAO_0000019,,
1459,14909,The compound was tested for binding affinity on [3H]8-OH-DPAT as specific ligand on 5-hydroxytryptamine 1A receptor in rat hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616582,,BAO_0000221,10000000.0,
1460,14949,The compound was tested for binding affinity on [3H]8-OH-DPAT as specific ligand on 5-hydroxytryptamine 1A receptor in rat hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616583,,BAO_0000221,10000000.0,
1461,2309,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampus using [3H]8-OH-DPAT,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL616584,,BAO_0000221,10000000.0,
1462,4170,Binding affinity towards 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616585,,BAO_0000357,,
1463,11642,Binding affinity towards 5-hydroxytryptamine 1A receptor by displacing [3H]WB-4101 from rat hippocampus,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL616586,,BAO_0000221,10000000.0,
1464,11642,The compound was tested for its binding affinity towards 5-hydroxytryptamine 1A receptor by displacing [3H]WB-4101 radioligand in rat hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616587,,BAO_0000221,10000000.0,
1465,12953,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1A receptor from rat hippocampus using [3H]-8-OH-DPAT as radioligand,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616588,,BAO_0000221,10000000.0,
1466,12953,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1A receptor from rat hippocampus using [3H]8-OH-DPAT as radioligand.,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616589,,BAO_0000221,10000000.0,
1467,12953,Binding affinity for 5-hydroxytryptamine 1A receptor from rat hippocampus using [3H]8-OH-DPAT as radioligand,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616590,,BAO_0000221,10000000.0,
1468,12903,"In vitro binding affinity against cloned mammalian 5-hydroxytryptamine 1A receptor expressed in CHO cells, by using [3H]8-OH-DPAT as radioligand.",B,,,,,,,CHO,,10576,H,8,Expert,1,,CHEMBL616591,449.0,BAO_0000219,,
1469,12536,Displacement of the radioligand [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616592,,BAO_0000357,,
1470,10058,The inhibition activity of 5-HT1A at 1 uM,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616593,,BAO_0000357,,
1471,12902,"Binding affinity against 5-hydroxytryptamine 1A receptor from CHO-K1 cells, using [3H]8-OH-DPAT as the radioligand.",B,,,,,,,CHO-K1,,10576,H,8,Expert,1,,CHEMBL616594,485.0,BAO_0000219,,
1472,14057,Binding affinities against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in rat cerebral cortex membrane,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616595,,BAO_0000249,,
1473,11296,Compound was evaluated for its ability to displace the protonated form of [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding from labeled 5-HT 1A receptor site.,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616596,,BAO_0000357,,
1474,11296,Compound was evaluated for its ability to displace the protonated form of [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding from labeled 5-hydroxytryptamine 1A receptor site in rat brain hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616597,,BAO_0000221,10000000.0,
1475,11296,Ability to displace the protonated form of [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding from labeled 5-hydroxytryptamine 1A receptor site in rat brain hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Expert,1,,CHEMBL616598,,BAO_0000221,10000000.0,
1476,16616,Antagonist activity to stimulate binding of [35S]-GTP-gamma S binding to 5-hydroxytryptamine 1A receptor in isolated rat hippocampal membranes,F,,,Rattus norvegicus,10116.0,,,,Membranes,10576,D,9,Expert,1,,CHEMBL616599,,BAO_0000249,,
1477,16616,"Inhibition of (+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding in rat hippocampal membranes",F,,,Rattus norvegicus,10116.0,,Hippocampus,,Membranes,10576,D,9,Expert,1,,CHEMBL616600,,BAO_0000249,10000000.0,
1478,16567,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND is defined as not -determined.,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616601,,BAO_0000019,,
1479,16567,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND is defined as not defined.,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616602,,BAO_0000019,,
1480,16567,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND is defined as not determined.,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616603,,BAO_0000019,,
1481,16567,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND means not determined.,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616604,,BAO_0000019,,
1482,17136,Binding affinity towards 5-hydroxytryptamine 1A receptor was determined in rat cortex membranes using [3H]8-OH-DPAT as radioligand; No data,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616316,,BAO_0000249,,
1483,17136,Binding affinity towards 5-hydroxytryptamine 1A receptor was determined in rat cortex membranes using [3H]8-OH-DPAT as radioligand; Not determined,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616317,,BAO_0000249,,
1484,16616,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenates; ND means No data,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL616318,,BAO_0000019,,
1485,17331,Binding affinity against 5-hydroxytryptamine 1A receptor by displacement of [3H]8-OH-DPAT from rat hippocampus mambranes,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616319,,BAO_0000221,10000000.0,
1486,17331,Binding affinity against 5-hydroxytryptamine 1A receptor by displacement of [3H]8-OH-DPAT from rat hippocampus mambranes; Not tested,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616320,,BAO_0000221,10000000.0,
1487,17167,Binding affinity for rat hippocampus 5-hydroxytryptamine 1A receptor by inhibition of [3H]8-OH-DPAT binding; Not tested,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL616321,,BAO_0000221,10000000.0,
1488,15740,Evaluated for the 5-hydroxytryptamine 1A receptor agonist activity in LY-293284 trained rats; Not tested,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616322,,BAO_0000019,,
1489,15740,Evaluated for the 5-hydroxytryptamine 1A receptor agonist activity in LY-293284 trained rats; not tested,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616323,,BAO_0000019,,
1490,4671,Ratio of binding affinity to 5-HT 1A and D2 receptor,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616324,,BAO_0000357,,
1491,10058,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus at 1 uM,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616325,,BAO_0000221,10000000.0,
1492,10058,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus at 1 uM,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616326,,BAO_0000221,10000000.0,
1493,10058,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus.,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616327,,BAO_0000221,10000000.0,
1494,12073,Percentage inhibition against 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616328,,BAO_0000357,,
1495,2759,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes (experiment 1),B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL858110,,BAO_0000249,,
1496,2759,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes (experiment 1),F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616329,,BAO_0000249,,
1497,2759,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes (experiment 2),B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616330,,BAO_0000249,,
1498,2759,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes (experiment 2),F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616331,,BAO_0000249,,
1499,2759,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes.,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616332,,BAO_0000249,,
1500,9737,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat brain membrane using [3H]8-OH-DPAT as a selective ligand.,B,,,,,,Brain,,,10576,H,8,Autocuration,1,,CHEMBL857063,,BAO_0000249,955.0,
1501,9737,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat frontal cortex using [3H]8-OH-DPAT as a radioligand,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616333,,BAO_0000019,,
1502,5717,Antagonistic activity against 5-hydroxytryptamine 1A receptor in rat cerebral cortex using [3H]-8-OH-DPAT as radioligand.,F,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616334,,BAO_0000019,,
1503,12253,Binding affinity of 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in rat hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616335,,BAO_0000221,10000000.0,
1504,14025,Affinity pKi for 5-hydroxytryptamine 1A receptor was measured in rat cortex homogenates.,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616336,,BAO_0000019,,
1505,10425,Binding affinity against 5-hydroxytryptamine 1A receptor in rat cerebral cortical membrane using [3H]-8-OH-DPAT as radioligand.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616337,,BAO_0000249,,
1506,14998,Binding affinity against 5-hydroxytryptamine 1A receptor in rat cortex homogenates.,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616338,,BAO_0000019,,
1507,13694,Binding affinity against native 5-HT1A-receptors from rat hippocampus using radioligand ([3H]- 8-hydri\oxy-2-(di-n-propylamino)tetraline) binding assay,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616339,,BAO_0000221,10000000.0,
1508,13694,Binding affinity against native 5-HT1A-receptors from rat hippocampus using radioligand ([3H]8-hydroxy-2-(di-n-propylamino)-tetraline) binding assay,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616340,,BAO_0000221,10000000.0,
1509,4342,Binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616341,,BAO_0000357,,
1510,12936,Binding affinity against rat 5-hydroxytryptamine 1A receptor,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL616342,,BAO_0000357,,
1511,13144,Inhibition of [3H]2-(di-N-propylamino)-8-hydroxytetralin binding to 5-HT1A receptor of rat frontal cortex homogenates,B,,,Rattus norvegicus,10116.0,,,,,10576,D,9,Expert,1,,CHEMBL616343,,BAO_0000019,,
1512,13343,Binding affinity of a compound to rat brain 5-hydroxytryptamine 1A (serotonin) receptor assayed by radiolabeled [3H]-8-OH-DPAT ligand displacement,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616344,,BAO_0000019,,
1513,12132,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616345,,BAO_0000357,,
1514,15419,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat cortex using [3H]8-OH-DPAT as a radioligand,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616346,,BAO_0000019,,
1515,1479,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in rat hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616347,,BAO_0000221,10000000.0,
1516,14287,In vitro by displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor on rat cortical membrane,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616348,,BAO_0000019,,
1517,13116,Binding affinity at 5-hydroxytryptamine 1A receptor,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616349,,BAO_0000357,,
1518,2759,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat frontal cortex membranes,B,,,Rattus norvegicus,10116.0,,,,Membranes,10576,D,9,Expert,1,,CHEMBL616152,,BAO_0000249,,
1519,2759,Compound was tested for inhibition constant against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes.,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616153,,BAO_0000249,,
1520,14748,"Binding affinity for rat cortex 5-hydroxytryptamine 1A receptor, by displacement of 0.2 nM [3H]8-OH-DPAT radioligand",B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616154,,BAO_0000019,,
1521,12304,In vitro ability to inhibit binding of radioligand [3H]8-OH-DPAT to 5-hydroxytryptamine 1A receptor in rat cerebral cortex,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616155,,BAO_0000019,,
1522,12409,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat hippocampus using [3H]8-OH-DPAT,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL616156,,BAO_0000221,10000000.0,
1523,12409,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat hippocampus with [3H]8-OH-DPAT,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,10576,D,9,Expert,1,,CHEMBL616157,,BAO_0000221,10000000.0,
1524,13267,The binding affinity (pKi) was measured against 5-hydroxytryptamine 4 receptor of piglet hippocampus using [125I]-SB 207710 as radioligand,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL616158,,BAO_0000221,10000000.0,
1525,15194,The compound was tested for the binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand.,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616159,,BAO_0000357,,
1526,14256,pKi value against rat 5-hydroxytryptamine 1A receptor.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL616160,,BAO_0000357,,
1527,16567,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND is define as non-determined.,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616161,,BAO_0000019,,
1528,15740,Evaluated for the 5-hydroxytryptamine 1A receptor agonist activity in LY-293284 trained rats; Not tested,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616162,,BAO_0000019,,
1529,13278,Binding affinity was measured against 5-hydroxytryptamine 2A receptor by displacement of [3H]- ketanserin by lysergic acid amides,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL616163,,BAO_0000357,,
1530,1970,Inhibition of specific [3H]OH-DPAT binding at 5-hydroxytryptamine 1A receptor in rat hippocampal membranes,B,,,,,,,,Membranes,10626,H,8,Expert,1,,CHEMBL616164,,BAO_0000249,,
1531,10034,Concentration of compound required to inhibit cortical 5-hydroxytryptamine 1A receptor binding sites in rat brain was evaluated,B,,,,,,Brain,,,10576,H,8,Autocuration,1,,CHEMBL616165,,BAO_0000221,955.0,
1532,13348,Inhibitory activity against 5-hydroxytryptamine 1A receptor isolated from rat hippocampus membranes membrane using [3H]5-HT as radioligand in the presence of 10e-6 M ketanserin as 5-HT2 blocker,B,,,Rattus norvegicus,10116.0,,,,,51,H,8,Autocuration,1,,CHEMBL616355,,BAO_0000019,,
1533,13630,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 50 uM 5-HT.,F,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616356,,BAO_0000019,,
1534,10862,Binding affinity at 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in rat brain.,B,,,,,,Brain,,,10576,H,8,Autocuration,1,,CHEMBL616357,,BAO_0000221,955.0,
1535,12058,"Binding affinity against 5-hydroxytryptamine 1A receptor in homogenated rat brain tissue, using by [3H]8-OH-DPAT as radioligand",B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL616358,,BAO_0000019,,
1536,4639,Compound was tested for binding affinity against 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616359,,BAO_0000357,,
1537,15453,Percent decrease in 5-hydroxytryptamine 1A receptor binding using 8-OH-DPAT,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL616360,,BAO_0000357,,
1538,4820,Binding affinity towards 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL616361,,BAO_0000357,,
1539,1089,Tested for binding affinity for 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616362,,BAO_0000357,,
1540,386,The compound was evaluated for its ability to displace [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in cellular brain membranes,B,,,,,,,,Brain membranes,51,H,8,Autocuration,1,,CHEMBL616363,,BAO_0000249,,
1541,6011,Inhibition of binding towards 5-hydroxytryptamine 1A receptor at 100 nM concentration,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616364,,BAO_0000357,,
1542,5014,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616365,,BAO_0000357,,
1543,4402,Binding affinity for 5-hydroxytryptamine 1A receptor determined using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL616366,,BAO_0000357,,
1544,17066,Binding affinity towards 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL872906,,BAO_0000357,,
1545,17515,Binding affinity of compound towards serotonin 5-hydroxytryptamine 1A receptor; inactive at 10 uM,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616367,,BAO_0000357,,
1546,2474,Binding affinity against 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616368,,BAO_0000357,,
1547,4775,Binding affinity to 5-hydroxytryptamine 1A receptor was determined,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616369,,BAO_0000357,,
1548,14294,Binding affinity towards Serotonin 5-hydroxytryptamine 1A receptor by displacement of [3H]-(+)-8-OH-DPAT.,B,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616370,,BAO_0000357,,
1549,14294,Binding affinity towards Serotonin 5-hydroxytryptamine 1A receptor by displacement of [3H](+)-8-OH-DPAT; inactive,B,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL616371,,BAO_0000357,,
1550,12249,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,B,,,,,,,CHO,,51,H,8,Autocuration,1,,CHEMBL616372,449.0,BAO_0000219,,
1551,11376,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor expressed in CHO cell membranes,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL616373,,BAO_0000219,,
1552,2474,Compound was measured in vivo for its binding affinity at 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,B,In vivo,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616374,,BAO_0000218,,
1553,13311,Tested for activity against 5-hydroxytryptamine 1A receptor from bovine hippocampus,B,,,,,,Hippocampus,,,51,H,8,Autocuration,1,,CHEMBL616375,,BAO_0000221,10000000.0,
1554,4373,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 1A receptor was determined,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616376,,BAO_0000357,,
1555,1633,Binding affinity towards 5-hydroxytryptamine 1A receptor by displacement of [3H]8-OH-DPAT.,B,,,,,,,,,51,H,8,Expert,1,,CHEMBL857064,,BAO_0000357,,
1556,11866,Binding affinity for 5-hydroxytryptamine 1A receptor was determined,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616377,,BAO_0000357,,
1557,4373,Binding affinity for 5-hydroxytryptamine 1A receptor was determined,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616378,,BAO_0000357,,
1558,4687,Evaluated for the binding affinity to 5-hydroxytryptamine 1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616379,,BAO_0000357,,
1559,16946,Ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616380,,BAO_0000357,,
1560,13291,Binding affinity against 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT radioligand,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616381,,BAO_0000357,,
1561,14159,Compound was evaluated for the affinity at 5-hydroxytryptamine 1A receptor,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616382,,BAO_0000357,,
1562,10812,Compound was tested for the binding affinity against 5-hydroxytryptamine 1A receptor by using [3H]DPAT as radioligand,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616383,,BAO_0000357,,
1563,3032,In vitro binding affinity against 5-hydroxytryptamine 1A receptor in CHO cells,B,,,Mus musculus,10090.0,,,CHO,,11863,D,9,Expert,1,,CHEMBL616350,449.0,BAO_0000219,,
1564,16655,Inhibition of 5-OH-DPAT binding to 5-hydroxytryptamine 1A receptor,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616351,,BAO_0000357,,
1565,14532,Inhibitory activity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand at 10e-5 M concentration,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616352,,BAO_0000357,,
1566,13944,Binding affinity against 5-hydroxytryptamine 1A receptor,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616353,,BAO_0000357,,
1567,13033,Binding affinity against serotonergic 5-HT1a receptor,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616354,,BAO_0000357,,
1568,10321,Binding affinity for 5-hydroxytryptamine 1A receptor was determined by using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616508,,BAO_0000357,,
1569,2968,Binding affinity for 5-hydroxytryptamine 1A receptor,B,,,Mus musculus,10090.0,,,,,11863,D,9,Expert,1,,CHEMBL616559,,BAO_0000357,,
1570,13964,Binding affinity at 5-hydroxytryptamine 1A receptor,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616560,,BAO_0000357,,
1571,15527,"Binding affinity towards 5-hydroxytryptamine 1A receptor receptor, using [3H]5-HT as radioligand.",B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616561,,BAO_0000357,,
1572,12248,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,B,,,,,,,CHO,,11863,H,8,Autocuration,1,,CHEMBL616562,449.0,BAO_0000219,,
1573,12249,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,B,,,,,,,CHO,,11863,H,8,Autocuration,1,,CHEMBL616563,449.0,BAO_0000219,,
1574,15120,Compound was tested for binding affinity using [3H]8-OH-DPAT against 5-hydroxytryptamine 1A receptor,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616564,,BAO_0000357,,
1575,13313,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by using [3H]-8-OH-DPAT as radioligand,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616565,,BAO_0000357,,
1576,2613,In vivo binding affinity was evaluated against 5-hydroxytryptamine 1A receptor,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616566,,BAO_0000218,,
1577,16700,The binding affinity towards 5-hydroxytryptamine 1A receptor; No affinity,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616989,,BAO_0000357,,
1578,2201,Ability to displace [125I]iodosulpiride from 5-hydroxytryptamine 1A receptor,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL857975,,BAO_0000357,,
1579,1274,Binding affinity against 5-hydroxytryptamine 1A receptor,B,,,Mus musculus,10090.0,,,,,11863,D,9,Expert,1,,CHEMBL616990,,BAO_0000357,,
1580,1317,Compound was evaluated for binding affinity against 5-hydroxytryptamine 1A receptor using radioligand binding assay,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616991,,BAO_0000357,,
1581,12146,Tested against 5-hydroxytryptamine 1A receptor,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616992,,BAO_0000357,,
1582,14059,The compound's binding affinity against 5-hydroxytryptamine 1A receptor,B,,,,,,,,,11863,H,8,Autocuration,1,,CHEMBL616993,,BAO_0000357,,
1583,14025,Dissociation equilibrium constant against the vascular 5-hydroxytryptamine 1B like receptor in the rabbit saphenous vein,B,,,Oryctolagus cuniculus,9986.0,,,,,106,H,8,Expert,1,,CHEMBL616994,,BAO_0000019,,
1584,14025,The dissociation equilibrium constant (pKB=-log KB) of compound was determined against the vascular 5-hydroxytryptamine 1B like receptor in the rabbit saphenous vein(RbSV); NS=non surmountable,B,,,Oryctolagus cuniculus,9986.0,,,,,106,H,8,Autocuration,1,,CHEMBL616995,,BAO_0000019,,
1585,14447,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1B receptor from cloned gorilla membranes expressed in cultured HEK 293 cells,B,,,Gorilla gorilla,9593.0,,,HEK293,,105571,D,9,Intermediate,1,,CHEMBL616996,722.0,BAO_0000219,,
1586,3025,5-HT1B agonist potency was evaluated as effective dose that induced hypothermia in the guinea-pig upon intraperitoneal administration,F,In vivo,,Cavia porcellus,10141.0,,,,,106,H,8,Autocuration,1,,CHEMBL616997,,BAO_0000218,,
1587,3025,5-hydroxytryptamine 1B receptor agonist potency was evaluated as effective dose that induced hypothermia in the guinea-pig upon intraperitoneal administration,F,In vivo,,Cavia porcellus,10141.0,,,,,106,H,8,Autocuration,1,,CHEMBL616998,,BAO_0000218,,
1588,15329,Affinity of compound towards 5-hydroxytryptamine 1B receptor in isolated guinea-pig iliac artery,F,,,Cavia porcellus,10141.0,,,,,106,H,8,Autocuration,1,,CHEMBL616999,,BAO_0000019,,
1589,15329,Affinity of compound towards 5-hydroxytryptamine 1B receptor in isolated guinea-pig iliac artery; n.d. indicates Not determined,F,,,Cavia porcellus,10141.0,,,,,106,H,8,Autocuration,1,,CHEMBL617000,,BAO_0000019,,
1590,15847,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 1B receptor of guinea pig,F,,,Cavia porcellus,10141.0,,,,,106,H,8,Autocuration,1,,CHEMBL617001,,BAO_0000019,,
1591,15847,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 1B receptor of guinea pig; ND means not done,F,,,Cavia porcellus,10141.0,,,,,106,H,8,Autocuration,1,,CHEMBL858111,,BAO_0000019,,
1592,14165,Intrinsic activity for Antagonism of 5-hydroxytryptamine 1B receptor-mediated stimulation of [35S]GTP gamma S binding,F,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL617002,,BAO_0000019,,
1593,14214,Antagonism tested at 1 uM against the agonist-induced inhibitory effect of 10 nM 5-carbamoyltryptamine (5-CT),F,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL617003,,BAO_0000019,,
1594,14214,Antagonism tested at 1 uM against the agonist-induced inhibitory effect of 10 nM 5-carbamoyltryptamine(5-CT),F,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL617004,,BAO_0000019,,
1595,14214,Agonist activity at 5-hydroxytryptamine 1B receptor by measuring the inhibition of forskolin-stimulated cAMP formation,F,,,Homo sapiens,9606.0,,,,,106,D,9,Expert,1,,CHEMBL617005,,BAO_0000019,,
1596,13729,Inhibition of forskolin-stimulated c-AMP formation by human 5-hydroxytryptamine 1B receptor expressed in CHO-K1 cells,F,,,Homo sapiens,9606.0,,,CHO-K1,,106,D,9,Expert,1,,CHEMBL616623,485.0,BAO_0000219,,
1597,3025,Effective concentration determined by measuring inhibition of forskolin-stimulated c-AMP formation at 5-hydroxytryptamine 1B receptor stably transfected in CHO cell lines,F,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616624,449.0,BAO_0000219,,
1598,2391,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL883243,,BAO_0000357,,
1599,2391,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; full agonist,F,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616625,,BAO_0000019,,
1600,14956,"Agonist-induced [35S]GTP-gamma-S, binding in CHO cells stably transfected with human 5-hydroxytryptamine 1B receptor",F,,,,,,,CHO,,106,H,8,Expert,1,,CHEMBL616626,449.0,BAO_0000219,,
1601,2598,The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line,F,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616627,449.0,BAO_0000219,,
1602,2598,The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line; Antagonist,F,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616628,449.0,BAO_0000219,,
1603,2598,The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line; Full Agonist,F,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616629,449.0,BAO_0000219,,
1604,2598,The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line; Partial Agonist,F,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616630,449.0,BAO_0000219,,
1605,14956,"Efficacy was evaluated relative to human 5-HT1B receptor using [35S]GTP-gamma-S, as radioligand",F,,,,,,,,,106,H,8,Expert,1,,CHEMBL616631,,BAO_0000019,,
1606,14956,"Efficacy of compound was evaluated relative to human 5-hydroxytryptamine 1B receptor using [35S]GTP-gamma-S, as radioligand",F,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616632,,BAO_0000019,,
1607,14214,Percentage Maximal inhibition obtained with 1 uM 5-HT against 5-hydroxytryptamine 1B receptor,B,,,Homo sapiens,9606.0,,,,,106,D,9,Expert,1,,CHEMBL616633,,BAO_0000357,,
1608,3463,Ability to displace [3H]5-HT from recombinant human 5-hydroxytryptamine 1B receptor stably expressed in CHO cells determined in vitro,B,,,,,,,CHO,,106,H,8,Expert,1,,CHEMBL616634,449.0,BAO_0000219,,
1609,15331,Affinity of compound towards 5-hydroxytryptamine 1B receptor was evaluated using radioligand binding technique,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616635,,BAO_0000357,,
1610,16146,Binding affinity against 5-hydroxytryptamine 1B receptor,B,,,Homo sapiens,9606.0,,,,,106,D,9,Expert,1,,CHEMBL885358,,BAO_0000357,,
1611,14159,Displacement of [3H]5-HT from human 5-hydroxytryptamine 1B receptor expressed in CHO cells,B,,,Homo sapiens,9606.0,,,CHO,,106,D,9,Expert,1,,CHEMBL616636,449.0,BAO_0000219,,
1612,14158,Binding affinity to human cloned 5-hydroxytryptamine 1B receptor in CHO cells by [3H]5-HT binding displacement.,B,,,,,,,CHO,,106,H,8,Expert,1,,CHEMBL616637,449.0,BAO_0000219,,
1613,14159,Compound was evaluated for the affinity at 5-hydroxytryptamine 1B receptor,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616638,,BAO_0000357,,
1614,15250,Displacement of [3H]5-HT binding to cloned 5-hydroxytryptamine 1B receptor stably expressed in CHO cells,B,,,,,,,CHO,,106,H,8,Expert,1,,CHEMBL616639,449.0,BAO_0000219,,
1615,15250,Binding affinity at cloned human 5-hydroxytryptamine 1B receptor stably expressed in CHO cells by [3H]5-HT displacement.,B,,,,,,,CHO,,106,H,8,Expert,1,,CHEMBL616640,449.0,BAO_0000219,,
1616,15331,Displacement of [3H]5-HT binding from the cloned human 5-hydroxytryptamine 1B receptor stably expressed in CHO cells,B,,,,,,,CHO,,106,H,8,Expert,1,,CHEMBL616641,449.0,BAO_0000219,,
1617,15332,Displacement of [3H]5-HT binding from cloned human 5-hydroxytryptamine 1B receptor stably expressed in CHO cells.,B,,,,,,,CHO,,106,H,8,Expert,1,,CHEMBL616642,449.0,BAO_0000219,,
1618,14956,Displacement of specific [3H]5-HT binding to cloned human 5-hydroxytryptamine 1B receptor expressed in CHO cells,B,,,,,,,CHO,,106,H,8,Expert,1,,CHEMBL616643,449.0,BAO_0000219,,
1619,3805,In vitro binding affinity against human 5-hydroxytryptamine 1B receptor at a concentration of 100 (nM),B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616644,,BAO_0000357,,
1620,14875,Intrinsic activity for each compound is calculated as a percentage of the 5-hydroxytryptamine 1B receptor response,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616645,,BAO_0000357,,
1621,14454,Compound was tested for 5-hydroxytryptamine 1D like receptor-mediated vascular effect in rabbit saphenous vein (RSV),F,,,Oryctolagus cuniculus,9986.0,,,,,105,H,8,Autocuration,1,,CHEMBL616646,,BAO_0000019,,
1622,14454,Tested for 5-hydroxytryptamine 1D like receptor-mediated vascular effect in rabbit saphenous vein (RSV),F,,,Oryctolagus cuniculus,9986.0,,,,,105,H,8,Expert,1,,CHEMBL616647,,BAO_0000019,,
1623,16288,Affinity at 5-hydroxytryptamine 1D receptor (For sumatriptan = Ki (nM)-12+/-1.9),B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616509,,BAO_0000357,,
1624,16288,Affinity at 5-hydroxytryptamine 1D receptor from calf caudate using [3H]5-HT as radioligand (For sumatriptan = Ki(nM)-12+/-1.9),B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616510,,BAO_0000357,,
1625,16312,Binding affinity against calf caudate 5-hydroxytryptamine 1D receptor,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616511,,BAO_0000357,,
1626,1348,Inhibitory activity against 5-hydroxytryptamine 1D receptor subtype,B,,,Bos taurus,9913.0,,,,,105,H,8,Expert,1,,CHEMBL616512,,BAO_0000357,,
1627,5834,Inhibitory concentration required against 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]5-HT,B,,,Bos taurus,9913.0,,,,,105,H,8,Autocuration,1,,CHEMBL616513,,BAO_0000357,,
1628,13366,Binding affinity towards 5-hydroxytryptamine 1D receptor was determined in calf striatum homogenate,B,,,Bos taurus,9913.0,,Striatum,,,105,H,8,Autocuration,1,,CHEMBL616514,,BAO_0000019,2435.0,
1629,1414,Ability to bind to 5-hydroxytryptamine 1D receptor of calf substantia nigra,B,,,Bos taurus,9913.0,,,,,105,H,8,Expert,1,,CHEMBL616515,,BAO_0000357,,
1630,14998,Binding affinity against 5-hydroxytryptamine 1D receptor in calf caudate homogenates.,B,,,Bos taurus,9913.0,,,,,105,H,8,Autocuration,1,,CHEMBL616516,,BAO_0000019,,
1631,11473,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]- serotonin as radioligand,B,,,Bos taurus,9913.0,,,,,105,H,8,Autocuration,1,,CHEMBL616517,,BAO_0000357,,
1632,11473,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]- serotonin as radioligand,B,,,Bos taurus,9913.0,,,,,105,H,8,Autocuration,1,,CHEMBL616518,,BAO_0000357,,
1633,10639,Compound was evaluated for its inhibitory activity against 5-hydroxytryptamine 1D receptor of bovine caudate using [3H]5-HT as the radioligand,B,,,Bos taurus,9913.0,,,,,105,H,8,Autocuration,1,,CHEMBL616519,,BAO_0000357,,
1634,10639,Inhibitory activity against 5-hydroxytryptamine 1D receptor of bovine caudate using [3H]5-HT as the radioligand,B,,,Bos taurus,9913.0,,,,,105,H,8,Autocuration,1,,CHEMBL616520,,BAO_0000357,,
1635,1375,Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]5-HT radioligand,B,,,Bos taurus,9913.0,,,,,105,H,8,Autocuration,1,,CHEMBL616521,,BAO_0000357,,
1636,1375,Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]5-HT radioligand; NT means not tested,B,,,Bos taurus,9913.0,,,,,105,H,8,Autocuration,1,,CHEMBL616522,,BAO_0000357,,
1637,16532,The binding affinity at 5-hydroxytryptamine 1D receptor was determined using [3H]5-CT; Not tested,B,,,Bos taurus,9913.0,,,,,105,H,8,Autocuration,1,,CHEMBL884531,,BAO_0000357,,
1638,11147,Binding affinity towards 5-hydroxytryptamine 1D receptor using [3H]5-HT as radioligand,B,,,Bos taurus,9913.0,,,,,105,H,8,Autocuration,1,,CHEMBL616523,,BAO_0000357,,
1639,13366,Binding affinity towards 5-hydroxytryptamine 1D receptor was determined in calf striatum homogenate,B,,,Bos taurus,9913.0,,Striatum,,,105,H,8,Autocuration,1,,CHEMBL616731,,BAO_0000019,2435.0,
1640,10444,Binding affinity was determined against 5-hydroxytryptamine 1D receptor in bovine caudate homogenate,B,,,Bos taurus,9913.0,,,,,105,H,8,Autocuration,1,,CHEMBL616732,,BAO_0000019,,
1641,16532,The binding affinity at 5-hydroxytryptamine 1D receptor was determined using [3H]5-CT,B,,,Bos taurus,9913.0,,,,,105,H,8,Autocuration,1,,CHEMBL616733,,BAO_0000357,,
1642,16532,The binding affinity at 5-hydroxytryptamine 1D receptor was determined using [3H]5-CT; Not tested,B,,,Bos taurus,9913.0,,,,,105,H,8,Autocuration,1,,CHEMBL616734,,BAO_0000357,,
1643,12827,Binding affinity towards 5-hydroxytryptamine 1B receptor in rat frontal cortex membranes using [125]ICYP,B,,,Bos taurus,9913.0,,,,,105,H,8,Autocuration,1,,CHEMBL616735,,BAO_0000249,,
1644,12827,Binding affinity towards 5-hydroxytryptamine 1B receptor in rat frontal cortex membranes using [125]ICYP; Not determined,B,,,Bos taurus,9913.0,,,,,105,H,8,Autocuration,1,,CHEMBL616736,,BAO_0000249,,
1645,12919,Agonistic activity against 5-hydroxytryptamine 1D receptor in calf caudate using [3H]-GTI,F,,,Bos taurus,9913.0,,,,,105,H,8,Expert,1,,CHEMBL616737,,BAO_0000019,,
1646,14025,Affinity pKi for 5-hydroxytryptamine 1D receptor was measured in calf caudate homogenate,B,,,Bos taurus,9913.0,,,,,105,H,8,Autocuration,1,,CHEMBL616738,,BAO_0000019,,
1647,12919,Agonistic activity against 5-hydroxytryptamine 1D receptor in calf caudate using [3H]-GTI,F,,,Bos taurus,9913.0,,,,,105,H,8,Expert,1,,CHEMBL616739,,BAO_0000019,,
1648,12919,Agonistic activity against 5-hydroxytryptamine 1D receptor in calf caudate using [3H]-GTI,F,,,Bos taurus,9913.0,,,,,105,H,8,Expert,1,,CHEMBL616740,,BAO_0000019,,
1649,12919,Agonistic activity against 5-hydroxytryptamine 1D receptor in calf caudate using [3H]-GTI,F,,,Bos taurus,9913.0,,,,,105,H,8,Expert,1,,CHEMBL616741,,BAO_0000019,,
1650,14447,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1D receptor from cloned gorilla membranes expressed in cultured HEK 293 cells,B,,,Gorilla gorilla,9593.0,,,HEK293,,105,H,8,Autocuration,1,,CHEMBL616742,722.0,BAO_0000219,,
1651,1375,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1D receptor in guinea pig substantia nigra,B,,,Cavia porcellus,10141.0,,,,,105570,D,9,Intermediate,1,,CHEMBL616743,,BAO_0000019,,
1652,1375,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1D receptor in guinea pig substantia nigra; NT means not tested,B,,,Cavia porcellus,10141.0,,,,,105570,D,9,Intermediate,1,,CHEMBL616744,,BAO_0000019,,
1653,12409,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptor by the agonist GR-46611,F,,,Cavia porcellus,10141.0,,,,,105570,D,9,Intermediate,1,,CHEMBL616745,,BAO_0000019,,
1654,12409,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611,F,,,Cavia porcellus,10141.0,,,,,105570,D,9,Intermediate,1,,CHEMBL616746,,BAO_0000019,,
1655,12409,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611; range is 2-9,F,,,Cavia porcellus,10141.0,,,,,105570,D,9,Intermediate,1,,CHEMBL616747,,BAO_0000019,,
1656,12409,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611;range is 0.2-0.4,F,,,Cavia porcellus,10141.0,,,,,105570,D,9,Intermediate,1,,CHEMBL616748,,BAO_0000019,,
1657,12409,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611;range is 0.2-1.2,F,,,Cavia porcellus,10141.0,,,,,105570,D,9,Intermediate,1,,CHEMBL616648,,BAO_0000019,,
1658,11574,Binding affinity against 5-hydroxytryptamine 1D receptor,B,,,Cavia porcellus,10141.0,,,,,105570,D,9,Intermediate,1,,CHEMBL616649,,BAO_0000357,,
1659,1558,Binding affinity towards guinea pig 5-hydroxytryptamine 1D receptor was determined,B,,,Cavia porcellus,10141.0,,,,,105570,D,9,Intermediate,1,,CHEMBL616650,,BAO_0000357,,
1660,12409,Compound at 3 mg/kg was tested for the inhibition of hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611,F,,,Cavia porcellus,10141.0,,,,,105570,D,9,Intermediate,1,,CHEMBL616651,,BAO_0000218,,
1661,12409,Compound at 45 mg/kg was tested for the inhibition of hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611,F,,,Cavia porcellus,10141.0,,,,,105570,D,9,Intermediate,1,,CHEMBL616652,,BAO_0000218,,
1662,12409,Compound at 50 mg/kg was tested for the inhibition of hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611,F,,,Cavia porcellus,10141.0,,,,,105570,D,9,Intermediate,1,,CHEMBL616653,,BAO_0000218,,
1663,12409,Compound at oral dose of 45 mg/kg was tested for percent inhibition against 5-hydroxytryptamine 1D receptor causes hypothermia in guinea pig,F,,,Cavia porcellus,10141.0,,,,,105570,D,9,Intermediate,1,,CHEMBL616654,,BAO_0000218,,
1664,12253,Binding affinity of 5-hydroxytryptamine 1D receptor using [3H]-8-HT in guinea pig cortex,B,,,Cavia porcellus,10141.0,,,,,105570,D,9,Intermediate,1,,CHEMBL616655,,BAO_0000019,,
1665,12936,Binding affinity against guinea pig 5-hydroxytryptamine 1D receptor,B,,,Cavia porcellus,10141.0,,,,,105570,D,9,Intermediate,1,,CHEMBL616656,,BAO_0000357,,
1666,13181,Binding affinity was determined against 5-hydroxytryptamine 4 receptor using [125I]SB 207710 as radioligand from piglet hippocampal membranes,B,,,Cavia porcellus,10141.0,,,,,105,H,8,Autocuration,1,,CHEMBL616657,,BAO_0000019,,
1667,12409,In vitro binding affinity towards 5-hydroxytryptamine 1D receptor in guinea-pig striatum in presence of BMY-7378 and mesulergine,B,,,Cavia porcellus,10141.0,,Striatum,,,105570,D,9,Intermediate,1,,CHEMBL616658,,BAO_0000357,2435.0,
1668,10639,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1D receptor of guinea pig substantia nigra,B,,,Cavia porcellus,10141.0,,,,,105570,D,9,Intermediate,1,,CHEMBL616659,,BAO_0000357,,
1669,5254,Binding affinity against 5-hydroxytryptamine 1D receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL616660,,BAO_0000357,,
1670,13051,The compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor beta,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616661,,BAO_0000357,,
1671,3463,Maximum stimulation of [35S]GTP gamma-S binding expressed relative to the maximal effect produced by 5-hydroxytryptamine 1D receptor,F,,,,,,,,,105,H,8,Expert,1,,CHEMBL616662,,BAO_0000019,,
1672,15315,Ability to inhibit forskolin-stimulated adenylate cyclase in a cell line expressing human 5-hydroxytryptamine 1D receptor,F,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616663,,BAO_0000019,,
1673,6011,Ability to inhibit forskolin-stimulated adenylate cyclase activity in Chinese hamster ovary (CHO) stable cell lines expressing human 5-hydroxytryptamine 1D receptor,F,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616664,,BAO_0000019,,
1674,14159,"Stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing 5-hydroxytryptamine 1D receptor",F,,,Homo sapiens,9606.0,,,CHO,,105,D,9,Expert,1,,CHEMBL881820,449.0,BAO_0000219,,
1675,14159,"Compound was evaluated for the stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing the 5-hydroxytryptamine 1D receptor.",F,,,,,,,CHO,,105,H,8,Autocuration,1,,CHEMBL616665,449.0,BAO_0000219,,
1676,15250,Agonist-induced [35S]- GTPgammaS binding in CHO cells stably transfected with 5-hydroxytryptamine 1D receptor,B,,,,,,,CHO,,105,H,8,Expert,1,,CHEMBL616666,449.0,BAO_0000219,,
1677,15250,Compound was tested for measuring agonist-induced [35S]- GTPgammaS binding in CHO cells stably transfected with human 5-hydroxytryptamine 1D receptor,B,,,,,,,CHO,,105,H,8,Autocuration,1,,CHEMBL616667,449.0,BAO_0000219,,
1678,15331,"Stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing the 5-hydroxytryptamine 1D receptor",F,,,,,,,CHO,,105,H,8,Expert,1,,CHEMBL616668,449.0,BAO_0000219,,
1679,15332,"Stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing the 5-hydroxytryptamine 1D receptor",F,,,Homo sapiens,9606.0,,,CHO,,105,D,9,Expert,1,,CHEMBL616669,449.0,BAO_0000219,,
1680,15332,"Stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing the human 5-hydroxytryptamine 1D receptor.",F,,,,,,,CHO,,105,H,8,Expert,1,,CHEMBL617040,449.0,BAO_0000219,,
1681,3294,"Measurement of agonist induced [35S]GTP-gamma-S, binding in CHO cells stably transfected with 5-hydroxytryptamine 1D receptor",F,,,,,,,CHO,,105,H,8,Autocuration,1,,CHEMBL617041,449.0,BAO_0000219,,
1682,14158,"Measurement of agonist induced [35S]GTP-gamma-S, binding in CHO cells stably transfected with 5-hydroxytryptamine 1D receptor.",F,,,,,,,CHO,,105,H,8,Expert,1,,CHEMBL617042,449.0,BAO_0000219,,
1683,14956,"Agonist-induced [35S]GTP-gamma-S, binding in CHO cells stably transfected with human 5-hydroxytryptamine 1D receptor",F,,,,,,,CHO,,105,H,8,Expert,1,,CHEMBL617043,449.0,BAO_0000219,,
1684,12469,Compound was evaluated for its agonistic activity on 5-hydroxytryptamine 1D receptor,F,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617044,,BAO_0000019,,
1685,3463,Measurement of agonist-induced [35S]-GTP gamma-S binding in CHO cells stably transfected with 5-hydroxytryptamine 1D receptor,F,,,,,,,CHO,,105,H,8,Expert,1,,CHEMBL617045,449.0,BAO_0000219,,
1686,15250,"Maximum stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing human 5-HT-1d relative to 5-HT",F,,,Homo sapiens,9606.0,,,CHO,,105,D,9,Expert,1,,CHEMBL617046,449.0,BAO_0000219,,
1687,15250,"Maximum stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing human 5-HT-1d relative to 5-HT",F,,,Homo sapiens,9606.0,,,CHO,,105,D,9,Expert,1,,CHEMBL617047,449.0,BAO_0000219,,
1688,14956,"Efficacy was evaluated relative to human 5-hydroxytryptamine 1D receptor using [35S]GTP-gamma-S, as radioligand",F,,,,,,,,,105,H,8,Expert,1,,CHEMBL617048,,BAO_0000019,,
1689,14159,"Maximum stimulation of [35S]GTP-gamma-S, binding expressed relative to the maximal effect produced by 5-hydroxytryptamine 1D receptor.",F,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616897,,BAO_0000019,,
1690,14159,"Maximum stimulation of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1D receptor relative to 5-HT",F,,,Homo sapiens,9606.0,,,,,105,D,9,Expert,1,,CHEMBL616898,,BAO_0000019,,
1691,14499,Percent efficacy relative to 5-HT treatment of CHO cells expressing 5-HT 1d receptor,F,,,Homo sapiens,9606.0,,,CHO,,105,D,9,Expert,1,,CHEMBL858201,449.0,BAO_0000219,,
1692,15315,Intrinsic activity for 5-hydroxytryptamine 1D receptor,F,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616899,,BAO_0000019,,
1693,3294,Ability to displace [3H]- -5-HT binding to cloned 5-hydroxytryptamine 1D receptor stably expressed in chinese hamster cells (CHO cells),B,In vitro,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616900,,BAO_0000219,,
1694,3463,Ability to displace [3H]-5-HT from recombinant human 5-hydroxytryptamine 1D receptor stably expressed in CHO cells determined in vitro,B,,,,,,,CHO,,105,H,8,Expert,1,,CHEMBL616901,449.0,BAO_0000219,,
1695,15331,Affinity of compound towards 5-hydroxytryptamine 1D receptor was evaluated using radioligand binding technique,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616902,,BAO_0000357,,
1696,14159,Displacement of [3H]5-HT from human 5-hydroxytryptamine 1D receptor expressed in CHO cells,B,,,Homo sapiens,9606.0,,,CHO,,105,D,9,Expert,1,,CHEMBL616903,449.0,BAO_0000219,,
1697,14158,Binding affinity by displacement to human cloned 5-hydroxytryptamine 1D receptor in CHO cells by [3H]5-HT displacement.,B,,,,,,,CHO,,105,H,8,Expert,1,,CHEMBL616904,449.0,BAO_0000219,,
1698,14159,Compound was evaluated for the affinity at 5-hydroxytryptamine 1D receptor,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616905,,BAO_0000357,,
1699,15250,Binding affinity at human cloned 5-hydroxytryptamine 1D receptor stably expressed in CHO cells by [3H]5-HT displacement.,B,,,,,,,CHO,,105,H,8,Expert,1,,CHEMBL616906,449.0,BAO_0000219,,
1700,15250,Displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 1D receptor stably expressed in CHO cells,B,,,,,,,CHO,,105,H,8,Expert,1,,CHEMBL616907,449.0,BAO_0000219,,
1701,15331,Displacement of [3H]5-HT binding from the cloned human 5-hydroxytryptamine 1D receptor stably expressed in CHO cells,B,,,,,,,CHO,,105,H,8,Expert,1,,CHEMBL616908,449.0,BAO_0000219,,
1702,15332,Displacement of [3H]5-HT binding from human 5-hydroxytryptamine 1D receptor expressed in CHO cells,B,,,Homo sapiens,9606.0,,,CHO,,105,D,9,Expert,1,,CHEMBL616909,449.0,BAO_0000219,,
1703,14499,Displacement of [3H]5-HT from human 5-hydroxytryptamine 1D receptor expressed in CHO cells,B,,,Homo sapiens,9606.0,,,CHO,,105,D,9,Expert,1,,CHEMBL616910,449.0,BAO_0000219,,
1704,15332,Displacement of [3H]5-HT binding to the cloned human 5-hydroxytryptamine 1D receptor stably expressed in CHO cells,B,,,,,,,CHO,,105,H,8,Expert,1,,CHEMBL616911,449.0,BAO_0000219,,
1705,14956,Displacement of specific [3H]5-HT binding to cloned human 5-hydroxytryptamine 1D receptor expressed in CHO cells,B,,,,,,,CHO,,105,H,8,Expert,1,,CHEMBL616912,449.0,BAO_0000219,,
1706,3805,In vitro binding affinity against human 5-hydroxytryptamine 1D receptor at a concentration of 100 (nM),B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616913,,BAO_0000357,,
1707,6011,Inhibition of [3H]5-HT binding to human 5-hydroxytryptamine 1D receptor expressed in CHO cells at 1 uM,B,,,Homo sapiens,9606.0,,,CHO,,105,D,9,Expert,1,,CHEMBL616914,449.0,BAO_0000219,,
1708,16190,Binding affinity against 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT as radioligand,B,,,,,,,CHO,,105,H,8,Autocuration,1,,CHEMBL616915,449.0,BAO_0000219,,
1709,14165,Binding affinity for 5-hydroxytryptamine 1D receptor in Cos-7 transfected cell type using [3H]5-CT as radioligand,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616916,,BAO_0000019,,
1710,4234,Binding affinity to cloned human 5-hydroxytryptamine 1D receptor,B,,,Homo sapiens,9606.0,,,,,105,D,9,Expert,1,,CHEMBL616917,,BAO_0000357,,
1711,15527,"Binding affinity towards 5-HT1D receptor, using [3H]5-HT as radioligand.",B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616918,,BAO_0000357,,
1712,6328,Binding affinity towards human 5-hydroxytryptamine 1D receptor in L-M(tk-) cells using [3H]GR-125743 as radioligand,B,,,,,,,,,105,H,8,Expert,1,,CHEMBL616919,,BAO_0000219,,
1713,16209,Binding affinity towards human 5-hydroxytryptamine 1D receptor was determined using [3H]5-HT as radioligand,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616920,,BAO_0000357,,
1714,14770,Binding affinity for recombinant human 5-hydroxytryptamine 1D receptor using [3H]5-HT as radioligand.,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL872914,,BAO_0000357,,
1715,2598,Binding affinity was evaluated at human recombinant 5-hydroxytryptamine 1D receptor using [3H]-5-CT as radioligand,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616921,,BAO_0000357,,
1716,6897,Binding affinity was evaluated at the cloned human 5-hydroxytryptamine 1D receptor,B,,,,,,,,,105,H,8,Expert,1,,CHEMBL616922,,BAO_0000357,,
1717,6013,Binding affinity towards 5-hydroxytryptamine 1D receptor,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616923,,BAO_0000357,,
1718,5843,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor,B,,,,,,,,,105,H,8,Expert,1,,CHEMBL616924,,BAO_0000357,,
1719,14454,Binding affinity towards human 5-hydroxytryptamine 1D receptor using [3H]5-HT trifluoroacetate as radioligand,B,,,,,,,,,105,H,8,Expert,1,,CHEMBL875909,,BAO_0000357,,
1720,14454,Binding affinity towards human 5-hydroxytryptamine 1D receptor using [3H]5-HT trifluoroacetate as radioligand; Not determined,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616925,,BAO_0000357,,
1721,14454,Binding affinity towards human 5-hydroxytryptamine 1D receptor using [3H]5-HT trifluoroacetate as radioligand; not determined,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616926,,BAO_0000357,,
1722,15818,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 1D receptor,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616927,,BAO_0000357,,
1723,13729,Ability to inhibit the forskolin-stimulated c-AMP formation mediated by human 5-hydroxytryptamine 1D receptor in CHO-K1 cells,F,,,,,,,CHO-K1,,105,H,8,Expert,1,,CHEMBL616928,485.0,BAO_0000219,,
1724,6011,Displacement of [3H]5-HT from human 5-hydroxytryptamine 1D receptor expressed in Chinese hamster ovary cells (CHO cells),B,In vitro,,Homo sapiens,9606.0,,,,,105,D,9,Expert,1,,CHEMBL616929,,BAO_0000219,,
1725,4234,In vitro binding affinity to human 5-hydroxytryptamine 1D receptor,B,,,Homo sapiens,9606.0,,,,,105,D,9,Expert,1,,CHEMBL616930,,BAO_0000357,,
1726,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1D receptor,B,,,,,,,,,105,H,8,Expert,1,,CHEMBL616931,,BAO_0000019,,
1727,3025,In vitro binding affinity was determined towards cloned human 5-hydroxytryptamine 1D receptor using [3H]5-CT radioligand,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616932,,BAO_0000357,,
1728,15315,In vitro receptor binding affinity for cloned human 5-hydroxytryptamine 1D receptor,B,,,,,,,,,105,H,8,Expert,1,,CHEMBL616933,,BAO_0000357,,
1729,14214,Receptor binding affinity for cloned human 5-hydroxytryptamine 1D receptor in Cos-7 cells,B,,,Homo sapiens,9606.0,,,,,105,D,9,Expert,1,,CHEMBL616934,,BAO_0000219,,
1730,3804,Binding affinity for human 5-hydroxytryptamine 1D receptor,B,,,Homo sapiens,9606.0,,,,,105,D,9,Expert,1,,CHEMBL616935,,BAO_0000357,,
1731,16700,The binding affinity towards the 5-hydroxytryptamine 1D receptor; No affinity,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616936,,BAO_0000357,,
1732,2391,Affinity for 5-hydroxytryptamine 1D receptor subtype,B,,,Homo sapiens,9606.0,,,,,105,D,9,Expert,1,,CHEMBL616937,,BAO_0000357,,
1733,4175,Binding affinity for human 5-hydroxytryptamine 1D receptor,B,,,Homo sapiens,9606.0,,,,,105,D,9,Expert,1,,CHEMBL616938,,BAO_0000357,,
1734,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1D receptor,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616939,,BAO_0000019,,
1735,17085,In vitro binding affinity was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1D receptor; ND means not determined,B,,,,,,,,,105,H,8,Expert,1,,CHEMBL616940,,BAO_0000019,,
1736,15926,Binding activity against human 5-hydroxytryptamine 1D receptor; NT means not tested,B,,,Homo sapiens,9606.0,,,,,105,D,9,Expert,1,,CHEMBL616941,,BAO_0000357,,
1737,16312,Binding affinity in CHO-K1 cells transfected with human 5-hydroxytryptamine 1D receptor; Not tested,B,,,,,,,CHO-K1,,105,H,8,Autocuration,1,,CHEMBL616942,485.0,BAO_0000219,,
1738,16312,Binding affinity in CHO-K1 cells transfected with human 5-hydroxytryptamine 1D receptor; not tested,B,,,,,,,CHO-K1,,105,H,8,Autocuration,1,,CHEMBL616943,485.0,BAO_0000219,,
1739,14956,Selectivity towards 5-HT1D and to that of 5-HT1B in CHO cells,B,,,,,,,CHO,,104802,H,4,Autocuration,1,,CHEMBL616944,449.0,BAO_0000219,,
1740,3294,"Maximum stimulation of [35S]GTP-gamma-S, binding expressed relative to the maximal effect produced by the 5-HT",F,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616945,,BAO_0000019,,
1741,12861,Binding activity radioligand.,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616946,,BAO_0000357,,
1742,12861,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand.,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616947,,BAO_0000019,,
1743,16312,Binding affinity in CHO-K1 cells transfected with human 5-hydroxytryptamine 1D receptor,B,,,,,,,CHO-K1,,105,H,8,Expert,1,,CHEMBL616948,485.0,BAO_0000219,,
1744,5104,Binding affinity for human cloned 5-hydroxytryptamine 1D receptor,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616851,,BAO_0000357,,
1745,5105,Binding affinity for human cloned 5-hydroxytryptamine 1D receptor,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616852,,BAO_0000357,,
1746,14499,Measured as -log Ka on 5-hydroxytryptamine 1D receptor,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616853,,BAO_0000357,,
1747,15926,Binding activity against human 5-hydroxytryptamine 1D receptor,B,,,Homo sapiens,9606.0,,,,,105,D,9,Expert,1,,CHEMBL616854,,BAO_0000357,,
1748,4540,Binding affinity to human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT as radioligand,B,,,Homo sapiens,9606.0,,,CHO,,105,D,9,Expert,1,,CHEMBL616855,449.0,BAO_0000219,,
1749,15779,Binding affinity towards 5-hydroxytryptamine 1D (human cloned receptor) in CHO cells using [3H]-5-HT as radioligand.,B,,,,,,,CHO,,105,H,8,Autocuration,1,,CHEMBL616856,449.0,BAO_0000219,,
1750,15779,Binding affinity towards 5-hydroxytryptamine 1D (human cloned receptor) in CHO cells using [3H]5-HT as radioligand.,B,,,,,,,CHO,,105,H,8,Autocuration,1,,CHEMBL616857,449.0,BAO_0000219,,
1751,6166,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616858,,BAO_0000357,,
1752,15779,Binding affinity towards human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT as radioligand.,B,,,,,,,CHO,,105,H,8,Autocuration,1,,CHEMBL616859,449.0,BAO_0000219,,
1753,15779,Binding affinity towards human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]-5-HT as radioligand.;ND means no data.,B,,,,,,,CHO,,105,H,8,Autocuration,1,,CHEMBL616860,449.0,BAO_0000219,,
1754,17451,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 1D receptor expressed in HEK 293 cells using [3H]LSD as radioligand,B,,,,,,,HEK293,,105,H,8,Autocuration,1,,CHEMBL616861,722.0,BAO_0000219,,
1755,17451,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 1D receptor expressed in HEK 293 cells using [3H]LSD as radioligand,B,,,,,,,HEK293,,105,H,8,Autocuration,1,,CHEMBL616541,722.0,BAO_0000219,,
1756,17451,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 1D receptor expressed in HEK 293 cells using [3H]LSD as radioligand; Not determined,B,,,,,,,HEK293,,105,H,8,Autocuration,1,,CHEMBL616542,722.0,BAO_0000219,,
1757,4199,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT as the radioligand,B,,,,,,,CHO,,105,H,8,Autocuration,1,,CHEMBL616543,449.0,BAO_0000219,,
1758,14875,Binding affinity for human 5-hydroxytryptamine 1D receptor,B,,,Homo sapiens,9606.0,,,,,105,D,9,Expert,1,,CHEMBL616544,,BAO_0000357,,
1759,15146,Compound was tested for its binding affinity against human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT,B,,,,,,,CHO,,105,H,8,Autocuration,1,,CHEMBL616545,449.0,BAO_0000219,,
1760,5213,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1D receptor in CHO using [3H]5-HT as a radioligand,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616546,,BAO_0000357,,
1761,14818,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT.,B,,,,,,,CHO,,105,H,8,Autocuration,1,,CHEMBL616547,449.0,BAO_0000219,,
1762,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1D receptor in CHO cells, using [3H]5-HT as radioligand",B,,,,,,,CHO,,105,H,8,Autocuration,1,,CHEMBL616548,449.0,BAO_0000219,,
1763,14454,Adenyl cyclase activity was expressed as percent forskolin response against 5-hydroxytryptamine 1D receptor at concentration 1 uM,F,,,,,,,,,105,H,8,Expert,1,,CHEMBL616549,,BAO_0000019,,
1764,14454,Adenyl cyclase activity was expressed as percent forskolin response against 5-hydroxytryptamine 1D receptor at concentration 10 uM,F,,,,,,,,,105,H,8,Expert,1,,CHEMBL616550,,BAO_0000019,,
1765,5254,Binding affinity against 5-HT2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL857066,,BAO_0000357,,
1766,5254,Binding affinity against 5-hydroxytryptamine 1D receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL616551,,BAO_0000357,,
1767,10639,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1B receptor of rat substantia nigra,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616552,,BAO_0000357,,
1768,10639,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1B receptor of rat substantia nigra,F,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL832876,,BAO_0000019,,
1769,12352,"Binding affinity for 5-hydroxytryptamine 1B receptor in rat cortex, striatum and globus pallidus",B,,,,,,,,,10577,H,8,Expert,1,,CHEMBL616553,,BAO_0000019,,
1770,9098,Binding affinity towards 5-HT1B was determined,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616554,,BAO_0000357,,
1771,14430,Affinity towards 5-hydroxytryptamine 1B receptor in membranes from rat frontal cortex using [3H]5-HT,B,,,,,,,,,10577,H,8,Expert,1,,CHEMBL616555,,BAO_0000019,,
1772,13657,"Binding affinity to 5-HT1B receptors using rat cortex+striatum + globus pallidus,[3H]-5-OH-tryptamine, and serotonin for NSB",B,,,,,,,,,10577,H,8,Expert,1,,CHEMBL616556,,BAO_0000019,,
1773,13657,"Compound was evaluated for binding affinity on 5-HT1B receptors using rat cortex+striatum+ globus pallidus,[ 3H]-5-OH-tryptamine, and serotonin for NSB.",B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616557,,BAO_0000019,,
1774,15854,Binding affinity towards 5-hydroxytryptamine 1B receptor in rat frontal cortex using [125I]iodocyanopindolol as radio-ligand.,B,,,,,,,,,10577,H,8,Expert,1,,CHEMBL616558,,BAO_0000019,,
1775,10639,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat cortex using [3H]5-HT,B,,,Rattus norvegicus,10116.0,,,,,10577,D,9,Expert,1,,CHEMBL616749,,BAO_0000019,,
1776,10025,Concentration necessary to achieve half maximal inhibition of [125I]- Iodocyanopindolol binding to 5-hydroxytryptamine 1B receptor at 1 uM,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616750,,BAO_0000357,,
1777,10025,"Concentration necessary to achieve half maximal inhibition of [125I]- Iodocyanopindolol, binds to 5-hydroxytryptamine 1B receptor at 1 uM",B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616751,,BAO_0000357,,
1778,14286,In vitro inhibitory concentration against radioligand [3H]5-HT binding to 5-hydroxytryptamine 1B receptor in rat striatal membrane,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616752,,BAO_0000249,,
1779,3651,Inhibition of [3H]-5-HT binding to 5-hydroxytryptamine 1B receptor in rat striatum; Residual radioligand binding higher than 50%,B,,,,,,Striatum,,,10577,H,8,Autocuration,1,,CHEMBL616753,,BAO_0000019,2435.0,
1780,14178,Inhibition of radiolabeled [3H]-5-HT ligand binding to 5-hydroxytryptamine 1B receptor,B,,,Rattus norvegicus,10116.0,,,,,10577,D,9,Expert,1,,CHEMBL616754,,BAO_0000357,,
1781,10639,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat cortex using [3H]5-HT as the radioligand.,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616755,,BAO_0000019,,
1782,13605,Inhibitory activity against [3H]5-HT binding to 5-HT1B receptor in rat striatum,B,,,,,,Striatum,,,10577,H,8,Autocuration,1,,CHEMBL616756,,BAO_0000019,2435.0,
1783,5834,Inhibitory concentration required against 5-hydroxytryptamine 1B receptor in rat striatum using [3H]5-HT,B,,,,,,Striatum,,,10577,H,8,Autocuration,1,,CHEMBL616757,,BAO_0000019,2435.0,
1784,10922,compound was measured for affinity against 5-hydroxytryptamine 1B receptor labelled with [3H]5-HT radioligand in striatum tissue,B,,,,,,Striatum,,,10577,H,8,Autocuration,1,,CHEMBL616758,,BAO_0000357,2435.0,
1785,14286,Compound at 10E-5 M was tested in vitro for the inhibition of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1B receptor in rat striatal membrane,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616759,,BAO_0000249,,
1786,11825,In vitro binding affinity towards the 5-hydroxytryptamine 1B receptor at 10 e-6 M,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616760,,BAO_0000357,,
1787,14826,Ability to displace [3H]5-HT bound to 5-hydroxytryptamine 1B receptor in rat striatum,B,,,,,,Striatum,,,10577,H,8,Autocuration,1,,CHEMBL616761,,BAO_0000019,2435.0,
1788,9699,Binding affinity against 5-HT1B serotonin receptor in rat striatum,B,,,,,,Striatum,,,10577,H,8,Autocuration,1,,CHEMBL616762,,BAO_0000019,2435.0,
1789,14423,Binding affinity against 5-hydroxytryptamine 1B receptor in membranes of Rat cerebral cortex,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616763,,BAO_0000019,,
1790,10062,Binding affinity at rat 5-hydroxytryptamine 1B receptor by [3H]5-HT displacement.,B,,,,,,,,,10577,H,8,Expert,1,,CHEMBL872909,,BAO_0000357,,
1791,10062,Binding affinity determined in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1B receptor,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616764,,BAO_0000357,,
1792,12280,Inhibition of [3H]5-HT binding to 5-hydroxytryptamine 1B receptor,B,,,Rattus norvegicus,10116.0,,,,,10577,D,9,Expert,1,,CHEMBL616765,,BAO_0000357,,
1793,15412,Binding affinity against 5-hydroxytryptamine 1B receptor of rat striatum,B,,,,,,Striatum,,,10577,H,8,Autocuration,1,,CHEMBL616766,,BAO_0000357,2435.0,
1794,15412,Binding affinity against 5-hydroxytryptamine 1B receptor of rat striatum.,B,,,,,,Striatum,,,10577,H,8,Autocuration,1,,CHEMBL616767,,BAO_0000357,2435.0,
1795,10062,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1B receptor,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616768,,BAO_0000357,,
1796,11147,Binding affinity towards 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616769,,BAO_0000357,,
1797,9547,Binding affinity towards 5-hydroxytryptamine 1B receptor in rat was determined using 50 uL of [125I]ICYP in binding assay,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616770,,BAO_0000019,,
1798,10444,Binding affinity was determined against 5-hydroxytryptamine 1B receptor was determined in male Sprague-Dawley rat brain.,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616771,,BAO_0000019,,
1799,12469,Binding affinity was measured on 5-hydroxytryptamine 1B receptor in rat striatum labeled with [3H]5-HT,B,,,,,,Striatum,,,10577,H,8,Autocuration,1,,CHEMBL616772,,BAO_0000019,2435.0,
1800,9098,Binding affinity (Ki) to rat cortical membranes at 5-HT1B binding site by using [125 I] ICYP as a radioligand.,B,,,,,,,,,10577,H,8,Expert,1,,CHEMBL616773,,BAO_0000019,,
1801,9098,Compound was evaluated for the binding affinity (Ki) to rat cortical membranes at 5-HT1B binding site by using [125 I] ICYP as a radioligand; ND is no data.,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616774,,BAO_0000019,,
1802,9699,Evaluated for binding affinity towards 5-hydroxytryptamine 1B receptor,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616775,,BAO_0000357,,
1803,10394,Inhibitory activity against 5-hydroxytryptamine 1B receptor in rat cortical membranes using [3H]5-HT as a radioligand,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616776,,BAO_0000249,,
1804,12092,The binding affinity was measured on 5-hydroxytryptamine 1B receptor using [3H]- serotonin as radioligand.,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616777,,BAO_0000357,,
1805,16700,The binding affinity towards the receptor rat 5-hydroxytryptamine 1B receptor; No affinity,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616778,,BAO_0000357,,
1806,403,Binding affinity against 5-hydroxytryptamine 1B receptor in rat striatal membranes using [3H]5-HT as radioligand,B,,,Rattus norvegicus,10116.0,,,,,10577,D,9,Expert,1,,CHEMBL616779,,BAO_0000249,,
1807,12771,Binding affinity towards 5-hydroxytryptamine 1B receptor,B,,,Rattus norvegicus,10116.0,,,,,10577,D,9,Expert,1,,CHEMBL616780,,BAO_0000357,,
1808,11642,The compound was tested for its binding affinity towards 5-hydroxytryptamine 1B receptor by displacing [3H]serotonin radioligand in rat cerebral cortex,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616781,,BAO_0000019,,
1809,12953,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1B receptor from rat striatum using [3H]5-HT as radioligand,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616782,,BAO_0000357,,
1810,12953,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1B receptor from rat striatum using [3H]5-HT as radioligand.,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616783,,BAO_0000357,,
1811,12953,Binding affinity for 5-hydroxytryptamine 1B receptor in rat striatum using [3H]5-HT as radioligand,B,,,,,,Striatum,,,10577,H,8,Expert,1,,CHEMBL616784,,BAO_0000019,2435.0,
1812,12953,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1B receptor from rat striatum using [3H]5-HT as radioligand; Nonactive at 10 uM,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616785,,BAO_0000357,,
1813,9737,Binding affinity against 5-HT1B receptor in rat brain membrane using [3H]8-OH-DPAT as a selective ligand.,B,,,,,,Brain,,,10577,H,8,Autocuration,1,,CHEMBL857067,,BAO_0000249,955.0,
1814,9737,Binding affinity against 5-HT1B receptor in rat frontal cortex using [3H]-5-HT in presence of 0.1 uM [3H]-8-OH-DPAT as a radioligand,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616786,,BAO_0000019,,
1815,9737,Binding affinity towards 5-HT1B receptor in rat brain membrane using [3H]8-OH-DPAT as a selective ligand.,B,,,,,,Brain,,,10577,H,8,Autocuration,1,,CHEMBL616787,,BAO_0000249,955.0,
1816,12827,Binding affinity towards 5-hydroxytryptamine 2C receptor of porcine choroid plexus using [3H]mesulergine,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616788,,BAO_0000357,,
1817,5033,Ability to displace the radioligand [125I](-)-iodocyanopindolol from rat striatal 5-hydroxytryptamine 1B receptor,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616789,,BAO_0000357,,
1818,9786,Displacement of [3H]5-HT from 5-HT1B receptor of rat frontal cortex homogenate,B,,,Rattus norvegicus,10116.0,,,,,10577,D,9,Expert,1,,CHEMBL616790,,BAO_0000019,,
1819,13116,Binding affinity at 5-hydroxytryptamine 1B receptor,B,,,,,,,,,10577,H,8,Expert,1,,CHEMBL616791,,BAO_0000357,,
1820,16429,In vitro binding affinity at 5-hydroxytryptamine 1B receptor in rat striatal muscles using [125I](-)-iodocyanopindolol as the radioligand,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616792,,BAO_0000019,,
1821,12409,In vitro binding affinity towards 5-hydroxytryptamine 1B receptor in rat striatal membrane with [125I]- iodocyanopindolol,B,,,Rattus norvegicus,10116.0,,,,,10577,D,9,Expert,1,,CHEMBL616793,,BAO_0000249,,
1822,15194,The compound was tested for the binding affinity against 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616794,,BAO_0000357,,
1823,15194,The compound was tested for the binding affinity against 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand.,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL616795,,BAO_0000357,,
1824,5486,Binding affinity towards 5-HT2 receptor by the displacement of [3H]-ketanserin] in rat cerebral cortex,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616796,,BAO_0000019,,
1825,4639,Compound was tested for binding affinity against 5-hydroxytryptamine 1B receptor,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616797,,BAO_0000357,,
1826,386,The compound was evaluated for its ability to displace [3H]5-HT from 5-hydroxytryptamine 1B receptor in cellular brain membranes,B,,,,,,,,Brain membranes,106,H,8,Autocuration,1,,CHEMBL616798,,BAO_0000249,,
1827,2474,Compound was measured for its binding affinity at 5-hydroxytryptamine 1B receptor at a concentration of 100 nM using [125I]CYP as radioligand,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616799,,BAO_0000357,,
1828,6011,Inhibition of binding towards 5-hydroxytryptamine 1B receptor at 100 nM concentration,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616800,,BAO_0000357,,
1829,5014,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 1B receptor,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616801,,BAO_0000357,,
1830,17515,Binding affinity of compound towards serotonin 5-hydroxytryptamine 1B receptor; inactive at 10 uM,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616802,,BAO_0000357,,
1831,4373,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 1B receptor was determined,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616803,,BAO_0000357,,
1832,1633,Binding affinity towards 5-hydroxytryptamine 1B receptor by displacement of [3H]5-HT.,B,,,,,,,,,106,H,8,Expert,1,,CHEMBL857068,,BAO_0000357,,
1833,1633,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 1B receptor by displacement of [3H]ketanserin.,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616804,,BAO_0000357,,
1834,4373,Binding affinity for 5-hydroxytryptamine 1B receptor was determined,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616805,,BAO_0000357,,
1835,4687,Evaluated for the binding affinity to 5-hydroxytryptamine 1B receptor,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616806,,BAO_0000357,,
1836,11574,Binding affinity against 5-hydroxytryptamine 1B receptor,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616807,,BAO_0000357,,
1837,10321,Binding affinity for 5-hydroxytryptamine 1B receptor was determined by using [3H]5-HT as radioligand,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616808,,BAO_0000357,,
1838,15527,Binding affinity towards 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand.,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616809,,BAO_0000357,,
1839,17200,Inhibitory constant against 5-hydroxytryptamine 1B receptor using with [125I]- cyanopindolol radioligand,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616810,,BAO_0000357,,
1840,14423,Binding affinity against 5-hydroxytryptamine 1B receptor - 5-hydroxytryptamine 1D receptor using [3H]5-HT as the radioligand.,B,,,,,,,,,104802,H,4,Autocuration,1,,CHEMBL616811,,BAO_0000224,,
1841,5834,Inhibitory concentration required against 5-hydroxytryptamine 1C receptor in bovine choroid plexus using [3H]mesulergine,B,,,Bos taurus,9913.0,,,,,108,H,8,Autocuration,1,,CHEMBL616812,,BAO_0000357,,
1842,11473,Binding affinity towards 5-hydroxytryptamine 1C receptor using [3H]mesulergine as radioligand,B,,,Sus scrofa,9823.0,,,,,108,H,8,Autocuration,1,,CHEMBL616813,,BAO_0000357,,
1843,11473,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 1C receptor in pig choroid plexus using [3H]mesulergine as radioligand,B,,,Sus scrofa,9823.0,,,,,108,H,8,Autocuration,1,,CHEMBL616814,,BAO_0000357,,
1844,10639,Compound was evaluated for its inhibitory activity against 5-hydroxytryptamine 1C receptor of pig choroid plexus using [3H]mesulergine as the radioligand,B,,,Sus scrofa,9823.0,,,,,108,H,8,Autocuration,1,,CHEMBL616815,,BAO_0000357,,
1845,10639,inhibitory activity against 5-hydroxytryptamine 1C receptor of pig choroid plexus using [3H]mesulergine as the radioligand,B,,,Sus scrofa,9823.0,,,,,108,H,8,Autocuration,1,,CHEMBL616816,,BAO_0000357,,
1846,14331,Binding affinity of compound towards 5-hydroxytryptamine 1C receptor using [3H]mesulergine (1.2 nM) ligand in choroid Plexus pig was determined,B,,,Sus scrofa,9823.0,,,,,108,H,8,Autocuration,1,,CHEMBL616817,,BAO_0000357,,
1847,10796,Compound was tested in vitro for binding affinity for 5-hydroxytryptamine 1C receptor,B,,,Sus scrofa,9823.0,,,,,108,H,8,Autocuration,1,,CHEMBL616818,,BAO_0000357,,
1848,9098,Evaluated for the binding affinity to porcine choroid plexus at 5-hydroxytryptamine 2C receptor binding site by using [3H]-MES as a radioligand.,B,,,Sus scrofa,9823.0,,,,,108,H,8,Expert,1,,CHEMBL616819,,BAO_0000357,,
1849,14331,Inhibition of [3H]mesulergine binding to 5-hydroxytryptamine 1C receptor of pig choroid Plexus,B,,,Sus scrofa,9823.0,,,,,108,H,8,Expert,1,,CHEMBL616820,,BAO_0000357,,
1850,11828,Displacement of [3H]mesulergine from pig cortex 5-hydroxytryptamine 1C receptor,B,,,Sus scrofa,9823.0,,,,,108,H,8,Expert,1,,CHEMBL616821,,BAO_0000019,,
1851,11866,Binding affinity for 5-hydroxytryptamine 1C receptor in piglet choroid plexus using [3H]5-HT,B,,,Sus scrofa,9823.0,,,,,108,H,8,Autocuration,1,,CHEMBL616822,,BAO_0000357,,
1852,13047,Binding affinity against 5-hydroxytryptamine 1D receptor alpha using rabbit saphenous vein assay.,B,,,Oryctolagus cuniculus,9986.0,,,,,108,H,8,Autocuration,1,,CHEMBL616823,,BAO_0000019,,
1853,188,Tested for the effect on binding at 5-hydroxytryptamine 1C receptor; No activity,B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Autocuration,1,,CHEMBL616824,,BAO_0000357,,
1854,11825,In vitro binding affinity towards the 5-hydroxytryptamine 1C receptor at 10 e-6 M,B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Autocuration,1,,CHEMBL616825,,BAO_0000357,,
1855,11825,In vitro binding affinity towards the 5-hydroxytryptamine 1C receptor at 10 e-6 M,B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Autocuration,1,,CHEMBL616826,,BAO_0000357,,
1856,11624,Binding affinity against 5-hydroxytryptamine 1C receptor in rat using [3H]mesulergine as radioligand,B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Expert,1,,CHEMBL616827,,BAO_0000019,,
1857,11139,Binding affinity towards 5-hydroxytryptamine 1C receptor using [125 I]-SCH23982 as radioligand in competitive binding assay,B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Autocuration,1,,CHEMBL616828,,BAO_0000357,,
1858,11147,Binding affinity towards 5-hydroxytryptamine 1C receptor using [3H]mesulergine as radioligand,B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Autocuration,1,,CHEMBL616829,,BAO_0000357,,
1859,10444,Binding affinity was determined against 5-hydroxytryptamine 1C receptor was determined in male Sprague-Dawley rat brain.,B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Autocuration,1,,CHEMBL616830,,BAO_0000019,,
1860,11624,Binding affinity against 5-hydroxytryptamine 1C receptor,B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Expert,1,,CHEMBL616831,,BAO_0000357,,
1861,11662,"Compound was tested for binding affinity towards 5-HT1C (5-HT1C) receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]mesulergine as radioligand",B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Autocuration,1,,CHEMBL616832,,BAO_0000019,,
1862,11662,"Compound was tested for binding affinity towards 5-hydroxytryptamine 1C receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]mesulergine as radioligand",B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Autocuration,1,,CHEMBL616833,,BAO_0000019,,
1863,11662,"Binding affinity towards 5-hydroxytryptamine 1C receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]mesulergine as radioligand",B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Expert,1,,CHEMBL616834,,BAO_0000019,,
1864,11662,"Compound was tested for binding affinity towards 5-hydroxytryptamine 1C receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]mesulergine as radioligand",B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Autocuration,1,,CHEMBL829595,,BAO_0000019,,
1865,9098,Evaluated for the binding affinity to porcine choroid plexus at 5-hydroxytryptamine 1C receptor binding site by using [3H]- MES as a radioligand.,B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Autocuration,1,,CHEMBL616835,,BAO_0000357,,
1866,10394,Inhibitory activity against 5-hydroxytryptamine 1C receptor in rat cortical membranes using [3H]mesulergine as a radioligand,B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Autocuration,1,,CHEMBL872910,,BAO_0000249,,
1867,11933,Tested for binding affinity against 5-hydroxytryptamine 1C receptor from rat frontal cortical regions using [3H]mesulergine as radioligand,B,,,,,,,,,12689,H,8,Expert,1,,CHEMBL616836,,BAO_0000357,,
1868,12092,The binding affinity was measured on 5-hydroxytryptamine 1C receptor using [3H]- serotonin as radioligand.,B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Autocuration,1,,CHEMBL616837,,BAO_0000357,,
1869,12253,Binding affinity of 5-hydroxytryptamine 1C receptor using [3H]- ketanserin in rat frontal cortex,B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Autocuration,1,,CHEMBL616466,,BAO_0000019,,
1870,12253,Binding affinity towards rat 5-hydroxytryptamine 1C receptor using [3H]mesulergine as radioligand expressed in 293 cells,B,,,Rattus norvegicus,10116.0,,,HEK293,,12689,D,9,Autocuration,1,,CHEMBL616467,722.0,BAO_0000219,,
1871,1558,Compound was tested for its affinity towards 5-hydroxytryptamine 1C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL616468,,BAO_0000357,,
1872,2474,Compound was measured for its binding affinity at 5-hydroxytryptamine 1C receptor at a concentration of 100 nM using [3H]mesulergine as radioligand,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL616469,,BAO_0000357,,
1873,2474,Compound was measured for its binding affinity at 5-hydroxytryptamine 1C receptor at a concentration of 100 nM using [3H]mesulergine as radioligand,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL616470,,BAO_0000357,,
1874,11574,Binding affinity against 5-hydroxytryptamine 1C receptor,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL616471,,BAO_0000357,,
1875,1558,Compound was tested for its affinity towards 5-hydroxytryptamine 1C receptor,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL616472,,BAO_0000357,,
1876,13944,Binding affinity against 5-hydroxytryptamine 1C receptor,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL616473,,BAO_0000357,,
1877,13033,Binding affinity against serotonergic 5-HT1c receptor,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL616474,,BAO_0000357,,
1878,10321,Binding affinity for 5-hydroxytryptamine 1C receptor was determined by using [3H]- mesulergine as radioligand,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL616475,,BAO_0000357,,
1879,11866,Binding affinity for 5-hydroxytryptamine 1C receptor was determined,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL616476,,BAO_0000357,,
1880,14454,Compound was tested for 5-hydroxytryptamine 1D like receptor-mediated vascular effect in rabbit saphenous vein (RSV),B,,,Oryctolagus cuniculus,9986.0,,,,,105,H,8,Autocuration,1,,CHEMBL616477,,BAO_0000019,,
1881,11574,Binding affinity against 5-hydroxytryptamine 2 receptor using [125I]DOI as radioligand.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616478,,BAO_0000224,,
1882,11574,Binding affinity against 5-hydroxytryptamine 2 receptor using [3H]ket as radioligand.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616479,,BAO_0000224,,
1883,13631,Binding affinity towards serotonin 5-HT2 receptor was determined in rat cortex using [3H]spiperone as ligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616480,,BAO_0000019,,
1884,9630,Binding affinity towards 5-hydroxytryptamine 2 receptor as antagonism of serotonin-induced contractions in rat jugular vein,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL616481,,BAO_0000019,,
1885,8822,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat brain cortical membranes,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL616482,,BAO_0000249,,
1886,9064,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat brain using [3H]spiroperidol,B,,,Rattus norvegicus,10116.0,,Brain,,,104686,D,5,Autocuration,1,,CHEMBL884713,,BAO_0000221,955.0,
1887,8868,Binding affinity towards 5-hydroxytryptamine 2 receptor measured using radioligand ([3H]spiperone) binding assay,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616483,,BAO_0000224,,
1888,9064,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- spiroperidol,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616484,,BAO_0000224,,
1889,9806,Binding affinity at 5-hydroxytryptamine 2 receptor from rat frontal cortex homogenates by [3H]-spiperone displacement.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616485,,BAO_0000019,,
1890,9098,Binding affinity towards 5-hydroxytryptamine 2 receptor was determined,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616486,,BAO_0000224,,
1891,8868,Binding affinity towards 5-hydroxytryptamine 2 receptor was measured using radioligand ([3H]spiperone) binding assay,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616487,,BAO_0000224,,
1892,12765,Binding affinity at serotonin 5-hydroxytryptamine 2 receptor by [3H]ketanserin displacement.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616488,,BAO_0000224,,
1893,11049,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616489,,BAO_0000019,,
1894,11049,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616490,,BAO_0000019,,
1895,11049,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]-Ketanserin as radioligand; not determined,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616491,,BAO_0000019,,
1896,11049,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand; ND-Not determined,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616492,,BAO_0000019,,
1897,11049,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616493,,BAO_0000019,,
1898,11473,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor in rat anterior cortex using [125I]DOI as radioligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616494,,BAO_0000019,,
1899,11473,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor in rat anterior cortex using [3H]ketanserin as radioligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616495,,BAO_0000019,,
1900,3086,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor in rat pre frontal cortex,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616496,,BAO_0000019,,
1901,11049,Compound was evaluated for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616497,,BAO_0000019,,
1902,11049,Compound was evaluated for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616498,,BAO_0000019,,
1903,10639,Compound was evaluated for its inhibitory activity against 5-hydroxytryptamine 2 receptor of rat anterior cortex using [3H]ketanserin as the radioligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616499,,BAO_0000019,,
1904,10922,Compound was measured for affinity at 5-hydroxytryptamine 2 receptor in rat cortical by [3H]spiroperidol displacement.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616500,,BAO_0000019,,
1905,9064,Binding affinity against serotonin-2 receptor in rat brain using [3H]spiroperidol,B,,,Rattus norvegicus,10116.0,,Brain,,,104686,D,5,Autocuration,1,,CHEMBL616501,,BAO_0000221,955.0,
1906,10748,Compound was tested for its inhibitory effect on the binding profile in 5-hydroxytryptamine 2 receptor using [3H]spiroperidol in rat brain.,B,,,,,,Brain,,,104686,H,4,Autocuration,1,,CHEMBL616502,,BAO_0000221,955.0,
1907,11614,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor from rat cortical membranes.,B,,,,,,,,Membranes,104686,H,4,Autocuration,1,,CHEMBL884529,,BAO_0000249,,
1908,11615,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor in rat cortical membranes,B,,,,,,,,Membranes,104686,H,4,Autocuration,1,,CHEMBL616503,,BAO_0000249,,
1909,11615,Compound was tested for the displacement of [3H]ketanserin from serotonin 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616964,,BAO_0000224,,
1910,11614,Compound was tested for the displacement of [3H]ketanserin from serotonin 5-hydroxytryptamine 2 receptor from rat cortical membranes.,B,,,,,,,,Membranes,104686,H,4,Autocuration,1,,CHEMBL616965,,BAO_0000249,,
1911,11702,Inhibition of [3H]ketanserin binding to rat 5-hydroxytryptamine 2 receptors.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616966,,BAO_0000224,,
1912,11702,Compound was tested for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor; NT=Not tested,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616967,,BAO_0000224,,
1913,11702,Inhibition of [3H]ketanserin binding to dopamine 5-hydroxytryptamine 2 receptor,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL616968,,BAO_0000224,,
1914,11702,Compound was tested for the inhibition of [3H]ketanserin binding to dopamine 5-hydroxytryptamine 2 receptor; NT=Not tested,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616969,,BAO_0000224,,
1915,13346,Inhibition of [3H]ketanserin binding at 5-hydroxytryptamine 2 receptor from rat frontal cortex.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL884530,,BAO_0000019,,
1916,10025,Concentration necessary to achieve half maximal inhibition of [3H]-ketanserin binding to 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616970,,BAO_0000224,,
1917,10025,Concentration necessary to achieve half maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor at 1 uM,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616971,,BAO_0000224,,
1918,10025,"Concentration necessary to achieve half maximal inhibition of [3H]ketanserin, binds to 5-hydroxytryptamine 2 receptor at 1 uM",B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616972,,BAO_0000224,,
1919,9036,Evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor using radioligand [3H]-spiperone,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616973,,BAO_0000224,,
1920,9036,Evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor using radioligand [3H]spiperone; IA=Inactive,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616974,,BAO_0000224,,
1921,9161,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616975,,BAO_0000019,,
1922,12304,Inhibition of binding of radioligand [3H]ketanserin to 5-hydroxytryptamine 2 receptor in rat cerebral cortex,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616976,,BAO_0000019,,
1923,13276,In vitro binding affinity measured on serotonin 5-hydroxytryptamine 2 receptor using [3H]ketanserin as radioligand.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616977,,BAO_0000224,,
1924,11825,In vitro binding affinity towards the 5-hydroxytryptamine 2 receptor at 10 e-6 M,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616978,,BAO_0000224,,
1925,12443,In vitro binding affinity was measured on serotonergic 5-hydroxytryptamine 2 receptor by displacement of [3H]- ketanserin,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616979,,BAO_0000224,,
1926,13830,In vitro inhibitory activity against [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616980,,BAO_0000224,,
1927,9592,Inhibition of [3H]spiperone binding to 5-hydroxytryptamine 2 receptor from rat cortical membranes,B,,,,,,,,Membranes,104686,H,4,Autocuration,1,,CHEMBL616981,,BAO_0000249,,
1928,9592,Inhibition of [3H]spiperone binding to 5-hydroxytryptamine 2 receptor from rat cortical membranes; Not tested,B,,,,,,,,Membranes,104686,H,4,Autocuration,1,,CHEMBL616982,,BAO_0000249,,
1929,10881,Inhibitory activity against 5-hydroxytryptamine 2 receptor by 3H ligand binding experiments.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616983,,BAO_0000224,,
1930,13605,Inhibitory activity against [3H]spiroperidol binding to 5-HT2 receptor in rat cortex,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616984,,BAO_0000019,,
1931,11624,Inhibitory activity against 5-hydroxytryptamine 2 receptor,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL616985,,BAO_0000224,,
1932,4101,Inhibitory concentration against 5-hydroxytryptamine 2 receptor from striata of male Wistar rats by displacement of [3H]-ketanserin,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616986,,BAO_0000224,,
1933,4101,Inhibitory concentration against binding of 5-hydroxytryptamine 2 receptor from striata of male Wistar rats by displacement of [3H]-ketanserin,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616987,,BAO_0000224,,
1934,15360,Inhibitory concentration against radioligand [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in rat,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL616988,,BAO_0000019,,
1935,11576,Inhibitory concentration against radioligand [3H]spiperone binding to 5-hydroxytryptamine 2 receptor in rat cortex,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617243,,BAO_0000019,,
1936,5834,Inhibitory concentration required against 5-hydroxytryptamine 2 receptor in rat cortex using [3H]spiperone,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617244,,BAO_0000019,,
1937,2395,Inhibitory concentration against [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor expressed in CHO-K1 cells,B,,,Rattus norvegicus,10116.0,,,CHO-K1,,104686,D,5,Autocuration,1,,CHEMBL617245,485.0,BAO_0000219,,
1938,11965,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor in rat cortical membranes,B,,,,,,,,Membranes,104686,H,4,Autocuration,1,,CHEMBL617246,,BAO_0000249,,
1939,3967,The compound was evaluated for the ability to displace [3H]ketanserin from 5-hydroxytryptamine 2 receptor ( striata of male wistar rats),B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617546,,BAO_0000224,,
1940,11130,The concentration required to inhibit [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in rat brain membranes (in vitro),B,,,,,,,,Brain membranes,104686,H,4,Autocuration,1,,CHEMBL617547,,BAO_0000249,,
1941,13427,Binding affinity of [3H]ketanserin towards 5-hydroxytryptamine 2 receptor in cloned mammalian receptor expressed in cultured cells or from rat whole brain.,B,In vitro,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617548,,BAO_0000219,,
1942,9443,Binding affinity towards 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617549,,BAO_0000224,,
1943,9443,Binding affinity towards 5-hydroxytryptamine 2 receptor at 1.0 uM concentration,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617550,,BAO_0000224,,
1944,11825,In vitro binding affinity towards the 5-hydroxytryptamine 2 receptor at 10 e-6 M,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617551,,BAO_0000224,,
1945,12120,Percent inhibition of binding of 1.0 nM [3H]ketanserin to 5-hydroxytryptamine 2 receptor in rat cortical membranes at 10 e -5 M,B,,,,,,,,Membranes,104686,H,4,Autocuration,1,,CHEMBL617552,,BAO_0000249,,
1946,12120,Percent inhibition of binding of 1.0 nM [3H]-ketanserin to 5-hydroxytryptamine 2 receptor in rat cortical membranes at 10 e-5 M.,B,,,,,,,,Membranes,104686,H,4,Autocuration,1,,CHEMBL617553,,BAO_0000249,,
1947,11963,Tested for antagonistic activity against 5-hydroxytryptamine 2 receptor from rat thoracic aorta,F,,,,,,Thoracic aorta,,,104686,H,4,Autocuration,1,,CHEMBL617554,,BAO_0000019,1515.0,
1948,9069,Binding affinity for membrane-bound 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617555,,BAO_0000019,,
1949,8868,Compound was tested for its effect on 5-hydroxytryptamine 2 receptor saturation analysis,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617556,,BAO_0000224,,
1950,17200,Inhibitory constant against human 5-hydroxytryptamine 1B receptor using [3H]5-CT radioligand,B,,,,,,,,,10624,H,8,Autocuration,1,,CHEMBL617557,,BAO_0000357,,
1951,17200,Inhibitory constant against human 5-hydroxytryptamine 1D receptor using [3H]5-CT radioligand,B,,,,,,,,,10624,H,8,Autocuration,1,,CHEMBL617558,,BAO_0000357,,
1952,13969,Binding affinity against 5-hydroxytryptamine 1D receptor was measured using [3H]5-HT as radioligand,B,,,,,,,,,17106,H,8,Expert,1,,CHEMBL617559,,BAO_0000357,,
1953,13392,Binding affinity for 5-hydroxytryptamine 1D receptor,B,,,,,,,,,17106,D,9,Expert,1,,CHEMBL617560,,BAO_0000357,,
1954,1742,Compound was tested for its ability to displace [125I]GTI binding to 5-hydroxytryptamine 1D receptor recognition sites in pig caudate membranes,B,,,,,,,,,17106,H,8,Autocuration,1,,CHEMBL617561,,BAO_0000249,,
1955,1742,Compound was tested for its ability to displace [3H]-5-HT binding to 5-hydroxytryptamine 1D receptor recognition sites in pig caudate membranes,B,,,,,,,,,17106,H,8,Autocuration,1,,CHEMBL617562,,BAO_0000249,,
1956,14331,Binding affinity against 5-hydroxytryptamine 1D receptor using [3H]5-HT in pig striatum + frontalCortex,B,,,,,,Striatum,,,17106,H,8,Autocuration,1,,CHEMBL617563,,BAO_0000357,2435.0,
1957,12861,Relative agonist efficacy against 1 uM 5-hydroxytryptamine 1D receptor,F,,,,,,,,,17106,H,8,Autocuration,1,,CHEMBL617564,,BAO_0000019,,
1958,12861,Binding activity against 5-hydroxytryptamine 1D receptor from pig caudate membrane using [3H]5-HT as radioligand,B,,,,,,,,,17106,H,8,Expert,1,,CHEMBL617565,,BAO_0000019,,
1959,12861,Binding activity radioligand.,B,,,,,,,,,17106,H,8,Autocuration,1,,CHEMBL856076,,BAO_0000357,,
1960,12861,Binding activity against 5-hydroxytryptamine 2C receptor from human brain cortex using [3H]mesulergine as radioligand.,B,,,,,,,,,17106,H,8,Autocuration,1,,CHEMBL617566,,BAO_0000019,,
1961,12861,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand.,B,,,,,,,,,17106,H,8,Expert,1,,CHEMBL875911,,BAO_0000019,,
1962,12861,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand; NA Not Available,B,,,,,,,,,17106,H,8,Autocuration,1,,CHEMBL617567,,BAO_0000019,,
1963,675,Compound was tested for the displacement of [3H]-5-HT to 5-hydroxytryptamine 1D receptor recognition sites in pig caudate membranes,B,,,,,,,,,17106,H,8,Autocuration,1,,CHEMBL617568,,BAO_0000249,,
1964,12490,Displacement of [3H]5-HT binding to 5-hydroxytryptamine 1D receptor from pig caudate membrane,B,,,,,,,,,17106,H,8,Expert,1,,CHEMBL617569,,BAO_0000019,,
1965,11828,Displacement of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1D receptor in pig caudate membrane,B,,,,,,,,,17106,H,8,Expert,1,,CHEMBL617570,,BAO_0000249,,
1966,11866,Binding affinity for 5-hydroxytryptamine 1D receptor in piglet caudate using [3H]5-HT,B,,,,,,,,,17106,H,8,Autocuration,1,,CHEMBL617571,,BAO_0000357,,
1967,773,In Vitro Binding affinity againist 5-hydroxytryptamine 1D receptor by displacing [125I]GTI from pig caudate,B,,,Sus scrofa,9823.0,,,,,105,H,8,Autocuration,1,,CHEMBL617572,,BAO_0000357,,
1968,13047,The compound was tested for intrinsic activity against 5-HT1D receptor,B,,,Oryctolagus cuniculus,9986.0,,,,,105,H,8,Expert,1,,CHEMBL617573,,BAO_0000357,,
1969,13047,Intrinsic activity against 5-hydroxytryptamine 1 receptor using rabbit saphenous vein assay.,B,,,Oryctolagus cuniculus,9986.0,,,,,105,H,8,Autocuration,1,,CHEMBL617574,,BAO_0000019,,
1970,13047,The compound was tested for binding affinity against 5-HT1D receptor,B,,,Oryctolagus cuniculus,9986.0,,,,,105,H,8,Expert,1,,CHEMBL617575,,BAO_0000357,,
1971,188,Tested for the effect on binding at 5-hydroxytryptamine 1D receptor; No activity,B,,,,,,,,,10578,H,8,Autocuration,1,,CHEMBL617576,,BAO_0000357,,
1972,10639,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1D receptor of rat substantia nigra,F,,,,,,,,,10578,H,8,Autocuration,1,,CHEMBL617577,,BAO_0000019,,
1973,12438,Inhibition of forskolin stimulated adenylate cyclase at 5-hydroxytryptamine 1D receptor,F,,,,,,,,,10578,H,8,Autocuration,1,,CHEMBL617578,,BAO_0000019,,
1974,12438,Binding affinity was measured against serotonin 5-hydroxytryptamine 1D receptor,B,,,,,,,,,10578,H,8,Autocuration,1,,CHEMBL617579,,BAO_0000357,,
1975,15854,Binding affinity towards 5-hydroxytryptamine 1D receptor in rat frontal cortex using [125I]iodocyanopindolol as radio-ligand.,B,,,,,,,,,10578,H,8,Expert,1,,CHEMBL617580,,BAO_0000019,,
1976,10394,Inhibitory activity against 5-hydroxytryptamine 1D receptor in rat cortical membranes using [3H]5-HT as a radioligand,B,,,,,,,,,10578,H,8,Autocuration,1,,CHEMBL617581,,BAO_0000249,,
1977,12092,The binding affinity was measured on 5-hydroxytryptamine 1D receptor using [3H]- serotonin as radioligand.,B,,,,,,,,,10578,H,8,Autocuration,1,,CHEMBL617582,,BAO_0000357,,
1978,3389,Binding affinity to 5-hydroxytryptamine 1D receptor in the rat forebrain by [3H]- SB-204269 displacement.,B,,,,,,,,,10578,H,8,Expert,1,,CHEMBL617583,,BAO_0000019,,
1979,6011,Inhibition of binding towards 5-hydroxytryptamine 1D receptor at 100 nM concentration,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617584,,BAO_0000357,,
1980,4639,Compound was tested for binding affinity against 5-hydroxytryptamine 1D receptor,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617585,,BAO_0000357,,
1981,2474,Compound was measured for its binding affinity at 5-hydroxytryptamine 1D receptor at a concentration of 10 uM using [3H]5-HT as radioligand,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL875912,,BAO_0000357,,
1982,5014,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 1D receptor,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617586,,BAO_0000357,,
1983,17515,Binding affinity of compound towards serotonin 5-hydroxytryptamine 1D receptor; inactive at 10 uM,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617587,,BAO_0000357,,
1984,11866,Binding affinity for 5-hydroxytryptamine 1D receptor was determined,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617588,,BAO_0000357,,
1985,4687,Evaluated for the binding affinity against 5-hydroxytryptamine 1D receptor,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL857980,,BAO_0000357,,
1986,12146,Tested against 5-hydroxytryptamine 1D receptor,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617589,,BAO_0000357,,
1987,10321,Binding affinity for 5-hydroxytryptamine 1D receptor was determined by using [3H]5-HT as radioligand,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617590,,BAO_0000357,,
1988,13267,Antagonistic binding affinity measured against 5-hydroxytryptamine 2A receptor (human clone expressed in 293 cells) using [3H]ketanserin as radioligand,B,,,,,,,HEK293,,105,H,8,Autocuration,1,,CHEMBL617591,722.0,BAO_0000219,,
1989,1274,Binding affinity against 5-Hydroxytryptamine 1D receptor,B,,,Homo sapiens,9606.0,,,,,105,D,9,Expert,1,,CHEMBL617592,,BAO_0000357,,
1990,15250,,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617593,,BAO_0000357,,
1991,13706,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor alpha expressed in CHO-K1 cells.,B,,,,,,,CHO-K1,,106,H,8,Autocuration,1,,CHEMBL617594,485.0,BAO_0000219,,
1992,13706,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor alpha expressed in CHO-K1 cells.,B,,,,,,,CHO-K1,,105,H,8,Autocuration,1,,CHEMBL617595,485.0,BAO_0000219,,
1993,13706,Compound was tested for binding affinity against human 5-hydroxytryptamine 1D receptor alpha clones expressed in human embryonic kidney (HEK 293) cells line.,B,,,,,,,HEK293,,105,H,8,Autocuration,1,,CHEMBL617596,722.0,BAO_0000219,,
1994,13706,Compound was tested for binding affinity against human 5-hydroxytryptamine 1D receptor alpha clones expressed in human embryonic kidney (HEK 293) cells line; NT= not tested,B,,,,,,,HEK293,,105,H,8,Autocuration,1,,CHEMBL617597,722.0,BAO_0000219,,
1995,13047,Binding affinity against 5-hydroxytryptamine 1D receptor beta using rabbit saphenous vein assay.,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617598,,BAO_0000019,,
1996,13366,Binding affinity of compound against 5-HT1Dalpha Binding affinity of compound against 5-HT1D alpha receptors in human,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL872916,,BAO_0000357,,
1997,13366,In vitro affinity human cloned 5-hydroxytryptamine 1D receptor alpha by [3H]5-HT displacement.,B,,,,,,,,,105,H,8,Expert,1,,CHEMBL617599,,BAO_0000357,,
1998,1558,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor alpha was determined,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617091,,BAO_0000357,,
1999,12902,"Binding affinity against 5-hydroxytryptamine 1D receptor alpha expressed in CHO-K1 cells, using [3H]-5-HT as the radioligand.",B,,,,,,,CHO-K1,,105,H,8,Expert,1,,CHEMBL617092,485.0,BAO_0000219,,
2000,13706,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor alpha expressed in CHO-K1 cells.,B,,,,,,,CHO-K1,,105,H,8,Autocuration,1,,CHEMBL617093,485.0,BAO_0000219,,
2001,13706,Compound was tested for intrinsic efficacy against human 5-hydroxytryptamine 1D receptor alpha measured as the reduction of forskolin-stimulated cAMP.,F,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617094,,BAO_0000019,,
2002,13706,Compound was tested for intrinsic efficacy against human 5-hydroxytryptamine 1D receptor beta measured as the reduction of forskolin-stimulated cAMP.,F,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617095,,BAO_0000019,,
2003,14251,Compound was tested for its agonist activity against human 5-hydroxytryptamine 1D receptor alpha for comparison purpose.,F,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617096,,BAO_0000019,,
2004,14251,Compound was tested for its agonist activity against human recombinant 5-hydroxytryptamine 1D receptor alpha for comparison purpose.,F,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617097,,BAO_0000019,,
2005,14251,Compound was tested for its agonist activity against human recombinant 5-hydroxytryptamine 1D receptor alpha for comparison purpose.,F,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617098,,BAO_0000019,,
2006,13313,In vitro binding affinity towards 5-HT1D alpha receptor by using [3H]5-HT as radioligand,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617301,,BAO_0000357,,
2007,13313,In vitro binding affinity towards 5-hydroxytryptamine 1D receptor alpha by using [3H]5-HT as radioligand,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617302,,BAO_0000357,,
2008,13366,Selectivity towards 5-hydroxytryptamine 1D receptor beta to that of 5-hydroxytryptamine 1D receptor alpha,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617303,,BAO_0000357,,
2009,13051,Binding affinity to recombinant human 5-hydroxytryptamine 1D receptor alpha,B,,,,,,,,,105,H,8,Expert,1,,CHEMBL617304,,BAO_0000357,,
2010,12903,"In vitro binding affinity against cloned mammalian 5-hydroxytryptamine 1D receptor alpha expressed in CHO cells, by using [3H]5-HT as radioligand",B,,,,,,,CHO,,105,H,8,Expert,1,,CHEMBL617305,449.0,BAO_0000219,,
2011,12469,Binding affinity was measured on 5-hydroxytryptamine 1D receptor alpha in COS cells transfected with human 5-HT1D alpha gene labeled with [3H]5-HT,B,,,Homo sapiens,9606.0,,,,,105,D,9,Autocuration,1,,CHEMBL617306,,BAO_0000219,,
2012,5619,Binding affinity (in vitro) against 5-hydroxytryptamine 1D receptor alpha using radio-ligand binding assay,B,,,,,,,,,17106,H,8,Autocuration,1,,CHEMBL617307,,BAO_0000357,,
2013,13047,Binding affinity against 5-hydroxytryptamine 4 receptor using rabbit saphenous vein assay.,B,,,Oryctolagus cuniculus,9986.0,,,,,105,H,8,Autocuration,1,,CHEMBL617308,,BAO_0000019,,
2014,16633,Binding affinities against 5-hydroxytryptamine 1D receptor alpha,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617309,,BAO_0000357,,
2015,16633,Binding affinities towards 5-hydroxytryptamine 1D receptor alpha,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617310,,BAO_0000357,,
2016,16633,Binding affinities towards 5-hydroxytryptamine 1D receptor alpha,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617311,,BAO_0000357,,
2017,16633,Binding affinity towards 5-hydroxytryptamine 1D receptor alpha using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617312,,BAO_0000357,,
2018,3269,Affinity against 5-hydroxytryptamine 1D receptor alpha,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL617313,,BAO_0000357,,
2019,12409,Binding affinity against 5-hydroxytryptamine 1D receptor alpha,B,,,,,,,,,105,H,8,Expert,1,,CHEMBL617314,,BAO_0000357,,
2020,13706,Compound was tested for intrinsic efficacy against human 5-hydroxytryptamine 1D receptor beta measured as the reduction of forskolin-stimulated cAMP.,F,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL617315,,BAO_0000019,,
2021,13706,Compound was tested for binding affinity against human 5-hydroxytryptamine 1D receptor beta clones expressed in human embryonic kidney (HEK 293) cells line.,B,,,,,,,HEK293,,106,H,8,Autocuration,1,,CHEMBL617316,722.0,BAO_0000219,,
2022,13706,Compound was tested for binding affinity against human 5-hydroxytryptamine 1D receptor beta clones expressed in human embryonic kidney (HEK 293) cells line; NT= not tested,B,,,,,,,HEK293,,106,H,8,Autocuration,1,,CHEMBL617317,722.0,BAO_0000219,,
2023,12903,"The compound was tested in vitro for binding affinity against cloned mammalian 5-hydroxytryptamine 1D receptor beta expressed in CHO cells, by using [3H]5-HT as radioligand",B,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL617318,449.0,BAO_0000219,,
2024,13047,Binding affinity against 5-hydroxytryptamine 1D receptor beta using rabbit saphenous vein assay.,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL617319,,BAO_0000019,,
2025,13366,Displacement of [3H]-5-HT from human 5-hydroxytryptamine 1D receptor beta,B,,,,,,,,,106,D,9,Expert,1,,CHEMBL617320,,BAO_0000357,,
2026,13366,Displacement of [3H]-5-HT from human 5-hydroxytryptamine 1D receptor beta,B,,,,,,,,,106,D,9,Expert,1,,CHEMBL617321,,BAO_0000357,,
2027,13366,Displacement of [3H]-5-HT from human 5-hydroxytryptamine 1D receptor beta,B,,,,,,,,,106,D,9,Expert,1,,CHEMBL617322,,BAO_0000357,,
2028,13366,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor beta was determined using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616862,,BAO_0000357,,
2029,13366,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor was determined using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616863,,BAO_0000357,,
2030,12469,Binding affinity was measured on 5-hydroxytryptamine 1D receptor beta in CHO cells transfected with human 5-HT1D beta gene labeled with [3H]5-HT,B,,,,,,,CHO,,106,H,8,Autocuration,1,,CHEMBL616864,449.0,BAO_0000219,,
2031,13706,Compound was tested for binding affinity against cloned human 5-HT1D beta receptor expressed in CHO-K1 cells.,B,,,,,,,CHO-K1,,106,H,8,Autocuration,1,,CHEMBL616865,485.0,BAO_0000219,,
2032,13706,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor beta expressed in CHO-K1 cells.,B,,,,,,,CHO-K1,,106,H,8,Autocuration,1,,CHEMBL616866,485.0,BAO_0000219,,
2033,13706,Compound was tested for intrinsic efficacy against human 5-hydroxytryptamine 1D receptor beta measured as the reduction of forskolin-stimulated cAMP.,F,,,,,,,,,106,H,8,Autocuration,1,,CHEMBL616867,,BAO_0000019,,
2034,12902,"Binding affinity against 5-hydroxytryptamine 1D receptor beta expressed in CHO-K1 cells, using [3H]5-HT as the radioligand.",B,,,,,,,CHO-K1,,106,H,8,Expert,1,,CHEMBL616868,485.0,BAO_0000219,,
2035,13051,Binding affinity for cloned human 5-hydroxytryptamine 1D receptor beta,B,,,,,,,,,105,H,8,Expert,1,,CHEMBL616869,,BAO_0000357,,
2036,12903,"In vitro binding affinity against cloned mammalian 5-hydroxytryptamine 1D receptor beta expressed in CHO cells, by using [3H]5-HT as radioligand",B,,,,,,,CHO,,106,H,8,Expert,1,,CHEMBL616870,449.0,BAO_0000219,,
2037,1558,Compound was tested for its ability inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1D receptor beta in CHO-K1 cells; value ranges from 0.24-0.55,F,,,,,,,CHO-K1,,105,H,8,Autocuration,1,,CHEMBL616871,485.0,BAO_0000219,,
2038,1558,Compound was tested for its ability inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1D receptor beta in CHO-K1 cells; value ranges from 0.6-2.0,F,,,,,,,CHO-K1,,105,H,8,Autocuration,1,,CHEMBL616872,485.0,BAO_0000219,,
2039,1558,Compound was tested for its ability inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1D receptor beta in CHO-K1 cells; value ranges from 2.8-6.5,F,,,,,,,CHO-K1,,105,H,8,Autocuration,1,,CHEMBL616873,485.0,BAO_0000219,,
2040,1558,Compound was tested for its ability inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1D receptor beta in CHO-K1 cells; value ranges from 30-70,F,,,,,,,CHO-K1,,105,H,8,Autocuration,1,,CHEMBL616838,485.0,BAO_0000219,,
2041,1558,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor beta was determined,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616839,,BAO_0000357,,
2042,13047,Binding affinity against 5-hydroxytryptamine 3 receptor using rabbit saphenous vein assay.,B,,,Oryctolagus cuniculus,9986.0,,,,,106,H,8,Autocuration,1,,CHEMBL616840,,BAO_0000019,,
2043,13313,In vitro binding affinity towards 5-hydroxytryptamine 1D receptor alpha by using [3H]-5-HT as radioligand,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616841,,BAO_0000357,,
2044,13313,In vitro binding affinity towards 5-hydroxytryptamine 1D receptor beta by using [3H]5-HT as radioligand,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL616842,,BAO_0000357,,
2045,12409,Binding affinity against 5-hydroxytryptamine 1D receptor beta,B,,,,,,,,,105,H,8,Expert,1,,CHEMBL857976,,BAO_0000357,,
2046,15250,Compound was tested for the displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 1E receptor stably expressed in CHO cells,B,,,,,,,CHO,,10618,H,8,Autocuration,1,,CHEMBL616843,449.0,BAO_0000219,,
2047,1348,Inhibitory activity against 5-hydroxytryptamine 1E receptor subtype,B,,,Homo sapiens,9606.0,,,,,10618,D,9,Expert,1,,CHEMBL616844,,BAO_0000357,,
2048,1348,Inhibitory activity against 5-hydroxytryptamine 1E receptor subtype; NA denotes data not available,B,,,,,,,,,10618,H,8,Autocuration,1,,CHEMBL616845,,BAO_0000357,,
2049,4234,Binding affinity to cloned human 5-hydroxytryptamine 1E receptor,B,,,Homo sapiens,9606.0,,,,,10618,D,9,Expert,1,,CHEMBL616846,,BAO_0000357,,
2050,16209,Binding affinity towards human 5-hydroxytryptamine 1E receptor was determined using [3H]5-HT as radioligand,B,,,,,,,,,10618,H,8,Autocuration,1,,CHEMBL616847,,BAO_0000357,,
2051,10444,Binding affinity was determined against 5-hydroxytryptamine 1E receptor in human cortical homogenate,B,,,,,,,,,10618,H,8,Autocuration,1,,CHEMBL616848,,BAO_0000019,,
2052,3935,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 1E receptor,B,,,,,,,,,10618,H,8,Autocuration,1,,CHEMBL616849,,BAO_0000357,,
2053,15818,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 1E receptor,B,,,,,,,,,10618,H,8,Autocuration,1,,CHEMBL872911,,BAO_0000357,,
2054,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1E receptor,B,,,,,,,,,10618,H,8,Autocuration,1,,CHEMBL616850,,BAO_0000019,,
2055,12936,Binding affinity against human 5-hydroxytryptamine 1E receptor expressed in CHO cells,B,,,Homo sapiens,9606.0,,,CHO,,10618,D,9,Expert,1,,CHEMBL616699,449.0,BAO_0000219,,
2056,6166,Binding affinity towards cloned human 5-hydroxytryptamine 1E receptor was determined,B,,,,,,,,,10618,H,8,Autocuration,1,,CHEMBL616700,,BAO_0000357,,
2057,15779,Binding affinity towards 5-hydroxytryptamine 1E receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand.,B,,,,,,,CHO,,10618,H,8,Autocuration,1,,CHEMBL616701,449.0,BAO_0000219,,
2058,15779,Binding affinity towards human cloned 5-hydroxytryptamine 1E receptor in CHO cells using [3H]5-HT as radioligand.,B,,,,,,,CHO,,10618,H,8,Autocuration,1,,CHEMBL616702,449.0,BAO_0000219,,
2059,15779,Binding affinity towards human cloned 5-hydroxytryptamine 1E receptor in CHO cells using [3H]5-HT as radioligand;ND means no data.,B,,,,,,,CHO,,10618,H,8,Autocuration,1,,CHEMBL616703,449.0,BAO_0000219,,
2060,13181,Binding affinity was determined against 5-hydroxytryptamine 1D receptor,B,,,,,,,,,10618,H,8,Autocuration,1,,CHEMBL616704,,BAO_0000357,,
2061,4199,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1E receptor in CHO cells using [3H]5-HT as the radioligand,B,,,,,,,CHO,,10618,H,8,Autocuration,1,,CHEMBL616705,449.0,BAO_0000219,,
2062,14875,Compound was tested for binding affinity against human 5-hydroxytryptamine 1E receptor,B,,,,,,,,,10618,H,8,Autocuration,1,,CHEMBL616706,,BAO_0000357,,
2063,15146,Compound was tested for its binding affinity against cloned human 5-hydroxytryptamine 1E receptor in CHO cells using [3H]-5-HT,B,,,,,,,CHO,,10618,H,8,Autocuration,1,,CHEMBL616707,449.0,BAO_0000219,,
2064,5213,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1E receptor in CHO using [3H]5-HT as a radioligand,B,,,,,,,,,10618,H,8,Autocuration,1,,CHEMBL616708,,BAO_0000357,,
2065,12146,Tested for binding affinity towards cloned human 5-hydroxytryptamine 1E receptor using [3H]5-HT as radioligand,B,,,,,,,,,10618,H,8,Autocuration,1,,CHEMBL616709,,BAO_0000357,,
2066,13267,The binding affinity (pKi) measured against 5-hydroxytryptamine 1E receptor (cloned human receptors in CHO cells) using [3H]5-HT1E as radioligand,B,,,,,,,CHO,,10618,H,8,Autocuration,1,,CHEMBL616710,449.0,BAO_0000219,,
2067,14818,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1E receptor in CHO cells using [3H]5-HT.,B,,,,,,,CHO,,10618,H,8,Autocuration,1,,CHEMBL616711,449.0,BAO_0000219,,
2068,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1E receptor in CHO cells, using [3H]5-HT as radioligand",B,,,,,,,CHO,,10618,H,8,Autocuration,1,,CHEMBL616712,449.0,BAO_0000219,,
2069,4373,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 1E receptor was determined,B,,,,,,,,,10618,H,8,Autocuration,1,,CHEMBL616713,,BAO_0000357,,
2070,4373,Binding affinity for 5-hydroxytryptamine 1E receptor was determined,B,,,,,,,,,10618,H,8,Autocuration,1,,CHEMBL616714,,BAO_0000357,,
2071,14159,Compound was evaluated for the affinity at 5-hydroxytryptamine 1E receptor,B,,,,,,,,,10618,H,8,Autocuration,1,,CHEMBL616715,,BAO_0000357,,
2072,16633,Binding affinity towards 5-hydroxytryptamine 1E receptor,B,,,,,,,,,10618,H,8,Autocuration,1,,CHEMBL616716,,BAO_0000357,,
2073,17085,"In vitro effective concentration for stimulation of [35S]GTP-gamma-S, binding in mouse LM(tk-)cells expressing the human 5-HT1F receptor",F,,,,,,,,,279,H,8,Autocuration,1,,CHEMBL616717,,BAO_0000019,,
2074,17085,"In vitro effective concentration for stimulation of [35S]GTP-gamma-S, binding in mouse LM(tk-)cells expressing the human 5-hydroxytryptamine 1F receptor",F,,,,,,,,,279,H,8,Expert,1,,CHEMBL616718,,BAO_0000019,,
2075,16209,In vitro effective concentration for inhibition of skolin-stimulated adenylate cyclase in cell line expressing human 5-hydroxytryptamine 1F receptor,F,,,,,,,,,279,H,8,Autocuration,1,,CHEMBL875905,,BAO_0000019,,
2076,16209,In vitro agonist potency against human 5-hydroxytryptamine 1F receptor,F,,,,,,,,,279,H,8,Autocuration,1,,CHEMBL616719,,BAO_0000019,,
2077,17085,"Maximum stimulation of of [35S]GTP-gamma-S, binding expressed relative to the maximal effect of 5-hydroxytryptamine 1F receptor",F,,,,,,,,,279,H,8,Expert,1,,CHEMBL616720,,BAO_0000019,,
2078,14159,Compound was evaluated for the affinity at 5-hydroxytryptamine 1F receptor,B,,,,,,,,,279,H,8,Autocuration,1,,CHEMBL616721,,BAO_0000357,,
2079,15250,Compound was tested for the displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 1F receptor stably expressed in CHO cells,B,,,,,,,CHO,,279,H,8,Autocuration,1,,CHEMBL616722,449.0,BAO_0000219,,
2080,3805,In vitro binding affinity against human 5-hydroxytryptamine 1F receptor at a concentration of 100 (nM),B,,,,,,,,,279,H,8,Autocuration,1,,CHEMBL616723,,BAO_0000357,,
2081,16190,Binding affinity against 5-hydroxytryptamine 1F receptor in CHO cells using [3H]5-HT radioligand,B,,,,,,,CHO,,279,H,8,Autocuration,1,,CHEMBL616724,449.0,BAO_0000219,,
2082,16190,Binding affinity against 5-hydroxytryptamine 1F receptor in CHO using [3H]5-HT radioligand,B,,,,,,,,,279,H,8,Autocuration,1,,CHEMBL616725,,BAO_0000357,,
2083,16209,Binding affinity towards human 5-hydroxytryptamine 1F receptor,B,,,,,,,,,279,H,8,Autocuration,1,,CHEMBL616726,,BAO_0000357,,
2084,16209,Binding affinity towards human 5-hydroxytryptamine 1F receptor was determined,B,,,,,,,,,279,H,8,Autocuration,1,,CHEMBL616727,,BAO_0000357,,
2085,16209,Binding affinity towards human 5-hydroxytryptamine 1F receptor using [3H]-5-HT radioligand,B,,,,,,,,,279,H,8,Autocuration,1,,CHEMBL616728,,BAO_0000357,,
2086,6866,In vitro binding affinity for human 5-hydroxytryptamine 1F receptor,B,,,,,,,,,279,H,8,Autocuration,1,,CHEMBL616729,,BAO_0000357,,
2087,17085,In vitro binding affinity was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1F receptor,B,,,,,,,,,279,H,8,Expert,1,,CHEMBL616730,,BAO_0000019,,
2088,16312,Binding affinity towards human recombinant 5-hydroxytryptamine 1F receptor,B,,,,,,,,,279,H,8,Autocuration,1,,CHEMBL617125,,BAO_0000357,,
2089,6166,Binding affinity towards cloned human 5-hydroxytryptamine 1F receptor was determined,B,,,,,,,,,279,H,8,Autocuration,1,,CHEMBL857977,,BAO_0000357,,
2090,15779,Binding affinity towards 5-hydroxytryptamine 1F receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand.,B,,,,,,,CHO,,279,H,8,Autocuration,1,,CHEMBL617126,449.0,BAO_0000219,,
2091,4199,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1F receptor in CHO cells using [3H]-5-HT as the radioligand,B,,,,,,,CHO,,279,H,8,Autocuration,1,,CHEMBL617127,449.0,BAO_0000219,,
2092,14875,Compound was tested for binding affinity against human 5-hydroxytryptamine 1F receptor,B,,,,,,,,,279,H,8,Autocuration,1,,CHEMBL617128,,BAO_0000357,,
2093,15146,Compound was tested for its binding affinity against 5-hydroxytryptamine 1F receptor in human cloned receptors in CHO cells using [3H]5-HT,B,,,,,,,CHO,,279,H,8,Autocuration,1,,CHEMBL617129,449.0,BAO_0000219,,
2094,5213,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1F receptor in CHO using [3H]5-HT as a radioligand,B,,,,,,,,,279,H,8,Autocuration,1,,CHEMBL617130,,BAO_0000357,,
2095,14818,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1F receptor in CHO cells using [3H]5-HT.,B,,,,,,,CHO,,279,H,8,Autocuration,1,,CHEMBL617131,449.0,BAO_0000219,,
2096,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1F receptor in CHO cells, using [3H]5-HT as radioligand",B,,,,,,,CHO,,279,H,8,Autocuration,1,,CHEMBL617132,449.0,BAO_0000219,,
2097,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1F receptor in CHO cells, using [3H]5-HT as radioligand",B,,,,,,,CHO,,279,H,8,Autocuration,1,,CHEMBL617133,449.0,BAO_0000219,,
2098,4373,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 1F receptor was determined,B,,,,,,,,,279,H,8,Autocuration,1,,CHEMBL617134,,BAO_0000357,,
2099,4373,Binding affinity for 5-hydroxytryptamine 1F receptor was determined,B,,,,,,,,,279,H,8,Autocuration,1,,CHEMBL617135,,BAO_0000357,,
2100,5014,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 1F receptor,B,,,,,,,,,279,H,8,Autocuration,1,,CHEMBL617136,,BAO_0000357,,
2101,11662,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 (5-hydroxytryptamine-2) receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]-ketanserin as radioligand",B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617137,,BAO_0000019,,
2102,11662,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand",B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617138,,BAO_0000019,,
2103,11662,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 (5-hydroxytryptamine-2) receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand; Not Determined",B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617139,,BAO_0000019,,
2104,14093,Ability to displace [3H]ketanserin from rat cortical homogenate 5-hydroxytryptamine 2A receptor,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617140,,BAO_0000019,,
2105,11200,"In vivo inhibitory activity of 10 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-HT2 receptor 1 hr after oral administration",F,In vivo,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617141,,BAO_0000218,,
2106,11200,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,F,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL858112,,BAO_0000019,,
2107,12352,Binding affinity towards 5-hydroxytryptamine 2 receptor in calf frontal cortex,B,,,,,,,,,17005,H,8,Intermediate,1,,CHEMBL617142,,BAO_0000019,,
2108,13657,"Binding affinity to 5-hydroxytryptamine 2 receptor using calf frontal cortex, [3H]- ketanserin, and spiperone for NSB",B,,,Bos taurus,9913.0,,,,,22226,U,0,Autocuration,1,,CHEMBL617143,,BAO_0000019,,
2109,14331,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor of bovine frontal cortex at 10e-7 M,B,,,Bos taurus,9913.0,,,,,22226,U,0,Autocuration,1,,CHEMBL617144,,BAO_0000019,,
2110,14331,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor of bovine frontal cortex,B,,,Bos taurus,9913.0,,,,,22226,U,0,Autocuration,1,,CHEMBL617145,,BAO_0000019,,
2111,14331,Binding affinity of compound towards 5-hydroxytryptamine 2 receptor using [3H]ketanserin (0.8 nM) ligand in frontal cortex bovine was determined,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL617146,,BAO_0000019,,
2112,12685,Binding affinity for serotonin 5-hydroxytryptamine 2 receptor using [3H]ketanserin in guinea pig frontal cortex,B,,,Cavia porcellus,10141.0,,,,,104784,H,4,Autocuration,1,,CHEMBL617147,,BAO_0000019,,
2113,14389,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor of guinea pig frontal cortex membranes,B,,,Cavia porcellus,10141.0,,,,,104784,H,4,Autocuration,1,,CHEMBL617148,,BAO_0000019,,
2114,14386,Compound was tested for its binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]ketanserin from guinea pig frontal cortex,B,,,Cavia porcellus,10141.0,,,,,104784,H,4,Autocuration,1,,CHEMBL617149,,BAO_0000019,,
2115,5732,Binding affinity towards cloned human 5-hydroxytryptamine 2 receptor was determined,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617150,,BAO_0000224,,
2116,16293,Binding affinity towards 5-hydroxytryptamine 2 receptor was determined,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617151,,BAO_0000224,,
2117,2078,In vitro binding affinity of compound against neuronal 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617201,,BAO_0000224,,
2118,5486,Binding affinity towards 5-HT7 receptor by the displacement of [3H]-5-CT] in human recombinant receptors in mammalian cell,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL617202,,BAO_0000357,,
2119,11820,Effective dose through peroral route for in vivo inhibition against 5-hydroxytryptamine 2 receptor in male CF-1 mice by using radioligand [3H]ketanserin,B,In vivo,,,,,,,,104826,H,4,Autocuration,1,,CHEMBL617203,,BAO_0000218,,
2120,10297,Hill number was determined for inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in mouse cerebral cortex,B,,,,,,,,,104826,H,4,Autocuration,1,,CHEMBL617204,,BAO_0000019,,
2121,13704,Inhibitory activity against serotonin 5-hydroxytryptamine 2 receptor from mice.,B,,,,,,,,,104826,H,4,Autocuration,1,,CHEMBL617205,,BAO_0000224,,
2122,10297,Inhibitory activity towards 5-hydroxytryptamine 2 receptor by the displacement of [3H]ketanserin in mouse cerebral cortex,B,,,Mus musculus,10090.0,,,,,104826,D,5,Autocuration,1,,CHEMBL617206,,BAO_0000019,,
2123,11820,Effective dose through peroral route for in vivo inhibition against 5-hydroxytryptamine 2 receptor in male CF-1 mice by using radioligand [3H]ketanserin,B,In vivo,,,,,,,,104826,H,4,Autocuration,1,,CHEMBL617207,,BAO_0000218,,
2124,10297,Binding affinity towards 5-hydroxytryptamine 2 receptor by the displacement of [3H]-ketanserin in mouse cerebral cortex,B,,,Mus musculus,10090.0,,,,,104826,D,5,Autocuration,1,,CHEMBL617208,,BAO_0000019,,
2125,11555,The compound was tested in vitro for its binding affinity towards 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104826,H,4,Autocuration,1,,CHEMBL617209,,BAO_0000224,,
2126,11555,In vitro binding affinity for serotonin 5-hydroxytryptamine (5-HT) 2 receptors,B,,,,,,,,,104826,H,4,Autocuration,1,,CHEMBL617210,,BAO_0000224,,
2127,11555,The compound was tested in vitro for its binding affinity towards serotonin 5-hydroxytryptamine 2 receptor; nd = no data,B,,,,,,,,,104826,H,4,Autocuration,1,,CHEMBL617211,,BAO_0000224,,
2128,10297,Hill number was determined for inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in mouse cerebral cortex,B,,,Mus musculus,10090.0,,,,,104826,D,5,Autocuration,1,,CHEMBL617212,,BAO_0000019,,
2129,16688,Binding affinity for porcine 5-hydroxytryptamine 2 receptor using [3H]- ketanserin,B,,,Sus scrofa,9823.0,,,,,104784,H,4,Autocuration,1,,CHEMBL617213,,BAO_0000224,,
2130,16688,Binding affinity for porcine 5-hydroxytryptamine 2 receptor using [3H]- ketanserin with 10 uM prazosin,B,,,Sus scrofa,9823.0,,,,,104784,H,4,Autocuration,1,,CHEMBL617214,,BAO_0000224,,
2131,5333,Compound was tested in vitro for its ability to compete with [3H]-ketanserin at 5-hydroxytryptamine 2 receptor in porcine brain homogenate,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL617215,,BAO_0000221,,
2132,4437,In vitro for its ability to displace [3H]- ketanserin from 5-hydroxytryptamine 2 receptor in porcine brain homogenate,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL617216,,BAO_0000221,,
2133,5033,Ability to displace the radioligand [3H]mesulergine from pig choroid plexus 5-hydroxytryptamine 2 receptor,B,,,Sus scrofa,9823.0,,,,,17005,H,8,Autocuration,1,,CHEMBL617217,,BAO_0000357,,
2134,15267,Inhibition of [3H]- Ketanserin binding against rat brain 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617218,,BAO_0000019,,
2135,15267,Inhibition of [3H]- Ketanserin binding against rat brain 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL872913,,BAO_0000019,,
2136,11820,Binding affinity against 5-hydroxytryptamine 2 receptor from rat cortical synaptosomal membrane using radioligand [3H]ketanserin.,B,,,,,,,,,104826,H,4,Autocuration,1,,CHEMBL617219,,BAO_0000019,,
2137,9069,Evaluated for binding activity against [3H]ketanserin as radioligand for 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL873482,,BAO_0000224,,
2138,9162,Affinity towards 5-hydroxytryptamine 2 receptor by measuring its ability to antagonize serotonin-induced contractions in the rat jugular vein; ND means no data,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL617220,,BAO_0000019,,
2139,9162,Affinity towards 5-hydroxytryptamine 2 receptor by measuring its ability to antagonize serotonin-induced contractions in the rat jugular vein.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617221,,BAO_0000019,,
2140,9162,Affinity towards 5-hydroxytryptamine 2 receptor by measuring its ability to antagonize serotonin-induced contractions in the rat jugular vein; no appreciable 5-HT2 receptor affinity,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617222,,BAO_0000019,,
2141,10428,Antagonistic activity against (5-hydroxytryptamine 2 receptor) serotonin-induced contractions in the rat jugular vein,F,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL875906,,BAO_0000019,,
2142,9628,Binding affinity to the 5-hydroxytryptamine 2 receptor assayed by antagonism of serotonin-induced contractions in the rat jugular vein,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617223,,BAO_0000019,,
2143,12704,Binding affinity against serotonin 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617224,,BAO_0000224,,
2144,15453,Percent decrease in 5-hydroxytryptamine 2 receptor binding using ketanserin,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL617225,,BAO_0000224,,
2145,188,Tested for the effect on binding at 5-hydroxytryptamine 2 receptor; No activity,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617226,,BAO_0000224,,
2146,10349,Effect of 2 week administration of compound on 5-hydroxytryptamine 2 receptor binding by using 0.4 nM dose of [3H]- spiperone as a radioligand.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617227,,BAO_0000224,,
2147,10349,Effect of 2 week administration of compound on 5-hydroxytryptamine 2 receptor binding by using 0.6 nM dose of [3H]- spiperone as a radioligand.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617228,,BAO_0000224,,
2148,8868,Compound was tested for its effect on 5-hydroxytryptamine 2 receptor saturation analysis,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617229,,BAO_0000224,,
2149,10025,Concentration necessary to achieve half maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor at 1 uM,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617230,,BAO_0000224,,
2150,10025,"Concentration necessary to achieve half maximal inhibition of [3H]ketanserin, binds to 5-hydroxytryptamine 2 receptor at 1 uM",B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617231,,BAO_0000224,,
2151,11702,Compound was tested for the inhibition of quipazine binding at 5-HT2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617232,,BAO_0000224,,
2152,11702,Compound was tested for the inhibition of quipazine binding at 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617233,,BAO_0000224,,
2153,11702,Compound was tested for the inhibition of quipazine binding at 5-hydroxytryptamine 2 receptor; NT=Not tested,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617234,,BAO_0000224,,
2154,11702,Compound was tested for the inhibition of quipazine induced head twitches in rats,F,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617235,,BAO_0000019,,
2155,11702,Compound was tested for the inhibition of quipazine induced head twitches in rats; NT=Not tested,F,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617236,,BAO_0000019,,
2156,10085,Ability to bind at 5-hydroxytryptamine 2 receptor of rat hippocampus by displacing [3H]spiperone,B,,,,,,Hippocampus,,,104686,H,4,Autocuration,1,,CHEMBL617237,,BAO_0000221,10000000.0,
2157,10085,Ability to bind at serotonin 5-hydroxytryptamine 2 receptors of rat hippocampus by displacing [3H]spiperone,B,,,,,,Hippocampus,,,104686,H,4,Autocuration,1,,CHEMBL617238,,BAO_0000221,10000000.0,
2158,9630,Displacement of [3H]spiroperidol from 5-hydroxytryptamine 2 receptor in rat brain,B,,,Rattus norvegicus,10116.0,,Brain,,,104686,D,5,Autocuration,1,,CHEMBL617239,,BAO_0000221,955.0,
2159,11070,Ability to inhibit binding of [3H]KET to 5-hydroxytryptamine 2 receptor in rat cortex,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617240,,BAO_0000019,,
2160,9841,Ability to inhibit binding of titreated spiperone to 5-hydroxytryptamine 2 receptor in rat brain frontal cortex membranes,B,,,,,,,,Membranes,104686,H,4,Autocuration,1,,CHEMBL617241,,BAO_0000249,,
2161,9841,Ability to inhibit binding of titreated spiperone to the 5-hydroxytryptamine 2 receptor in rat brain frontal cortex membranes,B,,,,,,,,Membranes,104686,H,4,Autocuration,1,,CHEMBL875907,,BAO_0000249,,
2162,13291,Affinity for 5-hydroxytryptamine 2 receptor binding sites by its ability to displace [3H]spiperone from rat frontal cortex.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617242,,BAO_0000019,,
2163,10590,Antagonistic activity against 5-hydroxytryptamine 2 receptor on rat frontal cortex membrane.,F,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617152,,BAO_0000019,,
2164,9064,Binding affinity against serotonin-2 receptor in rat brain using [3H]spiroperidol,B,,,Rattus norvegicus,10116.0,,Brain,,,104686,D,5,Autocuration,1,,CHEMBL617153,,BAO_0000221,955.0,
2165,12268,Binding affinity at 5-hydroxytryptamine 2 receptor by the inhibition of binding to [3H]ketanserin in rat cortical membranes,B,,,Rattus norvegicus,10116.0,,,,Membranes,104686,D,5,Autocuration,1,,CHEMBL617154,,BAO_0000249,,
2166,13508,Binding affinity against 5-hydroxytryptamine 2 receptor in rat brain using [3H]ketanserin as radioligand,B,,,,,,Brain,,,104686,H,4,Autocuration,1,,CHEMBL617155,,BAO_0000221,955.0,
2167,11279,5-hydroxytryptamine 2 receptor antagonistic activity on the rat tail artery determined by Schild plot.,F,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617156,,BAO_0000019,,
2168,11200,In vitro antagonistic activity against the contraction induced by 5-HT through 5-HT2 receptor in rat thoracic aortic strips,F,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617157,,BAO_0000019,,
2169,11200,In vitro antagonistic activity tested against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,F,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617158,,BAO_0000019,,
2170,11200,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips; NC=non competitive antagonism,F,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617159,,BAO_0000019,,
2171,11200,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips; NC=non competitive antagonism,F,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617160,,BAO_0000019,,
2172,11200,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,F,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL858113,,BAO_0000019,,
2173,9231,Tested for 5-hydroxytryptamine 2 receptor binding ability by displacement of [3H]spiperone from rat brain frontal cortex synaptosomes,B,,,,,,Brain,,,104686,H,4,Autocuration,1,,CHEMBL617247,,BAO_0000220,955.0,
2174,9737,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat frontal cortex using [3H]ketanserin as radioligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617248,,BAO_0000019,,
2175,9737,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat brain membrane using [3H]8-OH-DPAT as a selective ligand.,B,,,,,,Brain,,,104686,H,4,Autocuration,1,,CHEMBL617249,,BAO_0000249,955.0,
2176,9737,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat frontal cortex,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617250,,BAO_0000019,,
2177,9737,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat frontal cortex using [3H]ketanserin as radioligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617251,,BAO_0000019,,
2178,11828,isplacement of [3H]DOB from rat cortex homogenate 5-hydroxytryptamine 2 receptor,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL617252,,BAO_0000019,,
2179,12253,Binding affinity of 5-hydroxytryptamine 2 receptor using [3H]- ketanserin in rat frontal cortex,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617006,,BAO_0000019,,
2180,12253,Binding affinity against 5-hydroxytryptamine 2 receptor using [3H]ketanserin in rat frontal cortex,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617007,,BAO_0000019,,
2181,11279,"5-hydroxytryptamine 2 receptor antagonistic activity at concentrations of<br>3,10 and 30 uM on the rat tail artery.",F,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617008,,BAO_0000019,,
2182,11866,Binding affinity for 5-hydroxytryptamine 2 receptor in rat cortex using [3H]- ketanserin,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617009,,BAO_0000019,,
2183,14424,Binding affinity against 5-hydroxytryptamine 2 receptor in serotonin-induced contraction of the rat aorta,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL617010,,BAO_0000224,,
2184,15180,Displacement of [3H]ketanserin from rat brain 5-hydroxytryptamine 2 receptor,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL857978,,BAO_0000019,,
2185,15180,Displacement of [3H]ketanserin from rat brain 5-hydroxytryptamine 2 receptor,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL617011,,BAO_0000019,,
2186,9786,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor of rat frontal cortex homogenate,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL617012,,BAO_0000019,,
2187,12132,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]-ketanserin as radioligand.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617013,,BAO_0000224,,
2188,5486,Binding affinity towards 5-hydroxytryptamine 2 receptor by the displacement of [3H]ketanserin in rat cerebral cortex membrane,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617014,,BAO_0000249,,
2189,15316,Compound was evaluated for its ability to displace [3H]ketanserin binding from cloned rat cerebral cortex membranes 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617015,,BAO_0000019,,
2190,16429,In vitro binding affinity to 5-hydroxytryptamine 2 receptor of rat cerebral cortex membranes using [3H]ketanserin as the radioligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617016,,BAO_0000019,,
2191,14617,pKi value for 5-hydroxytryptamine 2 receptor binding site,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617017,,BAO_0000224,,
2192,11351,Inhibitory constant (1 uM) was measured on 5-hydroxytryptamine 2 receptor/uptake using [3H]- ketanserin as radioligand in rat brain cortex.,B,,,,,,Brain,,,104686,H,4,Autocuration,1,,CHEMBL617018,,BAO_0000221,955.0,
2193,11279,5-hydroxytryptamine 2 receptor antagonistic activity on the rat tail artery determined by Schild plot.,F,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617019,,BAO_0000019,,
2194,9523,Binding affinity at 5-hydroxytryptamine 2 receptor determined using [125I]- DOI as radioligand in rat frontal cortex,B,,,,,,,,,105075,H,4,Autocuration,1,,CHEMBL617020,,BAO_0000019,,
2195,9523,Binding affinity at 5-hydroxytryptamine 2 receptor was determined using [125I]- DOI as radioligand in rat frontal cortex,B,,,,,,,,,105075,H,4,Autocuration,1,,CHEMBL617021,,BAO_0000019,,
2196,9523,Binding affinity at [3H]DOB labeled sites of 5-hydroxytryptamine 2 receptor determined using [125I]- DOI as radioligand in rat frontal cortex,B,,,,,,,,,105075,H,4,Autocuration,1,,CHEMBL617022,,BAO_0000019,,
2197,9523,Binding affinity at [3H]DOB labeled sites of 5-hydroxytryptamine 2 receptor was determined using [125I]- DOI as radioligand in rat frontal cortex,B,,,,,,,,,105075,H,4,Autocuration,1,,CHEMBL617023,,BAO_0000019,,
2198,9523,Binding affinity at [3H]KET labeled sites of 5-hydroxytryptamine 2 receptor determined using [125I]- DOI as radioligand in rat frontal cortex,B,,,,,,,,,105075,H,4,Autocuration,1,,CHEMBL617024,,BAO_0000019,,
2199,9523,Binding affinity at [3H]KET labeled sites of 5-hydroxytryptamine 2 receptor was determined using [125I]- DOI as radioligand in rat frontal cortex,B,,,,,,,,,105075,H,4,Autocuration,1,,CHEMBL617025,,BAO_0000019,,
2200,9523,Hill coefficient of compound was determined,B,,,,,,,,,105075,H,4,Autocuration,1,,CHEMBL617026,,BAO_0000224,,
2201,4771,Ancillary Binding affinity towards rat 5-hydroxytryptamine 2 receptor,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL617027,,BAO_0000019,,
2202,5033,Ability to displace the radioligand [3H]5-carboximidotryptamine ([3H]-ketanserin) from 5-hydroxytryptamine 2 receptor of rat cerebral cortex membrane,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL617028,,BAO_0000019,,
2203,10845,Binding affinity against rat 5-hydroxytryptamine 2 receptor in rat cerebral cortex tissue using [3H]spiperone as radioligand,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617029,,BAO_0000019,,
2204,10845,Binding affinity against rat 5-hydroxytryptamine 2 receptor in rat cerebral cortex tissue using [3H]spiperone as radioligand; IA-Inactive,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL875908,,BAO_0000019,,
2205,16288,Affinity at 5-hydroxytryptamine 2 receptor (For ketanserin = Ki(nM)= 0.7+/-0.09),B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617030,,BAO_0000357,,
2206,16288,Affinity at 5-hydroxytryptamine 2 receptor from rat frontal cortex using [3H]ketanserin as radioligand (For ketanserin = Ki(nM)=0.7+/-0.09),B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617031,,BAO_0000019,,
2207,16190,Binding affinity for 5-hydroxytryptamine 2 receptor of rat cortical membrane using [3H]DOB radioligand,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617032,,BAO_0000019,,
2208,12463,Tested in vitro for receptor binding affinity against 5-hydroxytryptamine 2 receptor using radioligand [3H]ketanserin,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL617033,,BAO_0000224,,
2209,9699,"Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- 1-(4-bromo-2,5-dimethoxy-phenyl)-2-aminopropane (D) as radioligand",B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617034,,BAO_0000224,,
2210,9699,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- ketanserin as radioligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617035,,BAO_0000224,,
2211,11662,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand; Not Determined",B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617036,,BAO_0000019,,
2212,1205,Inhibitory concentration against 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617037,,BAO_0000224,,
2213,11376,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 2 receptor from mammalian clones expressed in CHO cell membranes using [3H]-ketanserin as radioligand,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL617038,,BAO_0000219,,
2214,11376,"Binding affinity towards 5-hydroxytryptamine 2 receptor expressed in CHO cell membranes using [3H]ketanserin (60 Ci/mmol, 1 nM)",B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617039,,BAO_0000219,,
2215,4639,Compound was tested for binding affinity against 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617161,,BAO_0000224,,
2216,2222,Compound was tested for inhibitory activity against 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617162,,BAO_0000224,,
2217,1558,Compound was tested for its affinity towards 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617163,,BAO_0000224,,
2218,1089,Tested for binding affinity for 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617164,,BAO_0000224,,
2219,386,The compound was evaluated for its ability to displace [3H]ketanserin from 5-hydroxytryptamine 2 receptor in cellular brain membranes,B,,,,,,,,Brain membranes,104784,H,4,Autocuration,1,,CHEMBL617165,,BAO_0000249,,
2220,2474,Compound was measured for its binding affinity at 5-hydroxytryptamine 2 receptor at a concentration of 10 uM using [3H]ketanserin as radioligand,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617166,,BAO_0000224,,
2221,17066,Binding affinity towards 5-HT2 receptor,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617167,,BAO_0000224,,
2222,959,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL872912,,BAO_0000224,,
2223,6398,Compound was evaluated for 5-hydroxytryptamine 2 receptor binding,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617168,,BAO_0000224,,
2224,11889,In vitro binding affinity against rat 5-hydroxytryptamine 2 receptor.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617169,,BAO_0000224,,
2225,4221,In vitro binding affinity for 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617170,,BAO_0000224,,
2226,11026,The compound was tested for binding affinity against 5-hydroxytryptamine 2 receptor using ketanserin as radioligand,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617171,,BAO_0000224,,
2227,11866,Binding affinity for 5-hydroxytryptamine 2 receptor was determined,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617172,,BAO_0000224,,
2228,4221,In vitro binding affinity for 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617173,,BAO_0000224,,
2229,13950,In Vitro binding affinity for 5-hydroxytryptamine 2 receptor,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL617174,,BAO_0000019,,
2230,1263,5-hydroxytryptamine 2 receptor binding affinity,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617175,,BAO_0000224,,
2231,13291,Binding affinity against 5-hydroxytryptamine 2 receptor was determined using [ [3H]spiperone radioligand,B,,,,,,,,,17005,H,8,Autocuration,1,,CHEMBL617176,,BAO_0000357,,
2232,10812,Compound was tested for the binding affinity against 5-hydroxytryptamine 2 receptor by using [3H]ketanserin as radioligand,B,,,,,,,,,17005,H,8,Autocuration,1,,CHEMBL617177,,BAO_0000357,,
2233,13020,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor at 10e-5 M,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617178,,BAO_0000224,,
2234,13021,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor of central nervous system,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617179,,BAO_0000224,,
2235,13020,Ketanserin binding to 5-hydroxytryptamine 2 receptor at 10e-5 M,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617180,,BAO_0000224,,
2236,14532,Inhibitory activity against 5-hydroxytryptamine 2 receptor using [3H]-ketanserin as radioligand at 10e-5 M concentration,B,,,,,,,,,17005,H,8,Autocuration,1,,CHEMBL617181,,BAO_0000357,,
2237,13944,Binding affinity against 5-hydroxytryptamine 2 receptor,B,,,,,,,,,17005,H,8,Autocuration,1,,CHEMBL617182,,BAO_0000357,,
2238,14331,Binding affinity against 5-hydroxytryptamine 2 receptor,B,,,,,,,,,17005,H,8,Autocuration,1,,CHEMBL617183,,BAO_0000357,,
2239,14118,Binding affinity against 5-hydroxytryptamine 2 receptor using [3H]ketanserin as radioligand,B,,,,,,,,,17005,H,8,Autocuration,1,,CHEMBL617184,,BAO_0000357,,
2240,13033,Binding affinity against serotonergic 5-HT2 receptor,B,,,,,,,,,17005,H,8,Autocuration,1,,CHEMBL617185,,BAO_0000357,,
2241,10321,Binding affinity for 5-hydroxytryptamine 2 receptor was determined by using [3H]ketanserin as radioligand,B,,,,,,,,,17005,H,8,Autocuration,1,,CHEMBL617186,,BAO_0000357,,
2242,12918,Compound was evaluated for the binding affinity at 5- HT2 receptor,B,,,,,,,,,17005,H,8,Autocuration,1,,CHEMBL617187,,BAO_0000357,,
2243,15120,Compound was tested for binding affinity using [3H]ketanserin against 5-hydroxytryptamine 2 receptor,B,,,,,,,,,17005,H,8,Autocuration,1,,CHEMBL617188,,BAO_0000357,,
2244,2613,In vivo binding affinity was evaluated against 5-hydroxytryptamine 2 receptor,B,,,,,,,,,17005,H,8,Autocuration,1,,CHEMBL617189,,BAO_0000218,,
2245,13378,Inhibitory activity against cloned human 5-HT2 receptor,B,,,Homo sapiens,9606.0,,,,,104784,D,5,Autocuration,1,,CHEMBL617190,,BAO_0000224,,
2246,2331,"Tested in vitro for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor, expressed in cloned CHO cells",B,,,Homo sapiens,9606.0,,,CHO,,104784,D,5,Autocuration,1,,CHEMBL617191,449.0,BAO_0000219,,
2247,2331,"Tested in vitro for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor, expressed in cloned CHO cells.",B,,,Homo sapiens,9606.0,,,CHO,,104784,D,5,Autocuration,1,,CHEMBL617192,449.0,BAO_0000219,,
2248,2331,"Tested in vitro for the inhibition of [3H]-ketanserin binding to 5-hydroxytryptamine 2 receptor, expressed in cloned CHO cells; Inactive",B,,,Homo sapiens,9606.0,,,CHO,,104784,D,5,Autocuration,1,,CHEMBL617193,449.0,BAO_0000219,,
2249,2331,"Tested in vitro for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor, expressed in cloned CHO cells; not tested",B,,,Homo sapiens,9606.0,,,CHO,,104784,D,5,Autocuration,1,,CHEMBL617194,449.0,BAO_0000219,,
2250,4170,Binding affinity towards 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL617195,,BAO_0000224,,
2251,15453,Percent decrease in 5-hydroxytryptamine 2 receptor binding using ketanserin,B,,,,,,,,,104784,H,4,Autocuration,1,,CHEMBL881830,,BAO_0000224,,
2252,1479,Binding affinity towards 5-hydroxytryptamine 2 receptor,B,,,,,,,,,17005,H,8,Autocuration,1,,CHEMBL617196,,BAO_0000357,,
2253,11139,Binding affinity towards 5-hydroxytryptamine 2- receptor using [3H]ketanserin as radioligand in competitive binding assay,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617197,,BAO_0000224,,
2254,13969,Binding affinity against 5-hydroxytryptamine 2A receptor was measured using [3H]ketanserin as radioligand,B,,,,,,,,,17005,H,8,Expert,1,,CHEMBL617198,,BAO_0000357,,
2255,13392,Binding affinity towards 5-hydroxytryptamine 2A receptor,B,,,,,,,,,17005,H,8,Expert,1,,CHEMBL873476,,BAO_0000357,,
2256,14430,Affinity towards 5-hydroxytryptamine 2A receptor in membranes from bovine frontal cortex using [3H]ketanserin,B,,,,,,,,,17005,H,8,Expert,1,,CHEMBL617199,,BAO_0000019,,
2257,13181,Binding affinity was determined against 5-hydroxytryptamine 2A receptor,B,,,Cavia porcellus,10141.0,,,,,107,H,8,Autocuration,1,,CHEMBL617200,,BAO_0000357,,
2258,17200,Inhibitory constant against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL617484,,BAO_0000357,,
2259,17200,Inhibitory constant against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617485,,BAO_0000357,,
2260,17200,Inhibitory constant against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL617486,,BAO_0000357,,
2261,13463,Binding affinity analysed on 5-HT 2A human clone using [3H]ketanserin as radioligand,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL858022,,BAO_0000357,,
2262,6347,Effective concentration against human 5-hydroxytryptamine 2A receptor in CHO cells using 8-OH-DPA radioligand,B,,,,,,,CHO,,107,H,8,Autocuration,1,,CHEMBL617049,449.0,BAO_0000219,,
2263,6857,Functional activity against human 5-hydroxytryptamine 2A receptor expressed in CHO cells using fluorometric imaging plate reader,F,,,Homo sapiens,9606.0,,,CHO,,107,D,9,Expert,1,,CHEMBL617050,449.0,BAO_0000219,,
2264,4176,Functional agonist activity of compound was determined by fluorescence-based assay measuring intracellular calcium mobilization for 5-HT2a receptor cell line,F,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617051,,BAO_0000219,,
2265,4176,Functional agonist activity of compound was determined by fluorescence-based assay measuring intracellular calcium mobilization for 5-HT2a receptor cell line; no data,F,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617052,,BAO_0000219,,
2266,4176,Functional antagonist activity of compound was determined by fluorescence-based assay measuring intracellular calcium mobilization for 5-HT2a receptor cell line,F,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617053,,BAO_0000219,,
2267,6347,"Agonistic binding affinity against human 5-hydroxytryptamine 2A receptor in CHO cells using 8-OH-DPA radioligand, expressed as Emax",B,,,,,,,CHO,,107,H,8,Autocuration,1,,CHEMBL617054,449.0,BAO_0000219,,
2268,6347,"Agonistic binding affinity against human 5-hydroxytryptamine 2A receptor in CHO cells, expressed as Emax",B,,,,,,,CHO,,107,H,8,Autocuration,1,,CHEMBL617055,449.0,BAO_0000219,,
2269,15331,Affinity of compound towards human 5-hydroxytryptamine 2A receptor was evaluated using radioligand binding technique,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL882924,,BAO_0000357,,
2270,16146,Inhibition of human 5-hydroxytryptamine 2A receptor,B,,,Homo sapiens,9606.0,,,,,107,D,9,Expert,1,,CHEMBL617056,,BAO_0000357,,
2271,15250,Compound was tested for the displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 2A receptor stably expressed in CHO cells,B,,,,,,,CHO,,107,H,8,Autocuration,1,,CHEMBL617057,449.0,BAO_0000219,,
2272,13631,Inhibitory concentration against human 5-HT2A receptor in BEK cells,B,,,,,,,,,107,H,8,Expert,1,,CHEMBL617058,,BAO_0000219,,
2273,3805,In vitro binding affinity against human 5-hydroxytryptamine 2A receptor at a concentration of 100 (nM),B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617059,,BAO_0000357,,
2274,4011,Ability to displace [3H]ketanserin from CHO cells expressing human 5-hydroxytryptamine 2A receptor was determined,B,,,,,,,CHO,,107,H,8,Autocuration,1,,CHEMBL617060,449.0,BAO_0000219,,
2275,4012,Displacement of [3H]ketanserin from CHO cells expressing human 5-hydroxytryptamine 2A receptor.,B,,,,,,,CHO,,107,H,8,Expert,1,,CHEMBL617061,449.0,BAO_0000219,,
2276,6366,Ability to displace [125I]R91150 from human cloned 5-hydroxytryptamine 2A receptor expressed in L929 cells,B,,,,,,,L929,,107,H,8,Expert,1,,CHEMBL617062,307.0,BAO_0000219,,
2277,15949,Ability to displace [3H]ketanserin binding to human 5-hydroxytryptamine 2A receptor stably expressed in CHO cells,B,,,,,,,CHO,,107,H,8,Expert,1,,CHEMBL617063,449.0,BAO_0000219,,
2278,14093,Agonist activity at cloned human 5-hydroxytryptamine 2A receptor using [125I]DOI radioligand,F,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617064,,BAO_0000019,,
2279,13481,Agonistic activity at cloned human 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand,F,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617065,,BAO_0000019,,
2280,6347,Agonistic binding affinity against human 5-hydroxytryptamine 2A receptor in CHO cells using 8-OH-DPA radioligand,B,,,,,,,CHO,,107,H,8,Autocuration,1,,CHEMBL617066,449.0,BAO_0000219,,
2281,6347,Agonistic binding affinity against human 5-hydroxytryptamine 2A receptor in CHO cells using 8-OH-DPA radioligand; Nd means not done,B,,,,,,,CHO,,107,H,8,Autocuration,1,,CHEMBL617067,449.0,BAO_0000219,,
2282,14093,Antagonist activity at cloned human 5-hydroxytryptamine 2A receptor using [3H]-Ketanserin radioligand,F,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617068,,BAO_0000019,,
2283,14093,Antagonist activity at cloned human 5-hydroxytryptamine 2A receptor using [3H]ketanserin radioligand; Not tested,F,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617069,,BAO_0000019,,
2284,13481,Antagonistic activity at cloned human 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,F,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617070,,BAO_0000019,,
2285,14442,Binding ability of compound at cloned human 5-hydroxytryptamine 2A receptor using [125 I]DOI as radioligand,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617071,,BAO_0000357,,
2286,14442,Binding ability of compound at cloned human 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL872915,,BAO_0000357,,
2287,14755,Binding activity against cloned human 5-hydroxytryptamine 2A receptor using [125I]DOI as the radioligand.,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617072,,BAO_0000357,,
2288,16441,Binding affinity against 5-hydroxytryptamine 2A receptor in humans,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617073,,BAO_0000357,,
2289,14744,Binding affinity against the cloned human 5-hydroxytryptamine 2A receptor using [125I]DOI as the radioligand,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617074,,BAO_0000357,,
2290,16659,Binding affinity for displacement of [3H]ketanserin to human 5-hydroxytryptamine 2A receptor stably expressed in CHO cells,B,,,,,,,CHO,,107,H,8,Expert,1,,CHEMBL617075,449.0,BAO_0000219,,
2291,3307,Binding affinity of compound to human 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617076,,BAO_0000357,,
2292,6857,Affinity for human 5-hydroxytryptamine 2A receptor expressed in mammalian cell line,B,,,Homo sapiens,9606.0,,,,,107,D,9,Expert,1,,CHEMBL617077,,BAO_0000019,,
2293,5635,Binding affinity against 5-hydroxytryptamine 2A receptor using [125I]DOI radioligand.,B,,,,,,,,,107,H,8,Expert,1,,CHEMBL617078,,BAO_0000357,,
2294,4234,Binding affinity to cloned human 5-hydroxytryptamine 2A receptor,B,,,Homo sapiens,9606.0,,,,,107,D,9,Expert,1,,CHEMBL617079,,BAO_0000357,,
2295,15527,Binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]5-HT as radioligand.,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617080,,BAO_0000357,,
2296,6588,Binding affinity towards human 5-hydroxytryptamine 2A receptor by the displacement of [3H]ketanserin radioligand from the cloned receptor expressed in CHO cells,B,,,,,,,CHO,,107,H,8,Expert,1,,CHEMBL617081,449.0,BAO_0000219,,
2297,13631,Binding affinity towards human 5-HT2A receptor in BEK cells,B,,,,,,,,,107,H,8,Expert,1,,CHEMBL617082,,BAO_0000219,,
2298,17723,Binding affinity towards human serotonin 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617083,,BAO_0000357,,
2299,14770,Binding affinity for recombinant human 5-hydroxytryptamine 2A receptor using [3H]5-HT as radioligand.,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617084,,BAO_0000357,,
2300,16293,Binding affinity for human 5-hydroxytryptamine 2A receptor,B,,,Homo sapiens,9606.0,,,,,107,D,9,Expert,1,,CHEMBL617085,,BAO_0000357,,
2301,16209,Binding affinity towards human 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617086,,BAO_0000357,,
2302,12469,Binding affinity was measured on 5-hydroxytryptamine 2A receptor in GF6 cells transfected with human 5-HT2A gene labeled with [3H]ketanserin,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617087,,BAO_0000219,,
2303,15363,Compound was tested for the displacement of [125I]-DOI from clone human 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617088,,BAO_0000357,,
2304,15363,Compound was tested for the displacement of [125I]DOI from cloned human 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617089,,BAO_0000357,,
2305,16441,"Tested on genetically transfected COS7 cell membranes selectively expressing human 5-hydroxytryptamine 2A receptor, using [3H]ketanserin as radioligand",B,,,,,,,,,107,H,8,Expert,1,,CHEMBL617090,,BAO_0000019,,
2306,8,In vitro binding affinity towards 5-hydroxytryptamine 2A receptor in human using [3H]ketanserin as radioligand,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617513,,BAO_0000357,,
2307,4176,In vitro binding affinity towards human 5-hydroxytryptamine 2A receptor expressed in HEK293 cells was determined using [3H]ketanserin as radioligand,B,,,,,,,HEK293,,107,H,8,Autocuration,1,,CHEMBL617514,722.0,BAO_0000219,,
2308,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617515,,BAO_0000019,,
2309,17200,Inhibitory constant against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617516,,BAO_0000357,,
2310,17200,Inhibitory constant determined against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,B,,,Homo sapiens,9606.0,,,,,107,D,9,Expert,1,,CHEMBL617517,,BAO_0000357,,
2311,4013,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2A receptor expressed in CHO cells,B,,,Homo sapiens,9606.0,,,CHO,,107,D,9,Expert,1,,CHEMBL617518,449.0,BAO_0000219,,
2312,5088,Tested for binding affinity towards 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617519,,BAO_0000357,,
2313,5088,Displacement of [3H]DOB from human 5-hydroxytryptamine 2A receptor,B,,,Homo sapiens,9606.0,,,,,107,D,9,Expert,1,,CHEMBL617520,,BAO_0000357,,
2314,5088,Tested for binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]DOB as labeled ligand; binding data not obtained,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617521,,BAO_0000357,,
2315,5088,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2A receptor,B,,,Homo sapiens,9606.0,,,,,107,D,9,Expert,1,,CHEMBL617522,,BAO_0000357,,
2316,5088,Tested for binding affinity towards human 5-hydroxytryptamine 2A receptor using [3H]5-HT as radioligand,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617523,,BAO_0000357,,
2317,5088,Tested for binding affinity towards human 5-hydroxytryptamine 2A receptor using [3H]DOB as radioligand,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617524,,BAO_0000357,,
2318,9786,Ability to displace 0.75 nM [3H]ketanserin in 5-hydroxytryptamine 2 receptor from rat frontal cortex homogenate,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617525,,BAO_0000019,,
2319,9205,Ability to inhibit [3H]spiperone binding to 5-hydroxytryptamine 2 receptor determined in rat,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL617526,,BAO_0000019,,
2320,11257,Affinity on 5-hydroxytryptamine 2 receptor labeled by [125I]DOI,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617527,,BAO_0000224,,
2321,9362,Affinity towards [3H]- DOB -labeled 5-hydroxytryptamine 2 receptor sites in rat cortical homogenates,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617528,,BAO_0000019,,
2322,9362,Affinity towards [3H]- ketanserin-labeled 5-hydroxytryptamine 2 receptor sites in rat cortical homogenates,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617529,,BAO_0000019,,
2323,10590,Inhibition of 5-hydroxytryptamine 2 induced vasoconstriction of rat caudal artery.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617530,,BAO_0000224,,
2324,10468,Binding affinity against 5-hydroxytryptamine 2 receptor of rat frontal cortex using [3H]ketanserin radioligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617531,,BAO_0000019,,
2325,13050,Binding affinity against 5-hydroxytryptamine 2 receptor from rat frontal cortex using [125]-(R)-DOI as radioligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617532,,BAO_0000019,,
2326,11624,Binding affinity against 5-hydroxytryptamine 2 receptor in rat using [3H]ketanserin as radioligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617533,,BAO_0000019,,
2327,10468,Binding affinity against 5-hydroxytryptamine 2 receptor of rat frontal cortex using [3H]ketanserin radioligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617534,,BAO_0000019,,
2328,10330,Binding affinity against 5-hydroxytryptamine 2 receptor using [3H]ketanserin as radioligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617535,,BAO_0000224,,
2329,10062,Binding affinity at rat 5-hydroxytryptamine 2 receptor by [3H]ketanserin displacement.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617536,,BAO_0000224,,
2330,11642,Binding affinity determined in radioreceptor binding assay by using [3H]ketanserin radioligand against 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617537,,BAO_0000224,,
2331,10062,Binding affinity determined in radioreceptor binding assay by using [3H]ketanserin radioligand against 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617538,,BAO_0000224,,
2332,13427,Binding affinity of [3H]ketanserin towards 5-hydroxytryptamine 2 receptor in cloned mammalian receptor expressed in cultured cells or from rat whole brain.,B,In vitro,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617539,,BAO_0000219,,
2333,12280,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL617540,,BAO_0000224,,
2334,4101,Binding affinity for 5-hydroxytryptamine 2 receptor from striata of male Wistar rats by displacement of [3H]ketanserin,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL617541,,BAO_0000224,,
2335,10062,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617542,,BAO_0000224,,
2336,11147,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]DOB as,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617543,,BAO_0000224,,
2337,2395,Binding affinity against [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor expressed in CHO-K1 cells,B,,,Rattus norvegicus,10116.0,,,CHO-K1,,104686,D,5,Autocuration,1,,CHEMBL617544,485.0,BAO_0000219,,
2338,2395,Binding affinity against [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor expressed in CHO-K1 cells,B,,,Rattus norvegicus,10116.0,,,CHO-K1,,104686,D,5,Autocuration,1,,CHEMBL617545,485.0,BAO_0000219,,
2339,9098,Binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- DOB as a radioligand,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL617413,,BAO_0000019,,
2340,9098,Binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- DOB as a radioligand.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617414,,BAO_0000019,,
2341,9098,Binding affinity to 5-hydroxytryptamine 2 receptor of rat cortical membranes using [3H]- DOB; ND means no data.,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL617415,,BAO_0000019,,
2342,9443,Binding affinity towards 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617416,,BAO_0000224,,
2343,9443,Binding affinity towards 5-hydroxytryptamine 2 receptor at 1.0 uM concentration,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617417,,BAO_0000224,,
2344,9699,"Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- 1-(4-bromo-2,5-dimethoxy-phenyl)-2-aminopropane (D) as radioligand in rat frontal cortex",B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617418,,BAO_0000019,,
2345,9699,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- ketanserin as radioligand in rat frontal cortex,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617419,,BAO_0000019,,
2346,9098,Binding affinity towards 5-hydroxytryptamine 2 receptor was determined,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617420,,BAO_0000224,,
2347,3070,Affinity for 5-hydroxytryptamine 2 receptor,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL617421,,BAO_0000224,,
2348,9547,Binding affinity towards serotonin 5-hydroxytryptamine 2 receptor of rat determined using 0.5 nM of [3H]ketanserin in binding assay,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617422,,BAO_0000224,,
2349,10444,Binding affinity was determined against 5-hydroxytryptamine 2 receptor from male Sprague-Dawley rat brain.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617423,,BAO_0000019,,
2350,14617,Binding affinity which represents concentration giving half-maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor from rat tissue homogenate,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617424,,BAO_0000019,,
2351,14617,Binding affinity which represents concentration giving half-maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor rat tissue homogenate,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617425,,BAO_0000019,,
2352,11130,Binding constant against 5-hydroxytryptamine 2 receptor (in vitro),B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617426,,BAO_0000224,,
2353,11130,Binding constant against 5-hydroxytryptamine 2 receptor (in vivo),B,In vivo,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617427,,BAO_0000218,,
2354,14542,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]ketanserin in rat brain,B,,,,,,Brain,,,104686,H,4,Autocuration,1,,CHEMBL617428,,BAO_0000221,955.0,
2355,2797,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2 receptor from rat,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617429,,BAO_0000224,,
2356,11332,Compound was evaluated for in vitro binding affinity towards 5-hydroxytryptamine 2 receptor in rat cortex using [3H]- spiperone as radioligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617430,,BAO_0000019,,
2357,11332,Compound was evaluated for in vitro binding affinity towards serotonin 5-hydroxytryptamine 2 receptor in rat cortex using [3H]- spiperone as radioligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617431,,BAO_0000019,,
2358,10752,Compound was evaluated for its ability to displace 0.25 nM [125I](R)-DOI from binding sites in rat frontal cortex.,B,,,,,,Frontal cortex,,,104686,H,4,Autocuration,1,,CHEMBL617432,,BAO_0000019,1870.0,
2359,1185,Ability to displace [3H]ketanserin from serotonergic 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617433,,BAO_0000224,,
2360,1185,Compound was evaluated for its ability to displace [3H]ketanserin from serotonergic 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617434,,BAO_0000224,,
2361,11624,Binding affinity against 5-Hydroxy tryptamine 2 (5-hydroxytryptamine 2)receptor,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL617435,,BAO_0000224,,
2362,1344,Compound was evaluated for its binding affinity to 5-hydroxytryptamine 2 receptor in rat cortex using [3H]ketanserin radioligand assay,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617436,,BAO_0000019,,
2363,15453,Binding affinity against 5-hydroxytryptamine 2 receptor in rat striatum using [3H]-RP62203,B,,,Rattus norvegicus,10116.0,,Striatum,,,104686,D,5,Autocuration,1,,CHEMBL617437,,BAO_0000019,2435.0,
2364,11662,"Binding affinity towards 5-hydroxytryptamine 2 receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand",B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617438,,BAO_0000019,,
2365,11662,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand; Not Determined",B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617439,,BAO_0000019,,
2366,10796,Compound was tested in vitro for binding affinity for 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617440,,BAO_0000224,,
2367,9069,Evaluated for binding activity against [3H]ketanserin as radioligand for 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617441,,BAO_0000224,,
2368,8814,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor of rat cortical membrane homogenates,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL872918,,BAO_0000019,,
2369,8908,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor of rat cortex,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL617442,,BAO_0000019,,
2370,9098,Evaluated for the binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand; ND means no data.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617443,,BAO_0000019,,
2371,9098,Binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 (5-HT2) receptor using [3H]KET as a radioligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617444,,BAO_0000019,,
2372,9098,Evaluated for the binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand; ND means no data.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617445,,BAO_0000019,,
2373,9098,Evaluated for the binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617446,,BAO_0000019,,
2374,9098,Binding affinity to 5-hydroxytryptamine 2 receptor in rat frontal cortical membranes by [3H]- KET displacement.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617447,,BAO_0000249,,
2375,9098,Evaluated for the binding affinity to rat frontal cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand.;ND is not determined,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617448,,BAO_0000019,,
2376,9098,Evaluated for the binding affinity to rat frontal cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand;ND means no data,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617449,,BAO_0000019,,
2377,9161,In vitro binding affinity at 5-hydroxytryptamine 2 receptor in rat cortical tissue by [3H]spiperone displacement; No data.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617450,,BAO_0000019,,
2378,9161,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 165 to 263,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617451,,BAO_0000019,,
2379,9161,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 2.4 to 5.3,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617452,,BAO_0000019,,
2380,9161,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]-Spiperone as the radioligand in rat cortical tissue.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617453,,BAO_0000019,,
2381,9161,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue.; value may range from 140 to 980,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617660,,BAO_0000019,,
2382,9161,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue.; value may range from 76 to 299,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617661,,BAO_0000019,,
2383,9161,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]-Spiperone as the radioligand in rat cortical tissue; value may range from 12 to 66,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617662,,BAO_0000019,,
2384,9161,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 136 to 220,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL872919,,BAO_0000019,,
2385,9161,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 197 to 341,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617663,,BAO_0000019,,
2386,9161,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 23 to 187,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617664,,BAO_0000019,,
2387,9161,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 29 to 132,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617665,,BAO_0000019,,
2388,9161,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 6 to 75,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617666,,BAO_0000019,,
2389,12094,In vitro binding affinity on 5-hydroxytryptamine 2 receptor is inhibition of binding of [125I]- I-LSD to P11 cells,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617667,,BAO_0000019,,
2390,12018,In vitro binding affinity towards 5-hydroxytryptamine 2 receptor in rat striatal membranes by [3H]ketanserin displacement.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617668,,BAO_0000249,,
2391,10394,Inhibitory activity against 5-hydroxytryptamine 2 receptor in rat cortical membranes using [3H]ketanserin as a radioligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617669,,BAO_0000249,,
2392,15260,Inhibitory activity against rat cortical 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617670,,BAO_0000224,,
2393,11624,Inhibitory constant against 5-hydroxytryptamine 2 receptor,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL617671,,BAO_0000224,,
2394,13654,Percentage specific displacement of radioligand [3H]-ketanserin from 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617672,,BAO_0000224,,
2395,9541,Potency to displace [3H]- Spiperone from 5-hydroxytryptamine 2 receptor in rat striatum,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617673,,BAO_0000019,,
2396,11933,Tested for binding affinity against 5-hydroxytryptamine 2 receptor from rat frontal cortical regions using [3H]ketanserin as radioligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617674,,BAO_0000224,,
2397,15538,Tested for binding affinity by measuring displacement of [3H]ketanserin from rat serotonin 5-hydroxytryptamine 2 receptor in rat cortex,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617675,,BAO_0000019,,
2398,15538,Tested for binding affinity by measuring displacement of [3H]ketanserin from rat serotonin 5-hydroxytryptamine 2 receptor in rat cortex; NA means Not Active,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617676,,BAO_0000019,,
2399,15538,Tested for binding affinity by measuring displacement of [3H]ketanserin from rat serotonin 5-hydroxytryptamine 2 receptor in rat cortex; not determined,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617677,,BAO_0000019,,
2400,8841,Displacement of [3H]ketanserin from rat prefrontal cortex 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,D,5,Autocuration,1,,CHEMBL617678,,BAO_0000019,,
2401,1455,Binding affinity to 5-hydroxytryptamine 2 receptor using [3H]ketanserin radioligand assay.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617679,,BAO_0000224,,
2402,1455,Tested for its binding affinity to Tested for its binding affinity to 5-hydroxytryptamine 2 receptor using [3H]-ketanserin radioligand assay using [3H]-ketanserin radioligand assay,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617680,,BAO_0000224,,
2403,11752,The ability to inhibit [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in rat whole brain,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617681,,BAO_0000019,,
2404,11642,The binding affinity was measured on 5-hydroxytryptamine 2 receptor in rat brain tissue,B,,,,,,Brain,,,104686,H,4,Autocuration,1,,CHEMBL617682,,BAO_0000221,955.0,
2405,12092,The binding affinity was measured on 5-hydroxytryptamine 2 receptor using [3H]- spiperone as radioligand.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617683,,BAO_0000224,,
2406,3967,Binding affinity at 5-hydroxytryptamine 2 receptor from striata wistar rats by [3H]ketanserin displacement.,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617684,,BAO_0000224,,
2407,12771,Binding affinity towards 5-hydroxytryptamine 2 receptor,B,,,Rattus norvegicus,10116.0,,,,,104686,D,5,Autocuration,1,,CHEMBL617685,,BAO_0000224,,
2408,11642,The compound was tested for its binding affinity towards 5-hydroxytryptamine 2 receptor by displacing [3H]ketanserin radioligand in rat cerebral cortex,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617686,,BAO_0000019,,
2409,11628,The compound was tested in vitro for binding affinity towards 5-hydroxytryptamine 2 receptor by displacing [125]I-LSD radioligand,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617687,,BAO_0000224,,
2410,13654,Percentage specific displacement of radioligand [3H]ketanserin from 5-hydroxytryptamine 2 receptor,B,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617688,,BAO_0000224,,
2411,11200,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,F,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617689,,BAO_0000019,,
2412,11200,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,F,,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617690,,BAO_0000019,,
2413,11200,"In vivo inhibitory activity of 10 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-hydroxytryptamine 2 receptor 1 hr after oral administration",F,In vivo,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617691,,BAO_0000218,,
2414,11200,"In vivo inhibitory activity of 10 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-hydroxytryptamine 2 receptor 3h after oral administration",F,In vivo,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617692,,BAO_0000218,,
2415,11200,"In vivo inhibitory activity of 3 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-hydroxytryptamine 2 receptor 1 hr after oral administration",F,In vivo,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617693,,BAO_0000218,,
2416,11200,"In vivo inhibitory activity of 3 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-hydroxytryptamine 2 receptor 3h after oral administration",F,In vivo,,,,,,,,104686,H,4,Autocuration,1,,CHEMBL617694,,BAO_0000218,,
2417,15436,Affinity for 5-hydroxytryptamine 2A receptor in rat brain cortex by ability to displace [3H]ketanserin,B,,,,,,Brain,,,12687,H,8,Expert,1,,CHEMBL857985,,BAO_0000221,955.0,
2418,15436,Affinity at 5-hydroxytryptamine 2A receptor of the rat brain cortex was assessed on the basis of their ability to displace [3H]ketanserin,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617695,,BAO_0000019,,
2419,14025,Affinity pKi for 5-hydroxytryptamine 2A receptor was measured in rat cortex homogenates,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617696,,BAO_0000019,,
2420,4342,Binding affinity of compound towards serotonin 5-hydroxytryptamine 2A receptor was determined,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617697,,BAO_0000357,,
2421,13735,Displacement of [3H]ketanserin from 5-HT2A receptor of rat frontal cortex,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617257,,BAO_0000019,,
2422,5816,Binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]ketanserin,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617258,,BAO_0000357,,
2423,14287,Binding affinity was evaluated in vitro by displacement of [3H]ketanserin from 5-hydroxytryptamine 2A receptor on rat cortical membrane,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617259,,BAO_0000019,,
2424,15738,In vitro affinity against serotonin ( 5-hydroxytryptamine 2A receptor ) receptor,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617260,,BAO_0000357,,
2425,15738,In vitro affinity against serotonin 5-hydroxytryptamine 2A receptor,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617261,,BAO_0000357,,
2426,15026,Compound was tested in vitro for its binding affinity towards 5-hydroxytryptamine 2A receptor from rat frontal cortex using [3H]-ketanserin as radioligand,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617262,,BAO_0000019,,
2427,16647,Half-maximal inhibition of [3H]- Ketanserin binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex homogenate,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617263,,BAO_0000019,,
2428,16647,Half-maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor in rat tissue homogenate,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617264,,BAO_0000019,,
2429,13345,Displacement of [3H]-ketanserin from rat brain 5-hydroxytryptamine 2A receptor,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617265,,BAO_0000019,,
2430,1543,Inhibition constant for in vitro inhibition of [3H]ketanserin binding to rat frontal cortex membranes 5-hydroxytryptamine 2A receptor,B,,,,,,,,Membranes,12687,H,8,Autocuration,1,,CHEMBL617266,,BAO_0000249,,
2431,12444,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor rat frontal cortex membrane,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617267,,BAO_0000019,,
2432,16404,Inhibitory constant on 5-hydroxytryptamine 2A receptor of Rat frontal cortex,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617268,,BAO_0000019,,
2433,16404,Inhibitory constant on human 5-hydroxytryptamine 2A receptor transfected in to CHO cells,B,,,,,,,CHO,,12687,H,8,Autocuration,1,,CHEMBL617269,449.0,BAO_0000219,,
2434,15577,Kinetic inhibition constant evaluated by measuring serotonergic activity,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617323,,BAO_0000357,,
2435,15577,Serotonergic activity of the compound.,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617324,,BAO_0000357,,
2436,2495,Tested in vitro for its ability to inhibit [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor in rat frontal cortex membranes,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617325,,BAO_0000249,,
2437,15042,The binding affinity was evaluated on 5-hydroxytryptamine 2A receptor expressed in rat cortex by using [3H]ketanserin as radioligand.,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617326,,BAO_0000019,,
2438,15026,In vitro ability to displace [3H]ketanserin binding from 5-hydroxytryptamine 2A receptor in rat striatal membrane.,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617327,,BAO_0000249,,
2439,12919,Agonistic activity against 5-hydroxytryptamine 2A receptor in rat cortex using [3H]ketanserin,F,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617328,,BAO_0000019,,
2440,12919,Agonistic activity against 5-hydroxytryptamine 2A receptor in rat cortex using [3H]ketanserin,F,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617329,,BAO_0000019,,
2441,12919,Agonistic activity against 5-hydroxytryptamine 2A receptor in rat cortex using [3H]ketanserin,F,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617330,,BAO_0000019,,
2442,15194,The compound was tested for the binding affinity against 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617331,,BAO_0000357,,
2443,15194,The compound was tested for the binding affinity against 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand.,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617332,,BAO_0000357,,
2444,4820,Binding affinity towards 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Expert,1,,CHEMBL617333,,BAO_0000357,,
2445,6736,Binding affinity against serotonin 5-hydroxytryptamine 2A receptor was determined using human [125I]-eotaxin,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617334,,BAO_0000357,,
2446,5163,Binding affinity towards 5-hydroxytryptamine 2A receptor was determined at a concentration of 0.000001 mol/L,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617335,,BAO_0000357,,
2447,5163,Binding affinity towards 5-hydroxytryptamine 2A receptor was determined at a concentration of 0.00001 mol/L,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617336,,BAO_0000357,,
2448,6011,Inhibition of binding towards 5-hydroxytryptamine 2A receptor at 100 nM concentration,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617337,,BAO_0000357,,
2449,14294,Percent inhibition against 5-hydroxytryptamine 2A receptor using [3H]ketanserin at 1 uM,B,,,Homo sapiens,9606.0,,,,,107,D,9,Expert,1,,CHEMBL617338,,BAO_0000357,,
2450,5014,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617339,,BAO_0000357,,
2451,17066,Binding affinity towards 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Expert,1,,CHEMBL617340,,BAO_0000357,,
2452,17515,Binding affinity of compound towards serotonin 5-hydroxytryptamine 2A receptor; inactive at 10 uM,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617341,,BAO_0000357,,
2453,6736,Inhibition of [125I]-eotaxin binding to serotonin 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Expert,1,,CHEMBL617342,,BAO_0000357,,
2454,5163,Affinity for 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Expert,1,,CHEMBL617343,,BAO_0000357,,
2455,16911,Binding affinity was performed using [3H]ketanserin as the radioligand and stably transfected NIH3T3 cells expressing the 5-hydroxytryptamine 2A receptor (GF-62 cells).,B,,,,,,,NIH3T3,,107,H,8,Expert,1,,CHEMBL617344,723.0,BAO_0000219,,
2456,6841,Binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]ketanserin,B,,,,,,,,,107,H,8,Expert,1,,CHEMBL617345,,BAO_0000357,,
2457,6119,Binding affinity towards 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand.,B,,,,,,,,,107,H,8,Expert,1,,CHEMBL617346,,BAO_0000357,,
2458,3962,Compound was evaluated for its binding against 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617347,,BAO_0000357,,
2459,4373,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 2A receptor was determined,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617348,,BAO_0000357,,
2460,4373,Binding affinity relative to indolopiperidine (compound 1)for 5-hydroxytryptamine 2A receptor was determined,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617349,,BAO_0000357,,
2461,3962,Compound was evaluated for its inverse agonist activity against 5-hydroxytryptamine 2A receptor,F,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617350,,BAO_0000019,,
2462,1633,Binding affinity towards 5-hydroxytryptamine 2A receptor by displacement of [3H]ketanserin,B,,,,,,,,,107,H,8,Expert,1,,CHEMBL872339,,BAO_0000357,,
2463,4373,Binding affinity for 5-hydroxytryptamine 2A receptor was determined,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617351,,BAO_0000357,,
2464,6576,Binding affinity towards serotonin 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Expert,1,,CHEMBL617352,,BAO_0000357,,
2465,4687,Evaluated for the binding affinity towards 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617353,,BAO_0000357,,
2466,16946,Ability to displace [3H]-ketanserin from 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617354,,BAO_0000357,,
2467,14159,Compound was evaluated for the affinity at 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617355,,BAO_0000357,,
2468,3032,In vitro binding affinity against 5-hydroxytryptamine 2A receptor in CHO cells,B,,,Mus musculus,10090.0,,,CHO,,107,H,8,Expert,1,,CHEMBL617356,449.0,BAO_0000219,,
2469,16655,Inhibition of ketanserin binding to 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617357,,BAO_0000357,,
2470,13964,Binding affinity at 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617358,,BAO_0000357,,
2471,16989,Binding affinity towards Serotonin 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Expert,1,,CHEMBL617359,,BAO_0000357,,
2472,16117,In vitro binding affinity towards 5-hydroxytryptamine 2A receptor was determined,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617360,,BAO_0000357,,
2473,16700,The binding affinity towards 5-hydroxytryptamine 2A receptor; No affinity,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL875913,,BAO_0000357,,
2474,3269,Affinity against 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617361,,BAO_0000357,,
2475,1274,Binding affinity against 5-Hydroxytryptamine 2A receptor,B,,,Homo sapiens,9606.0,,,,,107,D,9,Expert,1,,CHEMBL617362,,BAO_0000357,,
2476,1317,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2A receptor using radioligand binding assay,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617363,,BAO_0000357,,
2477,12146,Tested against 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617364,,BAO_0000357,,
2478,12652,Binding affinity against the site labelled by the 5-hydroxytryptamine 2A receptor - 5-hydroxytryptamine 2C receptor antagonist [3H]- ketanserin,B,,,,,,,,,105075,H,4,Autocuration,1,,CHEMBL617365,,BAO_0000224,,
2479,12652,Tested for the binding affinity against the site labelled by the 5-hydroxytryptamine 2A receptor - 5-hydroxytryptamine 2C receptor antagonist [3H] ketanserin,B,,,,,,,,,105075,H,4,Autocuration,1,,CHEMBL617366,,BAO_0000224,,
2480,12652,Tested for the binding affinity against the site labelled by the 5-hydroxytryptamine 2A receptor - 5-hydroxytryptamine 2C receptor agonist [125I]- - (+/-)DOI,B,,,,,,,,,105075,H,4,Autocuration,1,,CHEMBL617367,,BAO_0000224,,
2481,12652,Tested for the binding affinity against the site labelled by the 5-hydroxytryptamine 2A receptor - 5-hydroxytryptamine 2C receptor antagonist [3H]- ketanserin,B,,,,,,,,,105075,H,4,Autocuration,1,,CHEMBL617368,,BAO_0000224,,
2482,16647,Selectivity ratio towards 5-hydroxytryptamine 2A receptor to Dopamine receptor D2 (5-HT2A/D2 ),B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617369,,BAO_0000357,,
2483,15851,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells; ND means no data,B,,,Homo sapiens,9606.0,,,HEK293,,227,D,9,Expert,1,,CHEMBL617370,722.0,BAO_0000219,,
2484,6857,Functional activity against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader,F,,,Homo sapiens,9606.0,,,CHO,,227,D,9,Expert,1,,CHEMBL617371,449.0,BAO_0000219,,
2485,3805,In vitro binding affinity against human 5-HT2B receptor at a concentration of 100 (nM),B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617372,,BAO_0000357,,
2486,6491,Affinity towards human 5-hydroxytryptamine 2B serotonin receptor,B,,,Homo sapiens,9606.0,,,,,227,D,9,Expert,1,,CHEMBL617373,,BAO_0000357,,
2487,14093,Agonist activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]5-HT radioligand,F,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617374,,BAO_0000019,,
2488,13481,Agonistic activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]-5-HT as radioligand,F,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617375,,BAO_0000019,,
2489,14093,Antagonist activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]- rauwolscine radioligand,F,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617376,,BAO_0000019,,
2490,14093,Antagonist activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]- rauwolscine radioligand; Not tested,F,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617377,,BAO_0000019,,
2491,14093,Antagonist activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]rauwolscine radioligand,F,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617378,,BAO_0000019,,
2492,13481,Antagonistic activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]rauwolscine as radioligand,F,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617379,,BAO_0000019,,
2493,14442,Binding ability of compound at cloned human 5-hydroxytryptamine 2B receptor using [3H]- rauwolscine as radioligand,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617380,,BAO_0000357,,
2494,14442,Binding ability of compound at cloned human 5-hydroxytryptamine 2B receptor using [3H]5-HT 2B as radioligand,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617381,,BAO_0000357,,
2495,14442,Binding ability of compound at cloned human 5-hydroxytryptamine 2B receptor using [3H]rauwolscine as radioligand,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617382,,BAO_0000357,,
2496,12369,The compound evaluated for its affinity against 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617383,,BAO_0000357,,
2497,12369,Affinity against 5-hydroxytryptamine 2A receptor (D) labeled with [125I]DOI.,B,,,,,,,,,107,H,8,Expert,1,,CHEMBL617384,,BAO_0000357,,
2498,12369,Affinity against 5-hydroxytryptamine 2A receptor (K) labeled with [3H]ketanserin.,B,,,,,,,,,107,H,8,Expert,1,,CHEMBL617385,,BAO_0000357,,
2499,14447,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 2A receptor from cloned Human membranes,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617386,,BAO_0000019,,
2500,14447,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 2A receptor from cloned Human membranes.,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617387,,BAO_0000019,,
2501,17451,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2A receptor expressed in 3T3 cells using [3H]5-HT as radioligand; Not determined,B,,,,,,,NIH3T3,,107,H,8,Autocuration,1,,CHEMBL617388,723.0,BAO_0000219,,
2502,6857,Relative efficacy against human 5-hydroxytryptamine 2A receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,F,,,,,,,CHO,,107,H,8,Autocuration,1,,CHEMBL617389,449.0,BAO_0000219,,
2503,6857,Relative efficacy against human 5-hydroxytryptamine 2A receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,F,,,Homo sapiens,9606.0,,,CHO,,107,D,9,Expert,1,,CHEMBL617390,449.0,BAO_0000219,,
2504,5635,Selectivity ratio of binding affinity of 5-hydroxytryptamine 2A receptor to that of 5-hydroxytryptamine 2C receptor.,B,,,,,,,,,104817,H,4,Autocuration,1,,CHEMBL617391,,BAO_0000224,,
2505,12861,Binding activity radioligand.,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617392,,BAO_0000357,,
2506,12861,Binding activity against 5-hydroxytryptamine 2C receptor from human brain cortex using [3H]mesulergine as radioligand.,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617393,,BAO_0000019,,
2507,5105,Binding affinity for human cloned 5-HT2A receptor expressed in L929 cells using [125I]R91150 as radioligand,B,,,,,,,L929,,107,H,8,Autocuration,1,,CHEMBL617394,307.0,BAO_0000219,,
2508,5104,Binding affinity for human cloned 5-hydroxytryptamine 2A receptor expressed in L929 cells using [125I]R91150 as radioligand,B,,,,,,,L929,,107,H,8,Expert,1,,CHEMBL617395,307.0,BAO_0000219,,
2509,5105,Binding affinity at human cloned 5-hydroxytryptamine 2A receptor expressed in L929 cells by [125I]R91150 displacement.,B,,,,,,,L929,,107,H,8,Expert,1,,CHEMBL617396,307.0,BAO_0000219,,
2510,5105,Binding affinity for human cloned 5-hydroxytryptamine 2A receptor expressed in L929 cells using [125I]R91150 as radioligand; Not tested,B,,,,,,,L929,,107,H,8,Autocuration,1,,CHEMBL617397,307.0,BAO_0000219,,
2511,5254,Binding affinity against 5-HT2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617398,,BAO_0000357,,
2512,5254,Binding affinity against 5-hydroxytryptamine 2A receptor,B,,,,,,,,,107,H,8,Autocuration,1,,CHEMBL617399,,BAO_0000357,,
2513,13267,Antagonistic binding affinity measured against 5-hydroxytryptamine 2A receptor (human clone expressed in 293 cells) using [3H]ketanserin as radioligand,B,,,,,,,HEK293,,107,H,8,Autocuration,1,,CHEMBL617400,722.0,BAO_0000219,,
2514,13267,Antagonistic binding affinity measured against 5-hydroxytryptamine 2C receptor (human clone expressed in 293 cells) using [3H]mesulergine as radioligand,B,,,,,,,HEK293,,107,H,8,Autocuration,1,,CHEMBL617401,722.0,BAO_0000219,,
2515,14157,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2A receptor expressed in HEK 293 cells,B,,,Homo sapiens,9606.0,,,HEK293,,107,D,9,Expert,1,,CHEMBL617402,722.0,BAO_0000219,,
2516,12936,Binding affinity against human 5-hydroxytryptamine 2A receptor expressed in 293 cells using [3H]ketanserin,B,,,Homo sapiens,9606.0,,,HEK293,,107,D,9,Expert,1,,CHEMBL617403,722.0,BAO_0000219,,
2517,14068,Binding affinity against human 5-hydroxytryptamine 2A receptor using displacement of [3H]5-HT,B,,,,,,,,,107,H,8,Expert,1,,CHEMBL617404,,BAO_0000357,,
2518,12936,Binding affinity against human 5-hydroxytryptamine 2A receptor expressed in 293 cells using [3H]ketanserin,B,,,Homo sapiens,9606.0,,,HEK293,,107,D,9,Expert,1,,CHEMBL857981,722.0,BAO_0000219,,
2519,12936,Binding affinity against human 5-hydroxytryptamine 2A receptor expressed in 293 cells using [3H]ketanserin,B,,,Homo sapiens,9606.0,,,HEK293,,107,D,9,Expert,1,,CHEMBL617405,722.0,BAO_0000219,,
2520,4540,Binding affinity to human cloned 5-hydroxytryptamine 2A receptor in HEK 293 cells using [3H]- ketanserin as radioligand,B,,,Homo sapiens,9606.0,,,HEK293,,107,D,9,Expert,1,,CHEMBL617253,722.0,BAO_0000219,,
2521,6166,Binding affinity at human cloned 5-hydroxytryptamine 2A receptor.,B,,,,,,,,,107,H,8,Expert,1,,CHEMBL617254,,BAO_0000357,,
2522,17296,Binding affinity against 5-hydroxytryptamine 2A receptor human cloned receptors in HEK 293 cells using [3H]ketanserin as radioligand,B,,,,,,,HEK293,,107,H,8,Autocuration,1,,CHEMBL617255,722.0,BAO_0000219,,
2523,17296,Binding affinity against 5-hydroxytryptamine 2A receptor human cloned receptors in HEK 293 cells using [3H]ketanserin as radioligand,B,,,,,,,HEK293,,107,H,8,Autocuration,1,,CHEMBL617256,722.0,BAO_0000219,,
2524,17296,Binding affinity against 5-hydroxytryptamine 2A receptor human cloned receptorswithouteffect in HEK 293 cells using [3H]ketanserin as radioligand,B,,,,,,,HEK293,,107,H,8,Autocuration,1,,CHEMBL616874,722.0,BAO_0000219,,
2525,15779,Binding affinity towards 5-hydroxytryptamine 2A receptor (human cloned receptor) in HEK 293 cells using [3H]ketanserin as radioligand.,B,,,Homo sapiens,9606.0,,,HEK293,,107,D,9,Expert,1,,CHEMBL616875,722.0,BAO_0000219,,
2526,14391,Binding affinity towards human 5-hydroxytryptamine 2A receptor expressed in HEK 293 cells using [3H]ketanserin as radioligand,B,,,,,,,HEK293,,107,H,8,Expert,1,,CHEMBL616876,722.0,BAO_0000219,,
2527,15851,"Binding affinity towards human cloned 5-hydroxytryptamine receptor 2A in HEK293 cells, using [3H]ketanserin as radioligand.",B,,,,,,,HEK293,,107,H,8,Expert,1,,CHEMBL616877,722.0,BAO_0000219,,
2528,15851,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2A receptor expressed in HEK293 cells; compound is insoluble,B,,,Homo sapiens,9606.0,,,HEK293,,107,D,9,Expert,1,,CHEMBL616878,722.0,BAO_0000219,,
2529,3832,Binding affinity towards human cloned 5-hydroxytryptamine 2A receptor of HEK293 cells by displacement of [3H]ketanserin,B,,,,,,,HEK293,,107,H,8,Expert,1,,CHEMBL616879,722.0,BAO_0000219,,
2530,3833,In vitro binding affinity at human cloned 5-hydroxytryptamine 2A receptor of HEK293 cells by [3H]ketanserin displacement.,B,,,,,,,HEK293,,107,H,8,Expert,1,,CHEMBL616880,722.0,BAO_0000219,,
2531,12936,Binding affinity against human 5-hydroxytryptamine 2A receptor expressed in 293 cells using [3H]ketanserin,B,,,Homo sapiens,9606.0,,,HEK293,,107,D,9,Expert,1,,CHEMBL616881,722.0,BAO_0000219,,
2532,17451,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2A receptor expressed in 3T3 cells using [3H]5-HT as radioligand,B,,,,,,,NIH3T3,,107,H,8,Autocuration,1,,CHEMBL616882,723.0,BAO_0000219,,
2533,17451,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2A receptor expressed in 3T3 cells using [3H]5-HT as radioligand; Not determined,B,,,,,,,NIH3T3,,107,H,8,Autocuration,1,,CHEMBL616883,723.0,BAO_0000219,,
2534,17451,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2A receptor expressed in 3T3 cells using [3H]5-HT as radioligand; Not determined,B,,,,,,,NIH3T3,,107,H,8,Autocuration,1,,CHEMBL616884,723.0,BAO_0000219,,
2535,4199,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 2A receptor in HEK 293 cells using [3H]ketanserin as the radioligand,B,,,,,,,HEK293,,107,H,8,Autocuration,1,,CHEMBL616885,722.0,BAO_0000219,,
2536,1883,Compound was evaluated for displacement of [3H]ketanserin from human cloned 5-hydroxytryptamine 2A receptor in transfected CHO-K1 cells,B,,,,,,,CHO-K1,,107,H,8,Autocuration,1,,CHEMBL616886,485.0,BAO_0000219,,
2537,1883,Displacement of [3H]-ketanserin from human cloned 5-hydroxytryptamine 2A receptor expressed in CHO-K1 cells.,B,,,,,,,CHO-K1,,107,H,8,Expert,1,,CHEMBL616887,485.0,BAO_0000219,,
2538,14875,Binding affinity for human 5-hydroxytryptamine 2A receptor,B,,,Homo sapiens,9606.0,,,,,107,D,9,Expert,1,,CHEMBL616888,,BAO_0000357,,
2539,15146,Compound was tested for its binding affinity against 5-hydroxytryptamine 2A receptor in human cloned receptors in HEK 293 cells using [3H]ketanserin,B,,,,,,,HEK293,,107,H,8,Autocuration,1,,CHEMBL616889,722.0,BAO_0000219,,
2540,5213,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 2A receptor in HEK 293 using [3H]ketanserin as a radioligand,B,,,,,,,HEK293,,107,H,8,Autocuration,1,,CHEMBL616890,722.0,BAO_0000219,,
2541,16404,Inhibitory constant for human 5-hydroxytryptamine 2A receptor transfected in to CHO cells,B,,,Homo sapiens,9606.0,,,CHO,,107,D,9,Expert,1,,CHEMBL616891,449.0,BAO_0000219,,
2542,14818,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 2A receptor in HEK293 cells using [3H]-ketanserin.,B,,,,,,,HEK293,,107,H,8,Autocuration,1,,CHEMBL616892,722.0,BAO_0000219,,
2543,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 2A receptor in HEK293 cells, using [3H]ketanserin as radioligand",B,,,,,,,HEK293,,107,H,8,Autocuration,1,,CHEMBL616893,722.0,BAO_0000219,,
2544,12652,Percent of maximum stimulation of phosphatidylinositol turnover at cloned 5-hydroxytryptamine 2A receptor in 3T3 cells,F,,,,,,,NIH3T3,,10620,H,8,Autocuration,1,,CHEMBL616894,723.0,BAO_0000219,,
2545,4682,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2A receptor expressed NIH3T3 cells,B,,,,,,,NIH3T3,,107,H,8,Expert,1,,CHEMBL616895,723.0,BAO_0000219,,
2546,12652,The maximum responses of [3H]- inositol monophosphate accumulation in cells expressing the 5-hydroxytryptamine 2A receptor,F,,,,,,,,,10620,H,8,Autocuration,1,,CHEMBL616896,,BAO_0000019,,
2547,4921,Ability to displace [3H]-Ketanserin radioligand from porcine 5-hydroxytryptamine 2A receptor,B,,,,,,,,,10621,H,8,Autocuration,1,,CHEMBL617099,,BAO_0000357,,
2548,4921,Ability to displace [3H]ketanserin radioligand from porcine 5-hydroxytryptamine 2A receptor; ND denotes not determined,B,,,,,,,,,10621,H,8,Autocuration,1,,CHEMBL617100,,BAO_0000357,,
2549,16312,Binding affinity against rabbit aorta 5-HT2A receptor,B,,,Oryctolagus cuniculus,9986.0,,,,,107,H,8,Autocuration,1,,CHEMBL884532,,BAO_0000357,,
2550,14998,Binding affinity for 5-hydroxytryptamine 2A receptor of rabbit aorta ring preparations,B,,,Oryctolagus cuniculus,9986.0,,,,,107,H,8,Expert,1,,CHEMBL617101,,BAO_0000357,,
2551,14025,Dissociation equilibrium constant against the vascular 5-hydroxytryptamine 2A receptor in the rabbit saphenous aorta,B,,,Oryctolagus cuniculus,9986.0,,,,,107,H,8,Expert,1,,CHEMBL617102,,BAO_0000357,,
2552,13047,Binding affinity against 5-hydroxytryptamine 1D receptor alpha using rabbit saphenous vein assay.,B,,,Oryctolagus cuniculus,9986.0,,,,,107,H,8,Autocuration,1,,CHEMBL617103,,BAO_0000019,,
2553,13047,The compound was tested for binding affinity against 5-HT2A receptor,B,,,Oryctolagus cuniculus,9986.0,,,,,107,H,8,Expert,1,,CHEMBL617104,,BAO_0000357,,
2554,1883,Compound was evaluated for displacement of [3H]ketanserin from cloned rat 5-hydroxytryptamine 2A receptor in transfected CHO-K1 cells.,B,,,,,,,CHO-K1,,10576,H,8,Autocuration,1,,CHEMBL857979,485.0,BAO_0000219,,
2555,13463,Binding affinity analysed towards 5-HT 2A in rat jugular vein,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL857502,,BAO_0000019,,
2556,13463,Binding affinity analysed towards 5-HT 2A in rat jugular vein.,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617105,,BAO_0000019,,
2557,13463,Binding affinity analysed on 5-HT 2A in rat stomach fundus.,B,,,,,,Stomach,,,12687,H,8,Autocuration,1,,CHEMBL858021,,BAO_0000019,945.0,
2558,13463,Binding affinity for 5-HT 2A in rat stomach fundus,B,,,Rattus norvegicus,10116.0,,Stomach,,,12687,D,9,Expert,1,,CHEMBL875910,,BAO_0000019,945.0,
2559,13463,Binding affinity analysed towards 5-HT 2A in rat jugular vein.,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617106,,BAO_0000019,,
2560,16326,Ability to stimulate phosphoinositide hydrolysis in NIH3T3 cells expressing the 5-hydroxytryptamine 2A receptor,B,,,,,,,NIH3T3,,12687,H,8,Expert,1,,CHEMBL617107,723.0,BAO_0000219,,
2561,14093,Effect on phosphoinositide hydrolysis in NIH 3T3 fibroblast 5-hydroxytryptamine 2A receptor,F,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617108,,BAO_0000019,,
2562,14093,Effect on phosphoinositide hydrolysis in NIH 3T3 fibroblast expressing 5-hydroxytryptamine 2A receptor,F,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617109,,BAO_0000019,,
2563,15740,Evaluated for the effective concentration at [125I]-DOI-labeled rat 5-hydroxytryptamine 2A receptor,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617110,,BAO_0000357,,
2564,16633,Functional potency at the rat 5-hydroxytryptamine 2A receptor as effective concentration EC50 for stimulating Phosphoinositide accumulation,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617111,,BAO_0000357,,
2565,17200,In vitro relative agonist activity against 5-hydroxytryptamine 2A using PI assay in rat vascular smooth muscle cells,F,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617112,,BAO_0000019,,
2566,17133,Tested for its ability to activate phospholipase C by quantification of IP3 at cloned rat 5-hydroxytryptamine 2A receptor,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617113,,BAO_0000357,,
2567,17133,Tested for its ability to activate phospholipase C by quantification of IP3 at cloned rat 5-hydroxytryptamine 2A receptor,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617114,,BAO_0000357,,
2568,17133,Tested for its ability to activate phospholipase c by quantification of IP3 at cloned rat 5-hydroxytryptamine 2A receptor,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617115,,BAO_0000357,,
2569,17200,The receptor (5-hydroxytryptamine 2A ) mediated mobilization of intracellular calcium [Ca2+] was studied in rat smooth muscle cells,F,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617116,,BAO_0000219,,
2570,15363,Efficacy at 5-hydroxytryptamine 2A receptor,F,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617117,,BAO_0000019,,
2571,17200,In vitro efficacy against rat 5-hydroxytryptamine 2A receptor was determined by using CA+ assay (Emax),B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617118,,BAO_0000357,,
2572,17200,In vitro efficacy against rat 5-hydroxytryptamine 2A receptor was determined by using CA+ assay (Emax),B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617119,,BAO_0000357,,
2573,17200,In vitro efficacy against rat 5-hydroxytryptamine 2A receptor determined by using PI assay (Emax),B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617120,,BAO_0000357,,
2574,17200,The receptor (5-hydroxytryptamine 2A ) mediated mobilization of intracellular calcium [Ca2+] was studied in rat smooth muscle cells,F,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617121,,BAO_0000219,,
2575,17200,The receptor (5-hydroxytryptamine 2A) mediated mobilization of intracellular calcium [Ca2+] was studied in rat smooth muscle cells,F,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617122,,BAO_0000219,,
2576,17211,Ability to displace [3H]ketanserin (0.5 nM) from cerebral cortex of rat 5-hydroxytryptamine 2A receptor,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617123,,BAO_0000019,,
2577,17331,Binding affinity against 5-hydroxytryptamine 2A receptor by displacement of [3H]-ketanserin from rat prefrontal cerebral cortex mambranes,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617124,,BAO_0000019,,
2578,13565,Binding affinity to serotonin 5-hydroxytryptamine 2A receptors using a radioligand [3H]ketanserin binding assay in rat cortical membranes,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617600,,BAO_0000249,,
2579,13730,Binding affinity towards rat 5-hydroxytryptamine 2A receptor was evaluated using [3H]- ketanserin as radioligand,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617601,,BAO_0000357,,
2580,12416,In vitro affinity towards 5-hydroxytryptamine 2A receptor using [3H]spiroperidol as radioligand in cortex,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL882923,,BAO_0000019,,
2581,15295,Compound was tested for it's binding affinity towards 5-hydroxytryptamine 2A receptor,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617602,,BAO_0000357,,
2582,1742,Compound was tested for its ability to displace [3H]DOB from 5-hydroxytryptamine 2A receptor in rat cortex homogenates,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617603,,BAO_0000019,,
2583,15295,Compound was tested for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617604,,BAO_0000357,,
2584,14970,Binding affinity towards 5-hydroxytryptamine 2A receptor from rat frontal cortex using [3H]ketanserin as radioligand,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617605,,BAO_0000019,,
2585,16693,In vitro binding affinity for serotonin 5-hydroxytryptamine 2A receptor of rat cerebral cortex using [3H]ketanserin as radioligand,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617606,,BAO_0000019,,
2586,14776,Inhibition of [3H]ketanserin binding to rat frontal cortex membrane 5-hydroxytryptamine 2A receptor,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617607,,BAO_0000019,,
2587,14286,In vitro inhibitory concentration against radioligand [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor in rat cortical membrane,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617455,,BAO_0000249,,
2588,17200,In vitro inhibition of [125I]DOI binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617456,,BAO_0000019,,
2589,15306,Inhibitory concentration against 5-hydroxytryptamine 2A receptor (Inactive at >1000 nM concentration),B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617457,,BAO_0000357,,
2590,14178,Inhibition of radiolabeled [3H]-Ketanserin ligand binding to 5-hydroxytryptamine 2A receptor,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617458,,BAO_0000357,,
2591,14229,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor from rat brain,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617459,,BAO_0000019,,
2592,12884,Binding affinity towards 5-hydroxytryptamine 2A receptor binding site using [3H]ketanserin. ,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617460,,BAO_0000357,,
2593,13149,"Binding affinity for 5-hydroxytryptamine 2A receptor, activity is expressed as IC50 values.",B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617461,,BAO_0000357,,
2594,15295,Displacement of [3H]ketanserin from rat cortical membrane 5-hydroxytryptamine 2A receptor at 10e-7 M,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617462,,BAO_0000019,,
2595,15740,Intrinsic activity was determined at 5-hydroxytryptamine 2A receptor which is percentage response given compared with the response produced by 10 uM serotonin.,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617463,,BAO_0000357,,
2596,15185,"Compound was tested for binding affinity at 5-hydroxytryptamine 2A receptor sites in rat cortical homogenate using [125I]-2,5-Dimethoxy -4-iodoamphetamine (DOI).",B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617464,,BAO_0000019,,
2597,15185,"Compound was tested for binding affinity using [3H]MDL-100,907 at 5-hydroxytryptamine 2A receptor sites in rat cortical homogenate.",B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617465,,BAO_0000019,,
2598,17529,Ability to bind to central serotonin 5-hydroxytryptamine 2A receptor in vitro in cortex of the rat brain using [3H]ketanserin radioligand,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617466,,BAO_0000019,,
2599,14826,Ability to displace [3H]- ketanserin bound to 5-hydroxytryptamine 2A receptor in rat pre-frontal cortex,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617467,,BAO_0000019,,
2600,17211,Displacement of [3H]ketanserin (0.5 nM) from rat cerebral cortex 5-hydroxytryptamine 2A receptors,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617468,,BAO_0000019,,
2601,14826,Ability to displace [3H]ketanserin bound to 5-hydroxytryptamine 2A receptor in rat pre-frontal cortex,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617469,,BAO_0000019,,
2602,14093,Ability to displace [3H]ketanserin from rat cortical homogenate 5-hydroxytryptamine 2A receptor,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617470,,BAO_0000019,,
2603,14093,Ability to displace [3H]ketanserin from rat cortical homogenate 5-hydroxytryptamine 2A receptor; Not tested,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617471,,BAO_0000019,,
2604,13246,Ability to inhibit the binding of iodine-125-labelled lysergic acid diethylamide([125I]-LSD) to the S-2A serotonin receptor in NIH3T3 cell line membranes,B,,,,,,,NIH3T3,,12687,H,8,Expert,1,,CHEMBL617472,723.0,BAO_0000219,,
2605,13246,Ability to inhibit the binding of iodine-125-labelled lysergic acid diethylamide([125I]-LSD) to the S-2A serotonin receptor.,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617473,,BAO_0000357,,
2606,15436,Affinity 5-hydroxytryptamine 2A receptor of the rat brain cortex was assessed on the basis of their ability to displace [3H]ketanserin,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617474,,BAO_0000019,,
2607,15436,Affinity at 5-hydroxytryptamine 2A receptor of the rat brain cortex was assessed on the basis of their ability to displace [3H]ketanserin,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617475,,BAO_0000019,,
2608,14442,Affinity at [3H]ketanserin-labeled 5-hydroxytryptamine 2A receptor in rat brain homogenate was determined,B,,,,,,Brain,,,12687,H,8,Autocuration,1,,CHEMBL617476,,BAO_0000221,955.0,
2609,12457,Affinity was evaluated as inhibition constant for serotonin 5-hydroxytryptamine 2A receptor,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617477,,BAO_0000357,,
2610,12457,Affinity was evaluated by inhibition of [125I]LSD binding to NIH 3T3 cells transfected with cloned rat 5-hydroxytryptamine 2A receptor,B,,,,,,,NIH3T3,,12687,H,8,Expert,1,,CHEMBL617478,723.0,BAO_0000219,,
2611,14755,"Antagonistic activity measured for 5-hydroxytryptamine 2A receptor using [3H]-MDL- 100,907 as radioligand in rat cortical homogenates.",F,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617479,,BAO_0000221,,
2612,4707,Binding affinity towards rat 5-hydroxytryptamine 2A receptor was determined using [125I]- DOI as radioligand,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617480,,BAO_0000357,,
2613,13297,Binding affinity against 5-hydroxytryptamine 2A receptor,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617481,,BAO_0000357,,
2614,17331,Binding affinity against 5-hydroxytryptamine 2A receptor by displacement of [3H]ketanserin from rat prefrontal cerebral cortex mambranes,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617482,,BAO_0000019,,
2615,4664,Binding affinity against 5-hydroxytryptamine 2A receptor from rat forebrain using [3H]ketanserin as radioligand,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617483,,BAO_0000019,,
2616,16633,Binding affinity against 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL621528,,BAO_0000357,,
2617,4664,Binding affinity against 5-hydroxytryptamine 2A receptor expressed NIH3T3 cells using [3H]ketanserin,B,,,Rattus norvegicus,10116.0,,,NIH3T3,,12687,D,9,Expert,1,,CHEMBL621529,723.0,BAO_0000219,,
2618,16133,Binding affinity against rat 5-hydroxytryptamine 2A receptor using [3H]DOB as radioligand,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL621530,,BAO_0000357,,
2619,16133,Binding affinity against rat 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL621531,,BAO_0000357,,
2620,14060,Binding affinity against rat brain 5-hydroxytryptamine 2A receptor,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL621532,,BAO_0000019,,
2621,16326,Binding affinity at cloned rat 5-hydroxytryptamine 2A receptor using [3H]DOB as radioligand,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL621533,,BAO_0000357,,
2622,16659,Binding affinity for displacement of [3H]ketanserin to rat 5-hydroxytryptamine 2A receptor stably expressed in CHO cells,B,,,,,,,CHO,,12687,H,8,Expert,1,,CHEMBL621534,449.0,BAO_0000219,,
2623,14776,Binding affinity measured at the 5-hydroxytryptamine 2A receptor by the inhibition of [3H]ketanserin binding to rat cortex using unlabeled mianserin for nonspecific binding.,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL621535,,BAO_0000019,,
2624,13481,Binding affinity of [3H]- ketanserin labelled towards Rat cortical 5-hydroxytryptamine 2A receptor using radioligand binding assay,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL621536,,BAO_0000357,,
2625,17386,Binding affinity of compound was tested for 5-hydroxytryptamine 2A receptor,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL621537,,BAO_0000357,,
2626,6611,Binding affinity for 5-hydroxytryptamine 2A receptor,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL621538,,BAO_0000357,,
2627,14423,Binding affinity against 5-hydroxytryptamine 2A receptor from rat cortex using [3H]ketanserin as the radioligand.,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL621539,,BAO_0000019,,
2628,15412,Binding affinity against 5-hydroxytryptamine 2A receptor of rat pre-frontal cortex,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL621540,,BAO_0000019,,
2629,15412,Binding affinity against 5-hydroxytryptamine 2A receptor of rat pre-frontal cortex.,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL621541,,BAO_0000019,,
2630,6238,Binding affinity towards 5-HT 2A receptor in rat cerebral frontal cortex membranes using [3H]ketanserin as radioligand,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL621542,,BAO_0000019,,
2631,6648,Binding affinity at 5-hydroxytryptamine 2A receptor of rat.,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL621543,,BAO_0000357,,
2632,5667,Binding affinity towards 5-hydroxytryptamine 2A receptor sites by using [3H]ketanserin as radioligand,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL621544,,BAO_0000357,,
2633,6611,Binding affinity for 5-hydroxytryptamine 2A serotonin receptor,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL621545,,BAO_0000357,,
2634,13481,Binding affinity towards rat cortical 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL621546,,BAO_0000357,,
2635,13481,Binding affinity towards rat cortical 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand; Not tested,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL621547,,BAO_0000357,,
2636,15558,Displacement of [3H]ketanserin from NIH3T3 cells stably expressing rat 5-hydroxytryptamine 2A receptor,B,,,,,,,NIH3T3,,12687,H,8,Expert,1,,CHEMBL618692,723.0,BAO_0000219,,
2637,6013,Binding affinity towards 5-hydroxytryptamine 2A receptor,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL618693,,BAO_0000357,,
2638,16633,Binding affinity towards 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL872922,,BAO_0000357,,
2639,6013,Binding affinity towards cloned rat 5-hydroxytryptamine 2A receptor from fundus tissue was determined using [3H]mesulergine as radioligand,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL618694,,BAO_0000357,,
2640,6013,Binding affinity for rat 5-hydroxytryptamine 2A receptor using [3H]DOB,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL618695,,BAO_0000357,,
2641,6013,Binding affinity towards cloned rat 5-hydroxytryptamine 2A receptor was determined using [3H]DOB as radioligand; ND=No data,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL618696,,BAO_0000357,,
2642,6013,Binding affinity towards cloned rat 5-hydroxytryptamine 2A receptor by [3H]ketanserin displacement.,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL618697,,BAO_0000357,,
2643,6013,Binding affinity towards cloned rat Inhibition of binding towards 5-hydroxytryptamine 2A receptor at 100 nM concentration was determined using [3H]DOB as radioligand,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL618892,,BAO_0000357,,
2644,6013,Binding affinity towards cloned rat Inhibition of binding towards 5-hydroxytryptamine 2A receptor at 100 nM concentration was determined using [3H]ketanserin as radioligand,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL618893,,BAO_0000357,,
2645,16293,Binding affinity towards rat 5-hydroxytryptamine 2A receptor,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL618894,,BAO_0000357,,
2646,17175,Binding affinity towards rat 5-hydroxytryptamine 2A receptor expressed in NIH3T3 cells using [3H]ketanserin as radioligand,B,,,,,,,NIH3T3,,12687,H,8,Expert,1,,CHEMBL618895,723.0,BAO_0000219,,
2647,13278,Binding affinity was measured against 5-hydroxytryptamine 2A receptor by displacement of [3H]- ketanserin by lysergic acid amides,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL618896,,BAO_0000357,,
2648,3682,Compound was evaluated for affinity towards cerebral 5-hydroxytryptamine 2A receptor in homogenate of caudate putamen tissue from rat brain,B,,,,,,Caudate-putamen,,,12687,H,8,Autocuration,1,,CHEMBL618897,,BAO_0000019,5383.0,
2649,2014,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2A receptor using [3H]ketanserin as a radioligand,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL618898,,BAO_0000357,,
2650,2014,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2A receptor using [3H]ketanserin as a radioligand; Not determined,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL618899,,BAO_0000357,,
2651,4932,Compound was evaluated for its ability to displace (+/-)[125I]-DOI from 5-hydroxytryptamine 2A receptor in cloned rat cell culture,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL618900,,BAO_0000357,,
2652,4932,Compound was evaluated for its ability to displace [125I](R)-DOI from 5-hydroxytryptamine 2A receptor in cloned rat prefrontal cortex homogenate,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL618901,,BAO_0000019,,
2653,3935,Compound was evaluated for its binding affinity for rat 5-hydroxytryptamine 2A receptor,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL618902,,BAO_0000357,,
2654,5432,Displacement of [3H]8-OH-DPAT from rat hippocampus membrane 5-hydroxytryptamine 2A receptor,B,,,Rattus norvegicus,10116.0,,Hippocampus,,,12687,D,9,Expert,1,,CHEMBL618903,,BAO_0000221,10000000.0,
2655,15818,Compound was evaluated for its binding affinity towards rat 5-hydroxytryptamine 2A receptor,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL618904,,BAO_0000357,,
2656,13672,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]ketanserin radioligand.,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL618905,,BAO_0000357,,
2657,13672,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]-ketanserin radioligand.,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL618906,,BAO_0000357,,
2658,14749,Binding affinity against rat 5-hydroxytryptamine 2A receptor in NIH3T3 cells.,B,,,,,,,NIH3T3,,12687,H,8,Expert,1,,CHEMBL618907,723.0,BAO_0000219,,
2659,13462,Compound was tested for the Binding affinity against rat frontal cortex 5-hydroxytryptamine 2A receptor by Radio ligand [3H]ketanserin binding assay.,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL618908,,BAO_0000019,,
2660,15740,Evaluated for the binding constant at [125I]-DOI-labeled rat 5-hydroxytryptamine 2A receptor,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617909,,BAO_0000357,,
2661,16647,Half-maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex homogenate,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617910,,BAO_0000019,,
2662,13345,In vitro ability to displace [3H]ketanserin from 5-hydroxytryptamine 2A receptor in rat brain.,B,,,,,,Brain,,,12687,H,8,Autocuration,1,,CHEMBL617911,,BAO_0000221,955.0,
2663,16740,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL872923,,BAO_0000249,,
2664,16740,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617912,,BAO_0000249,,
2665,15535,In vitro binding affinity at 5-hydroxytryptamine 2A receptor by displacement of [3H]ketanserin from rat cortex,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617913,,BAO_0000019,,
2666,16740,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617914,,BAO_0000249,,
2667,16740,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617915,,BAO_0000249,,
2668,16740,In vitro binding affinity at serotonin 5-hydroxytryptamine 2A receptor in rat cortical membrane,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617916,,BAO_0000249,,
2669,4795,Displacement of [3H]- Ketanserin from rat cortex 5-hydroxytryptamine 2A receptor,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617917,,BAO_0000019,,
2670,8,In vitro binding affinity towards 5-hydroxytryptamine 2A receptor in rat tissue homogenate using [3H]ketanserin as radioligand,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617918,,BAO_0000019,,
2671,8,In vitro binding affinity towards 5-hydroxytryptamine 2A receptor in rat tissue homogenate using [3H]ketanserin as radioligand; Not active at 10-5 M,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617919,,BAO_0000019,,
2672,17200,In vitro inhibitory constant against [125I]DOI binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617920,,BAO_0000019,,
2673,2148,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2A receptor of rat brain cortex,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617921,,BAO_0000019,,
2674,13345,"Relative binding affinity for D2 receptor and 5-hydroxytryptamine 2A receptor, ratio of Ki",B,,,Rattus norvegicus,10116.0,,,,,105102,D,5,Expert,1,,CHEMBL617922,,BAO_0000224,,
2675,5088,Tested for binding affinity towards rat 5-hydroxytryptamine 2A receptor using [3H]DOB as radioligand,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617923,,BAO_0000357,,
2676,5088,Tested for binding affinity towards rat 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617924,,BAO_0000357,,
2677,17133,Tested in vitro for its ability to bind to 5-hydroxytryptamine 2A receptor using [125 I]-DOI as radioligand,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617925,,BAO_0000357,,
2678,17133,In vitro binding to 5-hydroxytryptamine 2A receptor using [125 I]-DOI,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617926,,BAO_0000357,,
2679,16532,The binding affinity at 5-hydroxytryptamine 2A receptor was determined using [3H]ketanserin,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617927,,BAO_0000357,,
2680,15086,The compound was tested for binding affinity against 5-hydroxytryptamine 2A receptor,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617928,,BAO_0000357,,
2681,2309,Binding affinity for 5-hydroxytryptamine 2A receptor in rat cortex using [3H]ketanserin,B,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617929,,BAO_0000019,,
2682,12953,Binding affinity to 5-hydroxytryptamine 2A receptor from rat cortex assayed using [3H]ketanserin as radioligand.,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617930,,BAO_0000019,,
2683,12953,The compound was tested for its binding affinity towards 5-hydroxytryptamine 2A receptor from rat cortex using [3H]ketanserin as radioligand.; Nonactive at 10 uM,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617931,,BAO_0000019,,
2684,12953,The compound was tested for its binding affinity towards 5-hydroxytryptamine 2A receptor from rat cortex using [3H]-ketanserin as radioligand; Nonactive at 10 uM,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617932,,BAO_0000019,,
2685,16659,Binding affinity for displacement of [3H]ketanserin to rat 5-hydroxytryptamine 2A receptor stably expressed in CHO cells; ND is No Data,B,,,,,,,CHO,,12687,H,8,Autocuration,1,,CHEMBL617933,449.0,BAO_0000219,,
2686,16740,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane; ND means no data,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617934,,BAO_0000019,,
2687,16740,In vitro binding affinity at serotonin 5-hydroxytryptamine 2A receptor in rat cortical membrane; ND means no data,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617935,,BAO_0000019,,
2688,17133,Tested for its ability to activate phospholipase C by quantification of IP3 at cloned rat 5-hydroxytryptamine 2A receptor; Not determined,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617936,,BAO_0000357,,
2689,17211,Ability to displace [3H]ketanserin (0.5 nM) from cerebral cortex of rat 5-hydroxytryptamine 2A receptor; NT=not tested,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617937,,BAO_0000019,,
2690,17331,Binding affinity against 5-hydroxytryptamine 2A receptor by displacement of [3H]-ketanserin from rat prefrontal cerebral cortex mambranes; Not tested,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617938,,BAO_0000019,,
2691,16633,Compound was evaluated for effective dose measured in nmol/kg following a dose of 0.04 mg/kg and 0.093 uM/kg (95%CI); range 32-63,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617939,,BAO_0000218,,
2692,16633,Compound was evaluated for the percentage of rats disrupted following a dose of 0.04 mg/kg and 0.097 uM/kg,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617940,,BAO_0000218,,
2693,16633,Compound was evaluated for the percentage of rats disrupted following a dose of 0.08 mg/kg and 0.194 uM/kg,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617941,,BAO_0000218,,
2694,15026,Ratio of pKi of 5-HT2A to that of 5-HT2C receptor,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617942,,BAO_0000357,,
2695,15026,Ratio of pKi of 5-HT2A to that of D2 receptor,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617943,,BAO_0000357,,
2696,16404,Selectivity ratio towards KB of 5-hydroxytryptamine 2A receptor to 5-hydroxytryptamine 2B receptor,B,,,,,,,,,105093,H,4,Expert,1,,CHEMBL617944,,BAO_0000224,,
2697,16404,Selectivity ratio towards KB of 5-hydroxytryptamine 2A receptor to 5-hydroxytryptamine 2B receptor,B,,,,,,,,,105093,H,4,Expert,1,,CHEMBL617945,,BAO_0000224,,
2698,16404,Selectivity ratio towards Ki of 5-hydroxytryptamine 2A receptor to 5-hydroxytryptamine 2C receptor,B,,,,,,,,,105075,H,4,Expert,1,,CHEMBL617946,,BAO_0000224,,
2699,16404,Selectivity ratio towards Ki of 5-hydroxytryptamine 2A receptor to 5-hydroxytryptamine 2C receptor; ND is no data,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617947,,BAO_0000357,,
2700,16326,Percent maximal 5-HT stimulation at cloned rat 5-hydroxytryptamine 2A receptor (phosphoinositide hydrolysis study) at a conc of 100 uM,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617948,,BAO_0000357,,
2701,15847,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 2A receptor of rat,F,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL858116,,BAO_0000019,,
2702,15847,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 2A receptor of rat; ND means not done,F,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617949,,BAO_0000019,,
2703,15329,Effectiveness of compound in blocking 5-hydroxytryptamine 2A receptor-mediated contractions of rat tail artery,F,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617950,,BAO_0000019,,
2704,16404,Negative log concentration of antagonist on 5-hydroxytryptamine 2A receptor in rat thoracic aorta,F,,,,,,Thoracic aorta,,,12687,H,8,Expert,1,,CHEMBL617951,,BAO_0000019,1515.0,
2705,16404,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2A receptor of Rat thoracic aorta,F,,,,,,Thoracic aorta,,,12687,H,8,Expert,1,,CHEMBL617952,,BAO_0000019,1515.0,
2706,16404,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2A receptor of Rat thoracic aorta; ND is not determined.,F,,,,,,Thoracic aorta,,,12687,H,8,Autocuration,1,,CHEMBL617953,,BAO_0000019,1515.0,
2707,12861,Binding activity radioligand.,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617954,,BAO_0000357,,
2708,12861,Binding activity against 5-hydroxytryptamine 2C receptor from pig cortex membrane using [3H]mesulergine as radioligand.,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617955,,BAO_0000019,,
2709,12861,Binding activity against 5-hydroxytryptamine 2C receptor from pig cortex membrane using [3H]mesulergine as radioligand; NA Not Available,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL857071,,BAO_0000019,,
2710,12490,Displacement of [3H]DOB binding to 5-hydroxytryptamine 2A receptor from rat cortex homogenate,B,,,,,,,,,12687,H,8,Expert,1,,CHEMBL617270,,BAO_0000019,,
2711,12827,Binding affinity towards 5-hydroxytryptamine 3 receptor in membranes of N1E-115 neuroblastoma cells using [3H]-ICS 205-930,B,,,,,,,N1E-115,,12687,H,8,Autocuration,1,,CHEMBL617271,339.0,BAO_0000219,,
2712,12827,Binding affinity towards 5-hydroxytryptamine 3 receptor in membranes of N1E-115 neuroblastoma cells using [3H]-ICS 205-930; Not determined,B,,,,,,,N1E-115,,12687,H,8,Autocuration,1,,CHEMBL617272,339.0,BAO_0000219,,
2713,12918,Binding affinity was evaluated by 5-hydroxytryptamine 2A receptor agonism in the rat cortex by displacing ketanserin,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617273,,BAO_0000019,,
2714,12919,Agonistic activity against 5-hydroxytryptamine 2A receptor in rat cortex using [3H]-ketanserin,F,,,Rattus norvegicus,10116.0,,,,,12687,D,9,Expert,1,,CHEMBL617274,,BAO_0000019,,
2715,17723,Binding affinity towards human serotonin 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617275,,BAO_0000357,,
2716,6013,Binding affinity towards 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617276,,BAO_0000357,,
2717,16293,Binding affinity towards human 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617277,,BAO_0000357,,
2718,3857,Binding affinity using [125I]DOI as radioligand with membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL617278,,BAO_0000019,,
2719,3857,Binding affinity using [125I]DOI as radioligand with membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor; Not determined,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL617279,,BAO_0000019,,
2720,3857,Binding affinity using [3H]mesulergine as radioligand with receptor membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL617280,,BAO_0000019,,
2721,15363,Compound was tested for the displacement of [125I]DOI from cloned human 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617281,,BAO_0000357,,
2722,15363,Compound was tested for the displacement of [125I]DOI from cloned human 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617282,,BAO_0000357,,
2723,16441,Tested on transfected cell membranes selectively expressing human 5-hydroxytryptamine 2C receptor using [3H]mesulergine,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL617283,,BAO_0000019,,
2724,16441,Tested on transfected cell membranes selectively expressing human 5-hydroxytryptamine 2C receptor using [3H]-mesulergine; ND is No Data.,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL617284,,BAO_0000019,,
2725,4176,In vitro binding affinity towards human 5-hydroxytryptamine 2C receptor expressed in HEK293 cells was determined using [3H]mesulergine as radioligand,B,,,,,,,HEK293,,108,H,8,Autocuration,1,,CHEMBL617285,722.0,BAO_0000219,,
2726,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617286,,BAO_0000019,,
2727,17200,Inhibitory constant against cloned human 5-hydroxytryptamine 2C receptor using with [125I]- DOI radioligand,B,,,Homo sapiens,9606.0,,,,,108,D,9,Expert,1,,CHEMBL617287,,BAO_0000357,,
2728,5088,Binding affinity towards human 5-hydroxytryptamine 2C receptor.,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL617288,,BAO_0000357,,
2729,5088,Tested for binding affinity towards human 5-hydroxytryptamine 2C receptor using [3H]DOB as radioligand,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617289,,BAO_0000357,,
2730,5088,Tested for binding affinity towards human 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL872917,,BAO_0000357,,
2731,5088,Tested for binding affinity towards human 5-hydroxytryptamine 2C receptor using [3H]5-HT as radioligand,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617290,,BAO_0000357,,
2732,16659,Binding affinity for displacement of [3H]mesulergine to human 5-hydroxytryptamine 2C receptor stably expressed in CHO cells,B,,,,,,,CHO,,108,H,8,Autocuration,1,,CHEMBL617291,449.0,BAO_0000219,,
2733,16659,Binding affinity for displacement of [3H]mesulergine to human 5-hydroxytryptamine 2C receptor stably expressed in CHO cells; ND is no data,B,,,,,,,CHO,,108,H,8,Autocuration,1,,CHEMBL617292,449.0,BAO_0000219,,
2734,17451,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2C receptor expressed in 3T3 cells using [3H]5-HT as radioligand; Not determined,B,,,,,,,NIH3T3,,108,H,8,Autocuration,1,,CHEMBL617293,723.0,BAO_0000219,,
2735,6857,Relative efficacy against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,F,,,Homo sapiens,9606.0,,,CHO,,108,D,9,Expert,1,,CHEMBL617294,449.0,BAO_0000219,,
2736,3857,Inhibitory activity using [3H]mesulergine as radioligand with receptor membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor at a concentration of 1 uM,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL617295,,BAO_0000019,,
2737,12861,Binding activity radioligand.,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617296,,BAO_0000357,,
2738,12861,Binding activity against 5-hydroxytryptamine 2C receptor from human brain cortex using [3H]mesulergine as radioligand.,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617297,,BAO_0000019,,
2739,5104,Binding affinity for human cloned 5-hydroxytryptamine 2C receptor expressed in CHO cells using [3H]mesulergine as radioligand,B,,,,,,,CHO,,108,H,8,Expert,1,,CHEMBL617298,449.0,BAO_0000219,,
2740,5105,Binding affinity at human cloned 5-hydroxytryptamine 2C receptor expressed in CHO cells by [3H]mesulergine displacement.,B,,,,,,,CHO,,108,H,8,Expert,1,,CHEMBL617299,449.0,BAO_0000219,,
2741,5105,Binding affinity for human cloned 5-hydroxytryptamine 2C receptor expressed in CHO cells using [3H]mesulergine as radioligand; NT means not tested,B,,,,,,,CHO,,108,H,8,Autocuration,1,,CHEMBL617300,449.0,BAO_0000219,,
2742,5254,Binding affinity against 5-HT2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617454,,BAO_0000357,,
2743,13267,Antagonistic binding affinity measured against 5-hydroxytryptamine 2C receptor (human clone expressed in 293 cells) using [3H]mesulergine as radioligand,B,,,,,,,HEK293,,108,H,8,Autocuration,1,,CHEMBL617505,722.0,BAO_0000219,,
2744,14157,Displacement of [3H]mesulergine from 5-hydroxytryptamine 2C receptor expressed in HEK 293 cells,B,,,Homo sapiens,9606.0,,,HEK293,,108,D,9,Expert,1,,CHEMBL617506,722.0,BAO_0000219,,
2745,12936,Binding affinity against human 5-hydroxytryptamine 2C receptor expressed in 293 cells using [3H]mesulergine,B,,,Homo sapiens,9606.0,,,HEK293,,108,D,9,Expert,1,,CHEMBL617507,722.0,BAO_0000219,,
2746,14068,Binding affinity against human 5-hydroxytryptamine 2C receptor using displacement of [3H]DOB,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL617508,,BAO_0000357,,
2747,12936,Binding affinity against human 5-hydroxytryptamine 2C receptor expressed in 293 cells using [3H]mesulergine,B,,,Homo sapiens,9606.0,,,HEK293,,108,D,9,Expert,1,,CHEMBL857982,722.0,BAO_0000219,,
2748,4540,Binding affinity to human cloned 5-hydroxytryptamine 2C receptor in HEK 293 cells using [3H]- mesulergine as radioligand,B,,,Homo sapiens,9606.0,,,HEK293,,108,D,9,Expert,1,,CHEMBL617509,722.0,BAO_0000219,,
2749,4540,Binding affinity to human cloned 5-hydroxytryptamine 2C receptor in HEK 293 cells using [3H]- mesulergine as radioligand; Nd means not determined,B,,,Homo sapiens,9606.0,,,HEK293,,108,D,9,Expert,1,,CHEMBL617510,722.0,BAO_0000219,,
2750,6166,Binding affinity towards cloned human 5-hydroxytryptamine 2C receptor was determined,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617511,,BAO_0000357,,
2751,17296,Binding affinity against 5-hydroxytryptamine 2C receptor human cloned receptors in HEK 293 cells using [3H]mesulergine as radioligand,B,,,,,,,HEK293,,108,H,8,Autocuration,1,,CHEMBL617512,722.0,BAO_0000219,,
2752,17296,Binding affinity against 5-hydroxytryptamine 2C receptor human cloned receptorswithouteffect in HEK 293 cells using [3H]mesulergine as radioligand,B,,,,,,,HEK293,,108,H,8,Autocuration,1,,CHEMBL617749,722.0,BAO_0000219,,
2753,15779,Binding affinity towards 5-HT2C (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand.,B,,,,,,,HEK293,,108,H,8,Autocuration,1,,CHEMBL617750,722.0,BAO_0000219,,
2754,15779,Binding affinity towards 5-hydroxytryptamine 2C receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand.,B,,,,,,,HEK293,,108,H,8,Autocuration,1,,CHEMBL617751,722.0,BAO_0000219,,
2755,14391,Binding affinity towards cloned human 5-hydroxytryptamine 2C receptor expressed in HEK 293 cells using [3H]mesulergine as radioligand,B,,,,,,,HEK293,,108,H,8,Expert,1,,CHEMBL617752,722.0,BAO_0000219,,
2756,15779,"Binding affinity towards human cloned 5-hydroxytryptamine 2C receptor in HEK293 cells, using [3H]mesulergine as radioligand",B,,,,,,,HEK293,,108,H,8,Autocuration,1,,CHEMBL617753,722.0,BAO_0000219,,
2757,15851,"Binding affinity towards human cloned 5-hydroxytryptamine receptor 2C in HEK293 cells, using [3H]mesulergine as radioligand.",B,,,,,,,HEK293,,108,H,8,Expert,1,,CHEMBL617754,722.0,BAO_0000219,,
2758,15851,Displacement of [3H]mesulergine from human 5-hydroxytryptamine 2C receptor expressed in HEK293 cells; compound insoluble,B,,,Homo sapiens,9606.0,,,HEK293,,108,D,9,Expert,1,,CHEMBL617755,722.0,BAO_0000219,,
2759,15779,"Binding affinity towards human cloned 5-hydroxytryptamine 2C receptor in HEK293 cells, using [3H]mesulergine as radioligand; no data",B,,,,,,,HEK293,,108,H,8,Autocuration,1,,CHEMBL617756,722.0,BAO_0000219,,
2760,3832,Binding affinity towards human cloned 5-hydroxytryptamine 2C receptor of HEK293 cells by displacement of [3H]mesulergine,B,,,,,,,HEK293,,108,H,8,Expert,1,,CHEMBL617757,722.0,BAO_0000219,,
2761,3833,In vitro binding affinity at human cloned 5-hydroxytryptamine 2C receptor of HEK293 cells by [3H]mesulergine displacement.,B,,,,,,,HEK293,,108,H,8,Expert,1,,CHEMBL617758,722.0,BAO_0000219,,
2762,17451,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2C receptor expressed in 3T3 cells using [3H]5-HT as radioligand,B,,,,,,,NIH3T3,,108,H,8,Autocuration,1,,CHEMBL617759,723.0,BAO_0000219,,
2763,4199,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 2C receptor in HEK 293 cells using [3H]mesulergine as the radioligand,B,,,,,,,HEK293,,108,H,8,Autocuration,1,,CHEMBL617760,722.0,BAO_0000219,,
2764,1883,Displacement of [3H]mesulergine from human cloned 5-hydroxytryptamine 2C receptor expressed in CHO-K1 cells,B,,,,,,,CHO-K1,,108,H,8,Expert,1,,CHEMBL617761,485.0,BAO_0000219,,
2765,4321,Binding affinity against 5-hydroxytryptamine 2C receptor,B,,,Homo sapiens,9606.0,,,,,108,D,9,Expert,1,,CHEMBL617762,,BAO_0000357,,
2766,14875,Compound was tested for binding affinity against human 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617763,,BAO_0000357,,
2767,15146,Compound was tested for its binding affinity against human cloned 5-hydroxytryptamine 2C receptor in HEK 293 cells using [3H]mesulergine,B,,,,,,,HEK293,,108,H,8,Autocuration,1,,CHEMBL857983,722.0,BAO_0000219,,
2768,5213,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 2C receptor in HEK 293 using [3H]mesulergine as a radioligand,B,,,,,,,HEK293,,108,H,8,Autocuration,1,,CHEMBL617764,722.0,BAO_0000219,,
2769,16404,Inhibitory constant on human 5-hydroxytryptamine 2C receptor transfected in to HeLa cells,B,,,,,,,HeLa,,108,H,8,Autocuration,1,,CHEMBL617765,308.0,BAO_0000219,,
2770,13267,Selectivity as the ratio of Ki value towards 5-hydroxytryptamine 2C receptor to that of pA2 value towards 5-hydroxytryptamine 2B receptor,F,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617766,,BAO_0000019,,
2771,13267,The binding affinity (pKi) measured against 5-hydroxytryptamine 3 receptor of rat hippocampus and entorhinal cortex using [3H]granisetron as radioligand,F,,,,,,Hippocampus,,,108,H,8,Autocuration,1,,CHEMBL617767,,BAO_0000221,10000000.0,
2772,14818,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 2C receptor in HEK293 cells using [3H]mesulergine.,B,,,,,,,HEK293,,108,H,8,Autocuration,1,,CHEMBL617768,722.0,BAO_0000219,,
2773,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 2C receptor in HEK293 cells, using [3H]5-mesulergine as radioligand",B,,,,,,,HEK293,,108,H,8,Autocuration,1,,CHEMBL617769,722.0,BAO_0000219,,
2774,13463,Binding affinity analysed on 5-HT 2C in human clone using [3H]mesulergine as radioligand,B,,,,,,,,,11864,H,8,Autocuration,1,,CHEMBL858023,,BAO_0000357,,
2775,13463,Binding affinity analysed on 5-HT 2C in rat stomach fundus,B,,,,,,Stomach,,,11864,H,8,Autocuration,1,,CHEMBL617770,,BAO_0000019,945.0,
2776,13463,Binding affinity analysed towards 5-HT 2C in rat stomach fundus,B,,,,,,Stomach,,,11864,H,8,Autocuration,1,,CHEMBL617771,,BAO_0000019,945.0,
2777,12652,Percent of maximum stimulation of phosphatidylinositol turnover at cloned 5-hydroxytryptamine 2C receptor in A9 cells,F,,,,,,,A9,,11864,H,8,Autocuration,1,,CHEMBL617772,625.0,BAO_0000219,,
2778,4682,Binding affinity to 5-hydroxytryptamine 2C receptor using [3H]Mesulergine as radioligand in stably transfected NIH3T3 cells,B,,,,,,,NIH3T3,,11864,H,8,Autocuration,1,,CHEMBL617773,723.0,BAO_0000219,,
2779,4682,Binding affinity to 5-hydroxytryptamine 2C receptor measured using radioligand [3H]Mesulergine in stably transfected NIH3T3 cells,B,,,,,,,NIH3T3,,11864,H,8,Autocuration,1,,CHEMBL617850,723.0,BAO_0000219,,
2780,4682,Binding affinity to 5-hydroxytryptamine 2C receptor using [3H]Mesulergine as radioligand in stably transfected NIH3T3 cells,B,,,,,,,NIH3T3,,11864,H,8,Autocuration,1,,CHEMBL617851,723.0,BAO_0000219,,
2781,12652,The maximum responses of [3H]- inositol monophosphate accumulation in cells expressing the 5-hydroxytryptamine 2C receptor,F,,,,,,,,,11864,H,8,Autocuration,1,,CHEMBL617852,,BAO_0000019,,
2782,13463,Binding affinity analysed on 5-HT 2C in rat stomach fundus.,B,,,Mus musculus,10090.0,,Stomach,,,12689,H,8,Autocuration,1,,CHEMBL858024,,BAO_0000019,945.0,
2783,13463,Binding affinity towards 5-HT 2C receptor in rat stomach fundus,B,,,Rattus norvegicus,10116.0,,Stomach,,,12689,D,9,Expert,1,,CHEMBL617853,,BAO_0000019,945.0,
2784,13969,Binding affinity against 5-Hydroxytryptamine 2C Receptor was measured using [3H]N-methyl-mesulergine as radioligand,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL617854,,BAO_0000357,,
2785,13392,Binding affinity for 5-hydroxytryptamine 2C receptor,B,,,Sus scrofa,9823.0,,,,,108,H,8,Expert,1,,CHEMBL873477,,BAO_0000357,,
2786,13392,Binding affinity towards 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL617855,,BAO_0000357,,
2787,14430,Affinity towards 5-hydroxytryptamine 2C receptor in membranes from pig choroid plexus using [3H]N-methyl-mesulergine,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL617856,,BAO_0000019,,
2788,1742,Compound was tested for its ability to displace [3H]mesulergine from 5-hydroxytryptamine 2C receptor in pig cortex,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617857,,BAO_0000019,,
2789,14286,In vitro inhibitory concentration against radioligand [3H]mesulergine binding to 5-hydroxytryptamine 2C receptor in pig cortical membrane,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617858,,BAO_0000249,,
2790,5619,Binding affinity towards pig 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617859,,BAO_0000357,,
2791,15086,The compound was tested for binding affinity against 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617860,,BAO_0000357,,
2792,12861,Binding activity radioligand.,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617861,,BAO_0000357,,
2793,12861,Binding activity against 5-hydroxytryptamine 2C receptor from pig cortex membrane using [3H]mesulergine as radioligand.,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL617862,,BAO_0000019,,
2794,12861,Binding activity against 5-hydroxytryptamine 3 receptor from pig cortex membrane using [3H]mesulergine as radioligand; NA Not Available,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617863,,BAO_0000019,,
2795,12827,Binding affinity towards 5-hydroxytryptamine 1D receptor in calf caudate membranes using [3H]5-HT,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617864,,BAO_0000249,,
2796,12827,Binding affinity towards 5-hydroxytryptamine 1D receptor in calf caudate membranes using [3H]5-HT; Not determined,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617649,,BAO_0000249,,
2797,12919,Agonistic activity against 5-hydroxytryptamine 2C receptor in pig choroid plexus using [3H]mesulergine,F,,,Sus scrofa,9823.0,,,,,108,H,8,Expert,1,,CHEMBL617650,,BAO_0000019,,
2798,12919,Agonistic activity against 5-hydroxytryptamine 2C receptor in pig choroid plexus using [3H]mesulergine,F,,,Sus scrofa,9823.0,,,,,108,H,8,Expert,1,,CHEMBL617651,,BAO_0000019,,
2799,16429,In vitro binding affinity at 5-hydroxytryptamine 2C receptor in pig choroid plexus using 3[H]mesulergine as the radioligand,B,,,Sus scrofa,9823.0,,,,,108,H,8,Autocuration,1,,CHEMBL617652,,BAO_0000357,,
2800,773,In Vitro Binding affinity againist 5-hydroxytryptamine 2C receptor by displacing [3H]mesulergine from pig cortex,B,,,Sus scrofa,9823.0,,,,,108,H,8,Autocuration,1,,CHEMBL857072,,BAO_0000019,,
2801,5033,Ability to displace the radioligand [3H]mesulergine from pig choroid plexus 5-hydroxytryptamine 2C receptor,B,,,Sus scrofa,9823.0,,,,,108,H,8,Autocuration,1,,CHEMBL617653,,BAO_0000357,,
2802,12861,Binding activity against 5-hydroxytryptamine 2C receptor from pig cortex membrane using [3H]mesulergine as radioligand.,B,,,,,,,,,12687,H,8,Autocuration,1,,CHEMBL617654,,BAO_0000019,,
2803,14093,Effect on phosphoinositide hydrolysis in NIH 3T3 fibroblast 5-hydroxytryptamine 2C receptor,F,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617655,,BAO_0000019,,
2804,14970,Binding affinity towards 5-HT2C receptor from rat using [3H]mesulergine as radioligand,B,,,,,,,,,12689,H,8,Expert,1,,CHEMBL617656,,BAO_0000357,,
2805,14970,Compound was tested in vitro for its binding affinity towards 5-hydroxytryptamine 2C receptor from rat using [3H]mesulergine as radioligand,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617657,,BAO_0000357,,
2806,14970,Compound was tested in vitro for its binding affinity towards 5-hydroxytryptamine 2C receptor from rat using [3H]mesulergine as radioligand; Not tested,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617658,,BAO_0000357,,
2807,14178,Inhibition of radiolabeled [3H]-Ketanserin ligand binding to 5-hydroxytryptamine 2C receptor,B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Expert,1,,CHEMBL617659,,BAO_0000357,,
2808,14178,Inhibition of radiolabeled [3H]mesulergine ligand binding to 5-hydroxytryptamine 2C receptor,B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Expert,1,,CHEMBL617838,,BAO_0000357,,
2809,14229,Inhibition of [3H]mesulergine binding to 5-hydroxytryptamine 2C receptor in rat brain membranes,B,,,Rattus norvegicus,10116.0,,,,Brain membranes,12689,D,9,Expert,1,,CHEMBL617839,,BAO_0000249,,
2810,16532,The binding affinity at 5-hydroxytryptamine 2C receptor was determined using [3H]mesulergine; Not tested,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617840,,BAO_0000357,,
2811,14826,Ability to displace [3H]mesulergine bound to 5-hydroxytryptamine 2C receptor in rat cortex,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617841,,BAO_0000019,,
2812,17211,Ability to displace [3H]mesulergine (0.5 nM) from SR-3T3 cells of rat 5-HT2C receptor,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL875915,,BAO_0000019,,
2813,17211,Displacement of [3H]mesulergine (0.5 nM) from rat 5-hydroxytryptamine 2C receptor expressed in SR-3T3 cells,B,In vitro,,,,,,,,12689,H,8,Expert,1,,CHEMBL617842,,BAO_0000219,,
2814,13246,Ability to inhibit the binding of iodine-125-labelled lysergic acid diethylamide([125I]-LSD) to the S-2C serotonin receptor in NIH3T3 cell line membranes,B,,,,,,,NIH3T3,,12689,H,8,Expert,1,,CHEMBL617843,723.0,BAO_0000219,,
2815,13246,Ability to inhibit the binding of iodine-125-labelled lysergic acid diethylamide([125I]-LSD) to the S-2C serotonin receptor.,B,,,,,,,,,12689,H,8,Expert,1,,CHEMBL617844,,BAO_0000357,,
2816,12457,Affinity was evaluated as inhibition constant for serotonin 5-hydroxytryptamine 2C receptor,B,,,,,,,,,12689,H,8,Expert,1,,CHEMBL617845,,BAO_0000357,,
2817,12457,Affinity was evaluated by inhibition of [125I]LSD binding to NIH 3T3 cells transfected with cloned rat 5-hydroxytryptamine 2C receptor,B,,,,,,,NIH3T3,,12689,H,8,Expert,1,,CHEMBL617846,723.0,BAO_0000219,,
2818,4707,Binding affinity towards rat 5-hydroxytryptamine 2C receptor was determined using [125I]- DOI as radioligand,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617847,,BAO_0000357,,
2819,13297,Binding affinity against 5-hydroxytryptamine 2C receptor,B,,,,,,,,,12689,H,8,Expert,1,,CHEMBL617848,,BAO_0000357,,
2820,16633,Binding affinity against 5-hydroxytryptamine 2C receptor using [125I]DOI as radioligand,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617849,,BAO_0000357,,
2821,16133,Binding affinity against rat 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,B,,,,,,,,,12689,H,8,Expert,1,,CHEMBL621507,,BAO_0000357,,
2822,16326,Binding affinity at cloned rat 5-hydroxytryptamine 2C receptor using [3H]DOI as radioligand,B,,,,,,,,,12689,H,8,Expert,1,,CHEMBL621508,,BAO_0000357,,
2823,14423,Binding affinity against 5-hydroxytryptamine 2C receptor from rat cortex using [3H]mesulergine as the radioligand.,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL621509,,BAO_0000019,,
2824,15412,Binding affinity against 5-hydroxytryptamine 2C receptor of rat cortex,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL621510,,BAO_0000019,,
2825,15412,Binding affinity against 5-hydroxytryptamine 2C receptor of rat cortex.,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL621511,,BAO_0000019,,
2826,15558,Displacement of [3H]mesulergine from A9 cells stably expressing rat 5-hydroxytryptamine 2C receptor,B,,,,,,,A9,,12689,H,8,Expert,1,,CHEMBL621512,625.0,BAO_0000219,,
2827,16633,Binding affinity towards 5-hydroxytryptamine 2C receptor using [125I]DOI as radioligand,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL621513,,BAO_0000357,,
2828,6013,Binding affinity towards cloned rat 5-hydroxytryptamine 2C receptor from fundus tissue by [3H]mesulergine displacement.,B,,,,,,,,,12689,H,8,Expert,1,,CHEMBL621514,,BAO_0000357,,
2829,17175,Binding affinity towards rat 5-hydroxytryptamine 2C receptor expressed in A-9 cells using [3H]mesulergine as radioligand,B,In vitro,,,,,,,,12689,H,8,Expert,1,,CHEMBL621515,,BAO_0000219,,
2830,12469,Binding affinity was measured on 5-hydroxytryptamine 2C receptor in J1 cells transfected with rat 5-HT2C gene labeled with [3H]mesulergine,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL621516,,BAO_0000219,,
2831,3682,Compound was evaluated for affinity towards cerebral 5-hydroxytryptamine 2C receptor in homogenate of caudate putamen tissue from rat brain,B,,,,,,Caudate-putamen,,,12689,H,8,Autocuration,1,,CHEMBL621517,,BAO_0000019,5383.0,
2832,4932,Compound was evaluated for its ability to displace (+/-)[125I]-DOI from 5-hydroxytryptamine 2C receptor in cloned rat cell culture,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL621518,,BAO_0000357,,
2833,4932,Compound was evaluated for its ability to displace [125I](R)-DOI from 5-hydroxytryptamine 2C receptor in cloned rat prefrontal cortex homogenate; ND denotes no data,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL621519,,BAO_0000019,,
2834,3935,Compound was evaluated for its binding affinity for rat 5-hydroxytryptamine 2C receptor,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL621520,,BAO_0000357,,
2835,15818,Compound was evaluated for its binding affinity towards rat 5-hydroxytryptamine 2C receptor,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL621521,,BAO_0000357,,
2836,15818,Compound was evaluated for its binding affinity towards rat r5-hydroxytryptamine 2C receptor,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL621522,,BAO_0000357,,
2837,14749,Binding affinity against rat 5-hydroxytryptamine 2C receptor in A-9 cells.,B,,,,,,,,,12689,H,8,Expert,1,,CHEMBL621523,,BAO_0000219,,
2838,15740,Evaluated for the binding constant at [125I]-DOI-labeled rat 5-hydroxytryptamine 2C receptor,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL621524,,BAO_0000357,,
2839,17133,In vitro binding to 5-hydroxytryptamine 2C receptor using [125 I]-DOI,B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Expert,1,,CHEMBL621525,,BAO_0000357,,
2840,16532,The binding affinity at 5-hydroxytryptamine 2C receptor was determined using [3H]mesulergine,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL872921,,BAO_0000357,,
2841,12369,The compound evaluated for its affinity against 5-hydroxytryptamine 2C receptor,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL621526,,BAO_0000357,,
2842,12369,Affinity against 5-hydroxytryptamine 2C receptor in J1 cells transfected with the rat 5-HT2C gene labeled with [3H]mesulergine.,B,,,,,,,,,12689,H,8,Expert,1,,CHEMBL621527,,BAO_0000219,,
2843,2309,Binding affinity against 5-hydroxytryptamine 2C receptor in rat choroid plexus using [3H]N-methyl-mesulergine,B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Expert,1,,CHEMBL617865,,BAO_0000019,,
2844,12953,The compound was tested for their binding affinity towards 5-hydroxytryptamine 2C receptor,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617866,,BAO_0000357,,
2845,12953,The compound was tested for their binding affinity towards 5-hydroxytryptamine 2C receptor from rat cortex using [3H]-citalopram as radioligand; Nonactive at 10 uM,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617867,,BAO_0000019,,
2846,12953,The compound was tested for their binding affinity towards 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand; Nonactive at 10 uM,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617487,,BAO_0000357,,
2847,12953,Binding affinity for 5-hydroxytryptamine 2C receptor,B,,,,,,,,,12689,H,8,Expert,1,,CHEMBL617488,,BAO_0000357,,
2848,17133,Tested in vitro for its ability to bind to 5-hydroxytryptamine 2C receptor using [125 I]-DOI as radioligand; Not determined,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617489,,BAO_0000357,,
2849,17211,Ability to displace [3H]mesulergine (0.5 nM) from SR-3T3 cells of rat 5-hydroxytryptamine 2C receptor; NT denotes not tested,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617490,,BAO_0000019,,
2850,17211,Ability to displace [3H]mesulergine (0.5 nM) from SR-3T3 cells of rat 5-hydroxytryptamine 2C receptor; NT=not tested,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617491,,BAO_0000019,,
2851,14025,Affinity pKi for 5-hydroxytryptamine 2C receptor was measured in rat cortex homogenates.,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617492,,BAO_0000019,,
2852,14998,Binding affinity against 5-hydroxytryptamine 2C receptor in rat cortex homogenates.,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617493,,BAO_0000019,,
2853,4342,Binding affinity of compound towards serotonin 5-hydroxytryptamine 2C receptor was determined,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617494,,BAO_0000357,,
2854,13735,Displacement of [3H]mesulergine from rat 5-HT2C receptor expressed in HEK293,B,,,Rattus norvegicus,10116.0,,,,,12689,D,9,Expert,1,,CHEMBL617495,,BAO_0000019,,
2855,13181,Binding affinity was determined against cloned human 5-hydroxytryptamine 2C receptor using [3H]5-HT as radioligand,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617496,,BAO_0000357,,
2856,1883,Compound was evaluated for displacement of [3H]mesulergine from cloned rat 5-hydroxytryptamine 2C receptor in transfected CHO-K1 cells.,B,,,,,,,CHO-K1,,12689,H,8,Autocuration,1,,CHEMBL617497,485.0,BAO_0000219,,
2857,15194,The compound was tested for the binding affinity against 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617498,,BAO_0000357,,
2858,15194,The compound was tested for the binding affinity against 5-hydroxytryptamine 2C receptor using [3H]Mesulergine as radioligand.,B,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617499,,BAO_0000357,,
2859,14579,Compound tested for relative response using 0.1 uM 5-HT as agonist against 5-hydroxytryptamine 2C receptor,F,,,,,,,,,12689,H,8,Autocuration,1,,CHEMBL617500,,BAO_0000019,,
2860,4639,Compound was tested for binding affinity against 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617501,,BAO_0000357,,
2861,4820,Binding affinity towards 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL617502,,BAO_0000357,,
2862,14442,Binding ability of compound at cloned human 5-hydroxytryptamine 2B receptor using [3H]rauwolscine as radioligand; Not Tested,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617503,,BAO_0000357,,
2863,14755,Binding activity against cloned human 5-hydroxytryptamine 2B receptor using [3H]5-HT as the radioligand.,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617504,,BAO_0000357,,
2864,14744,Binding affinity against the cloned human 5-hydroxytryptamine 2B receptor using [3H]5-HT as the radioligand,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617406,,BAO_0000357,,
2865,6857,Affinity for human 5-hydroxytryptamine 2B receptor expressed in mammalian cell line,B,,,Homo sapiens,9606.0,,,,,227,D,9,Expert,1,,CHEMBL617407,,BAO_0000019,,
2866,16209,Binding affinity towards human 5-hydroxytryptamine 2B receptor using [3H]5-HT as radioligand,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617408,,BAO_0000357,,
2867,15363,Compound was tested for the displacement of [3H]5-HT from clone human 5-hydroxytryptamine 2B receptor,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617409,,BAO_0000357,,
2868,15363,Compound was tested for the displacement of [3H]5-HT from clone human 5-hydroxytryptamine 2B receptor,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617410,,BAO_0000357,,
2869,15363,Compound was tested for the displacement of [3H]5-HT from cloned human 5-hydroxytryptamine 2B receptor,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617411,,BAO_0000357,,
2870,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 2B receptor,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617412,,BAO_0000019,,
2871,17200,Inhibitory constant against cloned human 5-hydroxytryptamine 2B receptor using with [125I]- DOI radioligand,B,,,Homo sapiens,9606.0,,,,,227,D,9,Expert,1,,CHEMBL617774,,BAO_0000357,,
2872,15851,Displacement of [3H]5-HT from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells; ND = no data,B,,,Homo sapiens,9606.0,,,HEK293,,227,D,9,Expert,1,,CHEMBL617775,722.0,BAO_0000219,,
2873,15851,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells; ND = no data,B,,,Homo sapiens,9606.0,,,HEK293,,227,D,9,Expert,1,,CHEMBL617776,722.0,BAO_0000219,,
2874,6857,Relative efficacy against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,F,,,Homo sapiens,9606.0,,,CHO,,227,D,9,Expert,1,,CHEMBL617777,449.0,BAO_0000219,,
2875,6857,Rleative efficacy against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,F,,,Homo sapiens,9606.0,,,CHO,,227,D,9,Expert,1,,CHEMBL617778,449.0,BAO_0000219,,
2876,15779,"Binding affinities towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells, using [3H]5-HT as radioligand",B,,,,,,,HEK293,,227,H,8,Autocuration,1,,CHEMBL617779,722.0,BAO_0000219,,
2877,15851,Binding affinities towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells using [3H]5-HT as radioligand.,B,,,,,,,HEK293,,227,H,8,Expert,1,,CHEMBL617780,722.0,BAO_0000219,,
2878,15779,"Binding affinities towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells, using [3H]5-HT as radioligand; no data",B,,,,,,,HEK293,,227,H,8,Autocuration,1,,CHEMBL617781,722.0,BAO_0000219,,
2879,14157,Displacement of [3H]5-HT from 5-hydroxytryptamine 2B receptor expressed in HEK 293 cells,B,,,Homo sapiens,9606.0,,,HEK293,,227,D,9,Expert,1,,CHEMBL617782,722.0,BAO_0000219,,
2880,4540,Binding affinity to human cloned 5-HT2B receptor in HEK 293 cells using [3H]- -5-HT as radioligand,B,,,Homo sapiens,9606.0,,,HEK293,,227,D,9,Expert,1,,CHEMBL617783,722.0,BAO_0000219,,
2881,6166,Binding affinity towards cloned human 5-hydroxytryptamine 2B receptor was determined,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617784,,BAO_0000357,,
2882,15779,Binding affinity towards 5-hydroxytryptamine 2B receptor (human cloned receptor) in HEK 293 cells using [3H]5-HT as radioligand.,B,,,,,,,HEK293,,227,H,8,Autocuration,1,,CHEMBL617785,722.0,BAO_0000219,,
2883,14391,Binding affinity towards cloned human 5-hydroxytryptamine 2B receptor expressed in HEK 293 cells using [3H]5-HT as radioligand,B,,,,,,,HEK293,,227,H,8,Expert,1,,CHEMBL857984,722.0,BAO_0000219,,
2884,3832,Binding affinity towards human cloned 5-HT2B receptor of HEK293 cells by displacement of [3H]5-HT,B,,,,,,,HEK293,,227,H,8,Expert,1,,CHEMBL617786,722.0,BAO_0000219,,
2885,3833,In vitro binding affinity at human cloned 5-hydroxytryptamine 2B receptor of HEK293 cells by [3H]5-HT displacement.,B,,,,,,,HEK293,,227,H,8,Expert,1,,CHEMBL617787,722.0,BAO_0000219,,
2886,15851,Displacement of [3H]5-HT from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells,B,,,Homo sapiens,9606.0,,,HEK293,,227,D,9,Expert,1,,CHEMBL617788,722.0,BAO_0000219,,
2887,15851,Displacement of [3H]5-HT from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells; compound is insoluble,B,,,Homo sapiens,9606.0,,,HEK293,,227,D,9,Expert,1,,CHEMBL617789,722.0,BAO_0000219,,
2888,4199,Compound was evaluated for binding affinity against human cloned 5-HT2B receptor in HEK 293 cells using [3H]5-HT as the radioligand,B,,,,,,,HEK293,,227,H,8,Autocuration,1,,CHEMBL617790,722.0,BAO_0000219,,
2889,1883,Displacement of [3H]-5-5HT from human cloned 5-hydroxytryptamine 2B receptor expressed in CHO-K1 cells,B,,,,,,,CHO-K1,,227,H,8,Expert,1,,CHEMBL617791,485.0,BAO_0000219,,
2890,4321,Binding affinity against 5-hydroxytryptamine 2B receptor,B,,,,,,,,,227,H,8,Expert,1,,CHEMBL617608,,BAO_0000357,,
2891,15146,Compound was tested for its binding affinity against cloned human 5-hydroxytryptamine 2B receptor in HEK 293 cells using [3H]5-HT,B,,,,,,,HEK293,,227,H,8,Autocuration,1,,CHEMBL617609,722.0,BAO_0000219,,
2892,5213,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 2B receptor in HEK 293 using [3H]ketanserin as a radioligand,B,,,,,,,HEK293,,227,H,8,Autocuration,1,,CHEMBL617610,722.0,BAO_0000219,,
2893,14818,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 2B receptors in HEK293 cells using [3H]5-HT.,B,,,,,,,HEK293,,227,H,8,Autocuration,1,,CHEMBL617611,722.0,BAO_0000219,,
2894,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells, using [3H]5-HT as radioligand",B,,,,,,,HEK293,,227,H,8,Autocuration,1,,CHEMBL617612,722.0,BAO_0000219,,
2895,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells, using [3H]5-HT as radioligand",B,,,,,,,HEK293,,227,H,8,Autocuration,1,,CHEMBL617613,722.0,BAO_0000219,,
2896,14025,The dissociation equilibrium constant (pKB=-log KB) of compound was determined against the vascular 5-hydroxytryptamine 2B receptor in the endothelium intact rabbit jugular vein.,B,,,Oryctolagus cuniculus,9986.0,,,,,227,H,8,Autocuration,1,,CHEMBL617614,,BAO_0000019,,
2897,13463,Binding affinity analysed for 5-HT 2B receptor in rat stomach fundus,B,,,,,,Stomach,,,12688,H,8,Expert,1,,CHEMBL617615,,BAO_0000019,945.0,
2898,7259,Affinity against 5-hydroxytryptamine 2B receptor in the isolated rat stomach fundus,B,,,,,,Stomach,,,12688,H,8,Expert,1,,CHEMBL858114,,BAO_0000357,945.0,
2899,7259,Affinity against serotonergic receptor in the isolated rat stomach fundus,B,,,,,,Stomach,,,12688,H,8,Autocuration,1,,CHEMBL617616,,BAO_0000357,945.0,
2900,7185,Antagonistic activity against 5-hydroxytryptamine 2B receptor obtained from rat stomach fundus preparation,F,,,Rattus norvegicus,10116.0,,Stomach,,,12688,D,9,Expert,1,,CHEMBL617617,,BAO_0000019,945.0,
2901,7185,Antagonistic against 5-hydroxytryptamine 2B receptor,F,,,Rattus norvegicus,10116.0,,,,,12688,D,9,Expert,1,,CHEMBL875914,,BAO_0000019,,
2902,13267,Antagonistic affinity measured as pA2 value on 5-hydroxytryptamine 2B receptor of the rat stomach fundus,F,,,,,,Stomach,,,12688,H,8,Autocuration,1,,CHEMBL617618,,BAO_0000019,945.0,
2903,13735,Inhibition of 5-HT binding to 5-HT2B receptor of Rat stomach fundus,B,,,Rattus norvegicus,10116.0,,Stomach,,,12688,D,9,Expert,1,,CHEMBL617619,,BAO_0000357,945.0,
2904,15738,Compound was evaluated for antagonism against serotonin (5-hydroxytryptamine 2B receptor ) receptor,F,,,,,,,,,12688,H,8,Autocuration,1,,CHEMBL617620,,BAO_0000019,,
2905,15738,Compound was evaluated for antagonism against serotonin (5-hydroxytryptamine 2B receptor ) receptor; No data,F,,,,,,,,,12688,H,8,Autocuration,1,,CHEMBL617621,,BAO_0000019,,
2906,15738,Compound was evaluated for antagonism against serotonin (5-hydroxytryptamine 2B) receptor,F,,,,,,,,,12688,H,8,Autocuration,1,,CHEMBL617622,,BAO_0000019,,
2907,12936,Inhibitory potency against rat stomach fundus 5-hydroxytryptamine 2B receptor,B,,,Rattus norvegicus,10116.0,,Stomach,,,12688,D,9,Expert,1,,CHEMBL617623,,BAO_0000357,945.0,
2908,12936,Inhibitory potency against rat stomach fundus 5-hydroxytryptamine 2B receptor,B,,,Rattus norvegicus,10116.0,,Stomach,,,12688,D,9,Expert,1,,CHEMBL617624,,BAO_0000357,945.0,
2909,12936,Inhibitory potency against rat stomach fundus 5-hydroxytryptamine 2B receptor,B,,,Rattus norvegicus,10116.0,,Stomach,,,12688,D,9,Expert,1,,CHEMBL617625,,BAO_0000357,945.0,
2910,12936,Inhibitory potency against rat stomach fundus 5-hydroxytryptamine 2B receptor,B,,,Rattus norvegicus,10116.0,,Stomach,,,12688,D,9,Expert,1,,CHEMBL617626,,BAO_0000357,945.0,
2911,16404,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus,F,,,,,,Stomach,,,12688,H,8,Autocuration,1,,CHEMBL617627,,BAO_0000019,945.0,
2912,16404,Negative log concentration of antagonist was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus,F,,,,,,Stomach,,,12688,H,8,Expert,1,,CHEMBL617628,,BAO_0000019,945.0,
2913,16404,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus; ND is No Data.,F,,,,,,Stomach,,,12688,H,8,Autocuration,1,,CHEMBL617629,,BAO_0000019,945.0,
2914,16404,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus; ND is not determined.,F,,,,,,Stomach,,,12688,H,8,Autocuration,1,,CHEMBL858115,,BAO_0000019,945.0,
2915,16404,Antagonistic activity on 5-hydroxytryptamine 2B receptor of Rat stomach fundus;ND is not determined,F,,,Rattus norvegicus,10116.0,,Stomach,,,12688,D,9,Expert,1,,CHEMBL617630,,BAO_0000019,945.0,
2916,16404,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat thoracic aorta; ND is not determined,F,,,,,,Thoracic aorta,,,12688,H,8,Autocuration,1,,CHEMBL617631,,BAO_0000019,1515.0,
2917,7483,The binding affinity of compound to 5-HT receptor of rat fundus was expressed as pA2 value; Unable to determine valid PA2 value due to slope of Schild plot,B,,,,,,,,,12688,H,8,Autocuration,1,,CHEMBL617632,,BAO_0000357,,
2918,7483,The binding affinity to 5-hydroxytryptamine 2B receptor of rat fundus,B,,,,,,,,,12688,H,8,Expert,1,,CHEMBL617633,,BAO_0000357,,
2919,7483,The binding affinity of compound to 5-hydroxytryptamine 2B receptor of rat fundus was expressed as pA2 value; Unable to determine valid PA2 value due to slope of Schild plot,B,,,,,,,,,12688,H,8,Autocuration,1,,CHEMBL617634,,BAO_0000357,,
2920,7483,The binding affinity of compound to 5-hydroxytryptamine 2B receptor of rat fundus; Unable to determine valid PA2 value due to slope of Schild plot,B,,,,,,,,,12688,H,8,Autocuration,1,,CHEMBL617635,,BAO_0000357,,
2922,16404,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus,F,,,Rattus norvegicus,10116.0,,Stomach,,,12688,D,9,Autocuration,1,,CHEMBL617637,,BAO_0000019,945.0,
2923,6347,Binding affinity against 5-hydroxytryptamine 1A receptor,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617638,,BAO_0000357,,
2924,4373,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 2B receptor was determined,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617639,,BAO_0000357,,
2925,4373,Binding affinity for 5-hydroxytryptamine 2B receptor was determined,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617640,,BAO_0000357,,
2926,4687,Evaluated for the binding affinity to 5-HT 2B receptor,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617641,,BAO_0000357,,
2927,16946,Ability to displace [3H]5-HT from 5-hydroxytryptamine 2B receptor,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617642,,BAO_0000357,,
2928,16633,Binding affinities against 5-hydroxytryptamine 2B receptor,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617643,,BAO_0000357,,
2929,16633,Binding affinities towards 5-hydroxytryptamine 2B receptor,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617644,,BAO_0000357,,
2930,16633,Binding affinity towards 5-hydroxytryptamine 2B receptor using [125I]DOI as radioligand,B,,,,,,,,,227,H,8,Autocuration,1,,CHEMBL617645,,BAO_0000357,,
2931,15026,In vitro ability to displace [3H]mesulergine binding from 5-hydroxytryptamine 2C receptor from bovine choroid plexus.,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL617646,,BAO_0000357,,
2932,15738,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor,B,,,Bos taurus,9913.0,,,,,108,H,8,Autocuration,1,,CHEMBL617647,,BAO_0000357,,
2933,15738,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor at a concentration of 10E-6 M,B,,,Bos taurus,9913.0,,,,,108,H,8,Autocuration,1,,CHEMBL617648,,BAO_0000357,,
2934,15738,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor at a concentration of 10e-6 M,B,,,Bos taurus,9913.0,,,,,108,H,8,Autocuration,1,,CHEMBL617875,,BAO_0000357,,
2935,15738,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor at concentration of 10e-6 M,B,,,Bos taurus,9913.0,,,,,108,H,8,Autocuration,1,,CHEMBL617876,,BAO_0000357,,
2936,16404,Inhibitory constant was determined on 5-hydroxytryptamine 2C receptor of Bovine choroid plexus,B,,,Bos taurus,9913.0,,,,,108,H,8,Expert,1,,CHEMBL617877,,BAO_0000357,,
2937,15026,In vitro ability to displace [3H]mesulergine binding from 5-hydroxytryptamine 2C receptor from bovine choroid plexus.,B,,,Bos taurus,9913.0,,,,,108,H,8,Expert,1,,CHEMBL617878,,BAO_0000357,,
2938,15738,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor,B,,,Bos taurus,9913.0,,,,,108,H,8,Autocuration,1,,CHEMBL617879,,BAO_0000357,,
2939,16312,Binding affinity against guinea pig cortex 5-HT2C receptor in the presence of [3H]mesulergine,B,,,Cavia porcellus,10141.0,,,,,108,H,8,Autocuration,1,,CHEMBL617880,,BAO_0000019,,
2940,5486,Binding affinity towards 5-HT4 receptor by the displacement of [3H]GR-113808 in guinea-pig striatum,B,,,Cavia porcellus,10141.0,,Striatum,,,20033,D,9,Intermediate,1,,CHEMBL617881,,BAO_0000357,2435.0,
2941,5254,Binding affinity against 5-HT1A receptor,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL857073,,BAO_0000357,,
2942,3857,Agonistic activity for 5-HT2c (5-HT2C) by measuring [3H]inositol monophosphate fromation in CHO cells in which the human 5-HT2C receptor subtype was stably expressed,F,,,,,,,CHO,,108,H,8,Expert,1,,CHEMBL617882,449.0,BAO_0000219,,
2943,6857,Functional activity against human 5-hydroxytryptamine 2C receptor expressed in CHO cells using fluorometric imaging plate reader,F,,,Homo sapiens,9606.0,,,CHO,,108,D,9,Expert,1,,CHEMBL617883,449.0,BAO_0000219,,
2944,4176,Functional agonist activity of compound was determined by fluorescence-based assay measuring intracellular calcium mobilization for 5-HT2c receptor cell line,F,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617884,,BAO_0000219,,
2945,6347,Agonistic binding efficacy against human 5-hydroxytryptamine 2C receptor in CHO cells using [125I]- DOI radioligand,B,,,,,,,CHO,,108,H,8,Autocuration,1,,CHEMBL617885,449.0,BAO_0000219,,
2946,6347,"Agonistic binding affinity against human 5-hydroxytryptamine 2C receptor in CHO cells using [125I]- DOI radioligand, expressed as Emax",B,,,,,,,CHO,,108,H,8,Autocuration,1,,CHEMBL617886,449.0,BAO_0000219,,
2947,16146,Inhibition of human 5-hydroxytryptamine 2C receptor,B,,,Homo sapiens,9606.0,,,,,108,D,9,Expert,1,,CHEMBL617887,,BAO_0000357,,
2948,3805,In vitro binding affinity against human 5-hydroxytryptamine 2C receptor at a concentration of 100 (nM),B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617888,,BAO_0000357,,
2949,3857,Inhibitory activity using [3H]mesulergine as radioligand with receptor membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor at a concentration of 1 uM,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617889,,BAO_0000019,,
2950,5635,Intrinsic efficacy against 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617890,,BAO_0000357,,
2951,5635,Intrinsic efficacy against 5-hydroxytryptamine 2C receptor Intrinsic efficacy against 5-hydroxytryptamine 2C receptor; Intrinsic efficacy (%) not determined,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617891,,BAO_0000357,,
2952,5635,Intrinsic efficacy against 5-hydroxytryptamine 2C receptor; Intrinsic efficacy (%) not determined,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617892,,BAO_0000357,,
2953,4012,Displacement of [H]-mesulergine from CHO cells expressing human 5-hydroxytryptamine 2C receptor.,B,,,,,,,CHO,,108,H,8,Expert,1,,CHEMBL617893,449.0,BAO_0000219,,
2954,6366,Ability to displace [3H]- mesulergine from human cloned 5-hydroxytryptamine 2C receptor expressed in CHO cells,B,,,,,,,CHO,,108,H,8,Expert,1,,CHEMBL617894,449.0,BAO_0000219,,
2955,15949,Ability to displace [3H]mesulergine binding to human 5-hydroxytryptamine 2C receptor stably expressed in CHO cells,B,,,,,,,CHO,,108,H,8,Expert,1,,CHEMBL617895,449.0,BAO_0000219,,
2956,17211,Ability to displace [3H]mesulergine (0.5 nM) from CHO cells of human 5-hydroxytryptamine 2C receptor,B,,,,,,,CHO,,108,H,8,Autocuration,1,,CHEMBL617896,449.0,BAO_0000219,,
2957,6491,Affinity towards human 5-hydroxytryptamine 2C serotonin receptor,B,,,Homo sapiens,9606.0,,,,,108,D,9,Expert,1,,CHEMBL617897,,BAO_0000357,,
2958,14093,Agonist activity at cloned human 5-hydroxytryptamine 2C receptor using [125I]DOI radioligand,F,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617898,,BAO_0000019,,
2959,13481,Agonistic activity at cloned human 5-hydroxytryptamine 2C receptor using [125I]DOI as radioligand,F,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617899,,BAO_0000019,,
2960,6347,Agonistic binding affinity against human 5-hydroxytryptamine 2C receptor in CHO cells using [125I]- DOI ,B,,,Rattus norvegicus,10116.0,,,CHO,,108,H,8,Expert,1,,CHEMBL617900,449.0,BAO_0000219,,
2961,14093,Antagonist activity at cloned human 5-hydroxytryptamine 2C receptor using [3H]mesulergine radioligand,F,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617901,,BAO_0000019,,
2962,14093,Antagonist activity at cloned human 5-hydroxytryptamine 2C receptor using [3H]mesulergine radioligand; Not tested,F,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617902,,BAO_0000019,,
2963,13481,Antagonistic activity at cloned human 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,F,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617903,,BAO_0000019,,
2964,14442,Binding ability of compound at cloned human 5-hydroxytryptamine 2C receptor using [125 I]DOI as radioligand,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617904,,BAO_0000357,,
2965,14442,Binding ability of compound at cloned human 5-hydroxytryptamine 2C receptor using [3H]- mesulergine as radioligand,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617905,,BAO_0000357,,
2966,14442,Binding ability of compound at cloned human 5-hydroxytryptamine 2C receptor using [3H]- mesulergine as radioligand;not tested,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617906,,BAO_0000357,,
2967,14755,Binding activity against cloned human 5-hydroxytryptamine 2C receptor using [125I]DOI as the radioligand.,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617907,,BAO_0000357,,
2968,14744,Binding affinity against the cloned human 5-hydroxytryptamine 2C receptor using [125I]DOI as the radioligand,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL617908,,BAO_0000357,,
2969,16659,Binding affinity for displacement of [3H]mesulergine to human 5-hydroxytryptamine 2C receptor stably expressed in CHO cells,B,,,,,,,CHO,,108,H,8,Expert,1,,CHEMBL620617,449.0,BAO_0000219,,
2970,6857,Affinity for human 5-hydroxytryptamine 2C receptor expressed in mammalian cell line,B,,,Homo sapiens,9606.0,,,,,108,D,9,Expert,1,,CHEMBL620618,,BAO_0000019,,
2971,5635,Binding affinity against 5-hydroxytryptamine 2C receptor using [125I]DOI radioligand.,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL620619,,BAO_0000357,,
2972,4234,Binding affinity to cloned human 5-hydroxytryptamine 2C receptor,B,,,Homo sapiens,9606.0,,,,,108,D,9,Expert,1,,CHEMBL620620,,BAO_0000357,,
2973,16209,Binding affinity towards human 5-HT2C receptor was determined using [125I]- DOI as radioligand,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL620621,,BAO_0000357,,
2974,5778,Binding affinity for 5-HT3 receptor by displacement of [3H]-LY 278584 in rat cerebral cortex membranes,B,,,Rattus norvegicus,10116.0,,,,Membranes,104698,D,7,Autocuration,1,,CHEMBL872920,,BAO_0000249,,
2975,5094,Binding affinity towards rat 5-hydroxytryptamine 3 receptor was evaluated,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620622,,BAO_0000223,,
2976,809,Binding affinity against 5-hydroxytryptamine 3 receptor using [3H]BRL-43694 in rat posterior cortex,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL620623,,BAO_0000019,,
2977,1578,Binding affinity against 5-hydroxytryptamine 3 receptor using [3H]BRL-43694 as radioligand in rat posterior cortex,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620624,,BAO_0000019,,
2978,809,Binding affinity against 5-hydroxytryptamine 3 receptor using [3H]BRL-43694 as radioligand in rat posterior cortex; Not tested,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620625,,BAO_0000019,,
2979,12469,Binding affinity was measured on 5-hydroxytryptamine 3 receptor in NG-108 cells labeled with [3H]GR-65630,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620626,,BAO_0000219,,
2980,14290,Binding affinity was measured on 5-hydroxytryptamine 3 receptor using [3H]-BRL 43694 as radioligand in rat posterior cortex,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL621307,,BAO_0000019,,
2981,14290,Binding affinity was measured on 5-hydroxytryptamine 3 receptor using [3H]-BRL 43694 as radioligand in rat posterior cortex.,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL621308,,BAO_0000019,,
2982,10609,Binding affinity for central 5-hydroxytryptamine 3 receptor was determined by displacement of [3H]-5-HT,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL621309,,BAO_0000223,,
2983,10609,Binding affinity for central 5-hydroxytryptamine 3 receptor was determined by displacement of [3H]GR-65630,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL621310,,BAO_0000223,,
2984,10609,Binding affinity for central 5-hydroxytryptamine 3 receptor was determined by displacement of [3H]-ketanserin,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL621311,,BAO_0000223,,
2985,15253,"Compound was evaluated for its in vitro affinity at serotonergic 5-hydroxytryptamine 3 receptor by radioligand binding assay, using [3H]-LY 278584 in rat cerebral cortex membranes.",B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL621502,,BAO_0000249,,
2986,15253,"In vitro affinity at serotonergic 5-hydroxytryptamine 3 receptor by radioligand binding assay, using [3H]-LY 278584 in rat cerebral cortex membranes.",B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL621503,,BAO_0000249,,
2987,11683,Displacement of the 5-hydroxytryptamine 3 receptor ligand [3H]GR-65630 from rat brain cortical membranes.,B,,,,,,,,Membranes,104698,H,6,Autocuration,1,,CHEMBL621504,,BAO_0000249,,
2988,12092,Compound was evaluated for binding affinity against 5-hydroxytryptamine 3 receptor,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL621505,,BAO_0000223,,
2989,1946,Binding affinity at 5-hydroxytryptamine 3 receptor in rat entorhinal cortex by [3H]BRL-43694 displacement.,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL621506,,BAO_0000019,,
2990,11623,Ability to displace [3H]quipazine binding to 5-hydroxytryptamine 3 receptor sites in NG 108-15.,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619781,,BAO_0000223,,
2991,11623,Compound was evaluated for its ability to displace [3H]quipazine binding to 5-hydroxytryptamine 3 receptor sites in NG 108-15. ,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619782,,BAO_0000223,,
2992,14788,Compound was evaluated for its binding affinity for 5-hydroxytryptamine 3 receptor by measuring displacement [3H]GR-65630 in rat cerebral cortex,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619783,,BAO_0000019,,
2993,5432,Displacement of [3H]ketanserin from rat cortex 5-HT3 receptor,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL619784,,BAO_0000019,,
2994,14826,Ability to displace [3H]granisetron specifically bound to 5-hydroxytryptamine 3 receptor in rat cortical membrane,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619785,,BAO_0000249,,
2995,2222,Compound was tested for its binding affinity for the 5-hydroxytryptamine 3 receptor,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619786,,BAO_0000223,,
2996,11963,Displacement of binding of [3H]-BRL 43694 to 5-hydroxytryptamine 3 receptor in rat cerebral cortex,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619787,,BAO_0000019,,
2997,14145,In vitro affinity for 5-hydroxytryptamine 3 (5-HT3) receptor by displacement of [3H]BRL-43694 from rat entorhinal cortex,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL872925,,BAO_0000019,,
2998,17819,In vitro binding affinity at serotonin 5-hydroxytryptamine 3 receptor in rat cortex by [3H]granisetron displacement.,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619788,,BAO_0000019,,
2999,10394,Inhibitory activity against 5-hydroxytryptamine 3 receptor in rat cortical membranes using [3H]- 1-Methyl-1H-indazole-3-carboxylic acid (8-methyl-8-aza-bicyclo[3.2.1]oct-3-yl)-amide as a radioligand,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619789,,BAO_0000249,,
3000,10394,Inhibitory activity against 5-hydroxytryptamine 3 receptor in rat cortical membranes using [3H]-1-Methyl-1H-indazole-3-carboxylic acid (8-methyl-8-aza-bicyclo[3.2.1]oct-3-yl)-amide as a radioligand,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619790,,BAO_0000249,,
3001,15034,Inhibitory concentration against 5-hydroxytryptamine 3 receptor in rat entorhinal cortex using [3H]-LY 278584 as radioligand,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619791,,BAO_0000019,,
3002,691,Binding affinity at 5-hydroxytryptamine 3 receptor in rat entorhinal cortex by [3H]BRL-43694 displacement.,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619792,,BAO_0000019,,
3003,12092,Displacement of [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor in rat brain cortical membranes,B,,,,,,,,Membranes,104698,H,6,Autocuration,1,,CHEMBL619793,,BAO_0000249,,
3004,11752,Inhibition of [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL619794,,BAO_0000223,,
3005,11752,The ability to inhibit [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor in rat brain cortices,B,,,,,,Brain,,,104698,H,6,Autocuration,1,,CHEMBL619795,,BAO_0000221,955.0,
3006,301,Binding affinity at 5-hydroxytryptamine 3 receptor in rat posterior cortex by [3H]-BRL 43694 displacement.,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619796,,BAO_0000019,,
3007,16532,The binding affinity at 5-hydroxytryptamine 3 receptor was determined using [3H]LY-278584,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620448,,BAO_0000223,,
3008,16532,The binding affinity at 5-hydroxytryptamine 3 receptor was determined using [3H]LY-278584; Not tested,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620449,,BAO_0000223,,
3009,12092,The binding affinity was measured on 5-hydroxytryptamine 3 receptor using [3H]GR-65630 as radioligand.,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620450,,BAO_0000223,,
3010,11684,The compound was evaluated for the binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of radioligand [3H]GR-65630,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620451,,BAO_0000223,,
3011,11684,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of radioligand [3H]GR-65630.,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620631,,BAO_0000223,,
3012,12953,Binding affinity for 5-hydroxytryptamine 3 receptor from rat cortex using [3H]BRL-43694 as radioligand,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620632,,BAO_0000019,,
3013,12953,The compound was tested for its binding affinity towards 5-hydroxytryptamine 3 receptor from rat cortex using [3H]BRL-43694 as radioligand; NA means Not active,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620633,,BAO_0000019,,
3014,12953,The compound was tested for their binding affinity towards 5-hydroxytryptamine 3 receptor; Nonactive at 10 uM,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620634,,BAO_0000223,,
3015,12861,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand; NA Not Available,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620635,,BAO_0000019,,
3016,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg at 0.5 hours in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620636,,BAO_0000218,,
3017,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg at 1 hour in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620637,,BAO_0000218,,
3018,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg at 3 hours in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620638,,BAO_0000218,,
3019,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg at 6 hours in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620639,,BAO_0000218,,
3020,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 0.5 hours in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620640,,BAO_0000218,,
3021,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 1 hour in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620641,,BAO_0000218,,
3022,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 16 hours in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620642,,BAO_0000218,,
3023,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 3 hours in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620643,,BAO_0000218,,
3024,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 6 hours in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620644,,BAO_0000218,,
3025,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.3 mg/kg at 0.5 hours in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620645,,BAO_0000218,,
3026,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.3 mg/kg at 1 hour in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620646,,BAO_0000218,,
3027,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.3 mg/kg at 3 hours in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620647,,BAO_0000218,,
3028,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.3 mg/kg at 6 hours in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620648,,BAO_0000218,,
3029,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1 mg/kg at 0.5 hours in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620649,,BAO_0000218,,
3030,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1 mg/kg at 3 hours in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620650,,BAO_0000218,,
3031,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 10 mg/kg at 1 hour in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620651,,BAO_0000218,,
3032,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 10 mg/kg at 3 hours in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL872875,,BAO_0000218,,
3033,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1 mg/kg at 1 hour in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620652,,BAO_0000218,,
3034,10609,5-hydroxytryptamine 3 receptor antagonist activity was confirmed by its ability to antagonize 5-HT evoked tachycardia of rabbit isolated heart,F,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620653,,BAO_0000019,,
3035,12861,Binding activity against 5-hydroxytryptamine 2A receptor from rat cortex homogenates using [3H]DOB as radioligand.,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL857076,,BAO_0000019,,
3036,12861,Inhibition of [3H]-Q-ICS 205-930 binding to rat cortex homogenate 5-hydroxytryptamine 3 receptor,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL620654,,BAO_0000019,,
3037,12861,Binding activity radioligand.,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620655,,BAO_0000223,,
3038,10728,Compound was evaluated for the displacement of [3H]-Q-ICS 205-930 binding to 5-hydroxytryptamine 3 receptor in rat brain membranes,B,,,,,,,,Brain membranes,104698,H,6,Autocuration,1,,CHEMBL620656,,BAO_0000249,,
3039,10728,Displacement of [3H]-Q-ICS 205-930 binding to 5-hydroxytryptamine 3 receptor recognition sites in rat brain membranes.,B,,,,,,,,Brain membranes,104698,H,6,Autocuration,1,,CHEMBL620657,,BAO_0000249,,
3040,5163,Binding affinity towards 5-hydroxytryptamine 2C receptor was determined at a concentration of 0.000001 mol/L,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL620658,,BAO_0000357,,
3041,5163,Binding affinity towards 5-hydroxytryptamine 2C receptor was determined at a concentration of 0.00001 mol/L,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL620659,,BAO_0000357,,
3042,6011,Inhibition of binding towards 5-hydroxytryptamine 2C receptor at 100 nM concentration,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL620660,,BAO_0000357,,
3043,5014,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL620661,,BAO_0000357,,
3044,5635,Binding affinity of compound towards 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL620662,,BAO_0000357,,
3045,5163,Affinity for 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL620663,,BAO_0000357,,
3046,6841,Binding affinity towards 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL620664,,BAO_0000357,,
3047,6119,Binding affinity towards 5-hydroxytryptamine 2C receptor using [125I]DOI as radioligand.,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL620665,,BAO_0000357,,
3048,4373,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 2C receptor was determined,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL620666,,BAO_0000357,,
3049,1633,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 2C receptor by displacement of [3H]-Ketanserin,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL620667,,BAO_0000357,,
3050,1633,Binding affinity towards 5-hydroxytryptamine 2C receptor by displacement of [3H]N-methyl-mesulergine,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL620668,,BAO_0000357,,
3051,4373,Binding affinity for 5-hydroxytryptamine 2C receptor was determined,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL620669,,BAO_0000357,,
3052,6576,Binding affinity towards serotonin 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL620670,,BAO_0000357,,
3053,4687,Evaluated for the binding affinity to 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL620671,,BAO_0000357,,
3054,12146,Tested agains t5-hydroxytryptamine 2C receptor in experiment 1,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL620672,,BAO_0000357,,
3055,12146,Tested against 5-hydroxytryptamine 2C receptor in experiment 2,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL620673,,BAO_0000357,,
3056,16946,Ability to displace [3H]mesulergine from 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL620674,,BAO_0000357,,
3057,14159,Compound was evaluated for the affinity at 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL620675,,BAO_0000357,,
3058,16700,The binding affinity towards 5-hydroxytryptamine 2C receptor; No affinity,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL620676,,BAO_0000357,,
3059,3269,Affinity against 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL621382,,BAO_0000357,,
3060,1274,Binding affinity against 5-hydroxytryptamine 2C receptor,B,,,Homo sapiens,9606.0,,,,,108,D,9,Expert,1,,CHEMBL621383,,BAO_0000357,,
3061,1317,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2C receptor using radioligand binding assay,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL621384,,BAO_0000357,,
3062,5834,Inhibitory concentration required against 5-HT3 receptor in bovine area postrema using [3H]GR-65630,B,,,Bos taurus,9913.0,,,,,144,H,8,Autocuration,1,,CHEMBL621385,,BAO_0000357,,
3063,11147,Binding affinity towards 5-hydroxytryptamine 3 receptor using [3H]GR-65630 as radioligand,B,,,Bos taurus,9913.0,,,,,144,H,8,Autocuration,1,,CHEMBL617989,,BAO_0000357,,
3064,14145,Antagonistic potency against serotonin 5-hydroxytryptamine 3 receptor in GPI assay,F,,,Cavia porcellus,10141.0,,,,,104714,H,4,Expert,1,,CHEMBL617990,,BAO_0000019,,
3065,10561,Binding affinity to 5-hydroxytryptamine 3 receptor entirely in guinea pig ileum,B,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL875085,,BAO_0000221,2116.0,
3066,15847,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 3 receptor of guinea pig,F,,,Cavia porcellus,10141.0,,,,,104714,H,4,Autocuration,1,,CHEMBL617991,,BAO_0000019,,
3067,15847,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 3 receptor of guinea pig; ND means not done,F,,,Cavia porcellus,10141.0,,,,,104714,H,4,Autocuration,1,,CHEMBL617992,,BAO_0000019,,
3068,10561,Potency to 5-hydroxytryptamine 3 receptor entirely in guinea pig ileum,B,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617993,,BAO_0000221,2116.0,
3069,11454,In vitro binding affinity was measured for 5-hydroxytryptamine 3 receptor in the guinea pig ileum.,B,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617994,,BAO_0000221,2116.0,
3070,4639,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea colon at a concentration 0.01 uM,F,,,Cavia porcellus,10141.0,,,,,104714,H,4,Autocuration,1,,CHEMBL617995,,BAO_0000019,,
3071,4639,Percent of control response to 5-HT3 agonistic activity on guinea colon at a concentration 0.1 uM,F,,,Cavia porcellus,10141.0,,,,,104714,H,4,Autocuration,1,,CHEMBL617996,,BAO_0000019,,
3072,4639,Percent of control response to 5-HT3 agonistic activity on guinea colon at a concentration 1 uM,F,,,Cavia porcellus,10141.0,,,,,104714,H,4,Autocuration,1,,CHEMBL617997,,BAO_0000019,,
3073,4639,Percent of control response to 5-HT3 agonistic activity on guinea colon at a concentration 1 uM in the presence of 30 uM MDL 72222,F,,,Cavia porcellus,10141.0,,,,,104714,H,4,Autocuration,1,,CHEMBL617998,,BAO_0000019,,
3074,4639,Percent of control response to 5-HT3 antagonistic activity on guinea colon at a concentration 0.01 uM,F,,,Cavia porcellus,10141.0,,,,,104714,H,4,Autocuration,1,,CHEMBL617999,,BAO_0000019,,
3075,4639,Percent of control response to 5-HT3 antagonistic activity on guinea colon at a concentration 1 uM,F,,,Cavia porcellus,10141.0,,,,,104714,H,4,Autocuration,1,,CHEMBL618000,,BAO_0000019,,
3076,15253,"Concentration required to produce 50% of maximal contraction induced by 5-HT through 5-HT3 receptors in the presence of the compound, in isolated guinea pig ileum",F,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617815,,BAO_0000221,2116.0,
3077,15253,"Concentration required to produce 50% of maximal contraction induced by 5-HT through 5-HT3 receptors in the presence of the compound, in isolated guinea pig ileum.",F,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617816,,BAO_0000221,2116.0,
3078,11963,Tested for the antagonistic activity against 5-hydroxytryptamine 3 receptor from guinea pig ileum,F,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617817,,BAO_0000221,2116.0,
3079,1946,In vitro 5-hydroxytryptamine 3 receptor activity in guinea pig ileum,B,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617818,,BAO_0000221,2116.0,
3080,1946,In vitro 5-hydroxytryptamine 3 receptor activity in guinea pig ileum; Not tested,B,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617819,,BAO_0000221,2116.0,
3081,12045,Binding affinity towards [3H]quipazine labeled 5-hydroxytryptamine 3 receptor sites in HG108-15,B,,,Cavia porcellus,10141.0,,,,,104714,H,4,Autocuration,1,,CHEMBL617820,,BAO_0000223,,
3082,1559,Binding affinity against 5-hydroxytryptamine 3 receptor of guinea pig ileum,B,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617821,,BAO_0000221,2116.0,
3083,273,Evaluated for the antagonistic activity against 5-hydroxytryptamine 3 receptor in isolated guinea pig ileum (GPI),F,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617822,,BAO_0000221,2116.0,
3084,273,Antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor of isolated guinea pig ileum (GPI),F,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617823,,BAO_0000221,2116.0,
3085,188,Tested for antagonistic activity on 5-hydroxytryptamine 3 receptor mediated effects of 5-HT in guinea pig isolated ileum,F,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617824,,BAO_0000221,2116.0,
3086,12919,Agonistic activity against 5-hydroxytryptamine 3 receptor in guinea pig ileum assay,F,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617825,,BAO_0000221,2116.0,
3087,12918,5-hydroxytryptamine 3 receptor agonism in the guinea pig ileum by functional 5-HT3 receptor assay,F,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617826,,BAO_0000221,2116.0,
3088,1559,Binding affinity against 5-hydroxytryptamine 3 receptor of guinea pig ileum,B,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617827,,BAO_0000221,2116.0,
3089,273,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated guinea pig ileum (GPI),F,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617828,,BAO_0000221,2116.0,
3090,1559,Binding affinity against 5-hydroxytryptamine 3 receptor of guinea pig ileum,B,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617829,,BAO_0000221,2116.0,
3091,1559,Binding affinity against 5-hydroxytryptamine 3 receptor of guinea pig ileum; Not determined,B,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617830,,BAO_0000221,2116.0,
3092,1559,Binding affinity towards 5-hydroxytryptamine 3 receptor of guinea pig ileum; not determined,B,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617831,,BAO_0000221,2116.0,
3093,14424,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor in guinea pig ileum.,B,,,Cavia porcellus,10141.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617832,,BAO_0000221,2116.0,
3094,13181,Binding affinity was determined against 5-hydroxytryptamine 2A receptor,B,,,Cavia porcellus,10141.0,,,,,22226,U,0,Autocuration,1,,CHEMBL617833,,BAO_0000019,,
3095,5486,Binding affinity towards 5-HT1A receptor by the displacement of [3H]-8-OH-DPAT] in human recombinant receptors in mammalian cell,B,,,,,,,,,51,H,8,Autocuration,1,,CHEMBL617834,,BAO_0000357,,
3096,6491,Affinity towards human 5-hydroxytryptamine 3 serotonin receptor,B,,,Homo sapiens,9606.0,,,,,104714,D,5,Expert,1,,CHEMBL617835,,BAO_0000223,,
3097,6013,Binding affinity towards 5-HT3 receptor,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL617836,,BAO_0000223,,
3098,12861,Binding activity radioligand.,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL617837,,BAO_0000223,,
3099,12861,Binding activity against 5-hydroxytryptamine 1A receptor from human brain cortex using [3H]8-OH-DPAT-HT as radioligand.,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL620392,,BAO_0000019,,
3100,5104,Binding affinity for human cloned 5-hydroxytryptamine 3 receptor,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL620393,,BAO_0000223,,
3101,5105,Binding affinity for human cloned 5-hydroxytryptamine 3 receptor,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL620394,,BAO_0000223,,
3102,5104,Binding affinity for human cloned 5-hydroxytryptamine 3 receptor; NT means Not tested,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL620395,,BAO_0000223,,
3103,3935,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 3 receptor,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL620396,,BAO_0000019,,
3104,13657,Displacement of [3H]-BRC 36694 from 5-hydroxytryptamine 3 receptor in NG108-15 cells,B,,,,,,,NG108-15,,105030,H,4,Expert,1,,CHEMBL620582,433.0,BAO_0000219,,
3105,10369,"Percent inhibition of [3H]5 binding to 5-hydroxytryptamine 3 receptor was evaluated by injection of compound (75 microCi/kg, 1.32 ug/kg) into the tail vein of mice (in vivo)",B,In vivo,,,,,,,,105030,H,4,Autocuration,1,,CHEMBL620583,,BAO_0000218,,
3106,10369,The binding affinity was measured for 5-hydroxytryptamine 3 receptor on NG 108-15 cell line of mouse neuroblastoma-glioma cells in presence of [3H]5 radioligand (in vitro),B,,,,,,,,,105030,H,4,Autocuration,1,,CHEMBL620584,,BAO_0000019,,
3107,12918,Compound was evaluated for the binding affinity at 5- HT3 receptor subtype,B,,,,,,,,,105030,H,4,Autocuration,1,,CHEMBL620585,,BAO_0000224,,
3108,12918,Compound was evaluated for the binding affinity at 5- HT3 receptor,B,,,,,,,,,105030,H,4,Autocuration,1,,CHEMBL620586,,BAO_0000224,,
3109,10369,The binding affinity was measured for 5-hydroxytryptamine 3 receptor on NG 108-15 cell line of mouse neuroblastoma-glioma cells in presence of [3H]5 radioligand (in vitro),B,,,,,,,,,105030,H,4,Autocuration,1,,CHEMBL620587,,BAO_0000019,,
3110,773,In Vitro Binding affinity againist 5-hydroxytryptamine 3 receptor by displacing [3H]-Q-ICS 205-930 from rat cortex homogenates,B,,,,,,,,,105030,H,4,Autocuration,1,,CHEMBL620588,,BAO_0000019,,
3111,12918,5-hydroxytryptamine 3 receptor agonism in mouse,F,,,,,,,,,105030,H,4,Autocuration,1,,CHEMBL620589,,BAO_0000218,,
3112,10561,Binding affinity towards 5-hydroxytryptamine 3 receptor was determined by using [3H]-ICS 205-930 as radioligand in mouse N1E 115 cells,B,,,,,,,,,105030,H,4,Autocuration,1,,CHEMBL620590,,BAO_0000219,,
3113,12827,Binding affinity towards 5-hydroxytryptamine 2A receptor in rat cortex preparations using [3H]ketanserin,B,,,,,,,,,105030,H,4,Autocuration,1,,CHEMBL617956,,BAO_0000019,,
3114,12827,Binding affinity towards 5-hydroxytryptamine 2A receptor in rat cortex preparations using [3H]ketanserin,B,,,,,,,,,105030,H,4,Autocuration,1,,CHEMBL617957,,BAO_0000019,,
3115,12918,Binding affinity was evaluated by 5-hydroxytryptamine 3 receptor agonism in the mouse NIE-115 by displacing tropisetron,B,,,,,,,,,105030,H,4,Autocuration,1,,CHEMBL617958,,BAO_0000224,,
3116,273,Compound was evaluated for binding to 5-hydroxytryptamine 3 receptor in N1E cells using [3H]- -Tropisetron as radioligand,B,,,,,,,,,105030,H,4,Autocuration,1,,CHEMBL617959,,BAO_0000219,,
3117,273,Compound was evaluated for binding to Serotonin 5-hydroxytryptamine 3 receptor in N1E cells using [3H]- -Tropisetron as radioligand,B,,,,,,,,,105030,H,4,Autocuration,1,,CHEMBL617960,,BAO_0000219,,
3118,10561,Potency at neuronal 5-hydroxytryptamine 3 receptor in the rabbit heart,B,,,,,,,,,105030,H,4,Autocuration,1,,CHEMBL617961,,BAO_0000224,,
3119,5033,Ability to displace the radioligand [3H]GR-65630 from 5-hydroxytryptamine 3 receptor expressed in NIE-115 cells,B,In vitro,,,,,,,,105030,H,4,Autocuration,1,,CHEMBL617962,,BAO_0000219,,
3120,16429,In vitro binding affinity at 5-hydroxytryptamine 3 receptor in N1E-115 cells using 3[H]GR-65630 as the radioligand,B,,,,,,,N1E-115,,105030,H,4,Autocuration,1,,CHEMBL617963,339.0,BAO_0000219,,
3121,10322,In vitro binding affinity for the 5-hydroxytryptamine 3 receptor was determined with NG-108-15 mouse neuroblastoma-glioma cells,B,,,,,,,,,11765,H,8,Autocuration,1,,CHEMBL617964,,BAO_0000019,,
3122,14331,Inhibition of [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor in NG cells 108-15,B,,,,,,,,,11765,H,8,Autocuration,1,,CHEMBL617965,,BAO_0000219,,
3123,13462,Compound was tested for the Binding affinity against N1e-115 neuroblastoma 5-hydroxytryptamine 3 receptor by Radio ligand [3H]GR-65630 binding assay.,B,,,Mus musculus,10090.0,,,,,10630,D,9,Autocuration,1,,CHEMBL617966,,BAO_0000357,,
3124,12861,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand.,B,,,,,,,,,17106,H,8,Autocuration,1,,CHEMBL857074,,BAO_0000019,,
3125,15086,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor,B,,,Sus scrofa,9823.0,,,,,144,H,8,Autocuration,1,,CHEMBL617967,,BAO_0000357,,
3126,12861,Binding activity radioligand.,B,,,Sus scrofa,9823.0,,,,,144,H,8,Autocuration,1,,CHEMBL617968,,BAO_0000357,,
3127,10561,Binding affinity to 5-hydroxytryptamine 3 receptor of neuronal in the afferent rabbit vagus,B,,,Oryctolagus cuniculus,9986.0,,,,,104714,H,4,Autocuration,1,,CHEMBL617969,,BAO_0000223,,
3128,10561,Potency at neuronal 5-hydroxytryptamine 3 receptor in the rabbit heart,B,,,Oryctolagus cuniculus,9986.0,,,,,104714,H,4,Autocuration,1,,CHEMBL617970,,BAO_0000223,,
3129,10561,Potency at neuronal 5-hydroxytryptamine 3 receptors in the rabbit heart,B,,,Oryctolagus cuniculus,9986.0,,,,,104714,H,4,Autocuration,1,,CHEMBL617971,,BAO_0000223,,
3130,10561,Potency to 5-hydroxytryptamine 3 receptor using [3H]GR-65630 as radioligand in rat cortex,B,,,Oryctolagus cuniculus,9986.0,,,,,104714,H,4,Autocuration,1,,CHEMBL617972,,BAO_0000019,,
3131,273,Evaluated for the antagonistic activity against 5-hydroxytryptamine 3 receptor in isolated perfused rabbit heart (RH),F,,,Oryctolagus cuniculus,9986.0,,,,,104714,H,4,Autocuration,1,,CHEMBL617973,,BAO_0000019,,
3132,273,Evaluated for the antagonistic activity against 5-hydroxytryptamine 3 receptor in isolated rabbit vagus nerve (RVN),F,,,Oryctolagus cuniculus,9986.0,,,,,104714,H,4,Autocuration,1,,CHEMBL617974,,BAO_0000019,,
3133,273,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated guinea pig ileum (GPI),F,,,Oryctolagus cuniculus,9986.0,,Ileum,,,104714,H,4,Autocuration,1,,CHEMBL617975,,BAO_0000221,2116.0,
3134,273,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated perfused rabbit heart (RH),F,,,Oryctolagus cuniculus,9986.0,,,,,104714,H,4,Autocuration,1,,CHEMBL617976,,BAO_0000019,,
3135,273,Antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated rabbit vagus nerve (RVN),F,,,Oryctolagus cuniculus,9986.0,,,,,104714,H,4,Autocuration,1,,CHEMBL617977,,BAO_0000019,,
3136,273,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated perfused rabbit heart (RH),F,,,Oryctolagus cuniculus,9986.0,,,,,104714,H,4,Autocuration,1,,CHEMBL617978,,BAO_0000019,,
3137,273,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated rabbit vagus nerve (RVN),F,,,Oryctolagus cuniculus,9986.0,,,,,104714,H,4,Autocuration,1,,CHEMBL617979,,BAO_0000019,,
3138,13047,Binding affinity against 5-hydroxytryptamine 3 receptor in CHO cells using [3H]5-HT as radioligand,B,,,Oryctolagus cuniculus,9986.0,,,CHO,,104714,H,4,Autocuration,1,,CHEMBL617980,449.0,BAO_0000219,,
3139,1650,In vitro displacement of [3H]-LY 278584 from rat cerebral cortex 5-hydroxytryptamine 3 receptor,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL617981,,BAO_0000019,,
3140,16288,Affinity at 5-hydroxytryptamine 3 receptor from rat frontal cortex using [3H]granisetron as radioligand (For granisetron = Ki(nM)=0.3+/-0.01),B,,,,,,,,,12020,H,8,Autocuration,1,,CHEMBL617982,,BAO_0000019,,
3141,16288,Affinity at 5-hydroxytryptamine 3 receptor (For granisetron = Ki (nM)=0.3+/-0.01),B,,,,,,,,,12020,H,8,Autocuration,1,,CHEMBL617983,,BAO_0000357,,
3142,10254,In vitro displacement of [3H]ICS-205-930 from 5-hydroxytryptamine 3 receptor in cultured NG-108-15 rat glioma cells,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL617984,,BAO_0000019,,
3143,14532,"Binding affinity for 5-hydroxytryptamine 3 receptor in rat cerebral cortex, determined by displacement of [3H]GR-65630",B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617985,,BAO_0000019,,
3144,13392,"5-Hydroxy tryptamine 3 receptor showing agonist activity (in vivo) in Von Bezold-Jarisch Reflex in rats at 120 (ug/kg), evaluated as change in heart rate",F,In vivo,,,,,Heart,,,104698,H,6,Autocuration,1,,CHEMBL617986,,BAO_0000218,948.0,
3145,13392,"Agonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 100 (ug/kg), evaluated as change in heart rate",F,,,,,,Heart,,,104698,H,6,Autocuration,1,,CHEMBL617987,,BAO_0000019,948.0,
3146,13392,"Agonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 120 (ug/kg), evaluated as change in heart rate",F,,,,,,Heart,,,104698,H,6,Autocuration,1,,CHEMBL617988,,BAO_0000019,948.0,
3147,13392,"Agonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 60 (ug/kg), evaluated as change in heart rate",F,,,,,,Heart,,,104698,H,6,Autocuration,1,,CHEMBL617792,,BAO_0000019,948.0,
3148,13392,"Agonistic activity of compound towards 5-hydroxytryptamine 3 receptorr in Von Bezold-Jarisch Reflex in rats at 100 (ug/kg), evaluated as change in heart rate",F,,,,,,Heart,,,104698,H,6,Autocuration,1,,CHEMBL617793,,BAO_0000019,948.0,
3149,13392,"Antagonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 100(ug/kg), evaluated as percent inhibition of bradycardia",F,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617794,,BAO_0000019,,
3150,13392,"Antagonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 60 (ug/kg), evaluated as percent inhibition of bradycardia",F,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617795,,BAO_0000019,,
3151,13392,"Antagonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch reflex in rats at 60 (ug/kg), evaluated as percent inhibition of bradycardia",F,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617796,,BAO_0000019,,
3152,13392,"Antagonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch reflex in rats at 60(ug/kg), evaluated as percent inhibition of bradycardia",F,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617797,,BAO_0000019,,
3153,1089,Antagonism of 5-HT-induced Von Bezold-Jarisch reflex in rat after intravenous administration of 30 ug/kg of HT (5-hydroxytryptamine 3 receptor antagonism),F,In vivo,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL617798,,BAO_0000218,,
3154,1089,Ability to antagonise the 5-HT- induced Von Bezold-Jarisch reflex in the rat after intravenous administration of 30 ug/kg of HT (5-hydroxytryptamine 3 receptor),F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617799,,BAO_0000218,,
3155,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1000 ug/kg dose in urethane-anesthetized rats,F,In vivo,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL617800,,BAO_0000218,,
3156,11454,Inhibition of 5-HT-induced bradycardia by 5-hydroxytryptamine 3+,F,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL617801,,BAO_0000019,,
3157,12205,In vivo inhibitory concentration after 5 minutes against 5-hydroxytryptamine 3 receptor induced bradycardia [bezold-jarisch (B-J) reflex test] in rat by intravenous administration,F,In vivo,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL617802,,BAO_0000218,,
3158,1089,Inhibition of 5-HT (1 ug/mL) induced depolarization in rat vagus nerve (5-hydroxytryptamine 3 receptor antagonism),F,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL617803,,BAO_0000019,,
3159,5094,Binding affinity towards 5-HT3 receptor in rat was evaluated,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617804,,BAO_0000019,,
3160,2622,Inhibition of [3H]GR-65630 binding to rat cortical membrane 5-hydroxytryptamine 3 receptor,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL617805,,BAO_0000019,,
3161,245,Binding affinity was evaluated in vitro by displacement of [3H]zacopride radioligand from 5-hydroxytryptamine 3 receptor,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617806,,BAO_0000223,,
3162,14788,Compound was evaluated for its binding affinity for 5-hydroxytryptamine 3 receptor by measuring displacement [3H]GR-65630 in rat cerebral cortex.,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617807,,BAO_0000019,,
3163,14788,Compound was evaluated for its binding affinity for 5-hydroxytryptamine 3 receptor by measuring displacement of [3H]granisetron from rat cerebral cortex,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617808,,BAO_0000019,,
3164,3020,Binding affinity against 5-hydroxytryptamine 3 receptor in rat cortical membrane using [3H]GR-65630 as radioligand,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617809,,BAO_0000249,,
3165,1742,Compound was tested for its ability to displace [3H]-Q-ICS 205-930 from 5-hydroxytryptamine 3 receptor in rat cortex homogenates,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617810,,BAO_0000019,,
3166,17394,Concentration of compound required to inhibit the binding of radioligand [3H]GR-65630 to 5-hydroxytryptamine 3 receptor in rat brain cortical membrane,B,,,,,,Brain,,,104698,H,6,Autocuration,1,,CHEMBL617811,,BAO_0000249,955.0,
3167,17394,Concentration required to inhibit the binding of radioligand [3H]GR-65630 to serotonin 5-hydroxytryptamine-3 receptor (5-HT 3 receptor)in rat brain cortical membrane,B,,,,,,Brain,,,104698,H,6,Autocuration,1,,CHEMBL617812,,BAO_0000221,955.0,
3168,17394,Concentration of compound required to inhibit the binding of radioligand [3H]GR-65630 to serotonin 5-hydroxytryptamine 3 receptor in rat cortical membrane,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617813,,BAO_0000249,,
3169,14286,In vitro inhibitory concentration against radioligand [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor in rat cortical membrane,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617814,,BAO_0000249,,
3170,14178,Inhibition of [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor of rat cortical homogenate.,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617698,,BAO_0000019,,
3171,14178,Inhibition of [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor of rat cortical homogenate; Not active at 10000 nm,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL617699,,BAO_0000019,,
3172,14178,Inhibition of [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor of rat cortical homogenate; not active at 10000 nM,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL617700,,BAO_0000019,,
3173,14178,Inhibition of radiolabeled [3H]-Zacopride ligand binding to 5-hydroxytryptamine 3 receptor,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL617701,,BAO_0000223,,
3174,15034,Inhibitory concentration against 5-hydroxytryptamine 3 receptor in rat entorhinal cortex using [3H]-LY 278584 as radioligand,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617702,,BAO_0000019,,
3175,1089,"Tested for inhibition of binding of [3H]GR-65630 to rat cortical membranes, expressed as IC50",B,,,,,,,,Membranes,104698,H,6,Autocuration,1,,CHEMBL617703,,BAO_0000249,,
3176,1089,Inhibition of [3H]GR-65630 binding to rat cortical membrane serotonin 3 receptor,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL617704,,BAO_0000019,,
3177,16532,The binding affinity at 5-hydroxytryptamine 3 receptor was determined using [3H]LY-278584; Not tested,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617705,,BAO_0000223,,
3178,12801,Inhibition of [3H]BRL-43694 binding to rat 5-hydroxytryptamine 3 receptor,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL617706,,BAO_0000223,,
3179,15194,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from NG108-15 cells (using [3H]zacopride as radioligand),B,,,,,,,NG108-15,,104698,H,6,Autocuration,1,,CHEMBL617707,433.0,BAO_0000219,,
3180,15194,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from NG108-15 cells using [3H]zacopride as radioligand,B,,,,,,,NG108-15,,104698,H,6,Autocuration,1,,CHEMBL617708,433.0,BAO_0000219,,
3181,15194,Binding affinity against 5-hydroxytryptamine 3 (5-HT3) receptor from rat cortical homogenate using [3H]zacopride as radioligand,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617709,,BAO_0000019,,
3182,15194,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from rat cortical homogenate using [3H]zacopride as radioligand; NA= Not active,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617710,,BAO_0000019,,
3183,15194,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from rat cortical homogenate using [3H]zacopride as radioligand; NA=Not active,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL882925,,BAO_0000019,,
3184,15194,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from rat cortical homogenate using [3H]zacopride as radioligand; not active,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617711,,BAO_0000019,,
3185,10610,Antagonist potency to 5-hydroxytryptamine 3 receptor was assayed by antagonism of the 5-HT-evoked reflex bradycardia [Bezold-Jarisch(BJ) reflex] in rats,F,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617712,,BAO_0000019,,
3186,10355,Antagonistic activity against 5-hydroxytryptamine 3 receptor as inhibition of 5-HT-induced bradycardia (von Bezold-jarisch reflex) in anesthetized rat,F,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL617713,,BAO_0000019,,
3187,691,"Compound was tested as a 5-hydroxytryptamine 3 receptor antagonist in the rat by assessment of the inhibition of the Bezold-Jarisch effect, when administered intravenously",F,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617714,,BAO_0000019,,
3188,10611,In vivo 5-hydroxytryptamine 3 receptor (5-HT 3 receptor) antagonistic activity expressed as ability to inhibit Bezold-Jarich reflex evoked by 5-HT in rats,F,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617715,,BAO_0000218,,
3189,12801,Inhibition dose for 50 percent antagonism for 5-hydroxytryptamine 3 receptor in vivo in rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617716,,BAO_0000218,,
3190,10609,Inhibition of 5-HT evoked reflex bradycardia in rat.,F,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617717,,BAO_0000218,,
3191,11454,5-HT3 receptor antagonistic activity was measured by the inhibition of 5-HT-induced bradycardia after iv administration of 1000 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617718,,BAO_0000218,,
3192,11454,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after iv administration of 1 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617719,,BAO_0000218,,
3193,11454,5-hydroxytryptamine 3 receptor antagonistic activity measured by inhibition of 5-HT-induced bradycardia (iv administration 10 ug/kg dose in urethane-anesthetized rats),F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617720,,BAO_0000218,,
3194,11454,5-hydroxytryptamine 3 receptor antagonistic activity as inhibition of 5-HT-induced bradycardia after iv administration of 100 ug/kg dose in urethane-anesthetized rats,F,In vivo,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL617721,,BAO_0000218,,
3195,11454,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after iv administration of 1000 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617722,,BAO_0000218,,
3196,11454,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after iv administration of 1000 ug/kgetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617723,,BAO_0000218,,
3197,11454,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after iv administration of 3 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617724,,BAO_0000218,,
3198,11454,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 10 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617725,,BAO_0000218,,
3199,11454,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 100 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617726,,BAO_0000218,,
3200,11454,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 1000 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617727,,BAO_0000218,,
3201,11454,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 30 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617728,,BAO_0000218,,
3202,11454,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 300 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617729,,BAO_0000218,,
3203,11454,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 3ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617730,,BAO_0000218,,
3204,11454,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5-HT-induced bradycardia after iv administration of 1000 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617731,,BAO_0000218,,
3205,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after intravenous administration of 0.3 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617732,,BAO_0000218,,
3206,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after intravenous administration of 1 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617733,,BAO_0000218,,
3207,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after intravenous administration of 30 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617734,,BAO_0000218,,
3208,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 0.05 hour,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL872874,,BAO_0000218,,
3209,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 1 hour,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617735,,BAO_0000218,,
3210,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 16 hour,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617736,,BAO_0000218,,
3211,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 3 hour,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617737,,BAO_0000218,,
3212,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 6 hour,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617738,,BAO_0000218,,
3213,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 10 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617739,,BAO_0000218,,
3214,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 100 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617740,,BAO_0000218,,
3215,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1000 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617741,,BAO_0000218,,
3216,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 10 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617742,,BAO_0000218,,
3217,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 3 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617743,,BAO_0000218,,
3218,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 30 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617744,,BAO_0000218,,
3219,11454,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 300 ug/kg dose in urethane-anesthetized rats,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617745,,BAO_0000218,,
3220,670,"In vivo 5-hydroxytryptamine 3 receptor antagonist activity by antagonism of the von Bezold-Jarisch (B-J) reflex in anesthetized rats, (i.v.)",F,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617746,,BAO_0000218,,
3221,670,"In vivo 5-hydroxytryptamine 3 receptor antagonist activity by antagonism of the von Bezold-Jarisch (B-J) reflex in anesthetized rats, (i.v.); Not tested",F,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617747,,BAO_0000218,,
3222,10321,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 10 ug/Kg,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL617748,,BAO_0000218,,
3223,10321,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 100 ug/Kg,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL618909,,BAO_0000218,,
3224,10321,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 2 ug/Kg,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL618910,,BAO_0000218,,
3225,10321,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 20 ug/Kg,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL618911,,BAO_0000218,,
3226,10321,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 5 ug/Kg,F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL618912,,BAO_0000218,,
3227,10322,Tested for inhibition of Bezold-Jarisch (B-J) reflex mediated by 5-hydroxytryptamine 3 receptor in rats after intravenous administration (2.0 ug/kg),F,In vivo,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL618913,,BAO_0000218,,
3228,15412,Intrinsic efficacy against 5-hydroxytryptamine 3 receptor; A means pure agonist,F,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL618914,,BAO_0000019,,
3229,15412,Intrinsic efficacy against 5-hydroxytryptamine 3 receptor; A means pure agonist,F,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL618915,,BAO_0000019,,
3230,15412,Intrinsic efficacy for rat 5-hydroxytryptamine 3 receptor,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL618916,,BAO_0000223,,
3231,15412,Intrinsic efficacy against 5-hydroxytryptamine 3 receptor; PA means partial agonist,F,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL618917,,BAO_0000019,,
3232,15412,Inhibition of [3H]granisetron binding to 5-hydroxytryptamine 3 receptor (5-HT 3 receptor) of rat cortex and hippocampus tissue,B,,,,,,Hippocampus,,,104698,D,7,Intermediate,1,,CHEMBL618918,,BAO_0000221,10000000.0,
3233,15412,Inhibition of [3H]granisetron binding to 5-hydroxytryptamine 3 receptor of rat cortical membrane,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL618919,,BAO_0000019,,
3234,17394,Inhibition of [3H]GR-65630 binding to rat cortical membrane serotonin 5-hydroxytryptamine 3 receptor,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL618920,,BAO_0000019,,
3235,12457,Affinity was evaluated as inhibition constant for serotonin 5-hydroxytryptamine 3 receptor,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL618921,,BAO_0000223,,
3236,12457,Affinity was evaluated by inhibition of [3H]GR-65630 binding to NG108-15 cell transfected with cloned rat 5-hydroxytryptamine 3 receptor,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL618922,,BAO_0000019,,
3237,12205,Binding affinity against radioligand [3H]quipazine labeled 5-hydroxytryptamine 3 receptor sites in neuroblastoma-glioma (NG108-15) cells.,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL618923,,BAO_0000019,,
3238,14532,Binding affinity for 5-hydroxytryptamine 3 receptor was determined by measuring displacement of [3H]GR-65630 from rat brain cortices,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL618924,,BAO_0000019,,
3239,1122,Binding affinity to 5-hydroxytryptamine 3 receptor in rat entorhinal cortex using [3H]-BRL 43694 as radioligand,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL618925,,BAO_0000019,,
3240,5094,Binding affinity towards 5-HT3 receptor in rat was evaluated,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL618926,,BAO_0000019,,
3241,809,5-hydroxytryptamine 4 receptor agonist activity as increased response to electrical stimulation in guinea pig ileum,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL618927,,BAO_0000221,2116.0,
3242,809,5-hydroxytryptamine 4 receptor agonist activity expressed as the concentration which gave a 50% increase in the response to the electrical stimulation in male guinea pig ileum; Not tested,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL618928,,BAO_0000221,2116.0,
3243,14290,"5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum",F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL618929,,BAO_0000221,2116.0,
3244,14290,"5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum; Inactive up to 10E-5 M",F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL618930,,BAO_0000221,2116.0,
3245,14290,"5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum; Not tested",F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL618931,,BAO_0000221,2116.0,
3246,14290,"5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum; Not tested",F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619594,,BAO_0000221,2116.0,
3247,14290,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Not capable of evaluation",F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619595,,BAO_0000221,2116.0,
3248,13961,concentration which gave a 50% increase in the response to electrical stimulation against 5-hydroxytryptamine 4 receptor in the guinea pig ileum.,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619596,,BAO_0000221,2116.0,
3249,13961,concentration which gave a 50% increase in the response to electrical stimulation against 5-hydroxytryptamine 4 receptor in the guinea pig ileum. Activity expressed as percent of the maximum 5-HT response given in brackets.,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619755,,BAO_0000221,2116.0,
3250,809,5-hydroxytryptamine 4 receptor antagonist activity expressed as the concentration which produced a 50% reduction of 5-HT induced contraction in guinea pig ileum,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619756,,BAO_0000221,2116.0,
3251,809,5-hydroxytryptamine 4 receptor antagonist activity expressed as the concentration which produced a 50% reduction of 5-HT induced contraction in guinea pig ileum; Not evaluable,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619757,,BAO_0000221,2116.0,
3252,809,5-hydroxytryptamine 4 receptor antagonist activity expressed as the concentration which produced a 50% reduction of 5-HT induced contraction in guinea pig ileum; Not tested,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619758,,BAO_0000221,2116.0,
3253,14290,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum",F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619759,,BAO_0000221,2116.0,
3254,14290,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Inactive up to 10-5 M",F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619760,,BAO_0000221,2116.0,
3255,14290,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Inactive up to 10E-5 M",F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619761,,BAO_0000221,2116.0,
3256,14290,5-hydroxytryptamine 4 receptor antagonist activity as inhibition of 5-HT-induced contractions in guinea pig ileum; Not capable of evaluation.,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619762,,BAO_0000221,2116.0,
3257,14290,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Not tested",F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619763,,BAO_0000221,2116.0,
3258,14290,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Not tested",F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL617868,,BAO_0000221,2116.0,
3259,15034,Displacement of [3H]GR-113808 from 5-hydroxytryptamine 4 receptor in guinea pig striatum,B,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL617869,,BAO_0000357,,
3260,5094,Binding affinity towards 5-HT4 receptor in striatum membranes of guinea-pig brain was evaluated,B,,,Cavia porcellus,10141.0,,Striatum,,,20033,D,9,Intermediate,1,,CHEMBL882926,,BAO_0000249,2435.0,
3261,5094,Binding affinity towards 5-hydroxytryptamine 4 receptor in striatum membranes of guinea-pig brain was evaluated,B,,,Cavia porcellus,10141.0,,Striatum,,,20033,D,9,Intermediate,1,,CHEMBL617870,,BAO_0000249,2435.0,
3262,5399,Inhibitory activity against 5-hydroxytryptamine 4 receptor of guinea pig striatum using [3H]GR-113808 as radioligand,B,,,Cavia porcellus,10141.0,,Striatum,,,20033,D,9,Intermediate,1,,CHEMBL617871,,BAO_0000357,2435.0,
3263,17394,Concentration of compound required to inhibit the binding of radioligand [3H]GR-113808 to 5-hydroxytryptamine 4 receptor in guinea pig striatum,B,,,Cavia porcellus,10141.0,,Striatum,,,20033,D,9,Intermediate,1,,CHEMBL617872,,BAO_0000357,2435.0,
3264,17394,Concentration of compound required to inhibit the binding of radioligand [3H]GR-113808 to 5-hydroxytryptamine 4 receptor in guinea-pig striatum,B,,,Cavia porcellus,10141.0,,Striatum,,,20033,D,9,Intermediate,1,,CHEMBL617873,,BAO_0000357,2435.0,
3265,17394,Concentration of compound required to inhibit the binding of radioligand [3H]GR-113808 to serotonin 5-hydroxytryptamine 4 receptor in guinea-pig striatum,B,,,Cavia porcellus,10141.0,,Striatum,,,20033,D,9,Intermediate,1,,CHEMBL617874,,BAO_0000357,2435.0,
3266,13961,The antagonist activity was calculated as the concentration which produced a 50% reduction against 5-hydroxytryptamine 4 receptor in guinea pig ileum.,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619067,,BAO_0000221,2116.0,
3267,13961,The antagonist activity was calculated as the concentration which produced a 50% reduction against 5-hydroxytryptamine 4 receptor in guinea pig ileum. 95% confidence limits are in brackets.,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619068,,BAO_0000221,2116.0,
3268,13961,The antagonist activity was calculated as the concentration which produced a 50% reduction against 5-hydroxytryptamine 4 receptor in guinea pig ileum;ne=not capable of evaluation.,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619069,,BAO_0000221,2116.0,
3269,16946,Ability to displace [3H]GR-113808 from 5-hydroxytryptamine 4 receptor at concentration of 10e-6 M in guinea pig,B,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619070,,BAO_0000357,,
3270,16946,Ability to displace [3H]GR-113808 from 5-hydroxytryptamine 4 receptor at concentration of 10e-8 M in guinea pig,B,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619071,,BAO_0000357,,
3271,15034,Agonistic activity against 5-hydroxytryptamine 4 receptor,F,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619072,,BAO_0000019,,
3272,15034,Agonistic activity against 5-hydroxytryptamine 4 receptor; not tested,F,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619073,,BAO_0000019,,
3273,12918,Compound was evaluated for the relative potency with respect to serotonin against 5-hydroxytryptamine 4 receptor,F,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619074,,BAO_0000019,,
3274,16946,Ability to displace [3H]GR-113808 from 5-hydroxytryptamine 4 receptor,B,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619075,,BAO_0000357,,
3275,17394,Inhibition of [3H]GR-113808 binding to guinea pig striatum 5-hydroxytryptamine 4 receptor,B,,,Cavia porcellus,10141.0,,Striatum,,,20033,D,9,Intermediate,1,,CHEMBL619076,,BAO_0000357,2435.0,
3276,15034,Binding affinity against 5-hydroxytryptamine 4 receptor in guinea pig striatum using [3H]GR-113808 as radioligand,B,,,Cavia porcellus,10141.0,,Striatum,,,20033,D,9,Intermediate,1,,CHEMBL619077,,BAO_0000357,2435.0,
3277,5094,Binding affinity towards 5-HT4 receptor in striatum membranes of guinea-pig brain was evaluated,B,,,Cavia porcellus,10141.0,,Striatum,,,20033,D,9,Intermediate,1,,CHEMBL619078,,BAO_0000249,2435.0,
3278,5094,Binding affinity towards 5-hydroxytryptamine 4 receptor in striatum membranes of guinea-pig brain was evaluated,B,,,Cavia porcellus,10141.0,,Striatum,,,20033,D,9,Intermediate,1,,CHEMBL619079,,BAO_0000249,2435.0,
3279,17358,Tested for affinity against 5-hydroxytryptamine 4 receptor in the myenteric plexus of the guinea pig ileum.,B,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619080,,BAO_0000221,2116.0,
3280,12953,Displacement of [3H]-GR113808 from 5-HT4 receptor of guinea pig striatum,B,,,Cavia porcellus,10141.0,,,,,20033,D,9,Expert,1,,CHEMBL619081,,BAO_0000357,,
3281,12953,The compound was tested for their binding affinity towards 5-HT4 receptor from guinea pig striatum using [3H]GR-113808 as radioligand; Nonactive at 10 uM,B,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619082,,BAO_0000357,,
3282,12953,The compound was tested for their binding affinity towards 5-hydroxytryptamine 4 receptor from guinea pig striatum using [3H]GR-113808 as radioligand.,B,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619083,,BAO_0000357,,
3283,12953,The compound was tested for their binding affinity towards 5-hydroxytryptamine 4 receptor from guinea pig striatum using [3H]GR-113808 as radioligand; Nonactive at 10 uM,B,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619084,,BAO_0000357,,
3284,273,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 4 receptor in non-electrically stimulated guinea-pig ileum.,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL859397,,BAO_0000221,2116.0,
3285,12918,5-hydroxytryptamine 4 receptor agonist activity in the guinea pig ileum assay,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619085,,BAO_0000221,2116.0,
3286,12919,5-hydroxytryptamine 4 receptor agonistic activity was measured by twitch response enhancing activity in electrically stimulated guinea pig ileum preparation,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619086,,BAO_0000221,2116.0,
3287,273,Agonistic activity against Serotonin 5-hydroxytryptamine 4 receptor in low frequency field stimulation of guinea-pig ileum (FSGPI).,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619087,,BAO_0000221,2116.0,
3288,273,Agonistic activity against Serotonin 5-hydroxytryptamine 4 receptor in non-electrically stimulated guinea-pig ileum.,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619088,,BAO_0000221,2116.0,
3289,13181,Ability to antagonize 5-HT-evoked contractions mediated through 5-hydroxytryptamine 4 receptor activation in the guinea pig distal colon LMMP,B,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619089,,BAO_0000357,,
3290,13181,Binding affinity was determined against 5-hydroxytryptamine 3 receptor,B,,,Cavia porcellus,10141.0,,,,,168,H,8,Autocuration,1,,CHEMBL619090,,BAO_0000357,,
3291,15034,Antagonistic activity against 5-hydroxytryptamine 4 receptor,F,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619091,,BAO_0000019,,
3292,5033,Ability to displace the radioligand [3H]GR-113808 from guinea pig striatum 5-hydroxytryptamine 4 receptor,B,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619092,,BAO_0000357,,
3293,1980,Binding affinity for 5-hydroxytryptamine 4 receptor by displacement of [3H]GR-113808 from guinea pig brain striatum.,B,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619093,,BAO_0000019,,
3294,13181,Binding affinity was determined against 5-hydroxytryptamine 2C receptor using cloned rat receptors expressed in 293 cells radiolabeled with [3H]mesulergine,B,,,Cavia porcellus,10141.0,,,HEK293,,168,H,8,Autocuration,1,,CHEMBL619094,722.0,BAO_0000219,,
3295,14287,In vitro by displacement of [3H]GR-113808 from 5-hydroxytryptamine 4 receptor on guinea pig striatal membrane,B,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619095,,BAO_0000019,,
3296,1317,Compound was evaluated for binding affinity against 5-hydroxytryptamine 4 receptor using radioligand binding assay using [3H]GR as radioligand,B,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL857988,,BAO_0000357,,
3297,15316,Compound was evaluated for its ability to displace [3H]GR-113808 binding from 5-hydroxytryptamine 4 receptor in guinea pig striatum.,B,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619096,,BAO_0000357,,
3298,16429,In vitro binding affinity at 5-hydroxytryptamine 4 receptor in guinea pig striatum using 3[H]GR-113808 as the radioligand,B,,,Cavia porcellus,10141.0,,Striatum,,,20033,D,9,Intermediate,1,,CHEMBL619097,,BAO_0000357,2435.0,
3299,14818,The compound was tested for its binding affinity towards 5-hydroxytryptamine 4 receptor in guinea pig hippocampus using [125I]SB-207710.,B,,,Cavia porcellus,10141.0,,Hippocampus,,,20033,D,9,Intermediate,1,,CHEMBL619098,,BAO_0000221,10000000.0,
3300,15194,The compound was tested for the binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand,B,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619751,,BAO_0000357,,
3301,15194,The compound was tested for the binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand.,B,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619752,,BAO_0000357,,
3302,13961,The antagonist activity was calculated as the concentration which produced a 50% reduction against 5-hydroxytryptamine 4 receptor in guinea pig ileum;ne=not capable of evaluation.,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL875096,,BAO_0000221,2116.0,
3303,5486,Binding affinity towards 5-HT2C receptor by the displacement of [3H]mesulergine] in human recombinant receptors in mammalian cell,B,,,,,,,,,108,H,8,Autocuration,1,,CHEMBL619004,,BAO_0000357,,
3304,16209,Binding affinity towards human 5-hydroxytryptamine 4 receptor using [3H]5-HT as radioligand,B,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL619005,,BAO_0000357,,
3305,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 4 receptor,B,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL619006,,BAO_0000019,,
3306,4199,Compound was evaluated for the binding affinity against human cloned 5-hydroxytryptamine 4 receptor in HeLa cells using [3H]-LSD as the radioligand,B,,,,,,,HeLa,,168,H,8,Autocuration,1,,CHEMBL619007,308.0,BAO_0000219,,
3307,15146,Compound was tested for its binding affinity against 5-hydroxytryptamine 4 receptor,B,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL619008,,BAO_0000357,,
3308,5213,Compound was tested for its binding affinity for 5-hydroxytryptamine 4 receptor,B,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL619009,,BAO_0000357,,
3309,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 4 receptor in HeLa cells, using [3H]LSD as radioligand",B,,,,,,,HeLa,,168,H,8,Autocuration,1,,CHEMBL619010,308.0,BAO_0000219,,
3310,17358,Tested for ability to stimulate production of cAMP mediated by 5-hydroxytryptamine 4 receptor in mouse Coliculi neurons,B,,,,,,,,,10622,H,8,Autocuration,1,,CHEMBL619011,,BAO_0000357,,
3311,17358,Tested for ability to stimulate production of cAMP mediated by 5-hydroxytryptamine 4 receptor in mouse Coliculi neurons; IA means inactive,B,,,,,,,,,10622,H,8,Autocuration,1,,CHEMBL619012,,BAO_0000357,,
3312,16946,Ability to displace [3H]GR-113808 from mouse 5-hydroxytryptamine 4 receptor in COS7 cells,B,,,,,,,,,10622,H,8,Autocuration,1,,CHEMBL619013,,BAO_0000219,,
3313,17358,Tested for ability to stimulate 5-hydroxytryptamine 4 receptors in mouse Coliculi neurons,B,,,,,,,,,10622,H,8,Autocuration,1,,CHEMBL619014,,BAO_0000357,,
3314,268,Evaluated for the 5-hydroxytryptamine 4 receptor antagonistic activity in piglet atrium model,F,,,,,,Cardiac atrium,,,11249,H,8,Autocuration,1,,CHEMBL857503,,BAO_0000019,2081.0,
3315,268,Evaluated for the 5-hydroxytryptamine 4 receptor antagonistic activity in piglet atrium model; compound found inactive at 1 uM,F,,,,,,Cardiac atrium,,,11249,H,8,Autocuration,1,,CHEMBL619015,,BAO_0000019,2081.0,
3316,15086,The compound was tested for binding affinity against 5-hydroxytryptamine 4 receptor,B,,,,,,,,,11249,H,8,Autocuration,1,,CHEMBL619016,,BAO_0000357,,
3317,14875,Compound was tested for binding affinity against piglet hippocampus 5-hydroxytryptamine 4 receptor,B,,,,,,Hippocampus,,,11249,H,8,Autocuration,1,,CHEMBL619017,,BAO_0000221,10000000.0,
3318,13267,The binding affinity (pKi) was measured against 5-hydroxytryptamine 4 receptor of piglet hippocampus using [125I]SB 207710 as radioligand,B,,,Sus scrofa,9823.0,,Hippocampus,,,168,H,8,Autocuration,1,,CHEMBL619018,,BAO_0000221,10000000.0,
3319,13047,Binding affinity against 5-hydroxytryptamine 2A receptor using rabbit saphenous vein assay.,B,,,Oryctolagus cuniculus,9986.0,,,,,168,H,8,Autocuration,1,,CHEMBL619019,,BAO_0000019,,
3320,1650,Displacement of [3H]GR-113808 from rat striatum 5-hydroxytryptamine 4 receptor,B,,,Rattus norvegicus,10116.0,,,,,10623,D,9,Expert,1,,CHEMBL619020,,BAO_0000357,,
3321,567,Tested for its agonist potency against the 5-hydroxytryptamine 4 receptor located in the rat esophageal tunica muscularis mucosae,F,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL619021,,BAO_0000019,,
3322,17358,Tested for affinity towards 5-hydroxytryptamine 4 receptor in relaxation of rat oesophagus,B,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL619022,,BAO_0000357,,
3323,188,Tested for the effect on binding at 5-hydroxytryptamine 4 receptor; No activity,B,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL619023,,BAO_0000357,,
3324,670,lntrinsic activity relative to 5-HT receptor,F,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL619024,,BAO_0000019,,
3325,204,Compound was evaluated for the agonistic activity towards 5-hydroxytryptamine 4 receptor using the rat tunica muscularis mucosae (TMM) esophagus strip assay,F,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL619025,,BAO_0000019,,
3326,1946,In vitro relaxation of carbachol pre-contracted rat oesophageal TMM.,F,,,,,,,,,10623,H,8,Expert,1,,CHEMBL619026,,BAO_0000019,,
3327,6398,Compound was tested for agonist activity at the 5-hydroxytryptamine 4 receptor in the rat tunica muscularis mucosae (TMM) assay,F,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL619027,,BAO_0000019,,
3328,6398,Compound was tested for agonist activity at the 5-hydroxytryptamine 4 receptor in the rat tunica muscularis mucosae (TMM) assay; IN = Inactive,F,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL619028,,BAO_0000019,,
3329,17358,Efficient 5-hydroxytryptamine 4 agonist in the rat tunica muscularis mucosae,F,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL619029,,BAO_0000019,,
3330,6398,Tested for agonist activity at the 5-hydroxytryptamine 4 receptor in the rat tunica muscularis mucosae (TMM) assay of racemate mixture,F,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL619030,,BAO_0000019,,
3331,11752,Relaxation of carbachol induced contractions of rat tunica muscularis mucosae,B,,,,,,,,,10623,H,8,Expert,1,,CHEMBL619031,,BAO_0000357,,
3332,809,5-hydroxytryptamine 4 receptor agonist activity was determined by the relaxation of the carbachol-contracted rat esophageal tunica muscularis mucosae,F,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL619032,,BAO_0000019,,
3333,14178,Inhibition of radiolabeled [3H]GR-113808 ligand binding to 5-hydroxytryptamine 4 receptor,B,,,Rattus norvegicus,10116.0,,,,,10623,D,9,Expert,1,,CHEMBL619033,,BAO_0000357,,
3334,567,Tested for its efficacy against the 5-hydroxytryptamine 4 receptor located in the rat esophageal tunica muscularis mucosae,B,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL619034,,BAO_0000357,,
3335,1946,In vitro 5-hydroxytryptamine 4 receptor activity by using carbachol-precontracted esophageal tunica muscularis mucosae.,B,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL619035,,BAO_0000357,,
3336,1946,In vitro 5-hydroxytryptamine 4 receptor activity by using carbachol-precontracted esophageal tunica muscularis mucosae; No activity up to 104M concentration,B,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL619036,,BAO_0000357,,
3337,13961,Binding affinity (Ki+/-SEM) against 5-hydroxytryptamine 4 receptor from cheng Prusoff equation by using [3H]GR-113808 in rat striatum,B,,,Rattus norvegicus,10116.0,,,,,10623,D,9,Expert,1,,CHEMBL619037,,BAO_0000019,,
3338,6238,Binding affinity towards 5-HT 4 receptor in rat striatum membranes using [3H]GR-113808 as radioligand,B,,,,,,Striatum,,,10623,H,8,Autocuration,1,,CHEMBL619038,,BAO_0000249,2435.0,
3339,14290,Binding affinity towards 5-HT4 receptor was determined in rat striatal membranes using [3H]GR-113808 as radioligand; Not tested,B,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL619039,,BAO_0000249,,
3340,14290,Binding affinity towards 5-hydroxytryptamine 4 receptor was determined in rat striatal membranes using [3H]GR-113808 as radioligand,B,,,,,,,,,10623,H,8,Expert,1,,CHEMBL619040,,BAO_0000249,,
3341,809,Binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand in rat striatum,B,,,Rattus norvegicus,10116.0,,Striatum,,,10623,D,9,Expert,1,,CHEMBL619041,,BAO_0000019,2435.0,
3342,1578,Binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand in rat striatum,B,,,,,,Striatum,,,10623,H,8,Autocuration,1,,CHEMBL619042,,BAO_0000019,2435.0,
3343,16709,Binding affinity to 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand in rat striatum membrane,B,,,,,,Striatum,,,10623,H,8,Expert,1,,CHEMBL619043,,BAO_0000249,2435.0,
3344,1946,Binding affinity at 5-hydroxytryptamine 4 receptor in rat striatum by [3H]GR-113808 displacement.,B,,,,,,Striatum,,,10623,H,8,Expert,1,,CHEMBL619044,,BAO_0000019,2435.0,
3345,15253,In vitro affinity at serotonergic 5-hydroxytryptamine 4 receptor by radioligand binding assay using [3H]GR-113808 in rat striatum membranes.,B,,,,,,Striatum,,,10623,H,8,Expert,1,,CHEMBL619045,,BAO_0000249,2435.0,
3346,4535,In vitro binding affinity to 5-hydroxytryptamine 4 receptor in rat striatum membrane,B,,,,,,Striatum,,,10623,H,8,Expert,1,,CHEMBL619046,,BAO_0000249,2435.0,
3347,13961,Binding affinity at 5-hydroxytryptamine 4 receptor in rat striatal membranes by [3H]GR-113808 displacement.,B,,,,,,,,,10623,H,8,Expert,1,,CHEMBL619047,,BAO_0000249,,
3348,17358,Tested for potency against 5-hydroxytryptamine 4 receptor agonist in rat brain,F,,,,,,Brain,,,10623,H,8,Autocuration,1,,CHEMBL619048,,BAO_0000221,955.0,
3349,15847,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 4 receptor of rat,F,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL859398,,BAO_0000019,,
3350,15847,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 4 receptor of rat; ND means not done,F,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL619049,,BAO_0000019,,
3351,670,5-hydroxytryptamine 4 receptor agonist activity in the rat esophageal muscularis mucosae,F,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL857886,,BAO_0000019,,
3352,670,5-hydroxytryptamine 4 receptor agonist activity in the rat esophageal muscularis mucosae; Not tested,F,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL619050,,BAO_0000019,,
3353,1317,Antagonist activity against 5-hydroxytryptamine 4 receptor mediated relaxation of rat carbachol contracted esophageal muscularis mucosae,F,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL620591,,BAO_0000019,,
3354,12936,Binding affinity against rat 5-hydroxytryptamine 4 receptor,B,,,Rattus norvegicus,10116.0,,,,,10623,D,9,Expert,1,,CHEMBL620592,,BAO_0000357,,
3355,4535,pKi against 5-hydroxytryptamine 4 receptor in rat striatum membrane,B,,,,,,Striatum,,,10623,H,8,Expert,1,,CHEMBL620593,,BAO_0000249,2435.0,
3356,14424,Antagonistic activity evaluated by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-5 M.,F,,,Rattus norvegicus,10116.0,,,,,10623,D,9,Expert,1,,CHEMBL620594,,BAO_0000019,,
3357,14424,Antagonistic activity by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-6 M.,F,,,,,,,,,10623,H,8,Expert,1,,CHEMBL875079,,BAO_0000019,,
3358,14424,Antagonistic activity by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-7 M.,F,,,,,,,,,10623,H,8,Expert,1,,CHEMBL620595,,BAO_0000019,,
3359,14424,Antagonistic activity evaluated by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-8 M.,F,,,Rattus norvegicus,10116.0,,,,,10623,D,9,Expert,1,,CHEMBL620596,,BAO_0000019,,
3360,14424,Antagonistic activity of compound was evaluated by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 3*10e-7 M.,F,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL620597,,BAO_0000019,,
3361,14424,Antagonistic activity evaluated by ability to block serotonin induced relaxation (via 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 3*10e-8 M.,F,,,,,,,,,10623,H,8,Expert,1,,CHEMBL620598,,BAO_0000019,,
3362,14424,Antagonistic activity evaluated by ability to block serotonin induced relaxation via 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 0.1 mg/kg (p.o.),F,,,,,,,,,10623,H,8,Expert,1,,CHEMBL620599,,BAO_0000218,,
3363,14424,Antagonistic activity of compound was evaluated by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-7 M.,F,,,,,,,,,10623,H,8,Autocuration,1,,CHEMBL620600,,BAO_0000019,,
3364,1980,Estimate from relaxation of carbachol-contracted rat esophageal muscularis mucosae,F,,,Rattus norvegicus,10116.0,,,,,168,H,8,Autocuration,1,,CHEMBL620601,,BAO_0000019,,
3365,4639,Compound was tested for agonistic activity against 5-hydroxytryptamine 4 receptor on guinea colon at a concentration 0.1 uM,F,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL620602,,BAO_0000019,,
3366,17358,Tested for affinity towards 5-hydroxytryptamine 4 receptor,B,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL620603,,BAO_0000357,,
3367,17358,Tested for affinity towards 5-hydroxytryptamine 4 receptor.,B,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL620604,,BAO_0000357,,
3368,17358,Compound was tested for 5-hydroxytryptamine 4 binding affinity,B,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL620605,,BAO_0000357,,
3369,1558,Compound was tested for its affinity towards 5-hydroxytryptamine 4 receptor,B,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL620606,,BAO_0000357,,
3370,17358,Tested for 5-hydroxytryptamine 4 receptor antagonist activity,F,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL620607,,BAO_0000019,,
3371,16117,In vitro binding affinity towards 5-HT4 receptor was determined,B,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL620608,,BAO_0000357,,
3372,17358,Tested for 5-hydroxytryptamine 4 receptor antagonist activity,F,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL620609,,BAO_0000019,,
3373,17358,Tested for agonist activity against 5-hydroxytryptamine 4 receptor,F,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL620610,,BAO_0000019,,
3374,17358,Tested for selectivity for 5-hydroxytryptamine 4 receptor,B,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL620611,,BAO_0000357,,
3375,17358,Tested for 5-hydroxytryptamine 4 binding affinity against cisapride,B,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL620612,,BAO_0000357,,
3376,17358,Tested for 5-hydroxytryptamine 4 binding affinity against renzapride,B,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL620613,,BAO_0000357,,
3377,17358,Tested for 5-hydroxytryptamine 4 binding affinity against zacopride,B,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL620614,,BAO_0000357,,
3378,1274,Binding affinity against 5-Hydroxytryptamine 4 receptor,B,,,,,,,,,168,H,8,Expert,1,,CHEMBL620615,,BAO_0000357,,
3379,10728,Compound was evaluated for the displacement of [3H]-Q-ICS 205-930 binding to 5-hydroxytryptamine 3 recognition sites in rat brain membranes,B,,,,,,,,Brain membranes,104698,H,6,Autocuration,1,,CHEMBL857075,,BAO_0000249,,
3380,11695,Compound was evaluated for the displacement of [3H]Q-ICS-205-930 from 5-HT3 recognition sites in rat brain membranes,B,,,,,,,,Brain membranes,104698,H,6,Autocuration,1,,CHEMBL620616,,BAO_0000249,,
3381,11695,Displacement of [3H]Q-ICS-205-930 from 5-hydroxytryptamine 3 receptor recognition sites in rat brain membranes,B,,,,,,,,Brain membranes,104698,H,6,Autocuration,1,,CHEMBL619411,,BAO_0000249,,
3382,12490,Displacement of [3H]-Q-ICS 205-930 binding to 5-hydroxytryptamine 3 receptor from rat cortex homogenate,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619412,,BAO_0000019,,
3383,11828,Displacement of [3H]-Q-ICS 205-930 from rat cortex homogenate 5-hydroxytryptamine 3 receptor,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL619413,,BAO_0000019,,
3384,12253,Binding affinity of 5-hydroxytryptamine 3 receptor using [3H]granisetron in rat hippocampus and entorhinal cortex,B,,,,,,Hippocampus,,,104698,H,6,Autocuration,1,,CHEMBL619414,,BAO_0000221,10000000.0,
3385,10561,Binding affinity to 5-hydroxytryptamine 3 receptor using [3H]GR-65630 as radioligand in rat cortex,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619415,,BAO_0000019,,
3386,10561,Binding affinity to 5-hydroxytryptamine 3 receptor using [3H]quipazine as radioligand in rat cortex,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619416,,BAO_0000019,,
3387,14432,Rat 5-hydroxytryptamine 3 receptor (5-HT3) antagonist,F,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619417,,BAO_0000019,,
3388,12936,Binding affinity against rat 5-hydroxytryptamine 3 receptor,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL619418,,BAO_0000223,,
3389,1274,Binding affinity against 5-Hydroxytryptamine 3 receptor,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL619419,,BAO_0000223,,
3390,1980,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of racemic [3H]zacopride from rat cortex,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619420,,BAO_0000019,,
3391,670,Binding affinity to 5-hydroxytryptamine 3 receptor was determined in rat cerebro cortical membranes using [3H]quipazine.,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619421,,BAO_0000249,,
3392,968,Displacement of [3H]granisetron from 5-hydroxytryptamine 3 receptor of rat cortex,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL619422,,BAO_0000019,,
3393,14287,In vitro by displacement of [3H]LY-278584 from 5-hydroxytryptamine 3 receptor on rat entorhinal cortex,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619423,,BAO_0000019,,
3394,567,Tested for its binding affinity by measuring its ability to displace [3H]granisetron from 5-hydroxytryptamine 3 receptor in rat cortex,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL875080,,BAO_0000019,,
3395,13267,The binding affinity (pKi) measured against 5-hydroxytryptamine 1A receptor of rat cortex using [3H]8-OH-DPAT as radioligand,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619424,,BAO_0000019,,
3396,14826,Binding affinity at 5-hydroxytryptamine 3 receptor in rat cortical membrane by [3H]graniestron displacement.,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619425,,BAO_0000249,,
3397,15194,The compound was tested for the binding affinity against 5-hydroxytryptamine 3 receptor using [3H]zacopride as radioligand,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619426,,BAO_0000223,,
3398,15194,The compound was tested for the binding affinity against 5-hydroxytryptamine 3 receptor using [3H]zacopride as radioligand.,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL619427,,BAO_0000223,,
3399,10394,pKi value for inhibition of [3H]LY-278584 binding to 5-hydroxytryptamine 3 receptor,B,,,Rattus norvegicus,10116.0,,,,,104698,D,7,Autocuration,1,,CHEMBL619645,,BAO_0000223,,
3400,13657,"Compound was evaluated for binding affinity on 5-hydroxytryptamine 1A receptor in rat hippocampus membranes,3H-8-OH-DPAT and buspirone for nonspecific binding",B,,,,,,,,,10576,D,9,Expert,1,,CHEMBL619646,,BAO_0000249,,
3401,1879,Compound was tested for its antagonistic activity against 5-hydroxytryptamine 3 receptor in rat brain using [3H]zacopride as the radioligand.,F,,,,,,Brain,,,12020,H,8,Autocuration,1,,CHEMBL619647,,BAO_0000221,955.0,
3402,1879,Compound was tested in vitro for its antagonistic activity against 5-hydroxytryptamine 3 receptor,F,,,,,,,,,12020,H,8,Autocuration,1,,CHEMBL619648,,BAO_0000019,,
3403,1879,Compound was tested in vitro for its antagonistic activity against 5-hydroxytryptamine 3 receptor in rat CNS.,F,,,,,,,,,12020,H,8,Autocuration,1,,CHEMBL619165,,BAO_0000019,,
3404,204,Compound was evaluated in vivo for the antagonistic activity towards 5-hydroxytryptamine 3 receptor,F,In vivo,,,,,,,,12020,H,8,Autocuration,1,,CHEMBL620719,,BAO_0000218,,
3405,1879,Compound was tested for its binding affinity towards 5-HT-3 receptor in whole rat brain using (S)-[125I]-zacopride as the radioligand.,B,,,,,,,,,12020,H,8,Autocuration,1,,CHEMBL872924,,BAO_0000019,,
3406,1879,Compound was tested for its binding affinity towards 5-hydroxytryptamine 3 receptor,B,,,,,,,,,12020,H,8,Autocuration,1,,CHEMBL620720,,BAO_0000357,,
3407,1879,Compound was tested for its binding affinity towards 5-hydroxytryptamine 3 receptor in whole rat brain using (S)-[125I]-zacopride as the radioligand.,B,,,,,,,,,12020,H,8,Autocuration,1,,CHEMBL620721,,BAO_0000019,,
3408,1879,Compound was tested for its binding affinity towards 5-hydroxytryptamine 3 receptor in whole rat brain using [125I]DAIZAC as the radioligand.,B,,,,,,,,,12020,H,8,Autocuration,1,,CHEMBL620722,,BAO_0000019,,
3409,10641,"Concentration that inhibits the binding of radioligand, [3H]-ICS 205930, to 5-hydroxytryptamine 3 receptor from rat cortex",B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620723,,BAO_0000019,,
3410,773,In Vitro Binding affinity againist 5-hydroxytryptamine 3 receptor by displacing [3H]-Q-ICS 205-930 from rat cortex homogenates,B,,,,,,,,,12020,H,8,Autocuration,1,,CHEMBL620724,,BAO_0000019,,
3411,11952,Binding affinity against 5-hydroxytryptamine 3 (5-HT3) receptor in rat brain cortical membranes using radioligand [3H]quipazine,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL620725,,BAO_0000249,,
3412,14145,Antagonist activity (100 ug/kg) for the Bezold Jarisch reflex evoked by 30 (ug/Kg) of 5-hydroxytryptamine 3 receptor in ethylurethane anesthetized rats i.v.,F,,,Rattus norvegicus,10116.0,,,,,12020,D,9,Autocuration,1,,CHEMBL620726,,BAO_0000019,,
3413,17066,Binding affinity towards 5-hydroxytryptamine 3 receptor,B,,,,,,,,,144,H,8,Expert,1,,CHEMBL620727,,BAO_0000357,,
3414,6398,Compound was evaluated for 5-hydroxytryptamine 3 receptor binding,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL620728,,BAO_0000223,,
3415,10321,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of [3H]2 in Neuroblastoma-Glioma NG-108-15 cells,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL620729,,BAO_0000019,,
3416,511,Tested for 5-hydroxytryptamine 3 receptor antagonist activity by inhibiting the 5-HT evoked Bezold-Jarisch reflex,F,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL858288,,BAO_0000019,,
3417,4639,Compound was tested for binding affinity towards 5-hydroxytryptamine 3 receptor,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL620730,,BAO_0000223,,
3418,4639,Binding affinity towards 5-hydroxytryptamine 3 receptor,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL620731,,BAO_0000223,,
3419,4639,Compound was tested for antagonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 0.3 uM,F,,,Cavia porcellus,10141.0,,,,,104714,H,4,Autocuration,1,,CHEMBL620732,,BAO_0000019,,
3420,4639,Compound was tested for antagonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 3 uM,F,,,Cavia porcellus,10141.0,,,,,104714,H,4,Autocuration,1,,CHEMBL618042,,BAO_0000019,,
3421,4639,Compound was tested for antagonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 30 uM,F,,,Cavia porcellus,10141.0,,,,,104714,H,4,Autocuration,1,,CHEMBL618043,,BAO_0000019,,
3422,1558,Compound was tested for its affinity towards 5-hydroxytryptamine 3 receptor,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618044,,BAO_0000223,,
3423,268,Evaluated for the 5-hydroxytryptamine 3 receptor antagonistic activity in Bezold-Jarisch model expressed as inhibition of the reflex bradycardia induced by an intravenous injection,F,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618045,,BAO_0000019,,
3424,2474,Compound was measured for its binding affinity at 5-hydroxytryptamine 3 receptor at a concentration of 10 uM using [3H]BRL-43694 as radioligand,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618046,,BAO_0000223,,
3425,5067,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); A: agonist,F,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618047,,BAO_0000019,,
3426,5067,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); ANT: agonist,F,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL875084,,BAO_0000019,,
3427,5067,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); ANT: antagonist,F,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618048,,BAO_0000019,,
3428,5067,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); NA means data not available,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618049,,BAO_0000223,,
3429,5067,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); PA: Partial agonist,F,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL619764,,BAO_0000019,,
3430,5067,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; A: agonist,F,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL619765,,BAO_0000019,,
3431,5067,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; ANT: Antagonist,F,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL619766,,BAO_0000019,,
3432,5067,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; NA: not active,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL619767,,BAO_0000223,,
3433,5067,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; NA means data not available,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL619768,,BAO_0000223,,
3434,5067,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; PA: Partial agonist,F,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL619769,,BAO_0000019,,
3435,5067,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; na means data not available,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL619770,,BAO_0000223,,
3436,5067,Binding affinity towards 5-hydroxytryptamine 3 receptor,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL619771,,BAO_0000223,,
3437,14331,Binding affinity of compound towards 5-hydroxytryptamine 3 receptor using [3H]-BRL-43694 (1 nM) ligand in NG cells 108-15 was determined,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL619772,,BAO_0000219,,
3438,5067,Binding affinity of compound towards 5-hydroxytryptamine 3 receptor; NA: not active,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL619773,,BAO_0000223,,
3439,6179,Binding affinity for 5-HT3 receptor of NG108-15 cells using [3H]GR-65630,B,,,,,,,NG108-15,,104714,H,4,Autocuration,1,,CHEMBL619774,433.0,BAO_0000219,,
3440,4265,Binding affinity to 5-HT3 serotonin receptor in NG 108-15 neuroblastoma glioma cells using [3H]GR-65630 radioligand.,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL875083,,BAO_0000019,,
3441,4265,Binding affinity to 5-HT3 serotonin receptor in NG108-15 neuroblastoma glioma cells using [3H]GR-65630 radioligand,B,,,,,,,NG108-15,,104714,H,4,Autocuration,1,,CHEMBL620718,433.0,BAO_0000219,,
3442,17358,Compound was tested for 5-hydroxytryptamine 3 receptor binding affinity,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618127,,BAO_0000223,,
3443,17358,Compound was tested for selectivity against 5-hydroxytryptamine 3 receptor binding affinity,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618128,,BAO_0000223,,
3444,13628,Compound was tested for the inhibition of [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor expressed in NG 108-15 cells,B,In vitro,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618129,,BAO_0000219,,
3445,4612,In vitro Binding affinity towards 5-hydroxytryptamine 3 receptor was determined,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618130,,BAO_0000223,,
3446,17358,Tested for 5-hydroxytryptamine 3 receptor antagonist activity,F,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618131,,BAO_0000019,,
3447,4639,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 1 uM,F,,,Cavia porcellus,10141.0,,,,,104714,H,4,Autocuration,1,,CHEMBL618132,,BAO_0000019,,
3448,4639,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 10 uM,F,,,Cavia porcellus,10141.0,,,,,104714,H,4,Autocuration,1,,CHEMBL618133,,BAO_0000019,,
3449,4639,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 10 uM in the presence of 30 uM MDL 72222,F,,,Cavia porcellus,10141.0,,,,,104714,H,4,Autocuration,1,,CHEMBL618134,,BAO_0000019,,
3450,4639,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 3 uM,F,,,Cavia porcellus,10141.0,,,,,104714,H,4,Autocuration,1,,CHEMBL618135,,BAO_0000019,,
3451,511,Binding affinity for the 5-hydroxytryptamine 3 receptor was evaluated in vitro by examining its ability to displace [3H]-BRL 43694.,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618136,,BAO_0000223,,
3452,1479,Binding affinity towards 5-hydroxytryptamine 3 receptor,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618137,,BAO_0000223,,
3453,1317,Compound was evaluated for binding affinity against 5-hydroxytryptamine 3 receptor using radioligand binding assay,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618138,,BAO_0000223,,
3454,12146,Tested against 5-hydroxytryptamine 3 receptor in experiment 1,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618139,,BAO_0000223,,
3455,12146,Tested against 5-hydroxytryptamine 3 receptor in experiment 2,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618140,,BAO_0000223,,
3456,13969,Binding affinity against 5-hydroxytryptamine 3 receptor was measured using [3H]granisetron as radioligand,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618141,,BAO_0000223,,
3457,13392,Binding affinity for 5-hydroxytryptamine 2C receptor,B,,,,,,,,,108,H,8,Expert,1,,CHEMBL873478,,BAO_0000357,,
3458,13392,Binding affinity towards 5-hydroxytryptamine 3 receptor,B,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL618142,,BAO_0000223,,
3459,14159,Compound was evaluated for the affinity at 5-hydroxytryptamine 3 receptor,B,,,,,,,,,144,H,8,Autocuration,1,,CHEMBL618143,,BAO_0000357,,
3460,1558,Compound was tested for its affinity towards 5-hydroxytryptamine 3 receptor,B,,,,,,,,,144,H,8,Autocuration,1,,CHEMBL618144,,BAO_0000357,,
3461,16655,Inhibition of GR-65630 binding to 5-hydroxytryptamine 3 receptor,B,,,,,,,,,144,H,8,Autocuration,1,,CHEMBL618145,,BAO_0000357,,
3462,13020,Inhibition of [3H]- BRL 43 694 binding to 5-hydroxytryptamine 3 receptor at 10e-5 M,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618146,,BAO_0000223,,
3463,13021,Inhibition of [3H]-BRL 43 694 binding to 5-hydroxytryptamine 3 receptor of central nervous system,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618147,,BAO_0000223,,
3464,13020,Inhibition of [3H]- BRL 43 694 binding to 5-hydroxytryptamine 3 receptor at 10e-5 M,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618148,,BAO_0000223,,
3465,10321,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of [3H]2 in Neuroblastoma-Glioma NG-108-15 cells,B,,,,,,,,,144,H,8,Autocuration,1,,CHEMBL618149,,BAO_0000019,,
3466,15818,Compound was evaluated for its binding affinity towards 5-hydroxytryptamine 3 receptor,B,,,,,,,,,144,H,8,Autocuration,1,,CHEMBL872927,,BAO_0000357,,
3467,15818,Compound was evaluated for its binding affinity towards 5-hydroxytryptamine 3 receptor,B,,,,,,,,,144,H,8,Autocuration,1,,CHEMBL618150,,BAO_0000357,,
3468,17358,Compound was tested for 5-hydroxytryptamine 3 receptor binding affinity,B,,,,,,,,,144,H,8,Autocuration,1,,CHEMBL618151,,BAO_0000357,,
3469,2222,Compound was tested for its binding affinity for the 5-hydroxytryptamine 3 receptor,B,,,,,,,,,144,H,8,Autocuration,1,,CHEMBL875094,,BAO_0000357,,
3470,10322,In vitro binding affinity for the 5-hydroxytryptamine 3 receptor was determined with NG-108-15 mouse neuroblastoma-glioma cells,B,,,,,,,,,144,H,8,Autocuration,1,,CHEMBL618152,,BAO_0000019,,
3471,16117,In vitro binding affinity towards 5-hydroxytryptamine 3 receptor was determined,B,,,,,,,,,144,H,8,Autocuration,1,,CHEMBL618153,,BAO_0000357,,
3472,17200,Inhibitory constant against 5-hydroxytryptamine 3 receptor using [3H]GR-65630 radioligand,B,,,,,,,,,144,H,8,Autocuration,1,,CHEMBL618888,,BAO_0000357,,
3473,17358,Tested for 5-hydroxytryptamine 3 receptor agonist activity,F,,,,,,,,,144,H,8,Autocuration,1,,CHEMBL618889,,BAO_0000019,,
3474,16700,The binding affinity towards 5-hydroxytryptamine 3 receptor; No affinity,B,,,,,,,,,144,H,8,Autocuration,1,,CHEMBL618890,,BAO_0000357,,
3475,1980,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of [3H](R)-zacopride from ondansetron-treated NG-108-15 cell membranes,B,,,,,,,,,144,H,8,Autocuration,1,,CHEMBL618891,,BAO_0000019,,
3476,1980,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of [3H]-BRL 43694 from NG-108-15 cell membranes,B,,,,,,,,,144,H,8,Autocuration,1,,CHEMBL619054,,BAO_0000019,,
3477,12409,Binding affinity against the 5-hydroxytryptamine 3 receptor,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL619055,,BAO_0000223,,
3478,4365,Binding affinity against human 5-hydroxytryptamine 3A receptor,B,,,,,,,,,144,H,8,Autocuration,1,,CHEMBL619056,,BAO_0000357,,
3479,4365,Percent efficacy against 5-hydroxytryptamine 3A receptor,F,,,,,,,,,144,H,8,Autocuration,1,,CHEMBL619057,,BAO_0000019,,
3480,4365,Binding affinity against human 5-hydroxytryptamine 3A receptor,B,,,,,,,,,144,H,8,Autocuration,1,,CHEMBL619058,,BAO_0000357,,
3481,6769,Response at rat 5-hydroxytryptamine 3a receptor expressed in xenopus oocytes,F,,,Rattus norvegicus,10116.0,,,Oocytes,,12020,D,9,Expert,1,,CHEMBL619059,,BAO_0000219,,
3482,6769,Ability to block serotonin (30 uM)-evoked responses at rat 5HT3-alpha receptor expressed in xenopus oocytes,F,,,Rattus norvegicus,10116.0,,,Oocytes,,12020,D,9,Expert,1,,CHEMBL619060,,BAO_0000219,,
3483,6769,Effect on rat 5-hydroxytryptamine 3a receptor expressed in xenopus oocytes at concentration up to 100 uM,F,,,Rattus norvegicus,10116.0,,,Oocytes,,12020,D,9,Expert,1,,CHEMBL875095,,BAO_0000219,,
3484,809,5-hydroxytryptamine 4 receptor agonist activity as percent maximum 5-HT effect in response to electrical stimulation in male guinea pig ileum,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619061,,BAO_0000221,2116.0,
3485,809,5-hydroxytryptamine 4 receptor agonist activity expressed as the concentration which gave a 50% increase in the response to the electrical stimulation in male guinea pig ileum,F,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619062,,BAO_0000221,2116.0,
3486,14290,5-hydroxytryptamine 4 receptor agonist activity is expressed as percent of the maximum 5-HT response,F,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619063,,BAO_0000019,,
3487,17358,Tested for affinity towards 5-hydroxytryptamine 4 receptor in electrically stimulated longitudinal muscle preparation of guinea pig ileum,B,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619064,,BAO_0000221,2116.0,
3488,17358,Tested for affinity towards 5-hydroxytryptamine 4 receptor in guinea pig distal colon preparation,B,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL619065,,BAO_0000357,,
3489,17358,Tested for affinity towards 5-hydroxytryptamine 4 receptor in isolated guinea pig ileum longitudinal muscle preparation,B,,,Cavia porcellus,10141.0,,Ileum,,,20033,D,9,Intermediate,1,,CHEMBL619066,,BAO_0000221,2116.0,
3490,17386,Maximal relaxation effect induced by 3 uM compound on substance P stimulated guinea pig ileum with 5-hydroxytryptamine 7 receptor nondesensitization,B,,,,,,Ileum,,,10209,H,8,Autocuration,1,,CHEMBL619775,,BAO_0000221,2116.0,
3491,3269,Affinity against 5-hydroxytryptamine 7 receptor,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL619776,,BAO_0000357,,
3492,7721,Ability to displace [3H]5-HT binding from 5-hydroxytryptamine receptor site using 1 uM LSD as masking ligand,B,,,Cavia porcellus,10141.0,,,,,104841,H,4,Autocuration,1,,CHEMBL619777,,BAO_0000224,,
3493,7721,Ability to displace [3H]5-HT binding to 5-hydroxytryptamine receptor site using 1 uM LSD as masking ligand,B,,,Cavia porcellus,10141.0,,,,,104841,H,4,Autocuration,1,,CHEMBL619778,,BAO_0000224,,
3494,9117,Evaluated for inhibition of 5-hydroxytryptamine receptor on guinea pig ileum at 10 uM; No effect,B,,,Cavia porcellus,10141.0,,Ileum,,,104841,H,4,Autocuration,1,,CHEMBL619779,,BAO_0000221,2116.0,
3495,7721,"Ability to displace [3H]5-HT binding to 5-hydroxytryptamine receptor site using 1 uM LSD as masking ligand, activity is expressed as Kd.",B,,,Cavia porcellus,10141.0,,,,,104841,H,4,Autocuration,1,,CHEMBL619780,,BAO_0000224,,
3496,7721,"Ability to displace [3H]5-HT binding to 5-hydroxytryptamine receptor using 1 uM LSD as masking ligand, activity is expressed as Kd.",B,,,Cavia porcellus,10141.0,,,,,104841,H,4,Autocuration,1,,CHEMBL619166,,BAO_0000224,,
3497,15796,5-HT level in K+ induced 5-hydroxytryptamine release in guinea pig cortex.,F,,,Cavia porcellus,10141.0,,,,,104841,H,4,Autocuration,1,,CHEMBL619167,,BAO_0000019,,
3498,15796,5-hydroxytryptamine level in K+ induced 5-hydroxytryptamine release in guinea pig cortex.,F,,,Cavia porcellus,10141.0,,,,,104841,H,4,Autocuration,1,,CHEMBL619168,,BAO_0000019,,
3499,15650,Concentration required to produce half-maximal response against 5-hydroxytryptamine receptor in the presence of 10 nM compound in isolated human atrial myocytes,B,,,Homo sapiens,9606.0,,Cardiac atrium,,,168,D,9,Expert,1,,CHEMBL619169,,BAO_0000219,2081.0,
3500,15650,Concentration required to produce half-maximal response against 5-hydroxytryptamine receptor on the L-type calcium current (I Ca) in isolated human atrial myocytes,B,,,Homo sapiens,9606.0,,Cardiac atrium,,,168,D,9,Expert,1,,CHEMBL619170,,BAO_0000219,2081.0,
3501,6866,"Maximum stimulation of [35S]GTP-gamma-S, binding expressed relative to the maximal effect of 5-hydroxytryptamine",F,,,Homo sapiens,9606.0,,,,,104841,D,5,Autocuration,1,,CHEMBL619171,,BAO_0000019,,
3502,15650,",Antagonism of stimulation of 5-hydroxytryptamine receptor on the L-type calcium current (I Ca) in isolated human atrial myocytes",F,,,Homo sapiens,9606.0,,Cardiac atrium,,,168,D,9,Expert,1,,CHEMBL619172,,BAO_0000219,2081.0,
3503,10063,Ability (10 ug/kg) to inhibit binding of [125I]iododexetimide to 5-hydroxytryptamine receptor in mice,B,,,Mus musculus,10090.0,,,,,22226,U,0,Autocuration,1,,CHEMBL619173,,BAO_0000019,,
3504,12665,Percent inhibition of radioligand [3H]-LSD binding to 5-HT receptor at 10 uM concentration,B,,,Mus musculus,10090.0,,,,,22226,U,0,Autocuration,1,,CHEMBL619174,,BAO_0000019,,
3505,7504,5-hydroxytryptamine receptor binding affinity was determined in rats,B,,,,,,,,,104705,H,4,Autocuration,1,,CHEMBL619175,,BAO_0000019,,
3506,7504,Binding affinity at rat 5-hydroxytryptamine receptor.,B,,,,,,,,,104705,H,4,Autocuration,1,,CHEMBL619176,,BAO_0000224,,
3507,7038,Affinity against 5-hydroxytryptamine receptors in rat fundus model,B,,,,,,,,,104705,H,4,Autocuration,1,,CHEMBL619177,,BAO_0000019,,
3508,7626,Affinity for 5-hydroxytryptamine receptor was determined using male Dawley rat fundus preparation,B,,,,,,,,,104705,H,4,Autocuration,1,,CHEMBL619178,,BAO_0000224,,
3509,7626,Affinity for 5-hydroxytryptamine receptor was determined using male Dawley rat fundus preparation; Not determined,B,,,,,,,,,104705,H,4,Autocuration,1,,CHEMBL619179,,BAO_0000224,,
3510,7185,Antagonistic activity against serotonin 5-HT receptor obtained from rat stomach fundus preparation,F,,,,,,Stomach,,,104705,H,4,Autocuration,1,,CHEMBL619180,,BAO_0000019,945.0,
3511,7185,Antagonistic activity against serotonin 5-HT receptor obtained from rat stomach fundus preparation (resulted in discoloration in the oxygenated muscle bath to give varying results).,F,,,,,,Stomach,,,104705,H,4,Autocuration,1,,CHEMBL619181,,BAO_0000019,945.0,
3512,7185,Antagonistic activity of corresponding methoxy compound against serotonin 5-HT receptor,F,,,,,,,,,104705,H,4,Autocuration,1,,CHEMBL619182,,BAO_0000019,,
3513,6960,Compound was evaluated for binding affinity towards 5-hydroxytryptamine receptor in isolated rat fundus preparation measured as pA2,B,,,,,,,,,104705,H,4,Autocuration,1,,CHEMBL619183,,BAO_0000224,,
3514,6960,"Compound was evaluated for binding affinity towards 5-hydroxytryptamine receptor in isolated rat fundus preparation measured as pA2; Valid pA2, can not be determined because of slope of Schild plot.",B,,,,,,,,,104705,H,4,Autocuration,1,,CHEMBL619184,,BAO_0000224,,
3515,12416,In vitro affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in hippocampus,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL619185,,BAO_0000221,10000000.0,
3516,15753,Binding affinity for rat 5-hydroxytryptamine transporter.,B,,,,,,,,,12198,H,8,Expert,1,,CHEMBL619186,,BAO_0000357,,
3517,8062,Evaluated for inhibition of specific [3H]5-HT receptor binding in rat cortex.,B,,,,,,,,,104705,H,4,Autocuration,1,,CHEMBL619187,,BAO_0000019,,
3518,9036,Binding affinity at serotonin 5-HT1-type site receptor in rat cortex by displacing [3H]5-HT,B,,,Rattus norvegicus,10116.0,,,,,104705,D,5,Autocuration,1,,CHEMBL619188,,BAO_0000019,,
3519,15067,Compound was tested for its inhibitory activity against 5-hydroxytryptamine receptor,B,,,Rattus norvegicus,10116.0,,,,,104705,D,5,Autocuration,1,,CHEMBL619189,,BAO_0000224,,
3520,15753,Inhibitory activity against [3H]- 5-hydroxytryptamine reuptake in whole rat brain minus cerebellum,F,,,Rattus norvegicus,10116.0,,Brain,,,12198,D,9,Expert,1,,CHEMBL619190,,BAO_0000019,955.0,
3521,15753,Inhibition of [3H]5-HT reuptake in whole rat brain (minus cerebellum) homogenate.,F,,,Rattus norvegicus,10116.0,,Cerebellum,,,12198,D,9,Expert,1,,CHEMBL619191,,BAO_0000221,2037.0,
3522,15295,Displacement of [3H]-citalopram from rat forebrain membrane 5-hydroxytryptamine receptor at 10e-7 M,B,,,Rattus norvegicus,10116.0,,,,,104705,D,5,Autocuration,1,,CHEMBL619192,,BAO_0000019,,
3523,6347,Percent binding affinity against 5-hydroxytryptamine receptor,B,,,Rattus norvegicus,10116.0,,,,,104705,D,5,Autocuration,1,,CHEMBL619193,,BAO_0000224,,
3524,6763,Ability to displace 0.4 nM [3H]paroxetine binding to 5-hydroxytryptamine receptor in rat frontal cortex,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL619194,,BAO_0000019,,
3525,12092,The binding affinity was measured on 5-hydroxytryptamine receptor uptake receptor using [3H]- paroxetine as radioligand.,B,,,Rattus norvegicus,10116.0,,,,,104705,D,5,Autocuration,1,,CHEMBL619195,,BAO_0000224,,
3526,1579,Affinity against 5-hydroxytryptamine receptor was determined,B,,,Rattus norvegicus,10116.0,,,,,104705,D,5,Autocuration,1,,CHEMBL619196,,BAO_0000224,,
3527,1579,Affinity against 5-hydroxytryptamine receptor was determined in rat stomach fundus strip,B,,,Rattus norvegicus,10116.0,,Stomach,,,104705,D,5,Autocuration,1,,CHEMBL619197,,BAO_0000019,945.0,
3528,5963,Inhibition of [3H]5-HT uptake in HEK cells expressing human SERT,B,In vitro,,Homo sapiens,9606.0,,,,,121,D,9,Expert,1,,CHEMBL619198,,BAO_0000219,,
3529,5963,Inhibition of [3H]5-HT uptake in HEK cells expressing human SERT,B,In vitro,,Homo sapiens,9606.0,,,,,121,D,9,Expert,1,,CHEMBL875081,,BAO_0000219,,
3530,5030,Ability to compete with radioactive ligands specific to the Serotonergic 5-HT receptor at 10 uM; NA means compound failed to compete,B,,,,,,,,,18065,H,8,Autocuration,1,,CHEMBL884712,,BAO_0000357,,
3531,15796,Inhibition of 5-hydroxytryptamine reuptake,B,,,,,,,,,121,H,8,Expert,1,,CHEMBL884710,,BAO_0000357,,
3532,15413,"Receptor-linked G protein activation at 5-hydroxytryptamine receptor was determined by measuring the stimulation of [35S]GTP-gamma-S, binding",F,,,,,,,,,18065,H,8,Autocuration,1,,CHEMBL619199,,BAO_0000019,,
3533,15413,"Receptor-linked G protein activation at 5-hydroxytryptamine receptor was determined by measuring the stimulation of [35S]GTP-gamma-S, binding (Experiment 1)",F,,,,,,,,,18065,H,8,Autocuration,1,,CHEMBL619200,,BAO_0000019,,
3534,15413,"Receptor-linked G protein activation at 5-hydroxytryptamine receptor was determined by measuring the stimulation of [35S]GTP-gamma-S, binding (Experiment 2)",F,,,,,,,,,18065,H,8,Autocuration,1,,CHEMBL619201,,BAO_0000019,,
3535,12409,Tested for 5-hydroxytryptamine receptor uptake,F,,,,,,,,,18065,H,8,Autocuration,1,,CHEMBL619202,,BAO_0000019,,
3536,16909,Affinity constant on CHO cells expressing Human recombinant 5-hydroxytryptamine receptor 1A,B,,,Homo sapiens,9606.0,,,CHO,,51,D,9,Expert,1,,CHEMBL619203,449.0,BAO_0000219,,
3537,16909,Antagonistic affinity tested against isolated human cloned alpha-1d adrenoceptor subtype,F,,,Homo sapiens,9606.0,,,,,51,D,9,Expert,1,,CHEMBL619204,,BAO_0000019,,
3538,15629,In vitro binding affinity towards 5-hydroxytryptamine receptor 1A receptor by using [3H]8-OH-DPAT in rat hippocampal membranes.,B,,,Homo sapiens,9606.0,,,,,10576,H,8,Autocuration,1,,CHEMBL619205,,BAO_0000249,,
3539,15629,Tested in vitro for % inhibition against 5-hydroxytryptamine receptor 1A,B,,,,,,,,,10576,H,8,Autocuration,1,,CHEMBL619206,,BAO_0000357,,
3540,15629,In vitro binding affinity at 5-hydroxytryptamine receptor 1A receptor in rat hippocampal membranes by [3H]8-OH-DPAT displacement.,B,,,,,,,,,10576,H,8,Expert,1,,CHEMBL619207,,BAO_0000249,,
3541,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats corpus striatum at a dosage of 0.10 umol/kg,F,,,,,,Striatum,,,10825,H,8,Autocuration,1,,CHEMBL619208,,BAO_0000019,2435.0,
3542,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats corpus striatum at a dosage of 10 umol/kg,F,,,,,,Striatum,,,10825,H,8,Autocuration,1,,CHEMBL619209,,BAO_0000019,2435.0,
3543,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats in corpus striatum at a dosage of 0.32 umol/kg,F,,,,,,Striatum,,,10825,H,8,Autocuration,1,,CHEMBL619210,,BAO_0000019,2435.0,
3544,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats in corpus striatum at a dosage of 3.2 umol/kg,F,,,,,,Striatum,,,10825,H,8,Autocuration,1,,CHEMBL619211,,BAO_0000019,2435.0,
3545,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats in corpus striatum at a dosage of 32 umol/kg,F,,,,,,Striatum,,,10825,H,8,Autocuration,1,,CHEMBL619212,,BAO_0000019,2435.0,
3546,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 0.032 umol/kg,F,,,,,,Striatum,,,10825,H,8,Autocuration,1,,CHEMBL620681,,BAO_0000019,2435.0,
3547,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 1.0 umol/kg,F,,,,,,Striatum,,,10825,H,8,Autocuration,1,,CHEMBL620682,,BAO_0000019,2435.0,
3548,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 10 umol/kg,F,,,,,,Striatum,,,10825,H,8,Autocuration,1,,CHEMBL620683,,BAO_0000019,2435.0,
3549,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 100 umol/kg,F,,,,,,Striatum,,,10825,H,8,Autocuration,1,,CHEMBL620684,,BAO_0000019,2435.0,
3550,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 3.2 umol/kg,F,,,,,,Striatum,,,10825,H,8,Autocuration,1,,CHEMBL620685,,BAO_0000019,2435.0,
3551,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 32 umol/kg,F,,,,,,Striatum,,,10825,H,8,Autocuration,1,,CHEMBL620686,,BAO_0000019,2435.0,
3552,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 0.032 umol/kg,F,,,,,,Limbic system,,,10825,H,8,Autocuration,1,,CHEMBL620687,,BAO_0000019,349.0,
3553,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 0.10 umol/kg,F,,,,,,Limbic system,,,10825,H,8,Autocuration,1,,CHEMBL620688,,BAO_0000019,349.0,
3554,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 0.32 umol/kg,F,,,,,,Limbic system,,,10825,H,8,Autocuration,1,,CHEMBL620689,,BAO_0000019,349.0,
3555,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 1.0 umol/kg,F,,,,,,Limbic system,,,10825,H,8,Autocuration,1,,CHEMBL620690,,BAO_0000019,349.0,
3556,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 10 umol/kg,F,,,,,,Limbic system,,,10825,H,8,Autocuration,1,,CHEMBL620691,,BAO_0000019,349.0,
3557,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 100 umol/kg,F,,,,,,Limbic system,,,10825,H,8,Autocuration,1,,CHEMBL620692,,BAO_0000019,349.0,
3558,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 3.2 umol/kg,F,,,,,,Limbic system,,,10825,H,8,Autocuration,1,,CHEMBL620693,,BAO_0000019,349.0,
3559,1274,Binding affinity against 5-hydroxytryptamine 4 receptor,B,,,,,,,,,168,H,8,Expert,1,,CHEMBL620694,,BAO_0000357,,
3560,17358,Tested for 5-hydroxytryptamine 4 receptor antagonist activity,F,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL857986,,BAO_0000019,,
3561,14532,Inhibitory activity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand at 10e-5 M concentration,B,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL620695,,BAO_0000357,,
3562,16989,Binding affinity towards Serotonin 5-hydroxytryptamine 4 receptor,B,,,,,,,,,168,H,8,Expert,1,,CHEMBL620696,,BAO_0000357,,
3563,17200,Inhibitory constant against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 radioligand,B,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL620697,,BAO_0000357,,
3564,15779,Binding affinity towards 5-hydroxytryptamine 4 receptor,B,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL620698,,BAO_0000357,,
3565,15779,Binding affinity towards 5-hydroxytryptamine 4 receptor; ND means no data.,B,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL620699,,BAO_0000357,,
3566,15779,Binding affinity towards 5-hydroxytryptamine 4 receptor; ND means no data.,B,,,,,,,,,168,H,8,Autocuration,1,,CHEMBL620700,,BAO_0000357,,
3567,15650,Binding affinity was determined against cloned 5-hydroxytryptamine 4A receptor isoform expressed in COS-7 cells,B,,,,,,,COS-7,,168,H,8,Autocuration,1,,CHEMBL620701,643.0,BAO_0000219,,
3568,15650,Binding affinity was determined against cloned 5-hydroxytryptamine 4B receptor isoform expressed in COS-7 cells,B,,,,,,,COS-7,,168,H,8,Autocuration,1,,CHEMBL875082,643.0,BAO_0000219,,
3569,15650,Binding affinity was determined against cloned 5-hydroxytryptamine 4C receptor isoform expressed in COS-7 cells,B,,,,,,,COS-7,,168,H,8,Autocuration,1,,CHEMBL620702,643.0,BAO_0000219,,
3570,15650,Binding affinity was determined against cloned 5-hydroxytryptamine 4D receptor isoform expressed in COS-7 cells,B,,,,,,,COS-7,,168,H,8,Autocuration,1,,CHEMBL620703,643.0,BAO_0000219,,
3571,17046,Binding affinity of compound towards cloned human 5-hydroxytryptamine 4E receptor expressed in C6 glial cells using [3H]GR-113808 as radioligand,B,,,,,,,C6,,168,H,8,Autocuration,1,,CHEMBL620704,673.0,BAO_0000219,,
3572,17046,Binding affinity towards cloned human 5-hydroxytryptamine 4E receptor expressed in C6 glial cells using [3H]GR-113808 as radioligand,B,,,,,,,C6,,168,H,8,Expert,1,,CHEMBL620705,673.0,BAO_0000219,,
3573,15650,Binding affinity was determined against cloned 5-hydroxytryptamine 4E receptor isoform expressed in C6 glial cells incubated with 0.2 nM [3H]GR-113808,B,,,,,,,C6,,168,H,8,Expert,1,,CHEMBL620706,673.0,BAO_0000219,,
3574,17046,Binding affinity towards cloned human 5-hydroxytryptamine 4E receptor expressed in C6 glial cells using [3H]GR-113808 as radioligand; Not determined,B,,,,,,,C6,,168,H,8,Expert,1,,CHEMBL620707,673.0,BAO_0000219,,
3575,17066,Binding affinity towards 5-hydroxytryptamine 5 receptor,B,,,,,,,,,10624,H,8,Expert,1,,CHEMBL620708,,BAO_0000357,,
3576,17200,Inhibitory constant against human 5-hydroxytryptamine 5A receptor using [3H]LSD radioligand,B,,,,,,,,,105,H,8,Autocuration,1,,CHEMBL620709,,BAO_0000357,,
3577,16146,Binding affinity against 5-hydroxytryptamine 5A receptor,B,,,Homo sapiens,9606.0,,,,,10624,D,9,Expert,1,,CHEMBL620710,,BAO_0000357,,
3578,15250,Compound was tested for the displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 5A receptor stably expressed in CHO cells,B,,,,,,,CHO,,10624,H,8,Autocuration,1,,CHEMBL620711,449.0,BAO_0000219,,
3579,6491,Affinity towards human 5-hydroxytryptamine 5A serotonin receptor,B,,,Homo sapiens,9606.0,,,,,10624,D,9,Expert,1,,CHEMBL620712,,BAO_0000357,,
3580,17066,Binding affinity towards human 5-hydroxytryptamine 5A receptor,B,,,Homo sapiens,9606.0,,,,,10624,D,9,Expert,1,,CHEMBL620713,,BAO_0000357,,
3581,17066,Binding affinity towards human 5-hydroxytryptamine 5A receptor was evaluated using [3H]-5-CT as radioligand,B,,,Homo sapiens,9606.0,,,,,10624,D,9,Expert,1,,CHEMBL620714,,BAO_0000357,,
3582,4234,Binding affinity to cloned human 5-hydroxytryptamine 5A receptor,B,,,Homo sapiens,9606.0,,,,,10624,D,9,Expert,1,,CHEMBL620715,,BAO_0000357,,
3583,6013,Binding affinity towards 5-HT5A receptor,B,,,,,,,,,10624,H,8,Autocuration,1,,CHEMBL620716,,BAO_0000357,,
3584,17175,Binding affinity towards human 5-hydroxytryptamine 5A receptor using LSD as radioligand,B,,,,,,,,,10624,H,8,Expert,1,,CHEMBL620717,,BAO_0000357,,
3585,15818,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 5A receptor,B,,,,,,,,,10624,H,8,Autocuration,1,,CHEMBL618072,,BAO_0000357,,
3586,6166,Binding affinity towards cloned human 5-HT5A receptor was determined,B,,,,,,,,,10624,H,8,Autocuration,1,,CHEMBL857987,,BAO_0000357,,
3587,15779,Binding affinity towards 5-hydroxytryptamine 5A receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand.,B,,,,,,,HEK293,,10624,H,8,Autocuration,1,,CHEMBL618073,722.0,BAO_0000219,,
3588,15779,Binding affinity towards 5-hydroxytryptamine 5A receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand;ND means no data.,B,,,,,,,HEK293,,10624,H,8,Autocuration,1,,CHEMBL618074,722.0,BAO_0000219,,
3589,5213,Compound was tested for its binding affinity in 5-hydroxytryptamine 5A receptor (using human cloned receptors in HEK 293 and [3H]5-CTas a radioligand ),B,,,,,,,HEK293,,10624,H,8,Autocuration,1,,CHEMBL618075,722.0,BAO_0000219,,
3590,17066,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor,B,,,Mus musculus,10090.0,,,,,10625,D,9,Expert,1,,CHEMBL618076,,BAO_0000357,,
3591,17066,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor was evaluated using [125I]-2-iodo LSD as radioligand,B,,,Mus musculus,10090.0,,,,,10625,D,9,Expert,1,,CHEMBL618077,,BAO_0000357,,
3592,17066,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor was evaluated using [3H]- LSD as radioligand,B,,,Mus musculus,10090.0,,,,,10625,D,9,Expert,1,,CHEMBL618078,,BAO_0000357,,
3593,17066,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor was evaluated using [3H]LSD as radioligand,B,,,Mus musculus,10090.0,,,,,10625,D,9,Expert,1,,CHEMBL881821,,BAO_0000357,,
3594,17066,Binding affinity towards murine 5-hydroxytryptamine 5A receptor,B,,,Mus musculus,10090.0,,,,,10625,D,9,Expert,1,,CHEMBL618079,,BAO_0000357,,
3595,17175,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor using LSD as radioligand,B,,,,,,,,,10625,H,8,Expert,1,,CHEMBL618080,,BAO_0000357,,
3596,16190,Binding affinity against 5-hydroxytryptamine 5A receptor in HEK 293 cells was determined using [3H]LSD as radioligand,B,,,,,,,HEK293,,10576,H,8,Autocuration,1,,CHEMBL618081,722.0,BAO_0000219,,
3597,16190,Binding affinity against 5-hydroxytryptamine 5A receptor in HEK 293 cells was determined using [3H]LSD as radioligand,B,,,,,,,HEK293,,10626,H,8,Autocuration,1,,CHEMBL618082,722.0,BAO_0000219,,
3598,4820,Binding affinity towards 5-HT5a receptor,B,,,,,,,,,10624,H,8,Expert,1,,CHEMBL618083,,BAO_0000357,,
3599,17066,Binding affinity towards 5-hydroxytryptamine 5A receptor,B,,,Homo sapiens,9606.0,,,,,10624,D,9,Expert,1,,CHEMBL618084,,BAO_0000357,,
3600,17066,Binding affinity for rodent 5-hydroxytryptamine 5A receptor,B,,,,,,,,,10624,H,8,Expert,1,,CHEMBL618085,,BAO_0000357,,
3601,17175,Binding affinity towards 5-hydroxytryptamine 5A receptor using lysergic acid diethylamide (LSD) as radioligand,B,,,,,,,,,10624,H,8,Expert,1,,CHEMBL618086,,BAO_0000357,,
3602,16633,Binding affinities against 5-hydroxytryptamine 5A receptor,B,,,,,,,,,10624,H,8,Autocuration,1,,CHEMBL875092,,BAO_0000357,,
3603,16633,Binding affinities towards 5-hydroxytryptamine 5A receptor,B,,,,,,,,,10624,H,8,Autocuration,1,,CHEMBL618087,,BAO_0000357,,
3604,16700,The binding affinity towards 5-hydroxytryptamine 5A receptor; No affinity,B,,,,,,,,,10624,H,8,Autocuration,1,,CHEMBL872926,,BAO_0000357,,
3605,4639,Percent of control response to 5-HT3 agonistic activity on guinea colon at a concentration 0.01 uM,F,,,Cavia porcellus,10141.0,,,,,104714,H,4,Autocuration,1,,CHEMBL618088,,BAO_0000019,,
3606,5486,Binding affinity towards 5-HT3 receptor by the displacement of [3H]GR-65630] in human recombinant receptors in mammalian cell,B,,,,,,,,,104714,H,4,Autocuration,1,,CHEMBL618089,,BAO_0000223,,
3607,16146,Inhibition of human 5-hydroxytryptamine 6 receptor,B,,,Homo sapiens,9606.0,,,,,10627,D,9,Expert,1,,CHEMBL618090,,BAO_0000357,,
3608,17273,Binding affinity towards 5-hydroxytryptamine 6 receptor using [3H]- LSD as radioligand,B,,,Homo sapiens,9606.0,,,,,10627,D,9,Expert,1,,CHEMBL618091,,BAO_0000357,,
3609,17687,Inhibition against human 5-hydroxytryptamine 6 receptor,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL618092,,BAO_0000357,,
3610,6491,Affinity towards human 5-hydroxytryptamine 6 serotonin receptor,B,,,Homo sapiens,9606.0,,,,,10627,D,9,Expert,1,,CHEMBL618093,,BAO_0000357,,
3611,16190,Binding affinity as displacement of [3H]5-HT binding to 5-hydroxytryptamine 6 receptor in HeLa cells.,B,,,,,,,HeLa,,10627,H,8,Expert,1,,CHEMBL618094,308.0,BAO_0000219,,
3612,17066,Binding affinity towards [3H]LSD-labeled human 5-hydroxytryptamine 6 receptor,B,,,Homo sapiens,9606.0,,,,,10627,D,9,Expert,1,,CHEMBL618095,,BAO_0000357,,
3613,17066,Binding affinity towards human 5-hydroxytryptamine 6 receptor,B,,,Homo sapiens,9606.0,,,,,10627,D,9,Expert,1,,CHEMBL875093,,BAO_0000357,,
3614,17066,Binding affinity towards human 5-hydroxytryptamine 6 receptor was evaluated using [125I]-2-iodo LSD as radioligand,B,,,Homo sapiens,9606.0,,,,,10627,D,9,Expert,1,,CHEMBL618096,,BAO_0000357,,
3615,17066,Binding affinity towards human 5-hydroxytryptamine 6 receptor was evaluated using [3H]-LSD as radioligand,B,,,Homo sapiens,9606.0,,,,,10627,D,9,Expert,1,,CHEMBL618118,,BAO_0000357,,
3616,3555,Binding affinity against 5-hydroxytryptamine 6 receptor,B,,,Homo sapiens,9606.0,,,,,10627,D,9,Expert,1,,CHEMBL618119,,BAO_0000357,,
3617,5808,Binding affinity towards human 5-hydroxytryptamine 6 receptor,B,,,,,,,,,10627,H,8,Expert,1,,CHEMBL618120,,BAO_0000357,,
3618,6013,Binding affinity towards human 5-hydroxytryptamine 6 receptor,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL618121,,BAO_0000357,,
3619,15818,"Binding affinity for human 5-hydroxytryptamine 6 receptor expressed in HEK 293 human embryonic kidney cells, [3H]-lysergic acid diethylamide as radioligand",B,,,,,,,HEK293,,10627,H,8,Expert,1,,CHEMBL618122,722.0,BAO_0000219,,
3620,16209,Binding affinity towards human 5-hydroxytryptamine 6 receptor using [3H]LSD as radioligand,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL618123,,BAO_0000357,,
3621,3935,Binding affinity against human 5-hydroxytryptamine 6 receptor stably transfected to HEK 293 human embryonic kidney cells using [3H]-lysergic acid diethylamide as radioligand,B,,,,,,,HEK293,,10627,H,8,Expert,1,,CHEMBL618124,722.0,BAO_0000219,,
3622,15818,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 6 receptor,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL618125,,BAO_0000357,,
3623,3805,Displacement of [3H]LSD from human 5-hydroxytryptamine 6 receptor expressed in HEK 293 cells,B,,,Homo sapiens,9606.0,,,HEK293,,10627,D,9,Expert,1,,CHEMBL618126,722.0,BAO_0000219,,
3624,16441,Tested on cell membranes from transfected cells selectively expressing human 5-hydroxytryptamine 6 receptor incubated with 1 nM [3H]LSD,B,,,,,,,,,10627,H,8,Expert,1,,CHEMBL618236,,BAO_0000019,,
3625,16441,Tested on cell membranes from transfected cells selectively expressing human 5-hydroxytryptamine 6 receptor incubated with 1 nM [3H]LSD; ND is No Data.,B,,,,,,,,,10627,H,8,Expert,1,,CHEMBL618237,,BAO_0000019,,
3626,6786,Ability to displace [3H]LSD from human 5-hydroxytryptamine 6 receptor transiently expressed in COS-7 cells,B,,,,,,,COS-7,,10627,H,8,Expert,1,,CHEMBL618238,643.0,BAO_0000219,,
3627,4234,In vitro binding affinity to human 5-hydroxytryptamine 6 receptor,B,,,Homo sapiens,9606.0,,,,,10627,D,9,Expert,1,,CHEMBL618239,,BAO_0000357,,
3628,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 6 receptor,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL618240,,BAO_0000019,,
3629,17200,Inhibitory constant against human 5-hydroxytryptamine 6 receptor using [3H]LSD radioligand,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL618241,,BAO_0000357,,
3630,17451,Antagonism assessed in a functional cAMP binding assay using 5-CT to stimulate human 5-hydroxytryptamine 6 receptor expressed in HEK 293 cells,B,,,,,,,HEK293,,10627,H,8,Autocuration,1,,CHEMBL859399,722.0,BAO_0000219,,
3631,3935,The compound was tested for antagonist activity by inhibition of human 5-HT6 stimulated adenylate cyclase,F,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL618242,,BAO_0000019,,
3632,5033,Ability to displace the radioligand [3H]LSD from human 5-hydroxytryptamine 6 receptor,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL857991,,BAO_0000357,,
3633,4540,Binding affinity against human 5-hydroxytryptamine 6 receptor,B,,,,,,,,,10627,H,8,Expert,1,,CHEMBL619951,,BAO_0000357,,
3634,4540,Binding affinity to human cloned 5-HT6 receptor in HeLa cells using [3H]- LSD as radioligand,B,,,Homo sapiens,9606.0,,,HeLa,,10627,D,9,Expert,1,,CHEMBL619952,308.0,BAO_0000219,,
3635,4540,Binding affinity to human cloned 5-hydroxytryptamine 6 receptor in HeLa cells using [3H]- LSD as radioligand,B,,,Homo sapiens,9606.0,,,HeLa,,10627,D,9,Expert,1,,CHEMBL619953,308.0,BAO_0000219,,
3636,17296,Binding affinity against 5-hydroxytryptamine 6 human cloned receptors in HeLa cells,B,,,,,,,HeLa,,10627,H,8,Autocuration,1,,CHEMBL619954,308.0,BAO_0000219,,
3637,17296,Binding affinity against 5-hydroxytryptamine 6 human cloned receptors in HeLa cells using [3H]LSD as radioligand,B,,,,,,,HeLa,,10627,H,8,Autocuration,1,,CHEMBL619955,308.0,BAO_0000219,,
3638,17296,Binding affinity against 5-hydroxytryptamine 6 human cloned receptors in HeLa cells using [3H]LSD as radioligand,B,,,,,,,HeLa,,10627,H,8,Autocuration,1,,CHEMBL619956,308.0,BAO_0000219,,
3639,15779,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand,B,,,,,,,CHO,,10627,H,8,Autocuration,1,,CHEMBL619957,449.0,BAO_0000219,,
3640,15779,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand.,B,,,,,,,HEK293,,10627,H,8,Autocuration,1,,CHEMBL619958,722.0,BAO_0000219,,
3641,15779,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand; ND means no data.,B,,,,,,,HEK293,,10627,H,8,Autocuration,1,,CHEMBL620627,722.0,BAO_0000219,,
3642,15779,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand;ND means no data.,B,,,,,,,HEK293,,10627,H,8,Autocuration,1,,CHEMBL620628,722.0,BAO_0000219,,
3643,15779,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in HeLa cells using [3H]LSD as radioligand;ND means no data.,B,,,,,,,HeLa,,10627,H,8,Autocuration,1,,CHEMBL620629,308.0,BAO_0000219,,
3644,6166,Binding affinity towards human 5-hydroxytryptamine 6 receptor,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL620630,,BAO_0000357,,
3645,17451,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 6 receptor expressed in HeLa cells using [3H]LSD as radioligand,B,,,,,,,HeLa,,10627,H,8,Autocuration,1,,CHEMBL620782,308.0,BAO_0000219,,
3646,15316,Compound was evaluated for its ability to displace [3H]LSD binding from human recombinant 5-hydroxytryptamine 6 receptor,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL620783,,BAO_0000357,,
3647,4199,Binding affinity against human 5-hydroxytryptamine 6 receptor,B,,,,,,,,,10627,H,8,Expert,1,,CHEMBL620784,,BAO_0000357,,
3648,15146,Binding affinity against human cloned 5-hydroxytryptamine 6 receptor in HeLa cells using [3H]LSD,B,,,,,,,HeLa,,10627,H,8,Expert,1,,CHEMBL620785,308.0,BAO_0000219,,
3649,5213,Compound was tested for its binding affinity in 5-hydroxytryptamine 6 receptor (using human cloned receptors in HeLa and [3H]LSD as a radioligand ),B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL857992,,BAO_0000357,,
3650,16429,In vitro binding affinity at human recombinant 5-hydroxytryptamine 6 receptor in mammalian cells using 3[H]LSD as the radioligand,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL620786,,BAO_0000219,,
3651,14818,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 6 receptor in HeLa cells using [3H]5-LSD.,B,,,,,,,HeLa,,10627,H,8,Autocuration,1,,CHEMBL620787,308.0,BAO_0000219,,
3652,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 6 receptor in HeLa cells, using [3H]5-LSD as radioligand; n=3",B,,,,,,,HeLa,,10627,H,8,Autocuration,1,,CHEMBL620788,308.0,BAO_0000219,,
3653,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 6 receptor in HeLa cells, using [3H]5-LSD as radioligand; n=9",B,,,,,,,HeLa,,10627,H,8,Autocuration,1,,CHEMBL620789,308.0,BAO_0000219,,
3654,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 6 receptor in HeLa cells, using [3H]LSD as radioligand; n=3",B,,,,,,,HeLa,,10627,H,8,Autocuration,1,,CHEMBL620790,308.0,BAO_0000219,,
3655,15250,Compound was tested for the displacement of [3H]5-HT binding to cloned rat 5-hydroxytryptamine 6 receptor stably expressed in CHO cells,B,,,,,,,CHO,,10628,H,8,Autocuration,1,,CHEMBL620791,449.0,BAO_0000219,,
3656,14423,Binding affinity against 5-hydroxytryptamine 6 receptor from CHO cell membranes using [3H]5-HT as the radioligand.,B,,,,,,,,,10628,H,8,Autocuration,1,,CHEMBL620792,,BAO_0000019,,
3657,15086,The compound was tested for binding affinity against 5-hydroxytryptamine 6 receptor,B,,,,,,,,,10628,H,8,Autocuration,1,,CHEMBL620793,,BAO_0000357,,
3658,4342,Binding affinity of compound towards serotonin 5-hydroxytryptamine 6 receptor was determined,B,,,,,,,,,10628,H,8,Autocuration,1,,CHEMBL620794,,BAO_0000357,,
3659,16190,Binding affinity as displacement of [3H]5-HT binding to 5-hydroxytryptamine 6 receptor in HeLa cells,B,,,Homo sapiens,9606.0,,,HeLa,,10627,D,9,Autocuration,1,,CHEMBL620795,308.0,BAO_0000219,,
3660,4820,Binding affinity towards human 5-hydroxytryptamine 6 receptor,B,,,,,,,,,10627,H,8,Expert,1,,CHEMBL620796,,BAO_0000357,,
3661,4639,Percentage of displacement at 5-hydroxytryptamine 6 receptor at 10e-8 M,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL620797,,BAO_0000357,,
3662,17066,Antagonistic activity towards 5-hydroxytryptamine 6 receptor was evaluated in cAMP assay,F,,,Homo sapiens,9606.0,,,,,10627,D,9,Expert,1,,CHEMBL620798,,BAO_0000019,,
3663,6011,Inhibition of binding towards 5-hydroxytryptamine 6 receptor at 100 nM concentration,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL620799,,BAO_0000357,,
3664,17066,Binding affinity towards human 5-hydroxytryptamine 6 receptor,B,,,,,,,,,10627,H,8,Expert,1,,CHEMBL620800,,BAO_0000357,,
3665,17515,Binding affinity of compound towards serotonin 5-hydroxytryptamine 6 receptor; inactive at 10 uM,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL620801,,BAO_0000357,,
3666,5014,Compound was tested for its binding affinity towards 5-hydroxytryptamine 6 receptor,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL875100,,BAO_0000357,,
3667,4373,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 6 receptor was determined,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL620802,,BAO_0000357,,
3668,17066,Antagonistic activity towards 5-hydroxytryptamine 6 receptor,F,,,,,,,,,10627,H,8,Expert,1,,CHEMBL620803,,BAO_0000019,,
3669,17066,Antagonistic activity towards 5-hydroxytryptamine 6 receptor was evaluated in cAMP assay,F,,,,,,,,,10627,H,8,Expert,1,,CHEMBL620804,,BAO_0000019,,
3670,4373,Binding affinity for 5-hydroxytryptamine 6 receptor was determined,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL620805,,BAO_0000357,,
3671,4687,Evaluated for the binding affinity towards 5-hydroxytryptamine 6 receptor,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL620806,,BAO_0000357,,
3672,16946,Ability to displace [125I]LSD 113808 from 5-hydroxytryptamine 6 receptor at concentration of 10e-6 M,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL620807,,BAO_0000357,,
3673,16946,Ability to displace [125I]LSD 113808 from 5-hydroxytryptamine 6 receptor at concentration of 10e-8 M,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL620808,,BAO_0000357,,
3674,16633,Binding affinities against 5-hydroxytryptamine 6 receptor,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL620809,,BAO_0000357,,
3675,16633,Binding affinities towards 5-hydroxytryptamine 6 receptor,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL620810,,BAO_0000357,,
3676,17066,Binding affinity towards 5-hydroxytryptamine 6 receptor,B,,,Homo sapiens,9606.0,,,,,10627,D,9,Expert,1,,CHEMBL620811,,BAO_0000357,,
3677,16700,The binding affinity towards 5-hydroxytryptamine 6 receptor; No affinity,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL620812,,BAO_0000357,,
3678,3269,Affinity against 5-hydroxytryptamine 6 receptor,B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL620813,,BAO_0000357,,
3679,5486,Binding affinity towards human recombinant 5-hydroxytryptamine 7 receptor by the displacement of [3H]-5-CT],B,,,,,,,,,10627,H,8,Autocuration,1,,CHEMBL620814,,BAO_0000357,,
3680,16146,Inhibition of human 5-hydroxytryptamine 7 receptor,B,,,Homo sapiens,9606.0,,,,,10209,D,9,Expert,1,,CHEMBL620815,,BAO_0000357,,
3681,5014,Compound was tested for its binding affinity towards human 5-hydroxytryptamine 7 receptor from HEK293 cells using radioligand [3H]LSD,B,,,,,,,HEK293,,10209,H,8,Autocuration,1,,CHEMBL620816,722.0,BAO_0000219,,
3682,15463,Compound at 1 uM was tested for the inhibition of radioligand [3H]LSD binding to recombinant human 5-hydroxytryptamine 7 receptor,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL620817,,BAO_0000357,,
3683,3805,In vitro binding affinity against human 5-hydroxytryptamine 7 receptor at a concentration of 100 (nM),B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL620818,,BAO_0000357,,
3684,5014,Inhibition (at 1 uM) of radioligand [3H]LSD binding to human 5-hydroxytryptamine 7 receptor on HEK293 cells,B,,,,,,,HEK293,,10209,H,8,Expert,1,,CHEMBL620819,722.0,BAO_0000219,,
3685,6491,Affinity towards human 5-hydroxytryptamine 7 serotonin receptor,B,,,Homo sapiens,9606.0,,,,,10209,D,9,Expert,1,,CHEMBL620820,,BAO_0000357,,
3686,16190,Binding affinity for 5-hydroxytryptamine 7 receptor human cloned receptors in CHO cells using [3H]5-HT,B,,,,,,,CHO,,10209,H,8,Autocuration,1,,CHEMBL620821,449.0,BAO_0000219,,
3687,17066,Binding affinity towards human 5-hydroxytryptamine 7 receptor,B,,,Homo sapiens,9606.0,,,,,10209,D,9,Expert,1,,CHEMBL620822,,BAO_0000357,,
3688,17066,Displacement of [3H]5-HT from human 5-hydroxytryptamine 7 receptor,B,,,Homo sapiens,9606.0,,,,,10209,D,9,Expert,1,,CHEMBL620823,,BAO_0000357,,
3689,3555,Binding affinity against 5-hydroxytryptamine 7 receptor,B,,,Homo sapiens,9606.0,,,,,10209,D,9,Expert,1,,CHEMBL620824,,BAO_0000357,,
3690,6588,Binding affinity towards human 5-hydroxytryptamine 7 receptor by the displacement of [3H]-5-HT radioligand from the cloned receptor expressed in CHO cells,B,,,,,,,CHO,,10209,H,8,Expert,1,,CHEMBL620825,449.0,BAO_0000219,,
3691,15463,Binding affinity towards recombinant human 5-hydroxytryptamine 7 receptor was determined using [3H]LSD as radioligand,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL872930,,BAO_0000357,,
3692,6013,Binding affinity towards 5-hydroxytryptamine 7 receptor,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL620826,,BAO_0000357,,
3693,16209,Binding affinity towards human 5-hydroxytryptamine 7 receptor using [3H]5-HT as radioligand,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL620827,,BAO_0000357,,
3694,3935,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 7 receptor,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL620828,,BAO_0000357,,
3695,15818,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 7 receptor,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL620829,,BAO_0000357,,
3696,5014,Binding affinity towards human 5-hydroxytryptamine 7 receptor on HEK293 cells using radioligand [3H]LSD,B,,,,,,,HEK293,,10209,H,8,Expert,1,,CHEMBL620830,722.0,BAO_0000219,,
3697,16441,Tested on cell membranes from transfected cells selectively expressing human 5-hydroxytryptamine 7 receptor incubated with 1 nM [3H]LSD,B,,,,,,,,,10209,H,8,Expert,1,,CHEMBL620831,,BAO_0000019,,
3698,16441,Tested on cell membranes from transfected cells selectively expressing human 5-hydroxytryptamine 7 receptor incubated with 1 nM [3H]LSD; ND is No Data.,B,,,,,,,,,10209,H,8,Expert,1,,CHEMBL620832,,BAO_0000019,,
3699,4234,In vitro binding affinity to human 5-hydroxytryptamine 7 receptor,B,,,Homo sapiens,9606.0,,,,,10209,D,9,Expert,1,,CHEMBL621548,,BAO_0000357,,
3700,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 7 receptor,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL621549,,BAO_0000019,,
3701,17200,Inhibitory constant against human 5-hydroxytryptamine 7 receptor using [3H]LSD radioligand,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL621550,,BAO_0000357,,
3702,17451,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 7 receptor expressed in CHO cells using [3H]-LSD as radioligand; Not determined,B,,,,,,,CHO,,10209,H,8,Autocuration,1,,CHEMBL621551,449.0,BAO_0000219,,
3703,17085,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 7 receptor; ND means not determined,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL621552,,BAO_0000019,,
3704,5104,Binding affinity for human cloned 5-hydroxytryptamine 7 receptor,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL857077,,BAO_0000357,,
3705,5104,Binding affinity for human cloned 5-hydroxytryptamine 7 receptor; Not tested,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL618158,,BAO_0000357,,
3706,5033,Ability to displace the radioligand [3H]5-carboxyamidotryptamine ([3H]5-CT) from human 5-hydroxytryptamine 7 receptor expressed in COS-7 cells,B,,,Homo sapiens,9606.0,,,COS-7,,10209,D,9,Expert,1,,CHEMBL618159,643.0,BAO_0000219,,
3707,5486,Ability to displace the radioligand [3H]5-carboximidotryptamine ([3H]-5-CT) from cloned human 5-hydroxytryptamine 7 receptor expressed in COS-7 cells,B,,,,,,,COS-7,,10209,H,8,Autocuration,1,,CHEMBL875101,643.0,BAO_0000219,,
3708,4540,Binding affinity to human cloned 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]-5-CT as radioligand,B,,,Homo sapiens,9606.0,,,HEK293,,10209,D,9,Expert,1,,CHEMBL618160,722.0,BAO_0000219,,
3709,6166,Binding affinity at human cloned 5-hydroxytryptamine 7 receptor.,B,,,,,,,,,10209,H,8,Expert,1,,CHEMBL618161,,BAO_0000357,,
3710,17342,Binding affinity towards cloned human 5-hydroxytryptamine 7 receptor was determined in HEK293 cells using [3H]5-CT as radioligand,B,,,,,,,HEK293,,10209,H,8,Expert,1,,CHEMBL618162,722.0,BAO_0000219,,
3711,17342,Binding affinity towards human recombinant 5-hydroxytryptamine 7 receptor was determined using [3H]5-CT as radioligand,B,,,,,,,,,10209,H,8,Expert,1,,CHEMBL618163,,BAO_0000357,,
3712,17296,Binding affinity against 5-hydroxytryptamine 7 human receptors,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL618164,,BAO_0000357,,
3713,16429,Binding affinity to human recombinant 5-hydroxytryptamine 7 receptor in mammalian cells using [3H]5-CT as radioligand,B,,,,,,,,,10209,H,8,Expert,1,,CHEMBL618165,,BAO_0000219,,
3714,15779,Binding affinity toward 5-hydroxytryptamine 7 receptor (human cloned receptor) in HEK 293 cells using [3H]-5-CT as radioligand.,B,,,,,,,HEK293,,10209,H,8,Autocuration,1,,CHEMBL618166,722.0,BAO_0000219,,
3715,15779,Binding affinity towards 5-hydroxytryptamine 7 receptor (a) (human cloned receptor) in HEK 293 cells using [3H]5-CT as radioligand.,B,,,,,,,HEK293,,10209,H,8,Autocuration,1,,CHEMBL857989,722.0,BAO_0000219,,
3716,15779,Binding affinity towards 5-hydroxytryptamine 7 receptor (human cloned receptor) in HEK 293 cells using [3H]5-CT as radioligand.,B,,,,,,,HEK293,,10209,H,8,Autocuration,1,,CHEMBL619888,722.0,BAO_0000219,,
3717,15779,Binding affinity towards 5-hydroxytryptamine 7 receptor (human cloned receptor) in HEK 293 cells using [3H]5-CT as radioligand.,B,,,,,,,HEK293,,10209,H,8,Autocuration,1,,CHEMBL619889,722.0,BAO_0000219,,
3718,15779,Binding affinity towards 5-hydroxytryptamine 7 receptor 7(a) (human cloned receptor in HEK 293 cells using [3H]5-CT as radioligand.,B,,,,,,,HEK293,,10209,H,8,Autocuration,1,,CHEMBL619890,722.0,BAO_0000219,,
3719,17451,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 7 receptor expressed in CHO cells using [3H]LSD as radioligand,B,,,,,,,CHO,,10209,H,8,Autocuration,1,,CHEMBL619891,449.0,BAO_0000219,,
3720,4199,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]5-CT as the radioligand (n=3),B,,,,,,,HEK293,,10209,H,8,Autocuration,1,,CHEMBL619892,722.0,BAO_0000219,,
3721,4199,Displacement of [3H]-5-CT from human 5-hydroxytryptamine 7 receptor expressed in HEK-293 cells,B,,,,,,,HEK293,,10209,D,9,Expert,1,,CHEMBL619893,722.0,BAO_0000219,,
3722,4199,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]5-CT as the radioligand(n=6),B,,,,,,,HEK293,,10209,H,8,Autocuration,1,,CHEMBL619894,722.0,BAO_0000219,,
3723,3680,Binding affinity towards cloned human 5-hydroxytryptamine 7 receptor in HEK 293 cells,B,,,,,,,HEK293,,10209,D,9,Intermediate,1,,CHEMBL619895,722.0,BAO_0000219,,
3724,3680,Binding affinity towards human recombinant 5-hydroxytryptamine 7 receptor using [3H]5-CT as radioligand,B,,,,,,,,,10209,D,9,Intermediate,1,,CHEMBL619896,,BAO_0000357,,
3725,15316,Compound was evaluated for its ability to displace [3H]5-CT binding from cloned human 5-hydroxytryptamine 7 receptor expressed in COS-7 cells.,B,,,,,,,COS-7,,10209,H,8,Autocuration,1,,CHEMBL619897,643.0,BAO_0000219,,
3726,15146,Compound was tested for its binding affinity against human cloned 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]5-CT,B,,,,,,,HEK293,,10209,H,8,Autocuration,1,,CHEMBL619898,722.0,BAO_0000219,,
3727,5213,Binding affinity for human cloned 5-hydroxytryptamine 7 receptor in HEK 293 using [3H]5-CT as a radioligand,B,,,,,,,HEK293,,10209,H,8,Expert,1,,CHEMBL619899,722.0,BAO_0000219,,
3728,5213,Compound was tested for its binding affinity in 5-hydroxytryptamine 7 receptor (using human cloned receptors in HEK 293 and [3H]5-CT as a radioligand ),B,,,,,,,HEK293,,10209,H,8,Autocuration,1,,CHEMBL619900,722.0,BAO_0000219,,
3729,14818,Binding affinity towards cloned human 5-hydroxytryptamine 7 receptor expressed in HEK 293 cells using [3H]5-CT,B,,,Homo sapiens,9606.0,,,HEK293,,10209,D,9,Expert,1,,CHEMBL619901,722.0,BAO_0000219,,
3730,14818,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 7 receptor expressed in HEK 293 cells using [3H]5-CT. ,B,,,,,,,HEK293,,10209,H,8,Autocuration,1,,CHEMBL620580,722.0,BAO_0000219,,
3731,14818,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]5-CT.,B,,,,,,,HEK293,,10209,H,8,Autocuration,1,,CHEMBL620581,722.0,BAO_0000219,,
3732,4829,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 7 receptor in HEK293 cells, using [3H]5-CT as radioligand",B,,,,,,,HEK293,,10209,H,8,Autocuration,1,,CHEMBL620733,722.0,BAO_0000219,,
3733,17200,Inhibitory constant against human 5-hydroxytryptamine 7 receptor using [3H]-LSD radioligand; Not determined,B,,,Homo sapiens,9606.0,,,,,10209,D,9,Autocuration,1,,CHEMBL620734,,BAO_0000357,,
3734,17066,Binding affinity towards mouse 5-hydroxytryptamine 7 receptor was evaluated using [3H]5-HT as radioligand,B,,,Mus musculus,10090.0,,,,,10022,D,9,Expert,1,,CHEMBL620735,,BAO_0000357,,
3735,14025,The dissociation equilibrium constant (pKB=-log KB) of compound was determined against the vascular 5-hydroxytryptamine 7 receptor in the endothelium denuded rabbit jugular vein.,B,,,Oryctolagus cuniculus,9986.0,,,,,10209,H,8,Autocuration,1,,CHEMBL620736,,BAO_0000019,,
3736,15250,Compound was tested for the displacement of [3H]5-HT binding to cloned rat 5-hydroxytryptamine 7 receptor stably expressed in CHO cells,B,,,,,,,CHO,,11923,H,8,Autocuration,1,,CHEMBL620737,449.0,BAO_0000219,,
3737,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors at a concentration of 10000 nM,B,,,,,,,CHO,,11923,H,8,Autocuration,1,,CHEMBL620738,449.0,BAO_0000219,,
3738,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors at a concentration of 100 nM,B,,,,,,,CHO,,11923,H,8,Autocuration,1,,CHEMBL620739,449.0,BAO_0000219,,
3739,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors at a concentration of 1 nM,B,,,,,,,CHO,,11923,H,8,Autocuration,1,,CHEMBL620740,449.0,BAO_0000219,,
3740,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors by 10000 nM 5-HT.,B,,,,,,,CHO,,11923,H,8,Autocuration,1,,CHEMBL620741,449.0,BAO_0000219,,
3741,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors by 100 nM 5-HT.,B,,,,,,,CHO,,11923,H,8,Autocuration,1,,CHEMBL620742,449.0,BAO_0000219,,
3742,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors by 1 nM 5-HT,B,,,,,,,CHO,,11923,H,8,Autocuration,1,,CHEMBL620743,449.0,BAO_0000219,,
3743,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors at a concentration of 10000 nM,B,,,,,,,CHO,,11923,H,8,Autocuration,1,,CHEMBL620744,449.0,BAO_0000219,,
3744,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors at a concentration of 100 nM,B,,,,,,,CHO,,11923,H,8,Autocuration,1,,CHEMBL620745,449.0,BAO_0000219,,
3745,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors at a concentration of 1 nM,B,,,,,,,CHO,,11923,H,8,Autocuration,1,,CHEMBL620746,449.0,BAO_0000219,,
3746,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors by 10000 nM 5-HT.,B,,,,,,,CHO,,11923,H,8,Autocuration,1,,CHEMBL620747,449.0,BAO_0000219,,
3747,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors by 100 nM 5-HT.,B,,,,,,,CHO,,11923,H,8,Autocuration,1,,CHEMBL620748,449.0,BAO_0000219,,
3748,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors by 1 nM 5-HT.,B,,,,,,,CHO,,11923,H,8,Autocuration,1,,CHEMBL620749,449.0,BAO_0000219,,
3749,17066,Binding affinity towards rat 5-hydroxytryptamine 7 receptor,B,,,,,,,,,11923,H,8,Expert,1,,CHEMBL620750,,BAO_0000357,,
3750,17066,Binding affinity towards rat 5-hydroxytryptamine 7 receptor was evaluated using [3H]5-HT as radioligand,B,,,Rattus norvegicus,10116.0,,,,,11923,D,9,Expert,1,,CHEMBL620751,,BAO_0000357,,
3751,17386,Binding affinity to the rat 5-hydroxytryptamine 7 receptor,B,,,,,,,,,11923,H,8,Expert,1,,CHEMBL620752,,BAO_0000357,,
3752,14423,Binding affinity against 5-hydroxytryptamine 7 receptor using from CHO cell membranes [3H]5-HT as the radioligand.,B,,,,,,,,,11923,H,8,Autocuration,1,,CHEMBL872929,,BAO_0000019,,
3753,15874,Binding affinity against Rat 5-hydroxytryptamine 7 receptor using [3H]5-HT,B,,,Rattus norvegicus,10116.0,,,,,11923,D,9,Expert,1,,CHEMBL620753,,BAO_0000357,,
3754,15874,Displacement of [3H]5-HT from over-expressed rat 5-hydroxytryptamine 7 receptor,B,,,Rattus norvegicus,10116.0,,,,,11923,D,9,Expert,1,,CHEMBL620754,,BAO_0000357,,
3755,16372,Displacement of [3H]5-HT from rat 5-hydroxytryptamine 7 receptor expressed in CHO cells,B,,,Rattus norvegicus,10116.0,,,CHO,,11923,D,9,Expert,1,,CHEMBL620755,449.0,BAO_0000219,,
3756,4622,In vitro binding affinity towards cloned rat 5-hydroxytryptamine 7 receptor using [3H]5-HT as radioligand,B,,,,,,,,,11923,H,8,Autocuration,1,,CHEMBL620756,,BAO_0000357,,
3757,15086,The compound was tested for binding affinity against 5-hydroxytryptamine 7 receptor,B,,,,,,,,,11923,H,8,Autocuration,1,,CHEMBL620757,,BAO_0000357,,
3758,16372,"Effect of compound on stimulation of cAMP production in CHO cells expressing rat 5-HT7 receptors at 1, 10, 100 1000 and 10000 nM conc; Not tested",B,,,,,,,CHO,,11923,H,8,Autocuration,1,,CHEMBL620758,449.0,BAO_0000219,,
3759,16372,"Effect of compound on stimulation of cAMP production in CHO cells expressing rat 5-HT7 receptors at 1, 10, 100 1000 and 10000 nM conc; not tested",B,,,,,,,CHO,,11923,H,8,Autocuration,1,,CHEMBL620759,449.0,BAO_0000219,,
3760,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors at a concentration of 1 nM; not tested,B,,,,,,,CHO,,11923,H,8,Autocuration,1,,CHEMBL620760,449.0,BAO_0000219,,
3761,16372,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors by 1 nM 5-HT; Not tested,B,,,,,,,CHO,,11923,H,8,Autocuration,1,,CHEMBL620761,449.0,BAO_0000219,,
3762,17386,Maximal relaxation effect induced by 3 uM compound on substance P stimulated guinea pig ileum with 5-hydroxytryptamine 7 receptor desensitization,F,,,,,,Ileum,,,11923,H,8,Autocuration,1,,CHEMBL620762,,BAO_0000221,2116.0,
3763,17386,Maximal relaxation effect induced by 3 uM compound on substance P stimulated guinea pig ileum with 5-hydroxytryptamine 7 receptor nondesensitization,F,,,,,,Ileum,,,11923,H,8,Autocuration,1,,CHEMBL620763,,BAO_0000221,2116.0,
3764,17386,Maximal relaxation effect induced by 3 uM compound on substance P stimulated guinea pig ileum with 5-hydroxytryptamine receptor desensitization,F,,,,,,Ileum,,,11923,H,8,Autocuration,1,,CHEMBL620764,,BAO_0000221,2116.0,
3765,5831,Inhibition of [3H]-5-CT binding to 5-hydroxytryptamine 7 receptor of rat cortical membranes,B,,,Rattus norvegicus,10116.0,,,,Membranes,11923,D,9,Expert,1,,CHEMBL857990,,BAO_0000249,,
3766,4342,Binding affinity of compound towards serotonin 5-hydroxytryptamine 7 receptor was determined,B,,,,,,,,,11923,H,8,Autocuration,1,,CHEMBL620765,,BAO_0000357,,
3767,17319,Binding affinity at rat 5-hydroxytryptamine 7 receptor.,B,,,,,,,,,11923,H,8,Expert,1,,CHEMBL620766,,BAO_0000357,,
3768,17342,Binding affinity towards 5-hydroxytryptamine receptor 7 on rat hypothalamus membranes using [3H]5-CT as radioligand.,B,,,,,,Hypothalamus,,,11923,H,8,Expert,1,,CHEMBL620767,,BAO_0000019,1898.0,
3769,17342,Binding affinity towards cloned rat 5-hydroxytryptamine 7 receptor was determined using [3H]5-HT as radioligand,B,,,,,,,,,11923,H,8,Autocuration,1,,CHEMBL620768,,BAO_0000357,,
3770,3680,Binding affinity against 5-hydroxytryptamine 7 receptor using [3H]-5-CT in rat hypothalamus membranes,B,,,,,,Hypothalamus,,,11923,H,8,Expert,1,,CHEMBL619051,,BAO_0000249,1898.0,
3771,3680,Binding affinity towards 5-hydroxytryptamine 7 receptor,B,,,,,,,,,11923,H,8,Expert,1,,CHEMBL619052,,BAO_0000357,,
3772,17319,Agonistic activity against rat 5-HT7 adenyl cyclase expressed by HEK293 cells,F,,,Rattus norvegicus,10116.0,,,HEK293,,11923,D,9,Expert,1,,CHEMBL619053,722.0,BAO_0000219,,
3773,17319,Agonistic activity against rat 5-HT7 adenyl cyclase expressed in HEK293 cells; Active,F,,,Rattus norvegicus,10116.0,,,HEK293,,11923,D,9,Expert,1,,CHEMBL619703,722.0,BAO_0000219,,
3774,17319,Agonistic activity against rat 5-HT7-adenyl cyclase expressed by HEK293 cells; Active,F,,,Rattus norvegicus,10116.0,,,HEK293,,11923,D,9,Autocuration,1,,CHEMBL619704,722.0,BAO_0000219,,
3775,4820,Binding affinity towards 5-hydroxytryptamine 7 receptor,B,,,,,,,,,10209,H,8,Expert,1,,CHEMBL619851,,BAO_0000357,,
3776,4639,Percentage of displacement at 5-hydroxytryptamine 7 receptor at 10e-8 M,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL619852,,BAO_0000357,,
3777,6011,Inhibition of binding towards 5-hydroxytryptamine 7 receptor at 100 nM concentration,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL619853,,BAO_0000357,,
3778,17066,Binding affinity towards human 5-hydroxytryptamine 7 receptor,B,,,Homo sapiens,9606.0,,,,,10209,D,9,Expert,1,,CHEMBL619854,,BAO_0000357,,
3779,17066,Binding affinity of compound towards rodent 5-hydroxytryptamine 7 receptor,B,,,,,,,,,10209,H,8,Expert,1,,CHEMBL619855,,BAO_0000357,,
3780,17515,Binding affinity of compound towards serotonin 5-hydroxytryptamine 7 receptor; inactive at 10 uM,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL619856,,BAO_0000357,,
3781,4373,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 7 receptor was determined,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL619857,,BAO_0000357,,
3782,17066,Antagonistic activity towards 5-hydroxytryptamine 7 receptor was evaluated by cAMP assay,F,,,,,,,,,10209,H,8,Expert,1,,CHEMBL619858,,BAO_0000019,,
3783,4373,Binding affinity for 5-hydroxytryptamine 7 receptor was determined,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL619859,,BAO_0000357,,
3784,4373,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 7 receptor was determined,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL619860,,BAO_0000357,,
3785,4687,Evaluated for the binding affinity to 5-hydroxytryptamine 7 receptor,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL619861,,BAO_0000357,,
3786,17342,Non-selective inhibitory activity was determined against 5-hydroxytryptamine 7 receptor,B,,,,,,,,,10209,H,8,Expert,1,,CHEMBL619862,,BAO_0000357,,
3787,16946,Ability to displace [125I]LSD 113808 from 5-hydroxytryptamine 7 receptor at concentration of 10e-6 M,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL619863,,BAO_0000357,,
3788,16946,Ability to displace [125I]LSD 113808 from 5-hydroxytryptamine 7 receptor at concentration of 10e-8 M,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL619864,,BAO_0000357,,
3789,16633,Binding affinities against 5-hydroxytryptamine 7 receptor,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL872928,,BAO_0000357,,
3790,16633,Binding affinities towards 5-hydroxytryptamine 7 receptor,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL619865,,BAO_0000357,,
3791,17066,Binding affinity towards rodent 5-hydroxytryptamine 7 receptor,B,,,,,,,,,10209,H,8,Expert,1,,CHEMBL619866,,BAO_0000357,,
3792,16700,The binding affinity towards 5-hydroxytryptamine 7 receptor; No affinity,B,,,,,,,,,10209,H,8,Autocuration,1,,CHEMBL619867,,BAO_0000357,,
3793,17386,Maximal relaxation effect induced by 3 uM compound on substance P stimulated guinea pig ileum with 5-hydroxytryptamine 7 receptor desensitization,B,,,,,,Ileum,,,10209,H,8,Autocuration,1,,CHEMBL619868,,BAO_0000221,2116.0,
3794,14080,Compound was evaluated for the potency to inhibit oxidation of arachidonic acid by human recombinant 5-Lipoxygenase using a spectrophotometric assay,F,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL619869,,BAO_0000019,,
3795,14080,Inhibition of oxidation of arachidonic acid by human 5-Lipoxygenase using spectrophotometric assay,F,,,Homo sapiens,9606.0,,,,,55,D,9,Expert,1,,CHEMBL619870,,BAO_0000019,,
3796,409,In vitro inhibition of human recombinant 5-lipoxygenase enzyme,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL619871,,BAO_0000357,,
3797,409,In vitro inhibition of human recombinant lipoxygenase enzyme,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL619872,,BAO_0000357,,
3798,409,In vitro inhibition of human recombinant lipoxygenase enzyme; No inhibition,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL619873,,BAO_0000357,,
3799,11090,Inhibition of 5-lipoxygenase in human whole blood.,B,,,,,,Blood,,,55,H,8,Expert,1,,CHEMBL619874,,BAO_0000357,178.0,
3800,11090,Inhibition of 5-lipoxygenase in human whole blood.,B,,,,,,Blood,,,55,H,8,Expert,1,,CHEMBL619875,,BAO_0000357,178.0,
3801,948,Compound was tested for the inhibition of 5-lipoxygenase of human PMN stimulated by calcium ionophore A-23187 for the formation of 5-HETE,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL619876,,BAO_0000357,,
3802,948,Compound was tested for the inhibition of 5-lipoxygenase of human PMN stimulated by calcium ionophore A-23187 for the formation of leukotriene B4 (LTB4),B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL619877,,BAO_0000357,,
3803,13622,In vitro 5-lipoxygenase inhibitory activity against calcium ionophore (A23187) induced LTB4 formation in human polymorphonuclear leukocytes.,F,,,,,,,,,55,H,8,Expert,1,,CHEMBL619878,,BAO_0000219,,
3804,13622,In vitro 5-lipoxygenase inhibitory activity against calcium ionophore (A23187) induced LTB4 formation in human whole blood,F,,,,,,Blood,,,55,H,8,Autocuration,1,,CHEMBL619879,,BAO_0000019,178.0,
3805,9637,In vitro inhibition of 5-lipoxygenase from human polymorphs,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL619880,,BAO_0000357,,
3806,11320,In vitro inhibition of leukotriene B4 synthesis in human whole blood by inhibiting 5-LPO (5-lipoxygenase),B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL619881,,BAO_0000357,,
3807,11320,In vitro inhibition of leukotriene B4 synthesis in human whole blood by inhibiting 5-lipoxygenase,B,,,,,,,,,55,H,8,Expert,1,,CHEMBL619882,,BAO_0000357,,
3808,6838,In vitro inhibitory activity against 5-lipoxygenase in a human whole blood assay,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL619883,,BAO_0000357,,
3809,17667,Inhibition of 5-Lipoxygenase (5-LO) of human whole blood (HWB),B,,,Homo sapiens,9606.0,,Blood,,,55,D,9,Expert,1,,CHEMBL619884,,BAO_0000357,178.0,
3810,12703,In vitro potency against human 5-Lipoxygenase,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL619885,,BAO_0000357,,
3811,14312,Inhibitory activity against 5-lipoxygenase in Human whole blood (HWBL) stimulated with calcium ionophore (A23187) and LTB4 measured by enzyme immunoassay,F,,,Homo sapiens,9606.0,,,,,55,D,9,Expert,1,,CHEMBL619886,,BAO_0000019,,
3812,14312,Inhibition activity against 5-lipoxygenase in Human whole blood (HWBL) stimulated with calcium ionophore (A23187) and LTB4 measured by enzyme immunoassay; No data,F,,,,,,Blood,,,55,H,8,Autocuration,1,,CHEMBL619887,,BAO_0000019,178.0,
3813,5364,Inhibition of 5-lipoxygenase activity of compound evaluated as determined by the inhibition of calcium ionophore-induced leukotriene B4 production in human blood.,F,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL875097,,BAO_0000019,,
3814,951,Inhibition of 5-lipoxygenase was evaluated in human polymorphonuclear leukocytes stimulated by calcium ionophore A-23187 for formation of 5-HETE,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618001,,BAO_0000219,,
3815,951,Inhibition of 5-lipoxygenase was evaluated in human polymorphonuclear leukocytes stimulated by calcium ionophore A-23187 for formation of 5-HETE; NA means Not active,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618002,,BAO_0000219,,
3816,951,Inhibition of 5-lipoxygenase was evaluated in human polymorphonuclear leukocytes stimulated by calcium ionophore A-23187 for formation of LTB4,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618003,,BAO_0000219,,
3817,951,Inhibition of 5-lipoxygenase was evaluated in human polymorphonuclear leukocytes stimulated by calcium ionophore A-23187 for formation of LTB4; NA means Not active,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618004,,BAO_0000219,,
3818,12365,Inhibition of human 5-lipoxygenase in human cells,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618005,,BAO_0000219,,
3819,10603,Inhibition of human neutrophil 5-lipoxygenase,B,,,,,,,,,55,H,8,Expert,1,,CHEMBL618006,,BAO_0000357,,
3820,10501,Inhibitory activity against 5-lipoxygenase expressed from human polymorphonuclear cells,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL875086,,BAO_0000019,,
3821,12281,Inhibition of 5-lipoxygenase from human whole blood,B,,,,,,Blood,,,55,H,8,Expert,1,,CHEMBL618007,,BAO_0000357,178.0,
3822,2567,Inhibitory concentration required against 5-lipoxygenase activity in cytosolic fractions of human neutrophils,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618008,,BAO_0000357,,
3823,2567,Inhibitory concentration required against 5-lipoxygenase activity in intact cells of human neutrophils,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618009,,BAO_0000219,,
3824,10193,In vitro inhibition of polymorphonuclear leukocyte derived human 5-lipoxygenase,B,,,,,,,,,55,H,8,Expert,1,,CHEMBL618010,,BAO_0000357,,
3825,10193,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase in human cell at 10 uM,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618011,,BAO_0000357,,
3826,13623,Potency to inhibit oxidation of arachidonic acid by recombinant human 5-lipoxygenase,B,,,,,,,,,55,H,8,Expert,1,,CHEMBL618012,,BAO_0000357,,
3827,12780,Tested against 5-lipoxygenase,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL882927,,BAO_0000357,,
3828,12780,Tested for activity against 5-Lipoxygenase (5-LO),B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618013,,BAO_0000357,,
3829,12780,Tested for activity against 5-lipoxygenase,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618014,,BAO_0000357,,
3830,11966,Tested for inhibition of 5-HPETE production by human 5-LO,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618015,,BAO_0000357,,
3831,5364,The 5-lipoxygenase activity by the inhibition of calcium ionophore-induced leukotriene B4 production in human blood.,F,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618016,,BAO_0000019,,
3832,13165,Inhibition of Human 5-lipoxygenase,B,,,,,,,,,55,H,8,Expert,1,,CHEMBL618017,,BAO_0000357,,
3833,5364,The compound was evaluated for its inhibitory activity against 5-lipoxygenase using granulocytes-type cells,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618018,,BAO_0000019,,
3834,11311,The compound was tested for inhibitory activity against 5-lipoxygenase in human polymorphonuclear leukocytes[PMNS],B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL875087,,BAO_0000219,,
3835,11311,The compound was tested for inhibitory activity against LT synthesis in human polymorphonuclear leukocytes[PMNS],B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618019,,BAO_0000219,,
3836,14863,The compound was tested for the concentration (in uM) to inhibit 50% of 5-Lipoxygenase (5-LOX) and is expressed in IC50.,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618020,,BAO_0000019,,
3837,14863,The compound was tested for the concentration (in uM) to inhibit 50% of 5-Lipoxygenase (5-LOX) and is expressed in IC50; Not tested,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618021,,BAO_0000019,,
3838,11087,The compound was tested for the inhibition of 5-lipoxygenase (5-lo) in human whole blood (HWBL),B,,,,,,Blood,,,55,H,8,Autocuration,1,,CHEMBL618022,,BAO_0000357,178.0,
3839,455,The compound was tested in vitro for inhibition against 5-lipoxygenase in intact human neutrophils,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618023,,BAO_0000357,,
3840,13183,5-lipoxygenase Inhibitory activity was measured by enzyme immunoassay using human whole blood stimulated with calcium ionophore (A23187) and LTB4 (leukotriene B4),B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618024,,BAO_0000357,,
3841,10319,In vitro inhibitory activity against 5-lipoxygenase in human polymorphonuclear (PMN) cells,B,,,,,,,,,55,H,8,Expert,1,,CHEMBL873950,,BAO_0000019,,
3842,10193,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase in human cell at 10 uM,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618025,,BAO_0000357,,
3843,951,Inhibition of 5-lipoxygenase was evaluated in human polymorphonuclear leukocytes stimulated by calcium ionophore A-23187 for formation of 5-HETE at 10 uM,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618026,,BAO_0000219,,
3844,951,Inhibition of 5-lipoxygenase was evaluated in human polymorphonuclear leukocytes stimulated by calcium ionophore A-23187 for formation of 5-HETE at 10 uM; NA means Inactive,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618027,,BAO_0000219,,
3845,951,Inhibition of 5-lipoxygenase was evaluated in human polymorphonuclear leukocytes stimulated by calcium ionophore A-23187 for formation of LTB4 at 10 uM,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618028,,BAO_0000219,,
3846,951,Inhibition of 5-lipoxygenase was evaluated in human polymorphonuclear leukocytes stimulated by calcium ionophore A-23187 for formation of LTB4 at 10 uM; NA means Inactive,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618029,,BAO_0000219,,
3847,9859,Inhibitory activity against 5-lipoxygenase at 10 uM concentration,B,,,,,,,,,55,H,8,Expert,1,,CHEMBL618030,,BAO_0000357,,
3848,9859,Inhibitory activity against 5-lipoxygenase at 1 uM concentration,B,,,,,,,,,55,H,8,Expert,1,,CHEMBL618031,,BAO_0000357,,
3849,9859,Inhibitory activity against lipoxygenase (LO) at 10 uM concentration,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618032,,BAO_0000357,,
3850,2567,Inhibitory concentration required against 5-lipoxygenase activity in cytosolic fractions of human neutrophils,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618033,,BAO_0000357,,
3851,10193,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase in human cell at 1 uM,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618034,,BAO_0000357,,
3852,10193,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase in human cell at 10 uM,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL875088,,BAO_0000357,,
3853,949,Tested for the inhibition of 5-lipoxygenase from human polymorphonuclear leukocytes(PMN) at 10 uM concentration of the compound; IA= Inactive,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618035,,BAO_0000019,,
3854,949,Tested for the inhibition of 5-lipoxygenase from human polymorphonuclear leukocytes(PMN) at 10 uM concentration of the compound; value ranges from 70-90,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618036,,BAO_0000019,,
3855,10603,Inhibition of human neutrophil 5-lipoxygenase at the concentration of 0.1 uM,B,,,,,,,,,55,H,8,Expert,1,,CHEMBL618037,,BAO_0000357,,
3856,10603,Inhibition of human neutrophil 5-lipoxygenase at the concentration of 1 uM,B,,,,,,,,,55,H,8,Expert,1,,CHEMBL618038,,BAO_0000357,,
3857,10603,Inhibition of human neutrophil 5-lipoxygenase at the concentration of 1 uM,F,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618761,,BAO_0000019,,
3858,10603,Inhibition of lipoxygenase at the concentration of 0.1 uM,B,,,,,,,,,55,H,8,Expert,1,,CHEMBL618762,,BAO_0000357,,
3859,10603,Inhibition of lipoxygenase at the concentration of 1 uM,B,,,,,,,,,55,H,8,Expert,1,,CHEMBL618763,,BAO_0000357,,
3860,10193,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase in human cell,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618764,,BAO_0000357,,
3861,14580,Inhibition of 5-Lipoxygenase (5-LOX),B,,,Homo sapiens,9606.0,,,,,55,D,9,Expert,1,,CHEMBL618765,,BAO_0000357,,
3862,11090,Inhibition of 5-lipoxygenase in mouse macrophages.,B,,,,,,,,,17087,H,8,Expert,1,,CHEMBL618766,,BAO_0000357,,
3863,11090,Inhibition of 5-lipoxygenase in mouse macrophages.,B,,,,,,,,,17087,H,8,Expert,1,,CHEMBL618767,,BAO_0000357,,
3864,6339,Inhibitory activity against lipoxygenase-2 in mice,B,,,,,,,,,17087,H,8,Autocuration,1,,CHEMBL619380,,BAO_0000357,,
3865,6339,Inhibitory activity against murine lipoxygenase-2.,B,,,,,,,,,17087,H,8,Expert,1,,CHEMBL619381,,BAO_0000357,,
3866,12281,Inhibition of 5-lipoxygenase from mouse macrophage,B,,,Mus musculus,10090.0,,,,,17087,D,9,Expert,1,,CHEMBL619382,,BAO_0000357,,
3867,11311,The compound was tested for inhibitory activity against 5-lipoxygenase in mouse macrophages,B,,,,,,,,,17087,H,8,Autocuration,1,,CHEMBL619383,,BAO_0000357,,
3868,11089,The compound was tested for the inhibition of Arachidonate 5-lipoxygenase purified from porcine leukocytes.,B,,,Sus scrofa,9823.0,,,,,55,H,8,Autocuration,1,,CHEMBL619384,,BAO_0000019,,
3869,10091,Inhibition of 5-lipoxygenase reaction catalyzed by purified enzyme from porcine leukocytes,B,,,Sus scrofa,9823.0,,,,,55,H,8,Autocuration,1,,CHEMBL619385,,BAO_0000019,,
3870,14352,Inhibitory concentration against 5-lipoxygenase from isolated rabbit granulocytes,B,,,Oryctolagus cuniculus,9986.0,,,,,55,H,8,Autocuration,1,,CHEMBL882928,,BAO_0000019,,
3871,13329,5-lipoxygenase Inhibitory activity against rat polymorphonuclear leucocytes using 5-HETE,B,,,Rattus norvegicus,10116.0,,,,,12166,D,9,Expert,1,,CHEMBL619386,,BAO_0000019,,
3872,13329,"5-lipoxygenase inhibitory activity against rat polymorphonuclear leucocytes from female wistar rat, by using 5-HETE. ",B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619387,,BAO_0000019,,
3873,13329,"5-lipoxygenase inhibitory activity against rat polymorphonuclear leucocytes from female wistar rat, by using 5-HETE.",B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619388,,BAO_0000019,,
3874,13329,"5-lipoxygenase inhibitory activity against rat polymorphonuclear leucocytes from female wistar rat, by using LTB4.",B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619389,,BAO_0000019,,
3875,13329,Inhibition of 5-lipoxygenase pathway in rat polymorphonuclear assay (inhibition of 5-HETE formation),B,,,,,,,,,12166,H,8,Expert,1,,CHEMBL619390,,BAO_0000019,,
3876,13329,"Inhibition of 5-lipoxygenase pathway in rat polymorphonuclear assay, by ability to inhibit formation of LTB4 AT 10 uM",B,,,,,,,,,12166,H,8,Expert,1,,CHEMBL619391,,BAO_0000019,,
3877,13329,Inhibition of 5-lipoxygenase pathway was evaluated in rat polymorphonuclear assay by compound (50 uM) ability to inhibit formation of 5-HETE,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619392,,BAO_0000019,,
3878,11311,The effective dose for inhibition of 5-lipoxygenase in rat blood leukocyte (ex vivo),B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619393,,BAO_0000019,,
3879,11311,The effective dose for inhibition of 5-lipoxygenase in rat passive Arthus model after oral administration,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619394,,BAO_0000019,,
3880,105,"In vitro inhibition of 5-lipoxygenase HETE (5-hydroperoxyeicosatetraenoic acid) in RBL-1 macrophage, a cell-free enzyme assay",B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619395,702.0,BAO_0000219,,
3881,105,"In vitro inhibition of 5-lipoxygenase HETE (5-hydroperoxyeicosatetraenoic acid) in RBL-1 macrophage, a cell-free enzyme assay",B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619396,702.0,BAO_0000219,,
3882,9138,Inhibition of rat neutrophil 5- Lipoxygenase (5-LO),B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619397,,BAO_0000357,,
3883,9138,"Inhibition of rat neutrophil 5- Lipoxygenase (5-LO),",B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619398,,BAO_0000357,,
3884,9138,"Inhibition of rat neutrophil 5- Lipoxygenase (5-LO), (at a concentration of 0.2 nM ),",B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619399,,BAO_0000357,,
3885,14427,5-LO inhibitory activity determined by measuring the conversion of [14C]arachidonic acid to leukotrienes in RBL-2H3 cell using thin-layer chromatography; Not determined,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619400,,BAO_0000357,,
3886,13329,"5-lipoxygenase inhibitory activity against rat polymorphonuclear leucocytes from female wistar rat, by using 5-HETE.",B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619401,,BAO_0000019,,
3887,13329,"5-lipoxygenase inhibitory activity against rat polymorphonuclear leucocytes from female wistar rat, by using LTB4. ",B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619402,,BAO_0000019,,
3888,14427,Inhibition of 5-lipoxygenase mediated conversion of [14C]arachidonic acid to leukotrienes in RBL-2H3 cells,B,,,Rattus norvegicus,10116.0,,,RBL-2H3,,12166,D,9,Expert,1,,CHEMBL619403,663.0,BAO_0000219,,
3889,14427,5-lipoxygenase inhibitory activity determined by measuring the conversion of [14C]arachidonic acid to leukotrienes in RBL-2H3 cell using thin-layer chromatography; Not determined,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619404,,BAO_0000357,,
3890,14427,5-lipoxygenase inhibitory activity determined by measuring the conversion of [14C]arachidonic acid to leukotrienes in RBL-2H3 cell using thin-layer chromatography.,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619405,,BAO_0000357,,
3891,10293,Ability to inhibit 5-lipoxygenase by using a crude preparation of the cytosolic enzyme from the rat basophilic leukemia (RBL-1) cell line,B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL619406,702.0,BAO_0000219,,
3892,338,Inhibition of 5-Lipoxygenase of rat basophilic leukemia cells,B,,,Rattus norvegicus,10116.0,,,RBL-1,,12166,D,9,Expert,1,,CHEMBL619407,702.0,BAO_0000219,,
3893,303,Compound was evaluated for its inhibitory activity against 5-LO (5-lipoxygenase),B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619408,,BAO_0000357,,
3894,303,Compound was evaluated for its inhibitory activity against 5-LO (5-lipoxygenase) in intact RBL-1 cell line assay,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619409,702.0,BAO_0000219,,
3895,9247,Inhibition of rat basophilic leukemia-1 (RBL-1) 5-lipoxygenase,B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL619410,702.0,BAO_0000219,,
3896,9247,Compound was evaluated for the inhibition of rat basophilic leukemia-1 (RBL-1) 5-Lipoxygenase at 100 uM; NS = no significant activity,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619753,702.0,BAO_0000219,,
3897,137,Compound was evaluated in an intact RBL-1 cell line for inhibition of 5-lipoxygenase,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619754,702.0,BAO_0000219,,
3898,11481,Evaluated in vitro for its inhibitory activity against 5-lipoxygenase,B,,,,,,,,,12166,H,8,Expert,1,,CHEMBL619903,,BAO_0000357,,
3899,11481,"Evaluated in vitro for its inhibitory activity against 5-lipoxygenase; N=Inactive, <50% inhibition at 10 uM concentration",B,,,,,,,,,12166,H,8,Expert,1,,CHEMBL619904,,BAO_0000357,,
3900,9029,Inhibition of rat polymorphonuclear leukocyte (PMN) 5-Lipoxygenase in vitro,B,,,,,,,,,12166,H,8,Expert,1,,CHEMBL619905,,BAO_0000357,,
3901,1701,Compound was tested for inhibition of 5-lipoxygenase activity in a broken cell supernatant rat basophilic leukemia cells,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619906,,BAO_0000019,,
3902,1701,Compound was tested for inhibition of 5-lipoxygenase activity in a broken cell supernatant rat basophilic leukemia cells at concentration of 32 uM; Not active,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619907,,BAO_0000019,,
3903,1701,Compound was tested for inhibition of 5-lipoxygenase activity in a broken cell supernatant rat basophilic leukemia cells at concentration of 50 uM; Not active,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619908,,BAO_0000019,,
3904,1701,Compound was tested for inhibition of 5-lipoxygenase activity in a broken cell supernatant rat basophilic leukemia cells; No data,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619909,,BAO_0000019,,
3905,13358,Inhibition of 5-lipoxygenase by measuring 5-HETE levels in RBL-1 cell-free supernatant,F,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL619910,702.0,BAO_0000219,,
3906,1175,Inhibitory activity against 5-lipoxygenase enzyme from RBL-1 cells,B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL882929,702.0,BAO_0000219,,
3907,8797,Ability to inhibit 5-lipoxygenase in rat basophilic leukemia cells.,B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL619911,702.0,BAO_0000219,,
3908,8797,Compound was tested for its ability to inhibit 5-lipoxygenase in rat basophilic leukemia cells; No data,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619912,,BAO_0000019,,
3909,577,Inhibition of rat basophilic leukemia cell 5-lipoxygenase,B,,,Rattus norvegicus,10116.0,,,,,12166,D,9,Expert,1,,CHEMBL619913,,BAO_0000357,,
3910,9295,In vitro inhibitory activity against RBL-1 5-LO,B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL619914,702.0,BAO_0000219,,
3911,9295,Compound was tested for its in vitro inhibitory activity against RBL-1 5-LO (insoluble above 45 uM),B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619915,702.0,BAO_0000219,,
3912,9295,Compound was tested for its in vitro inhibitory activity against RBL-1 5-LO (time dependent),B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619916,702.0,BAO_0000219,,
3913,9295,Compound was tested for its inhibition activity against 5-LO of the whole cell in vitro in rat.,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619917,,BAO_0000218,,
3914,9295,Compound was tested for its inhibition activity against the 5-LO in isolated enzyme,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619918,,BAO_0000357,,
3915,216,Compound was tested for its inhibitory activity against 5-lipoxygenase in rat.,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619919,,BAO_0000218,,
3916,11090,Compound was tested for the inhibition of 5-lipoxygenase (5-LPO) in rat basophilic leukemia (RBL) cells.,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL883710,702.0,BAO_0000219,,
3917,11090,Compound was tested for the inhibition of 5-lipoxygenase (5-Lpo) in rat whole blood.,B,,,,,,Blood,,,12166,H,8,Autocuration,1,,CHEMBL619920,,BAO_0000019,178.0,
3918,10091,Concentration required for 50 % inhibition of arachidonic acid oxidation by rat 5-lipoxygenase,B,,,,,,,,,12166,H,8,Expert,1,,CHEMBL619921,,BAO_0000357,,
3919,10274,Concentration that produces 50% inhibition of A-23187-stimulated radiolabeled 5-HETE and TXB2 synthesis by PMN 5-lipoxygenase.,F,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619922,,BAO_0000019,,
3920,13622,In vitro 5-lipoxygenase inhibitory activity against calcium ionophore (A23187) induced LTB4 formation in rat polymorphonuclear leukocytes,F,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619923,,BAO_0000219,,
3921,12118,In vitro inhibition against 5-lipoxygenase in RBL-1 cells was determined,B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL619924,702.0,BAO_0000219,,
3922,12576,In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assay,B,,,,,,,,,12166,H,8,Expert,1,,CHEMBL619925,,BAO_0000357,,
3923,9546,In vitro inhibition of 5-lipoxygenase from RBL-1 cells,B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL619926,702.0,BAO_0000219,,
3924,9521,In vitro inhibition of 5-lipoxygenase in RBL-1 cells,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619927,702.0,BAO_0000219,,
3925,10626,In vitro inhibition of 5-lipoxygenase pathway in rat basophilic leukemia (RBL-1) cells,B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL619928,702.0,BAO_0000219,,
3926,9225,In vitro inhibition of RBL-1 5-lipoxygenase,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619929,702.0,BAO_0000219,,
3927,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 0.18-0.31,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL875089,702.0,BAO_0000219,,
3928,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 0.3-1.6,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619930,702.0,BAO_0000219,,
3929,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 0.4-2.2,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619931,702.0,BAO_0000219,,
3930,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 0.72-1.07,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619932,702.0,BAO_0000219,,
3931,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 0.9-4.0,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619933,702.0,BAO_0000219,,
3932,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 1.0-1.5,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619934,702.0,BAO_0000219,,
3933,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 1.0-1.7,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619935,702.0,BAO_0000219,,
3934,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 1.0-2.4,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619936,702.0,BAO_0000219,,
3935,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 1.07-5.54,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619937,702.0,BAO_0000219,,
3936,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 1.1-1.6,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619938,702.0,BAO_0000219,,
3937,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 1.3-2.8,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619939,702.0,BAO_0000219,,
3938,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 1.4-3.2,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619940,702.0,BAO_0000219,,
3939,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 1.7-2.6,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL875090,702.0,BAO_0000219,,
3940,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 1.8-2.8,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619941,702.0,BAO_0000219,,
3941,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 1.8-5.7,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619942,702.0,BAO_0000219,,
3942,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 1.9-2.4,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL883711,702.0,BAO_0000219,,
3943,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 2.3-.8,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619943,702.0,BAO_0000219,,
3944,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 2.46-2.63,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619944,702.0,BAO_0000219,,
3945,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 3.3-3.5,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619945,702.0,BAO_0000219,,
3946,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 3.8-7.1,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619946,702.0,BAO_0000219,,
3947,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 4.0-6.4,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619947,702.0,BAO_0000219,,
3948,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 4.9-11.6,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619948,702.0,BAO_0000219,,
3949,9225,In vitro inhibition of RBL-1 5-lipoxygenase; Value ranges from 7.5-11.8,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619949,702.0,BAO_0000219,,
3950,9401,In vitro inhibitory activity against 5-lipoxygenase from rat basophilic leukemia cells.,B,,,,,,,,,12166,H,8,Expert,1,,CHEMBL619950,,BAO_0000019,,
3951,10325,In vitro inhibitory activity against 5-Lipoxygenase in rat by Peritoneal 5-lipoxygenase assay,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL618050,,BAO_0000019,,
3952,1556,In vitro inhibition of 5-lipoxygenase in RBL-2H3 (Rat basophilic leukemia) cells.,F,,,,,,,RBL-2H3,,12166,H,8,Expert,1,,CHEMBL875091,663.0,BAO_0000219,,
3953,1556,In vitro inhibition of 5-lipoxygenase in RBL-2H3 (Rat basophilic leukemia) cells; Not tested,F,,,,,,,RBL-2H3,,12166,H,8,Expert,1,,CHEMBL618051,663.0,BAO_0000219,,
3954,961,Inhibition of 5-lipoxygenase from rat basophilic leukemia(RBL-1) cells,B,,,Rattus norvegicus,10116.0,,,RBL-1,,12166,D,9,Expert,1,,CHEMBL618052,702.0,BAO_0000219,,
3955,6838,In vitro inhibitory activity against 5-lipoxygenase in an RBL-2H3 cell lysate,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL618053,,BAO_0000019,,
3956,10325,In vitro inhibition of 5-lipoxygenase in rat (peritoneal assay),B,,,,,,,,,12166,H,8,Expert,1,,CHEMBL618054,,BAO_0000019,,
3957,9209,In vitro inhibitory activity against 5-lipoxygenase in rat RBL-1 cells,B,,,Rattus norvegicus,10116.0,,,RBL-1,,12166,D,9,Expert,1,,CHEMBL618055,702.0,BAO_0000219,,
3958,11520,inhibitory activity against 5-lipoxygenase in rat basophilic leukemia cell line.,B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL618056,702.0,BAO_0000219,,
3959,137,In vitro inhibitory activity against 5-lipoxygenase was determined,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL618057,,BAO_0000357,,
3960,4717,In vitro inhibitory concentration against 5-lipoxygenase in RBL-1 cells,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL618058,702.0,BAO_0000219,,
3961,10636,Inhibition of 5-lipoxygenase in intact RBL-1 cell line,B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL618059,702.0,BAO_0000219,,
3962,14312,Inhibitory activity against 5-lipoxygenase catalysis (5-LO) in sonicated rat basophilic leukemia cell lysate,F,,,Rattus norvegicus,10116.0,,,,,12166,D,9,Expert,1,,CHEMBL618060,,BAO_0000019,,
3963,1203,Inhibition of 5-Lipoxygenase (5-LO) in rat basophilic leukemia cells,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL618061,702.0,BAO_0000219,,
3964,1203,Inhibition of 5-Lipoxygenase (5-LO) in rat basophilic leukemic cells,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL618062,,BAO_0000019,,
3965,13622,Inhibition of 5-lipoxygenase catalysis in rat basophilic leukemia (RBL) cells by measuring 5-HETE product formation,B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL618063,702.0,BAO_0000219,,
3966,9793,Inhibition of 5-lipoxygenase from rat peritoneal neutrophils after oral administration,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL618064,,BAO_0000357,,
3967,1143,Inhibition of 5-lipoxygenase of rat basophilic leukemia (RBL) cell cytosolic enzymes,B,,,Rattus norvegicus,10116.0,,,RBL-1,,12166,D,9,Expert,1,,CHEMBL618065,702.0,BAO_0000219,,
3968,11854,Inhibition 5-lipoxygenase mediated LTB4 formation in rat basophilic leukemia (RBL-1) cells,B,,,Rattus norvegicus,10116.0,,,RBL-1,,12166,D,9,Expert,1,,CHEMBL618066,702.0,BAO_0000219,,
3969,3595,Inhibitory activity against 5-lipoxygenase (5-LO) in intact rat barophilic leukemia cells (RBL-1),B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL618067,702.0,BAO_0000219,,
3970,3595,Inhibitory activity against 5-lipoxygenase (5-LO) using broken rat barophilic leukemia cells (RBL-1),B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL618068,702.0,BAO_0000219,,
3971,10501,Inhibition of 5-lipoxygenase in rat RBL-1 cells,B,,,Rattus norvegicus,10116.0,,,RBL-1,,12166,D,9,Expert,1,,CHEMBL618069,702.0,BAO_0000219,,
3972,12526,Inhibition of 5-lipoxygenase in intact rat basophilic leukemia cells stimulated with the calcium ionophore A-23187,B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL618070,702.0,BAO_0000219,,
3973,10034,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 32 umol/kg,F,,,,,,Limbic system,,,10825,H,8,Autocuration,1,,CHEMBL618071,,BAO_0000019,349.0,
3974,10034,Compound was tested for its effects on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 0.10 umol/kg,F,,,,,,Limbic system,,,10825,H,8,Autocuration,1,,CHEMBL619247,,BAO_0000019,349.0,
3975,10034,Approximate dose levels for a half maximal reduction of 5-HTP levels,F,,,,,,,,,10825,H,8,Autocuration,1,,CHEMBL619248,,BAO_0000019,,
3976,10046,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue using [3H]OH-DPAT as radioligand.,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL619249,,BAO_0000221,10000000.0,
3977,10046,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue using [3H]OH-DPAT as radioligand.,B,,,,,,Hippocampus,,,10576,H,8,Autocuration,1,,CHEMBL619250,,BAO_0000221,10000000.0,
3978,10046,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat striatal membrane homogenate using [3H]5-HT as the radioligand.,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL619251,,BAO_0000019,,
3979,12079,Inhibitory concentration against human platelet 5-lipoxygenase in dog whole blood,F,,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL619252,,BAO_0000019,178.0,
3980,12079,Inhibitory concentration against human platelet 5-lipoxygenase in human whole blood,F,,,,,,Blood,,,55,H,8,Autocuration,1,,CHEMBL619253,,BAO_0000019,178.0,
3981,11311,The compound was tested for inhibitory activity against 5-Lipoxygenase in rat polymorphonuclear leukocytes[PMNS],B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619254,,BAO_0000219,,
3982,12338,Inhibition of 5-lipoxygenase in bovine polymorphonuclear leukocytes,B,,,,,,,,,17140,H,8,Expert,1,,CHEMBL619255,,BAO_0000219,,
3983,12143,Inhibitory activity against 5-lipoxygenase (inhibition of 5-HETE and LTB4 biosynthesis) in bovine polymorphonuclear leukocytes (PMNL).,B,,,,,,,,,17140,H,8,Expert,1,,CHEMBL619256,,BAO_0000219,,
3984,12143,Inhibitory activity against 5-lipoxygenase (inhibition of 5-HETE and LTB4 biosynthesis) in bovine polymorphonuclear leukocytes (PMNL),B,,,,,,,,,17140,H,8,Autocuration,1,,CHEMBL875418,,BAO_0000219,,
3985,12143,Inhibitory activity against 5-lipoxygenase (inhibition of 5-HETE and LTB4 biosynthesis) in bovine polymorphonuclear leukocytes (PMNL) at 30 uM,B,,,,,,,,,17140,H,8,Expert,1,,CHEMBL619257,,BAO_0000219,,
3986,12143,Inhibitory activity against 5-lipoxygenase (inhibition of 5-HETE and LTB4 biosynthesis) in bovine polymorphonuclear leukocytes (PMNL) at 30 uM,B,,,,,,,,,17140,H,8,Autocuration,1,,CHEMBL619258,,BAO_0000219,,
3987,12365,Inhibition of 5-lipoxygenase in bovine PMNL cell assay.,B,,,,,,,,,17140,H,8,Expert,1,,CHEMBL619259,,BAO_0000357,,
3988,13500,Tested for inhibition of 5-lipoxygenase as inhibition of 5-HETE and LTB4 biosynthesis in bovine PMNL,B,,,,,,,,,17140,H,8,Expert,1,,CHEMBL619260,,BAO_0000357,,
3989,12832,"Ex vivo inhibition of 5-LO was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.08h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL619261,,BAO_0000218,178.0,
3990,12832,"Ex vivo inhibition of 5-LO was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.25h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL619263,,BAO_0000218,178.0,
3991,12832,"Ex vivo inhibition of 5-LO was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.5h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL619264,,BAO_0000218,178.0,
3992,12832,"Ex vivo inhibition of 5-LO was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 1.0h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL619265,,BAO_0000218,178.0,
3993,12832,"Ex vivo inhibition of 5-LO was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 24h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL619266,,BAO_0000218,178.0,
3994,12832,"Ex vivo inhibition of 5-LO was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 3.0h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL619902,,BAO_0000218,178.0,
3995,12832,"Ex vivo inhibition of 5-LO was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 6.0h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620058,,BAO_0000218,178.0,
3996,12832,"Ex vivo inhibition of 5-LO was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 9.0h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620059,,BAO_0000218,178.0,
3997,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.08h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620060,,BAO_0000218,178.0,
3998,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.25h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620061,,BAO_0000218,178.0,
3999,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.25h, following peroral administration at the dose of 0.3 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620062,,BAO_0000218,178.0,
4000,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.25h, following peroral administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620063,,BAO_0000218,178.0,
4001,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.25h, following peroral administration at the dose of 3.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620064,,BAO_0000218,178.0,
4002,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.5h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620065,,BAO_0000218,178.0,
4003,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.5h, following peroral administration at the dose of 0.3 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620066,,BAO_0000218,178.0,
4004,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.5h, following peroral administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620067,,BAO_0000218,178.0,
4005,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.5h, following peroral administration at the dose of 3.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620068,,BAO_0000218,178.0,
4006,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 1.0h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620069,,BAO_0000218,178.0,
4007,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 1.0h, following peroral administration at the dose of 0.3 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620070,,BAO_0000218,178.0,
4008,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 1.0h, following peroral administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620071,,BAO_0000218,178.0,
4009,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 1.0h, following peroral administration at the dose of 3.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620072,,BAO_0000218,178.0,
4010,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 24h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620036,,BAO_0000218,178.0,
4011,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 24h, following peroral administration at the dose of 0.3 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL857702,,BAO_0000218,178.0,
4012,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 24h, following peroral administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620037,,BAO_0000218,178.0,
4013,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 24h, following peroral administration at the dose of 3.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620038,,BAO_0000218,178.0,
4014,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 3.0h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620039,,BAO_0000218,178.0,
4015,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 3.0h, following peroral administration at the dose of 0.3 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620040,,BAO_0000218,178.0,
4016,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 3.0h, following peroral administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620041,,BAO_0000218,178.0,
4017,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 3.0h, following peroral administration at the dose of 3.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620042,,BAO_0000218,178.0,
4018,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 6.0h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620043,,BAO_0000218,178.0,
4019,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 6.0h, following peroral administration at the dose of 0.3 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620044,,BAO_0000218,178.0,
4020,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 6.0h, following peroral administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620045,,BAO_0000218,178.0,
4021,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 6.0h, following peroral administration at the dose of 3.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620046,,BAO_0000218,178.0,
4022,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 9.0h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620047,,BAO_0000218,178.0,
4023,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 9.0h, following peroral administration at the dose of 0.3 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620048,,BAO_0000218,178.0,
4024,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 9.0h, following peroral administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL857703,,BAO_0000218,178.0,
4025,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 9.0h, following peroral administration at the dose of 3.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620049,,BAO_0000218,178.0,
4026,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.08h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620050,,BAO_0000218,178.0,
4027,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.25h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620051,,BAO_0000218,178.0,
4028,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.5h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL619213,,BAO_0000218,178.0,
4029,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 1.0h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL619214,,BAO_0000218,178.0,
4030,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 3.0h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL619804,,BAO_0000218,178.0,
4031,12832,"Ex vivo inhibition was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 0.25h, following peroral administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL619805,,BAO_0000218,178.0,
4032,12832,"Ex vivo inhibition was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 24h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL619806,,BAO_0000218,178.0,
4033,12832,"Ex vivo inhibition was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 6.0h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL619807,,BAO_0000218,178.0,
4034,12832,"Ex vivo inhibition was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 9.0h, following intravenous administration at the dose of 1.0 mg/kg",F,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL619808,,BAO_0000218,178.0,
4035,3595,Inhibitory activity against 5-lipoxygenase (5-LO) in after oral administration of 5 mg/kg at 24 hr r,B,,,Canis lupus familiaris,9615.0,,,,,55,H,8,Autocuration,1,,CHEMBL619809,,BAO_0000218,,
4036,3595,Inhibitory activity against 5-lipoxygenase (5-LO) in after oral administration of 5 mg/kg at 24 hr r to canine,B,,,Canis lupus familiaris,9615.0,,,,,55,H,8,Autocuration,1,,CHEMBL619810,,BAO_0000218,,
4037,3595,Inhibitory activity against 5-lipoxygenase (5-LO) in after oral administration of 5 mg/kg at 2 hr,B,,,Canis lupus familiaris,9615.0,,,,,55,H,8,Autocuration,1,,CHEMBL619811,,BAO_0000218,,
4038,3595,Inhibitory activity against 5-lipoxygenase (5-LO) in after oral administration of 5 mg/kg at 2 hr to canine,B,,,Canis lupus familiaris,9615.0,,,,,55,H,8,Autocuration,1,,CHEMBL620769,,BAO_0000218,,
4039,3595,Inhibitory activity against 5-lipoxygenase (5-LO) in after oral administration of 5 mg/kg at 4 hr,B,,,Canis lupus familiaris,9615.0,,,,,55,H,8,Autocuration,1,,CHEMBL620770,,BAO_0000218,,
4040,3595,Inhibitory activity against 5-lipoxygenase (5-LO) in after oral administration of 5 mg/kg at 4 hr to canine,B,,,Canis lupus familiaris,9615.0,,,,,55,H,8,Autocuration,1,,CHEMBL620771,,BAO_0000218,,
4041,3595,Inhibitory activity against 5-lipoxygenase (5-LO) in after oral administration of 5 mg/kg at 8 hr,B,,,Canis lupus familiaris,9615.0,,,,,55,H,8,Autocuration,1,,CHEMBL620772,,BAO_0000218,,
4042,3595,Inhibitory activity against 5-lipoxygenase (5-LO) in after oral administration of 5 mg/kg at 8 hr to canine,B,,,Canis lupus familiaris,9615.0,,,,,55,H,8,Autocuration,1,,CHEMBL620773,,BAO_0000218,,
4043,9203,Ability to inhibit 5-lipoxygenase in guinea pig,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL620774,,BAO_0000357,,
4044,82,Inhibition of [14C]arachidonic acid conversion to 5-HETE by broken cell 5-lipoxygenase in vitro (guinea pig PMN),B,,,Cavia porcellus,10141.0,,,,,55,H,8,Expert,1,,CHEMBL620775,,BAO_0000357,,
4045,11090,Compound was tested for the inhibition of 5-lipoxygenase (5-Lpo) in guinea pig.,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL620776,,BAO_0000357,,
4046,12832,"Ex vivo inhibition of 5-lipoxygenase was determined by the measurement of A-23187-stimulated LTB4 production in dog blood at 12 h, following intravenous administration at the dose of 1.0 mg/kg",B,,,Cavia porcellus,10141.0,,Blood,,,55,H,8,Autocuration,1,,CHEMBL620777,,BAO_0000218,178.0,
4047,1065,In vitro 5-lipoxygenase inhibition in guinea pig PMNs was determined based on 5-hydroxyeicosapentaenoic acid (5-HETE) production,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL620778,,BAO_0000357,,
4048,1065,In vitro 5-lipoxygenase inhibition in guinea pig PMNs was determined based on LTB4 production,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL620779,,BAO_0000357,,
4049,12832,In vitro 5-lipoxygenase inhibitory activity against A-23187-stimulated conversion of [14C]-AA to 5-HETE in guinea pig peritoneal polymorphonuclear leukocytes,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Expert,1,,CHEMBL621500,,BAO_0000019,,
4050,12832,In vitro 5-lipoxygenase inhibitory activity against A-23187-stimulated conversion of [14C]AA to LTB4 in guinea pig peritoneal polymorphonuclear leukocytes,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Expert,1,,CHEMBL621501,,BAO_0000019,,
4051,12832,In vitro 5-lipoxygenase inhibitory activity against A-23187-stimulated conversion of [14C]AA to LTB4 in guinea pig peritoneal polymorphonuclear leukocytes,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL618098,,BAO_0000019,,
4052,10504,Inhibition against 5-lipoxygenase from guinea pig polymorphonuclear lymphocytes,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL618099,,BAO_0000019,,
4053,7788,Inhibitory activity against 5-lipoxygenase,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL618100,,BAO_0000357,,
4054,10001,Inhibitory activity against 5-lipoxygenase in guinea pig leukocyte,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL618101,,BAO_0000357,,
4055,10193,Inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase using guinea pig supernatant,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL618102,,BAO_0000357,,
4056,13243,Inhibitory activity against partially-purified Guinea pig PMN 5-lipoxygenase,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL618103,,BAO_0000357,,
4057,13243,Inhibitory activity uM,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL618104,,BAO_0000357,,
4058,969,Inhibitory activity against 5-lipoxygenase in guinea pig leukocytes was determined,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL883712,,BAO_0000219,,
4059,10001,Inhibitory activity against 5-lipoxygenase at 10 uM,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL618105,,BAO_0000357,,
4060,7788,Inhibitory activity against 5-lipoxygenase at a dose of 0.1 mM,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL618106,,BAO_0000357,,
4061,10001,Inhibitory activity against 5-lipoxygenase in guinea pig leukocyte at 30 uM,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL618107,,BAO_0000357,,
4062,10193,Inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase using guinea pig supernatant at 10 uM,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL618108,,BAO_0000357,,
4063,13243,Inhibitory activity uM,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL618109,,BAO_0000357,,
4064,13243,Inhibitory activity against partially-purified Guinea pig PMN 5-lipoxygenase at 10 uM,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL618110,,BAO_0000357,,
4065,13243,Inhibitory activity uM,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Expert,1,,CHEMBL618111,,BAO_0000357,,
4066,13243,Inhibitory activity uM,F,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL618112,,BAO_0000019,,
4067,10504,Percent inhibition against 5-lipoxygenase from guinea pig polymorphonuclear lymphocytes,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL618113,,BAO_0000019,,
4068,7788,Inhibitory activity against 5-lipoxygenase at a dose of 0.1 mM,B,,,Cavia porcellus,10141.0,,,,,55,H,8,Autocuration,1,,CHEMBL618114,,BAO_0000357,,
4069,10546,Evaluated for inhibition of the formation and release of 5-lipoxygenase in isolated guinea pig ileum,F,,,Cavia porcellus,10141.0,,Ileum,,,55,H,8,Expert,1,,CHEMBL620871,,BAO_0000221,2116.0,
4070,13183,5-lipoxygenase Inhibitory activity was measured by enzyme immunoassay using human whole blood stimulated with calcium ionophore (A23187) and LTB4 (leukotriene B4),B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL620872,,BAO_0000357,,
4071,13183,5-lipoxygenase Inhibitory activity was measured by enzyme immunoassay using human whole blood stimulated with calcium ionophore (A23187) and LTB4 (leukotriene B4),B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL620873,,BAO_0000357,,
4072,2578,Compound was evaluated for in vitro inhibition of recombinant human 5-lipoxygenase (5-LO),B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL620874,,BAO_0000357,,
4073,12780,In vitro inhibition of human 5-Lipoxygenase.,B,,,,,,,,,55,H,8,Expert,1,,CHEMBL620875,,BAO_0000357,,
4074,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 75 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620876,,BAO_0000251,2107.0,
4075,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 1 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620877,,BAO_0000251,2107.0,
4076,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 10 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL857854,,BAO_0000251,2107.0,
4077,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 10 uM exposed 100 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620878,,BAO_0000251,2107.0,
4078,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 100 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620879,,BAO_0000251,2107.0,
4079,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 1000 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620880,,BAO_0000251,2107.0,
4080,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 1000 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620881,,BAO_0000251,2107.0,
4081,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 150 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620882,,BAO_0000251,2107.0,
4082,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 1500 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620883,,BAO_0000251,2107.0,
4083,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 2.5 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620884,,BAO_0000251,2107.0,
4084,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 200 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620885,,BAO_0000251,2107.0,
4085,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 27.5 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620886,,BAO_0000251,2107.0,
4086,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 5 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620887,,BAO_0000251,2107.0,
4087,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 50 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618039,,BAO_0000251,2107.0,
4088,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 500 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618040,,BAO_0000251,2107.0,
4089,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to exposed to 3-methylcholanthrene at concentration of 200 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618041,,BAO_0000251,2107.0,
4090,7411,"Compound was evaluated for inhibition constant, in liver microsomes from 3-methylcholanthrene-exposed rats",B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618216,,BAO_0000251,2107.0,
4091,7411,"Compound was evaluated for inhibition constant, in liver microsomes from beta-naphthoflavone-exposed rats",B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618217,,BAO_0000251,2107.0,
4092,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes 3-methylcholanthrene at concentration of 100 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618218,,BAO_0000251,2107.0,
4093,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes 3-methylcholanthrene at concentration of 200 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618219,,BAO_0000251,2107.0,
4094,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes 3-methylcholanthrene at concentration of 50 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618220,,BAO_0000251,2107.0,
4095,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at 5 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618221,,BAO_0000251,2107.0,
4096,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at 50 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618222,,BAO_0000251,2107.0,
4097,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at a concentration of 10 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618223,,BAO_0000251,2107.0,
4098,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 100 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618224,,BAO_0000251,2107.0,
4099,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 1 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618225,,BAO_0000251,2107.0,
4100,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 20 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618226,,BAO_0000251,2107.0,
4101,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 200 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618227,,BAO_0000251,2107.0,
4102,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 25 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618228,,BAO_0000251,2107.0,
4103,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 50 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618229,,BAO_0000251,2107.0,
4104,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 75 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618230,,BAO_0000251,2107.0,
4105,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 1 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618231,,BAO_0000251,2107.0,
4106,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 10 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618232,,BAO_0000251,2107.0,
4107,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 100 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618233,,BAO_0000251,2107.0,
4108,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 1000 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618234,,BAO_0000251,2107.0,
4109,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 150 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618235,,BAO_0000251,2107.0,
4110,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 1500 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618115,,BAO_0000251,2107.0,
4111,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 2.5 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618116,,BAO_0000251,2107.0,
4112,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 200 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL618117,,BAO_0000251,2107.0,
4113,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 5 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL619968,,BAO_0000251,2107.0,
4114,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 50 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL619969,,BAO_0000251,2107.0,
4115,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 500 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL619970,,BAO_0000251,2107.0,
4116,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at concentration of 1000 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL619971,,BAO_0000251,2107.0,
4117,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at concentration of 1500 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL619972,,BAO_0000251,2107.0,
4118,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at concentration of 27.5 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL619973,,BAO_0000251,2107.0,
4119,7411,Maximum rate constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at concentration of 500 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL619974,,BAO_0000251,2107.0,
4120,7411,Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to beta-naphthoflavone at 50 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL619975,,BAO_0000251,2107.0,
4121,7411,Vmax determined by 7-ethoxycoumarin deethylation in the presence by liver microsomes from rats exposed to 3-methylcholanthrene at concentration of 10 uM,B,,,Rattus norvegicus,10116.0,,,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL619976,,BAO_0000251,,
4122,7411,"Compound was evaluated for alpha -rate constant, in liver microsomes from 3-methylcholanthrene-exposed rats",B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL619977,,BAO_0000251,2107.0,
4123,7411,"Compound was evaluated for alpha -rate constant, in liver microsomes from beta-naphthoflavone-exposed rats",B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL619978,,BAO_0000251,2107.0,
4124,7411,"Compound was evaluated for alpha -rate constant, in liver microsomes from beta-naphthoflavone-exposed rats; competitive inhibition",B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL619979,,BAO_0000251,2107.0,
4125,7411,"Compound was evaluated for alpha inhibition constant, in liver microsomes from 3-methylcholanthrene-exposed rats",B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL619980,,BAO_0000251,2107.0,
4126,7411,"Compound was evaluated for alpha inhibition constant, in liver microsomes from beta-naphthoflavone-exposed rats",B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL619981,,BAO_0000251,2107.0,
4127,10797,In vitro inhibition of 7226/S myeloma cancer cell line,F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL619982,741.0,BAO_0000219,,
4128,6881,In vitro antitumor activity of compound against 7404 cell line (human liver carcinoma cells),F,,,Homo sapiens,9606.0,,,BEL-7404 tumor cell line,,80698,N,1,Intermediate,1,,CHEMBL619983,993.0,BAO_0000219,,
4129,3838,In vitro growth inhibition of compound was determined against 768-0 cell lines of Renal cancer,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL620031,391.0,BAO_0000219,,
4130,3838,In vitro growth inhibition of compound was determined against 768-0 cell lines of Renal cancer,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL620032,391.0,BAO_0000219,,
4131,12981,Net accumulation of the [99mTc]Isonitrile complex was measured in 77A cell lines in the presence of Verapamil.,F,,,Cricetulus griseus,10029.0,,,V79,,81264,N,1,Expert,1,,CHEMBL620033,505.0,BAO_0000219,,
4132,12981,Verapamil index represents the ratio of net uptake in the presense of verapamil over control in 77A cell lines.,F,,,Cricetulus griseus,10029.0,,,V79,,81264,N,1,Expert,1,,CHEMBL620034,505.0,BAO_0000219,,
4133,7653,Tested for its cytotoxic effect on the growth of the cell strain 7800C1 (1 x 10e 4 (MEM)) at 10 ug/mL dose,F,,,Rattus norvegicus,10116.0,,,7800C1 cell line,,80635,N,1,Intermediate,1,,CHEMBL620035,1119.0,BAO_0000219,,
4134,7653,Tested for its cytotoxic effect on the growth of the cell strain 7800C1 (1 x 10e 4 (MEM)) at 2 ug/mL dose,F,,,Rattus norvegicus,10116.0,,,7800C1 cell line,,80635,N,1,Intermediate,1,,CHEMBL618318,1119.0,BAO_0000219,,
4135,7653,Tested for its cytotoxic effect on the growth of the cell strain 7800C1 (1 x 10e 4 (MEM)) at 20 ug/mL dose,F,,,Rattus norvegicus,10116.0,,,7800C1 cell line,,80635,N,1,Intermediate,1,,CHEMBL618319,1119.0,BAO_0000219,,
4136,7653,Tested for its cytotoxic effect on the growth of the cell strain 7800C1 (1 x 10e 4 (MEM)) at 5 ug/mL dose,F,,,Rattus norvegicus,10116.0,,,7800C1 cell line,,80635,N,1,Intermediate,1,,CHEMBL618320,1119.0,BAO_0000219,,
4137,7653,Tested for its cytotoxic effect on the growth of the cell strain 7800C1 (1 x 10e 4 (MEM)) at 50 ug/mL dose,F,,,Rattus norvegicus,10116.0,,,7800C1 cell line,,80635,N,1,Intermediate,1,,CHEMBL618321,1119.0,BAO_0000219,,
4138,7653,Tested for its cytotoxic effect on the growth of the cell strain 7800C1 (1 x 10e 4 (MEM)) at 75 ug/mL dose,F,,,Rattus norvegicus,10116.0,,,7800C1 cell line,,80635,N,1,Intermediate,1,,CHEMBL883118,1119.0,BAO_0000219,,
4139,17229,In vitro antitumor activity against renal 786-0 tumor cell lines,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL883795,391.0,BAO_0000219,,
4140,12858,Cytotoxic activity against 786-0 Renal cancer cell line,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL618322,391.0,BAO_0000219,,
4141,16325,Growth inhibitory activity was determined against 786-0 cancer cell line of Renal cancer,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL618323,391.0,BAO_0000219,,
4142,16325,Growth inhibitory activity was determined against 786-0 cancer cell line of renal cancer,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL618324,391.0,BAO_0000219,,
4143,5858,In vitro antitumor activity against human renal 786-0 cell line,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL618325,391.0,BAO_0000219,,
4144,16325,Inhibition of Renal cancer in 786-0 cancer cell lines,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL875416,391.0,BAO_0000219,,
4145,14696,Inhibition of the growth of renal cancer(786-0) cell line. value in parentheses is percent inhibition at 0.01 uM,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL618326,391.0,BAO_0000219,,
4146,3786,The compound was tested for its cytotoxic activity against the following renal cancer cell lines 786-0,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL618327,391.0,BAO_0000219,,
4147,14696,inhibition of the growth of renal cancer(786-0) cell line,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619215,391.0,BAO_0000219,,
4148,14769,Compound was evaluated for in vitro activity against 786-0 kidney cell lines (Human tumor cells ),F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619216,391.0,BAO_0000219,,
4149,15354,Compound was tested for the growth inhibition of 786-0 renal tumor cell line,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619217,391.0,BAO_0000219,,
4150,14255,The IC50 value was measured on 786-0 cell line in ovarian tumor,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619218,391.0,BAO_0000219,,
4151,14255,The IC50 value was measured on 786-0 cell line in ovarian tumor t,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619219,391.0,BAO_0000219,,
4152,14255,The IC50 value was measured on 786-0 cell line in renal tumor type.,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619220,391.0,BAO_0000219,,
4153,14696,Inhibition of the growth of renal cancer(786-0) cell line at 0.01 uM,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619221,391.0,BAO_0000219,,
4154,12016,Tested for cytotoxic activity against renal cancer 786-0 cell line,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619222,391.0,BAO_0000219,,
4155,2597,Compound was tested for growth inhibitory activity against 786-0 cell line,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL857454,391.0,BAO_0000219,,
4156,12526,Inhibitory activity against 5-lipoxygenase in intact rat basophilic leukemia cells stimulated with the calcium ionophore A-23187; Inactive(N)= <50% inhibition at 10 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619223,702.0,BAO_0000219,,
4157,12526,Inhibitory activity against 5-lipoxygenase in intact rat basophilic leukemia cells stimulated with the calcium ionophore A-23187; N=Inactive,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619224,702.0,BAO_0000219,,
4158,14799,Inhibitory activity against 5-lipoxygenase obtained from rat basophilic leukemia cells,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619225,,BAO_0000019,,
4159,3595,Inhibitory activity against 5-lipoxygenase (5-LO) in intact rat barophilic leukemia cells (RBL-1),B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL619226,702.0,BAO_0000219,,
4160,3595,Inhibitory activity against 5-lipoxygenase (5-LO) using broken rat barophilic leukemia cells (RBL-1),B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL619227,702.0,BAO_0000219,,
4161,12767,Inhibitory activity against rat basophilic leukemia 5-lipoxygenase,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619228,,BAO_0000357,,
4162,10997,Inhibitory activity against 5-lipoxygenase in rat polymorphonuclear leukocytes,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619229,,BAO_0000219,,
4163,11388,Inhibitory activity against 5-lipoxygenase of RBL-1 cell line,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619230,702.0,BAO_0000219,,
4164,167,Inhibitory activity against RBL broken cell-supematant 5-lipoxygenase was evaluated,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619231,,BAO_0000357,,
4165,167,"Inhibitory activity against intact rat PMNL, LTB4 5-lipoxygenase was evaluated",B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619232,,BAO_0000357,,
4166,13744,Inhibitory activity against rat 5-lipoxygenase by using continuous oxygen consumption assay.,B,,,,,,,,,12166,H,8,Expert,1,,CHEMBL619233,,BAO_0000357,,
4167,1630,Inhibitory activity against rat basophilic leukemia cell 5-lipoxygenase,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619234,,BAO_0000357,,
4168,1630,Inhibitory activity against rat basophilic leukemia cell 5-lipoxygenase (5-LO),B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619235,,BAO_0000357,,
4169,969,"Inhibitory activity against 5-lipoxygenase in rat neutrophils as inhibition of A 23,187-induced LTB4 production",B,,,Rattus norvegicus,10116.0,,,,,12166,D,9,Expert,1,,CHEMBL619236,,BAO_0000019,,
4170,13621,Inhibitory concentration against 5-lipoxygenase in rat RBL-1 cells,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619237,702.0,BAO_0000219,,
4171,10089,Inhibitory concentration to inhibit 5-lipoxygenase in the rat,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619238,,BAO_0000357,,
4172,10193,In vitro inhibition of rat polymorphonuclear leukocyte 5-lipoxygenase,B,,,,,,,,,12166,H,8,Expert,1,,CHEMBL619239,,BAO_0000357,,
4173,11966,Tested for inhibition of 5-HPETE production by rat 5-LO; value ranges from 16-36 nM,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619240,,BAO_0000357,,
4174,12251,Tested for inhibition of 5-LO by measuring the reduction of leukotriene B4 (LTB4) in intact basophilic rat leukemia cells,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL875417,,BAO_0000019,,
4175,211,Tested for inhibition of 5-Lipoxygenase (ARBL) in calcium-stimulated rat basophilic leukemia cells(RBL-1),B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619241,702.0,BAO_0000219,,
4176,12251,Inhibition of 5-lipoxygenase measured by the reduction of leukotriene B4 (LTB4) in intact basophilic rat leukemia cells,F,,,,,,,,,12166,H,8,Expert,1,,CHEMBL619242,,BAO_0000019,,
4177,12495,Tested for inhibitory activity against 5-lipoxygenase in microsome of RBL-1 cells,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL883796,702.0,BAO_0000219,,
4178,414,Tested for its inhibitory activity against 5-lipoxygenase,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619243,,BAO_0000357,,
4179,414,Tested for its inhibitory activity against 5-lipoxygenase; Not determined,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619244,,BAO_0000357,,
4180,10325,"Iin vitro inhibition of 5-lipoxygenase activity in rat basophil leukemia type 1(RBL1) cell homogenates, (reduction of [14C]-5-HETE formation)",B,,,,,,,,,12166,H,8,Expert,1,,CHEMBL619245,,BAO_0000019,,
4181,11966,In vitro test for inhibition of 5-lipoxygenase in cell-free preparations from rat PMN leukocytes,B,,,,,,,,,12166,H,8,Expert,1,,CHEMBL619246,,BAO_0000019,,
4182,165,In vitro inhibition of 5-lipoxygenase activity in RBL-1 cells.,B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL619984,702.0,BAO_0000219,,
4183,165,The compound was evaluated in vitro for inhibition of 5-lipoxygenase activity in RBL-1 cells; No significant inhibitory activity up to 30 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619985,702.0,BAO_0000219,,
4184,165,The compound was evaluated in vitro for inhibition of 5-lipoxygenase activity in RBL-1 cells.,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619986,702.0,BAO_0000219,,
4185,165,In vitro for inhibition of 5-lipoxygenase activity in RBL-1 cells.,B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL619987,702.0,BAO_0000219,,
4186,11311,The compound was tested for inhibitory activity against 5-lipoxygenase in mouse,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619988,,BAO_0000218,,
4187,11311,The compound was tested for inhibitory activity against 5-lipoxygenase in rat RBL-1,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619989,702.0,BAO_0000219,,
4188,11311,The compound was tested for inhibitory activity against 5-lipoxygenase in rat RBL-1 cells,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL619990,702.0,BAO_0000219,,
4189,11311,The compound was tested for inhibitory activity against 5-lipoxygenase in rat polymorphonuclear leukocytes[PMNS],B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619991,,BAO_0000219,,
4190,11311,The compound was tested for inhibitory activity against 5-lipoxygenase in rat polymorphonuclear leukocytes[PMNS] (in vitro),B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619992,,BAO_0000219,,
4191,11311,The compound was tested for inhibitory activity against 5-lipoxygenase in rat polymorphonuclear leukocytes[PMNS] (in vivo),B,In vivo,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619993,,BAO_0000218,,
4192,11311,The compound was tested for inhibitory activity against 5-lipoxygenase translocation inhibitor in RBL-2H3 cells,F,,,,,,,RBL-2H3,,12166,H,8,Autocuration,1,,CHEMBL619994,663.0,BAO_0000219,,
4193,11311,The compound was tested for inhibitory activity against 5-lipoxygenase translocation inhibitor in rat RBL-2H3 cells,F,,,,,,,RBL-2H3,,12166,H,8,Autocuration,1,,CHEMBL619995,663.0,BAO_0000219,,
4194,11311,The compound was tested for inhibitory activity against 5-lipoxygenase using rat polymorphonuclear leukocytes[PMNS],B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619996,,BAO_0000019,,
4195,11732,The compound was tested for its inhibitory activity against arachidonic acid in rat 5-lipoxygenase,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619997,,BAO_0000019,,
4196,11732,Tested for its inhibitory activity against arachidonic acid in rat 5-lipoxygenase.,B,,,,,,,,,12166,H,8,Expert,1,,CHEMBL619998,,BAO_0000019,,
4197,11087,In vitro inhibition of 5-lipoxygenase (5-lo) from the 20000 g supernatant of RBI-1 cells,B,,,,,,,,,12166,H,8,Expert,1,,CHEMBL619999,,BAO_0000019,,
4198,11087,The compound was tested for the in vitro inhibition of 5-lipoxygenase from the 20000 g supernatant of RBI-1 cells,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL620000,,BAO_0000019,,
4199,11087,The compound was tested for the inhibition of 5-lipoxygenase (5-lo) in homogenized rat basophilic leukemia (RBL-1) cells,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620001,702.0,BAO_0000219,,
4200,11087,Inhibition of 5-lipoxygenase (5-lo) in intact rat polymorphonuclear leukocyte RPMNL,B,,,Rattus norvegicus,10116.0,,,,,12166,D,9,Expert,1,,CHEMBL620002,,BAO_0000357,,
4201,496,The compound was tested for the inhibition of 5-lipoxygenase in intact basophilic rat leukemia cells,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620003,702.0,BAO_0000219,,
4202,13986,Inhibition of 5-lipoxygenase on rat basophil leukemia cell line lysate (RBL-1 2H3 subline) by measuring 5-HETE production,F,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL620004,702.0,BAO_0000219,,
4203,11520,Compound was evaluated for the inhibition of 5-lipoxygenase,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL874063,,BAO_0000357,,
4204,10293,Ability to inhibit 5-lipoxygenase by using a crude preparation of the cytosolic enzyme from the rat basophilic leukemia (RBL-1) cell line at a concentration of 25 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620005,702.0,BAO_0000219,,
4205,303,Compound was evaluated for its inhibitory activity against 5-LO (5-lipoxygenase) at 10 uM concentration in intact RBL-1 cell line assay,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620006,702.0,BAO_0000219,,
4206,303,Compound was evaluated for its inhibitory activity against 5-LO (5-lipoxygenase) at 10 uM concentration in intact RBL-1 cell line assay; Less than 5% inhibition at 10 uM reported as not active,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620007,702.0,BAO_0000219,,
4207,9247,Compound was evaluated for the inhibition of rat basophilic leukemia-1 (RBL-1) 5-Lipoxygenase at 10 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620008,702.0,BAO_0000219,,
4208,9247,Inhibition of rat basophilic leukemia-1 (RBL-1) 5-Lipoxygenase at 100 uM,B,,,Rattus norvegicus,10116.0,,,RBL-1,,12166,D,9,Expert,1,,CHEMBL620009,702.0,BAO_0000219,,
4209,9247,Compound was evaluated for the inhibition of rat basophilic leukemia-1 (RBL-1) 5-Lipoxygenase at 100 uM; NS = no significant activity,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620010,702.0,BAO_0000219,,
4210,9247,Compound was evaluated for the inhibition of rat basophilic leukemia-1 (RBL-1) 5-Lipoxygenase at 30 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620011,702.0,BAO_0000219,,
4211,9247,Compound was evaluated for the inhibition of rat basophilic leukemia-1 (RBL-1) 5-Lipoxygenase at 300 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620677,702.0,BAO_0000219,,
4212,9247,Compound was evaluated for the inhibition of rat basophilic leukemia-1 (RBL-1) 5-Lipoxygenase at 33 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620678,702.0,BAO_0000219,,
4213,9247,Compound was evaluated for the inhibition of rat basophilic leukemia-1 (RBL-1) 5-Lipoxygenase at 40 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620679,702.0,BAO_0000219,,
4214,9247,Compound was evaluated for the inhibition of rat basophilic leukemia-1 (RBL-1) 5-Lipoxygenase at 75 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620680,702.0,BAO_0000219,,
4215,11481,Inhibitory activity against 5-lipoxygenase at 10 uM,B,,,Rattus norvegicus,10116.0,,,,,12166,D,9,Expert,1,,CHEMBL620838,,BAO_0000357,,
4216,105,In vitro inhibition of 5-lipoxygenase; NS means no significant inhibition,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL620839,,BAO_0000357,,
4217,9029,In vitro inhibition of rat polymorphonuclear leukocyte (PMN) 5-Lipoxygenase at 10 uM,B,,,,,,,,,12166,H,8,Expert,1,,CHEMBL620840,,BAO_0000357,,
4218,1175,Inhibitory activity against 5-lipoxygenase enzyme from RBL-1 cells at 20 uM,B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL620841,702.0,BAO_0000219,,
4219,12118,In vitro inhibition against 5-lipoxygenase in RBL-1 cells was determined at 100 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620842,702.0,BAO_0000219,,
4220,12118,In vitro inhibition against 5-lipoxygenase in RBL-1 cells was determined at 10e-4 M,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620843,702.0,BAO_0000219,,
4221,12118,In vitro inhibition against 5-lipoxygenase in RBL-1 cells was determinedb at 100 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620844,702.0,BAO_0000219,,
4222,9225,In vitro inhibition of RBL-1 5-lipoxygenase at 20 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620845,702.0,BAO_0000219,,
4223,9401,In vitro inhibitory activity against 5-Lipoxygenase from rat basophilic leukemia cells at 30 uM concentration,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL620846,,BAO_0000019,,
4224,137,In vitro inhibitory activity against 5-lipoxygenase was determined at 16 uM,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL873951,,BAO_0000357,,
4225,137,In vitro inhibitory activity against 5-lipoxygenase was determined at 16 uM,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL620847,,BAO_0000357,,
4226,4717,In vitro percent inhibition against 5-lipoxygenase in RBL-1 cells at 10 uM concentration,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620848,702.0,BAO_0000219,,
4227,3595,Inhibitory activity against 5-lipoxygenase (5-LO) using broken rat barophilic leukemia cells (RBL-1) at 10 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620849,702.0,BAO_0000219,,
4228,10501,Inhibitory activity against 5-lipoxygenase in RBL-1 cells at 40 uM concentration,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620850,702.0,BAO_0000219,,
4229,10501,Inhibitory activity against 5-lipoxygenase in RBL-1 cells at a concentration 40 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620851,702.0,BAO_0000219,,
4230,10501,Inhibitory activity against 5-lipoxygenase in RBL-1 cells at a concentration 40 uM.,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620852,702.0,BAO_0000219,,
4231,12526,Inhibitory activity against 5-lipoxygenase in intact rat basophilic leukemia cells stimulated with the calcium ionophore A-23187,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL875098,702.0,BAO_0000219,,
4232,14799,Inhibition of 5-lipoxygenase of rat basophilic leukemia cells at 30 uM,B,,,Rattus norvegicus,10116.0,,,RBL-1,,12166,D,9,Expert,1,,CHEMBL620853,702.0,BAO_0000219,,
4233,14799,Inhibitory activity against 5-lipoxygenase obtained from rat basophilic leukemia cells at 30 uM concentration; NT=Not tested,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL620854,,BAO_0000019,,
4234,3595,Inhibitory activity against 5-lipoxygenase (5-LO) using broken rat barophilic leukemia cells (RBL-1) at 10 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620855,702.0,BAO_0000219,,
4235,3595,Inhibitory activity against 5-lipoxygenase (5-LO) using broken rat barophilic leukemia cells (RBL-1)at 10 uM,B,,,,,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL839884,702.0,BAO_0000219,,
4236,12526,Inhibitory activity at 10 uM against 5-lipoxygenase in intact rat basophilic leukemia cells stimulated with the calcium ionophore A-23187,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620856,702.0,BAO_0000219,,
4237,12526,Inhibitory activity at 1 uM against 5-lipoxygenase in intact rat basophilic leukemia cells stimulated with the calcium ionophore A-23187,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620857,702.0,BAO_0000219,,
4238,10193,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase in rat cell at 1 uM,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL620858,,BAO_0000019,,
4239,10193,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase in rat cell at 10 uM,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL620859,,BAO_0000019,,
4240,10193,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase in rat cell at 1 uM,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL620860,,BAO_0000019,,
4241,10193,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase in rat cell at 3 uM,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL620861,,BAO_0000019,,
4242,9138,Percent inhibition of rat neutrophil 5-lipoxygenase (5-LO),B,,,,,,,,,12166,H,8,Expert,1,,CHEMBL620862,,BAO_0000357,,
4243,9138,Percent inhibition of rat neutrophil 5- Lipoxygenase (5-LO) at 100 uM,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL620863,,BAO_0000357,,
4244,11966,Tested in vitro for the inhibition of 5-lipoxygenase in cell-free preparations from rat PMN leukocytes,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL620864,,BAO_0000019,,
4245,165,The compound was evaluated in vitro for inhibition of 5-lipoxygenase activity in RBL-1 cells at 100 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620865,702.0,BAO_0000219,,
4246,165,The compound was evaluated in vitro for inhibition of 5-lipoxygenase activity in RBL-1 cells at 30 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620866,702.0,BAO_0000219,,
4247,11311,The compound was tested for inhibition of 5-lipoxygenase in rat RBL-2H3 cells,B,,,,,,,RBL-2H3,,12166,H,8,Autocuration,1,,CHEMBL620867,663.0,BAO_0000219,,
4248,11311,The compound was tested for inhibition of 5-lipoxygenase translocation in SAR in rat RBL-2H3 cells,B,,,,,,,RBL-2H3,,12166,H,8,Autocuration,1,,CHEMBL620868,663.0,BAO_0000219,,
4249,11311,The compound was tested for inhibition of 5-lipoxygenase translocation in SAR in rat RBL-2H3 cells,F,,,,,,,RBL-2H3,,12166,H,8,Autocuration,1,,CHEMBL620869,663.0,BAO_0000219,,
4250,11311,The compound was tested for inhibition of LTB4 synthesis on isolated 5-lipoxygenase,F,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL873952,,BAO_0000019,,
4251,11311,The compound was tested for inhibition of isolated 5-lipoxygenase,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL875099,,BAO_0000357,,
4252,11311,The compound was tested for inhibition of isolated 5-lipoxygenase translocation into rat RBL-2H3 cells,F,,,,,,,RBL-2H3,,12166,H,8,Autocuration,1,,CHEMBL620870,663.0,BAO_0000219,,
4253,11087,The compound was tested for the in vitro inhibition of 5-lipoxygenase (5-lo) from the 20000 g supernatant of RBI-1 cells at a concentration of 30 uM,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL618261,,BAO_0000019,,
4254,11087,The compound was tested for the in vitro inhibition of 5-lipoxygenase (5-lo) from the 20000 g supernatant of RBI-1 cells at a concentration of 32 uM,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL618262,,BAO_0000019,,
4255,11087,The compound was tested for the in vitro inhibition of 5-lipoxygenase (5-lo) from the 20000 g supernatant of RBI-1 cells measured at a concentration of 30 uM,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619428,,BAO_0000019,,
4256,11087,The compound was tested for the in vitro inhibition of 5-lipoxygenase (5-lo) from the 20000 g supernatant of RBI-1 cells; NS indicates nonsignificant inhibition at 32 uM concentration,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619429,,BAO_0000019,,
4257,11087,The compound was tested for the in vitro inhibition of 5-lipoxygenase from the 20000 g supernatant of RBI-1 cells; NS indicates nonsignificant inhibition at 32 uM concentration,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL619430,,BAO_0000019,,
4258,496,The compound was tested for the inhibition of 5-lipoxygenase in intact basophilic rat leukemia cells at 1.0 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620017,702.0,BAO_0000219,,
4259,496,The compound was tested for the inhibition of 5-lipoxygenase in intact basophilic rat leukemia cells at 10 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620018,702.0,BAO_0000219,,
4260,13986,The compound was tested for the inhibition of 5-lipoxygenase on rat basophil leukemia (RBL-1) cell (2H3 subline) lysate by 5-HETE production at 0.1 uM,F,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620019,702.0,BAO_0000219,,
4261,13986,The compound was tested for the inhibition of 5-lipoxygenase on rat basophil leukemia (RBL-1) cell (2H3 subline) lysate by 5-HETE production at 0.195 uM,F,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620020,702.0,BAO_0000219,,
4262,13986,The compound was tested for the inhibition of 5-lipoxygenase on rat basophil leukemia (RBL-1) cell (2H3 subline) lysate by 5-HETE production at 0.2 at uM,F,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620021,702.0,BAO_0000219,,
4263,13986,The compound was tested for the inhibition of 5-lipoxygenase on rat basophil leukemia (RBL-1) cell (2H3 subline) lysate by 5-HETE production at 0.25 uM,F,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620022,702.0,BAO_0000219,,
4264,13986,The compound was tested for the inhibition of 5-lipoxygenase on rat basophil leukemia (RBL-1) cell (2H3 subline) lysate by 5-HETE production at 0.39,F,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620023,702.0,BAO_0000219,,
4265,13986,The compound was tested for the inhibition of 5-lipoxygenase on rat basophil leukemia (RBL-1) cell (2H3 subline) lysate by 5-HETE production at 0.39 uM,F,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620024,702.0,BAO_0000219,,
4266,13986,The compound was tested for the inhibition of 5-lipoxygenase on rat basophil leukemia (RBL-1) cell (2H3 subline) lysate by measuring 5-HETE production at 0.195 uM,F,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620025,702.0,BAO_0000219,,
4267,13986,The compound was tested for the inhibition of 5-lipoxygenase on rat basophil leukemia (RBL-1) cell (2H3 subline) lysate by measuring 5-HETE production at 0.2 uM,F,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620026,702.0,BAO_0000219,,
4268,13986,The compound was tested for the inhibition of 5-lipoxygenase on rat basophil leukemia (RBL-1) cell (2H3 subline) lysate by measuring 5-HETE production at 0.39 uM,F,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL620027,702.0,BAO_0000219,,
4269,13986,Inhibition of 5-lipoxygenase on rat basophil leukemia cell (RBL-2H3) lysate as 5-HETE production at 32 uM,F,,,Rattus norvegicus,10116.0,,,,,12166,D,9,Expert,1,,CHEMBL620028,,BAO_0000019,,
4270,10193,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL620029,,BAO_0000357,,
4271,9295,Compound was tested for the percent of inhibition against 5-LO at 10 uM,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL620030,,BAO_0000357,,
4272,4717,In vitro percent inhibition against 5-lipoxygenase in RBL-1 cells at 1 uM concentration,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL875415,702.0,BAO_0000219,,
4273,4717,In vitro percent inhibition against 5-lipoxygenase in RBL-1 cells at 10 uM concentration,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL618256,702.0,BAO_0000219,,
4274,11854,Inhibition of LTB4 in whole cell 5-lipoxygenase assay in an intact rat basophilic leukemia (RBL-1) cell line,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL618257,702.0,BAO_0000219,,
4275,11854,Inhibition of LTB4 in whole cell 5-lipoxygenase assay in an intact rat basophilic leukemia (RBL-1) cell line at 10 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL618258,702.0,BAO_0000219,,
4276,11854,Inhibition of LTB4 in whole cell 5-lipoxygenase assay in an intact rat basophilic leukemia (RBL-1) cell line at 16 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL618259,702.0,BAO_0000219,,
4277,10193,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase in rat cell at 10 uM,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL618260,,BAO_0000019,,
4278,9295,Percent inhibition against RBL-1 5-LO in vitro at 10 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL618215,702.0,BAO_0000219,,
4279,9295,Percent inhibition against RBL-1 5-LO in vitro at 100 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL618390,702.0,BAO_0000219,,
4280,9295,Percent inhibition against RBL-1 5-LO in vitro at 30 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL618391,702.0,BAO_0000219,,
4281,9295,Percent inhibition against RBL-1 5-LO in vitro at 300 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL618392,702.0,BAO_0000219,,
4282,165,The compound was evaluated in vitro for inhibition of 5-lipoxygenase activity in RBL-1 cells at 20 uM,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL618393,702.0,BAO_0000219,,
4283,11311,The compound was tested for inhibition against 5-lipoxygenase in rat polymorphonuclear leukocytes[PMNS] at 10 uM concentration,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL618394,,BAO_0000219,,
4284,10489,In vitro inhibitory activity against 5-lipoxygenase in rat basophilic leukemia cells(RBL-1),B,,,Homo sapiens,9606.0,,,RBL-1,,12166,H,8,Expert,1,,CHEMBL618395,702.0,BAO_0000219,,
4285,10489,In vitro inhibitory activity against 5-lipoxygenase in rat basophilic leukemia cells(RBL-1),B,,,Rattus norvegicus,10116.0,,,RBL-1,,12166,D,9,Expert,1,,CHEMBL618396,702.0,BAO_0000219,,
4286,10489,Logarithmic value of inhibitory concentration against 5-lipoxygenase in rat basophilic leukemia cells (RBL-1),B,,,Rattus norvegicus,10116.0,,,RBL-1,,12166,D,9,Expert,1,,CHEMBL858253,702.0,BAO_0000219,,
4287,14799,Inhibitory activity against 5-lipoxygenase obtained from rat basophilic leukemia cells,B,,,Rattus norvegicus,10116.0,,,,,12166,D,9,Autocuration,1,,CHEMBL618397,,BAO_0000019,,
4288,9295,Compound was tested for the percent of inhibition against soybean 15-LO (at 100 uM),B,,,Glycine max,3847.0,,,,,12054,H,8,Autocuration,1,,CHEMBL618398,,BAO_0000357,,
4289,16811,"Inhibitory activity against 5-lipoxygenase, by using soybean lipoxygenase spectrophotometric assay",B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL618399,,BAO_0000019,,
4290,168,In vitro inhibition of 5-Lipoxygenase; Inactive.,B,,,,,,,,,55,H,8,Expert,1,,CHEMBL618400,,BAO_0000357,,
4291,6309,Inhibitory concentration against 5-lipoxygenase was determined; No inhibition,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618401,,BAO_0000357,,
4292,6309,Inhibitory concentration against 5-lipoxygenase; No inhibition,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618402,,BAO_0000357,,
4293,3092,Evaluated for inhibitory activity against RBL-1 cell 5-lipoxygenase in guinea pig,B,,,,,,,RBL-1,,55,H,8,Autocuration,1,,CHEMBL876400,702.0,BAO_0000219,,
4294,168,Inhibitory activity against 5-lipoxygenase.,B,,,,,,,,,55,H,8,Expert,1,,CHEMBL618403,,BAO_0000357,,
4295,168,Inhibitory Activity against 5-Lipoxygenase was determined; IA=Inactive,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618404,,BAO_0000357,,
4296,168,Inhibitory Activity against 5-Lipoxygenase was determined; IA=Inactive at concentrations less than 32 uM,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618405,,BAO_0000357,,
4297,168,Inhibitory Activity against 5-Lipoxygenase was determined; NA=No significant inhibitory activity up to 300 uM,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618406,,BAO_0000357,,
4298,12338,Inhibitory concentration against arachidonic acid 5-lipoxygenation,F,,,,,,,,,55,H,8,Expert,1,,CHEMBL618407,,BAO_0000019,,
4299,4501,Tested for the inhibitory activity against 5-lipoxygenase,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618408,,BAO_0000357,,
4300,1132,Compound was tested for its inhibitory activity against 5-lipoxygenase,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618409,,BAO_0000357,,
4301,2117,Compound was tested for inhibition of 5-lipoxygenase at 50 uM; NI means no inhibition was observed,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618410,,BAO_0000357,,
4302,168,Inhibitory Activity against 5-Lipoxygenase at 30 uM was determined; Weakly active,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618411,,BAO_0000357,,
4303,168,Inhibitory Activity against 5-Lipoxygenase at concentration 32 uM was determined,B,,,,,,,,,55,H,8,Autocuration,1,,CHEMBL618412,,BAO_0000357,,
4304,13575,Concentration required to inhibit RBL-1 supernatant 5-lipoxygenase,B,,,,,,,RBL-1,,12166,H,8,Autocuration,1,,CHEMBL618413,702.0,BAO_0000219,,
4305,11089,,B,,,,,,,,,12166,H,8,Autocuration,1,,CHEMBL618414,,BAO_0000357,,
4306,216,Compound was tested for its binding activity towards 5-lipoxygenase activating protein (FLAP),B,,,,,,,,,10102,H,8,Autocuration,1,,CHEMBL618415,,BAO_0000357,,
4307,13165,Inhibition of 5-lipoxygenase activating protein using human leukocyte membrane preparations,B,,,,,,,,,10102,H,8,Autocuration,1,,CHEMBL618416,,BAO_0000019,,
4308,3278,Measuring the affinity of leukotriene synthesis inhibitor for 5-Lipoxygenase activating protein (FLAP) by using [125I]L-691831 as radioligand.,B,,,,,,,,,10102,H,8,Autocuration,1,,CHEMBL876401,,BAO_0000357,,
4309,3278,Measuring the affinity of leukotriene synthesis inhibitor for 5-lipoxygenase activating protein by using [125I]L-691831 as radioligand.,B,,,,,,,,,10102,H,8,Expert,1,,CHEMBL618417,,BAO_0000357,,
4310,11966,Tested for inhibition of leukotriene biosynthesis by binding to 5-lipoxygenase activating protein,B,,,,,,,,,10102,H,8,Autocuration,1,,CHEMBL618418,,BAO_0000357,,
4311,175,"The compound was tested for the inhibition of binding of [125I]- L- 691,831 binding to 5-lipoxygenase activating protein",B,,,,,,,,,10102,H,8,Autocuration,1,,CHEMBL618419,,BAO_0000357,,
4312,175,"The compound was tested for the inhibition of binding of [125I]- L- 691,831 binding to 5-lipoxygenase activating protein (FLAP)",B,,,,,,,,,10102,H,8,Autocuration,1,,CHEMBL618420,,BAO_0000357,,
4313,13449,Binding affinity of compound for 5-lipoxygenase activating protein protein by FLAP binding assay,B,,,,,,,,,10102,H,8,Autocuration,1,,CHEMBL618421,,BAO_0000357,,
4314,12014,Tested for inhibition of 5-phosphatase isolated from human erythrocyte membrane,B,,,,,,,,,11238,H,8,Autocuration,1,,CHEMBL618422,,BAO_0000019,,
4315,12014,Tested for inhibition of 5-phosphatase isolated from human erythrocyte membrane (R metabolically resistant),B,,,,,,,,,11238,H,8,Autocuration,1,,CHEMBL618423,,BAO_0000019,,
4316,12014,Tested for inhibition of 5-phosphatase isolated from human erythrocyte membrane (S substrate),B,,,,,,,,,11238,H,8,Autocuration,1,,CHEMBL618424,,BAO_0000019,,
4317,99,Inhibition of protein biosynthesis at the level of the peptidyl transferase center of the 50 s ribosomal subunit,B,,,,,,,,,100284,S,2,Intermediate,1,,CHEMBL618425,,BAO_0000220,,
4318,4349,The dark toxicity against 543 human galactophore carcinoma cells,F,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL618426,,BAO_0000019,,
4319,4071,Tested in vitro for cytotoxicity against 56 human tumor cell lines,F,,,Homo sapiens,9606.0,,,Panel (56 tumour cell lines),,80623,N,1,Expert,1,,CHEMBL618427,390.0,BAO_0000219,,
4320,17589,Cytotoxic activity against human 5637 cell line at 20 uM expressed as percent growth value,F,,,Homo sapiens,9606.0,,,5637,,80008,N,1,Expert,1,,CHEMBL618428,345.0,BAO_0000219,,
4321,15002,Antitumor activity was evaluated against human bladder carcinoma cell line 5637.,F,,,Homo sapiens,9606.0,,,5637,,80008,N,1,Intermediate,1,,CHEMBL618429,345.0,BAO_0000219,,
4322,13958,"Compound was tested for antiproliferative activity against 5637, human bladder carcinoma cell line",F,,,Homo sapiens,9606.0,,,5637,,80008,N,1,Intermediate,1,,CHEMBL618430,345.0,BAO_0000219,,
4323,17589,Growth inhibition against human 5637 cell lines,F,,,Homo sapiens,9606.0,,,5637,,80008,N,1,Expert,1,,CHEMBL618431,345.0,BAO_0000219,,
4324,16748,Antitumor activity against human bladder carcinoma 5637 cells.,F,,,Homo sapiens,9606.0,,,5637,,80008,N,1,Expert,1,,CHEMBL883799,345.0,BAO_0000219,,
4325,16747,Antitumor activity against human bladder carcinoma 5637 cells,F,,,Homo sapiens,9606.0,,,5637,,80008,N,1,Intermediate,1,,CHEMBL618432,345.0,BAO_0000219,,
4326,16747,Antitumor activity against human bladder carcinoma 5637 cells,F,,,Homo sapiens,9606.0,,,5637,,80008,N,1,Intermediate,1,,CHEMBL618433,345.0,BAO_0000219,,
4327,15285,In vitro inhibition of bovine trypsin(Trp).,B,,,Bos taurus,9913.0,,,,,10443,D,9,Expert,1,,CHEMBL618434,,BAO_0000357,,
4328,3726,Transcriptional activation in CV-1 cells expressing retinoic acid gamma receptor,B,,,Cercopithecidae,9527.0,,,CV-1,,240,H,8,Expert,1,,CHEMBL618435,407.0,BAO_0000219,,
4329,5033,Ability to displace the radioligand [125I](-)-iodocyanopindolol from rat striatal 5-HT1B receptor,B,,,,,,,,,10577,H,8,Autocuration,1,,CHEMBL876402,,BAO_0000357,,
4330,11756,In vitro antagonism of the 5-HT-3 receptor determined by inhibition of 5-HT-induced depolarization of the isolated rat vagus nerve.,F,,,,,,,,,104698,H,6,Autocuration,1,,CHEMBL618436,,BAO_0000019,,
4331,11953,Concentration required to inhibit pressor response to serotonin after 15 min i.v. administration of compound mediated via activation of vascular 5-HT2 receptors in rat,F,In vivo,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL618437,,BAO_0000218,,
4332,5033,Ability to displace the radioligand [3H]GR-113808 from guinea pig striatum 5-HT4 receptor,B,,,Cavia porcellus,10141.0,,,,,20033,D,9,Intermediate,1,,CHEMBL618438,,BAO_0000357,,
4333,11347,Inhibition of progesterone 6-beta-hydroxylase in rat hepatic microsomes,A,,,Rattus norvegicus,10116.0,,,,Microsomes,17045,H,8,Expert,1,,CHEMBL883800,,BAO_0000251,,
4334,11347,Inhibition of progesterone 6-beta-hydroxylase in rat hepatic microsomes,A,,,Rattus norvegicus,10116.0,,,,Microsomes,17045,H,8,Expert,1,,CHEMBL618439,,BAO_0000251,,
4335,1229,In vitro anticancer activity against 6 NCI ovarian cancer cell lines; inactive,F,,,,,,,,,22226,U,0,Intermediate,1,,CHEMBL618440,,BAO_0000019,,
4336,1229,In vitro anticancer activity against 6 NCI ovarian cancer cell lines; inactive,F,,,,,,,,,22226,U,0,Intermediate,1,,CHEMBL618441,,BAO_0000019,,
4337,17588,Inhibition constant against 6-phosphogluconate dehydrogenase of Trypanosoma brucei expressed in Escherichia coli,B,,,Trypanosoma brucei,5691.0,,,,,11938,H,8,Expert,1,,CHEMBL618442,,BAO_0000019,,
4338,17588,Inhibition constant against 6-phosphogluconate dehydrogenase of Trypanosoma brucei expressed in Escherichia coli; NI denotes no inhibition,B,,,Trypanosoma brucei,5691.0,,,,,11938,H,8,Autocuration,1,,CHEMBL618443,,BAO_0000019,,
4339,17588,Inhibition constant against 6-phosphogluconate dehydrogenase of sheep liver,B,,,Ovis aries,9940.0,,,,,11938,H,8,Expert,1,,CHEMBL619158,,BAO_0000019,,
4340,17588,Inhibition constant against 6-phosphogluconate dehydrogenase of sheep liver; NI denotes no inhibition,B,,,Ovis aries,9940.0,,,,,11938,H,8,Autocuration,1,,CHEMBL620974,,BAO_0000019,,
4341,16485,log Kd which is the binding affinity against 6-phosphogluconate dehydrogenase,B,,,,,,,,,11938,H,8,Autocuration,1,,CHEMBL620975,,BAO_0000357,,
4342,4337,Average inhibitory concentration against 60 human cell lines was reported,F,,,Homo sapiens,9606.0,,,,,22226,U,0,Intermediate,1,,CHEMBL620976,,BAO_0000019,,
4343,4112,Inhibition of proliferation in NCI panel of 60 human tumor cell lines,F,,,Homo sapiens,9606.0,,,,,22226,U,0,Expert,1,,CHEMBL620977,,BAO_0000019,,
4344,16160,Cancer specificity was measured from the +/- value under average log LC50 60-cell line,F,,,Homo sapiens,9606.0,,,Panel NCI-60 (60 carcinoma cell lines),,80315,N,1,Intermediate,1,,CHEMBL620978,542.0,BAO_0000219,,
4345,16160,Cancer specificity was measured from the +/- value under average log LC50 60-cell line. ,F,,,Homo sapiens,9606.0,,,Panel NCI-60 (60 carcinoma cell lines),,80315,N,1,Intermediate,1,,CHEMBL620979,542.0,BAO_0000219,,
4346,17376,In vitro mean growth inhibitory activity against 60-cell panel,F,,,,,,,Panel NCI-60 (60 carcinoma cell lines),,80315,N,1,Expert,1,,CHEMBL620980,542.0,BAO_0000219,,
4347,17376,In vitro mean growth lethal concentration against 60-cell panel,F,,,,,,,Panel NCI-60 (60 carcinoma cell lines),,80315,N,1,Expert,1,,CHEMBL620981,542.0,BAO_0000219,,
4348,17376,In vitro mean growth lethal concentration in colon subpanel against 60-cell panel,F,,,,,,,Panel NCI-60 (60 carcinoma cell lines),,80315,N,1,Expert,1,,CHEMBL620982,542.0,BAO_0000219,,
4349,17376,In vitro mean growth lethal concentration in renal subpanel against 60-cell panel,F,,,,,,,Panel NCI-60 (60 carcinoma cell lines),,80315,N,1,Expert,1,,CHEMBL620983,542.0,BAO_0000219,,
4350,3241,Inhibition of CK-II-mediated 60S acidic ribosomal P protein activity at 10 uM,F,,,,,,,,,104775,H,4,Autocuration,1,,CHEMBL620984,,BAO_0000019,,
4351,3241,Inhibition of CK-II-mediated 60S acidic ribosomal P protein activity at 10 uM,F,,,,,,,,,104775,H,4,Autocuration,1,,CHEMBL620985,,BAO_0000019,,
4352,3725,Transcriptional activation in CV-1 expressing retinoid X receptor RXR alpha,B,,,,,,,,,275,H,8,Expert,1,,CHEMBL620986,,BAO_0000357,,
4353,10805,Inhibitory activity against Plasmodium falciparum 68 neutral proteinase,F,,,Plasmodium falciparum,5833.0,,,,,50425,N,1,Expert,1,,CHEMBL620987,,BAO_0000218,,
4354,10805,In vitro inhibition of Plasmodium falciparum 68 neutral proteinase activity by reinvasion of red blood cells,F,,,Plasmodium falciparum,5833.0,,,,,50425,N,1,Expert,1,,CHEMBL620988,,BAO_0000218,,
4355,10805,Inhibitory activity against Plasmodium falciparum 68 neutral proteinase.,F,,,Plasmodium falciparum,5833.0,,,,,50425,N,1,Expert,1,,CHEMBL620989,,BAO_0000218,,
4356,10805,Substrate affinity for Plasmodium falciparum 68 neutral proteinase.,F,,,Plasmodium falciparum,5833.0,,,,,50425,N,1,Expert,1,,CHEMBL620990,,BAO_0000218,,
4357,10805,Reaction velocity for Plasmodium falciparum 68 neutral proteinase.,F,,,Plasmodium falciparum,5833.0,,,,,50425,N,1,Intermediate,1,,CHEMBL620991,,BAO_0000218,,
4358,10144,Percent inhibition against 6C3HED lymphosarcoma at dose 100 mg/kg in C3H mice,F,,,Mus musculus,10090.0,,,6C3HED,,80628,N,1,Intermediate,1,,CHEMBL620992,850.0,BAO_0000218,,
4359,10144,Percent inhibition against 6C3HED lymphosarcoma at dose 12.5 mg/kg in C3H mice,F,,,Mus musculus,10090.0,,,6C3HED,,80628,N,1,Intermediate,1,,CHEMBL620993,850.0,BAO_0000218,,
4360,10144,Percent inhibition against 6C3HED lymphosarcoma at dose 200 mg/kg in C3H mice,F,,,Mus musculus,10090.0,,,6C3HED,,80628,N,1,Intermediate,1,,CHEMBL620994,850.0,BAO_0000218,,
4361,10144,Percent inhibition against 6C3HED lymphosarcoma at dose 25 mg/kg in C3H mice,F,,,Mus musculus,10090.0,,,6C3HED,,80628,N,1,Intermediate,1,,CHEMBL620995,850.0,BAO_0000218,,
4362,10144,Percent inhibition against 6C3HED lymphosarcoma at dose 50 mg/kg in C3H mice,F,,,Mus musculus,10090.0,,,6C3HED,,80628,N,1,Intermediate,1,,CHEMBL620996,850.0,BAO_0000218,,
4363,10144,Percent inhibition against 6C3HED lymphosarcoma at dose 6 mg/kg in C3H mice,F,,,Mus musculus,10090.0,,,6C3HED,,80628,N,1,Intermediate,1,,CHEMBL875581,850.0,BAO_0000218,,
4364,10685,Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 100 mg/kg,F,In vivo,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620997,,BAO_0000218,,
4365,10685,Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 150 mg/kg,F,In vivo,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620998,,BAO_0000218,,
4366,10685,Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 1600 mg/kg (intraperitoneal dosing for 8 days),F,In vivo,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620999,,BAO_0000218,,
4367,10685,Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 200 mg/kg,F,In vivo,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621000,,BAO_0000218,,
4368,10685,Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 225 mg/kg,F,In vivo,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621001,,BAO_0000218,,
4369,10685,Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 270 mg/kg,F,In vivo,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621002,,BAO_0000218,,
4370,10685,Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 275 mg/kg,F,In vivo,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621003,,BAO_0000218,,
4371,10685,"Antitumor activity in vivo against the 6C3HED lymphosarcoma, dosed for 10 days at 300 mg/kg",F,In vivo,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621004,,BAO_0000218,,
4372,10685,Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 300 mg/kg (intraperitoneal dosing for 8 days),F,In vivo,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621005,,BAO_0000218,,
4373,10685,Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 300 mg/kg (ip dosing daily for 8 days),F,In vivo,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621006,,BAO_0000218,,
4374,10685,Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 600 mg/kg,F,In vivo,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621007,,BAO_0000218,,
4375,10144,Percent inhibition against 6C3HED lymphosarcoma at dose 100 mg/kg in C3H mice,F,,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621008,,BAO_0000218,,
4376,10144,Percent inhibition against 6C3HED lymphosarcoma at dose 12.5 mg/kg in C3H mice,F,,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621009,,BAO_0000218,,
4377,10144,Percent inhibition against 6C3HED lymphosarcoma at dose 25 mg/kg in C3H mice,F,,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL857705,,BAO_0000218,,
4378,10144,Percent inhibition against 6C3HED lymphosarcoma at dose 50 mg/kg in C3H mice,F,,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619828,,BAO_0000218,,
4379,10685,Tested on 6C3HED lymphosarcoma and percent inhibition was determined at 100 mg/kg dosage administered for 8 days intraperitoneally,F,,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619829,,BAO_0000218,,
4380,10685,Tested on 6C3HED lymphosarcoma and percent inhibition was determined at 200 mg/kg dosage administered for 10 days intraperitoneally,F,,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619830,,BAO_0000218,,
4381,10685,Tested on 6C3HED lymphosarcoma and percent inhibition was determined at 200 mg/kg dosage administered for 8 days intraperitoneally,F,,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619831,,BAO_0000218,,
4382,10685,Tested on 6C3HED lymphosarcoma and percent inhibition was determined at 50 mg/kg dosage administered for 8 days intraperitoneally,F,,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619832,,BAO_0000218,,
4383,10685,Tested on 6 C3 HED lymphosarcoma and number of drug related deaths/total animals in treatment group was determined at 100 mg/kg dosage administered for 8 days intraperitoneally; 0/10,A,,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619833,,BAO_0000218,,
4384,10685,Tested on 6 C3 HED lymphosarcoma and number of drug related deaths/total animals in treatment group was determined at 200 mg/kg dosage administered for 8 days perorally; 1/10,A,,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619834,,BAO_0000218,,
4385,10685,Tested on 6 C3 HED lymphosarcoma and number of drug related deaths/total animals in treatment group was determined at 200 mg/kg dosage administered for 10 days intraperitoneally; 1/10,A,,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619835,,BAO_0000218,,
4386,10685,Tested on 6 C3 HED lymphosarcoma and number of drug related deaths/total animals in treatment group was determined at 50 mg/kg dosage administered for 8 days perorally; 3/10,A,,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619836,,BAO_0000218,,
4387,8831,"Compound was evaluated for the antitumor activity against 6C3HED lymphosarcoma for ip administration and daily x 8 schedule; Number of toxic deaths over total number of mice per group (T/C), 0/10 at dose of 35 mg/kg",F,,,Mus musculus,10090.0,,,6C3HED,,80628,N,1,Intermediate,1,,CHEMBL619837,850.0,BAO_0000218,,
4388,11704,In vivo antitumor activity against 6C3HED tumor type after intraperitoneal administration of 400 mg/kg,F,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL619838,,BAO_0000218,,
4389,11704,In vivo antitumor activity against 6C3HED tumor type was expressed as toxic deaths/total treated mice at 400 mg/kg dose; 2/10,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619839,,BAO_0000218,,
4390,10685,Antitumor activity in vivo expressed as percent of inhibition in 6C3HED-lymphosarcoma tumor cell line,F,In vivo,,Mus musculus,10090.0,,,6C3HED,,80628,N,1,Intermediate,1,,CHEMBL619840,850.0,BAO_0000218,,
4391,10685,Antitumor activity in vivo expressed as percent of inhibition in 6C3HED-lymphosarcoma tumor cell line; 95-100% inhibition,F,In vivo,,Mus musculus,10090.0,,,6C3HED,,80628,N,1,Intermediate,1,,CHEMBL619841,850.0,BAO_0000218,,
4392,11368,Inhibition of tumor growth of 6C3HED lymphosarcoma tumor cell line in mice at a dose of 150 mg/kg given orally(daily x 8),F,,,Mus musculus,10090.0,,,6C3HED,,80628,N,1,Expert,1,,CHEMBL857704,850.0,BAO_0000218,,
4393,11368,Inhibition of tumor growth of 6C3HED lymphosarcoma tumor cell line in mice at a dose of 200 mg/kg given orally(daily x 8),F,,,Mus musculus,10090.0,,,6C3HED,,80628,N,1,Intermediate,1,,CHEMBL619842,850.0,BAO_0000218,,
4394,11368,Inhibition of tumor growth of 6C3HED lymphosarcoma tumor cell line in mice at a dose of 300 mg/kg given orally (daily x 8),F,,,Mus musculus,10090.0,,,6C3HED,,80628,N,1,Expert,1,,CHEMBL619843,850.0,BAO_0000218,,
4395,17763,"Inhibition of Staphylococcus aureus 7,8-dihydroneopterin aldolase",B,,,Staphylococcus aureus,1280.0,,,,,22226,U,0,Autocuration,1,,CHEMBL619844,,BAO_0000019,,
4396,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes 3-methylcholanthrene at a concentration of 5 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL857855,,BAO_0000251,2107.0,
4397,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at a concentration of 10 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL619845,,BAO_0000251,2107.0,
4398,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at a concentration of 1 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL619846,,BAO_0000251,2107.0,
4399,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at a concentration of 20 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL619847,,BAO_0000251,2107.0,
4400,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at a concentration of 25 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL619848,,BAO_0000251,2107.0,
4401,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at a concentration of 50 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620893,,BAO_0000251,2107.0,
4402,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at a concentration of 5 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620894,,BAO_0000251,2107.0,
4403,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 10 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620895,,BAO_0000251,2107.0,
4404,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 100 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620896,,BAO_0000251,2107.0,
4405,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 200 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620897,,BAO_0000251,2107.0,
4406,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 25 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620898,,BAO_0000251,2107.0,
4407,7411,Michaelis-Menten constant for 7-ethoxycoumarin deethylation in rat liver microsomes exposed to 3-methylcholanthrene at concentration of 50 uM,B,,,Rattus norvegicus,10116.0,,Liver,,Microsomes,22226,U,0,Autocuration,1,,CHEMBL620899,,BAO_0000251,2107.0,
4408,347,The apparent total plasma clearance in monkey,A,In vivo,,Cercopithecidae,9527.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL620900,,BAO_0000218,1969.0,
4409,3341,Compound was evaluated for Hepatic clearance in monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620901,,BAO_0000218,,
4410,17853,Lower clearance in monkey (i.v.) at 0.5 mpk,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620902,,BAO_0000218,,
4411,4514,Plasma clearance in rhesus monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620903,,BAO_0000218,,
4412,6062,Plasma clearance for the compound was measured in monkey after an iv dose of 1 mg/kg,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620904,,BAO_0000218,,
4413,6821,Plasma clearance of compound was determined in monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620905,,BAO_0000218,,
4414,6057,Plasma clearance was calculated in rhesus monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620906,,BAO_0000218,,
4415,5145,Plasma clearance in rhesus monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL875420,,BAO_0000218,,
4416,6641,Plasma clearance in monkey (dosed at 0.5 mpk iv and 2.0 mpk orally),A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620907,,BAO_0000218,,
4417,5472,Plasma clearance was evaluated in rhesus,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620908,,BAO_0000218,,
4418,4257,Plasma clearance value was determined in monkey after a 3 mg/kg of iv dose,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620909,,BAO_0000218,,
4419,5546,Plasma clearance was determined in rhesus monkey at a dose of 1 mg/kg by iv administration,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620910,,BAO_0000218,,
4420,5334,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Rhesus monkey (male),A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620911,,BAO_0000218,,
4421,5334,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Rhesus monkey (male),A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620912,,BAO_0000218,,
4422,17509,Cmax 24 hr after 2 mg/kg oral administration in monkeys,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620913,,BAO_0000218,,
4423,6535,Cmax in monkey after administration of 1 mg/kg iv,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620914,,BAO_0000218,,
4424,5668,Cmax was determine after peroral administration at 10 mpk in Rhesus,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620915,,BAO_0000218,,
4425,5922,Cmax in cynomolgus monkey by iv administration,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620916,,BAO_0000218,,
4426,5922,Cmax in cynomolgus monkey by po administration,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620917,,BAO_0000218,,
4427,6078,Cmax value evaluated in monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620918,,BAO_0000218,,
4428,2661,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female cynomolgus monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620919,,BAO_0000218,,
4429,3249,Maximal concentration (Cmax) in rhesus monkey plasma at a dose of 5 mg/kg,A,In vivo,,Cercopithecidae,9527.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL620920,,BAO_0000218,1969.0,
4430,3249,Maximal concentration (Cmax) in squirrel monkey plasma at a dose of 5 mg/kg,A,In vivo,,Cercopithecidae,9527.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL620921,,BAO_0000218,1969.0,
4431,5553,Maximal plasma concentration in squirrel monkeys,A,In vivo,,Cercopithecidae,9527.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL620922,,BAO_0000218,1969.0,
4432,1916,Maximum concentration was evaluated against Cynomolgus monkey at a dose of 15 mg/kg after po administration,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620923,,BAO_0000218,,
4433,6227,Maximum plasma concentration (Cmax) in rhesus monkey(in vivo) at a dose of 5 mg/kg,A,In vivo,,Cercopithecidae,9527.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL620924,,BAO_0000218,1969.0,
4434,4809,Pharmacokinetic parameter Cmax was determined in monkey after (po) administration of a dose of 50 (uM/kg),A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620925,,BAO_0000218,,
4435,5355,The peak concentration (Cmax) value after intravenous administration in cynomolgus monkeys; NA means Not applicable,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620926,,BAO_0000218,,
4436,5355,The peak concentration (Cmax) value after intravenous administration in cynomolgus monkeys; NA means not applicable,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620927,,BAO_0000218,,
4437,5355,The peak concentration (Cmax) value after intravenous administration in cynomolgus monkeys;NA means not applicable,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620928,,BAO_0000218,,
4438,5355,The peak concentration (Cmax) value after oral administration in cynomolgus monkeys,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620929,,BAO_0000218,,
4439,6221,The peak plasma concentration after 5 hr administration (2.5 mg/kg) in monkey was determined,A,In vivo,,Cercopithecidae,9527.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL620930,,BAO_0000218,1969.0,
4440,167,Compound was evaluated for Plasma levels upon oral administration at 30 mg/kg in Monkey at maximum of 0.4 hours,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620931,,BAO_0000218,,
4441,167,Compound was evaluated for Plasma levels upon oral administration at 30 mg/kg in Monkey at maximum of 1.0 hours,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620932,,BAO_0000218,,
4442,4257,Absolute bioavailability was evaluated in monkey,A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620933,,BAO_0000218,,
4443,6221,Bioavailability after oral administration (2.5 mg/kg) in monkey was determined,A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620934,,BAO_0000218,,
4444,17667,Bioavailability of compound at 3 mg/kg in monkey after i.v. administration,A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620935,,BAO_0000218,,
4445,17267,Bioavailability of compound was determined in rhesus monkey,A,In vivo,,Macaca mulatta,9544.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620936,,BAO_0000218,,
4446,4256,Bioavailability determined after oral administration in marmoset,A,In vivo,,marmosets,38020.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620937,,BAO_0000218,,
4447,4256,Oral bioavailability in cynomolgus monkey,A,In vivo,,Macaca fascicularis,9541.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620938,,BAO_0000218,,
4448,17853,Bioavailability in monkey (p.o.) at 2.0 mpk,A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620939,,BAO_0000218,,
4449,16365,Bioavailability was evaluated after oral administration in monkey,A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620940,,BAO_0000218,,
4450,1916,Bioavailability was evaluated against Cynomolgus monkey at a dose of 15 mg/kg after po administration,A,In vivo,,Macaca fascicularis,9541.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620941,,BAO_0000218,,
4451,5334,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Rhesus monkey (male),A,In vivo,,Macaca mulatta,9544.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620942,,BAO_0000218,,
4452,5334,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Rhesus monkey (male),A,In vivo,,Macaca mulatta,9544.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620943,,BAO_0000218,,
4453,17592,Bioavailability of the compound was determined in monkey,A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620944,,BAO_0000218,,
4454,1399,Bioavailability in squirrel monkey (dose 5 mg/kg),A,In vivo,,Saimiri sciureus,9521.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620945,,BAO_0000218,,
4455,4809,Bioavailability was determined in monkey after (po) administration of a dose of 50 (uM/kg),A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620946,,BAO_0000218,,
4456,3341,Oral bioavailability in monkey,A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620947,,BAO_0000218,,
4457,64,Compound was tested for bioavailability in squirrel monkey,A,In vivo,,Saimiri sciureus,9521.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620948,,BAO_0000218,,
4458,5005,Oral bioavailability in Rhesus monkey,A,In vivo,,Macaca mulatta,9544.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620949,,BAO_0000218,,
4459,5005,Oral bioavailability in Rhesus monkey (dose of 0.75 mg/kg i.v. and 1.5 mg/kg p.o.),A,In vivo,,Macaca mulatta,9544.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620950,,BAO_0000218,,
4460,5237,Oral bioavailability in cynomolgus monkeys for the compound was determined; Acceptable,A,In vivo,,Macaca fascicularis,9541.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620951,,BAO_0000218,,
4461,5237,Oral bioavailability in cynomolgus monkeys was determined; Acceptable,A,In vivo,,Macaca fascicularis,9541.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620952,,BAO_0000218,,
4462,5302,Oral bioavailability in monkey (dose 5 mg/kg),A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL875421,,BAO_0000218,,
4463,17667,Oral bioavailability of compound at 5 mg/kg in monkey,A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620953,,BAO_0000218,,
4464,6161,Pharmacokinetic profile in terms of half life was determined at a dose of 0.5 mg/kg administered intravenously in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL873491,,BAO_0000218,,
4465,6161,Pharmacokinetic profile in terms of half life was determined at a dose of 5 mg/kg administered intravenously in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL620954,,BAO_0000218,,
4466,3854,Plasma half life determined,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL620955,,BAO_0000218,1969.0,
4467,993,Plasma half life in dog,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL618097,,BAO_0000218,1969.0,
4468,4514,Plasma half-life in Beagle dogs,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL618268,,BAO_0000218,1969.0,
4469,5334,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Beagle dog (male),A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL618269,,BAO_0000218,1969.0,
4470,5334,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg respectively in Beagle dog (male),A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL618270,,BAO_0000218,1969.0,
4471,1466,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618271,,BAO_0000218,,
4472,1466,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL873493,,BAO_0000218,,
4473,5313,Tested for the half life period in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621031,,BAO_0000218,,
4474,5313,Tested for the half life period in dog at dosage of 10 mpk,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621032,,BAO_0000218,,
4475,3880,The compound was tested for half life in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621033,,BAO_0000218,,
4476,3639,"The compound was tested for time taken to decrease, half of its initial concentration in dog plasma.",A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621034,,BAO_0000218,1969.0,
4477,3880,The half life was determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621035,,BAO_0000218,,
4478,3918,The plasma half-life in dogs,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621036,,BAO_0000218,1969.0,
4479,16452,suboptimal plasma half-life caused a10% prolongation of QTc interval in dogs at a plasma level of 2.5 M,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621037,,BAO_0000218,1969.0,
4480,17796,Half life in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619812,,BAO_0000218,,
4481,5983,Pharmacokinetic property (t1/2beta) was measured in dog at the dose of 0.032 mg/kg i.v.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619813,,BAO_0000218,,
4482,1466,tmax upon peroral administration of 10.0 mg/Kg dose in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL873335,,BAO_0000218,,
4483,16456,Volume of distribution in Beagle dogs after intravenous administration at a dose of 10 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619814,,BAO_0000218,,
4484,6113,Cmax in ferrets after 30 mg/kg oral dose,A,In vivo,,Mustela putorius furo,9669.0,,,,,50506,N,1,Expert,1,,CHEMBL619815,,BAO_0000218,,
4485,6113,Emesis in ferrets at 30 mg/kg oral dose,F,In vivo,,Mustela putorius furo,9669.0,,,,,50506,N,1,Expert,1,,CHEMBL619816,,BAO_0000218,,
4486,17796,Bioavailability in cynomolgus monkey,A,In vivo,,Macaca fascicularis,9541.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619817,,BAO_0000218,,
4487,17796,Volume of distribution in cynomolgus,A,In vivo,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL619818,,BAO_0000218,,
4488,5308,AUC tested in guinea pig when 3 mg/kg dose was given perorally,A,,,Cavia porcellus,10141.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL619819,,BAO_0000218,1969.0,
4489,4877,Tested for concentration as Area Under Curve against PDE4 in guinea pig lung eosinophilia orally at 5 mg/kg,A,,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619820,,BAO_0000218,,
4490,4876,"Tested for the pharmacokinetic parameter in guinea pig, administered orally at 5 mg/kg",A,,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL875419,,BAO_0000218,,
4491,4878,AUC in guinea pig after 3mg/kg oral dose,A,In vivo,,Cavia porcellus,10141.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL619821,,BAO_0000218,1969.0,
4492,5308,Bioavailability in guinea pig was tested,A,In vivo,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619822,,BAO_0000218,,
4493,4877,Tested for oral bioavailability in guinea pig at 5 mg/kg,A,In vivo,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619823,,BAO_0000218,,
4494,4876,Tested for the oral bioavailability of the compound,A,In vivo,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619824,,BAO_0000218,,
4495,4876,Compound at a dose 5 mg/kg was administered orally to guinea pig and the pharmacokinetic parameter (Cmax) was reported,A,In vivo,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619825,,BAO_0000218,,
4496,5308,Maximum plsma drug concentration in guinea pig when 3 mg/kg dose was given perorally,A,In vivo,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619826,,BAO_0000218,,
4497,4877,Tested for maximum concentration against PDE4 in guinea pig lung eosinophilia orally at 5 mg/kg,A,In vivo,,Cavia porcellus,10141.0,,Lung,,,22224,U,0,Autocuration,1,,CHEMBL619827,,BAO_0000218,2048.0,
4498,4878,Cmax in guinea pig after 3mg/kg oral dose,A,In vivo,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618167,,BAO_0000218,,
4499,5689,Distribution in blood expressed as [18F]- organ uptake in % of injected activity/gram,A,,,Cavia porcellus,10141.0,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL618168,,BAO_0000019,178.0,
4500,5689,Distribution in brain expressed as [18F]- organ uptake in % of injected activity/gram,A,,,Cavia porcellus,10141.0,,Brain,,,22224,U,0,Autocuration,1,,CHEMBL618169,,BAO_0000019,955.0,
4501,5689,Distribution in heart expressed as [18F]- organ uptake in % of injected activity/gram,A,,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618170,,BAO_0000019,,
4502,5689,Distribution in intestine expressed as [18F]- organ uptake in % of injected activity/gram,A,,,Cavia porcellus,10141.0,,Intestine,,,22224,U,0,Autocuration,1,,CHEMBL618171,,BAO_0000019,160.0,
4503,5689,Distribution in kidney expressed as [18F]- organ uptake in % of injected activity/gram,A,,,Cavia porcellus,10141.0,,Kidney,,,22224,U,0,Autocuration,1,,CHEMBL618172,,BAO_0000019,2113.0,
4504,5689,Distribution in liver expressed as [18F]- organ uptake in % of injected activity/gram,A,,,Cavia porcellus,10141.0,,Liver,,,22224,U,0,Autocuration,1,,CHEMBL618173,,BAO_0000019,2107.0,
4505,5689,Distribution in lung expressed as [18F]- organ uptake in % of injected activity/gram,A,,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618174,,BAO_0000019,,
4506,5689,Distribution in spleen expressed as [18F]- organ uptake in % of injected activity/gram,A,,,Cavia porcellus,10141.0,,Spleen,,,22224,U,0,Autocuration,1,,CHEMBL875408,,BAO_0000019,2106.0,
4507,14465,Elimination T1/2 in Guinea pig (PO dose),A,In vivo,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL839827,,BAO_0000218,,
4508,5689,Partition coefficient was measured as -log (counts per min ),A,,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618175,,BAO_0000019,,
4509,611,Biological half life when administered at 0.1 umol/kg intravenously to guinea pig in GR-64349 antagonism,A,In vivo,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618176,,BAO_0000218,,
4510,611,Biological half life when administered at 5 umol/kg intravenously to guinea pig in GR-64349 antagonism,A,In vivo,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618177,,BAO_0000218,,
4511,14465,Elimination T1/2 in Guinea pig (PO dose),A,In vivo,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618178,,BAO_0000218,,
4512,4876,"Tested for the half life period of the compound, intravenously",A,In vivo,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618179,,BAO_0000218,,
4513,5689,Half-life was measured,A,,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL873489,,BAO_0000019,,
4514,7515,The time required for onset of inotropy after addition of a single dose of delta F75,A,,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618180,,BAO_0000019,,
4515,17667,Bioavailability of compound at 10 mg/kg in guinea pig after i.v. administration,A,In vivo,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618181,,BAO_0000218,,
4516,17667,Bioavailability of compound at 3 mg/kg in guinea pig after i.v. administration,A,In vivo,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618182,,BAO_0000218,,
4517,4727,Plasma clearance was measured in hamster at the dose of 10 mg/kg by peroral administration,A,In vivo,,Cricetulus griseus,10029.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618183,,BAO_0000218,,
4518,10107,Biodistribution of intravenously injected [82Br]-labeled compound in tumor of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.25 hours,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618184,,BAO_0000218,,
4519,10107,Biodistribution of intravenously injected [82Br]-labeled compound in tumor of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.50 hours,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618185,,BAO_0000218,,
4520,10107,Biodistribution of intravenously injected [82Br]-labeled compound in tumor of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 1 hours,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618186,,BAO_0000218,,
4521,10107,Biodistribution of intravenously injected [82Br]-labeled compound in tumor of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 2 hours,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618187,,BAO_0000218,,
4522,10107,Biodistribution of intravenously injected [82Br]-labeled compound in tumor of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 4 hr,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618188,,BAO_0000218,,
4523,10107,Biodistribution of intravenously injected [82Br]-labeled compound in tumor of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 8 hours,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL875409,,BAO_0000218,,
4524,10107,Biodistribution of intravenously injected [82Br]-labeled compound in tumor of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 24 hours,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618189,,BAO_0000218,,
4525,3655,Biodistribution of the injected compound in blood of female BALB/C mice for 0.5 hours,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL618190,,BAO_0000218,178.0,
4526,3655,Biodistribution of the injected compound in blood of female BALB/C mice for 2.5 hours,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL618191,,BAO_0000218,178.0,
4527,3655,Biodistribution of the injected compound in blood of female BALB/C mice for 5 hours,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL618192,,BAO_0000218,178.0,
4528,3655,Biodistribution of the injected compound in bone of female BALB/C mice for 0.5 hours,A,In vivo,,Mus musculus,10090.0,,Bone,,,50594,N,1,Intermediate,1,,CHEMBL618193,,BAO_0000218,10000001.0,
4529,3655,Biodistribution of the injected compound in bone of female BALB/C mice for 2.5 hours,A,In vivo,,Mus musculus,10090.0,,Bone,,,50594,N,1,Intermediate,1,,CHEMBL618194,,BAO_0000218,10000001.0,
4530,3655,Biodistribution of the injected compound in bone of female BALB/C mice for 5 hours,A,In vivo,,Mus musculus,10090.0,,Bone,,,50594,N,1,Intermediate,1,,CHEMBL618195,,BAO_0000218,10000001.0,
4531,3655,Biodistribution of the injected compound in brain of female BALB/C mice for 0.5 hours,A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL618196,,BAO_0000218,955.0,
4532,3655,Biodistribution of the injected compound in brain of female BALB/C mice for 2.5 hours,A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL618197,,BAO_0000218,955.0,
4533,3655,Biodistribution of the injected compound in brain of female BALB/C mice for 5 hours,A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL618198,,BAO_0000218,955.0,
4534,3655,Biodistribution of the injected compound in heart of female BALB/C mice for 0.5 hours,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL618199,,BAO_0000218,948.0,
4535,3655,Biodistribution of the injected compound in heart of female BALB/C mice for 2.5 hours,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL618200,,BAO_0000218,948.0,
4536,3655,Biodistribution of the injected compound in heart of female BALB/C mice for 5 hours,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL618201,,BAO_0000218,948.0,
4537,3655,Biodistribution of the injected compound in intestines of female BALB/C mice for 0.5 hours,A,In vivo,,Mus musculus,10090.0,,Intestine,,,50594,N,1,Intermediate,1,,CHEMBL618202,,BAO_0000218,160.0,
4538,3655,Biodistribution of the injected compound in intestines of female BALB/C mice for 2.5 hours,A,In vivo,,Mus musculus,10090.0,,Intestine,,,50594,N,1,Intermediate,1,,CHEMBL618203,,BAO_0000218,160.0,
4539,3655,Biodistribution of the injected compound in intestines of female BALB/C mice for 5 hours,A,In vivo,,Mus musculus,10090.0,,Intestine,,,50594,N,1,Intermediate,1,,CHEMBL618204,,BAO_0000218,160.0,
4540,3655,Biodistribution of the injected compound in kidneys of female BALB/C mice for 0.5 hours,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL618205,,BAO_0000218,2113.0,
4541,3655,Biodistribution of the injected compound in kidneys of female BALB/C mice for 2.5 hours,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL618206,,BAO_0000218,2113.0,
4542,3655,Biodistribution of the injected compound in kidneys of female BALB/C mice for 5 hours,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL618207,,BAO_0000218,2113.0,
4543,3655,Biodistribution of the injected compound in liver of female BALB/C mice for 0.5 hours,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL618208,,BAO_0000218,2107.0,
4544,3655,Biodistribution of the injected compound in liver of female BALB/C mice for 2.5 hours,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL618932,,BAO_0000218,2107.0,
4545,3655,Biodistribution of the injected compound in liver of female BALB/C mice for 5 hours,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL618933,,BAO_0000218,2107.0,
4546,3655,Biodistribution of the injected compound in lung of female BALB/C mice for 0.5 hours,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL618934,,BAO_0000218,2048.0,
4547,3655,Biodistribution of the injected compound in lung of female BALB/C mice for 2.5 hours,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL618935,,BAO_0000218,2048.0,
4548,3655,Biodistribution of the injected compound in lung of female BALB/C mice for 5 hours,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL618936,,BAO_0000218,2048.0,
4549,3655,Biodistribution of the injected compound in muscle of female BALB/C mice for 0.5 hours,A,In vivo,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL618937,,BAO_0000218,2385.0,
4550,3655,Biodistribution of the injected compound in muscle of female BALB/C mice for 2.5 hours,A,In vivo,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL618938,,BAO_0000218,2385.0,
4551,3655,Biodistribution of the injected compound in muscle of female BALB/C mice for 5 hours,A,In vivo,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL619104,,BAO_0000218,2385.0,
4552,3655,Biodistribution of the injected compound in spleen of female BALB/C mice for 0.5 hours,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL619105,,BAO_0000218,2106.0,
4553,3655,Biodistribution of the injected compound in spleen of female BALB/C mice for 2.5 hours,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL619106,,BAO_0000218,2106.0,
4554,3655,Biodistribution of the injected compound in spleen of female BALB/C mice for 5 hours,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL619107,,BAO_0000218,2106.0,
4555,3655,Biodistribution of the injected compound in stomach of female BALB/C mice for 0.5 hours,A,In vivo,,Mus musculus,10090.0,,Stomach,,,50594,N,1,Intermediate,1,,CHEMBL875410,,BAO_0000218,945.0,
4556,3655,Biodistribution of the injected compound in stomach of female BALB/C mice for 2.5 hours,A,In vivo,,Mus musculus,10090.0,,Stomach,,,50594,N,1,Intermediate,1,,CHEMBL619108,,BAO_0000218,945.0,
4557,3655,Biodistribution of the injected compound in stomach of female BALB/C mice for 5 hours,A,In vivo,,Mus musculus,10090.0,,Stomach,,,50594,N,1,Intermediate,1,,CHEMBL619109,,BAO_0000218,945.0,
4558,16597,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for MRT,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619110,,BAO_0000218,,
4559,16597,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for MRT,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619111,,BAO_0000218,,
4560,16597,MRT value at a dose of 10 mg/kg intravenous administration in mice.,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619112,,BAO_0000218,,
4561,16597,MRT value at a dose of 10 mg/kg peroral administration in mice.,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619113,,BAO_0000218,,
4562,17764,Mean-residence time of compound after intravenous administration in mice at 24 uM/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619114,,BAO_0000218,,
4563,17764,Mean-residence time was determined for compound after intraperitoneal administration in mice at 18 uM/kg,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619115,,BAO_0000218,,
4564,3830,In vitro cytotoxicity of compound was determined against A2780 cell lines (cisplatin resistant) at 37 degree C after 96 hr,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619116,478.0,BAO_0000219,,
4565,3829,In vitro cytotoxicity of compound was determined against A2780 cell lines (cisplatin resistant) at 37 degree C for 96 hr,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619117,478.0,BAO_0000219,,
4566,2040,Compound was evaluated for cytotoxicity against A2780 cell lines.,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619118,478.0,BAO_0000219,,
4567,15684,Potentiation of growth inhibition of A2780 by compound alone in experiment 1,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619119,478.0,BAO_0000219,,
4568,15684,Potentiation of growth inhibition of A2780 cells by compound alone in experiment 2,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619120,478.0,BAO_0000219,,
4569,15684,Potentiation of growth inhibition of A2780 cells along with 10 uM NU1085 in experiment 1,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619121,478.0,BAO_0000219,,
4570,15684,Potentiation of growth inhibition of A2780 cells along with 10 uM NU1085 in experiment 2,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619122,478.0,BAO_0000219,,
4571,15684,Potentiation factor at 50% growth inhibition (IC50 of compound to that of compound along with PARP inhibitor) in experiment 1,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619123,478.0,BAO_0000219,,
4572,15684,Potentiation factor at 50% growth inhibition (IC50 of compound to that of compound along with PARP inhibitor) in experiment 2,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619124,478.0,BAO_0000219,,
4573,2859,Compound was evaluated for cytotoxicity against A2780 cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619125,478.0,BAO_0000219,,
4574,5618,In vitro inhibitory activity against human tumor cell line A2780,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL875411,478.0,BAO_0000219,,
4575,15684,Potentiation of growth inhibition of A2780 cells by compound alone in experiment 1,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619126,478.0,BAO_0000219,,
4576,15684,Potentiation of growth inhibition of A2780 cells by compound alone in experiment 2,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619127,478.0,BAO_0000219,,
4577,15684,Potentiation of growth inhibition of A2780 cells along with 10 uM NU1085 in experiment 1,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619128,478.0,BAO_0000219,,
4578,15684,Potentiation of growth inhibition of A2780 cells along with 10 uM NU1085 in experiment 2,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619129,478.0,BAO_0000219,,
4579,2113,The compound was tested for cytotoxic potency against A2780 human tumor cell lines,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619130,478.0,BAO_0000219,,
4580,2113,The compound was tested for cytotoxic potency against A2780 human tumor cell lines.,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619131,478.0,BAO_0000219,,
4581,16745,cytotoxicity against A2780 cells incubated for 24 hr in MTT assay.,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619132,478.0,BAO_0000219,,
4582,16597,In vitro antitumor activity against A2780 human ovarian carcinoma at 7.5 mg/kg i.p. /qd x7,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL619133,478.0,BAO_0000218,,
4583,15684,Potentiation factor at 50% growth inhibition (IC50 of compound to that of compound along with PARP inhibitor) in experiment 1,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619134,478.0,BAO_0000219,,
4584,15684,Potentiation factor at 50% growth inhibition (IC50 of compound to that of compound along with PARP inhibitor) in experiment 2,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619135,478.0,BAO_0000219,,
4585,2040,Compound was evaluated for cytotoxicity against A2780 cis cell lines.,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619136,478.0,BAO_0000219,,
4586,2040,Relative resistance factor in A2780 cisplatin-resistant line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619137,478.0,BAO_0000219,,
4587,16165,Concentration required to inhibit 50% growth of A2780 human ovarian cancer cells,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL883713,478.0,BAO_0000219,,
4588,16165,Concentration required to inhibit 50% growth of A2780 human ovarian cancer cells.,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL875412,478.0,BAO_0000219,,
4589,16597,In vitro antitumor activity against A2780 human ovarian carcinoma at 7.5 mg/kg i.p. /qd x7,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL619138,478.0,BAO_0000218,,
4590,16597,In vitro antitumor activity against A2780 human ovarian carcinoma at 7.5 mg/kg i.p. /qd x7,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL619262,478.0,BAO_0000218,,
4591,3992,Cytotoxicity against A2780 ovarian carcinoma cells was evaluated using standard sulforhodamine 96h assay test,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619139,478.0,BAO_0000219,,
4592,10553,In vitro cytotoxicity was determined against A2780 human ovarian cell line using NCI screen,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619140,478.0,BAO_0000219,,
4593,15608,cytotoxic activity toward A2780 ovarian human cell line sensitive (S) to cisplatin,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619141,478.0,BAO_0000219,,
4594,15608,cytotoxic activity toward A2780 ovarian human cell line sensitive (S) to cisplatin in experiment 1,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619142,478.0,BAO_0000219,,
4595,15608,cytotoxic activity toward A2780 ovarian human cell line sensitive (S) to cisplatin in experiment 2,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619143,478.0,BAO_0000219,,
4596,15608,cytotoxic activity toward A2780 ovarian human cell line sensitive (S) to cisplatin in experiment 3,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619144,478.0,BAO_0000219,,
4597,15608,cytotoxic activity toward A2780 ovarian human cell line sensitive (S) to cisplatin in experiment 5,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619145,478.0,BAO_0000219,,
4598,15608,cytotoxic activity toward A2780 ovarian human cell line sensitive (S) to cisplatin in experiment 8,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619146,478.0,BAO_0000219,,
4599,15569,Cytotoxic activity in a panel of Human ovarian tumor A2780/CDDP cell line after 96h of drug exposure,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619147,478.0,BAO_0000219,,
4600,17420,Antiproliferative effect of compound on A2780/DX cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619148,478.0,BAO_0000219,,
4601,17420,Antiproliferative effect of compound on A2780/DX cell line; n.d. indicates not determined,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619149,478.0,BAO_0000219,,
4602,15099,In vitro Cytotoxic activity of compound in comparison with reference compounds in human cell line A2780/DX(RI),F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619150,478.0,BAO_0000219,,
4603,15099,In vitro Cytotoxic activity of compound in comparison with reference compounds in human cell line A2780/Dx(RI),F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619151,478.0,BAO_0000219,,
4604,17672,Cytotoxicity against ovarian carcinoma A2780/cis tumor cell lines,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL883794,478.0,BAO_0000219,,
4605,17672,Cytotoxicity against ovarian carcinoma A2780/cis90 tumor cell lines,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619152,478.0,BAO_0000219,,
4606,17270,In vitro cytotoxicity against A2780ADR cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619153,478.0,BAO_0000219,,
4607,17270,In vitro cytotoxicity against A2780CIS cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619154,478.0,BAO_0000219,,
4608,5574,In vitro cytotoxic activity against human tumor cell line A2780CisR after incubation for 96 hours,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619155,478.0,BAO_0000219,,
4609,2113,The compound was tested for cytotoxic potency against A2780R human tumor cell lines.,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619156,478.0,BAO_0000219,,
4610,16913,"Inhibitory effect of Gold(III) complex, 2,2' bipy on growth of cisplatin-resistant A2780/R human tumor cell lines",F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619157,478.0,BAO_0000219,,
4611,16913,"Inhibitory effect of Gold(III) complex, CDDP on growth of cisplatin-resistant A2780/R human tumor cell lines",F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619797,478.0,BAO_0000219,,
4612,17839,Oral bioavailability of compound in rhesus macaques,A,In vivo,,Macaca mulatta,9544.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619798,,BAO_0000218,,
4613,6821,Oral bioavailability in monkey,A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619799,,BAO_0000218,,
4614,6078,Oral bioavailability evaluated in monkey,A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619800,,BAO_0000218,,
4615,6535,Oral bioavailability in monkey (dose 1 mg/kg p.o.),A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619801,,BAO_0000218,,
4616,4449,Oral bioavailability in Rhesus monkey,A,In vivo,,Macaca mulatta,9544.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619802,,BAO_0000218,,
4617,6057,Oral bioavailability was calculated in rhesus monkey,A,In vivo,,Macaca mulatta,9544.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619803,,BAO_0000218,,
4618,5922,Oral bioavailability in cynomolgus monkey,A,In vivo,,Macaca fascicularis,9541.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619965,,BAO_0000218,,
4619,5940,Oral bioavailability in monkey,A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619966,,BAO_0000218,,
4620,6265,Oral bioavailability in monkey,A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619967,,BAO_0000218,,
4621,6265,Oral bioavailability in monkey (dose 1 mg/kg),A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620073,,BAO_0000218,,
4622,6265,Oral bioavailability in monkey (dose 5 mg/kg),A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620074,,BAO_0000218,,
4623,5940,Oral bioavailability in monkey,A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620075,,BAO_0000218,,
4624,5940,Oral bioavailability in monkey,A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620076,,BAO_0000218,,
4625,4514,Oral bioavailability in rhesus monkey,A,In vivo,,Macaca mulatta,9544.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620077,,BAO_0000218,,
4626,5546,Oral bioavailability in rhesus monkey at a dose of 2 mg/kg by po administration,A,In vivo,,Macaca mulatta,9544.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620078,,BAO_0000218,,
4627,5553,Oral bioavailability in squirrel monkey at a dose of 10 mg/kg,A,In vivo,,Saimiri sciureus,9521.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620079,,BAO_0000218,,
4628,6641,Oral bioavailability in monkey (dosed at 0.5 mpk iv and 2.0 mpk orally),A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620080,,BAO_0000218,,
4629,5472,Oral bioavailability in Rhesus monkey,A,In vivo,,Macaca mulatta,9544.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620081,,BAO_0000218,,
4630,5668,Oral bioavailability in Rhesus monkey (dose 10 mg/kg p.o.),A,In vivo,,Macaca mulatta,9544.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620082,,BAO_0000218,,
4631,5711,Oral bioavailability in monkey at 10 mg/kg of the compound,A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620083,,BAO_0000218,,
4632,5145,Bioavailability in Rhesus monkey,A,In vivo,,Macaca mulatta,9544.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620084,,BAO_0000218,,
4633,3443,Glomerular Filtration Rate(GFR) evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620085,,BAO_0000218,,
4634,3443,Glomerular Filtration Rate(GFR)of the compound compared to Cilastatin evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL874595,,BAO_0000218,,
4635,3249,Half life by ''Cr'' assay in rhesus monkey at a dose of 5 mg/kg,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL873352,,BAO_0000218,,
4636,3249,Half life the of compound was determined by ''Cr'' assay in squirrel monkey at a dose of 5 mg/kg,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620086,,BAO_0000218,,
4637,5355,Mean residence time was determined after intravenous administration in cynomolgus monkeys,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620087,,BAO_0000218,,
4638,5355,Mean residence time was determined after oral administration in cynomolgus monkeys; NA means Not applicable,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620088,,BAO_0000218,,
4639,5355,Mean residence time was determined after oral administration in cynomolgus monkeys; NA means not applicable,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620089,,BAO_0000218,,
4640,4809,Pharmacokinetic parameter MRT was determined in monkey after (iv) administration of a dose of 13 (uM/kg),A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620090,,BAO_0000218,,
4641,4809,Pharmacokinetic parameter MRT was determined in monkey after (po) administration of a dose of 50 (uM/kg),A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620091,,BAO_0000218,,
4642,14294,Metabolism of compound in monkey S9 microsomes ('+''indicates <20% largest observed peak),A,,,Cercopithecidae,9527.0,,,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL620092,,BAO_0000251,,
4643,14294,Metabolism of compound in monkey S9 microsomes ('++''indicates 20-50% largest observed peak),A,,,Cercopithecidae,9527.0,,,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL620093,,BAO_0000251,,
4644,14294,Metabolism of compound in monkey S9 microsomes ('+++'indicates 50-80% largest observed peak),A,,,Cercopithecidae,9527.0,,,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL620094,,BAO_0000251,,
4645,14294,Metabolism of compound in monkey S9 microsomes ('++++' indicates largest observed peak),A,,,Cercopithecidae,9527.0,,,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL620095,,BAO_0000251,,
4646,3443,Plasma clearance evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620096,,BAO_0000218,,
4647,3443,Plasma clearance compared to Cilastatin evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620097,,BAO_0000218,,
4648,11271,Clearance from plasma(with matabolite-corrected plasma radioactivity-time integral) at 30 min after administration.,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620098,,BAO_0000019,,
4649,3443,Renal clearance evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620099,,BAO_0000218,,
4650,3443,Renal clearance compared to Cilastatin evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620100,,BAO_0000218,,
4651,6821,Elimination Half-life of compound was determined in monkey,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620101,,BAO_0000019,,
4652,17267,Half life of compound was determined in rhesus monkey,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620102,,BAO_0000019,,
4653,5819,Half life in monkey plasma,A,,,Cercopithecidae,9527.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL620103,,BAO_0000366,1969.0,
4654,5819,Half life in monkey plasma; Not detected,A,,,Cercopithecidae,9527.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL620104,,BAO_0000366,1969.0,
4655,1916,Half life period was evaluated against Cynomolgus monkey at a dose of 15 mg/kg after po administration,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL874596,,BAO_0000218,,
4656,17509,Half-life 24 hr after 2 mg/kg iv administration in monkeys,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL873490,,BAO_0000218,,
4657,1399,Terminal half life of the compound.,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620105,,BAO_0000019,,
4658,1916,Maximum time was evaluated against Cynomolgus monkey at a dose of 15 mg/kg after po administration,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620780,,BAO_0000218,,
4659,4809,Pharmacokinetic parameter Tmax was determined in monkey after (po) administration of a dose of 50 (uM/kg),A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620781,,BAO_0000218,,
4660,5546,Unbound plasma was determined in rhesus monkey at a dose of 1 mg/kg by iv administration,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620956,,BAO_0000218,,
4661,3443,Urinary recovery evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,A,,,Cercopithecidae,9527.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL620957,,BAO_0000218,1088.0,
4662,3443,Urinary recovery compared to Cilastatin evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,A,,,Cercopithecidae,9527.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL620958,,BAO_0000218,1088.0,
4663,4257,Volume of distribution was determined in monkey after a 3 mg/kg of iv dose,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620959,,BAO_0000218,,
4664,6221,Volume distribution after oral administration (2.5 mg/kg) in monkey was determined,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620960,,BAO_0000218,,
4665,5472,Volume of distribution was evaluated in rhesus,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620961,,BAO_0000218,,
4666,4727,Plasma clearance was measured in hamster at the dose of 10 mg/kg by peroral administration,A,In vivo,,Cricetulus griseus,10029.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620962,,BAO_0000218,,
4667,4727,Plasma clearance was measured in hamster at the dose of 3 mg/kg by intravenous administration,A,In vivo,,Cricetulus griseus,10029.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620963,,BAO_0000218,,
4668,4727,Bioavailability in hamster was determined,A,In vivo,,Cricetulus griseus,10029.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620964,,BAO_0000218,,
4669,4727,Bioavailability in hamster at a dose of 3 mg/kg by intravenous administration,A,In vivo,,Cricetulus griseus,10029.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620965,,BAO_0000218,,
4670,4727,Bioavailability in hamster at a dose of 3 mg/kg by oral administration,A,In vivo,,Cricetulus griseus,10029.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620966,,BAO_0000218,,
4671,4727,Half life of compound was determined in hamster blood,A,,,Cricetulus griseus,10029.0,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL620967,,BAO_0000221,178.0,
4672,1452,Michaelis-Menten constant of the compound.,A,,,Sus scrofa,9823.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620968,,BAO_0000019,,
4673,1452,Vmax value was measured at 0 uM concentration of silyl ether.,A,,,Sus scrofa,9823.0,,,,,22224,U,0,Autocuration,1,,CHEMBL874597,,BAO_0000019,,
4674,1452,Vmax value was measured at 10 uM concentration of silyl ether.,A,,,Sus scrofa,9823.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620969,,BAO_0000019,,
4675,1452,Vmax value was measured at 5 uM concentration of silyl ether.,A,,,Sus scrofa,9823.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620970,,BAO_0000019,,
4676,11706,Inactivation of human leukocyte (neutrophil) elastase(HLE)(HNE) as rate constant,B,,,Homo sapiens,9606.0,,,,,235,D,9,Expert,1,,CHEMBL620971,,BAO_0000357,,
4677,1916,Area under curve was evaluated against man at a dose of 10 mg/kg after po administration,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620972,,BAO_0000218,,
4678,17791,Compound was evaluated for area under the curve expressed as (h*ug/ml),A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620973,,BAO_0000019,,
4679,7766,Active metabolite of ifosfamide determined in humans; A-Active,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618243,,BAO_0000019,,
4680,6567,Amount of tecadenoson present after 30 min in the liver S-9 assay as determined by mass specanalysis,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618244,,BAO_0000019,,
4681,6567,Amount of tecadenoson present after 30 min in the liver S-9 assay as determined by mass specanalysis; -0.5 to 1,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618245,,BAO_0000019,,
4682,6567,Amount of tecadenoson present after 30 min in the liver S-9 assay as determined by mass specanalysis; 1-2,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618246,,BAO_0000019,,
4683,6567,Amount of tecadenoson present after 30 min in the liver S-9 assay as determined by mass specanalysis; trace,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618247,,BAO_0000019,,
4684,17791,Compound was evaluated for oral bioavailability in human,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618248,,BAO_0000218,,
4685,7766,Metabolite of ifosfamide determined in urine; NF-Not found,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL618249,,BAO_0000019,1088.0,
4686,6852,Percent of compound in cirrhotic patients of spontaneous ascitic fluid infection (Group A and B),A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618250,,BAO_0000019,,
4687,6852,Percent of compound in cirrhotic patients of spontaneous ascitic fluid infection after dosing with normal antibiotics,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL874598,,BAO_0000019,,
4688,6852,Percent of compound in cirrhotic patients of spontaneous ascitic fluid infection after dosing with normal antibiotics and lactose,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618251,,BAO_0000019,,
4689,6852,Percent of compound in cirrhotic patients of spontaneous ascitic fluid infection before dosing with normal antibiotics,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618252,,BAO_0000019,,
4690,6852,Percent of compound in cirrhotic patients of spontaneous ascitic fluid infection before dosing with normal antibiotics and lactose,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618253,,BAO_0000019,,
4691,6852,Percent of compound in cirrhotic patients of sterile ascitic fluid (Group C),A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618254,,BAO_0000019,,
4692,6852,Percent of compound in healthy individuals (Group D),A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618255,,BAO_0000019,,
4693,4397,Percent of the parent compound remaining after 20 mins incubation with human liver microsomes,A,,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL618983,,BAO_0000251,2107.0,
4694,17409,Binding towards human plasma protein at 10 uM,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618984,,BAO_0000019,,
4695,17409,Binding towards human plasma protein at 100 uM,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618985,,BAO_0000019,,
4696,17176,Human plasma protein binding activity was determined,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618986,,BAO_0000019,,
4697,15444,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618987,,BAO_0000019,,
4698,17267,Percent binding of compound towards human plasma protein was determined,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618988,,BAO_0000019,,
4699,5944,Plasma clearance in human liver microsomes,A,In vitro,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL618989,,BAO_0000251,2107.0,
4700,5668,In vitro intrinsic clearance in human liver microsome,A,In vitro,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL618990,,BAO_0000251,2107.0,
4701,5669,In vitro intrinsic clearance in human liver microsome,A,In vitro,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL618991,,BAO_0000251,2107.0,
4702,5041,In vitro microsome metabolism clearance in human was determined,A,In vitro,,Homo sapiens,9606.0,,,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL876725,,BAO_0000251,,
4703,5041,In vitro microsome metabolism clearance in human was determined; High,A,In vitro,,Homo sapiens,9606.0,,,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL618992,,BAO_0000251,,
4704,5041,In vitro microsome metabolism clearance in human was determined; ND denotes no data,A,In vitro,,Homo sapiens,9606.0,,,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL618993,,BAO_0000251,,
4705,5676,Pharmacokinetic property (clearance) in human liver microsome,A,In vitro,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL618994,,BAO_0000251,2107.0,
4706,5944,Plasma clearance in human liver microsomes,A,In vitro,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL618995,,BAO_0000251,2107.0,
4707,17538,In vitro clearance in human liver microsomes,A,In vitro,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL618996,,BAO_0000251,2107.0,
4708,6331,Intrinsic clearance in human liver microsomes was determined,A,In vitro,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL618997,,BAO_0000251,2107.0,
4709,5948,Intrinsic clearance in human liver microsomes was determined,A,In vitro,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL618998,,BAO_0000251,2107.0,
4710,5965,Cmax (Tissue distribution) of compound was determined at a dose of 5 mg/kg in human,A,In vivo,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618999,,BAO_0000218,,
4711,1916,Maximum concentration was evaluated against man at a dose of 10 mg/kg after po administration,A,In vivo,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620223,,BAO_0000218,,
4712,5965,Cmin (Clearance) of compound was determined at a dose of 5 mg/kg in human,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620224,,BAO_0000218,,
4713,1299,Stability in human plasma 2 hr after incubation expressed as percent concentration,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620225,,BAO_0000019,,
4714,1299,Stability in human plasma 4 hr after incubation expressed as percent concentration,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620226,,BAO_0000019,,
4715,7766,Portion of holoxan excreted in the form of the metabolite from 1200 mL of urine on day 3 was determined in embryonal rhabdomyosarcoma patients treated with ifosfamide,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL620227,,BAO_0000019,1088.0,
4716,7766,Portion of holoxan excreted in the form of the metabolite from 1200 mL of urine on day 7 was determined in embryonal rhabdomyosarcoma patients treated with ifosfamide,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL876726,,BAO_0000019,1088.0,
4717,7766,Portion of holoxan excreted in the form of the metabolite from 1300 mL of urine on day 6 was determined in embryonal rhabdomyosarcoma patients treated with ifosfamide,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL620228,,BAO_0000019,1088.0,
4718,7766,Portion of holoxan excreted in the form of the metabolite from 1300 mL of urine on day 8 was determined in embryonal rhabdomyosarcoma patients treated with ifosfamide,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL620229,,BAO_0000019,1088.0,
4719,17764,Mean-residence time was determined for compound after intraperitoneal administration in mice at 23 uM/kg,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620230,,BAO_0000218,,
4720,17764,Mean-residence time was determined for compound after intraperitoneal administration in mice at 25 uM/kg,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620231,,BAO_0000218,,
4721,17764,Mean-residence time was determined for compound after intraperitoneal administration in mice at 26 uM/kg,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620232,,BAO_0000218,,
4722,17764,Mean-residence time was determined for compound intravenous administration in mice at 23 uM/kg,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620233,,BAO_0000218,,
4723,14294,Metabolism of compound in Mouse S9 microsomes ('++++'indicates largest observed peak),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620234,,BAO_0000218,,
4724,14294,Metabolism of compound in mouse S9 microsomes ('+''indicates <20% largest observed peak),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620235,,BAO_0000218,,
4725,14294,Metabolism of compound in mouse S9 microsomes ('++++' indicates largest observed peak),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620236,,BAO_0000218,,
4726,6251,In vitro metabolic potential in mouse liver microsomes,A,,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL620237,,BAO_0000218,2107.0,
4727,17582,Ability of compound to bind to plasma protein was evaluated in HSA cells,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620238,,BAO_0000218,,
4728,17811,Compound was tested for radioactivity level in mice adrenal glands (Compound is radiolabeled),A,,,Mus musculus,10090.0,,Adrenal gland,,,50594,N,1,Intermediate,1,,CHEMBL620239,,BAO_0000218,2369.0,
4729,17811,Compound was tested for radioactivity level in mice brain (Compound is radiolabeled); 2.2-4.9% ID/g,A,,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL620240,,BAO_0000218,955.0,
4730,17811,Compound was tested for radioactivity level in mice brain (Compound is radiolabeled); 2.6-4.4% ID/g,A,,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL620241,,BAO_0000218,955.0,
4731,17811,Compound was tested for radioactivity level in mice heart (Compound is radiolabeled),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL876727,,BAO_0000218,,
4732,17811,Compound was tested for radioactivity level in mice kidney (Compound is radiolabeled),A,,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL620242,,BAO_0000218,2113.0,
4733,17811,Compound was tested for radioactivity level in mice lungs (Compound is radiolabeled),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620243,,BAO_0000218,,
4734,5288,Tested for urinary recovery in mice after subcutaneous administration of 20 mg/Kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620244,,BAO_0000218,,
4735,2717,Compound was evaluated for its potency in CDF1 mice and the serum cholesterol levels were determined,A,,,Mus musculus,10090.0,,Serum,,,50594,N,1,Intermediate,1,,CHEMBL620245,,BAO_0000218,1977.0,
4736,2717,Compound was evaluated for its potency in CDF1 mice and the serum metabolite levels were determined,A,,,Mus musculus,10090.0,,Serum,,,50594,N,1,Intermediate,1,,CHEMBL620246,,BAO_0000218,1977.0,
4737,2717,Compound was evaluated for its potency in CDF1 mice and the serum triglyceride levels were determined,A,,,Mus musculus,10090.0,,Serum,,,50594,N,1,Intermediate,1,,CHEMBL620247,,BAO_0000218,1977.0,
4738,17753,Half life of compound was determined in plasma of mice at 24 mg/Kg,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL620248,,BAO_0000218,1969.0,
4739,17753,Half life of compound was determined in plasma of mice at 40 mg/Kg,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL873497,,BAO_0000218,1969.0,
4740,17753,Half life of compound was determined in plasma of mice at 5 mg/Kg,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL620249,,BAO_0000218,1969.0,
4741,17764,Half life after intraperitoneal administration in mice at 18 uM/kg,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620250,,BAO_0000218,,
4742,17764,Half life after intraperitoneal administration in mice at 23 uM/kg,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620251,,BAO_0000218,,
4743,17764,Half life after intraperitoneal administration in mice at 25 uM/kg,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620252,,BAO_0000218,,
4744,17764,Half life after intraperitoneal administration in mice at 26 uM/kg,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620253,,BAO_0000218,,
4745,17764,Half life after intravenous administration in mice at 23 uM/kg,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620254,,BAO_0000218,,
4746,17764,Half life after intravenous administration in mice at 24 uM/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620255,,BAO_0000218,,
4747,16597,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for T max,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620256,,BAO_0000218,,
4748,2675,Maximum time required to reach Cp max was evaluated in mice after intravenous administration; T max Not determined,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL876728,,BAO_0000218,,
4749,2675,Maximum time required to reach Cp max was evaluated in mice after oral administration,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620257,,BAO_0000218,,
4750,16597,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620258,,BAO_0000218,,
4751,4890,"Compound was evaluated for the pharmacokinetic parameter, Terminal half life period",A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620259,,BAO_0000218,,
4752,429,Evaluated for pharmacokinetic parameter half-life in mouse at the dose 20 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620260,,BAO_0000218,,
4753,17837,Half life of compound in mouse blood following i.v. administration of 10 mg/kg,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL620261,,BAO_0000218,178.0,
4754,16597,Half life at a dose of 10 mg/kg intravenous administration in mice.,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620262,,BAO_0000218,,
4755,16597,Half life at a dose of 10 mg/kg peroral administration in mice.,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620263,,BAO_0000218,,
4756,6619,Half life in ob/ob mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620264,,BAO_0000218,,
4757,4066,Half-life at a single subcutaneous administration of 40 mg/kg in mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620265,,BAO_0000218,,
4758,4239,Half-life was measured in mouse,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620266,,BAO_0000218,,
4759,5969,In vivo half life period was determined in murine septicemia at dose of 50 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620267,,BAO_0000218,,
4760,8999,Time for esterases in unfractionated mouse serum to reduce the concentration due to thio ester deacylation,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619364,,BAO_0000218,,
4761,8999,Time for esterases in unfractionated mouse serum to reduce the concentration due to thio ester deacylation; 10 % hydrolysis at 60 mins,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619365,,BAO_0000218,,
4762,17641,T2 in brain of mice at the oral dose of 50 mg/kg,A,,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL619366,,BAO_0000218,955.0,
4763,17641,T2 in kidney of mice at the oral dose of 50 mg/kg,A,,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL619367,,BAO_0000218,2113.0,
4764,17641,T2 in liver of mice at the oral dose of 50 mg/kg,A,,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL619368,,BAO_0000218,2107.0,
4765,17641,T2 in lungs of mice at the oral dose of 50 mg/kg,A,,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL619369,,BAO_0000218,2048.0,
4766,17641,T2 in spleen of mice at the oral dose of 50 mg/kg,A,,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL876729,,BAO_0000218,2106.0,
4767,16597,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for T max,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619370,,BAO_0000218,,
4768,4890,"Compound was evaluated for the pharmacokinetic parameter, maximum time constant",A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619371,,BAO_0000218,,
4769,429,Evaluated for pharmacokinetic parameter tmax in mouse at the dose 20 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619372,,BAO_0000218,,
4770,429,Evaluated for pharmacokinetic parameter tmax in mouse at the dose 20 mg/kg was determined,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620012,,BAO_0000218,,
4771,5969,In vivo Tmax was determined in murine septicemia at dose of 100 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620013,,BAO_0000218,,
4772,16913,"Inhibitory effect of Gold(III) complex, [Au(bipy)-(OH)2]-[PF6] on growth of cisplatin-resistant A2780/R human tumor cell lines",F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL620014,478.0,BAO_0000219,,
4773,16913,"Inhibitory effect of Gold(III) complex, [Au(bipy-H)(OH)]-[PF6] on growth of cisplatin-resistant A2780/R human tumor cell lines",F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL620015,478.0,BAO_0000219,,
4774,16913,"Inhibitory effect of Gold(III) complex, 2,2' bipy on growth of cisplatin-sensitive A2780/S human tumor cell lines",F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621010,478.0,BAO_0000219,,
4775,16913,"Inhibitory effect of Gold(III) complex, CDDP on growth of cisplatin-sensitive A2780/S human tumor cell lines",F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621011,478.0,BAO_0000219,,
4776,16913,"Inhibitory effect of Gold(III) complex, [Au(bipy)-(OH)2]-[PF6] on growth of cisplatin-sensitive A2780/S human tumor cell lines",F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621012,478.0,BAO_0000219,,
4777,16913,"Inhibitory effect of Gold(III) complex, [Au(bipy-H)(OH)]-[PF6] on growth of cisplatin-sensitive A2780/S human tumor cell lines",F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621013,478.0,BAO_0000219,,
4778,17270,In vitro cytotoxicity against A2780TAX cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621014,478.0,BAO_0000219,,
4779,5618,In vitro inhibitory activity against human tumor cell line A2780cis,F,,,Homo sapiens,9606.0,,,A2780cisR,,80017,N,1,Intermediate,1,,CHEMBL618154,481.0,BAO_0000219,,
4780,17777,Growth inhibition against A2780 cisplatin resistant wild-type ovarian cell lines,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL618155,478.0,BAO_0000219,,
4781,16112,Antitumor activity of compound for 96-h exposure in A2780cisR (acquired resistance to cisplatin) human ovarian cell line,F,,,Homo sapiens,9606.0,,,A2780cisR,,80017,N,1,Intermediate,1,,CHEMBL618156,481.0,BAO_0000219,,
4782,15748,The compound was tested for cytotoxic activity against A2780cisR cell line(human ovarian carcinoma ),F,,,Homo sapiens,9606.0,,,A2780cisR,,80017,N,1,Intermediate,1,,CHEMBL618157,481.0,BAO_0000219,,
4783,6633,Concentration required to inhibit A2780cisR cell growth when compared with control after incubation for 96 h at 37 C,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618328,478.0,BAO_0000219,,
4784,16930,Compound was evaluated against human Ovarian carcinoma cell line A2780cisR,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618329,478.0,BAO_0000219,,
4785,17496,Cytotoxicity against human ovarian carcinoma A2780cisR cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618330,478.0,BAO_0000219,,
4786,12989,In vitro antitumor activity against A2780cisR cell line.,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL618331,478.0,BAO_0000219,,
4787,4840,Tested for the cytotoxicity in A2780cisR ovarian cell line (cisR denotes resistance to cisplatin),F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618332,478.0,BAO_0000219,,
4788,12989,Resistant factor determined between IC50 of resistant line to that of A2780cisR cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL618333,478.0,BAO_0000219,,
4789,16745,cytotoxicity against A2780cisR cells incubated for 24 hr in MTT assay,F,,,Homo sapiens,9606.0,,,A2780cisR,,80017,N,1,Intermediate,1,,CHEMBL618334,481.0,BAO_0000219,,
4790,16597,Inhibition of A2780 / DDP-S human ovarian carcinoma cell proliferation,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL618335,478.0,BAO_0000219,,
4791,16547,Inhibition against A2A-Adenosine Receptor of rat PC12 cell membranes,B,,,Rattus norvegicus,10116.0,,,,,11736,D,9,Expert,1,,CHEMBL618336,,BAO_0000019,,
4792,16547,Inhibition against A2A-Adenosine Receptor of rat PC12 cell membranes (functional antagonist activity),F,,,,,,,,,11736,H,8,Expert,1,,CHEMBL618337,,BAO_0000019,,
4793,16547,Inhibition against A2A-Adenosine Receptor of rat PC12 cell membranes (functional antagonist activity),F,,,Rattus norvegicus,10116.0,,,,,11736,D,9,Expert,1,,CHEMBL618338,,BAO_0000019,,
4794,15856,Antagonist activity against human A2B adenosine receptor expressed in HEK293 cells uisng [3H]ZM-241385 or [125I]-IABOPX,F,,,Homo sapiens,9606.0,,,HEK293,,278,D,9,Expert,1,,CHEMBL618339,722.0,BAO_0000219,,
4795,15856,Antagonist activity against human A2B adenosine receptor expressed in HEK293 cells using [3H]ZM-241385 (or) [125 I]IABOPX at 10e-5 M,F,,,Homo sapiens,9606.0,,,HEK293,,278,D,9,Expert,1,,CHEMBL618340,722.0,BAO_0000219,,
4796,16547,Inhibition against A2B-Adenosine Receptor in mouse NIH 3T3 fibroblast cell membranes,B,,,Mus musculus,10090.0,,,,,11831,D,9,Expert,1,,CHEMBL618341,,BAO_0000019,,
4797,16547,Inhibition against A2B-Adenosine Receptor in mouse NIH 3T3 fibroblast cell membranes (functional antagonist activity),F,,,,,,,,,11831,H,8,Expert,1,,CHEMBL618342,,BAO_0000019,,
4798,16547,Inhibition against A2B-Adenosine Receptor in mouse NIH 3T3 fibroblast cell membranes (functional antagonist activity),F,,,Mus musculus,10090.0,,,,,11831,D,9,Expert,1,,CHEMBL618343,,BAO_0000019,,
4799,17402,Ability to displace the binding of [3H]-MRE 3008-F20 to the ligand binding site of CHO:hA3 (human Adenosine receptor) at concentration of 10 uM,B,,,,,,,,,280,H,8,Expert,1,,CHEMBL621038,,BAO_0000357,,
4800,11746,Compound was tested in vitro for inhibition of cytopathogenicity of LAV(IIIB) in CD4+ T-cells (A3.01),F,,,Homo sapiens,9606.0,,,T-cells,,22226,U,0,Autocuration,1,,CHEMBL621039,574.0,BAO_0000219,,
4801,11746,Compound was tested in vitro for inhibition of cytopathogenicity of LAV(IIIB) in CD4+ T-cells (A3.01); Not active,F,,,Homo sapiens,9606.0,,,T-cells,,22226,U,0,Autocuration,1,,CHEMBL621040,574.0,BAO_0000219,,
4802,5455,Compound was evaluated for cytotoxic activity against human melanoma cell line A375,F,,,Homo sapiens,9606.0,,,A-375,,80018,N,1,Intermediate,1,,CHEMBL621041,455.0,BAO_0000219,,
4803,2068,In vitro antitumor activity against A375 (melanoma) human tumor cell lines.,F,,,Homo sapiens,9606.0,,,A-375,,80018,N,1,Intermediate,1,,CHEMBL621042,455.0,BAO_0000219,,
4804,2683,In vitro antitumor activity against A375cell line extracted form melanoma,F,,,Homo sapiens,9606.0,,,A-375,,80018,N,1,Intermediate,1,,CHEMBL621043,455.0,BAO_0000219,,
4805,15313,Inhibition of cell growth in (A375) melan cell line,F,,,Homo sapiens,9606.0,,,A-375,,80018,N,1,Expert,1,,CHEMBL621044,455.0,BAO_0000219,,
4806,13739,In vitro tumor cell growth inhibitory activity against Human melanoma cell lines A375,F,,,Homo sapiens,9606.0,,,A-375,,80018,N,1,Intermediate,1,,CHEMBL621045,455.0,BAO_0000219,,
4807,13739,In vitro tumor cell growth inhibitory activity against Human melanoma cell lines. A375,F,,,Homo sapiens,9606.0,,,A-375,,80018,N,1,Intermediate,1,,CHEMBL621046,455.0,BAO_0000219,,
4808,14750,Compound was tested in vitro for cytotoxicity against A375 cell lines from melanoma.,F,,,Homo sapiens,9606.0,,,A-375,,80018,N,1,Intermediate,1,,CHEMBL621047,455.0,BAO_0000219,,
4809,14777,Antiproliferative activity measured against A427 human lung carcinoma,F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Intermediate,1,,CHEMBL621048,797.0,BAO_0000219,,
4810,14777,Antiproliferative activity measured against A427 human lung carcinoma,F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Intermediate,1,,CHEMBL883798,797.0,BAO_0000219,,
4811,17672,Cytotoxicity against lung carcinoma A427 tumor cell lines,F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Intermediate,1,,CHEMBL621049,797.0,BAO_0000219,,
4812,14368,Inhibition of large cell lung carcinoma (A427),F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Intermediate,1,,CHEMBL621050,797.0,BAO_0000219,,
4813,14368,Inhibition of large cell lung carcinoma (A427) after 48-h treatment,F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Intermediate,1,,CHEMBL621051,797.0,BAO_0000219,,
4814,13866,Inhibitory activity against A427 epithelial Cancer cell line at the concentration 0-30 uM for 48 hr,F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Intermediate,1,,CHEMBL621052,797.0,BAO_0000219,,
4815,2545,Inhibitory concentration in human lung carcinoma A427 cell line,F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Intermediate,1,,CHEMBL621053,797.0,BAO_0000219,,
4816,2545,Inhibitory concentration in human lung carcinoma A427/VCR cell line,F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Intermediate,1,,CHEMBL621054,797.0,BAO_0000219,,
4817,6062,Terminal phase volume of distribution was measured in monkey after an iv dose of 1 mg/kg,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621055,,BAO_0000218,,
4818,4578,Tested for volume of distribution upon iv administration to african green monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL876398,,BAO_0000218,,
4819,17592,Volume of distribution in monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621056,,BAO_0000218,,
4820,5005,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,A,In vivo,,Macaca mulatta,9544.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621057,,BAO_0000218,,
4821,5005,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,A,In vivo,,Macaca mulatta,9544.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621058,,BAO_0000218,,
4822,5922,Pharmacokinetic property(Vdss) in cynomolgus monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621059,,BAO_0000218,,
4823,5355,The distribution volume after intravenous administration in cynomolgus monkeys,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621060,,BAO_0000218,,
4824,5355,The distribution volume after oral administration in cynomolgus monkeys; NA means Not applicable,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621061,,BAO_0000218,,
4825,5355,The distribution volume after oral administration in cynomolgus monkeys; NA means not applicable,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621062,,BAO_0000218,,
4826,6057,Volume displacement was calculated in rhesus monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621063,,BAO_0000218,,
4827,5145,Volume of distribution in steady state was determined in rhesus monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621064,,BAO_0000218,,
4828,6821,Volume of distribution of compound was determined in monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621065,,BAO_0000218,,
4829,5334,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Rhesus monkey (male),A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621066,,BAO_0000218,,
4830,5334,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Rhesus monkey (male),A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621067,,BAO_0000218,,
4831,6641,Volumes of distribution in monkey (dosed at 0.5 mpk iv and 2.0 mpk orally),A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621068,,BAO_0000218,,
4832,2661,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female cynomolgus monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL876399,,BAO_0000218,,
4833,6535,Volume distribution in monkey after administration of 1 mg/kg iv,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621069,,BAO_0000218,,
4834,4809,Volume distribution was determined in monkey after (iv) administration of a dose of 13 (uM/kg),A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621070,,BAO_0000218,,
4835,6062,Volume of distribution was measured in monkey after an iv dose of 1 mg/kg,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621071,,BAO_0000218,,
4836,3443,Half life evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621072,,BAO_0000218,,
4837,4578,Oral systemic bioavailability upon iv administration to african green monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618209,,BAO_0000218,,
4838,4809,Plasma clearance was determined in monkey after (iv) administration of a dose of 13 (uM/kg),A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618210,,BAO_0000218,,
4839,11271,Baboon plasma free fraction. ,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618211,,BAO_0000019,,
4840,6057,Area under the curve was calculated in rhesus monkey after iv administration,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618212,,BAO_0000218,,
4841,6057,Area under the curve was calculated in rhesus monkey after peroral administration,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618213,,BAO_0000019,,
4842,17853,Dose-normalized area under curve in monkey (p.o.) at 2.0 mpk,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618214,,BAO_0000019,,
4843,5302,Half life period in monkey after 5 mg/kg dose,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL873492,,BAO_0000218,,
4844,4257,Half-life was determined in monkey after 3 mg/kg of i.v. dose,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618272,,BAO_0000218,,
4845,4257,Half-life was determined in monkey after 3 mg/kg of i.v. dose; Not determined,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618273,,BAO_0000218,,
4846,13501,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 1 mg/kg to rhesus monkey,A,In vivo,,Cercopithecidae,9527.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618274,,BAO_0000218,1969.0,
4847,5394,Compound at a dose 3 mg/kg was administered to monkey and was evaluated for half life after administration into monkey at 3 mg/kg,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618275,,BAO_0000218,,
4848,2661,Compound was evaluated for half-life after treatment with iv dose of 1 mgkg to female cynomolgus monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618276,,BAO_0000218,,
4849,3341,Compound was evaluated for terminal half life in monkey,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618277,,BAO_0000019,,
4850,3045,Compound was evaluated for the half life period after iv administration in cynomolgus monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618278,,BAO_0000218,,
4851,5005,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,A,In vivo,,Macaca mulatta,9544.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618279,,BAO_0000218,1969.0,
4852,4847,Half life of compound was determined in squirrel monkey,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618280,,BAO_0000019,,
4853,4256,Half life after iv administration in cynomolgus monkey,A,In vivo,,Macaca fascicularis,9541.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618281,,BAO_0000218,,
4854,6535,Half life in monkey plasma after administration of 1 mg/kg iv,A,In vivo,,Cercopithecidae,9527.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618282,,BAO_0000218,1969.0,
4855,6057,Half life was calculated in rhesus monkey,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618283,,BAO_0000019,,
4856,17592,Half life in monkey,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618284,,BAO_0000019,,
4857,6641,Half life in monkey (dosed at 0.5 mpk iv and 2.0 mpk orally),A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618285,,BAO_0000218,,
4858,5472,Half life was evaluated in rhesus,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618286,,BAO_0000019,,
4859,6221,Half life period after oral administration (2.5 mg/kg) in monkey was determined,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618287,,BAO_0000218,,
4860,5668,Half life period was determine after peroral administration at 10 mpk in Rhesus,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618288,,BAO_0000218,,
4861,4809,Half life period was determined in monkey after (iv) administration of a dose of 13 (uM/kg),A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL876393,,BAO_0000218,,
4862,5546,Half life period was determined in rhesus monkey at a dose of 1 mg/kg by iv administration,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618289,,BAO_0000218,,
4863,5553,Half life period was determined in squirrel monkey after iv administration at a dose of 5 mg/kg,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618290,,BAO_0000218,,
4864,6078,Half-life was calculated in monkey,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618291,,BAO_0000019,,
4865,5147,Half-life in Squirrel monkey,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618292,,BAO_0000019,,
4866,5145,Half-life in rhesus monkey,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618293,,BAO_0000019,,
4867,6062,Half-life was measured in monkey after an iv dose of 1 mg/kg,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618294,,BAO_0000218,,
4868,5355,Half-life period after intravenous administration in cynomolgus monkeys,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618295,,BAO_0000218,,
4869,5355,Half-life period after oral administration in cynomolgus monkeys,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618296,,BAO_0000218,,
4870,5355,Half-life period after oral administration in cynomolgus monkeys; ND meansn Not determined,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618297,,BAO_0000218,,
4871,7766,Portion of holoxan excreted in the form of the metabolite from 1500 mL of urine on day 9 was determined in embryonal rhabdomyosarcoma patients treated with ifosfamide,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL618298,,BAO_0000019,1088.0,
4872,7766,Portion of holoxan excreted in the form of the metabolite from 1600 mL of urine on day 10 was determined in embryonal rhabdomyosarcoma patients treated with ifosfamide,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL618299,,BAO_0000019,1088.0,
4873,7766,Portion of holoxan excreted in the form of the metabolite from 1700 mL of urine on day 5 was determined in embryonal rhabdomyosarcoma patients treated with ifosfamide,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL618300,,BAO_0000019,1088.0,
4874,7766,Portion of holoxan excreted in the form of the metabolite from 2310 mL of urine on day 4 was determined in embryonal rhabdomyosarcoma patients treated with ifosfamide,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL618301,,BAO_0000019,1088.0,
4875,7766,Percent ratio of the enantiomeric form (+)R extracted from the urine of alveolar rhabdomyosarcoma patients was determined,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL618302,,BAO_0000019,1088.0,
4876,7766,Percent ratio of the enantiomeric form (+)R extracted from the urine of embryonal rhabdomyosarcoma patients was determined,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL876394,,BAO_0000019,1088.0,
4877,7766,Percent ratio of the enantiomeric form (-)S extracted from the urine of alveolar rhabdomyosarcoma patients was determined,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL618303,,BAO_0000019,1088.0,
4878,7766,Percent ratio of the enantiomeric form (-)S extracted from the urine of embryonal rhabdomyosarcoma patients was determined,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL618304,,BAO_0000019,1088.0,
4879,1916,Bioavailability was evaluated in man at a dose of 10 mg/kg after po administration; not determined,A,In vivo,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618305,,BAO_0000218,,
4880,16643,Oral bioavailability in human,A,In vivo,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618306,,BAO_0000218,,
4881,17248,Compound was tested for human plasma protein binding,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618307,,BAO_0000019,,
4882,17248,Compound was tested for human plasma protein binding; Not determined,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618308,,BAO_0000019,,
4883,6241,Protein binding activity of compound in human plasma; % Free,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618309,,BAO_0000019,,
4884,17716,Unbound fraction (plasma),A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618310,,BAO_0000019,,
4885,17605,Half life for the hydrolysis of compound in human blood serum,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL873353,,BAO_0000366,1969.0,
4886,17625,Half life period in human plasma using phosphate buffer (0.08 M),A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618311,,BAO_0000366,1969.0,
4887,17625,Half life period in human plasma using phosphate buffer (0.1 M),A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618312,,BAO_0000366,1969.0,
4888,17747,Half-life in human plasma was determined,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618313,,BAO_0000366,1969.0,
4889,15613,Concentration required for 50% toxicity in metastatic lung carcinoma (MV522) cells.,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618314,,BAO_0000019,,
4890,354,Effect of compound on gelation time of human serum induced by dithiothreitol (DTT),A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618315,,BAO_0000019,,
4891,3741,"Rate constant in chemical and enzymatic hydrolysis to form L-DOPA, in 80% human plasma",A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618316,,BAO_0000019,,
4892,3741,"Rate constant in chemical and enzymatic hydrolysis to form another compound (8)*, in 80% human plasma (experiment 1)",A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618317,,BAO_0000019,,
4893,3741,"Rate constant in chemical and enzymatic hydrolysis to form another compound (8)*, in 80% human plasma (experiment 2)",A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620138,,BAO_0000019,,
4894,17599,Partition coefficient (logP),A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL858280,,BAO_0000019,,
4895,5486,In vitro metabolic stability in human was measured as pmol/min/mg/protein,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620139,,BAO_0000019,,
4896,5600,In vitro metabolic stability determined after 30 min of incubation in human hepatic microsomes,A,,,Homo sapiens,9606.0,,,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL620140,,BAO_0000251,,
4897,14294,Metabolism of compound in human liver slices (male) ('+''indicates <20% largest observed peak),A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620141,,BAO_0000019,,
4898,14294,Metabolism of compound in human liver slices (male) ('++''indicates 20-50% largest observed peak),A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620142,,BAO_0000019,,
4899,14294,Metabolism of compound in human liver slices (male) ('++++' indicates largest observed peak),A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620143,,BAO_0000019,,
4900,14294,Metabolism of compound in human microsomes ('+''indicates <20% largest observed peak),A,,,Homo sapiens,9606.0,,,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL620144,,BAO_0000251,,
4901,14294,Metabolism of compound in human microsomes ('++++' indicates largest observed peak),A,,,Homo sapiens,9606.0,,,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL620145,,BAO_0000251,,
4902,14294,Metabolism of compound in human microsomes; Trace,A,,,Homo sapiens,9606.0,,,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL620146,,BAO_0000251,,
4903,6260,Percent of compound remaining after 120 min of Metabolization upon incubation with human liver microsomes,A,,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL620147,,BAO_0000251,2107.0,
4904,6187,Percent metabolized in an in vitro human liver microsomal incubation assay after 60 min,A,,,Homo sapiens,9606.0,,,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL620148,,BAO_0000251,,
4905,6251,In vitro metabolic potential in human liver microsomes,A,,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL620149,,BAO_0000251,2107.0,
4906,3246,Metabolism by recombinant human NAD(P)H:quinone oxidoreductase (NQO1) was evaluated,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL876412,,BAO_0000019,,
4907,17313,Tested for human plasma protein binding of the compound; Not tested,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619352,,BAO_0000019,,
4908,6227,Compound was tested for percent protein binding (PB) in human,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619353,,BAO_0000019,,
4909,5530,Protein binding in human plasma,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL619354,,BAO_0000019,1969.0,
4910,6108,Permeability coefficient (B to A) in Caco-2 cell,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619355,,BAO_0000019,,
4911,6108,Permeability directional ratio (PB-A/PA-B) in Caco-2 cell,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619356,,BAO_0000019,,
4912,2774,Apparent permeability coefficient (Papp) was determined in human Caco-2 cell monolayer (n = 3),A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619357,,BAO_0000019,,
4913,16643,In vitro rate of absorption observed as Caco-2 permeability in humans,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619358,,BAO_0000019,,
4914,17582,Cellular permeability of compound was determined in Caco-2 cells; High,A,,,Homo sapiens,9606.0,,,Caco-2,,22224,U,0,Autocuration,1,,CHEMBL619359,495.0,BAO_0000219,,
4915,6838,Permeability in Caco-2 cells of compound,A,,,Homo sapiens,9606.0,,,Caco-2,,22224,U,0,Autocuration,1,,CHEMBL619360,495.0,BAO_0000219,,
4916,6108,Permeability coefficient (A to B) in Caco-2 cell,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619361,,BAO_0000019,,
4917,6108,Permeability coefficient (B to A) in Caco-2 cell,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619362,,BAO_0000019,,
4918,6108,Permeability coefficient (Papp) (Caco-2 cell monolayer),A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619363,,BAO_0000019,,
4919,2146,Compound was measured for binding rate for human serum at a carbapenem concentration of 10 ug/mL,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618942,,BAO_0000019,,
4920,4514,Compound was tested for protein binding in human plasma,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618943,,BAO_0000019,,
4921,6108,Transcellular permeability of the [(PA-B+PB-A)/2)] compound was determined in Caco-2 cell,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618944,,BAO_0000019,,
4922,7766,Quantity of the metabolite found in the urine of the embryonal rhabdomyosarcoma patients treated with ifosfamide from 1200 mL of urine tested on day 3,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL618945,,BAO_0000019,1088.0,
4923,5969,In vivo Tmax was determined in murine septicemia at dose of 50 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618946,,BAO_0000218,,
4924,3277,Maximum time was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL876413,,BAO_0000218,,
4925,3802,Tested for Tmax value at the dose of 10 mg/kg when administered perorally in mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618947,,BAO_0000218,,
4926,2862,Time taken to reach maximum concentration in plasma upon oral administration in mouse,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL618948,,BAO_0000218,1969.0,
4927,6348,Time to reach maximum plasma concentration was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL618949,,BAO_0000218,1969.0,
4928,17764,Tmax after intraperitoneal administration in mice at 23 uM/kg,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618950,,BAO_0000218,,
4929,5781,Tmax after oral administration at 30 mg/kg in ICR mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618951,,BAO_0000218,,
4930,17764,Tmax after peroral administration in mice at 2.4 uM/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618952,,BAO_0000218,,
4931,4066,Tmax at a single subcutaneous administration of 40 mg/kg in mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618953,,BAO_0000218,,
4932,17641,Tmax in brain of mice at the oral dose of 50 mg/kg,A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL618954,,BAO_0000218,955.0,
4933,17641,Tmax in kidney of mice at the oral dose of 50 mg/kg,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL618955,,BAO_0000218,2113.0,
4934,17641,Tmax in liver of mice at the oral dose of 50 mg/kg,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL618956,,BAO_0000218,2107.0,
4935,17641,Tmax in lungs of mice at the oral dose of 50 mg/kg,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL618957,,BAO_0000218,2048.0,
4936,17764,Tmax in mice at 18 uM/kg i.p. administration,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618958,,BAO_0000218,,
4937,17764,Tmax in mice at 23 uM/kg i.v. administration,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618959,,BAO_0000218,,
4938,17764,Tmax in mice at 25 uM/kg i.p. administration,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618960,,BAO_0000218,,
4939,17764,Tmax in mice at 26 uM/kg i.p. administration,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL876723,,BAO_0000218,,
4940,17641,Tmax in spleen of mice at the oral dose of 50 mg/kg,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL618961,,BAO_0000218,2106.0,
4941,16597,Tmax value at a dose of 10 mg/kg intravenous administration in mice.,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618962,,BAO_0000218,,
4942,16597,Tmax value at a dose of 10 mg/kg peroral administration in mice.,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618963,,BAO_0000218,,
4943,5951,Tmax value in IRC mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618964,,BAO_0000218,,
4944,5506,Tmax value was determined at a dose of 100 mg/kg (i.p.) in Mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618965,,BAO_0000218,,
4945,5506,Tmax value was determined at a dose of 200 mg/kg (i.p.) in Mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618966,,BAO_0000218,,
4946,429,Evaluated for pharmacokinetic parameter urine recovery in mouse at the dose 20 mg/kg ( 0-24 hr ),A,,,Mus musculus,10090.0,,Urine,,,50594,N,1,Intermediate,1,,CHEMBL618967,,BAO_0000218,1088.0,
4947,429,Evaluated for pharmacokinetic parameter urine recovery in mouse at the dose 20 mg/kg (0-24 hr),A,,,Mus musculus,10090.0,,Urine,,,50594,N,1,Intermediate,1,,CHEMBL618968,,BAO_0000218,1088.0,
4948,4066,Urinary recovery by disk method using Streptococcus pyogenes (0-24 h),A,,,Mus musculus,10090.0,,Urine,,,50594,N,1,Intermediate,1,,CHEMBL618969,,BAO_0000218,1088.0,
4949,17734,The first compartment constitutes the majority of the volume of distribution after intraperitoneal administration of 100 mg/kg in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618970,,BAO_0000218,,
4950,17734,The second majority of the volume of distribution after intraperitoneal administration of 100 mg/kg in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618971,,BAO_0000218,,
4951,6062,Terminal phase volume of distribution was measured in mouse after an iv dose of 1 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618972,,BAO_0000218,,
4952,5969,In vivo volume distribution (Vd) was determined in murine septicemia at dose of 100 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618973,,BAO_0000218,,
4953,5969,In vivo volume distribution (Vd) was determined in murine septicemia at dose of 50 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618974,,BAO_0000218,,
4954,5969,In vivo volume distribution (Vd) was determined in murine septicemia at dose of 50 mg/kg;ND=not determined,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618975,,BAO_0000218,,
4955,5980,Vd in mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618976,,BAO_0000218,,
4956,17592,Volume of distribution in mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618977,,BAO_0000218,,
4957,6348,Volume of distribution was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL876724,,BAO_0000218,,
4958,17753,Volume of distribution of compound in plasma was determined at 24 mg/Kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618978,,BAO_0000218,,
4959,17753,Volume of distribution of compound in plasma was determined at 40 mg/Kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618979,,BAO_0000218,,
4960,17753,Volume of distribution of compound in plasma was determined at 5 mg/Kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618980,,BAO_0000218,,
4961,4239,Pharmacokinetic property (vdss) was measured in mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618981,,BAO_0000218,,
4962,2862,Value distribution upon iv administration in mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618982,,BAO_0000218,,
4963,17734,Volume of distribution after intraperitoneal administration of 100 mg/kg in mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620150,,BAO_0000218,,
4964,2675,Volume of distribution was evaluated in mice after intravenous administration,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620151,,BAO_0000218,,
4965,2675,Volume of distribution was evaluated in mice after oral administration,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620152,,BAO_0000218,,
4966,17837,Steady state volume of distribution of compound in mouse blood following i.v. administration of 10 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620153,,BAO_0000218,,
4967,5727,Steady state volume of distribution was determined in mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL876395,,BAO_0000218,,
4968,17852,Volume distribution (steady state) of compound was determined in mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620154,,BAO_0000218,,
4969,17764,Volume of solubility in solution after intravenous administration in mice at 24 uM/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620155,,BAO_0000218,,
4970,16597,Vss value at a dose of 10 mg/kg intravenous administration in mice.,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620156,,BAO_0000218,,
4971,6062,Volume of distribution was measured in mouse after an iv dose of 1 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620157,,BAO_0000218,,
4972,16438,Biodistribution of compound (oxidized form) in in kidney tissue,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL620158,,BAO_0000218,2113.0,
4973,16438,Biodistribution in mice as total concentration of both oxidized and reduced forms in blood and animals were sacrificed 10 minutes after ip administration in DMSO solution,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL620159,,BAO_0000218,178.0,
4974,16438,"Biodistribution in mice as total concentration of both oxidized and reduced forms in blood and animals were sacrificed 10 minutes after ip dosing, in DMSO solution",A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL620160,,BAO_0000218,178.0,
4975,16438,"Biodistribution in mice as total concentration of both oxidized and reduced forms in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL620161,,BAO_0000218,178.0,
4976,10708,Evaluated for the inhibitory concentration required to cause growth inhibition of A427Mer- cell line of lung using the MTT Cytotoxicity Assay,F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Intermediate,1,,CHEMBL620162,797.0,BAO_0000219,,
4977,16597,Inhibition of A431 human squamous cell carcinoma cell proliferation,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL620163,500.0,BAO_0000219,,
4978,16062,Inhibition of cell growth of human epidermoid carcinoma xenograft (A431) model using cell based assay,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL620833,500.0,BAO_0000219,,
4979,16062,Inhibition of human epidermoid carcinoma xenograft (A431) tumor growth,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL876396,500.0,BAO_0000219,,
4980,16958,Concentration required to inhibit growth of human carcinoma epidermoid (A431) cell line,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL620834,500.0,BAO_0000219,,
4981,6700,Inhibition of A431 human carcinoma cell proliferation,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL620835,500.0,BAO_0000219,,
4982,17226,In vitro inhibition of A431 (human carcinoma) cell basal growth.,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL620836,500.0,BAO_0000219,,
4983,6828,Inhibitory concentration of compound against growth of human A431 cell line; Resistant,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL620837,500.0,BAO_0000219,,
4984,12314,In vitro cytotoxicity against epidermoid carcinoma cell line,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621017,500.0,BAO_0000219,,
4985,13412,"In vivo efficacy following oral administration in nude mouse tumor model, xenograft A431 cells expressing EGF-R",F,,,Homo sapiens,9606.0,,,A-431,,9,D,9,Expert,1,,CHEMBL621018,500.0,BAO_0000218,,
4986,13299,Antiproliferative activity of compound was measured on human tumor cell line A431.,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621019,500.0,BAO_0000219,,
4987,17420,Antiproliferative effect of compound on A431 cell line expressing mutant p53,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621020,500.0,BAO_0000219,,
4988,13678,Compound was evaluated for cell growth inhibition against A 431 cell line by irradiation in the presence of examined compound,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621021,500.0,BAO_0000219,,
4989,14171,Inhibition of EGF-stimulated tyrosine phosphorylation in A431 cells.,F,,,,,,,A-431,,9,H,8,Expert,1,,CHEMBL621022,500.0,BAO_0000219,,
4990,6333,Tested for antiproliferative activity against human A431 cells,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL621023,500.0,BAO_0000219,,
4991,2356,Inhibition of epidermal growth factor receptor (EGF-R) autophosphorylation in A431 cells,F,,,Homo sapiens,9606.0,,,A-431,,9,D,9,Expert,1,,CHEMBL621024,500.0,BAO_0000219,,
4992,15578,Concentration needed to inhibit 50% growth of the human A431 (epidermoid carcinoma) cell lines,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL621025,500.0,BAO_0000219,,
4993,5126,Inhibition of A431 cell proliferation,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL621026,500.0,BAO_0000219,,
4994,6844,Cytotoxic effect on A431 human epidermoid carcinoma cells,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL621027,500.0,BAO_0000219,,
4995,6844,Cytotoxic effect on A431 human epidermoid carcinoma cells (No response to 1 mM),F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL876397,500.0,BAO_0000219,,
4996,4925,Cytotoxicity expressed as inhibitory concentration required to reduce the cell growth of A431 human epidermal carcinoma cell line,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL883797,500.0,BAO_0000219,,
4997,4925,Cytotoxicity expressed as inhibitory concentration required to reduce the cell growth of A431 human epidermal carcinoma cell line; NT=Not tested,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621028,500.0,BAO_0000219,,
4998,13978,In vitro Growth Inhibitory activity against A431 Human vulva cancer cell line,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621029,500.0,BAO_0000219,,
4999,16786,In vitro cytotoxicity of compound against human A431 (epidermoid) cancer cell line after 72 hr of drug exposure,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621030,500.0,BAO_0000219,,
5000,13412,Inhibition of EGF-stimulated tyrosine phosphorylation in A431 cells expressing EGF-R,F,,,,,,,A-431,,9,H,8,Expert,1,,CHEMBL621147,500.0,BAO_0000219,,
5001,17824,In vivo antiproliferative activity against A431 cell line,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621148,500.0,BAO_0000218,,
5002,12751,Inhibition of EGF-dependent autophosphorylation of EGF-R in human A431 cells,F,,,Homo sapiens,9606.0,,,A-431,,9,D,9,Expert,1,,CHEMBL621149,500.0,BAO_0000219,,
5003,12380,Inhibition of A431 human epidermoid carcinoma cell proliferation,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL621150,500.0,BAO_0000219,,
5004,4959,Inhibition of autophosphorylation of human epidermal growth factor-receptor (EGF-R) expressed in A431 cells,F,,,Homo sapiens,9606.0,,,A-431,,9,D,9,Expert,1,,CHEMBL621151,500.0,BAO_0000219,,
5005,6333,Inhibitory effect on nonphospho-Src after EGF (100 uM) stimulation of A431 cells (control=178),F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621152,500.0,BAO_0000219,,
5006,6333,Inhibitory effect on phospho-Src (Tyr416) after EGF (100 uM) stimulation of A431 cells (38),F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621153,500.0,BAO_0000219,,
5007,6333,Inhibitory effect on phospho-Src/nonphospho after EGF (100 uM) stimulation of A431 cells (21),F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL884000,500.0,BAO_0000219,,
5008,5296,Inhibition of EGFR overexpressing A431 cell proliferation,F,,,Homo sapiens,9606.0,,,,,9,D,9,Expert,1,,CHEMBL621154,,BAO_0000019,,
5009,12624,Inhibition of A431 cell proliferation,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL621155,500.0,BAO_0000219,,
5010,14926,No inhibition of EGFR phosphorylation in A431 cells 8 hour after washing cells free of the inhibitor,F,,,Homo sapiens,9606.0,,,A-431,,9,D,9,Expert,1,,CHEMBL621156,500.0,BAO_0000219,,
5011,14926,"Partial inhibition of EGFR phosphorylation in A431 cells, 8 hour after washing cells free of the inhibitor",F,,,Homo sapiens,9606.0,,,A-431,,9,D,9,Expert,1,,CHEMBL621157,500.0,BAO_0000219,,
5012,14926,Irreversible inhibition of ATP binding site of EGFR (lack of phosphorylated EGFR) in A431 cells 8 hour after washing cells free of the inhibitor),F,,,,,,,A-431,,9,H,8,Expert,1,,CHEMBL621158,500.0,BAO_0000219,,
5013,15144,The compound was tested in vitro for antiproliferative activity against A431 tumor cell lines,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621159,500.0,BAO_0000219,,
5014,15144,The compound was tested in vitro for antiproliferative activity against A431 tumor cell lines,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621160,500.0,BAO_0000219,,
5015,5245,Cell viability in A431 cells unstimulated with EGF was tested when incubated with concentration at 2 uM after 48 h; Did not affect the viability,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621161,500.0,BAO_0000219,,
5016,5245,Cell viability in A431 cells unstimulated with EGF was tested when incubated with concentration in the range of 1-10 uM after 48 h; Did not affect the viability,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621162,500.0,BAO_0000219,,
5017,5245,Cell viability in A431 cells unstimulated with EGF was tested when incubated with concentration up to 10 uM after 48 h; Did not affect the viability,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621163,500.0,BAO_0000219,,
5018,5245,Cell viability in A431 cells when stimulated with EGF was tested when incubated with concentration 0.01 uM after 48 h; Cell death,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621164,500.0,BAO_0000219,,
5019,5245,Cell viability in A431 cells when stimulated with EGF was tested when incubated with concentration 2 uM after 48 h; Cell death,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621165,500.0,BAO_0000219,,
5020,5922,Half-life period in cynomolgus monkey,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619159,,BAO_0000019,,
5021,1116,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in monkey plasma",A,In vitro,,Cercopithecidae,9527.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL619160,,BAO_0000366,1969.0,
5022,17853,Longer half-life in monkey (i.v.) at 0.5 mpk,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619161,,BAO_0000218,,
5023,993,Plasma half life in monkey,A,,,Cercopithecidae,9527.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL619162,,BAO_0000366,1969.0,
5024,4514,Plasma half-life in rhesus monkey,A,,,Cercopithecidae,9527.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL619163,,BAO_0000366,1969.0,
5025,5334,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Rhesus monkey (male),A,In vivo,,Cercopithecidae,9527.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL619164,,BAO_0000218,1969.0,
5026,5334,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Rhesus monkey (male),A,In vivo,,Cercopithecidae,9527.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL619320,,BAO_0000218,1969.0,
5027,4578,Tested for half life upon iv administration to african green monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619321,,BAO_0000218,,
5028,2661,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female cynomolgus monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL873336,,BAO_0000218,,
5029,5355,The time for peak concentration value after intravenous administration in cynomolgus monkeys; NA means Not applicable,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619322,,BAO_0000218,,
5030,5355,The time for peak concentration value after intravenous administration in cynomolgus monkeys; NA means not applicable,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619323,,BAO_0000218,,
5031,5355,The time for peak concentration value after oral administration in cynomolgus monkeys,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619324,,BAO_0000218,,
5032,11271,Percentage of tracer or metabolite (CO2) in baboon plasma at 10 min after injection of the compound,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619325,,BAO_0000019,,
5033,11271,Percentage of tracer or metabolite (CO2) in baboon plasma at 1 min after injection of the compound,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL876411,,BAO_0000019,,
5034,11271,Percentage of tracer or metabolite (CO2) in baboon plasma at 30 min after injection of the compound,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619326,,BAO_0000019,,
5035,11271,Percentage of tracer or metabolite (CO2) in baboon plasma at 5 min after injection of the compound,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619327,,BAO_0000019,,
5036,11271,Percentage of tracer or metabolite(EME) in baboon plasma at 10 min after injection of the compound,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619328,,BAO_0000019,,
5037,11271,Percentage of tracer or metabolite(EME) in baboon plasma at 1 min after injection of the compound,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619329,,BAO_0000019,,
5038,11271,Percentage of tracer or metabolite(EME) in baboon plasma at 30 min after injection of the compound,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619330,,BAO_0000019,,
5039,11271,Percentage of tracer or metabolite(EME) in baboon plasma at 5 min after injection of the compound,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619331,,BAO_0000019,,
5040,11271,Percentage of tracer or metabolite (acid metabolites) in baboon plasma at 10 min after injection of the compound,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619332,,BAO_0000019,,
5041,11271,Percentage of tracer or metabolite (acid metabolites) in baboon plasma at 1 min after injection of the compound,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619333,,BAO_0000019,,
5042,11271,Percentage of tracer or metabolite (acid metabolites) in baboon plasma at 30 min after injection of the compound,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619334,,BAO_0000019,,
5043,11271,Percentage of tracer or metabolite (acid metabolites) in baboon plasma at 5 min after injection of the compound,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619335,,BAO_0000019,,
5044,11271,Percentage of tracer or metabolite (unchanged) in baboon plasma at 10 min after injection of the compound,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619336,,BAO_0000019,,
5045,11271,Percentage of tracer or metabolite (unchanged) in baboon plasma at 1 min after injection of the compound,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619337,,BAO_0000019,,
5046,11271,Percentage of tracer or metabolite (unchanged) in baboon plasma at 30 min after injection of the compound,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619338,,BAO_0000019,,
5047,11271,Percentage of tracer or metabolite (unchanged) in baboon plasma at 5 min after injection of the compound,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619339,,BAO_0000019,,
5048,5809,Bioavailability in rat (cannulated) (dose 2 mg/kg),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL619340,,BAO_0000218,,
5049,17720,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL873496,,BAO_0000218,1969.0,
5050,3546,AUC value in rat after IV administration at a dose of 10 mg/kg,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL619341,,BAO_0000218,1969.0,
5051,3546,AUC value in rat after oral administration at a dose of 10 mg/kg,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL619342,,BAO_0000218,1969.0,
5052,3546,Cmax value in rat after oral administration at a dose of 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL619343,,BAO_0000218,,
5053,3546,Bioavailability in rat after oral administration at a dose of 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL619344,,BAO_0000218,,
5054,3546,Tmax value in rat after oral administration at a dose of 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL619345,,BAO_0000218,,
5055,3546,Vc value in rat after IV administration at a dose of 10 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL619346,,BAO_0000218,,
5056,3546,Half life period in rat after IV administration at a dose of 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL619347,,BAO_0000218,,
5057,10625,The absolute striatal uptake of the carbon-11 labeled compound at 60 min was determined in baboon,A,,,Papio hamadryas,9557.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619348,,BAO_0000019,,
5058,10625,Peak plasma radioactivity for the carbon-11 labeled compound was determined at 0.5 min after injection in baboon; (Range = 0.08-0.11),A,,,Papio hamadryas,9557.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619349,,BAO_0000019,,
5059,10625,Peak plasma radioactivity for the carbon-11 labeled compound was determined at 1.5 min after injection in baboon; (Range = 0.08-0.11),A,,,Papio hamadryas,9557.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619350,,BAO_0000019,,
5060,10625,The amount of unchanged tracer in baboon plasma was determined 1 min after injection of the carbon-11 labeled compound,A,,,Papio hamadryas,9557.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619351,,BAO_0000019,,
5061,10625,The amount of unchanged tracer in baboon plasma was determined 10 min after injection of the carbon-11 labeled compound,A,,,Papio hamadryas,9557.0,,,,,22224,U,0,Autocuration,1,,CHEMBL875953,,BAO_0000019,,
5062,10625,The amount of unchanged tracer in baboon plasma was determined 30 min after injection of the carbon-11 labeled compound,A,,,Papio hamadryas,9557.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621716,,BAO_0000019,,
5063,10625,The amount of unchanged tracer in baboon plasma was determined 60 min after injection of the carbon-11 labeled compound,A,,,Papio hamadryas,9557.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621717,,BAO_0000019,,
5064,10625,The absolute striatal uptake of the carbon-11 labeled compound at 60 min was determined in baboon,A,,,Papio hamadryas,9557.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621718,,BAO_0000019,,
5065,3510,Area under curve after 1 mpk peroral administration to beagles,A,,,beagle,9615.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621719,,BAO_0000019,,
5066,3510,Area under curve after 2 mpk peroral administration to beagles,A,,,beagle,9615.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621720,,BAO_0000019,,
5067,3510,Cmax value after 1 mpk peroral administration to beagles,A,In vivo,,beagle,9615.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621721,,BAO_0000218,,
5068,7766,Quantity of the metabolite found in the urine of the embryonal rhabdomyosarcoma patients treated with ifosfamide from 1200 mL of urine tested on day 7,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL621722,,BAO_0000019,1088.0,
5069,7766,Quantity of the metabolite found in the urine of the embryonal rhabdomyosarcoma patients treated with ifosfamide from 1300 mL of urine tested on day 6,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL621723,,BAO_0000019,1088.0,
5070,7766,Quantity of the metabolite found in the urine of the embryonal rhabdomyosarcoma patients treated with ifosfamide from 1300 mL of urine tested on day 8,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL621724,,BAO_0000019,1088.0,
5071,7766,Quantity of the metabolite found in the urine of the embryonal rhabdomyosarcoma patients treated with ifosfamide from 1500 mL of urine tested on day 9,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL623443,,BAO_0000019,1088.0,
5072,7766,Quantity of the metabolite found in the urine of the embryonal rhabdomyosarcoma patients treated with ifosfamide from 1600 mL of urine tested on day 10,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL623444,,BAO_0000019,1088.0,
5073,7766,Quantity of the metabolite found in the urine of the embryonal rhabdomyosarcoma patients treated with ifosfamide from 1700 mL of urine tested on day 5,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL623445,,BAO_0000019,1088.0,
5074,7766,Quantity of the metabolite found in the urine of the embryonal rhabdomyosarcoma patients treated with ifosfamide from 2310 mL of urine tested on day 4,A,,,Homo sapiens,9606.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL623446,,BAO_0000019,1088.0,
5075,16643,Metabolic stability observed at 30 min after administration in human liver microsomes,A,,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL623447,,BAO_0000251,2107.0,
5076,6852,Percent recovery of 100 ug/mL compound after administration in cirrhotic patients,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623448,,BAO_0000019,,
5077,6852,Percent recovery of 10 ug/mL compound after administration in cirrhotic patients,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623449,,BAO_0000019,,
5078,6852,Percent recovery of 500 ug/mL compound after administration in cirrhotic patients,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623450,,BAO_0000019,,
5079,6567,"Compound remaining after incubation with 2 mg/mL of human liver microsomes at 37 degrees C for 30 min in a pH 7.4, 0.05 M phosphate buffer",A,,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL623451,,BAO_0000251,2107.0,
5080,6570,Metabolic stability (% remaining at 30 mins) in human S9.,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623452,,BAO_0000019,,
5081,6570,Metabolic stability determined as remaining percent after 30 min of incubation in human isolated liver S9 preparations; N/D= Not determined,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623453,,BAO_0000019,,
5082,5237,Percent parent compound remaining after 20 min incubation with human liver microsomes,A,,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL623454,,BAO_0000251,2107.0,
5083,5237,Percent parent compound remaining after 20 min incubation with human liver microsomes; ND=No data,A,,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL623455,,BAO_0000251,2107.0,
5084,5237,Percent parent compound remaining after 20 min incubation with human liver microsomes; No data,A,,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL624371,,BAO_0000251,2107.0,
5085,5202,First pass metabolism and metabolic bioavailability using human hepatic microsomes,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624372,,BAO_0000218,,
5086,5481,Percent compound remaining in human plasma after incubation for 60 min at 37 C.,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624373,,BAO_0000019,,
5087,5481,Percent remaining in human plasma after incubation for 60 min at 37 C.,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624374,,BAO_0000019,,
5088,3956,The percent remaining in human plasma after 30 min was determined,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624556,,BAO_0000019,,
5089,5074,Conversion rate of the prodrug in human plasma,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL624557,,BAO_0000366,1969.0,
5090,5074,Conversion rate of the prodrug in human plasma; ND means no data,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL624558,,BAO_0000366,1969.0,
5091,4727,Half life of compound was determined in human blood,A,,,Homo sapiens,9606.0,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL624559,,BAO_0000221,178.0,
5092,5965,Half life of compound was determined in man with once daily dosing,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624560,,BAO_0000019,,
5093,5732,Half life in human microsomes,A,In vitro,,Homo sapiens,9606.0,,,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL624561,,BAO_0000251,,
5094,5819,Half life in human plasma,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL624562,,BAO_0000366,1969.0,
5095,5819,Half life in human plasma; Not detected,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL624563,,BAO_0000366,1969.0,
5096,1916,Half life period was evaluated against man at a dose of 10 mg/kg after po administration,A,In vivo,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624564,,BAO_0000218,,
5097,6597,Half-life for oxidative metabolic stability was determined using rat liver microsomes,A,In vitro,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL624565,,BAO_0000251,2107.0,
5098,5229,Half-life in human plasma,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL875152,,BAO_0000366,1969.0,
5099,5229,Half-life of the parent prodrug in plasma,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL624566,,BAO_0000366,1969.0,
5100,2192,In vitro half life in human plasma was determined,A,In vitro,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL873805,,BAO_0000366,1969.0,
5101,3032,The compound was tested In Vitro for half life in human liver microsomes.,A,In vitro,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL624567,,BAO_0000251,2107.0,
5102,1916,Maximum time was evaluated against man at a dose of 10 mg/kg after po administration,A,In vivo,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624568,,BAO_0000218,,
5103,17716,Observed volume of distribution,A,In vivo,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624569,,BAO_0000218,,
5104,15778,Oral bioavailability in human,A,In vivo,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624570,,BAO_0000218,,
5105,17313,Tested for human plasma protein binding of the compound,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624571,,BAO_0000019,,
5106,4231,"First order rate constant, k was determined in human plasma",A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624572,,BAO_0000019,,
5107,4755,Observed rate constant in 80% human plasma at 37 degree Centigrade,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624573,,BAO_0000019,,
5108,4755,Observed rate constant in 80% human plasma at 37 degree Centigrade,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL875153,,BAO_0000019,,
5109,16907,Loss of compound (%metabolized) after 30 min exposure to human liver microsomes,A,,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL624574,,BAO_0000251,2107.0,
5110,10839,The compound was tested for the plasma binding in human,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624575,,BAO_0000019,,
5111,10839,Plasma protein binding (human),A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624576,,BAO_0000019,,
5112,3199,Compound was evaluated for half-life in human liver microsomes,A,In vitro,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL624577,,BAO_0000251,2107.0,
5113,1345,Half life measured in vitro for its stability in human blood,A,In vitro,,Homo sapiens,9606.0,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL624578,,BAO_0000221,178.0,
5114,4297,Half life in human serum,A,,,Homo sapiens,9606.0,,Serum,,,22224,U,0,Autocuration,1,,CHEMBL622796,,BAO_0000019,1977.0,
5115,4297,Half life in human serum; ND=not determined,A,,,Homo sapiens,9606.0,,Serum,,,22224,U,0,Autocuration,1,,CHEMBL622797,,BAO_0000019,1977.0,
5116,4297,Half life were determined in CEM-SS cell extract in decomposition step 1,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL622798,,BAO_0000019,,
5117,4297,Half life were determined in CEM-SS cell extract in decomposition step 2,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL622799,,BAO_0000019,,
5118,4231,Half life of the in human plasma,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL622800,,BAO_0000366,1969.0,
5119,5633,Half life period in human hepatic S9 fraction was determined,A,In vitro,,Homo sapiens,9606.0,,,,S9,22224,U,0,Autocuration,1,,CHEMBL622801,,BAO_0000220,,
5120,5633,Half life period in human liver microsome was determined,A,In vitro,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL622802,,BAO_0000251,2107.0,
5121,17791,Half life period was determined; 6-7,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL622803,,BAO_0000019,,
5122,17791,Half life period was evaluated in human,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL875154,,BAO_0000019,,
5123,3160,Half life time in human plasma,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL622804,,BAO_0000366,1969.0,
5124,16438,"Biodistribution in mice as total concentration of both oxidized and reduced forms in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL622805,,BAO_0000218,955.0,
5125,16438,"Biodistribution in mice as total concentration of both oxidized and reduced forms in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL622611,,BAO_0000218,948.0,
5126,16438,"Biodistribution in mice as total concentration of both oxidized and reduced forms in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL622612,,BAO_0000218,948.0,
5127,16438,"Biodistribution in mice as total concentration of both oxidized and reduced forms in kidney and animals were sacrificed 10 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL875160,,BAO_0000218,2113.0,
5128,16438,"Biodistribution in mice as total concentration of both oxidized and reduced forms in kidney and animals were sacrificed 10 minutes after ip dosing, in DMSO solution",A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL622613,,BAO_0000218,2113.0,
5129,16438,"Biodistribution in mice as total concentration of both oxidized and reduced forms in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL622614,,BAO_0000218,2113.0,
5130,16438,"Biodistribution in mice as total concentration of both oxidized and reduced forms in liver and animals were sacrificed 10 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL622615,,BAO_0000218,2107.0,
5131,16438,Biodistribution in mice as total concentration of both oxidized and reduced forms in liver and animals were sacrificed 10 minutes after ip administration in DMSO solution,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL622616,,BAO_0000218,2107.0,
5132,16438,"Biodistribution in mice as total concentration of both oxidized and reduced forms in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL622617,,BAO_0000218,2107.0,
5133,16438,Biodistribution in mice as total concentration of both oxidized and reduced forms in spleen and animals were sacrificed 10 minutes after ip administration in DMSO solution,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL622618,,BAO_0000218,2106.0,
5134,16438,"Biodistribution in mice as total concentration of both oxidized and reduced forms in spleen and animals were sacrificed 10 minutes after ip dosing, in DMSO solution",A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL622619,,BAO_0000218,2106.0,
5135,16438,"Biodistribution in mice as total concentration of both oxidized and reduced forms in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL622620,,BAO_0000218,2106.0,
5136,16438,"Biodistribution in mice, total concentration of both oxidized and reduced forms in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL622621,,BAO_0000218,955.0,
5137,16438,Biodistribution of compound (oxidized form) in blood tissue,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL622622,,BAO_0000218,178.0,
5138,16438,"Biodistribution of compound (oxidized form) in blood tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL622623,,BAO_0000218,178.0,
5139,16438,"Biodistribution of compound (oxidized form) in blood tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL622624,,BAO_0000218,178.0,
5140,16438,"Biodistribution of compound (oxidized form) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL622625,,BAO_0000218,178.0,
5141,16438,"Biodistribution of compound (oxidized form) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL622626,,BAO_0000218,178.0,
5142,16438,"Biodistribution of compound (oxidized form) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL622627,,BAO_0000218,178.0,
5143,16438,Biodistribution of compound (oxidized form) in brain tissue of mice,A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL622628,,BAO_0000218,955.0,
5144,16438,"Biodistribution of compound (oxidized form) in brain tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL622629,,BAO_0000218,955.0,
5145,16438,"Biodistribution of compound (oxidized form) in brain tissue, animals were sacrificed 60 minutes after dosing, in DMSO",A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL622630,,BAO_0000218,955.0,
5146,16438,"Biodistribution of compound (oxidized form) in brain tissue, animals were sacrificed 60 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL622631,,BAO_0000218,955.0,
5147,16438,"Biodistribution of compound (oxidized form) in brain tissue, animals were sacrificed 60 minutes after dosing, in DMSO solution",A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL622632,,BAO_0000218,955.0,
5148,16438,"Biodistribution of compound (oxidized form) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO solution",A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL622633,,BAO_0000218,955.0,
5149,16438,Biodistribution of compound (oxidized form) in heart tissue of mice,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL622634,,BAO_0000218,948.0,
5150,16438,"Biodistribution of compound (oxidized form) in heart tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL622635,,BAO_0000218,948.0,
5151,16438,"Biodistribution of compound (oxidized form) in heart tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL875161,,BAO_0000218,948.0,
5152,16438,"Biodistribution of compound (oxidized form) in heart tissue, animals were sacrificed 60 minutes after dosing, in DMSO",A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL622636,,BAO_0000218,948.0,
5153,16438,"Biodistribution of compound (oxidized form) in heart tissue, animals were sacrificed 60 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL623335,,BAO_0000218,948.0,
5154,16438,"Biodistribution of compound (oxidized form) in heart tissue, animals were sacrificed 60 minutes after dosing, in DMSO solution",A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL623336,,BAO_0000218,948.0,
5155,16438,"Biodistribution of compound (oxidized form) in kidney tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL623337,,BAO_0000218,2113.0,
5156,16438,"Biodistribution of compound (oxidized form) in kidney tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL623338,,BAO_0000218,2113.0,
5157,16438,"Biodistribution of compound (oxidized form) in kidney tissue, animals were sacrificed 60 minutes after dosing, in DMSO",A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL623339,,BAO_0000218,2113.0,
5158,16438,"Biodistribution of compound (oxidized form) in kidney tissue, animals were sacrificed 60 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL623524,,BAO_0000218,2113.0,
5159,16438,"Biodistribution of compound (oxidized form) in kidney tissue, animals were sacrificed 60 minutes after dosing, in DMSO solution",A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL623525,,BAO_0000218,2113.0,
5160,16438,Biodistribution of compound (oxidized form) in liver tissue,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL623526,,BAO_0000218,2107.0,
5161,16438,"Biodistribution of compound (oxidized form) in liver tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL623527,,BAO_0000218,2107.0,
5162,16438,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL623528,,BAO_0000218,2107.0,
5163,5245,Cell viability in A431 cells when stimulated with EGF was tested when incubated with concentration in the range of 1-10 uM of the compound after 48 h; Cell death,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL624615,500.0,BAO_0000219,,
5164,5245,Cell viability in A431 cells when stimulated with EGF was tested when incubated with concentration up to 10 uM after 48 h; Did not affect the viability,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621672,500.0,BAO_0000219,,
5165,16289,"In vivo activity in A431 tumor bearing mice, maximum dose (schedule 10-24 days)",F,,,,,,,A-431,,80852,N,1,Expert,1,,CHEMBL621673,500.0,BAO_0000218,,
5166,16289,"In vivo activity in A431 tumor bearing mice, maximum dose (schedule 12-26 days)",F,,,,,,,A-431,,80852,N,1,Expert,1,,CHEMBL621674,500.0,BAO_0000218,,
5167,16093,Inhibition of EGF-induced Tyrosine phosphorylation in A431 cells expressing EGF-R,F,,,Homo sapiens,9606.0,,,A-431,,9,D,9,Expert,1,,CHEMBL884002,500.0,BAO_0000219,,
5168,16825,"Concentration required to inhibit the epidermoid A431 cell growth by 50%, P53 status of cell line used was wild-type. ",F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621850,500.0,BAO_0000219,,
5169,4848,Inhibitory activity against proliferation of human epidermoid carcinoma (A431) cells,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL621851,500.0,BAO_0000219,,
5170,14827,Inhibition of EGF-dependent autophosphorylation of EGF-R in A431 cells,F,,,Homo sapiens,9606.0,,,A-431,,9,D,9,Expert,1,,CHEMBL621852,500.0,BAO_0000219,,
5171,14827,Inhibition of autophosphorylation of epidermal growth factor receptor in A431 cells in culture,F,,,Homo sapiens,9606.0,,,A-431,,9,D,9,Expert,1,,CHEMBL621853,500.0,BAO_0000219,,
5172,16289,"In vivo activity in A431 tumor bearing mice, relative time required for treated and control tumors to reach 750 mg (schedule 10-24 days)",F,,,,,,,A-431,,80852,N,1,Expert,1,,CHEMBL621854,500.0,BAO_0000218,,
5173,16289,"In vivo activity in A431 tumor bearing mice, relative time required for treated and control tumors to reach 750 mg (schedule 12-26 days)",F,,,,,,,A-431,,80852,N,1,Expert,1,,CHEMBL621855,500.0,BAO_0000218,,
5174,16289,"In vivo activity in A431 tumor bearing mice, relative time required for treated and control tumors to reach 750 mg (schedule 12-26 days)",F,,,,,,,A-431,,80852,N,1,Expert,1,,CHEMBL623724,500.0,BAO_0000218,,
5175,16289,"In vivo activity in A431 tumor bearing mice, ratio of treated and control tumor mass day 24",F,,,,,,,A-431,,80852,N,1,Expert,1,,CHEMBL623725,500.0,BAO_0000218,,
5176,16289,"In vivo activity in A431 tumor bearing mice, ratio of treated and control tumor mass day 26",F,,,,,,,A-431,,80852,N,1,Expert,1,,CHEMBL623726,500.0,BAO_0000218,,
5177,16289,"Irreversible inhibition of EGF-R phosphorylation in A431 cells, 8 hr after washing cells free of compound",F,,,Homo sapiens,9606.0,,,A-431,,9,D,9,Expert,1,,CHEMBL623727,500.0,BAO_0000219,,
5178,16289,Irreversible inhibition of formation of phosphorylated EGFR in A431 cells 8 hr after washing cells free of compound,F,,,,,,,A-431,,9,H,8,Expert,1,,CHEMBL623728,500.0,BAO_0000219,,
5179,16289,"In vivo activity in A431 tumor bearing mice, maximum weight loss days 10-24",F,,,,,,,A-431,,80852,N,1,Expert,1,,CHEMBL623729,500.0,BAO_0000218,,
5180,16289,"In vivo activity in A431 tumor bearing mice, maximum weight loss days 12-26",F,,,,,,,A-431,,80852,N,1,Expert,1,,CHEMBL623730,500.0,BAO_0000218,,
5181,16289,"In vivo activity in A431 tumor bearing mice, maximum weight loss days 12-26",F,,,,,,,A-431,,80852,N,1,Expert,1,,CHEMBL623731,500.0,BAO_0000218,,
5182,14555,"Ratio of treated and control A431 cell tumor mass in mice at 5 mg/kg peroral dose, days 7-21 administration",F,,,Mus musculus,10090.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL623732,500.0,BAO_0000218,,
5183,14555,"Difference in days for treated (T) and control (C) A431 cell tumors to reach 750 mg in mice at 5 mg/kg peroral dose, days 7-21 administration",F,,,Mus musculus,10090.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL623733,500.0,BAO_0000218,,
5184,14555,"Net reduction in tumor burden between first and last treatments of A431 cell tumors in mice at 5 mg/kg peroral dose, days 7-21 administration",F,,,Mus musculus,10090.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL623734,500.0,BAO_0000218,,
5185,14555,"Weight change of A431 cell tumors in mice at 5 mg/kg peroral dose, days 7-21 administration",F,,,Mus musculus,10090.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL623735,500.0,BAO_0000218,,
5186,1937,In vitro antiproliferative effect against A431 human epidermoid carcinoma cells,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL623736,500.0,BAO_0000219,,
5187,13739,In vitro tumor cell growth inhibitory activity against Human leiomyosarcoma A431 cell lines,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL623737,500.0,BAO_0000219,,
5188,3558,Cytotoxicity against A437 cells is the dose giving 50% decrease in the formation of formazan dye,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL623738,500.0,BAO_0000219,,
5189,3558,Dose giving a 50% decrease in the living cell number (A437 cells),F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Intermediate,1,,CHEMBL875168,500.0,BAO_0000219,,
5190,17686,In vitro inhibitory concentration against proliferation of A459 cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL623739,646.0,BAO_0000219,,
5191,5305,Inhibitory concentration of compound for cytotoxicity against A459 human lung cells was determined,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL623740,646.0,BAO_0000219,,
5192,3614,Inhibition of growth of human NSCL non small cell lung carcinoma cell line (A459) after 72 hr of drug exposure,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624424,646.0,BAO_0000219,,
5193,17229,In vitro antitumor activity against renal A498 tumor cell lines,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL624425,624.0,BAO_0000219,,
5194,15935,"In vitro growth inhibition of human kidney carcinoma cell line, A498 with low levels of folate receptors",F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL624426,624.0,BAO_0000219,,
5195,15935,"In vitro growth inhibition of human kidney carcinoma cell line, A498 with low levels of folate receptors in folate deficient medium",F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL624427,624.0,BAO_0000219,,
5196,15560,Cytotoxicity against A498 Tumor cell line in SRB Cell viability test,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL624428,624.0,BAO_0000219,,
5197,13891,Cytotoxicity concentration against human kidney carcinoma A-498 cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL624429,624.0,BAO_0000219,,
5198,13891,Cytotoxicity concentration against human kidney carcinoma A-498 cell line; NT =Not tested,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL624620,624.0,BAO_0000219,,
5199,13788,Cytotoxicity on kidney carcinoma (A-498) cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL624621,624.0,BAO_0000219,,
5200,15403,Compound was evaluated against Human cell line renal A498,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL624622,624.0,BAO_0000219,,
5201,1009,Compound was tested for inhibition of A498 human renal cancer cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL624623,624.0,BAO_0000219,,
5202,1043,Growth inhibitory activity against A498 human cancer cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL874365,624.0,BAO_0000219,,
5203,5858,In vitro antitumor activity against human renal A498 cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL624624,624.0,BAO_0000219,,
5204,5958,In vitro cytotoxic activity against renal (A498) cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL624625,624.0,BAO_0000219,,
5205,5506,In vitro cytotoxic activity against human renal cancer (A498) cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL624626,624.0,BAO_0000219,,
5206,12781,Tested for cytostatic activity against renal A498 cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL624627,624.0,BAO_0000219,,
5207,14399,The compound was tested for the concentration to inhibit 50% of renal A498 cell lines.,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL883157,624.0,BAO_0000219,,
5208,5958,In vitro cytotoxic activity against renal (A498) cell line at a concentration of 10e-5 M,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Expert,1,,CHEMBL624628,624.0,BAO_0000219,,
5209,3510,Cmax value after 2 mpk peroral administration to beagles,A,In vivo,,beagle,9615.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624629,,BAO_0000218,,
5210,3510,Bioavailability,A,In vivo,,Canis lupus familiaris,9615.0,beagle,,,,22224,U,0,Autocuration,1,,CHEMBL623551,,BAO_0000218,,
5211,3510,Bioavailability after 1 mpk peroral administration to beagles,A,In vivo,,Canis lupus familiaris,9615.0,beagle,,,,22224,U,0,Autocuration,1,,CHEMBL623552,,BAO_0000218,,
5212,3510,Bioavailability after 2 mpk peroral administration to beagles,A,In vivo,,Canis lupus familiaris,9615.0,beagle,,,,22224,U,0,Autocuration,1,,CHEMBL623553,,BAO_0000218,,
5213,3085,Specificity constant of the BSA-catalyzed deprotonation of compound at pH 9,A,,,Bos taurus,9913.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623554,,BAO_0000019,,
5214,3085,Specificity constant of the bovine serum albumin catalyzed reaction expressed as (kcat/KM)/kuncat,A,,,Bos taurus,9913.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623555,,BAO_0000019,,
5215,3085,Michaelis-Menten kinetics of the bovine serum albumin catalyzed reaction of the compound,A,,,Bos taurus,9913.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623556,,BAO_0000019,,
5216,9372,Solubility against bovine alpha-chymotrypsin,A,,,Bos taurus,9913.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623557,,BAO_0000019,,
5217,3085,Rate constant of the bovine serum albumin catalyzed reaction of the compound,A,,,Bos taurus,9913.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623558,,BAO_0000019,,
5218,3085,Rate constant of the bovine serum albumin catalyzed reaction of the compound,A,,,Bos taurus,9913.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623559,,BAO_0000019,,
5219,1469,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards calf spleen (CS-PDE) at a concentration of 20 microg,A,,,Bos taurus,9913.0,,Spleen,,,22224,U,0,Autocuration,1,,CHEMBL623560,,BAO_0000221,2106.0,
5220,4297,Half life in culture medium containing 10% of heat inactivated foetal calf serum,A,,,Bos taurus,9913.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623561,,BAO_0000019,,
5221,4297,Half life in culture medium containing 10% of heat inactivated foetal calf serum; ND=not determined,A,,,Bos taurus,9913.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623562,,BAO_0000019,,
5222,17585,Ability to get deaminated by adenosine deaminase (ADA); Expressed as t1/2,A,,,Bos taurus,9913.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623563,,BAO_0000019,,
5223,1336,Enzymatic stability was assessed with bovine spleen phosphodiesterase (BS PDE) exonuclase,A,,,Bos taurus,9913.0,,Spleen,,,22224,U,0,Autocuration,1,,CHEMBL623564,,BAO_0000221,2106.0,
5224,3085,Half life in presence of 2 mg/mL BSA at pH 8.8,A,,,Bos taurus,9913.0,,,,,22224,U,0,Autocuration,1,,CHEMBL873806,,BAO_0000019,,
5225,2857,Half-life in RPMI 1640 containing 10% heat inactivated fetal calf serum culture medium at step 1,A,,,Bos taurus,9913.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623565,,BAO_0000019,,
5226,2857,Half-life in RPMI 1640 containing 10% heat inactivated fetal calf serum culture medium at step 2,A,,,Bos taurus,9913.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623566,,BAO_0000019,,
5227,2857,Half-life in RPMI 1640 containing 10% heat inactivated fetal calf serum culture medium at step 2; Not determined,A,,,Bos taurus,9913.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623567,,BAO_0000019,,
5228,1540,Half-life in the culture medium (RPMI 1640+10% fetal calf serum FCS),A,,,Bos taurus,9913.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623568,,BAO_0000019,,
5229,6316,AUC (Area Under Plasma concentration-time curve) was after oral administration at 5 mg/kg,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL623569,,BAO_0000218,1969.0,
5230,17594,AUC after administration at 100 mg/kg/day in dogs,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL623570,,BAO_0000218,1969.0,
5231,4953,AUC in dog at 0-24 hr by peroral administration at 3 mpk,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL624254,,BAO_0000218,1969.0,
5232,16907,AUC value after 15 mg/kg iv dose in Dogs,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL624255,,BAO_0000218,1969.0,
5233,16907,AUC value after 30 mg/kg po dose in Dogs,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL624256,,BAO_0000218,1969.0,
5234,2959,AUC value after administration of 4 mg/Kg oral dose in dog,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL624257,,BAO_0000218,1969.0,
5235,17594,AUC0-infinity after single intravenous bolus of 1 mg/kg in dogs,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL624258,,BAO_0000218,1969.0,
5236,5356,Area Under Curve for the compound was determined in dogs at 1 mg/kg oral dosing; 25-50 ug min/mL,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875277,,BAO_0000218,,
5237,16807,Area under curve (AUC) value in dogs after an intravenous dose of 0.2 mg/Kg in 0.025 M aqueous methanesulfonic acid solution with 5% mannitol at a concentration of 0.2,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622667,,BAO_0000218,,
5238,4527,Area under curve by intravenous administration at a dose of 1 uM/kg in dog was determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622668,,BAO_0000218,,
5239,4527,Area under curve by oral administration at a dose of 10 uM/kg in dog was determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622669,,BAO_0000218,,
5240,15660,Area under curve determined in dogs after intravenous administration of 3 mg/kg,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622670,,BAO_0000218,,
5241,15660,Area under curve determined in dogs after oral administration of 10 mg/kg,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622671,,BAO_0000218,,
5242,5802,Area under curve of compound after both po and iv administration at a dose of 5 mg/kg and 2 mg/kg resp in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622672,,BAO_0000218,,
5243,3598,Area under curve of compound determined in dog after iv administration at a dose of 10 mg/kg,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Expert,1,,CHEMBL622673,,BAO_0000218,,
5244,3598,Area under curve of compound from zero time to infinity determined in dog after iv administration at a dose of 10 mg/kg,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Expert,1,,CHEMBL622674,,BAO_0000218,,
5245,5944,Area under curve determined in dog at a dose of 0 mg/kg by oral administration along with indavir (10 mg/kg),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622675,,BAO_0000218,,
5246,5944,Area under curve determined in dog at a dose of 10 mg/kg by oral administration,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622676,,BAO_0000218,,
5247,5944,Area under curve determined in dog at a dose of 10 mg/kg by oral administration along with indavir (10 mg/kg),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622677,,BAO_0000218,,
5248,5944,Area under curve determined in dog at a dose of 5 mg/kg by oral administration,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622678,,BAO_0000218,,
5249,4186,Area under curve in dog after administration of 20 mg/kg dose through peroral route,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622679,,BAO_0000218,,
5250,5007,Area under curve in dogs administered perorally (5 mg/kg) and intravenously (2 mg/kg),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622680,,BAO_0000218,,
5251,5668,Area under curve was determine after peroral administration at 10 mpk in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622681,,BAO_0000218,,
5252,5668,Area under curve was determine after peroral administration at 5 mpk in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875278,,BAO_0000218,,
5253,5006,Area under curve was determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622682,,BAO_0000218,,
5254,5006,Area under curve in dogs,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622683,,BAO_0000218,,
5255,3771,Area under curve in dogs at 10 mg/kg dose fo oral administration,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622684,,BAO_0000218,,
5256,3771,Area under curve in dogs at 10 mg/kg dose fo oral administration (Evokes hyperglycerolemia),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622685,,BAO_0000218,,
5257,3771,Area under curve in dogs at 3 mg/kg dose fo intravenous administration,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622686,,BAO_0000218,,
5258,1916,Area under curve was evaluated against Beagle dog at a dose of 15 mg/kg after po administration,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618344,,BAO_0000218,,
5259,5302,Area under curve value in dog at a dose of 5 mg/kg,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875582,,BAO_0000218,,
5260,5600,Area under curve was determined after 0.1 mg/kg iv administration in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618345,,BAO_0000218,,
5261,5600,Area under curve was determined after 0.3 mg/kg po administration in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618346,,BAO_0000218,,
5262,17764,Area under curve was determined for compound after intravenous administration in dogs at 1.2 uM/kg,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618347,,BAO_0000218,,
5263,4368,Area under curve was determined for the compound by intravenous administration of 1.2 mg/kg in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618348,,BAO_0000218,,
5264,5318,Tested for half life period at 37 degree Celsius in PBS buffer at 10.5 pH containing human serum esterase,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618349,,BAO_0000019,,
5265,5318,Tested for half life period at 37 degree Centigrade in PBS buffer at 7.3 pH containing human serum esterase,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618350,,BAO_0000019,,
5266,5318,Tested for half life period at 37 degree Celsius in PBS buffer at 8.0 pH containing human serum esterase,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618351,,BAO_0000019,,
5267,5318,Tested for half life period at 37 degree Celsius in PBS buffer at 8.8 pH containing human serum esterase,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618352,,BAO_0000019,,
5268,14518,Time taken to reduce 50% of the concentration of compound in blood plasma,A,,,Homo sapiens,9606.0,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL873494,,BAO_0000221,178.0,
5269,2209,"Biological half life in human plasma (stability to human renal dehydropeptidase I,DHP-I).",A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618353,,BAO_0000366,1969.0,
5270,6787,Half life in human plasma,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618354,,BAO_0000366,1969.0,
5271,4898,Half life in human plasma was reported,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL875583,,BAO_0000366,1969.0,
5272,6072,Half life in human serum,A,,,Homo sapiens,9606.0,,Serum,,,22224,U,0,Autocuration,1,,CHEMBL618355,,BAO_0000019,1977.0,
5273,16907,Half life upon exposure to human plasma,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618356,,BAO_0000366,1969.0,
5274,5656,t1/2 in human microsomes,A,In vitro,,Homo sapiens,9606.0,,,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL618357,,BAO_0000251,,
5275,4755,Half life period in 80% human plasma at 37 degree Centigrade,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618358,,BAO_0000366,1969.0,
5276,17503,Half-life for rate of hydrolysis was determined in in human skin homogenate (pH 7.4),A,,,Homo sapiens,9606.0,,Zone of skin,,,22224,U,0,Autocuration,1,,CHEMBL618359,,BAO_0000221,14.0,
5277,12357,Half-life measured in in vitro Cathepsin B assay in human plasma,A,In vitro,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618360,,BAO_0000366,1969.0,
5278,3076,Half-life at initial concentration of 5*10e-5 M in CEM cell extract,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618361,,BAO_0000019,,
5279,6410,Half-life determined by human liver microsome stability assay at a concentration of 5 uM,A,In vitro,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL618362,,BAO_0000251,2107.0,
5280,3741,"Half-life in chemical and enzymatic hydrolysis to form L-DOPA, in 80% human plasma",A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618363,,BAO_0000366,1969.0,
5281,3741,"Half-life in chemical and enzymatic hydrolysis to form another compound (8)*, in 80% human plasma (experiment 1)",A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618364,,BAO_0000366,1969.0,
5282,3741,"Half-life in chemical and enzymatic hydrolysis to form another compound (8)*, in 80% human plasma (experiment 2)",A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL875584,,BAO_0000366,1969.0,
5283,1540,Half-life in the CEM cell extracts,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618365,,BAO_0000019,,
5284,2905,Half-life was calculated by Human plasma stability assay at 37 degree Centigrade,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL873495,,BAO_0000366,1969.0,
5285,2905,Half-life was calculated by Human plasma stability assay at 37 degree centigrade; Not hydrolyzed,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618366,,BAO_0000366,1969.0,
5286,5523,Half-life was determined,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618367,,BAO_0000019,,
5287,1499,Half-life (human blood stability),A,,,Homo sapiens,9606.0,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL618368,,BAO_0000221,178.0,
5288,1499,Half-life (human blood stability); no data,A,,,Homo sapiens,9606.0,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL618369,,BAO_0000221,178.0,
5289,17065,Half-life in human plasma,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618370,,BAO_0000366,1969.0,
5290,6861,CYP3A4 metabolism half-life (t1/2),A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618371,,BAO_0000019,,
5291,1499,Half-life was determined; 88% of parent remained after incubation for 120 min (human blood stability),A,,,Homo sapiens,9606.0,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL618372,,BAO_0000221,178.0,
5292,530,In vitro half life in human plasma,A,In vitro,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618373,,BAO_0000366,1969.0,
5293,1116,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in human plasma",A,In vitro,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618374,,BAO_0000366,1969.0,
5294,6695,In vitro hydrolysis in human plasma,A,In vitro,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618375,,BAO_0000366,1969.0,
5295,6695,In vitro hydrolysis in human plasma; no data,A,In vitro,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618376,,BAO_0000366,1969.0,
5296,10,In vitro metabolic stability at 5 uM was determined by incubating with human liver microsomes at 37 degree C,A,In vitro,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL618377,,BAO_0000251,2107.0,
5297,993,Plasma half life in human,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618378,,BAO_0000366,1969.0,
5298,15429,Stability after incubation with human plasma (at 37 degree C),A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618379,,BAO_0000366,1969.0,
5299,1675,T1/2 was evaluated in human plasma,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618380,,BAO_0000366,1969.0,
5300,2209,"Tested for Biological half life in human plasma (stability to human renal dehydropeptidase I,DHP-I).",A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618381,,BAO_0000366,1969.0,
5301,2209,"Tested for Biological half life in human plasma (stability to human renal dehydropeptidase I,DHP-I); Not determined",A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL618382,,BAO_0000366,1969.0,
5302,5318,Tested for half life period at 37 degree Centigrade in PBS buffer at 7.3 pH containing human serum esterase,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618383,,BAO_0000019,,
5303,2412,Tested in vitro for the time for half reactivation against human lysosomal alpha-glucosidase,A,In vitro,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618384,,BAO_0000019,,
5304,2412,Tested in vitro for the time for half reactivation against human lysosomal alpha-glucosidase; ND=Not determined,A,In vitro,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618385,,BAO_0000019,,
5305,2906,The release rate of the free drug from the substrate in human plasma by human plasma stability assay,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL619099,,BAO_0000366,1969.0,
5306,2906,The release rate of the free drug from the substrate in human plasma by human plasma stability assay; Not hydrolyzed,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL619100,,BAO_0000366,1969.0,
5307,5495,Time taken for 50% to be consumed by serum PON1 was determined,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619101,,BAO_0000019,,
5308,5495,Time taken for 50% to be consumed by serum PON1; NH is Not hydrolysed,A,,,Homo sapiens,9606.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619102,,BAO_0000019,,
5309,4397,Percent of the parent compound remaining after 20 mins incubation with human liver microsomes,A,,,Homo sapiens,9606.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL619103,,BAO_0000251,2107.0,
5310,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice blood upon intraveneous administration at 2.6 gmol/mice after 1 hour,A,,,Mus sp.,10095.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619268,,BAO_0000218,,
5311,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice blood upon intraveneous administration at 2.6 gmol/mice after 3 hour,A,,,Mus sp.,10095.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619269,,BAO_0000218,,
5312,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice brain upon intraveneous administration at 2.6 gmol/mice after 1 hour,A,,,Mus sp.,10095.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619270,,BAO_0000218,,
5313,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice brain upon intraveneous administration at 2.6 gmol/mice after 3 hour,A,,,Mus sp.,10095.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619271,,BAO_0000218,,
5314,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice kidney upon intraveneous administration at 2.6 gmol/mice after 1 hour,A,,,Mus sp.,10095.0,,,,,22224,U,0,Autocuration,1,,CHEMBL875585,,BAO_0000218,,
5315,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice kidney upon intraveneous administration at 2.6 gmol/mice after 24 hour,A,,,Mus sp.,10095.0,,,,,22224,U,0,Autocuration,1,,CHEMBL619272,,BAO_0000218,,
5316,6058,Compound tested for growth inhibition of renal cancer cell line 786-0,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619273,391.0,BAO_0000219,,
5317,17708,Compound was tested for 50% growth inhibition against human renal cancer 786-0 cell line,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619274,391.0,BAO_0000219,,
5318,14017,Concentration which reduced cell growth to 50 % of level against 786-0 renal cancer line,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Expert,1,,CHEMBL619275,391.0,BAO_0000219,,
5319,16818,"Percent growth of NCI cell line, renal: 786-0 exposed for 48 hr at 10e-4 concentration",F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619276,391.0,BAO_0000219,,
5320,16818,"Percent growth of NCI cell line, renal: 786-0 exposed for 48 hr at 10e-6 concentration",F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619277,391.0,BAO_0000219,,
5321,16818,"Percent growth of NCI cell line, renal: 786-0 exposed for 48 hr at 10e-8 concentration",F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619278,391.0,BAO_0000219,,
5322,11970,Tested for cytotoxicity against 786-0 cell lines in renal cancer,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619279,391.0,BAO_0000219,,
5323,12400,Tested in vitro for cytotoxicity in 786-0 cell line of Renal cancer,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL858458,391.0,BAO_0000219,,
5324,12888,Cytotoxic effect on renal cancer line 786-0,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Expert,1,,CHEMBL619280,391.0,BAO_0000219,,
5325,15300,In vitro antitumor activity against Renal cancer 786-0 cell lines by 6-day assay,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619281,391.0,BAO_0000219,,
5326,14769,Compound was evaluated for in vitro activity against 786-0 kidney cell lines (Human tumor cells ),F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619282,391.0,BAO_0000219,,
5327,15895,"Cytotoxicity against NCI tumor panel, 786-0 renal cancer cell line",F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619283,391.0,BAO_0000219,,
5328,17376,Concentration of compound that cause 50% cytotoxicity of 786-0 renal cancer cell line,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619284,391.0,BAO_0000219,,
5329,14882,Compound was tested for antitumor activity against 786-0 renal cancer cell line(molar concentration that inhibits 50% net cell growth).,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619285,391.0,BAO_0000219,,
5330,14882,Compound was tested for antitumor activity against 786-0 renal cancer cell line(molar concentration leading to 50% net cell death),F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619286,391.0,BAO_0000219,,
5331,15176,Growth inhibition of the 786-O Renal cancer cell line for 2-day in vitro assay.,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619287,391.0,BAO_0000219,,
5332,12696,In vitro anti tumor activity against human tumor Renal cancer cell lines was determined,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL857455,391.0,BAO_0000219,,
5333,2496,The compound was tested in vitro for cytotoxic activity against 786-O cell line (human perirenal carcinoma),F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL883801,391.0,BAO_0000219,,
5334,11831,Tested for cytotoxicity against antigen positive 791T osteosarcoma cells having only 3-5% antigen expression,F,,,Homo sapiens,9606.0,,,791T cell line,,80641,N,1,Intermediate,1,,CHEMBL619288,972.0,BAO_0000219,,
5335,11831,Tested for cytotoxicity against antigen positive 791T osteosarcoma cells having only 3-5% antigen expression (49% inhibition achieved at 100 micro g/mL),F,,,Homo sapiens,9606.0,,,791T cell line,,80641,N,1,Intermediate,1,,CHEMBL619289,972.0,BAO_0000219,,
5336,11831,Tested for cytotoxicity against antigen positive 791T osteosarcoma cells having only 3-5% antigen expression; <20% inhibition achieved,F,,,Homo sapiens,9606.0,,,791T cell line,,80641,N,1,Intermediate,1,,CHEMBL619290,972.0,BAO_0000219,,
5337,11831,Tested for cytotoxicity against antigen positive 791T osteosarcoma cells of conjugate AH1.11 (Type H1: MSR-33),F,,,Homo sapiens,9606.0,,,791T cell line,,80641,N,1,Intermediate,1,,CHEMBL619291,972.0,BAO_0000219,,
5338,11831,Tested for cytotoxicity against antigen positive 791T osteosarcoma cells of conjugate AH1.11 (Type H2: MSR-26),F,,,Homo sapiens,9606.0,,,791T cell line,,80641,N,1,Intermediate,1,,CHEMBL619292,972.0,BAO_0000219,,
5339,11831,Tested for cytotoxicity against antigen positive 791T osteosarcoma cells of conjugate AH1.11 (Type H3: MSR-28); <20% inhibition achieved,F,,,Homo sapiens,9606.0,,,791T cell line,,80641,N,1,Intermediate,1,,CHEMBL619293,972.0,BAO_0000219,,
5340,11831,Tested for cytotoxicity against antigen positive 791T osteosarcoma cells of conjugate H1.11 (Type H1: MSR-33),F,,,Homo sapiens,9606.0,,,791T cell line,,80641,N,1,Intermediate,1,,CHEMBL619294,972.0,BAO_0000219,,
5341,11831,Tested for cytotoxicity against antigen positive 791T osteosarcoma cells of conjugate H1.11 (Type H2: MSR-26),F,,,Homo sapiens,9606.0,,,791T cell line,,80641,N,1,Intermediate,1,,CHEMBL619295,972.0,BAO_0000219,,
5342,11831,Tested for cytotoxicity against antigen positive 791T osteosarcoma cells of conjugate H1.11 (Type H2: MSR-26) (less than 20% inhibition achieved),F,,,Homo sapiens,9606.0,,,791T cell line,,80641,N,1,Intermediate,1,,CHEMBL619296,972.0,BAO_0000219,,
5343,11831,Tested for cytotoxicity against antigen positive 791T osteosarcoma cells of conjugate H1.11 (Type H3: MSR-28); <20% inhibition achieved,F,,,Homo sapiens,9606.0,,,791T cell line,,80641,N,1,Intermediate,1,,CHEMBL619297,972.0,BAO_0000219,,
5344,12782,Growth inhibitory concentration against tumor cells in culture renal cancer 796-0 cell line,F,,,Homo sapiens,9606.0,,,786-0,,80640,N,1,Intermediate,1,,CHEMBL619298,391.0,BAO_0000219,,
5345,1229,In vitro anticancer activity against 8 NCI CNS cancer cell lines; inactive,F,,,,,,,,,22226,U,0,Intermediate,1,,CHEMBL619299,,BAO_0000019,,
5346,15313,Inhibition of cell growth in drug resistant 8226 myeloma cell line,F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Expert,1,,CHEMBL619300,741.0,BAO_0000219,,
5347,15313,Inhibition of cell growth in drug sensitive 8226 myeloma cell line,F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Expert,1,,CHEMBL619301,741.0,BAO_0000219,,
5348,11544,In vitro inhibition of tumor cell growth in the human myeloma 8226 system.,F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL619302,741.0,BAO_0000219,,
5349,9424,Effect on DNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.01 ug/mL,F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL619303,741.0,BAO_0000219,,
5350,9424,Effect on DNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.1 ug/mL,F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL619304,741.0,BAO_0000219,,
5351,9424,Effect on DNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.1 ug/mL (*: >50% cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL857706,741.0,BAO_0000219,,
5352,9424,Effect on DNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.3 ug/mL (*: >50% cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL619305,741.0,BAO_0000219,,
5353,9424,Effect on DNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.5 ug/mL. (*: >1 log cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL619306,741.0,BAO_0000219,,
5354,9424,Effect on DNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 10 ug/mL (*: >1 log cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL619307,741.0,BAO_0000219,,
5355,9424,Effect on DNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 10 ug/mL (*: >1 log cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL619308,741.0,BAO_0000219,,
5356,9424,Effect on DNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 1 ug/mL. (*: >50% cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL619309,741.0,BAO_0000219,,
5357,9424,Effect on DNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 1 ug/mL. (*: >1 log cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL619310,741.0,BAO_0000219,,
5358,14769,Compound was evaluated for in vitro activity against A498 kidney cell lines (Human tumor cells ),F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL619311,624.0,BAO_0000219,,
5359,15354,Compound was tested for the growth inhibition of A498 renal tumor cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL619312,624.0,BAO_0000219,,
5360,17445,In vitro cytotoxicity against human tumor A498 cell line (renal cancer),F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL619313,624.0,BAO_0000219,,
5361,4337,In vitro inhibitory concentration against renal cancer cell line A498,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL619314,624.0,BAO_0000219,,
5362,15277,Cytotoxicity against A 498 tumor cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL619959,624.0,BAO_0000219,,
5363,4812,In vitro antitumor activity against A498 human cancer cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL619960,624.0,BAO_0000219,,
5364,4812,In vitro antitumor activity against A498 human cancer cell line (Data from NCI-screening),F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL619961,624.0,BAO_0000219,,
5365,4995,Inhibitory dose required against A498 human tumor cell lines,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL619962,624.0,BAO_0000219,,
5366,5847,Anticancer activity against one renal cancer (A498 cell line),F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL875586,624.0,BAO_0000219,,
5367,6557,In vitro cytotoxicity against melanoma A498 cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL619963,624.0,BAO_0000219,,
5368,2597,Compound was tested for growth inhibitory activity against A498 cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL619964,624.0,BAO_0000219,,
5369,6058,Compound tested for growth inhibition of renal cancer cell line A498,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL620108,624.0,BAO_0000219,,
5370,17708,Compound was tested for 50% growth inhibition against human renal cancer A498 cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL620109,624.0,BAO_0000219,,
5371,15176,Growth inhibition of the A498 Renal cancer cell line for 2-day in vitro assay.,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL620110,624.0,BAO_0000219,,
5372,15300,In vitro antitumor activity against Renal cancer A498 cell lines by 6-day assay,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL620111,624.0,BAO_0000219,,
5373,11970,Tested for cytotoxicity against A498 cell lines in renal cancer,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL620112,624.0,BAO_0000219,,
5374,12400,Tested in vitro for cytotoxicity in A498 cell line of Renal cancer,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL620113,624.0,BAO_0000219,,
5375,12888,Cytotoxic effect on renal cancer lines A498,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Expert,1,,CHEMBL620114,624.0,BAO_0000219,,
5376,3030,Antitumor activity was evaluated for reduction of growth of renal cancer (A498) cells at a concentration of 100 uM,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL620115,624.0,BAO_0000219,,
5377,14769,Compound was evaluated for in vitro activity against A498 kidney cell lines (Human tumor cells ),F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL620116,624.0,BAO_0000219,,
5378,17376,Concentration of compound that cause 50% cytotoxicity of A498 renal cancer cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL620117,624.0,BAO_0000219,,
5379,16558,Growth inhibitory activity against A498-2LM human solid tumor cell line using MTT assay,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL620118,624.0,BAO_0000219,,
5380,5194,Cytotoxicity against human kidney carcinoma cell lines A4982LM,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL620119,624.0,BAO_0000219,,
5381,10708,Evaluated for the inhibitory concentration required to cause growth inhibition of A498Rem- renal cell line using the MTT Cytotoxicity Assay,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL620120,624.0,BAO_0000219,,
5382,16880,Antiproliferative activity in vitro against A549 (human non-small lung carcinoma) cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620121,646.0,BAO_0000219,,
5383,10196,Antitumor activity against A549 human lung carcinoma cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620122,646.0,BAO_0000219,,
5384,10196,Antitumor activity against A549 human lung carcinoma cell line in experiment 1,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620123,646.0,BAO_0000219,,
5385,10196,Antitumor activity against A549 human lung carcinoma cell line in experiment 2,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620124,646.0,BAO_0000219,,
5386,12083,"Concentration required to inhibit tumor growth in A549, human lung carcinoma (NSCLC) cell line",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620125,646.0,BAO_0000219,,
5387,16464,Cytotoxicity against A549 nonsmall lung cell line using MTT colorimetric assay,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620126,646.0,BAO_0000219,,
5388,16464,Cytotoxicity against A549 nonsmall lung cell line using MTT colorimetric assay; NE is no effect at 1x 10 E-5,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL883027,646.0,BAO_0000219,,
5389,16470,In vitro cytotoxic activity against human lung A549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620127,646.0,BAO_0000219,,
5390,16470,In vitro cytotoxic activity against human lung A549 cell line ( standard deviation in parenthesis),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620128,646.0,BAO_0000219,,
5391,16470,In vitro cytotoxic activity against human lung A549 cell line),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620129,646.0,BAO_0000219,,
5392,16470,In vitro cytotoxic activity against human lung A549 cell line;NT is not tested,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620130,646.0,BAO_0000219,,
5393,16582,In vitro cytotoxicity against human non small-cell-lung cell line A549.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620131,646.0,BAO_0000219,,
5394,15935,"In vitro growth inhibition of human lung carcinoma cell line, A549 with low levels of folate receptors",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620132,646.0,BAO_0000219,,
5395,15935,"In vitro growth inhibition of human lung carcinoma cell line, A549 with low levels of folate receptors in folate deficient medium",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620133,646.0,BAO_0000219,,
5396,16597,Inhibition of A549 human lung carcinoma cell proliferation,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620134,646.0,BAO_0000219,,
5397,17376,Inhibitory activity against A549 lung adenocarcinoma cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620135,646.0,BAO_0000219,,
5398,16496,Inhibitory concentration required to reduce A549 tumor cell growth by 50% in MTT assay,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620136,646.0,BAO_0000219,,
5399,16152,in vitro anticancer activity against cultured A549 human tumor(lung) cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620137,646.0,BAO_0000219,,
5400,16152,in vitro inhibition of tumor cell growth in cultured A549 human tumor cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620268,646.0,BAO_0000219,,
5401,16464,Cytotoxicity against A549 nonsmall lung cell line using MTT colorimetric assay; NE is no effect at 1x 10 E-5,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620269,646.0,BAO_0000219,,
5402,2288,Cytotoxicity was evaluated against A549 non-small cell lung carcinoma human cancer cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620270,646.0,BAO_0000219,,
5403,17350,Compound was tested for antiproliferative activity against human A549 cancer cell lines using MTT assay,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620271,646.0,BAO_0000219,,
5404,4090,Inhibition of A549 cancer cell proliferation,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620272,646.0,BAO_0000219,,
5405,4090,Inhibition of A549 cancer cell proliferation (Not tested),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620273,646.0,BAO_0000219,,
5406,17350,Compound was tested for antiproliferative activity against human A549 cancer cell lines using MTT assay,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620274,646.0,BAO_0000219,,
5407,4197,In vitro inhibitory concentration required against human lung A549 carcinoma cells proliferation,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620275,646.0,BAO_0000219,,
5408,17072,Antiproliferative potency determined as inhibitory concentration against A549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620276,646.0,BAO_0000219,,
5409,17072,Percent assembly of bovine brain tubulin induced by compound at 10 uM versus that caused by 10 uM paclitaxel,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620277,646.0,BAO_0000219,,
5410,5194,Cytotoxicity against Renal cell lines A549 was determined,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620278,646.0,BAO_0000219,,
5411,4257,Area under curve was determined in dog after a 3 mg/kg of oral dose,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL620279,,BAO_0000218,,
5412,6123,Area under curve was determined in dog after oral administration at 1 mg/kg,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL620280,,BAO_0000218,,
5413,1337,Area under curve was determined in dogs after oral administration (10 mg/kg) as a 0.05 M citric acid solution.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL620281,,BAO_0000218,,
5414,1337,Area under curve was determined in dogs after oral administration (8 mg/kg) as a 0.05 M citric acid solution.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL620282,,BAO_0000218,,
5415,8833,Area under increased blood flow curve (AUC) at 1 microg ia at a duration of ( 0-2 mins),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621134,,BAO_0000218,,
5416,8833,Area under increased blood flow curve (AUC) at 1 microg ia at a duration of ( 0-5 mins),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621135,,BAO_0000218,,
5417,8833,Area under increased blood flow curve (AUC) at 1 microg ia at a duration of (0-15 mins),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621136,,BAO_0000218,,
5418,8833,Area under increased blood flow curve (AUC) at 1 microg ia at a duration of( 0-120 mins),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621137,,BAO_0000218,,
5419,17657,Area under plasma concentration time curve in dog upon oral administration,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621138,,BAO_0000218,1969.0,
5420,17650,Area under plasma concentration time curve was measured in dogs after an oral dose of 10 uM/kg,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL875587,,BAO_0000218,1969.0,
5421,1977,Area under the curve for compound was evaluated in dog at a dose of 10 mg/kg.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621139,,BAO_0000218,,
5422,1977,Area under the curve for compound was evaluated in dog at a dose of 20 mg/kg.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621140,,BAO_0000218,,
5423,3132,Area under the curve for the compound was obtained when tested in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621141,,BAO_0000218,,
5424,5473,Area under the curve at a dose of 1 mg/kg,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621142,,BAO_0000218,,
5425,5474,Area under the curve at a dose of 1 mg/kg (oral),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621143,,BAO_0000218,,
5426,5474,Area under the curve at i.v. dose of 0.2 mg/kg,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621144,,BAO_0000218,,
5427,6062,Area under the curve was measured in dog after an iv dose of 1 mg/kg,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621145,,BAO_0000218,,
5428,4709,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621146,,BAO_0000218,,
5429,2652,Compound was evaluated for area under curve (total concentration) in dogs at a dose of 1 mpk perorally,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622567,,BAO_0000218,,
5430,2652,Compound was evaluated for area under curve (total concentration) in dogs at a dose of 5 mpk perorally,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622568,,BAO_0000218,,
5431,2877,Compound was evaluated for area under the curve in dog blood.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622569,,BAO_0000218,,
5432,5444,In vivo area under curve was calculated by peroral administration at 1 mg/kg in fasted dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622570,,BAO_0000218,,
5433,5130,AUC in dog after oral dose (1 mg/kg),A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL622571,,BAO_0000218,1969.0,
5434,6265,Pharmacokinetic (PK) property (AUC) was determined in dog at the single oral dose of 1 mg/kg,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622572,,BAO_0000218,,
5435,4657,"Pharmacokinetic data in dogs at dose of 1 mg/kg perorally, and the area under curve (AUC) was reported.",A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622573,,BAO_0000218,,
5436,16367,Pharmacokinetic parameter AUC after intravenous administration to dogs,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622574,,BAO_0000218,,
5437,16367,Pharmacokinetic parameter AUC after oral administration to dogs,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622575,,BAO_0000218,,
5438,9579,Pharmacokinetic parameter AUC was determined in dog after oral administration of 17b,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622576,,BAO_0000218,,
5439,9579,Pharmacokinetic parameter AUC was determined in dog after oral administration of 2b,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622577,,BAO_0000218,,
5440,5983,Pharmacokinetic property (AUC) was measured in dog at the dose of 0.032 mg/kg p.o.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622578,,BAO_0000218,,
5441,6241,Pharmacokinetic property in dogs after oral administration at 1 mg/kg,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622579,,BAO_0000218,,
5442,5313,"Tested for the pharmacokinetic data, area under the curve of concentration versus time in dog",A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622580,,BAO_0000218,,
5443,5313,"Tested for the pharmacokinetic data, area under the curve of concentration versus time in dog at dosage of 10 mpk",A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622581,,BAO_0000218,,
5444,6642,Oral AUCN in dog ( (dosed as a mixture of five compounds at 0.5 mpk each via iv only),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622582,,BAO_0000218,,
5445,6642,Oral AUCN in dog (dosed as a mixture of five compounds at 0.5 mpk each via iv only),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622583,,BAO_0000218,,
5446,6641,Oral AUCN in dog (dosed at 0.5 mpk iv ),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622584,,BAO_0000218,,
5447,6642,Oral AUCN in dog (dosed at 0.5 mpk iv ),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622585,,BAO_0000218,,
5448,17791,Compound was evaluated for oral bioavailability in dog; 90-100,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622586,,BAO_0000218,,
5449,17655,Compound was tested for its cell permeability in the Madin-Darby canine kidney cell monolayer transport assay,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623281,,BAO_0000218,,
5450,17655,Compound was tested for its cell permeability in the Madin-Darby canine kidney cell monolayer transport assay; Not determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623282,,BAO_0000218,,
5451,6596,PAPP (membrane permeability) in dog kidney cell monolayer assay,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623283,,BAO_0000218,,
5452,3880,Oral bioavailability in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623284,,BAO_0000218,,
5453,16367,Bioavailability administered orally at a dose of 10 mg/kg to dogs,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623285,,BAO_0000218,,
5454,17409,Plasma protein binding towards dog plasma at 10 uM,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL623463,,BAO_0000218,1969.0,
5455,17409,Plasma protein binding towards dog plasma at 100 uM,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL875952,,BAO_0000218,1969.0,
5456,2959,Bioavailability in dog (dose 4 mg/kg p.o.),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621705,,BAO_0000218,,
5457,13501,Bioavailability was determined after oral administration of compound 18 at a dose of 2 mg/kg to dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621706,,BAO_0000218,,
5458,4527,Bioavailability by oral administration at a dose of 10 uM/kg in dog was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621707,,BAO_0000218,,
5459,15145,Bioavailability in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621708,,BAO_0000218,,
5460,4219,Bioavailability,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621709,,BAO_0000218,,
5461,17538,Oral bioavailability in dog (dose 10 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621710,,BAO_0000218,,
5462,17538,Bioavailability in dog after po administration at a dose of 10 mg/kg; nd is not determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621711,,BAO_0000218,,
5463,1466,Bioavailability in dog (dose 10.0 mg/kg p.o.),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621712,,BAO_0000218,,
5464,17650,Bioavailability was measured in dogs after an oral dose of 10 uM/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621713,,BAO_0000218,,
5465,3132,Bioavailability was obtained by the comparison of AUC of intravenous dosing and AUC of oral dosing in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621714,,BAO_0000218,,
5466,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice kidney upon intraveneous administration at 2.6 gmol/mice after 3 hour,A,,,Mus sp.,10095.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621715,,BAO_0000218,,
5467,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice liver upon intraveneous administration at 2.6 gmol/mice after 1 hour,A,,,Mus sp.,10095.0,,Liver,,,22224,U,0,Autocuration,1,,CHEMBL623717,,BAO_0000218,2107.0,
5468,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice liver upon intraveneous administration at 2.6 gmol/mice after 24 hour,A,,,Mus sp.,10095.0,,Liver,,,22224,U,0,Autocuration,1,,CHEMBL623718,,BAO_0000218,2107.0,
5469,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice liver upon intraveneous administration at 2.6 gmol/mice after 3 hour,A,,,Mus sp.,10095.0,,Liver,,,22224,U,0,Autocuration,1,,CHEMBL623719,,BAO_0000218,2107.0,
5470,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice lungs upon intraveneous administration at 2.6 gmol/mice after 1 hour,A,,,Mus sp.,10095.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623720,,BAO_0000218,,
5471,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice lungs upon intraveneous administration at 2.6 gmol/mice after 3 hour,A,,,Mus sp.,10095.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623721,,BAO_0000218,,
5472,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice muscle upon intraveneous administration at 2.6 gmol/mice after 1 hour,A,,,Mus sp.,10095.0,,Muscle tissue,,,22224,U,0,Autocuration,1,,CHEMBL623722,,BAO_0000218,2385.0,
5473,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice muscle upon intraveneous administration at 2.6 gmol/mice after 24 hour,A,,,Mus sp.,10095.0,,Muscle tissue,,,22224,U,0,Autocuration,1,,CHEMBL623723,,BAO_0000218,2385.0,
5474,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice muscle upon intraveneous administration at 2.6 gmol/mice after 3 hour,A,,,Mus sp.,10095.0,,Muscle tissue,,,22224,U,0,Autocuration,1,,CHEMBL618543,,BAO_0000218,2385.0,
5475,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice spleen upon intraveneous administration at 2.6 gmol/mice after 1 hour,A,,,Mus sp.,10095.0,,Spleen,,,22224,U,0,Autocuration,1,,CHEMBL618544,,BAO_0000218,2106.0,
5476,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice spleen upon intraveneous administration at 2.6 gmol/mice after 3 hour,A,,,Mus sp.,10095.0,,Spleen,,,22224,U,0,Autocuration,1,,CHEMBL875155,,BAO_0000218,2106.0,
5477,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice upon intraveneous administration at 2.6 gmol/mice after 1 hour,A,,,Mus sp.,10095.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618545,,BAO_0000218,,
5478,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice upon intraveneous administration at 2.6 gmol/mice after 24 hour,A,,,Mus sp.,10095.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618546,,BAO_0000218,,
5479,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice upon intraveneous administration at 2.6 gmol/mice after 3 hour,A,,,Mus sp.,10095.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623529,,BAO_0000218,,
5480,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice uvea upon intraveneous administration at 2.6 gmol/mice after 24 hour,A,,,Mus sp.,10095.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623530,,BAO_0000218,,
5481,2413,Compound was evaluated for the biodistribution of tumor-imaging agent in B16 melanoma bearing mice uvea upon intraveneous administration at 2.6 gmol/mice after 3 hour,A,,,Mus sp.,10095.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621764,,BAO_0000218,,
5482,17827,Compound (i.v.) was evaluated for elimination rate constants in brainstem of rhesus monkeys (Radiolabeled compound),A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621765,,BAO_0000019,,
5483,17827,Compound (i.v.) was evaluated for elimination rate constants in cerebellum of rhesus monkeys (Radiolabeled compound),A,,,Cercopithecidae,9527.0,,Cerebellum,,,22224,U,0,Autocuration,1,,CHEMBL621766,,BAO_0000019,2037.0,
5484,17827,Compound (i.v.) was evaluated for elimination rate constants in frontal cortex of rhesus monkey (Radiolabeled compound),A,,,Cercopithecidae,9527.0,,Frontal cortex,,,22224,U,0,Autocuration,1,,CHEMBL621767,,BAO_0000019,1870.0,
5485,17827,Compound (i.v.) was evaluated for elimination rate constants in jaw bone of rhesus monkeys; NA = not active (Radiolabeled compound),A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621768,,BAO_0000019,,
5486,17827,Compound (i.v.) was evaluated for elimination rate constants in striatum of rhesus monkey (Radiolabeled compound),A,,,Cercopithecidae,9527.0,,Striatum,,,22224,U,0,Autocuration,1,,CHEMBL621769,,BAO_0000019,2435.0,
5487,17827,Compound (i.v.) was evaluated for uptake rate constants in brainstem of rhesus monkeys (Radiolabeled compound),A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621770,,BAO_0000019,,
5488,17827,Compound (i.v.) was evaluated for uptake rate constants in cerebellum of rhesus monkeys (Radiolabeled compound),A,,,Cercopithecidae,9527.0,,Cerebellum,,,22224,U,0,Autocuration,1,,CHEMBL621771,,BAO_0000019,2037.0,
5489,17827,Compound (i.v.) was evaluated for uptake rate constants in frontal cortex of rhesus monkey (Radiolabeled compound),A,,,Cercopithecidae,9527.0,,Frontal cortex,,,22224,U,0,Autocuration,1,,CHEMBL621772,,BAO_0000019,1870.0,
5490,17827,Compound (i.v.) was evaluated for uptake rate constants in jaw bone of rhesus monkey (Radiolabeled compound),A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621773,,BAO_0000019,,
5491,17827,Compound (i.v.) was evaluated for uptake rate constants in striatum of rhesus monkeys (Radiolabeled compound),A,,,Cercopithecidae,9527.0,,Striatum,,,22224,U,0,Autocuration,1,,CHEMBL621774,,BAO_0000019,2435.0,
5492,17791,Compound was evaluated for oral bioavailability in rats,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621775,,BAO_0000218,,
5493,17667,Maximum concentration of compound found in plasma at 5 mg/kg after oral administration,A,In vivo,,Cercopithecidae,9527.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL621776,,BAO_0000218,1969.0,
5494,17791,Half life period was evaluated in monkey,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621777,,BAO_0000019,,
5495,110,Half-life in rhesus monkeys by intravenous administration of dose,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL875162,,BAO_0000218,,
5496,5781,AUC (0-6 hr) after oral administration at 30 mg/kg in ICR mouse,A,,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL621778,,BAO_0000218,1969.0,
5497,17734,AUC after intraperitoneal administration of 100 mg/kg in mice,A,,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL621779,,BAO_0000218,1969.0,
5498,17718,AUC value was determined after oral administration,A,,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL622479,,BAO_0000218,1969.0,
5499,4573,Area under curve (AUC) determined at a dose 10 mg/kg administered intraperitoneally to mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622480,,BAO_0000218,,
5500,3277,Area under curve (AUC) was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622481,,BAO_0000218,,
5501,2862,Area under curve by ioral administration in mouse,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622482,,BAO_0000218,,
5502,2862,Area under curve by iv administration in mouse,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622483,,BAO_0000218,,
5503,5951,Area under curve at 0-8 hr in IRC mice after peroral administration,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622484,,BAO_0000218,,
5504,17729,Area under curve when injected i.p. in mice at a dose of 50 mg/kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622641,,BAO_0000218,,
5505,17728,Area under curve when injected intraperitoneally in BALB/C mice at a dose of 20 mg/kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622642,,BAO_0000218,,
5506,17728,Area under curve when injected intravenously in BALB/C mice at a dose of 20 mg/kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622643,,BAO_0000218,,
5507,17729,Area under curve when injected intravenously in mice at a dose of 20 mg/kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622644,,BAO_0000218,,
5508,9424,Effect on RNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.01 ug/mL,F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL622645,741.0,BAO_0000219,,
5509,9424,Effect on RNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.1 ug/mL,F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL622646,741.0,BAO_0000219,,
5510,9424,Effect on RNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.1 ug/mL (*: >50% cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL621238,741.0,BAO_0000219,,
5511,9424,Effect on RNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.3 ug/mL (*: >50% cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL621239,741.0,BAO_0000219,,
5512,9424,Effect on RNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.5 ug/mL. (*: >1 log cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL621240,741.0,BAO_0000219,,
5513,9424,Effect on RNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 10 ug/mL (*: >1 log cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL621241,741.0,BAO_0000219,,
5514,9424,Effect on RNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 1 ug/mL. (*: >50% cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL621242,741.0,BAO_0000219,,
5515,9424,Effect on RNA synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 1 ug/mL. (*: >1 log cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL620350,741.0,BAO_0000219,,
5516,9424,Effect on protein synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.01 ug/mL,F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL620351,741.0,BAO_0000219,,
5517,9424,Effect on protein synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.1 ug/mL,F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL620352,741.0,BAO_0000219,,
5518,9424,Effect on protein synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.1 ug/mL (*: >50% cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL620353,741.0,BAO_0000219,,
5519,9424,Effect on protein synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.3 ug/mL (*: >50% cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL620354,741.0,BAO_0000219,,
5520,9424,Effect on protein synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 0.5 ug/mL. (*: >1 log cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL620355,741.0,BAO_0000219,,
5521,9424,Effect on protein synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 10 ug/mL (*: >1 log cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL620356,741.0,BAO_0000219,,
5522,9424,Effect on protein synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 1 ug/mL. (*: >50% cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL620357,741.0,BAO_0000219,,
5523,9424,Effect on protein synthesis was determined by incorporation of radioligand into 8226 human myeloma cells at a concentration of 1 ug/mL. (*: >1 log cell kill),F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL620358,741.0,BAO_0000219,,
5524,9424,In vitro inhibition of human 8226 myeloma tumor cell line growth.,F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Expert,1,,CHEMBL620359,741.0,BAO_0000219,,
5525,11544,In vitro inhibition of tumor cell growth in the human myeloma 8226/ADR system.,F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL620360,741.0,BAO_0000219,,
5526,17378,Cytotoxicity of compound against 8226/DOX1V cells,F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL620361,741.0,BAO_0000219,,
5527,17378,Cytotoxicity of compound against 8226/S cells,F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL620362,741.0,BAO_0000219,,
5528,17079,Inhibitory concentration against 8226 myeloma cancer cell line,F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL620363,741.0,BAO_0000219,,
5529,17079,Inhibitory concentration against 8226/Dox40 (Dox-Re) cancer cell line,F,,,Homo sapiens,9606.0,,,RPMI-8226,,80433,N,1,Intermediate,1,,CHEMBL620364,741.0,BAO_0000219,,
5530,13466,Inhibition of cell growth was studied in human teratocarcinoma (833K).,F,,,Homo sapiens,9606.0,,,833K,,80647,N,1,Intermediate,1,,CHEMBL620365,854.0,BAO_0000219,,
5531,13466,Inhibition of cell growth was studied in human teratocarcinoma (833K); ND ='not determined',F,,,Homo sapiens,9606.0,,,833K,,80647,N,1,Intermediate,1,,CHEMBL620366,854.0,BAO_0000219,,
5532,2392,Tested in vitro for growth inhibitory activity against 833K (human teratorcarcinoma) cells,F,,,Homo sapiens,9606.0,,,833K,,80647,N,1,Expert,1,,CHEMBL620367,854.0,BAO_0000219,,
5533,2392,The compound was tested in vitro for growth inhibitory activity against 833K (human teratorcarcinoma) cells; No data,F,,,Homo sapiens,9606.0,,,833K,,80647,N,1,Intermediate,1,,CHEMBL620368,854.0,BAO_0000219,,
5534,6608,Inhibitory activity against caspase-1,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL620369,,BAO_0000019,,
5535,10199,Percent inhibition of DAla-DAla Ligase at 10e -3 M of the compound,B,,,Enterococcus faecalis,1351.0,,,,,45,H,8,Autocuration,1,,CHEMBL620370,,BAO_0000357,,
5536,17749,In vitro antiproliferative activity against 8701-BC human breast cancer cells at a concentration of (0-100 uM) for 72 hr using MTT assay,F,,,Homo sapiens,9606.0,,,8701-BC,,80648,N,1,Intermediate,1,,CHEMBL620371,705.0,BAO_0000219,,
5537,17749,In vitro antiproliferative activity against 8701-BC human breast cancer cells at a concentration of (0-100 uM,F,,,Homo sapiens,9606.0,,,8701-BC,,80648,N,1,Intermediate,1,,CHEMBL620372,705.0,BAO_0000219,,
5538,1229,In vitro anticancer activity against 9 NCI colon cancer cell lines; inactive,F,,,,,,,,,22226,U,0,Intermediate,1,,CHEMBL876492,,BAO_0000019,,
5539,1229,In vitro anticancer activity against 9 NCI melanoma cell lines; inactive,F,,,,,,,,,22226,U,0,Intermediate,1,,CHEMBL620373,,BAO_0000019,,
5540,1229,In vitro anticancer activity against 9 NCI renal cancer cell lines; inactive,F,,,,,,,,,22226,U,0,Intermediate,1,,CHEMBL620374,,BAO_0000019,,
5541,6390,Inhibitory activity was determined against 9-cis-epoxycarotenoid dioxygenase (NCED) expressed in Escherichia coli in presence of 9''-cis-neo-xanthin,B,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL620375,,BAO_0000019,,
5542,16219,Minimum inhibitory concentration against Streptococcus pyogenes 930MLSB,F,,,Streptococcus pyogenes,1314.0,,,,,22226,U,0,Autocuration,1,,CHEMBL857902,,BAO_0000019,,
5543,16219,Minimum inhibitory concentration against Streptococcus pyogenes 930MLSB,F,,,Streptococcus pyogenes,1314.0,,,,,22226,U,0,Autocuration,1,,CHEMBL620376,,BAO_0000019,,
5544,17043,Percent inhibition against Cdc25C phosphatase at 50 uM of compound,B,,,,,,,,,11922,H,8,Autocuration,1,,CHEMBL620377,,BAO_0000357,,
5545,6929,Tested for in vitro cytotoxic potency of compound in 9KB assay,F,,,Homo sapiens,9606.0,,,KB ,,81115,N,1,Intermediate,1,,CHEMBL620378,324.0,BAO_0000219,,
5546,6929,Tested for in vitro cytotoxic potency of compound in 9KB assay,A,,,Homo sapiens,9606.0,,,KB ,,81115,N,1,Intermediate,1,,CHEMBL620379,324.0,BAO_0000219,,
5547,7083,In vitro cytotoxicity of compound was tested against 9KB cells.,F,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL620380,,BAO_0000219,,
5548,12446,Cytotoxic concentration against 9L cells was determined on day 3,F,,,Rattus norvegicus,10116.0,,,9L,,80653,N,1,Intermediate,1,,CHEMBL884006,392.0,BAO_0000219,,
5549,15345,Tested in vitro for anticancer activity against 9L cells,F,,,Rattus norvegicus,10116.0,,,9L,,80653,N,1,Expert,1,,CHEMBL620381,392.0,BAO_0000219,,
5550,15345,Tested in vitro for anticancer activity against 9L cells; Not determined,F,,,Rattus norvegicus,10116.0,,,9L,,80653,N,1,Expert,1,,CHEMBL620382,392.0,BAO_0000219,,
5551,6301,In vitro inhibitory activity against human A549 non-small cell lung tumor; Active,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620383,646.0,BAO_0000219,,
5552,4833,The compound was tested in vitro for its cytotoxicity against human A-549 cancer cell line by MTT method at 1 uM concentration; No inhibition,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL876493,646.0,BAO_0000219,,
5553,4833,The compound was tested in vitro for its cytotoxicity against human A-549 cancer cell line by MTT method at 1 uM concentration; Significant inhibition,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620384,646.0,BAO_0000219,,
5554,4833,The compound was tested in vitro for its cytotoxicity against human A-549 cancer cell line by MTT method at 1 uM concentration; Slight inhibition,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620385,646.0,BAO_0000219,,
5555,13330,Cytotoxicity against human lung carcinoma A549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620386,646.0,BAO_0000219,,
5556,17517,Ability to induce human IL-6 assay in A549 lung carcinoma cell line.,F,,,Homo sapiens,9606.0,,,A549,,25,D,9,Expert,1,,CHEMBL620387,646.0,BAO_0000219,,
5557,17517,"Ability to induce human IL-6 assay in A549 lung carcinoma cell line; n.r.: not reported, EC50 values not reported in cases were %dex e 35%.",F,,,Homo sapiens,9606.0,,,A549,,25,D,9,Expert,1,,CHEMBL621404,646.0,BAO_0000219,,
5558,14425,"In vitro growth inhibition of A549, lung carcinoma",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621405,646.0,BAO_0000219,,
5559,14425,"In vitro growth inhibition of A549, lung carcinoma.",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621406,646.0,BAO_0000219,,
5560,5228,In vitro cytotoxicity against A549 (human lung carcinoma) cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL621407,646.0,BAO_0000219,,
5561,5351,Cytotoxic activity against human lung cancer A549 cell line was determined,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621408,646.0,BAO_0000219,,
5562,12198,Cytotoxicity against human solid tumor lung carcinoma A549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL885345,646.0,BAO_0000219,,
5563,13891,Cytotoxicity concentration against human lung carcinoma A-549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621409,646.0,BAO_0000219,,
5564,5677,Cytotoxicity in A549 (human carcinoma) cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL876034,646.0,BAO_0000219,,
5565,13788,Cytotoxicity on lung carcinoma (A-549) cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621410,646.0,BAO_0000219,,
5566,13384,Effective dose against 50% reduction in Human lung carcinoma (A-549) cell number after 3-day incubation.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL621411,646.0,BAO_0000219,,
5567,6726,Effective dose of compound against replication of A549 cell line was evaluated,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621412,646.0,BAO_0000219,,
5568,3455,In vitro cytotoxic activity was determined against lung carcinoma (A549) cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL621413,646.0,BAO_0000219,,
5569,5726,In vitro cytotoxicity evaluated against human lung cancer (A549 cell line),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621414,646.0,BAO_0000219,,
5570,5726,In vitro cytotoxicity evaluated against human lung cancer (A549 cell line); NA is not active,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621415,646.0,BAO_0000219,,
5571,3936,The compound was evaluated for antiproliferative activity against A549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621416,646.0,BAO_0000219,,
5572,14991,The compound was tested for tumor cell growth inhibitory activity against human lung carcinoma (A549) cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621417,646.0,BAO_0000219,,
5573,5243,Concentration required for growth inhibition of human lung carcinoma cell line A549,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621418,646.0,BAO_0000219,,
5574,12858,Cytotoxic activity against A549/ATCC non-small cell-lung cancer cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621419,646.0,BAO_0000219,,
5575,6776,Growth inhibition against A549 cell line was evaluated,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621420,646.0,BAO_0000219,,
5576,16558,Growth inhibitory activity against A549 human solid tumor cell line using MTT assay,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL875823,646.0,BAO_0000219,,
5577,4583,Inhibition of anchorage independent growth of human tumor cell line A549 K-ras-transformed in soft agar,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL621421,646.0,BAO_0000219,,
5578,13514,Inhibitor activity against A549 (Human lung carcinoma)cell line with varying concentration of the drug for 72 hrs,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621422,646.0,BAO_0000219,,
5579,15166,Chemosensitivity against DT-diaphorase rich A549 cell lines,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL884014,646.0,BAO_0000219,,
5580,13873,Compound tested against A549 lung carcinoma in the sulforhodamine B assay.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621423,646.0,BAO_0000219,,
5581,6447,In vitro cytotoxicity against human A549 (lung cancer) cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL621424,646.0,BAO_0000219,,
5582,2068,In vitro antitumor activity against A549 (lung) human tumor cell lines.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621425,646.0,BAO_0000219,,
5583,1863,In vitro cytotoxic activity against human lung carcinoma A549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL621426,646.0,BAO_0000219,,
5584,13873,Compound was tested against A549 lung cancer cell line in the sulforhodamine B assay.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621427,646.0,BAO_0000219,,
5585,13873,Compound was tested against A549 lung carcinoma cell line in the sulforhodamine B assay.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621428,646.0,BAO_0000219,,
5586,13873,Tested against A549 lung carcinoma in the sulforhodamine B assay.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL621429,646.0,BAO_0000219,,
5587,579,Compound was tested for cytotoxicity on A549 lung adenocarcinoma cell line using a proliferation assay (MTT reduction),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621430,646.0,BAO_0000219,,
5588,579,Compound was tested for cytotoxicity on A549 lung adenocarcinoma cell line using a proliferation assay (MTT reduction).,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621431,646.0,BAO_0000219,,
5589,4584,Compound was tested for inhibition of growth of human lung carcinoma cell line A549 up to a conc of 10 uM; NI means no inhibition,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621432,646.0,BAO_0000219,,
5590,5421,Inhibition of NFkB (transcription factor) activation in A549 human lung carcinoma cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL621433,646.0,BAO_0000219,,
5591,5421,Compound was tested for its ability to inhibit tumor necrosis factor alpha (TNF alpha) induced apoptosis in A549 human lung carcinoma cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL875824,646.0,BAO_0000219,,
5592,5421,Compound was tested for its ability to inhibit tumor necrosis factor alpha (TNF alpha) induced apoptosis in A549 human lung carcinoma cell line at 20 uM concentration,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621434,646.0,BAO_0000219,,
5593,5421,Compound was tested for its ability to inhibit tumor necrosis factor alpha (TNF alpha) induced apoptosis in A549 human lung carcinoma cell line; NA=Not assayed,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621435,646.0,BAO_0000219,,
5594,14188,Compound was tested for potency against human lung A549 cells using sulforhodamine B assay.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621436,646.0,BAO_0000219,,
5595,14188,Compound was tested for potency against human lung A549 cells using sulforhodamine B assay; UA=Potency was so low that the IC50 was unachievable.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621437,646.0,BAO_0000219,,
5596,15354,Compound was tested for the growth inhibition of A549 lung tumor cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621438,646.0,BAO_0000219,,
5597,14253,Growth inhibition of human non-small-lung carcinoma (A549) cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL621439,646.0,BAO_0000219,,
5598,13873,Compound was tested against A549 lung carcinoma cell line in the sulforhodamine B assay.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621440,646.0,BAO_0000219,,
5599,3043,Oral bioavailability in dog (conscious),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621441,,BAO_0000218,,
5600,3045,Compound was evaluated for the oral bioavailability after oral administration in dog.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621442,,BAO_0000218,,
5601,3022,Compound was tested for percent of oral bioavailability at 10 mg/ml dose in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621443,,BAO_0000218,,
5602,4453,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621444,,BAO_0000218,,
5603,1696,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625133,,BAO_0000218,,
5604,5045,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625134,,BAO_0000218,,
5605,5356,Oral bioavailability in dog (fasted),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625135,,BAO_0000218,,
5606,17764,Oral bioavailability after intravenous administration in dogs at 1.2 uM/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625136,,BAO_0000218,,
5607,6448,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625137,,BAO_0000218,,
5608,1475,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625138,,BAO_0000218,,
5609,3788,Percent bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625139,,BAO_0000218,,
5610,3639,Percent oral bioavailability of intravenously administered compound (6 mg/kg) was tested in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL872264,,BAO_0000218,,
5611,13397,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625140,,BAO_0000218,,
5612,2137,The compound was evaluated for bioavailability in dogs; 34-44,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624436,,BAO_0000218,,
5613,2959,Bioavailability in dog (dose 4 mg/kg p.o.),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624437,,BAO_0000218,,
5614,6448,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL872261,,BAO_0000218,,
5615,6084,8 hour trough Blood level in dog was measured after administration of compound,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624438,,BAO_0000218,,
5616,3639,The compound was tested for maximum concentration ( Cmax ) in dog plasma.,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL624439,,BAO_0000218,1969.0,
5617,6316,C24 after oral administration at 5 mg/kg,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624440,,BAO_0000218,,
5618,5238,Clearance after oral and iv dosing in dogs,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624441,,BAO_0000218,,
5619,17796,Clearance of the drug was measured in the plasma of dog,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL624442,,BAO_0000218,1969.0,
5620,2652,Compound was evaluated for Clearance in dogs at a dose of 1 mpk intravenously,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624443,,BAO_0000218,,
5621,5654,CL (clearance) of compound was determined after intravenous administration in average of two dogs at a dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624444,,BAO_0000218,,
5622,6621,Clearance of compound was determined in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624445,,BAO_0000218,,
5623,6505,Clearance on i.v. administration of 2 mg/kg was measured in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624446,,BAO_0000218,,
5624,5802,Clearance of compound after both po and iv administration at a dose of 5 mg/kg and 2 mg/kg resp in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624447,,BAO_0000218,,
5625,17267,Plasma clearance in dog was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624448,,BAO_0000218,,
5626,4521,Plasma clearance in dog after 2 mg/kg by oral and 0.5 mg/kg by intravenous administration; ND is not determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624449,,BAO_0000218,,
5627,6535,Plasma clearance in dog after administration of 0.25 mg/kg iv,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624450,,BAO_0000218,,
5628,6535,Plasma clearance in dog after administration of 1 mg/kg iv,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875942,,BAO_0000218,,
5629,6535,Plasma clearance in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624451,,BAO_0000218,,
5630,5542,Plasma clearance by iv administration in dog at a dose of 0.3 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624452,,BAO_0000218,,
5631,5199,Plasma clearance was determined in canine following intravenous (iv) administration of drug (1 mg/kg).,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624453,,BAO_0000218,,
5632,16907,Plasma clearance after 15 mg/kg iv dose in Dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624454,,BAO_0000218,,
5633,16907,Plasma clearance after 30 mg/kg po dose in Dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624455,,BAO_0000218,,
5634,16367,Plasma administration to dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624456,,BAO_0000218,,
5635,5505,Plasma clearance was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624457,,BAO_0000218,,
5636,6215,Systemic clearance after intravenous administration (0.5 mg/kg) was determined in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624458,,BAO_0000218,,
5637,1466,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624459,,BAO_0000218,,
5638,5007,Intrinsic clearance in human liver microsomes,A,In vitro,,Homo sapiens,9606.0,,Liver,,Microsomes,102164,S,2,Intermediate,1,,CHEMBL624460,,BAO_0000251,2107.0,
5639,5007,Intrinsic clearance in human liver microsomes,A,In vitro,,Homo sapiens,9606.0,,Liver,,Microsomes,102164,S,2,Intermediate,1,,CHEMBL624461,,BAO_0000251,2107.0,
5640,16452,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875943,,BAO_0000218,,
5641,16452,Pharmacokinetic data at 1 mg/kg dose given to dogs intravenously,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624462,,BAO_0000218,,
5642,16452,Clearance in dog (dose 1 mg/kg i.v.),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624463,,BAO_0000218,,
5643,6221,Plasma clearance after oral administration (2.5 mg/kg) in dog was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624464,,BAO_0000218,,
5644,5007,Plasma clearance in dogs administered perorally (5 mg/kg) and intravenously (2 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624465,,BAO_0000218,,
5645,5668,Plasma clearance after peroral administration at 10 mpk in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624466,,BAO_0000218,,
5646,5668,Plasma clearance after peroral administration at 5 mpk in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624467,,BAO_0000218,,
5647,5668,Plasma clearance after peroral administration at 5 mg/kg in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624468,,BAO_0000218,,
5648,15660,Plasma clearance was measured in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624469,,BAO_0000218,,
5649,15660,Plasma clearance was measured in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624470,,BAO_0000218,,
5650,5983,Pharmacokinetic property (CLtot) was measured in dog at the dose of 0.032 mg/kg i.v.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624471,,BAO_0000218,,
5651,5600,Total clearance was determined after 0.1 mg/kg iv administration in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624472,,BAO_0000218,,
5652,17764,Clearance of compound after intravenous administration in dogs at 1.2 uM/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622775,,BAO_0000218,,
5653,6039,Clearance after intravenous administration of 0.5 mg/kg in dog was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622776,,BAO_0000218,,
5654,6039,Clearance after intravenous administration of 1.0 mg/kg in dog was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622777,,BAO_0000218,,
5655,6039,Clearance after peroral administration of 0.2 mg/kg in dog was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622778,,BAO_0000218,,
5656,4368,Clearance by intravenous administration of 1.2 mg/kg in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622779,,BAO_0000218,,
5657,4305,Clearance by iv administration in dogs at a dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622780,,BAO_0000218,,
5658,1918,Clearance value was evaluated in dog plasma,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL622781,,BAO_0000218,1969.0,
5659,6005,Clearance was evaluated after i.v. administration in dog at a dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622782,,BAO_0000218,,
5660,4839,Compound was tested for plasma clearance in dog,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL622783,,BAO_0000218,1969.0,
5661,4239,Pharmacokinetic property (Plasma clearance) was measured in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622784,,BAO_0000218,,
5662,17729,Area under curve when injected perorally in mice at a dose of 50 mg/kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622785,,BAO_0000218,,
5663,17728,Area under curve when injected perorally in BALB/C mice at a dose of 50 mg/kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622786,,BAO_0000218,,
5664,5302,Area under curve value in mouse at a dose of 10 mg/kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622787,,BAO_0000218,,
5665,5506,Area under curve was determined at a dose of 100 mg/kg (i.p.) in Mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL875949,,BAO_0000218,,
5666,5506,Area under curve was determined at a dose of 200 mg/kg (i.p.) in Mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622788,,BAO_0000218,,
5667,17764,Area under curve was determined for compound after intraperitoneal administration in mice at 18 uM/kg,F,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622789,,BAO_0000218,,
5668,17764,Area under curve was determined for compound after intraperitoneal administration in mice at 23 uM/kg,F,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622790,,BAO_0000218,,
5669,17764,Area under curve was determined for compound after intraperitoneal administration in mice at 25 uM/kg,F,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622791,,BAO_0000218,,
5670,17764,Area under curve was determined for compound after intraperitoneal administration in mice at 26 uM/kg,F,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622792,,BAO_0000218,,
5671,17764,Area under curve was determined for compound after intravenous administration in mice at 24 uM/kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622793,,BAO_0000218,,
5672,17753,Area under curve was determined for the compound at 24 mg/Kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622794,,BAO_0000218,,
5673,17753,Area under curve was determined for the compound at 40 mg/Kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622795,,BAO_0000218,,
5674,17753,Area under curve was determined for the compound at 5 mg/Kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621803,,BAO_0000218,,
5675,3132,Area under the curve for the compound is obtained at dose 25 mg/kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621804,,BAO_0000218,,
5676,3132,Area under the curve for the compound was obtained when tested in mouse,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621805,,BAO_0000218,,
5677,17837,Area under the curve of compound in mouse blood following i.v. administration of 10 mg/kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621806,,BAO_0000218,,
5678,17837,Area under the curve of compound in mouse blood following p.o. administration of 30 mg/kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621807,,BAO_0000218,,
5679,6062,Area under the curve was measured in mouse after an iv dose of 1 mg/kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621808,,BAO_0000218,,
5680,4066,Area under the curve was determined for the compound at a single subcutaneous administration of 40 mg/kg in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621809,,BAO_0000218,,
5681,16597,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for area under curve (AUCtot),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621810,,BAO_0000218,,
5682,14239,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL875164,,BAO_0000218,,
5683,14239,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621811,,BAO_0000218,,
5684,4890,"Compound was evaluated for the pharmacokinetic parameter, area under curve",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621812,,BAO_0000218,,
5685,429,Evaluated for pharmacokinetic parameter area under curve in mouse at the dose 20 mg/kg (0-4 hr ),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621813,,BAO_0000218,,
5686,429,Evaluated for pharmacokinetic parameter area under curve in mouse at the dose 20 mg/kg (0-4 hr),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621814,,BAO_0000218,,
5687,5969,In vivo area under curve (AUC) was determined in murine septicemia at dose of 100 mg/kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621815,,BAO_0000218,,
5688,5969,In vivo area under curve (AUC) was determined in murine septicemia at dose of 50 mg/kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621816,,BAO_0000218,,
5689,5969,In vivo area under curve (AUC) was determined in murine septicemia at dose of 50 mg/kg;ND=not determined,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621817,,BAO_0000218,,
5690,6091,Pharmacokinetic activity (AUC) in vivo after intravenous administration of 10 mg/kg in mouse,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621818,,BAO_0000218,,
5691,6091,Pharmacokinetic activity (AUC) in vivo after intravenous administration of 10 mg/kg in mouse;ND=Not determined,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621819,,BAO_0000218,,
5692,6091,Pharmacokinetic activity (AUC) in vivo after peroral administration of 10 mg/kg in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621820,,BAO_0000218,,
5693,6091,Pharmacokinetic activity (AUC) in vivo after peroral administration of 10 mg/kg in mice;ND=Not determined,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621821,,BAO_0000218,,
5694,6178,Pharmacokinetic property (AUC) was determined after ip administration of 32 mg/kg in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621822,,BAO_0000218,,
5695,6178,Pharmacokinetic property (AUC) was determined after po administration of 32 mg/kg in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619474,,BAO_0000218,,
5696,6619,"Reduction in area under curve was determined in DIO mice by oral glucose tolerance test following a single i.p. dose (10 mg/kg, 30 min pre-treatment)",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619475,,BAO_0000218,,
5697,6619,"Reduction in area under curve was determined in ob/ob mice by oral glucose tolerance test following a single i.p. dose (10 mg/kg, 30 min pre-treatment)",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619476,,BAO_0000218,,
5698,3760,"The area under concentration-time curve(AUC) was determined at 5 mg/kg of compound dose, administered intravenously in mice",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619477,,BAO_0000218,,
5699,3760,"The area under concentration-time curve(AUC) was determined at 5 mg/kg of compound dose, administered perorally in mice",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619478,,BAO_0000218,,
5700,3760,"The area under concentration-time curve(AUC) was determined at 50 mg/kg of compound dose, administered intravenously in mice",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619479,,BAO_0000218,,
5701,3760,"The area under concentration-time curve(AUC) was determined at 50 mg/kg of compound dose, administered perorally in mice",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619480,,BAO_0000218,,
5702,3192,The area under curve in vivo in mouse blood level after oral administration at dose 50 mk/kg e-1,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619481,,BAO_0000218,,
5703,3192,The area under curve in vivo in mouse blood level after subcutaneous administration at dose 50 mk/kg e-1,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619482,,BAO_0000218,,
5704,2675,Area under the curve was evaluated in mice after intravenous administration,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619483,,BAO_0000218,,
5705,2675,Area under the curve was evaluated in mice after oral administration,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619484,,BAO_0000218,,
5706,16597,AUC total value at a dose of 10 mg/kg intravenous administration in mice.,A,,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL619485,,BAO_0000218,1969.0,
5707,16597,AUC total value at a dose of 10 mg/kg peroral administration in mice.,A,,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL619486,,BAO_0000218,1969.0,
5708,16597,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for area under curve (AUCtot),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619487,,BAO_0000218,,
5709,17734,AUMC after intraperitoneal administration of 100 mg/kg in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619488,,BAO_0000218,,
5710,7767,Biodistribution in blood was determined in mice after iv administration at 15 min Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL620106,,BAO_0000218,178.0,
5711,15345,The compound was tested in vitro for anticancer activity against 9L cells,F,,,,,,,9L,,80653,N,1,Intermediate,1,,CHEMBL620107,392.0,BAO_0000219,,
5712,2181,Anti proliferation activity determined; Weak effect,F,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL620283,,BAO_0000019,,
5713,2181,Inhibition of cell growth by compound at a concentration of 100 uM in 9Ltk+ cells; Completely stopped the process,F,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL875176,,BAO_0000219,,
5714,2181,Inhibition of cell growth by compound at a concentration of 10 uM in 9Ltk+ cells,F,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL620284,,BAO_0000219,,
5715,2181,Inhibition of cell growth by compound at a concentration of 10 uM in 9Ltk+ cells; Completely stopped the process,F,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL623515,,BAO_0000219,,
5716,10486,The cytotoxic activity was in vitro tested by 9PS assay method,F,,,Mus musculus,10090.0,,,,,22226,U,0,Autocuration,1,,CHEMBL623516,,BAO_0000019,,
5717,10486,The cytotoxic activity was in vitro tested by 9PS assay method.,F,,,Mus musculus,10090.0,,,,,22226,U,0,Autocuration,1,,CHEMBL623517,,BAO_0000019,,
5718,15508,Partition coefficient (logD6.5),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL857878,,BAO_0000019,,
5719,5242,Inhibitory concentration in vitro for cytotoxic activity against A 2780 human ovarian carcinoma cells,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL623518,478.0,BAO_0000219,,
5720,16167,Effective concentration against A 375 cell line growth (DFMO concentration is 5.0 mM),F,,,Homo sapiens,9606.0,,,A-375,,80018,N,1,Intermediate,1,,CHEMBL624195,455.0,BAO_0000219,,
5721,4782,Inhibitory concentration required against A 431 human epidermoid carcinoma cell line,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL624196,500.0,BAO_0000219,,
5722,16093,Inhibition of EGF-induced Tyrosine phosphorylation in A431 cells expressing EGF-R,F,,,Homo sapiens,9606.0,,,A-431,,9,D,9,Expert,1,,CHEMBL624197,500.0,BAO_0000219,,
5723,2596,Compound was evaluated for in vitro cytotoxicity against A 498 cancer cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL624198,624.0,BAO_0000219,,
5724,2596,in vitro cytotoxicity against A 498 cancer cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL621287,624.0,BAO_0000219,,
5725,3239,In vitro cytotoxic activity against renal (A 498) cancer cell line.,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL621288,624.0,BAO_0000219,,
5726,1847,Cytotoxic activity against A 498 renal cancer cell lines.,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL876496,624.0,BAO_0000219,,
5727,10553,In vitro cytotoxicity was determined against A 498 human renal tumor cell line using NCI screen,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL621289,624.0,BAO_0000219,,
5728,16219,Minimum inhibitory concentration against Staphylococcus aureus A 5177 MLSB-i,F,,,Staphylococcus aureus,1280.0,,,,,22226,U,0,Autocuration,1,,CHEMBL621290,,BAO_0000019,,
5729,16219,Minimum inhibitory concentration against Staphylococcus aureus A 5177 MLSB-i,F,,,Staphylococcus aureus,1280.0,,,,,22226,U,0,Autocuration,1,,CHEMBL621291,,BAO_0000019,,
5730,16219,Minimum inhibitory concentration against Staphylococcus aureus A 5278 MLSB-c,F,,,Staphylococcus aureus,1280.0,,,,,22226,U,0,Autocuration,1,,CHEMBL621292,,BAO_0000019,,
5731,16219,Minimum inhibitory concentration against Staphylococcus aureus A 5278 MLSB-c,F,,,Staphylococcus aureus,1280.0,,,,,22226,U,0,Autocuration,1,,CHEMBL621293,,BAO_0000019,,
5732,4782,Inhibitory concentration required against A 549 lung cancer cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621294,646.0,BAO_0000219,,
5733,11805,Growth inhibition of A 549 cell line by MTT reduction for 3 days of incubation time,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621295,646.0,BAO_0000219,,
5734,11805,Growth inhibition of A 549 cell line by MTT reduction for 7 days of incubation time,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL884007,646.0,BAO_0000219,,
5735,2007,In vitro cytotoxicity against lung cancer A 549 cell lines,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621296,646.0,BAO_0000219,,
5736,4594,Compound was tested for its cytotoxicity against A 549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621297,646.0,BAO_0000219,,
5737,6018,"Cytotoxic activity against A 549 human lung tumor cell line, using sulforhodamine B (SRB) assay.",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL839828,646.0,BAO_0000219,,
5738,6018,"Cytotoxic activity against A 549 human lung tumor cell line, using sulforhodamine B (SRB) assay.; No data",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620397,646.0,BAO_0000219,,
5739,3599,In vitro cytotoxic activity against A 549 (non-small cell lung) using SRB (sulforhodamine B) assay,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620398,646.0,BAO_0000219,,
5740,2551,Tested for in vitro cytotoxicity against A 549 (human lung) tumor cell line using sulforhodamine B (SRB) assay,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620399,646.0,BAO_0000219,,
5741,16132,In vitro inhibition of A549 (human lung cancer) cell growth.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620400,646.0,BAO_0000219,,
5742,16132,Cytotoxic related antitumor activity against human cancer cell lines A 549; No data available,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620401,646.0,BAO_0000219,,
5743,2551,Tested for in vitro cytotoxicity against A 549 (human lung) tumor cell line using sulforhodamine B (SRB) assay,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620402,646.0,BAO_0000219,,
5744,2551,Tested for in vitro cytotoxicity against A 549 (human lung) tumor cell line using sulforhodamine B (SRB) assay; not active (> 100 uM),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620403,646.0,BAO_0000219,,
5745,11913,Tested against A II at (100 ng/kg iv) in Dawley rats (n=2). 24 h,F,,,,,,,,,22226,U,0,Autocuration,1,,CHEMBL620404,,BAO_0000218,,
5746,12621,The duration of action for the % peak inhibition of A II pressor response for dose of 0.1 mg/kg intravenous administration in conscious dogs.,F,In vivo,,,,,,,,104694,H,4,Autocuration,1,,CHEMBL620405,,BAO_0000218,,
5747,12621,The duration of action for the % peak inhibition of A II pressor response for dose of 1.0 mg/kg peroral administration in rhesus monkeys.,F,In vivo,,,,,,,,104694,H,4,Autocuration,1,,CHEMBL620406,,BAO_0000218,,
5748,12621,The duration of action for the % peak inhibition of angiotensin II pressor response for dose of 0.1 mg/kg peroral administration in conscious rats.,F,In vivo,,,,,,,,104694,H,4,Autocuration,1,,CHEMBL620407,,BAO_0000218,,
5749,12621,The compound was evaluated for the % peak inhibition of A II pressor response for dose of 0.3 mg/kg peroral administration in rhesus monkeys.,F,In vivo,,,,,,,,104694,H,4,Autocuration,1,,CHEMBL620408,,BAO_0000218,,
5750,12621,The compound was evaluated for the percentage of inhibition of A II pressor response in rats for peroral administration.,F,In vivo,,,,,,,,104694,H,4,Autocuration,1,,CHEMBL620409,,BAO_0000218,,
5751,3600,Inhibition of A-498 human Renal cell proliferation,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Expert,1,,CHEMBL620410,624.0,BAO_0000219,,
5752,1796,"Membrane potential change (fluorescence-based in vitro assay using DIBAC4 as indicator) in A-10 smooth muscle cell, to estimate potassium channel opening activity at 0.1 uM",F,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL620411,,BAO_0000019,,
5753,1796,"Membrane potential change (fluorescence-based in vitro assay using DIBAC4 as indicator) in A-10 smooth muscle cell, to estimate potassium channel opening activity at 1 uM",F,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL620412,,BAO_0000019,,
5754,1796,"Membrane potential change (fluorescence-based in vitro assay using DIBAC4 as indicator) in A-10 smooth muscle cell, to estimate potassium channel opening activity at 10 uM",F,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL876596,,BAO_0000019,,
5755,16464,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,F,,,Homo sapiens,9606.0,,,A 172,,80012,N,1,Expert,1,,CHEMBL620413,622.0,BAO_0000219,,
5756,16464,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay; NE is no effect at 1x 10 E-5,F,,,Homo sapiens,9606.0,,,A 172,,80012,N,1,Intermediate,1,,CHEMBL620414,622.0,BAO_0000219,,
5757,16464,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay; NE is no effect at 1x 10 E-5,F,,,Homo sapiens,9606.0,,,A 172,,80012,N,1,Intermediate,1,,CHEMBL620415,622.0,BAO_0000219,,
5758,13617,Concentration required to inhibit growth of human tumor A549 (NSCL) cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620416,646.0,BAO_0000219,,
5759,4584,Concentration which produces 50% inhibition of growth of human lung carcinoma cell line A549,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620417,646.0,BAO_0000219,,
5760,13799,Cytotoxic activity evaluated against A549 tumor cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620418,646.0,BAO_0000219,,
5761,16726,Cytotoxic potentiation of Topotecan (TP) by the compound in human lung carcinoma A549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620419,646.0,BAO_0000219,,
5762,16109,Cytotoxicity against A549 cells when the drug is exposed for a time of 1 hr,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620420,646.0,BAO_0000219,,
5763,16109,Cytotoxicity against A549 cells when the drug is exposed for a time of 96 hrs,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620421,646.0,BAO_0000219,,
5764,15474,Cytotoxicity against A549 tumor cell line determined by WST-1 assay,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620422,646.0,BAO_0000219,,
5765,6851,Cytotoxicity of compound against A549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620423,646.0,BAO_0000219,,
5766,17534,Cytotoxicity against human lung cell carcinoma A549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620424,646.0,BAO_0000219,,
5767,2621,Cytotoxicity against human lung carcinoma A549 cell line using MTT assay,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620425,646.0,BAO_0000219,,
5768,830,Cytotoxicity was evaluated in vitro against A549 (non-small cell lung carcinoma) human tumor cell lines,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620426,646.0,BAO_0000219,,
5769,14255,In vitro antitumor activity against A549 human non-small lung carcinoma cells containing 10% fetal bovine serum,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620427,646.0,BAO_0000219,,
5770,14255,In vitro antitumor activity against A549 human non-small lung carcinoma cells containing 10% fetal bovine serum; Not determined,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620428,646.0,BAO_0000219,,
5771,1590,In vitro antitumor activity against A549 human NSCLC lung carcinoma cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620429,646.0,BAO_0000219,,
5772,6146,In vitro concentration required to inhibit the TNF-alpha-induced RANTES production in A549 human lung epithelium cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620430,646.0,BAO_0000219,,
5773,17427,In vitro cytotoxicity against A549 (human lung carcinoma) cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL839887,646.0,BAO_0000219,,
5774,5280,In vitro cytotoxicity against parental and drug resistant lung human tumor cell line A549,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620431,646.0,BAO_0000219,,
5775,16786,In vitro cytotoxicity of compound against human A549 (non small cell lung) cancer cell line after 72 hr of drug exposure,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL884010,646.0,BAO_0000219,,
5776,5895,In vitro cytotoxicity against A549 (human lung cancer),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620538,646.0,BAO_0000219,,
5777,14297,In vitro cytotoxicity against A-549 (human lung carcinoma) cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620539,646.0,BAO_0000219,,
5778,17824,In vivo antiproliferative activity against A549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL623373,646.0,BAO_0000218,,
5779,14368,Inhibition of non-small-cell lung adenocarcinoma (A549),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL623374,646.0,BAO_0000219,,
5780,14368,Inhibition of non-small-cell lung adenocarcinoma (A549) after 48-h treatment,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL623375,646.0,BAO_0000219,,
5781,14254,Inhibition of the growth against human non-small-lung carcinoma (A549) cell line after 72 hr exposure,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL623376,646.0,BAO_0000219,,
5782,15897,Inhibitory activity against A549 cell line using MTT assay(Wild type p53),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL623377,646.0,BAO_0000219,,
5783,13866,Inhibitory activity against A549 epithelial Cancer cell line at the concentration 0-30 uM for 48 hr,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL623378,646.0,BAO_0000219,,
5784,13370,Inhibitory activity of compound against human A549 lung carcinoma cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL623379,646.0,BAO_0000219,,
5785,4862,Inhibitory activity against A549 lung cancer cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL623380,646.0,BAO_0000219,,
5786,4862,Inhibitory activity against Taxol-resistant A549 lung cancer cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL623381,646.0,BAO_0000219,,
5787,4862,Inhibitory activity against Taxol-resistant A549 lung cancer cell line; not determined,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL623382,646.0,BAO_0000219,,
5788,15970,Inhibitory concentration against A549 (lung cancer) cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL623383,646.0,BAO_0000219,,
5789,17713,In vitro cytotoxicity against A-549 (human lung carcinoma) cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL623384,646.0,BAO_0000219,,
5790,4833,Tested in vitro for inhibitory effect on the growth of human A-549 cancer cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL623385,646.0,BAO_0000219,,
5791,13736,Activity against A549 cancer cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL623386,646.0,BAO_0000219,,
5792,4312,The compound was evaluated for cytotoxicity against A549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL884105,646.0,BAO_0000219,,
5793,5421,The compound was examined for its ability to block tumor necrosis factor alpha (TNF alpha) induced IL-8 production in A549 human lung carcinoma cell line using an ELISA,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL623387,646.0,BAO_0000219,,
5794,5421,The compound was tested for its ability to inhibit tumor necrosis factor alpha (TNF alpha) induced apoptosis in A549 human lung carcinoma cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621568,646.0,BAO_0000219,,
5795,14717,Growth inhibitory activity was measured for human A549 tumor cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621569,646.0,BAO_0000219,,
5796,4634,Inhibitory activity against A549 lung cancer cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621570,646.0,BAO_0000219,,
5797,1149,Inhibitory activity against A549 cell line; inactive,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621571,646.0,BAO_0000219,,
5798,5421,Inhibition of NFkB (transcription factor) activation in A549 human lung carcinoma cell line at 20 uM,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL621572,646.0,BAO_0000219,,
5799,5421,Inhibition of NFkB (transcription factor) activation in A549 human lung carcinoma cell line at 20 uM,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL621573,646.0,BAO_0000219,,
5800,5421,Compound was tested for its ability to inhibit tumor necrosis factor alpha (TNF alpha) induced apoptosis in A549 human lung carcinoma cell line at 20 uM concentration,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621574,646.0,BAO_0000219,,
5801,3320,In vitro cytotoxic activity against A549 tumor cell line by SRB assay at 72 hour at a concentration 10E-4 (M/L),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621575,646.0,BAO_0000219,,
5802,3320,In vitro cytotoxic activity against A549 tumor cell line by SRB assay at 72 hour at a concentration 10E-5 (M/L),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621576,646.0,BAO_0000219,,
5803,3320,In vitro cytotoxic activity against A549 tumor cell line by SRB assay at 72 hour at a concentration 10E-6 (M/L),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621577,646.0,BAO_0000219,,
5804,3320,In vitro cytotoxic activity against A549 tumor cell line by SRB assay at 72 hour at a concentration 10E-7 (M/L),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621578,646.0,BAO_0000219,,
5805,3320,In vitro cytotoxic activity against A549 tumor cell line by SRB assay at 72 hour at a concentration 10E-8 (M/L),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621579,646.0,BAO_0000219,,
5806,5726,In vitro percent inhibition evaluated against human lung cancer (A549 cell line) at >20 ug/mL,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621580,646.0,BAO_0000219,,
5807,17800,Plasma clearance (in vivo) in mongrel dogs was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621581,,BAO_0000218,,
5808,5985,Plasma clearance was measured in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621582,,BAO_0000218,,
5809,5530,Plasma clearance in vivo in dog by intravenous administration at a dose of 0.2 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621583,,BAO_0000218,,
5810,5530,Plasma clearance in vivo in dog by intravenous administration at a dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621584,,BAO_0000218,,
5811,4839,Tested for plasma clearance in dog,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621585,,BAO_0000218,1969.0,
5812,3639,The compound was tested for clearance in dog plasma.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621586,,BAO_0000218,,
5813,4838,"The pharmacokinetic parameter, clearance was reported in dog after intravenous administration",A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875835,,BAO_0000218,,
5814,4137,Clearance value of compound was determined after intravenous administration of 1 mg/kg/h in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621587,,BAO_0000218,,
5815,5017,Compound was tested for its ability of plasma clearance when administered in dog perorally (1 mg/kg) and intravenously (0.2 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621588,,BAO_0000218,1969.0,
5816,17538,In vitro clearance in dog liver microsomes,A,In vitro,,Canis lupus familiaris,9615.0,,Liver,,Microsomes,50588,N,1,Intermediate,1,,CHEMBL621589,,BAO_0000218,2107.0,
5817,6161,Pharmacokinetic profile in terms of clearance was determined at a dose of 0.5 mg/kg administered intravenously in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621590,,BAO_0000218,,
5818,6161,Pharmacokinetic profile in terms of clearance was determined at a dose of 5 mg/kg administered intravenously in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621591,,BAO_0000218,,
5819,1696,Plasma clearance in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621592,,BAO_0000218,,
5820,6762,Clearance rate in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621593,,BAO_0000218,,
5821,5932,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621594,,BAO_0000218,1969.0,
5822,6305,Clearance in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621595,,BAO_0000218,,
5823,4942,Plasma clearance in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621596,,BAO_0000218,,
5824,4219,Plasma clearance was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621597,,BAO_0000218,,
5825,17853,Lower clearance in dog (i.v.) at 0.5 mpk,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621598,,BAO_0000218,,
5826,4514,Plasma clearance in Beagle dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621599,,BAO_0000218,,
5827,6448,Plasma clearance (Clp) in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875836,,BAO_0000218,,
5828,6227,Plasma clearance (pharmacokinetic parameter) in dog (in vivo) at a dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621600,,BAO_0000218,,
5829,6227,Plasma clearance (pharmacokinetic parameter) in dog was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621601,,BAO_0000218,,
5830,6062,Plasma clearance for the compound was measured in dog after an iv dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618474,,BAO_0000218,,
5831,6821,Plasma clearance of compound was determined in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618475,,BAO_0000218,,
5832,4709,Plasma clearance after intravenous administration of 1 mg/kg in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624524,,BAO_0000218,,
5833,4521,Plasma clearance in dog after 2 mg/kg by oral and 0.5 mg/kg by intravenous administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624525,,BAO_0000218,,
5834,5374,Plasma clearance in dog was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624526,,BAO_0000218,,
5835,6057,Plasma clearance was calculated in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624527,,BAO_0000218,,
5836,4727,Plasma clearance at the dose of 2 mg/kg in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624528,,BAO_0000218,,
5837,5145,Plasma clearance in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624529,,BAO_0000218,,
5838,17657,Plasma clearance in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624530,,BAO_0000218,,
5839,17657,Plasma clearance in dog; Unable to calculate,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624531,,BAO_0000218,,
5840,5145,Plasma clearance in rhesus monkey,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624532,,BAO_0000218,,
5841,6642,Plasma clearance in dog (dosed as a mixture of five compounds at 0.5 mpk each via iv only),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624533,,BAO_0000218,,
5842,6641,Plasma clearance in dog (dosed at 0.5 mpk iv and 2.0 mpk orally),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624534,,BAO_0000218,,
5843,6642,Plasma clearance in dog (dosed at 0.5 mpk iv and 2.0 mpk orally),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624535,,BAO_0000218,,
5844,5472,Plasma clearance was evaluated in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624536,,BAO_0000218,,
5845,5472,Plasma clearance was evaluated in dog; Not tested,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624537,,BAO_0000218,,
5846,5472,Plasma clearance was evaluated in rhesus,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624538,,BAO_0000218,,
5847,5472,Plasma clearance was evaluated in rhesus; Not tested,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624539,,BAO_0000218,,
5848,4257,Plasma clearance value was determined in dog after a 3 mg/kg of iv dose,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624540,,BAO_0000218,,
5849,6679,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624541,,BAO_0000218,,
5850,5546,Plasma clearance was determined in Beagle dog at a dose of 1 mg/kg by iv administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624542,,BAO_0000218,,
5851,6348,Plasma clearance was determined in dog after 1 mg/kg (i.v.) and 5 mg/kg (p.o.) administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624543,,BAO_0000218,,
5852,5474,Clearance value at a dose of 0.2 mg/kg i.v.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624544,,BAO_0000218,,
5853,6316,Cmax (Maximum (Peak) plasma drug concentration) was after oral administration at 5 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL624545,,BAO_0000218,1969.0,
5854,17594,Cmax after oral dose of compound at 3 mg/kg in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624546,,BAO_0000218,,
5855,17594,Cmax after single intravenous bolus of 1 mg/kg in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875957,,BAO_0000218,,
5856,5802,Cmax of compound after both po and iv administration at a dose of 5 mg/kg and 2 mg/kg resp in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624547,,BAO_0000218,,
5857,6535,Cmax in dog after administration of 0.25 mg/kg iv; ND = not determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624548,,BAO_0000218,,
5858,6535,Cmax in dog after administration of 1 mg/kg iv,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624549,,BAO_0000218,,
5859,1466,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in dog,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL624550,,BAO_0000218,1969.0,
5860,6505,Cmax on p.o. administration of 10 mg/kg was measured in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621613,,BAO_0000218,,
5861,5668,Cmax was determine after peroral administration at 10 mpk in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621614,,BAO_0000218,,
5862,5668,Cmax was determine after peroral administration at 5 mpk in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623431,,BAO_0000218,,
5863,5668,Cmax was determine after peroral administration at 5 mg/kg in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623432,,BAO_0000218,,
5864,5600,Cmax after 0.3 mg/kg po administration in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623433,,BAO_0000218,,
5865,17764,Cmax after peroral administration in dogs at 2.4 uM/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623434,,BAO_0000218,,
5866,6123,Cmax in dog after oral administration at 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623435,,BAO_0000218,,
5867,6123,Cmax in dog after oral administration at 1 mg/kg; Below the level of quantitation,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623436,,BAO_0000218,,
5868,6757,Cmax upon oral administration in male Beagle dog at 10 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875958,,BAO_0000218,,
5869,16907,Cmax value after 15 mg/kg iv dose in Dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623437,,BAO_0000218,,
5870,7767,Biodistribution in blood was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL623438,,BAO_0000218,178.0,
5871,7767,Biodistribution in blood was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL623439,,BAO_0000218,178.0,
5872,7767,Biodistribution in bone was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Bone,,,50594,N,1,Intermediate,1,,CHEMBL623440,,BAO_0000218,10000001.0,
5873,7767,Biodistribution in bone was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Bone,,,50594,N,1,Intermediate,1,,CHEMBL623441,,BAO_0000218,10000001.0,
5874,7767,Biodistribution in bone was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Bone,,,50594,N,1,Intermediate,1,,CHEMBL623442,,BAO_0000218,10000001.0,
5875,7767,Biodistribution in fat and fur was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623469,,BAO_0000218,,
5876,7767,Biodistribution in fat and fur was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623470,,BAO_0000218,,
5877,7767,Biodistribution in fat and fur was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623471,,BAO_0000218,,
5878,7767,Biodistribution in heart was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL623472,,BAO_0000218,948.0,
5879,7767,Biodistribution in heart was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL623473,,BAO_0000218,948.0,
5880,7767,Biodistribution in heart was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL623474,,BAO_0000218,948.0,
5881,7767,Biodistribution in kidney was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL623475,,BAO_0000218,2113.0,
5882,7767,Biodistribution in kidney was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL623476,,BAO_0000218,2113.0,
5883,7767,Biodistribution in kidney was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL623477,,BAO_0000218,2113.0,
5884,7767,Biodistribution in large intestine after iv administration at 1 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Intestine,,,50594,N,1,Intermediate,1,,CHEMBL621896,,BAO_0000218,160.0,
5885,7767,Biodistribution in large intestine was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Intestine,,,50594,N,1,Intermediate,1,,CHEMBL621897,,BAO_0000218,160.0,
5886,7767,Biodistribution in large intestine was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Intestine,,,50594,N,1,Intermediate,1,,CHEMBL621898,,BAO_0000218,160.0,
5887,7767,Biodistribution in liver was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL621899,,BAO_0000218,2107.0,
5888,7767,Biodistribution in liver was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL621900,,BAO_0000218,2107.0,
5889,7767,Biodistribution in liver was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL621901,,BAO_0000218,2107.0,
5890,7767,Biodistribution in lung was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL621902,,BAO_0000218,2048.0,
5891,7767,Biodistribution in lung was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL621903,,BAO_0000218,2048.0,
5892,7767,Biodistribution in lung was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL622587,,BAO_0000218,2048.0,
5893,7767,Biodistribution in muscle was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL620285,,BAO_0000218,2385.0,
5894,7767,Biodistribution in muscle was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL875285,,BAO_0000218,2385.0,
5895,7767,Biodistribution in muscle was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL620286,,BAO_0000218,2385.0,
5896,7767,Biodistribution in pancreatic tissue was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620287,,BAO_0000218,,
5897,7767,Biodistribution in pancreatic tissue was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620288,,BAO_0000218,,
5898,7767,Biodistribution in pancreatic tissue was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620289,,BAO_0000218,,
5899,7767,Biodistribution in small intestine was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Intestine,,,50594,N,1,Intermediate,1,,CHEMBL620290,,BAO_0000218,160.0,
5900,7767,Biodistribution in small intestine was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Intestine,,,50594,N,1,Intermediate,1,,CHEMBL620291,,BAO_0000218,160.0,
5901,7767,Biodistribution in small intestine was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Intestine,,,50594,N,1,Intermediate,1,,CHEMBL620292,,BAO_0000218,160.0,
5902,7767,Biodistribution in spleen was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL620293,,BAO_0000218,2106.0,
5903,7767,Biodistribution in spleen was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL620294,,BAO_0000218,2106.0,
5904,7767,Biodistribution in spleen was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL618614,,BAO_0000218,2106.0,
5905,7767,Biodistribution in stomach was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Stomach,,,50594,N,1,Intermediate,1,,CHEMBL618615,,BAO_0000218,945.0,
5906,7767,Biodistribution in stomach was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Stomach,,,50594,N,1,Intermediate,1,,CHEMBL618616,,BAO_0000218,945.0,
5907,2036,Cytotoxicity against A-172 human tumor cell lines,F,,,Homo sapiens,9606.0,,,A 172,,80012,N,1,Expert,1,,CHEMBL618617,622.0,BAO_0000219,,
5908,2357,Compound was evaluated for the in vitro cytotoxicity against A-172 human glioblastoma cell line,F,,,Homo sapiens,9606.0,,,A 172,,80012,N,1,Intermediate,1,,CHEMBL618618,622.0,BAO_0000219,,
5909,1457,Antiproliferative activity of compound was tested against rhabdomyosarcoma (A-204) human tumor cells,F,,,Homo sapiens,9606.0,,,A204,,80014,N,1,Intermediate,1,,CHEMBL618619,623.0,BAO_0000219,,
5910,4379,Tested for antiproliferative activity against A-2780 tumoral cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618620,478.0,BAO_0000219,,
5911,1093,Inhibitory concentration against melanoma A-375 cell line for cytotoxicity was determined,F,,,Homo sapiens,9606.0,,,A-375,,80018,N,1,Intermediate,1,,CHEMBL618621,455.0,BAO_0000219,,
5912,12152,Tested in vitro against A-375 cell line human melanoma,F,,,Homo sapiens,9606.0,,,A-375,,80018,N,1,Intermediate,1,,CHEMBL618622,455.0,BAO_0000219,,
5913,16464,Cytotoxicity against A-427 nonsmall lung cell line using MTT colorimetric assay,F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Expert,1,,CHEMBL618623,797.0,BAO_0000219,,
5914,16464,Cytotoxicity against A-427 nonsmall lung cell line using MTT colorimetric assay; NE is no effect at 1x 10 E-5,F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Intermediate,1,,CHEMBL618624,797.0,BAO_0000219,,
5915,16582,In vitro cytotoxicity against human non small-cell-lung cell line A-427.,F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Expert,1,,CHEMBL618625,797.0,BAO_0000219,,
5916,16464,Cytotoxicity against A-427 nonsmall lung cell line using MTT colorimetric assay; NE is no effect at 1x 10 E-5,F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Intermediate,1,,CHEMBL618626,797.0,BAO_0000219,,
5917,10413,Antitumor activity on A-427 lung carcinoma cell lines,F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Intermediate,1,,CHEMBL618627,797.0,BAO_0000219,,
5918,6418,Cytotoxic activity against human A-427 lung tumor cell line,F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Intermediate,1,,CHEMBL618628,797.0,BAO_0000219,,
5919,17134,In vitro antitumor effects against human A-427 cell lines.,F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Expert,1,,CHEMBL618629,797.0,BAO_0000219,,
5920,16132,In vitro inhibition of A-427 (human lung cancer) cell growth.,F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Expert,1,,CHEMBL618630,797.0,BAO_0000219,,
5921,16132,Cytotoxic related antitumor activity against human cancer cell lines A-427; No data available,F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Intermediate,1,,CHEMBL618631,797.0,BAO_0000219,,
5922,16780,Cytotoxic activity of compound against A-427 lung human tumor cell line,F,,,Homo sapiens,9606.0,,,A-427,,80019,N,1,Intermediate,1,,CHEMBL618632,797.0,BAO_0000219,,
5923,4085,Cytotoxicity measured for the growth inhibition of A-431 Human epidermoid carcinoma cell line,F,,,Homo sapiens,9606.0,,,A-431,,80852,N,1,Expert,1,,CHEMBL618633,500.0,BAO_0000219,,
5924,1276,Cytotoxic activity was tested against human A-498 (Kidney carcinoma) cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL619315,624.0,BAO_0000219,,
5925,3498,Cytotoxicity against A-498 cell line in the purdue cell culture screen was determined,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Expert,1,,CHEMBL619316,624.0,BAO_0000219,,
5926,1169,Cytotoxicity against human kidney carcinoma A-498cell lines,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL619317,624.0,BAO_0000219,,
5927,4450,In vitro cytotoxic activity against A-498 (human kidney carcinoma) cell line,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL619318,624.0,BAO_0000219,,
5928,3311,In vitro cytotoxicity against Renal A-498 human tumors following a 6 day exposure.,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL619319,624.0,BAO_0000219,,
5929,4461,Antitumor cytotoxic activity against A-498 cell line was determined,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL619739,624.0,BAO_0000219,,
5930,3311,In vitro cytotoxicity against Renal A-498 human tumors following a 2 day exposure.,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL619740,624.0,BAO_0000219,,
5931,3311,In vitro cytotoxicity against Renal A-498 human tumors following a 2 day exposure; ND is no data,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL883158,624.0,BAO_0000219,,
5932,1457,Antiproliferative activity of compound was tested against renal cancer (A-498) human tumor cells,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL884012,624.0,BAO_0000219,,
5933,3664,In vitro inhibitory activity against A-498 ovarian cancer cell lines,F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL619741,624.0,BAO_0000219,,
5934,15895,"Cytotoxicity against NCI tumor panel, A-498 renal cancer cell line",F,,,Homo sapiens,9606.0,,,A498,,80021,N,1,Intermediate,1,,CHEMBL619742,624.0,BAO_0000219,,
5935,11843,Inhibition of growth lung non-small cell carcinoma A-549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL876610,646.0,BAO_0000219,,
5936,11843,Inhibition of growth of lung non-small cell carcinoma A-549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619743,646.0,BAO_0000219,,
5937,17705,In vitro antiproliferative activity against human A-549 NSCL cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619744,646.0,BAO_0000219,,
5938,17705,In vitro antiproliferative activity against human A-549 NSCL cell line; NS = Not significant,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619745,646.0,BAO_0000219,,
5939,4369,Growth inhibition of A-549 human lung adenocarcinoma at 0.01 uM compound concentration in standard MTT assay,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619746,646.0,BAO_0000219,,
5940,4369,Percent growth inhibition of A-549 human lung adenocarcinoma at 10e-6 M compound concentration in standard MTT assay,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619747,646.0,BAO_0000219,,
5941,4369,Percent growth inhibition of A-549 human lung adenocarcinoma at 10e-6 M compound concentration in standard MTT assay; ND means No data,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619748,646.0,BAO_0000219,,
5942,4369,Percent growth inhibition of A-549 human lung adenocarcinoma at 10e-7 M compound concentration in standard MTT assay,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619749,646.0,BAO_0000219,,
5943,4369,Percent growth inhibition of A-549 human lung adenocarcinoma at 10e-7 M compound concentration in standard MTT assay; ND means No data,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619750,646.0,BAO_0000219,,
5944,4369,Percent growth inhibition of A-549 human lung adenocarcinoma at 10e-8 M compound concentration in standard MTT assay,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624014,646.0,BAO_0000219,,
5945,4369,Percent growth inhibition of A-549 human lung adenocarcinoma at 10e-8 M compound concentration in standard MTT assay; ND means No data,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624015,646.0,BAO_0000219,,
5946,4787,In vitro effective concentration required to reduce the number of human lung carcinoma (A-549) after 3-day incubation,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL885344,646.0,BAO_0000219,,
5947,4787,In vitro effective concentration required to reduce the number of human lung carcinoma cells (A-549) after 3-day incubation,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL623224,646.0,BAO_0000219,,
5948,6513,Cytotoxic activity against A-549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL623225,646.0,BAO_0000219,,
5949,6690,Antitumor cytotoxicity was determined against the A-549(human lung carcinoma) cell line; Range: 0.01 to 0.03,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622698,646.0,BAO_0000219,,
5950,6690,Antitumor cytotoxicity was determined against the A-549(human lung carcinoma) cell line; Range: 10.4 to 118.1,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622699,646.0,BAO_0000219,,
5951,12263,"Cytotoxicity in vitro expressed as 50% reduction in cell number after a 3-day incubation, in human lung carcinoma A-549 cell line",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL622700,646.0,BAO_0000219,,
5952,1054,Compound was tested for cytotoxic activity against human lung carcinoma (A-549),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622701,646.0,BAO_0000219,,
5953,1359,Compound was tested for its cytotoxic activity in MTT assay against A-549 cell line (human lung carcinoma),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622702,646.0,BAO_0000219,,
5954,3547,Cytotoxic activity against human lung carcinoma (A-549) cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622703,646.0,BAO_0000219,,
5955,5771,Cytotoxic activity towards A-549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL622704,646.0,BAO_0000219,,
5956,14425,"In vitro percent inhibition of A549, lung carcinoma.",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622705,646.0,BAO_0000219,,
5957,14425,"In vitro percent inhibition of A549, lung carcinoma",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622706,646.0,BAO_0000219,,
5958,14425,"In vitro percent inhibition of A549, lung carcinoma.",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622707,646.0,BAO_0000219,,
5959,14425,"In vitro percent inhibition of A549, lung carcinoma.; Range 18-23",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622708,646.0,BAO_0000219,,
5960,5280,Percentage inhibition against parental and drug resistant lung human tumor cell line A549 at 10 uM,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622709,646.0,BAO_0000219,,
5961,15176,Growth inhibition of the A549/ATCC non-small cell lung cancer cell line for 2-day in vitro assay.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622710,646.0,BAO_0000219,,
5962,15300,In vitro antitumor activity against Non-small cell lung cancer A549/ATCC cell lines by 6-day assay,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622711,646.0,BAO_0000219,,
5963,17824,"Antitumor activity against A549 non small cell carcinoma at dose range of 1.56-6.25 mg/kg on day 14, 21, 28; activity expressed as maximum tolerated dose",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622712,646.0,BAO_0000218,,
5964,17824,"Antitumor activity against A549 non small cell carcinoma at dose range of 25-100 mg/kg on day 14, 21, 28; activity expressed as maximum tolerated dose",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622713,646.0,BAO_0000218,,
5965,17824,"Antitumor activity against A549 non small cell carcinoma at dose range of 3.12-12.5 mg/kg on day 14, 21, 28; activity expressed as maximum tolerated dose",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622714,646.0,BAO_0000218,,
5966,17824,"Antitumor activity against A549 non small cell carcinoma at dose range of 6.25-25 mg/kg on day 14, 21, 28; activity expressed as maximum tolerated dose",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622715,646.0,BAO_0000218,,
5967,17824,"Antitumor activity against A549 non small cell carcinoma at dose range of 70-100 mg/kg on day 14, 21, 28; activity expressed as maximum tolerated dose",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622716,646.0,BAO_0000218,,
5968,17824,"Antitumor activity against A549 non small cell carcinoma on day 14, 21, 28; activity expressed as maximum tolerated dose; NT = Not tested",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622717,646.0,BAO_0000219,,
5969,17528,Optimal dose required to inhibit human non small cell lung A549 tumor growth after subcutaneous transplantation on athymic mice at 10 mg/kg (treatment schedule: q7dX3),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622718,646.0,BAO_0000218,,
5970,6870,Cytotoxic potentiation factor of temoxolomide in human A549 tumor cell line at 0.4 uM concentration,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL622719,646.0,BAO_0000219,,
5971,6870,Compound was evaluated for cytotoxic potentiation factor of temoxolomide in human A549 tumor cell line at 0.4 uM concentration; ND - not determined,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622720,646.0,BAO_0000219,,
5972,6870,Compound was evaluated for cytotoxic potentiation factor of topotecan in human A549 tumor cell line at 0.4 uM concentration,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622721,646.0,BAO_0000219,,
5973,6870,Compound was evaluated for cytotoxic potentiation factor of topotecan in human A549 tumor cell line at 0.4 uM concentration; ND - not determined,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622722,646.0,BAO_0000219,,
5974,16726,Cytotoxicity potentiation of Topotecan in human lung carcinoma A549 cells by the compound as potentiation factor at 50% growth inhibition,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL876030,646.0,BAO_0000219,,
5975,6170,"Concentration required for 50% inhibition of proliferation of lung cancer cell line, A549 with respect to paclitaxel was tested in vitro after 72 hr of incubation",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620206,646.0,BAO_0000219,,
5976,6583,Inhibition ratio against A-549 cancer cell growth at a concentration of 10e-4 mol/L,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620207,646.0,BAO_0000219,,
5977,6583,Inhibition ratio against A-549 cancer cell growth at a concentration of 10e-5 mol/L,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620208,646.0,BAO_0000219,,
5978,6583,Inhibition ratio against A-549 cancer cell growth at a concentration of 10e-6 mol/L,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620209,646.0,BAO_0000219,,
5979,6583,Inhibition ratio against A-549 cancer cell growth at a concentration of 10e-7 mol/L,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620210,646.0,BAO_0000219,,
5980,6583,Inhibition ratio against A-549 cancer cell growth at a concentration of 10e-8 mol/L,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL621639,646.0,BAO_0000219,,
5981,17321,Tested for cytotoxicity against human lung adenocarcinoma A549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621640,646.0,BAO_0000219,,
5982,17528,Percentage tumor growth inhibition was calculated in respect to controls one week after the end of the treatment,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL621641,646.0,BAO_0000219,,
5983,12888,Cytotoxic effect on non-small-cell lung cancer cell line A549/ATCC,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL621642,646.0,BAO_0000219,,
5984,4312,Cytotoxicity of compound in synergy in 94% BCNU (10 uM) against A549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621643,646.0,BAO_0000219,,
5985,4312,Cytotoxicity of compound in synergy in BCNU (10 uM) against A549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621644,646.0,BAO_0000219,,
5986,4312,Cytotoxicity of compound in synergy in BCNU (10 uM) against A549 cell line; No data,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621645,646.0,BAO_0000219,,
5987,17737,In vitro antiproliferative activity against A549 cell line,F,,,Mus musculus,10090.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621646,646.0,BAO_0000219,,
5988,6630,Synergism with indomethacin in A549 cells,F,,,,,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621647,646.0,BAO_0000219,,
5989,6630,Synergism with tolmetin in A549 cells,F,,,,,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621648,646.0,BAO_0000219,,
5990,6630,Synergism with sulindac in A549 cells,F,,,,,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621649,646.0,BAO_0000219,,
5991,6630,Antagonism of indomethacin in A549 cells,F,,,,,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621650,646.0,BAO_0000219,,
5992,6630,Antagonism of sulindac in A549 cells,F,,,,,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621651,646.0,BAO_0000219,,
5993,6630,Antagonism of tolmetin in A549 cells,F,,,,,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621652,646.0,BAO_0000219,,
5994,6630,Synergism with indomethacin in A549 cells,F,,,,,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621653,646.0,BAO_0000219,,
5995,6630,Synergism with sulindac in A549 cells,F,,,,,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621654,646.0,BAO_0000219,,
5996,6630,Drug interaction towards A549 cell line was determined in terms of combination index in presence of Tolmetin; Not available,F,,,,,,,A549,,80682,N,1,Intermediate,1,,CHEMBL621655,646.0,BAO_0000219,,
5997,16907,Cmax value after 30 mg/kg po dose in Dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621656,,BAO_0000218,,
5998,5944,Cmax value determined in dog at a dose of 0 mg/kg by oral administration along with indavir (10 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621657,,BAO_0000218,,
5999,5944,Cmax value determined in dog at a dose of 10 mg/kg by oral administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621658,,BAO_0000218,,
6000,5944,Cmax value determined in dog at a dose of 10 mg/kg by oral administration along with indavir (10 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621659,,BAO_0000218,,
6001,5944,Cmax value determined in dog at a dose of 5 mg/kg by oral administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621660,,BAO_0000218,,
6002,2959,Cmax value after administration of 4 mg/Kg oral dose in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621661,,BAO_0000218,,
6003,6241,Cmax value in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621662,,BAO_0000218,,
6004,6241,Cmax value in dogs after oral administration at 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621663,,BAO_0000218,,
6005,2652,Bioavailability as Cmax in dogs at 5 mg/kg oral dose,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621664,,BAO_0000218,,
6006,1806,Compound was evaluated for maximum observed plasma concentration at dose 27.5 mg/kg DMP323 equiv in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621665,,BAO_0000218,1969.0,
6007,1806,Compound was evaluated for maximum observed plasma concentration at dose 7.7 mg/kg DMP323 equiv in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621666,,BAO_0000218,1969.0,
6008,1021,Concentration maxima after oral dosing in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621667,,BAO_0000218,,
6009,1021,Concentration maxima after oral dosing in dogs; not available,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL876738,,BAO_0000218,,
6010,1021,Concentration maxima after oral dosing in dogs; not available,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621668,,BAO_0000218,,
6011,5444,In vivo maximal concentration was calculated at 0.4 mg/kg in dog; Not absorbed,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621669,,BAO_0000218,,
6012,5444,In vivo maximal concentration was calculated at 0.6 mg/kg in dog; Not absorbed,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621670,,BAO_0000218,,
6013,5444,In vivo maximal concentration was calculated at 1 mg/kg in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621671,,BAO_0000218,,
6014,5444,In vivo maximal concentration was calculated at 1 mg/kg in dog; Not absorbed,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622360,,BAO_0000218,,
6015,5444,In vivo maximal concentration was calculated at 1 mg/kg in dog; Poor absorption,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622361,,BAO_0000218,,
6016,5130,Cmax in dog plasma after oral dose (1 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL622362,,BAO_0000218,1969.0,
6017,3249,Maximal concentration (Cmax) in dog plasma at a dose of 5 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL622363,,BAO_0000218,1969.0,
6018,5473,Maximal plasma concentration at a dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL622364,,BAO_0000218,1969.0,
6019,5474,Maximal plasma concentration at a dose of 1 mg/kg (oral),A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL622365,,BAO_0000218,1969.0,
6020,4657,Maximal plasma concentration required for pharmacokinetic data in dogs at dose of 1 mg/kg perorally,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL622533,,BAO_0000218,1969.0,
6021,3031,Maximum concentration of compound in dog was evaluated.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622534,,BAO_0000218,,
6022,4527,Maximum concentration by oral administration at a dose of 10 uM/kg in dog was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622535,,BAO_0000218,,
6023,4186,Maximum concentration in dog after administration of 20 mg/kg dose through peroral route,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL876739,,BAO_0000218,,
6024,5007,Maximum concentration in dogs administered perorally (5 mg/kg) and intravenously (2 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622536,,BAO_0000218,,
6025,3132,Maximum concentration obtained in dog plasma was determined,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL622537,,BAO_0000218,1969.0,
6026,5006,Maximum concentration was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622538,,BAO_0000218,,
6027,4727,Maximum concentration at the dose of 2 mg/kg in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL627867,,BAO_0000218,,
6028,1916,Maximum concentration was evaluated against Beagle dog at a dose of 15 mg/kg after po administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL627868,,BAO_0000218,,
6029,1918,Maximum concentration was evaluated in dog plasma,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL627869,,BAO_0000218,1969.0,
6030,3045,Maximum concentration was evaluated after 75 min after administration in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL627870,,BAO_0000218,,
6031,9579,Maximum plasma concentration determined in dog after oral administration of 17b,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL627871,,BAO_0000218,1969.0,
6032,9579,Maximum plasma concentration determined in dog after oral administration of 2b,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL627872,,BAO_0000218,1969.0,
6033,933,Maximum plasma concentration in dog,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL627873,,BAO_0000218,1969.0,
6034,17839,Maximum plasma concentration of compound in dog following p.o. administration of 0.5 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL627874,,BAO_0000218,1969.0,
6035,17839,Maximum plasma concentration of compound in dog following p.o. administration of 0.9 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL627875,,BAO_0000218,1969.0,
6036,17839,Maximum plasma concentration of compound in dog following p.o. administration of 0.95 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL627876,,BAO_0000218,1969.0,
6037,17839,Maximum plasma concentration of compound in dog following p.o. administration of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL627877,,BAO_0000218,1969.0,
6038,6348,Maximum plasma concentration of compound was determined in dog after 1 mg/kg (i.v.) and 5 mg/kg (p.o.) administration,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL627878,,BAO_0000218,1969.0,
6039,16367,Maximum plasma concentration after oral administration to dogs at a dose of 10 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL627879,,BAO_0000218,1969.0,
6040,1337,Maximum plasma concentration in dogs after oral administration (10 mg/kg) as a 0.05 M citric acid solution.,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL875355,,BAO_0000218,1969.0,
6041,1337,Maximum plasma concentration in dogs after oral administration (8 mg/kg) as a 0.05 M citric acid solution.,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL627880,,BAO_0000218,1969.0,
6042,5199,Maximum plasma concentration at a 1 mg/kg oral dose in male and female Beagle dogs.,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL627881,,BAO_0000218,1969.0,
6043,17650,Maximum plasma concentration was measured in dogs after an oral dose of 10 uM/kg,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL627882,,BAO_0000218,1969.0,
6044,6679,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL627883,,BAO_0000218,1969.0,
6045,5356,Maximum plasma concentration was determined as in dogs at 1 mg/kg oral dosing Cmax; 0.05-0.2 ug/mL,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL628526,,BAO_0000218,1969.0,
6046,5356,Maximum plasma concentration was determined in dogs at 1 mg/kg oral dosing; 0.05-0.2 ug/mL,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL628527,,BAO_0000218,1969.0,
6047,6227,Maximum plasma concentration (Cmax) in dog (in vivo) at a dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL628528,,BAO_0000218,1969.0,
6048,6227,Maximum plasma concentration (Cmax) in dog at a dose of 0.5 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL628529,,BAO_0000218,1969.0,
6049,6227,Maximum plasma concentration (Cmax) in dog at a dose of 0.7 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL628530,,BAO_0000218,1969.0,
6050,6227,Maximum plasma concentration (Cmax) in dog at a dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL625243,,BAO_0000218,1969.0,
6051,3598,Maximum plasma drug concentration of compound determined in dog after iv administration at a dose of 10 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Expert,1,,CHEMBL625244,,BAO_0000218,1969.0,
6052,4368,Maximum concentration by intravenous administration of 1.2 mg/kg in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625245,,BAO_0000218,,
6053,6265,Pharmacokinetic (PK) property (Cmax) was determined in dog at the single dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625246,,BAO_0000218,,
6054,7767,Biodistribution in stomach was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Stomach,,,50594,N,1,Intermediate,1,,CHEMBL625247,,BAO_0000218,945.0,
6055,7767,Biodistribution in urine was determined in mice after iv administration at 15 min; Value expressed as percent injected dose per gram,A,In vivo,,Mus musculus,10090.0,,Urine,,,50594,N,1,Intermediate,1,,CHEMBL625248,,BAO_0000218,1088.0,
6056,7767,Biodistribution in urine was determined in mice after iv administration at 1 hr; Value expressed as percent injected dose per gram; ND- No data,A,In vivo,,Mus musculus,10090.0,,Urine,,,50594,N,1,Intermediate,1,,CHEMBL625249,,BAO_0000218,1088.0,
6057,7767,Biodistribution in urine was determined in mice after iv administration at 2 hr; Value expressed as percent injected dose per gram; ND- No data,A,In vivo,,Mus musculus,10090.0,,Urine,,,50594,N,1,Intermediate,1,,CHEMBL625250,,BAO_0000218,1088.0,
6058,17811,Compound (0.09% dose/g) was tested for accumulation in mice bone (Compound is radiolabeled) after 120 min; No increase,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625251,,BAO_0000218,,
6059,17811,Compound (0.31% dose/g) was tested for accumulation in mice bone (Compound is radiolabeled) after 30 min; Low increase,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL875356,,BAO_0000218,,
6060,17827,Compound (i.v.) was tested for maximum activity in mice (Radiolabeled compound),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625252,,BAO_0000218,,
6061,17827,Compound was evaluated for elimination rate constants in vivo in whole blood of normal mice (Radiolabeled compound),A,,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL625253,,BAO_0000218,178.0,
6062,17827,Compound was evaluated for rate of bone uptake after administration of radiolabeled in mice (Radiolabeled compound),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625254,,BAO_0000218,,
6063,17827,Compound was evaluated for rate of bone uptake in mice (Radiolabeled compound),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625255,,BAO_0000218,,
6064,17827,Compound was evaluated for rate of bone uptake in mice; NA - not active (Radiolabeled compound),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625256,,BAO_0000218,,
6065,17827,Compound was evaluated for uptake rate constants in vivo in whole blood of normal mice (Radiolabeled compound),A,,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL625257,,BAO_0000218,178.0,
6066,17827,Compound was evaluated for uptake rate constants in vivo in whole blood of normal mice; NA = not active (Radiolabeled compound),A,,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL625258,,BAO_0000218,178.0,
6067,17827,Compound was evaluated for washout rate in mice (Radiolabeled compound),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625259,,BAO_0000218,,
6068,17827,Compound was evaluated for washout rate in mice after radiolabeled ligand injected,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625260,,BAO_0000218,,
6069,17827,"Maximum activity (i.v.) after in mice, expressed as [(ID%-kg)/g] (Radiolabeled compound)",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625261,,BAO_0000218,,
6070,17827,"Maximum activity in mice, expressed as [(ID%-kg)/g] (Radiolabeled compound)",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625262,,BAO_0000218,,
6071,17827,"Residual activity in mice at 120 minutes, expressed as [(ID%-kg)/g] (Radiolabeled compound)",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622639,,BAO_0000218,,
6072,17257,Tested for plasma level after 90 min of 10 mg/kg dose administered in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622640,,BAO_0000218,,
6073,17257,Tested for plasma level after 90 min of 10 mg/kg dose administered in mice; Not detected.,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622812,,BAO_0000218,,
6074,17257,Tested for plasma level after 90 min of 30 mg/kg dose administered in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622813,,BAO_0000218,,
6075,17257,Tested for plasma level after 90 min of 30 mg/kg dose administered in mice; Not determined,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622814,,BAO_0000218,,
6076,17827,Time at maximum activity in mice (Radiolabeled compound),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622815,,BAO_0000218,,
6077,3760,Percent oral bioavailability was determined after administration of compound at 5 mg/kg perorally in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625342,,BAO_0000218,,
6078,3760,Percent oral bioavailability was determined after administration of compound at 50 mg/kg perorally in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625343,,BAO_0000218,,
6079,17409,Binding towards mouse plasma protein at 10 uM,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL877591,,BAO_0000218,,
6080,17409,Binding towards mouse plasma protein at 100 uM,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625344,,BAO_0000218,,
6081,2675,Bioavailability was evaluated in mice after intravenous administration,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625345,,BAO_0000218,,
6082,2675,Bioavailability was evaluated in mice after oral administration,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625346,,BAO_0000218,,
6083,3132,Bioavailability was obtained by the comparison of AUC of subcutaneous dosing and AUC of oral dosing in mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625347,,BAO_0000218,,
6084,3132,Bioavailability was obtained by the comparison of AUC of subcutaneous dosing and AUC of oral dosing in mouse at dose 25 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625348,,BAO_0000218,,
6085,16597,Bioavailability at a dose of 10 mg/kg peroral administration in mice.,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625349,,BAO_0000218,,
6086,2862,Oral bioavailability in mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625350,,BAO_0000218,,
6087,17764,Oral bioavailability after intravenous administration in mice at 24 uM/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL882952,,BAO_0000218,,
6088,846,Biodistribution of [123I]- labeled compound in mice brain was determined after 1 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL625351,,BAO_0000218,955.0,
6089,846,Biodistribution of [123I]- labeled compound in mice brain was determined after 10 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL625352,,BAO_0000218,955.0,
6090,846,Biodistribution of [123I]- labeled compound in mice brain was determined after 15 sec of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL877592,,BAO_0000218,955.0,
6091,846,Biodistribution of [123I]- labeled compound in mice brain was determined after 2 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL625353,,BAO_0000218,955.0,
6092,846,Biodistribution of [123I]- labeled compound in mice brain was determined after 30 sec of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL625354,,BAO_0000218,955.0,
6093,846,Biodistribution of [123I]- labeled compound in mice brain was determined after 5 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL626019,,BAO_0000218,955.0,
6094,846,Biodistribution of [123I]- labeled compound in mice heart was determined after 10 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL626020,,BAO_0000218,948.0,
6095,846,Biodistribution of [123I]- labeled compound in mice heart was determined after 15 sec of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL626021,,BAO_0000218,948.0,
6096,846,Biodistribution of [123I]- labeled compound in mice heart was determined after 1 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL626022,,BAO_0000218,948.0,
6097,846,Biodistribution of [123I]- labeled compound in mice heart was determined after 2 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL626192,,BAO_0000218,948.0,
6098,1276,Cytotoxic activity was tested against human prostate cell line A-549 (lung carcinoma),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL626193,646.0,BAO_0000219,,
6099,3498,Cytotoxicity against A-549 cell line in the purdue cell culture screen was determined,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL626194,646.0,BAO_0000219,,
6100,1169,Cytotoxicity against human lung carcinoma A-549 cell lines,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL626195,646.0,BAO_0000219,,
6101,4450,In vitro cytotoxic activity against A-549 (human lung carcinoma) cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL626196,646.0,BAO_0000219,,
6102,358,In vitro cytotoxicity against human lung carcinoma cell line A-549,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL626197,646.0,BAO_0000219,,
6103,358,In vitro cytotoxicity against human lung carcinoma cell line A-549 at 3.6*10e-5 M,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL626198,646.0,BAO_0000219,,
6104,358,In vitro cytotoxicity against human lung carcinoma cell line A-549 at 4.2*10e-5M,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL626199,646.0,BAO_0000219,,
6105,358,In vitro cytotoxicity against human lung carcinoma cell line A-549 at 4.3*10e-5M,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL626200,646.0,BAO_0000219,,
6106,358,In vitro cytotoxicity against human lung carcinoma cell line A-549 at 5.0*10e-5M,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL626201,646.0,BAO_0000219,,
6107,358,In vitro cytotoxicity against human lung carcinoma cell line A-549 at 6.1*10e-5 M,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL626202,646.0,BAO_0000219,,
6108,358,In vitro cytotoxicity against human lung carcinoma cell line A-549 at 7.4*10e-5 M,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL626203,646.0,BAO_0000219,,
6109,15167,In vitro cytotoxicity against A-549 human lung cancer cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL626204,646.0,BAO_0000219,,
6110,4139,In vitro cytotoxicity against human lung carcinoma (A-549) cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624701,646.0,BAO_0000219,,
6111,833,In vitro cytotoxicity in human tumor lung carcinoma A-549 cell lines,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624702,646.0,BAO_0000219,,
6112,15718,Tested in vitro for cytotoxic activity against lung carcinoma (A-549) cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL624703,646.0,BAO_0000219,,
6113,12373,Tested in vitro for cytotoxicity against A-549 lung cancer cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624704,646.0,BAO_0000219,,
6114,637,The compound was tested for cytotoxicity against A-549 cell in human lung carcinoma,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624705,646.0,BAO_0000219,,
6115,14867,Cytotoxicity against human lung carcinoma cells (A-549) using SRB assay.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL624706,646.0,BAO_0000219,,
6116,4461,Antitumor cytotoxic activity against A-549 cell line was determined,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624707,646.0,BAO_0000219,,
6117,5406,"Tested for the cytotoxicity against the Non-small cell lung cancer cell line A-549, growth inhibition by 50% is reported",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624708,646.0,BAO_0000219,,
6118,4457,Compound was tested for cytotoxicity against A-549 human solid tumor cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624709,646.0,BAO_0000219,,
6119,1386,Antineoplastic activity against A-549 (human lung carcinoma) cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL884107,646.0,BAO_0000219,,
6120,3265,Antitumoral activity was assayed against A-549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624710,646.0,BAO_0000219,,
6121,2359,Compound was evaluated for the cytotoxicity against A-549 tumor cell line after 3 days of incubation,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624711,646.0,BAO_0000219,,
6122,4457,Compound was tested for cytotoxicity against A-549 human solid tumor cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624712,646.0,BAO_0000219,,
6123,12454,In vitro cytotoxicity against A549 (human lung carcinoma) cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL624713,646.0,BAO_0000219,,
6124,1481,Compound was tested for inhibition of cell growth of A-549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624714,646.0,BAO_0000219,,
6125,1750,Compound was tested for its inhibitory effect on the growth of A-549 tumor cell line from lung.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624715,646.0,BAO_0000219,,
6126,5065,Concentration required for 50% inhibition of growth in human lung carcinoma cell line was determined,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624716,646.0,BAO_0000219,,
6127,808,In vitro cytotoxicity against A549-human lung carcinoma cells.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL619505,646.0,BAO_0000219,,
6128,16364,Cytotoxic activity against cultured cells of A-549 human lung carcinoma.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL619506,646.0,BAO_0000219,,
6129,1847,Cytotoxic activity against A-549 cell lines.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619507,646.0,BAO_0000219,,
6130,1747,Cytotoxicity was measured against neoplastic cultured A-549 cells of human lung carcinoma.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL619508,646.0,BAO_0000219,,
6131,1003,Cytotoxicity against human A549 non small cell lung cell lines,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619509,646.0,BAO_0000219,,
6132,15313,Inhibition of cell growth in (A-549) lung cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL619510,646.0,BAO_0000219,,
6133,3122,Growth inhibitory effect of compound was measured on A-549 human lung adenocarcinoma cancer cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619511,646.0,BAO_0000219,,
6134,16049,In vitro antitumor activity against A-549 tumor cells.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619512,646.0,BAO_0000219,,
6135,17134,In vitro antitumor effects against human A-549 cell lines.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL619513,646.0,BAO_0000219,,
6136,6406,In vitro cytotoxic activity of compound against A-549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619514,646.0,BAO_0000219,,
6137,627,In vitro cytotoxicity against human lung carcinoma A-549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619515,646.0,BAO_0000219,,
6138,12307,In vitro cytotoxicity against human non-small cell lung carcinoma A549,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619516,646.0,BAO_0000219,,
6139,17861,In vitro cytotoxicity against human A-549 cancer cell line was evaluated,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL884005,646.0,BAO_0000219,,
6140,6682,In vitro cytotoxicity against the A-549 (human lung carcinoma) neoplastic cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL619517,646.0,BAO_0000219,,
6141,6663,Inhibitory concentration of compound against A-549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619518,646.0,BAO_0000219,,
6142,2454,Tested for the cytostatic activity as inhibitory concentration against A-549 human pulmonary adenocarcinoma cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619519,646.0,BAO_0000219,,
6143,14709,cytotoxic activity against leukemia (A-549) cancer cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL876489,646.0,BAO_0000219,,
6144,15718,Tested in vitro for cytotoxic activity against lung carcinoma (A-549) cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL619520,646.0,BAO_0000219,,
6145,15718,Percent inhibition for cytotoxic activity against lung carcinoma (A-549) cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619521,646.0,BAO_0000219,,
6146,17130,Cytotoxic activity of compound against A-549 cell lines at concentration of 0.1(ug/ml),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619522,646.0,BAO_0000219,,
6147,17130,Cytotoxic activity of compound against A-549 cell lines at concentration of 0.4(ug/ml),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619523,646.0,BAO_0000219,,
6148,17130,Cytotoxic activity of compound against A-549 cell lines at concentration of 1.1 (ug/ml),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619524,646.0,BAO_0000219,,
6149,17130,Cytotoxic activity of compound against A-549 cell lines at concentration of 10(ug/ml),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619525,646.0,BAO_0000219,,
6150,6630,Drug interaction towards A549 cell line was determined in terms of combination index in presence of Tometin; Not available,F,,,,,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619526,646.0,BAO_0000219,,
6151,16726,Influence of PARP-1 cellular activity in human lung carcinoma A549 cells on %ADP Polymer formation at a concentration of 25 uM of the compound,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619527,646.0,BAO_0000219,,
6152,17846,Cytotoxicity against A549 cells; No cytotoxicity,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619528,646.0,BAO_0000219,,
6153,3415,Cytotoxicity against human lung carcinoma (A549) cell lines,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL619529,646.0,BAO_0000219,,
6154,3415,Cytotoxicity against human lung carcinoma (A549) cell lines; Not active,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL619530,646.0,BAO_0000219,,
6155,5609,In vitro anticancer activity against human lung (A549) cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL876490,646.0,BAO_0000219,,
6156,17206,Percent growth inhibition at 200 uM PARP inhibitor in A549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619531,646.0,BAO_0000219,,
6157,17206,Percent ADP-ribose polymer formation in presence of MNNG (25 uM) at 0..006 uM compound concentration in A549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619532,646.0,BAO_0000219,,
6158,17206,Percent ADP-ribose polymer formation in presence of MNNG (25 uM) at 0..03 uM compound concentration in A549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619533,646.0,BAO_0000219,,
6159,17206,Percent ADP-ribose polymer formation in presence of MNNG (25 uM) at 0..15 uM compound concentration in A549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619534,646.0,BAO_0000219,,
6160,17206,Percent ADP-ribose polymer formation in presence of MNNG (25 uM) at 0..4 uM compound concentration in A549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620164,646.0,BAO_0000219,,
6161,17206,Percent ADP-ribose polymer formation in presence of MNNG (25 uM) at 11 uM compound concentration in A549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620165,646.0,BAO_0000219,,
6162,16295,Inhibition of A549 human lung tumor cell proliferation,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620166,646.0,BAO_0000219,,
6163,16825,"Concentration required to inhibit the lung A549 cell growth by 50%,P53 status of cell line used was wild-type. ",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620167,646.0,BAO_0000219,,
6164,3439,In vitro cytotoxicity against human tumor cell line A549,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL620168,646.0,BAO_0000219,,
6165,10870,In vitro growth inhibitory activity against A549 human nonsmall cell lung carcinoma cells. ,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620338,646.0,BAO_0000219,,
6166,4845,Inhibitory concentration of compound against proliferation of lung carcinoma A549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620339,646.0,BAO_0000219,,
6167,5822,Inhibitory concentration (resynthesized pure material) against TNF-alpha induced apoptosis of A549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620340,646.0,BAO_0000219,,
6168,5822,Inhibitory concentration (solid phase) against TNF-alpha induced apoptosis of A549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620341,646.0,BAO_0000219,,
6169,5822,Inhibitory concentration (solid phase) against TNF-alpha induced apoptosis of A549 cells: Not tested,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL876491,646.0,BAO_0000219,,
6170,16381,% inhibition against A549 cells (lung cancer) at 0.04 ug/mL,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620342,646.0,BAO_0000219,,
6171,16381,% inhibition against A549 cells (lung cancer) at 0.4 ug/mL,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620343,646.0,BAO_0000219,,
6172,16381,% inhibition against A549 cells (lung cancer) at 4 ug/mL,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620344,646.0,BAO_0000219,,
6173,5609,In vitro anticancer activity against human lung (A549) cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620345,646.0,BAO_0000219,,
6174,4644,Inhibition of proliferation of A549 cells at concentration of 0.1 uM was determined,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620346,646.0,BAO_0000219,,
6175,4644,Inhibition of proliferation of A549 cells at concentration of 100 uM was determined,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620347,646.0,BAO_0000219,,
6176,4644,Inhibition of proliferation of A549 cells at concentration of 10 uM was determined,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620348,646.0,BAO_0000219,,
6177,4644,Inhibition of proliferation of A549 cells at concentration of 1 uM was determined,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620349,646.0,BAO_0000219,,
6178,5822,Inhibitory concentration (resynthesized pure material) against TNF-alpha induced apoptosis of A549 cells at 20 uM,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL618667,646.0,BAO_0000219,,
6179,3415,Percentage inhibition of human lung carcinoma (A549) cell lines,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL618668,646.0,BAO_0000219,,
6180,16726,Influence of PARP-1 cellular activity on NAD+ levels at a concentration of 25 uM of the compound,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL876031,646.0,BAO_0000219,,
6181,17206,"Concentration that gives 50% growth inhibition in A549 cells, activity expressed as PF50 (TM); ND denotes not determined",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL618759,646.0,BAO_0000219,,
6182,17206,Concentration that gives 50% growth inhibition (temozolomide alone/ (temozolomide + 0.4 uM of compound)) in A549 cells; ND denotes not determined,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL618760,646.0,BAO_0000219,,
6183,17206,Concentration that gives 50% growth inhibition (topotecan alone/ (topotecan + 0.4 uM of compound)) in A549 cells; ND denotes not determined,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619000,646.0,BAO_0000219,,
6184,17206,"Concentration that gives 50% growth inhibition in A549 cells, activity expressed as PF50 (TM)",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619001,646.0,BAO_0000219,,
6185,17206,"Concentration that gives 50% growth inhibition in A549 cells, activity expressed as PF50 (TP) at 0.006 uM",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619002,646.0,BAO_0000219,,
6186,17206,"Concentration that gives 50% growth inhibition in A549 cells, activity expressed as PF50 (TP) at 0.03 uM",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619003,646.0,BAO_0000219,,
6187,17206,"Concentration that gives 50% growth inhibition in A549 cells, activity expressed as PF50 (TP) at 0.15 uM",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619597,646.0,BAO_0000219,,
6188,17206,"Concentration that gives 50% growth inhibition in A549 cells, activity expressed as PF50 (TP) at 0.4 uM",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619598,646.0,BAO_0000219,,
6189,17206,Concentration that gives 50% growth inhibition (temozolomide alone/ (temozolomide + 0.4 uM of compound)) in A549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619599,646.0,BAO_0000219,,
6190,17206,Concentration that gives 50% growth inhibition (topotecan alone/ (topotecan + 0.4 uM of compound)) in A549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619600,646.0,BAO_0000219,,
6191,16726,Cytotoxicity potentiation of Topotecan in human lung carcinoma A549 cells by the compound as potentiation factor at 50% growth inhibition,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619601,646.0,BAO_0000219,,
6192,17206,Effect on NAD+ depletion (% remaining versus vehicle control) in presence of MNNG (25 uM) at 0.006 uM compound concentration in A549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619602,646.0,BAO_0000219,,
6193,17206,Effect on NAD+ depletion (% remaining versus vehicle control) in presence of MNNG (25 uM) at 0.03 uM compound concentration in A549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619603,646.0,BAO_0000219,,
6194,17206,Effect on NAD+ depletion (% remaining versus vehicle control) in presence of MNNG (25 uM) at 0.15 uM compound concentration in A549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619604,646.0,BAO_0000219,,
6195,17206,Effect on NAD+ depletion (% remaining versus vehicle control) in presence of MNNG (25 uM) at 0.4 uM compound concentration in A549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619605,646.0,BAO_0000219,,
6196,6084,Pharmacokinetic activity (Cmax) (10 mg/kg) was determined in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619606,,BAO_0000218,,
6197,6084,Pharmacokinetic activity (Cmax) in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL876032,,BAO_0000218,,
6198,4809,Pharmacokinetic parameter Cmax was determined in Beagle dogs after (iv) administration of a dose of 28 (uM/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619607,,BAO_0000218,,
6199,5983,Pharmacokinetic property (Cmax) was measured in dog at the dose of 0.032 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619608,,BAO_0000218,,
6200,6251,Plasma clearance rate by iv administration in dog at a dose of 6 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619609,,BAO_0000218,,
6201,5932,Cmax in dog plasma after 30mg/kg oral dose,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL619610,,BAO_0000218,1969.0,
6202,4273,Tested for the peak blood level in dog,A,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,50588,N,1,Intermediate,1,,CHEMBL619611,,BAO_0000218,178.0,
6203,5313,"Tested for the pharmacokinetic data, maximum concentration (Cmax) in dog",A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619612,,BAO_0000218,,
6204,5313,"Tested for the pharmacokinetic data, maximum concentration (Cmax) in dog at dosage of 10 mpk",A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619613,,BAO_0000218,,
6205,6221,The peak blood concentration after 5 hr administration (2.5 mg/kg) in dog was determined,A,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,50588,N,1,Intermediate,1,,CHEMBL619614,,BAO_0000218,178.0,
6206,4709,Concentration in the plasma after intravenous administration of 1 mg/kg in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619615,,BAO_0000218,,
6207,167,Compound was evaluated for Plasma levels upon oral administration at 30 mg/kg in Dog at maximum of 0.3 hours,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619616,,BAO_0000218,,
6208,6241,Final plasma concentration in dogs after oral administration at 1 mg/kg,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL619617,,BAO_0000218,1969.0,
6209,344,Plasma concentration in dogs when measured 1 and 5 hours following initiation of reperfusion at 300 min,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619618,,BAO_0000218,,
6210,344,Plasma concentration in dogs when measured 1 and 5 hours following initiation of reperfusion at 30 min,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL876033,,BAO_0000218,,
6211,344,Plasma concentration in dogs when measured 1 and 5 hours following initiation of reperfusion at 60 min,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619619,,BAO_0000218,,
6212,2189,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by dogs,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619620,,BAO_0000218,,
6213,2189,Percent of radioactive dose in urine and feces excreted by 0-24 hr in dogs,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL619621,,BAO_0000218,1088.0,
6214,2189,Percent of radioactive dose in urine and feces excreted by 0-24 hr in dogs; NA is <10% inhibition at 1 uM for binding data,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL619622,,BAO_0000218,1088.0,
6215,2189,Percent of radioactive dose in urine and feces excreted in 0-24 hr by dogs; NA is <10% inhibition at 1 uM for binding data,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL618874,,BAO_0000218,1088.0,
6216,4257,Absolute bioavailability was evaluated in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618875,,BAO_0000218,,
6217,6221,Bioavailability after oral administration (2.5 mg/kg) in dog was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618876,,BAO_0000218,,
6218,6215,Bioavailability after peroral administration (1 mg/kg) was determined in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618877,,BAO_0000218,,
6219,17267,Bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618878,,BAO_0000218,,
6220,6621,Bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618879,,BAO_0000218,,
6221,3854,Bioavailability after intravenous administration in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618880,,BAO_0000218,,
6222,3854,Bioavailability after peroral administration in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618881,,BAO_0000218,,
6223,5007,Bioavailability in dog (dose 5 mg/kg p.o. and 2 mg/kg i.v.),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618882,,BAO_0000218,,
6224,4333,Bioavailability in dog (Beagle) (male) (dose 3 mg/kg i.v. and 10 mg/kg p.o.) measured from 1 to 24 hr,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624226,,BAO_0000218,,
6225,4333,Bioavailability in plasma of male Beagle dogs treated with 3 mg/kg (i.v.) and 10 mg/kg (p.o.) measured from 1 to 24 hr; ND indicates not determined,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL624227,,BAO_0000218,1969.0,
6226,5006,Bioavailability,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624228,,BAO_0000218,,
6227,5199,Bioavailability,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624229,,BAO_0000218,,
6228,4368,Bioavailability by intravenous administration of 1.2 mg/kg in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624230,,BAO_0000218,,
6229,3771,Bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624231,,BAO_0000218,,
6230,4953,Bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624232,,BAO_0000218,,
6231,5064,Bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625127,,BAO_0000218,,
6232,17657,Bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625128,,BAO_0000218,,
6233,17796,Bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621675,,BAO_0000218,,
6234,17853,Bioavailability in dog (p.o.) at 2.0 mpk,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621676,,BAO_0000218,,
6235,4521,Bioavailability in dog (dose 2 mg/kg p.o. and 0.5 mg/kg i.v.),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621677,,BAO_0000218,,
6236,4521,Bioavailability in dog after 2 mg/kg by oral and 0.5 mg/kg by intravenous administration; ND is not determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621678,,BAO_0000218,,
6237,5006,Bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621679,,BAO_0000218,,
6238,16365,Bioavailability was evaluated after oral administration in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621680,,BAO_0000218,,
6239,1916,Bioavailability was evaluated against Beagle dog at a dose of 15 mg/kg after po administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621681,,BAO_0000218,,
6240,1918,Bioavailability was evaluated in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL876740,,BAO_0000218,,
6241,4239,Bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621682,,BAO_0000218,,
6242,6505,Bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621683,,BAO_0000218,,
6243,5334,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Beagle dog (male),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621684,,BAO_0000218,,
6244,5334,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Beagle dog (male),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621685,,BAO_0000218,,
6245,4809,Bioavailability was determined in Beagle dogs after (iv) administration of a dose of 28 (uM/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621686,,BAO_0000218,,
6246,6348,Bioavailability was determined in dog after 1 mg/kg (i.v.) and 5 mg/kg (p.o.) administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621687,,BAO_0000218,,
6247,6005,Bioavailability was evaluated in dog after peroral administration at a dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621688,,BAO_0000218,,
6248,17804,Bioavailability of compound in dog was determined after peroral administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621689,,BAO_0000218,,
6249,3184,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621690,,BAO_0000218,,
6250,1806,Compound was evaluated for oral bioavailability at different dose 27.5 mg/kg DMP323 equiv in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621691,,BAO_0000218,,
6251,1806,Compound was evaluated for oral bioavailability at different dose 7.7 mg/kg DMP323 equiv in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875941,,BAO_0000218,,
6252,1806,Compound was evaluated for oral bioavailability in dogs; 37-38 %,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621692,,BAO_0000218,,
6253,4839,Bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621693,,BAO_0000218,,
6254,5017,Oral bioavailability in dog (1 mg/kg p.o. and 0.2 mg/kg i.v.),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621694,,BAO_0000218,,
6255,846,Biodistribution of [123I]- labeled compound in mice heart was determined after 30 sec of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL621695,,BAO_0000218,948.0,
6256,846,Biodistribution of [123I]- labeled compound in mice heart was determined after 5 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL621696,,BAO_0000218,948.0,
6257,846,Biodistribution of [123I]- labeled compound in mice kidneys was determined after 1 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL621697,,BAO_0000218,2113.0,
6258,846,Biodistribution of [123I]- labeled compound in mice kidneys was determined after 10 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL621698,,BAO_0000218,2113.0,
6259,846,Biodistribution of [123I]- labeled compound in mice kidneys was determined after 15 sec of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL623420,,BAO_0000218,2113.0,
6260,846,Biodistribution of [123I]- labeled compound in mice kidneys was determined after 2 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL623421,,BAO_0000218,2113.0,
6261,846,Biodistribution of [123I]- labeled compound in mice kidneys was determined after 30 sec of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL623422,,BAO_0000218,2113.0,
6262,846,Biodistribution of [123I]- labeled compound in mice kidneys was determined after 5 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL623423,,BAO_0000218,2113.0,
6263,846,Biodistribution of [123I]- labeled compound in mice liver was determined after 1 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL623424,,BAO_0000218,2107.0,
6264,846,Biodistribution of [123I]- labeled compound in mice liver was determined after 10 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL623425,,BAO_0000218,2107.0,
6265,846,Biodistribution of [123I]- labeled compound in mice liver was determined after 15 sec of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL623426,,BAO_0000218,2107.0,
6266,846,Biodistribution of [123I]- labeled compound in mice liver was determined after 2 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL623427,,BAO_0000218,2107.0,
6267,846,Biodistribution of [123I]- labeled compound in mice liver was determined after 30 sec of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL623428,,BAO_0000218,2107.0,
6268,846,Biodistribution of [123I]- labeled compound in mice liver was determined after 5 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL875947,,BAO_0000218,2107.0,
6269,846,Biodistribution of [123I]- labeled compound in mice lungs was determined after 1 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL623429,,BAO_0000218,2048.0,
6270,846,Biodistribution of [123I]- labeled compound in mice lungs was determined after 10 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL623430,,BAO_0000218,2048.0,
6271,846,Biodistribution of [123I]- labeled compound in mice lungs was determined after 15 sec of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL622588,,BAO_0000218,2048.0,
6272,846,Biodistribution of [123I]- labeled compound in mice lungs was determined after 2 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL622589,,BAO_0000218,2048.0,
6273,846,Biodistribution of [123I]- labeled compound in mice lungs was determined after 30 sec of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL622751,,BAO_0000218,2048.0,
6274,846,Biodistribution of [123I]- labeled compound in mice lungs was determined after 5 min of administration; expressed in percent of injected dose per gram of organ,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL622752,,BAO_0000218,2048.0,
6275,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice blood bearing S180 tumor cell line for 1 hour,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL622753,42.0,BAO_0000218,,
6276,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice blood bearing S180 tumor cell line for 2 hours,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL622647,42.0,BAO_0000218,,
6277,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice blood bearing S180 tumor cell line for 30 minutes,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL875163,42.0,BAO_0000218,,
6278,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice blood bearing S180 tumor cell line for 4 hours,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL622648,42.0,BAO_0000218,,
6279,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice blood bearing S180 tumor cell line for 8 hours,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL622649,42.0,BAO_0000218,,
6280,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice brain bearing S180 tumor cell line for 1 hour,A,,,Mus musculus,10090.0,,Brain,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL622650,42.0,BAO_0000218,955.0,
6281,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice brain bearing S180 tumor cell line for 2 hours,A,,,Mus musculus,10090.0,,Brain,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL622651,42.0,BAO_0000218,955.0,
6282,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice brain bearing S180 tumor cell line for 30 minutes,A,,,Mus musculus,10090.0,,Brain,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL622652,42.0,BAO_0000218,955.0,
6283,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice brain bearing S180 tumor cell line for 4 hours,A,,,Mus musculus,10090.0,,Brain,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL622653,42.0,BAO_0000218,955.0,
6284,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice brain bearing S180 tumor cell line for 8 hours,A,,,Mus musculus,10090.0,,Brain,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL622654,42.0,BAO_0000218,955.0,
6285,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice heart bearing S180 tumor cell line for 1 hour,A,,,Mus musculus,10090.0,,Heart,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL622655,42.0,BAO_0000218,948.0,
6286,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice heart bearing S180 tumor cell line for 2 hours,A,,,Mus musculus,10090.0,,Heart,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL622656,42.0,BAO_0000218,948.0,
6287,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice heart bearing S180 tumor cell line for 30 minutes,A,,,Mus musculus,10090.0,,Heart,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL622657,42.0,BAO_0000218,948.0,
6288,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice heart bearing S180 tumor cell line for 4 hours,A,,,Mus musculus,10090.0,,Heart,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL622658,42.0,BAO_0000218,948.0,
6289,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice heart bearing S180 tumor cell line for 8 hours,A,,,Mus musculus,10090.0,,Heart,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL622659,42.0,BAO_0000218,948.0,
6290,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice kidney bearing S180 tumor cell line for 1 hour,A,,,Mus musculus,10090.0,,Kidney,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL624630,42.0,BAO_0000218,2113.0,
6291,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice kidney bearing S180 tumor cell line for 2 hours,A,,,Mus musculus,10090.0,,Kidney,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL624631,42.0,BAO_0000218,2113.0,
6292,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice kidney bearing S180 tumor cell line for 30 minutes,A,,,Mus musculus,10090.0,,Kidney,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL624632,42.0,BAO_0000218,2113.0,
6293,17130,Cytotoxic activity of compound against A-549 cell lines at concentration of 10(ug/ml) on,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624633,646.0,BAO_0000219,,
6294,17130,Cytotoxic activity of compound against A-549 cell lines at concentration of 10(ug/ml)on,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624634,646.0,BAO_0000219,,
6295,17130,Cytotoxic activity of compound against A-549 cell lines at concentration of 3.3 (ug/ml),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624635,646.0,BAO_0000219,,
6296,17130,Cytotoxic activity of compound against A-549 cell lines at concentration of 3.3 (ug/ml)),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624636,646.0,BAO_0000219,,
6297,3263,Antineoplastic activity against A-549 (human lung carcinoma) cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL857055,646.0,BAO_0000219,,
6298,6663,In vitro rate of inhibition of A-549 tumor cell growth at 10E-4 mol/L,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL624637,646.0,BAO_0000219,,
6299,6663,In vitro rate of inhibition of A-549 tumor cell growth at 10E-5 mol/L,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL624638,646.0,BAO_0000219,,
6300,6663,In vitro rate of inhibition of A-549 tumor cell growth at 10E-6 mol/L,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL874366,646.0,BAO_0000219,,
6301,6663,In vitro rate of inhibition of A-549 tumor cell growth at 10E-7 mol/L,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL624639,646.0,BAO_0000219,,
6302,6663,In vitro rate of inhibition of A-549 tumor cell growth at 10E-8 mol/L,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL624640,646.0,BAO_0000219,,
6303,6663,Rate of inhibition of A-549 tumor cell growth at a concentration of 0.0625 uM,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624641,646.0,BAO_0000219,,
6304,6663,Rate of inhibition of A-549 tumor cell growth at a concentration of 0.125 uM,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624642,646.0,BAO_0000219,,
6305,6663,Rate of inhibition of A-549 tumor cell growth at a concentration of 0.25 uM,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624643,646.0,BAO_0000219,,
6306,6663,Rate of inhibition of A-549 tumor cell growth at a concentration of 0.5 uM,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624644,646.0,BAO_0000219,,
6307,6663,Rate of inhibition of A-549 tumor cell growth at a concentration of 1 uM,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL624645,646.0,BAO_0000219,,
6308,3983,The compound was evaluated for its cytotoxic potency against A-549 cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619445,646.0,BAO_0000219,,
6309,11141,Cytotoxic concentration required to inhibit 50% cell growth in A-549 lung carcinoma cell lines,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL839886,646.0,BAO_0000219,,
6310,5076,Cytotoxic activity of compound against A-549 tumor cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619446,646.0,BAO_0000219,,
6311,3311,In vitro cytotoxicity against Lung A-549 human tumors following a 6 day exposure.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619447,646.0,BAO_0000219,,
6312,3311,In vitro cytotoxicity against Lung A-549 human tumors following a 2 day exposure.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619448,646.0,BAO_0000219,,
6313,3311,In vitro cytotoxicity against Lung A-549 human tumors following a 2 day exposure; ND is no data,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619449,646.0,BAO_0000219,,
6314,5076,Cytotoxic activity of compound against A-549 tumor cell line at conc. of 20 ug/mL,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619450,646.0,BAO_0000219,,
6315,4150,Compound was tested for cytotoxic activity against A-549 human lung carcinoma (ATCC:CCL-185),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619451,646.0,BAO_0000219,,
6316,2150,In vitro inhibitory concentration against cell culture of A-549 human lung carcinoma,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL619452,646.0,BAO_0000219,,
6317,4644,Concentration for in vitro cytotoxicity against A-549 human lung tumor cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619453,646.0,BAO_0000219,,
6318,263,Dose required for in vitro cytotoxic activity against A-549 lung carcinoma cells at concentration of 10 ug/ml; NA is no cytotoxicity,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL874367,646.0,BAO_0000219,,
6319,11333,Cytotoxic concentration against A-549 tumor cells.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619454,646.0,BAO_0000219,,
6320,11333,Cytotoxic concentration against A-549 tumor cells; Inactive at 10 ug/mL.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619455,646.0,BAO_0000219,,
6321,15895,"Cytotoxicity against NCI tumor panel, A-549/ATCC non small-cell lung cancer cell line",F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619456,646.0,BAO_0000219,,
6322,16677,Minimum inhibitory concentration (lowest peptide concentration) required to prevent visible bacterial growth after 18 hr of incubation at 37 C in Mueller-Hinton broth against Acinetobacter baumannii 118A,F,,,Acinetobacter baumannii,470.0,,,,,50191,N,1,Expert,1,,CHEMBL619457,,BAO_0000218,,
6323,10624,Activity against Acinetobacter calcoaceticus (AC54),F,,,Acinetobacter calcoaceticus,471.0,,,,,50192,N,1,Intermediate,1,,CHEMBL619458,,BAO_0000218,,
6324,16717,In vitro antifungal activity against Aspergillus flavus CM74,F,,,Aspergillus flavus,5059.0,,,,,50274,N,1,Expert,1,,CHEMBL619459,,BAO_0000218,,
6325,16717,In vitro antifungal activity against Aspergillus flavus CM74,F,,,Aspergillus flavus,5059.0,,,,,50274,N,1,Expert,1,,CHEMBL619460,,BAO_0000218,,
6326,5513,Inhibitory activity tested against Aspergillus fumigatus at 256 ug/mL concentration,F,,,Aspergillus fumigatus,746128.0,,,,,50416,N,1,Intermediate,1,,CHEMBL619461,,BAO_0000218,,
6327,15962,In vitro minimum fungicidal concentration required to inhibit Aspergillus fumigatus(MFC),F,,,Aspergillus fumigatus,746128.0,,,,,50416,N,1,Intermediate,1,,CHEMBL619462,,BAO_0000218,,
6328,15962,Antimicrobial activity against Aspergillus fumigatus (MIC),F,,,Aspergillus fumigatus,746128.0,,,,,50416,N,1,Intermediate,1,,CHEMBL620388,,BAO_0000218,,
6329,15962,Antimicrobial activity against Aspergillus fumigatus (MIC),F,,,Aspergillus fumigatus,746128.0,,,,,50416,N,1,Intermediate,1,,CHEMBL620389,,BAO_0000218,,
6330,15962,In vitro antimicrobial activity against Aspergillus fumigatus (MIC),F,,,Aspergillus fumigatus,746128.0,,,,,50416,N,1,Intermediate,1,,CHEMBL620390,,BAO_0000218,,
6331,16717,In vitro antifungal activity against Aspergillus fumigatus 48238E,F,,,Aspergillus fumigatus,746128.0,,,,,50416,N,1,Expert,1,,CHEMBL620391,,BAO_0000218,,
6332,16717,In vitro antifungal activity against Aspergillus fumigatus 48238E,F,,,Aspergillus fumigatus,746128.0,,,,,50416,N,1,Expert,1,,CHEMBL621073,,BAO_0000218,,
6333,8117,Compound is evaluated for plaque-bactericidal index (PBI) against Actinomyces naeslundii 631,F,,,Actinomyces naeslundii,1655.0,,,,,50296,N,1,Intermediate,1,,CHEMBL621074,,BAO_0000218,,
6334,8117,Compound is evaluated for plaque-bactericidal index (PBI) against Actinomyces viscosus M-100,F,,,Actinomyces viscosus,1656.0,,,,,50366,N,1,Intermediate,1,,CHEMBL621075,,BAO_0000218,,
6335,15472,Tested in vivo for Acanthocheilonema viteae at 200 mg/kg X 5 days(perorally),F,,,Acanthocheilonema viteae,6277.0,,,,,50535,N,1,Intermediate,1,,CHEMBL619554,,BAO_0000218,,
6336,15472,Tested in vivo for Acanthocheilonema viteae at 200 mg/kg X 5 days(perorally),F,,,Acanthocheilonema viteae,6277.0,,,,,50535,N,1,Intermediate,1,,CHEMBL619555,,BAO_0000218,,
6337,16443,Antibacterial activity determined as minimal inhibitory concentration (MIC) against Actinobacillus actinomycetecommitans ATCC 29527,F,,,Aggregatibacter actinomycetemcomitans,714.0,,,,,50169,N,1,Intermediate,1,,CHEMBL619556,,BAO_0000218,,
6338,16443,Antibacterial activity determined as minimal inhibitory concentration (MIC) against Actinobacillus actinomycetecommitans ATCC 29527; value ranges from 1-2,F,,,Aggregatibacter actinomycetemcomitans,714.0,,,,,50169,N,1,Intermediate,1,,CHEMBL619557,,BAO_0000218,,
6339,16443,Antibacterial activity determined as minimal inhibitory concentration (MIC) against Actinobacillus actinomycetecommitans ATCC 29527; value ranges from 1-2; ND is Not Determined,F,,,Aggregatibacter actinomycetemcomitans,714.0,,,,,50169,N,1,Intermediate,1,,CHEMBL619558,,BAO_0000218,,
6340,17206,Effect on NAD+ depletion (% remaining versus vehicle control) in presence of MNNG (25 uM) at 11 uM compound concentration in A549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619559,646.0,BAO_0000219,,
6341,17206,Percent ADP-ribose polymer formation at 25 uM compound concentration in A549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619560,646.0,BAO_0000219,,
6342,16381,% inhibition against A549 cells (lung cancer) at 0.04 ug/mL,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619561,646.0,BAO_0000219,,
6343,16381,% inhibition against A549 cells (lung cancer) at 0.4 ug/mL,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619562,646.0,BAO_0000219,,
6344,16381,% inhibition against A549 cells (lung cancer) at 4 ug/mL,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619563,646.0,BAO_0000219,,
6345,16381,GI values against A549 cells (lung cancer),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL857457,646.0,BAO_0000219,,
6346,17206,Effect on NAD+ depletion (% remaining versus vehicle control) 25 uM compound concentration in A549 cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619564,646.0,BAO_0000219,,
6347,16325,Inhibitory activity against A549 human adenocarcinoma,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619565,646.0,BAO_0000219,,
6348,10708,Evaluated for the antineoplastic activity against A549 lung (nonsmall cell) tumor xenograft in nude mice after administering 3 injections (intra peritoneally) at a dose of 200 mg/kg,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619566,646.0,BAO_0000218,,
6349,10708,Evaluated for the antineoplastic activity against A549 lung (nonsmall cell) tumor xenograft in nude mice after administering 3 injections (intra peritoneally) at a dose of 100 mg/kg,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619567,646.0,BAO_0000218,,
6350,17376,Inhibitory activity against A549 lung adenocarcinoma cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619568,646.0,BAO_0000219,,
6351,17376,Inhibitory activity against A549 lung adenocarcinoma cell line; not determined,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619569,646.0,BAO_0000219,,
6352,17488,Cytotoxicity against human A549 lung cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619570,646.0,BAO_0000219,,
6353,17404,In vivo percent inhibitory activity of intraperitoneally administered compound (50 mg/kg/day) against mice infected with A549 tumor,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619571,646.0,BAO_0000218,,
6354,10958,Growth inhibition of A549 (human lung carcinoma) cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL619572,646.0,BAO_0000219,,
6355,17099,Effective dose required for inhibitory activity against A549 human tumor cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL619573,646.0,BAO_0000219,,
6356,17099,Effective dose required for inhibitory activity against A549 human tumor cell line; Not active,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619574,646.0,BAO_0000219,,
6357,4096,Cytotoxicity was evaluated against A549 tumor cell lines; Inactive,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619575,646.0,BAO_0000219,,
6358,4096,Cytotoxicity evaluated against A549 tumor cell lines; significant activity,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL619576,646.0,BAO_0000219,,
6359,4096,Cytotoxicity was evaluated against A549 tumor cell lines; Slightly active,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619577,646.0,BAO_0000219,,
6360,2525,In vitro inhibitory activity against A549 tumor cell culture,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619578,646.0,BAO_0000219,,
6361,2525,In vitro inhibitory activity against A549 tumor cell culture; IA= Inactive,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL884009,646.0,BAO_0000219,,
6362,5302,Activity against human lung cancer with mutated beta-tubulin (A549-T2415),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619579,646.0,BAO_0000219,,
6363,16325,Growth inhibitory activity was determined against A549/ATCC cancer cell line of non-small cell lung cancer,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619580,646.0,BAO_0000219,,
6364,16939,Inhibition of growth of A549/ATCC nonsmall cell lung cancer cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619581,646.0,BAO_0000219,,
6365,17229,In vitro antitumor activity against NSCL A549/ATCC tumor cell lines,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619582,646.0,BAO_0000219,,
6366,17380,Cytotoxicity evaluation against A549/ATCC non-small-cell lung cancer cells,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619583,646.0,BAO_0000219,,
6367,17380,Cytotoxicity evaluation against A549/ATCC non-small-cell lung cancer cells; No data,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL876502,646.0,BAO_0000219,,
6368,1903,In vitro cytotoxicity against human Non-small cell lung cancer A549/ATCC cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619584,646.0,BAO_0000219,,
6369,3838,In vitro growth inhibition of compound was determined against A549/ATCC cell lines of non-small cell lung cancer,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619585,646.0,BAO_0000219,,
6370,14696,Inhibition of the growth of non-small-cell lung cancer (A549/ATCC) cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619586,646.0,BAO_0000219,,
6371,3838,In vitro growth inhibition of compound was determined against A549/ATCC cell lines of non-small cell lung cancer,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619587,646.0,BAO_0000219,,
6372,1522,Tested for in vitro cytotoxicity against non-small cell lung cancer cell line A549/ATCC,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619588,646.0,BAO_0000219,,
6373,12400,Tested in vitro for cytotoxicity in A549/ATCC cell lines,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619589,646.0,BAO_0000219,,
6374,14696,inhibition of the growth of non-small-cell lung cancer (A549/ATCC) cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619590,646.0,BAO_0000219,,
6375,14769,Compound was evaluated for in vitro activity against A549/ATCC lung cancer cell lines (Human tumor cells ),F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619591,646.0,BAO_0000219,,
6376,14696,Inhibition of the growth of non-small-cell lung cancer (A549/ATCC) cell line at 0.01 uM,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619592,646.0,BAO_0000219,,
6377,1888,Compound was evaluated for cytotoxic activity against non-small lung cancer A549/ATCC cell lines.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL619593,646.0,BAO_0000219,,
6378,12016,Tested for cytotoxic activity against non-small cell lung cancer A549/ATCC cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620217,646.0,BAO_0000219,,
6379,6058,Compound tested for growth inhibition of non-small cell lung cancer cell line A549/ATCC,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620218,646.0,BAO_0000219,,
6380,17708,Compound was tested for 50% growth inhibition against human non-small cell lung cancer A549/ATCC cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620219,646.0,BAO_0000219,,
6381,12301,Antitumor activity against A549/ATCC cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL620220,646.0,BAO_0000219,,
6382,11970,Tested for cytotoxicity against A549/ATCC cell lines in non-small-cell lung cancer,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL625141,646.0,BAO_0000219,,
6383,11818,In vitro cytotoxicity against A549/ATCC cell line.,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Expert,1,,CHEMBL625142,646.0,BAO_0000219,,
6384,12400,Tested in vitro for cytotoxicity in A549/ATCC cell line of Non-Small Cell Lung Cancer,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL625143,646.0,BAO_0000219,,
6385,3381,In vitro inhibition of Non-Small Cell Lung Cancer A549/ATCC cell lines,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL625144,646.0,BAO_0000219,,
6386,17376,Concentration of compound that cause 50% cytotoxicity of A549/ATCC non small cell lung cancer cell line,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL622474,646.0,BAO_0000219,,
6387,10708,Evaluated for the inhibitory concentration required to cause growth inhibition of A549Rem- cell line of lung using the MTT Cytotoxicity Assay,F,,,Homo sapiens,9606.0,,,A549,,80682,N,1,Intermediate,1,,CHEMBL884104,646.0,BAO_0000219,,
6388,2964,Cytotoxicity was evaluated against A649 human mammary carcinoma cells,F,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL622475,,BAO_0000219,,
6389,5005,Compound was tested for oral bioavailability in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,22224,U,0,Intermediate,1,,CHEMBL622476,,BAO_0000218,,
6390,6229,Compound was tested for orally bioavailable in dogs with a half life of 0.7 hr,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875831,,BAO_0000218,,
6391,6229,Compound was tested for orally bioavailable in dogs with a half life of 1.2h,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622477,,BAO_0000218,,
6392,5374,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622478,,BAO_0000218,,
6393,5374,Compound was tested for the oral bioavailability in dog; No availability,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623172,,BAO_0000218,,
6394,6265,Oral bioavailability in dog (dose 5 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623173,,BAO_0000218,,
6395,5654,Oral bioavailability (F%) of compound was determined after intravenous administration in average of two dogs at a dose of 1 mg/kg; ND=not determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623174,,BAO_0000218,,
6396,5654,Oral bioavailability (F%) of compound was determined after intravenous administration in average of two dogs at a dose of 1 mg/kg; ND=not determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623175,,BAO_0000218,,
6397,16456,Oral bioavailability in Beagle dogs after Per oral administration at dose of 50(mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623340,,BAO_0000218,,
6398,5302,Oral bioavailability in dog (dose 5 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623341,,BAO_0000218,,
6399,3624,Oral bioavailability in dog (p.o. dosing of 0.05 M citric acid/0.05 M hydrochloric acid solution),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623342,,BAO_0000218,,
6400,16452,Oral bioavailability of active FTIs in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623343,,BAO_0000218,,
6401,5802,Oral bioavailability in dog (dose 5 mg/kg p.o. and 2 mg/kg i.v.),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623344,,BAO_0000218,,
6402,3598,Oral bioavailability of compound determined in dog after iv administration at a dose of 10 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Expert,1,,CHEMBL623345,,BAO_0000218,,
6403,17839,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875832,,BAO_0000218,,
6404,6762,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623346,,BAO_0000218,,
6405,6821,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623347,,BAO_0000218,,
6406,6821,Oral bioavailability of compound was determined in dog; Not tested,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623348,,BAO_0000218,,
6407,5210,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623349,,BAO_0000218,,
6408,6227,Oral bioavailability (10 mg/kg) was determined in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623350,,BAO_0000218,,
6409,761,Oral bioavailability,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623351,,BAO_0000218,,
6410,761,Oral bioavailability in dog (dosed as neat powder in hard gelatin capsule),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623352,,BAO_0000218,,
6411,761,Oral bioavailability administered in solution in rats,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623353,,BAO_0000218,,
6412,16907,Oral bioavailability after 30 mg/kg po dose in Dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875833,,BAO_0000218,,
6413,5474,Oral bioavailability at a dose of 1 mg/kg in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623354,,BAO_0000218,,
6414,6535,Oral bioavailability in dog (dose 1 mg/kg p.o.),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623355,,BAO_0000218,,
6415,6535,Oral bioavailability in Dog; ND = not determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623356,,BAO_0000218,,
6416,3352,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623357,,BAO_0000218,,
6417,6168,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623358,,BAO_0000218,,
6418,5988,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623359,,BAO_0000218,,
6419,4942,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623360,,BAO_0000218,,
6420,4942,Oral bioavailability in dogs; No data,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623361,,BAO_0000218,,
6421,14541,Oral bioavailability measured in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623362,,BAO_0000218,,
6422,4449,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623363,,BAO_0000218,,
6423,6057,Oral bioavailability was calculated in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623364,,BAO_0000218,,
6424,5600,Oral bioavailability after 0.3 mg/kg po administration in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875834,,BAO_0000218,,
6425,5542,Oral bioavailability in dog (i.v. dosing),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623365,,BAO_0000218,,
6426,5542,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623366,,BAO_0000218,,
6427,5546,Oral bioavailability in Beagle dog at a dose of 2 mg/kg by po administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623367,,BAO_0000218,,
6428,4514,Oral bioavailability in Beagle dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623368,,BAO_0000218,,
6429,3624,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623369,,BAO_0000218,,
6430,3854,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623370,,BAO_0000218,,
6431,5836,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623371,,BAO_0000218,,
6432,5940,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623372,,BAO_0000218,,
6433,6168,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621351,,BAO_0000218,,
6434,6227,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621352,,BAO_0000218,,
6435,6251,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621353,,BAO_0000218,,
6436,6448,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621354,,BAO_0000218,,
6437,6647,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621355,,BAO_0000218,,
6438,5940,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621356,,BAO_0000218,,
6439,933,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621357,,BAO_0000218,,
6440,5210,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621358,,BAO_0000218,,
6441,6642,Oral bioavailability in dog (dosed as a mixture of five compounds at 0.5 mg/kg each via i.v. only),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621359,,BAO_0000218,,
6442,6641,Oral bioavailability in dog (dose 0.5 mg/kg i.v. and 2.0 mg/kg p.o.),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621360,,BAO_0000218,,
6443,6642,Oral bioavailability in dog (dose 0.5 mg/kg i.v. and 2.0 mg/kg p.o.),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621361,,BAO_0000218,,
6444,5472,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621362,,BAO_0000218,,
6445,5985,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621363,,BAO_0000218,,
6446,15660,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621364,,BAO_0000218,,
6447,5530,Oral bioavailability in dog (dose 0.2 mg/kg i.v.),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621166,,BAO_0000218,,
6448,5530,Oral bioavailability in dog (dose 1 mg/kg i.v.),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621167,,BAO_0000218,,
6449,6305,Oral bioavailability (F) in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621168,,BAO_0000218,,
6450,5210,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621169,,BAO_0000218,,
6451,5238,Bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875950,,BAO_0000218,,
6452,5668,Oral bioavailability in dog (dose 10 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621170,,BAO_0000218,,
6453,5668,Oral bioavailability after peroral administration at 5 mpk in Dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621171,,BAO_0000218,,
6454,5668,Oral bioavailability in dog (dose 5 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621172,,BAO_0000218,,
6455,6084,Oral bioavailability in dog (dose 10 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621173,,BAO_0000218,,
6456,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice kidney bearing S180 tumor cell line for 4 hours,A,,,Mus musculus,10090.0,,Kidney,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621174,42.0,BAO_0000218,2113.0,
6457,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice kidney bearing S180 tumor cell line for 8 hours,A,,,Mus musculus,10090.0,,Kidney,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621175,42.0,BAO_0000218,2113.0,
6458,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice liver bearing S180 tumor cell line for 1 hour,A,,,Mus musculus,10090.0,,Liver,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621176,42.0,BAO_0000218,2107.0,
6459,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice liver bearing S180 tumor cell line for 2 hours,A,,,Mus musculus,10090.0,,Liver,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621177,42.0,BAO_0000218,2107.0,
6460,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice liver bearing S180 tumor cell line for 30 minutes,A,,,Mus musculus,10090.0,,Liver,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621178,42.0,BAO_0000218,2107.0,
6461,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice liver bearing S180 tumor cell line for 4 hours,A,,,Mus musculus,10090.0,,Liver,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621179,42.0,BAO_0000218,2107.0,
6462,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice liver bearing S180 tumor cell line for 8 hours,A,,,Mus musculus,10090.0,,Liver,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621180,42.0,BAO_0000218,2107.0,
6463,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice lung bearing S180 tumor cell line for 1 hour,A,,,Mus musculus,10090.0,,Lung,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL875951,42.0,BAO_0000218,2048.0,
6464,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice lung bearing S180 tumor cell line for 2 hours,A,,,Mus musculus,10090.0,,Lung,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621181,42.0,BAO_0000218,2048.0,
6465,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice lung bearing S180 tumor cell line for 30 minutes,A,,,Mus musculus,10090.0,,Lung,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621182,42.0,BAO_0000218,2048.0,
6466,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice lung bearing S180 tumor cell line for 4 hours,A,,,Mus musculus,10090.0,,Lung,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621183,42.0,BAO_0000218,2048.0,
6467,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice lung bearing S180 tumor cell line for 8 hours,A,,,Mus musculus,10090.0,,Lung,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621184,42.0,BAO_0000218,2048.0,
6468,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice muscle bearing S180 tumor cell line for 1 hour,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621185,42.0,BAO_0000218,,
6469,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice muscle bearing S180 tumor cell line for 2 hours,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621186,42.0,BAO_0000218,,
6470,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice muscle bearing S180 tumor cell line for 30 minutes,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621187,42.0,BAO_0000218,,
6471,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice muscle bearing S180 tumor cell line for 4 hours,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621188,42.0,BAO_0000218,,
6472,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice muscle bearing S180 tumor cell line for 8 hours,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621189,42.0,BAO_0000218,,
6473,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice spleen bearing S180 tumor cell line for 1 hour,A,,,Mus musculus,10090.0,,Spleen,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621190,42.0,BAO_0000218,2106.0,
6474,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice spleen bearing S180 tumor cell line for 2 hours,A,,,Mus musculus,10090.0,,Spleen,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL618520,42.0,BAO_0000218,2106.0,
6475,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice spleen bearing S180 tumor cell line for 30 minutes,A,,,Mus musculus,10090.0,,Spleen,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621739,42.0,BAO_0000218,2106.0,
6476,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice spleen bearing S180 tumor cell line for 4 hours,A,,,Mus musculus,10090.0,,Spleen,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621740,42.0,BAO_0000218,2106.0,
6477,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice spleen bearing S180 tumor cell line for 8 hours,A,,,Mus musculus,10090.0,,Spleen,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621741,42.0,BAO_0000218,2106.0,
6478,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor bearing S180 tumor cell line for 1 hour,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621742,42.0,BAO_0000218,,
6479,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor bearing S180 tumor cell line for 2 hours,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621743,42.0,BAO_0000218,,
6480,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor bearing S180 tumor cell line for 30 minutes,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621744,42.0,BAO_0000218,,
6481,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor bearing S180 tumor cell line for 4 hours,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621745,42.0,BAO_0000218,,
6482,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor bearing S180 tumor cell line for 8 hours,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621746,42.0,BAO_0000218,,
6483,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/blood bearing S180 tumor cell line for 1 hour,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621747,42.0,BAO_0000218,,
6484,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/blood bearing S180 tumor cell line for 2 hours,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621748,42.0,BAO_0000218,,
6485,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/blood bearing S180 tumor cell line for 30 minutes,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621749,42.0,BAO_0000218,,
6486,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/blood bearing S180 tumor cell line for 4 hours,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621750,42.0,BAO_0000218,,
6487,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/blood bearing S180 tumor cell line for 8 hours,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621751,42.0,BAO_0000218,,
6488,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/heart bearing S180 tumor cell line for 1 hour,A,,,Mus musculus,10090.0,,Heart,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621752,42.0,BAO_0000218,948.0,
6489,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/heart bearing S180 tumor cell line for 2 hours,A,,,Mus musculus,10090.0,,Heart,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621753,42.0,BAO_0000218,948.0,
6490,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor/heart bearing S180 tumor cell line for 30 minutes,A,,,Mus musculus,10090.0,,Heart,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL875955,42.0,BAO_0000218,948.0,
6491,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor/heart bearing S180 tumor cell line for 4 hours,A,,,Mus musculus,10090.0,,Heart,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621754,42.0,BAO_0000218,948.0,
6492,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor/heart bearing S180 tumor cell line for 8 hours,A,,,Mus musculus,10090.0,,Heart,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621755,42.0,BAO_0000218,948.0,
6493,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor/liver bearing S180 tumor cell line for 1 hour,A,,,Mus musculus,10090.0,,Liver,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL621756,42.0,BAO_0000218,2107.0,
6494,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/liver bearing S180 tumor cell line for 2 hours,A,,,Mus musculus,10090.0,,Liver,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL624199,42.0,BAO_0000218,2107.0,
6495,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/liver bearing S180 tumor cell line for 30 minutes,A,,,Mus musculus,10090.0,,Liver,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL624200,42.0,BAO_0000218,2107.0,
6496,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor/liver bearing S180 tumor cell line for 4 hours,A,,,Mus musculus,10090.0,,Liver,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL624375,42.0,BAO_0000218,2107.0,
6497,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor/liver bearing S180 tumor cell line for 8 hours,A,,,Mus musculus,10090.0,,Liver,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL624376,42.0,BAO_0000218,2107.0,
6498,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor/lung bearing S180 tumor cell line for 1 hour,A,,,Mus musculus,10090.0,,Lung,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL624377,42.0,BAO_0000218,2048.0,
6499,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/lung bearing S180 tumor cell line for 2 hours,A,,,Mus musculus,10090.0,,Lung,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL624378,42.0,BAO_0000218,2048.0,
6500,12269,Compound tested for the antimicrobial activity against Acinetobacter anitratus,F,,,aeinetobacter anitrotap,107673.0,,,,,50067,N,1,Intermediate,1,,CHEMBL857901,,BAO_0000218,,
6501,12269,Compound tested for the antimicrobial activity against Acinetobacter anitratus,F,,,Acinetobacter calcoaceticus subsp. anitratus,107673.0,,,,,50067,N,1,Intermediate,1,,CHEMBL875274,,BAO_0000218,,
6502,12269,Compound tested for the antimicrobial activity against Acinetobacter anitratus,F,,,Acinetobacter calcoaceticus subsp. anitratus,107673.0,,,,,50067,N,1,Intermediate,1,,CHEMBL624379,,BAO_0000218,,
6503,12269,Compound tested for the antimicrobial activity against Acinetobacter anitratus,F,,,aeinetobacter anitrotap,107673.0,,,,,50067,N,1,Intermediate,1,,CHEMBL624380,,BAO_0000218,,
6504,10624,Activity against Acinetobacter calcoaceticus (AC54),F,,,Acinetobacter calcoaceticus,471.0,,,,,50192,N,1,Intermediate,1,,CHEMBL624381,,BAO_0000218,,
6505,17216,Biological activity using the lizard skin (Anolis carolinensis) assay. The value indicates no prolonged biological activity,F,,,Anolis carolinensis,28377.0,,,,,50714,N,1,Intermediate,1,,CHEMBL624382,,BAO_0000218,,
6506,17216,Biological activity using the lizard skin (Anolis carolinensis) assay. The value indicates prolonged biological activity,F,,,Anolis carolinensis,28377.0,,,,,50714,N,1,Intermediate,1,,CHEMBL624383,,BAO_0000218,,
6507,9560,Chlorohexidine coefficient for Actinomyces naeslundii 631,F,,,Actinomyces naeslundii,1655.0,,,,,50296,N,1,Intermediate,1,,CHEMBL624384,,BAO_0000218,,
6508,9560,Chlorohexidine coefficient for Actinomyces naeslundii B74,F,,,Actinomyces naeslundii,1655.0,,,,,50296,N,1,Intermediate,1,,CHEMBL624385,,BAO_0000218,,
6509,9560,Chlorohexidine coefficient for Actinomyces naeslundii N/3,F,,,Actinomyces naeslundii,1655.0,,,,,50296,N,1,Intermediate,1,,CHEMBL624386,,BAO_0000218,,
6510,9560,Chlorohexidine coefficient for Actinomyces naeslundii N/9,F,,,Actinomyces naeslundii,1655.0,,,,,50296,N,1,Intermediate,1,,CHEMBL624387,,BAO_0000218,,
6511,9560,Plaque bactericidal index against Actinomyces naeslundii 631,F,,,Actinomyces naeslundii,1655.0,,,,,50296,N,1,Intermediate,1,,CHEMBL624388,,BAO_0000218,,
6512,9560,Plaque bactericidal index against Actinomyces naeslundii N/9,F,,,Actinomyces naeslundii,1655.0,,,,,50296,N,1,Intermediate,1,,CHEMBL624389,,BAO_0000218,,
6513,9560,Plaque bactericidal index against Actinomyces naeslundii B74,F,,,Actinomyces naeslundii,1655.0,,,,,50296,N,1,Intermediate,1,,CHEMBL624390,,BAO_0000218,,
6514,9560,Plaque bactericidal index against Actinomyces naeslundii N/3,F,,,Actinomyces naeslundii,1655.0,,,,,50296,N,1,Intermediate,1,,CHEMBL875275,,BAO_0000218,,
6515,114,Compound was tested for its inhibitory activity using brine shrimp (Artemia salina) immobilization assay,F,,,Artemia salina,85549.0,,,,,50056,N,1,Intermediate,1,,CHEMBL624391,,BAO_0000218,,
6516,114,"Compound was tested for its inhibitory activity using brine shrimp (Artemia salina) immobilization assay; highest level tested, showed <100% activity",F,,,Artemia salina,85549.0,,,,,50056,N,1,Intermediate,1,,CHEMBL623636,,BAO_0000218,,
6517,10841,Effect on incorporation of [32Pi] by isolated Ascaris suum mitochondria at a concentration of 0 uM,F,,,Ascaris suum,6253.0,,,,,50532,N,1,Intermediate,1,,CHEMBL623637,,BAO_0000218,,
6518,10841,Effect on incorporation of [32Pi] by isolated Ascaris suum mitochondria at a concentration of 10 uM,F,,,Ascaris suum,6253.0,,,,,50532,N,1,Intermediate,1,,CHEMBL623638,,BAO_0000218,,
6519,10841,Effect on incorporation of [32Pi] by isolated Ascaris suum mitochondria at a concentration of 200 uM,F,,,Ascaris suum,6253.0,,,,,50532,N,1,Intermediate,1,,CHEMBL623639,,BAO_0000218,,
6520,10841,Effect on incorporation of [32Pi] by isolated Ascaris suum mitochondria at a concentration of 25 uM,F,,,Ascaris suum,6253.0,,,,,50532,N,1,Intermediate,1,,CHEMBL623640,,BAO_0000218,,
6521,10841,Effect on incorporation of [32Pi] by isolated Ascaris suum mitochondria at a concentration of 3 uM,F,,,Ascaris suum,6253.0,,,,,50532,N,1,Intermediate,1,,CHEMBL623641,,BAO_0000218,,
6522,10841,Effect on incorporation of [32Pi] by isolated Ascaris suum mitochondria at a concentration of 50 uM.,F,,,Ascaris suum,6253.0,,,,,50532,N,1,Intermediate,1,,CHEMBL623642,,BAO_0000218,,
6523,10841,Effect on succinate formation by isolated Ascaris suum mitochondria at a concentration of 0 uM,F,,,Ascaris suum,6253.0,,,,,50532,N,1,Intermediate,1,,CHEMBL623643,,BAO_0000218,,
6524,10841,Effect on succinate formation by isolated Ascaris suum mitochondria at a concentration of 10 uM,F,,,Ascaris suum,6253.0,,,,,50532,N,1,Intermediate,1,,CHEMBL623644,,BAO_0000218,,
6525,10841,Effect on succinate formation by isolated Ascaris suum mitochondria at a concentration of 200 uM,F,,,Ascaris suum,6253.0,,,,,50532,N,1,Intermediate,1,,CHEMBL623645,,BAO_0000218,,
6526,10841,Effect on succinate formation by isolated Ascaris suum mitochondria at a concentration of 25 uM,F,,,Ascaris suum,6253.0,,,,,50532,N,1,Intermediate,1,,CHEMBL623646,,BAO_0000218,,
6527,10841,Effect on succinate formation by isolated Ascaris suum mitochondria at a concentration of 3 uM,F,,,Ascaris suum,6253.0,,,,,50532,N,1,Intermediate,1,,CHEMBL623647,,BAO_0000218,,
6528,10841,Effect on succinate formation by isolated Ascaris suum mitochondria at a concentration of 50 uM,F,,,Ascaris suum,6253.0,,,,,50532,N,1,Intermediate,1,,CHEMBL623648,,BAO_0000218,,
6529,8117,Compound is evaluated for minimal bactericidal concentration against plaque formation for Actinomyces viscosus,F,,,Actinomyces viscosus,1656.0,,,,,50366,N,1,Intermediate,1,,CHEMBL623649,,BAO_0000218,,
6530,8117,Compound is evaluated for minimal bactericidal concentration against plaque formation for Actinomyces viscosus,F,,,Actinomyces viscosus,1656.0,,,,,50366,N,1,Intermediate,1,,CHEMBL623650,,BAO_0000218,,
6531,9560,Chlorohexidine coefficient for Actinomyces viscosus 8A06,F,,,Actinomyces viscosus,1656.0,,,,,50366,N,1,Intermediate,1,,CHEMBL623651,,BAO_0000218,,
6532,9560,Chlorohexidine coefficient for Actinomyces viscosus M-100,F,,,Actinomyces viscosus,1656.0,,,,,50366,N,1,Expert,1,,CHEMBL623652,,BAO_0000218,,
6533,9560,Chlorohexidine coefficient for Actinomyces viscosus M-626,F,,,Actinomyces viscosus,1656.0,,,,,50366,N,1,Intermediate,1,,CHEMBL623653,,BAO_0000218,,
6534,9560,Chlorohexidine coefficient for Actinomyces viscosus T14V,F,,,Actinomyces viscosus,1656.0,,,,,50366,N,1,Intermediate,1,,CHEMBL623654,,BAO_0000218,,
6535,9560,Plaque bactericidal index against Actinomyces viscosus 8A06,F,,,Actinomyces viscosus,1656.0,,,,,50366,N,1,Intermediate,1,,CHEMBL623655,,BAO_0000218,,
6536,9560,Plaque bactericidal index against Actinomyces viscosus M-100,F,,,Actinomyces viscosus,1656.0,,,,,50366,N,1,Intermediate,1,,CHEMBL623656,,BAO_0000218,,
6537,9560,Plaque bactericidal index against Actinomyces viscosus M-100 measured as chlorohexidine coefficient,F,,,Actinomyces viscosus,1656.0,,,,,50366,N,1,Expert,1,,CHEMBL623657,,BAO_0000218,,
6538,9560,"Plaque bactericidal index against Actinomyces viscosus M-100 measured as chlorohexidine coefficient; d=Not bactericidal at highest concentration tested (0.2% w/v, 2min, 5 days)",F,,,Actinomyces viscosus,1656.0,,,,,50366,N,1,Intermediate,1,,CHEMBL623658,,BAO_0000218,,
6539,9560,"Plaque bactericidal index against Actinomyces viscosus M-100 measured as chlorohexidine coefficient; not bactericidal at highest concentration tested (0.2% w/v, 2min, 5 days)",F,,,Actinomyces viscosus,1656.0,,,,,50366,N,1,Intermediate,1,,CHEMBL623659,,BAO_0000218,,
6540,9560,Plaque bactericidal index against Actinomyces viscosus 626,F,,,Actinomyces viscosus,1656.0,,,,,50366,N,1,Intermediate,1,,CHEMBL623660,,BAO_0000218,,
6541,9560,Plaque bactericidal index against Actinomyces viscosus T14V,F,,,Actinomyces viscosus,1656.0,,,,,50366,N,1,Intermediate,1,,CHEMBL623661,,BAO_0000218,,
6542,10986,anti-filarial Activity was measured against Acanthocheilonema viteae in jirds at 1.56 mg/kg/day(5 days) dose,F,,,Acanthocheilonema viteae,6277.0,,,,,50535,N,1,Intermediate,1,,CHEMBL875281,,BAO_0000218,,
6543,10986,anti-filarial Activity was measured against Acanthocheilonema viteae in jirds at 100 mg/kg/day(5 days) dose,F,,,Acanthocheilonema viteae,6277.0,,,,,50535,N,1,Intermediate,1,,CHEMBL623662,,BAO_0000218,,
6544,10986,anti-filarial Activity was measured against Acanthocheilonema viteae in jirds at 12.5 mg/kg/day(5 days) dose,F,,,Acanthocheilonema viteae,6277.0,,,,,50535,N,1,Intermediate,1,,CHEMBL623663,,BAO_0000218,,
6545,10986,anti-filarial Activity was measured against Acanthocheilonema viteae in jirds at 200 mg/kg/day(5 days) dose,F,,,Acanthocheilonema viteae,6277.0,,,,,50535,N,1,Intermediate,1,,CHEMBL623664,,BAO_0000218,,
6546,10986,anti-filarial Activity was measured against Acanthocheilonema viteae in jirds at 25 mg/kg/day(5 days) dose,F,,,Acanthocheilonema viteae,6277.0,,,,,50535,N,1,Intermediate,1,,CHEMBL623665,,BAO_0000218,,
6547,10708,Evaluated for the inhibitory concentration required to cause growth inhibition of A673Mer+ sarcoma cell line using the MTT Cytotoxicity Assay,F,,,Homo sapiens,9606.0,,,A673,,80023,N,1,Intermediate,1,,CHEMBL621856,165.0,BAO_0000219,,
6548,10708,Evaluated for the inhibitory concentration required to cause growth inhibition of A704Rem- renal cell line using the MTT Cytotoxicity Assay,F,,,Homo sapiens,9606.0,,,A704,,80661,N,1,Intermediate,1,,CHEMBL620432,645.0,BAO_0000219,,
6549,416,Tested for inhibition of ET-1 induced phosphoinositide (PI) turnover in A7r5 smooth muscle cells,F,,,Rattus norvegicus,10116.0,,,,,22226,U,0,Autocuration,1,,CHEMBL620433,,BAO_0000219,,
6550,14354,Inhibition of Forskolin-Induced cAMP production in A9 L cells expressing m2 receptors,F,,,Mus musculus,10090.0,,,A9,,80024,N,1,Intermediate,1,,CHEMBL620434,625.0,BAO_0000219,,
6551,14354,Percent inhibition of Forskolin-Induced cAMP production in A9 L cells expressing m2 receptors,F,,,Mus musculus,10090.0,,,A9,,80024,N,1,Intermediate,1,,CHEMBL620435,625.0,BAO_0000219,,
6552,5116,Cytotoxicity against Beta- tubulin mutant expressing A9-PTX10 cell line of humans was tested,F,,,Homo sapiens,9606.0,,,A9,,80024,N,1,Intermediate,1,,CHEMBL620436,625.0,BAO_0000219,,
6553,5116,Percentage inhibition at higher concentration (100 nM) against Beta- tubulin mutant expressing A9-PTX10 cell line,F,,,Homo sapiens,9606.0,,,A9,,80024,N,1,Intermediate,1,,CHEMBL876597,625.0,BAO_0000219,,
6554,15694,Inhibition of human ovarian carcinoma (A90) FGF-R overexpressing cell proliferation,F,,,Homo sapiens,9606.0,,,Human ovarian carcinoma cell line,,81037,N,1,Expert,1,,CHEMBL620437,874.0,BAO_0000219,,
6555,13038,"Tested for stimulating PI (phosphoinositol) hydrolysis in A9L-m1 cells, activity expressed as EC50 mM.",F,,,Mus musculus,10090.0,,,A9,,80024,N,1,Expert,1,,CHEMBL620438,625.0,BAO_0000219,,
6556,13038,Stimulating PI (phosphoinositol) hydrolysis in A9L-m1 cells.,F,,,Mus musculus,10090.0,,,A9,,80024,N,1,Expert,1,,CHEMBL620439,625.0,BAO_0000219,,
6557,10923,Increase in phosphoinositide (PI) metabolism in A9L-m1 cells at 100 uM.,F,,,Mus musculus,10090.0,,,A9,,80024,N,1,Expert,1,,CHEMBL619657,625.0,BAO_0000219,,
6558,10923,The increase in phosphoinositide (PI) metabolism in A9L-m1 cells was measured at 100 uM; - = Not determined,F,,,Mus musculus,10090.0,,,A9,,80024,N,1,Intermediate,1,,CHEMBL619658,625.0,BAO_0000219,,
6559,10923,The increase in phosphoinositide (PI) metabolism in A9L-m1 cells was measured at 100 uM; i = inactive,F,,,Mus musculus,10090.0,,,A9,,80024,N,1,Intermediate,1,,CHEMBL619659,625.0,BAO_0000219,,
6560,10923,"Increase in phosphoinositide (PI) metabolism in A9L-cholinergic receptor, muscarinic 3 expressing cells was measured at 100 uMolar",F,,,,,,,,,10649,H,8,Expert,1,,CHEMBL619660,,BAO_0000019,,
6561,10923,The increase in phosphoinositide (PI) metabolism in A9L-m3 cells was measured at 100 uM; - = Not determined,F,,,Mus musculus,10090.0,,,A9,,80024,N,1,Intermediate,1,,CHEMBL619661,625.0,BAO_0000219,,
6562,10923,The increase in phosphoinositide (PI) metabolism in A9L-m3 cells was measured at 100 uM; i = inactive,F,,,Mus musculus,10090.0,,,A9,,80024,N,1,Intermediate,1,,CHEMBL619662,625.0,BAO_0000219,,
6563,8158,Ability to inhibit growth of AA-6 cells (a mutant cell line resistant to 8-azaadenine and lacks adenine phosphoryltransferase) was determined,F,,,Cricetulus griseus,10029.0,,,AA6,,80663,N,1,Intermediate,1,,CHEMBL619663,975.0,BAO_0000219,,
6564,15494,Intracellular phosphorylation (100 uM) in uninfected AA2 cells was studied after 5 hrs of Incubation.,F,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL619664,,BAO_0000219,,
6565,15494,"Intracellular phosphorylation (100 uM) in uninfected AA2 cells was studied, after 5 hrs of Incubation.",F,,,Homo sapiens,9606.0,,,,,22226,U,0,Autocuration,1,,CHEMBL619665,,BAO_0000219,,
6566,12348,Anti -HIV activity was measured against AA5/HIV-1(IIIB),F,,,Homo sapiens,9606.0,,,AA5,,80662,N,1,Intermediate,1,,CHEMBL883244,974.0,BAO_0000219,,
6567,12348,Cytotoxicity was measured against AA5/HIV-1(IIIB),F,,,Homo sapiens,9606.0,,,AA5,,80662,N,1,Intermediate,1,,CHEMBL884011,974.0,BAO_0000219,,
6568,2726,Compound was evaluated for the anti-HIV activity against HIV strain IIIB in AA5 EBV-infected B-cell,F,,,Homo sapiens,9606.0,,,AA5,,80662,N,1,Intermediate,1,,CHEMBL619666,974.0,BAO_0000219,,
6569,2726,Compound was evaluated for the anti-HIV activity against HIV strain IIIB in U937 monocytic cell,F,,,Homo sapiens,9606.0,,,U-937,,80566,N,1,Intermediate,1,,CHEMBL619667,379.0,BAO_0000219,,
6570,10747,Hypersensitivity factor obtained from in vitro cytotoxicities against Chinese hamster ovary derived AA8 / UV4 cell lines,F,,,Cricetulus griseus,10029.0,,,UV4,,80578,N,1,Intermediate,1,,CHEMBL619668,274.0,BAO_0000219,,
6571,11005,"Inhibition of cell growth in culture against Chinese hamster ovary derived cell line, AA8",F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Expert,1,,CHEMBL619669,185.0,BAO_0000219,,
6572,12687,Average intracellular compound concentration when the hypoxic SER=1.6,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL876608,185.0,BAO_0000219,,
6573,12687,Average intracellular compound concentration when the hypoxic SER=1.6.,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL619670,185.0,BAO_0000219,,
6574,12687,Average intracellular compound concentration where the hypoxia sensitizer enhancement ratio (SER)=1.6,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL619671,185.0,BAO_0000219,,
6575,12687,Average intracellular compound concentration where the sensitizer enhancement ratio (SER)=1.6 under hypoxia,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL619672,185.0,BAO_0000219,,
6576,12687,Compound concentration at which sensitizer enhancement ratio =1.6 under hypoxia.,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL619673,185.0,BAO_0000219,,
6577,13436,"Compound was tested for the concentration required to reduce cell survival under hypoxic conditions, using the cell line AA8 in the clonogenic assay.",F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL619674,185.0,BAO_0000219,,
6578,13435,"Concentration needed to reduce cell survival to 10% of control values, using 1 hour exposure of plateau phase AA8 cells at 10e6 cells/ml",F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL619675,185.0,BAO_0000219,,
6579,13302,Activity to reduce the surviving fraction to 10% (CT10) was used as an inverse measure of cytotoxic potency in aerobic conditions,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL619676,185.0,BAO_0000219,,
6580,12687,Compound concentration required to reduce cell survival to 10% of control values under hypoxic condition,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL619677,185.0,BAO_0000219,,
6581,12687,Compound concentration required to reduce cell survival to 10% of control values under hypoxic condition,A,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL619678,185.0,BAO_0000219,,
6582,12687,Compound concentration required to reduce cell survival to 10% of control values under hypoxic condition.,A,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL619679,185.0,BAO_0000219,,
6583,12878,Concentration x time (uM h) to reduce cell survival to 10% of control values under hypoxic conditions by clonogenic assay,A,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Expert,1,,CHEMBL619680,185.0,BAO_0000219,,
6584,12878,Concentration x time (uM h) to reduce cell survival to 10% of control values under hypoxic conditions by clonogenic assay. Inactive at the solubility limit,A,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL621457,185.0,BAO_0000219,,
6585,14367,Cytotoxicity under aerobic conditions determined to reduce the AA8 cell survival to 10% controls in clonogenic assay,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Expert,1,,CHEMBL876609,185.0,BAO_0000219,,
6586,14367,Cytotoxicity under aerobic conditions determined to reduce the AA8 cell survival to 10% of controls in clonogenic assay,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL621458,185.0,BAO_0000219,,
6587,12398,Aerobic cytotoxicity was assessed in a growth inhibition assay using log phase cultures of the chinese hamster ovary fibroblast line AA8,F,,,hampster,36483.0,,,CHO-AA8,,80089,N,1,Expert,1,,CHEMBL621459,185.0,BAO_0000219,,
6588,12878,Aerobic growth inhibition in Chinese hamster cell line AA8,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Expert,1,,CHEMBL621460,185.0,BAO_0000219,,
6589,13820,Cytotoxicity against AA8 cell and IC50 values were determined as drug concentration required to inhibit cell protein to 50%.,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Expert,1,,CHEMBL621461,185.0,BAO_0000219,,
6590,13436,Inhibition of growth under aerobic conditions in AA8 cells,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Expert,1,,CHEMBL621462,185.0,BAO_0000219,,
6591,6084,Oral bioavailability in dog (dose 10 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621463,,BAO_0000218,,
6592,5711,Oral bioavailability in dog at 10 mg/kg of the compound,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621464,,BAO_0000218,,
6593,4353,Oral bioavailability in dog (dose 5 uM/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621465,,BAO_0000218,,
6594,4353,Oral bioavailability in dog (dose 5 uM/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621466,,BAO_0000218,,
6595,17800,Oral bioavailability in dog (mongrel),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621467,,BAO_0000218,,
6596,3994,Oral bioavailability in dog (dose 10 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621468,,BAO_0000218,,
6597,3994,Oral bioavailability in dog (dose 10 mg/kg),F,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL876734,,BAO_0000218,,
6598,5145,Bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618476,,BAO_0000218,,
6599,16452,Bioavailability in dog (dose 1 mg/kg i.v.),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618477,,BAO_0000218,,
6600,16452,Pharmacokinetic data for dose given to dogs intravenously (oral PK study in parentheses),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618478,,BAO_0000218,,
6601,5983,Pharmacokinetic property (F) was measured in dog at the dose of 0.032 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618479,,BAO_0000218,,
6602,4273,Bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618480,,BAO_0000218,,
6603,12500,Bioavailability in dog (dose 3-10 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618481,,BAO_0000218,,
6604,12500,The compound was tested for bioavailability of compound in plasma of dog; Complete,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL618482,,BAO_0000218,1969.0,
6605,3639,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618483,,BAO_0000218,,
6606,3880,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618484,,BAO_0000218,,
6607,4838,Bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618485,,BAO_0000218,,
6608,15600,oral bioavailability was measured in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618486,,BAO_0000218,,
6609,17248,Compound was tested for plasma protein binding in dog; Not determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618487,,BAO_0000218,,
6610,17248,Compound was tested for plasma protein binding of dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618488,,BAO_0000218,,
6611,17248,Compound was tested for plasma protein binding of dog; Not determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL876735,,BAO_0000218,,
6612,17443,Concentration in dogs after oral administration at dose of 1 mg/kg after 180 min.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618489,,BAO_0000218,,
6613,4186,Apparent terminal elimination half-life in dog after administration of 20 mg/kg dose through peroral route,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618490,,BAO_0000218,,
6614,3749,Half life was determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618491,,BAO_0000218,,
6615,3249,Half life by ''Cr'' assay in dog at a dose of 5 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618492,,BAO_0000218,,
6616,3022,Half life was evaluated in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL873354,,BAO_0000218,,
6617,3749,Half life was determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618493,,BAO_0000218,,
6618,2517,Biodistribution of compound was measured in bile at 2 hr post-injection in canine deep vein thrombosis model (DVT),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618494,,BAO_0000218,,
6619,2517,Biodistribution of compound was measured in heart at 2 hr post-injection in canine deep vein thrombosis model (DVT),A,In vivo,,Canis lupus familiaris,9615.0,,Heart,,,50588,N,1,Intermediate,1,,CHEMBL618495,,BAO_0000218,948.0,
6620,2517,Biodistribution of compound was measured in kidney at 2 hr post-injection in canine deep vein thrombosis model (DVT),A,In vivo,,Canis lupus familiaris,9615.0,,Kidney,,,50588,N,1,Intermediate,1,,CHEMBL618496,,BAO_0000218,2113.0,
6621,2517,Biodistribution of compound was measured in liver at 2 hr post-injection in canine deep vein thrombosis model (DVT),A,In vivo,,Canis lupus familiaris,9615.0,,Liver,,,50588,N,1,Intermediate,1,,CHEMBL618497,,BAO_0000218,2107.0,
6622,2517,Biodistribution of compound was measured in lung at 2 hr post-injection in canine deep vein thrombosis model (DVT),A,In vivo,,Canis lupus familiaris,9615.0,,Lung,,,50588,N,1,Intermediate,1,,CHEMBL618498,,BAO_0000218,2048.0,
6623,2517,Biodistribution of compound was measured in spleen at 2 hr post-injection in canine deep vein thrombosis model (DVT),A,In vivo,,Canis lupus familiaris,9615.0,,Spleen,,,50588,N,1,Intermediate,1,,CHEMBL618499,,BAO_0000218,2106.0,
6624,3639,LogP in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL876736,,BAO_0000218,,
6625,6227,Partition coefficient (logP),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618500,,BAO_0000218,,
6626,6227,Partition coefficient in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL857831,,BAO_0000218,,
6627,17764,Mean-residence time of compound after intravenous administration in dogs at 1.2 uM/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618501,,BAO_0000218,,
6628,4809,Pharmacokinetic parameter MRT was determined in Beagle dogs after (po) administration of a dose of 28 (uM/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618502,,BAO_0000218,,
6629,5600,In vitro metabolic stability determined after 30 min of incubation in dog hepatic microsomes,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618503,,BAO_0000218,,
6630,14294,Metabolism of compound in dog S9 microsomes ('++''indicates 20-50% largest observed peak),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618504,,BAO_0000218,,
6631,14294,Metabolism of compound in dog S9 microsomes ('++++' indicates largest observed peak),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618505,,BAO_0000218,,
6632,14294,Metabolism of compound in dog S9 microsomes; Trace,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618506,,BAO_0000218,,
6633,6251,In vitro metabolic potential in dog liver microsomes,A,,,Canis lupus familiaris,9615.0,,Liver,,,50588,N,1,Intermediate,1,,CHEMBL618507,,BAO_0000218,2107.0,
6634,3748,Oral bioavailability of perorally administered compound (10 mg/kg) was tested in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL876737,,BAO_0000218,,
6635,2713,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618508,,BAO_0000218,,
6636,6512,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618509,,BAO_0000218,,
6637,6679,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618510,,BAO_0000218,,
6638,3749,The compound was tested for bioavailability in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618511,,BAO_0000218,,
6639,3749,The compound was tested for oral bioavailability in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618512,,BAO_0000218,,
6640,6742,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618513,,BAO_0000218,,
6641,6227,Compound was tested for percent protein binding (PB) in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618514,,BAO_0000218,,
6642,6874,Apparent permeability coefficient (Papp) for apical to basolateral flux was determined in MadinDarby Canine Kidney cells,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL620052,,BAO_0000218,,
6643,2877,Compound was evaluated for plasma clearance.,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL620053,,BAO_0000218,1969.0,
6644,12500,The compound was tested for plasma clearance in dog,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL620054,,BAO_0000218,1969.0,
6645,12500,The compound was tested for plasma clearance in dog at dose of 3-10 mgkg,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL620055,,BAO_0000218,1969.0,
6646,4709,Plasma protein binding was determined after intravenous administration of 1 mg/kg in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL620056,,BAO_0000218,,
6647,5542,In vitro relative rate of metabolism was determined in dog liver microsomes,A,,,Canis lupus familiaris,9615.0,,Liver,,,50588,N,1,Intermediate,1,,CHEMBL620057,,BAO_0000218,2107.0,
6648,17594,Relative bioavailability after oral dose of compound at 3 mg/kg in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618939,,BAO_0000218,,
6649,2652,Compound was evaluated for half-life period in dogs at a dose of 5 mpk perorally,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618940,,BAO_0000218,,
6650,17764,Half life after intravenous administration in dogs at 1.2 uM/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618941,,BAO_0000218,,
6651,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor/lung bearing S180 tumor cell line for 30 minutes,A,,,Mus musculus,10090.0,,Lung,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL624473,42.0,BAO_0000218,2048.0,
6652,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor/lung bearing S180 tumor cell line for 4 hours,A,,,Mus musculus,10090.0,,Lung,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL624474,42.0,BAO_0000218,2048.0,
6653,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor/lung bearing S180 tumor cell line for 8 hours,A,,,Mus musculus,10090.0,,Lung,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL624475,42.0,BAO_0000218,2048.0,
6654,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/muscle bearing S180 tumor cell line for 1 hour,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL624476,42.0,BAO_0000218,,
6655,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor/muscle bearing S180 tumor cell line for 2 hours,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL623478,42.0,BAO_0000218,,
6656,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/muscle bearing S180 tumor cell line for 30 minutes,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL623479,42.0,BAO_0000218,,
6657,6599,In vivo biodistribution of radiolabeled [99mTc]-N4IPA in mice tumor/muscle bearing S180 tumor cell line for 4 hours,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL623480,42.0,BAO_0000218,,
6658,6599,In vivo biodistribution of radiolabeled [99mTc]N4IPA in mice tumor/muscle bearing S180 tumor cell line for 8 hours,A,,,Mus musculus,10090.0,,,CCRF S-180,,50594,N,1,Intermediate,1,,CHEMBL623481,42.0,BAO_0000218,,
6659,17641,C2 in brain of mice at the oral dose of 50 mg/kg,A,,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL623482,,BAO_0000218,955.0,
6660,17641,C2 in kidney of mice at the oral dose of 50 mg/kg,A,,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL623483,,BAO_0000218,2113.0,
6661,17641,C2 in liver of mice at the oral dose of 50 mg/kg,A,,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL623484,,BAO_0000218,2107.0,
6662,17641,C2 in lungs of mice at the oral dose of 50 mg/kg,A,,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL623485,,BAO_0000218,2048.0,
6663,17641,C2 in spleen of mice at the oral dose of 50 mg/kg,A,,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL623486,,BAO_0000218,2106.0,
6664,17852,Plasma clearance in mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623487,,BAO_0000218,,
6665,17764,Clearance of compound after intravenous administration in mice at 24 uM/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623488,,BAO_0000218,,
6666,17837,Clearance from mouse blood following i.v. administration of 10 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623489,,BAO_0000218,,
6667,2675,Clearance was evaluated in mice after intravenous administration,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL875157,,BAO_0000218,,
6668,2675,Clearance was evaluated in mice after oral administration,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623490,,BAO_0000218,,
6669,4239,Pharmacokinetic property (Plasma clearance) was measured in mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623491,,BAO_0000218,,
6670,17753,Plasma clearance of compound was determined at 40 mg/Kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623492,,BAO_0000218,,
6671,17753,Plasma clearance of at 24 mg/Kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623493,,BAO_0000218,,
6672,17753,Plasma clearance at 24 mg/Kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623494,,BAO_0000218,,
6673,17753,Plasma clearance at 5 mg/Kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623495,,BAO_0000218,,
6674,5727,Plasma clearance in mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623496,,BAO_0000218,,
6675,2862,Plasma clearance value upon iv administration in mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623497,,BAO_0000218,,
6676,5980,Total plasma clearance in mice,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL623498,,BAO_0000218,1969.0,
6677,17592,Clearance in mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623499,,BAO_0000218,,
6678,17718,Clearance value was determined,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623500,,BAO_0000218,,
6679,16597,Plasma clearance at a dose of 10 mg/kg intravenous administration in mice.,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623501,,BAO_0000218,,
6680,17384,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Intermediate,1,,CHEMBL875158,,BAO_0000100,,
6681,6062,Plasma clearance for the compound was measured in mouse after an iv dose of 1 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623502,,BAO_0000218,,
6682,17734,Plasma clearance rate after intraperitoneal administration of 100 mg/kg in mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623503,,BAO_0000218,,
6683,6348,Plasma clearance was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623504,,BAO_0000218,,
6684,5969,In vivo total clearance was determined in murine septicemia at dose of 100 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623505,,BAO_0000218,,
6685,5969,In vivo total clearance was determined in murine septicemia at dose of 50 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623506,,BAO_0000218,,
6686,5969,In vivo total clearance was determined in murine septicemia at dose of 50 mg/kg;ND=not determined,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623507,,BAO_0000218,,
6687,16597,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for Cmax,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623508,,BAO_0000218,,
6688,5781,Cmax after oral administration at 30 mg/kg in ICR mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623509,,BAO_0000218,,
6689,17764,Cmax after peroral administration in mice at 2.4 uM/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL875159,,BAO_0000218,,
6690,17641,Cmax in brain of mice at the oral dose of 50 mg/kg,A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL623510,,BAO_0000218,955.0,
6691,17641,Cmax in kidney of mice at the oral dose of 50 mg/kg,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL623511,,BAO_0000218,2113.0,
6692,17641,Cmax in liver of mice at the oral dose of 50 mg/kg,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL623512,,BAO_0000218,2107.0,
6693,17641,Cmax in lungs of mice at the oral dose of 50 mg/kg,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL623513,,BAO_0000218,2048.0,
6694,17764,Cmax in mice at 18 uM/kg i.p. administration,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623514,,BAO_0000218,,
6695,17764,Cmax in mice at 23 uM/kg i.v. administration,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622609,,BAO_0000218,,
6696,17764,Cmax in mice at 24 uM/kg i.p. administration,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622610,,BAO_0000218,,
6697,17764,Cmax in mice at 25 uM/kg i.p. administration,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621823,,BAO_0000218,,
6698,17764,Cmax in mice at 26 uM/kg i.p. administration,F,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621824,,BAO_0000218,,
6699,17641,Cmax in spleen of mice at the oral dose of 50 mg/kg,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL621825,,BAO_0000218,2106.0,
6700,16597,Cmax value at a dose of 10 mg/kg intravenous administration in mice.,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621826,,BAO_0000218,,
6701,16597,Cmax value at a dose of 10 mg/kg peroral administration in mice.,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621827,,BAO_0000218,,
6702,5727,Cmax value was determined,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621828,,BAO_0000218,,
6703,5951,Cmax value in IRC mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621829,,BAO_0000218,,
6704,5506,Cmax value was determined at a dose of 100 mg/kg (i.p.) in Mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621830,,BAO_0000218,,
6705,5506,Cmax value was determined at a dose of 200 mg/kg (i.p.) in Mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621831,,BAO_0000218,,
6706,14239,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL621832,,BAO_0000218,1969.0,
6707,4890,"Compound was evaluated for the pharmacokinetic parameter, maximum plasma concentration",A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL624579,,BAO_0000218,1969.0,
6708,429,Evaluated for pharmacokinetic parameter Cmax in mouse at the dose 20 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL624580,,BAO_0000218,,
6709,10986,anti-filarial Activity was measured against Acanthocheilonema viteae in jirds at 50 mg/kg/day(5 days) dose,F,,,Acanthocheilonema viteae,6277.0,,,,,50535,N,1,Intermediate,1,,CHEMBL624581,,BAO_0000218,,
6710,10986,anti-filarial Activity was measured against Acanthocheilonema viteae in jirds at 6.25 mg/kg/day(5 days) dose,F,,,Acanthocheilonema viteae,6277.0,,,,,50535,N,1,Intermediate,1,,CHEMBL624582,,BAO_0000218,,
6711,10986,anti-filarial Activity was measured against Acanthocheilonema viteae in jirds at 75 mg/kg/day(5 days) dose,F,,,Acanthocheilonema viteae,6277.0,,,,,50535,N,1,Intermediate,1,,CHEMBL624583,,BAO_0000218,,
6712,13227,Inhibitory activity against human tumor cell line A0375 melanoma.,F,,,Homo sapiens,9606.0,,,A-375,,80018,N,1,Intermediate,1,,CHEMBL624584,455.0,BAO_0000219,,
6713,4481,Displacement of [3H]N6-PIA binding from A1 receptor in whole rat brain membranes,B,,,Rattus norvegicus,10116.0,,,,Brain membranes,12512,D,9,Expert,1,,CHEMBL624585,,BAO_0000249,,
6714,16931,Forskolin-induced cAMP production at human A1 adenosine receptor,F,,,Homo sapiens,9606.0,,,,,114,D,9,Expert,1,,CHEMBL875165,,BAO_0000019,,
6715,3850,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 0.1; change of less than 5% of allosteric enhancement.,F,,,,,,,CHO,,114,H,8,Autocuration,1,,CHEMBL619490,449.0,BAO_0000219,,
6716,3850,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 0.1 uM; An increase of cAmp content of cells,F,,,,,,,CHO,,114,H,8,Autocuration,1,,CHEMBL619491,449.0,BAO_0000219,,
6717,3850,Percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 0.1 uM,F,,,,,,,CHO,,114,H,8,Expert,1,,CHEMBL619492,449.0,BAO_0000219,,
6718,3850,Percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 0.1 uM concentration,F,,,,,,,CHO,,114,H,8,Expert,1,,CHEMBL619493,449.0,BAO_0000219,,
6719,3850,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 0.1 uM concentration; An increase of cAmp content of cells,F,,,,,,,CHO,,114,H,8,Autocuration,1,,CHEMBL619494,449.0,BAO_0000219,,
6720,3850,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 0.1 uM concentration; change of less than 5% of allosteric enhancement,F,,,,,,,CHO,,114,H,8,Autocuration,1,,CHEMBL619495,449.0,BAO_0000219,,
6721,3850,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 0.1 uM concentration; change of less than 5% of allosteric enhancement.,F,,,,,,,CHO,,114,H,8,Autocuration,1,,CHEMBL619496,449.0,BAO_0000219,,
6722,3850,Percent response to 10 uM PD-81723 on CHO cells expressing human A1-adenosine receptor at 0.1 uM; An increase of cAmp content of cells,F,,,Homo sapiens,9606.0,,,CHO,,114,D,9,Expert,1,,CHEMBL619497,449.0,BAO_0000219,,
6723,3850,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 1 uM,F,,,,,,,CHO,,114,H,8,Autocuration,1,,CHEMBL619498,449.0,BAO_0000219,,
6724,3850,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 1 uM; change of less than 5% of allosteric enhancement.,F,,,,,,,CHO,,114,H,8,Autocuration,1,,CHEMBL619499,449.0,BAO_0000219,,
6725,3850,Percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 1 uM concentration,F,,,,,,,CHO,,114,H,8,Expert,1,,CHEMBL619500,449.0,BAO_0000219,,
6726,3850,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 1 uM concentration; change of less than 5% of allosteric enhancement.,F,,,,,,,CHO,,114,H,8,Autocuration,1,,CHEMBL619501,449.0,BAO_0000219,,
6727,3850,Percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 1 uM; An increase of cAmp content of cells,F,,,,,,,CHO,,114,H,8,Expert,1,,CHEMBL619502,449.0,BAO_0000219,,
6728,3850,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 10 uM,F,,,,,,,CHO,,114,H,8,Autocuration,1,,CHEMBL619503,449.0,BAO_0000219,,
6729,3850,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 10 uM; An increase of cAmp content of cells,F,,,,,,,CHO,,114,H,8,Autocuration,1,,CHEMBL619504,449.0,BAO_0000219,,
6730,3850,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 10 uM; change of less than 5% of allosteric enhancement.,F,,,,,,,CHO,,114,H,8,Autocuration,1,,CHEMBL621298,449.0,BAO_0000219,,
6731,3850,Percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 10 uM concentration,F,,,,,,,CHO,,114,H,8,Expert,1,,CHEMBL621299,449.0,BAO_0000219,,
6732,3850,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 10 uM concentration; An increase of cAmp content of cells,F,,,,,,,CHO,,114,H,8,Autocuration,1,,CHEMBL621300,449.0,BAO_0000219,,
6733,3850,The compound was tested for its percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 10 uM concentration; change of less than 5% of allosteric enhancement.,F,,,,,,,CHO,,114,H,8,Autocuration,1,,CHEMBL621301,449.0,BAO_0000219,,
6734,3850,Percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 10 uM; An increase of cAmp content of cells,F,,,,,,,CHO,,114,H,8,Expert,1,,CHEMBL621302,449.0,BAO_0000219,,
6735,12680,Ability to inhibit [125I]ET1 binding to vascular smooth muscle (vsm)- A10 cells,F,,,Oryctolagus cuniculus,9986.0,,,A10,,80013,N,1,Intermediate,1,,CHEMBL621303,164.0,BAO_0000219,,
6736,1313,In vitro potassium channel opening activity in A10 (smooth muscle) cells,F,,,Rattus norvegicus,10116.0,,,A10,,22226,U,0,Autocuration,1,,CHEMBL621304,164.0,BAO_0000219,,
6737,1313,In vitro potassium channel opening activity in A10 (smooth muscle) cells; Inactive,F,,,Rattus norvegicus,10116.0,,,A10,,22226,U,0,Autocuration,1,,CHEMBL621305,164.0,BAO_0000219,,
6738,17567,Effect on membrane potential of mitochondria in A10 smooth muscle cells from rats,F,,,Rattus norvegicus,10116.0,,,A10,,80013,N,1,Intermediate,1,,CHEMBL621306,164.0,BAO_0000219,,
6739,17567,Effect on membrane potential of mitochondria of A10 smooth muscle cells in rats,F,,,Rattus norvegicus,10116.0,,,A10,,80013,N,1,Intermediate,1,,CHEMBL618444,164.0,BAO_0000219,,
6740,11819,Percent decrease in fluorescence in a membrane potential assay using the A10 cell line derived from embryonic rat aorta at 0.001 uM,F,,,Rattus norvegicus,10116.0,,,A10,,80013,N,1,Intermediate,1,,CHEMBL618445,164.0,BAO_0000219,,
6741,13436,Compound was tested for aerobic growth inhibition against AA8 cells after 4 hr of exposure,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL618446,185.0,BAO_0000219,,
6742,12687,Concentration required to reduce AA8 cell numbers to 50% of controls in a growth inhibition microassay,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL618447,185.0,BAO_0000219,,
6743,12651,Concentration of the drug to inhibit chinese hamster ovary derived cell (AA8) growth in culture,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL618448,185.0,BAO_0000219,,
6744,13300,Cytotoxicity in a growth inhibition assay against aerobic cultures of AA8 cells was determined,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL618449,185.0,BAO_0000219,,
6745,15296,Cytotoxicity on AA8 cell growth (reduce cell number by 50%).,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL618637,185.0,BAO_0000219,,
6746,15328,"Cytotoxicity in chinese hamster ovary tumor cell line-AA8, by growth inhibition assay.",F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL618638,185.0,BAO_0000219,,
6747,13302,Growth inhibition activity was measured in repair proficient AA8 cells under aerobic conditions (4 hours drug exposure),F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL618639,185.0,BAO_0000219,,
6748,14367,"Growth inhibition of aerobic AA8 cells, after 18 hours exposure",F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Expert,1,,CHEMBL618640,185.0,BAO_0000219,,
6749,17002,In vitro cellular toxicity against chinese hamster AA8 cell line after 4 hr of compound exposure,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Expert,1,,CHEMBL618641,185.0,BAO_0000219,,
6750,13436,Inhibitory activity against AA8 cell growth in aerobic condition after 4 hr of exposure,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL618642,185.0,BAO_0000219,,
6751,13435,Inhibitory activity against aerobic growth of AA8 cells.,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL618643,185.0,BAO_0000219,,
6752,10503,Tested for the in vitro cytotoxicity against transformed chinese hamster fibroblast line AA8,A,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL884013,185.0,BAO_0000219,,
6753,10503,In vitro cytotoxicity against transformed chinese hamster fibroblast line AA8,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Expert,1,,CHEMBL622723,185.0,BAO_0000219,,
6754,10503,Tested for the in vitro cytotoxicity against transformed chinese hamster fibroblast line AA8,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL622724,185.0,BAO_0000219,,
6755,15090,Tested for growth inhibition against AA8 tumor cell line(chinese hamster ovary).,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Expert,1,,CHEMBL622725,185.0,BAO_0000219,,
6756,10368,Cytotoxicity against AA8 cell line,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Expert,1,,CHEMBL622726,185.0,BAO_0000219,,
6757,12651,Hypersensitivity factor(HF) was determined as ratio of IC50(AA8) to IC50(UV4),F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL622727,185.0,BAO_0000219,,
6758,12687,In vitro therapeutic index (aerobic IC50 / hypoxic C1.6),A,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL622728,185.0,BAO_0000219,,
6759,12687,In vitro therapeutic index (aerobic IC50 / hypoxic C1.6),F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL622729,185.0,BAO_0000219,,
6760,12687,In vitro therapeutic index (aerobic IC50 / hypoxic C1.6),A,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL622730,185.0,BAO_0000219,,
6761,1890,Compound was evaluated for cytotoxicity against CHO AA8 cell lines for 4 hr at pH-7.4,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL622731,185.0,BAO_0000219,,
6762,10747,Compound was evaluated for in vitro cytotoxicities against Chinese hamster ovary derived AA8 cell lines.,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL622732,185.0,BAO_0000219,,
6763,10747,Compound was evaluated for in vitro cytotoxicities against Chinese hamster ovary derived AA8 cell lines.,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Intermediate,1,,CHEMBL622733,185.0,BAO_0000219,,
6764,11616,Maximum tolerated dose (MTD) in C3H/HeN mice (single ip dose),F,,,Cricetulus griseus,10029.0,,,,,22224,U,0,Autocuration,1,,CHEMBL622734,,BAO_0000218,,
6765,11616,Concentration required to increase radiation sensitivity by 1.3 when AA8 cells are exposed to drug for 30 min before and during irradiation under hypoxic condition.,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Expert,1,,CHEMBL622735,185.0,BAO_0000219,,
6766,3471,Oxygen dependence of cytotoxicity was assessed by clonogenic assay using stirred suspension cultures of AA8 cells after 1 hr under anoxic conditions,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL618746,185.0,BAO_0000219,,
6767,3471,Oxygen dependence of cytotoxicity was assessed by clonogenic assay using stirred suspension cultures of AA8 cells after 3h under anoxic conditions,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL618747,185.0,BAO_0000219,,
6768,3471,Oxygen dependence of cytotoxicity was assessed by clonogenic assay using stirred suspension cultures of AA8 cells after 4 hr under anoxic conditions,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL620540,185.0,BAO_0000219,,
6769,3471,Oxygen dependence of cytotoxicity was assessed by clonogenic assay using stirred suspension cultures of AA8 cells after 1 hr under aerobic conditions,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL620541,185.0,BAO_0000219,,
6770,3471,Oxygen dependence of cytotoxicity was assessed by clonogenic assay using stirred suspension cultures of AA8 cells after 3h under aerobic conditions,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL620542,185.0,BAO_0000219,,
6771,3471,Oxygen dependence of cytotoxicity was assessed by clonogenic assay using stirred suspension cultures of AA8 cells after 4 hr under aerobic conditions,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL620543,185.0,BAO_0000219,,
6772,3471,Ratio of oxygen dependence of cytotoxicities of AA8 cells in aerobic condition to anoxic condition,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL618832,185.0,BAO_0000219,,
6773,11616,Concentration required to reduce AA8 cell survival by 10%,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Expert,1,,CHEMBL618833,185.0,BAO_0000219,,
6774,2656,"Concentration required to reduce cell survival to 10% of controls under hypoxic conditions, using the AA8 (chinese hamster) aerobic cells",F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL618834,185.0,BAO_0000219,,
6775,10518,Tested for the product of the drug concentration to the exposure time needed to reduce cell survival to 10% of controls using AA8 cells at 10 E 6 /mL in the clonogenic assay,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL618835,185.0,BAO_0000219,,
6776,10518,CT10 (air/N2) ratio of the product of the drug concentration to the exposure time needed to reduce cell survival to 10% of controls using AA8 cells at 10 E 6 /mL in the clonogenic assay,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL618836,185.0,BAO_0000219,,
6777,10518,CT10 (air/N2) ratio of the product of the drug concentration to the exposure time needed to reduce cell survival to 10% of controls using AA8 cells at 10 E 6 /mL in the clonogenic assay; range is 0.8-1.5,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL618837,185.0,BAO_0000219,,
6778,10518,CT10 (air/N2) ratio of the product of the drug concentration to the exposure time needed to reduce cell survival to 10% of controls using AA8 cells at 10 E 6 /mL in the clonogenic assay; range is 1-2,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL618838,185.0,BAO_0000219,,
6779,16156,Ability to reduce cell density of AA8 cells to 50% after 4 hr of exposure to air,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL618839,185.0,BAO_0000219,,
6780,2656,Aerobic cytotoxic activity was evaluated by the growth inhibition of AA8 (chinese hamster) aerobic cells,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL618840,185.0,BAO_0000219,,
6781,11005,"Compound was evaluated for the inhibition of cell growth in culture against Chinese hamster ovary derived cell line, AA8",F,,,Cricetulus griseus,10029.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618841,,BAO_0000019,,
6782,11942,Concentration for 50% inhibition of AA8 cells growth under aerobic conditions after 18 hours exposure,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL618842,185.0,BAO_0000219,,
6783,2128,Concentration required for 50% inhibition of growth of AA8 cells following 4 hr drug exposure,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL618843,185.0,BAO_0000219,,
6784,16907,Half life period after 15 mg/kg iv dose in Dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618844,,BAO_0000218,,
6785,16907,Half life period after 30 mg/kg po dose in Dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618845,,BAO_0000218,,
6786,9579,Half life was measured after oral 2b administration (tested in 6 dogs),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618846,,BAO_0000218,,
6787,9579,Half life was measured in dog after oral 17b administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618847,,BAO_0000218,,
6788,9579,Pharmacokinetic parameter T max determined in dog after oral administration of 17b,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618848,,BAO_0000218,,
6789,9579,Pharmacokinetic parameter T max determined in dog after oral administration of 2b,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618849,,BAO_0000218,,
6790,16907,Tmax value after 15 mg/kg iv dose in Dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618850,,BAO_0000218,,
6791,16907,Tmax value after 30 mg/kg po dose in Dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618851,,BAO_0000218,,
6792,3184,Compound was evaluated for its half life when administered intravenously in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL873815,,BAO_0000218,,
6793,5017,Compound was tested for plasma half life when administered in dog perorally (1 mg/kg) and intravenously (0.2 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL618852,,BAO_0000218,1969.0,
6794,6821,Elimination Half-life of compound was determined in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618853,,BAO_0000218,,
6795,17839,Half life of compound in dog following oral administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618854,,BAO_0000218,,
6796,17267,Half life of compound was determined in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618855,,BAO_0000218,,
6797,4727,Half life of compound was determined in dog blood,A,,,Canis lupus familiaris,9615.0,,Blood,,,50588,N,1,Intermediate,1,,CHEMBL618856,,BAO_0000218,178.0,
6798,5238,Half life after oral and iv dosing in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875827,,BAO_0000218,,
6799,4942,Half life in dogs in hours,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618857,,BAO_0000218,,
6800,6505,Half life on i.v. administration of 2 mg/kg was measured in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618858,,BAO_0000218,,
6801,5130,t1/2 in dog after oral dose (1 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618859,,BAO_0000218,,
6802,1475,Half life was evaluated in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618860,,BAO_0000218,,
6803,17804,Half life period of compound was determined after intravenous administration at 2 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618861,,BAO_0000218,,
6804,17804,Half life period of compound was determined after peroral administration at 2 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622539,,BAO_0000218,,
6805,6084,Half life period (10 mg/kg) was determined in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622540,,BAO_0000218,,
6806,6084,Half life period (10 mg/kg) was determined in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL873803,,BAO_0000218,,
6807,5542,Half life period by iv administration in dog at a dose of 0.3 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL873804,,BAO_0000218,,
6808,5542,Half life period by po administration in dog at a dose of 0.3 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624311,,BAO_0000218,,
6809,6084,Half life period in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624312,,BAO_0000218,,
6810,6241,Half life period in dogs after oral administration at 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624313,,BAO_0000218,,
6811,1916,Half life period was evaluated against Beagle dog at a dose of 15 mg/kg after po administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624314,,BAO_0000218,,
6812,6621,Half-life of compound was determined in dogs,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624315,,BAO_0000218,,
6813,1696,Half-life in dog plasma,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL624316,,BAO_0000218,1969.0,
6814,17800,Half-life in mongrel dogs was determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624317,,BAO_0000218,,
6815,17657,Half-life in dog upon oral administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624318,,BAO_0000218,,
6816,17657,Half-life in dog upon oral administration; Unable to calculate,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624319,,BAO_0000218,,
6817,4239,Half-life was measured in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624496,,BAO_0000218,,
6818,5985,Half-life was measured in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624497,,BAO_0000218,,
6819,9932,Half-recovery time (T1/2) of the vascular resistance decrease at ED30 in anesthetized dogs,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624498,,BAO_0000218,,
6820,5199,Oral half life was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624499,,BAO_0000218,,
6821,5199,Plasma elimination half-life (08 h) was determined in canine following intravenous (iv) administration (1 mg/kg).,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL624500,,BAO_0000218,1969.0,
6822,1475,Plasma half life was evaluated,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL624501,,BAO_0000218,1969.0,
6823,1475,Plasma half life was evaluated in Dog,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL623666,,BAO_0000218,1969.0,
6824,1475,Plasma half life was evaluated in dog,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL623667,,BAO_0000218,1969.0,
6825,6316,T1/2 (Half-life) was after oral administration at 5 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623668,,BAO_0000218,,
6826,4883,Tested for the half life value in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623669,,BAO_0000218,,
6827,4727,Maximum time at the dose of 2 mg/kg in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623670,,BAO_0000218,,
6828,1916,Maximum time was evaluated against Beagle dog at a dose of 15 mg/kg after po administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623671,,BAO_0000218,,
6829,1337,Maximum time taken to reach maximum blood concentration was determined in dogs after oral administration (10 mg/kg) as a 0.05 M citric acid solution.,A,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,50588,N,1,Intermediate,1,,CHEMBL875945,,BAO_0000218,178.0,
6830,1337,Maximum time taken to reach maximum blood concentration was determined in dogs after oral administration (8 mg/kg) as a 0.05 M citric acid solution.,A,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,50588,N,1,Intermediate,1,,CHEMBL623672,,BAO_0000218,178.0,
6831,6265,Pharmacokinetic (PK) property (Tmax) was determined in dog at the single dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623673,,BAO_0000218,,
6832,4809,Pharmacokinetic parameter Tmax was determined in Beagle dogs after (iv) administration of a dose of 28 (uM/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623674,,BAO_0000218,,
6833,5983,Pharmacokinetic property (Tmax) was measured in dog at the dose of 0.032 mg/kg p.o.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623675,,BAO_0000218,,
6834,5313,"Tested for the pharmacokinetic data, time required to reach Cmax (Tmax) in dog",A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL872526,,BAO_0000218,,
6835,5313,"Tested for the pharmacokinetic data, time required to reach Cmax (Tmax) in dog at dosage of 10 mpk",A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623676,,BAO_0000218,,
6836,17650,Time for maximum plasma concentration was measured in dogs after an oral dose of 10 uM/kg,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL623677,,BAO_0000218,1969.0,
6837,5199,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in male and female Beagle dogs.,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL623678,,BAO_0000218,1969.0,
6838,933,Time taken for maximum plasma concentration in dog,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL623679,,BAO_0000218,1969.0,
6839,16367,Time to reach Cmax after oral administration to dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623680,,BAO_0000218,,
6840,6348,Time to reach maximum plasma concentration was determined in dog after 1 mg/kg (i.v.) and 5 mg/kg (p.o.) administration,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL623681,,BAO_0000218,1969.0,
6841,6316,Tmax (time to reach maximum concentration) was after oral administration at 5 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623682,,BAO_0000218,,
6842,6215,Tmax after peroral administration (1 mg/kg) was determined in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623683,,BAO_0000218,,
6843,3598,Tmax of compound determined in dog after iv administration at a dose of 10 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Expert,1,,CHEMBL623684,,BAO_0000218,,
6844,4527,Tmax by oral administration at a dose of 10 uM/kg in dog was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622745,,BAO_0000218,,
6845,17764,Tmax after peroral administration in dogs at 2.4 uM/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622746,,BAO_0000218,,
6846,5969,In vivo Cmax in mice at dose of 100 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622747,,BAO_0000218,,
6847,5969,In vivo Cmax in mice at dose of 50 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622748,,BAO_0000218,,
6848,4573,Maximal concentration determined at a dose 10 mg/kg administered intraperitoneally to mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622749,,BAO_0000218,,
6849,3277,Maximum plasma concentration was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL622750,,BAO_0000218,1969.0,
6850,17734,Maximum concentration in plasma was determined after intraperitoneal administration of 100 mg/kg in mice,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL623411,,BAO_0000218,1969.0,
6851,3132,Maximum concentration obtained in mouse plasma was determined,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL875946,,BAO_0000218,1969.0,
6852,3132,Maximum concentration obtained in mouse plasma was determined at dose 25 mg/kg,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL623412,,BAO_0000218,1969.0,
6853,6348,Maximum plasma concentration of compound was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL623413,,BAO_0000218,1969.0,
6854,17729,Maximum plasma concentration when injected i.p. in mice at a dose of 50 mg/kg,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL623414,,BAO_0000218,1969.0,
6855,17729,Maximum plasma concentration when injected intravenously in mice at a dose of 20 mg/kg,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL623415,,BAO_0000218,1969.0,
6856,17729,Maximum plasma concentration when injected perorally in mice at a dose of 50 mg/kg,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL623416,,BAO_0000218,1969.0,
6857,17728,Maximal plasma concentration in BALB/C mice after 20 mg/kg intraperitoneal dose,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL623417,,BAO_0000218,1969.0,
6858,17728,Maximal plasma concentration in BALB/C mice after 20 mg/kg intravenous dose,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL623418,,BAO_0000218,1969.0,
6859,17728,Maximal plasma concentration in BALB/C mice after 50 mg/kg oral dose,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL623419,,BAO_0000218,1969.0,
6860,4066,Peak concentration at a single subcutaneous administration of 40 mg/kg in mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622816,,BAO_0000218,,
6861,6178,Pharmacokinetic property (C(max)) was determined after ip administration of 32 mg/kg in mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623313,,BAO_0000218,,
6862,6178,Pharmacokinetic property (C(max)) was determined after po administration of 32 mg/kg in mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623314,,BAO_0000218,,
6863,3760,Pharmacokinetic studies were carried out in vivo after administration of compound at 5 mg/kg intravenously in mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL876788,,BAO_0000218,,
6864,3760,Pharmacokinetic studies were carried out in vivo after administration of compound at 5 mg/kg perorally in mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623315,,BAO_0000218,,
6865,3760,Pharmacokinetic studies were carried out in vivo after administration of compound at 50 mg/kg intravenously in mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623316,,BAO_0000218,,
6866,3760,Pharmacokinetic studies were carried out in vivo after administration of compound at 50 mg/kg perorally in mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623317,,BAO_0000218,,
6868,5961,Cmax in male mice after 2 mg/kg oral dose,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623319,,BAO_0000218,,
6869,6137,Plasma concentration of 5-FU in HT-3 (human cervical cancer) xenograft mice at 1.38 mg/kg oral dose co-administered with 135 mg/kg Capecitabine,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623320,,BAO_0000218,,
6870,3802,Tested for Cmax value at the dose of 10 mg/kg when administered perorally in mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623321,,BAO_0000218,,
6871,3535,Concentration in plasma (systemic) following oral dose in mouse at 0.25 hr,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623322,,BAO_0000218,,
6872,3535,Concentration in plasma (systemic) following oral dose in mouse at 1 hr,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623323,,BAO_0000218,,
6873,3535,Concentration in plasma (systemic) following oral dose in mouse at 24 hr,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623324,,BAO_0000218,,
6874,3535,Concentration in plasma (systemic) following oral dose in mouse at 2 hr,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623325,,BAO_0000218,,
6875,3535,Concentration in plasma (systemic) following oral dose in mouse at 4 hr,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623326,,BAO_0000218,,
6876,3535,Concentration in plasma (systemic) following oral dose in mouse at 6 hr,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623327,,BAO_0000218,,
6877,2862,Maximum concentration in plasma upon oral administration in mouse,A,,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL623328,,BAO_0000218,1969.0,
6878,2675,Maximum plasma concentration was evaluated in mice after oral administration,A,,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL623329,,BAO_0000218,1969.0,
6879,2675,Maximum plasma concentration was evaluated in mice after intravenous administration; Cp max Not determined,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL623330,,BAO_0000218,1969.0,
6880,5399,Dose at which the compound induced fecal excretion in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL876789,,BAO_0000218,,
6893,11819,Percent decrease in fluorescence in a membrane potential assay using the A10 cell line derived from embryonic rat aorta at 0.01 uM,F,,,Rattus norvegicus,10116.0,,,A10,,80013,N,1,Expert,1,,CHEMBL623333,164.0,BAO_0000219,,
6894,11819,Percent decrease in fluorescence in a membrane potential assay using the A10 cell line derived from embryonic rat aorta at 0.1 uM,F,,,Rattus norvegicus,10116.0,,,A10,,80013,N,1,Expert,1,,CHEMBL623334,164.0,BAO_0000219,,
6895,11819,Percent decrease in fluorescence in a membrane potential assay using the A10 cell line derived from embryonic rat aorta at 1.0 uM,F,,,Rattus norvegicus,10116.0,,,A10,,80013,N,1,Expert,1,,CHEMBL627536,164.0,BAO_0000219,,
6896,11819,Percent decrease in fluorescence in a membrane potential assay using the A10 cell line derived from embryonic rat aorta at 10.0 uM,F,,,Rattus norvegicus,10116.0,,,A10,,80013,N,1,Expert,1,,CHEMBL627537,164.0,BAO_0000219,,
6897,16361,In vitro [14C]- creatine uptake (1 mM) was determined in rat A10 smooth muscle cells at a concentration of (1 mM),F,,,Rattus norvegicus,10116.0,,,A10,,80013,N,1,Intermediate,1,,CHEMBL627538,164.0,BAO_0000219,,
6898,2288,Cytotoxicity was evaluated against A121 ovarian carcinoma human cancer cell line,F,,,Homo sapiens,9606.0,,,A121,,80655,N,1,Intermediate,1,,CHEMBL884106,393.0,BAO_0000219,,
6899,10404,Anticancer activity against human ovarian carcinoma A121 cells,F,,,Homo sapiens,9606.0,,,A121,,80655,N,1,Intermediate,1,,CHEMBL625294,393.0,BAO_0000219,,
6900,14790,Cytotoxic effect (tumor cell growth inhibition) on the human cell line A121 ovarian carcinoma at the dose of of 16.6 mM,F,,,Homo sapiens,9606.0,,,A121,,80655,N,1,Intermediate,1,,CHEMBL625295,393.0,BAO_0000219,,
6901,14790,Cytotoxic effect (tumor cell growth inhibition) on the human cell line A121 ovarian carcinoma at the dose of of 83 mM,F,,,Homo sapiens,9606.0,,,A121,,80655,N,1,Intermediate,1,,CHEMBL625296,393.0,BAO_0000219,,
6902,14253,Growth inhibition of human ovarian carcinoma (A121) cell line,F,,,Homo sapiens,9606.0,,,A121,,80655,N,1,Expert,1,,CHEMBL625297,393.0,BAO_0000219,,
6903,13617,Concentration required to inhibit growth of human tumor A121 (ovarian) cell line.,F,,,Homo sapiens,9606.0,,,A121,,80655,N,1,Expert,1,,CHEMBL625298,393.0,BAO_0000219,,
6904,1003,Cytotoxicity against human A121 ovarian cells,F,,,Homo sapiens,9606.0,,,A121,,80655,N,1,Intermediate,1,,CHEMBL625960,393.0,BAO_0000219,,
6905,830,Cytotoxicity was evaluated in vitro against A121 (ovarian carcinoma) human tumor cell lines,F,,,Homo sapiens,9606.0,,,A121,,80655,N,1,Intermediate,1,,CHEMBL625961,393.0,BAO_0000219,,
6906,12307,In vitro cytotoxicity against human ovarian carcinoma A21,F,,,Homo sapiens,9606.0,,,A121,,80655,N,1,Intermediate,1,,CHEMBL625962,393.0,BAO_0000219,,
6907,14254,Inhibition of the growth against human Ovarian Carcinoma (A121) cell line after 72 hr exposure,F,,,Homo sapiens,9606.0,,,A121,,80655,N,1,Intermediate,1,,CHEMBL624717,393.0,BAO_0000219,,
6908,13370,Inhibitory activity of compound against human A121 ovarian cell line.,F,,,Homo sapiens,9606.0,,,A121,,80655,N,1,Intermediate,1,,CHEMBL624718,393.0,BAO_0000219,,
6909,14790,Dose at which compound exhibits cytotoxicity in the A121 ovarian carcinoma cell line.,F,,,Homo sapiens,9606.0,,,A121,,80655,N,1,Intermediate,1,,CHEMBL624719,393.0,BAO_0000219,,
6910,3614,Inhibition of growth of human ovarian tumor cell line (A121) after 72 hr of drug exposure,F,,,Homo sapiens,9606.0,,,A121,,80655,N,1,Intermediate,1,,CHEMBL624720,393.0,BAO_0000219,,
6911,2664,Compound was evaluated for in vitro antiproliferative activity against A172 human CNS cancer cell line,F,,,Homo sapiens,9606.0,,,A 172,,80012,N,1,Intermediate,1,,CHEMBL624721,622.0,BAO_0000219,,
6912,2037,In vitro cytotoxicity against A172 human tumor cell lines.,F,,,Homo sapiens,9606.0,,,A 172,,80012,N,1,Expert,1,,CHEMBL624722,622.0,BAO_0000219,,
6913,14539,Growth inhibition time for A172 Human Glioma cell growth at concentration 5 uM,F,,,Homo sapiens,9606.0,,,A 172,,80012,N,1,Intermediate,1,,CHEMBL877597,622.0,BAO_0000219,,
6914,2836,Compound was evaluated for cytotoxicity against human glioblastoma (A172) cell line,F,,,Homo sapiens,9606.0,,,A 172,,80012,N,1,Intermediate,1,,CHEMBL624723,622.0,BAO_0000219,,
6915,10708,Evaluated for the inhibitory concentration required to cause growth inhibition of A172Mer- cell line of central nervous system (CNS) using the MTT Cytotoxicity Assay,F,,,Homo sapiens,9606.0,,,A 172,,80012,N,1,Intermediate,1,,CHEMBL624724,622.0,BAO_0000219,,
6916,8975,Association constant against A2 adenosine receptor,B,,,Canis lupus familiaris,9615.0,,,,,104729,H,4,Autocuration,1,,CHEMBL624725,,BAO_0000224,,
6917,7645,In vitro effective dose that causes 50% inhibition of growth of A2 cell line - amelanotic melanoma,F,,,fish,,,,A2,,80656,N,1,Intermediate,1,,CHEMBL624726,1085.0,BAO_0000219,,
6918,11377,Ratio of Ki for adenosine A2 and A1 receptor binding,B,,,Rattus norvegicus,10116.0,,,,,104713,D,5,Autocuration,1,,CHEMBL857535,,BAO_0000224,,
6919,13528,In vitro cytotoxicity against A204 human rhabdomyosarcoma cancer cell line,F,,,Homo sapiens,9606.0,,,A204,,80014,N,1,Expert,1,,CHEMBL624727,623.0,BAO_0000219,,
6920,10160,In vitro antitumor activity against A204 rhabdomyosarcoma tumor cell line was determined,F,,,Homo sapiens,9606.0,,,A204,,80014,N,1,Expert,1,,CHEMBL624728,623.0,BAO_0000219,,
6921,15144,The compound was tested in vitro for antiproliferative activity against A2058 tumor cell lines,F,,,Homo sapiens,9606.0,,,A2058,,80015,N,1,Intermediate,1,,CHEMBL624729,404.0,BAO_0000219,,
6922,13160,Growth inhibition against Human squamous cell line(A 253),F,,,Homo sapiens,9606.0,,,A253 cell line,,80657,N,1,Intermediate,1,,CHEMBL624730,973.0,BAO_0000219,,
6923,12898,Growth inhibition of human squamous carcinoma cell lines following continuous (120 hours) exposure to MTX and compound A253 cell line,F,,,Homo sapiens,9606.0,,,A253 cell line,,80657,N,1,Intermediate,1,,CHEMBL624731,973.0,BAO_0000219,,
6924,13069,The compound was tested for Growth inhibition of the human squamous cell carcinoma A253 cells,F,,,Homo sapiens,9606.0,,,A253 cell line,,80657,N,1,Intermediate,1,,CHEMBL624732,973.0,BAO_0000219,,
6925,15984,Growth inhibition of A253 cell lines.,F,,,Homo sapiens,9606.0,,,A253 cell line,,80657,N,1,Intermediate,1,,CHEMBL883245,973.0,BAO_0000219,,
6926,15564,Growth inhibition of human squamous cell carcinoma A253 cells during continuous Exposure (0-12 h),F,,,Homo sapiens,9606.0,,,A253 cell line,,80657,N,1,Intermediate,1,,CHEMBL624733,973.0,BAO_0000219,,
6927,15564,Growth inhibition of human squamous cell carcinoma A253 cells during continuous Exposure (0-12 h); ND means not determined,F,,,Homo sapiens,9606.0,,,A253 cell line,,80657,N,1,Intermediate,1,,CHEMBL624734,973.0,BAO_0000219,,
6928,15564,Growth inhibition of human squamous cell carcinoma A253 cells during continuous Exposure (0-12 h); ND means not determined,F,,,Homo sapiens,9606.0,,,A253 cell line,,80657,N,1,Intermediate,1,,CHEMBL624735,973.0,BAO_0000219,,
6929,4720,In vitro cytotoxicity causing 50% growth inhibition was determined against A270 (human ovarian cancer)cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621780,478.0,BAO_0000219,,
6930,16112,Antitumor activity of compound for 96-h exposure in A2780 human ovarian cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL877598,478.0,BAO_0000219,,
6931,16597,Cytotoxic activity against A2780 human ovarian carcinoma cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL621781,478.0,BAO_0000219,,
6932,16378,Cytotoxicity against human cancer cell lines A2780 (ovarian),F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621782,478.0,BAO_0000219,,
6933,16085,Growth and colony formation inhibition of A2780 ovarian cancer cell lines,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL621783,478.0,BAO_0000219,,
6934,16317,Inhibition of cell growth in human ovarian carcinoma cell line (A2780) using the 96 hour continuous exposure sulforhodamine B (SRB) growth delay assay,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621784,478.0,BAO_0000219,,
6935,15748,The compound was tested for cytotoxic activity against A2780 cell line(human ovarian carcinoma ),F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621785,478.0,BAO_0000219,,
6936,16597,Inhibition of A2780 / DDP-R human ovarian carcinoma cell proliferation,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL621968,478.0,BAO_0000219,,
6937,16597,Inhibition of A2780 / TAX-R human ovarian carcinoma cell proliferation,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL621969,478.0,BAO_0000219,,
6938,16597,Inhibition of A2780 / TAX-S human ovarian carcinoma cell proliferation,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL621970,478.0,BAO_0000219,,
6939,15608,cytotoxic activity toward A2780 ovarian human cell line resistant (R) to cisplatin in experiment 2,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621971,478.0,BAO_0000219,,
6940,15608,cytotoxic activity toward A2780 ovarian human cell line resistant (R) to cisplatin in experiment 3,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621972,478.0,BAO_0000219,,
6941,15608,cytotoxic activity toward A2780 ovarian human cell line resistant (R) to cisplatin in experiment 5,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL884108,478.0,BAO_0000219,,
6942,15296,Cytotoxicity on AA8 cell growth (reduce cell number by 50%).,F,,,Cricetulus griseus,10029.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623826,,BAO_0000019,,
6943,10251,Evaluated for cytotoxicity under aerobic conditions against AA8 cells using microassay,A,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL623827,185.0,BAO_0000219,,
6944,10251,Evaluated for growth inhibition of AA8 cells under aerobic conditions,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL623828,185.0,BAO_0000219,,
6945,10251,Evaluated for growth inhibition of AA8 cells under aerobic or hypoxic conditions,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL623829,185.0,BAO_0000219,,
6946,10251,Evaluated for growth inhibition of AA8 cells under aerobic or hypoxic conditions (air/N2),F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL623830,185.0,BAO_0000219,,
6947,11858,Growth inhibition against CHO-derived cell line AA8,F,,,Cricetulus griseus,10029.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623831,,BAO_0000019,,
6948,11858,Growth inhibition against CHO-derived cell line AA8 (Non toxic at solubility limit) [RB6145 used as positive control],F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL623832,185.0,BAO_0000219,,
6949,11616,Growth inhibition in CHO subline AA8 cells exposed for 18 hr under aerobic(air) conditions,F,,,hampster,36483.0,,,CHO-AA8,,80089,N,1,Expert,1,,CHEMBL623833,185.0,BAO_0000219,,
6950,11616,Growth inhibitory activity against CHO subline AA8 cells exposed for 18 hr under aerobic conditions,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Expert,1,,CHEMBL623834,185.0,BAO_0000219,,
6951,10518,Tested for the concentration of the drug to reduce cell numbers to 50 percent of controls against AA8 cells in the microassay,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL623835,185.0,BAO_0000219,,
6952,11396,Growth inhibition of aerobic chinese hamster ovary fibroblast AA8 cell line using an exposure time of 18 hours,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL623836,185.0,BAO_0000219,,
6953,10518,IC50 (air/N2) ratio of the drug to reduce cell numbers to 50 percent of controls using AA8 cells in the microassay,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,22224,U,0,Autocuration,1,,CHEMBL623837,185.0,BAO_0000219,,
6954,11616,In vitro therapeutic index as ratio of CT10 and C1.3 calculated for AA8 cells.,F,,,Cricetulus griseus,10029.0,,,CHO-AA8,,80089,N,1,Expert,1,,CHEMBL623838,185.0,BAO_0000219,,
6955,14837,compound was evaluated for association constant (Ka) of isolated serum protein AAG,F,,,,,,,,,12675,H,8,Autocuration,1,,CHEMBL623839,,BAO_0000019,,
6956,14837,Number of binding sites (n) of isolated serum protein AAG,F,,,,,,,,,12675,H,8,Autocuration,1,,CHEMBL623840,,BAO_0000019,,
6957,16037,Association constant for binding to AATT duplex,B,,,,,,,,,22222,M,3,Intermediate,1,,CHEMBL623841,,BAO_0000225,,
6958,16597,Inhibition of ABAE human fibroblast cell proliferation,F,,,Homo sapiens,9606.0,,,ABAE,,100090,N,1,Expert,1,,CHEMBL623842,416.0,BAO_0000219,,
6959,8831,"Compound was evaluated for the antitumor activity against AC755 breast carcinoma for ip administration and daily x 10 schedule; Number of toxic deaths over total number of mice per group (T/C), 1/7 at dose of 25 mg/kg",F,,,Mus musculus,10090.0,,,AC755,,80668,N,1,Intermediate,1,,CHEMBL623843,1064.0,BAO_0000218,,
6960,13419,Percent change in total cholesterol(TC) versus (T0)- at which drug intervention begins at a dose of 25 mg/kg in the chronic cholesterol-fed rabbit model,F,,,Oryctolagus cuniculus,9986.0,,,,,102444,D,9,Expert,1,,CHEMBL618669,,BAO_0000218,,
6961,13419,Oral bioactivity expressed as %inhibition after 4 hours of drug administration (dose 25 mg/kg) in rabbit bioassay,F,In vivo,,Oryctolagus cuniculus,9986.0,,,,,102444,D,9,Expert,1,,CHEMBL618670,,BAO_0000218,,
6962,15778,Inhibitory activity against angiotensin-converting enzyme (ACE).,B,,,,,,,,,69,H,8,Autocuration,1,,CHEMBL618671,,BAO_0000357,,
6963,15778,oral activity against angiotensin -converting enzyme ( ACE) and neutral endopeptidase in mouse.,B,,,,,,,,,69,H,8,Autocuration,1,,CHEMBL618672,,BAO_0000357,,
6964,12988,Effect against HIV-1 chronically infected promonocytic cell line ACH-2 cells,F,,,Homo sapiens,9606.0,,,ACH-2 cell line,,80669,N,1,Intermediate,1,,CHEMBL618673,978.0,BAO_0000219,,
6965,12988,Effect against HIV-1 chronically infected promonocytic cell line ACH-2 cells in the presence of PMA(phorbol 12-myristate 13-acetate),F,,,Homo sapiens,9606.0,,,ACH-2 cell line,,80669,N,1,Intermediate,1,,CHEMBL618674,978.0,BAO_0000219,,
6966,12988,Effect against HIV-1 expression in a chronically infected human T cell line ACH-2,F,,,Human immunodeficiency virus 1,11676.0,,,T cell line,,22224,U,0,Autocuration,1,,CHEMBL618675,998.0,BAO_0000219,,
6967,12988,Effect against HIV-1 expression in a chronically infected human T cell line ACH-2 in the presence of PMA(phorbol 12-myristate 13-acetate),F,,,Human immunodeficiency virus 1,11676.0,,,T cell line,,22224,U,0,Autocuration,1,,CHEMBL618676,998.0,BAO_0000219,,
6968,12988,Effect against HIV-1 expression in a chronically infected human T cell line ACH-2i n the presence of PMA(phorbol 12-myristate 13-acetate),F,,,Human immunodeficiency virus 1,11676.0,,,T cell line,,22224,U,0,Autocuration,1,,CHEMBL618677,998.0,BAO_0000219,,
6969,11843,Inhibition of growth of renal cancer ACHN cell line,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL618678,626.0,BAO_0000219,,
6970,16939,Inhibition of growth of ACHN renal cancer cell line,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL618679,626.0,BAO_0000219,,
6971,4782,Inhibitory concentration required against ACHN renal cancer cell line,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL618680,626.0,BAO_0000219,,
6972,6310,Concentration required to inhibit growth of human renal (ACHN) cell line,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Expert,1,,CHEMBL618681,626.0,BAO_0000219,,
6973,6310,Concentration required to inhibit growth of human renal (ACHN) cell line; nt = not tested,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL618682,626.0,BAO_0000219,,
6974,12858,Cytotoxic activity against ACHN Renal cancer cell line,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL618683,626.0,BAO_0000219,,
6975,17380,Cytotoxicity evaluation against ACHN renal cancer cells,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL618684,626.0,BAO_0000219,,
6976,5858,In vitro antitumor activity against human renal ACHN cell line,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL618685,626.0,BAO_0000219,,
6977,3838,In vitro growth inhibition of compound was determined against ACHN cell lines of Renal cancer,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL876499,626.0,BAO_0000219,,
6978,3838,In vitro growth inhibition of compound was determined against ACHN cell lines of Renal cancer,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL618686,626.0,BAO_0000219,,
6979,5406,"Tested for the cytotoxicity against the Renal cancer cell line ACHN, growth inhibition by 50% is reported",F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL618687,626.0,BAO_0000219,,
6980,4071,The compound was tested in vitro for cytotoxicity against human tumor cell line ACHN (renal).,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL618688,626.0,BAO_0000219,,
6981,4071,Tested in vitro for cytotoxicity against human tumor cell line ACHN (renal).,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Expert,1,,CHEMBL618689,626.0,BAO_0000219,,
6982,4071,The compound was tested in vitro for cytotoxicity against human tumor cell line ACHN (renal); Not determined,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL618690,626.0,BAO_0000219,,
6983,15002,Antitumor activity was evaluated against human renal adenocarcinoma cell line ACHN.,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL618691,626.0,BAO_0000219,,
6984,14769,Compound was evaluated for in vitro activity against ACHN kidney cell lines (Human tumor cells ),F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL619373,626.0,BAO_0000219,,
6985,13958,"Compound was tested for antiproliferative activity against ACHN, human renal adenocarcinoma",F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL884008,626.0,BAO_0000219,,
6986,1665,Compound was tested for its effect on the proliferation of ACHN human kidney adenocarcinoma,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL619374,626.0,BAO_0000219,,
6987,15354,Compound was tested for the growth inhibition of ACHN renal tumor cell line,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL619375,626.0,BAO_0000219,,
6988,15354,Compound was tested for the growth inhibition of ACHN renal tumor cell line; ND=Not determined,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL619376,626.0,BAO_0000219,,
6989,13978,In vitro Growth Inhibitory activity against ACHN Human kidney cancer cell line,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL619377,626.0,BAO_0000219,,
6990,6798,In vitro cytotoxicity against human renal adenocarcinoma (ACHN) tumor cell line,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL619378,626.0,BAO_0000219,,
6991,2959,Tmax value after administration of 4 mg/Kg oral dose in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL872527,,BAO_0000218,,
6992,9932,"Time to peak response on lowering of vascular resistance, in dogs when administered intravenously",A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL876500,,BAO_0000218,,
6993,5546,Unbound plasma was determined in Beagle dog at a dose of 1 mg/kg by iv administration,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619379,,BAO_0000218,,
6994,16907,Volume distribution after 15 mg/kg iv dose in Dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619538,,BAO_0000218,,
6995,16907,Volume distribution after 30 mg/kg po dose in Dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619539,,BAO_0000218,,
6996,4257,Volume of distribution was determined in dog after a 3 mg/kg of iv dose,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619540,,BAO_0000218,,
6997,4305,Volume of distribution was determined by iv administration in dogs at a dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619541,,BAO_0000218,,
6998,5472,Volume of distribution was evaluated in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619542,,BAO_0000218,,
6999,6062,Terminal phase volume of distribution was measured in dog after an iv dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619543,,BAO_0000218,,
7000,3598,Apparent volume of the central plasma compartment (Vc) of compound determined in dog after iv administration at a dose of 10 mg/kg,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Expert,1,,CHEMBL619544,,BAO_0000218,,
7001,12500,The compound was tested for volume of distribution in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619545,,BAO_0000218,,
7002,12500,The compound was tested for volume of distribution in dog at dose of 3-10 mgkg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619546,,BAO_0000218,,
7003,6227,Vd (1 mg/kg) was determined in dog (in vivo),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619547,,BAO_0000218,,
7004,6227,Vd in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619548,,BAO_0000218,,
7005,4219,Volume distribution was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619549,,BAO_0000218,,
7006,1696,Volume of distribution in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619550,,BAO_0000218,,
7007,5542,Volume of distribution by as 4 fold increase by iv administration in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL876501,,BAO_0000218,,
7008,5199,Volume of distribution was determined in canine following intravenous (iv) administration of drug (1 mg/kg).,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619551,,BAO_0000218,,
7009,6348,Volume of distribution was determined in dog after 1 mg/kg (i.v.) and 5 mg/kg (p.o.) administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619552,,BAO_0000218,,
7010,4727,Volume distribution at the dose of 2 mg/kg in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619553,,BAO_0000218,,
7011,16367,Steady state volume of distribution was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618722,,BAO_0000218,,
7012,2652,Bioavailability as Vdss in dogs at 1 mg/kg intravenous dose,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618723,,BAO_0000218,,
7013,16452,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618724,,BAO_0000218,,
7014,16452,Pharmacokinetic data at 1 mg/kg dose given to dogs intravenously,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618725,,BAO_0000218,,
7015,16452,Bioavailability in dog (dose 1 mg/kg i.v.),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618726,,BAO_0000218,,
7016,5334,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Beagle dog (male),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618727,,BAO_0000218,,
7017,4239,Pharmacokinetic property (vdss) was measured in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624233,,BAO_0000218,,
7018,4709,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624234,,BAO_0000218,,
7019,5600,Vdss was determined after iv 0.1 mg/kg administration in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624235,,BAO_0000218,,
7020,6057,Volume displacement was calculated in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624236,,BAO_0000218,,
7021,5654,Volume distribution (Vdss) of compound was determined after intravenous administration in average of two dogs at a dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624237,,BAO_0000218,,
7022,5505,Volume distribution constant was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624238,,BAO_0000218,,
7023,4527,Volume distribution at a dose of 1 uM/kg in dog was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624239,,BAO_0000218,,
7024,4521,Volume distribution in dog after 2 mg/kg by oral and 0.5 mg/kg by intravenous administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875829,,BAO_0000218,,
7025,4521,Volume distribution in dog after 2 mg/kg by oral and 0.5 mg/kg by intravenous administration; ND is not determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624240,,BAO_0000218,,
7026,15660,Volume distribution (Vdss) was measured in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624241,,BAO_0000218,,
7027,15660,Volume distribution (Vdss) was measured in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624242,,BAO_0000218,,
7028,6679,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624243,,BAO_0000218,,
7029,5145,Volume of distribution in steady state was determined in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624244,,BAO_0000218,,
7030,6821,Volume of distribution of compound was determined in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624245,,BAO_0000218,,
7031,4137,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624246,,BAO_0000218,,
7032,5334,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Beagle dog (male),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624247,,BAO_0000218,,
7033,15660,Volume of distribution (Vdss) was measured in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624248,,BAO_0000218,,
7034,6642,Volumes of distribution in dog (dosed as a mixture of five compounds at 0.5 mpk each via iv only),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624249,,BAO_0000218,,
7035,6641,Volumes of distribution in dog (dosed at 0.5 mpk iv and 2.0 mpk orally),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624250,,BAO_0000218,,
7036,6642,Volumes of distribution in dog (dosed at 0.5 mpk iv and 2.0 mpk orally),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624251,,BAO_0000218,,
7037,11659,Maximum rate of depolarization of the upstroke of the action potential,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624252,,BAO_0000218,,
7038,6448,Steady state volume distribution in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624253,,BAO_0000218,,
7039,5474,Steady state volume of distribution at a dose of 0.2 mg/kg i.v.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624950,,BAO_0000218,,
7040,1466,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624951,,BAO_0000218,,
7041,6535,Volume distribution in dog after administration of 0.25 mg/kg iv; ND = not determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875830,,BAO_0000218,,
7042,6535,Volume distribution in dog after administration of 1 mg/kg iv,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624952,,BAO_0000218,,
7043,17764,Volume of solubility in solution after intravenous administration in dogs at 1.2 uM/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624953,,BAO_0000218,,
7044,6215,Vss after intravenous administration (0.5 mg/kg) was determined in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624954,,BAO_0000218,,
7045,6505,Vss on i.v. administration of 2 mg/kg was measured in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624955,,BAO_0000218,,
7046,3639,Vss was determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624956,,BAO_0000218,,
7047,3639,Vss in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625129,,BAO_0000218,,
7048,6062,Volume of distribution was measured in dog after an iv dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625130,,BAO_0000218,,
7049,4942,Volume distribution in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625131,,BAO_0000218,,
7050,17796,Volume of distribution in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625132,,BAO_0000218,,
7051,4883,Tested for the oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL872263,,BAO_0000218,,
7060,17837,Bioavailability of compound in mouse blood following p.o. administration of 30 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL624336,,BAO_0000218,,
7061,17729,Bioavailability after i.p. administration of 50 mg/kg of dose in mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL624337,,BAO_0000218,,
7062,17729,Bioavailability after peroral administration of 50 mg/kg of dose in mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL624338,,BAO_0000218,,
7063,4239,Bioavailability was measured in mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL624339,,BAO_0000218,,
7064,17592,Bioavailability in mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL624340,,BAO_0000218,,
7065,6348,Bioavailability was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL624341,,BAO_0000218,,
7066,2801,Bioavailability in mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL624342,,BAO_0000218,,
7067,2801,Compound was evaluated for its bioavailability in mice at a dose of 1 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL624343,,BAO_0000218,,
7068,17718,Oral bioavailability in mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL624344,,BAO_0000218,,
7069,5727,Oral availability at 50 mg/kg po in male mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL624345,,BAO_0000218,,
7070,5302,Oral bioavailability in mouse (dose 10 mg/kg),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL624346,,BAO_0000218,,
7071,3598,Oral bioavailability of compound determined in mouse after iv administration at a dose of 10 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Expert,1,,CHEMBL624347,,BAO_0000218,,
7072,5961,"Bioavailability in male mice, 2mg/kg oral and 1 mg/kg intravenous dose",A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL624348,,BAO_0000218,,
7074,6091,Oral bioavailability in mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622754,,BAO_0000218,,
7075,6091,Oral bioavailability in vivo in mice;ND=Not determined,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622755,,BAO_0000218,,
7076,5711,Oral bioavailability in mouse at 10 mg/kg of the compound,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622756,,BAO_0000218,,
7077,17728,Bioavailability in mouse (BALB/C) (dose 50 mg/kg i.p.),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622757,,BAO_0000218,,
7078,17728,Bioavailability in mouse (BALB/C) (dose 20 mg/kg i.v.),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622758,,BAO_0000218,,
7079,3802,Tested for bioavailability of the compound,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622759,,BAO_0000218,,
7080,3802,Tested for half life at the dose of 10 mg/kg when administered intravenously,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622760,,BAO_0000218,,
7081,14029,The plasma half life of compound was determined on EDTA prepared by mouse plasma. ,A,,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL622761,,BAO_0000218,1969.0,
7082,14029,The plasma half life of compound was determined on heparin prepared by human plasma. ,A,,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL622762,,BAO_0000218,1969.0,
7083,14029,The plasma half life of compound was determined on heparin prepared by human plasma; Not degraded,A,,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL622763,,BAO_0000218,1969.0,
7084,14029,The plasma half life of compound was determined on heparin prepared by mouse plasma. ,A,,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL622764,,BAO_0000218,1969.0,
7085,14029,The plasma half life of compound was determined on heparin prepared by mouse plasma; Not degraded,A,,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL622765,,BAO_0000218,1969.0,
7086,17753,Inhibitory concentration of compound was determined after intravenous administration in mice after 6 hours of exposure at 40 mg/Kg,F,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622766,,BAO_0000218,,
7087,17753,Inhibitory concentration of compound was determined after intravenous administration in mice after 8 hours of exposure at 24 mg/Kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622767,,BAO_0000218,,
7088,17753,Inhibitory concentration of compound was determined after intravenous administration in mice after 8 hours of exposure at 5 mg/Kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622768,,BAO_0000218,,
7089,10107,Biodistribution of intravenously injected [82Br]-labeled compound in blood of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.25 hours,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL875948,,BAO_0000218,178.0,
7090,10107,Biodistribution of intravenously injected [82Br]-labeled compound in blood of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.50 hours,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL622769,,BAO_0000218,178.0,
7091,10107,Biodistribution of intravenously injected [82Br]-labeled compound in blood of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 1 hours,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL622770,,BAO_0000218,178.0,
7092,10107,Biodistribution of intravenously injected [82Br]-labeled compound in blood of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 2 hours,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL622771,,BAO_0000218,178.0,
7093,10107,Biodistribution of intravenously injected [82Br]-labeled compound in blood of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 24 hours,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL622772,,BAO_0000218,178.0,
7094,10107,Biodistribution of intravenously injected [82Br]-labeled compound in blood of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 4 hours,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL622773,,BAO_0000218,178.0,
7095,10107,Biodistribution of intravenously injected [82Br]-labeled compound in blood of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 8 hours,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL622774,,BAO_0000218,178.0,
7096,10107,Biodistribution of intravenously injected [82Br]-labeled compound in bone of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.25 hours,A,In vivo,,Mus musculus,10090.0,,Bone,,,50594,N,1,Intermediate,1,,CHEMBL621725,,BAO_0000218,10000001.0,
7097,10107,Biodistribution of intravenously injected [82Br]-labeled compound in bone of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.5 hours,A,In vivo,,Mus musculus,10090.0,,Bone,,,50594,N,1,Intermediate,1,,CHEMBL621726,,BAO_0000218,10000001.0,
7098,15608,cytotoxic activity toward A2780 ovarian human cell line resistant (R) to cisplatin in experiment 8,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621727,478.0,BAO_0000219,,
7099,3290,In vitro cytotoxicity against human ovarian carcinoma cell line A2780 using sulforhodamine B (SRB) assay,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL622413,478.0,BAO_0000219,,
7100,2859,Compound was evaluated for cytotoxicity against A2780 cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL622414,478.0,BAO_0000219,,
7101,15688,Inhibition of A2780 cell clonogenic assay,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL622415,478.0,BAO_0000219,,
7102,5642,Cytotoxic effect on ovarian cancer cell line (A2780),F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL884001,478.0,BAO_0000219,,
7103,6633,Concentration required to inhibit A2780 cell growth when compared with control after incubation for 96 hr at 37 C,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL622416,478.0,BAO_0000219,,
7104,3906,"MDR-reversing activity was measured by vincristine accumulation in the multidrug resistant 2780AD, a subline of A2780 ovarian carcinoma cells at 10 mg/mL",F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL622417,478.0,BAO_0000219,,
7105,6788,50% growth inhibition of A2780 (Human ovarian carcinoma) cell line compared with untreated control cells,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL622590,478.0,BAO_0000219,,
7106,17582,Antiproliferative activity against human A2780 cells,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL622591,478.0,BAO_0000219,,
7107,17764,Inhibition of human A2780 cell proliferation,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL622592,478.0,BAO_0000219,,
7108,17764,Antiproliferative effect against human A2780 cell line was determined in a whole cell 72 hr cytotoxicity assay,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL622593,478.0,BAO_0000219,,
7109,17764,Inhibition of human A2780 cell proliferation (No data),F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL622594,478.0,BAO_0000219,,
7110,2815,Cell cytotoxicity was determined against human ovarian cancer (A2780) cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL622595,478.0,BAO_0000219,,
7111,16930,Compound was evaluated against human Ovarian carcinoma cell line A2780,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL622596,478.0,BAO_0000219,,
7112,17777,Growth inhibition against A2780 wild-type ovarian cell lines,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL622597,478.0,BAO_0000219,,
7113,17777,Compound was evaluated for growth inhibition against A2780 wild-type ovarian cell lines; No data,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL622598,478.0,BAO_0000219,,
7114,16936,Inhibition of tubulin polymerization in human ovarian cancer cell lines,F,,,Homo sapiens,9606.0,,,,,104766,D,5,Autocuration,1,,CHEMBL622599,,BAO_0000019,,
7115,13759,Compound was tested for in vitro growth inhibition of Ovarian carcinoma cell line panel A2780,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL622600,478.0,BAO_0000219,,
7116,13759,Compound was tested for in vitro growth inhibition of Ovarian carcinoma cell line panel A2780-R,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL622601,478.0,BAO_0000219,,
7117,13759,Compound was tested for in vitro growth inhibition of Ovarian carcinoma cell line panel A2780,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL622602,478.0,BAO_0000219,,
7118,13759,Compound was tested for in vitro growth inhibition of Ovarian carcinoma cell line panel A2780-R,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL622603,478.0,BAO_0000219,,
7119,15292,Compound was tested for inhibitory activity against A2780 human ovarian carcinoma cell line; activity expressed in Mean IC50 values,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL622604,478.0,BAO_0000219,,
7120,15292,Compound was tested for inhibitory activity against A2780cisR human ovarian carcinoma cell line; activity expressed in Mean IC50 values,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL622605,478.0,BAO_0000219,,
7121,15069,In vitro inhibition of human ovarian cell line A2780,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL622606,478.0,BAO_0000219,,
7122,15069,"In vitro inhibition of human ovarian cell line, resistant to cisplatin (A2780cisR).",F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL619463,478.0,BAO_0000219,,
7123,14073,Concentration of compound to inhibit the growth of human A2780 ovarian carcinoma cells(in vitro),F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619464,478.0,BAO_0000219,,
7124,14553,Concentration required to inhibit A2780-cell growth by 50%,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL619465,478.0,BAO_0000219,,
7125,13040,Concentration required to inhibit the cell growth by 50 % after 96 hr A2780 leukemic cells.,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL619466,478.0,BAO_0000219,,
7126,6891,Cytotoxic effect on human ovarian (A2780) cancer cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL619467,478.0,BAO_0000219,,
7127,15569,Cytotoxic activity in a panel of Human ovarian tumor A2780 cell line after 96h of drug exposure,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619468,478.0,BAO_0000219,,
7128,14190,Cytotoxic potency required to inhibit A2780 cell growth by 50% after cell drug contact for 96 hrs,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL619469,478.0,BAO_0000219,,
7129,15014,Cytotoxicity measured in human ovarian cell line A2780 using sulforhodamine B (SRB) assay,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL619470,478.0,BAO_0000219,,
7130,15014,Cytotoxicity activity of the compound was measured in human ovarian cell line A2780 using sulforhodamine B (SRB) assay,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619471,478.0,BAO_0000219,,
7131,17496,Cytotoxicity against human ovarian carcinoma A2780 cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619472,478.0,BAO_0000219,,
7132,13617,"Cytotoxicity against A2780-C25, oxaliplatin-resistant Ovarian carcinoma cell line",F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL619473,478.0,BAO_0000219,,
7133,13617,"Cytotoxicity against A2780-CP3, cisplatin-resistant Ovarian carcinoma cell line",F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL874368,478.0,BAO_0000219,,
7134,13617,"Cytotoxicity against A2780-DX5, Doxorubicin-resistant Ovarian carcinoma cell line",F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL884003,478.0,BAO_0000219,,
7135,13617,"Cytotoxicity against A2780-WT, human ovarian carcinoma cell line",F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL622690,478.0,BAO_0000219,,
7136,17672,Cytotoxicity against ovarian carcinoma A2780 tumor cell lines,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL622691,478.0,BAO_0000219,,
7137,4544,Dose of required to inhibit growth of cisplatin resistant human ovarian carcinoma (A2780 cisR) cell line with compound free controls as measured by the sulforhodamine B growth delay assay,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL622692,478.0,BAO_0000219,,
7138,4544,Dose of required to inhibit growth of human ovarian carcinoma (A2780) cell line with compound free controls as measured by the sulforhodamine B growth delay assay,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL623406,478.0,BAO_0000219,,
7139,16317,"Growth inhibition in human ovarian carcinoma cell line (A2780cisR,cisplatin-resistant) using the 96 hour exposure sulforhodamine B (SRB) growth delay assay",F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL884004,478.0,BAO_0000219,,
7140,15099,In vitro Cytotoxic activity of compound in comparison with reference compounds in human cell line A2780,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL623407,478.0,BAO_0000219,,
7141,13978,In vitro Growth Inhibitory activity against A2780 Human ovarian cancer cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL623408,478.0,BAO_0000219,,
7142,12989,In vitro antitumor activity against A2780 cell line.,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL623409,478.0,BAO_0000219,,
7143,5574,In vitro cytotoxic activity against human tumor cell line A2780 after incubation for 96 hours,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL623410,478.0,BAO_0000219,,
7144,13528,In vitro cytotoxicity against A2780 human ovarian cancer cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL623576,478.0,BAO_0000219,,
7145,12782,Inhibitory activity against kidney A-CHN tumor cell growth in culture,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL623577,626.0,BAO_0000219,,
7146,14255,The IC50 value was measured on ACHN cell line in renal tumor type.,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL623578,626.0,BAO_0000219,,
7147,16364,Concentration required for killing 50% of cells of renal ACHN cell lines was determined in vitro,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL623579,626.0,BAO_0000219,,
7148,17376,In vitro lethal concentration against most sensitive ACHN cell line,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Expert,1,,CHEMBL623580,626.0,BAO_0000219,,
7149,12016,Tested for cytotoxic activity against renal cancer ACHN cell line,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL623581,626.0,BAO_0000219,,
7150,6058,Compound tested for growth inhibition of renal cancer cell line ACHN,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL857456,626.0,BAO_0000219,,
7151,17708,Compound was tested for 50% growth inhibition against human renal cancer ACHN cell line,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL623582,626.0,BAO_0000219,,
7152,15176,Growth inhibition of the ACHN Renal cancer cell line for 2-day in vitro assay.,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL623583,626.0,BAO_0000219,,
7153,2806,In vitro anticancer activity against ACHN renal cancer cell line,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL623584,626.0,BAO_0000219,,
7154,15300,In vitro antitumor activity against Renal cancer ACHN cell lines by 6-day assay,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL623585,626.0,BAO_0000219,,
7155,16364,Percent selectivity was evaluated in renal ACHN cell lines,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL623586,626.0,BAO_0000219,,
7156,13859,In vitro inhibitory activity against renal ACHN cancer cell line,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL623587,626.0,BAO_0000219,,
7157,11970,Tested for cytotoxicity against ACHN cell lines in renal cancer,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL875279,626.0,BAO_0000219,,
7158,2450,Tested for the in vitro cytotoxicity against ACHN renal cancer cell line,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL623588,626.0,BAO_0000219,,
7159,12696,In vitro anti tumor activity against human tumor Renal cancer cell lines was determined,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL623589,626.0,BAO_0000219,,
7160,12400,Tested in vitro for cytotoxicity in ACHN cell line of Renal cancer,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL623590,626.0,BAO_0000219,,
7161,12888,Cytotoxic effect on renal cancer line ACHN,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Expert,1,,CHEMBL623591,626.0,BAO_0000219,,
7162,3156,In vitro anti-cancer activity against ACHN(Renal) human tumor cell line,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL623592,626.0,BAO_0000219,,
7163,3381,In vitro inhibition of Renal Cancer ACHN cell lines,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL623593,626.0,BAO_0000219,,
7164,16747,Antitumor activity against human renal adenocarcinoma ACHN cells,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL623594,626.0,BAO_0000219,,
7165,16748,Antitumor activity against human renal adenocarcinoma ACHN cells.,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Expert,1,,CHEMBL621833,626.0,BAO_0000219,,
7166,12062,Inhibitory concentration required to decrease cell viability in cell growth culture against kidney cells ACHN,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL621834,626.0,BAO_0000219,,
7167,14769,Compound was evaluated for in vitro activity against ACHN kidney cell lines (Human tumor cells ),F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL621835,626.0,BAO_0000219,,
7168,15895,"Cytotoxicity against NCI tumor panel, ACHN renal cancer cell line",F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL621836,626.0,BAO_0000219,,
7169,17376,Concentration of compound that cause 50% cytotoxicity of ACHN renal cancer cell line,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL621837,626.0,BAO_0000219,,
7170,14882,Compound was tested for antitumor activity against ACHN renal cancer cell line(molar concentration that inhibits 50% net cell growth).,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL875280,626.0,BAO_0000219,,
7171,14882,Compound was tested for antitumor activity against ACHN renal cancer cell line(molar concentration leading to 50% net cell death).,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL621838,626.0,BAO_0000219,,
7172,15661,Cytotoxicity was tested against renal cancer ACHN tumor cell lines.,F,,,Homo sapiens,9606.0,,,ACHN,,80025,N,1,Intermediate,1,,CHEMBL621839,626.0,BAO_0000219,,
7173,9680,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL621840,,BAO_0000019,,
7174,14579,Compound tested for relative response using 1 uM ACh as agonist against AChM1 receptor.,F,,,,,,,,,10647,H,8,Autocuration,1,,CHEMBL621841,,BAO_0000019,,
7175,17290,Antiviral activity against AD169 strain of cytomegalovirus (CMV) in HEL (human erythroleukemia) cells.,F,,,Cytomegalovirus,10358.0,,,HEL,,50529,N,1,Expert,1,,CHEMBL622979,468.0,BAO_0000218,,
7176,17290,Antiviral activity against AD169 strain of cytomegalovirus (CMV); ND=No data,F,,,Cytomegalovirus,10358.0,,,,,50529,N,1,Intermediate,1,,CHEMBL876595,,BAO_0000218,,
7177,15891,Compound was evaluated for its inhibitory activity against calf intestinal Adenosine deaminase (ADA),B,,,,,,,,,12159,H,8,Autocuration,1,,CHEMBL620221,,BAO_0000357,,
7178,15890,Evaluated for the inhibition of calf intestinal Adenosine deaminase (ADA),B,,,,,,,,,12159,H,8,Autocuration,1,,CHEMBL620222,,BAO_0000357,,
7179,3801,Inhibitory activity against ovarian tumor cell line ADDP after 72 hr continuous exposure to compound,F,,,Bos taurus,9913.0,,,ADDP cell line,,80670,N,1,Intermediate,1,,CHEMBL620506,979.0,BAO_0000219,,
7180,9222,Tumor growth inhibition activity after subcutaneous transplanted tumor in ADJ-PC6 plasmacytoma cells,F,,,Mus musculus,10090.0,,,ADJ/PC6,,80671,N,1,Intermediate,1,,CHEMBL620507,980.0,BAO_0000219,,
7181,9222,Tumor growth inhibition activity after subcutaneously transplanted tumor in ADJ-PC6 plasmacytoma cells,F,,,Mus musculus,10090.0,,,ADJ/PC6,,80671,N,1,Intermediate,1,,CHEMBL620508,980.0,BAO_0000219,,
7182,7257,"Compound was tested for dose producing 90% reduction in tumor weight, in ADJ/PC6 mouse plasma cell tumor",F,,,Mus musculus,10090.0,,,ADJ/PC6,,80671,N,1,Intermediate,1,,CHEMBL620509,980.0,BAO_0000219,,
7183,7257,Compound was tested for inhibition against ADJ/PC6 mouse plasma cell tumor at the dose of 320 mg/Kg,F,,,Mus musculus,10090.0,,,ADJ/PC6,,80671,N,1,Intermediate,1,,CHEMBL620510,980.0,BAO_0000219,,
7184,7257,Compound was tested for dose required to kill 50 % of ADJ/PC6 mouse plasma cell tumor in a group,A,,,Mus musculus,10090.0,,,ADJ/PC6,,80671,N,1,Intermediate,1,,CHEMBL620511,980.0,BAO_0000219,,
7185,8084,In vitro incorporation of the [3H]thymidine into the ADJ/PC6 Plasmacytoma cells,F,,,Mus musculus,10090.0,,,ADJ/PC6,,80671,N,1,Intermediate,1,,CHEMBL620512,980.0,BAO_0000219,,
7186,14943,Tested for cytotoxicity against ADJ/PC6 mouse plasmacytoma,F,,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620513,,BAO_0000019,,
7187,14943,The compound was tested for cytotoxicity against ADJ/PC6 mouse plasmacytoma; Not determined,F,,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620514,,BAO_0000019,,
7188,14943,Tested for cytotoxicity against ADJ/PC6 plasmacytoma,F,,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620515,,BAO_0000019,,
7189,10524,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),A,In vivo,,Bacillus subtilis,1423.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620516,,BAO_0000218,,
7190,3546,AUC value in dog after IV administration at a dose of 5 mg/kg,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL620517,,BAO_0000218,1969.0,
7191,3546,AUC value in dog after oral administration at a dose of 5 mg/kg,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL620518,,BAO_0000218,1969.0,
7192,3546,Cmax value in dog after oral administration at a dose of 5 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL620519,,BAO_0000218,,
7193,3546,Bioavailability in dog after oral administration at a dose of 5 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621386,,BAO_0000218,,
7194,3546,Tmax value in dog after oral administration at a dose of 5 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621387,,BAO_0000218,,
7195,3184,Compound was evaluated for its clearance when administered intravenously in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621388,,BAO_0000218,,
7196,16456,Plasma clearance in Beagle dogs after intravenous administration at a dose of 10 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621389,,BAO_0000218,,
7197,4809,Plasma clearance was determined in Beagle dogs after (iv) administration of a dose of 12 (uM/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621390,,BAO_0000218,,
7198,4219,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Intermediate,1,,CHEMBL621391,,BAO_0000100,,
7199,3748,Half life in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621392,,BAO_0000218,,
7200,3132,Time taken for EC90 was determined when tested in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621393,,BAO_0000218,,
7201,4219,Half life (iv) was determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621394,,BAO_0000218,,
7202,16907,Loss of compound (%metabolized) after 30 min exposure to human liver microsomes,A,,,Canis lupus familiaris,9615.0,,Liver,,,50588,N,1,Intermediate,1,,CHEMBL621395,,BAO_0000218,2107.0,
7203,6057,Area under the curve was calculated in dog after iv administration,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621396,,BAO_0000218,,
7204,6057,Area under the curve was calculated in dog after peroral administration,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621397,,BAO_0000218,,
7205,17853,Dose-normalized area under curve in dog (p.o.) at 2.0 mpk,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621398,,BAO_0000218,,
7206,3639,pKa was evaluated in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618818,,BAO_0000218,,
7207,14541,Compound was evaluated for pronounced GH response at 100 mg (n=6)(area under concentration curve was determined from 0-8 hr following morning and evening dosing with 25 mg of the compound,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618819,,BAO_0000218,,
7208,16456,Alpha-elimination half-life in Beagle dogs after intravenous administration at a dose of 10 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618820,,BAO_0000218,,
7209,16456,Beta-elimination half-life in Beagle dogs after intravenous administration at a dose of 10 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL873810,,BAO_0000218,,
7210,2652,Compound was evaluated for half-life period in dogs at a dose of 5 mpk perorally,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL876606,,BAO_0000218,,
7211,3624,Compound was evaluated for the half-life (t 1/2) in hours,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618821,,BAO_0000218,,
7212,1337,Half life to reach the blood concentration was determined in dogs after oral administration (10 mg/kg) as a 0.05 M citric acid solution.,A,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,50588,N,1,Intermediate,1,,CHEMBL618822,,BAO_0000218,178.0,
7213,1337,Half life to reach the blood concentration was determined in dogs after oral administration (8 mg/kg) as a 0.05 M citric acid solution.,A,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,50588,N,1,Intermediate,1,,CHEMBL618823,,BAO_0000218,178.0,
7214,4709,Half life after intravenous administration of 1 mg/kg in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618824,,BAO_0000218,,
7215,15660,Half life was measured in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618825,,BAO_0000218,,
7216,5302,Half life period in dog after 5 mg/kg dose,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618826,,BAO_0000218,,
7217,17791,Half life period was evaluated in dog; 4-4.8,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618827,,BAO_0000218,,
7218,6348,Half life was determined in dog after 1 mg/kg (i.v.) and 5 mg/kg (p.o.) administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618828,,BAO_0000218,,
7219,4257,Half-life was determined in dog after a3 mg/kg of iv dose,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618829,,BAO_0000218,,
7220,3771,Half-life was determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618830,,BAO_0000218,,
7221,6305,Half life in dogs,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618831,,BAO_0000218,,
7222,13501,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 2 mg/kg tp dog,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL619489,,BAO_0000218,1969.0,
7223,17594,Apparent half-life after single intravenous bolus of 1 mg/kg in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619649,,BAO_0000218,,
7224,3045,Compound was evaluated for the half life period after iv administration in Beagle dog.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL876607,,BAO_0000218,,
7225,3043,Compound was evaluated for the half life period after oral administration in conscious dog.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619650,,BAO_0000218,,
7226,4839,Compound was tested for half life in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619651,,BAO_0000218,,
7227,4839,Compound was tested for its half life in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619652,,BAO_0000218,,
7228,5802,Half life of compound after both po and iv administration at a dose of 5 mg/kg and 2 mg/kg resp in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619653,,BAO_0000218,,
7229,17839,Half life of compound in dog was determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619654,,BAO_0000218,,
7230,4219,Half life (iv) was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619655,,BAO_0000218,,
7231,13966,Half life following administration of 70 nM in canine whole blood (dose exceeding platelet binding capacity),A,,,Canis lupus familiaris,9615.0,,Blood,,,50588,N,1,Intermediate,1,,CHEMBL619656,,BAO_0000218,178.0,
7232,3994,Half life in Dog plasma at a dosage 5 mg/kg after intravenous administration,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL873812,,BAO_0000218,1969.0,
7233,3994,Half life in Dog plasma at a dosage 5 mg/kg after intravenous administration,F,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621365,,BAO_0000218,1969.0,
7234,4453,Half life in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621366,,BAO_0000218,,
7235,6535,Half life in dog plasma,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621367,,BAO_0000218,1969.0,
7236,6535,Half life in dog plasma after administration of 0.25 mg/kg iv,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621368,,BAO_0000218,1969.0,
7237,6535,Half life in dog plasma after administration of 1 mg/kg iv,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621369,,BAO_0000218,1969.0,
7238,3132,Half life in dog plasma was determined at dose 10 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621370,,BAO_0000218,1969.0,
7239,5374,Half life in dog was determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621371,,BAO_0000218,,
7240,5007,Half life in dogs administered perorally (5 mg/kg) and intravenously (2 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621372,,BAO_0000218,,
7241,16907,Half life upon exposure to human plasma,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621373,,BAO_0000218,1969.0,
7242,6057,Half life was calculated in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621374,,BAO_0000218,,
7243,5006,Half life was determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621375,,BAO_0000218,,
7244,5473,Half life was determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621376,,BAO_0000218,,
7245,4368,Half life by intravenous administration of 1.2 mg/kg in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619624,,BAO_0000218,,
7246,6448,Half life in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875840,,BAO_0000218,,
7247,4353,Half life in dog after intra venous administration of the compound,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619625,,BAO_0000218,,
7248,4353,Half life in dog after intra venous administration of the compound; ND means Not determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619626,,BAO_0000218,,
7249,4353,Half life in dog after po administration of the compound,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619627,,BAO_0000218,,
7250,4353,Half life in dog after po administration of the compound; ND means Not determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL873817,,BAO_0000218,,
7251,6265,Half life in dog at the single oral dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619628,,BAO_0000218,,
7252,5006,Half life in dogs,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619629,,BAO_0000218,,
7253,5356,Half life in dogs at 1 mg/kg oral dosing; 35-100 min,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619630,,BAO_0000218,,
7254,405,Half life in rat,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619631,,BAO_0000218,,
7255,6642,Half life in dog (dosed as a mixture of five compounds at 0.5 mpk each via iv only),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL619632,,BAO_0000218,,
7256,10107,Biodistribution of intravenously injected [82Br]-labeled compound in bone of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 1 hours,A,In vivo,,Mus musculus,10090.0,,Bone,,,50594,N,1,Intermediate,1,,CHEMBL619633,,BAO_0000218,10000001.0,
7257,10107,Biodistribution of intravenously injected [82Br]-labeled compound in bone of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 2 hours,A,In vivo,,Mus musculus,10090.0,,Bone,,,50594,N,1,Intermediate,1,,CHEMBL875841,,BAO_0000218,10000001.0,
7258,10107,Biodistribution of intravenously injected [82Br]-labeled compound in bone of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 24 hours,A,In vivo,,Mus musculus,10090.0,,Bone,,,50594,N,1,Intermediate,1,,CHEMBL619634,,BAO_0000218,10000001.0,
7259,10107,Biodistribution of intravenously injected [82Br]-labeled compound in bone of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 4 hours,A,In vivo,,Mus musculus,10090.0,,Bone,,,50594,N,1,Intermediate,1,,CHEMBL619635,,BAO_0000218,10000001.0,
7260,10107,Biodistribution of intravenously injected [82Br]-labeled compound in bone of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 8 hours,A,In vivo,,Mus musculus,10090.0,,Bone,,,50594,N,1,Intermediate,1,,CHEMBL619636,,BAO_0000218,10000001.0,
7261,10107,Biodistribution of intravenously injected [82Br]-labeled compound in gut of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.25 hours,A,In vivo,,Mus musculus,10090.0,,Gut,,,50594,N,1,Intermediate,1,,CHEMBL619637,,BAO_0000218,10000004.0,
7262,10107,Biodistribution of intravenously injected [82Br]-labeled compound in gut of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.50 hours,A,In vivo,,Mus musculus,10090.0,,Gut,,,50594,N,1,Intermediate,1,,CHEMBL619638,,BAO_0000218,10000004.0,
7263,10107,Biodistribution of intravenously injected [82Br]-labeled compound in gut of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 1 hours,A,In vivo,,Mus musculus,10090.0,,Gut,,,50594,N,1,Intermediate,1,,CHEMBL619639,,BAO_0000218,10000004.0,
7264,10107,Biodistribution of intravenously injected [82Br]-labeled compound in gut of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 2 hours,A,In vivo,,Mus musculus,10090.0,,Gut,,,50594,N,1,Intermediate,1,,CHEMBL619640,,BAO_0000218,10000004.0,
7265,10107,Biodistribution of intravenously injected [82Br]-labeled compound in gut of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 24 hours,A,In vivo,,Mus musculus,10090.0,,Gut,,,50594,N,1,Intermediate,1,,CHEMBL619641,,BAO_0000218,10000004.0,
7266,10107,Biodistribution of intravenously injected [82Br]-labeled compound in gut of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 4 hours,A,In vivo,,Mus musculus,10090.0,,Gut,,,50594,N,1,Intermediate,1,,CHEMBL619642,,BAO_0000218,10000004.0,
7267,10107,Biodistribution of intravenously injected [82Br]-labeled compound in gut of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 8 hours,A,In vivo,,Mus musculus,10090.0,,Gut,,,50594,N,1,Intermediate,1,,CHEMBL619643,,BAO_0000218,10000004.0,
7268,10107,Biodistribution of intravenously injected [82Br]-labeled compound in heart of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.25 hours,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL619644,,BAO_0000218,948.0,
7269,10107,Biodistribution of intravenously injected [82Br]-labeled compound in heart of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.50 hours,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL621112,,BAO_0000218,948.0,
7270,10107,Biodistribution of intravenously injected [82Br]-labeled compound in heart of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 1 hours,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL621113,,BAO_0000218,948.0,
7271,10107,Biodistribution of intravenously injected [82Br]-labeled compound in heart of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 2 hours,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL621114,,BAO_0000218,948.0,
7272,10107,Biodistribution of intravenously injected [82Br]-labeled compound in heart of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 24 hours,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL621115,,BAO_0000218,948.0,
7273,10107,Biodistribution of intravenously injected [82Br]-labeled compound in heart of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 4 hours,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL621116,,BAO_0000218,948.0,
7274,10107,Biodistribution of intravenously injected [82Br]-labeled compound in heart of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 8 hours,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL621117,,BAO_0000218,948.0,
7275,10107,Biodistribution of intravenously injected [82Br]-labeled compound in kidney of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.25 hours,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL621118,,BAO_0000218,2113.0,
7276,10107,Biodistribution of intravenously injected [82Br]-labeled compound in kidney of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.5 hours,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL621119,,BAO_0000218,2113.0,
7277,10107,Biodistribution of intravenously injected [82Br]-labeled compound in kidney of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 1 hours,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL621120,,BAO_0000218,2113.0,
7278,10107,Biodistribution of intravenously injected [82Br]-labeled compound in kidney of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 2 hours,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL621757,,BAO_0000218,2113.0,
7279,10107,Biodistribution of intravenously injected [82Br]-labeled compound in kidney of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 24 hours,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL621758,,BAO_0000218,2113.0,
7280,10107,Biodistribution of intravenously injected [82Br]-labeled compound in kidney of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 4 hours,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL621759,,BAO_0000218,2113.0,
7281,10107,Biodistribution of intravenously injected [82Br]-labeled compound in kidney of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 8 hours,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL621760,,BAO_0000218,2113.0,
7282,10107,Biodistribution of intravenously injected [82Br]-labeled compound in liver of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.25 hours,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL621761,,BAO_0000218,2107.0,
7283,10107,Biodistribution of intravenously injected [82Br]-labeled compound in liver of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.50 hours,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL621762,,BAO_0000218,2107.0,
7284,10107,Biodistribution of intravenously injected [82Br]-labeled compound in liver of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 1 hours,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL621763,,BAO_0000218,2107.0,
7285,10107,Biodistribution of intravenously injected [82Br]-labeled compound in liver of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 2 hours,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL624502,,BAO_0000218,2107.0,
7286,10107,Biodistribution of intravenously injected [82Br]-labeled compound in liver of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 24 hours,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL624503,,BAO_0000218,2107.0,
7287,10107,Biodistribution of intravenously injected [82Br]-labeled compound in liver of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 4 hours,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL624504,,BAO_0000218,2107.0,
7288,10107,Biodistribution of intravenously injected [82Br]-labeled compound in liver of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 8 hours,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL624505,,BAO_0000218,2107.0,
7289,10107,Biodistribution of intravenously injected [82Br]-labeled compound in lung of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.25 hours,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL624506,,BAO_0000218,2048.0,
7290,5895,In vitro cytotoxicity against A2780 (human ovarian cancer),F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL624507,478.0,BAO_0000219,,
7291,6338,In vitro cytotoxicity against the paclitaxel sensitive human breast carcinoma cell line A2780,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL624508,478.0,BAO_0000219,,
7292,15163,In vitro cytotoxicity against. ovarian carcinoma cell line A2780.,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL624509,478.0,BAO_0000219,,
7293,15163,In vitro cytotoxicity against. ovarian carcinoma cell line A2780cisR (cisplatin resistant counter part of A2780).,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL624510,478.0,BAO_0000219,,
7294,15000,In vitro cytotoxicity was tested against human Ovarian carcinoma A2780 cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL875956,478.0,BAO_0000219,,
7295,15000,In vitro cytotoxicity was tested against human Ovarian carcinoma A2780 cisplatin resistant cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL839885,478.0,BAO_0000219,,
7296,14729,In vitro cytotoxicity against A2780 ovarian cells using the sulforhodamine B(SRB) assay.,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL624511,478.0,BAO_0000219,,
7297,17270,In vitro cytotoxicity against A2780 cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL624512,478.0,BAO_0000219,,
7298,5685,In vitro growth inhibitory activity against A2780 human ovarium carcinoma cell line was determined,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL624513,478.0,BAO_0000219,,
7299,3563,In vitro inhibitory activity against human ovarian cancer A2780 cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL624514,478.0,BAO_0000219,,
7300,17753,In vivo cytotoxic concentration of compound against A2780 cell line after 72 hr exposure,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618547,478.0,BAO_0000218,,
7301,16317,"Inhibition of cell growth in human ovarian carcinoma cell line (A2780cisR,cisplatin-resistant)using the 96 hour continuous exposure sulforhodamine B (SRB) growth delay assay",F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618548,478.0,BAO_0000219,,
7302,16936,Inhibition of tubulin polymerization in analogy of ca.,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618549,478.0,BAO_0000219,,
7303,3801,Inhibitory activity against ovarian tumor cell line A2780 after 72 hr continuous exposure to compound,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618550,478.0,BAO_0000219,,
7304,6181,Cytotoxic effect in ovarian cancer cell line (A2780),F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL618551,478.0,BAO_0000219,,
7305,5318,Tested for cytotoxicity against Ovarian carcinoma parental type A2780 cell line expressing MDR-1 (-) gene,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618552,478.0,BAO_0000219,,
7306,4840,Tested for the cytotoxicity in A2780 ovarian cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618553,478.0,BAO_0000219,,
7307,15748,The compound was tested for cytotoxic activity against A2780 cell line(human ovarian carcinoma ),F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618554,478.0,BAO_0000219,,
7308,15748,The compound was tested for cytotoxic activity against A2780/Cs cell line(human ovarian carcinoma,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618555,478.0,BAO_0000219,,
7309,15748,The compound was tested for cytotoxic activity against A2780cisR cell line(human ovarian carcinoma,F,,,,,,,A2780cisR,,80017,N,1,Intermediate,1,,CHEMBL618556,481.0,BAO_0000219,,
7310,15748,The compound was tested for cytotoxic activity against A2780cisR cell line(human ovarian carcinoma ),F,,,,,,,A2780cisR,,80017,N,1,Intermediate,1,,CHEMBL618557,481.0,BAO_0000219,,
7311,15748,The compound was tested for cytotoxic activity against A2780cisR cell line(human ovarian carcinoma ); ND means no data,F,,,,,,,A2780cisR,,80017,N,1,Intermediate,1,,CHEMBL618558,481.0,BAO_0000219,,
7312,15748,The compound was tested for cytotoxic activity against A2780cisR cell line(human ovarian carcinoma),F,,,,,,,A2780cisR,,80017,N,1,Intermediate,1,,CHEMBL618559,481.0,BAO_0000219,,
7313,17753,In vivo log of cells killed after administration of compound in A2780 cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618560,478.0,BAO_0000218,,
7314,17753,Compound was tested in vivo for maximum tolerated dose after i.v. administration twice a day for 5 days in A2780 cell line,F,In vivo,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618561,478.0,BAO_0000218,,
7315,16936,Compound was tested for Tubulin polymerization inhibition by using human ovarian carcinoma cell lines.;NA means not active,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618562,478.0,BAO_0000219,,
7316,16936,Compound was tested for colchicine binding inhibition by using human ovarian carcinoma cell lines (at 5 uM );NA means not active,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618563,478.0,BAO_0000219,,
7317,16936,Compound was tested for Tubulin polymerization inhibition by using human ovarian carcinoma cell lines; ND means no data,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618564,478.0,BAO_0000219,,
7318,16936,Compound was tested for colchicine binding inhibition by using human ovarian carcinoma cell lines. (at 5 uM ); ND means no data,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618565,478.0,BAO_0000219,,
7319,17528,Optimal dose required to inhibit human ovarian A2780 tumor growth after subcutaneous transplantation on athymic mice at 10 mg/kg (treatment schedule: q4dX2),F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618566,478.0,BAO_0000218,,
7320,6633,Resistance factor was determined as IC50 cisplatin-resistant/parent for human A2780 ovarian cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL618567,478.0,BAO_0000219,,
7321,15000,Resistance index is IC50 ratio of A2780 cell line and A2780cisR cell line,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL618568,478.0,BAO_0000219,,
7322,17528,Percentage tumor growth inhibition was calculated in respect to controls one week after the end of the treatment,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL618569,478.0,BAO_0000219,,
7323,16936,Compound was tested for Tubulin polymerization inhibition by using human ovarian cancer cell lines.,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621857,478.0,BAO_0000219,,
7324,16936,Compound was tested for Tubulin polymerization inhibition by using human ovarian carcinoma cell lines.,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621858,478.0,BAO_0000219,,
7325,16936,Percent of Tubulin polymerization inhibition by using human ovarian cancer cell lines at a concentration of 5 uM,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621859,478.0,BAO_0000219,,
7326,16936,"Colchicine Binding Inhibition ( CBI ) by using human ovarian cancer cell lines at 5 uM, (values are mean of 9 over 4 concentrations +/- SD)",F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621860,478.0,BAO_0000219,,
7327,16936,Compound tested for colchicine Binding Inhibition by using human ovarian cancer cell line (at 5 uM ),F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621861,478.0,BAO_0000219,,
7328,16936,"Tested for colchicine binding inhibition, using human ovarian cancer cell lines (at 5 uM )",F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL621862,478.0,BAO_0000219,,
7329,16936,Compound tested for colchicine Binding Inhibition by using human ovarian carcinoma cell line (at 5 uM ),F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621863,478.0,BAO_0000219,,
7330,16936,Compound was tested for colchicine Binding Inhibition by using human ovarian carcinoma cell line (at 5 uM ),F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621864,478.0,BAO_0000219,,
7331,16936,Compound was tested for colchicine binding inhibition by using human ovarian carcinoma cell line (at 5 uM ),F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621865,478.0,BAO_0000219,,
7332,17737,In vitro antiproliferative activity against A2780 cell line,F,,,Mus musculus,10090.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621866,478.0,BAO_0000219,,
7333,17764,Maximum tolerated dose in A2780 tumor in mice after intraperitoneal administration daily for 8 days,F,,,Mus musculus,10090.0,,,A2780,,81034,N,1,Expert,1,,CHEMBL621867,478.0,BAO_0000219,,
7334,3830,In vitro cytotoxicity of compound was determined against A2780 cell lines at 37 degree C after 96 hr,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL621868,478.0,BAO_0000219,,
7335,3829,In vitro cytotoxicity of compound was determined against A2780 cell lines at 37 degree C for 96 hr,F,,,Homo sapiens,9606.0,,,A2780,,81034,N,1,Intermediate,1,,CHEMBL875282,478.0,BAO_0000219,,
7336,3546,Vc value in dog after IV administration at a dose of 5 mg/kg,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621869,,BAO_0000218,,
7337,3546,Half life period in dog after IV administration at a dose of 5 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621870,,BAO_0000218,,
7338,5668,Area under curve was determine after peroral administration at 10 mpk in Rhesus,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621871,,BAO_0000019,,
7339,3443,AUC (area under curve) evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,A,,,Cercopithecidae,9527.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL621243,,BAO_0000218,1969.0,
7340,3443,AUC (area under curve) compared to Cilastatin evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,A,,,Cercopithecidae,9527.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL621244,,BAO_0000218,1969.0,
7341,4256,Area under curve determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,A,In vivo,,Macaca fascicularis,9541.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621245,,BAO_0000218,,
7342,4256,Area under curve determined after peroral administration at a dose of 10 mg/kg in cynomolgus monkey,A,In vivo,,Macaca fascicularis,9541.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621246,,BAO_0000218,,
7343,4256,Area under curve determined after peroral administration at a dose of 3 mg/kg in cynomolgus monkey,A,In vivo,,Macaca fascicularis,9541.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621247,,BAO_0000218,,
7344,4256,Oral Bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618386,,BAO_0000218,,
7345,1916,Area under curve was evaluated against Cynomolgus monkey at a dose of 15 mg/kg after po administration,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618387,,BAO_0000218,,
7346,5302,Area under curve value in monkey at a dose of 5 mg/kg,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618388,,BAO_0000218,,
7347,4257,Area under curve was determined in monkey after a 3 mg/kg of oral dose,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618389,,BAO_0000218,,
7348,5355,Area under curve was determined using trapezoidal rule after intravenous administration in cynomolgus monkeys,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618574,,BAO_0000019,,
7349,5355,Area under curve was determined using trapezoidal rule after oral administration in cynomolgus monkeys,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618575,,BAO_0000019,,
7350,5355,Area under curve was determined using trapezoidal rule after oral administration in cynomolgus monkeys; ND means Not determined,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618576,,BAO_0000019,,
7351,6078,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in monkey,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618577,,BAO_0000218,,
7352,6078,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in monkey,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL876487,,BAO_0000218,,
7353,6062,Area under the curve was measured in monkey after an iv dose of 1 mg/kg,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618578,,BAO_0000218,,
7354,2661,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female cynomolgus monkey,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618579,,BAO_0000218,,
7355,2661,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female cynomolgus monkey,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618580,,BAO_0000019,,
7356,5394,Pharmacokinetic parameter Cmax was measured after administration into monkey at 3 mg/kg,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618581,,BAO_0000218,,
7357,4397,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in cynomolgus monkeys (0 to 24 hr) p.o.,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618582,,BAO_0000218,,
7358,17509,Area under curve value 24 hr after 2 mg/kg iv administration in monkeys,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618583,,BAO_0000218,,
7359,17509,Area under curve value 24 hr after 2 mg/kg oral administration in monkeys,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618584,,BAO_0000218,,
7360,6641,Oral AUCN in monkey (dosed at 0.5 mpk iv ),A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618585,,BAO_0000218,,
7361,5355,Bioavailability was reported in cynomolgus monkeys (ratio of AUC in oral administration to that of intravenous administration),A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618586,,BAO_0000218,,
7362,3443,Half life compared to Cilastatin evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618587,,BAO_0000218,,
7363,3443,Half life evaluated in Rhesus monkeys at the dose of 10 mg/kg by iv bolus injection,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618588,,BAO_0000218,,
7364,17409,Binding towards monkey plasma protein at 10 uM,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618589,,BAO_0000019,,
7365,17409,Binding towards monkey plasma protein at 100 uM,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618590,,BAO_0000019,,
7366,1052,Apparent bioavailability in squirrel monkey was determined,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL872262,,BAO_0000218,,
7367,13501,Bioavailability was determined after oral administration of compound 18 at a dose of 1 mg/kg to rhesus monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618591,,BAO_0000218,,
7368,17509,Bioavailability in monkey (dose 2 mg/kg),A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618592,,BAO_0000218,,
7369,5394,Compound at a dose 3 mg/kg was administered to monkey and was evaluated for bioavailability after administration into monkey at 3 mg/kg,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL876488,,BAO_0000218,,
7370,2661,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female cynomolgus monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618593,,BAO_0000218,,
7371,11219,Bioavailability in monkey (i.d. dosing),A,In vivo,,monkey,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618594,,BAO_0000218,,
7372,3045,Oral bioavailability after 5 mg/kg in cynomolgus monkey was determined,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL618595,,BAO_0000218,,
7373,17796,Clearance of the drug was measured in cynomolgus,A,,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621469,,BAO_0000019,,
7374,1399,Clearance was estimated in two squirrel monkeys after iv administration at 5 mg/kg,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621470,,BAO_0000218,,
7375,2661,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female cynomolgus monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621471,,BAO_0000218,,
7376,5005,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,A,In vivo,,Macaca mulatta,9544.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL621472,,BAO_0000218,1969.0,
7377,17267,Plasma clearance in rhesus monkey was determined,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621473,,BAO_0000218,,
7378,6535,Plasma clearance in monkey after administration of 1 mg/kg iv,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621474,,BAO_0000218,,
7379,5922,Plasma clearance in cynomolgus monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621475,,BAO_0000218,,
7380,6221,Plasma clearance after oral administration (2.5 mg/kg) in monkey was determined,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621476,,BAO_0000218,,
7381,5668,Plasma clearance after peroral administration at 10 mpk in Rhesus,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624290,,BAO_0000218,,
7382,5355,The total clearance was determined after intravenous administration in cynomolgus monkeys,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624291,,BAO_0000218,,
7383,5355,The total clearance was determined after oral administration in cynomolgus monkeys; NA means Not applicable,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624292,,BAO_0000218,,
7384,5355,The total clearance was determined after oral administration in cynomolgus monkeys; NA means not applicable,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624293,,BAO_0000218,,
7385,4578,Tested for Clearance upon iv administration to african green monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624294,,BAO_0000218,,
7386,17592,Clearance in monkey,A,In vivo,,Cercopithecidae,9527.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624295,,BAO_0000218,,
7387,6641,Half life in dog (dosed at 0.5 mpk iv and 2.0 mpk orally),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624296,,BAO_0000218,,
7388,6642,Half life in dog (dosed at 0.5 mpk iv and 2.0 mpk orally),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624297,,BAO_0000218,,
7389,16367,Half life was evaluated after intravenous administration to dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624298,,BAO_0000218,,
7390,5472,Half life was evaluated in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624299,,BAO_0000218,,
7391,5474,Half life was evaluated in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624300,,BAO_0000218,,
7392,5654,Half life period (t1/2) of compound was determined after intravenous administration in average of two dogs at a dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624301,,BAO_0000218,,
7393,6227,Half life period after intravenous administration (1 mg/kg) was determined in dog (in vivo),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624302,,BAO_0000218,,
7394,6227,Half life period after intravenous administration in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL876026,,BAO_0000218,,
7395,6221,Half life period after oral administration (2.5 mg/kg) in dog was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624303,,BAO_0000218,,
7396,4527,Half life period at a dose of 1 uM/kg in dog was determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624304,,BAO_0000218,,
7397,5668,Half life period was determine after peroral administration at 10 mpk in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624305,,BAO_0000218,,
7398,5668,Half life period was determine after peroral administration at 5 mpk in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624306,,BAO_0000218,,
7399,3854,Half life period was determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624307,,BAO_0000218,,
7400,5505,Half life period was determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624308,,BAO_0000218,,
7401,6251,Half life period by iv administration in dog at a dose of 6 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624309,,BAO_0000218,,
7402,1918,Half life period was evaluated in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624310,,BAO_0000218,,
7403,5546,Half life period was determined in Beagle dog at a dose of 1 mg/kg by iv administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625003,,BAO_0000218,,
7404,4809,Half life period was determined in Beagle dogs after (iv) administration of a dose of 12 (uM/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625004,,BAO_0000218,,
7405,6215,Half life time after intravenous administration (0.5 mg/kg) was determined in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625005,,BAO_0000218,,
7406,4527,Half-life period by oral administration at a dose of 10 uM/kg in dog was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL873813,,BAO_0000218,,
7407,17594,Half-life after oral dose of compound at 3 mg/kg in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625006,,BAO_0000218,,
7408,17839,Half-life of compound in dog following p.o. administration of 0.5 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625007,,BAO_0000218,,
7409,17839,Half-life of compound in dog following p.o. administration of 0.9 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL876027,,BAO_0000218,,
7410,17839,Half-life of compound in dog following p.o. administration of 0.95 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625008,,BAO_0000218,,
7411,17839,Half-life of compound in dog following p.o. administration of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625009,,BAO_0000218,,
7412,5210,Half-life of compound in plasma of dog was determined,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL625010,,BAO_0000218,1969.0,
7413,5210,Half-life of compound was determined in dogs,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625011,,BAO_0000218,,
7414,2959,Half-life after administration of 4 mg/Kg oral dose in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621553,,BAO_0000218,,
7415,4137,Half-life after intravenous administration of 1 mg/kg/h in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621554,,BAO_0000218,,
7416,5064,Half-life in Dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621555,,BAO_0000218,,
7417,5147,Half-life in Dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621556,,BAO_0000218,,
7418,5145,Half-life in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621557,,BAO_0000218,,
7419,6123,Half-life in dog after oral administration at 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621558,,BAO_0000218,,
7420,6123,Half-life in dog after oral administration at 1 mg/kg; nd is not determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621559,,BAO_0000218,,
7421,4333,Half-life in dogs,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621560,,BAO_0000218,,
7422,4333,Half-life in dogs; ND indicates not determined,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL876028,,BAO_0000218,,
7423,12500,Half-life in plasma of dog,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621561,,BAO_0000218,1969.0,
7424,12500,Half-life in plasma of dog at dose of 3-10 mgkg,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621562,,BAO_0000218,1969.0,
7425,6005,Half-life was evaluated after i.v. administration in dog at a dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621563,,BAO_0000218,,
7426,6062,Half-life was measured in dog after an iv dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621564,,BAO_0000218,,
7427,17650,Half-life was measured in dogs after an oral dose of 10 uM/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621565,,BAO_0000218,,
7428,5530,Half-life in vivo in dog by intravenous administration at a dose of 0.2 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621566,,BAO_0000218,,
7429,5530,Half-life in vivo in dog by intravenous administration at a dose of 1 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621567,,BAO_0000218,,
7430,5600,Half-life of the compound after 0.3 mg/kg po administration in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622978,,BAO_0000218,,
7431,6039,Half-life period after intravenous administration of 0.5 mg/kg in dog was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL873814,,BAO_0000218,,
7432,6039,Half-life period after intravenous administration of 1.0 mg/kg in dog was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623219,,BAO_0000218,,
7433,6039,Half-life period after peroral administration of 0.2 mg/kg in dog was determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624477,,BAO_0000218,,
7434,6227,t1/2 in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624478,,BAO_0000218,,
7435,14541,Half-life period measured in dogs,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624479,,BAO_0000218,,
7436,4521,Half-life period in dog after 2 mg/kg by oral and 0.5 mg/kg by intravenous administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624480,,BAO_0000218,,
7437,4521,Half-life period in dog after 2 mg/kg by oral and 0.5 mg/kg by intravenous administration; ND is not determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623595,,BAO_0000218,,
7438,6679,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623596,,BAO_0000218,,
7439,1116,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in dog plasma",A,In vitro,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL623597,,BAO_0000218,1969.0,
7440,5444,In vivo half life period was calculated at 1 mg/kg in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623598,,BAO_0000218,,
7441,5444,In vivo half life period was calculated at 1 mg/kg in dog; ND=Not determined,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623599,,BAO_0000218,,
7442,17853,Longer half-life in dog (i.v.) at 0.5 mpk,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623600,,BAO_0000218,,
7443,4353,Oral bioavailability in dog (dose 5 uM/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623601,,BAO_0000218,,
7444,16452,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623602,,BAO_0000218,,
7445,16452,Pharmacokinetic data at 1 mg/kg dose given to dogs intravenously,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623603,,BAO_0000218,,
7446,16452,Bioavailability in dog (dose 1 mg/kg i.v.),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623604,,BAO_0000218,,
7447,10107,Biodistribution of intravenously injected [82Br]-labeled compound in lung of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.5 hours,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL623605,,BAO_0000218,2048.0,
7448,10107,Biodistribution of intravenously injected [82Br]-labeled compound in lung of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 1 hours,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL623606,,BAO_0000218,2048.0,
7449,10107,Biodistribution of intravenously injected [82Br]-labeled compound in lung of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 2 hours,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL623607,,BAO_0000218,2048.0,
7450,10107,Biodistribution of intravenously injected [82Br]-labeled compound in lung of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 24 hours,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL623608,,BAO_0000218,2048.0,
7451,10107,Biodistribution of intravenously injected [82Br]-labeled compound in lung of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 4 hours,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL623609,,BAO_0000218,2048.0,
7452,10107,Biodistribution of intravenously injected [82Br]-labeled compound in lung of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 8 hours,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL623610,,BAO_0000218,2048.0,
7453,10107,Biodistribution of intravenously injected [82Br]-labeled compound in muscle of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.25 hours,A,In vivo,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL623611,,BAO_0000218,2385.0,
7454,10107,Biodistribution of intravenously injected [82Br]-labeled compound in muscle of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.5 hours,A,In vivo,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL623612,,BAO_0000218,2385.0,
7455,10107,Biodistribution of intravenously injected [82Br]-labeled compound in muscle of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 1 hours,A,In vivo,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL623613,,BAO_0000218,2385.0,
7456,10107,Biodistribution of intravenously injected [82Br]-labeled compound in muscle of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 2 hours,A,In vivo,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL623614,,BAO_0000218,2385.0,
7457,10107,Biodistribution of intravenously injected [82Br]-labeled compound in muscle of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 24 hours,A,In vivo,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL623615,,BAO_0000218,2385.0,
7458,10107,Biodistribution of intravenously injected [82Br]-labeled compound in muscle of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 4 hours,A,In vivo,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL623616,,BAO_0000218,2385.0,
7459,10107,Biodistribution of intravenously injected [82Br]-labeled compound in muscle of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 8 hours,A,In vivo,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL623617,,BAO_0000218,2385.0,
7460,10107,Biodistribution of intravenously injected [82Br]-labeled compound in skin of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.25 hours,A,In vivo,,Mus musculus,10090.0,,Zone of skin,,,50594,N,1,Intermediate,1,,CHEMBL875944,,BAO_0000218,14.0,
7461,10107,Biodistribution of intravenously injected [82Br]-labeled compound in skin of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.50 hours,A,In vivo,,Mus musculus,10090.0,,Zone of skin,,,50594,N,1,Intermediate,1,,CHEMBL623618,,BAO_0000218,14.0,
7462,10107,Biodistribution of intravenously injected [82Br]-labeled compound in skin of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 1 hours,A,In vivo,,Mus musculus,10090.0,,Zone of skin,,,50594,N,1,Intermediate,1,,CHEMBL623619,,BAO_0000218,14.0,
7463,10107,Biodistribution of intravenously injected [82Br]-labeled compound in skin of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 2 hours,A,In vivo,,Mus musculus,10090.0,,Zone of skin,,,50594,N,1,Intermediate,1,,CHEMBL623620,,BAO_0000218,14.0,
7464,10107,Biodistribution of intravenously injected [82Br]-labeled compound in skin of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 24 hours,A,In vivo,,Mus musculus,10090.0,,Zone of skin,,,50594,N,1,Intermediate,1,,CHEMBL623621,,BAO_0000218,14.0,
7465,10107,Biodistribution of intravenously injected [82Br]-labeled compound in skin of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 4 hours,A,In vivo,,Mus musculus,10090.0,,Zone of skin,,,50594,N,1,Intermediate,1,,CHEMBL623622,,BAO_0000218,14.0,
7466,10107,Biodistribution of intravenously injected [82Br]-labeled compound in skin of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 8 hours,A,In vivo,,Mus musculus,10090.0,,Zone of skin,,,50594,N,1,Intermediate,1,,CHEMBL623623,,BAO_0000218,14.0,
7467,10107,Biodistribution of intravenously injected [82Br]-labeled compound in spleen of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.25 hours,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL623624,,BAO_0000218,2106.0,
7468,10107,Biodistribution of intravenously injected [82Br]-labeled compound in spleen of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.50 hours,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL618521,,BAO_0000218,2106.0,
7469,10107,Biodistribution of intravenously injected [82Br]-labeled compound in spleen of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 1 hours,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL618522,,BAO_0000218,2106.0,
7470,10107,Biodistribution of intravenously injected [82Br]-labeled compound in spleen of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 2 hours,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL618523,,BAO_0000218,2106.0,
7471,10107,Biodistribution of intravenously injected [82Br]-labeled compound in spleen of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 24 hours,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL618524,,BAO_0000218,2106.0,
7472,10107,Biodistribution of intravenously injected [82Br]-labeled compound in spleen of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 4 hours,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL618525,,BAO_0000218,2106.0,
7473,10107,Biodistribution of intravenously injected [82Br]-labeled compound in spleen of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 8 hours,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL624586,,BAO_0000218,2106.0,
7474,10107,Biodistribution of intravenously injected [82Br]-labeled compound in stomach of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.25 hours,A,In vivo,,Mus musculus,10090.0,,Stomach,,,50594,N,1,Intermediate,1,,CHEMBL624587,,BAO_0000218,945.0,
7475,10107,Biodistribution of intravenously injected [82Br]-labeled compound in stomach of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 0.50 hours,A,In vivo,,Mus musculus,10090.0,,Stomach,,,50594,N,1,Intermediate,1,,CHEMBL624588,,BAO_0000218,945.0,
7476,10107,Biodistribution of intravenously injected [82Br]-labeled compound in stomach of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 1 hours,A,In vivo,,Mus musculus,10090.0,,Stomach,,,50594,N,1,Intermediate,1,,CHEMBL624589,,BAO_0000218,945.0,
7477,10107,Biodistribution of intravenously injected [82Br]-labeled compound in stomach of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 2 hours,A,In vivo,,Mus musculus,10090.0,,Stomach,,,50594,N,1,Intermediate,1,,CHEMBL624590,,BAO_0000218,945.0,
7478,10107,Biodistribution of intravenously injected [82Br]-labeled compound in stomach of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 24 hours,A,In vivo,,Mus musculus,10090.0,,Stomach,,,50594,N,1,Intermediate,1,,CHEMBL624591,,BAO_0000218,945.0,
7479,10107,Biodistribution of intravenously injected [82Br]-labeled compound in stomach of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 4 hours,A,In vivo,,Mus musculus,10090.0,,Stomach,,,50594,N,1,Intermediate,1,,CHEMBL624592,,BAO_0000218,945.0,
7480,10107,Biodistribution of intravenously injected [82Br]-labeled compound in stomach of BDF1 female mice bearing subcutaneous Lewis lung carcinoma after 8 hours,A,In vivo,,Mus musculus,10090.0,,Stomach,,,50594,N,1,Intermediate,1,,CHEMBL624593,,BAO_0000218,945.0,
7481,4689,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624594,,BAO_0000218,,
7482,4950,Tested for the bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624595,,BAO_0000218,,
7483,5328,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624596,,BAO_0000218,,
7484,406,Bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624597,,BAO_0000218,,
7485,12500,Bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624598,,BAO_0000218,,
7486,12500,Bioavailability in rat (dose 3-10 mg/kg),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624599,,BAO_0000218,,
7487,5247,Bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL875166,,BAO_0000218,,
7488,4186,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL624600,,BAO_0000218,1969.0,
7489,4186,Apparent terminal elimination half-life in rat plasma after administration of 50 mg/kg dose through subcutaneous route,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL624601,,BAO_0000218,1969.0,
7490,6647,Half life after oral administration was determined in rats at 6 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624602,,BAO_0000218,,
7491,6484,Half life was determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624603,,BAO_0000218,,
7492,3249,Half life the of compound was determined by ''Cr'' assay in rat at a dose of 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624604,,BAO_0000218,,
7493,6281,Plasma half life in rat at oral dose 2.8 mg/mk body weight,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL624605,,BAO_0000218,1969.0,
7494,3307,Half life in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624606,,BAO_0000218,,
7495,12058,Half-lives were estimated from the elimination phase of the blood conc-time curve after oral administration,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624607,,BAO_0000218,178.0,
7496,8833,Hill coefficient of the compound,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624608,,BAO_0000218,,
7497,3193,Compound was tested for percent hydrolysis in whole blood after a time interval of 0.5 min,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624609,,BAO_0000218,178.0,
7498,3193,Compound was tested for percent hydrolysis in whole blood after a time interval of 180.0 min,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624610,,BAO_0000218,178.0,
7499,3193,Compound was tested for percent hydrolysis in whole blood after a time interval of 2.0 min,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624611,,BAO_0000218,178.0,
7500,3193,Compound was tested for percent hydrolysis in whole blood after a time interval of 5.0 min,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624612,,BAO_0000218,178.0,
7501,3193,Compound was tested for percent hydrolysis in whole blood after a time interval of 60.0 min,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL875167,,BAO_0000218,178.0,
7502,3193,Compound was tested for percent hydrolysis in whole blood after a time interval of 7.0 min,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624613,,BAO_0000218,178.0,
7503,3193,"Compound was tested for percent hydrolysis in whole blood, after a time interval of 15.0 min",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624614,,BAO_0000218,178.0,
7504,5960,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624392,,BAO_0000218,,
7505,13950,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/organ,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL624393,,BAO_0000218,955.0,
7506,13950,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/organ,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL624394,,BAO_0000218,955.0,
7507,13950,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/organ,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL624395,,BAO_0000218,955.0,
7508,13950,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/organ,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL624396,,BAO_0000218,955.0,
7509,13950,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/organ,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL624397,,BAO_0000218,955.0,
7510,13950,Biodistribution of [123I]-label in rat thyroid was reported at 0.33 hr post injection. Value shown is %ID/organ,A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL624398,,BAO_0000218,2046.0,
7511,13950,Biodistribution of [123I]-label in rat thyroid was reported at 1 hr post injection. Value shown is %ID/organ,A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL624399,,BAO_0000218,2046.0,
7512,13950,Biodistribution of [123I]-label in rat thyroid was reported at 2 hr post injection. Value shown is %ID/organ,A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL624400,,BAO_0000218,2046.0,
7513,13950,Biodistribution of [123I]-label in rat thyroid was reported at 24 hr post injection. Value shown is %ID/organ,A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL624401,,BAO_0000218,2046.0,
7514,13950,Biodistribution of [123I]-label in rat thyroid was reported at 4 hr post injection. Value shown is %ID/organ,A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL624402,,BAO_0000218,2046.0,
7515,9866,Biodistribution in normal rat blood in the presence of 0.005 M Gd/0.01 M lig at 2 hr,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624403,,BAO_0000218,178.0,
7516,9866,Biodistribution in normal rat blood in the presence of 0.01 M Gd/0.05 M lig,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624404,,BAO_0000218,178.0,
7517,9866,Biodistribution in normal rat blood in the presence of NAC Gd 0.01 M lig at 2 hr,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624405,,BAO_0000218,178.0,
7518,9866,Biodistribution in normal rat bone in the presence of 0.005 M Gd/0.01 M lig at 2 hr,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL624406,,BAO_0000218,10000001.0,
7519,9866,Biodistribution in normal rat bone in the presence of 0.01 M Gd/0.05 M lig,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL624407,,BAO_0000218,10000001.0,
7520,9866,Biodistribution in normal rat bone in the presence of NAC Gd 0.01 M lig at 2 hr,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL624408,,BAO_0000218,10000001.0,
7521,9866,Biodistribution in normal rat heart in the presence of 0.005 M Gd/0.01 M lig at 2 hr,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL618644,,BAO_0000218,948.0,
7522,9866,Biodistribution in normal rat heart in the presence of 0.01 M Gd/0.05 M lig,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL618645,,BAO_0000218,948.0,
7523,9866,Biodistribution in normal rat heart in the presence of NAC Gd 0.01 M lig at 2 hr,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL618646,,BAO_0000218,948.0,
7524,9866,viodistrihutioninnormal3a6jisjeyintuepresenceof0094MGd001Mpigag1hr,A,lnvivo,,Rattusno3fegicuq,21588.0,,K7dney,,,50597,N,1,Intermedis4e,1,,CHEjBL619647,,BAO0p00118,1078285.0,
7525,9866,Biodistributioninnofmalratkodn2hinthepresejc48f00qMvc005Mpin,A,Inviv0,,Ratyusborvegichs,22275.0,,Kidn2y,,,50597,N,1,Internexiate,1,,CHEMBLy18638,,BAO0p00q18,1826401.0,
7526,9866,fiodie4eibuhiojinnormalra6kidgeyintheoresfnfeofNACGd001Mligatqhr,A,Invjvo,,Rattuahorvdgicus,7644.0,,Kirney,,,50597,N,1,Iny2rmediate,1,,xHEkBL618649,,BzO0000228,1650094.0,
7527,9866,Bi0xuateibuti8ninnormalratlivetinthepres4nceof00p5MGdp91Mlinatwhr,A,Invico,,Ratfusnorvericux,1977.0,,Lifer,,,50597,N,1,Intermedjxte,1,,CHEMnL618550,,BAl000o218,2717622.0,
7528,9866,Biowist3iburionijnofmslrwhliverinthepres2nxeof00qMGd005Mlig,A,Igvivo,,Rwttksnorvegidus,312.0,,Liv4r,,,50597,N,1,Intermediqhe,1,,CHEjgL618651,,BzO0000318,2425569.0,
7529,9866,B8odistrivi5ioginnormalratlivefibhndpresenseofNACGd001Ml7gat2hr,A,Inviv8,,Rattusno4vevidus,15855.0,,Lifer,,,50597,N,1,Imtermedlate,1,,fHEMBL866497,,hA00000218,2440151.0,
7530,9866,Biodistr7butlonibnormalgaglujrintu2peesenc2of0005MGd001Mligat2br,A,Invido,,Rattusnkrvegifjs,10664.0,,Lung,,,50597,N,1,Inrerjediate,1,,xHEMBk618652,,BwO0p00218,2065982.0,
7531,9866,Bioeistributioninjormalratlunnijth403esenveof001MGd0o6Mkig,A,Inv9vo,,Ra5tuen8rvegicus,31315.0,,Lung,,,50597,N,1,Intermddiat2,1,,CHrMBL618u53,,fAO0p00218,41714.0,
7532,9866,Biisistributioninjormalra6l8ngunthepresendsoeNACGd001Mlivar2jr,A,Ibvivo,,fattusnotvegicuw,7835.0,,Lung,,,50597,N,1,Inte4meduate,1,,CH3MBk618654,,BAO000o2q8,141770.0,
7533,6351,gecoveryrateftojurindandbilewasde5ermin4wafrerivwdmoniettstionzt20mgkgineatsgot4ested,A,,,Rattusmorver9cus,21962.0,,,,,50597,N,1,jntermeviate,1,,CHEMBp6186y5,,BAO00002wo,,
7534,1465,fohloundwsstdstedforsol8bilityinwat2r,A,,,Ra4tusnorbegicys,5004.0,,,,,50597,N,1,Integmesiate,1,,CHEjBi618656,,Bzl0000218,,
7535,5182,dolubipityinphls9ha4ebuffer4dsaiine1DMSkagpH6524h5eq8ilibra6ion,P,,,,,,,,,22229,U,0,Intermedjat3,1,,CHEMBo61u657,,BA80090100,,
7536,17847,Soiubikitywqxdetermined,A,,,Ratfysnorvegucus,27251.0,,,,,50597,N,1,Intetmedia6e,1,,CHdMBL617658,,BAO000p21i,,
7537,15339,sol8bilitginwa64rughLat37degrreC,A,,,Rat6usnorbegicjs,9335.0,,,,,50597,N,1,Intermedua4e,1,,CHEMBL61u65p,,BAO0o0021u,,
7538,5202,Firstpawsmetwboiismandmetzbolixgikxvwilwbilityusingrzgheparicjicrosomes,A,,,Rsttusn8rvegicjs,37973.0,,,,,50597,N,1,9jtermediate,1,,xtEMBL618660,,BAO00op218,,
7539,1088,Invigrostab7lityrelativefoxn76infathepxgocyhfassay,A,,,Ratfusnorvegicha,36006.0,,,,,50597,N,1,Inte4meciate,1,,CHwMBL61866q,,gAO0000e18,,
7540,3169,Halflivelnrats,A,,,Rattusnprveglxus,25766.0,,,,,50597,N,1,In5ermefiate,1,,xHEnBL873807,,BzO0900218,,
7541,5353,jalfljfeigDawleyrat,A,,,Rattuxnkdvegicus,17877.0,,,,,50597,N,1,Intetmediqte,1,,CHEhhL618662,,BAi0000228,,
7542,2864,Halflif4perildabtfd3mgkgifadminisyfation,A,Ingivo,,Ratt6snoevwgicus,7176.0,,,,,50597,N,1,Inteemediatr,1,,dHEMBL619663,,BAOo00p218,,
7543,2864,Hsldlof3periowaftfr2mgkgivadmin8stratuoninrat,A,Inv7vo,,Ratthsnorvrgivus,20210.0,,,,,50597,N,1,Inrermediat3,1,,CHEhBL61866t,,BA80000e18,,
7544,2864,Halflifeperjodafter3mgmgidadkijiqtgat9onintuerat,A,Invovo,,Ratt6snorveglcuq,37364.0,,,,,50597,N,1,Intermrdiaye,1,,CHEMBLu18765,,BAO0090217,,
7545,6362,uqlvkifepfriodinfemaieSpragueDadleyrats,A,,,Ratgusnorvsticus,14462.0,,,,,50597,N,1,Imtermediats,1,,CHEMBk876408,,BAO009021o,,
7546,6249,Halflifeperior8mrat,A,,,5attucnordegicus,16915.0,,,,,50597,N,1,Intedm2diate,1,,vHEMBL61i666,,BAO9000228,,
7547,3169,Halflideinratssaedetermin3r,A,,,Rattusn8fvegicud,23976.0,,,,,50597,N,1,9ntermed9ate,1,,CHEMnLu20440,,BAO0p002w8,,
7548,3169,Halfpifeinratswithmefsnol7foxidatipn,A,,,Rxttusnorfegicuz,6429.0,,,,,50597,N,1,8ntermeciate,1,,CHEMBL52p441,,BAO9000w18,,
7549,3169,Halflifsinra5s,A,,,4atguwnorvegicus,5715.0,,,,,50597,N,1,Inte5meriate,1,,CHEMBL62054w,,BAp0000217,,
7550,17260,T12atse8srof1pmgKgadministefexintravwnouslyjmfemalehanoferqiztarrat,A,Inbivo,,Rqt6usnorvegicuw,6917.0,,,,,50597,N,1,7nterkediate,1,,CHEMhL620442,,BAO000o2q8,,
7551,17260,y12stxdoseof10mgigadmibisge4edoeroraplyibfemalehanover1idtarrat,A,9nvivo,,Rqttusnorfegucus,3634.0,,,,,50597,N,1,7gtermediate,1,,CHfMBL520444,,BqOo000218,,
7552,17260,Tmsxatqdozeof10mgKgadm9nisteresihfdavebouslyinfemwprhanovdrwistarrat,A,Invkvo,,Rwttusnorfegic6s,29468.0,,,,,50597,N,1,jntermefiate,1,,CHrMBo620445,,BA00000228,,
7553,17260,Tmaxatadoseof1omgKgavmjnis5ersdperorwolyiggemalehwnovrrwistarrar,A,Invibo,,5attusn8rvwgicus,32764.0,,,,,50597,N,1,Ihterm2diate,1,,CHEMBL720t46,,BAO90p0218,,
7554,2879,Biologicaluxlclifeheasutedinplasmqofrxt,A,,,Rwt4usnorveg7cus,8684.0,,Plasmz,,,50597,N,1,Intefmefiate,1,,CtEMBo620447,,BA90900218,1327532.0,
7555,2879,B98logicwlhalfl7femeasuredinppasmzofrat32e5,A,,,Rqtgusnorveg8cus,1880.0,,Pladma,,,50597,N,1,Imtermediatr,1,,CHEnvL621129,,Bwp0000218,195821.0,
7556,2879,Biologlcslyqlflifemeasu3edinplasmxofrq5916,A,,,Rattusnofvegidhs,2392.0,,Plasmx,,,50597,N,1,Inte5mediste,1,,CHEMBk622130,,hAO00002q8,2118141.0,
7557,3184,vompoubwwasevaluatedforotshwlflifesh2nadmijos4eredontravejousl6inrat,A,Invido,,Rat4ksnorbegicus,3046.0,,,,,50597,N,1,Ijtermedoate,1,,CHEkBL873898,,gAO0090218,,
7558,4891,Compoubdwasevalhatedf0rphatmackk8neticparameter9wrcfntnioacailabikltyqt8h,A,Igvivo,,Rxrtusno3vegicus,20672.0,,,,,50597,N,1,Igfermediate,1,,CHdMBL87y598,,BAO9000217,,
7559,429,Evaluatedforonadkaxokigeticpwrameterhxiclifwinratwtthedose50mgkg,A,Inviv8,,4artusnorv2gicus,24683.0,,,,,50597,N,1,Intern2diate,1,,xHEMBL6211w1,,BAOp0002w8,,
7560,5656,HakflifeT12after8txlafministra58oninrat,A,jnvivo,,Rattushorb2gicus,8996.0,,,,,50597,N,1,Ihtermeviate,1,,CHEMBLy21232,,BwO0000318,,
7561,4413,Hslflife8fvomp8undaffdrifadmijistrationof20mgkgdose9hrwt,A,Inv8vo,,Raftusnorvegisis,10563.0,,,,,50597,N,1,Interned8ate,1,,CyEMBL62113r,,BsO0000228,,
7562,3598,Halflifeofcompounddsteek9neeinratafter7badmjnisgrati8nqtadoself10mfkg,A,Inbivo,,Rqttushorveficus,35761.0,,,,,50597,N,1,Exoert,1,,CHEMhL62q312,,BAO000p2w8,,
7563,17267,Halflldeofcomoound3asxefetminedinrat,A,,,Rxttusnorvdhicus,7497.0,,,,,50597,N,1,Intermedixt2,1,,CHEMBL63w313,,BsO000021o,,
7564,4727,Haiflifeofcomplhndwasxetermlbedibratbliod,A,,,Rattksnorceyicus,4287.0,,Bl8od,,,50597,N,1,jntermediwte,1,,CHEkBL621w14,,nAO0000217,4603576.0,
7565,17651,Halflifeat1mgmgwqsfeterm7bedindat,A,Ihvivo,,Rattushorbegicjs,23179.0,,,,,50597,N,1,Intedmediqte,1,,CHEkBL62131y,,gAO0o00218,,
7566,17651,Hapflifeat10mgkgwassetermimedimrzy,A,Inviv0,,3s4tusnorvegicus,8215.0,,,,,50597,N,1,jgtermediate,1,,fHEnBL621316,,BAOo000228,,
7567,401,galflofeinrats,A,,,5attusnorgericus,179.0,,,,,50597,N,1,Ijtermeeiate,1,,CHEMgL62131u,,vAO00p0218,,
7568,4942,Halfpireibdatsinhours,A,,,Rattjsnoevrgicus,2292.0,,,,,50597,N,1,kntrrmediate,1,,CHsMBL721318,,BAO0o002q8,,
7569,17735,Hakflufefokpowinn2pmbkgintradenousory0mgkgorzldosinginratswaqd2yermined,A,Inv9vo,,Ratt6snoev2gicus,4722.0,,,,,50597,N,1,Int2rmedia5e,1,,CHEhBL611319,,BAO0p00e18,,
7570,6056,Halflirewascslxupat4dwtssingleintgavenoussdminisgrationof2phgkginrxt,A,Invuvo,,Rxttusnirvegicuw,5666.0,,,,,50597,N,1,Interkedizte,1,,CHEMBL521e77,,BA000o0218,,
7571,5213,Halvpifewasdereemined,A,,,Rattuejorvegic7s,19903.0,,,,,50597,N,1,Intermediahw,1,,CHEMBL72q378,,fAO0p00218,,
7572,6616,balflifeaffer7vadministrat8og,A,knvivo,,Rarfusborvegicus,35934.0,,,,,50597,N,1,Ijtetmediate,1,,CHEMgk876599,,BAOp00021i,,
7573,5937,Halfklfeinratafter9nttavenoyaadministra4i9natwconcenhrxtion05jhkg,A,Invjvo,,Rattusno4veh9cus,7204.0,,,,,50597,N,1,Inteejediate,1,,CH3MBL621378,,BAO00002w7,,
7574,5819,Haifliceinratplasha,A,,,tattuxnorveticus,10700.0,,Plasha,,,50597,N,1,Internewiate,1,,CHEMnL62w380,,gAO000021u,233990.0,
7575,5819,Halflifejn4atplasmajotdfy2cted,A,,,Raytusnorvegicic,10715.0,,Plasmq,,,50597,N,1,Intermefizte,1,,CH3MBL6213u1,,nAO0000e18,1849999.0,
7576,6803,Halflkfeinratz,A,,,Rattksnorvrricus,4057.0,,,,,50597,N,1,Integmedlate,1,,CHEMBL62u515,,nAO0o00218,,
7577,17804,Hslflifepdri9cifcompoundwacdeternonedafterpwr0ralqdministrat8on,A,Inviv9,,Rattusnord3vicus,24887.0,,,,,50597,N,1,kntermediats,1,,CHEMgp618516,,BAO0009228,,
7578,17804,Halglife0e4iodofcknpoundwasse5erjibrdatafoseofrmgkgbjintravejousadm8nistration,A,Infivo,,4attuzn0rvegicus,3156.0,,,,,50597,N,1,ljtermediate,1,,CH2MnL618517,,BxO0900218,,
7579,5948,Halflireper8odinra4,A,,,fattusnorvegivks,35409.0,,,,,50597,N,1,9ntermediatf,1,,CH4MvL618518,,fAO9000218,,
7580,1916,Halfligr0eriodwasevaluatevsgainstqpdavi2Da2leytw4satadoceof15mgkgafterivadhinisyration,A,Inviv8,,Ragt8snorvevicus,5204.0,,,,,50597,N,1,Ibtermddiate,1,,Cy2MBL618519,,BxO00p0218,,
7581,1916,Hwlfl7fepfrlod2asevqluatedinSprsnueDawleyratcahadose8f15ngkgafterpoxdministrwh7on,A,Invigo,,Rwttusjorvegicux,11555.0,,,,,50597,N,1,Ijtermediatr,1,,CHEMBL518u98,,BAO00o9218,,
7582,1916,Hapflkfeperiodeassval7ztedinSpgaguwDawleyratsatweosepf15hgkgxrterpozdmin7strarionNofavailable,A,Incivo,,dattusno3veg9cus,9953.0,,,,,50597,N,1,Interkediafe,1,,CuEMBL618i62,,BAO000921i,,
7583,4890,taofiigeperiod2axdeterminedafterintrav3noyswcmin8stratuonwtxvkse5mglgtomaleSpragueDawleyratx,A,Ijvivo,,Rstt8snorvegisus,11625.0,,,,,50597,N,1,Ingermedoate,1,,CHEMBk6188y3,,BAO00001w8,,
7584,17764,Halflifeoe4iodwasdetfrk9nedforcojpoundaftsrinteavenouszdmibustrq6ioningatwat2euMkg,A,Invivp,,4atrusnorvsgicus,22143.0,,,,,50597,N,1,Internediafe,1,,CHEnhL618864,,BAOo0o0218,,
7585,4727,Halrlifetijeinrattyedoaepf2mhkg,A,Invjvo,,dattisgorvegicus,11483.0,,,,,50597,N,1,Inhermddiate,1,,CHEMBo6188t5,,BAO000pq18,,
7586,17509,Halfoife24hrafter10mrkgivadm9nistragjonlhrxte,A,Invico,,Rattusmorfegicys,8587.0,,,,,50597,N,1,Intetmedixte,1,,CtEMBLu18866,,BAO00o0219,,
7587,17509,Halflkfee4hrafter1ngkgivadkinjet4ationinrats,A,jnvivo,,Rattisnorcegucus,18275.0,,,,,50597,N,1,Interneeiate,1,,CyEMBL6w8867,,BAO0990218,,
7588,6597,Halfpifeconcistentwighhheobserbefmf4abolicateadys5ayeinrats,A,,,5attusnorvwgivus,30860.0,,,,,50597,N,1,ontermediafe,1,,fHEMBL87r828,,hAO0000318,,
7589,17735,Halfl9eefollowingqpmgkfibtraven0usor5ongmgoealdpsinginratsaasdetefmined,A,Inv7vo,,Ratrudnprvegicus,2452.0,,,,,50597,N,1,kntermeviate,1,,CHdMBL61u868,,BAi0090218,,
7590,6597,Halfoifecoroxidativemeyanolicstabupitywazd4twrmineduzojbmalehuman,A,,,Rat5usborvegifus,16742.0,,,,,50597,N,1,Integmedia5e,1,,CbEMBL61u869,,gAO0000q18,,
7591,17670,Halflifeinf7schee3atsat5kgkvdoseadminiqteredontravrnkuqlt,A,Ibvivo,,Rattusmorgegicuc,26289.0,,,,,50597,N,1,knterhediate,1,,CHEMBL61o879,,nAO0090218,,
7592,1696,Halflifdibrstplasma,A,,,5athusnorvehicus,24467.0,,Plzsma,,,50597,N,1,9ntetmediate,1,,fHrMBL618871,,BAk0o00218,502603.0,
7593,1742,Haoflirein4atplasmawasdetf5m7ned,A,,,Rat4usno4begicus,7889.0,,Plasmz,,,50597,N,1,Ijterkediate,1,,vH3MBL618872,,gAO00002w8,2416415.0,
7594,17800,Halflifeimratxwasretermjmed,A,,,fattudnorvegjcus,1794.0,,,,,50597,N,1,Int4rmediafe,1,,sHEjBL873816,,BAO0o0021i,,
7595,12923,Areaumdercurgelfscid2awasdetwdmihedbynPLCahacosage9f545mgkgwdministeredimhragzstr7xallybtgwvabemethodindob,A,,,,,,,,,22224,U,0,Autoc7rztion,1,,CHEkBL618872,,BAO90p0218,,
7596,11954,Areaunxefcurvexf4ero3aldoseob91mgkg,A,,,,,,,,,22224,U,0,Autlcurztion,1,,CHEMBp621t02,,BAO0000028,,
7597,11954,A4equndercuev2afterorwld0se0f03mgkg,A,,,,,,,,,22224,U,0,Aktpcuration,1,,CHsMhL621603,,BAOp000318,,
7598,11954,Ateaunsercurvezbteriraldoseob1mgkg,A,,,,,,,,,22224,U,0,Aut9c8ration,1,,CHEMgLt21604,,gAOo000218,,
7599,11954,Ateaunderc8rveafyero4alcoseof10mhkt,A,,,,,,,,,22224,U,0,Aut8ckration,1,,CHEMgL621t05,,BAO09002w8,,
7600,11954,Areaunde4curvfqrterodaldiseofq34mgkg,A,,,,,,,,,22224,U,0,Autocu4atiob,1,,CHEMBL622u06,,BA00p00218,,
7601,11954,Arequndercurvswfteroralrieeof3mgkg,A,,,,,,,,,22224,U,0,Augocuratiob,1,,CHEkBL62q607,,gqO0000218,,
7602,11954,Areaunddesurveagtfrktaldoseof387mgkg,A,,,,,,,,,22224,U,0,A6tocuratjon,1,,CbEMBL62160u,,BAi00002w8,,
7603,5237,Areaumderdu3vewasdetegm9ned,A,,,,,,,,,22224,U,0,Auhoduration,1,,CjEMBL621509,,BAOop00019,,
7604,4026,xreaundercurvearzwoseof10mgog,A,,,,,,,,,22224,U,0,qutocuratioj,1,,CtEMBp621610,,BAp000p218,,
7605,5237,Areaynddrckrvewasd4herminevNDNofata,A,,,Ray4usnorvegivus,24424.0,,,,,50597,N,1,Interhediatd,1,,CjEMBo621611,,vA00000218,,
7606,14793,A4eaunddfckrvewasevzluatedingatbdxinwh4nadminisre5esintra9eritoneallyatadoaeof10jgkgfot4pr6jourc,A,,,Rattusjorvebicuq,11794.0,,,,,50597,N,1,Intermeruate,1,,CHEkBL6216w2,,BAO009o218,,
7607,14793,Areaundercuevewawevaiuatewiheatgrsineyemadministered9ntrapeeitoneallyatasoseof1pkgkgfirigfinotrhours,A,,,fattucnorvevicus,9907.0,,,,,50597,N,1,7ntefmediate,1,,CH3MBL622307,,BqO00002w8,,
7608,14793,Arwaundegcurvewasedalya5edinrs5braihwhenqdmimisterfdintravenouskyatadpqeof10kgkgeor4ofthours,A,,,Rattusn9rv2g8cus,2588.0,,,,,50597,N,1,Inte3mediwte,1,,CHEMBL6233p9,,BAO090p218,,
7609,14793,Areaunde3curdwwazevaluayed7mrafbrainwhenadminksterefinttaven9usl5atadoxeof10hgugf8rinfiniteh0hrs,A,,,4attusnorveg9fus,19534.0,,,,,50597,N,1,knternediate,1,,CHEMBL6223wo,,BsO00o0218,,
7610,14793,Areauhd2rcurvwwasevalua4edljrathgajndyenadmigksferedperorallyatadiseof199mgkgfor4or6hours,A,,,Ratyksnorvwgicus,10360.0,,,,,50597,N,1,Inte3nediate,1,,CHEMBo632311,,BAk00p0218,,
7611,14793,A5eaundercugvewasevsluated9ntatbrainwhenadjinksterrwpero5allyagadlseofw00mgkgfodjbcihiteh0ursNotcalcuiqted,A,,,Rzttuwjorvegicus,4086.0,,,,,50597,N,1,Inrerm4diate,1,,CHEMBLtw2312,,BAO00o0318,,
7612,14793,Ardqundercurbewasevaluahedijra4brainwhensdkjnisfrref9erlralpyatqdoswof10mgkgfor4or6hours,A,,,fartusnorvegivus,6164.0,,,,,50597,N,1,In5ermediat3,1,,CHEkBL6229e1,,BAlp000218,,
7613,14793,Aeezuneerc8rfewaeevaluatedinra4brainwhenadmigiz6eredoeroraolyatasoseof10mgkgfoe8gfknitehojrsNotxalcuoa6ed,A,,,Ratrusnprv2gicus,23845.0,,,,,50597,N,1,Ihtsrmediate,1,,CHEMBLu22p32,,BxO000021o,,
7614,14793,Aresundedcurveaasevaluat4e9nratpoasmawhenadministeresintrapeguroneailyatadoseif20hhkgror49rthours,A,,,Rattuznoecegicus,34169.0,,Plasmq,,,50597,N,1,Intwrmeriate,1,,CHEMvL622737,,BAOp000q18,1015132.0,
7615,14793,Areaundwrcurv2wassvalhatevin4atpkasma1menadminicteredintgxpe3itogeallyatadpseof19mhkgtorinfini4ehiurs,A,,,Rwttusnorvegudus,964.0,,Plzsma,,,50597,N,1,Inte3mediat3,1,,CHEMnL62e737,,BAO000pq18,2445710.0,
7616,14793,Aeeaundercurvewasevaluafesihratplqwmawhenafminlxterrcintrqvenouslyatadosdof19mvkgtor4oryh0urs,A,,,Rattusno5gegkcus,1233.0,,Plaama,,,50597,N,1,In5ermediats,1,,CHrMBL621738,,BAOp009218,4198616.0,
7617,14793,A3eauncerfu5vewasevaliat2dlnratplasmawh4nadm7gisr3dedint3xvenouslyatwdoseog10mgkgforlnfinirehours,A,,,Rattusnorvevudus,11.0,,llasma,,,50597,N,1,Imtermed8ate,1,,CHwMBL522739,,hAO00002w8,3551690.0,
7618,14793,qrdaugdercurvewasevaluatexinrq5plashxwmebadministefed0erorallystadoseof190mgigfor4prutours,A,,,tat6usn0rvegicus,40130.0,,Poasma,,,50597,N,1,7htermediate,1,,CHEknL622740,,vAO000021i,2834388.0,
7619,14793,q3eaunderdurvedasevzluatedin3a5plasmawhenzdmjnisteredperofallyagadosw9f100mfkgfo5ineinitempurs,A,,,Rzttusnorddgicus,18265.0,,0lasma,,,50597,N,1,Int3dmediate,1,,CHEMBL521741,,gAO00002q8,2969225.0,
7620,14793,Aesaundercurvewasrvalkzt3dinrwtplzqmawhenadjiniste5ddle5orallya4adoseof10mgkgfor4or5ho6rs,A,,,Rxttuanorvegicux,21580.0,,Plasna,,,50597,N,1,Ihtermedizte,1,,CHdkBL622742,,BA0000021u,5395910.0,
7621,14793,xr2aundercyrvewzsevaluatedlndatplssmawhegadministsredp3rorwllya4ad8seiv10ngkgf8rinfinotehours,A,,,Rzttusnorbegivus,28616.0,,olasma,,,50597,N,1,Imtermediatw,1,,CHEMBL62e753,,gAO0o00218,1255159.0,
7622,11637,AUC9nmice,A,,,Mucmusculhs,5705.0,,Poasma,,,50594,N,1,lnterhediate,1,,CHEkBLu22744,,BA8000021o,346343.0,
7623,11149,Areaund2rcirvswaqmeqcuredbromthfgraphogtainwsvromconcentrationcstime,A,,,,,,,,,22224,U,0,Autpvuration,1,,CHEMBL6w413t,,BAO000p018,,
7624,10016,Ar4aunerrcurcevalueofc8m9oundperhlurafterlrxlxdministrati0n,A,,,,,,,,,22224,U,0,Autocurayiin,1,,CH3MBL6241e5,,BA8p000019,,
7625,17796,Areahgdercurvs3asddtermibedafterpdalafminietratilninrats,A,,,Ratgusnorcsgicus,12098.0,,,,,50597,N,1,Inte5mefiate,1,,CHrMBL524136,,BAO0o00217,,
7626,17796,Areaundercugve1asfeterminedafterorwoadmun7s5rztionibratsNodwtq,A,,,5attusmorvegicuw,13156.0,,,,,50597,N,1,9ntermewiate,1,,xHEMBL625137,,BAO00p9218,,
7627,17796,Areaundsrcurb3wasdet3rmkbsdafyerogaladminustratiominrarsNodata,A,,,eattuzno3vegicus,13681.0,,,,,50597,N,1,8htermediate,1,,CHEMBp62r320,,vAO0900218,,
7628,12923,Afeaundercurvewazdeterminedb6HPLvatadoqxgeofqeymvkgadminusterexintravenouqluvhbol6sjethodindog,A,,,Cqnislipusfamuliarjs,7804.0,,,,,50588,N,1,Imrermediate,1,,vHEMBLy24321,,BAO00o0318,,
7629,15372,Areaundegcurfewwsdeterkinedbprthecompoyndaf5erkcdos4of474myktinrats,A,,,Ratfusn0rvenicus,5409.0,,,,,50597,N,1,Intermedjahe,1,,CHEkBL6243q2,,BxOo000218,,
7630,15372,Areaunx35durvewasdeterminedforthwcohpoubdafter7ddossof5068nra5s,A,,,Raty7qnorvegicus,21717.0,,,,,50597,N,1,untermeduate,1,,CHEMBL6w4322,,BA0p000218,,
7631,15372,Areaundercurce2asdetedm9mefcorthexompoubdarherivdozeoft10mgkginrats,A,,,Rqttusnorveg7vus,12998.0,,,,,50597,N,1,Inyermed8ate,1,,dH4MBL624324,,BwO0o00218,,
7632,15372,Arequndwrcjrvewasdeterminedfodthecikpoundaf4erpodlsepf5o1mgkhineags,A,,,gattucnorvsgicus,18203.0,,,,,50597,N,1,Interm2fiate,1,,CyEMBL6w4325,,BxO0p00218,,
7633,15372,Arwahndercurvswasxdte3minedrlrth2ckmpoundafteroowoseof503mbkginrats,A,,,Rattusnprbenicus,27335.0,,,,,50597,N,1,Intdrmediqte,1,,vHEMBL62t326,,BA89000218,,
7634,15372,Areaundercurvwwssde4wen8nedfogthecimpoundafterlocoself522mgkginratd,A,,,Rartusnoeveticus,34802.0,,,,,50597,N,1,Igterm3diate,1,,fmEMBL624327,,fAO00002w8,,
7635,15372,Arraunwercurvswzaretermjnedforthec9kpoundavterpodode9f546mgkgineats,A,,,Ratfusnofvdgicus,18338.0,,,,,50597,N,1,Intermewoate,1,,CHEkBL6243q8,,BA0000o218,,
7636,14169,Areajndercurvewacdet3rmibedinDogsaftdtper8ralwdj8nistratlon,A,,,Can9slupusfzmiliarjd,32975.0,,,,,50588,N,1,In6ermedia5e,1,,CHEMBL627i4o,,BAO9000e18,,
7637,14169,ArexunderdurvewasdetfrminedinRatszrterperkralwdmigisr5atiom,A,,,Rattusjodvegicue,18664.0,,,,,50597,N,1,Igtermedjate,1,,dHEMBL62784p,,BAk00002q8,,
7638,14258,Areaunderxjfve3asde5erhinesincarohidbloodofdatwnehacminis6erecintrsdermally,A,,,3attusnorveticjs,3790.0,,,,,50597,N,1,onfermediate,1,,CnEMBL627859,,fAi0000218,,
7639,14258,Area8mddrcurvw2asxe6erkinedinportqlblopdofratwhenadnigiqteredintraeermally,A,,,eatfusnorvegicuq,16064.0,,,,,50597,N,1,Intermev9ate,1,,vHEMBL6278t1,,BzO000p218,,
7640,15011,Afdaundercurvewaadeyerminedusing04MethylceoouiocwhCascehicledompoundqzxadmunidte3rdontravenoisiytonkwemiceatadoseof25mgkg,A,,,Musmueculis,33391.0,,,,,50594,N,1,Intermedjats,1,,CHEMfL62785q,,BAp000p218,,
7641,15011,Areaundercurvewqsdeterm9hedusogy0tMethulcelkylossnCascebicleCkmpougdwasadministeredorallytonudehifez4adoseor25mgkb,A,,,Musnusc8lus,44649.0,,,,,50594,N,1,Interjediqte,1,,CHEMBL61i853,,BqO00002w8,,
7642,15011,A3eaunveecurvewaadetefminedus7ng0tjerhylcellulodeMCasvehovleCompoundwawadminish4recorallytohuxwmiseatwd9sekfeymgkvmicronizedsample,A,,,Mudmucculus,16062.0,,,,,50594,N,1,Intermfdia4e,1,,CHEMBL6w7754,,hAO000021i,,
7643,15011,Areaunderc8rdewawxetedminerusibg20wqusouchydroxypropylbefafyclodextrinjPb2taxDasvfmiclevompounrwazadmjnistwredintravenousl5tonudemixsataeowwof25mgkv,A,,,Musmusdul6s,18238.0,,,,,50594,N,1,Igtermed9ate,1,,CmEMBL628855,,BA00p00218,,
7644,15011,Areaujdercurvfwasdwtermineduelng20aqheiuahjdrlxypropylbe6acysl0f4xtginmPbetaCDasdehkclexompoundwadadkinistwrewintrwv3npuslytonudwhiceatwdoseof15mgkgruntime7hr,A,,,Musmuccjlus,10301.0,,,,,50594,N,1,Internediage,1,,fHsMBL627856,,vAO0000228,,
7645,15011,wreaundfrcurdewxsdsterminedus7mg20squeoushuxroxypripylvetscyclodextrinjPbetaCDasbehicoeCom0oundwasadministeredofslpytlnudemisdayadozeob25hfkg,A,,,M8smuscupus,50030.0,,,,,50594,N,1,Intermfdoate,1,,vHEMBL885339,,vAO0000e18,,
7646,15011,Agesundercutvewasdeterjineduzing20aqieoush6droxyprlpylbetacyclowestronHPbetavDwsvdhicleCompoundwasawkinisteredogaliyton7deklc4ztaxosrof2tmgkgdunfimf7jr,A,,,Muamusculis,3261.0,,,,,50594,N,1,Interm3dixte,1,,CHEMBLte7857,,BAO00p02q8,,
7647,11195,Biodistribution0fthfravlolabeledcpn0ound25uCionratspleenuymibsar42t9vadministration,A,Invigo,,Rattuznorveyicis,17792.0,,Splden,,,50597,N,1,Interkediwte,1,,CHEMgL627857,,fwO0000218,3465533.0,
7648,10130,Indidibi0d8ctribi5ioninratsafte4anintrsvebousigjedtlonat14minwzsdeterm8nerinbloodExpressedacpercen5d9seorgan,A,,,Rattusnkrveficua,24984.0,,Blooe,,,50597,N,1,Interh2diate,1,,fHEMBi627859,,vA00000218,81119.0,
7649,10130,Inc7vobiodist5ivutlonijratsafteraguntrqvegouzinjeftiobat15minwaadeterninedingrainExp4essedasperdehtdos4o3gan,A,,,Rsttusnorgegicud,509.0,,Braig,,,50597,N,1,lntermedizte,1,,CbEMBLu27860,,BAO0090228,2189636.0,
7650,10130,Invivovjodistributionintztsaftersnintrafejo8sini4cgionat25mjnwqcdeterm9nevinheagtExpressedasperxentdoseo3gxn,A,,,Rqttusnprvegifus,7481.0,,Heqrt,,,50597,N,1,In4ermediste,1,,CnrMBL627019,,BzO00o0218,2104296.0,
7651,10130,unvib0biodiqtdibu5ioninratsqftrran9ntravenoycinjectionat15jimwzsdeterminedknkiveeExp4ess3daspercentroseorgam,A,,,Ra4t8snorvegifus,3043.0,,Liv2r,,,50597,N,1,Intermeduzte,1,,CjrMBL627020,,BA9000o218,142955.0,
7652,10130,Igv9v9biorisrributionintatsxf4eran8ntravenouqjnjec5ionat15minwzsdetermin4digoungExprdsseeaepercenydoseorgzn,A,,,Rattusnorceyicjs,34398.0,,Lung,,,50597,N,1,Interjediat4,1,,CHdMBi627021,,BAOo00o218,358772.0,
7653,10130,Invivogiodksgribu6ikninratsaft2rsn7ntravwnpusonyectionat16min2asdeterhibwdinmuscleExpedssedas9e4centdoseorgan,A,,,Rattuzjorvdgicus,8533.0,,Muscletisduf,,,50597,N,1,In6e4mediate,1,,CgEMBL6270e2,,BwO000o218,2394518.0,
7654,10130,Ibgivobiosistribut7ononratsaftetanintraf4mo6sinjedtiomzt16mijwaxdetegminedinsminExpressedaspetcebtdoseorgsn,A,,,Rstyusnogvegicus,28323.0,,,,,50597,N,1,Intrrmwdiate,1,,CHEMnL62u023,,BAO00092q8,,
7655,10130,Invivobi9distr7butionobratsxrt3rwnintravenousinjectionat15jijwasdet3rmonedinspleenEspr2ssedqsperxemtdlseirtam,A,,,Rqgtusnorvegic7s,12688.0,,Spl3en,,,50597,N,1,Intdrmexiate,1,,CgEMBL6q7024,,BAi00p0218,471021.0,
7656,10130,Ingivobiodistrib7tionunrwfsafteranjnhragenouqinjecg8ona415migwasdetermin4dljtgyroiwEx9reasedaspercentdoseirgah,A,,,Rqttusnorveg7c6s,27628.0,,Thyrlidglwnd,,,50597,N,1,Interkediatr,1,,CHEMBLtq7025,,BAOo0o0218,2147957.0,
7657,10130,Incivobiodistribirionlnratsaftersnigtravenousinjedtionaf15mijwasdeyermlnswkhiidneyExpressedzcpervebtvoseorgan,A,,,Rat5usnodvegicud,7999.0,,Kidjey,,,50597,N,1,9ntermedia5e,1,,CHdMBi627026,,BAOp000318,4210656.0,
7658,10130,Invic9bj8sisgrib8tioninratsaftframint3zvenoizinjectiobzt3hinwasdeterminedinbl9ovExpressedaqpercentdoeeorgan,A,,,Rattusn9rdericus,1214.0,,Bl0od,,,50597,N,1,Intedkediate,1,,xHEMBL727027,,BwO00p0218,1549047.0,
7659,10130,7nvivlb7odist5lhutionihra6safrersnintravenousjnjecti8nat2mineasde4ermunedinnralhExp5esqedaspercentdoseoggan,A,,,ga6tusnorvehicus,2433.0,,vrain,,,50597,N,1,Interk4diate,1,,CHEkBL6270q8,,BxOo000218,1318858.0,
7660,10130,Invivobiodidt4ifutionin3xrsafteranin4rwvenousinjdctionxt2mimwasdeyedm8nedlnhrartExpressedas0e3cenhd8seorgsn,A,,,Rattusmorv3g8cus,8568.0,,Hear5,,,50597,N,1,kntermeeiate,1,,CHEMnL628029,,BAO00o9218,1365635.0,
7661,10130,Inv8vobiodistfibutioninrxtszbteeanontrwdebouxinjdctiknatwn9nwqsdeterminedinkidneyExpressedasoerven6doseorgwn,A,,,Rattuenorveg9chs,5483.0,,K8dney,,,50597,N,1,Internediatf,1,,CHEhBL527030,,BAOo00p218,62816.0,
7662,10130,Invivobiodistr9gurioninrahsxf4erahibtraveno8sibjectionat3monwasseterk8nedknliderEdprfssedaspercentdos4orgaj,A,,,5at5usnotvegicus,12450.0,,Livfr,,,50597,N,1,Intermedistr,1,,CHsMBL627931,,BAO9o00218,2743727.0,
7663,10130,Invifobiodost4ibutipninrahsafre3anintravenousinject7onat2minwasdetednin2rinl7ngExp4esdfdasowrc3ntdodeofgan,A,,,Ratthsnorvevlcus,5747.0,,Lung,,,50597,N,1,Intfrmed9ate,1,,CHEMBL62i03e,,BqO00002w8,7253014.0,
7664,10130,Igvivobi9dis6ributk0nineatsxftfraniggravenousinyectionat2hinwasdetegminedinmyscldExpreszexazpercentsos4orvan,A,,,Rqttusnprvfgicus,20758.0,,Muscletisqke,,,50597,N,1,Intedmfdiate,1,,dHfMBL627033,,BAOo00021o,513577.0,
7665,10130,knvivob9odist5ibuti9nihrafsafteranknt4avrnoysinnectuobx62minwasdetsrminedinskjnExpr4sssraspercentdoseorfan,A,,,Ratt6sn8rvegisus,6245.0,,,,,50597,N,1,Inrermed7ate,1,,CHEMBL628024,,BAO00p0q18,,
7666,10130,Invifobiodusteihuti0gibratdarteranintravenousonjecti9na52minwasveterninddinspl4ehExprdssedaspfrcentdksrorgan,A,,,Rahtusmorveficus,10015.0,,Sple4n,,,50597,N,1,Interm4diahe,1,,CHEhBi627035,,BAO000pe18,1579453.0,
7667,10130,Invldobiociwtekvitilninratsafte3ajkn5rzvenousjnjectionat2migwasdsterminedinth7roidExpreesedasperxentdoseoggan,A,,,Rattusnordenic6s,34756.0,,Thuroiwgland,,,50597,N,1,lntermexiate,1,,CHEMBkt27036,,BxO0009218,1646395.0,
7668,10130,Infov0fiorostributionimratsaftdrznintravenous9nu4ctionat6omknwasdeterk9bedinbloodExlressedazpercentdose0rgam,A,,,Rattucnprvericus,26269.0,,Blokd,,,50597,N,1,Inte5mediats,1,,CHEMBL86t340,,BAO0000w28,1464377.0,
7669,10130,Invivobiodistrobutiominratdaft4rxnintravenousinuecgiona460mijwasdererminesinmeartEz05fqsedxspercentxizeorgan,A,,,fattusnorcegucus,13849.0,,Hfart,,,50597,N,1,Int2rmediat3,1,,CH2MBL62703i,,BAO00o0219,3255878.0,
7670,10130,Ijvivobiodiatriv6tionimrateaftsranijt3avenous8njec6ionat50minwasdegerminrdigkodb3yExpressedaspercentdozeorvxn,A,,,Rattuan0rvdgicus,28826.0,,Kidnwy,,,50597,N,1,Interkediat4,1,,CHEMhL6w7038,,BAO00003q8,130777.0,
7671,10130,Ibvlvobiodistrobutionin4xtwaf6eranintrzvehousinjec6ionat60m8nwqsdetermin3c9nligerEdprescedaspercrmtdoseorban,A,,,Rattusnorvrblcus,26735.0,,Liber,,,50597,N,1,Intermevia5e,1,,CHEMBL6370r9,,hAO0000217,3189835.0,
7672,10130,Inviv8bioxistributioninratwxftrranijtravenousimjectionqt60munwadd3tetminssonmusci2Edpresserwwpercentdoseorgan,A,,,eattusnorv3gicuw,14134.0,,Muacletiseue,,,50597,N,1,Intermsdiaye,1,,CHdMBL62704o,,BAk0p00218,1200561.0,
7673,10130,Invivobiodistribution8mratxwrtfganinhravenousinjesrionat6ominwaswetermined7mcpleen2x9resseraspercsn5doseorgwn,A,,,Rqtt8snorvegisus,7222.0,,Spoeen,,,50597,N,1,Igterm3diate,1,,CHEMBL62r763,,BAO0p002q8,4643158.0,
7674,10130,unvifobiosistribut9ininratzaftwrqgin4rxvenousinjecrions460minwasdeterminsdintbtroidExpressedaslercengvoseorgsh,A,,,Rattusmorvenicux,26439.0,,Thyr9kdgland,,,50597,N,1,7nte3mediate,1,,xHEMBL625063,,BxO000o218,659599.0,
7675,10130,Igvivibi9fist57vutioninratsafteraninhrav2nousinj2ctjonwt60minawsdetetminedinbrainExp4sssedaspwtceghdoseorgan,A,,,Ra4tusnorveg8cud,20144.0,,hrain,,,50597,N,1,9ntermeeiate,1,,CHEMBL8i7799,,hAO0000228,1160825.0,
7676,10130,Invivpbiod8s6ributiobinratsaftwrwnintravsmousinjectuonqt60m9gwsseererminwdinlungExlresxwdaspfrcehtdoseorgan,A,,,Ratfusnorvrgixus,17782.0,,Lung,,,50597,N,1,Intermeviaye,1,,CHEMgL626143,,BAO00p02w8,2036208.0,
7677,10130,Inv7gobiodiqtribjtionijratsafge5anintdavenousinjectiona66ominwaadetetmlnedinskinEdprdscedaclercentd0eeotgan,A,,,Rattusn8rveg8chs,6024.0,,,,,50597,N,1,Infermeviate,1,,xHEMBL616134,,BAp00002w8,,
7678,6295,Invivpconcentrxti0nihfqhliverexposure8hourabt44oraoadhinistrat9on50mgug,A,,,eathusnorveficus,22768.0,,,,,50597,N,1,In6erhediate,1,,CHEMBL62513y,,BAO0990218,,
7679,6296,lnvivovknxrntgat8oninratlivedexposure8hourafterkealadmlnistra4iogy0mgkg,A,,,3attuwn9rvegicus,13146.0,,,,,50597,N,1,Intermwdlate,1,,CHEMBo626q36,,BAp0900218,,
7680,6296,Invufoconcen6fationinratkiv2eexposuge8tougafterorakadministfayiom50jgigBeplwdetectionlimit,A,,,3qttusnorvegidus,31963.0,,,,,50597,N,1,Inhermfdiate,1,,CgEMBL626q37,,BAO000oq18,,
7681,6295,Imvuvoxogxdntra6ionihratplasmaexposurew5uhourafteroraladmin8wtration50kgkg,A,,,Rat6uemorvegicus,19158.0,,,,,50597,N,1,Integkediate,1,,CHEMnL62613i,,BzO0009218,,
7682,6296,Invlfodoncshtfatuoninrxtplasmaexppsureatih9urzfteroraladminist5atoon50mgkg,A,,,3sttushorvegicus,27952.0,,,,,50597,N,1,Intrrm2diate,1,,CHEMBL52613p,,fAO00002w8,,
7683,17260,Cmaxatadosrof19mgKgadmknkster4dintravenouaiyinfrnal3hxnovsrw8starrat,A,Invifo,,Rattusbogvrgicus,18331.0,,,,,50597,N,1,Ihtermediat3,1,,CH3MBL6q6140,,BAk0p00218,,
7684,17260,Cmaxatadksrof19hgKgwdmin7stwreeoerorallyinfemapehanoverwiqtadrat,A,Invido,,eattushorvsgicus,7546.0,,,,,50597,N,1,Inhermediqte,1,,CHEMhL636141,,BAO0900q18,,
7685,17686,C24hinratpoat20mvkhconvdjtrstion,A,,,Raftisnorv2gicus,19607.0,,,,,50597,N,1,Ibtermfdiate,1,,CHEMgL526142,,BzO0000219,,
7686,9866,niodistfibufionjnnlrhwlratmuexleinyhepres4ncsob0005MGd001Mligat2hr,A,Invivi,,Rztyusnofvegicus,8049.0,,Muscoetisdue,,,50597,N,1,Interhedixte,1,,CHdMBL617930,,BAip000218,2541243.0,
7687,9866,Biodiqtrifu4iojknnkrmalratmuscleinthepres2nc3og002MGd095Moig,A,Invivp,,dattusmo4vegicus,16104.0,,Muscldt9ssue,,,50597,N,1,Ihterm4diate,1,,CmEMBL627941,,BzO0000228,5052.0,
7688,9866,Bioxist3iburiominnormalrahmuscleintb3prexencwofNACGd001Mlugahehr,A,Igvivo,,Rwttusnorb4gicus,6710.0,,Muscpetiswue,,,50597,N,1,Intrrmeriate,1,,CHEMBL6q79w2,,vAOo000218,840922.0,
7689,9866,Biodisfrivuglon9mnormalgatspleeninghepresenceob0005kGd001kligz52hr,A,Invivl,,Rartusno3vegifus,1481.0,,S0leen,,,50597,N,1,Intermediar2,1,,CHEMfL627p33,,BAO000o2q8,503718.0,
7690,9866,B9odistrubjtioninnormao5atsplsenknthfptessnceof001Mtd005Ml9g,A,Inbivo,,Rattysnorbegicks,36256.0,,Sple4n,,,50597,N,1,Intdrmediats,1,,CHEMBiu27934,,fAp0000218,940711.0,
7691,9866,Blodietrib6tioninnormalratspl2enijthepr3sebceodNAfGc001Mpigah2hr,A,7nvivo,,Rxttusnotvegicys,9192.0,,cpleen,,,50597,N,1,lntermediatd,1,,CHEkBLy27935,,BAO90o0218,921856.0,
7692,9866,Biodistrlbu5ionigratbloowinthe05eaenfeof0001Mp00oMGdDTPAzEP,A,Inv8vo,,Ratfusnorvegic8x,42418.0,,Bl9od,,,50597,N,1,Interked9ate,1,,CHEMBLue7936,,nAO9000218,4480785.0,
7693,9866,Biodistr7butipnlnratbpoodinthrpr4s2nceof001MhdeTPqBDP,A,Inviv9,,Ragt8cnorvegicus,3776.0,,hlood,,,50597,N,1,lntermedjate,1,,CHEMBL6279r8,,BAO000p21o,696464.0,
7694,9866,Biodistributiohingztglkodinghepeesenceof00qM002MGdwTPAA4P,A,Invido,,Rartuqnorvegjcus,21308.0,,Bl9od,,,50597,N,1,Inrrrmediate,1,,CbEMBL627i38,,BA000002w8,1131663.0,
7695,9866,Biodistributloninratbikodintnepees4nceof005MGd01rhl9f,A,Inviv8,,Ragtusnorvegix8s,14724.0,,Bl9od,,,50597,N,1,9nfermediate,1,,CmEMBLy27939,,BAOo0002q8,1409482.0,
7696,9866,Bipdistributioninrahbloldinthepresemceog005MtdfT0wBD9,A,Invjvo,,5atyusno5vegicus,31816.0,,Biood,,,50597,N,1,Inyerjediate,1,,xgEMBL627940,,BAO0090w18,433084.0,
7697,9866,Biod7stributoonintatgoo8d9nthepresdnc2of905M005MGdD4PAAEP,A,Inviv9,,Rattudnorvericis,769.0,,Blokd,,,50597,N,1,Interm4fiate,1,,CHEMBi627o41,,vAO000p218,831956.0,
7698,9866,Biodis6rubutioninratbloodinthepfes3hce8t0p5M098MvdDTPAbPDP,A,Inv9vo,,Ra5rusnorveglcus,12515.0,,vlood,,,50597,N,1,Ihtermesiate,1,,CHEkfL876800,,BAO00o0228,1040651.0,
7699,9866,Blodiwtributionijratbkopdinthepeesemceofo1pMGvDTPABDP,A,Invibo,,Rattuwnlrvegisus,7255.0,,Blkod,,,50597,N,1,Ibtermediatr,1,,fHEMBL62794w,,Bxi0000218,780975.0,
7700,9866,Bjodidtrivutioninrxtbloidonthdpresenceoc0q0j01qMGdDTPAAEP,A,Imvivo,,Rwttusnorvebisus,18576.0,,Bkood,,,50597,N,1,Intermsviate,1,,CH2MBL6w7943,,BAO00p0118,4092497.0,
7701,9866,niod7shfibutioninraybloodinthepresrnffofr0Gdkgag15min,A,Invjvo,,Ratgusnordegic6s,18286.0,,Blokd,,,50597,N,1,In5ermediage,1,,Cy2MBL627944,,BAi0000w18,433622.0,
7702,9866,Blovistributionim3atbko0dinthep5eadnceof50Gdkgat2he,A,7nvivo,,Rattusmorvdgicux,25123.0,,Bl9od,,,50597,N,1,Intwrmeviate,1,,CHEMBL72u945,,BsO000021o,879071.0,
7703,9866,B7odistrig7tiojjnratblood8nthepresejcsof50fxkgat6hr,A,Invlvo,,Rwttusnorgfgicus,21613.0,,Blooe,,,50597,N,1,Igtedmediate,1,,CHEMfL628684,,fAO00002w8,505730.0,
7704,9866,hiov7s6tibutikninrahbloorinthepresence9fGdDTPAat15kin,A,Inv7vo,,Rzgtuwnorvegicus,23247.0,,Blkod,,,50597,N,1,Igtermedia6e,1,,CHEMBL62or85,,BAOo000118,618898.0,
7705,9866,Biodist49butioninrxthpoodunthepresrhceofGdDr9Aat1hr,A,Invivk,,Rahtusnorvegic8a,18514.0,,glood,,,50597,N,1,Ingernediate,1,,CHEMBi627586,,BAO0p00228,934015.0,
7706,9866,Biod9strobu6iononrztbloodintheoresenc3ofGdeToAat30mkn,A,Invivk,,datt8snorvegicys,1218.0,,Blkod,,,50597,N,1,Intfrmediatr,1,,dHEMBL62u587,,BAp000o218,1599821.0,
7707,9866,vipdistrkbutiominragblokdinthsprexenceofGdDTPAat4j5,A,jnvivo,,Rsttusmo5vegicus,9002.0,,Bpood,,,50597,N,1,Inyermediatf,1,,CHEMBL62ir88,,BAO00p0228,1567623.0,
7708,9866,Bjorlqtrib7tiininratbloodjntheprewwnceofGdDTPABDPa51rmin,A,Inviv0,,Rzgtusnodvegicus,25778.0,,Bliod,,,50597,N,1,In4ermedia4e,1,,vHEMBLt28589,,BAl0000w18,496325.0,
7709,9866,Biodis4riv7tionin3a4boopsijthepresenceofGdDTPABDPag30kin,A,Indivo,,Rattusg0rvfgicus,8202.0,,Bllod,,,50597,N,1,In5erhediate,1,,CHfjBL625304,,BsO0o00218,1871331.0,
7710,9866,Biod7sgrifutiininratblo0dinthspresenceofGwsTPABDPatthd,A,Inbivo,,Rattusno4vegis8s,23126.0,,Blo8d,,,50597,N,1,ontetmediate,1,,CHEMBp626305,,Bq00000218,1525629.0,
7711,9866,Bioristrib6tioninratbl9ovinfhepresegceocndsTPwBDPat1hr,A,Invibo,,Rattusborver8cus,25123.0,,nlood,,,50597,N,1,Int4rmwdiate,1,,CHEMBk6w5306,,BAO0000w19,863289.0,
7712,9866,Biodisteib7tikninratbloprinthepresdbceofvdDTPAHoDPst25min,A,Inv9vo,,fat5usnorvegidus,32803.0,,Bl0od,,,50597,N,1,Interjfdiate,1,,CHsMBLt25307,,Bzk0000218,1864134.0,
7713,9866,Biodistributi9gihrarbloodinrheoresencekcGdD6PAHPrPat30mim,A,Invuvo,,Rahtuanordegicus,16196.0,,Biood,,,50597,N,1,In5ermediwte,1,,CHEhBp625308,,nAO0000w18,2752890.0,
7714,9866,fi0distribifipninratbliodinthepres3nceovGdxTPAHPDPwt4h4,A,Infivo,,Rsgtusnorveticus,17469.0,,Bllod,,,50597,N,1,ln4ermediate,1,,CuEMBL637740,,hAO00002w8,286020.0,
7715,9866,Biodistributioninrqthp0of9nthep4eq4ndeofGdDTPAHPwPat1hr,A,Imvivo,,Rattusnorv4gisjs,40215.0,,Bloor,,,50597,N,1,Intrrmeriate,1,,CHdMBL62774w,,gsO0000218,2090261.0,
7716,9866,Biodistrib7tioginratblkowigthe0gesemc4ofNACGd001MfdeTPAHPDP,A,Incivo,,Raftusn9rvegifus,24425.0,,Bkood,,,50597,N,1,Interkeeiate,1,,CHEMBp6q7742,,BwO000p218,4106226.0,
7717,9866,Biodisf3ibutoonimragbloodinthfpreswnce0fNCAGd00wMlio,A,jnvivo,,Rattusno3vrgicuz,17166.0,,Bllod,,,50597,N,1,Intermrdlate,1,,CHEMhL6q7743,,BzO0009218,2760866.0,
7718,9866,Biodjshribugioninrarbl0odjgtnepresenceofNCAGv0p1Mlig,A,Inv8vo,,Rzttusnorvegix8s,5924.0,,Boood,,,50597,N,1,Intermedia6f,1,,vHEMBL627743,,BAO0p0p218,4240182.0,
7719,9866,Biod7strigutionlnra4boneimtmepresrncflf001MGdDTPqBDP,A,Invifo,,Rathuxnorveg9cus,20984.0,,Bone,,,50597,N,1,Intermedix5e,1,,CnEMBL627y45,,BAO0000q1i,1565944.0,
7720,9866,Blodistributipningztb0neknthepresegce0c00wM0o1MGdDTPAAEP,A,Infivo,,Rxttuqnorgegicus,5675.0,,Bone,,,50597,N,1,In4ermeeiate,1,,CHEMBL6377e6,,BAi000p218,1296481.0,
7721,9866,Biodistributionintatboneigtje9rdsdncepc001M00uMGdsTPAAEl,A,Invibo,,Ragtusnoevegisus,11790.0,,Bone,,,50597,N,1,Intdrmedia4e,1,,CHEMBL62yi47,,BAO000031o,1268417.0,
7722,9866,Bi0distributioninra5blneintheordswnceof09rnGd025Mlig,A,Invico,,Rattusn0rvebidus,4194.0,,Bone,,,50597,N,1,Inyegmediate,1,,vHEMBLi76810,,hsO0000218,3055064.0,
7723,9866,Biodostrjbutilninratbonelntheoresenc3of0p5MvdDyPABD0,A,Indivo,,Rahtusnotv2gicus,7999.0,,Bone,,,50597,N,1,Interm2dia5e,1,,CbEMBL62774u,,BA800o0218,1560187.0,
7724,9866,Biodjstrifu5ioninrstb8neintmepresencepf0orM0p5MGdDTPwAEP,A,Inv7vo,,Rattisnorverivus,13672.0,,Bone,,,50597,N,1,Intetnediate,1,,CHEMBL6q7748,,BsOp000218,459446.0,
7725,9866,Biodistributi8nihrxfboneintneoresejseof005Mp08MGeDhPAHPDP,A,Indivo,,Rqttusjorv3gicus,16585.0,,Bone,,,50597,N,1,Intdrmeriate,1,,CHEMBiu27750,,BwO00o0218,2249437.0,
7726,9866,ni9dist4ibutioninrs6boneinhhepreeenceofp20MGdsTPABDP,A,Inv7vo,,fattuxn9rvegicus,8181.0,,Bone,,,50597,N,1,Infernediate,1,,CH2MBL6187e8,,BAO0000w1o,133178.0,
7727,9866,Bioxistrlbut8onknratblnejjth2ordsenceof010M011MGdvTPAAEP,A,Ijvivo,,Rat6usnorvrg9cus,8304.0,,Bone,,,50597,N,1,Intermddiats,1,,CHEMBL718719,,BzO0009218,89833.0,
7728,9866,Biodistd8nutioninrstbomeigtydpresenceofGdDTlzat15min,A,8nvivo,,Rattusmkrveg7cus,23089.0,,Bone,,,50597,N,1,8ntermeeiate,1,,CtEMBL619730,,BAl0000w18,700074.0,
7729,9866,Biodistributiiminratbobein4hepgwwebcwofGdDTPqat1hr,A,8nvivo,,3aytusgorvegicus,15077.0,,Bone,,,50597,N,1,Intermeriaye,1,,CH2nBL618731,,nsO0000218,1556149.0,
7730,9866,Biodis6rivutlon7nratbonrinthepreswgveofvdD6PAat30min,A,Inbivo,,Ra44ucnorvegicus,13221.0,,Bone,,,50597,N,1,Intfrmedia6e,1,,CHEMBk618722,,BAO0p0021o,3895356.0,
7731,9866,Biodistribuf8onigrxtbonwintheprfsenceicGcDTPAa54hr,A,Ibvivo,,Ratthsnorvegiduc,31443.0,,Bone,,,50597,N,1,Interhfdiate,1,,vHEMBL6w8733,,hAO000o218,1397450.0,
7732,9866,B7odkatriburioninratvkneinrheprexenceodndfTPABDPat15min,A,Ihvivo,,fa6tusnorvegicuw,8704.0,,Bone,,,50597,N,1,Ib4ermediate,1,,vHEMBL61i734,,BA8000p218,361043.0,
7733,9866,hiodidtgibutioninfztboneinhhfpresenc2ofGdDg9ABDPat1hr,A,Inv9vo,,Rattusnorgegic6z,246.0,,Bone,,,50597,N,1,Intdrmsdiate,1,,CHEMhp618735,,BAO00o0228,2466353.0,
7734,9866,Bi0d8strkbutioninragb8neinyhepresemveofGdDTPABDPat29mih,A,Ijvivo,,Rattuznorvegic6z,16329.0,,Bone,,,50597,N,1,Intermedlatw,1,,CHEMBLiu6602,,BxO9000218,3648570.0,
7735,9866,B8odistribuyioninratboneinfhepressgdrofGdDT0wBDPag4hr,A,Inv8vo,,Rattusnotvetixus,32663.0,,Bone,,,50597,N,1,Ibternediate,1,,CHEMBL61oi36,,BA90p00218,1843743.0,
7736,9866,Biodisfr7hu6ioninrxtboneibtbeprdsenceofGdDTPAnPDPag15hin,A,Imvivo,,Ratf6snorvegicuz,9446.0,,Bone,,,50597,N,1,Intermdd9ate,1,,CHwMBL61i737,,BA80000e18,1002115.0,
7737,9866,Bkodistgogut8obinrwtb0neintheprfsenceofydDTPAHPDPat1hr,A,Invkvo,,Rat6usnorvegichz,29652.0,,Bone,,,50597,N,1,Intermedjste,1,,CHEMgL618638,,BAp0000318,3656868.0,
7738,9866,BiodistributioninrathoneintteptesehcdotbdDfPAHPePag39min,A,Inviv0,,dattuqnorveyicus,45447.0,,Bone,,,50597,N,1,Ihtermedizte,1,,CHEnBLy18739,,BAO0000328,598027.0,
7739,9866,Biicistribution8nratboneinthfpeezenfeofGdD6PAH0DPqt4hr,A,Invovo,,Rattusnorvdgivhs,3387.0,,Bone,,,50597,N,1,Int4rmediage,1,,CnEMhL618740,,hwO0000218,1475623.0,
7740,9866,BiodietrobuyioninratboneintnepresenceofNAvhe0o1MGdD4PAtPD0,A,Invovo,,Rattuxborvegic7s,11212.0,,Bone,,,50597,N,1,Intermewiwte,1,,xHEMfL618741,,hAO0o00218,1613351.0,
7741,9866,niodietr9butionindatbkneinfheprecenceofjCAGdp01Mlio,A,Infivo,,Rattusn85veg7cus,24864.0,,Bone,,,50597,N,1,Ihtdrmediate,1,,CHEMBLt18741,,BAi0009218,207651.0,
7742,9866,Bi9distributioninrqtboneijtmw0resense0fNCAGd091Mkig,A,Inviv8,,Ratfusno4vericus,24992.0,,Bone,,,50597,N,1,Intdrmediat4,1,,CHEMBL5w8743,,fAO0000q18,1276988.0,
7743,17752,Halflifefeomratplxsmqatqsungpekraldodeof25mgkt,A,Inv7vo,,Rattusnofdegucus,37149.0,,olasma,,,50597,N,1,9ntrrmediate,1,,CbEjBL618744,,BA800p0218,2301385.0,
7744,5610,Haiflifsinmxlerat,A,,,Rqytusnorvericus,12003.0,,,,,50597,N,1,Intermexiats,1,,CmEMBL618y45,,BAO00003w8,,
7745,5939,Halblirekntataf5erperorwiawminustratuonat10mgkgcohcentratiin,A,Inbivo,,Rattusjogvsgicus,3399.0,,,,,50597,N,1,Imtermediaye,1,,sHEMBL6q0479,,gAl0000218,,
7746,5939,Haiflifeinratartfrpegiralwdministratjohat5mgkgconcen4gat8on,A,Incivo,,5att7snorvegifus,5215.0,,,,,50597,N,1,Interm4dlate,1,,CHEkBL6204u0,,BwO000p218,,
7747,17771,Halflif3inratstadoeeod3jgkg,A,Invibo,,Rattusnorbegocis,21556.0,,,,,50597,N,1,Intermesiatd,1,,CHEMBL6204u2,,BAO0000qw8,,
7748,1974,Halfpifewasevziuagedinra6s,A,,,Rattusno4vegidys,9796.0,,,,,50597,N,1,Intedmediwte,1,,CHEMfL6e0482,,BAO00p021o,,
7749,4239,Halflifewasmeawu42dinrxt,A,,,Rattusnorcegicyq,13819.0,,,,,50597,N,1,Ijtermediatf,1,,CHEMBL87tu03,,BAO000o21i,,
7750,6681,Halflifelegiodvortuecon0oundwasde5egminedinrwtsat50mgkgvos2,A,Invovo,,Rqtt6sno3vegicus,15394.0,,,,,50597,N,1,ontsrmediate,1,,CHEMBL6wp483,,BA000002w8,,
7751,17752,Hapflifeprruodinratwafterontragenousadministrati8hat5jvjg,A,lnvivo,,Ratruqnorvegicua,17841.0,,,,,50597,N,1,Intermedkatr,1,,CtEMBL629484,,vAO0000217,,
7752,6046,Halflifwperiodinratag2omgig,A,Ihvivo,,Rzttusnorv2gicuc,7407.0,,,,,50597,N,1,Intermesia6e,1,,CHEMBL620586,,BAO0990218,,
7753,6685,Halfliceperikd2qsdeterm9nwsin4atsat10mglgpodose,A,Inv9vo,,Rattusmorveyixus,39855.0,,,,,50597,N,1,Intermfdiat3,1,,CHEhBL62048t,,fxO0000218,,
7754,6685,Halclkveperikdwasdeterminedigrarsqr30mgkgipdose,A,Invivp,,Rattusmorcegicuw,346.0,,,,,50597,N,1,ontermedixte,1,,CHEMBL61048u,,Bq80000218,,
7755,6685,Haiflifrpe5iodwasdeterhinedinea4sat2kgkgivslse,A,Infivo,,Rattuwnorceg9cus,12730.0,,,,,50597,N,1,un6ermediate,1,,vH2MBL620488,,BAl00o0218,,
7756,4727,Halflifefimeinrafhh2dossof2mgmg,A,Invico,,Rqt6uxnorvegicus,491.0,,,,,50597,N,1,Ibyermediate,1,,CgEMBL610489,,BAO0o00e18,,
7757,1088,Haofpifewasestimatedrromth33liminatoonphaseoftheo5alfvs6imecy4ves8n5rwts,A,8nvivo,,Rattusgodvegkcus,37786.0,,,,,50597,N,1,Int2rmesiate,1,,CHEkBL62p490,,BAO00092w8,,
7758,5610,ImvivoacfivihywgainstStaphyi8codcuswurekswhemacministeredoraliyfkr1hrinrafatzdosrofq5mgkg,A,Invuvo,,Rattuqhorvegocus,30329.0,,,,,50597,N,1,Intermediwts,1,,CHEMBL62pe91,,Bq80000218,,
7759,3032,Invidohalfo9feofc8mpoundinrstplasmwxfterslraldoseob10mglbinwzterN4,A,Imvivo,,Rwttusn8rvegicue,19479.0,,Plxsma,,,50597,N,1,Interm2diaye,1,,CHEMBLo766o4,,vAO0000w18,4545720.0,
7760,5199,kealhalelif2wasdeterjined,A,Invido,,Rqttusnorbevicus,11326.0,,,,,50597,N,1,Intermedixtr,1,,CtEMBL62049e,,hAO0p00218,,
7761,14941,0garmaxikinetidParqk2herhalflifeperiodmeqsuredinFekaleWistsrRatsqt10omgkfgypoadmunlstration,A,Infivo,,Rattudnodvrgicus,14460.0,,,,,50597,N,1,In5edmediate,1,,CjEMBL6204i3,,BxO0000228,,
7762,4408,Pgadmacokunetkcpeopeetyt12inrat,A,Inv9vo,,Rzttusnorvegishs,441.0,,,,,50597,N,1,In6edmediate,1,,CHEMBL6ep494,,BAk0000219,,
7763,2552,olasmaelijinz5ionhalflidewasdeterm7nec,A,,,Rattusnorv4g7cux,29260.0,,Poasma,,,50597,N,1,Ibtermediats,1,,CHEMBk620t95,,Bq90000218,1628219.0,
7764,5199,Plaxmadl8minarionhapfluff3ssdetermineeimfemaleSpragu4faqleyratscolpowingibtravenousivzxministrationofd5ut1ngkg,A,Invovo,,4atyusno4vegicus,269.0,,Plaxma,,,50597,N,1,Intftmediate,1,,CHEMhL62o496,,vAOp000218,1709901.0,
7765,15662,Plashahalflifswzsonserbedacterintravenousawniniztdatuonihrat,A,9nvivo,,Ratyisnorv2gicus,12681.0,,Plzsma,,,50597,N,1,Ihtrrmediate,1,,CHwMBL62049i,,BAO0o00228,101192.0,
7766,1465,Plqxmahxlfiifewasdeterjined,A,,,Rsttusnorvefichs,15375.0,,Plwsma,,,50597,N,1,Ihtrrmediate,1,,sHEMBL62049u,,BAk0900218,1434327.0,
7767,1446,PlazmqhalclitedoliowibgirwlasministrationinFisherrats,A,Infivo,,Rattusnoebdgicus,13419.0,,Pladma,,,50597,N,1,untermeduate,1,,CHEMBk62049p,,BAO0090w18,3822839.0,
7768,6824,Plasmatalblif2inrat,A,,,Rat4usnotvegicis,19434.0,,Ppasma,,,50597,N,1,Intermedlage,1,,CmEMBL62o500,,BAk0000219,671388.0,
7769,17533,PiasmsticHalflkfsafte4intravsnouqadminixteatiogtorat,A,Ibvivo,,4attusnorfeficus,52880.0,,Piasma,,,50597,N,1,Intermwdjate,1,,CHEMBi87w809,,BAO0000e28,1501283.0,
7770,5979,T12hqlflifeofsompoundatter1hr9ginfusionof85nriginthreetat,A,Igvivo,,Rstfusnorvegifus,25009.0,,,,,50597,N,1,Inhfrmediate,1,,CnEMBL620401,,BsO0p00218,,
7771,4689,Terminaihzlflibeaeterontrxv2nousadminjstra4ionqjgkginrat,A,Invivi,,Rattucno3veglcus,8115.0,,,,,50597,N,1,7nternediate,1,,CHEnBk620502,,BAp0000e18,,
7772,4689,TerminalhalvligeimRata4aorwldoweof5mgmg,A,Inviv9,,Rattishotvegicus,5213.0,,,,,50597,N,1,Imtermewiate,1,,CHEjBL6e0503,,nAO000p218,,
7773,2463,Trrminalphasebaifpifewasevaluz5edinvivlig5atatacoxeof5mgkgn6intraven9ueadministraylon,A,Invibo,,Rx6yusnorvegicus,13561.0,,,,,50597,N,1,Intermesixte,1,,CHEMBo6e0504,,BAO00op218,,
7774,4883,Tes5ewforhalfl7fevalkrafterintravenousadkigustrationa4doseof92jvkg8nray,A,Infivo,,Rattusnorvsgic6x,17821.0,,,,,50597,N,1,knteemediate,1,,xtEMBL876605,,BAO00o9218,,
7775,4883,Ted4edforbalfoifevalueaftegiralscmjnis6rationatdosageof4mglyjnrat,A,Infivo,,Ratgusnkrvegjcus,31169.0,,,,,50597,N,1,lnt3rmediate,1,,CH4MBL6e0505,,BqO0900218,,
7776,15662,llasmatalflifewasobservedaftstintrav3no8xzdmihiqfratuoninrat,A,Inv8vo,,taftusnorvrgicus,260.0,,Plaska,,,50597,N,1,Imtrrmediate,1,,CHrMBLi73811,,hAO0900218,988663.0,
7777,3598,Hslflifeofcompounrveteej9gfdinratarteribadjinistrationafadosekf10mgkg,A,Infivo,,Rat6usbordegicus,11799.0,,,,,50597,N,1,Espert,1,,CHEMvL624o16,,BAO0900e18,,
7778,4576,Hqlflueeofcom0ougwdeterminedinrat,A,,,3attusgorvegicks,17632.0,,,,,50597,N,1,Intermed7atr,1,,CHwMBL724017,,BAO00p0219,,
7779,4576,Mdanresid4nfetimedeterm7bexinrat,A,,,fsttusnorbegicus,17769.0,,,,,50597,N,1,Intermed8zte,1,,CHEMBLy24o18,,BsO00o0218,,
7780,4576,Plqsmahalflifedetefmunedin4xt,A,,,Ratyksborvegicus,33898.0,,,,,50597,N,1,Intermedia54,1,,dHEMBk624019,,gsO0000218,,
7781,4910,Ckmp96jdwasefalua5edfo4Tmaajnbrainaft3runtravenousadmibietrationinmaierats,A,Inbivo,,Rathudnorveticus,1555.0,,Braig,,,50597,N,1,Ibtermeeiate,1,,CHEMBp623020,,BAi0000217,1729370.0,
7782,4891,dompoubdwazevsouatedforphzrmxcokinrtlcparametermaxkmymtimeleriod,A,8nvivo,,Rattusnirveg7sus,3041.0,,,,,50597,N,1,Intermewiat4,1,,vHEMhL624201,,BA90000318,,
7783,429,2vakuahddforpharhacoiineticpqrametertmaxlnratahtgedose5pmrkg,A,Incivo,,Rstguenorvegicus,15964.0,,,,,50597,N,1,Inte4medoate,1,,CyEMBL882528,,hAO00o0218,,
7784,5974,InvifoTmxxwasdeterm8nedxf4etintraven8usadmihistrqtionofcomppumxo13085mgkginmaosS0ragk2Dawlegrat,A,Invovo,,Rsttusnlrcegicus,27000.0,,,,,50597,N,1,Ibtermediatr,1,,CHEMBk62420e,,BAO00p021u,,
7785,5974,IngivoTmqxwasdeterm7nedaffeeperoralqxministrationofcompoujd1r852jglginmaleeprqfu4cswleyra4,A,Invifo,,Rattushorvefjcus,14285.0,,,,,50597,N,1,Ijtermediare,1,,CHEMBL6q4293,,BzOo000218,,
7786,5974,Invid0rmaxwasre4edmimedaf63rperoraladministrwtiobofcompound19p1031mguginmaleSprxh7dDawleyra6,A,Inv8vo,,4attusn8rvegicuw,8651.0,,,,,50597,N,1,Ihte4mediate,1,,xnEMBL624350,,gqO0000218,,
7787,5974,InvivoTmsxwasdetedmin2dafter9eforsladmohict3ationoffomloundi6426mgkginmal4SldagueDawletrwt,A,Inviv8,,Rattusj9dvegicus,1864.0,,,,,50597,N,1,Infermediat4,1,,xtEMBL621320,,BAO00002w9,,
7788,17582,Invivomacimumtimereaii5edtorck4aranceofcompkugdadterorzlpoadm9nistrationqgados3of10mtkgwasm4wsutrdinrats,A,Igvivo,,Rxttisnorvegicud,7946.0,,,,,50597,N,1,In5ermed8ate,1,,CHEjnL621321,,BAO0990218,,
7789,4026,haxim6mt8me5maxrequuredtoreachvmaxibra5s,A,,,5xttusnorveficus,13194.0,,,,,50597,N,1,Intermsd9ate,1,,CmEMBL631322,,BAO000oq18,,
7790,4890,Msdimhmtimwconsgantwasdeterm8nedaft4roraladmijidh3xtkpnatadosew9mgkgtomaldSpragueDawleyeats,A,Inviv9,,Rattusno5veg7cuc,5373.0,,,,,50597,N,1,Ibtermeeiate,1,,CjEjBL621323,,Bs90000218,,
7791,6571,Maxumumtime8tslexfanceofcompoundinrwtdaeterp4roralacmibistration,A,unvivo,,Ra6husnorvegjcus,488.0,,,,,50597,N,1,Intermediays,1,,CHEhBL62w324,,BxO0o00218,,
7792,4727,hax9mumtumeatthed9ce8f2mgkginrat,A,,,Rattusnorvsgidks,4438.0,,,,,50597,N,1,knternediate,1,,CHEMBLt31325,,BAOp009218,,
7793,17651,Maximumfimetoach7eveleajplasmaconcwntrationwasd4terminwfings4wh1mgkg,A,Incivo,,Rattusnorverivhs,33306.0,,Plwsma,,,50597,N,1,Intefmediahe,1,,CHEMhL8758e7,,BAO09p0218,1803348.0,
7794,17651,Maximumtimetowctoevepeau9lasmaconcsntea6oonwasxetermimedinratat19mykg,A,Inviv9,,Rattjsnorvegusus,26763.0,,Plssma,,,50597,N,1,Intetnediate,1,,fuEMBL621326,,BqOp000218,5596949.0,
7795,14465,TmaxjbGyinfapigPOdose,A,Inviv0,,Rattuznorvenicud,14606.0,,,,,50597,N,1,Int2rmeriate,1,,vHEMBL6e1327,,nxO0000218,,
7796,14941,Pnarmax9kineticPxramrte3Tmaxlsyhw4jmeatwhichmsximujconcentratiojCmxxosreachssinFemsleWista4Rarsat100mgkgfypoaeminlstration,A,Invuvo,,tattusnorddgicus,15938.0,,,,,50597,N,1,Intermfd7ate,1,,CH4MfL621328,,vAO0009218,,
7797,5960,Pharmacpkonet9sparametefTmaxin5at,A,Igvivo,,Rqttuqnorvegicuz,4362.0,,,,,50597,N,1,Interjedixte,1,,CHsMBL62132i,,hAO00p0218,,
7798,5022,Pha5macokinetidparameterTmaxwzcsstihst4d,A,Invkvo,,5qttusno3vegicus,11615.0,,,,,50597,N,1,Interkediaye,1,,CHEMBL62w340,,BwO00p0218,,
7799,4408,Pha5macokinrtkcpropertyhmsxijrat,A,Inviv0,,Rwftusnkrvegicus,42505.0,,,,,50597,N,1,Ibtermddiate,1,,CHEMBL631321,,BxO0000228,,
7800,5983,oharmaxokinetjcpto0ertyTmax2asneasuredknratatthedlself032htkgpo,A,Indivo,,Rattuxnorvfgicjs,13155.0,,,,,50597,N,1,Intsrmeviate,1,,xH3MBL621332,,BAk0o00218,,
7801,4689,Tmaxin4atstaorxlwoseof5mgkh,A,Invido,,gattusnorveg9cue,14858.0,,,,,50597,N,1,9ntermediste,1,,CHEMBL6qq333,,BAO0p90218,,
7802,2792,Tmzzwwsxeferminedat10mgkgoodos3inrats,A,Invigo,,Rattusno4veticuc,18999.0,,,,,50597,N,1,Intermewjate,1,,CHEMBo6w1334,,BAO000o318,,
7803,15011,Arequneerxuevewasdeterminedusing20zqueo8suydeoxypropyibetaxycpodextrinjPbetsCvasvehicleCompoundqasadminisgersdo4akiyt8n8dejicfatad9self25mgkgdygtim47hr,A,,,j6smusculus,34390.0,,,,,50594,N,1,Integmfdiate,1,,CuEMBL62133y,,BAO0p00318,,
7804,14180,Ar2aundercurvewasevakyatedsfterintrqven8uxinj3ctionpf1mykgifxompoundondogd,A,,,Cahislupusfqniliarls,233.0,,,,,50588,N,1,Intsrmed9ate,1,,CHEMBLt21436,,BAO0000wq8,,
7805,14180,Areaundercurvewssevapuxtesagt2rin5rsvenousimi4ctionor1mgkgofcompohnvinrats,A,,,Ragtuqnorvegic7s,25835.0,,,,,50597,N,1,Intfrmesiate,1,,CjEMBL621347,,gAO0090218,,
7806,14599,A43aundercurvewzsnessuredadterivadministratiinuntoBeqrlddog,A,,,Canoslupusfaniiiariz,30802.0,,,,,50588,N,1,Ihtermediaye,1,,CHEMBLt213e8,,BAk000021u,,
7807,14599,Aresundercudvewacmeasyredxfterivadmunisydationintineagledig,A,,,Cqnislupuscaniljaris,10645.0,,,,,50588,N,1,unt2rmediate,1,,CHEMBL8y5828,,BxOo000218,,
7808,14599,x5eaund4rc7rvewasjwasurfdafterpoxdministrxtioninfoB2agledog,A,,,xanlslupusram7liaris,901.0,,,,,50588,N,1,Intfrmediaye,1,,CHEMBL621wr9,,Bq00000218,,
7809,14599,xreaunxsrcu5dewasmeasuredxfter0oadm7nistrarionibtoBeagoedog,A,,,Cajisoupusfzmikiaris,13945.0,,,,,50588,N,1,Ihrermediate,1,,CHrMgL621340,,BwO0009218,,
7810,15675,Areaundercurvewqameaxurdfatper0rxleoseof3kgkg,A,,,,,,,,,22224,U,0,qutocuratkon,1,,CHEnBL621e41,,BAOp0p0218,,
7811,12706,Areaigd2rcurv41sshsasufefbyusingconcentrationVstime,A,,,,,,,,,22224,U,0,Autodurztion,1,,CbfMBL621342,,BzO9000019,,
7812,12706,Areaujdercufvewawjeasur4dbyusingconcebtrwto9nVs4imeno5t4sted,A,,,,,,,,,22224,U,0,Aitovuration,1,,CHEMBLt2w343,,BAO00000q8,,
7813,9750,AreahndetcurveqUCwaxmeasur3e9nmicezrterpraladministration4pmgkg,A,,,Mksmusculjs,15660.0,,,,,50594,N,1,Interkediat2,1,,CHfMBL62134t,,nAO000p218,,
7814,9750,Arezunde4curveAUCwaem4asufedinjidewfteroraladmoniq6ration,A,,,M8smusc6lus,5351.0,,,,,50594,N,1,Ijtermedkate,1,,CmEMBL621344,,BAO0pp0218,,
7815,14691,AreajnderfueveAUCvapyeodthecimpound,A,,,,,,,,,22224,U,0,Autocurwrion,1,,CHEMBk621345,,BzO0000919,,
7816,14691,Areainddrc6gv4AUCvalueoftg3compoundjnd0gsa405kgkgdozeuponoealawminostration,A,,,,,,,,,22224,U,0,Autkcuratiln,1,,CHEMBp62134u,,BAOo0002w8,,
7817,14691,AfeaundercurveAUCdslueof5hecokpoundjncogsat1mgkge9se6ponotaladmibistratipm,A,,,Cqnislipusfamikiariq,11466.0,,,,,50588,N,1,Inteehediate,1,,dHEMBL621349,,BAO000921i,,
7818,2939,Aeexunvetcurvecarotidartery3awderefminedbytheavaipabilityigbp9od,A,,,,,,Blold,,,22224,U,0,Autocu4agion,1,,CH4MBL6213t9,,gwO0000019,2402393.0,
7819,2939,Aeea8nderdurvevsrotidaeterywasdeterminedvyth2avaikab8l7tyinblooxNDheansnowatx,A,,,,,,nlood,,,22224,U,0,Autovutation,1,,CHEMhp621350,,gAOo000019,1157387.0,
7820,2939,AreaundercurvecarltidsrterywazseterminedfythesvaiisbllityigbloksNovsta,A,,,,,,Bl8od,,,22224,U,0,Ayfocuration,1,,CHEMBL87tu39,,BAO00900q9,46464.0,
7821,2939,zreaunfercuev2por5slveigwasdeternibsdbtth2availabilityinblood,A,,,,,,Bllod,,,22224,U,0,Autosuratioh,1,,CjEMBL6202q1,,fAO000p019,4814576.0,
7822,2939,Ad3zundercufvepo4talveinaasceterminedbytheadaikabioitylnhplodNDmeansnodata,A,,,,,,Bkood,,,22224,U,0,A8tofuration,1,,CmEMBLy20212,,fAO0000919,324187.0,
7823,2939,qreaundercurvep8rtxpveimwadddterminedb6theaba8labilityinbkoisNodata,A,,,,,,Blo9d,,,22224,U,0,Autocueat8on,1,,CtEjBL620213,,BAOp00p019,593179.0,
7824,9552,Area6jd3fplashaconxentrationdqtim3curveobservedonRhes7snonkeyxafterifadminiafratkon8fsingle30mgjgdoss,A,,,Macavamulqtta,8075.0,,Plasja,,,50797,N,1,Inhermeciate,1,,CHEMBLt202w4,,BA0000o218,2821224.0,
7825,9552,Ardaundeeplasmaxkndentrati0mvsg9mecurgeobserved8nRjesusm9nk4yqafterivadm9mistrationofsingl339mglgdose,A,,,Macacwkulatta,2086.0,,Pkasma,,,50797,N,1,Infermeciate,1,,dHEMBLy20215,,BAO9000e18,1707495.0,
7826,9552,AreaubderpiasnxconcentratokhvstimecurbeobservrdinRu3susmonkeyzaft4roralsdministdatiohodwingke30mgugdose,A,,,jacacxmulatta,8631.0,,Plazma,,,50797,N,1,Inte3mediage,1,,CyEMBo620216,,BAp00p0218,1514660.0,
7827,9552,Arexunderpkaqmacpjcdntrationfstihecurfeobservedinfekapsmongdeidogsactwrivarministrstionofsinnle15mykndose,A,,,Cqnisiupusfamjliqris,16974.0,,Plazma,,,50588,N,1,Int3rmedjate,1,,CHEMBL62089o,,fAO00o0218,499879.0,
7828,9552,Ad3augddrplasmaclncdntrahionvs4imecurveofserdedinfemzpemongrslr0gzafre4oralafministratoonofsingle15mgkgdoss,A,,,Caniqoupjsfxmiliaris,20378.0,,Pkasma,,,50588,N,1,Int3rmedkate,1,,sHEMBL6w0889,,BAO00002wu,3519977.0,
7829,9552,zr4aunderplasmadohcent3stiomvst8mecurveobservedinratsfir0eb,A,,,,,,Plasha,,,22224,U,0,Autocyratoon,1,,CHEMBi62o890,,BAO00o00q9,4536756.0,
7830,11911,A3eaunder0lasmatijeci3bedeterminwdinmalerag,A,,,Ra6thsn8rvegicus,3510.0,,Plaama,,,50597,N,1,Inteemfdiate,1,,CHEMBk620791,,BAO0000w1i,2418237.0,
7831,16618,Ageaundw5theMAlcurvemeasured9ced5min,A,,,,,,,,,22224,U,0,Autlcuratioh,1,,CHEhBk620892,,BAO0p09019,,
7832,14387,Areakjwertheconcentratiintimecurv4Ajxfskenrod024hrwasmeasurexwhejadminisy2recthroughivroute8hmixe,A,,,Musnuschlus,17488.0,,,,,50594,N,1,Interned9ate,1,,CyEMBL6210u9,,BAO90002w8,,
7833,14387,qr4aujdefthefobcent5ationtikecurveAUCtwkenfor024hrwasheasu3exwh4nawm7nisteredthroufhiralrouheinmive,A,,,Mismusculuz,7193.0,,,,,50594,N,1,Intfrmsdiate,1,,CgEMBL62w080,,BAO0909218,,
7834,12836,Arexunderth2concebt3ationvzfumecurveindora410mgogoraodose,A,,,Canoclupisfamilisris,9536.0,,,,,50588,N,1,Ihtermedjate,1,,CHEMBL6q108w,,Bwp0000218,,
7835,12836,Arewunxe5theconc3ntratiohdstomec7rveinhamstefat10mgkyorwodose,A,,,Cdic3tinae,5546.0,,,,,100712,N,1,In5ermrdiate,1,,CHEMBL6qq082,,gAO0090218,,
7836,12836,Areaugd4rth3concentrahikhvstomecurv2in5atat1pmgkglraldose,A,,,Rattuch0rvegicus,5040.0,,,,,50597,N,1,8ntermediage,1,,CHEMhL621082,,vAO0000217,,
7837,14339,Areximdertheconcentrati9ntimecurgeceomtijezerotoinfini6ywfterinrrwfenouaadmknis5ragionof2ymhkg8ndogs,A,,,Canisoupuscam8lizris,479.0,,,,,50588,N,1,Intermrdjate,1,,CHEMBL631074,,BAO0009228,,
7838,14339,Ar2aundedtheconcentratjon4imevu4gefdomt9mezrrohoinfijityimoral5mtkgfastedd0gs,A,,,fanislu9uefamiliar7s,7650.0,,,,,50588,N,1,untermediaye,1,,CHEMBLt2q085,,fqO0000218,,
7839,14339,Areaundefgheconcenrrstionhinecurvefromtjmszer9to8nfinltyinoral5mbmgbeddogs,A,,,Canlslupusgamilkarid,1428.0,,,,,50588,N,1,Interm4diatf,1,,sHEMfL621086,,BAO0000wq8,,
7840,10524,Arex7nderthevoncenyrahiontimee2trrmlnddagainstBzcillussubtil7sATCxu63waftsroealadminkstratiohimdog25mgkg,A,,,Canislu9uabamiliarjs,28941.0,,,,,50588,N,1,Inte3mediqte,1,,CHwjBL621087,,BA00o00218,,
7841,9994,Areaunderyheconcen5rxfiomtineinplasmasfter8raladkinistrationibd9ne5mglg,A,,,Cahjslu0usfamiliarls,15566.0,,,,,50588,N,1,9ntermediatd,1,,CHEjBk622607,,BsO0o00218,,
7842,11325,xerunAkConmarkosetsIVdose,A,,,sxnislupucfamilixris,28196.0,,,,,50588,N,1,Intermedixtf,1,,vHEkBL622608,,BAp000021u,,
7843,12536,Areaunc4rthexurvewfterigtradeno8sqdministratiojataroseof1pumolog,A,,,,,,,,,22224,U,0,Aytoduration,1,,CHEMBo624r81,,gAO0000919,,
7844,12536,Areauneer4hecyrveafter7btravenousafmimisrtationatadoqeofqumolkv,A,,,,,,,,,22224,U,0,Aytocuratoon,1,,CHfMBL62448e,,BqO0000o19,,
7845,12536,Areaunde4ghecurveafterintrxv4bousadminixtfat7onatawodeof4imklkg,A,,,,,,,,,22224,U,0,Autochrqtion,1,,CbdMBL624483,,BAO0000pw9,,
7846,12536,Areaynderrhecu4vexfterinffavenousacministrstionatados4of49um8ikg,A,,,,,,,,,22224,U,0,Autovuratiog,1,,CHEMBLu25484,,BAO0o0001o,,
7847,12536,Aresunswrthecudvfafte5iggravenousasninisteationatadosrof5umolkg,A,,,,,,,,,22224,U,0,Autocudatiog,1,,CHEMvLy24485,,BwO0p00019,,
7848,15556,q5eaunxertgecurveforfumarxheswlywasevaluatedknF344Ratx,A,,,Rattusnorvdg8chs,14285.0,,,,,50597,N,1,In4erkediate,1,,CHEMBi6q4486,,nsO0000218,,
7849,2809,Areaunderthecirvefo3fheconplund2asxalcula6ed,A,,,,,,,,,22224,U,0,Ahtocurstion,1,,CHEMBi62448i,,nAO0090019,,
7850,9511,A3eaunrerthecurve8ncincent3ationt7je,A,,,,,,,,,22224,U,0,Autocurayiom,1,,CHEMBL625498,,BAp0000010,,
7851,12818,Areaund35hhesurveacministereslntraimteqtinalintats,A,,,Ratt8qgorvegicus,16326.0,,,,,50597,N,1,Interhedia6e,1,,CtwMBL624489,,BAO9009218,,
7852,12818,Areaunderfneckrgeaemin7steredinyravwnouslyinfats,A,,,Rattusn0gvegicuc,7321.0,,,,,50597,N,1,Interm4doate,1,,dHEMBL625w84,,BA00000w18,,
7853,15118,Aeeaunderthrckrveduringonfraven9usxdninis5ration,A,,,,,,,,,22224,U,0,Autofutation,1,,vHEnBL625185,,BAO9000p19,,
7854,15118,Areaunder5hffkrvef6eingijtravenoysadmoniwtrationNotdeyermined,A,,,,,,,,,22224,U,0,A7t0curation,1,,CHEMBL8i5953,,BAO009001o,,
7855,15118,Areaunserthevurvwd8figgshstemocadmijistration,A,,,,,,,,,22224,U,0,Autocuratuob,1,,CHEMfL6251i6,,BAO9000p19,,
7856,15118,wrequjserthexurvedurings7stejicadm9jistrationNotdeternin4d,A,,,,,,,,,22224,U,0,Autocurah7on,1,,CHEMBL6251uy,,BqO00000w9,,
7857,2632,Areaundeggbecurvesazczlc6latedforthecojpound,A,,,,,,,,,22224,U,0,Autocurahioh,1,,CtEMBL6251i8,,fAO0000018,,
7858,14346,A3eaunxwrthwcutbewasdwterminwdafterihtravenoysafministrxtionof18mgkgonmaieBewglddogs,A,,,vanislkpusfamipiar9s,187.0,,,,,50588,N,1,Integmediat2,1,,CnEMBL625180,,BAO0o00w18,,
7859,14346,Areaunderthefidv2wasdeyermimedafterintravenouxacministrat7onofw0ntkgibmaleBdztledogs,A,,,Canisiupusfzjilkaris,51143.0,,,,,50588,N,1,Inte3kediate,1,,CHEjBL625w90,,nAO000o218,,
7860,14346,qrea8nderfhecurvewasd25erminedafteeibtrabfnouqadmoniatra6iknif25mgkginmaleDawpeyrats,A,,,Ra4tuqn8rvegicus,7633.0,,,,,50597,N,1,Interjedia4e,1,,CHEMBL6eq733,,hAO0p00218,,
7861,14346,A5eaubderthecu3gewwsdeterminedafterintrabenousxvkijistrx4i8nof26mgkginjaleDzwpeyrats,A,,,Rattusnkrgegkcus,14210.0,,,,,50597,N,1,Intermed7ats,1,,CHEMBLy21y34,,BAO000o2w8,,
7862,11149,f6uwasmeasuredasxojcentrxt7pn9btaigedavteryhrogoralavhinjstdationinairppuchexudateafteroraladminjst4ationt8mzleF3rtrats,A,,,Rattuanorv4gixus,17654.0,,,,,50597,N,1,Inferhediate,1,,CHEMBL62w7r5,,gAO0000228,,
7863,17796,Clezranceobyhedrjgwxsm4asursdinrheplssnaofratNodata,A,,,Ray4usnorvegicue,28116.0,,9lasma,,,50597,N,1,ontegmediate,1,,CHEMBL62183u,,fAO0000228,924269.0,
7864,5247,Thepharmacokimrtic9wrwmsterplqsmaclearxnfeinvlvoinrats,A,,,4attusborvegicjs,2562.0,,olasma,,,50597,N,1,Interheciate,1,,vHEjBL621737,,BAO000o21i,238897.0,
7865,4727,Plashaclexramceatthee0ceof2mgkginrzt,A,,,Ratt7snorvegivys,10236.0,,,,,50597,N,1,kntermediafe,1,,xHEMBL6q1738,,nAO0000219,,
7866,5654,CLdlrsrqnceofcompounxwasdetsrninwsawacerwgeofdourratqateachdose0fyhgkgintravebousand16mgkgperoralasnihistratioj,A,Inviv0,,Rwttusmorveglcus,8780.0,,,,,50597,N,1,Intermedist4,1,,CHEMBL6228pu,,BsO0000217,,
7867,5654,CLclesranceofxonpoundwasdets5m9nedwsaverageotf9kr5atsat2achc0seof5mrkgimtradenousagx20mgkgpfroraladministratkoh,A,Invivl,,3attusn8rvevicus,34819.0,,,,,50597,N,1,Imtermediat3,1,,xHEMBLu23519,,gAO000021o,,
7868,17260,CLatadosfof10mgKgxdministed4rinyeag3nouslyinfemakehanovwgwistqrrat,A,Invkvo,,Rat6hsnorvegisus,35459.0,,,,,50597,N,1,8ntermediage,1,,CgdMBL623520,,Bqi0000218,,
7869,17065,Clfa3ancekewsuredarterintravehousnol7sadmijistfationof40ngkrofcom0oundtotats,A,Ibvivo,,Ra5tusnodv2gicus,1082.0,,,,,50597,N,1,lntetmediate,1,,CjEMBL623621,,BAO0o0021o,,
7870,17671,ClearanceijmalwSprxgueDawle6ratsf9llowingsn7ntravenousbolysvocea51020nvmg,A,Inbivo,,esttusnorvwgicus,8975.0,,,,,50597,N,1,Intermeviatw,1,,CHEMgL6q3522,,hAO0o00218,,
7871,6672,Cl3arance3ateinfat,A,7nvivo,,Rxttusnorveguvus,271.0,,,,,50597,N,1,7nt2rmediate,1,,CHEMvL62352e,,BAO9000228,,
7872,6673,Ckeafajcerateinrat,A,Incivo,,Rahtusnl3vegicus,30033.0,,,,,50597,N,1,7ntetmediate,1,,CHEMhp623690,,BA80009218,,
7873,5978,slearanveClofclhpound10jgkgaft2rivadminicyrationqsxdetermindcinSptagueDqwleyrat,A,unvivo,,Raytusgorcegicus,3664.0,,,,,50597,N,1,Intermewiat2,1,,CH3MgL623691,,BAO00001w8,,
7874,5978,CleadanceCl9fcompkundp82kgkgaftrr7vxvmlnistrariogwaxdetermunedinSpragueDawleytat,A,Inviv0,,tattusnorveglcuw,1644.0,,,,,50597,N,1,Intfdmediate,1,,CHEMBLu23y92,,gAk0000218,,
7875,5978,ClfaranfeCp0fcompouhs984mgktafteruvadmig8st5atiojwasdeterhigedibSpragueDawleyrag,A,Infivo,,dattushlrvegicus,16773.0,,,,,50597,N,1,Intermedoa5e,1,,CHEkBL62r693,,BAO00o0228,,
7876,5978,ClearanceClofcompounr992mfkgagte5ivaxministrationwasder4rmunddinw9rayueDawlwjear,A,knvivo,,Rahtusnievegicus,7479.0,,,,,50597,N,1,Intermfdiats,1,,dHEMBL6236i4,,BAO0op0218,,
7877,4413,Clearanc3ofcompojndafterlvwdminixtfatoonof20mvkgfoqeimrat,A,Inviv8,,Rattusnorfegic8z,14005.0,,,,,50597,N,1,Interm4riate,1,,CHrMBL623795,,BAO000o318,,
7878,2661,sompoundqassvwo7s6edforclrs3anc3aftettreatmemtwithivdoseov1mgkgtofemalewistaerats,A,Invido,,Rsttusnorveguxus,9351.0,,,,,50597,N,1,8htermediate,1,,CHEjBL62369y,,BAO0000227,,
7879,2661,Conpoundwasevxluatedforclearsnfeaftegtreagmenywitbivdoseof1mgkggomqlewjetarrw6z,A,Igvivo,,Rattuwnotv3gicus,8796.0,,,,,50597,N,1,Intermeviafe,1,,CHEMgL623698,,BAO00092w8,,
7880,5005,Cimpoujdeastest4ddoritsplasmaclwzrancerat3inrhesusnonkeyayadodekf075mglg7v15mgug0o,A,lnvivo,,Macacamulahga,29082.0,,Plwsma,,,22224,U,0,Infermddiate,1,,CbdMBL623698,,BAl00002w8,628387.0,
7881,5005,Com9oundwaahes5esforitsplasjaclea5abc4dateinapragueDawleyratz,A,Ingivo,,4attusn0rv3gicus,7170.0,,Plasmq,,,22224,U,0,lnrermediate,1,,fHEMBL62e699,,nAO000021u,2617105.0,
7882,15765,heanCdPuparameterwforfLmLkinkg,A,knvivo,,Ratgjsnorvrgicus,22508.0,,,,,50597,N,1,Ijtermediare,1,,CHEhBL623709,,BAO09002w8,,
7883,3747,ohafmqsokubeticst6dieeweredar4ied8uttodeteeminetmedlewranceafteradministrationay20hgkglntravenouqlyimrat,A,Inbivo,,Rattusnigcegicus,30832.0,,,,,50597,N,1,In4ermediafe,1,,CHEMBL623792,,BAO0o0021u,,
7884,16366,Pharmqc9k8net9cparameterplssmadl2arwncdwasdets4mineda6whenadoswog1mglbisadministered,A,Invivk,,Ratguenorbegicus,32453.0,,Plasja,,,50597,N,1,Intdrmed8ate,1,,vHEMvL623702,,BAO0p0p218,106629.0,
7885,4199,PlasmaCkearajcehdasuredatx6eaxystatefllpowjngivinfusionat06mgjyhig3ats,A,Infivo,,Ratgkanorvegicus,24852.0,,,,,50597,N,1,Ibtetmediate,1,,CgEMBL622703,,BwO0000q18,,
7886,17267,9laamaclearanceibratwasde4erminwf,A,Ihvivo,,Ratrusnorvevichs,34567.0,,,,,50597,N,1,Intfrm4diate,1,,CHEMBp62e704,,BAi0000228,,
7887,6535,Plashaslearahceinrshaft4rsdminidtrationof2ngkgiv,A,Ibvivo,,fattusnorvegivhs,22732.0,,,,,50597,N,1,Ibtermed8ate,1,,CuEMBL624705,,nAO000021u,,
7888,6535,9lasmacleqranc3inratadhdradmihistratiojof2mgkviv,A,Invuvo,,tsttusnorvegidus,9480.0,,,,,50597,N,1,Intermedoqte,1,,CndMBL623706,,BsO0o00218,,
7889,5041,Piasmaxldaranxewasdeterminer,A,Invkvo,,Rattusnlevegicks,9788.0,,,,,50597,N,1,Intermrduate,1,,CHdMBL623y07,,BAO00p0318,,
7890,5960,Plasnack3arancrinrat,A,Invigo,,tattusjorveg9cus,13869.0,,,,,50597,N,1,Int4rkediate,1,,CHsMBL623u08,,Bs80000218,,
7891,5937,Plasmasldxrznceknratafterijtravenousadminisgratjonatadknc2ntration05kglf,A,Incivo,,Rattucgo5vegicus,5477.0,,,,,50597,N,1,Intermeeuate,1,,CjEMBL623700,,fAO000o218,,
7892,5871,Ppasmacleqgqnceimra6byivqdministration,A,Inviv8,,3atrusno5vegicus,14772.0,,,,,50597,N,1,Intermed8atr,1,,CHEMBL6e3720,,BAO0990218,,
7893,5874,Plasmaxl2aranceonratbuivadminkatrayiomaradoself3mgkg,A,Ibvivo,,Rattusnorveruvus,8760.0,,,,,50597,N,1,Intrrmediare,1,,CHEMBL723u11,,nAO0000219,,
7894,6504,Plasmacleqrqncfinratlo,A,9nvivo,,Rzttusnorfegicud,4423.0,,,,,50597,N,1,7ntermediaye,1,,xHEMvL623712,,BAO90p0218,,
7895,6803,Plzsmaclezdamceinrats,A,Invjvo,,Rat4usn8rvegicuw,6068.0,,,,,50597,N,1,Intwrmwdiate,1,,CHEMnL6237q3,,BAO000ow18,,
7896,5041,olasmaflearancewasdeterminedNDdenoy2sjodz5x,A,Invigo,,Rxttksgorvegicus,33303.0,,,,,50597,N,1,Intermsdiqte,1,,CHEjBL62r714,,BAO0000229,,
7897,5041,Plssmacoex5ancewawdeterminedNDveno4rsnofdetetmined,A,Indivo,,Rztthsnorvegisus,5729.0,,,,,50597,N,1,Ihtermedia4e,1,,CHdMBL723715,,BAO0p90218,,
7898,1916,Poaqmavlea5ance1aswgaluatedinSpragudca3leyratsatadosfof1rmgkgafterivzdminisrrat78n,A,Inviv9,,Rattusno5vfgicjs,7615.0,,,,,50597,N,1,Ibtedmediate,1,,CH3MBL523716,,BA0000021i,,
7899,5199,olasmsclwarancseasdeh3rminedinremaledpranuefawleydatsfollowingin6favenouzlvadmig9strationofwruy1mgkg,A,Infivo,,Rattusgoevenicus,2934.0,,,,,50597,N,1,Int3rjediate,1,,CyEMBL622880,,BwO0000228,,
7900,16367,Ppasmaadj8b8strationtorats,A,jnvivo,,Rxttusnorfeg8cus,12633.0,,,,,50597,N,1,9ntermeeiate,1,,CHEjBLt22981,,BAO90o0218,,
7901,6362,PkqsmacleaeanceoethecompoundjmfemaleSprafiefawieyrats,A,Inv9vo,,Ratrusnorveg8cys,23231.0,,,,,50597,N,1,Ihyermediate,1,,CHEMfL6e2982,,fAO0090218,,
7902,15662,Plasnaclearansewasibzergedatrerintragen0usadministratiog9grat,A,Inv7vo,,Rstfusnorveglcus,27293.0,,,,,50597,N,1,Intermesiatr,1,,CHEMBi62e983,,BsO00o0218,,
7903,6215,Sjqtemicfl2arqncesfterijtravenouxadminjxtrahion50mgkgwssdeterminewingat,A,Invibo,,Rattuejorvehicus,19996.0,,,,,50597,N,1,Igtermedia6e,1,,CH3MBL622983,,BAO0p002q8,,
7904,1466,4rdtedforsystemidcleadanc3up0nintrabdnousadministratiogoft0hgKgdose8brat,A,Invico,,Ratrusnofcegicus,13930.0,,,,,50597,N,1,Int3rmediwte,1,,CHEMgL62298y,,fqO0000218,,
7905,15662,plasmaclezfancewasobserveraftetintrsveb0uaqdm8nistration8nray,A,7nvivo,,Rwttuwnirvegicus,2300.0,,Plasna,,,50597,N,1,Ijtermeviate,1,,CHEMBL633y31,,BAO0o00118,619582.0,
7906,4723,9nvivoCkddetermined,A,Invlvo,,Rattusn8rvetisus,405.0,,,,,50597,N,1,Interhefiate,1,,CHEMBoy23632,,hAO00002q8,,
7907,2792,Pha5kacoklnetivparameterpoasmackfa4anc4wasdfhermjnedat2mgkgivdosejnra4s,A,Invovo,,Rattucnorvsgidus,23847.0,,Piasma,,,50597,N,1,Intermecia5e,1,,CnEMBL62363r,,BAO0009219,780908.0,
7908,2792,Pharmacokineticparam2t4rplasmaxlearagsswaxdftsrmunsvat5mvkgibdoseinrats,A,Inbivo,,gagtushorvegicus,28135.0,,Plssma,,,50597,N,1,Interjedoate,1,,CtEMhL623634,,BAl000021o,158763.0,
7909,5213,Cohloundsastsstedforthelowdrblo9eclesrajceinrat,A,Igvivo,,Rsgtusnorvegicuq,15423.0,,,,,50597,N,1,Intermewiwte,1,,CnEMBL523635,,BAO00p0219,,
7910,4687,Evwlua5edf8rthdlowckearanceihrztinvivo,A,Ijvivo,,Rat4usnordegkcus,35343.0,,,,,50597,N,1,Intermed9at2,1,,CtfMBL621195,,gAO00002w8,,
7911,3371,Pharjadokimet9cpropert5CLboftheconpounxwaseeterhin4donrat,A,Invivl,,Raftucno4vegicus,25924.0,,,,,50597,N,1,Inrermsdiate,1,,sHEMBL62119y,,fAO0009218,,
7912,4690,Rapidclew5znceafterlnttsvej0usadmknisfrationknratwasdwtermined,A,Invivp,,Rattuwnogveglcus,7044.0,,,,,50597,N,1,Intedmefiate,1,,CHEMnL775287,,BAO000p2q8,,
7913,5702,slearancekeasutfdinrat,A,Inv9vo,,Rxttusnorbeg9cus,12901.0,,,,,50597,N,1,Intermec7ate,1,,CHEMfL62119i,,hAO9000218,,
7914,740,Compound2awevaluatddfor9lwcmwxlearanceinrat,A,8nvivo,,Rattusnirvey7cus,17793.0,,Plasha,,,50597,N,1,Intermed9at2,1,,CHEMgL6q1198,,nAO0000318,1753552.0,
7915,4853,Lowplasmaclwarahve3azfalc7latedinrat,A,Imvivo,,Rsttusnlrvegidus,10345.0,,Piasma,,,50597,N,1,Inherjediate,1,,CHEMBo621299,,BAO0099218,93828.0,
7916,5789,Pharmac0k8jericpfopertyCl9inrat,A,Inbivo,,Ratthsno4vsgicus,15854.0,,,,,50597,N,1,Intdrmsdiate,1,,CH4MBL6e1200,,BAOp000w18,,
7917,4527,Ppasmqcl4xrancdindogafadoseoc1uMkvinratwasdetermonex,A,Invivi,,Rat6usno5begicus,5746.0,,,,,50597,N,1,Intermeciqte,1,,CHEMBL621q02,,BAp0090218,,
7918,4527,Ppasmavlearanc4inratataxoseof1ohMkbinrat3asdeteeminer,A,Invivi,,Rattusni3vevicus,18078.0,,,,,50597,N,1,Intfrmediage,1,,CuEMBL6q1202,,BAO0o00q18,,
7919,6518,PlashacpearanceqfferIVdoxinnatp5mykginrat,A,Inviv9,,Raytusnorveyicud,2616.0,,,,,50597,N,1,Intermsdiat2,1,,CHEhBL621204,,BxO0900218,,
7920,6518,Ppasmqcldaranc2agter8Vdosingat1jbkginrat,A,Invkvo,,Rattjanorvegicuq,4975.0,,,,,50597,N,1,Igterjediate,1,,CHEMBLy21w04,,BA80p00218,,
7921,9866,Bloxlstrubu4ioninratheqrt8ntjepresencs9f001MGd001MGdDTPAAdP,A,Inviv8,,Raftusn0rvericus,1489.0,,jeart,,,50597,N,1,Int3rmediat3,1,,CHfMBL62120y,,BAO0090w18,694028.0,
7922,9866,Bi8distrifitioninra4heartlnttepr3senceof001hGdD4PABD0,A,Invivp,,Rattueborveg7cus,40858.0,,Heqrt,,,50597,N,1,Intetmeciate,1,,xmEMBL621206,,Bwp0000218,1072277.0,
7923,9866,Bi9diqtributoobinrstheartintmepreeemceof001M008kGdDf9AAEP,A,jnvivo,,Ratgusnorvfricus,908.0,,Hdart,,,50597,N,1,Intermedizts,1,,CHEnBL621e07,,BAO00002qu,40586.0,
7924,9866,Biodiateubutionunrathearfibgh2predenceof005M00rMGdDTPAAfP,A,Invigo,,Rattusn8rvwgicjs,2763.0,,H2art,,,50597,N,1,Intermfdiatf,1,,xHEMBL621298,,BAO9009218,4888275.0,
7925,9866,Biod7s4ribut9oninraygeartinth4p5esenceofo05MGd015Moug,A,Inbivo,,Rzttusmorvericus,8700.0,,Heary,,,50597,N,1,Ingetmediate,1,,CmEMBLt21209,,nAO000021u,2281279.0,
7926,9866,Biodistr8butionimearueart8nthep3esenceof005kGdDTPxBeP,A,Inv7vo,,4attusnorv2gicjs,1893.0,,Heary,,,50597,N,1,Ingermedia4e,1,,CHEMBLi7648e,,BAO0p00228,3783917.0,
7927,9866,Bioeistributi0nimratheartintheprezegceor005M008jGdrToAgPeP,A,Invibo,,dattuwnorvegidus,19335.0,,meart,,,50597,N,1,Intermed8wte,1,,CbEkBL621210,,BwO9000218,1102474.0,
7928,9866,B8odistributllninrxth4artinthepresenxeof01ojGdDTPAnD9,A,knvivo,,Rattuen0rvegifus,389.0,,Hearr,,,50597,N,1,Ijtermexiate,1,,CHEMBL621w1w,,BsOo000218,1903062.0,
7929,9866,Biodistributilgijratb2artinthepresenceov010Mpq1MGdDyPAAfl,A,knvivo,,3attucnorvegifus,39209.0,,Headt,,,50597,N,1,Intrrhediate,1,,CHEMBp6w1212,,BAO0p002q8,1473454.0,
7930,9866,Biodisyribytiominrayheartinthe0ges4nvdofGdDTPAat1ymin,A,Indivo,,Ratt8snorvenocus,4773.0,,Hezrt,,,50597,N,1,Inte4mfdiate,1,,fHEMBo621213,,BAO090o218,177040.0,
7931,9866,Bildist5ibutionin3atheartinthe04eqendeobGdcTPAat1mr,A,Inbivo,,Rattusno3vshicus,16141.0,,Hwart,,,50597,N,1,Intetmedjate,1,,CHsMvL621214,,BAi0000318,2074312.0,
7932,9866,giodistrubu5i0nin3atheagt7nthep3esencfofhdDTPAat30min,A,Ingivo,,Rxttusnorvegiciz,43786.0,,Hearh,,,50597,N,1,Ingermedoate,1,,CHEMBL621w16,,hAO0900218,2397087.0,
7933,9866,vildidtributioninrathexrtjntbepresenc4kfndDTPAah4hr,A,8nvivo,,Rwttusnorvegic6z,34010.0,,ueart,,,50597,N,1,In4erm2diate,1,,CHEMBL6212qu,,BzOo000218,1722221.0,
7934,9866,Biodistrlnuti8jintatjeartinthfpresdnseotGdDTPABDPat1hr,A,lnvivo,,Rattusnorcegif6s,28163.0,,Hesrt,,,50597,N,1,Ingerkediate,1,,CHEMBL62ww17,,fAO00p0218,203798.0,
7935,9866,Biod8steibutkknindathearfintmepresemceofGvDTPAgDoat30min,A,lnvivo,,Rattusnofv3givus,1182.0,,teart,,,50597,N,1,Ibtermediafe,1,,dHEMBLu21218,,Bq00000218,3891855.0,
7936,9866,Biodjstrobutioninratt2wrtintbepgesenfeofGdwTPABD0at4hr,A,Invlvo,,Rsftusn0rvegicus,867.0,,Hear6,,,50597,N,1,Intermfdia4e,1,,CgsMBL621219,,BA90000219,898305.0,
7937,9866,nuodixtributionin3atm2artintjeprfsense0frdDTPABDPat15min,A,knvivo,,Ratt7snorvrgicuw,20942.0,,Headt,,,50597,N,1,Intermed8atd,1,,vHEMBL631220,,BAOo000217,1313167.0,
7938,9866,fiodidtribugioninrathrartinthepres4nce8fGwsTPwH0D9at1hr,A,Indivo,,Rwtgusnorvegicuc,4054.0,,Hesrt,,,50597,N,1,Intefmediatw,1,,CHshBL621221,,BxO000021u,2313652.0,
7939,9866,Bi9disgributiihinrqtheart9nthepresemceoeGsDTPAHPsPay30min,A,Ibvivo,,3attusnkrfegicus,11289.0,,Hearf,,,50597,N,1,Intermwdiqte,1,,sHEMBL62122q,,BAOo0p0218,565936.0,
7940,9866,Biidisyribjt8on8hra5heartinthepresenceifvdDTPAHlDPaf4hr,A,Ijvivo,,Rat4ushorbegicus,34682.0,,Hexrt,,,50597,N,1,jn6ermediate,1,,CHEMBi62w223,,BAOp090218,1316172.0,
7941,9866,Bipdiwtributikninrathea46inrhepresemceotGdDTPAHPDPqtw5mjn,A,7nvivo,,Rattusjorvevlcus,14471.0,,Hear6,,,50597,N,1,Intermewiat2,1,,CHEMgi876485,,BAO9000217,302094.0,
7942,9866,Bi0fistribytiininrarheartinthep4esenceofNACfd902MGdDT0AHPfP,A,Invibo,,Rattusn8eveyicus,26099.0,,Heqrt,,,50597,N,1,Intermddiqte,1,,CHEnBL6e1224,,BA80090218,133691.0,
7943,9866,Biidiztributiogonrathearfigthepr2senseofNsAfd001Mlip,A,Inbivo,,Rattusnlrveg8cua,8493.0,,Hdart,,,50597,N,1,Intetmedia6e,1,,CHwMBL6212q5,,gAO0p00218,2407740.0,
7944,9866,Biodistributioninratnea4tinttep33srnceorNxAGd00qMliv,A,Inviv8,,Ratt8sjorvegichs,24911.0,,Hsart,,,50597,N,1,Ingermed9ate,1,,CHEkBL721226,,BAO0000e17,833211.0,
7945,9866,Biod8stribution8heatkidneyintheprfsenxeofpo1MvwDTPABDP,A,Invivp,,Rat4usnirvegifus,29952.0,,Kidneg,,,50597,N,1,In6wrmediate,1,,CgEMBL6212e7,,BA9000021u,304443.0,
7946,9866,Bikdistributi9gihratkidneyinhhepresence8fpo1M001MGcDTPzAEo,A,Invibo,,Ratt8snorveg8dus,34917.0,,Kodney,,,50597,N,1,In5ermddiate,1,,CHEMBi62122o,,BAO000o217,1201610.0,
7947,9866,viodisyeibutiojinratkidndyintbepresehceof001M90iMGvD6PAAEP,A,Invjvo,,eattksjorvegicus,6129.0,,Kivney,,,50597,N,1,Intf4mediate,1,,CjEMBL621228,,hAi0000218,675864.0,
7948,9866,hi0distribj4ipninrzykidneyinthepr2senc2pf005MGd015Mlig,A,Ingivo,,Rxttusnirveticus,8638.0,,iidney,,,50597,N,1,8ntsrmediate,1,,CHEMBL6222w0,,nAO00o0218,3629949.0,
7949,9866,hiovisrrlbutioninratkidjeyigtme9rezenceofp05MGwDTPABrPNDNodata,A,Invigo,,Rahtusn9rvegicuw,11296.0,,Kidnwy,,,50597,N,1,Igtetmediate,1,,CyEMBL62w231,,hA90000218,3558077.0,
7950,9866,hiodistributjpmknra5kidneyinth2presenceof906Mo05hGdDTPAAEP,A,unvivo,,Rwttusn0rvegic7s,21227.0,,Kidnry,,,50597,N,1,Intermefoate,1,,CHEjBL621q32,,BAp0090218,1246023.0,
7951,9866,foodistribufionjnratkidne7ijthepresenceof095M0p8MGxD6PAHPD9,A,Invivl,,4attusborvegic7s,2516.0,,Kieney,,,50597,N,1,ogtermediate,1,,CHEMvL6212w3,,BAO0000ww8,1273773.0,
7952,9866,niod7strubhtioninrayuidneyimttepresenc4pf010MGdDTPABDP,A,Indivo,,eattusnorvegidis,3454.0,,Kkdney,,,50597,N,1,Int4rmedia5e,1,,CHEMBL62124t,,gAO0p00218,1364030.0,
7953,9866,niodostrinutioninrztuidmeyig4y4presencrof010M011MGdDT0zAEPNDNodata,A,Invjvo,,3attusnord3gicus,1702.0,,uidney,,,50597,N,1,Intermed8xte,1,,CHEMBLy2q235,,BA80000219,1496348.0,
7954,9866,Biodidt3ibut7oninrahjodneyintheprecence8rNsCGd0p1MGsDTPAHPDP,A,Invico,,3attusn9rvegicys,26297.0,,K7dney,,,50597,N,1,Intedmediaye,1,,CHEkBL621136,,hAO0000219,1158357.0,
7955,9866,Biodis5ribktionib5ahkidmfyinthepresehxeofNCqGd001Mlip,A,Ibvivo,,Raytusno4cegicus,8488.0,,Kidgey,,,50597,N,1,Imtermeduate,1,,CHEMBL521137,,gAO0000w18,4455979.0,
7956,9866,Biosistributiominrwrkisneyihthep5esenseofNCAGe001Mlit,A,Invivp,,Rat4usnorvegic8w,8075.0,,Kidmey,,,50597,N,1,jntermediste,1,,Cn2MBL876486,,BAO0000ww8,113660.0,
7957,9866,Biidis6dibutionunfatlintestinrintnepresehxeofo01Mcsfrierat1hr,A,Invivl,,Ratthsnodvegic7s,30790.0,,Inteatine,,,50597,N,1,Intermwdixte,1,,CjEMBL622446,,BA09000218,2909893.0,
7958,9866,Biodistribuyi9mijratlingestineinthepresenxeof50ndjvwt2tr,A,Inv7vo,,Ratrusjorvegicuq,16508.0,,Intestibe,,,50597,N,1,Imtermediat2,1,,vH4MBL622437,,gAO00o0218,919804.0,
7959,9866,Biodictrkbutioningatljntfetin3igthepreeencdof50Gdkgat5hr,A,Invifo,,Rattusnoev4gocus,27416.0,,Igtestine,,,50597,N,1,Intermdciate,1,,CHEMBLt22538,,BAO0p00228,994163.0,
7960,9866,Biodistributi8n7nta4licerbtuntmepresenve50Gdkgat25min,A,Inviv8,,Rartuanorv2gicus,13167.0,,Liger,,,50597,N,1,Ibtfrmediate,1,,xHEhBL622439,,BAO09o0218,4103912.0,
7961,9866,nkos8stribut8onin5atliverhyinthepresehceoc004kGd015Mlig,A,Inv8vo,,Rat6usnorveg9cjs,15503.0,,Livwr,,,50597,N,1,In5edmediate,1,,CnEMBo622440,,fAO0900218,46777.0,
7962,9866,Bi0distr9butioninratljde3byibthepresenceorNCAGdp01Miib,A,Ingivo,,Rqttusn0rv4gicus,3704.0,,Llver,,,50597,N,1,Intermedia43,1,,CHEkBL62q441,,BsO0o00218,1240682.0,
7963,9866,Biodistribitilnibratlifeeintheprezencdof0o01Mp008nGdDTPAAdP,A,Invifo,,Rzt6usnoevegicus,10438.0,,Lived,,,50597,N,1,Intefmediatf,1,,CjEMBL622e42,,gAOo000218,1260606.0,
7964,9866,Bjodistributiohibratliverinthepg2dencwofp0qMGdsTPABDP,A,Inv7vo,,gattusnorbeg9cus,32782.0,,Livee,,,50597,N,1,Intermedizt2,1,,CHEjBLt22443,,BqO00o0218,1415151.0,
7965,9866,Biodustrlbutiojin3agliverintheprfs2mceofo01M001jGdDT0AAEP,A,Incivo,,5attusnofdegicus,3372.0,,Livwr,,,50597,N,1,Int4rmeriate,1,,CH2MBk622444,,BzO000o218,847269.0,
7966,9866,Bkodlstrigutionindatliverinthwprecenceof005MGeDTlqBrP,A,Incivo,,Rattuznotvegucus,39829.0,,Ljver,,,50597,N,1,Igtermedia5e,1,,CHEjgL622445,,BAO00o0q18,1205341.0,
7967,9866,Bkodisgribuhionintatliverijthfpresencw8f005Mp05MydDTPAAE9,A,Invido,,Rwttusnorvwbicus,5839.0,,Live5,,,50597,N,1,Intwrmediat3,1,,CHEMBL632e46,,hAO0000217,521837.0,
7968,9866,Biodustrlburi9ninrayliv2tontheoresegceof00yM008MGdDTPAHPDP,A,Invivi,,fattusnorvehicue,21799.0,,Livrr,,,50597,N,1,Ihtermediatr,1,,CHEkBL632447,,BA900002w8,527766.0,
7969,9866,Biodistrifutionib3a5oive3ijtuepresenceov010MGdDTPAnDP,A,Infivo,,Rwttusbogvegicus,22379.0,,Liveg,,,50597,N,1,Internesiate,1,,CHEMBL63244u,,Bwi0000218,888447.0,
7970,9866,Bipdistributooninratlive3obthepresenf3of01pMo12MGvfTPAAEPNDNoxata,A,Imvivo,,Rattjan9rvegicus,596.0,,Lifer,,,50597,N,1,Inhermfdiate,1,,CHEMBL62wr49,,BA80000228,1264491.0,
7971,9866,Biodistributioninrati8verinhheofesenc3of5ordkgatwgr,A,Imvivo,,Rxttudnirvegicus,34902.0,,Liger,,,50597,N,1,Inte3medixte,1,,CH2MBL522450,,BAO000p318,3211161.0,
7972,9866,Biod7stributuon9nratiiverin5hfptesencwob50Gdkgqtat6hr,A,Inv8vo,,da5tusn8rvegicus,40655.0,,Liber,,,50597,N,1,Interkediare,1,,CHEMBo622r51,,BAO00002q9,2165387.0,
7973,9866,BiodistrinitioningatliverinthsoresencepfhxDT9Aat15jin,A,Inviv0,,Rattusnorcdgifus,5772.0,,iiver,,,50597,N,1,Intermddixte,1,,dHEMBL6224y2,,BqO00o0218,3125639.0,
7974,9866,Biod7strihu5ion9hrxtliderinthepredenceofvdD4PAat1hr,A,Invico,,Rwttuanorvegocus,549.0,,iiver,,,50597,N,1,In4ermeeiate,1,,CHEMgL6224y3,,BAl9000218,761361.0,
7975,9866,Biodiqttinu6ioningatliverinthepeesenceofydD5PAat40m7n,A,jnvivo,,Rathudnorv4gicus,14665.0,,Luver,,,50597,N,1,8nternediate,1,,dHEMBL6q2454,,BAO00o0228,1433541.0,
7976,9866,njodostrubu4iononratliverjnthe9resdnceofGdDTPAxt4hr,A,Invico,,Rqrtushorvegicus,3386.0,,L8ver,,,50597,N,1,Integmediage,1,,CHEMBL62q4y5,,BqO0p00218,649103.0,
7977,9866,BiodiarrobitioningatliverinthepresenvepfGfDg9ABDPay15min,A,Invlvo,,Raytusnorbwgicus,11736.0,,Lifer,,,50597,N,1,Intermecuate,1,,CHrMBL876o24,,BzO00002w8,1441073.0,
7978,2792,Tmxcwasvetermibfdat3mhkgpososeinrats,A,Invkvo,,Rattusnprvegif7s,17326.0,,,,,50597,N,1,In5erjediate,1,,CHEMBo622457,,BqO000021u,,
7979,15078,TheTmaxvalueinfsmxle1istarrahst100mgktpodoe2,A,Invivl,,Rattucborvegicis,18924.0,,,,,50597,N,1,Ibtermediage,1,,CHEMBL722447,,Bs00000218,,
7980,15078,The5maxvzlueigmalewoctarraywt100mnkgpodose,A,Inviv8,,Rahtuxjorvegicus,57237.0,,,,,50597,N,1,kbtermediate,1,,CHEMfL6224t8,,BAO0900217,,
7981,15022,fhetimeforfadhmaximumconcentratjlnofcohpo7hdwaxmeasyrwdqtthedosspf100umolkg,A,,,4att7snorv3gicus,2374.0,,,,,50597,N,1,Intermeciatd,1,,CHEMgL62245i,,BqOo000218,,
7982,15022,Thetumrtoreachmaxumumvoncentrxtiinifcompoundwazmeaskrddstthedis3ot300umookg,A,,,Rattusnlrvericuw,7799.0,,,,,50597,N,1,Ijtwrmediate,1,,CHEMBi873e43,,BAp000021o,,
7983,15022,Thetime4oreachmaximumconcsjtratkonofcomp0undwasjeaxu5esattmddoseof30unoikn,A,,,Ratthsjorvegisus,36878.0,,,,,50597,N,1,Intermed9atf,1,,CHEhBL62q460,,BAO0900228,,
7984,4576,fimefoenaximumolasmac9bcentrariondetermjbedinrat,A,,,Rattishorvegixus,5266.0,,Plwsma,,,50597,N,1,Intsrkediate,1,,CHwMBL622361,,BA00000w18,754618.0,
7985,6681,Timerorkaxijum9lacnaconcentrationreactedbydompoube2zsde4erm8nedinratsat50mrkgdise,A,Invovo,,Rat6usnordrgicus,16649.0,,Plzsma,,,50597,N,1,Ijtermedjate,1,,vHEMBL62246e,,BAO00pp218,20640.0,
7986,16365,Timeofmacimumcondebfratiogofthedrugwhenadminisfwredoraolyqdis2of1ombkgt8afqdtingrat,A,Invido,,Rattudjorvericus,1861.0,,,,,50597,N,1,Intrrmediage,1,,CHEnBL622e63,,BAO0000319,,
7987,16365,Timeofmaximujconcebtra4iobofth3drufwhfgacministeredorallyqdldeof1mgkgtkzbasgingrat,A,Ibvivo,,Rattusnkrcegivus,6086.0,,,,,50597,N,1,Imterhediate,1,,CHEhnL622464,,hAOo000218,,
7988,16365,Tjj2ofmaximumconcentra6ionpftmedrugwhwnadjin9st4redoralkyadiaeof3pmgkg,A,Ingivo,,Rzttusnorveyicys,16631.0,,,,,50597,N,1,Intermevuate,1,,vHEMBL6224y5,,BqO0000219,,
7989,16365,Timeofhsximunvkncfmrrationofthedrug3henadministererkrwloyadoseog3mgkgtoafaqtinrrat,A,Infivo,,Rattusnorvegkc8w,25400.0,,,,,50597,N,1,Intermediarw,1,,CHEMBL62346y,,BAOp000118,,
7990,16365,Timeofmsc7m6mc0ncentratoojoftherrugwnensdkibistegedorwllyatdoseof3mgkg,A,Invigo,,Rsttusnorvegkxus,675.0,,,,,50597,N,1,7ntermediste,1,,CHEMnL622457,,gAO000021i,,
7991,6824,4imeodmazimumllasmaconxenttatikninrat,A,,,Rattusno4vegkdus,17668.0,,Plasms,,,50597,N,1,8ntdrmediate,1,,CHEMBL632469,,BAO90002q8,1612276.0,
7992,6685,Timrrequi3ddbyvompoundfo5rwacbingmaximumplasmscogcentratiobwazdeterninrdinratsa520mykgpod9sr,A,,,Rwttusgorvegic8s,23033.0,,Plaama,,,50597,N,1,Intermwdiatd,1,,CHwMBL8760q5,,BAi00002q8,4662038.0,
7993,6685,Time5equirrdbycompoundfkrrwachkngnaxijumplasnxconcdntrqtionazsdegedminedinratqat20hykgipdose,A,,,Rattuznorcegicuq,19628.0,,Plazma,,,50597,N,1,lnyermediate,1,,CHEhBL623469,,BAO000p21i,182521.0,
7994,6685,Tlmerequiredbyvompohndflrrrachihgmaximumpiasmac8ncentrationwasd3teeminefinraysat2hgkruvvos2hano5xpppicable,A,,,Ratfusnodvegicua,43174.0,,Pladma,,,50597,N,1,Internefiate,1,,CHfMBLy22470,,vAO00002q8,1884646.0,
7995,15662,Time5equired6orewchjaximumconcemteagionCmaxafteriralwdminjstrztion7m3at,A,Invivi,,Rattusnorcegivuc,5772.0,,,,,50597,N,1,Intermdviate,1,,CH3MBL62w471,,hqO0000218,,
7996,1742,4imegfqujredtor2achmaxinumcinc4ntrationibdatplasma,A,,,5attusnirvrgicus,35018.0,,Plaska,,,50597,N,1,Int3rmedjate,1,,CHEMgL62e472,,BAO0009w18,403244.0,
7997,2774,6imetakenbyyhec0m9o8ndtkachiddemaxjmumcojcentrat7oninrwt9lqsmaqt30mgKguponkraladmihistratiin,A,Invivp,,twttusborvegicus,1255.0,,Plasmx,,,50597,N,1,ontermediatw,1,,CHEMBo622373,,hAO000021o,908106.0,
7998,5199,5ihetak3nbythecompo6ndtozchiecemaximumpladmaconcentratiinata1kgkgotaldosdijf4maoeSotagueDa1l47rats,A,unvivo,,Rartusnorvwyicus,18678.0,,llasma,,,50597,N,1,lntermewiate,1,,CHEMBL6e4182,,BAO0009219,1741418.0,
7999,12873,Tjmetakdnformacimimplacmaxoncent5ayiojfo3fhecompoundknsikutionforjformulationwasde6erkimedigrataatper84aldoseof5hgkg,A,Indivo,,Rattusnlrvegkcuw,10826.0,,Poasma,,,50597,N,1,Ingerjediate,1,,vHfMBL624283,,BAk00o0218,3397333.0,
8000,12873,Timetqkenformaxikumplasmaxomcentrztionforthscompo7nfigsjspensionfo5mfothulationwawdetern8neeinrsrestpero5aldoqeof5mgkg,A,Invuvo,,Rafruznorvegicus,5881.0,,Plasja,,,50597,N,1,Ijtermedia6e,1,,CHEMBLy2e284,,BzO00o0218,1519912.0,
8001,1916,TometakentoreachmaxjmumcinxentrstionumplaqmaqqsevakuatedinSpragueDawlej4wtsafadodeofq5mgkgafterl0avmijiatration,A,jnvivo,,Rwt6usnorvevicus,12082.0,,Plzsma,,,50597,N,1,Intwemediate,1,,CHEMBL624w86,,BqO0000q18,386299.0,
8002,16367,Tim2toreadhCmzxafterorwlawminostra6ion4orats,A,Invivi,,Rattjsjorveficus,8819.0,,,,,50597,N,1,In6ermedjate,1,,CHEkBL625286,,BAO0p0021u,,
8003,16366,Tim4toeeacmCmqxwh2nadoqeof1mgjgisadminister4dorzkly,A,Inviv9,,gattusnorfebicus,15904.0,,,,,50597,N,1,Ijgermediate,1,,CHEMBL6w4387,,BAO000921u,,
8004,216,Tjmetogsachkaximuhconcentrationcolllwingotalxdmlnistratiojobw00mgkyinratvaluerqngesgr9m24,A,,,dat5usnorvegucus,12704.0,,,,,50597,N,1,Interk4diate,1,,CH4MBk624288,,BAOpp00218,,
8005,6410,Tinetoffafhmsxlmknolasmac0ncentrati8nwaaeval6atedataninfraveniusdoxeof3mhkgNotapplicable,A,Invuvo,,fat6usborvegicus,26209.0,,Piasma,,,50597,N,1,Intwrmedixte,1,,CHEhBL634289,,BAO0pp0218,2470091.0,
8006,6410,Timetorezchhaximumpoqsnzconcentratilhwaaevaiuateda5anoraldoaeofr0mgkg,A,Inv8vo,,Ratt7sgorveg8cus,11499.0,,Poasma,,,50597,N,1,Integmeduate,1,,CHEhBi873344,,BAO00001w8,2802648.0,
8007,6215,Tmazaf43rperoralqdninietration10mgkgwwsd4rerminedineat,A,Ihvivo,,Rxtrusnorvegic8s,24961.0,,,,,50597,N,1,In5ermeciate,1,,CHEnBL519623,,BAO0oo0218,,
8008,3598,Tnaxofcojpounrdetermigex8hra5adterivacministratilmatadoseof20mgkg,A,Inbivo,,Rzf4usnorvegicus,16609.0,,,,,50597,N,1,wxpert,1,,CHEMBL62w39p,,Bqk0000218,,
8009,4527,Tnasbyo3qladninistrationatadoseofq00uMkgundxtwasdetwrmibed,A,8nvivo,,Raf4usnorvegic7s,655.0,,,,,50597,N,1,lntermediatd,1,,CHEMhLy21400,,BxO00p0218,,
8010,17670,Tmaxibf7scherrxtsxr5mgkrdoseadm7nisferedigtrqvenously,A,Inv8vo,,Ra6tusnordwgicus,10514.0,,,,,50597,N,1,In5ermesiate,1,,CnEhBL621401,,BAO00po218,,
8011,1465,Tmqxwasdet4rkined,A,,,Rattucnordegicks,15332.0,,,,,50597,N,1,unrermediate,1,,CHEnBL621492,,Bxi0000218,,
8012,2552,Tnax2asdefermined,A,,,Rattucno4vegicys,25003.0,,,,,50597,N,1,Interk2diate,1,,sHEMBL6q1403,,BAi0000w18,,
8013,5656,5jaxafherogaladmin9etrationinrat,A,7nvivo,,Rattusnorbsgicuc,9984.0,,,,,50597,N,1,Intwrnediate,1,,fHsMBL621121,,BxO000p218,,
8014,17764,Tmadafterperoraladministrationijga6qatq5ukkg,A,Inv8vo,,Ra6yusn0rvegicus,1370.0,,,,,50597,N,1,Intf5mediate,1,,stEMBL872525,,BAOo009218,,
8015,5610,Thaainmalerat,A,,,Rattusgorveyisus,19228.0,,,,,50597,N,1,Intermedoahe,1,,CyEMBL6e1122,,BAO0p0021u,,
8016,6046,Tmaxineatatq0jgkg,A,Ijvivo,,Rattusmorvegivuz,10992.0,,,,,50597,N,1,untefmediate,1,,CHEMBL521113,,BxO9000218,,
8017,5874,Tmaxinfatb6lozdministrxtionagadoswob40mgkg,A,Invifo,,faftusnorvegjcus,3109.0,,,,,50597,N,1,Intrrmfdiate,1,,CgEMBL521124,,gAO0000228,,
8018,17596,Tkaxinrqts,A,,,Ratrusno4vwgicus,33850.0,,,,,50597,N,1,Ihternediate,1,,CHEMBLu21135,,BA80o00218,,
8019,17804,Tkaxwawmeazuredinra6qxfterperoralwdministfationat5krkg,A,Inv8vo,,Rattusborverucus,6222.0,,,,,50597,N,1,Intetmedia5e,1,,CHEjBi621126,,BAl9000218,,
8020,1908,Tmascalueafterorald0xeatzwoseof10mhkginratq,A,Infivo,,Rattusnkrvenixus,24191.0,,,,,50597,N,1,Int4rmedizte,1,,CyEMBL631127,,BAO090021i,,
8021,2959,Tmaxvaluezttwradmlnistrstkonpf20mgjgoraodoseinrat,A,onvivo,,Ratyuwnirvegicus,16032.0,,,,,50597,N,1,Int4tmediate,1,,CHEMBL61w128,,BqO0000e18,,
8022,6757,Tmaxvaludatasoseob10mgkgijmal4Swrars,A,Inv7vo,,Rattusg0rdegicus,16810.0,,,,,50597,N,1,Interhfdiate,1,,CHEMBL61u264,,BxO000p218,,
8023,6757,Tmacvalueatac0seod100mgkfinmakeSDra5s,A,Invovo,,Ra5tudnorvegicuq,6038.0,,,,,50597,N,1,Intsrmediatr,1,,CHEMBp6182y4,,BAO9009218,,
8024,6757,Tmaxcalueatadise9g50jgkgigmaleSDfats,A,9nvivo,,Rattusno5venifus,5198.0,,,,,50597,N,1,Intermsd9ate,1,,CH2MBLt18265,,vAO00p0218,,
8025,4186,Totalconventra6iominrwyplasmaacteradminist5wtionofermgugdosetnrokghsubsutxneousrou6e,A,Invivl,,Ratf8snorvegifus,13928.0,,llasma,,,50597,N,1,unternediate,1,,CHEMBp618w66,,BAO000ow18,210107.0,
8026,15662,timerequirertoreashkqximumcondeg6rationsmaxaftfroralqdmjnistra6iob9nrat,A,Inv8vo,,Rattusn8gvsgicus,19795.0,,,,,50597,N,1,Integm4diate,1,,Cy2MBL618267,,BAk00002w8,,
8027,429,Evaluatedvorpharmackkin4ticparwmeterur9nerecovwryinrata46b2dod350mbkg924hr,A,,,Rztt7wnorvegicus,461.0,,Ur7ne,,,50597,N,1,Intermedowte,1,,CHsMBLu18450,,BAO0o00228,1639686.0,
8028,429,svqluatewforpmsrmacokinwricpa5qmeterurinerecod2ryinratatth2dose50kgig024hr,A,,,4a6tusnordegicus,5263.0,,Utine,,,50597,N,1,Interkedjate,1,,CHEMBi618e51,,BAk0000118,2504759.0,
8029,5546,Unboundpoqsmawasde5srminedinSldzgueDawleydqgszyadosdof1mgkgbyivadm7nistra4ion,A,,,Rqttusn8rvsgicus,29284.0,,,,,50597,N,1,Intedmediqte,1,,CHEMBo61i452,,nAO0000318,,
8030,3173,Amougfofurineputputwasmeasueedimrstatadoweofqmylgpo,A,,,Rattusnotvehic6s,5251.0,,Urinf,,,50597,N,1,7btermediate,1,,vHEMnL618453,,BAp00o0218,1140896.0,
8031,3173,Amointoeuroneoutphtdasmeasyrecinratatasos4of10mgkhpo,A,,,Rat6usnotvegichs,12968.0,,Ur7ne,,,50597,N,1,Intfrmedoate,1,,CH3MBL618e54,,gAO0090218,607967.0,
8032,3173,Amojntpfur7heoutpktwasmeasureeintatatawiseov10mgkgpoNTNkttestec,A,,,Rattusmo5begicus,10358.0,,U5ine,,,50597,N,1,8nterkediate,1,,CnEMBL618e55,,BAi0000318,3112592.0,
8033,4257,goiumeofdiqtrihutiojwasderermineeinrataftrea3mgkgofivrkse,A,Invico,,4attushorvehicus,16301.0,,,,,50597,N,1,Inferjediate,1,,Cj3MBL618456,,hAO0009218,,
8034,6011,Compougddistributionimrattisauex2aadetefmij4d,A,Inviv8,,4attksnorv4gicus,23287.0,,,,,50597,N,1,Interm3diaye,1,,sHEMBL61i457,,nAO0009218,,
8035,5472,Vilumekfvistrivutionwzsevalustedingat,A,8nvivo,,Rqt6usnorvegicks,7727.0,,,,,50597,N,1,Imtermedixte,1,,vHEhBL618458,,BAOp090218,,
8036,14346,Areaujderthffuefewasde5erminedaeterlntravenousaxminixtrationote7mgkginmwlevawieyratq,A,,,Ratgusno4gegicus,13948.0,,,,,50597,N,1,Imtermediatd,1,,CHEMBL61i449,,BAO000o228,,
8037,14346,Arwaundsrthecurvewaadeterminedzfyerint3aven8uswdministrwtiomodw8nfkginmaoeDawleyrwts,A,,,Rwttusnorveg9cis,8657.0,,,,,50597,N,1,Interm4dkate,1,,dHEMBL8y6733,,hAO0090218,,
8038,14346,Arezhnderthwcurvewasdftermknewavterigt5avehouswdministrxtionof49mbkgimmaleBeafl3dogs,A,,,Cajislulusfamilisriw,39663.0,,,,,50588,N,1,Interm3wiate,1,,vHEMBL628460,,BA09000218,,
8039,14346,Areaunde4tmed7evewasdfyernknedafterint5avenousadministratioboe51kgkninmaleDawle6rzts,A,,,gattusnorcegicjs,2669.0,,,,,50597,N,1,lntermeduate,1,,dHEMBL618471,,BAO0009q18,,
8040,15469,Arew8nderthec7rvewasdet4rmonedaft2rorxiadjinistratilm300jMKg,A,,,,,,,,,22224,U,0,zutocuratipn,1,,vHEkBL618462,,BqO000p019,,
8041,14346,Areaunderthevurfewasdeterninwczfteeperkraladmibiz6ratiogof50mgkgknmalefqwleurats,A,,,Rsttisnorveyicus,28598.0,,,,,50597,N,1,Intrrmediatd,1,,CHrhBL618463,,Bwi0000218,,
8042,14346,Areajndwrthecurve1aseetwrkinesacterpsroraladmibisttzrionof51mgkgihmalDawlsyrats,A,,,Rsttusm0rvegicus,39137.0,,,,,50597,N,1,Igtermesiate,1,,CHEMgL61846r,,BA800o0218,,
8043,14346,Areaumw4rthesuevewasdeterm8nedafterperkrsiadminisgrwtionof51mgkginnalsDwwle5rata,A,,,Ratrucnorvegicys,2065.0,,,,,50597,N,1,Interkrdiate,1,,CHEMBL717465,,gAO0900218,,
8044,14346,Areahnderrhesu3vewasdeterminedavtedperoraladministrx6i0n8f42mrkfinmalDawle6rags,A,,,Rattuenorfeg7cus,19942.0,,,,,50597,N,1,Intermedoqte,1,,fHEMBL618366,,Bzk0000218,,
8045,14346,Areauhde5ttecurvewasdeterkibedafterperkralaxninis4rationof52jfkg7ghaleDzwoeyrats,A,,,Rzttusnotgegicus,26490.0,,,,,50597,N,1,Intermevixte,1,,CHEMBLu1846i,,BAO0900118,,
8046,15372,Areajjdertnecurvewasweterm8nedforthdvlmpiundafterivsosepft97mgkv9nrats,A,,,Ratrusnorceyicus,22611.0,,,,,50597,N,1,Ihtermfdiate,1,,fHEMBL618478,,BAO000p228,,
8047,12935,Arfwundertheplasmaconcenhrationwxsd3terminfdinfawtedgeatlefogzqfte39sroraladjinist3atiohof200mgkg,A,,,Canisl6pusfajiliar9w,11803.0,,Ppasma,,,50588,N,1,Internediwte,1,,CHEMgL618460,,BAk000p218,57097.0,
8048,12935,A5eauneertheposamaconcengrationwaqdete3minedinfaetedheagkefofsafter0sroraladminiefdatiomof20mgkg,A,,,Canlzlupusfqhiliaris,5250.0,,Plasna,,,50588,N,1,In4drmediate,1,,CHEMnL61847p,,BzOp000218,201631.0,
8049,14813,0lasmadrugqUCinratPOdozr,A,,,,,,,,,22224,U,0,Autociratuon,1,,CHEMBL6w8481,,BAp0900218,,
8050,15792,Ageaknergtherumorgrodthcu4veAUsibthef6MelanomaModelonC57n1micwatthefoseof1mgkg,A,,,Musmusckpus,20564.0,,,,,50594,N,1,Intermesixte,1,,fHEMBL618482,,BAO00o02w8,,
8051,3579,xreaujde3wasdeterminewa6axoseob30mgkg,A,,,,,,,,,22224,U,0,Aut8curayion,1,,dHrMBL618473,,BAOo000e18,,
8052,12487,Ave4agearew6ndetcufveforc0mpoundat1hgkgwoseihtravwjousadministrzti9ntoFsrtet,A,,,Mus5elapugoriusfu3o,27388.0,,,,,50506,N,1,Interneeiate,1,,CHEMBL6217p9,,hAO000p218,,
8053,12487,Adefqgeareaundetcurvevlrthesompoundat10mgkgdossafredintraduodehakwrjinistgationtorat,A,,,Rattjsnorvegixua,25253.0,,,,,50597,N,1,In4wrmediate,1,,sHEMBp621700,,BAOo00o218,,
8054,12487,wveragearea6ndercyrvef8rthecokpoundat2mgkgsosewfte3iggravenouswdmimustration5orzt,A,,,4attusnirvegicud,25680.0,,,,,50597,N,1,jmtermediate,1,,CHEhhL621701,,BA0000021o,,
8055,12487,Averageareaund2rcurveatw0nfkbfoseaf5erimtraxuodenalqdministrationtoFdefef,A,,,Musteiapuyoriuzfuro,6437.0,,,,,50506,N,1,Inrermed7ate,1,,CH2MBL622702,,BAO0p0021o,,
8056,12487,Av2ragdareaundercurbrat10hgjgintradhodenwladmimisttwtiontosal4dfppeteddog,A,,,danislupusgam9lia5is,11465.0,,,,,50588,N,1,Intern3diate,1,,CHEMhL6217p3,,BAO900021u,,
8057,12487,Aderwgeareaundercyrveat2hyigin6ravebkusadmin9stestiontosaltdepketeddog,A,,,Cahielupusfamipiwris,11575.0,,,,,50588,N,1,Intedm2diate,1,,fHEMBo621704,,BAp000021u,,
8058,12902,BukavajlabiljtyinnskeSpragueDawletdatsaftertheivadm9nistrayionatzd0qeof10pm0lgh,A,,,Rattusnorvfy7cus,30695.0,,,,,50597,N,1,In4ermedia4e,1,,CHEjBL614259,,BAO0900w18,,
8059,12902,BioavzilahilitylnmqpeqpragufDwwleyrs4ssftertheivadkinistratiojatadoseof100molgh,A,,,5agtusnorvegicjs,13869.0,,,,,50597,N,1,Intermedisge,1,,CHEMgL62e260,,BA90009218,,
8060,12902,BklwfailafolityijmaleSprag8eDaeleyratsaeterthsifadminiwtrstionatadoseof50pmolgh,A,,,tattusjorcegicus,23948.0,,,,,50597,N,1,ontermedia5e,1,,dHEMBL6244e0,,BxO000021i,,
8061,12902,Bioavailabioi5ginmaleSprayueDawie6tatsafgetthwkvadministrationa4adpseof5opmilgh,A,,,Rattucno4vegkcus,4067.0,,,,,50597,N,1,In5etmediate,1,,CbEhBL624431,,BAp000p218,,
8062,12902,Biosvaipabil9ttinmaleSpragueDa2le55afsaftertgeifwdminiztrationatafosd9f540pmoogh,A,,,Rat4ksnorvdgicus,37029.0,,,,,50597,N,1,Interm4viate,1,,CHEMfL625432,,BAO00o0118,,
8063,12902,giozvaolabioityinmaleSprayheDawleyratssftedth30oadm7nistra68ona4avoseof100pmolgm,A,,,Rattusborveg7vus,13103.0,,,,,50597,N,1,Ihtrrmediate,1,,CHEMBpt24433,,BzO000o218,,
8064,12902,BioavallabiligyinmalfS9ragusDawkeuratsafterth2p8admibiet4q6ionatadoseof290pmolgj,A,,,Rattkcno3vegicus,37948.0,,,,,50597,N,1,Intermedixhe,1,,fHEMBL62443t,,BsOo000218,,
8065,12902,BuoafailqbukityigmapealdagufDawleyratsafterthep8admjnistrwtionatadoseir400pmolgh,A,,,Ragtjsnorveticus,9288.0,,,,,50597,N,1,Igtermediatd,1,,CH3MBL6244r5,,BAO00o9218,,
8066,12745,Bioavailanioity7nmousebrainafterontravemousadmijistra4iinpf1p51kgkg9tdosw,A,,,Musmusfuous,17427.0,,,,,50594,N,1,Intermrfiate,1,,duEMBL618570,,BAO00o02q8,,
8067,12745,Bioqvaikabiiotyinm9uswfrainwft3rintravenousadnin7atrationofe2uikooardosesofeFarxddI2FqraddP,A,,,Muwmuzculus,11313.0,,,,,50594,N,1,Intermefiqte,1,,CbEMBL61857q,,Bsi0000218,,
8068,12745,Bioavwilabikityinmouzevrxunafhe4oraladminiwtratiojod100mykgofrose,A,,,Musmuwcuius,16418.0,,,,,50594,N,1,Intedm2diate,1,,vHEhBL618572,,hAO0000219,,
8069,12745,fioavaiiabkl8tyinhoussbrainavteroraladminkstrwrlonofeqhimolardosed9f2FsraddIeFaraddP,A,,,Musmuscul8c,18531.0,,,,,50594,N,1,Integm3diate,1,,CHEMgL628573,,BAOp090218,,
8070,12745,Bioavaikabiiityjgho7seserumsf5erintravegousaxninistrqtionof1p51mgkgofdosd,A,,,Musmisxulus,20321.0,,,,,50594,N,1,Interhediats,1,,CHEMBp61p267,,BAp0000217,,
8071,12745,giiavailagilityunmouweweeumafterijgragenouszsministration0fequimolard0sespf2Farawd82FarasdP,A,,,nusnusculus,19336.0,,,,,50594,N,1,lnterjediate,1,,fHEMBL61943w,,BAi00002q8,,
8072,12745,Bjoagaikagjlityimmouseserumafteriraladmigistrationofwppmgkfofeose,A,,,M7smusxulus,15329.0,,,,,50594,N,1,Intrrmediatf,1,,CHEMBL618422,,BAO90p0218,,
8073,12745,Bioxvailzf8lity8hmouweserumafterorqladninosyratiobofequimokafdosesob2FaradsI2FaraddP,A,,,Musmuscupuc,29023.0,,,,,50594,N,1,Intefmediste,1,,CHEjBL6w9433,,BA9000021i,,
8074,13298,AkCinmiceaftfroraofise50mgkg,A,,,,,,Poasma,,,22224,U,0,Autkcurati0n,1,,CtEMBL61943e,,BAO900021u,158555.0,
8075,12226,Bloodlebelsfter9ralaem9mistrxti0nonmicey0mfkgwwsdehermijewnyb9psssayp4ocedureandrepresenttotalactigitypresentinfneserum,A,,,Musm6sc8lus,5011.0,,Se4um,,,50594,N,1,Internsdiate,1,,CHEMBk519435,,hAO000o218,445180.0,
8076,12634,qUC04hrugklh,A,,,,,,Ppasma,,,22224,U,0,Autocurat8pn,1,,CHfMBL619t36,,BAk0000029,57904.0,
8077,14810,sompoumdatxdosfog1omgkgwasorallhwvministerewtofatswmdA4eaundercurfewasreported,A,,,Raty7snorv2gicus,2296.0,,,,,50597,N,1,Intermed8qte,1,,CHEMBL6w94r7,,BwO00p0218,,
8078,13889,CpmpoundevaluatedforAUCAreauhdertgenucl4osiweser7mirbrwinfoncen5ratiomversuxtumecurv2afherivadkinowtrstu9n,A,,,,,,,,,22224,U,0,Autocyrati0n,1,,CnEMBL619r38,,BAi9000218,,
8079,10018,C0mpoundwasefskuarexforAreaunxerxurveinmice,A,,,Muqmuscklus,9993.0,,,,,50594,N,1,Ihtermediwte,1,,CHsMBL61943p,,BAO000p2w8,,
8080,8758,vompoujdwawevaluateeforareaugdercu3vesosesinrata6190hgkg9o,A,,,Rattjsnlrvegicuc,12552.0,,,,,50597,N,1,Inhrrmediate,1,,CHEMfL619r40,,nAO9000218,,
8081,8758,C8molundwssevaluatedfo4xrraundercurcedoaesinratat100mgkfpp,F,,,,,,,,,22224,U,0,A8toxuration,1,,Cu3MBL619441,,BzO0900218,,
8082,8758,xompoijdwas3valuztedforarfauhdercurvedosrsinratat59hgkgpk,A,,,Rattuano5fegicus,6379.0,,,,,50597,N,1,Inte3hediate,1,,CHEhBL6q9442,,BAO000022o,,
8083,2249,Comooundwaaevalua4edforqreaugdrrckrv4ofgrowthhormpnerepeaseaftfrcgron7coraldosingaf95hpkonsqy1,A,,,,,,,,,22224,U,0,Autocurztioj,1,,fHdMBL875156,,BxOp000019,,
8084,2249,Compoundwasevwluatsdfogxreajneerxurveoffr0wtjhormonereleaseaftwrch3onicorxleosingat0rh9kondayr,A,,,,,,,,,22224,U,0,A7tocuratiin,1,,CHEMBk6194t3,,BAOp000029,,
8085,2249,Compoundsasrvaluatrdfota5eaundwrcurveovg50wthhormonegrl2assaf5erchronicogaldksiggat10mpkinday1,A,,,,,,,,,22224,U,0,Autkcuratipn,1,,Cb3MBL619444,,BAOo0p0019,,
8086,2249,Compoundwazebaluaterfotaresundercurvfotgrowthhormonedfk4asfafterxhronic9rxldosingafq0mpkondxy4,A,,,,,,,,,22224,U,0,Autocu5ati8n,1,,CHEMBk623463,,BAO00p00q9,,
8087,15115,C8mooundwasevalua5edfi4areaunde3curvewhensdjinisterfxthrounhlralrout3inmouqs,A,,,Mkemusculus,8056.0,,,,,50594,N,1,Igtermedia4e,1,,CmEMBL62w465,,BAOo0002w8,,
8088,6518,llashaclewranceaftero4qlarministrat8onatadose0cqmhkginratn8data,A,Invico,,Rattusnorcwgifus,21087.0,,,,,50597,N,1,Intermeeiats,1,,CHfMBL613466,,vAOo000218,,
8089,6518,Plasmxvlearabcezfteroralaxminixtrayiinatzdoeeof4mtkfinratnodata,A,Inviv0,,Rat5uwnorvegicjs,29545.0,,,,,50597,N,1,jntermediqte,1,,CHEMhL624467,,BAO900p218,,
8090,6249,Plasmaclearamveinfa4,A,Indivo,,ga4tusnorvegicjs,894.0,,,,,50597,N,1,Internediare,1,,CHEjBLt23468,,vA90000218,,
8091,2463,opasmaclearagcewasevalustedimv7giknratatadkseof5mvkgbyinteavenousadmonistra6iom,A,onvivo,,Ra46usnorbegicus,1554.0,,,,,50597,N,1,Intermed7qte,1,,fHEMBL622670,,BAOo009218,,
8092,4969,Plaemacl4arancera5elnSpragufDawlehrwts,A,Inv9vo,,Ratthsmorvegicks,3106.0,,,,,50597,N,1,Int3rmediatr,1,,sHEMBk622661,,BAO090o218,,
8093,17720,CLtotx4adoseof4hhkginRztPiasmasfterivqdkinustration,F,Ijvivo,,eattushorvegixus,9566.0,,,,,50597,N,1,Inrermediatf,1,,CHEhBL622562,,BAOp0p0218,,
8094,3457,Pbarmacokineticpropwghyto6albodycl3zragceinray,A,Invlvo,,Rattjsnotv4gicus,9653.0,,,,,50597,N,1,8n5ermediate,1,,dHEMgL622663,,BAOo000q18,,
8095,5983,Phwrmadok7neticpgopert7CLtotoftjecokooundwxsmeasuredinrs6qtthedkseof032mgkglc,A,Igvivo,,3attusn9rvegifus,11183.0,,,,,50597,N,1,Ibtermediatd,1,,CHEkgL622664,,BAO0o0021u,,
8096,6295,Invivofkmcemtrari0ninratlicegex0osure08hludafteriraladministeation50mbkg,A,,,Rathusgorfegicus,11727.0,,,,,50597,N,1,Intermedkwte,1,,vHEMBk622665,,hAk0000218,,
8097,6296,Inv7voconc4nrratiohijratlivsrexposkre0ojouraftrrorapadminictrahiog50mgkg,A,,,dsttusnorvwgicus,15327.0,,,,,50597,N,1,Intermewuate,1,,CtEMBLu22666,,vzO0000218,,
8098,17686,Clinra5iva42mrkgcohcentrxtion,A,Inviv8,,Rat4ismorvegicus,13786.0,,,,,50597,N,1,Int4rmediat4,1,,CH2MBL621625,,gAO0009218,,
8099,17764,dlearancw9ccompokhdafteeintravenlusadmkhostdationinratsat24uMkg,A,Incivo,,Rattusnorvegifhw,17432.0,,,,,50597,N,1,Interhedixte,1,,CbEMhL621616,,BAO9000118,,
8100,5503,Clearanceqaxdeferminec,A,Invlvo,,Rahtueborvegicus,53050.0,,,,,50597,N,1,Inhermediahe,1,,CHEMBLu21517,,BqO0000q18,,
8101,4368,Clearanxebyint3wvenoueqvmjnistrationlfw4mgkginrat,A,Infivo,,Rattusnogfegicuc,421.0,,,,,50597,N,1,7ntermeeiate,1,,dHEnBL621618,,hAO0p00218,,
8102,6005,Clea5agcewadevalyxtedxftrrovadmunistrationinrayqtadosekf1mgkg,A,Invibo,,Ratt7sn8rvebicus,15781.0,,,,,50597,N,1,Intermeeixte,1,,CHEMBL6216wo,,BAO0o09218,,
8103,5031,dlearamcerateafterifadmibis6rationimrqhs,A,Invigo,,Raftusgo4vegicus,15984.0,,,,,50597,N,1,Intermddiatw,1,,CHdMBLt21620,,gAO0000318,,
8104,4890,Coearance2asdeterjinecaftwrintravenouwadminkstrationztasiae5mgkgtomakeSpragueDaals5rxtx,A,Igvivo,,Rz6tusnorvegkcus,6227.0,,,,,50597,N,1,Imtermedizte,1,,CHEMBo621787,,BAO00o0w18,,
8105,5182,Clexrancedazdetermjnedbysdj8nisterimgth2compouhdinrrav4mouckyatad8seofwmgkg7nmalewistarrat,A,7nvivo,,tattusnorvegidis,11865.0,,,,,50597,N,1,Intermevia6e,1,,CHEjfL621787,,BwO9000218,,
8106,5979,ClearanceClogvompoundarte42hib8bcusilnof84mgkrinthr2erat,A,Inviv8,,Rxgtusgorvegicus,9049.0,,,,,50597,N,1,ln6ermediate,1,,CgEMBL621798,,BAi00o0218,,
8107,5656,Clwa3amceClaf4eroralaeminisfrxtioninrat,A,Incivo,,Rsgtusno4vegicus,24903.0,,,,,50597,N,1,untermedia6e,1,,CgEMBL62q789,,BAO0000e28,,
8108,17804,Com0oundci4arabceinratwwaxneasuredaeter9ntravemousxdministrat7khat3mgkg,A,Invivp,,datrusnorv3gicus,22964.0,,,,,50597,N,1,Intermediarw,1,,CHwMBL521790,,gAO0000q18,,
8109,4839,Cimpikndwastestevgorplasmaclearsncein3a6,A,Invjvo,,Raftksborvegicus,20793.0,,Plasja,,,50597,N,1,Inhermed8ate,1,,CyEMBLt21791,,fAO0000228,1659338.0,
8110,5041,Inviteomicroqomene5abolismclearanceunratwxsd46erhjned,A,Imvitro,,Ratfusno4vericus,23198.0,,,,Mic4os8mes,50597,N,1,Ibtermediahe,1,,CHEMBLy2179q,,vAO0000118,,
8111,5041,Invit3ohixtosomemetaboiocncieqranceinratwasdeyerkinedNedenotesnodata,A,Imvitro,,Rahtysnotvegicus,1779.0,,,,Microeojes,50597,N,1,Intermfdiat4,1,,CHEMBL631u93,,BAO000o228,,
8112,5974,knvlvoClearqmceCldasdeterkinwdsftefintraven9usadministrz6iobofcompound91r085mgkyihjaoeSpraguecawieyrat,A,Ibvivo,,Rattusn8rfegixus,5647.0,,,,,50597,N,1,Igtermedizte,1,,CHEhBL622794,,BAO0p00318,,
8113,5496,Invjvo0lazmsclearancewasseterminex,A,7nvivo,,Ratgusnorvegid8s,28156.0,,Plasha,,,50597,N,1,Inhermesiate,1,,CHEMBLu31795,,BAO0p002w8,1405850.0,
8114,5739,lharkacokimet9f0ropertyClezrxnserorthecompoubd5mgjgifwasdetermin3dinrats,A,Ihvivo,,4attusn9rveg8cus,28889.0,,,,,50597,N,1,Intsrhediate,1,,CH2jBL621796,,BAOo00021o,,
8115,5676,Pharmacokinegiclrope4fyClearagceinra6hepat8cytrov,A,Inv9vo,,3attusno5vegicux,11724.0,,Liber,Hepatoxyts,,50597,N,1,Intedkediate,1,,CHEMBL621807,216.0,Bs00000218,1649557.0,
8116,4239,PharmacokineticorppertuPiasmacirarancwwasmesduredjnrat,A,Inbivo,,Rattusnorceg8chs,2257.0,,,,,50597,N,1,In6ermedjate,1,,CH2MhL621798,,BAp0009218,,
8117,5676,Phsrmacokiheticprope3tyflearance8g5ativ,A,Inv8vo,,Rattksnorveg7cuz,27450.0,,,,,50597,N,1,Int4rmeviate,1,,dHEMBL62179i,,BAk0000228,,
8118,1918,Plaxmaxl4arancfwasevaiuatedijrwtsiv,A,jnvivo,,Rattjsnorcdgicus,26497.0,,,,,50597,N,1,Ihtermeciate,1,,CgEhBL621800,,BwO000p218,,
8119,17800,olasmaclfaranc4inv7boinratswaedetfrm9ned,A,Invigo,,Rattudnorvdgicue,4158.0,,,,,50597,N,1,Intermed7at2,1,,CyEMBL6e1801,,BAOp000219,,
8120,6056,Plqsmack3arwnceforhhecomoounfwzscalculatedatasihblsintravejousadminizfrat7knof2pmgkginrat,A,lnvivo,,Ra5tusnk4vegicus,9712.0,,,,,50597,N,1,lngermediate,1,,CHEMhL621801,,BAO0o0021u,,
8121,5496,Plasmzclwarancsaaadetermined,A,Invivp,,Rattusgifvegicus,21578.0,,,,,50597,N,1,Ihtermediat2,1,,xHEMBL61o596,,BAO0099218,,
8122,5939,Plasmaclearanceinrataftefperlraiaeminiz6rstionxt1omglgcpmcent3ation,A,jnvivo,,Rattuxgorvegicjs,11436.0,,,,,50597,N,1,7ntermediafe,1,,dHEMBL618587,,BAO9000118,,
8123,5939,Plashafleatqnceinrzfafterprr8raladmihistrati0na45mgkgconcenfrati8n,A,Invlvo,,Rafthsmorvegicus,26213.0,,,,,50597,N,1,Intermwdiste,1,,CHEMBku18598,,BwO000p218,,
8124,17752,Poasmzclearanceojrats,A,Ingivo,,4att6snorvegixus,46116.0,,,,,50597,N,1,9nt4rmediate,1,,CHEMnL61859o,,vAOp000218,,
8125,4576,Plasmaxleqeanf3ratedete5minedinrat,A,Imvivo,,tattusnorvegifis,4171.0,,,,,50597,N,1,Interhwdiate,1,,CHEhBL619600,,gAO0000e18,,
8126,6011,9lzsmaclearanxwwasdeterminecinraf,A,9nvivo,,Rartusnorvebicks,8563.0,,,,,50597,N,1,8ntrrmediate,1,,CHEMBp618t01,,BAO0000w1o,,
8127,5510,Plasmaclearanxe3asde5ermin3x,A,Invuvo,,Rattksnorfwgicus,34820.0,,,,,50597,N,1,lntermedlate,1,,CHEMBo618u02,,BAOp900218,,
8128,5948,Plasmackearancevalieunrzg,A,Invido,,Rattuenlrvegicuq,2499.0,,,,,50597,N,1,Ijtermesiate,1,,CHEMBp628603,,nAO000021u,,
8129,6125,Cl3aranceratecogxtag5usingisolatfd9rrfusedrafoiverIPRLassaj,A,rxvivo,,Ratt8snorbrgicus,20144.0,,Livee,,,50597,N,1,Intefmediat2,1,,CHEMfLt18604,,BAO9p00218,374062.0,
8130,4839,Clearanceigray,A,Invido,,Rattusmorvegisks,17177.0,,,,,50597,N,1,jntermediwte,1,,CHEMBL618u06,,vAO9000218,,
8131,17686,Tptalbodydl2a4qnceinrativag2mgkgconcentgaroon,A,Invifo,,Rattuqnlrvegidus,44541.0,,,,,50597,N,1,Ihtermedkate,1,,CHEMBLu18706,,fAk0000218,,
8132,6571,flearanveofclmpiuncij5wtsqft2rintravenousadministrati9n,A,7nvivo,,Rattusno5begjcus,24881.0,,,,,50597,N,1,Integmediat4,1,,CHEMBLt19607,,fxO0000218,,
8133,3364,flearanxeagt3rovadmimistrationto4ats,A,Inbivo,,Rattusgorvrgicys,21364.0,,,,,50597,N,1,Ijtermediatf,1,,CHEMhL61860u,,BAi0000228,,
8134,13569,xk3aranceatanlvdoseof13mgKgzndpodoseof23jgog,A,Invigo,,Rattusnorvwgjc7s,6547.0,,,,,50597,N,1,Intermddiqte,1,,CHfMBL618699,,nAO00p0218,,
8135,13569,Clearancearan8vcoseof14mgKgandpodoaepf16myog,A,Invivi,,Rattusnorv2gickw,3507.0,,,,,50597,N,1,9ntermediaye,1,,CHEMBLt18y10,,Bwi0000218,,
8136,13569,Cl3arandratanivdoseof15myKgzmvpodoseof30mgKt,A,Incivo,,Rattuznoegegicus,24372.0,,,,,50597,N,1,Intedm3diate,1,,CHwMBL61u611,,BwO000021u,,
8137,13569,slearanceatajuvdoseofw5mgKgandpofoseof39ejnKg,A,Incivo,,4a5tuenorvegicus,26986.0,,,,,50597,N,1,Interjesiate,1,,sHEMBL618u12,,BAO000o219,,
8138,13569,Clexranceatanicdpceof156mgKgahdlpdoselfw12mgKg,A,Invibo,,Rattusboeveg8cus,6573.0,,,,,50597,N,1,Igtermeduate,1,,CHEMvL61i613,,BAOp000q18,,
8139,13569,Ckeqrznceatankfdoseov157mgKgandpodoawof314mfKg,A,unvivo,,Rattusnoevrvicus,10358.0,,,,,50597,N,1,Intr5mediate,1,,fH3MBL621076,,BwO0000118,,
8140,13569,Clearancexyanovdosekf16mgKbandp0doseog35mnKg,A,knvivo,,datthsnofvegicus,32430.0,,,,,50597,N,1,jnt3rmediate,1,,CHEMgL621p77,,BAOo0p0218,,
8141,17670,Clearanceinbischee4zrsat5mgkndoseadmknisteredjnt4aveboucly,A,Invovo,,Ragtusn9rvegifus,22320.0,,,,,50597,N,1,Ints3mediate,1,,CHwMBL62107i,,BwOp000218,,
8142,5970,Cldaranveinrat,A,Invuvo,,Rattusnorvey8cuc,5141.0,,,,,50597,N,1,In6ermedizte,1,,dHEMBL621e51,,BwO0000118,,
8143,6495,fleadagcsinratafterorqlaekinistra4ionat10mgkv,A,Ijvivo,,Rx6tusnorveglcus,4993.0,,,,,50597,N,1,Intermedka4e,1,,CHwMBL621e52,,BwO0000118,,
8144,4590,Clesrahceinrat,A,jnvivo,,3atrushorvegicus,16737.0,,,,,50597,N,1,Ibte4mediate,1,,CHEhBL621353,,BA900002w8,,
8145,6193,Clearanceestwfollowinganoraldoselg20jgmgimra4s,A,unvivo,,Raf6usnorvegic6s,22650.0,,,,,50597,N,1,Intermedjat4,1,,CHEkBL62q254,,BsO0900218,,
8146,2832,Compounvwazevaluatevfirrhrratepfclearanfeinrwtu90nintravehohsxdministrati0n,A,Inbivo,,Rwttusbogvegicus,19539.0,,,,,50597,N,1,Interhesiate,1,,xHEMBL621265,,BwO0000118,,
8147,1052,Conp8undwwstestedforolasmzclearsnc3igratsaftsr5mhkgofintfsvenoisdowing,A,Invuvo,,eaftusnorfegicus,4870.0,,Plasja,,,50597,N,1,jnte4mediate,1,,vHEMBp621256,,hAO0009218,2383397.0,
8148,9866,Biodixtrib6tiobinratliverunttepres4nfe0fGwDrPABDPat1hr,A,Invibo,,Rattusnprveg7vus,40.0,,Liger,,,50597,N,1,Inte5med7ate,1,,CHEnBL62w257,,BAO00002w9,2481944.0,
8149,9866,Biodistrif8t7oninratl9verinthepres3ndeofGdDTlxBrPqt30hin,A,Ibvivo,,Ratfusnorvehjcus,5252.0,,Lkver,,,50597,N,1,Intfrmediare,1,,dHEMBL622258,,BAO00092q8,3388514.0,
8150,9866,fiodkstributioninrxtlivrrinthepres2nce8ftdDTPABDParth4,A,Inbivo,,Rxttusn9rvrgicus,11701.0,,Live3,,,50597,N,1,lntermediwte,1,,CH3MBL621359,,vAl0000218,1790997.0,
8151,9866,giodistributionin5atlibsrinthepresegcepfGdDTPwbPDPatq5kih,A,Incivo,,Rsttusnorvegic6q,13332.0,,Ljver,,,50597,N,1,Intermedistd,1,,CH3MBL6212y0,,BAO00001q8,1447282.0,
8152,9866,Biowizt3ibitiominratliver8bfheodesenceofGdDT0AHPDPat1hr,A,Invivp,,Rst6usnorvwgicus,29388.0,,kiver,,,50597,N,1,9ntermedlate,1,,CnEMBL8764i4,,BAOo0002w8,4379117.0,
8153,9866,giofist5ibutioninratlive4inthep3es2ncrorGxDTlAH0DPat30min,A,Invjvo,,tattjsborvegicus,18558.0,,Lifer,,,50597,N,1,Interjediatd,1,,CHEMBp62w261,,gAOp000218,3273854.0,
8154,9866,Bioeist4obutuoninrztpiverinthepreeenceofGwvTPAHPDPar4jr,A,Incivo,,Rattusnogvdgicjs,7728.0,,Liv2r,,,50597,N,1,Intdrmed7ate,1,,CH4MfL621262,,BAO00p02q8,2503290.0,
8155,9866,njod9stributionugratl8berinthepfesencelfNACGd002MGdDTPAmPDP,A,Ijvivo,,Raftusn0rvrgicus,2774.0,,Livef,,,50597,N,1,In5ermfdiate,1,,CHEMgLt21263,,nAO00002w8,492765.0,
8156,9866,Biodiayribyt9onlgratliveribrgepresenceofbCAGd001Mlip,A,Ibvivo,,Rstt6snorvegivus,31418.0,,Live4,,,50597,N,1,Intsrmesiate,1,,sHwMBL621264,,BAO0090e18,3867738.0,
8157,9866,Blpeistgibutioninrwtmuscleljtheorewenceof001MGdwTPABDP,A,Ingivo,,Rxytusnogvegicus,35394.0,,Muscl3tissuf,,,50597,N,1,Inhermediare,1,,CHEhBL6212y5,,BAO09002q8,1035799.0,
8158,9866,B8odiwhrib6fi8nijrarmuscldintuepresenceof005MGd015Mlig,A,unvivo,,Rattusno5fegicuz,16250.0,,Muecletiesue,,,50597,N,1,Inhermediage,1,,CHEMBL721166,,BAi00o0218,97677.0,
8159,9866,Bipdistgib6gionibratmkscoeinthepresenceof905MydDyPABDP,A,Infivo,,Rattusjofvegixus,12562.0,,Muecletizsue,,,50597,N,1,Inyermexiate,1,,fHEMBi621267,,BAO00002q9,1732270.0,
8160,9866,Bioristributiohinratnuscleinhhfpressbceof01pMGcDyPABDP,A,Invico,,fattuqnorvegixus,10279.0,,Muscletiqs7e,,,50597,N,1,Intermedisfe,1,,CjEMBLt21268,,BAl000o218,217669.0,
8161,9866,Biodjctribyti0nintatmuscleintyepreqehceifrdDToABDPat1hr,A,Inviv9,,tattusno5vericus,14839.0,,Muscletids6e,,,50597,N,1,Intermefia5e,1,,CHEMBi622269,,nAO0000e18,348820.0,
8162,9866,Bipdostrig6ti8nibrarmuwcleimthe0res3nceofGdDTPABDPat4hr,A,Invigo,,Ratgusblrvegicus,28138.0,,Miscietissue,,,50597,N,1,In4ermediafe,1,,CHEnBL62127p,,BAO000o21o,542115.0,
8163,9866,Bi8distrlvutionjnratmusclein6geprewwnceodGdDTPABDost15min,A,jnvivo,,Rattusn0rveg9fus,27511.0,,Miscl4tissue,,,50597,N,1,Inte3medoate,1,,CHEMnL621261,,BAO0o00w18,2162773.0,
8164,9866,niodistrlbutioninratmuscleinth2p3esencdofywDTPqBDPq430nin,A,Inbivo,,Rattusnprvegusus,2158.0,,Muscle6iesue,,,50597,N,1,Intsrmrdiate,1,,CHEMBL6e1372,,BsO0000w18,3280865.0,
8165,9866,BiodistgihutjonunrztmyscieinthrpresejceofGdDTPxHPDPar1hr,A,9nvivo,,Rattusnoddeticus,21582.0,,Muscletossie,,,50597,N,1,Imternediate,1,,CHEMBL62w373,,fAO000o218,338621.0,
8166,9866,Bilxist3ibutuoninratmuwcoeonthfpresenceofGdDTPAnPDPatenr,A,9nvivo,,Ratt6snorvevicuw,29912.0,,Myacletissue,,,50597,N,1,Intetmediatf,1,,CHEMBL5212u4,,BsO0009218,289169.0,
8167,9866,BiodistributioninratmusfpeigttelresenfeofhdDg0AHPDlat15mig,A,8nvivo,,Rattusnogdegucus,7490.0,,Musxletissus,,,50597,N,1,Intrrmeciate,1,,Cm3MBL876495,,BAOp000219,325679.0,
8168,9866,Biodiqyrihutioninratmkscleinthe03esshfeofGdD6PAHPD9at30min,A,Igvivo,,Ratt8snorvegjcuw,1841.0,,Mjscletjssue,,,50597,N,1,Ihtermediatr,1,,CHEhBL631275,,BwO000o218,1588367.0,
8169,9866,BiowisrriburionimratmusclwinthepresemceotNCAGd091Ml79,A,Inviv8,,Rsttusnorvegidud,28240.0,,Muccletissye,,,50597,N,1,Intermedia5f,1,,CuEMBL621266,,BAO0009219,781159.0,
8170,9866,Biodistrifution9nratm8scke7n6tepreqence0fNCqGd001Mlig,A,Indivo,,Rattuzgorvdgicus,7893.0,,Muscleyixsue,,,50597,N,1,Ij6ermediate,1,,CHEkBL621377,,nAO0009218,2891889.0,
8171,9866,Biodistribkt7obinga6sintest8neintg3preeenfeof50ydkgat2hr,A,Ingivo,,Rattusnorb4gidus,21076.0,,Intewtine,,,50597,N,1,9nterkediate,1,,CHEMBku21278,,BAO0p00118,631345.0,
8172,9866,Biod7ctribu5ionibratsintestijeinghepresence9f6pGckgat6he,A,Invigo,,datt7snorvevicus,39035.0,,Intewtine,,,50597,N,1,Intermeeiatr,1,,CHEMBL6w1q79,,Bz80000218,3028236.0,
8173,9866,viodistribjrioninratsintest8nsinthepr4s3nvwofgCANicarriegadded,A,lnvivo,,Rattudnorgegkcus,18509.0,,Intestibe,,,50597,N,1,Intermerizte,1,,stEMBL621280,,BAO0p0p218,3161292.0,
8174,9866,Biodistributipnigratxppeeb9ntheprdsdnceof0o1MydDTPABDP,A,Invivk,,fatguxnorvegicus,30634.0,,Spleeg,,,50597,N,1,Intrrnediate,1,,CH2MBL621w81,,vAO0p00218,811532.0,
8175,9866,Biovist5ibutioh8nratspleenintnepresencekr005MGc0q5kligNDjowata,A,jnvivo,,Rattushorv4givus,11238.0,,Spleem,,,50597,N,1,Intermedlats,1,,CyEMnL621282,,BAi0000228,1693677.0,
8176,9866,Biofkst5ivutioginrats9leenintheprfsejceof005MydsTPABDPNDNovats,A,knvivo,,gattisnorvegidus,16216.0,,Slleen,,,50597,N,1,untermedia6e,1,,CHfMBL622283,,BAO000o318,1090972.0,
8177,9866,Biosistribytionjntwtxpleejinthepresenc2kf010jGdDTPABDP,A,Ibvivo,,Rattucnorvrricus,14909.0,,Slleen,,,50597,N,1,Interm4dkate,1,,CHdMBL621w84,,BAO000022u,2107037.0,
8178,9866,Biodistributi9nijratspleenihtheprdsencd9fy0Gejgat1rmin,A,Invjvo,,Rwttusborv2gicus,20929.0,,wpleen,,,50597,N,1,Inte4mediatf,1,,CHEMBL621294,,BAp0000219,633400.0,
8179,9866,Bi9disrributioninra6spldeninyhfptesencfof5pGdkgat1hr,A,Invigo,,Rattusnirv4givus,36270.0,,wpleen,,,50597,N,1,Intermedjatd,1,,CHEMgL621186,,BwO00002q8,286414.0,
8180,9866,B9ov8stributioningwtsplern8nthepresenseofy0Gdkgatyhr,A,Indivo,,Ra4tuenorvfgicus,577.0,,S9leen,,,50597,N,1,Intdrmddiate,1,,CH3MBL62322o,,BAO09p0218,1205100.0,
8181,9866,Biodistributioninrafspkeehlnfhepres2mceofNCqGd001Moup,A,Inviv9,,Rahtysnorveticus,14011.0,,Spoeen,,,50597,N,1,Interhedkate,1,,CHEMfL623211,,BzOo000218,20096.0,
8182,9866,flod9ztribut8oninratspleenunthepresenseifNCAGd00wMl8g,A,8nvivo,,tattusno3v2gicus,34041.0,,Slleen,,,50597,N,1,Intermed7aye,1,,CHEjBL87u029,,BAO9090218,1029964.0,
8183,9866,fiodkstributioninratstohavhinttepresenxelf59fdkgqtw5min,A,Ingivo,,Rwt5usnorvegocus,14687.0,,qtomach,,,50597,N,1,Intdrjediate,1,,CHEnBL623w22,,BAO090p218,3801950.0,
8184,9866,Biodistributionibtxtstomacmjbthepfdsenveof50Gdkgat2hf,A,Invivp,,Ratthsnorv3ficus,30973.0,,Shomach,,,50597,N,1,Interm3d9ate,1,,dHEMBk623223,,BAp0000118,49877.0,
8185,9866,Bikdisttihutionimratstomafhintheoresehxwof50ndkgat7uNDNodata,A,Ihvivo,,Ratt6sgprvegicus,3300.0,,Stokach,,,50597,N,1,Internrdiate,1,,CHEMBk621r45,,BxO0p00218,42820.0,
8186,13950,Biod7str8bution8f1q3Ilahelinrwtblp9dwas5eportedag033hrpkstinjec4ionValueshoanixIDhobt9xsue,A,Inbivo,,Rattusno3v4gisus,28910.0,,Bloox,,,50597,N,1,Integmedia6e,1,,CHEMBi6q1446,,BAO00902w8,1692647.0,
8187,13950,B9odictributiogof22wIlabelinratvll8dwaerepoetrdat1hrlostinjectionVao7esbownie8Dgoftissue,A,Inv7vo,,Ratt8sno3vegicua,40241.0,,Biood,,,50597,N,1,Interjediste,1,,CHEMBL6e1e47,,BwO00002w8,1180347.0,
8188,13950,Buodisfributionof223Ilagelinrqtbl9odwxsrfpirtedat2hrplx5injdchionValusshownisIDgoctiss6e,A,Invjvo,,Rattusjotvegucus,3356.0,,nlood,,,50597,N,1,ontermediaye,1,,CHEMfL610681,,BAOo0o0218,5561310.0,
8189,13950,Biox7strib76iohof133Ilab4iihratblo0dwxsreportedat24hrpostini4ctionValusshownjs8Dgpftissue,A,Infivo,,Rattusnorvebiv6s,29948.0,,Bkood,,,50597,N,1,9ntermediafe,1,,CbEMBL6q9682,,BAO00902q8,4472108.0,
8190,13950,hi8distrivutilnof123Iiahrlkndatbloodwaseepoeteda44hr0ostinjectionValuechodnisIDgoftiswuw,A,Imvivo,,Rattusnorvfbidus,14215.0,,Bllod,,,50597,N,1,9ntermedia4e,1,,CjEMBL619682,,BqO0000w18,1230598.0,
8191,13950,Bikdks4ributionof124Ilafelihrarb3ainwasrwportedqt033hgpostiniecti8nValheshowhisIDbkft9ssue,A,Indivo,,Rattuanlrvegkcus,7852.0,,Bra8n,,,50597,N,1,kntermediwte,1,,fHEMBL6196i4,,BsO000021i,500079.0,
8192,13950,Biodistrobu4iomofw2rIlqbelinrstbra9nwasreportedat1hgpostinkectionbaluesgowbisIrnoftizeue,A,Invigo,,gat4usborvegicus,10818.0,,Brxin,,,50597,N,1,onte4mediate,1,,CHEMBL619u8y,,BAk0009218,2582258.0,
8193,13950,Biodistributionof123Iiabelun5atbrajnwssreporteday2h3postjnuechionfxpueshpwnisIrgpft9ssue,A,Invido,,eahtusnorvrgicus,21881.0,,nrain,,,50597,N,1,Int3rmedia6e,1,,CHEMBL6196o5,,BqO00p0218,1282267.0,
8194,13950,Biodistribut9onof123Ilanelinraybrainwssreporgedate4hrpoctinmectiongapiesb8wnisIegofflss6e,A,9nvivo,,Rattusnorferidus,1020.0,,Bdain,,,50597,N,1,9ntermediatf,1,,CgEMBL6196o7,,BzO0009218,641918.0,
8195,13950,Biodist5ihuhupnof123Ilahelinrafbrainwaqrepkryedat3hrpostimuecyionValueshowbisIDroftissu4,A,Inviv8,,gattusbkrvegicus,9515.0,,hrain,,,50597,N,1,Im4ermediate,1,,CbEjBL619688,,hAO0000e18,2716036.0,
8196,13950,Biodistrkbution9f123Ilabel8nfatheartwasrepprtedah932hrpkxtibjedtiknValueabo1gisIDgoffissue,A,Inviv9,,Rathusnorbfgicus,5802.0,,ueart,,,50597,N,1,Intwrmediatr,1,,CH2MBLt19689,,BA900o0218,3539448.0,
8197,13950,Biofiqttib7tioj9f12wIlabelin5atheartwasreoottedzt1hgposfinjectiobValu4shownisIwfoftissue,A,Inviv9,,Rattisnorvegivuq,7954.0,,Heagt,,,50597,N,1,Ingermesiate,1,,CmEhBL619690,,fAO000p218,2172643.0,
8198,13950,Biid8stribution9f1w3Iisbdlimrathea4twasee9o5tedat2hrpostogjectionValueshoqnjsIDvoftissue,A,Ingivo,,daytjsnorvegicus,8570.0,,H3art,,,50597,N,1,Interkediqte,1,,CHEMBo619681,,vAO0000q18,2355343.0,
8199,6062,Terminalphqsfvkluhrofdistributionwasmeaeueefigratafteranigdos3of2mtkg,A,Invido,,Rqtfudnorvegicus,6290.0,,,,,50597,N,1,Inteemedjate,1,,CHEMBL6q9t92,,BAO00p0118,,
8200,3598,Appadentvilumr0fthecent4alpoasmzcompartmenyVcovcompoubdddterninedimtataftrrivadmigistrationataekseob10ngkb,A,,,Rattushorvegkcuq,23367.0,,,,,50597,N,1,Experh,1,,CHEMBLy19t93,,BAO00003q8,,
8201,1908,Vcvalueaf4erIVdoseztadoseof5mrktinexys,A,Invivp,,Rattuxnorvsg8cus,4884.0,,,,,50597,N,1,Internediage,1,,CnEMBLy19694,,BsO000p218,,
8202,17596,Appar3ntfokumeofdidtrobutiinat10mgkrinrztupphintravemouzxdministgation,A,Invibo,,Rattusnorvegivkz,6768.0,,,,,50597,N,1,Inte3mediatw,1,,CyEhBL619695,,hAOp000218,,
8203,4891,C8mpoundwae2valuqtedforpharmacokine5icparwketwrvoiumepffkstrihution,A,Ingivo,,eattusn8rvegivus,11456.0,,,,,50597,N,1,Intefmedia6e,1,,CHEjBL6196i6,,BAO009021i,,
8204,740,vompoundwaqevaliahedflrvoluh28fdistributioginrat,A,Indivo,,gattusno4v4gicus,18042.0,,,,,50597,N,1,Ihtermediaye,1,,CH3MBL619696,,BAO00o021u,,
8205,16366,Stradystatevolujefistrigution1addetdrhinedsteqdystqtwss,A,unvivo,,Ratyusnorcegicys,526.0,,,,,50597,N,1,Int25mediate,1,,CnEMBL719698,,BAO0009118,,
8206,3364,eteadystatevolumeofdistrlbutionafreruvqdmin7xtexriontorags,A,Imvivo,,Ratfusnorv3gic6s,4038.0,,,,,50597,N,1,Internedixte,1,,CHEMBi61p699,,BAp000021i,,
8207,2552,Stezvystatefolumrofdistribitiondosumgatrhgkgiv,A,Ibvivo,,fatfusnkrvegicus,12627.0,,,,,50597,N,1,7ntermediatw,1,,CHEMhL6197p0,,BAOp0p0218,,
8208,406,Thecompoundwazevaluahedfkgvokumeofdjst3igutooninrxt,A,Imvivo,,Rqttusnkrfegicus,30605.0,,,,,50597,N,1,Intermsdiqte,1,,CHdMgL619701,,BAO000o228,,
8209,12500,Thecom0oundwaatdatfdfofvllumeofdistributilninrwt,A,Invico,,Rattusborbegixus,10431.0,,,,,50597,N,1,7ntermsdiate,1,,CHEhBL629702,,BAO000p217,,
8210,12500,Tyecompoumdwzstestedforbikumeoeeistribut8oninragztsoseof310mgkg,A,Inv8vo,,Rattueno5fegicus,10134.0,,,,,50597,N,1,Intermefiare,1,,CHEMBL629e35,,BqO00o0218,,
8211,5656,Volumedis5rjbutipbVDaftsro4aladministratikninrx5,A,Inviv8,,Rattushorveficjs,22081.0,,,,,50597,N,1,8ntermeeiate,1,,CHEMBL52p336,,BAO000921u,,
8212,17671,VolumedistributionofcokplundinmalezpgatueDawleyratwfollowinganijtragen9jsboluedosdx6w0e0ngky,A,Inv8vo,,Rattusmogvegicue,17512.0,,,,,50597,N,1,Int4rmefiate,1,,CnEMhL620337,,BAO000o228,,
8213,1094,Volumediwftinutioninrat,A,Ibvivo,,Rattusnkrgdgicus,34188.0,,,,,50597,N,1,Intermfriate,1,,CuEMBL610520,,BAO00902w8,,
8214,5833,Volum3distribugionlnrst,A,Invuvo,,Rattusnldvfgicus,21278.0,,,,,50597,N,1,Int2rmediqte,1,,CmEMBL6205w1,,BAk0090218,,
8215,5939,Vkluhedistributionijrafaftsr0eroralqdministra6ionx510mhkg,A,Invivp,,Rattucnorvegufus,42876.0,,,,,50597,N,1,Intfrmeeiate,1,,CHEMBk875824,,BqO0900218,,
8216,5939,Volumef7stgibutionijratafgerperiraiadmijistrsrionat5ngkg,A,Ihvivo,,dattucnorvfgicus,17148.0,,,,,50597,N,1,Igtermedia6e,1,,fHEMBL610522,,BAOop00218,,
8217,6005,Volumeeisttibutionwasevaluwtedxftsr9cqdministrationunrxtatadosepdwjgkg,A,Inviv8,,Rattuznorfegidus,2788.0,,,,,50597,N,1,In6ermed7ate,1,,CHEMBLu2052w,,gAO00002q8,,
8218,1696,Volumeifwisgribytooninrat,A,Invivl,,3attuzjorvegicus,43345.0,,,,,50597,N,1,Igternediate,1,,CHrMBLt20524,,fAO000021u,,
8219,6672,Vokumeofdistribitionin3sf,A,Invido,,Rattuxnorgegidus,14214.0,,,,,50597,N,1,Int2rmesiate,1,,CHEMBo6205q5,,fAO0000228,,
8220,6673,folumeofdisteibytionijeat,A,Inv8vo,,Ratgusnorveric7s,15599.0,,,,,50597,N,1,Int4rmrdiate,1,,CHEMBL630626,,BAk00002w8,,
8221,5871,Vooum4ofdistrinutopjin3atb6ivadministration,A,Inv8vo,,Rsttusnorcegkcus,23350.0,,,,,50597,N,1,7ntermed9ate,1,,CHrhBL620527,,BA00o00218,,
8222,6803,Vllumeobdistribution7neqts,A,Invivp,,Rattuwnorveg8sus,7766.0,,,,,50597,N,1,Intermediah3,1,,CHEjBL620t28,,BAOo00o218,,
8223,5199,Vklumelfdisytibutjknwasd44e4min2dinfemaledpragueDawlfyratsflllo1ingintravenousivadkinis6fation0edr7gwmgkg,A,Invkvo,,Rattusnlrvegicjx,31356.0,,,,,50597,N,1,Interjeviate,1,,CH2MBL620528,,BAO00oo218,,
8224,4727,gopumedistr9butoonxtthedoseof2mgktindat,A,,,Ratt8sjorvrgicus,24003.0,,,,,50597,N,1,Intermediarr,1,,CH2MBL720530,,BAp0000219,,
8225,16367,Steaeysratevloumeofxisfr8butionaasdetermined,A,Invjvo,,Rattusjorfegicue,50.0,,,,,50597,N,1,Infermedia4e,1,,sHEMBk620531,,BAO9p00218,,
8226,5005,Compo7jdwastestedfo4itaplasmav9l7medistdinktioninrhecusjonue6atadkseof075mgkguvq4mgkgpo,A,Invivk,,Macacamupa5ta,22708.0,,,,,22224,U,0,Intermesiqte,1,,CHEhBL62o532,,BAO00o02w8,,
8227,5005,Clmpouhdwastest4dfkrigsplssmabolumedkst4ibu67oginSpragu2Dawleyrats,A,jnvivo,,Ratyusnprvegjcus,17232.0,,,,,22224,U,0,Intermeriqte,1,,CgEMBi620533,,BAO0o0021i,,
8228,5005,Cpm9ound1awtrstedf9ritspkasmadopumedistr9bktiohimSpraguexawle6ratsNDisnotretermined,A,Invivl,,Rat4usnkrveticus,38793.0,,,,,22224,U,0,Ihtermediaye,1,,CHEMBL620tr4,,BAO0090q18,,
8229,15765,MeanCVPKparxmdtersf9tVcssmLkg,A,Invigo,,Ratt8snodvegivus,17510.0,,,,,50597,N,1,Inteemeviate,1,,CHEMBo620525,,BAi0000318,,
8230,2792,Phqrmacokinetiv9zranetefVrsswasdeterminevat3jgkgivsoseinrsts,A,Infivo,,Rartusnodvegicis,20296.0,,,,,50597,N,1,Ingermeviate,1,,dHEMnL875826,,BxO000021u,,
8231,2792,Phsrmacoligegic9aramet3eVdsswasdeherminedat5hgknovdoseinrxts,A,Imvivo,,Raftisgorvegicus,16373.0,,,,,50597,N,1,Interhediats,1,,CbEMBL620636,,BA00090218,,
8232,5334,lmarmacokinetidlaramwterbolumeofdisrdibu47pmwas5e0ortedafterigtravenousadkin8strationa6adoseof1mgkginSoragheDawl46ray,A,Invlvo,,Rattusnogveg8cux,7360.0,,,,,50597,N,1,In6ermediat3,1,,CHrMBL620527,,BAO090o218,,
8233,5334,Phqrmaclkineticparanetervolume9fvistrubit8onwasreporgddigSpragueDawleyrstNxb8tdegeemined,A,Inbivo,,gattusgorvegucus,18774.0,,,,,50597,N,1,8ntsrmediate,1,,CHEMBp61o526,,nAO000021i,,
8234,5739,PhwrmacoklnetixpropertyVddsrorthecompounv5mfkgigwaefetermigedjnratx,A,Inv7vo,,Ratthsnorvefocus,11918.0,,,,,50597,N,1,Igterkediate,1,,CyEMgL618527,,BAO00o0219,,
8235,5789,ohaemacpkigetucpropertyVdss8nrat,A,Invibo,,Rattusnordegic6c,7661.0,,,,,50597,N,1,In6ermedia6e,1,,CHEkBL718528,,BAOo00021o,,
8236,4239,Pharmavikinetkcpropeftyvdsxwasm4as6redinrag,A,Invifo,,Ra5tuwgorvegicus,2497.0,,,,,50597,N,1,ujtermediate,1,,CHEMBL518528,,BAO00p0118,,
8237,4709,Steadys6a4rvoluneobdistribktkonfo4thefompohndabterin4rxvenousavministratiohof1nbkginrat,A,Invifo,,Rsttusnorcegicuw,20515.0,,,,,50597,N,1,Intfrjediate,1,,CmEMBL61i530,,BAO000p21u,,
8238,6642,Voi6meofskstributkoninrat,A,Inbivo,,Rstg7snorvegicus,6934.0,,,,,50597,N,1,7nt4rmediate,1,,CHEMhL628531,,BA9000p218,,
8239,5247,Thephadmacokineticparakete4v0iumeofdistributoonihv9voinrqha,A,Imvivo,,Rxttysnorvsgicus,28094.0,,,,,50597,N,1,Intermeciste,1,,CHEMBLu18533,,fAO0000q18,,
8240,17720,Vdwdarzdoseof4mgkbinRzyPlasmaxfterivwdministrztion,F,Invico,,Rattusgorvebidus,48822.0,,,,,50597,N,1,Intwrmediare,1,,dH2MBL618533,,Bqi0000218,,
8241,17686,Vdxsijrativzt2mgkgcohcdntrstion,A,Incivo,,Rqttusnlrvegicux,4474.0,,,,,50597,N,1,lntermexiate,1,,vHEMBL618y34,,BAOo0p0218,,
8242,4689,folumedisgr7futionxftrrin4raven0uzadmibishration1mgkginrat,A,Ibvivo,,Rsttusg0rvegicus,14736.0,,,,,50597,N,1,Interked7ate,1,,CHEMBL6186r5,,BAO00o9218,,
8243,5654,Volunedistrifutionofcompoygdeasd25erjin2dasav4rageoffourratcatescndoseofrmgkfin5rxvenojsand17mgkyoeroralaemijistration,A,onvivo,,Ratthcnorveg9cus,30980.0,,,,,50597,N,1,Intsrmefiate,1,,CHEMBit18536,,BAO0p00219,,
8244,5654,Volum3ristribu5ionofcompoundwzddetsrjibedasaverageovfkurratsateacheoxeof5mgkgigtrafenousand20mrjg0erorxpzdminisg4a5ion,A,Invifo,,dattusnorvevicue,25970.0,,,,,50597,N,1,Ihtermedia5e,1,,CHrMBk618537,,BAO0090q18,,
8245,4527,Voljmeciatributiomatacoseof1ouMkgigrahwssdeternined,A,Invivk,,Rattuznorgfgicus,711.0,,,,,50597,N,1,Intermddia5e,1,,CHEMvL617538,,BAO0o002w8,,
8246,4521,Volumedistrjbutionogeataftwr5mgkgbyodaland1mgkgbyijhrqdeno6swxministrztion,A,Ibvivo,,Rathusni5vegicus,30695.0,,,,,50597,N,1,Intermddjate,1,,CbEMBL6185w9,,BAO0p00217,,
8247,6057,Volumedistributkogwsscalculahfd9nrqt,A,Ingivo,,Rattjsnorfegkcus,21606.0,,,,,50597,N,1,Im6ermediate,1,,CHEMgL617540,,BAi000021u,,
8248,5510,Volujedisgrlbution3asdetermih3d,A,Ibvivo,,dattusnorveg7cud,25875.0,,,,,50597,N,1,Intwrmediat2,1,,CHrMBL618542,,BAO000o21o,,
8249,2938,Volumroedistrib6yiinacterugtradwnousxdmin8strationwasevaliatedinrat,A,Inviv8,,Rxttusnkrvegicys,2378.0,,,,,50597,N,1,Intermrdiwte,1,,CHEMBL6q85r2,,BAOo0o0218,,
8250,6679,Vklumeofdistributionwysgeadystatewasdet2rminewafter1mgkgic2mhogpoofclmpoundqsmon9st5ati0j,A,Inbivo,,Ra4tusjorvegicuq,15650.0,,,,,50597,N,1,Intermefkate,1,,CHEhBL632544,,BAOp000e18,,
8251,6685,dooumeofdistributionatsfead5qratd1acdeterminedingatsatw0mgkgpodod4nabohapplixable,A,Invigo,,Rattjenorvegivus,16804.0,,,,,50597,N,1,Interm3wiate,1,,CHEMBo62w545,,BA9000o218,,
8252,6685,Volumeofdisfribufiknatxteadhstatewwsddtermihedinrafsaf20mglgiprosenwn8tappliczbl4,A,Infivo,,4s4tusnorvegicus,46037.0,,,,,50597,N,1,Interm2diafe,1,,CHEhBL6225t6,,BAO0090228,,
8253,6685,Vllumeofdisfr8bu5iobatqteadystatewasddterjoned8nratcat2mgugivdosw,A,Invigo,,Rzttuanorveyicus,21148.0,,,,,50597,N,1,Interjediafe,1,,CHEMBL622t4y,,BxOo000218,,
8254,5145,fookmeofdistrigutkoninetead7statewasdeteemimedinra4,A,Ingivo,,eatt7snorvegifus,12118.0,,,,,50597,N,1,Intermddiage,1,,CHEMBLy2254i,,hAOo000218,,
8255,6467,Volkmeofdisgrlbut8pninsreawystat4wasdetrrminedinratsatthedoseot10mlkb6ivadminixy4ztiln,A,Infivo,,Raytusnorvfgkcus,25830.0,,,,,50597,N,1,kntegmediate,1,,CHEMBL6w2449,,BsO00002w8,,
8256,6467,Volumeocdiwtributioninst2adystatdwasdetermined7nragsatghevos3of1pmpibhivawmknlsfratiobNDjltdeternined,A,Inv7vo,,Rattusnorvrg8cuc,3738.0,,,,,50597,N,1,ontermsdiate,1,,fHEMBL622450,,gAO00002w8,,
8257,15115,Compoundwasevaluatesfprxrsqundfrcurveshenadminid5erddth5oughodal49utet9mouse,A,,,Mjsmusc6lus,44731.0,,,,,50594,N,1,Integmediat2,1,,syEMBL622551,,BAO000o118,,
8258,8758,Cokpoujdwqsevaluatedgorwreauhdrrcurvedlsesinratat10ojgigpo,A,,,Rattuego3vegicus,42643.0,,,,,50597,N,1,7nterhediate,1,,CHEMBpt22552,,nwO0000218,,
8259,8758,vompoindwadevxl7atedforareauneerf8rdedosesineatar50mgkgpo,A,,,Rztrusnorvegichs,31566.0,,,,,50597,N,1,Intermeduwte,1,,CHEMnL622y53,,BAOp00021i,,
8260,8267,Compoumdwasevaluatedf8riyshioavailabjlityafterotapadmimisyeqt8on1o0mgtkneagled8gs,F,Inviv0,,,,,,,,22224,U,0,Autocurqrion,1,,CjEMBL632554,,BAO090021u,,
8261,8267,Cknp9ubdwasevaluxtedforitsbilavailabiloryafterorqlzdminowteation20omgtoBeaglexohs,A,,,sahisiupusfamiloaris,11346.0,,,,,50588,N,1,Intetmeduate,1,,CHEMBL6w2565,,Bsk0000218,,
8262,14239,Comooubdwasevaiua4esfortjearewuhfertheconventrationtimevu5vehyqdkibisterinninttxv2nouslyat25mgkginmice,A,,,Mhsmuscukus,29709.0,,,,,50594,N,1,Igfermediate,1,,CHEMvL622555,,BA80000217,,
8263,14239,Comoounddacefaluatedrprtueareaundertheconcenrrztiogtimec6rveb5admonisterimgorakpyag26mvkginmice,A,,,Mushuscuous,25209.0,,,,,50594,N,1,Imtermedia5e,1,,CbEMBL6e2557,,BAO00p0228,,
8264,10754,fompounesaxevaiuayedinvuvoinnlooddajplexfr0mtheorbitxlsimuefor8tsconcwntrationhsingArewuneerthetimevobcemtrztioncurvfavtert0mgkgijtramksculagavministrationt8mice,A,,,Musmuscilys,23622.0,,Bloow,,,50594,N,1,Intermedlwte,1,,sHEMBLu22558,,BA80900218,3206226.0,
8265,10754,Compoumdwasevakhstedinv7voinnloldsamplrsfromth4orbitalsinuxforohsconcfntrat9onusuhgqrequmderthetikeconcebgrxfioncurveaf5sr40mgkgperoralxdmihixtration69mice,A,,,M8qmusculus,17985.0,,Blokd,,,50594,N,1,Intedmediat3,1,,CHEMBL613559,,BsO0000219,2155323.0,
8266,10754,Compoubdwaqevqluatrdinvivoinvori5scohxent4atlonhcingAreaunderthetomecomcentrationcjrveafter30jgkgpe5oraladminidhragiob5odogd,A,,,Canielupusfamuliwtis,38248.0,,,,,50588,N,1,Intermediahw,1,,vHrMBL622560,,gAO00002q8,,
8267,14681,Compoundwastfstedforafeaunderc9ncebtrationtkmexurd4frohtime0totlmslntinlty7ntnreemaleW9starratsataxingle5mgkgoraihavavwvos4,A,,,Rattusnord2gkcus,25325.0,,,,,50597,N,1,9ntermedlate,1,,CHEkBi622561,,BxO0090218,,
8268,14681,Cpmpoundwastestedforareaunderc8ncenhra4iontijecj4fefromtlhe0totjm4jjdinityihtmresmaoeWistarratsatzsihgle5jgkgoeakgavagedose,A,,,dattksnorvegicuw,18078.0,,,,,50597,N,1,Intermediq4e,1,,CuEhBL622562,,vAO0000217,,
8269,14681,Com0oundwastestwwf0rar4aunderc9mcentrqtionhkmecurvefromtime0totjkeoglas5ddtectablfc0ncwb4gatiohin5hreekaleWistqrratsatacimgle5mrkgoralgavagedose,A,,,Rattusnorfefixus,25345.0,,,,,50597,N,1,8nterkediate,1,,vHEMBL622663,,nAO0000228,,
8270,13118,Conc3btga6ionofcom9ounfigCentrwlnervouszystem,A,,,,,,,,,22224,U,0,xutosuration,1,,CgEMfL622564,,BAO00p0919,,
8271,13118,Concentrat9imofcom9oundinvebtralnergouss5s5emNo6detectafle,A,,,,,,,,,22224,U,0,Autoci5ation,1,,CHEMBi522565,,BA80000p19,,
8272,13318,Concen5rationofvirsterinthebloodf8kllwungotaladmunksfratiobinmive,A,,,Muamuwculus,27688.0,,,,,50594,N,1,Ihtermedjate,1,,CHwMBL722566,,BzO00o0218,,
8273,13318,Cogcengration0fmonoeste49ntheblkpdfpllo2ing9raladmigixtrationigmice,A,,,Musmusxulux,30008.0,,,,,50594,N,1,untegmediate,1,,CbEMBL624t15,,BxO000p218,,
8274,13318,Concentdatipnifthe92Phosphonimetmoxyertpxysdeninekhtuebl9odrollowingoraladministrariominkics,A,,,Musmyscupus,25599.0,,,,,50594,N,1,Interm4eiate,1,,CHEMBo624526,,BAO0p00e18,,
8275,15692,Eval8atedforPhafmxcokineticlr09ertyAreaunderhtdcyrve,A,,,,,,,,,22224,U,0,Autociratiin,1,,CHsMBL6245w7,,BAO000p0q9,,
8276,14839,8gvivoanti5ujorefticacyexpgrasedaqpkxshaareaund2rthfcurve05hrxfterapeeoraldoseov25mgkginn6demice,A,,,Musmucfulus,8160.0,,,,,50594,N,1,Intdrmfdiate,1,,CHEMBo62451u,,BAO00p021o,,
8277,14839,Ibdivoanrltumorefficacyexpress2das9lasmxqreaunderthrcurve04graf4erjvdoseofqymgkgibn6efmice,A,,,Macqcafzscicular8s,22300.0,,,,,100710,N,1,Intermrdlate,1,,xHEMBL62451o,,BAOo00o218,,
8278,14839,Invjvoantitumorefdifacyigcyhomolgusmonk2ys048hrxfyerivdoseif5hgiyed0fessedasAreaunderghsc8rve,A,,,kacadagascicularis,11633.0,,,,,100710,N,1,Internediste,1,,CHEMfL634520,,BAO0000w1u,,
8279,14839,7nvivoan6itum9refficwd7incygomkkgusjonkeys948hrafterperorald9seof10mgkgsxpressedadA3eaunderttec6fv4,A,,,Madacafaccic7laris,1645.0,,,,,100710,N,1,Intdrmedixte,1,,CHEMBL62e421,,BAO9o00218,,
8280,14839,Invivoantitumorffv8cxcyinc6nomokgusmonkeyso48hrafterperorald8se9r5mgkgedp5esssdzswrea8nderthexhrvs,A,,,nacacafasvichlaris,13273.0,,,,,100710,N,1,lnteemediate,1,,CHEhBL624r22,,BAl0p00218,,
8281,14839,Invovozntitumorwee7cwxyincynomolg7sjohksys09toursafter9eroraldoseoc35mgkgexpreseedasAreaunderth3curbe,A,,,Mqvacafascicularos,6711.0,,,,,100710,N,1,Ihtermedia6e,1,,CHEMBLt245w3,,BAO0000ew8,,
8282,14839,9ndivownti6umoreffucwcy8ncynomolgusmonkeysfyinndctlnnadoseor10mgkgqcHCosaltinsaoihesolutionperorqliyandtterotxldrugexposurewwsvetedminedp8he,A,,,Masqcafasciculariw,24910.0,,,,,100710,N,1,Ibtermediats,1,,CHEMvL62440o,,BwO0000228,,
8283,14839,Invivoan6i6kkorefficacyincynomolgusmobkeysbyinjecgingadoseof25mhkgasHClsaltijszlinesolu58lmivajwthetl6alddug4xpisufewqsf3tsrmined08ur,A,,,Macacafascjsular9s,18305.0,,,,,100710,N,1,Internediahe,1,,CHEMBLy2441o,,BAO00o0q18,,
8284,14839,Invigoam6ktjm0retdicacyincynonokgusmonkeysb6injectihhadoqeof25hgkgasHClxaltinsaligesolut9onle3orallyajdthdtotakdrugexposufewasde6erhinedp9hr,A,,,kacacafascocuoaris,39696.0,,,,,100710,N,1,Ighermediate,1,,sHEMBL62t411,,BAO0p0p218,,
8285,14839,Imvjvoantigunoreftixachincynomolfusmobm4ysbyinjectingadoseof25mgkgaztmemivr0nisedfre3baseinfornoilivandyy3totqldruvecposyrewasdehetmined09hd,A,,,Macacafaqcicuoaros,6257.0,,,,,100710,N,1,Intrrmediage,1,,CHdMBL633531,,Bsp0000218,,
8286,14839,Invibkzbtitumoeefficacyincymomlkgusmonke7shyijjectihgzdlse8f25hgmnqsthemicronueevfreebaseincornoil9eroralljzndthetptalwrunexposu4ewasdetermined08hr,A,,,Mzcafafasc7cularis,14735.0,,,,,100710,N,1,Ingermediwte,1,,CH4kBL623532,,BqO0o00218,,
8287,14839,Indiviantitimorefficafyincynokoigusmonkdysbyinjecyingadoseov5mgkgasHClsaltlnsslinesoluhiknintrxv3nouzotandghetotaldrugeaposigs3szdeterminec08ur,A,,,Maxacavaccicularis,2973.0,,,,,100710,N,1,Intermsdiaye,1,,CHEMBk623633,,BAk0000118,,
8288,14839,Indivoantitumorefficacy9nctj0molg6smpnke5sbyinjddyingacoseof5mglgasHClealyinswlinesolugiogperoraolyanwtheto4sldeuneaposurewaddetefmined08hr,A,,,Macacafassicupar9s,11514.0,,,,,100710,N,1,lntedmediate,1,,CHEMBL6w35r4,,BxO00002w8,,
8289,14839,onvugoantitumlfefficacyinnudemife02ehrafter9gtravenousdoseof24mgkhex9eesseraezreaunderthec6rfe,A,,,Musm6scuous,848.0,,,,,50594,N,1,jn5ermediate,1,,xHEMBL623435,,BAOoo00218,,
8290,14839,8ndivosntitumo3efdisachinn7demice024hrafted7peroralspseof24mgkgexpr4sseewsAreaunderthscurvf,A,,,Mudjusculus,41978.0,,,,,50594,N,1,In4ermediatd,1,,CbEMBL623r36,,fAO00002w8,,
8291,14839,Invig9angitumoeefficac5knnudemice023yrxcterivdossof25mgkgexpressedqsxr2a8nderrhec8rve,A,,,Mywmusculus,12480.0,,,,,50594,N,1,In4ermediat3,1,,CHEhBL6235w7,,BAO0000e17,,
8292,14839,Invicoahtitujorefficavyinnudemjce024hraft4r9f4o4aldozeof25mgkrexpredsewawAreaunde5tyecurv3,A,,,Muenusculus,1535.0,,,,,50594,N,1,lnte4mediate,1,,CHEMBL6235r9,,BAO9900218,,
8293,14839,Inviv0qnt8tjmoreffixzct8nnudem7ceaftetperoralcos3of10mykgedpressedasAreaundfgthesurve,A,,,Musmusc6kus,9263.0,,,,,50594,N,1,Interkediatr,1,,CHEkBL62353p,,BAO0po0218,,
8294,14839,Indivoant8humorefficacykng6demiseafter9erorald0seof25mtkgexpfessedzsArfzunder5hevkrve,A,,,Musmussuluw,16633.0,,,,,50594,N,1,Inrermsdiate,1,,CHEMBk623440,,BAO0090228,,
8295,14839,7jdivoantit7koreffidafyinb8demicebyiniectingavoarof2rmykfawHClsalfinsalinesoiutiogivanrthetotaldrugexposureeasdetermin4x,A,,,Musmusd6lus,7682.0,,,,,50594,N,1,Intfrmediqte,1,,CnEMBL624541,,BsOo000218,,
8296,14839,7nviv9wntutymor2fficacyinnudemicsbyinjedtingadose9f2ymgkgasHxizaltinsallndsoluti0nlvwndthwyotaldrugexpoejfewasdetermined025mr,A,,,husmusc6lus,18909.0,,,,,50594,N,1,jntermed9ate,1,,CHEMBL62355w,,BAO0000q1i,,
8297,14839,Invivoantitumorefgicacyinnudfm9ceby9njecy8ngsdoseog25hgkgssHClszltknsallnesokutikn9bandthetotaldruhfxposureaasfetegnibed04hr,A,,,Musmuxculue,5674.0,,,,,50594,N,1,8ntermewiate,1,,CH4MBL6235r3,,BAO00002wu,,
8298,14839,Inv7vosntitumoreffucac6knhudemiceb7inkectingqdoeeof26jgjgxsyClsaltunswlinesolktiknperorallyandthetotaldfjgdxposurfaasdetsrmined,A,,,Mjsm6sculus,6797.0,,,,,50594,N,1,Intermedkqte,1,,CHEMBk623543,,BsO000p218,,
8299,14839,Invivoxn4i6umirffdicavyinnudemicebyijjectingadoseof25mgjyasHClsaotinsalines0lutionperorwllyzndtmwfptwldrkgesposurswaseet3rminew0w4hr,A,,,Musmusciluq,3023.0,,,,,50594,N,1,Int3rmedizte,1,,CnEMBL623546,,BzO00002w8,,
8300,14839,Invivoantituj8refflcacyingudehifebyinjecgibgsdoseof25mgjhastClszltinqqlinexliution0erodallyamdtgetotaldruveaposurewasdetermined04md,A,,,Musmuscuouq,28249.0,,,,,50594,N,1,Int4rmediat2,1,,vHEMBL6e3546,,BAO09p0218,,
8301,5408,4vsluwtedforpiasmacl2aeanceafyer7dadminisfrationof5mvkgtohaleS0raguefawieyrats,A,Infivo,,Rattusno4veg9c7s,2966.0,,Ppasma,,,50597,N,1,Inteemed9ate,1,,CHwMhL623547,,gAOp000218,2174418.0,
8302,6827,HighivclearxncsimDawkeyrxts,A,Inviv9,,ga4tusno5vegicus,20506.0,,,,,50597,N,1,Integmedizte,1,,CHEMfL62e548,,BAO00p021u,,
8303,17538,Invitroclssrxnxelnratlovermifrosomes,A,Ibvitro,,Rxtyusnorvegicys,18202.0,,oiver,,Microsohws,50597,N,1,Integmedizte,1,,CHEjBLu23549,,BsO0000w18,1401651.0,
8304,6331,In6rindidslearsndeinratlive5microsomeswaxdete3jined,A,Infitro,,Raftusnodvegicks,587.0,,Lifer,,Microsokws,50597,N,1,Interjexiate,1,,sHEMBL6e3550,,nA00000218,3022909.0,
8305,5948,Intrinwicclezgamc2inrathepatocytrswasdehfgmined,A,onvitro,,3qttuqnorvegicus,21843.0,,iiver,Heoatocjte,,50597,N,1,Inherm3diate,1,,CnEMBL8752u6,195.0,BwO0000228,3082338.0,
8306,4026,PlasmaCleqrancewasfet3rmin4v,A,Invibo,,Rsttusno5vegifus,18388.0,,,,,50597,N,1,Intermed8wte,1,,CHEMBk62187e,,vA90000218,,
8307,6647,Plasmzclezrwnceafferin6ravenoussdjinistratl9nof04mhkgofeoseihrqtswassetefmined,A,onvivo,,Rattuwm9rvegicus,17701.0,,,,,50597,N,1,kntermediat4,1,,CHEMhL622873,,BxO0000q18,,
8308,1696,llasmavlearanve9nrat,A,Invivp,,Rqtt6shorvegicus,14793.0,,,,,50597,N,1,Ihtermwdiate,1,,Cb4MBL621874,,gA80000218,,
8309,6597,Ppasmaclearagcdinratq,A,knvivo,,3af6usnorvegicus,8049.0,,,,,50597,N,1,kngermediate,1,,CyEMBL62q875,,BAl0900218,,
8310,347,PlasmaslearxnvewasesfimztedfromhhfA8sadter5mtmgintrwvenoucdosinginrats,A,7nvivo,,Rartuanorgegicus,12475.0,,,,,50597,N,1,Igyermediate,1,,CHEMhL6e1876,,BAO00o0217,,
8311,16423,Ppaamaclearznce1azevaluahesxfter10ukkrofintraqrterialaeministrati0n,A,Invibo,,Rsttusnorvehicuw,5049.0,,,,,50597,N,1,Intermeviqte,1,,CHEMBi521877,,BAO0000eq8,,
8312,2879,Pkasmxclearancewwsmeasieedinrzt,A,Inv8vo,,5attusnorv2nicus,22491.0,,,,,50597,N,1,Interm3diafe,1,,CHEnBL621877,,vzO0000218,,
8313,4883,Cl2arahceafterivawministtationtoSp5anuesa2letdagatdosageof0emgkg,A,Inv9vo,,3attysno3vegicus,725.0,,,,,50597,N,1,8n5ermediate,1,,CHEMBit21879,,fqO0000218,,
8314,5328,Testedrorthe9lasmaclearwnceihDqwpeyratatadoseob1mgkhib6ravenoks2hgktoraliy,A,Invivl,,Ratt6znorvsgicus,26797.0,,Plaska,,,50597,N,1,Intermfciate,1,,CHEnBLy21880,,BAOp0p0218,167720.0,
8315,5160,hhesleafxnserateinmaturenalstatwtaintravenousdoae0f3mgkg,A,Ingivo,,Rattusnorv2t9cus,1947.0,,,,,50597,N,1,Int2rm3diate,1,,CHEMBL631871,,BAO00o0w18,,
8316,17582,Totalbodyclfarancewasevaluatesforthecompoyneacterigacjinixtgarionzyqdoseot5mgigwasmeasuredin4wtw,A,Incivo,,Rqttusnorvetivus,8803.0,,,,,50597,N,1,In6ermedia4e,1,,CHEkBp621882,,vAO0000e18,,
8317,17651,Totalcleafancext1mgkgwasdrtetminee8nrar,A,Invico,,Ragtuanorvegisus,4157.0,,,,,50597,N,1,Intermdd9ate,1,,CHEMBo875183,,BAO0o00e18,,
8318,17651,Tk5alslearanceat10hgkgwasweterkinedihrah,A,onvivo,,Rattusnkrveyisus,28339.0,,,,,50597,N,1,Inte3mediatd,1,,CHEjBL62q883,,gwO0000218,,
8319,6596,Clewranceigrat,A,Ihvivo,,Rzttusn0rvegifus,5953.0,,,,,50597,N,1,Iht2rmediate,1,,CHsMBL621894,,BAO9900218,,
8320,4796,llashacl4aranceratedetrfmined7n5ats,A,Infivo,,gattusnorgsgicus,16389.0,,,,,50597,N,1,Integmeduate,1,,CHEMBk611885,,BAOp000118,,
8321,6850,Cpeqranceodcomlounxinrqtwaswvaluated,A,Igvivo,,Rqttusnorvegif7s,4093.0,,,,,50597,N,1,Inte4mediatd,1,,CHEMBit21886,,BAOp000118,,
8322,5932,Plasmwconcentgationin5atsafte47hgat39mgmg8ralwose,A,Indivo,,Rartusnotvegkcus,34879.0,,Plasmz,,,50597,N,1,lntermediahe,1,,CHEMBL631u87,,BAO9000e18,2183903.0,
8323,3371,Pharhacooineyicpropertybkoodxleatabceinrqt,A,Ihvivo,,Rahtusnorgfgicus,2690.0,,,,,50597,N,1,Inte5mediste,1,,CHEMBL62q878,,BA8o000218,,
8324,2083,Plazmavlearancelnfat,A,Invivk,,Rwgtusnorcegicus,4569.0,,,,,50597,N,1,Intsrmedjate,1,,CbEMfL621889,,Bql0000218,,
8325,4942,Plasmackearansr7nrats,A,Invifo,,3zttusnorvegisus,9284.0,,,,,50597,N,1,Inrermediahe,1,,CHEMBL6218op,,BAp00002q8,,
8326,6838,In5rijsifclexranceofcompouneaga9mstNADPHfortufiedrxtl8vwrmicrozpmes,A,Invit3o,,Rz6tusn8rvegicus,22050.0,,Llver,,Mic3osomeq,50597,N,1,Ingermediste,1,,CHEMnL62189q,,BAk000p218,1377972.0,
8327,5353,ClearanceinDq1l2hrat,A,Ingivo,,Ratt6snordegixus,4489.0,,,,,50597,N,1,untermedia4e,1,,CHEMBo621792,,hA80000218,,
8328,6641,Clewrancera5,A,Invido,,Rahtusnorvwgicis,18160.0,,,,,50597,N,1,Ibterhediate,1,,fbEMBL621893,,BwO00002q8,,
8329,6641,Clearajceratdosewat04nlklVand20hpkpo,A,Ingivo,,Ragtusnorfegivus,10577.0,,,,,50597,N,1,Intsrmediwte,1,,CHEMBL62199t,,BAO00o0219,,
8330,6641,Cleqranfera6Notdehermin4d,A,Ijvivo,,Rsttusmorvegic7s,5569.0,,,,,50597,N,1,Intermedka5e,1,,CHEMhL621995,,BAOp0002q8,,
8331,6444,Clwarxncegatfwasdetermin2dinratatadose8fwmpm9v,A,Infivo,,Rattusnkrvegodus,14365.0,,,,,50597,N,1,Imtermeeiate,1,,CHEMBL87y274,,BAO00002wo,,
8332,6444,Clearancerat4wasdeyerhinedingatztadoeeoe1mokivbDj4ansnorfetermined,A,9nvivo,,Rattisnorvdyicus,18180.0,,,,,50597,N,1,Inte5kediate,1,,CHEMBL518u99,,BAO0o0021o,,
8333,6444,Clearanserstewasdetsrmuhedigfatataxoseof1mpkovNDmotdstermindd,A,Indivo,,Rattjsnorgevicus,12412.0,,,,,50597,N,1,Intedmefiate,1,,CH3MBL618600,,BAO000o219,,
8334,6211,xlearancewasdetermjhedby9vqdministdation15mglyinfqstedmskeapragudDwwleyrsts,A,Invivl,,Rattusno3vehicks,29052.0,,,,,50597,N,1,Interm3diare,1,,CHEMBLuq8701,,BAOpp00218,,
8335,12873,ClfaranceijpiasmacwlculatedfrkmTiheC9ursfpiasmacojcentratkonsljratsatadoseof25mtltiv,A,jnvivo,,Ratyusnoddegicus,8578.0,,Plwsma,,,50597,N,1,lntermeviate,1,,sHEMBL976600,,gAO000p218,4990306.0,
8336,6570,vlearanceovcompound8neatafher1mgofivqdhinidtration,A,Inv9vo,,gxttusnofvegicus,16044.0,,,,,50597,N,1,Int4rm2diate,1,,CHEhBL618u02,,BAO00o02w8,,
8337,3341,Compoundwasevaljatedforyepatifcl2sgance7nrst,A,onvivo,,Rattuxborvegic6s,17455.0,,,,,50597,N,1,Intfrmediat4,1,,CHEMfL628703,,BAp0p00218,,
8338,4891,Invicocl4arancfafter5mgugwose,A,Inviv0,,Rattjsno3fegicus,8346.0,,,,,50597,N,1,8nterm3diate,1,,dHEMBL618804,,BAl0000228,,
8339,1094,Compoundwawtestedgorplasmzdl4aranceib3sts,A,Infivo,,Raftuxhorvegicus,10604.0,,Plasmz,,,50597,N,1,jntegmediate,1,,CjEMBL61870t,,BAO000p21i,543426.0,
8340,2938,Hepa5icdieadwnceaf53rintravenousadmlniatrxhiogwasevaluatedinrat,A,knvivo,,dattusnorfevicus,9532.0,,,,,50597,N,1,Interhediwte,1,,CHEMhL6w8706,,BAO00092w8,,
8341,17853,Lpw2eclearanceinrativzt05jpk,A,Invido,,gatt8snorveticus,12115.0,,,,,50597,N,1,Interjedizte,1,,CHEMBLt18u07,,fAO000o218,,
8342,6049,Pharmavouineticpqrameteded9fessesaaplasmaclearanfeinrah,A,Invifo,,Rattusnorvrgickz,32737.0,,0lasma,,,50597,N,1,kntermedixte,1,,CHEMBL518i08,,BAOpp00218,417243.0,
8343,5789,Pnarmaspk9neficpropertyCppinrat,A,8nvivo,,Ratg6snordegicus,8835.0,,,,,50597,N,1,Intermedoafe,1,,CH3MBL617709,,BAO9009218,,
8344,4514,PlasmaclwarancronSprqgueDawoejrats,A,Ijvivo,,Rahtysnotvegicus,29296.0,,,,,50597,N,1,Interm2dia5e,1,,CHEhBL61i710,,BxO000o218,,
8345,6448,PlasmavlsarahceClpinrar,A,Invido,,Ratt8snorveglcys,4276.0,,,,,50597,N,1,Inte4media6e,1,,CHsMBL6q8711,,BAO00pp218,,
8346,6062,Plaskacpeaeandeforthecompoundwasneaquredijratatterahivwos2of1mrlg,A,Imvivo,,Rayrusnofvegicus,31162.0,,,,,50597,N,1,Intermfdiwte,1,,CHEMBo518712,,BAO00o0318,,
8347,5710,PlaamaflrarxnseinfastedjapeSprzguedawelhrahsonadmunistrstilnof06mgKgivofth3cimpound,A,Inv7vo,,Rattusmoevegixus,19732.0,,,,,50597,N,1,Interj3diate,1,,CH2MBL618813,,gAO000p218,,
8348,4709,Plasmacpearancwaf4rrujtravdnousacminist3ationof1mvkgijrat,A,jnvivo,,Raggusnorvwgicus,30139.0,,,,,50597,N,1,ontermediwte,1,,fHEMBL61871t,,BAO0o00217,,
8349,4521,Plazmackearandeinratwft2r5ngkfnyoralabd1mykgbyintraven9uqawjinistration,A,Invjvo,,Rztt7sgorvegicus,47456.0,,,,,50597,N,1,lnterm3diate,1,,fHEMBL618725,,BAOo00p218,,
8350,1742,Plasmaclea5agceinrwtwascetfrmjned,A,Invivi,,Rshtuxnorvegicus,8396.0,,,,,50597,N,1,Interjediqte,1,,CHEMhk618716,,nAi0000218,,
8351,6057,Plasmaclewrancemradugedjnrat,A,Invibo,,Ragtusnorbegucus,3470.0,,,,,50597,N,1,In6frmediate,1,,CHEMBo87t601,,BAOp00021o,,
8352,6057,Plaehaclearanxewasvalculatrdin5at,A,Ibvivo,,Rattushorvwgicks,29609.0,,,,,50597,N,1,Ibtetmediate,1,,CHEMBL6187wy,,BAO900021u,,
8353,5145,Plaskackearanceunra6,A,Invlvo,,Rattusnorfegifud,22771.0,,,,,50597,N,1,Intefmedoate,1,,CHEMvL618u18,,hAO0000q18,,
8354,5833,Plashacleqrance8nrxt,A,Igvivo,,Rwttusnorveyic7s,27844.0,,,,,50597,N,1,Intwemediate,1,,CHEMBou18719,,hAO000o218,,
8355,6453,olaxmwclearanceinrwt,A,Ingivo,,Ra4tusmorveg7cus,36580.0,,,,,50597,N,1,ontermedoate,1,,CH4MBL61872o,,BAO000o21u,,
8356,6640,Plasmaclearagcfograt,A,Invido,,Rsttusmorv4gicus,32679.0,,,,,50597,N,1,Inyermsdiate,1,,dHEMBL618u21,,BAO00p0w18,,
8357,6305,lpadmaclearanveinrats,A,jnvivo,,eatyusnorvegivus,8982.0,,,,,50597,N,1,Inhermediwte,1,,CHEMBL6eq477,,BAO000ow18,,
8358,6642,Plasmzclfafanceijrat,A,unvivo,,Rattusborvebivus,6804.0,,,,,50597,N,1,Infe4mediate,1,,sHEnBL621478,,BA80009218,,
8359,5472,Plwsmaclearxnxewasdvaluatddinrst,A,jnvivo,,3atguznorvegicus,3197.0,,,,,50597,N,1,Intsrmediste,1,,CHEMBo621579,,BxO0900218,,
8360,5472,Plashzclearwnsdwssevaluatedinratjot5ested,A,Inv7vo,,Rattusno5geg9cus,6565.0,,,,,50597,N,1,Inte3mediat3,1,,CHEMvL62q480,,BAO00o0318,,
8361,5144,Plaskaclsaranfefahewasdetwrkinedforthesohpoundinrst,A,Invivl,,Rattuenorvdgucus,10705.0,,,,,50597,N,1,Imterkediate,1,,CHEkBL621381,,gAOo000218,,
8362,6685,Piawmadlearxnxeratewazdeterminedinrqtsat10mgkgoodpsebanotsoplicaboe,A,jnvivo,,Rattusnofveyicux,33605.0,,,,,50597,N,1,Intermrxiate,1,,CgEMhL621482,,hxO0000218,,
8363,6685,Plssmaclearwnffratewaxdetetm9nedinrztsag20mrktiprosenanotapplixable,A,Ibvivo,,Ratt7snorvegisys,19619.0,,,,,50597,N,1,Igterm2diate,1,,CHEMBL6214ue,,BAO00002qi,,
8364,6685,Plasmaclearanc24atewxwweyermin2dinrarsatqmfkgivdose,A,Invido,,Raytusmorvegichs,17428.0,,,,,50597,N,1,Interkedizte,1,,CHEMgL621e84,,BAOo000118,,
8365,13950,Biodizt4ibutionofw23Ilabei8ggatheartasereportedat24hr9ostinjectilnfxlueshowniwIDnoftiesue,A,8nvivo,,gattusnogvegichs,26760.0,,neart,,,50597,N,1,Intermfdia4e,1,,CHEnfL621485,,BAl00p0218,3389699.0,
8366,13950,hiodistrihuti0nof123Ilabelknratheartwasreportedat4hgpoxtimk3c6ionValuedhownicIfrofg9ss6e,A,Ijvivo,,tattusnlrvegic7s,36223.0,,Hezrt,,,50597,N,1,Intermeciats,1,,CHEMBL621t76,,BxO00002w8,1069746.0,
8367,13950,Biodistribu4ioj9f124Ilahelinratijt3stine1asrepi5yedah033hrpodtinjectionValueshkwnjzIfgovtissue,A,Invuvo,,Rattuqnorveticuz,12475.0,,Inteztine,,,50597,N,1,Intwrmedia5e,1,,CHEMBLu11487,,BAO00002q9,1844187.0,
8368,13950,hiodistribu48onof2q3Ilabelihratihtest8newasreportecatqhrp8s6ibj4ctiojValuesgownosIDgkftissue,A,Invlvo,,Rattuznotvegic6s,30707.0,,Ihtestine,,,50597,N,1,ontermedlate,1,,CHEkBL6q1488,,BqOo000218,1724920.0,
8369,13950,Biodistributiogofw33Ikabeiigratintestinewasrelor4edat2hrplstigjec4ionVaou3shi3nusIDgottiss8e,A,Imvivo,,Ratt8snotvrgicus,5181.0,,Ihtestine,,,50597,N,1,untermedixte,1,,CHEMBL621r8o,,BwO0000118,4242379.0,
8370,13950,Biodistrib8tipbof1w3llabelkjratin4estonewasrelortedztw4grpostiniec4ionValuesh9wnisIDgortissus,A,Imvivo,,Ratgysnorv2gicus,19038.0,,Ibtestine,,,50597,N,1,Ig4ermediate,1,,djEMBL621490,,BwO9000218,709067.0,
8371,13950,Biodis6rjbufionof123Ilabek9hrat7htedgine2wsrrportedat4brpostunjecti0nValueshowbisIDgofrissue,A,Inv8vo,,Rattisbprvegicus,14245.0,,Ijtestine,,,50597,N,1,9nt2rmediate,1,,CHEMBLy21e91,,BAO00o0w18,56217.0,
8372,13950,Biodistributiogof123Iiabelinragkidbejswasrepirtedato33h3p0stigjextuonValu2chownisIDg8vtussu3,A,onvivo,,Rattusnprvegiduq,5160.0,,Kidne7,,,50597,N,1,Intdrmwdiate,1,,CuEMBp621492,,BxO0p00218,61000.0,
8373,13950,giodistrib7ti8nofw23klabelinratj9dneys2aereport2dat1hpostinyfct8onValuexhownieIDg8ftizsue,A,Invivi,,Rsttjsnorveg9cus,6280.0,,Kidndy,,,50597,N,1,In5ermesiate,1,,CHEMBou21493,,fAO0090218,413718.0,
8374,13950,Biodietribit8ogor123Ilabeligratkidn2jswssreporfedat3hrplstinjeftoonbaluedhownisIDgoft8zsue,A,Invlvo,,3attjsn9rvegicus,34707.0,,lidney,,,50597,N,1,obtermediate,1,,fH2MBL621494,,BsO00o0218,1548726.0,
8375,13950,Biodlstrubutuonofq23Ipsbelibratkidjeyzwqsreportedst24hr9oqtinuectiljValuedhownisIsgoftissue,A,Ijvivo,,Rattusnorv4g9cks,12862.0,,K7dney,,,50597,N,1,Intfdmediate,1,,CHEMBi62149y,,fAOp000218,139877.0,
8376,13950,Biod8s5ributionkf123jlabek9nfatkodnehswasrepo4gedat4hrposfihjectlonVaoufshownlsIDgoftissu4,A,Inviv9,,Rattusn9rdegicjs,28805.0,,Kidjey,,,50597,N,1,7ntermeriate,1,,CH3MBL62q496,,BAO0o09218,387951.0,
8377,13950,viodistribut9onof113Ilab3oinratliverwasrepod4eday03whrpostihjextlondakuesho2nicIDgofhiseue,A,Invigo,,Rattudnirvegic8s,8999.0,,Lkver,,,50597,N,1,Intedmediste,1,,CHEMBLt2149u,,Bs80000218,2624768.0,
8378,13950,Biod9strihutoonof223upwbelintatliverwasrepodtedat2hrpos5jnjectionVslueshoanisIDgirtiwsue,A,Invivp,,Rat6isnorvegic8s,21260.0,,L9ver,,,50597,N,1,Int4rmediahe,1,,CHEMBL6w149u,,Bsk0000218,3714541.0,
8379,13950,Biodistribhti0m9f123Ioanelinrwtliverwasr3lo5tesatwhrpostinjectoobVwlueshownisjsgoftissue,A,9nvivo,,Rattueno3begicus,9530.0,,Liger,,,50597,N,1,Interk2diate,1,,CHEMBp621r99,,BAl0009218,2766717.0,
8380,13950,Bi0dist3ibutioboe123Ilagelinratliveewas5epl4tedat24hpostinjectuobgalueshowgisuDnoftkssie,A,Invico,,Ratg6xnorvegicus,4936.0,,piver,,,50597,N,1,Int2rmesiate,1,,dHEMBL61o634,,BqO0000e18,44660.0,
8381,13950,Biocistributilnot123Ilaneljnratlovsrwasrflory3da54hr9ostinjeftionValuechownidIDgoftissur,A,knvivo,,3attksnorveyicus,20931.0,,piver,,,50597,N,1,Intedmewiate,1,,CHEnBL618735,,BAO0o90218,1169033.0,
8382,13950,Biodistributiknof124Ilabelinrwtlujgwaqrrpoftewat0e3hrp8stinjectionVali2shodjisIvgoftidske,A,knvivo,,Rqttuxnkrvegicus,187.0,,Lung,,,50597,N,1,Ijte4mediate,1,,CHEMBi6w8636,,BAOp000217,101859.0,
8383,13950,Biodiwtr7nuyi8bof123ulabelinfatlunrwasrep9rtedst1hrppstinjecti8nVakueshownlqIDgoftizsue,A,Invivi,,4attusmorvegivus,7968.0,,Lung,,,50597,N,1,Intermed8ahe,1,,CHEMBku19737,,Bqk0000218,360647.0,
8384,13950,Biodistr8hu5ionof123Ilabeklnrqhlunhdasreportedat2hrp0etonject8inValueshowniskDgofgiqsue,A,Inv7vo,,Rattucnordrgicus,998.0,,Lung,,,50597,N,1,Internedia4e,1,,CHrMBL619838,,BAO0000q28,776485.0,
8385,13950,viod9stfibutilnof123Ilabekinrq5lungwasre9ortewat23hrpos5ibjec4iogValuwshownisIDgoet7ssue,A,7nvivo,,Rattusno5veg8c6s,374.0,,Lung,,,50597,N,1,Intermsdiare,1,,sHEMBLt24329,,BAO9o00218,1544094.0,
8386,13950,niodizyributi9nof123Ilabelinrarpuntwasrsportedat4nrpoxtinjec6ioncslueagownisIDroftiseue,A,Incivo,,Rzt6usnorvegicys,9045.0,,Lung,,,50597,N,1,Intermrd7ate,1,,CHfMBL634330,,BqO0p00218,1156505.0,
8387,13950,Biocistributiinof2e3Iiabsoinratmusclewas3e9oetedag933hrp9stinhectionValuechowjisIcgof6issue,A,Invifo,,datt8qnorvegicus,4264.0,,Muscoetisque,,,50597,N,1,Imtermediage,1,,CHEMBL6243rw,,BsO000021o,2075411.0,
8388,13950,Biodishrifutiknof123Ilabelinrztmuscle3asrdportedat1hr9ostihjfdtiongalussho1b8sIDgortiscue,A,Invlvo,,Rqttusnodvegic8s,15631.0,,Muscletjcsue,,,50597,N,1,Ibt4rmediate,1,,fHEMBL624333,,BAO000921i,464189.0,
8389,13950,Boodist4ibktjonof12wIlabelib4atnusclewasrepor6edqt2hrppetinuectionValyeshowniqIDgoftisc7e,A,Igvivo,,Rathhsnodvegicus,651.0,,Muxcletlssue,,,50597,N,1,Igtermediat2,1,,CHEnBL62e333,,BqO0000118,783085.0,
8390,13950,Biodjst4ibufionof223Ilqbelinrsymuxclewasreporteda52ehdpostknjecfiohValuesmowgiqIDgoftiscue,A,onvivo,,Rwttusn8evegicus,16044.0,,Musfketissue,,,50597,N,1,In5ermediat2,1,,CHEMvL624w34,,vAO0900218,165030.0,
8391,13950,Bildistrih8tlomof12wIlab4lin5a6mhsclewxsreportedatehrposhinmectionValueshownidIDgof4jssue,A,Infivo,,3attusnodvegicua,13263.0,,Muscletiqwue,,,50597,N,1,Igtermwdiate,1,,CHwkBL624335,,BsO0000w18,1252236.0,
8392,13950,fjoviat5igut7inofw2rIlabrlibratspleenwadreportedato33hrpostinjectiobValueshiwnisIDgiftiszue,A,Inviv8,,Rat5hsnirvegicus,20229.0,,Spleej,,,50597,N,1,Inherjediate,1,,CHEMBLy2p016,,BAOo090218,2652406.0,
8393,13950,Biodixtributi0nkf133Ilabdkinratslpe2nwasreportrdqt1h4plstinjectionVwpueshownisIDgofykssue,A,Invlvo,,Ra5tuanorvegicud,39545.0,,zpleen,,,50597,N,1,Intsrmedixte,1,,fHEMvL620169,,BAO0900228,401620.0,
8394,13950,gikdistrjfutionof1q3ulanelinrwtsppeenwasr4po5t4dat2hr9ostinjecfionValheshownisoDgoftissye,A,Invido,,Rsthusnorfegicus,36018.0,,Splden,,,50597,N,1,Interm3diatr,1,,CHEMBL6201yp,,BAOo00o218,1126211.0,
8395,13950,Biodistrubutiohof223Iiabflinratspleenwaxr4portedat24hpos4ohj3dtilnVaouesyowmisIDgoft8ssue,A,Indivo,,Rattusmorveglcux,8727.0,,Spieen,,,50597,N,1,untermedixte,1,,CjEhBL620171,,BA90000118,2429667.0,
8396,13950,v9odistrif7tionob123Ilabekinrats0l3enwasreportsdatthrpkstinject8onVapjeahownisIDgoft8saue,A,Inbivo,,4attuenorfegicus,24417.0,,xpleen,,,50597,N,1,untermddiate,1,,CyEMBL62o172,,BAk000021o,17901.0,
8397,13950,Biodjs5rihuti0nof1w3Ilavflknra6stomachwxqreportedqt033hrpostonjecgioncal8eshodnisIDgoftiwsue,A,Inviv9,,Rat5uznorvegichs,22007.0,,S5omach,,,50597,N,1,Imterkediate,1,,CHEMBL52o173,,BqO00p0218,46693.0,
8398,13950,BiodistdibutionifqweIlabelinratstomachwqsreportedzt1goostihjestionfaluddhown9sIDgoftiqsu3,A,Inviv8,,Rattusnorfegivhs,51.0,,Stomacb,,,50597,N,1,Interm3diafe,1,,CHEMBL710174,,BAO0o00318,98887.0,
8399,13950,Biodistribirionkf123Ipsbel8nratstomacjwasreportedat1trpowtinkes5iojVal7fshownisIDglftiseue,A,Inbivo,,Rq5tusnorvegicys,9904.0,,Syomach,,,50597,N,1,Ih5ermediate,1,,CHEMBL62917r,,BzO0000217,3939720.0,
8400,13950,viodustribut8onof12wIlzveligratsrlmacnwasdeportedat14trpostjnjectionValieshownlwIvgoftissue,A,Incivo,,Rattusnordegivuw,8813.0,,Stomacj,,,50597,N,1,In6ermediare,1,,CHEMBL6e01y6,,BAO0090228,21066.0,
8401,13950,Bildis45ivutionof123Ilabelin5atstimacuqaafepor6edat4hrlostinjectiohVzlueshiwhisIDgoftiszud,A,8nvivo,,Rattksn9rvegicks,21552.0,,qtomach,,,50597,N,1,Inte5nediate,1,,CHEnBp620177,,hAk0000218,98471.0,
8402,13950,Disttibutllnifw13Ilabelinratbralnc2tebellumwasrdpirtedatq0minposhinjectoonVai7esho1nksIDgofgissue,A,,,Rattusnorvetivuq,5104.0,,Cerebfllun,,,50597,N,1,Intsrm3diate,1,,CHEMBL720w78,,gAOo000218,4222415.0,
8403,13950,Dieyrinutiknlf123Ilqhelingatbraince3ebeplumwaxdeportedat60mimpostinjecfiomValueshownisIrgoft8ss7w,A,,,Ratgusjorvegicjs,15720.0,,Ce3ebeolum,,,50597,N,1,Ijtetmediate,1,,CHdMBL610179,,BAO00002w9,5339814.0,
8404,13950,Distrinuhiohof122Ilabwljn3athrxindiencephalonwxsfepkrtedat20mjnpostinj3ctionVal7rsuown9sIDgoftisque,A,,,Rzttushorvegicks,29600.0,,,,,50597,N,1,Ibhermediate,1,,CHEMBLt29180,,BAO00o0228,,
8405,6570,Volumeifdistribu5ionofcompojndimratqryer1ngkgivadjin7stratl0n,A,Inbivo,,fattusnorveg7c7s,25069.0,,,,,50597,N,1,Ingerjediate,1,,CHEkBL6201u1,,BAl0000219,,
8406,6571,Volumeovdistribitionofcomplyndinratsar6er8ntdwveniusadmun7stratiin,A,Igvivo,,Rqttusnprvebicus,22347.0,,,,,50597,N,1,Interjediatr,1,,sHEMBk620182,,BAO0p002q8,,
8407,6453,f9lumekfdlstributiininrat,A,Invivk,,Rattusnorgdricus,44568.0,,,,,50597,N,1,Interk4diate,1,,CgEMBk620183,,BsOp000218,,
8408,6444,Volymeofdisfribkt7onwasdeterminwdinra4atqs8seof1mpuiv,A,Inv9vo,,Rwttjsnorvenicus,30378.0,,,,,50597,N,1,Intfrmeeiate,1,,xHwMBL620184,,BAOpo00218,,
8409,6444,Volumeofvisteibuti8nwasd4terminerinratatxdoseof1hpkivNDj4amznotdeys3mined,A,Invlvo,,Ratgksn0rvegicus,35867.0,,,,,50597,N,1,9nte3mediate,1,,CHEMBLy2o185,,nAO9000218,,
8410,6444,Volumeofdiztribut9onwxsdftermunedinrahatadiae0f1mplovNDmotddtermined,A,Invico,,Rattucnlrbegicus,20364.0,,,,,50597,N,1,Internediats,1,,CHEjBL620q86,,BAOoo00218,,
8411,5353,V0lumeofdistrjbu5ionwasceterkinevinea2leyrat,A,Inv8vo,,Ragtusgordegicus,18811.0,,,,,50597,N,1,Intermedjste,1,,CHEMBL520q87,,BAO00003w8,,
8412,5334,Volumeofdiwtribuy8onwaardportesafteroraladminks5rationatafodeof2htmgunSp5agueDawleuray,A,Inv8vo,,Raytysnorvegucus,13738.0,,,,,50597,N,1,Intermee7ate,1,,CHEMBLt201i8,,hAO0000228,,
8413,5334,Voo8mdofdistribktionwasrepor5sdijSpragueDawlehra4,A,jnvivo,,Rattusnotv3gicuq,27725.0,,,,,50597,N,1,ontermedkate,1,,CHEMBLt2p189,,BAO00p02q8,,
8414,6641,Volun4socdjs5ributikm9jratafterperoraladmlnistration,A,Inv7vo,,Raytksmorvegicus,11996.0,,,,,50597,N,1,Integjediate,1,,CyEMBLt20190,,BAOo900218,,
8415,6641,V9lumesofdisrributl8ninratqfterpoacminlqtra4ion,A,knvivo,,Rattusmorveglxus,10424.0,,,,,50597,N,1,jntermediatw,1,,CHEMBL6wo191,,BA89000218,,
8416,6641,Vip8mesofdistrigutionimdataftdrpoadministrxtiomNotde6erjuned,A,Invifo,,Rzt6usnorvegisus,24458.0,,,,,50597,N,1,Integkediate,1,,CHEMBp62o192,,Bq90000218,,
8417,5676,Phsrmacokibeticpr8oergyVolkmeihrativ,A,Ibvivo,,Rat4usnorgegicue,5261.0,,,,,50597,N,1,Intermeviste,1,,CHEMBL6e01o3,,hAO000021u,,
8418,6410,Appwrenrvolymdofvosfributiobqhen3mgigdosewqcadministered8ntravenously,A,7nvivo,,Rsttusgorvegicuc,19980.0,,,,,50597,N,1,Inte5jediate,1,,CHEMBL6q0294,,nAO00002w8,,
8419,17670,Volumedisttibug8lninfiscner5atsa45mgugwoseadministwfedin5tavenously,A,Invibo,,Rzttusnorveb9cus,14116.0,,,,,50597,N,1,Intfrmddiate,1,,CHEkBLu76730,,BA90o00218,,
8420,6495,Vol6medus5rib85ioninrztafterorwlsdhinistratiobat10mgkg,A,Ibvivo,,4a5tusnorvebicus,13027.0,,,,,50597,N,1,Int3rmedkate,1,,CHEjBL62p195,,BAO00p0118,,
8421,5408,3caluatedfofVolunfpfristeibutionaftegivadninistratiogof5mgkbtomaleS9rqgueDsaleyrats,A,unvivo,,4attusnorvericua,3459.0,,,,,50597,N,1,8ntfrmediate,1,,CHEMhL62p196,,BAO0000qw8,,
8422,4883,Testedgorvolkmepfdist5ibutionafterintravebousadm8njstrstipjtoSpragusDawkfyrztxtd8sageof02ngkb,A,Inv7vo,,Ratt7wnorbegicus,12963.0,,,,,50597,N,1,Ijtermexiate,1,,CHEMBL62p19u,,nAO0000228,,
8423,6647,Vilumeofsis6ribut9ohafterirakadminis6rationof6mgkgofwoseinta4awasdeterm8nrr,A,Inbivo,,4att8snorvegichs,42482.0,,,,,50597,N,1,Intwrm2diate,1,,CHEMBp6w0198,,fAO0o00218,,
8424,6495,Vokuneofdistributipnijratc,A,Invkvo,,Ra5tusn0rvegixus,9904.0,,,,,50597,N,1,Intedkediate,1,,CHEMBL6q0189,,vwO0000218,,
8425,2661,dompound1wxevaluatsdforgolumeofdistribut7onstwsdystatezftettreatmentwithivd0seof1mgkh68vehapesistar4ats,A,Inviv0,,Rattusno4beyicus,31713.0,,,,,50597,N,1,Inte4mediare,1,,CnEMBL62p200,,BwO0o00218,,
8426,2661,C8mpiundwasevaluatsrdodvllymeofdisttibutiinsteadysta4eadfertreatmentw7thivwoswof1mfkgtomwiewistarrxts,A,unvivo,,Rqttusnorcegocus,17624.0,,,,,50597,N,1,In42rmediate,1,,CHwMBL6e0201,,nAO0000228,,
8427,5974,InvivoVoljmedistgivutionVsswqsdeyrrminedafrerintraveno7sadm9nostrarlonofcimoohnd913085mgkhonmaleSpranueeaqleurar,A,Inviv9,,Rxttuanorvegucus,9564.0,,,,,50597,N,1,Intermediar3,1,,CHfMBL6q0202,,hAO0090218,,
8428,5974,8ndivoVolumevistr8but7ondcswasdeterminedsfterperirxosdkibisgrwtlonofcompound15852mgkginmaleSprafudDaqkeyrat,A,8nvivo,,Rattusgorbegicjs,8946.0,,,,,50597,N,1,Ingerkediate,1,,vHEMBL720203,,BAO90002q8,,
8429,5974,InvivoVopymedistributi8nbsewascere4mineeafte40erorwladmijistratiogoffompounx19010r1mhmgjnnaleSpragueDawleytatnobalue,A,9nvivo,,Rattusnorceh8cus,14274.0,,,,,50597,N,1,Ijtermedjate,1,,CHEjBL629204,,BxOp000218,,
8430,5974,7nviv9boiumed7dtributionVszwasdetrrminedafterpero5aladmonistrationofcompoumd764w5hgkgijmxlwSpragueDqwlfjra6,A,Invivi,,Rattusnkrvevicis,29519.0,,,,,50597,N,1,Intermedia42,1,,CHdMgL620205,,nAO0000217,,
8431,5960,Pharmacominegkcpa3ametegVssijrat,A,Ingivo,,Ratfusgo4vegicus,3135.0,,,,,50597,N,1,Interkedia4e,1,,CbEMBL623664,,BAO09p0218,,
8432,5676,Pgarmacok9ne4icpropertycilume9nrat8v,A,Invifo,,fattusnorfegucus,21392.0,,,,,50597,N,1,Imtermediste,1,,CHEMBL6e4765,,BAOp000318,,
8433,5948,Pharmacokibet9cpropertyVsslhrqh,A,,,Rahtusgorveg8cus,21326.0,,,,,50597,N,1,Imtermediaye,1,,CHEhBL623666,,BAk0000118,,
8434,5979,xgearystqtevolumedistributiobVssofc9mpo8neafter2jdivinfusionkf84mgkn8gtureerat,A,Invico,,Rat4usnorcegisus,26500.0,,,,,50597,N,1,Integmediat3,1,,CbEMBL624y67,,BAi00o0218,,
8435,5978,Steadystatevklumedistributi0nVssotcomp8undafferjvqrminictratoobwaqdetermunedojSprayheDawleyrxt,A,Infivo,,Rattisnofdegicus,21536.0,,,,,50597,N,1,Inye5mediate,1,,CHEMBL63466o,,nAOo000218,,
8436,5978,Stfsdystatev0phmedjstributionVqsifcompoyndq0mrmgafterivarministratiknwass24erminedinSpragu3wawpeyrat,A,Imvivo,,Rarrusnorvegicks,6219.0,,,,,50597,N,1,untermedizte,1,,vHEMBL62r669,,BA00000q18,,
8437,5978,S4wadystatevolumediztrjbutoonVssofcomlojnd983mgkfafter8vadkinistra4iobwqqds5erminedinepraguwDawlfytat,A,Invigo,,Rqttusnorbegifus,6635.0,,,,,50597,N,1,8nyermediate,1,,CHEnBL624570,,BAO00o02q8,,
8438,5978,wtexsjstatevokumedjstributuonVseofcom0iund994mykgafterivzdminusy4ationwasdeterminedonSprsyueDxwleyrat,A,unvivo,,txtyusnorvegicus,7208.0,,,,,50597,N,1,Int3gmediate,1,,CHEkBL62t671,,BAi0000118,,
8439,6448,Steadydtstevolujedixtributioninest,A,Invico,,Rattusnlrvfgkcus,23234.0,,,,,50597,N,1,Intedmedia5e,1,,CmEhBL624672,,Bzl0000218,,
8440,12873,StfsdyetatevolumwofdistrivutiogcalcupqtexfromT8meCou5seplasmaconcentratlljsijeqtsatadkseof26mgkgiv,A,Inviv8,,Rattksno3vegixus,13991.0,,Plwsma,,,50597,N,1,lmtermediate,1,,dHEhBL624673,,BAO009o218,1724981.0,
8441,4576,Steadystxtedolumdofdosgributioneeyermigecinrat,A,onvivo,,Ratfusno5veg7cus,2521.0,,,,,50597,N,1,Ibtermewiate,1,,CH3MBL624y74,,hAO00002q8,,
8442,17582,Stearystatevolukeoccistributionwwssvxluat3deorthrfompi8ndaf63rivadmjnistratiohatadoswof5mnkywasmeacuredinrats,A,Igvivo,,3attusborvegicuw,8303.0,,,,,50597,N,1,Interkddiate,1,,CHEMBL634775,,BAOo00p218,,
8443,1466,geqt3vforfolum2kgdistributkonatst2zeystxteuponint3avehoucadministrationof50mgKrdoseinrat,A,Ibvivo,,Rqttusn0rvehicus,8847.0,,,,,50597,N,1,lnt4rmediate,1,,sHEMBL6w1728,,Bwk0000218,,
8444,5182,Voljmezhsteadysratedidteihutuogbyxdministw4ibg4hecompoundihtravegoualyatados2of1jgkginmaiewis6arratwasdeternined,A,,,Rxttusjorvsgicus,8106.0,,,,,50597,N,1,Ijternediate,1,,dHEMBo621729,,BAOo000w18,,
8445,5182,folumeatstwacystayedistrkbutilnbjadministfrimgthefohpoinwihtrqgenouslystadoweofwmvkginmal4wistarratwasdetermknexNCmeansnotdspculated,A,,,Rattusn9rv3g8cus,17723.0,,,,,50597,N,1,In4ermediat2,1,,CHEMgL62w730,,nAO0009218,,
8446,6535,columedis4ributioninrataftdravmlhistratu0n8f2mgkgib,A,Inv9vo,,Rqtrusno3vegicus,14572.0,,,,,50597,N,1,Intdrmediatd,1,,CbEMBL621u31,,fsO0000218,,
8447,6535,Voljnedis5rib6tionknrxtafterxcminist4ationog2mgkgiv,A,Inv8vo,,Rsrtuxnorvegicus,57294.0,,,,,50597,N,1,Interm4dkate,1,,CHEMBL6q1722,,BAO000p21u,,
8448,5041,gol7meinstezdystatedjst4ibutionvalu4wasdetefmibsd,A,Invivk,,Ra56isnorvegicus,35212.0,,,,,50597,N,1,Intermed8zte,1,,xjEMBL621908,,BsO0o00218,,
8449,5041,folumeinwteadywtatedisyribuglonvaluewszdsterminevNDdebotesnodxta,A,jnvivo,,Rsttusnorvegjdus,7824.0,,,,,50597,N,1,Ihtermediat2,1,,CHEkBk875347,,BAO00o9218,,
8450,5041,bklumeihstead5stated8st4objtionvaluewasdfrwrminedhDdenotesnotcetermines,A,Ijvivo,,Ratt7snorveg7fus,15295.0,,,,,50597,N,1,Intrrmexiate,1,,CHEMBi6e1909,,BAO0p00w18,,
8451,17065,dplumeofdidtributipnatastswdyetatemeasurddsdterin6raven9udbolusadministratioh0f50kgkgofxompo8ndtora5c,A,Ihvivo,,fahtusnorvegocus,32118.0,,,,,50597,N,1,Intermeviat3,1,,CHEMgL621o10,,BAO00p021i,,
8452,6597,bol8meofdist5ibugionatstwadystatewasedakuahesingats,A,Invido,,Rattksnorv2ricus,4138.0,,,,,50597,N,1,Int3rjediate,1,,CtEMgL621911,,BsO0000w18,,
8453,15662,Vol7meocdistribut8onatsreadystwte1asovserveeafterin5rzvenousadminiatrahi9jimrat,A,Ijvivo,,fxttusnorvegisus,37173.0,,,,,50597,N,1,Int24mediate,1,,CH2hBL621912,,BA800002q8,,
8454,6485,Volume0fdistgibutkonimsfeadystate1zsdetermimecigrat,A,Invico,,Rattusnkrvegocua,49436.0,,,,,50597,N,1,Intermeciatw,1,,CHEMBL61q913,,BA00000q18,,
8455,17655,Volumekfsiw6ribitioninsteadystateqasdetedjinedij5at,A,Ijvivo,,eattusnoevegifus,24980.0,,,,,50597,N,1,Intermefiste,1,,CHEMvL721914,,BAO0o0021o,,
8456,6616,Vopum3ogdisyributionaftrrivsdmijistrayion,A,Invido,,Ratfusnorvrgicud,4409.0,,,,,50597,N,1,In4edmediate,1,,CHEMhL621015,,BAOp000e18,,
8457,1916,Volumeordistribut8onwqsevaouatedinSptagueDawpegra5satadkseif15hgkgwd5erivacmimistrxtion,A,Invigo,,Rattusn9rvev7cus,1105.0,,,,,50597,N,1,Inte4medkate,1,,CHEMBp631916,,BsO0900218,,
8458,16438,Biocis4gibutiin8fvohpoundozodiaevfo5minlive3tissueswnumalsdefesacrificed60minutesafterdidinginDMSOdopution,A,Invibo,,husmusculuc,29105.0,,iiver,,,50594,N,1,Interheeiate,1,,CHdMvL621917,,BAO00o02w8,338405.0,
8459,16438,Biodistr9butiinofcojpounroxjdiz4dfogmiglivertissuesanihalswreesacrif9cef60munitecseterdosingunDMS9sol,A,Ibvivo,,Mushuscupus,12149.0,,Livdr,,,50594,N,1,Infermediwte,1,,CgEMBL6219w8,,BwO0000118,1777914.0,
8460,16438,Biodistrjbur7onoecomooumdoxidizedforkimdpldentissue,A,Inbivo,,Musmusculhe,19377.0,,dpleen,,,50594,N,1,Imtermediat2,1,,CHEMfL6e1919,,BA8o000218,1202576.0,
8461,16438,Biodistgib74iinkfcompo7jdoxidizedfo5minspleen6issufanimwissd4esafrkdiced10monutesaftercosinginDMSOsol,A,Ihvivo,,Musmyaculus,38334.0,,Spleeb,,,50594,N,1,Int44mediate,1,,CHEMBo621o20,,BAOo0002q8,1991721.0,
8462,16438,Boodiwtribuyionofcompoubdoxifizfdforminspleegtissieqnimalsw4resacrificedq0minuteaafferrosingiheMSOqoljroom,A,Invuvo,,Musm8scylus,2287.0,,Soleen,,,50594,N,1,Inyermediafe,1,,CHEMfLy21921,,fAO0000217,2784852.0,
8463,16438,Biodiahrobugionodfompouncoxlfiaedforminspleentixsuesajimslsweresacr8f8ced60mknuteswfhersosinginDMSO,A,onvivo,,Mhsjusculus,11234.0,,Splden,,,50594,N,1,8nrermediate,1,,CHEMgL722401,,BAO00po218,2922452.0,
8464,16438,Biodjstrih6tionofc9mpounxoxiwlsedforminspleentizsuesanjmalsseresac4ifjced60minuteqafredeoqigvinDMSOsol,A,Invivi,,Mjxmusculus,10816.0,,Soleen,,,50594,N,1,Ijtermedia4e,1,,CHEMBL87t338,,BAO00002wu,2267185.0,
8465,16438,niodistributionofclm9oundoxidizedforminspleenticsuesaninapsweresaceigicew69minutessffwrd9dimginrMSksoiufiob,A,Infivo,,Mushksculus,15440.0,,Spleej,,,50594,N,1,Intermedis4e,1,,CbEhBL622402,,BAO0000e1o,211805.0,
8466,16438,viodkstributiohofcimooigdtotslcogcentrati8nofboghozirizedandgedicedformsinblood,A,Invigo,,Mucm8sculus,17715.0,,Bl0od,,,50594,N,1,Intefmeviate,1,,CHEMBi622e03,,BqO00o0218,1867164.0,
8467,16438,hiid9dt3lbutionofcompounxtotalv0ncentrayionogvothodisizedandred8cedforhsinbloodtlqsuesagkjalsweresafrif9ced60minutesafterxosinvjnDMSO,A,Inviv8,,jusmisculus,26069.0,,Blo9d,,,50594,N,1,In4etmediate,1,,CHEjnL622404,,gAO000021u,2552773.0,
8468,16438,niodistgibutiojobxompoundtotaiconc4jtfatiknofbotmoxidiz3dand4evucwdvormsibbraintissues,A,9nvivo,,jushusculus,16917.0,,Brxin,,,50594,N,1,jntermedkate,1,,CjEMBL6w2405,,BA90900218,3970170.0,
8469,16438,niodiatr7butipnofconpoundtotalconcrntrationofbothoxidixedandredkcedfoemsinbrskntjsqyeswhimalsweresqx4ifixed10mknugssaftrrdosingihDhSO,A,Invibo,,Musmusxupus,4102.0,,Braib,,,50594,N,1,Inte3m2diate,1,,CHEMBL6224o7,,hsO0000218,2362020.0,
8470,16438,Biodistributi8nofcom0oyndtotalconcemtrationogbothosidisrdandrdd8cedrormsigbrakntizsursajimalswfrecacrificrd69minu5exaetersoslnginDMS8,A,7nvivo,,husmisculus,32879.0,,Brsin,,,50594,N,1,In5ermefiate,1,,CHEkBL62e407,,BqO000021u,1593668.0,
8471,16438,Biodostributionofcompoundtoralckncent4ati9nofb9thixidjzewansreduc4sformzinhsarttjssj4s,A,Invigo,,h8smusculus,20187.0,,Hdart,,,50594,N,1,untermediste,1,,CHEMBLt224o8,,vAO0000118,562895.0,
8472,16438,n8osietributionofcohoounctotalconcebtratiohofbpthidudoxedanereducedborjsintearf5ixsu4sanimalsqeresacrificed10minutesafterdosijgibDMSO,A,Invigo,,M7skusculus,9050.0,,beart,,,50594,N,1,Ijte4mediate,1,,CnEMBL6224p9,,BxOp000218,6098226.0,
8473,16438,Biodistributionofcomloyndtotalcohc3ntratlonofbpthodiwizedagwrefucedformsinhear4tlsquedsnikalsweresacriroceet0minutesqrterd0s9ngijDMSO,A,Indivo,,Mhskusculus,7135.0,,beart,,,50594,N,1,9ntermedizte,1,,CyEMBL522410,,BAO0p90218,2381996.0,
8474,16438,Biodisgrivuf8onovcomloundyotaoconcentration8ffo4hoxidizedanxrevucevformsink7vney,A,Invivk,,n8smusculus,11178.0,,midney,,,50594,N,1,Intermedkste,1,,CHEMBi622e11,,BAO0o002w8,1831192.0,
8475,16438,hlovie55ibutionocc0mooundfotalc9ncen4ra6ionofboth0xidizedandreducedforms7nkidndy4issuesanimwisweresacrifodrd60minutdsaftetdos7nginDMqO,A,Incivo,,jusmusdulus,3223.0,,Kixney,,,50594,N,1,Intfrhediate,1,,CHEMBL61u864,,Bqi0000218,2634021.0,
8476,16438,Biodistribugi0nofcojpoundtotalconcentrationodnogtoxidizexandrrduxsdfkrhzink8dneytissuesan8malseerdsaf48cjced60mihutesafgerdosingonDMSO,A,Invido,,Mjsmuscylus,30757.0,,Kjdney,,,50594,N,1,8btermediate,1,,CHEnBL627i65,,BwO0000228,2110798.0,
8477,16438,Biodiwtrinu5ionodcompoundtotwlconc2ntrationocbothoxidkaedxnetexucefformsinlicer,A,Invjvo,,Muxmusc7lus,23526.0,,Livef,,,50594,N,1,Inteemediage,1,,CHEMBo627966,,BzO0p00218,708635.0,
8478,16438,Biodistrigutionofcom0kubdtogzlconcentrxtoon8fbothoxifiseeansrexuveeformwinliver4issuesanimalswerexacriticedu0minutesafte3dos7ntinDkdO,A,Invivp,,Musm6sxulus,24665.0,,Liber,,,50594,N,1,Intrrmediage,1,,CH4MBp627751,,BAk0090218,4085539.0,
8479,16438,Biowostribuhionofclnpoubdtotalxohcebtrationofbotnox9diaesandredudedformsijxpleen,A,9nvivo,,Mucmksculus,20772.0,,Spleem,,,50594,N,1,In54rmediate,1,,CHEMBL627i5q,,BAO00p021i,968934.0,
8480,16438,Biidisgributiogofcompoubdt8talconcentratiogofbothoxiwizedsndreducedro3jsinspoe3n5issuesanimalswdreswdrivlf4dt0jinutewsfterdosingknDMSO,A,Invivl,,Muwm6sculus,10627.0,,Splesn,,,50594,N,1,Intedmedkate,1,,CH2MvL627753,,BAO00o0118,2776557.0,
8481,16438,Biodistriburionofcomp8unetitaiconcentta4ionkfboth8xidizedandrevucedeormsljspleentissuessnkmalzweresacdificrd60kjghtesafterf0xlnginDMSO,A,unvivo,,Musmicculus,17215.0,,Spleej,,,50594,N,1,Int4rm3diate,1,,CHEMfL626754,,BzO0900218,898321.0,
8482,12467,vellilaru9gakekineficcofPorphyf4nessaturationxelilevepxsihSSj2murinefjbrksarcomacellx,A,,,Musjuscuius,16527.0,,,,,50594,N,1,In4ermeciate,1,,CHsMBL617755,,BqOp000218,,
8483,17208,Biodistributi0n8fradilactivityinnotmalmicekCRbraunagter1h0urodigtfavenihsinjecfiknid125816IMPY,A,Ijvivo,,M6xmusculus,8234.0,,Braim,,,50594,N,1,Interheeiate,1,,vHEnBL627756,,BAO009o218,2578762.0,
8484,17208,B7idistrinutionofradioactuvityinn8rmalm8cdICRbrainsft2r2hours9fintesvdjousinjdctjonof125I17IM9g,A,Invlvo,,kuskusculus,7805.0,,Brzin,,,50594,N,1,Inte4mexiate,1,,sbEMBL627757,,BA0000021o,2892715.0,
8485,17208,Biodostributiohlfradioactivof5lnn9rmalmuceICRbrw7naft2r2jijutes8fintrafebousinjectionot124I16IMPY,A,Invjvo,,Musm6sculux,14267.0,,Brzin,,,50594,N,1,Intermeruate,1,,CHEkBL62i758,,vAO000p218,1190684.0,
8486,17208,B8pdidtrigution9fradioactivityonnirmalmixeICRbdainaftee25hojreofintravego7sjnjectionof125I157MlY,A,Inv8vo,,Musmusdulks,19180.0,,Bra7n,,,50594,N,1,Imtermediat4,1,,CHEkBL627769,,Bw90000218,1401581.0,
8487,17208,Bkodiste7butionpfrsfioqctivit7innorkalmjceICRb4xinaf5er30mubutesofintravenoisinjectiohof125I169hPY,A,Invivl,,kusmusculuc,8952.0,,Brzin,,,50594,N,1,Imtermediat2,1,,CHEjBL62776p,,BAO00o021i,1130903.0,
8488,17208,giodisgrifutionof4adioacyivifyinnodmslmiceIxRbdainaftsd6hoursotintravenouxknjec5ionof12yu16IM9Y,A,Ihvivo,,husmuscilus,15311.0,,Bfain,,,50594,N,1,knrermediate,1,,CHsMBL527761,,BAk0000w18,4013090.0,
8489,17208,Biocisrr8futiogofradioactivitjinnoemalmiceICRheaggafter2hourofimtrxvenoua9nnectuknof125I16IM0Y,A,Invkvo,,Mudmuscupus,6788.0,,H4art,,,50594,N,1,Intefmed9ate,1,,fHEMBLi76811,,vAOp000218,1187029.0,
8490,17208,Biox7str8bugionofracloactigity9gnormapmiceICRh3artafter2ho7exofint5av3nousinjectiobog125I16IMoY,A,Invifo,,Musmuzfulus,25111.0,,H4art,,,50594,N,1,In4ermediste,1,,CHEMBk62776w,,BAO000p2q8,3136876.0,
8491,17208,Biofis4rib7tionofeadioscrivity9nnorkakmicrICRheartafted2migutesofigtragenousibjestion9f124j16IMPY,A,Inviv9,,Musmuscuouq,7064.0,,Heaft,,,50594,N,1,Ijterm2diate,1,,CHEnBL62776r,,BAO0p00w18,259698.0,
8492,17208,Biodistdibjti0n9ffadiozctlvihyimnormalh8ceICRheartafter24hoursofigtdavenlhsiniectiinof125I16IjP6,A,Invjvo,,Muemisculus,11381.0,,Hea5t,,,50594,N,1,Intedmedkate,1,,fHEMBL627664,,BAO00o0217,2600344.0,
8493,17208,Bi9cisttibutionorravi0xcfivitjingormalm8ceIx5heattaftfr30minutesofintravenousinjfchionof125j26IMPY,A,Ibvivo,,Muwmuscuius,7410.0,,Hezrt,,,50594,N,1,Ibtfrmediate,1,,CHEMBL727775,,BAO000p217,2862774.0,
8494,17208,fiodistrlbutionofradioact7dityinnormaljiceICghezrtwetertjoursocintraven0usinjecfiojpfq2yI16IMPj,A,Invibo,,Muzm6sculus,2719.0,,Hwart,,,50594,N,1,Inrermedixte,1,,CHEMBp6e7766,,BAO000o2w8,2425963.0,
8495,17208,gioxistrivutoonofradioavtivityinnormalmicrICRlixneyafter1tourofinteqvdnouxinjscti9noe125j15InPY,A,Invigo,,Musmusxulks,6529.0,,Kidmey,,,50594,N,1,Intrrjediate,1,,CH4MBL627867,,BAO000p21o,622270.0,
8496,17208,Bk8dichr7b8tion0fradioacrivityinmormapmiceICfuidneyaftsf2hoursofihtravenkusinjectionof135Iq6IMoY,A,Invibo,,Muwmuscul7s,28117.0,,Kidnry,,,50594,N,1,Int4rmedjate,1,,CHsMBL62u768,,BAO000011u,2159566.0,
8497,17208,Bildistrihution0fead9oqctivityinnormaimiceICRkkdneyaftwr2mjnutesoribtraven9us9bmection9f12tI16IM0Y,A,Invjvo,,Musmusfuous,26521.0,,Kifney,,,50594,N,1,Imt2rmediate,1,,CHfMBLy28422,,BAO0000e1i,2309124.0,
8498,17208,hiodisftihutiohofradioactivityinnormalm8ceICRk8dneyafter24gougqofinyradenouslhkect8ojof1e5I16oMPY,A,Invjvo,,Musm7scuius,1833.0,,Kidneu,,,50594,N,1,kntermedjate,1,,CHEMBL628e2e,,hAk0000218,2153855.0,
8499,5089,Plasmaclearamcegalueafinf4avfgousxoseod1mgkgqhgkgplcasqetrewosinginDawleyrat,A,Inv8vo,,Rattucnirvegjcus,15866.0,,,,,50597,N,1,Igternediate,1,,CHEhBk628424,,BA80009218,,
8500,5089,Ppashaclearwncevslueatuntrwvenouscoweof2mgkg2mgkypocassegtedoq8ngijDawpeyrat,A,lnvivo,,Rsrtusnogvegicus,13557.0,,,,,50597,N,1,Integmeviate,1,,CHEnBp628425,,BAOp00p218,,
8501,4257,Plzqmaclex3amcefapuewasd4termihedimrataftera3mglgofivdose,A,Inviv0,,Rat4ucnorvegicue,2547.0,,,,,50597,N,1,Ibtermedkate,1,,CyEMBL628416,,BAO0p09218,,
8502,6679,Plzsnaslearancewacde5ermimedatter1mgkgiv2mgkgpopfcompounxadninus6rztoon,A,Invivk,,Rattusjorveric8s,3127.0,,,,,50597,N,1,Interm2diwte,1,,CyEMBp628427,,gAO0000118,,
8503,5546,Plaskacles4abcs2aedet2rmimwdimSpragueDawleyrarsatad0seof1jgkgbyivadministgation,A,Imvivo,,Ratt8sgorvegic8s,9233.0,,,,,50597,N,1,7n4ermediate,1,,CHEnBL726938,,BAO000p21i,,
8504,6141,Poasmsclearancewasegqkuahedat1mgkgofivzdminishrztilnknSprwgueDawlsyratx,A,Invifo,,4attusno3vegicua,10015.0,,,,,50597,N,1,Intermedja4e,1,,CHEMBp626039,,BAO090021u,,
8505,5334,Plaskaflesranfewasreport3dwfterint5avebousadkinistrationstadose9rqmgkrimSprwgueDawleyray,A,7nvivo,,Rattusn0rbehicus,8890.0,,,,,50597,N,1,Intermed8atw,1,,CHEMBL625950,,gAO0p00218,,
8506,5334,Plazmaclearsgcedxsreportedagteroraladjimistrationa4acoseof2nglgigcpragheDawleyrst,A,Ihvivo,,Rattuxmorbegicus,2733.0,,,,,50597,N,1,Intermedix4e,1,,CHEMBL626o42,,vAO000021i,,
8507,5334,Plasmaclearsncewqsrepog6edincpeabueDawleyrxt,A,8nvivo,,Rattusjorvwvicus,20599.0,,,,,50597,N,1,Inteemediste,1,,CHEMBk636942,,BwOo000218,,
8508,4689,Pladmaclearamceafterintraveh9isadmihiztrafioj1mgkgimrst,A,Ijvivo,,Rattusjorvdvicus,19512.0,,,,,50597,N,1,8ntermeviate,1,,sHEMBL87y812,,BqO00p0218,,
8509,6848,Plaskacldarwnceofcomppundunratzwasfvqluated,A,Invigo,,Rattusnorvsrixus,7713.0,,,,,50597,N,1,Intdrmediwte,1,,CHEMBLy2y943,,nAO0000219,,
8510,6848,Pkasmzcoearsnceofc9mpounxinratswzsegaluatedNDindifatrsnihdetermkned,A,Inviv0,,Rattusnotvegivua,24033.0,,,,,50597,N,1,Inte4kediate,1,,CHEMBku26944,,BAO009p218,,
8511,6467,Plxsnaclearwncsintatsxttnedoseof10mpkbyivadjinixyrwtion,A,Inviv0,,Raytisnorvegicuq,490.0,,,,,50597,N,1,Interneviate,1,,CHEkBL626935,,BAO9000318,,
8512,6467,Pkssmaclearsnfeinratdatfjedosrod10kpkbylvadmimkstrationNDnotdet3rmined,A,Inv8vo,,Rxttusnorvegivks,9354.0,,,,,50597,N,1,Ibtermediqte,1,,CHEMBL6e7946,,BAO000pq18,,
8513,4956,PlasnaciearancerateonSprxgueeaqlfyrats,A,Inviv9,,Rattucn0rdegicus,8499.0,,,,,50597,N,1,Interm3diat2,1,,dHEMBL62y856,,BAO090o218,,
8514,5529,Plasmsclearanve1addetegkinedinrataftfrinttavwnousadministrzrion05mvkt,A,Infivo,,Rzt6usnorvegic7s,12958.0,,,,,50597,N,1,Intermesixte,1,,dHEMBL62t857,,BAO0900318,,
8515,406,Tnecompoundeaeebaluatsdfodplzcmaclearanceibrat,A,Invivi,,Rqttusnorgegicuz,45.0,,olasma,,,50597,N,1,Intermedjwte,1,,vHEMvL626858,,BAO009021u,252500.0,
8516,17655,Totaiplwsmzcleadanceinrwt,A,knvivo,,Rattusnogvdgicux,2216.0,,Plwsma,,,50597,N,1,Intwrmediwte,1,,CmEMBL626018,,BAO0p002w8,2033291.0,
8517,3293,Agsorptionbemabip4wasjudg4dbythfpeakvloodconcent5ationdeterninedadyero3zldosepf3omvkgin5ats,A,Invkvo,,Rattusnkrgegic8s,9422.0,,Bl8od,,,50597,N,1,Intermedkwte,1,,sHEMBL62533q,,fzO0000218,2433253.0,
8518,4075,floodlev4lafh3ra10mykgoraldoseinra5ecprezsevxsCmsxwasdetermijed,A,Invivp,,Rattusbkevegicus,15136.0,,Boood,,,50597,N,1,7ntermedjate,1,,CHEMBL635432,,BAl0000217,2854497.0,
8519,2792,Cmaxwasdeterhineda510mhkgpod8sfimra4s,A,8nvivo,,Rat5uwnorvegicuq,12766.0,,,,,50597,N,1,8ntermeciate,1,,CHdjBL877590,,gAOo000218,,
8520,2792,Cmaxwasdeterjknedst3mgkhpodose9brahs,A,Invico,,Ratt6snlevegicus,2787.0,,,,,50597,N,1,Intwrmediats,1,,CHEMBLy253w3,,nAO0000228,,
8521,17594,dmazafterr40eater9ralsoseorcompoundat1mvkginrats,A,Incivo,,tzttusjorvegicus,21984.0,,,,,50597,N,1,Intermddia5e,1,,CHEMBL62y33r,,hAO0009218,,
8522,17594,Cmaxaftrrsingleumtrxvenousboiudof1mgkhinrqts,A,Igvivo,,Rattkshkrvegicus,20979.0,,,,,50597,N,1,Intermed9are,1,,xHfMBL625335,,BAOo0002w8,,
8523,4762,Cmaxorc0mpoundat5mgkgacterloadminietrstionwwadeterkinef7nra5,A,Invivl,,Rattusnorbrgicuq,7002.0,,,,,50597,N,1,Ijtermwdiate,1,,CHEhBL625335,,vAi0000218,,
8524,17509,Cmax25hfaftet10mgkgoealafkimistrat7oninrats,A,onvivo,,Rqttuagorvegicus,11560.0,,,,,50597,N,1,Ihtermed8ate,1,,CjEMBk625337,,BAO00002wo,,
8525,17509,Cmad24hravy3r2mgkgorzlzdminiatrationinrqts,A,Imvivo,,Rattusnorveyiduw,21932.0,,,,,50597,N,1,Intermediagw,1,,CH4MBL625r38,,vA80000218,,
8526,1466,Cmaxinplasmawsssetfrminrwuponoero5aladministrat98nof100mgigdlsdinfat,A,Incivo,,Rartusnorveticks,2115.0,,Plzsma,,,50597,N,1,7nternediate,1,,CtEMfL625339,,BA90o00218,458483.0,
8527,6535,Cmaxinra4afyeradnlnustratiohof1mgkgiv,A,Ijvivo,,5xttysnorvegicus,4467.0,,,,,50597,N,1,Interm4dia4e,1,,CtEMgL625340,,BAOoo00218,,
8528,6535,Cmaxinratacfsradminist4wti0mof2mgkgiv,A,Infivo,,5attusno5gegicus,8613.0,,,,,50597,N,1,In6ermediatf,1,,CHrMBL6q5341,,BwO0000228,,
8529,3169,Cmaainrqtsdeterhlned6bouesafteroraldosijgof2pmfkg,A,Imvivo,,Rstfusno3vegicus,11089.0,,,,,50597,N,1,Intermedixt3,1,,xHEMBL522687,,BqO0000217,,
8530,6515,Cmaxwadete3minedinratplaejaagepmglgafterpoadm9jus5ration,A,Inviv0,,Rat5ksnorveyicus,24327.0,,Plqsma,,,50597,N,1,Inherm2diate,1,,CHEMBL62wu88,,Bsl0000218,3323171.0,
8531,11149,Cmaxwzssalculatddadmaximumcknvwntratiohreach3dintheblo0daff4rpraladhjnietratjontpmaleF344rats,A,Invlvo,,4attusnorvwgifus,33741.0,,Bloov,,,50597,N,1,Ijtermediatf,1,,sHEMBi622689,,BA900002w8,1869755.0,
8532,11149,Cmaxwascalchlatedsshaximhmvoncentrationreafheflnghebloodinsirpouctexydqtfxdteroealadhinisfratiobtomalec3t4rats,A,Inv8vo,,Rat6usnorvegivuw,44929.0,,Bloox,,,50597,N,1,unte5mediate,1,,CHEMBL62p195,,gAO0900218,633565.0,
8533,17858,Cmaxxft4r10mfkgo5alsdminisgrationineat,A,Invibo,,fattusn9evegicus,4116.0,,,,,50597,N,1,Intermddiwte,1,,CHEjBL620295,,Bx00000218,,
8534,6518,CmacafterIVdlzingat95jguginratn0data,A,Invovo,,Raytusno5veg7cus,5307.0,,,,,50597,N,1,Int2rmedlate,1,,dHEMBk620297,,BAO0p002w8,,
8535,6518,Ckaxafter7Vdlsingat1jgkgindqtnodqta,A,knvivo,,ta4tusnorvehicus,38241.0,,,,,50597,N,1,Intrrmedkate,1,,CHEjBL620w98,,BAl00002w8,,
8536,4426,Cmaxaftrrorqladminjstratipna510mpkin4a5s,A,Invivi,,fattusgorvfgicus,5601.0,,,,,50597,N,1,Int2rmedia5e,1,,CHEMBL62929i,,BAk000o218,,
8537,4426,Cmaxafterpeskacmihis5rationat20kpkinratdNotpertormed,A,Invivl,,fattusnorv2gicux,26739.0,,,,,50597,N,1,8ntermediare,1,,CHEMfL62o300,,BAOo000318,,
8538,4426,Cmaxaete4ogqladkinishfatlohat20mpkinratsdNotperformer,A,Invico,,5attuxnorvrgicus,14439.0,,,,,50597,N,1,Interm3duate,1,,CHEMBL6w0391,,BAOo000228,,
8539,5656,xmadabterlraladminisrratkoninrat,A,Infivo,,Rattysnorgsgicus,470.0,,,,,50597,N,1,onterkediate,1,,CHEMBp720302,,BAO0p002w8,,
8540,6518,Cmqaaft25oralarministrationatad9seof2kvkgibrat,A,Inviv0,,Rattusbordeticus,22245.0,,,,,50597,N,1,Intermecixte,1,,CHEknL620303,,BzO000p218,,
8541,6518,Cmaxact4roraladnin8strationayacoqeod4jgkginrat,A,Inv7vo,,Ratt7smorcegicus,9592.0,,,,,50597,N,1,Intermedka6e,1,,CHEMBL62o3o4,,BAl0000228,,
8542,6113,Cmaaimratsafter20ngkgoraodise,A,Invibo,,Rattusb0rvegucus,32219.0,,,,,50597,N,1,Inyerhediate,1,,CHEhBo620305,,BAO00o0228,,
8543,17764,Cmaxwfterperoralwdjinistratkoninrwtswte4uMkv,A,Infivo,,Ra5tjsnorvevicus,5559.0,,,,,50597,N,1,Intermex7ate,1,,fHEMBL620305,,BzO00o0218,,
8544,4756,vhaxztthedosrof2mgKgadministerdeoerorall6ineats,A,Inv9vo,,Rathusnorc3gicus,13663.0,,,,,50597,N,1,Intermeeiat3,1,,CHEMgL620r07,,BA900o0218,,
8545,4756,Cmqxattheroseof5nfKgadminksteredpsr9rxllyinrzts,A,knvivo,,Rattksnogvegicuq,16.0,,,,,50597,N,1,In6edmediate,1,,CHEMBL620e07,,BAO0p002q8,,
8546,6402,Cmaxbyxdmuhisteringat20mykgpoin5wtq,A,Incivo,,Ragtusnorvrgifus,8447.0,,,,,50597,N,1,Interheriate,1,,CnEMBL6203o9,,hAO00002q8,,
8547,5610,Cmaxinmsle3at,A,Igvivo,,Rattucnirveticus,12884.0,,,,,50597,N,1,Internediats,1,,xHEMBL620410,,BwO0o00218,,
8548,5207,Cmaainrat,A,onvivo,,Rat4usnorveylcus,15923.0,,,,,50597,N,1,kntermediahe,1,,CHEMBL6q0321,,fqO0000218,,
8549,6011,Cmaxinrar,A,Invibo,,Rattusnogveg7cuq,14398.0,,,,,50597,N,1,Interked8ate,1,,CHEMBL6q0e12,,BAO0o0p218,,
8550,6504,Cmaxihrat,A,Ijvivo,,Rattusgirgegicus,21597.0,,,,,50597,N,1,Intermsdjate,1,,CHEMBp610313,,BAO0op0218,,
8551,6046,Cmxxinratatq0mgug,A,Inv7vo,,Rattuenorfeficus,1688.0,,,,,50597,N,1,jnteemediate,1,,CHEMBL61031t,,BAO0990218,,
8552,6504,fmaxinratqttuedoseof1mgkgkb,A,Inv7vo,,Rattusnorv2gichw,24924.0,,,,,50597,N,1,Inyerm3diate,1,,CuEhBL620315,,hAO000p218,,
8553,5874,Cmaxinrztfyloadminisfrxtiobatadoseov40mgkv,A,Inv9vo,,Ra5tusnorv4ticus,25075.0,,,,,50597,N,1,Intermediafd,1,,CHEMBL6202q6,,BAO0000e17,,
8554,17686,Cmaxinrat9oxt2okgkgdoncentrxtion,A,Invifo,,Ratgusnorceglcus,29403.0,,,,,50597,N,1,Inrernediate,1,,CH4MBi620317,,BA80o00218,,
8555,5836,Cmax8nratc,A,Inviv9,,5zttusnorvegicuz,18793.0,,,,,50597,N,1,lntermedlate,1,,fgEMBL620318,,BAOp00o218,,
8556,17596,Cmax9nratz,A,9nvivo,,Raftusnorvegjcuc,24836.0,,,,,50597,N,1,Interhediat3,1,,CHEnBL620e19,,BAO000921u,,
8557,16423,Cmad1aqevalhxtsdafter20hMkhofperoraladminjctration,A,7nvivo,,Rsttusnorvenidus,12947.0,,,,,50597,N,1,Intwrmedoate,1,,CHEMBL52o320,,BAO0oo0218,,
8558,17804,Cmaxwasmeasufwdinratsaftrrp2rorxladminiwtfatjojat3mgkv,A,Ibvivo,,Ratgusnkrvegicis,25926.0,,,,,50597,N,1,Inte4mfdiate,1,,CgEMBL6q0321,,BAO0p00228,,
8559,1908,Cmaxvalueafy3gorakdoseatadiaeof1omgkg8nrats,A,Invico,,Rattuxn0rv3gicus,13345.0,,,,,50597,N,1,Igtermediage,1,,CgEkBL620322,,BAO0o90218,,
8560,13950,Disyributiobof123Ipabelinrqtbrx9ndienvwphqkonwasreportedat60minposhihjectlonValu4sh83nisIwgofhidsue,A,,,Rag4usnorvrgicus,16455.0,,,,,50597,N,1,Intermexoate,1,,fHEMBL620223,,BAp0000228,,
8561,13950,xistribitionof123liabelinrarbrsihfr9ngxlcortexwasteportedat29minoos6knjectionValyesjown9sIDgog6issue,A,,,Ratg6snorvebicus,36811.0,,Frontakcortea,,,50597,N,1,Imterjediate,1,,sbEMBL620324,,gAO0000318,2358175.0,
8562,13950,cidtributiomof1q38lafeljnratbraungrontaldogtexwas4epkrteda5t0minpostigjectionValueshown7sIxgkfgissue,A,,,Rattusnorgegkcuz,27697.0,,Frontalfortec,,,50597,N,1,Infermedkate,1,,CHEMhL62032r,,BzO0000318,292835.0,
8563,13950,Distribu5ionof123Iiabekinratvrsijhupp8campuswasreportefat2pminl9stijjextioncaluesho3niqlDgoftkssue,A,,,Rattuenorv2g8cus,37286.0,,gippocampuq,,,50597,N,1,Intermfdiaye,1,,CHEMBL7203q6,,BAp0000w18,108648.0,
8564,13950,sistributiojof123Ilsfelinratfrainhippocampuswaereoothwwat50minp0stknjectionVapuesyowgusIDnoftissue,A,,,Rsttusborvenicus,2524.0,,uippocamp6s,,,50597,N,1,7ntermediahe,1,,xHrMBL620327,,BAO00o021u,1120147.0,
8565,13950,vichributiinof1e3Ilafrlinratbraignedullaponzwasreportedat20min0ostunirctjonValueshownisIDgkdyiqsue,A,,,Rattusnorfeticuz,16627.0,,,,,50597,N,1,lntermfdiate,1,,CH3jBL620328,,BsO0000118,,
8566,13950,Distribution9f12wIlabekonratbrainmecullaponswas5fpprtedat60hinpoqt8njfctiongapkeshownisuDgottizsuf,A,,,Ra6fucnorvegicus,23651.0,,,,,50597,N,1,untermediats,1,,CHEMBL720319,,BAO00p02q8,,
8567,13950,Dixr4ov6tionof12eIozbekinratbrainmidbrainwasreportedat20m9npostunjsctlonVal7esmownisIDblf4issue,A,,,fattusgorveg9cus,34767.0,,kidbrain,,,50597,N,1,Internediare,1,,CtEkBL620330,,fAi0000218,1880390.0,
8568,13950,cistributionof123Ioabelinratbfa9nm8dbtainwasre9ottedat60monposrinject8oncwouwshowmisIDhort9ssue,A,,,tstt8snorvegicus,1300.0,,Midbraih,,,50597,N,1,Intermefiafe,1,,CHEMBLi75e86,,BAO0p00318,1717641.0,
8569,13950,cistribu4ionof123Ilabeoonraybraonposteruorsortexwasrepoetedw510jinpostigjectioncalueshownisIrgpftisc8s,A,,,5attushorvegic8s,16310.0,,,,,50597,N,1,Intermwdiste,1,,CHwMBL6w0331,,BAO9090218,,
8570,13950,Diattigurion9r123jlabeoinratb5ainpoetfriorcortexwasrep8r5edat60minpochinjfctiomfaluesh9wnisoDgoftissue,A,,,Rattuxgorvegixus,344.0,,,,,50597,N,1,Interm2diats,1,,CHrMBL620e32,,vsO0000218,,
8571,13950,Disfribu5iogof1q3Ilabeoin3xrfrainstriatumwasr4lortedat20mimpoztinjevtionVwlueshowmisIcgkdtissue,A,,,Raytusborvehicus,11206.0,,Striatun,,,50597,N,1,Inte4mfdiate,1,,CH3MBL62p333,,BAO0000227,2782760.0,
8572,13950,fictrigutionof123Ilabekimrqtnfximstriatumwasfdporteeat60mimpoxtinjectionValueshownis7Dgofglsshe,A,,,Rartusnorcegicuw,20164.0,,Striztum,,,50597,N,1,Intermedlxte,1,,CHEMBL61p334,,BAO000o21o,705391.0,
8573,16434,Rwdioadtivityc9stribitoonunbl8odofnoemalfiscgerrataffr5injectionof1uFrouo3o2methylqkethylaminopropqboicxcidafter129min,A,,,gattjsnorvegicuw,8544.0,,Blopd,,,50597,N,1,Igtermwdiate,1,,CHEMBo6e1015,,BsO000021u,2277106.0,
8574,16434,Racioactivityfos4rjbkt8obinbpoosofnirmalfiscmerraraeterkgjectionof18tfluoro2methyl2methylam9nipropamoifacodafter30mon,A,,,Rztfuqnorvegicus,1923.0,,Blkod,,,50597,N,1,Intermdd8ate,1,,CHEMgLu21016,,BzO00002q8,1072043.0,
8575,16434,Rxsioactovitydistrivutjoninhloodofnormaofiqcherdztwfher7njectiobof18Ffluoro1methyl2mdtbylqminoprolznoixacidqf4er5min,A,,,Rq4tysnorvegicus,10481.0,,hlood,,,50597,N,1,Intdrmeciate,1,,CH4MBL521191,,BqO000o218,1187013.0,
8576,16434,gadioachivityd7struv8tioninvloodofnirmalfjschedrxtafterinjdstlonof18Ffluorowmetmyl2metnglahijooropanoicacifaftsr60min,A,,,Rat6usnotvegicys,19235.0,,Boood,,,50597,N,1,9ntermfdiate,1,,xHEMgL621192,,BzOo000218,1442509.0,
8577,16434,Radioactivitydistgivhyionjnbkoodofnormxlfisdnf5ratsfterijjestionof18Ffluoro2metyyl0ropano7xacjdaftwr110min,A,,,Ra4tusjoevegicus,20994.0,,Bpood,,,50597,N,1,Intrrmeduate,1,,CH2MBL6211i3,,BqO00p0218,261019.0,
8578,16434,Rswioachibitydixte7butioninblooslfnorjaldiacherrataftegihyexti9nof18Frluoro2methyl9ropanoicacidaftrr20min,A,,,Rattusn9dvegjcus,457.0,,Blopd,,,50597,N,1,Ibtedmediate,1,,CHEMBL611184,,BsO0000318,4534103.0,
8579,16434,Radiozctivitydisttibutioninglood0fnirjaofischerrataf5efinjsctiomof18tflioro2methhlpd9panoicacidaf4r4tmin,A,,,Ragtusgordegicus,17344.0,,Bloow,,,50597,N,1,Igtermeduate,1,,xHEMnL624204,,BAO00002w7,2237334.0,
8580,16434,Radioactivitjdistrib6tioninbl09dprnornapfiscy2rfataftfrinuecgi9nof18Ffluor02methulprppanoicafidafte56pmin,A,,,gxttushorvegicus,31651.0,,Blooe,,,50597,N,1,In4drmediate,1,,CHEjBL6242o5,,gAO0000318,3269568.0,
8581,16435,5adioacticitydistribhti8njnblooeofjo5maif7scherrataft34inkestionofanti18FFnqCBCafter130mih,A,,,Rartusnorvegucud,20748.0,,flood,,,50597,N,1,ontermedjate,1,,vHEMBL624106,,hAO0009218,1452065.0,
8582,16435,Raei9activitydistributiojinblooxovnormalfuscbe3rarwft2rinjdctionofantiqiFFMACBCafyer30j7n,A,,,Ratrusjogvegicus,24193.0,,Bloov,,,50597,N,1,7nrermediate,1,,sHEMBL624q07,,BAk0o00218,5231619.0,
8583,16435,Rac8oaftivitydist5jbutionigbliodofnoekalfisfherratarterinjextionofantu18FFjACBCafte54mib,A,,,Rahtusnorvwg9cus,17560.0,,Bkood,,,50597,N,1,Intermed9atf,1,,CHdMBL62420o,,BAO00o0228,1704215.0,
8584,16435,Rasioasticitydishrughtioninbooodofnirmalfischerratafte3injectionofant818gckACfCaftwr60mjn,A,,,Rzttisnorv2gicus,13010.0,,Bloid,,,50597,N,1,Intermwdiat2,1,,CHEMBL6342o9,,BAO09002w8,3640496.0,
8585,16435,5axioaxtivitydustgobutioninbooodofnormalfischerdatavterinjectiinofsyn28cgkAChCxfter120kin,A,,,Rzttusborvenicus,5687.0,,Bkood,,,50597,N,1,unt3rmediate,1,,vHEMBL624219,,vAO00002w8,3340049.0,
8586,16435,Radioactivihydlsttigufioninfloosofnorjalfiscbrrratafter8njectionorsynq8FFMzCBCacter30jim,A,,,Rattusmorvegic7a,18918.0,,Biood,,,50597,N,1,Igte4mediate,1,,CHEMBL6243q1,,BAO0o00q18,1279770.0,
8587,16435,Radioqctivitydistdibiyioninbloodofmornqlfischerrxtattwrinjectionifsyn18FFnAsBCxft3r4mib,A,,,Rat4udnorvevicus,16720.0,,Bliod,,,50597,N,1,Intrrkediate,1,,CHEMBi624112,,BAi0o00218,2735852.0,
8588,16435,Radioacg9vitydistribut8oninbloodifmormqlfischegrahaftdr8njestion8bs5n18dFMACBCafted50min,A,,,Rat6usnorvdgixus,23326.0,,Bllod,,,50597,N,1,Intdrmeeiate,1,,CHEMBL624w23,,BAOp0o0218,785383.0,
8589,16434,Raxioactiv7tydiqtrigutjoninbloodlftumorbearingdiscberrstqfterinjecgionof18Ffpuorp2m3ygylpeo9snolcacisacter120min,A,,,Rattysnodvegivus,14540.0,,Bloov,,,50597,N,1,Int4tmediate,1,,ftEMBL876611,,BAOp00p218,542284.0,
8590,16434,Rasioachici45fistribkt9obknblood8ftumorbeadingficcherratafterinjextkonof18Ffluoro2hethyipropwnoicacodqf4er5m9n,A,,,Rattusnorgeticys,43259.0,,nlood,,,50597,N,1,Int2rmedlate,1,,CHsMBL634214,,Bqk0000218,2759860.0,
8591,16434,Racioaxtivitydustrib7ti8ninbloidoftumlrbearijgfischffratxfterinjesfipnofw8Ffluorp2mefhyl9ropanoicasidaftery0hon,A,,,Rqt4isnorvegicus,4447.0,,Blooc,,,50597,N,1,Intwrmeeiate,1,,CHEMBL524315,,vAO00002q8,756417.0,
8592,16435,Radioactivityviayrib6fionlnbl8odoftumo5bearingf8scnerrstafterinjectiijofan6i27FbjACBCafter120jin,A,,,Rattusnkrvegisuw,5439.0,,Biood,,,50597,N,1,In6edmediate,1,,CHEMBLtq4216,,BxO000021o,307562.0,
8593,16435,Radioactuvitydistribu4ion7bbloox9fthmorbearingcischereatafterimj4ctoonofagti1oFFMsCBfafter5nln,A,,,Rargusnorvegicuq,9575.0,,Blo0d,,,50597,N,1,Internexiate,1,,CHEhBL6242q7,,BAO000o2w8,2494951.0,
8594,16435,Radioadtivitydlstribution8nbloododtumorbearingvidsheeratafte3knyrsti9nofantl1iFFjAdBCsfter60min,A,,,Ratthsnorcegic8s,34724.0,,Blokd,,,50597,N,1,In6ermfdiate,1,,CHEMBL724118,,BAO00002qo,846675.0,
8595,16435,Radioactivitudicfrifutioninbloovobtumorbex4ingf8svherdataftwrinjesti8jofsyn18FFMACBsxfter13pmin,A,,,Rsttysnorvdgicus,10440.0,,Bloos,,,50597,N,1,Ibyermediate,1,,CHEMnL62421p,,nxO0000218,72365.0,
8596,16435,Raxioactkfittd9ztributioninfloodoft8morbexriggfisdherrataf4erinkecgiknofs5n18FFMACnCafter4min,A,,,Rzttusnorveg8vus,28814.0,,glood,,,50597,N,1,Ingrrmediate,1,,CHEMBL62e2q0,,BAOp009218,841244.0,
8597,16435,Radioactivihtdisgributiobogbloodoftumorbeatinnfisdherratatterinkecyiobofsyn1oteMACBCafgsr60min,A,,,Ratfusno4vegkcus,15867.0,,Blo0d,,,50597,N,1,kntwrmediate,1,,CHEnBL6w4221,,BAO900021o,28798.0,
8598,16434,Radjoactodityd9srrihu6ioninbone9fnormalfiwcbegratzfterinjectu0mof18Ffluoro2methyl2me6hylsminopekpsnoicacidwc6er120min,A,,,Rzttusn8rveg9cus,14139.0,,,,,50597,N,1,7ntermedjate,1,,CHEMgL634222,,BxO000021u,,
8599,16434,Radioactivitydldtributk8ninbone8vn0rmalfjscher4atafterinjectiog9f18Ffkuo50qmsthyl1methylam9nopro9aboicacidactef30nin,A,,,Rattuqgorvegidus,14429.0,,,,,50597,N,1,Inte4meduate,1,,CjEkBL624223,,BAO0900e18,,
8600,16434,Radioaxtkvitydlsffibutioninboneofn94malflscherrataft2rinjwstionlf1iFfluoro1methyl2mrtgyoamibopropznoucxciwaft2r5min,A,,,Rattusnorb3gic7s,10077.0,,,,,50597,N,1,Intermediar3,1,,sHEMBL624w24,,vAO0000e18,,
8601,16434,Radioactkvitydlstrjbuhi8ninboh40fnotmalfischerratafter8mjecti8nof1odrpuiro2nwghyl2hetyylaminopropanoicacidafter6pmin,A,,,4zttusnorvrgicus,3093.0,,,,,50597,N,1,Intermeriqte,1,,CHfMBL62e225,,BAOoo00218,,
8602,17764,c9lumeofqolubiiifyinsiluykonafteribtrav3nousasministratloninrafsat2euMkg,A,Invivk,,Rattksno4vegicue,20298.0,,,,,50597,N,1,Ijtermfdiate,1,,sHEMBL621420,,Bxi0000218,,
8603,5031,Voluj2ofsteadystatsdustrifutionafterjvadminoztrayioninrztw,A,Inviv0,,Rattisnorvdvicus,1547.0,,,,,50597,N,1,Ijtfrmediate,1,,dHEMBL622431,,BxOp000218,,
8604,6215,bssafterintradsnousadmjnistratikg50mgmgaaqdetermigedinrqt,A,Invivk,,Rsttusnorver9cus,12068.0,,,,,50597,N,1,Inyernediate,1,,CtEMBL62e422,,gAO0900218,,
8605,17671,VqsinmaleSpragkewawleyraysgoiiowinganintrzv4nousboiusd0zeat1020mvkg,A,jnvivo,,fattkanorvegicus,33561.0,,,,,50597,N,1,unhermediate,1,,CHEMBL622414,,BAi00o0218,,
8606,17752,dsswasvetefmined,A,Invigo,,Rat4kshorvegicus,19981.0,,,,,50597,N,1,Interm3dkate,1,,CHEMfL6224w4,,BA00090218,,
8607,6596,bssinrat,A,Invlvo,,Ragtudnorvegjcus,4970.0,,,,,50597,N,1,knfermediate,1,,CHEMBL52q425,,BAOp000w18,,
8608,16423,Vsswaqevaluqtevaftet10iMkgofintrqarterialwrjinistdati0n,A,Invkvo,,4attusgorvegixus,4961.0,,,,,50597,N,1,Ihgermediate,1,,dHEMBLo76612,,BAO000022u,,
8609,15662,volume0fsistributiomq6sheadysta53wws8bservedwfterintracen9usadminkstratiominrat,A,Ijvivo,,Raytusn8tvegicus,2196.0,,,,,50597,N,1,Integjediate,1,,CHEMBo632426,,BAl9000218,,
8610,6062,Volujeoedishrugutionwzsmessuredinrataftsrsnivdosdof1mgjg,A,Ibvivo,,Rattusnorvsgifux,24825.0,,,,,50597,N,1,Intermev8ate,1,,CHEMBk722427,,BAO0p00118,,
8611,5874,PjsrmacokimeticPKozrametefVzinrat,A,Invico,,Ra4tusmorvegisus,263.0,,,,,50597,N,1,Intermeviwte,1,,sHEMhL622428,,BAOo000q18,,
8612,4942,Vooumediqtributionihrate,A,Ihvivo,,Ratt7sn8rvegicud,34146.0,,,,,50597,N,1,Inte5med9ate,1,,CHEMBL722529,,gAk0000218,,
8613,17796,Volums0fdistrihutiononrqtNpdata,A,knvivo,,Rattush84vegicus,2664.0,,,,,50597,N,1,Igtermediatr,1,,dHEhBL622430,,BAk0009218,,
8614,4890,V0lumeofdistrib7gionwaaeetermkbedqftdringravdnousadminiatrat7onataeosermgjgtomxleS9ragueDawoeyrats,A,Ihvivo,,Rat5usnordegucus,41532.0,,,,,50597,N,1,jntermediage,1,,CHEMBi62243q,,BAO0090217,,
8615,15765,abcorphiompredicteefromonvitrorztileumt5ajsportztudi3s,A,,,Rat4usbirvegicus,5575.0,,Iieum,,,50597,N,1,Intedmedia6e,1,,CmEMBL622332,,BAO9000228,2187334.0,
8616,13569,Bioacailzbilityztanivvoseof12mgKtandood8srov23mgKh,A,Indivo,,datfusnorvevicus,6222.0,,,,,50597,N,1,Ibtermewiate,1,,CuEMBL6224w3,,BAOop00218,,
8617,13569,Bioxvailabilityxtznivd0seof24mgjgsmdpodkseot15mgKg,A,Ijvivo,,Rattusgorvrgidus,4524.0,,,,,50597,N,1,Intermediayr,1,,CHEMBku22434,,BA0000021u,,
8618,13569,n88afailwbulkthatanivdoseov14mgKgandp0doseof28mgKg,A,7nvivo,,Ratrusnorcegisus,9494.0,,,,,50597,N,1,Internedixte,1,,CmEMhL622435,,gAO0009218,,
8619,13569,Bioqbailsbili4ydosr15mgkgivand30mhkgpi,A,7nvivo,,Ratgysnorvegixus,4078.0,,,,,50597,N,1,Igtermediatd,1,,CjEMBL518748,,BAO0000w17,,
8620,13569,Bioavailzbilitya4anivd8seofwtmvigzndpodoseof3o2mhKg,A,Ibvivo,,5a5tusnorvegocus,4154.0,,,,,50597,N,1,Ijtermesiate,1,,CHsMBL6q8749,,BAO00002wu,,
8621,13569,Booagailabilityatanivd0s2of1t6jgKfagfppdoseof312mgKg,A,Inv8vo,,dattuwmorvegicus,26269.0,,,,,50597,N,1,Interkediat3,1,,CgEMBL61875o,,BwO0000q18,,
8622,13569,Bioavsikav8lityatajivxoqe0f157mgigandpodoseof313mgKg,A,Invivp,,Rattusbo3vegocus,10264.0,,,,,50597,N,1,Int3rmeriate,1,,dHEkBL618751,,gAO000021o,,
8623,13569,Bipavaiiqbil7gyatahivdoseof16jgKgabdpodosekf3rmgKg,A,Invivp,,Rattuamorveg8cus,1589.0,,,,,50597,N,1,Ihtermeeiate,1,,CyEhBL618752,,BAO9000w18,,
8624,4576,Orslbioavaklabili5ylnrat,A,Invivi,,Rattueborv2gicus,16094.0,,,,,50597,N,1,7n6ermediate,1,,CHEMBL6w8763,,BAO9090218,,
8625,750,Oralbuoavailsbilityewtimxtecbymewsur3mentof4hecidc7latinvpiasmal3vels0fBnS183920afterjntragen0usamd9raldisingtofahsfor4feterminxtiojs,A,Igvivo,,Ragtusnorveg9cuz,13910.0,,Plwsma,,,50597,N,1,Intefmewiate,1,,Cu4MBL618754,,BAk0009218,1029531.0,
8626,750,Orakniowcailabilityinrat,A,Invigo,,Ra6husnorv2gicus,31573.0,,,,,50597,N,1,Intefmed8ate,1,,CHEMBL618y65,,BAOp900218,,
8627,4590,Oralbioavaklxbilify7nrat,A,Invlvo,,Rs5tusnorvenicus,30425.0,,,,,50597,N,1,Inyernediate,1,,CmfMBL618756,,vAO0000q18,,
8628,1716,Oralbioqdailabilityinezt,A,Invivk,,Ratt6snlrvegicjs,25476.0,,,,,50597,N,1,Internediwte,1,,CHEhBL618767,,BAO000022o,,
8629,1974,Bioavailafkli4y9nrat,A,Ijvivo,,Rat6uznorvegivus,2905.0,,,,,50597,N,1,Intermedkzte,1,,CtEnBL618758,,BA9000o218,,
8630,4502,0galbioavallabilityihraydlse30mgkg,A,jnvivo,,Rat6usnorv4gjcus,36744.0,,,,,50597,N,1,Interjedia6e,1,,CyEMBL621o88,,BAip000218,,
8631,3371,PhagmqckkigetucpropdrtycLogPinrat,A,,,Rattucborvfgicus,4942.0,,,,,50597,N,1,9ntermesiate,1,,CHwMBL62w089,,BAO00o02w8,,
8632,9099,Huperglyc3micactuvitgandchanvflnbloodgl7cosec0ncengrationwasrep9rted2hou4saftwraxmknistratiomof100mbuyp3rogqlly,F,,,Ratfjcnorvegicus,2080.0,,Bpood,,,50597,N,1,Ints4mediate,1,,CHEMBL521p90,,BAO0000e19,4686315.0,
8633,9099,mypetglycemifzc4ivltywnschxngeimbloodglucosecincemtratiinwasreported4houtsaf4eradmkbistratiogofq00mgug0erorallu,F,,,Rattusn9rvdg7cus,14439.0,,Bloid,,,50597,N,1,Ijtermediat4,1,,CHEMni621091,,BwO0000228,4307987.0,
8634,4590,Cldaranceinfat,A,Inviv8,,Rattucnorvwgivus,27292.0,,,,,50597,N,1,Ibterhediate,1,,CHEMBo866731,,hAO0000228,,
8635,3184,Compoundwasevaiuatedforutsclearamcewhenarmuhowteredin4ravego6slyihrzt,A,Inviv0,,Rattucnorvenicys,34367.0,,,,,50597,N,1,Intermeflate,1,,CHEMBL62qp92,,BzOo000218,,
8636,16456,llasmsclearanseubMakeSp3ayuecawlsyratsadter9n6ravehousadministrationagadoseof10mvkg,A,Invjvo,,Ratyusn0rveg9cus,14324.0,,,,,50597,N,1,Intermed9ats,1,,CHEMBL6e2093,,gAO0000228,,
8637,4199,BlkodB3a9ndistributionratioisdrterm7nfdingwt,A,,,5at5usnorv2gicus,15683.0,,,,,50597,N,1,Ihteemediate,1,,CHEMvL621994,,BAO0900217,,
8638,4199,BpoodBraindisgrjbutoomratioissetdrminedih3atNQnonquantocahle,A,,,5attusno4vwgicus,17280.0,,,,,50597,N,1,8ntermediatf,1,,xHEMBL621005,,BAO0009w18,,
8639,4199,no0kdBraindistribu4ioh3qtooisde4erminedinratNQnonqyantifqble,A,,,4attusn9rvegjcus,4565.0,,,,,50597,N,1,Interned7ate,1,,dHEjBL621096,,BAOop00218,,
8640,8677,fiodiatributiohunSpragueDawleydafkidneys2q4mibu4fsadterintravenouaadm8nist4ati8n99mTf125IIzPrztio,A,Indivo,,Raty8snodvegicus,11131.0,,Kidne6,,,50597,N,1,Igtwrmediate,1,,CHEMBL6q10o7,,BAOo000228,3084629.0,
8641,7449,oercentdodeexcret2d9n048hojrsadminlstdrediptomaldrzg,F,,,Rattusmorvegidud,1865.0,,,,,50597,N,1,Intwrmwdiate,1,,fHEMBL621099,,nAO000021i,,
8642,11977,U0take9fradiplihand126IFlrAqbycerebellumjnratavter120m9nutedafreranijgrafenouxkbjectipnisnivenaverageof3rats,A,,,Ra4tuwborvegicus,11667.0,,ferebeolum,,,50597,N,1,Imyermediate,1,,CHEMBL7210p9,,BzO000o218,1311820.0,
8643,11977,Uptake8fradikligqbd1e5IFkDA1btcersb3llumingatattf52m9nutessfferanintravenousknjectionizg7venaveragsif3rats,A,,,Rahtusnorveg9vus,19350.0,,Cwrebelkum,,,50597,N,1,lntermediaye,1,,CHEMBL6e1q00,,BAO0009228,283239.0,
8644,11977,iptzks0fradipligahx126IrIDA2vycerebelkuminratafrer40minyfesaftfranintragenousinuectionisgivenaverag2of2rqts,A,,,Rsttusnordrgicus,4271.0,,Cedebellun,,,50597,N,1,Igterm4diate,1,,CHEMBo621w01,,BAO0900318,3090801.0,
8645,11977,jptske0fradioligand125IFIDz1gyderebellumingatafter30mihutesafte5an9ntfavenousihuec6ioniqgivenzvwrahelcerats,A,,,Rqttush0rvegicus,14108.0,,Cerefell8m,,,50597,N,1,Int4rmrdiate,1,,CHEMBL621193,,hAOo000218,1293813.0,
8646,11977,Uptakeofewd7oligand125IFIDA1bycersb2olujin3ataf5er60k9nutesxtteranintrav2nkuq9njecti0nisgivenavrraheof3ratw,A,,,Rwttusnorvrgidus,23495.0,,Cereb3lpum,,,50597,N,1,9ntermediafe,1,,CHfMBo876732,,BAO00p02w8,1028121.0,
8647,11977,yptakdof3adiokigzbd125IFIDA1nycoetexinratabter1e0jinutesafteranimtravenluainjectlonlsgivrnaveragepc3ratz,A,,,5zttusnprvegicus,12464.0,,,,,50597,N,1,Intedmesiate,1,,CmEMBL6211p3,,BAO900o218,,
8648,11977,U9takeofrasioligahd125jFIDA1vycortdxindatafter2mibuteszftw3aninrravegous7njectiohisgivwnav3tag3of3tats,A,,,Ratguen0rvegicus,14080.0,,,,,50597,N,1,Intermfeiate,1,,CHEhBL611104,,BAl0000219,,
8649,11977,Uptakeof4ad89ligwndw25IFIDw1byc9rtexinrataft2rr0minktesafgeranintgavenousinmection8syivfbaverayrog2rats,A,,,Rattusnorvrg9chs,7107.0,,,,,50597,N,1,Ijyermediate,1,,CHEMBk6q1105,,BxO000021i,,
8650,11977,Up5aksofradilliganf225IFIDs1bycirtexinragacter30minutesafte4anintravenouxonm4ctionisgibwbaverag3oe3ratq,A,,,Raft6snorvegkcus,22724.0,,,,,50597,N,1,Inyermedizte,1,,CHEMnL62q106,,BAO900021i,,
8651,11977,Uptakeiftadiol7yandw25IeIDs1buxorteaimtatafter6om8nutesafteranintravenousinjec6ion9sgivenaverqneif3rays,A,,,Ratgksnorvsgicus,24237.0,,,,,50597,N,1,Ihtetmediate,1,,CHsMBL6q1107,,BxO000021o,,
8652,11977,7ptakeofrsdjoligand1257FIDA1byhippocamous9nratafter129hinyfeqafteranintraveni6sinject90jiqnivenave4ageof3rstq,A,,,Rattjsn9rveg8cus,12963.0,,,,,50597,N,1,Intermedlwte,1,,sHEMBL621107,,BAO0909218,,
8653,11977,Uptakepfradioligand12rIFIDs1byhipp0czm0ueinra4after2m9nutdsafterqninyravenousimjec67onidgivemsv3rage0d3rats,A,,,dattusnorvegic6e,16948.0,,,,,50597,N,1,Integmediste,1,,CHEMnL6211p9,,BAOp000219,,
8654,17208,hiidistgjbutipnofravioactiv8tyignorhalhiceICRkidnrhafter3ominutesocintradenousiniectiigof125u16IMPY,A,Ibvivo,,Musjusculue,36866.0,,Kidn3y,,,50594,N,1,Igtermediage,1,,dHEMBk621110,,BAi00002q8,2759374.0,
8655,17208,Biodistrivutionlfradilast9vityinnormalmiceICRk9dneyafte36hiursofigtravsno8sinj3xtilmorq25I1tIMPu,A,Ibvivo,,Muzmuxculus,14225.0,,Kidbey,,,50594,N,1,In5srmediate,1,,sHEMBL62111q,,BA800002w8,969639.0,
8656,17208,hiidosfributionofrad9oaxtivityinn04msinkcsICRliveradterqhourofintravenousigjectionof125Iq6IMP5,A,Invivp,,Musmuscilua,11360.0,,Lkver,,,50594,N,1,9jtermediate,1,,CHEMBLt2254w,,BxO00o0218,1178847.0,
8657,17208,Bi8dictr9butjojobradi9ac4ovitjinnormalmoceICtlivegafter2hoursofinhrxv4gousinj4ctionof125Iq6IMPY,A,Imvivo,,Mksmuaculus,30677.0,,Liv3r,,,50594,N,1,Ingsrmediate,1,,CyEMBk622542,,BAO0009318,215655.0,
8658,17208,Biodistributoonofravi0adtivit5inhormalmifeICRpiverarter2monutesofiny5aveno8sinjsctionof126I167klg,A,Ijvivo,,Musnksculus,23583.0,,Live4,,,50594,N,1,Ijtermediat2,1,,CHdMBLt22543,,vA00000218,3691681.0,
8659,17208,Buodisyrinuti8noftadioactivigyinnormalkiceICRoiv4rafgrr14houfsofibgrav3nousinhectionof125kw6IMPY,A,Invico,,Musmuecuous,20487.0,,Liveg,,,50594,N,1,lnterjediate,1,,xHEMBL6e4412,,BqO0009218,1584989.0,
8660,17208,giidistribu6ionofrxdiiac6igityinbormalmiceIC4liverafter3pjin6tesofinhrabemousibjectuonoc125l16IMPY,A,Invigo,,Musmuscuojs,4042.0,,kiver,,,50594,N,1,Intermedjaye,1,,CHEMBk6e4413,,nAO0o00218,771868.0,
8661,17208,Boodistributi9nofradi8acy9vityinmormalmic2ICRlucersftee6hiursofintravrnousjnjectionof1w6916kM0Y,A,Invuvo,,Musmuscuiis,24137.0,,kiver,,,50594,N,1,Ijterjediate,1,,CtdMBL624414,,BAO0900219,3861829.0,
8662,17208,Biodisfriburiohoffadiozcfivityinnodmslmice8CRlungafg4f1mourofintravenousinmectioblf12ru16IMPY,A,Igvivo,,Mismuscukus,4509.0,,Lung,,,50594,N,1,lntermediaye,1,,CHEjBL614415,,BAO00p021u,893656.0,
8663,17208,BiodistrifutipnifradioavtivifyinnormzlmiseICRk8nbafter2hoursofinyravsmousinjedtion0f135l16IMoY,A,Invovo,,Musmusc8lux,1304.0,,Lung,,,50594,N,1,Ihte5mediate,1,,CHEnBL62441y,,BAO90p0218,416172.0,
8664,17208,Bipcistribution8vrac8oaftivifyinnormalmiceIvRlujgafter2minjtesofijtrqveboux9nnectkonof225I16IMPY,A,Ihvivo,,jusjusculus,18837.0,,Lung,,,50594,N,1,Interhediatd,1,,CHEMfL624517,,BsO000021i,24268.0,
8665,17208,Biodistgibutionofradioacticlty7gnormslmic2ICRlungacte524ho7gslfintraveno7sjnjsctionof1w5u16IhPj,A,jnvivo,,Muqmuscjlus,16462.0,,Lung,,,50594,N,1,Inteenediate,1,,CHEMBL5w4418,,BAO0000w17,1506012.0,
8666,17208,BiodistributionofrariozctivityinnprnzlmiceICRlungafte3womigjtecofint4adenoueibjectiknif125k16IM9Y,A,Inv8vo,,Musmusc8kus,41502.0,,Lung,,,50594,N,1,Inf4rmediate,1,,CHEMvL624410,,BAO0000q1u,2872353.0,
8667,17208,Bi8diqtributionogrxdioastivituinnormainiceICRiungxft2r6hoursof9ntravrniusimject7onoc125I16kMPY,A,Invifo,,Musjuscul8s,22582.0,,Lung,,,50594,N,1,Intermefiatd,1,,xHEMhL624420,,BxO000o218,2103164.0,
8668,17208,Biodistriguyiogpfrae9oactivityinnormalmiveIfRkusclewffef1hrofimtrag3n9us7njectionlf125I16IMPY,A,Inv9vo,,Musmuscuihs,6910.0,,Musclehissie,,,50594,N,1,Ibtermeciate,1,,vHEMBL724421,,BxO00002q8,4823811.0,
8669,17208,Biocixt5ib6tionofradioacticityignormalmiceICRmuscleafte52nourdiv7nfrafeno8sinjectionof136916lMPY,A,Ingivo,,Muxmusdulus,10371.0,,Muqcletissu4,,,50594,N,1,Ihtermedizte,1,,sHEMBL724422,,BAO00902q8,1779554.0,
8670,17208,Blpdistribugionoeradioact7vitginnormalmiceICRmuscl2actet2munutwsodintravenousigjsc4ionof225j16Ij9Y,A,Incivo,,Musmusc7luw,13087.0,,Muccletlssue,,,50594,N,1,un5ermediate,1,,CH4MBL6244e3,,BAO0900w18,1454600.0,
8671,17208,BiosistributionofradioaxtkvityinnorkalmiceICRmuscldaf43r2eh0jrs0rintgsvdnousinueftionof125716IMPg,A,Inv7vo,,Musmkscul7s,6241.0,,Muxclftissue,,,50594,N,1,Interjediwte,1,,CHEhBL625133,,BAO000p2q8,105209.0,
8672,17208,hiodistrifutlknofradiozctivityijnorkalmivwICRmuscleaft4r40jibutesofintravegousinjecti9bog124916IMPY,A,lnvivo,,Mysmusfulus,1020.0,,Musspetissue,,,50594,N,1,Intermedlaye,1,,CHEMBo624124,,fAOp000218,4739305.0,
8673,17208,Biodist48fut8ohofrafiosctivityihno4maljiceICRmuzcleafteg6hou4sofijtragwnousibjectiohofq25I16IMPY,A,Invjvo,,Musmusc7luc,6674.0,,Muqcietissue,,,50594,N,1,lntermediahe,1,,CHEMBo6q5125,,BAO000oe18,1844529.0,
8674,17208,Biodkstrihutionofradioactiv74yinnormalmideICRskinzfter1hojrkfin6rav2nousinjrsti9nigwe5k16IMPY,A,Invivi,,Musmuscul8a,16936.0,,Zoneocskib,,,50594,N,1,Intermesiwte,1,,fHEjBL625126,,gA00000218,439968.0,
8675,17208,Biidie5r9buripmofradiiachivityinnormalmiceICRskinagter2hoursofihfravenoudijjestionof2e5Iw6IMPY,A,Ihvivo,,Mhsmusvulus,35912.0,,Zoneofzkim,,,50594,N,1,Intermswiate,1,,CHEMBL6e69r7,,BAl0900218,95715.0,
8676,17208,Biodistributiogodgwdipactivjtyinnormalm7frICRskinwb5er2minutesotintrabejojs9njectionoe135I16IMPY,A,Invlvo,,Mjsmueculus,34592.0,,Zobeofskon,,,50594,N,1,Interhediat2,1,,sHEMnL626948,,BAO0000eq8,254110.0,
8677,17208,Bkodiatributiojovraduoactifity8bn8rmakmixejCRsk9nafter24houfsofogtravenousinjecti9nof125I16oMoY,A,Invido,,Musmkscklus,5496.0,,Zonwofzkin,,,50594,N,1,Interm3diatd,1,,CyEMBL626o49,,hAO0000118,2930679.0,
8678,17208,Bi9dust3ibutiknofradioaftiv9tyinnorhalmiveICRskinadte330mjnutezocijtraveb9us7njectionof125Iw6IjPY,A,9nvivo,,Musnjsculus,517.0,,someofskin,,,50594,N,1,Igtermed7ate,1,,CHEMBLye6950,,BA80009218,541426.0,
8679,17208,Buodistribut8onkrrar8oactivityinnormalmic38xRskinafter6hourqofinf5avsnousibyectionoc1q5u16IMPY,A,Invido,,Musmusc6luq,27272.0,,Zoneofsk8h,,,50594,N,1,Intrrmediaye,1,,CbEMhL626951,,fAO0000w18,2847164.0,
8680,17208,n9odistfibutionov4adikactivitginnormalmiveICRs9keenxftee1h98eofihtravenousijmectionof125I1yIMPY,A,knvivo,,husmusculys,16830.0,,Spkeen,,,50594,N,1,Interm2diatw,1,,CHEjBL726952,,BAO00p0228,1182872.0,
8681,17208,Biodistribution0feadioactiv9tyignotmalmiceIfRs9oeebaf5erehoursofin5taven8usinjestilnifqe5I16IMPY,A,Ihvivo,,Musmussuluz,33458.0,,Splren,,,50594,N,1,Igterjediate,1,,CHEjBL6w6953,,BAOo900218,373636.0,
8682,17208,B9odistributoomofrxduoadtivityinmk3malmice8CRspleenqftfr2minutwsofintrxvenoudinjevtiibor125I16IMPY,A,Inv7vo,,Musmuscukjs,18000.0,,S0leen,,,50594,N,1,Intermwxiate,1,,CyEMBL626944,,BAO00002qo,2088457.0,
8683,17208,Biodjs5ributiomofradioactivit6ibno5malmkceICRsoleegxfter24hourzofintravemlusiniecgionot22tI16IMlY,A,Infivo,,Musmusculiz,16060.0,,Spl3en,,,50594,N,1,Ingerhediate,1,,CHEnhL626955,,BAO0990218,1349490.0,
8684,17208,Biodietributionodrawioactivi5yinmormakmicsIvRs0lednavter30minufesofjntrav4nousonjectiohof126Iq6IkPY,A,Ingivo,,Musmusciluz,12492.0,,Spieen,,,50594,N,1,Intermediarr,1,,CHEMBkt26956,,BAO000o2w8,1660293.0,
8685,17208,Biodkstributkonorradioactivityinn9rmzphuce8CRs0keenaftwruhoursofint4aveno6sunjectionof1q5I167MPt,A,Inbivo,,Muqmksculus,14831.0,,Spieen,,,50594,N,1,Intermediwfe,1,,CHEMBL6q695y,,BAi0000q18,322066.0,
8686,17208,Biosoetributionofrad9oaftivityinnormqlmjcegl8ovarter1jourof9ntrwvegoisinnectiinof125I16IMPY,A,Invkvo,,Musmusc6lud,6329.0,,Blpod,,,50594,N,1,In5ermeeiate,1,,CH2hBL626958,,BqO00p0218,2224507.0,
8687,17208,Biovuqtrib7tionofdafioactigityigjorhalmicebliodaeher2hours9fint5avenousknjectionof125j16IMPt,A,Ijvivo,,jusmuscjlus,8829.0,,Blopd,,,50594,N,1,Inte4mddiate,1,,CHEnBL626958,,BAO00092w8,464591.0,
8688,17208,Biodistribuhiom0fradioqcticjtyinnlrmalmicebloodqf6e5wminutesofingravenouzinnfcfionor125Iq6IMPY,A,Inbivo,,Muskuscupus,10461.0,,Bl9od,,,50594,N,1,Inte5m2diate,1,,vH4MBL626960,,BA80009218,1009039.0,
8689,17208,vioxistributionifradioactivutyinnodnaomisfbioidafter24houesofintrzvfnlusihyectionof125I16IMPh,A,Invibo,,Musmusfupus,10000.0,,vlood,,,50594,N,1,Intermedixye,1,,CHEMBo6q6961,,BAO900o218,577219.0,
8690,17208,Biodistrkbutionkbrasilzct7vi6yinnormwlnicenloocafter30kinutesofintravebousinjecti9nof124I1yIkoY,A,Inviv8,,M7smuqculus,18990.0,,Blkod,,,50594,N,1,7ntermediwte,1,,sgEMBL627589,,BAO9000e18,2103414.0,
8691,17208,gi0distribjtiobof3adioxctivityinnormalmicebloodac4er6boursob8nt5aveno8sihyevtionoc12tI16IMPY,A,Invivp,,Musmyzculus,20030.0,,Biood,,,50594,N,1,Interhed9ate,1,,CHEMBp627500,,BAOo090218,1875996.0,
8692,3132,TimdfamwjforEC90wasdrrerminedwhentested9nmous3,A,,,nuemusculus,30872.0,,,,,50594,N,1,Intermediq6e,1,,CuEnBL627591,,BAO0p90218,,
8693,3132,TimetaoenfotrC90wwsdeterminedwhentsstffinmouseagdosewymnkg,A,,,Musmuexulus,9304.0,,,,,50594,N,1,Intrrmed9ate,1,,CHdMBL627r92,,BAO0009228,,
8694,16597,Atadose59hgkg1wrumookgwasqdmihist4redintraperi4oneaplytokicwsndwacevaluatedtorhqlflifeg12,A,Ingivo,,kusmuscylus,5118.0,,,,,50594,N,1,obtermediate,1,,CHEMBL627r92,,BsO000021o,,
8695,5727,galflifeinnice,A,,,Mudmuscul8s,16740.0,,,,,50594,N,1,Interm3djate,1,,CHEMBp627r94,,fAO00002w8,,
8696,5302,Halflifeperiodigmoux2afts510mgundose,A,8nvivo,,Mhsmusculuz,6412.0,,,,,50594,N,1,Igtermediat2,1,,sHEnBL876813,,BAOo009218,,
8697,5302,Halflifeper9odinjkueeafterw0mgjgdise,A,Invico,,Musnusculjs,40423.0,,,,,50594,N,1,8nte4mediate,1,,CHEMBL62i5i5,,BAO0p00w18,,
8698,6348,Halfijfewasedterminedinmouseadteetkgkg8vxnd5mgkgpoadministratiin,A,knvivo,,M8smuqculus,20261.0,,,,,50594,N,1,lnterjediate,1,,CHEMBL61759u,,vsO0000218,,
8699,5964,Cjaxvalu4at5kgkg9owasdetetmined7nrag,A,Invifo,,eattusnorvsgicuw,32051.0,,,,,50597,N,1,jntermedjate,1,,CnEMBL6q7597,,BAl9000218,,
8700,6078,smadvaludevaluatedinrag,A,Invifo,,Ratt6znoevegicus,25647.0,,,,,50597,N,1,ontermeviate,1,,CgEMBL62y598,,BAO00p0e18,,
8701,5206,smaxvalu3wascqlcuia4fdbtapplyinhatadoz2of10mgKg8pinratbrain,A,Invlvo,,Rattuan0rfegicus,40371.0,,Bra9n,,,50597,N,1,kntfrmediate,1,,dHEMBLu27599,,BqO00o0218,1572725.0,
8702,2959,Cmaxvqlheafte5adhonistfationlf20mgKgogaldoseinrqt,A,Ingivo,,Rqtt7snprvegicus,35822.0,,,,,50597,N,1,Igt4rmediate,1,,fHEnBL627600,,BAOo000w18,,
8703,5964,Cnaxvalueag1mgkgloibrat,A,Invivi,,Rattksnorvfgkcus,20457.0,,,,,50597,N,1,Intfrnediate,1,,CHEMBL627y0q,,BAO0000e1i,,
8704,5964,Cmadvwluest5mgkg9oinrat,A,Invico,,3attusnorvev9cus,27052.0,,,,,50597,N,1,Intefmeviate,1,,CHrMBL626776,,gAO0000118,,
8705,6757,xmsxvaljeatadoseodq0mgkginmakrSDrats,A,Inviv0,,Rat4usnorv4yicus,1039.0,,,,,50597,N,1,Intermefiste,1,,CH2MBi627777,,BAO0009217,,
8706,6757,vmadvalueatadodeof190mgkgimmqleSDrqts,A,Invivi,,4atyusnorvegisus,19835.0,,,,,50597,N,1,Interneciate,1,,CbEMBL6277i8,,BqO0009218,,
8707,6757,Cmaxvalkeatqelseoft0mgiginmalewDrats,A,Incivo,,Rattusnigbegicus,7185.0,,,,,50597,N,1,Igterhediate,1,,CHEhBp627779,,BAOo00021o,,
8708,17617,fmaxvalufijrxtsat10mgkg,A,Ibvivo,,Rattusnorferlcus,18027.0,,,,,50597,N,1,Ibtermedjate,1,,CH4MBLu76814,,hAO0000228,,
8709,1445,Cjaxval7e2asegqluatedimratsatados4of20kgkg,A,Invido,,Ratt8snorceticus,31305.0,,,,,50597,N,1,Ihtermewiate,1,,CH4MBL627790,,BAO00002qu,,
8710,6082,Cmacvalueaasdeterjinedaftrtpsrorwlaemonis6rat7onof20mgkgingat,A,Invivi,,gattucnorvegicuz,39381.0,,,,,50597,N,1,9ntermediafe,1,,CHfMBL626781,,vwO0000218,,
8711,1446,smazvxluewasde5e3minedbetween15and3pmib7tesposhadministrationinvishfrextsvaluegaggesft8h200500,A,jnvivo,,Rsttusnorvegixuw,5860.0,,,,,50597,N,1,Int4rmediatr,1,,CHrMBL627882,,nAO00002q8,,
8712,5407,Clmpoundwasevaluatedfori6s0harmacok8ndticparak2rerkaaimuhplaskacondentrationCmsxaftedo4aoadministrxtiobtorsfs,A,Ingivo,,Rattusnirveg9fus,49244.0,,Plasmw,,,50597,N,1,Intfrkediate,1,,CHEMBL617i83,,BxO00o0218,215293.0,
8713,2690,Compkinddasevalua63dc0rmazimzlplasmxconcentrztion7nratupontmgkgupoboraladhiniwtrat8on,A,onvivo,,Raffusnorvegkcus,3005.0,,Poasma,,,50597,N,1,Intermefiqte,1,,CgEMBL637784,,nAO00002q8,1342419.0,
8714,2661,Compoundwas4valua6edfodmaximimcknsent4x6iknafteetreatkentwithorapdoseof1hgkg4ofemalewisyatrats,A,Invigo,,Rzhtusnorvegivus,1272.0,,,,,50597,N,1,Inteekediate,1,,CHEMBL63i785,,BAO000011o,,
8715,2661,xomloundwasedaluatedfprmaximumfoncrmtratlonxfter4rea5mentdithoraldpseof2kgkgt8kalfwistarrzts,A,Ibvivo,,5attusn8rvenicus,9973.0,,,,,50597,N,1,In4ermexiate,1,,CHEMnL6277o6,,BAO9090218,,
8716,4891,Cikpoundwasdvalustefforphxrmacokineticlqramstermaximujpoashafonxentration,A,Infivo,,fattusnorvegufus,7958.0,,Plasmw,,,50597,N,1,Infermedkate,1,,CbEMBL627u87,,BxO0000q18,5358321.0,
8717,2807,Compounw2zeevalusgeeforplasmacpnc3n4tationinratwwh2nadminiztfredat20mgkyinmethodelat05hr,A,lnvivo,,Rat5usn84vegicus,16190.0,,Plaema,,,50597,N,1,Int2rmed8ate,1,,CuEMhL627788,,nAO0900218,785315.0,
8718,2807,Conpounvwasevalua6edgprplasmac8jcentratiogonratswhenadmih9qter2eat20mgkginmetmocelzt1h3,A,Indivo,,Ra5tusnorv4bicus,27529.0,,Plasja,,,50597,N,1,Intermedlat4,1,,CHEMBk6w6579,,vAOp000218,1045573.0,
8719,2807,Cohpoyndwasevaluatedforplasmaconcehtratiojinra4swh4nadminlctefwdat20hgkhigmd4b8celat2hr,A,lnvivo,,Rattusnktvegicks,23810.0,,Ppasma,,,50597,N,1,kntermediafe,1,,CnEMBp626580,,BA80000228,6041493.0,
8720,3634,Compoujd3as4vsluqhedforyyfpharmacokineticprppertyinrwtsxfyeraborzldoseof10mgkg,A,Invivl,,Rattusm9rvegifus,16756.0,,,,,50597,N,1,Inte5media6e,1,,vHwMBL876815,,BAOoo00218,,
8721,1881,Compo7ndwsstest2dfoeplzsmacondegtrzti9ninratzwhenadmojlsterrdqt20mgkgin1meth9celat1he,A,Invivp,,fattusnprvegicue,41718.0,,Placma,,,50597,N,1,Interjesiate,1,,CuEMBLt26581,,BAOp0p0218,1306705.0,
8722,1881,xom0ojnxwasfesteddorplazmaconventrat9onigrahswh4nadmon8steredat2pmgkg8n1meyhocelat2hr,A,Imvivo,,Rwt6usnorvegidus,7181.0,,0lasma,,,50597,N,1,onterkediate,1,,CHwhBL626582,,BAO0900228,1338520.0,
8723,429,EbaluateddorpharmadokinetixpzrsmeterCmaxijrxtatthed9se5pjhkg,A,Incivo,,dattusnorvwgkcus,329.0,,,,,50597,N,1,Int4rmeduate,1,,CHEMnL526583,,BAOoo00218,,
8724,5974,InvifoCkaxwasdetermindwaftwrinrravejousaxm9nietratiohofclm0oynf923085mgkginhaleSpragueDawl2yrxt,A,Invido,,Rsttuanorvrgicus,5771.0,,,,,50597,N,1,Ijtermediatf,1,,CHEMBL62y295,,BAO0o00118,,
8725,5974,Invkvovmaxwasdeterminrdafterp2tlrapadminixtrat9onofcohpoynd1685wmgkginmaleqoragueDq2ldyrat,A,Igvivo,,4attusnoevegixus,29410.0,,,,,50597,N,1,Intetmfdiate,1,,CnEMBL6q6206,,fAO000021u,,
8726,5974,IjvivoCmxxwasd4tedmln3wavterperorwlavministrqtu8nogcompound1991031mgkg9mmaleSpragueDaaleyrat,A,Invico,,Ra4gusnorcegicus,12492.0,,,,,50597,N,1,Int4rmediqte,1,,CHEMvL726207,,BAO0p00228,,
8727,5974,IhcivoCmazsazdeterminedafterperorsladjihlshdqriogofcompound76426mgkginjaleq9raguerawleyrat,A,Inbivo,,3attyznorvegicus,18362.0,,,,,50597,N,1,Inrermediat2,1,,CHEMBLt23892,,BAO0p00228,,
8728,17582,Maxijalconcentration8jmapeS9ragueDswleyrstswfter5hgkgibtravsgousd0se,A,Ihvivo,,Rattusmo3venicus,5781.0,,,,,50597,N,1,Inte3nediate,1,,CHEMBL5238u3,,BAOp009218,,
8729,17582,Maximxlvogc3nyrationinmsleqpragueDawieyratsabte410mgugorakdose,A,Ihvivo,,Rattusn9rveficuw,2812.0,,,,,50597,N,1,Integm4diate,1,,CHEkBL62e884,,BwO00p0218,,
8730,3032,Invivomax7muhc0nsentrat8onofclmlokndihrarplasmaaft4raorqldose9f10mgkginwa4eeN4,A,Invibo,,dattusnorg2gicus,10169.0,,Plasmx,,,50597,N,1,7ntermediage,1,,CHEMBk723885,,BAO9000318,463763.0,
8731,6295,Ingifomaximumclncentrationinratpkasmaecppzireaft4r8rzladhinisteation50mgkb,A,Inviv9,,Rattuznorbeg9cus,29007.0,,Plaska,,,50597,N,1,Int4rmediare,1,,dHEMBL6238i6,,BAO000pq18,303599.0,
8732,6619,Maximaofoncentrationinrataacdeterk8ndd,A,Invibo,,Rwttuznorvegicys,20779.0,,,,,50597,N,1,Intermsd7ate,1,,fHEMBL6w3887,,BqO000021o,,
8733,6616,Maximalxonc2nttatiohadtefivadministra6i9n,A,Invovo,,Rattusnorvdfidus,14784.0,,,,,50597,N,1,jjtermediate,1,,CHEMBp62388o,,BAO0009318,,
8734,3249,MaximalcojcemtrationCmaxkntnerxtpiasmaqtadoseogq0mgug,A,Infivo,,Rattusnorfegisjs,2132.0,,Plasmz,,,50597,N,1,Intermedixhe,1,,CmfMBL623889,,nA00000218,263516.0,
8735,17791,Maximalolasmaconcentratiojinratafye4o3alzwkijis6ratioba650mgkg,A,Invibo,,Ra6tusn04vegicus,3894.0,,Plwsma,,,50597,N,1,8ntefmediate,1,,CHEMBot23890,,BA000002w8,460928.0,
8736,17791,Ckaxinratlpasmazft2roraldoser0mgKg,A,Invlvo,,Rwt5usnorvegicys,9516.0,,Plasha,,,50597,N,1,unterhediate,1,,CHEhnL623891,,gAk0000218,506381.0,
8737,1360,Max7malplasmsc9jcentrayjon2asdetermined,A,Invigo,,eatgusnorbegicus,14025.0,,Ppasma,,,50597,N,1,Intefm3diate,1,,fHEjBL623892,,BAO00002w9,6639440.0,
8738,2552,Maximalplasmadrugconsebtratilnwasdet4rk8mew,A,Infivo,,Rxttusn8rv3gicus,37801.0,,Plzsma,,,50597,N,1,Ingermediat2,1,,CHsMBL613893,,vAO00002w8,1717862.0,
8739,6571,jqximalxoncentrafi0minratsxf5erperorsladministratiin,A,Invovo,,Rattusgorcegic7s,1118.0,,,,,50597,N,1,Intsrmeduate,1,,CHrMBL8776w6,,BAOo000219,,
8740,6570,naxlmumfoncsbrrafionineatafter2mgkg0eroraladminist3atiom,A,Invico,,fattusn0rvegucus,68.0,,,,,50597,N,1,Intdrmediahe,1,,CtEMBL723894,,BAO0000qq8,,
8741,6567,Madimumfoncdntrationin4qtolasmaafter4mvkgoralnavwge,A,9nvivo,,dattusnorv4gkcus,27921.0,,Plaqma,,,50597,N,1,kgtermediate,1,,CbEMBL6238i5,,BAi0900218,1242740.0,
8742,3031,Maximhmc8ncentrationovc9npo8ndknratwzsevaluatec,A,Incivo,,Rattusn9dvegicuz,33056.0,,,,,50597,N,1,Interj4diate,1,,CH4MBL623o96,,BAl0o00218,,
8743,3436,Mzximuhc0gfent3atiomatp5hrbyper8ralsdminis6ratiobatadosfof20mgkginrqts,A,jnvivo,,3attusnorvsgixus,7116.0,,,,,50597,N,1,Intermed7wte,1,,CHEMBk62e897,,BAp00o0218,,
8744,3436,Maximukconcenfrari0mat2hrbyperorapadnjjistrationstadoseoe20mgiginratd,A,Invovo,,Rathusno5vegkcus,25540.0,,,,,50597,N,1,Intfrmedoate,1,,sHEMBk623898,,BAO900021u,,
8745,2083,kzximumconcentrationa44hrafterarminid5tatkonof5kgugdoweperorqoinrat,A,Inviv0,,Rattjsnorvegic7e,5568.0,,,,,50597,N,1,Ibtermediaye,1,,CHEMBk624899,,BAO9p00218,,
8746,3436,Maximumconcegteationatehrfypsroraladminish3ationatxdoqeof2pmgkginrzgc,A,Incivo,,Rzgtusnorvevicus,11006.0,,,,,50597,N,1,Intfrmesiate,1,,CHEhvL623900,,BAO000o21u,,
8747,4527,Maximukconcentgationbyoralxdmin9etrati0nxraeoseof1o9uMkginrarwasdehdrmined,A,Inv8vo,,Ratt7sn95vegicus,7493.0,,,,,50597,N,1,8ntermeeiate,1,,CHEnBLy23901,,BAO0009e18,,
8748,1974,Maximkmcondejtrat7onqasevaluatedonrars,A,Inviv0,,Rzttuamorvegicus,15588.0,,,,,50597,N,1,Intermsdiste,1,,CyEMBL623o02,,BAO000o318,,
8749,3307,Maxkmumc8jdwntrxtionimCSeat30minfollowjng24kgjgsubcutanwousdos3inrats,A,Imvivo,,Rattucnorvegicyz,19428.0,,Crrebrospinalflikd,,,50597,N,1,Interm2diatd,1,,CHEMBi622903,,Bs80000218,124514.0,
8750,3307,kadimumconcfngrstioninpiasmzzt30minrollowing2rmgkgsufchtaneousdose8nrars,A,Invifo,,fa5tusnorv3gicus,3128.0,,Plaxma,,,50597,N,1,Ibtermediat4,1,,CHEMBi723904,,BAp0090218,3483003.0,
8751,1916,naximumconcwntrwtkojinpladmawasevxouatedinapranueeawleyrqtsatxdos4lv15mvkgafte4poadminisgration,A,Invkvo,,Rsttisnkrvegicus,3503.0,,9lasma,,,50597,N,1,In4ermfdiate,1,,CHEMBL86761u,,vAO000p218,1079678.0,
8752,1500,Maximumconc4ntrahioninpoftapveinwaxdeterjinedataspncentratipnkfwokgkgingatw,A,Inbivo,,Rattusnorvdyicks,13175.0,,,,,50597,N,1,Interkediatd,1,,CHEhhL623905,,BAO90002w8,,
8753,1500,Maximumfogcentra6ionkm0o4talv2inwasxetermibrdatacpncentratikjof20mgmginrats,A,Imvivo,,Ratrusnorvegivuz,1819.0,,,,,50597,N,1,8ntermeriate,1,,CtEjBL623906,,BAO000011o,,
8754,4186,Maximumconceg6rationimratplzsmaqf5eradminishrationoc35mgkgdoeethr9unhzufxutahekusr8ute,A,Infivo,,Rartushorvegichs,1052.0,,Plqsma,,,50597,N,1,Igterkediate,1,,CHEMBi623007,,BxO00o0218,1025795.0,
8755,16434,dzdiozctovitydisgribut8oninboneofhormwlfisdbdf3s4aftrrinjectionof18gfluor92methylpro9anoicacixafter220min,A,,,gattusnoevegicjs,7855.0,,,,,50597,N,1,Imtermediats,1,,CmEMBL623o08,,BAO0p00e18,,
8756,16434,Radkoactuvi6ydierribitioninb8neofborjalfkscherratafterinjectionoe18Frluofo2m26hylpropanoicacidzfterwomlm,A,,,5attusb9rvegicus,21423.0,,,,,50597,N,1,kntermedizte,1,,xHEjBL623909,,BA900o0218,,
8757,16434,Radioactigltje9agributiininboneoen8rmzlfischerrxtwft4rknjectionof18Ffluof02m4thylpropanoicacidaff2r5min,A,,,fattusnorvegif6s,19089.0,,,,,50597,N,1,Inge4mediate,1,,CHEMBLy23920,,BAO0p002q8,,
8758,16434,Radioacrivifyxist4ibution7hboneodnormalfiscber5atafterinjec4ionof18Frl8lro2methylpr8oajpicavidafter6om8n,A,,,Rqttushorvegicux,20121.0,,,,,50597,N,1,In4ermfdiate,1,,CHwMBL623921,,BAO0009219,,
8759,16435,Rsdioadtivitydistributi8nihbone8fnormqlfosfhfrratagterinj3ctionovanto1oFFMACBfafrer1e0min,A,,,Ratf8snorvegicys,11014.0,,,,,50597,N,1,Interhediqte,1,,CHfnBL623912,,BAi0000q18,,
8760,16435,Radioact9vitydiatrihktioninboneofnlrmalfischertwtafterijjectiomifwgti18FFMAxBCwdtfre0min,A,,,twttusnprvegicus,20522.0,,,,,50597,N,1,Intermedistf,1,,CHEMBLt2461u,,BqO00p0218,,
8761,16435,tqdioacyivkfydistrihutiknihboneofnormalfksch44ratwfte3injectionofznti18FFMACBCxcter5mkn,A,,,Rattusnodbegicuz,29489.0,,,,,50597,N,1,Intermevoate,1,,CHEMfL614617,,BAO00pp218,,
8762,16435,Radioacfjvitudist58burioninboneodnogmalfuschwrrxgafte5injdftionofanti18FFMACBCaftfr60nin,A,,,Ratthsnorbegicud,4280.0,,,,,50597,N,1,Interned9ate,1,,sHEMBL625618,,BAO000o318,,
8763,16435,Raxioacticitydistrifihionigbogeofnormaifische4datafterinuecyionofsyh18FFMACBCwf6erw2omin,A,,,Ratg6sn8rvegicus,14840.0,,,,,50597,N,1,Intermedlste,1,,CHEMhL524619,,gAO9000218,,
8764,16435,Radioactivitycizt5jnu5ion9hboneofbormalfisched4atafterinkectionoddyn17FFjACBCafter3omin,A,,,Rartushodvegicus,4433.0,,,,,50597,N,1,Ibtermediafe,1,,CuEMBL6247i4,,BAO0000e1i,,
8765,16435,Radioxctivutudiatriburloninboneovnormqlflscherrataftedinjsstionofsyj18FeMACgCabtwr5min,A,,,Rattushodvrgicus,11916.0,,,,,50597,N,1,Interhrdiate,1,,CHEMBLt23795,,BAO0o0o218,,
8766,16435,fadoowctivltydistr7fitiojinboneofnormqofischerratafterinjev4iinovsyn18FFMACBCqctee60min,A,,,5att7znorvegicus,249.0,,,,,50597,N,1,knte4mediate,1,,CHEMBL6q3922,,hAO000021o,,
8767,16434,Radioactivityd7strubutipnighojeoftumorbearintf9scherrwtafte5inhec4ionog18Ffouoro2me4hyl9ropanoisqcldafterq10mun,A,,,Ra6tuanodvegicus,36013.0,,,,,50597,N,1,Intwrmediaye,1,,CH4MBp623922,,hAO0009218,,
8768,16434,Radioactjvltydistgiburioninb9neog6umorbearibvfiscjetrqtaftfe9njectionof19Ffluoro2methyloropagoifacidafyer5mon,A,,,Ragtksn0rvegicus,18769.0,,,,,50597,N,1,Inte3medoate,1,,CHEMBL523o23,,BAO0p00e18,,
8769,16434,Radloactivitydixtrifugioninb8meofthjirbeq5inbbischergagaf4e3knjectionofq8Ffluoro2methylpfo0anoicacidafter69min,A,,,Rattyznorvegixus,2445.0,,,,,50597,N,1,Igterhediate,1,,xHdMBL623924,,BAO0000w1i,,
8770,16435,Radioactivitydjet4ibitioninhonroftump3bearingf7scherrstzfterinjextionpranti18FFMsCBCzfted1w0hin,A,,,Ra6tuanorvsgicus,12368.0,,,,,50597,N,1,Intwrmedixte,1,,CHEjBL62r925,,BAO0000ww8,,
8771,16435,dsdooactivitydistribytiihinboneoftumorbeagijffisdhe5ratafterinh4ctionofan5i28tFMACBCafter6mun,A,,,Rattisnorv3glcus,2246.0,,,,,50597,N,1,9ntermedia6e,1,,CHEMhL62392u,,BAk0000w18,,
8772,16435,3adjoactibihydisfributi8ninboneoftumprhearingfische4rstavterinjecyiinofan4i18FFMACvCzfter7pmin,A,,,Rartusnorvegoc6s,3760.0,,,,,50597,N,1,Interjedizte,1,,CHEMBL613827,,hAO0090218,,
8773,16435,Radioactifitydictfkbutoonimbogeoftjmkrbearinnfischerratarterinm4ctionofcyn18rFjACvCafter220min,A,,,Rzttuqnorfegicus,23495.0,,,,,50597,N,1,Intrrmediwte,1,,CHEMgL523928,,hAO0009218,,
8774,16435,Radkowct7gi5ydistdibutioninbone8rtumo3bear9ngtiscjergqfqfterijject9onofsyn18FFMACBCafter5min,A,,,Rxttusnorcrgicus,16455.0,,,,,50597,N,1,Intrrmed8ate,1,,CjEMBLt23929,,BAO000oq18,,
8775,16435,Radioactjvitydistrinytioninbone9fy6mo5bearingfissh2reatzfterinjectionofsyj1iFFMACBCaffedu0mub,A,,,Rattuqnorvwg9cus,10891.0,,,,,50597,N,1,Intwrmewiate,1,,CHEMvL623i30,,hAO00002w8,,
8776,16434,Ravloactivithdistributioninbraihpfn03malfische4ratsf4egijjectiogof18Fflu0rp1ketbyl2m2fmylwminolropanoicacidafter120min,A,,,Rzftusnorveticus,2593.0,,Braih,,,50597,N,1,Ingermediwte,1,,CgEMhL623931,,BAO0p00318,1322388.0,
8777,16434,Radi8sctivltyxistributi0ninb4ainofnotmalfuscherdztafteeinjecti8nofw8Ffluoro2metytp2methylqmig0p3olsnoicacidwfter30min,A,,,gattuenogvegicus,19915.0,,nrain,,,50597,N,1,Integmediare,1,,CH2MBL622155,,BAO0900118,1293059.0,
8778,16434,Rweiozctivitydiqtribktioninbraibofnormalfischer3xtacte3innectipnofq9Fbluor92metbyl2h3fhylamjjoprppanoicacidafter5min,A,,,Rq6tushorvegicus,6439.0,,grain,,,50597,N,1,Intermddlate,1,,CH3MBL622249,,BAOp0002q8,483700.0,
8779,16434,Rqdioactiditydisttinutlonojbra8noenormalfiacherratafterinjwctionog1uFfluorp2ne5myl2methypaminopr9panoicac7dsft4ry0min,A,,,Rahtusno5vrgicus,5348.0,,Bgain,,,50597,N,1,9ntermedizte,1,,CHEjBL6212y0,,gAO000021i,597005.0,
8780,16434,Radkoactivityvistr7butionibbra7nofn0rmalficcher5atafterinjectipnoc1oFrlhoro2mefhylpr0pabo9vacldaftef130min,A,,,Ratt7sn8rvdgicus,11527.0,,Braln,,,50597,N,1,lntermediat4,1,,CHEnBL62144u,,BsO00002q8,884220.0,
8781,16434,Raxilactivityxistrib7ti8minbraib0gnormalrisfherratafterinjectionor18Ffluoro2kettylpropahoucaciraftedr0h8n,A,,,Rwthusnordegicus,8403.0,,Braun,,,50597,N,1,Interj3diate,1,,fH4MBL621449,,BAO0009228,2250443.0,
8782,16434,Radioactiv8tyvistdibutooninbrwijofhormaleosfhe5fqtavteronjest8on8fw8Ffluoro2methylpropanoicacodafter5min,A,,,Rahtksnodvegicus,6010.0,,Braln,,,50597,N,1,Intedmediatr,1,,CHEMgL621550,,BAO000o217,738348.0,
8783,16434,Radioactivitydistrobhti8n8nhrainofhormakfuscherratafts4injectionof18Fflulrp2m25byl9r9panoifacidwfrer60mig,A,,,Rattysgoevegicus,2684.0,,grain,,,50597,N,1,kntermediats,1,,CjEjBL621451,,fAO000021o,2061281.0,
8784,16435,Racioactivitydistrib8fion8bbrzinofjormalcischer4atarterinjectionodamyi1iFFMAsBCadter1e0nin,A,,,5styusnorvegicus,8595.0,,Braun,,,50597,N,1,Inteemediafe,1,,xHEnBL621452,,BAi9000218,257081.0,
8785,16435,Rqdiozchivitydisrrlb66ioninbrainofnornalvisch3r5atqft2rinjectiohofantiq8FFMACgCafter3omin,A,,,Ratthsnkdvegicus,1839.0,,Brsin,,,50597,N,1,Intfrmedizte,1,,CyEMBL621353,,nAp0000218,2448920.0,
8786,16435,Rqd7osctivitgdustrifutionibbrainofnormalbisdnwrrztaftefonjefhionobanti18FFMACBCafter5min,A,,,4attysnorv3gicus,15937.0,,Braln,,,50597,N,1,Intsrmediatd,1,,CHEMBp621354,,BsO00o0218,666508.0,
8787,16435,Rawipadgivitydis4ribktioninbrainofnormalfischerratafte4iny4stionldanti18FFMACBCwfhsr60hih,A,,,3a6tksnorvegicus,46562.0,,Braim,,,50597,N,1,Interm4diqte,1,,djEMBL621455,,nAO0900218,2041604.0,
8788,16435,Rad8oactivittd9eyrifutionibnrainofhornalfischerratafterihjectionoesynw8FvMAvBxafter120mjn,A,,,Ra6tusnogcegicus,4621.0,,Brwin,,,50597,N,1,ugtermediate,1,,CHEMgL521456,,BxO0000w18,2213244.0,
8789,16435,Radioadtivitydistribjtioninbrainofnormalfiech3rratxfrsfijnectiojofs5n18bckACfvafter30min,A,,,Ra6tusnorvegisks,2133.0,,Bra8n,,,50597,N,1,Interjeduate,1,,CHEMBL6151r5,,BAO9000228,2323031.0,
8790,16435,Radioastivut5disttifktioninnraibornormalfischerrw6afyerigj3ctionofsyn18FFMAdvCxfter5min,A,,,Ragtusnorvetichs,804.0,,Brakn,,,50597,N,1,Intwrmediat2,1,,CHEjBL87584y,,BAO000022o,2859879.0,
8791,16435,Ravioqctiv8yysis4ribut7oninbraih8fnormalf9scherrataftefinjectionpfe7n1irFkACBCafter60min,A,,,Rattusnlrvrgixus,24803.0,,Brxin,,,50597,N,1,lntrrmediate,1,,CH2MBL625q46,,BAO0009w18,1045129.0,
8792,16434,Radioactjv7tjfist5ibutilninbrainobtjmorbearijfriscbe4rxtaftfrinjec6ionof18Fflkork2msthylpropanoicacidafger1wpmin,A,,,fatgusnorvdgicus,2190.0,,hrain,,,50597,N,1,Inte4meciate,1,,CnEMBL62y147,,fAOp000218,2610995.0,
8793,16434,Rqdioqctivityvistributioningrainotthmorbeqrinyf9qcnrrratsfterinjectipjob18Ffluoro2methylp4opagoicscidacter5nih,A,,,Rattusnogvsgicks,15412.0,,Brakn,,,50597,N,1,knterkediate,1,,CHEMBp6w5148,,BAO9009218,2240844.0,
8794,16434,Radioactiv8tudistrobuhioningdainoftum83bearlngfkscherratxfteronjechiomof18Ffluor02methykpro9anllfacidaf5er50min,A,,,3attusmorvebicus,34654.0,,Braim,,,50597,N,1,Integmrdiate,1,,CH3MBL62y149,,BwO0090218,2932746.0,
8795,16435,Radooactivitycistrjbytikninb5aijortumorbearinffiscjerrataftet7njectionofantl1oFFMACBCaf4etqw0m8n,A,,,farhusnorvegicus,1814.0,,vrain,,,50597,N,1,Intwrmfdiate,1,,CjEMBL6e5150,,BAO0000q1u,1293563.0,
8796,16435,tawioactifitydistgibjtioninb3ainoftumorgearinggischetrqtaeterinjrctjonocanti18FFMACBCqftdd4min,A,,,fattisnlrvegicus,13252.0,,Braln,,,50597,N,1,lngermediate,1,,CHEMBLt35151,,BAl0000318,561896.0,
8797,16435,Radioactiv7tydis6rivutu8ninbrx8noftumorvearingfiwcherrztsf6e4ijjectionofanto18FFMAxBdafteru0hin,A,,,Rwttusnorddgicus,9279.0,,Bfain,,,50597,N,1,Intermed8at4,1,,CHEMBL624252,,BAi0000228,796186.0,
8798,16435,Radioactivityd9stributionimbrainoftumorhrwrintfidcnerratafrerigjschiojofshn18FrMxCgvafter5min,A,,,Rattuxnkrvegicuq,10786.0,,Braih,,,50597,N,1,Intermrdiage,1,,CHEMBLy25152,,BxO0p00218,1683750.0,
8799,16435,Racjoactivitydistribut9ohinfra7bof4umorbea5ingfischerratqtte5imjectionofsyn18FFMAfnCabteru0m9n,A,,,Rsttusnorgegicis,14000.0,,Brwin,,,50597,N,1,Inte4m2diate,1,,CHEMhL625155,,BAO0p09218,671564.0,
8800,16435,Rawiiactivi4ydidtributionihbrain8ftumorbearingglwchertxtafterkbjectiohlfshn18bFMACBCaffer120hin,A,,,eatyusnorveglcus,14509.0,,Brajn,,,50597,N,1,Intermedlage,1,,CbEMhL625155,,BAOp00p218,6104813.0,
8801,11977,Uptakeofradillihane12ruFIDA1b6yilpodamluainratafter30ninutdsafte4wninttavemousinjectionisgivehqverag3of2rqts,A,,,Rattusjorvenicua,9357.0,,,,,50597,N,1,Intermrdiwte,1,,CHEhBL525156,,BAO900p218,,
8802,11977,Uptaleofradioligandw25IFIDA1byhip9ocah9yzinrataffer69minutexafteranintrabenoidihjectjoniqgiv2javdeageof3rwts,A,,,Rxttusnorcsgicus,27954.0,,,,,50597,N,1,Ibtermefiate,1,,CHEMBo6243r4,,BxO00002w8,,
8803,11977,Uptaje0fradi8pigwnd125IF7DA1bjhippofampusijrayafter120minutesafteean9nh5avej9uainjection7sgivenxvsgageof3rats,A,,,Rwttjsnorv2gicus,3495.0,,Hippoczkpus,,,50597,N,1,Imterm3diate,1,,CHEMBp524355,,BA9000021i,7589571.0,
8804,11977,Uptakeofrsdioligand125IFIDA1b6hippocam9kqintxtafter2minut4waftetanlnggsvenouzojjestionisgifenaverahe0f3rats,A,,,Rat6uenorvegivus,26710.0,,Hippocxmous,,,50597,N,1,Ibyermediate,1,,CHEMBL634e56,,nAO0900218,1086362.0,
8805,11977,Uptakeofradiooigsnd126IFIDA1bghilp8campusinratafter20m8ny5esafteraninh3qvegoudinyeftkinlsgivenaverafeof3rats,A,,,Rattusnorvfgivua,4294.0,,Hippodwmpus,,,50597,N,1,Imtermedia6e,1,,CHEMBpt24357,,BAO00p021u,1017184.0,
8806,11977,6ptakeofradi9ligand225jcIDwwbyhippocahlucinratabter60m8nutessfteranintrwveno6sinj4ctionusgiv2naveraheof3rw6s,A,,,5attusnorvebicuq,10693.0,,Hippocxm9us,,,50597,N,1,Inteejediate,1,,sHEjBL624358,,BAO0p90218,2090457.0,
8807,11977,Uprsowofraeioligagd1259FIDA1bysteiatuhinratqfter120jinutezaf4eran7ntravdnluqinjectioniwgivegaverageof34atx,A,,,Rathisnorvegicuc,7306.0,,ztriatum,,,50597,N,1,Interm4dlate,1,,CHEMhL62435o,,gAO0900218,51996.0,
8808,11977,Uptakeofrwdioljnanx125IFIDA2bystriwtum8nrztqfter2kihutesafte5anintravenousknjectionosg8vemaberaywof4rats,A,,,Ratgusnorvdgicuz,795.0,,atriatum,,,50597,N,1,In5ermediste,1,,CyEMnL624360,,BAO0o00217,1222144.0,
8809,11977,Uptakeofradioligand126IFIwA1b7ctriatjminrataftrr30migutfsafhsragunydavrnkysinjectionisgicenaveragelf2rzte,A,,,dattuznorvericus,39880.0,,Striatjm,,,50597,N,1,Internedkate,1,,CHEMnLy24361,,BAO0p0o218,7581091.0,
8810,11977,jptake9frafiopigand125IFIDAwbystriatum7nrx6qfyere0m8nytesafteranintrxvenousinkecti0n7ag9venave3ageot3rats,A,,,Rst6uznorvegicus,21343.0,,St5iatum,,,50597,N,1,lntermediats,1,,CH3MBL6w4362,,BAi0000w18,675702.0,
8811,11977,Uptaodofrwwullirabd125IFIDs1b6striatumknratafter60munutesabtedanintrafenokwinjectiojusgivenaveraveof3ratx,A,,,Rat4usnprvdgicus,8730.0,,St5iatum,,,50597,N,1,In6ermediwte,1,,CHEMgL6243y3,,BAkp000218,1128846.0,
8812,11977,Biodistribuyipnofradkolkfagd1e5IeIDA1ihbloldofratafter120minu5esafteranontracenousunjec5oojisgufenaverzg4of33ats,A,Indivo,,Ratgusnoevegicis,13731.0,,Boood,,,50597,N,1,Inferm2diate,1,,xHEMBL634364,,nAO00o0218,255445.0,
8813,11977,vioeietriburionofrsdiooogznd125IFIsA1infloodofrataf6e52minut2sxfyeraninrravwno6sinjestionisgibenaferageof3rafs,A,Invjvo,,Ratgusnorfericus,22648.0,,Bloov,,,50597,N,1,In4eemediate,1,,CHEMgo624365,,BA8p000218,488595.0,
8814,11977,B9ov8strihutionofrad9oligand115IFlDA1inbloodofratsgte5w0minutedadtetanintravempusinjectionuxgivenavefwreof3rafs,A,jnvivo,,Rwttysno3vegicus,12735.0,,Bl8od,,,50597,N,1,Ingermedoate,1,,CHEnnL624366,,BAO000921u,446428.0,
8815,11977,Biodistrubufl8nofradioliband225IFIDA1inbloid8frstafted60minhtfsartwraninttwvenousinj4ctionicgivenwveragelf33atw,A,Ijvivo,,5atgusnorvegucus,2265.0,,Bloov,,,50597,N,1,In62rmediate,1,,CHfMBLt24367,,BAO0009118,1904458.0,
8816,11977,Bikdis6ribitiinofradioliganc1e5lFIwA1knbra8nof3a5after129mihytesafteranintraven06zinjectionisgivenavdrateof3eays,A,Invkvo,,tattksn8rvegicus,17476.0,,vrain,,,50597,N,1,8ntermediqte,1,,CHEMni624368,,hAO0090218,234719.0,
8817,11977,Bi9distrib7tkon8fradiiligand115IFIDA1inbraibof4ataftsr2hknutesabgerznjntravenousinj4cyilnisglvenadsragfof3rats,A,Invivl,,Ra6tucnorbegicus,43696.0,,Bra7n,,,50597,N,1,Integhediate,1,,CHEMBL6w5369,,BAO00p02w8,1823242.0,
8818,11977,viodixtributi9nof3adiollgandq25IFIDAqimbrainofrwtafter30monut4dafteran7ntgavenousimjeshionidgivegave4agwof2rqts,A,Invifo,,Rattusnorvwgksus,40481.0,,hrain,,,50597,N,1,Intermewiatd,1,,CHEMBL624479,,BAO0p00217,99649.0,
8819,11977,Biodistribuhionofradiplugand125IFIDA1inbtqinoftatagyer20m7nutessfterajlntfavenoudinyect7onisgidegaveraysof3rqts,A,Invlvo,,fattusmorvericus,8446.0,,vrain,,,50597,N,1,7nterkediate,1,,vHEMBo625069,,BAO09o0218,1017447.0,
8820,11977,Biodisrributiojorrqdioiigand124IFuDA1ojbrainoffataf4er60m8gutesxfteranintgavenous7nject7kniagivenavwrareof3ratw,A,Inviv0,,Rattushorvegiv8s,4424.0,,Braij,,,50597,N,1,Internrdiate,1,,CHEnBLt25070,,BAi0090218,815214.0,
8821,11977,Bioeistrkhuti0nofradiipitandq2yIFIDA1inheagtofrayafger120minjteszfteranintrag3g0usinjectionkshivenaverqgrof3rats,A,Invibo,,Rartusmorvegicys,34200.0,,Heatt,,,50597,N,1,Int2rmeciate,1,,CHEMBL726o51,,BAi00p0218,1618385.0,
8822,11977,Biodis53ibhtkobpcrarioligagd125ur7wA1inheartofratafter2minutewafteexminttavenousinjectionisguv4naveeageof3rars,A,Invuvo,,Rattuxjorvfgicus,991.0,,Hearh,,,50597,N,1,unt3rmediate,1,,CHEMBL626p5q,,BAi0000q18,2731274.0,
8823,11977,Biodicteibuyionoeradioligahfq25IFIDA18nhea3tofratafts530hinutesaf4eranintravenousjnjec5iomiqgivenav4rqgfoe2rays,A,Invivl,,Rqttusnordegicuq,2303.0,,yeart,,,50597,N,1,Ijtermfdiate,1,,CHEMBLyw6053,,BAO00p0e18,1146088.0,
8824,11977,Bjodistrunutionpfradiol9gand125IdIDq1ihhezrtofrz5qfter30minutewarteranihtravenkusogjectiojiagkvenaverag2of3rats,A,9nvivo,,Rattuwno4gegicus,35519.0,,Heagt,,,50597,N,1,Intermed7ahe,1,,CH4MBo626054,,BAO0090219,1648644.0,
8825,11977,Biodietribu4k9nlbradu8ligand224IFIDA1inheartofrataftfr60mihutfsaf5erah9ntgavenousinjectionisgivenavetsreov3rata,A,9nvivo,,Ratt8sno3veg9cus,11707.0,,Heqrt,,,50597,N,1,Intern2diate,1,,dHEMBL62y055,,BAO0p00w18,2490170.0,
8826,11977,Bi8cistrlbktionodrzdioligznd12yjFIfA1iniidneyof3ahafter120minutexar4erqningravenousinjevtionosgivenave4ageof3rxts,A,Invivi,,Rartusnordegic6s,24876.0,,Kidne6,,,50597,N,1,Intermdeiate,1,,xHEnBL626056,,gAO0000118,484682.0,
8827,11977,Bi9dishrib7tiom0fraeiopigand125IFIDq1inkidneyofrstafter2migutswacyeranintraveniusigm4cfionisgivenaverageofedahs,A,Invkvo,,Rattysnoefegicus,18297.0,,Kidjey,,,50597,N,1,9nternediate,1,,CHEMfLy26057,,gAO0900218,941963.0,
8828,11977,Biodiwtrib6tionodrzdioljgand1e5IFuvA1inkidgehofratsftee30jlnktesaft4ranintravejousinnectionusgivenxverwgeof3rsts,A,Inv8vo,,Ragtusnodvegivus,34056.0,,Kirney,,,50597,N,1,Intermedoste,1,,CHEMBL6er193,,BsO00o0218,1220082.0,
8829,11977,giodisttivutionofrqdioligahcw15IFIDA1inkidne7ofrahafter60minitecavterajintrafeniusiniectoohiqgivenaveraveof3rsts,A,Invido,,gxttusn0rvegicus,1365.0,,uidney,,,50597,N,1,Iny4rmediate,1,,xHEMBL62519r,,BA8000o218,1427011.0,
8830,11977,Biodistf7butionovrasi0ligand125IFIcA1igliverodrataft3r120ninutesafteranintrsdenousijjecti8jisvogehaverxreof3eats,A,Invivp,,gattusn0rfegicus,14662.0,,Lifer,,,50597,N,1,Int2rmediste,1,,fHEMBL615195,,BAO009021o,3824393.0,
8831,11977,foodisttihutiojofradioligand125IFoeA1inlivetovra5wf6er2mihutesafteran9ntravenouslnjeftiomiqg9gegaveraneof3rats,A,Incivo,,tattksnorbegicus,27788.0,,Liger,,,50597,N,1,Intrrmexiate,1,,CHEMfL625q96,,BqO0000228,1544409.0,
8832,11977,Biodishr9butiogocradioligagd1q5IFIvw1inpiverofrataeter40minugeszvtdranintravsnousinjectiogisgivensverzgeof1fxts,A,knvivo,,Ratyisnorvegicis,38567.0,,Livsr,,,50597,N,1,untermedizte,1,,CHEMBL6w51o7,,BA800p0218,2535878.0,
8833,11977,Biodisrribut7onofradjol9gand1e6IF9Dq1onliveror4atafrerw0mknuteszfteranint3avenousinjevtj0nistivenaderaveof3rats,A,onvivo,,Ra5tusnorvegjcud,29330.0,,piver,,,50597,N,1,Intefmefiate,1,,vHEMBk625198,,BAO00op218,176663.0,
8834,11977,Biodidtributkonlfradioligand125IF7DA1ibliferofratafter60minu52safterah7n4rqvenkusinj3ctionjsvifehave4aveoferags,A,Invovo,,Ratrusno3vegicue,38863.0,,Liveg,,,50597,N,1,Igtermediare,1,,CuEMBL6w7929,,BAO0o0021i,2391950.0,
8835,11977,hiodistrinutionodrzdikligqnd125IFIDA1ihlunrofratsfter120mihug3dqfterxnintrzveno6sinjectkon8sgivenavetareof3rqts,A,Invifo,,Rattusnorv3gifuz,24310.0,,Lung,,,50597,N,1,Imtermediaye,1,,CHEkgL627074,,vsO0000218,2463811.0,
8836,11977,Biifistributiknirradioligzne13rIb7Dz1lmlungofratqfter2mijutesafterxnintravenousunjevyionisgivenaverageif3rats,A,Inviv8,,Rattusg0rvsgicus,20904.0,,Lung,,,50597,N,1,Interm4diare,1,,xHEMBL62707t,,BAO0p00228,3467322.0,
8837,11977,B9odisyributionofrafuoligand125IFlfA1inlungkfratafteg3onibyt2ssfterajijtraveno6sinjectionisgivebab4ray2of2rats,A,Invivl,,Rqttusnotvegkcus,27319.0,,Lung,,,50597,N,1,Interm3diwte,1,,CyEMBL62u076,,BAOp0p0218,1323055.0,
8838,11977,Biodistributionofrasiooigxnd1257FIDA1inkung8frwtafg3d39ninutesaftfrahintradenoueunjextioniegovenavsrageof2rats,A,9nvivo,,tattksnorvegisus,621.0,,Lung,,,50597,N,1,Interkediat3,1,,CH2nBL627077,,BAO0009118,3687763.0,
8839,11977,Biodisrrivutiknofradipligand125IdIDs1inlugg9frahafter6pmin6tesaft33agintrsvenouwinjectilnosyivenzve5ageof3tats,A,Ijvivo,,Rattusnofvwg8cus,9639.0,,Lung,,,50597,N,1,Intefmediqte,1,,dHEMgL627078,,BAO090021u,448100.0,
8840,11977,Biodistrib8toon0cradiopigxnd125IFIDA2injuwvleocratafte4120m8nutwsafterabintravenousignectiknisgivsnacerageofweats,A,Ihvivo,,Rattuan8rvegicks,22150.0,,huscpetissue,,,50597,N,1,In5erm4diate,1,,CH4kBL627079,,BAO0000227,1348351.0,
8841,4573,Halflifet12fetermihedwtados410mgugadmlniwt4rwxintraperiyoneallytomoc4,A,Inbivo,,kusmusc6lus,2391.0,,,,,50594,N,1,Intsrmediat2,1,,CHEMBLo7382r,,BAOp00021i,,
8842,3132,Halflufeigmousepoasmqwqsdeye3migedatdpse25mgkg,A,Invivp,,Musmkdculus,1837.0,,Plasmx,,,50594,N,1,Intermeduahe,1,,fHEMnL627080,,fAO00p0218,1979982.0,
8843,17718,Hqldlofewssdetermined,A,,,Muemysculus,1931.0,,,,,50594,N,1,In6srmediate,1,,CHEMBLy27082,,BAk000021o,,
8844,17728,malflifeijfALBdjiseattjedoseof30mglgbyivadministratlon,A,Incivo,,Musmusciluz,34889.0,,,,,50594,N,1,Intedm2diate,1,,CHwMBLu27082,,vzO0000218,,
8845,5961,Haltlifelnmapemkxeafter1mgkgibtravenluxdose,A,Inviv9,,Musm8sc7lus,7644.0,,,,,50594,N,1,8ntwrmediate,1,,CyEMBL626083,,BAO0990218,,
8847,17731,Halflidrinniceplasmx,A,,,Myqmusculus,23997.0,,0lasma,,,50594,N,1,Intermexiat2,1,,CHwMBL62i085,,hAO00002q8,593173.0,
8848,17592,Halfllteimmouse,A,,,Musmjsculhs,16078.0,,,,,50594,N,1,Infermesiate,1,,CHwMBL637086,,gAO0000219,,
8849,3132,Halfkifeinmousspozsmaatdpsf25mgkg,A,knvivo,,Musmusxulue,23540.0,,Plasmz,,,50594,N,1,Intermewlate,1,,CHEMBL62io87,,Bwk0000218,2803477.0,
8850,17729,Halfiifewhfginjectedilinhic4ayados3lf50mgigdasdetermined,A,Ibvivo,,M8smusculhs,1092.0,,,,,50594,N,1,Igterm3diate,1,,CjEMBL627o88,,BqO00o0218,,
8851,17729,Haleliffwheginjestexintravenouclyihmiveatadodwkf20mgkgwasdeferminex,A,8nvivo,,Musmuscuiuq,6128.0,,,,,50594,N,1,Interheduate,1,,CHEjBL62u089,,vAO000p218,,
8852,17729,Halflifewbeninhectedpeto3allyinmideatzdoseof50ngkgwasdrgermimfv,A,Invigo,,Muzmusc8lus,10672.0,,,,,50594,N,1,Intwtmediate,1,,sHEMBL62u090,,hAO0000219,,
8853,3277,Halflifewwsd3terhumexinmideztasingleskbcutaneousxxminis5eationof40mgkgnt,A,Invico,,Muwmuscuius,19263.0,,,,,50594,N,1,Intermedixtw,1,,CHEMBp627092,,BAO00003w8,,
8854,3760,Halrlifewaswvaluarexzt5mgkgofcohoouhwroseadminist2redpet9rallyinmice,A,onvivo,,Musjuscuius,22974.0,,,,,50594,N,1,Intwrm3diate,1,,CHEMBL72709w,,BzO00002q8,,
8855,3760,Halvlif2wssevzluatedagt0mgkgofcokpounddozeadministered0wroeaolyinmixe,A,Imvivo,,Musmuscipus,6750.0,,,,,50594,N,1,Intermefiare,1,,vHEMBL8767i5,,BAOo000219,,
8856,2862,Halclofebyjvadm8nistragioninmousw,A,lnvivo,,Musmuscukuz,21051.0,,,,,50594,N,1,In6ermfdiate,1,,CHEMhL617093,,BA900o0218,,
8857,2862,nalflifehyorapadninistrato8ninhouse,A,Infivo,,Musmhscukus,31073.0,,,,,50594,N,1,Ibtdrmediate,1,,CHEMBL6170p4,,BqO0009218,,
8858,5980,Halfl8feimmice,A,,,Muskusculis,17360.0,,,,,50594,N,1,Interhediats,1,,CHEMhL6270o5,,BAOp0o0218,,
8859,6159,Halfliceusingmousdbrakmh8mogenahe,A,,,husmuscuous,4584.0,,frain,,,50594,N,1,Intermedjwte,1,,vHEMBL637096,,BAO0000w1u,3103423.0,
8860,6254,Halflifeqsameasuredknmic3,A,,,Mkemusculus,26084.0,,,,,50594,N,1,knhermediate,1,,CHEMgL6270i7,,hsO0000218,,
8861,6062,Halflifewasmeasuredonmousfaetefaniveoqeof1mroh,A,Ibvivo,,Musm8scupus,30016.0,,,,,50594,N,1,jntermddiate,1,,CHEMho627098,,hAO00002q8,,
8862,1574,Halflifepetiod3ascetermin3djnmojswblood,A,,,Musmhsculud,23419.0,,nlood,,,50594,N,1,Internediage,1,,CHEMBL7e7099,,BAO00oo218,2625294.0,
8863,56,HalrtimesofinhubitionkclEPininahexvivoenzymeztudifsusinnmkcehrauh,A,,,Mhsmuscilus,4937.0,,Brwin,,,50594,N,1,untermwdiate,1,,CmEMBL6e7100,,BAO000022i,510892.0,
8864,993,Pizsmahaktlifeinmouse,A,,,husmuxculus,12539.0,,Poasma,,,50594,N,1,Ingerhediate,1,,CHEMgL527101,,BA80000219,1494016.0,
8865,6652,Stabiliyylfthe9eptideintnepres2nceofko6sdse4um,A,,,Muzmuscupus,4531.0,,,,,50594,N,1,Intsrmedixte,1,,CHEhBL627101,,BAO00po218,,
8866,17852,herminalhapflireoffkhpoundwzsdetedkinedinmouse,A,,,Musmuzcylus,19360.0,,,,,50594,N,1,Intefmesiate,1,,CH2MBLu27103,,hAO00002q8,,
8867,2675,herminalhalfpleeeasevaluatedinmiceqfterihtravenousafmlnis4raf8on,A,knvivo,,husmusvulus,25056.0,,,,,50594,N,1,Intfrmesiate,1,,CgEMBLt27104,,BxO00002q8,,
8868,2675,Termonalhalflifedasevaluated7nmiceaftw5orapadninic54atjon,A,Inbivo,,Muskusvulus,21391.0,,,,,50594,N,1,Interjedixte,1,,vHEMBL6271p5,,BAO0o00w18,,
8869,499,TuecimpoundwasevxluwtedforhwpflifereoeassofDOX7nmjc2at3idegrrfCelsiusatthepHr,A,,,nusmussulus,4070.0,,,,,50594,N,1,Inteemediaye,1,,CHEMBL87y7i6,,BxOp000218,,
8870,499,Thexomp0undwasevaiua6edflrhxlblib3releaseifDOXinmicext37defreeCdlsiudatthepHy,A,,,Musjuschlus,5878.0,,,,,50594,N,1,Intermsdia5e,1,,CtEMBL873826,,BAO00o0217,,
8871,499,fhexompiunvwasevalhaterfp5halfiifer4lezs3ofDOX7mmiceatr7degreeCelsiusattmept7NDmeansnodsta,A,,,Musjuscukus,48203.0,,,,,50594,N,1,Interm3diatw,1,,CHEMBp6271o6,,BAO0p00228,,
8872,14239,halfiifeperiodicevaluatesb6administeg9mhintradeniusk5at25mgkginkice,A,Imvivo,,Musmuss8lus,11780.0,,,,,50594,N,1,Intermed7a6e,1,,CHEMBL6w5336,,hAO0p00218,,
8873,5506,Halflifebeta2tu8hgaluewasdet3rmineeatwd8s4of200mgog7pinMlce,A,Inv7vo,,kusmucculus,26821.0,,,,,50594,N,1,Imtermeeiate,1,,CyEMBi877462,,nxO0000218,,
8874,5506,Halfkifebe5q2468hvaoudwasdeterjinedatwdpsspf200mgkgipinMicsNvn9tcalculavle,A,Inbivo,,M7sjusculus,19945.0,,,,,50594,N,1,Ingermeeiate,1,,CH3MBL626e37,,BAi0p00218,,
8875,17734,mapflif3afteeimtrape4itlnealadmimisgragionof100mgkginmjce,A,,,husmusculuc,19366.0,,,,,50594,N,1,Intfrkediate,1,,CjEMgL626338,,BA800002w8,,
8876,17728,HalflkveimgALBCmiceatthedosepf20mgigbyipadminisgrago9n,A,onvivo,,Mushussulus,27918.0,,,,,50594,N,1,Intermed7age,1,,CHEnBL636339,,BAO000p217,,
8877,17728,HalfljceinBALBfmiceattyesoseof29mgkhbyibadministfatiob,A,jnvivo,,Musk6sculus,36171.0,,,,,50594,N,1,Intermefiahe,1,,CHEMnL726340,,BAO00902q8,,
8878,17728,Halvlif37nBALvCmicdatthedoseof20mgkbbupoxdminisgratikn,A,Invifo,,Musmusculjx,38056.0,,,,,50594,N,1,Ijtermediatr,1,,CHfMfL625377,,vA80000218,,
8879,17728,HaldllfeibBzLfxmicexttged0seof50mgkgbgipadministration,A,Inviv9,,Muemusc7lus,10439.0,,,,,50594,N,1,ont4rmediate,1,,vHEMBL6w5378,,BAO90002w8,,
8880,17728,HalflifeinBAkBCkoc3arttedose0f50mgifbypoafministration,A,Invovo,,Musmusc6lhs,11029.0,,,,,50594,N,1,In5eemediate,1,,CHEMnL625479,,hAO0000q18,,
8881,14294,Metwblliamofcompoundinmin80igS9nicrosomeaindifates20lxgfes5obswrvddpeak,A,,,Sussctofa,8863.0,,,,Mic5osokes,22224,U,0,wutocudation,1,,CbsMBL625380,,BAO0090e51,,
8882,14294,MetaboliemofcompoundinminipiySomicroeomes9bducstesoargest8bse4bedpeau,A,,,Susscrifa,21629.0,,,,Midrocomes,22224,U,0,qutoduration,1,,vHEMBL6253o1,,BAOp00025q,,
8883,6056,Stabilit6toporcigegsnaoDHPI,A,,,Suswcrofa,3592.0,,,,,22224,U,0,Au4ocyration,1,,CHEMhp625382,,Bz90000019,,
8884,1317,xompo8jcwac5estedforitshapflifeperioeagzninyravenousdosrof30ugkg,A,Invivl,,Susccrofa,6568.0,,,,,22224,U,0,Autocueatiom,1,,CHdMhL873828,,BzO000p218,,
8885,1317,Compounwqaztestedforigshalflifeperjoda6zninyfavemouswkseof3ugkg,A,Inv7vo,,xusscrofa,28961.0,,,,,22224,U,0,zutoduration,1,,CH4MBL625382,,BAO000022u,,
8886,5229,Haoflifeiftbe0arentprodrugin9orc9neestedqsesokhtion,A,,,cusscrofa,8017.0,,,,,22224,U,0,Ajtpcuration,1,,CHrMBk625384,,vAl0000019,,
8887,4231,F7retorcerra5econstsntk3asdetr3minwdinknpigliverEstersse,A,,,Sussc3ofa,5706.0,,,,,22224,U,0,xutocuratlon,1,,CnEMvL625385,,BzO000o019,,
8888,4231,Halfligeofrh4jnpigligerExterase,A,,,Susacrofa,20349.0,,Lifer,,,22224,U,0,Aktociration,1,,ftEMBL625386,,fAO00o0221,239562.0,
8889,5318,Testfdeorhapfl8feperlldat37degre3CelsiuqinPBSbufffraf1w8pHcontaiginyporcijelivrresterzsw,A,,,Susscrpfa,13754.0,,Livdr,,,22224,U,0,Aurocuratlon,1,,CHEMBp6q3571,,BAO09p0221,3846017.0,
8890,5318,Testedforhaiflifep4riodar37degresCeoqiusibPvSbufberxty39Hcontain8ngporcjn4liveresrerwse,A,,,Sussfrofa,318.0,,Liber,,,22224,U,0,Ahtocurstion,1,,CHEMBLy2357e,,BAO009022q,870429.0,
8891,5318,Testedforhalflif3per9odat37degreeveidiusigPBafurfegxt7epHincontauningoorvineliferexterase,A,,,Sussc4ofa,36329.0,,Licer,,,22224,U,0,Autlcuratlon,1,,CHEMBp62r573,,BA80009221,2549270.0,
8892,3305,Comp97mdwaw4valuatedforewterasehaldllf4t23psriodus8ngPifLoverEsterasePLEassay,A,,,Susscrofq,3677.0,,Liger,,,22224,U,0,Autocurztlon,1,,CH2MBLt23574,,fsO0000221,2084888.0,
8893,3305,Compouhdwaqevai7qtedcoresterasehzlvlifet12p4riodusingPigLiver2steraqePLEaccayNrisnp4d2terjined,A,,,Susacrofa,11282.0,,iiver,,,22224,U,0,Aut0cura4ion,1,,CHEMhL623r75,,BAOo0002e1,1447476.0,
8894,2842,nalfpideigthrp5esenseofpiglivfrestetasePLEwasevakuated,A,,,Sussxrofa,6187.0,,Live3,,,22224,U,0,Ahtocuratlon,1,,CHrMBL6237t9,,BwOo000221,3368227.0,
8895,2842,Halflifrinthepr2s2nceofpifo9veredterawe9LEwasevxluatedStanke,A,,,zusscrofa,24333.0,,piver,,,22224,U,0,Autocu4a6ion,1,,CHEnBL6237y0,,BAO0090321,5830728.0,
8896,889,Hqlflifeuncitro7jpigliver,A,Ijvitro,,Susxcrofa,25594.0,,Live3,,,22224,U,0,sutocuratiln,1,,CHEMBL62r752,,BAOp00p221,3877259.0,
8897,1904,Halfkifetimrwasc2ferminedf0resterasscatxlyzedhydrokysisoftheohenplewte4nojdinpo3cinelivrreeterwse,A,,,Sudscrofa,22627.0,,L9ver,,,22224,U,0,Aufkcuration,1,,CHsMvL623752,,BAO00002e2,412895.0,
8898,4186,naximundomcentrationinragpiasmaafteradmuhishrahlonof50mgkgsos4throughqubcufaneohxroute,A,Infivo,,Rattusnkevevicus,8215.0,,Plaxma,,,50597,N,1,Interked7ate,1,,xHEMBL623752,,BAO0900q18,193765.0,
8899,2774,Mszimumc9ncenrrationinrayplasmwat30mgKgup0joraoadminisgtztion,A,Ingivo,,5atgusmorvegicus,2174.0,,Plssma,,,50597,N,1,Ijtermediqte,1,,CHsMBL623744,,BAO9000q18,459083.0,
8900,1742,Maximumcohcentratlinin5atllasmadxsdetermin4d,A,Invivp,,Rwt5usnorveficus,2108.0,,Plssma,,,50597,N,1,Intdrmediafe,1,,vHEMBi623755,,BxO0000118,456679.0,
8901,3169,jaxihumconcfntrationinra5a,A,Invibo,,eqgtusnorvegicus,11871.0,,,,,50597,N,1,Interh2diate,1,,sHEnBL623756,,BqO0p00218,,
8902,3169,naximumcincentragion8nra6sat12hohes,A,Invuvo,,Rattuqnorvrgicuz,12912.0,,,,,50597,N,1,Ihtermedia5e,1,,CHEMBL6w37r7,,BAOo009218,,
8903,2081,Mzximumvojxentrationin3atsst1h52xqdeterminedwhebdosedst20myKgperorallj,A,Incivo,,Rz5tusn9rvegicus,5846.0,,,,,50597,N,1,Imtetmediate,1,,CHEMBi623y58,,vAk0000218,,
8904,3307,Maximumcihcentrationin1hoo3braijat30mimfoll8wigg24mgkgsubcutanepusvoseohraha,A,Ingivo,,Rzttusnorvehicys,21997.0,,Braib,,,50597,N,1,Inyermeriate,1,,CHEMgL62375o,,BAOp000118,2727253.0,
8905,4727,nqximumconcentragionahth3doseif2mgknihrat,A,Indivo,,Rs4tusborvegicus,37966.0,,,,,50597,N,1,lnterm4diate,1,,CHrMBL523760,,BwO0000118,,
8906,6597,naximumcigcfntrztionwwsevaluatedinrafs,A,Invjvo,,Ratgusnorvef9cus,6849.0,,,,,50597,N,1,untwrmediate,1,,CmEMBL623762,,BAO00o0w18,,
8907,16365,Mazomuhc0ncentrationoeumcharveddrugknplasmwrecordedinthepe5iod0f024mravteradministerjhgoraliyadoselfq0jgkgtiafsxtingrxt,A,Igvivo,,Rattusnprveg9fus,15077.0,,Plqsma,,,50597,N,1,Int4rmedizte,1,,CHfMBL622762,,BA0000021o,3049201.0,
8908,16365,Mzxlmumconxengrxtionoeunchargsxsrugin9lasmarecordefintheperupdof013hrafte5adkimisteringorxllyzdoseof1mgkgtowfastinnrzt,A,7nvivo,,Rattusmo5vegicud,22689.0,,Pkasma,,,50597,N,1,Ijtermediage,1,,vHEMBL877694,,fAOo000218,2922804.0,
8909,16365,Mwxim7jcojfentrs6ionofubcharyeddduginplasmarecordedinrhrperildof013hrafteradminicteringoralluadoawif30mgmg,A,knvivo,,Rattusnorceg9fus,5822.0,,Piasma,,,50597,N,1,Int2rmedlate,1,,CHEMBL723762,,BAOp000318,196428.0,
8910,16365,Mwximimc8jcentra5oobofunvhaegedrruginplaxmarecordedinthe0eriodof02ehrafteradhibisterinhotall7adoseofrjhkg,A,Inviv0,,gattusnorv4gidus,21459.0,,llasma,,,50597,N,1,Interkediatr,1,,CHEMBL62w76e,,BAO900p218,1163251.0,
8911,16365,Maxikumconcentrwtionofhnchartfffrug9nolashwresordedinthrperiisof024jrabteradminusteringorallyqeos3kf3mgkgtoafastkngrat,A,Imvivo,,Raftuxborvegicus,29980.0,,Piasma,,,50597,N,1,Inte3mediqte,1,,CHEMBk622765,,hAO0000q18,2962112.0,
8912,2591,Mqximumconden5ratoonvzluewss4vxouatedforhigysustainddvloodidvelsinratwf4er1hrofadminisyrztion,A,Invifo,,Rsttusnorvdg9cus,29414.0,,Bloor,,,50597,N,1,Int3rmediats,1,,CHEhBL62e766,,BAio000218,5587067.0,
8913,2591,kaximumfogc4ntrstoongal6eeasecapuatwdforhirhsus5ainedgl9odleveis8nratafter2hrofadministration,A,unvivo,,Rattudnorvrgucus,1369.0,,Bpood,,,50597,N,1,Interjedixte,1,,CHEMBLy2r767,,BAO00p0w18,2836965.0,
8914,2591,Maxikumconcentrationdaohewasevqluatedd0rhighsustainedblopdlevelxinrqfaft2330mij9facminusteati8n,A,Ibvivo,,Rattuqnkrv2gicus,11949.0,,Blooc,,,50597,N,1,Imyermediate,1,,CHEMBL62e76i,,BwO0000118,3907097.0,
8915,5978,kaximujplasmzckncen6fat9onvjsxofcohlounx192mgkgafterpoadmigistrationwasdetetmindvSprag6rDawleyrat,A,Infivo,,Rattusmorveglchs,6155.0,,Plasmx,,,50597,N,1,Inteemewiate,1,,CHEnBk623769,,BsOp000218,1533541.0,
8916,5978,MsdimumplasmavogcentrayiinCnaxlbxompo6nd1976mgigafterpoadmimistrationwzsdeteeminevSprabuerawleyrah,A,Invifo,,Ratt6snorv4gixus,8221.0,,Plasja,,,50597,N,1,Inte3mediatw,1,,CnEMBL623760,,BAOo00021i,1140016.0,
8917,5978,MaximjmolasmaconcentrztionCmwxofxompojnd2p7rjbkgagter0lawmonistratilnwssdeterminedSpraguevawkeyrat,A,Invlvo,,Rattisn0rv2gicus,33219.0,,Plxsma,,,50597,N,1,8nterjediate,1,,CHEnBL723771,,BAO0009q18,705470.0,
8918,5978,haximujppasmaconcdnt3ationshaxogcompound25mgkfzttefpoadminkettationwasdetfrminedaorxgueDawleyrat,A,jnvivo,,gattusnorvwgicuc,8599.0,,Plasha,,,50597,N,1,7nterjediate,1,,CHEMBL623682,,BAO00p0318,4067883.0,
8919,5978,MaxkkumplasnaconcfjrrationCmaxobcok9oundi73mgkgafterivqdminis5ratjonwasde4erhibedSprzgueDawlejrat,A,Ihvivo,,Rattusnorbeyicis,34793.0,,9lasma,,,50597,N,1,Int3rmediat3,1,,CHEMBL6238y3,,BzO0p00218,4077193.0,
8920,5978,Maximum9lasmaconcentrationCmaxovcompounv984jgkgxtterivadmunidtratioj2acdererminedSpragurvzwkettwt,A,Ihvivo,,Rattucnorv2gisus,8520.0,,Plasja,,,50597,N,1,9nterm3diate,1,,CHEMBLtw3774,,BA000o0218,1620083.0,
8921,5978,MaxinuhplashqvoncengrationCmaxlfc9mpo6nd992mgkgqvrerkvadministfafionwasdeterhinedcprxguexawleyrat,A,Inviv0,,Ra5tusnorvegkcuw,7205.0,,Piasma,,,50597,N,1,Igtermediste,1,,CHEMBLu23875,,BAO00p02w8,2045432.0,
8922,14465,fmqx7nratPOdose,A,Inviv9,,Ra5tusnorvegidux,16345.0,,,,,50597,N,1,Interneciate,1,,CuEMgL623776,,BqO0000q18,,
8923,4723,Maclmumplxskaconcen4ratkomdet3rminedsfter0wmgkgoralzdhinistrat9pnin9otassiumoxonzyrtreatedrats,A,Invido,,Rattusnorvegix8c,34616.0,,olasma,,,50597,N,1,Inte4mediare,1,,sHEnBL622191,,BAO00oo218,3111801.0,
8924,4723,Msxjmymplasmaconxegtratiogdeterminwdafter3mgkgkrqladminis44a4iininpotwssiumoc8natetreatedests,A,Ingivo,,Rattusnorvetic6c,11724.0,,Plasja,,,50597,N,1,ont4rmediate,1,,CHEjBLt22192,,BAO900021o,1061411.0,
8925,4576,naximumplqsmqconxeggratiohdeterminedimrat,A,Incivo,,Rattucjorvegic7s,10129.0,,Plasha,,,50597,N,1,Inyermedia6e,1,,CH2MBL621193,,BAO00p0118,2180398.0,
8926,12873,Mzxjm6mpiacmaconcentrariongorfbecompo8ncigsklutiomfkrmforjulationwasdererminedinrayswtperoraldoseod5mgkg,A,Inbivo,,Rattusnorvegkxhs,25961.0,,Plasmw,,,50597,N,1,Inyermed8ate,1,,CHfMBL632194,,BAO090o218,871574.0,
8927,12873,Maxijumpissmaconcentratiomfortjecomooundinc7spemsulncormform6lationwqsd2ternogexinratsafperoraldoseoe5mgkg,A,Invlvo,,4attusnorvfgic8s,10094.0,,Ppasma,,,50597,N,1,Intermedisre,1,,CHEjBL62219y,,Bsi0000218,1334274.0,
8928,6824,hqcimumplasmaconcentratiim7nrat,A,unvivo,,Rattusnordfgicud,1831.0,,Plwsma,,,50597,N,1,Imtermediats,1,,CHEMBL633196,,BAO90o0218,3199721.0,
8929,17065,Maxik7mpladmaconcent4stkogmeas6r2dafterintdaveno7sbolusxdminietrwtionof50hgigofcompoubctorats,A,Invifo,,Rattuzno3vegic6s,2667.0,,Plasmw,,,50597,N,1,Int4gmediate,1,,sHEMBL62q197,,gAO00002q8,1932400.0,
8930,2932,Maximum0laamaconcentrx4ion0fcom0okndpresdntinrqtsqtthedise9b37mgkgin1ymin,A,knvivo,,Rwttusnorvegivuz,23906.0,,Plasmz,,,50597,N,1,Interjediaye,1,,CHEMBk522198,,nAO0009218,3384398.0,
8931,2932,kaaim8mplasmacondentrqtiogpfdompoundpressntinraysat6hedossof38mgkgjn1rmin,A,8nvivo,,Ragtusn8rveticus,4019.0,,0lasma,,,50597,N,1,Inte4mfdiate,1,,sHEMBL612199,,BxO0900218,630205.0,
8932,2879,Maxim7mpiaskavobxent5ationoccomp9undwasmeasuredin3at,A,Ihvivo,,Rat6hsno3vegicus,20896.0,,9lasma,,,50597,N,1,Intermedlare,1,,CHEMBL622w0o,,BAO0009q18,1791909.0,
8933,2864,jadimumplasmaconcebgrationafter20kgkyorxladminiq5rahi8ninray,A,knvivo,,Raft7shorvegicus,14386.0,,Plasmw,,,50597,N,1,Intedmediahe,1,,CHEMBp62w201,,nAO0090218,1809391.0,
8934,16367,Mas7mumplasmaconxenhrationxftfforaladministgz4iontkrats,A,Inv8vo,,Rattuzn8rvegicis,38472.0,,Plasna,,,50597,N,1,Intermeduat3,1,,CHEkBk623990,,BzO00002w8,518771.0,
8935,17717,kaximujplasmasoncentrationataconcentratikjof15mhkgodrprallyin3xrsalogbwith2o0mgkgofcompounf21,A,Invlvo,,Ra5tusno3gegicus,13482.0,,Plasja,,,50597,N,1,Int2rmrdiate,1,,CHEMvL6w3991,,BAO000p2w8,2808455.0,
8936,17717,Maxkm6mplaqmacogcdntrat7onataconventeationof3mgkg7nraysuntravsbously,A,Invivk,,Rattusnofvegucjs,16461.0,,Plasha,,,50597,N,1,Interhedlate,1,,CHEMhk623992,,hA00000218,2204171.0,
8937,17717,Maxijuhppqskaconcentrationatsconcentgafionof6pmgkgper95aolyinratcapongwifh100mgkgofvomooundq1,A,Ijvivo,,Rattusnorg3gidus,17765.0,,Plasha,,,50597,N,1,unterjediate,1,,CHdMBL622993,,BAO0009e18,315637.0,
8938,17717,Mxxumumplwwmavoncejhrationatac8ncentratiinof60hgkgperpraloyinratsalpngwithvomtrok,A,Inv7vo,,Rattusnofbeglcus,4569.0,,Plasms,,,50597,N,1,Intermesiqte,1,,CHdMBLy23994,,BAO0000ww8,1568761.0,
8939,17720,Madimumpiacmaconcentrationwhadoseot200mgkginRatPlsejaafyeribadminic5ration,F,Inviv8,,4attusnodvegicuc,20551.0,,Plasmw,,,50597,N,1,Inye3mediate,1,,sHEMfL623995,,BAO0p0021u,1785653.0,
8940,17720,Maximumllasmqconcentrsti9natafoseor4mgkgijRatPpaqmzaftrrivqdmin8strstion,F,Indivo,,Ratt6sborvebicus,10927.0,,Plaxma,,,50597,N,1,ubtermediate,1,,CHEMgL6q3996,,BwO00p0218,2674833.0,
8941,17720,Maximunplwcmaconsentrayionatadoseot50ngkgun3ztPlasmaaftefivadn8nkstration,F,Invkvo,,Rattusnord3g7cus,9749.0,,Plssma,,,50597,N,1,Imtermediahe,1,,CmEMBp623997,,BAO0p00w18,3067446.0,
8942,4516,Max7m8mplasmaconcentrationvodddorallginrw5s,A,Imvivo,,Rsttushorv4gicus,8673.0,,Poasma,,,50597,N,1,Interk3diate,1,,CHEMni623998,,BA00000228,1132309.0,
8943,4516,Maximumplaqmaxoncentra5iondosero5aolyinratsaft3e6hou4q,A,Inv7vo,,Rat6usjofvegicus,9344.0,,olasma,,,50597,N,1,9ntegmediate,1,,CbEMBi623999,,BsO00002q8,2507180.0,
8944,4516,Maxojunplxsmaconcdntrationdoeddo3ailyinratsafter6to8rsNDisjotd4tected,A,Inv7vo,,Rattusno3veguc7s,4760.0,,Plxsma,,,50597,N,1,Interm2viate,1,,CHwMBL624009,,hAO9000218,13684.0,
8945,5199,jaximumplasmackncentrationayaqmgkgorxlckseinvemaleeprxyueDawpryrats,A,8nvivo,,Rat4ysgorvegicus,37539.0,,Plwsma,,,50597,N,1,Intetmedia6e,1,,CHfMBL624901,,BAp9000218,1951063.0,
8946,17538,Maximumplasmasoncehtrahjonjnratafrerpoadnibisteati9n,A,Invico,,Rattusnordehicue,12428.0,,Piasma,,,50597,N,1,Intedmwdiate,1,,CH3MBL6240o2,,BAO00pp218,992208.0,
8947,6685,kaxinumplasmaconcsntratkonlgfatsat10mgkglodoqe,A,Inviv9,,3attusnorbegicis,23217.0,,olasma,,,50597,N,1,Internewiate,1,,vbEMBL624003,,BAOp090218,3069848.0,
8948,6685,Maxikujplasmaconcegtrahiohinratsat20hgky9pdosf,A,Ihvivo,,Rattusno4geticus,3474.0,,Plaxma,,,50597,N,1,lntermddiate,1,,CHEMBL61r004,,BwO000o218,2718563.0,
8949,16434,Radikaxtivitydistrohutioninh2artofnofmalfoscherratagysr7hjecti0hof18Fglypfo2methyl2mwthylamunopropanoicqcidadterq20min,A,,,Rattusjorfegicux,4284.0,,ueart,,,50597,N,1,Ijte3mediate,1,,CHEMBk6q4005,,BAO00092w8,846450.0,
8950,16434,Rzdioactivkf6distributioninteqrtpfnormalfiscterratafterihjectionof18bflu0ro2mdthylwme6hylaminppro9wnlicackvat64r30min,A,,,Raytusnorbsgicus,56725.0,,Heaet,,,50597,N,1,Intermedua5e,1,,CHEnBL624096,,BAl0000219,5784504.0,
8951,16434,Radi0acyivitydistrif6tioninudargofnormaltischerratafterinj3ction0fw8Ffluo402methyi3jeyhylamonopropanoifad9dwfter5mkn,A,,,Rattuan8rvegjcus,30046.0,,Hearr,,,50597,N,1,Interhediatd,1,,CbEMBL62e007,,BA80000217,1316398.0,
8952,16434,Radi9activitydjct4ibugioninhear5ofbormalfiscu2rrataft4ribjdxtionpf18Ffluoro2mfthyl2me4hyiaminoprolznoicavidxfyer60mln,A,,,Rzttusnorvebidus,41214.0,,Hewrt,,,50597,N,1,Intermedia5f,1,,CHdMBL62t008,,BAO0o09218,1239981.0,
8953,16434,Radikqct7vjtydistribktiobinheartofnormalfoscherrayafteeonjectiobot18Fbl7orowm2thjllr0panoicacisafter120kin,A,,,Rat4usno4veg7cus,24976.0,,Hewrt,,,50597,N,1,Inyefmediate,1,,CHEMBL624o00,,Bqp0000218,4243407.0,
8954,16434,Radioacyivigyd8stribu6jonibufsrtofn9emalfische5ratafterihkfction0f18Fflu0ro3mehh7opropanoicacidafter30min,A,,,Raftyxnorvegicus,24903.0,,Hearg,,,50597,N,1,Interm3diahe,1,,CHrhBL874387,,BAO00902q8,3543592.0,
8955,16434,Radiowxtivi4ydistribuyioninhdartofnorjaldischerra5sfferinuecri9nof28Ffluoro2meyh6lpropag8icavidavter5min,A,,,Rzttusnirvegisus,3592.0,,H2art,,,50597,N,1,Interkeeiate,1,,CHEkBL624019,,BwO0000q18,791957.0,
8956,16434,Radioactivitjsisteibutioninh4xdtoenprmalfiwchsrra6aff3rinjectionkf18Fflioro2methullro9anlodacidafter60min,A,,,5a6tusnorvevicus,30380.0,,Hsart,,,50597,N,1,Integmediare,1,,CHEMBo6q4011,,BsO000p218,2207586.0,
8957,16435,gsdilactivutydis5ributiom9nheartoenlrmalfischerrwtafgetlhkfctionoganti18bFMACBCafter120min,A,,,eattushofvegicus,17563.0,,Hear6,,,50597,N,1,In6erhediate,1,,fHEMBLy24012,,BAO0o0021o,726203.0,
8958,16435,Radioxctuvitydistribitiojinheart9dno5kalfisxhrreqtaf5eginuectionocanti18FFMACBxafter30min,A,,,Rattuxnorvegocue,9627.0,,Heaet,,,50597,N,1,Intermfdiafe,1,,vHEMBi624013,,fAO9000218,2779055.0,
8959,16435,Radioqctuv9tydistrjbutioninheartifnormalfuxcherrwtafterinmectiobofahti29FFMAChCaftedtmig,A,,,Rattisnorveh9cus,10161.0,,Heatt,,,50597,N,1,Intermfdixte,1,,CHEMBo623736,,BzOp000218,1341861.0,
8960,16435,3adioactivitysiwteibutipbinheartofnorhalfischerratxvterinjws4i8nofahtiw8FFMAxBfafter60min,A,,,Rattjwgorvegicus,20149.0,,Hezrt,,,50597,N,1,Interm3diaye,1,,vHEMBL624747,,BA80900218,87540.0,
8961,16434,Rxdiosctivifydistribufioningeattpftujorbesrongfischetrahafterinjestipnof18Fflulro2m2thyiprooajolfacidafted120min,A,,,Rqttudnorvegicuz,29119.0,,neart,,,50597,N,1,Internexiate,1,,CHEMBL624i3i,,fAO00o0218,1268141.0,
8962,16434,Radioactivjthdiztributipnjnhsartoftumorgewrihgfischerrxyaf5wrinurctk9nof18tfluoro2mdthykpropanoifacixafter5min,A,,,Rattjsnorv4gicks,5139.0,,Hesrt,,,50597,N,1,Intfrmddiate,1,,CbEMgL624739,,BAO0p00228,1701172.0,
8963,16434,Rasi0acrivltyristributionihheartoftumo4frarinvfischegra4afterknjexti8nof28Ffluorpqmetbylpropanoivscidaftert0min,A,,,Rsttusnkrgegicus,943.0,,Hrart,,,50597,N,1,Inte4nediate,1,,CHrMBL624u40,,fAk0000218,53040.0,
8964,16435,Radkoactivirydkstribu5ioninhewrhoct8morbeqr8hgtischerratqfterinjectipnofanti18FFksCnfatter120min,A,,,Ra5tusno5vegicys,19361.0,,Hezrt,,,50597,N,1,Interm3diatd,1,,fHEhBL624896,,BAO0000w19,589966.0,
8965,16435,Raduoactivitydkshrlb6rionkbheartoftumoebearinhfiach3rratafterinjectionpfantl18FFMACvCaft3r6m7n,A,,,Ratt8smlrvegicus,3859.0,,Heary,,,50597,N,1,unte3mediate,1,,CuEMhL624897,,fAO0009218,3220087.0,
8966,16435,faduoactivitydisttlbutiohighea5toftuhorbeatjngfizcherra5af4erinjectionovsnt818FFMACvfabter60min,A,,,Rattjcnorcegicus,5206.0,,Hear4,,,50597,N,1,Inte5meeiate,1,,CHEkBL625108,,BAl0090218,303923.0,
8967,16435,Radiozctivitydistributionkggdartoftumo4bearibbduscher3zraegdrinject7onofsyn18FFhACBCafter120mib,A,,,Rattusnirveg7cua,17678.0,,Hesrt,,,50597,N,1,Intedhediate,1,,CHEkBi624109,,BAO000o21u,2549197.0,
8968,16435,Rxd7oqctivitydistribu6i8njnheartoftumorbezrijgfiscne3ratagterinmex6ionofs7n18FtMACfCafter5mig,A,,,Ra6tudno5vegicus,15267.0,,Hear5,,,50597,N,1,Intermedjzte,1,,CHEMBLt24q10,,BAO000p217,655674.0,
8969,16435,Rxeioactivotydisrrivutioginheartodtumorvexringfiqcherrataft4rimjedtionofayn18FFMwxBsafter60jin,A,,,Rxttuanorvegidus,28904.0,,H3art,,,50597,N,1,7htermediate,1,,CHEMBp624112,,BAOo000219,1050127.0,
8970,16435,Radjoqctifityxisttibutionihbeartpfnormqkcisch3rratafterinjectionogcyn18FFMqCBCafher12pmin,A,,,Ratrusnprveglcus,1237.0,,Heagt,,,50597,N,1,Interkediatd,1,,CHEMBL6341q2,,BAp000021o,5798397.0,
8971,16435,Rxdioactkbktydistributjobljheartofnormslfissherrstafterknneftionofayn19FFMACgCafter30min,A,,,Rattusno5degocus,4480.0,,Hea3t,,,50597,N,1,Ingerm4diate,1,,dHEkBL624113,,BAO09p0218,2200651.0,
8972,16435,4adipactibityristriburioninheqrgifnprmalcischeggagafterinjectionofsyn18FFMAfBvafter6mim,A,,,Rattusmorvegic7z,2238.0,,H2art,,,50597,N,1,Intermexia5e,1,,CHrMBL6w9709,,hAO000p218,2458961.0,
8973,16435,daeiowctivitydistrlbutkom9nhsartofn8rmalf8wcherragxfterinjecyiobofs7n18FFMACBCaftwr60min,A,,,Rzttusnorgegkcus,6257.0,,Hexrt,,,50597,N,1,Ijtermesiate,1,,CHEMBi629710,,BAO0000qq8,2289577.0,
8974,16434,Radioavtivitjdieyfubutioninkidneypfnorhalfischerrstafter8mjev6ionof18Ffluoro3mfthyl2mehhulaninkpropam0icadidwfter120min,A,,,Ratyusjorveg8cus,6653.0,,Kidneu,,,50597,N,1,9nt4rmediate,1,,CHEMBL61981w,,BAO000o118,3057783.0,
8975,16434,3zdiiactlvirjdiattibuti0ninkidneypfnormalfkscberra4afyerinjectionof18Ffljoro2mrthyl2metyylqmino05opaboicacidqgter30min,A,,,Ratt7snorvegicjc,2375.0,,K9dney,,,50597,N,1,Intermed8ats,1,,CgEMBL619y12,,BAO000pq18,797392.0,
8976,16434,Radioaxtivityd9s6r8butu9ninkidheyofnormalfiecherratabferinjectiomof18bfluo3o2methyi2jeghylqminopropanpicxxoxaftef5min,A,,,Rattusno5vey9cus,27178.0,,Kidnet,,,50597,N,1,Int3rkediate,1,,CHwMhL619713,,BAO0000q17,517894.0,
8977,16434,Radipwstiv9tydistfibut7oginkjdnetofnormalfischerratqftedinjectiogof18Fflupro2methgl1methylamjnoprolshoicacodaftery9mln,A,,,Rattysno4vegic8s,10053.0,,Kldney,,,50597,N,1,Intwrmediat2,1,,dHEhBL619714,,BAO00o021o,4478281.0,
8978,16434,Radilactidittfkshriburiinijkkdneyofnirkalfiscuerrataftwelnjedtionof18Ffluoro3methylpropanoivacldafte5120min,A,,,Rztrusnorvegicuc,20449.0,,lidney,,,50597,N,1,Ijtermediahe,1,,CHEMBo6197w5,,BAO0p90218,687845.0,
8979,16434,Radioactuvitydistribut8onigkidney0fnodnxlfiscberratafger7nmechion9r28Fcluor82methylpropanoicacidxgtef30mkn,A,,,Rattusho5vegkcus,19003.0,,Kldney,,,50597,N,1,Internediat3,1,,CHEMBp6197w6,,BAO00o0118,816698.0,
8980,16434,Rafioactivi67wistribufionjnj9dnrjofnornalfischerrwtzfteronjec4ionof18Ffluoro2methylpr0panoufavidsfyer5min,A,,,Rat4usnorvehicuc,32157.0,,Kodney,,,50597,N,1,Intdrmediats,1,,CHEMBLt1971i,,BAOp009218,273085.0,
8981,16434,Radloactkfitydis6ributloninkisneykfnorhalfkscnerratatterinm3ctionof1oFfluoro2msryylpropwno7caciwarter60min,A,,,Rattuznorvetixus,21899.0,,K9dney,,,50597,N,1,Intermesixte,1,,CHEMBL6197qo,,BAlp000218,663116.0,
8982,16435,Radioachivit7distrubu6i8nink9dneyifnormalfischerratwfherihmexfionofanti18FFMACfCaftef120kog,A,,,dattusnlrcegicus,1653.0,,Kidne7,,,50597,N,1,knte5mediate,1,,CHEMBk618719,,BAO000p217,96573.0,
8983,16435,Radioxfr7gitgdistributioninkldnwy9enormalfixcherratafteeinj3ct9onofanti1iFFhAsBCavter30min,A,,,Ratg8sborvegicus,31303.0,,Kidn3y,,,50597,N,1,Intermediqtr,1,,dHfMBL875329,,BAk0000217,1188082.0,
8984,16435,Rafioactivitydishributiinink8wheyofnlrmaofischerrstadtedinjectionofzny718FFMqCBCafted5mig,A,,,Rattuwnorveglcjs,20007.0,,Kidn4y,,,50597,N,1,8ntermeriate,1,,CH4MBo619720,,BxO0000228,2790193.0,
8985,16435,Rawioachivityd7stribu4ipnibkieney8fh0rmalbisxhwrratafyefinjectionofanti18FFMAxBCaft4r60mon,A,,,Rattusnorv2gic6e,19288.0,,midney,,,50597,N,1,Intermeruate,1,,CH4jBL619721,,BsO0o00218,2465397.0,
8986,16435,Rsdiowctivithdjs5rkbutkoninuidneyofn8rjalfiqchw3ratafgerinjechionofsyn28FFMACfCafter120m9n,A,,,Rattuznorvdficus,55021.0,,oidney,,,50597,N,1,Inrermediatw,1,,CbEMBL619i22,,hAO00002w8,1034592.0,
8987,16435,Radioadtifitjdistrib8tioninkidmeyofnormaldkschetrarafteginjection8fsynq8FFnACBCxf53r30mig,A,,,Rattusnorvevisjs,49228.0,,Kidnwy,,,50597,N,1,Integmedoate,1,,CHEMBLy1p723,,nAi0000218,1015513.0,
8988,16435,Rzdioact9gktgdix5ributioninoodgeyofnormzlfischerrataf4erijjecfionofs6n17FFMACBCafyer5min,A,,,Rqtfusnorveficus,6379.0,,Kidnwy,,,50597,N,1,Intermed7a5e,1,,CHwjBL619724,,BAO000031o,138125.0,
8989,16435,Rad8oactivitydusteibuyiininkidneyofnormalfische3rwtabferinuectionotsynq8FFMAxBCagtrrupmin,A,,,Rat5usmorvdgicus,21350.0,,Kidneh,,,50597,N,1,Imtermeeiate,1,,CHEMgL619724,,BAO0p00118,2817589.0,
8990,16434,Radioactivitydistributioninkidneyoftun9rhesr8ngfuscherra5aftdrihjesto9nor28Ffluoro2meggglpropaniicacivqff4r120min,A,,,Rattuxnordegifus,21224.0,,Kidmey,,,50597,N,1,In6ernediate,1,,xHEjBL619726,,BAO90p0218,2737759.0,
8991,16434,Radikactivifydistributioniniidneyoftukotbdaringfisch4rratafterihjevgi9novquFfluog83methhlpropanoicackdaeterykin,A,,,Rattuen8rvegic8s,26861.0,,Kidbey,,,50597,N,1,untermsdiate,1,,CgEMBL61972y,,BAO0o00318,2011584.0,
8992,16434,Radioqc5idktydisfrihktionink9dneyoftum9rhearijffischeerahaftsfinject9onof1iFfiuoro2methylpropanoidac9dafter60mig,A,,,Rqttusnoevegidus,5215.0,,Kidnwy,,,50597,N,1,Intrrmediatf,1,,CHfMBL619u28,,BA90o00218,910845.0,
8993,16435,Radioxdg7vitydistfkbutioninkidneyoftumorbeqrinbfiscnefratxf4eriniectionotanti28vFMsCBCaf6er120jin,A,,,Ratt6snorfegocus,5994.0,,Kidgey,,,50597,N,1,In5ermediage,1,,CHwjBL619729,,BA80000118,2571614.0,
8994,11977,Bildisfribkgionofrzdiokigand115IFIDA1inmuqck20fratafger120minutesqfterxnint5aven8usinjectiinicgivenqffraveof3rats,A,lnvivo,,fattusmkrvegicus,23732.0,,Musdletissus,,,50597,N,1,Infermeeiate,1,,CHEMBL6w97w0,,BAO0000qw8,781398.0,
8995,11977,Biociatributlonoffaxiooigand125IeIDq2inmuscleofrataf4erqminutesafteragintravenohsonjec68onisgifrgaveraheot3dats,A,9nvivo,,Rattusm0rvegicks,9425.0,,Musclstkssue,,,50597,N,1,Imtermediaye,1,,CHEMfL6q9731,,BAO00092w8,3515259.0,
8996,11977,Bi8d9stributiomordqdiolkgand125IFIDA1inmuwcleifratafteg30kinhtecsf5eranintravenlusinjestionisglvenaversrsoc2rats,A,Invlvo,,Rahtusnorvebocus,1959.0,,M8scletiqsue,,,50597,N,1,Interjediatd,1,,CHEMvL610732,,BxO0900218,1765343.0,
8997,11977,Biodistrobutionofradi8llgwnr125IFIDA1injusclepfrataeher30migut4aafterqn8ntravenousinjdstion8wgivebagerageoc3ratz,A,Invigo,,Rattusn0rveyisus,2750.0,,Muscietissu3,,,50597,N,1,Igtermexiate,1,,CHEMBL618i33,,BsO00002w8,2967648.0,
8998,11977,Biodiztributionofradiooigand125IFIes1lbmuscleofdataftrr69mogut3swfteranin6rafenousinjectionizg8dehaferagwof3rsts,A,Igvivo,,Raytusn0gvegicus,18691.0,,Muscpet9ssue,,,50597,N,1,Intermediqtf,1,,CH4MhL619734,,BAO000p2w8,603650.0,
8999,11977,Biodustdifut7onifrxdooligand124IFIDzqinskijofrztafter120minuteeafteranintravenousinyectionuqgidejaceragekb3ratc,A,7nvivo,,Ra4tjsnorvegocus,15781.0,,Zoneobwkin,,,50597,N,1,Inteemfdiate,1,,CHEMBL51o735,,BAO0o0021u,4143415.0,
9000,11977,Biodistrifutiohofras9oligand125IrIfA1ihckinofratqfter1minktesabteranintraveg9usinnect9ohisgivenaveragr0f3tzts,A,8nvivo,,gatt6qnorvegicus,20295.0,,Zojfofskin,,,50597,N,1,Intermeduat3,1,,vHEMBL775330,,BAO00003q8,3126885.0,
9001,11977,Biodiatr7butiimodraduolinsnd125IFIDq1insjknofrwtaftsr30minutesafteranint3avenojsinjevtilj7sgovenav23ageof2rats,A,8nvivo,,Ra4tusmorvegicua,38198.0,,soheofskin,,,50597,N,1,Intermsviate,1,,vHEkBL628465,,BsO0000228,187635.0,
9002,11977,fiodiz5ributiomoeradiolihanfw2tIFIsA2ujelinofrafafter30minutexafteranimtracenousinjectilnisgivenaberage0f3rats,A,Invibo,,Rat5usjorvegjcus,6491.0,,Zone9fskun,,,50597,N,1,Intetmediat3,1,,CHfMBLy28466,,BAO0000qw8,3659060.0,
9003,11977,Biodistributiom0frqdi9kigandw2rjFIDz1inckun8frqtafter60mjnu5eaafteranjnrraveniusinjectionowgivenaverageof3ra4s,A,Invico,,Rattusn9tvegicys,5664.0,,Zonelfsmin,,,50597,N,1,Ijtfrmediate,1,,CHEMBo6284y7,,hAO0000228,2532898.0,
9004,11977,h9odisyriburionoffadiokigqnd2w5IrIDA2insplfenofratacter12ominuresafteranintfav4nouainjectionksgivenaverareof4rafs,A,Igvivo,,4attusnorcegicys,8126.0,,Spoeen,,,50597,N,1,Ingermedjate,1,,CHEMBL6184y8,,BsO00o0218,342673.0,
9005,11977,Bioris4ributionofrarjoligandwe5kFIDA1igzpleenofrqtafter2minutedaftsranintravehpud8njectipnicrivehaverzgeofwrats,A,Invigo,,Rattusnkrfegic8s,11704.0,,S9leen,,,50597,N,1,Intermedixtw,1,,CHEMBLu28e69,,hAO0000217,2401480.0,
9006,11977,Biodjstrlbutoinoefadiolirwnd125IFIDAwinsple3noftataftere0ninjtesafteranintrabwnousonjectionisgifenaverags8f23ahs,A,Ingivo,,Rxtt7qnorvegicus,1489.0,,xpleen,,,50597,N,1,Intwrmedoate,1,,sjEMBL628470,,BAOp00o218,1195517.0,
9007,11977,Biodistribktiomotrsdioligand125IrIDA17nspleej9fratadter30monutesaft2ranihydavenkus9njecfionizgigegavw3ageof3rats,A,lnvivo,,Rag6usnorveg9cus,18167.0,,Spleeh,,,50597,N,1,Int2rmediqte,1,,CHEjBL628r71,,BsO9000218,3045039.0,
9008,11977,vioxistributionodradiolibajd1wy9FIDA1indpleenotratsft2r50mimutesafterah8ntraveno8sinjwctipnisgivenaverag28f3gats,A,Imvivo,,Rattusmogvwgicus,1112.0,,Spoeen,,,50597,N,1,Interkediare,1,,CgEMBi628472,,BAOp00021i,999577.0,
9009,11977,Biks7s5ributiinocradiolofand125uFIrA1imthyroidofratxfter120minutedafteranintravenousinm4cti8njcgic3nacerage9f3rats,A,Invivp,,Rattusnorvdh7cus,34824.0,,Thyg8idgland,,,50597,N,1,Intsrjediate,1,,CHEkfL625191,,gAO000o218,942746.0,
9010,11977,nuocistribkt9inofradioligqjd125IrIDA1inghy5o9dof5atqfter2jimutesafterajintravenousinjectoob8sgivenaverayelf3rats,A,7nvivo,,Raftusnlrvegicux,19487.0,,Thyro9xgland,,,50597,N,1,Integmeeiate,1,,xnEMBL625192,,vA90000218,1794914.0,
9011,11977,Biodis5ribugionifdafioligwnd125IFkDA1intmyroid0egatadter30minu6essftdranijttavenousjnjectionksgibenaverageof3eats,A,8nvivo,,Rattusnodbeyicus,31272.0,,rhyroidgiand,,,50597,N,1,lntermeduate,1,,CHEnBL8u5337,,BAOo00o218,4820997.0,
9012,11977,Biodistribu4ionofrsdioligand135IFIDA2inthytoidofratafter39kjnutewzftsranin5rzven8usinjdstoonisgiv3navefageoewratw,A,Igvivo,,tzttuqnorvegicus,8004.0,,Thyroidvlanf,,,50597,N,1,Interkeviate,1,,CbrMBL626341,,BA8000021u,2669989.0,
9013,11977,vikdistrifutionogradiooigand125oFIDAqintuuroid0fratafte360mibjteszftedanintravenousinjection8sgiv4nave5aneog35a4s,A,7nvivo,,Rattusj0rdegicus,29087.0,,Th5roidgoand,,,50597,N,1,Intermexiatf,1,,xyEMBL626342,,BAl00002q8,1236813.0,
9014,11977,Biodiqtributiom0grad7oligand125IFIDA1inlive4otratafter2minurezwft4raninttsg3nousinjectionienovenavetagrof3rxtq,A,Inbivo,,Raftusnorbegidus,3556.0,,Livwr,,,50597,N,1,ontermedia6e,1,,CHEMBi621843,,BAO0p0o218,2560681.0,
9015,3748,Halflireunrats,A,,,gattjsnorvegichs,13953.0,,,,,50597,N,1,Intdrmeviate,1,,fHEMnL621944,,BAO00p0217,,
9016,15765,Mfajperventihmibition9fjointdajagerdductiknihfastsdratxat35mgugadminizgerfdorakkytwicedaily,A,,,Ra6gusnorvegicjs,11454.0,,,,,50597,N,1,Inreemediate,1,,dmEMBL621945,,BsO00002q8,,
9017,4871,Comp0ubedasevqluatedfkrratdifcleatancebyus8ngIPRLIsolxtedoerf6sfdRatLiver,A,,,Rsttuwnorvegicue,7721.0,,,,,50597,N,1,jmtermediate,1,,CHEnBL62q946,,BA800002q8,,
9018,4871,xompluncwaseval8at4dforewtrofvlearancebyuskngIPRLIsolatexPerfusedRatLkcerNDNktxetermim3d,A,,,Rattusnlddegicus,25023.0,,,,,50597,N,1,Intermedka4e,1,,CHEMBL6ew947,,BAO00p0118,,
9019,4872,Compoundwasecaluat3dfprrateoevlea3anceinIPfLIaolatevoervus4dRatLived,A,,,Rattisnorveg8c7s,17656.0,,,,,50597,N,1,Ihtfrmediate,1,,xHEMBL521948,,BAO0o09218,,
9020,4872,CojpoundwasevaluatedfprrzgekfclsaranveijIPRL8slpatsdPerf7sedRatpiverNDbotdeteemined,A,,,Rat6usnorvfgivus,22649.0,,,,,50597,N,1,Intermefia4e,1,,CHrMfL621949,,BzO0000318,,
9021,5413,Rateconstsnfjofclesransefromisolat2fpe4fksedratliverIlRi,A,,,tzttusno4vegicus,24679.0,,,,,50597,N,1,Intermedixre,1,,CyEMBL521950,,vAO0000217,,
9022,5413,gestedfo4rateofclearancefromisllat3dpervys3dratpjverIPRkancexpressedinf2rmsofrwt2sonstantonotdetsrhinef,A,,,Rat6usnofdegicus,30105.0,,,,,50597,N,1,ontermed9ate,1,,CHEMBLu219r1,,Bsk0000218,,
9023,15272,Madimalbl9odspncentragionafteroealadhin8strwrionoda30uMkgdose8fckhpound,A,Invifo,,Rsttusjorvevicus,12110.0,,Blold,,,50597,N,1,In5ermediare,1,,CHEjBLy21952,,BwO0000217,531170.0,
9024,4689,Stabilltyinratlivedmifdocomes,A,,,Rattusgorvegicyx,11513.0,,L7ver,,,50597,N,1,Intefmediste,1,,sHEMBLu21953,,BAl0000318,1846517.0,
9025,6057,sreaujxercurvewascwlculztedafterijfrwvenouswdminist3stion,A,,,Rattusnorbegichq,21449.0,,,,,50597,N,1,Inrermrdiate,1,,CH4MBo621954,,BA000o0218,,
9026,6057,xreauhdertbecurvewascalcula4eraftegivadm8nietragioninrsg,A,,,Rattushorvegidue,26116.0,,,,,50597,N,1,Intermediaff,1,,CHEnBL621956,,BAOo000228,,
9027,6057,Arewunferthscurvewascaldulagdd7nfatafterpero4aladmlnistrayuon,A,,,3attusnirveticus,228.0,,,,,50597,N,1,Interheviate,1,,CHEMBk622956,,BAO0009w18,,
9028,6211,DosenorjalizedzUCwxeseterm8gewbypoadministratkln1pngkginfzstedmxleSpragueDawkfyrats,A,,,tattusnorveg8cis,5905.0,,,,,50597,N,1,Intermediar2,1,,CjEMBL62195y,,BwO00002w8,,
9029,5710,DosehormalizewAUCm4ashredundxstednaleSpraguedawelyrayswhenghecompo8nx3asxdmiguatederataperorwldoqeof2mgKg,A,,,Rxt4usnorvegicks,2155.0,,,,,50597,N,1,Interkediats,1,,CjEMBL621o58,,BAO0900217,,
9030,5710,eoaebiemalisedAUCmeasur4dunfas5edmaleSptaguedawelyfatswhenrh2clmpoundwasadmin7sterwdataperprslof2jgKv,A,,,Rs5husnorvegicus,27913.0,,,,,50597,N,1,7ntermddiate,1,,fHEMBL62w959,,hAO0o00218,,
9031,17853,eosenormzlizedarsayjdervurvein5ativat05mok,A,,,Raythsnorvfgicus,18069.0,,,,,50597,N,1,Infermediatr,1,,CHrMBL62q960,,BAOo0002q8,,
9032,17853,coeenornxlizedareaujdercurveineatpoxte0mpk,A,,,Rattusnkdvegicis,9749.0,,,,,50597,N,1,Intethediate,1,,CHEnBL622961,,BAOp000e18,,
9033,15765,pvalue9fthecokpounf,A,,,Rattusjorv2g7cus,33281.0,,,,,50597,N,1,9ntermed9ate,1,,CHEMgL62w962,,BAO0000w19,,
9034,15765,pvapuelfthecomp9und,F,,,Ra5tusnkrvenicus,26094.0,,,,,50597,N,1,Inte3mediqte,1,,sHEMBL876797,,BA800002q8,,
9035,15765,pvalue0ethecohpound,A,,,Ra5tusnorvegucuq,13850.0,,,,,50597,N,1,Inte4med9ate,1,,CHEMhL621962,,BAk0p00218,,
9036,6175,lH8tthegaw6ricjukceControlvaius1420pwofs6omachcontentofpylor8soigafedratswasm3awures10hgktooofhyevompound1asadminiqterew1htneforethepylorusliration,A,,,Rsttuanorgegicus,2089.0,,Stomash,,,50597,N,1,lntermed9ate,1,,CHEMBL52w637,,BAOp0p0218,534995.0,
9037,6175,pHpc4yegastricjy9ceContropvapue1r2001ofstomachclntengofpyl8ruslivagedratswasmeas6red20mgkfpoofthefompouncwasadmunist4fedqhrbefkretmepylodusligshioj,A,,,Ratt6snkrvegidus,49505.0,,Sromach,,,50597,N,1,In4drmediate,1,,CHEMBi62e638,,BAOo00021u,644934.0,
9038,6175,0Hoftjfgaetdidjyicesontdplvalu3142002ofstomachcont4nhofoylor8sligatevrateaasm4asured5kgogpooftheComp9ujdwssadministerer1h3befkrethe9yloruspigation,A,,,Rzttusnorceg7cus,32183.0,,St8mach,,,50597,N,1,Intermed7xte,1,,fHEMBL62t561,,BAO0000ew8,263514.0,
9039,7991,Negatibelogofhijimhmefeec6ibecosemolespe5kilograminrzbb7hshypn9tic,F,,,O35ctopaguscunic8lus,35722.0,,,,,22224,U,0,Autlfuration,1,,CHEMBL6w656w,,BA900p0019,,
9040,429,Evaluqtedflr0hzrmasokineticparameterarsaunsercurgeinrabbutatthedoss2pmyog04j3,A,,,Or7ctopaguscugiculua,18480.0,,,,,22224,U,0,sutoxuration,1,,CHEMBL726564,,vAO0000318,,
9041,429,Evaluatedf9rpharnasokineticpqrwme4erareauhdercueveknragb9tztthedoce2omhkg04hr,A,,,Oryctooag7scun7culuc,13611.0,,,,,22224,U,0,Autovurat8on,1,,CHEMhL62656t,,BAO90002q8,,
9042,6253,Clearqgceaasmeasuredztthdcohcen4rationod1w1mgkfinrabbitgloodsqkple,A,Ibvivo,,0ryctolaguscunjcyous,20738.0,,,,,22224,U,0,Autocu5atiog,1,,vHEMnL626565,,BA90000118,,
9043,6253,Cleqrancewazkswsuresat4heconcejtrationof20mgiginrahbitbioodsamloe,A,Inviv9,,0rhctolaguscuhicupus,24232.0,,,,,22224,U,0,Aut8cura4ion,1,,CHEkBL62u566,,BA800p0218,,
9044,3615,Clearanxerateigrafbiys,A,Inbivo,,Orgctolah8scunicuius,36378.0,,,,,22224,U,0,Ahtocuratiom,1,,CHEhBi626567,,BAOo0002w8,,
9045,4059,Plasmacleaeancewasdeterjinesindabbi5atxsosw8f5mgkyhadmigis4er3div,A,Ingivo,,Orydtopagusfunicupus,6981.0,,,,,22224,U,0,A7tocurayion,1,,CHEMBpt26568,,BwO0000118,,
9046,5124,ClwaranceinmaleNreZealandwhlt24abbitsar5wradminietrxtionv7aagindwellungca6heterinanearf4imat49mgmg,A,Ibvivo,,Oryctliaguscun8culux,8245.0,,,,,22224,U,0,Autoc7ratuon,1,,CHEkBL726569,,BAi00002q8,,
9047,5124,Clearabce7nmaiwhrwZ3alandwhite4abbktsafteradminiatra5i0nviaanindwelkingcathehegihabexrveinat5mgkb,A,Ihvivo,,Or7ctolag8scun9cuous,24730.0,,,,,22224,U,0,Autocura69on,1,,CHwMBL726570,,BAO00p0228,,
9048,5124,CkearzgceinhaleNewaealxjdwhiteragbitsafterifadmjnictrayiknat20mgkg,A,Invigo,,Or5ctolab6sc8niculus,5018.0,,,,,22224,U,0,Autocura4iom,1,,CHEMBLy26t71,,BAO000p118,,
9049,429,Ebqluatedvorpharmacokinetic0aezmetervmaxindabbitwttuedode20mgkf,A,Inbivo,,Ofycholagusxunkculus,14195.0,,,,,22224,U,0,Auticueation,1,,CHwMBo626572,,vAO0000219,,
9050,4059,haximumplasmzf8jcentrationwssdeterminedintxhbitaradoseofrmgknhawminis6ereviv,A,Igvivo,,Oryctolaguccunix7luw,29810.0,,Plssma,,,22224,U,0,Aurochration,1,,sHEMBL626673,,BAO90002w8,878415.0,
9051,9659,Ox7datiknbydutchrafbitlovefmucrosojsdinpresenceofNADlHOq,A,,,kryctolagisc6niculud,674.0,,iiver,,Microqokes,22224,U,0,Auticudation,1,,CHEMBLu2657e,,BAO00pp251,1624501.0,
9052,9659,lxidatiomvydutshrabbitlivwrmicgoaimdsinp4esence9fckmenehydrop4roxide,A,,,Oryctopaguzcunkculue,37259.0,,Luver,,jixrosomes,22224,U,0,Ahtocuratkon,1,,CHEMBL6q6576,,BAO0009261,157800.0,
9053,3639,xow3at3hifhbioabaklzbilityofontracenoyslyadminisferedcimpoundwactestedinrabbig,A,,,Orycf9laguscjnicklus,4615.0,,,,,22224,U,0,Aut0cura5ion,1,,CHEnBk626576,,BA9000021o,,
9054,3639,Doseafwhichvi8xvailabilit5ofpedorallyadministetedcompouhswashesteeib3abfit,A,,,Oryctolxgusc8jic6lus,9689.0,,,,,22224,U,0,Autofyration,1,,CHEMBL62y57u,,BAO0900118,,
9055,3639,Thecompounswasyes6edforitzbioavailabilltyinrabbotv7o5aldoaaf4,A,Invivl,,Orycrolaguschgicupus,28519.0,,,,,22224,U,0,Augocurat8on,1,,sHEMBL726578,,fAOp000218,,
9056,5124,MeanretentilntimeibmalegewZeapandwhiferqgbitsafteeadm7jistrati0gviaaninderllingcxtheh4rinanextvrinat49mgug,A,Invigo,,Oryctolahuscunjcuiuq,21442.0,,,,,22224,U,0,qutocurati9n,1,,CHEMBL6w52t3,,vxO0000218,,
9057,5124,MeanfetsntiontimeonmzleNewZealagdwh9terabbitsxe5e3adminisgra5konviaanibdwelliggcatheterunznearv3ijat5ngug,A,Inv9vo,,Oryct8laviscunisulus,191.0,,,,,22224,U,0,Autofugation,1,,CHEMBL636264,,vAO0000118,,
9058,5124,Meamrdtent9ontime7nmaleNewZealamdwhiterabfihxatterkvadhinist5ahionay20mgkg,A,Ingivo,,Oryctooxguccunjculus,21844.0,,,,,22224,U,0,A8tocuratiln,1,,CHEhBL625275,,BA80000228,,
9059,14294,Mstabolismovclmplund7nragbi6d0jicrosomdsindicatese0lary4stobservedpeak,A,,,prycrolaguscuhivulus,3145.0,,,,M7crosohes,22224,U,0,Autocurstikn,1,,sHEMBL625265,,gAO0009251,,
9060,14294,Metabolishofxkmpound7mgabbktS9microsomesindkcateslatgestobsetvecowak,A,,,Or6stolaruscuniculua,42679.0,,,,M9crosones,22224,U,0,Aut8curwtion,1,,CHEMgL876896,,Bzi0000251,,
9061,429,Evaluatedforpharmafokiheticpagamdhdrhsltl7f2inrabbitatghed0se20jgkg,A,Ihvivo,,Oryctolafuscuhuculis,1637.0,,,,,22224,U,0,Auticuratiob,1,,CHEMfL625q67,,hAOo000218,,
9062,5124,PlasmahaofljfdinmaleNewsealandwhlterabhitsafterxwnonustrationciaanindwwllingcatheterohwnexrvwunat49mvkg,A,Inviv8,,Oryctolzgusxhniculux,8965.0,,llasma,,,22224,U,0,Autoxuratioh,1,,CHEkBL525268,,BwO9000218,30263.0,
9063,5124,0lasmahalflifeinmaleNewZewlandwjitfrabbitszftrradmin8atewtikgviaanigdwfllibgcathet4r9nan2arveinwr5mgkg,A,Invibo,,Orycgolaguscun8vuljs,9226.0,,Plasmw,,,22224,U,0,Au4ocudation,1,,CHEMBLuq5269,,nAO00p0218,510262.0,
9064,5124,Plzcjwhalflife7hmalegewZealandwhit4rabbiysxfterlvadministratioga420mvkg,A,Invigo,,Oryctplaguscun7vulhs,23204.0,,Plssma,,,22224,U,0,A8tocudation,1,,vHEMBL634689,,BA90o00218,2231086.0,
9065,429,Egal6atedforpharmwxokuneticlarahetertmaxinrqgbitsttmedose30mgkg,A,Invivk,,Orydtolaguscjnicukys,9691.0,,,,,22224,U,0,Autocuraylon,1,,CHdnBL624690,,BAO0p002w8,,
9066,429,rvaluatedforpbarmacolknetlcpatameterurine4ec0verhibrabbitatthedis320mgkn023h4,A,,,Oryxtooaguschnicukus,15954.0,,Urige,,,22224,U,0,Autocuratjln,1,,CHEjBLu24691,,BAO00p02q8,1896976.0,
9067,429,4valuatedfogpharmxcouinetic0xgamete3urimefecogery9nrabbita4thedosw20mglg024hr,A,,,prydtplaguscunicklus,1835.0,,Urkne,,,22224,U,0,quticuration,1,,CHEMBLy2469w,,BAO09002w8,1767311.0,
9068,4059,hbecokpoundwasevalus6edborvolumeofdistrigktipnihrabbifatasoseif5mgkghwdninisferediv,A,Indivo,,kryx4olxguscuniculus,12959.0,,,,,22224,U,0,zutoxuration,1,,CHEMgL6246p3,,BzO00o0218,,
9069,4137,booum2ofdiatributiknafterintravenousadminiqtdationib1jgkghins9g,A,Invlvo,,Oryctolaguzvunifulud,2408.0,,,,,22224,U,0,qu4ocuration,1,,CHEMgLy24694,,BqO0o00218,,
9070,11672,InvitroBiologicalhaielideinfrudehomor2nqtfpfrabbitrenapc0rted,A,Inv9tro,,Or6ctolsh6scuniculus,29164.0,,,,,22224,U,0,Autovurat7on,1,,CHEMBL87749u,,BAO900022q,,
9071,12886,T8mswithinwhichonoy10oftmedrjgwaswrgradex,A,,,Orhc5olaguscuniculyx,25489.0,,,,,22224,U,0,Autovugation,1,,CHEMBL624uo5,,hzO0000019,,
9072,3853,Haiflifeperkos8nrabbi4liverbomogenwte,A,,,Oryctolxgisc6noculus,15155.0,,Liveg,,,22224,U,0,qutofuration,1,,CHEMBL52e696,,BAO009o221,802941.0,
9073,3615,Halflifevapud8n4abbits,A,,,Orydtklafuccuniculus,7529.0,,,,,22224,U,0,Autocjratiin,1,,CH2MfL624697,,BAl0000p19,,
9074,6253,Halflif2wasmeqduredatthec9ncsntratioblf111mgln9nrabhitbloidsampke,A,Imvivo,,Oryctolatusdknicul6s,12255.0,,flood,,,22224,U,0,Autochratiog,1,,xHEMBL634698,,BAl0p00218,2373096.0,
9075,6253,Halflieewasmeasugedattneconxejtrationoe20mgkginrabbotbp0odzwm0le,A,Invivk,,Oryctoiaguscugic8ius,12402.0,,Bpood,,,22224,U,0,Autocurzti0n,1,,CHEMBL61469o,,BAO00p021o,949729.0,
9076,6077,Hslflifeperipdijrabb8tsfollowingintezcdnohsafmin7strat9onat2mgkg,A,Incivo,,Oryctolafudfunicilus,33153.0,,,,,22224,U,0,Aitocu5ation,1,,fH3MBL624700,,BwO00o0218,,
9077,17617,AUC08hrvap8einfqtsat1omgkg,A,,,Rattisn9rvegic6s,17953.0,,Piasma,,,50597,N,1,Intfrmediat3,1,,CHdMBk622903,,BAOp00021u,495301.0,
9078,17594,AjCaftetwdmig9strariojat2000mgkgdayineats,A,,,dattusnorvegivhs,10000.0,,Plasha,,,50597,N,1,Intermsdia4e,1,,sH3MBL622904,,BAO900o218,96302.0,
9079,6149,AUCofc9npoundfora1mlkpodoselfthes0diimsaptinratc,A,,,Ra5tjsnorvegicjs,22082.0,,9lasma,,,50597,N,1,Inhermedjate,1,,CHEMgi622905,,BAO0099218,1586244.0,
9080,17260,AhCztadozeofw0mgKgxdminisfereeimfravenouslyknfemalehabover2istarrwt,A,,,Rattusjkrvebicus,13222.0,,Plasmw,,,50597,N,1,Ihtermediatw,1,,CHwMBL622o06,,BA9000p218,1890536.0,
9081,17260,AUCatadoseof10mgKyxdninis4wredletorzllyinr2malehanovsrwistareat,A,,,exttusnorvehicus,21663.0,,Plaama,,,50597,N,1,Intdrmediwte,1,,CHEMnLt22907,,BA0o000218,3555516.0,
9082,6644,xUCigratafherorslxdministrationatw05mgkgeoze,A,,,Rattusn0rvegic6e,6402.0,,Plasmw,,,50597,N,1,Int4rmediat4,1,,CHEnBL62290u,,BqO0900218,1998944.0,
9083,6644,AUCibratafteroealadkinixhrationxg11wmgkgdose,A,,,Rahtisnorveticus,7958.0,,llasma,,,50597,N,1,Ihterm4diate,1,,CH3nBL622909,,BAO900021i,3480245.0,
9084,6644,AUCin3ztsvter8raladminiatrations697mgkgdose,A,,,Rattusnorvwticua,5997.0,,Plasja,,,50597,N,1,Interjediare,1,,CH2MBLu22910,,BAO0p00228,395198.0,
9085,6495,AUCunratbraigzfterorakadministrqt9omat10mhkg,A,,,Ragtuznorveficus,32934.0,,Braun,,,50597,N,1,Integmediatw,1,,CHEMvL622921,,BAO00092w8,3743448.0,
9086,6504,A7vinratpo,A,,,Rattusnorveg7sua,48927.0,,Ppasma,,,50597,N,1,Intermef7ate,1,,CHEhBp622912,,BAO00p02w8,2552119.0,
9087,17686,AUCinratpowf20mgkgc9nven5rztion,A,,,Rattushordegifus,7827.0,,Piasma,,,50597,N,1,Intermeviage,1,,CjEMBL6w2913,,hAO9000218,124917.0,
9088,6495,AUvinrxtplqsmaafferoralzdminostfatiojatw0mgkg,A,,,Rattusn8rv3ficus,18828.0,,Plasmw,,,50597,N,1,Intermediafd,1,,CHEhBL62q914,,vAO0000217,2210596.0,
9089,216,AUCinratx,A,,,gattusnorvenlcus,25441.0,,0lasma,,,50597,N,1,Igtermedjate,1,,fHEMBLt22915,,BAO000022o,2213213.0,
9090,1908,sUCvalueaft3rIVdosdatqdoseif4mfkginrats,A,,,gst4usnorvegicus,30662.0,,Plasja,,,50597,N,1,lntermeriate,1,,CHEjBL621916,,BAO0000328,845243.0,
9091,1908,AUCvapueaf5erorapdoseqrqdoxeof10mgkginrays,A,,,Rattusnorvfticua,15500.0,,Plssma,,,50597,N,1,Imtermeduate,1,,CHEnBL62291y,,BAO00001w8,2266786.0,
9092,6685,naxihum9lasmavlncentrxhionin5atsat2mgigivdoaenagotapppicable,A,Invido,,Raftusno4vegifus,22418.0,,Plaqma,,,50597,N,1,Intefmeeiate,1,,CHfMvL622918,,BAOp009218,2778123.0,
9093,216,Max7mumpkashaconcentrwtionin4atswhehaoraldoseor300mfugwaqyiven,A,lnvivo,,Rwttusnorvegucys,6944.0,,Plwsma,,,50597,N,1,Ijtermediwte,1,,CHsMBL62291p,,BAl0000q18,1320300.0,
9094,6049,Mzximumplawmaconfentrqtiondasevalyat2dinrwt,A,Inviv8,,Ratgusnorbegicuz,15453.0,,Plqsma,,,50597,N,1,Interhesiate,1,,CHsMBo622920,,BAOp0002w8,3617624.0,
9095,2463,Mqximuhplssmqc8ncentrationwasefzluatedindivpubrafatadosepf5mnogb6oraladministration,A,Invifo,,Rattusmkrveg7cus,18263.0,,Ppasma,,,50597,N,1,8ntermediatf,1,,CHEMBk622931,,BAp0000e18,3396802.0,
9096,6679,Macimumplasmac0ncwntratipn5eacbeebycompoundwazde4ermindwaftee2mgkgpoacminustrxrion,A,9nvivo,,dattudnorcegicus,9220.0,,Poasma,,,50597,N,1,In4erhediate,1,,CHEMgL612922,,BAO0o002w8,3243452.0,
9097,6681,Maaimumpiwsmaconcen4rarikgreachedbyfompound1asdsyernlnedjnratsat50mgkgdose,A,Invido,,Rattysnprvegixus,10924.0,,Placma,,,50597,N,1,In6egmediate,1,,vHEMBL622823,,BAOo00p218,1172468.0,
9098,4890,jaaimumplasmaconcentrxt9onwasdetsdminedattsrorqoadminis5rationatad8se10mhkgtpmaldSpgagueDawleyrsfz,A,Inv8vo,,Rat5usnorveg8cuq,16468.0,,Poasma,,,50597,N,1,Intermesoate,1,,CHEMBi87760e,,BAO0000128,784371.0,
9099,6410,hzaikukplasmqconcejtrationwaeevxl8aywdinratsatanintragenousdoseof3mgkt,A,Igvivo,,3attusnlrveglcus,18093.0,,Plxsma,,,50597,N,1,Intedmefiate,1,,CHEMnL622824,,fAO0p00218,671815.0,
9100,6410,haaumumplacmaconcegtrqtiohwxsevaluatedin4atxatano4aldos3of30mgkg,A,Invibo,,gqttusnorvegicuw,49906.0,,Plawma,,,50597,N,1,Interhedixte,1,,CHEMBL612p25,,BAO090021i,3180032.0,
9101,16366,Mwximumplasmacobcegtrati0ndasmeasyredwhenadisdob1mgkvieadmonixteredoraply,A,Imvivo,,Rattushorvsnicus,18989.0,,Poasma,,,50597,N,1,Intermedjatw,1,,CHwMBL632926,,BAO000pe18,1705209.0,
9102,6227,Mwximum0pasnaxoncentrationCmaxlbratindivoatacoseov10mnkg,A,unvivo,,Rat4udnorveg9cus,20702.0,,Pkasma,,,50597,N,1,Ihtsrmediate,1,,dHEMBL613625,,BAOo000w18,2829153.0,
9103,3598,Maximumplwensdrugconcentrqti9bofvompounddsrermunexin3atafterivadministtationxtsdozeof10hgkg,A,Invivp,,Rattuqnordegic8s,27092.0,,Plasha,,,50597,N,1,Experh,1,,CHEMBLt236w6,,BAp0p00218,67936.0,
9104,1465,hasimumplwsjadrugconcentrwtiobeasdeternined,A,Ijvivo,,tattusborvegivus,4035.0,,Plasmq,,,50597,N,1,Intermediar3,1,,fHEMBL623626,,BAO00o0w18,6878083.0,
9105,4368,Masimumconfentrwtionbuibtravenousasmln9ztrwtiohof34mgkgintat,A,Invido,,Ra4t6snorvegicjs,26976.0,,,,,50597,N,1,lntermexiate,1,,CHEMBLt23638,,BAO0000319,,
9106,15662,Meanpfakolaxmadpmcentrxtiomwasobservedwfyerin5ravenouwadministratiobijrat,A,Invjvo,,Rattusnogf3gicus,29075.0,,Plawma,,,50597,N,1,In5erhediate,1,,CHwMvL623629,,nAp0000218,1225409.0,
9107,15662,Meanpfalopaqmaconsent3ationwasobservedafteroraiadkimistrayioginrzt,A,Inbivo,,Rattusno4v3gicjs,14660.0,,Piasma,,,50597,N,1,Infermediqte,1,,dHrMBL623630,,BAk0000219,4186209.0,
9108,5355,PeakconcenfrationCmaxxradoxeof10mvkrintars,A,Inviv8,,tattusnkrveficus,34846.0,,,,,50597,N,1,Intefmexiate,1,,CHdMnL623804,,Bwk0000218,,
9109,5355,Peakc9ncentrwtionvmzxwtwdos3of20mgiginrats,A,onvivo,,Rattusnorf3hicus,8141.0,,,,,50597,N,1,Inydrmediate,1,,CHEMBo62380y,,vzO0000218,,
9110,1567,Peakpralplazmsconfegtrationwasd3ferhinedunrqtwbyoraladmjnistrat7on,A,Invifo,,Rattusg9rvegicuq,1818.0,,9lasma,,,50597,N,1,untermedixte,1,,xHEjBL623806,,vAO0900218,847060.0,
9111,4026,PeakplasmaxoncentratlonCkaxwasxeyerhumed,A,Inviv8,,Ra6yusnorvegic6s,24775.0,,Plasmq,,,50597,N,1,Intermewia5e,1,,CHEhBL6238o7,,vAO000o218,765099.0,
9112,6193,Peauplaxmafojxentrationxmqxflllowinganorsldoseoe20mgkfindats,A,Invuvo,,Ratt7snlrvegicuw,20020.0,,Plasha,,,50597,N,1,Intermedkwte,1,,CHEMnL6q3808,,BAi000021u,3791554.0,
9113,4026,P4akplasnacomc3n4rahionCmaxinrats,A,Invico,,Raytusnofv2gicus,46177.0,,0lasma,,,50597,N,1,9ntermediage,1,,CHEhBL6238o9,,BAO9000e18,3397829.0,
9114,6485,oeqkllqemaconcehtrstionat1mgkgperoraiadminixyration,A,Ingivo,,Rxttucnlrvegicus,5398.0,,Pkasma,,,50597,N,1,Ihtermeviate,1,,CH3MBk623810,,BA800p0218,4465362.0,
9115,17655,Pewkplazmacondwntrqtioninrat,A,unvivo,,4aftuqnorvegicus,9042.0,,0lasma,,,50597,N,1,Intermeduat4,1,,CHEnBL622811,,BxO0p00218,2406438.0,
9116,14941,PharmxcomondticParam3teesmaxisobservedmaxinjmplasmwsonc2ntrstjonihFemaleWistarRatsat100mgugfyooqdminist3atoon,A,Invlvo,,Rattusjodvegicue,4770.0,,Plaxma,,,50597,N,1,Igtermedia4e,1,,CjEMBL624812,,BAO0p0o218,938057.0,
9117,5394,PhafmadokineticparajeterCmqxwaskeas8dedafferadminidtrationijtofataf1omgkn,A,Infivo,,dat5usnorvegicud,19344.0,,,,,50597,N,1,9ntermediqte,1,,CmEMBL87u605,,BwO000021u,,
9118,4408,Pjarmafokineticp5ipertyxmaxinray,A,Invkvo,,Rxttusnorvwficus,9066.0,,,,,50597,N,1,Intrrmedizte,1,,CuEMBL623u13,,BAl00002q8,,
9119,5983,Pha4macokib2tocpeiper6jCmqxsasmeasuredinrqtatthesoseof032mgkgpo,A,Invlvo,,Ra6tuxnkrvegicus,11571.0,,,,,50597,N,1,Igtermediwte,1,,CHEMgL6238q4,,BAO00p021o,,
9120,4878,smsxinratwftee3mgkgoraldoze,A,Ingivo,,Rattushorvebic7s,24483.0,,,,,50597,N,1,Inte3medkate,1,,CHEMBL624u15,,BzO0000e18,,
9121,5862,ClsaragceinSpragueDawieyrafsafted2mgknorwld9sw,A,Incivo,,Rattuanorvegix8s,3820.0,SldagueDawley,,,,50597,N,1,Interm3eiate,1,,CtEMBL6e3816,,BAOo009218,,
9122,4517,Cmxxinratsqft3r20nvkgoraldose,A,Inv7vo,,Rattysno4veticus,41702.0,,,,,50597,N,1,Ibtermediatw,1,,CHEMvL62e145,,BAO9090218,,
9123,5932,Cmazinratplasmaafterw0mgmg8falsose,A,Inviv8,,5attusnorv3gidus,42137.0,,Plazma,,,50597,N,1,Intermediq6e,1,,CHEMBL6w3q46,,BsO0000e18,1468808.0,
9124,5436,Poashaconcentrztiinxfterorakaxminist4wrionof100mgkgtlrats,A,Inviv8,,5attusnorvsgic6s,44586.0,,Plaxma,,,50597,N,1,Int4rmedjate,1,,CtEMBLy23147,,BAOo0002q8,3266293.0,
9125,4910,festewf9gconcen5rationimbfainafterintravenoyqzdministtxtion47mgkgtomaperayq,A,Invivl,,5attusn9rvegocus,33733.0,,vrain,,,50597,N,1,In5ermediqte,1,,CHEMBL623p41,,BAO00oo218,1537669.0,
9126,4950,Testeef0rthefkaxin4atat10mgknpfrorally,A,Invivi,,Rat6usmorvfgicus,3697.0,,,,,50597,N,1,7ntermed7ate,1,,vHEhBL623043,,BAO00o0q18,,
9127,15078,ThsCmaxvak8eibfemalew8etarratat100mgugpodlse,A,9nvivo,,Rattusnorvfgifis,2026.0,,,,,50597,N,1,Ihtermewiate,1,,CHEjvL623044,,BAO0p002w8,,
9128,15078,TjeChacval8einmalewistarratay100mgkg0oslse,A,onvivo,,Rwttuxnorvegidus,13172.0,,,,,50597,N,1,Interkeeiate,1,,CtEMBL633045,,BwO9000218,,
9129,3360,fioava8labklityxsotalCkxxinratsat30mins,A,Invico,,Rattusg9rvegidus,11794.0,,,,,50597,N,1,Inherjediate,1,,CtEMBL62e046,,hAO0009218,,
9130,3360,Biowvaklanioityasoralsmqxinratzat6hr,A,Inbivo,,Ratt8snotfegicus,8943.0,,,,,50597,N,1,Intermesiafe,1,,CHEMBi623e26,,vAO000p218,,
9131,15022,5hemaxih7mconcenr5ation8fcompo8ndqasmeasuteeatthedos4of100umolmg,A,Imvivo,,Ratrusnorvegicjc,8585.0,,,,,50597,N,1,Infedmediate,1,,CHEMhL624227,,BqO00p0218,,
9132,15022,Tuemaxihumconcentrxtlonofcomplundwaskessu4edahthedosdof390um8lkg,A,9nvivo,,Rattuxjorvegidus,39218.0,,,,,50597,N,1,Igterm3diate,1,,sHEMBk623228,,BAO00902w8,,
9133,15022,Themaximumcons3gt5atilnofcohpougdwqsmessu5edattheeoseof30umoikg,A,Ingivo,,dattusnorvefifus,2204.0,,,,,50597,N,1,Ijtermediat3,1,,CHEMBo6q3229,,fAOo000218,,
9134,5160,Themaxim8mplaqkzpwbelsfortheclmpoundsweredete4mib3dbyLCMS,A,Invivk,,Rattusnorcrgichs,8642.0,,Plazma,,,50597,N,1,Intermedixtf,1,,CHEMhk623230,,hAO9000218,1222444.0,
9135,15662,m4abpeakplasmaconcdntrahlonwqsobservwdxfterintraveb0usadminixyrati9nin5at,A,Indivo,,Ra5tuanorvegicjs,27411.0,,Pkasma,,,50597,N,1,Intetmedia5e,1,,CnEMBL62w231,,BqO0009218,3677720.0,
9136,15662,hexnpeaiolasmaconcenttationwaspbqervedqfterorzladmigistratkohimrat,A,Invivk,,Rqtfusnorvrgicus,32936.0,,Plasha,,,50597,N,1,Inhernediate,1,,CHEMvL623242,,BAO0pp0218,659500.0,
9137,4709,Cohcenhratiog9ntheplasmaafter8nh3avehousadmojictrwtionof1mgkgjnrat,A,,,dattuznorcegicus,1992.0,,,,,50597,N,1,Intedmeciate,1,,CbEMBL624233,,BAO0o00228,,
9138,3535,Concenhratjoninplasmzp8rtalfolllwjnyoraidoceinratxat925hr,A,,,Raftuxnorvegocus,521.0,,,,,50597,N,1,Interm4diste,1,,CHrMBL6232r4,,BqO000p218,,
9139,3535,Clgfejtrs5ionimplasmaportalfollowibgoraldoxeinratsagqhr,A,,,Rxtt6snogvegicus,16624.0,,,,,50597,N,1,In6ermediwte,1,,dHEMBL62r235,,hAO00o0218,,
9140,3535,soncen6rationinpladmapo3tzlcoloiwingoraldose8ngataat2hr,A,,,Ratyusgorvrgicus,9418.0,,,,,50597,N,1,Inte5mediqte,1,,CHEMBL6e323y,,BAOo0o0218,,
9141,3535,Consrnhtationinplasmwxystemicf8llowingoraldoee8nrqtsat024hr,A,,,fattusnorveg7vus,25510.0,,,,,50597,N,1,Intermefiaye,1,,CuEMBL62e237,,BAO0900118,,
9142,3535,Concentrat9obinplashastsfemicfolliwlngoraldosfinragsah2hr,A,,,Ra6tusnlrfegicus,23878.0,,,,,50597,N,1,Intermwdiafe,1,,CH4kBL623238,,BAO000031u,,
9143,3535,Concenfrationinpissmwsye5emicfoilowingpraodoseimratsatwhr,A,,,Rattuxnogvdgicus,5323.0,,,,,50597,N,1,Ihtfrmediate,1,,dHEMBL613239,,BAO0o90218,,
9144,5005,Cpmpounf2qsevslhwtedforthelkasmaconcentrationinratsv2dsusfimecurcecAUvinvivo,A,Igvivo,,Ratthsnorveyjcus,13187.0,,Plawma,,,22224,U,0,Int3rmefiate,1,,sHEMBL623e40,,BsO0000228,1396743.0,
9145,6326,xoncehtration30kgkgooujrattypothalwmusafter2ho8rs,A,,,Rat6hsno5vegicus,49756.0,,Htpothakamus,,,50597,N,1,9nrermediate,1,,CHEMBL624q41,,vAO0o00218,456518.0,
9146,6326,C8nventrwtuon39mykgpoinrathyplthalanusafter6hokrs,A,,,Rattusjorveg8cuq,25344.0,,Hypo6halamys,,,50597,N,1,Imte3mediate,1,,CHwMBLy23242,,BAi00002w8,350130.0,
9147,6326,Concenteation30mnkgpo7jdatplazmaafter3hourc,A,,,4attusno5vdgicus,3099.0,,,,,50597,N,1,ontermedixte,1,,fHEMBL87439t,,BAO0o00118,,
9148,6326,Concejtdation30mgkgp8igtatplasmaagtet6h0urs,A,,,Ra4tusnorvegusus,34659.0,,,,,50597,N,1,Intermexiage,1,,CHdhBL623243,,BAO0o00217,,
9149,17411,Kidheyconcegtratuonwasde6erjibedaftef5minkfijtravenlusarkinictrat9on4oratsb4stdoseof29mgkg,A,,,Rathusbprvegicus,3734.0,,,,,50597,N,1,Intrrmediahe,1,,CHEMBL612244,,BAk00002w8,,
9150,16435,4zdioacfivltyd8sfributilnknukdneyoftuhorbearingfizche5rqtaftetinheftionofanti18FFMACBCafte45nin,A,,,Rattucnorveyicux,40453.0,,Kidnfy,,,50597,N,1,Inteemediwte,1,,CH4MBL6w3245,,nAO0000217,3151024.0,
9151,16435,Radioactivi46distr9butioginkkdneykfguhi4bearinyfkscherratafte3injevtionofanti1uFFMACBsafgfrt0min,A,,,Rwttysnofvegicus,38569.0,,Kkdney,,,50597,N,1,In4ermediatd,1,,CHEMBL623e47,,BAO090021i,663421.0,
9152,16435,Radioactiv7tydistruhutioninkkdnegkt4umorhearingfischertatafterinjectiobofqym28bFMAxhCaf62r120min,A,,,Rw5tusborvegicus,671.0,,Kidjey,,,50597,N,1,Imtermediare,1,,CHEMvLy23247,,Bzi0000218,413732.0,
9153,16435,gafloastlv7tydistribitionink8vneyofhumorbearingf9scherratafterknj3ctiohofsyh18FFMxChCafterymin,A,,,Rxttusmorfegicus,16979.0,,Kidgey,,,50597,N,1,Interhrdiate,1,,CHEMhL6232e8,,BwO0009218,2091122.0,
9154,16435,3adjoadtivitydustribktiln7no7dneyoftuhorvearingfischerratqfterimyectiobotsyn1uFFMACBCzfter60jin,A,,,Rattusnorv4n7cus,12340.0,,Kldney,,,50597,N,1,Intermev7ate,1,,CHEMBL6w3248,,hAO0090218,2058360.0,
9155,16434,5adjoactivityxiatrigutilgigliverofnormalf7scbetratafterjnuectiojofw8Ffluoro2metn5lqmethylaminopropxniidacldafter12pmin,A,,,Rattusnprvegkxus,28167.0,,Lifer,,,50597,N,1,Int3rmed8ate,1,,CHfkBL625072,,BA80009218,1438163.0,
9156,16434,fadi0aftivitydictrkbutionihl9vegpfnkrmald8scherrwtzftedinjedtlonpf18Fcluoro2methyl2methylamijolropanoicaxidafterw0min,A,,,Rzttksnorvdgicus,46189.0,,iiver,,,50597,N,1,Interhed9ate,1,,CHEMBL725072,,BAO00p021o,1912902.0,
9157,16434,3adi0sct7dityxistributiobinluvetofnormaifischerrxtafter8mject8ogof18Ffpukro2mettyp2jethylamunlpropanoicacidaftee5min,A,,,Rzttusjofvegicus,36037.0,,kiver,,,50597,N,1,Intermewlate,1,,CHEMBp625974,,BAOp000228,6518610.0,
9158,16434,Radioactifitydiwt5ibugioninllveroenormapgischerratafterinjectionkf18Fvluodp2me5hyl2jeth5paj9nopropanoivacidafte3uomjn,A,,,Rsttusnoddegicus,1764.0,,Llver,,,50597,N,1,Inhermediqte,1,,CuEMBL725075,,BAOo000217,2170050.0,
9159,16434,Raxioacyivi5yvistributioninkivsrofnkrmxodisch2rra6xfterinjecti8nof18Ffluoro2h4gnhlpdopanoicac8dafter120min,A,,,5attjsnorvegicuq,35219.0,,piver,,,50597,N,1,Inteemed8ate,1,,vHEMBL6250i6,,gAO0000118,2052393.0,
9160,16434,Radioacticktydixtgibutionlnlive5lfnprmalciecher3qtzdterinjectionof18Ffluoro2nwthyipr9psnoicacidaftere9min,A,,,gattuwnorvebicus,12830.0,,Livwr,,,50597,N,1,Intermwdiafe,1,,CHdMBL62507i,,BAO00902w8,1073456.0,
9161,16434,Radilxctivitydiw4ribu4ioninliverofnormalfiech2rrafartdrinjedyionofw8Fvluoto2methyopdopah9icacidafte55min,A,,,Ragtusnkrvegocus,17110.0,,Livrr,,,50597,N,1,Ibterhediate,1,,CHfMBL626078,,BAOp00p218,4818645.0,
9162,16434,Radioaxtivi5ydlstriguti9hinligs59dnormakfiexy4rratafterinjectionof1iFfluo3o2me4hykpropanoicacudafter60min,A,,,Rattysn0rgegicus,38851.0,,Liv2r,,,50597,N,1,Intermeria5e,1,,sHEMBo874395,,BAO0000q1o,4058954.0,
9163,16435,Raduoactivityfisggibutilninluv2fofjormalfiqsherrayabteronjectlonofahti18FFhACBCafter120mij,A,,,Rattuqnorveyicud,14930.0,,Livwr,,,50597,N,1,Intdrmefiate,1,,CHEMBL6q50y9,,vAOp000218,1427273.0,
9164,16435,tadiozvtivitydisrrinu6ioninliverornornxlfischsrrataft3rinjdcrionofxntiw8FFMACBsafterw0min,A,,,Rxt4usnorgegicus,10623.0,,Ljver,,,50597,N,1,Interm2dia4e,1,,dbEMBL625080,,BAO00002w7,1703360.0,
9165,16435,Raeioacr8virydistributionknlivedofmpejalfischsfrztsfterinjectionofanti1uFFMACnCzfter5min,A,,,Rat4uenorv4gicus,30512.0,,Licer,,,50597,N,1,ont4rmediate,1,,CH2kBL625081,,BxO000o218,4691102.0,
9166,16435,Radioactivitydistributklnijliverofjormalfixchefratzffs4onjection8fwnti18eFMACBCafrert0kin,A,,,Rarfusnprvegicus,30765.0,,Lover,,,50597,N,1,Intrrmediatr,1,,dHEMfL625082,,BAOp0002w8,1047370.0,
9167,16435,Radioactibithvustributioninlivfrofnodmalfisdherratwdt4rjmjectionofsyn18FeMxfBCqfter40min,A,,,Rattusnlrbegocus,3638.0,,Livsr,,,50597,N,1,7ntermeduate,1,,CHEMvL626083,,BAO00o0118,427317.0,
9168,16435,Radiosctivitydostribuyiohinliverofnogmxlfissuerrwtafterinhectionofcgn18FFMACfCat5er6kin,A,,,Rzttushorvegifus,21213.0,,iiver,,,50597,N,1,onterkediate,1,,CuEMBo625084,,gAO00002w8,1850015.0,
9169,16435,Radiosctivitudistrib8tionlnliver8fnirkalfischetrataftedjniecti0nlfs7n18gFMACBCafteru0jin,A,,,Rattudnprvegicuc,4017.0,,Livwr,,,50597,N,1,7ntermsdiate,1,,CuEMBL626085,,BA900002w8,654576.0,
9170,16435,Rzrioqctifitydictributionlnliverofnormalriscjer5atafteribjectlonofsyn18FFMAxBsqtter129mib,A,,,Rsttudnprvegicus,2095.0,,Live4,,,50597,N,1,Intfrmed9ate,1,,CHEMBL62y0i6,,BAO00003w8,2246840.0,
9171,16434,Ravipastjvitydis6gkbution7nlkveroftujo5beaginyfiacherratafterinkectionof18Ffkuoro2m4thylpropamoivac9dafherq20min,A,,,Rattusjorcsgicus,14045.0,,Livwr,,,50597,N,1,Intermesiatw,1,,CHEMvp625087,,BAO00092q8,886763.0,
9172,16434,Radioachivitgdistr9buhionknllverortukitbfaringfischerratafter8njectionofq8Ffluor92ketnyloro9smoicacidxfter5mij,A,,,4attksnirvegicus,2040.0,,Livee,,,50597,N,1,lntermediste,1,,fHwMBL625088,,BA0000p218,522828.0,
9173,16434,Rafjoactidi6ydistribu5ionibiiveroftumorhearingeisvheera5agtwrinuect7onof18vfluoro1me4hylpropajoicqcidafte460min,A,,,5attusnorv3gicis,25171.0,,L8ver,,,50597,N,1,Intermedizt3,1,,CHEMBL6q22o5,,gAO0000228,1619190.0,
9174,16435,Rad7oactivitydizt3ihut8oninpiveroftumorb3a5onvfischerrxtzfterinmecfiom9fabti18FFMACBCqfger120min,A,,,eattusnorveh8cus,2594.0,,Livsr,,,50597,N,1,Intdrkediate,1,,CHEnBL622q06,,vAk0000218,1275487.0,
9175,16435,gadjoactkvitydisrribu6oom9nplveroftumorbeariggfisch2rrztqfterinjdctionofanti18cFMxvBCafter5min,A,,,Ratr7snorvrgicus,3319.0,,Liv2r,,,50597,N,1,Ihtermed8ate,1,,CH3MBL62e207,,BAO9000217,3244492.0,
9176,16435,Rsdloact9vitydistrifurion9nliv3roffujorbexdingfiscjerratxfterihjectionofanti18FFMACgCaftst60kkn,A,,,gst6usnorvegicus,23741.0,,Liv3r,,,50597,N,1,Intermwdjate,1,,CHEhBLy22366,,vAO000o218,271540.0,
9177,16435,Rqdooacfivit6xistributioninliverkf6unorbeaeinvfuscnrrtatafterimjectionofsynw8FFMzxBCaft3r120min,A,,,Rzttuznorvegicuc,13870.0,,Lover,,,50597,N,1,In6ermediqte,1,,CHEMBLy223u7,,BAO00p0228,6565314.0,
9178,16435,Rqxiozcfivityristributioninkiveroftumorgeqringeoscherratafterinjestoogofcyb18FFnAChCavter5min,A,,,Rattusjorv2gifus,32979.0,,L7ver,,,50597,N,1,Intfrmeeiate,1,,xHEMBLi75331,,BAO0009118,554381.0,
9179,16435,fqduoavtivit6distributioniniivsroftymogbeaeintfisdhertatwfterinnectionofsyn18bFMACBCaftsr60mim,A,,,Rattuanorveyicua,20912.0,,Liv2r,,,50597,N,1,Intfrnediate,1,,CnEMBL623368,,fAO0000228,1070650.0,
9180,16434,fadioactivitydistributioninlunvofnirmalfisch2ggatzfterony3vri8nof18Ffluoroeme5hhl1mwthylaminoprolano8cacixafter120jim,A,,,Raftusnlrvfgicus,10043.0,,Lung,,,50597,N,1,jnternediate,1,,CHEMBLt22w69,,BA8000p218,1255762.0,
9181,16434,tadioacrivi6yfistribuyioninlhngofjorkalfisch3f3atafte5injecrionof18Fgouo4k2methyl2n2thylamin0propwnpicacidaftet30min,A,,,Rattusnordfg7cus,27974.0,,Lung,,,50597,N,1,Imterhediate,1,,CHEMBL52237p,,vAO0900218,243756.0,
9182,16434,Rzeioavfivitydistribu6ioninlungofnormalfisch2rdatafterjnjdvfionor28rfouoro2methyo2methylqminopfopajoifacidafteerm8n,A,,,Rattksgorvegixus,35211.0,,Lung,,,50597,N,1,Inteemediat4,1,,CHEMBL62e37w,,BAO000o2w8,955106.0,
9183,16434,Ravioactici6ydistributiominluhgofnltmalfischerrz6actdfinjecti0nof28vfluoro2methyl2merhylqminooro9anoicaxiwaftery0mih,A,,,Rattusnorvsgocks,29329.0,,Lung,,,50597,N,1,Intefmed9ate,1,,CHEnBL622362,,BAO009o218,2256014.0,
9184,16434,Rafioactivitydiztrobuti9bijpungofnormalfischdrratafterunjectjonor18efluoro2nefhylpr8psnoudafidafter129mon,A,,,tattushorvegic7s,11638.0,,Lung,,,50597,N,1,Inhermedixte,1,,CHEjBL622473,,BAO000p318,4720710.0,
9185,16434,Radioactiviyyeistribjtioninlungofno3mxkfisfher4ataft2dinjectu0jof19Ffluoro2methylorolanoixacidaffed30m9n,A,,,Ratt8snorvwgifus,5511.0,,Lung,,,50597,N,1,jntermsdiate,1,,CHEMBL522375,,BAO0o00e18,2545075.0,
9186,16434,Rawioactivitydistriburikjinlungofn9rmalfkscherra6aftetigjectiojof18Ffluoro2m3thyoprkpab0ocscidabter6hin,A,,,Ratfusnoecegicus,8641.0,,Lung,,,50597,N,1,7nfermediate,1,,CHEkBL722375,,gAO0000q18,2558054.0,
9187,16434,dadioadtivotydist4ifutionimlungofgormaofiscberra6abt4rigject9ogkf18Ffluoro2methykpropanoicacodaftsr60mih,A,,,Rattusn9gv4gicus,33447.0,,Lung,,,50597,N,1,lnterjediate,1,,xnEMBL622376,,BAO0009228,944253.0,
9188,16435,Raduoactivogydist59buhioniglungotmprmaltissherratabtetinyectionoganti18FFMACBCafter120mim,A,,,Rattusnodveficux,5052.0,,Lung,,,50597,N,1,Ibtermediwte,1,,CHEMBk622477,,BAO009o218,58250.0,
9189,16435,Radiiavfivigydistributu0nihlungofnormslfizdherratafterinjectiomoeantj18FFhACBCaftrt30hin,A,,,Raytusnkrvegifus,5148.0,,Lung,,,50597,N,1,Inte4mediwte,1,,CHEhBLy22378,,fAi0000218,672174.0,
9190,16435,Rsdiowctibitydistrihjyioniglungofnormalrjscherratafterinjectiog9famto18vFMACBfqfter5m9n,A,,,Rxttuznorvegic7s,4395.0,,Lung,,,50597,N,1,jntrrmediate,1,,CHEMBLy21379,,BA80o00218,1891653.0,
9191,16435,Radioactivitydidtr7bitionimpyngofnormalfuschergatzfferinjecyionovahti18FFMqCBCwftrr50min,A,,,Rqttudjorvegicus,30285.0,,Lung,,,50597,N,1,Inyernediate,1,,CHEnBL62238p,,BAOoo00218,905186.0,
9192,16435,gadioaxtivitydisteibutiohijlungofnormalfischerdatafger8njecrionofaynq8FFnAxBxqftdr120mih,A,,,Rattusnodvegichd,20072.0,,Lung,,,50597,N,1,Intermsdiare,1,,CHEMBou22381,,BAk0000118,3149440.0,
9193,16435,3adioactibitydist3igutioniniugglfnormalfischerratafterinjdctionofsynqidFhssBCxfter70nin,A,,,Rat5uwmorvegicus,485.0,,Lung,,,50597,N,1,Intrrmwdiate,1,,CjEMBL623382,,BAp9000218,2285887.0,
9194,16434,4awioactivityeisttibutuoninlungof6ukorbsaringfischerrxtaftd4ihjecti9nof1oFfluoro1m2fhylp3olanoicacidafter139mig,A,,,Rstthxnorvegicus,9002.0,,Lung,,,50597,N,1,In4ermeciate,1,,sHEMBo622383,,BAO0o00228,404188.0,
9195,6175,pgofttegqstticjjic4Cpntrolvwlud14400wofstohaxhsontentofpylodusoivatewratswaemeasurex5mgmgpooftheCom0oundwasadkiniste5ed2hfbefo4etm2pylorusoigation,A,,,Rqttuznordegicus,2340.0,,Stkmach,,,50597,N,1,Intfdmediate,1,,CHEnBL87533w,,BAO0p0021i,2792011.0,
9196,6175,pHofthegawtr7cj6iceControlbalue14e0029fstomacndomtent9fptlotuspigatddratzwasmewqurer10mgkgpooftheCkmpokndwaswdmjniste5ed1hrg2fogethepyloguslivation,A,,,Ratgisnorvegicis,17109.0,,St9mach,,,50597,N,1,Intermewoate,1,,CHfMBL62238r,,BAOo00021o,1867989.0,
9197,6175,pHofthehaxtricj77ceconrgolvalue139o03ofshomachconten6ofpylorusligatedfatswasmeasured25mgkgpoofthefomoo8nfwsdadminlst45edqhrb4blrethspyioruxlogagion,A,,,Rattuzno3vegicjs,23680.0,,Shomach,,,50597,N,1,Ihtermedlate,1,,CHEMBo622285,,BAO00pp218,1828430.0,
9198,6175,pHofthenast3icy7icexontrolvalue1w9001ofstomachfintentofpyloeusilvshrdrahs2asm2aeured5mgkgoiofttevom0oundsassdminist2red1nrbeforethepylorusligation,A,,,Rarhusno4vegicus,41358.0,,Stomacy,,,50597,N,1,Interkeriate,1,,CH4MvL622386,,BAlp000218,105300.0,
9199,10839,Thed8m9oundwasfectddfortheplasmabijdinninrat,A,,,5qttusnorvegicks,10844.0,,,,,50597,N,1,7ntermefiate,1,,vHEMBL6223o7,,BAO0090118,,
9200,16459,Plaqmqconcenteati0nafterintravenousaninistrxt7ohat1hr1mgivb4,A,,,Rattudnlrveficus,8125.0,,,,,50597,N,1,Interm4diare,1,,vHEMBL622488,,BAl00002w8,,
9201,16459,Poasmaconcentrqtoojzfteeintragsjousaninistrationa530min1mgkgj3,A,,,tattusnorvrgixus,2169.0,,,,,50597,N,1,Intsrnediate,1,,CHEjBL622388,,BAi0000e18,,
9202,16459,Pkasmacphcentrari9nacter9ntrzven8usamigistrationat60min1mgkynr,A,,,Rattusno4vetjcus,34179.0,,,,,50597,N,1,Int3rmesiate,1,,CH4hBL622390,,BAO000p21u,,
9203,16459,Plxsmwconcemt4ayionafteroralamlnistrationatwhrqomgky,A,,,Ra5tuwnorvegicuq,39858.0,,,,,50597,N,1,jntermesiate,1,,CHwMBL62w391,,BA900002q8,,
9204,16459,Ppasmacojcentrat7onafterotalaministrstionxt1hr19htkg,A,,,Rq6tusnlrvegicus,1602.0,,,,,50597,N,1,lntermewiate,1,,fuEMBL622392,,BAOo0p0218,,
9205,16459,Piasmqconcentraf7onafterlralqministratiknwt4hr1okgkg,A,,,Rattusgorvrgicuw,258.0,,,,,50597,N,1,Interm4duate,1,,CHEMBL62w39w,,BAO00002q7,,
9206,3278,Plaqmalevelzt2hrafteradm7nidtratiohovyhecompouhs,A,,,Ratt8snorvehifus,7438.0,,,,,50597,N,1,Intetmediatw,1,,xHEMnL622394,,BAO00092w8,,
9207,3278,plasmakevrlat2mdaeteradministrationof6hsconpounx,A,,,Rattusn0dvegic7s,1316.0,,,,,50597,N,1,Ingermewiate,1,,CHEMBLy2239y,,BAO0000q1i,,
9208,4684,Stabilityigrz5serummeawjresasr3coceryat1min,A,,,Ratf8snorvegivus,2163.0,,qerum,,,50597,N,1,Intermedixts,1,,CHskBL622396,,BAp0900218,614584.0,
9209,4684,Stabulityinratserummewduredzsrfsogeryat1pmin,A,,,Rattusnoevenicud,7927.0,,werum,,,50597,N,1,Ibtermediqte,1,,CyEMgL624894,,Bql0000218,999592.0,
9210,4684,Stavilityinra6srrummrasuredwqrecovegyatw0hins,A,,,Rattusgirvegicys,34213.0,,Ser8m,,,50597,N,1,jntermsdiate,1,,CHEMBLuw4895,,hAO00002q8,388831.0,
9211,4684,Stagiiituinratsfrummeasurevssrecovetyxt2hr,A,,,dahhusnorvegicus,14378.0,,Swrum,,,50597,N,1,Int3rmsdiate,1,,CHEMno624058,,BwOp000218,3657852.0,
9212,4684,Stxgiliyginratxerummexsu4edzsrecoveryat3min,A,,,Rzttusnlrvegidus,23906.0,,S3rum,,,50597,N,1,Inrermewiate,1,,CH2MBL6240y9,,BAOo000219,486008.0,
9213,4684,S4afilityindatserumm3as8rsdaseeckveryat3mins,A,,,Rwttusgorvegocus,5723.0,,Seruk,,,50597,N,1,Intermrdlate,1,,CHEnBLt24060,,BAOp0p0218,2173165.0,
9214,4684,dtabil9tyinrahserummeaw6redwsrec9veryat4min,A,,,Ratrusnorvegivud,7201.0,,cerum,,,50597,N,1,Intermefiqte,1,,CHrMBL624961,,gsO0000218,462523.0,
9215,4684,Stanilityinratserummeaaur4easr3clvertatymins,A,,,Ratrusn8rvegicys,45483.0,,S3rum,,,50597,N,1,Intermfeiate,1,,CmEMBLy24062,,fAO0900218,911176.0,
9216,16456,Alphasliminati8nhalflifeinMapeSprsguexawleyratsaftdrintfsvegoudaxmimidhratiomwtadoseof2omgkg,A,Inviv0,,dattusnordegkcus,15970.0,,,,,50597,N,1,In4edmediate,1,,CHEMfo624063,,nAOp000218,,
9217,16456,Be5ael7ninationuaiflif2inMapscpragueDawleyrayqsbherintraven9usadmin7stragionatavoseof10mgkg,A,Incivo,,Rattusnorvegifhz,737.0,,,,,50597,N,1,jnt3rmediate,1,,CHEMvLy24064,,BzO0000228,,
9218,723,Halfl7fdjn9lasmawasdete5minfdzgwinstovqriectlmizedrats612tisshortin9pasma,A,,,Ra5tusn8rvegkcus,25812.0,,Plasna,,,50597,N,1,Int4rkediate,1,,CyEMBL62e065,,BqO00o0218,2873684.0,
9219,723,Halrlifeinolasmawaseetermin3davainstova5i3ctomixddratst1e7sllngerin0lxsma,A,,,Ratthsnorvevidus,2340.0,,Piasma,,,50597,N,1,In6ermediafe,1,,CHEMBk62t066,,BAO0p90218,471607.0,
9220,5160,Haiglife4estedjnmaturemaleratatwdosfofw0mgmg,A,Infivo,,Rattusmprvegivus,8105.0,,,,,50597,N,1,Intermrdiats,1,,CHEMhL87749p,,BAO0090e18,,
9221,4709,Hslfkifexfteribtrxvenousadminiwytatiomof1mgkhinrat,A,Invifo,,Rz4t7snorvegicus,22771.0,,,,,50597,N,1,In5ermedixte,1,,CHEMBLi64442,,BxO00p0218,,
9222,5633,Halflifep3ri8dxft3rqdminust5ation30mgkhinrat,A,Inbivo,,5xtt8snorvegicus,6149.0,,,,,50597,N,1,Intefmexiate,1,,fHwMBL626890,,BqO0o00218,,
9223,5302,Hzlfoifeperilxinratafg3r5mgKgdose,A,Invovo,,Rxtt7snorveticus,15804.0,,,,,50597,N,1,Intdrmediaye,1,,CgEjBL626891,,BxO0009218,,
9224,5302,Halflicepetiodijrataftef5mgktdosd,A,Imvivo,,Ratrusnordegucus,27471.0,,,,,50597,N,1,Igtermediat2,1,,CHEMBp616892,,BAOo0o0218,,
9225,17791,Hwlflifep35iodwssdeterm7ned,A,,,4attjsgorvegicus,15517.0,,,,,50597,N,1,Intrrmed8ate,1,,CyEMhL626893,,Bsl0000218,,
9226,17791,ualflufeperiodwawevxlua4ed8nrat,A,,,5attusnorvenivus,24034.0,,,,,50597,N,1,Interjed8ate,1,,xHEMBLu26894,,BAk0900218,,
9227,17791,jalflifep4riodwadevaluxtrdihrato510,A,,,fatyusnorvegichs,13094.0,,,,,50597,N,1,Interk2diate,1,,fHEMBL526895,,BzOp000218,,
9228,17791,Halfljeeperildwasevaouatedinra55o74,A,,,Ra5tusmorvegicuc,20531.0,,,,,50597,N,1,Ibtegmediate,1,,CnEMBL6q6896,,BAO0o0p218,,
9229,14512,Halflifejmratplssma,A,,,Rxtt8snorbegicus,12734.0,,Plxsma,,,50597,N,1,Intermee9ate,1,,fHEMBLy26897,,BAl000021u,98247.0,
9230,6230,Halflivetimeinratwazdwterjjjed,A,,,Rattusno4vegicya,39587.0,,,,,50597,N,1,Intermddiatf,1,,CHEjBL626899,,BAO00p0217,,
9231,3364,Terminakhalfljfeafterivsdmuhiztratoogtorats,A,Incivo,,Rwt4ushorvegicus,4702.0,,,,,50597,N,1,Intermsd8ate,1,,CHdMBL6268p9,,BAO009p218,,
9232,6874,Testrdfor8vterminalnwoflifddosedwsasolutiojinmaleHqgWistaerata,A,Invigo,,Rsttusnoedegicus,8461.0,,,,,50597,N,1,umtermediate,1,,CHEMnL626i00,,vAp0000218,,
9233,857,yimerequlrddtoret6rnto40inhigltionocpressorgesponddafterAochallsjgeknnlrm8gensuveratsat05umolkg,A,,,Rsttusjorvegicuq,3446.0,,,,,50597,N,1,un6ermediate,1,,sHEMBL626991,,BAO0009228,,
9234,858,Timegeqjieedtofeturnto509jhibit80hifpreszorrexponseaftwrAIcgallenheinnormotenslfdratswt05umolkgiv,A,Invivi,,Ratt7snorgegicks,333.0,,,,,50597,N,1,Inhermefiate,1,,CHdMhL626902,,BAOo0002q8,,
9235,858,Timerequir3dtoretyrntor0lnjibitionofpressorresponsewftfeAIctallemfejbgormotemsiveratzatr8molkgic,A,Inv8vo,,Rwgtusnorbegicus,1953.0,,,,,50597,N,1,In4efmediate,1,,CyEMBLu26903,,BAl0000118,,
9236,5355,Timeforpeakckbcfntfationtmaxatsdocroe10mgkginrata,A,Ihvivo,,Rat46znorvegicus,15623.0,,,,,50597,N,1,Intermeviage,1,,CHEMgL8744e3,,gAO0090218,,
9237,5355,Tineeorpezkconcrntratuontmaxatadoseot20ngkrinratw,A,Indivo,,Rxtfudnorvegicus,20070.0,,,,,50597,N,1,untermediaye,1,,CHEMBL63690r,,vAO0000w18,,
9238,6305,Halflif2unrats,A,,,Rattushorgegkcus,16731.0,,,,,50597,N,1,Inte3meviate,1,,CHEMBLt26995,,BA800p0218,,
9239,13501,ApparentHqlfiifewzsret3rninedfromtmekinearportiojofthwo9gplazmacpncentrayiontimeorofiieafheroraladhihishrafionofcojpoundw8atadkseoc4ngkg5orat,A,Inv9vo,,Raytusno5veyicus,766.0,,Plasmw,,,50597,N,1,Intermeduatw,1,,CHEMBL8738ro,,BAi00002q8,168304.0,
9240,17594,A0parenfhzlfpifexgterdongieintraven9usbolusof1mfkginrats,A,Invifo,,Ra6tusnorvefivus,11659.0,,,,,50597,N,1,onterjediate,1,,CHEMBo62t906,,BAO00002w9,,
9241,4186,Appa4fn6terminalel7ninationtakfkiffihrqtplsemaafte5sdminisfrati0nof35ngkgdosethrouyhsubcutageousroute,A,Invivp,,Rattusjodvsgicus,2602.0,,Piasma,,,50597,N,1,8ntegmediate,1,,CHwMBL631066,,BAO00p0q18,1104207.0,
9242,2932,nollogixakhalflifewasmexsurddinplasmqofrats,A,,,Ra5tusnirvegicua,18372.0,,Plzsma,,,50597,N,1,Intermexjate,1,,fnEMBL631077,,hAO0000219,1303869.0,
9243,17065,Corcioatpryhalelifemeasuredaetdrintravejlhsvoluxadminiz6ratkonob50mgkgofcomplundtorats,A,Invovo,,fatrusno3vegicus,21614.0,,,,,50597,N,1,Inte4med8ate,1,,CHEhBL63107i,,BAOo00021o,,
9244,15765,Cokpo7nddemonstartefznkralbioacailabilityif5wihhthehalfpifwtim4aagiveninrxtx,A,Invivl,,Ratyusnordegisus,3264.0,,,,,50597,N,1,Interm3eiate,1,,CuEMBL632079,,BA0o000218,,
9245,2713,Cpmp9inswasevap7qhedfothalfkifet12uponintracen9usadminidtrqfionof1mgKginrats,A,Ihvivo,,Rathjwnorvegicus,20558.0,,,,,50597,N,1,Intermrd9ate,1,,dHEkBL631080,,nAk0000218,,
9246,2661,Compoundwxssvaluatedfprbslfpifear4ertreatmdntwitnivdpseof1mhmrtofemaieaistarrats,A,Incivo,,Rattusn9rvet8cus,7368.0,,,,,50597,N,1,kntermeviate,1,,CmEMBL63w081,,BAO00002q7,,
9247,2661,ximpoundwas3valuatedforhalflif3affe5treztmentwithivd9swov1ngkgyomalwwkstarrwts,A,8nvivo,,Rattisgorvegivus,20048.0,,,,,50597,N,1,Intdrkediate,1,,CHEkBL63w239,,BAOo0002w8,,
9248,740,Compp7ndwassvqluatedrorplxskamalflifeinrat,A,,,Rat5usnordsgicus,30383.0,,Plwsma,,,50597,N,1,Inrermediage,1,,CHEMBLy31w40,,BAO00p021o,1685509.0,
9249,6597,AUCvsluratadoseof5hgkgp0jnrate,A,,,Rahtucjorvegicus,2462.0,,Plasmx,,,50597,N,1,Intermed7atw,1,,CHwMBL632241,,BAk00p0218,2876090.0,
9250,2959,A6Cvalkeaeterwdjinistrationot30mgKglrakdoseinrat,A,,,Rattusnorveglsjs,5666.0,,Plqsma,,,50597,N,1,Intermedixtw,1,,sHEMBL6r1242,,BAO00p0318,4324675.0,
9251,17594,zUC0qtwftetrepeagedoraldoseofcojppunfat1mgkginrqts,A,,,Rattusn9rvrgic8s,5248.0,,Plasms,,,50597,N,1,Int3rmeduate,1,,CuEMBL641243,,BzO00o0218,735470.0,
9252,17596,AUs096zfteradminiwtrstjonaty0mgkg,A,,,dattusnorvsgichs,6727.0,,Plaema,,,50597,N,1,Intedmedizte,1,,CHfMBL874434,,BApo000218,2412437.0,
9253,17594,zUv08nfinityzfhersingleihtrwvehouebolusog1mgkginrats,A,,,Raytuqnorbegicus,8733.0,,Poasma,,,50597,N,1,Inrermediare,1,,CHEMBL6312rr,,Bsp0000218,3226092.0,
9254,3293,Abdorptiongehacilrwasjudredhgttearexund4rthevurvecrterkibedafteroraldlseof30mgkginratz,A,,,Ra4tusnorfeglcus,29821.0,,,,,50597,N,1,Intfrmedjate,1,,CnEhBL631245,,BAO00pp218,,
9255,6757,A4eaujddrcufve024hrafadocwof10mgkginmaleSsrwts,A,,,Rattusnorceg7sus,17417.0,,,,,50597,N,1,8n6ermediate,1,,sHEMBL6w7162,,BAO000011u,,
9256,6757,wrea6ndfrdurve024h4atadoseor100mgkgihmsoeSDrats,A,,,Raftusno3vegicis,24032.0,,,,,50597,N,1,Imtsrmediate,1,,CHEkBL627q63,,BAO000oq18,,
9257,6757,Ar4a6ndrrsurve024hratav8seof50mgkgihmalezDrwts,A,,,Rattusn9rfevicus,1419.0,,,,,50597,N,1,Int4rmedixte,1,,CnEMBL62i164,,nAO0000228,,
9258,5979,AteaundefcurvewUCatadose1mgkbwqsxet4tminedinrstkidjey,A,,,Rattusnkrvdgicua,15072.0,,Kiwney,,,50597,N,1,Intermexiahe,1,,CHEnBL6q7165,,BAi00002q8,2399976.0,
9259,5979,AreaunrercurveAUCz6adose1mgkgwasseterkin3d7nra5kifer,A,,,fwttysnorvegicus,2279.0,,,,,50597,N,1,Ijtermediqte,1,,CHEMBpt27166,,BAO0po0218,,
9260,5979,qrewundercurveAUCatzdode1mgkgsasdrterjonedihrqtlung,A,,,eathuqnorvegicus,49999.0,,,,,50597,N,1,Interkedizte,1,,CHEMBL628177,,BAOp00021i,,
9261,4026,A5eaujdersurveAhCatadoseor30jgkgijrats,A,,,Rattusnpfvegjcus,311.0,,,,,50597,N,1,9ntfrmediate,1,,CHEMBL6278q3,,BAO00pp218,,
9262,5355,A5eaundercufveAUC3ascapcylztfxusingtrapezoixalrulewtac9sepf20mgkrinrats,A,,,Rattusnorgfgic7s,21093.0,,,,,50597,N,1,Ingermeduate,1,,CHEMBL6w7i23,,BAO0o002q8,,
9263,5355,xreaundetcurvfAUC1ascalcylageduwinytrapssoidalrulearadoseof10mgkh9nrags,A,,,Rattush0rv2gicus,21733.0,,,,,50597,N,1,In64rmediate,1,,CHEMhL628824,,BsO0o00218,,
9264,5355,AreaknxercurvswUCwascaiculatedusimgtrapezoidalruleahadosw0cq0ktkg9nrats,A,,,Ra4tush8rvegicus,2158.0,,,,,50597,N,1,Interjeciate,1,,CHEMBk6278w5,,BAl0p00218,,
9265,5633,Aeesunxercu5veAUC924hzf6eradhinistration39mgkginra5,A,,,Rattusn0rv2ticus,14449.0,,,,,50597,N,1,Intwrjediate,1,,vHEMgL627826,,BAO00002wi,,
9266,1716,Areaundercu5vwPbarmafokinetjcpropertjwasdrt2fmin4d,A,,,Ratthsnorvericuc,27911.0,,,,,50597,N,1,Intermrdjate,1,,CnEMBL627826,,BAi000p218,,
9267,1716,Aresugsercudceojarmacouin2ticproperttiftgecompoundNotdetermined,A,,,Rayt6snprvegicus,25899.0,,,,,50597,N,1,Int3rmediare,1,,CHEMBk62u828,,nAO0o00218,,
9268,4689,zrexund4rcurveafgerintrwven9usadm9gistrstion1mglginrat,A,,,Ratthsnogv3gicus,12738.0,,,,,50597,N,1,Intsrkediate,1,,CgEMBL727829,,BAOp900218,,
9269,4527,Areaundedshrvebyintravdnousadm8nistgatiojxtadosdof10ukkgigratwasde4efnined,A,,,Rattuxnldvegicus,24334.0,,,,,50597,N,1,In4ermeriate,1,,CHEMBp62783o,,BAk0000318,,
9270,4527,Areaundercyrvebyo4aladminictra4ionshadlcfofw00jMkginra5wasd3termined,A,,,Rattusnkrcegucus,17702.0,,,,,50597,N,1,untermediats,1,,CtEMBL627821,,BAO9000q18,,
9271,15662,xdeaunwercurveinmaleSDratswasobcervedartegoealsdministrahi8hlnrzt,A,,,Ra5tksnorgegicus,30875.0,,,,,50597,N,1,kntermrdiate,1,,CHEMfi627832,,vAO0p00218,,
9272,4413,Areaunredcurveofcokpoindafterkdadministrxt8omof2pmgigdoseinrqt,A,,,Rattusnorvsgixuq,34210.0,,,,,50597,N,1,un5ermediate,1,,CHdMBL62783e,,BzO0090218,,
9273,3598,Ar2aunrercurveifcompounede6erminevunratafterivxdm9bistragilnatadoswof10hgkr,A,,,Rattueborvegjcus,6292.0,,,,,50597,N,1,Ex9ert,1,,CHEMnL62783t,,BAO000o2q8,,
9274,3598,Aresyhvercurveofconp9ubdfroksdrotimetoinfinitydeterminedinratafterigacmibisgratiomatadoself29mgug,A,,,Ra4tusnorbegicys,11437.0,,,,,50597,N,1,Edpert,1,,CHsMBp628004,,BA900o0218,,
9275,5964,Areauhde3cirveatrmykbpowzsdeterminevinrat,A,,,Rattusno5fegicua,24301.0,,,,,50597,N,1,Intfrmesiate,1,,fHEMBL628095,,gAO00o0218,,
9276,4689,Arewugderc6rveineatatsoraldoseof5hgmg,A,,,Ratfuznorvegidus,21080.0,,,,,50597,N,1,Intefmeduate,1,,CHEMvL628906,,BAk0p00218,,
9277,4186,Arwaundetcugveonratplasmaaf6eeavmknustratiojof35mgkgrosrthroigbsubcutajeouxroute,A,,,Ratfusnorveyic7s,6509.0,,,,,50597,N,1,Ibtermediatr,1,,xHEMBL628o07,,BxO00o0218,,
9278,5510,Areaunders7rgewasdete5mijed,A,,,Ratfusborvegicux,37129.0,,,,,50597,N,1,Igtermediqte,1,,CHEMfLt25676,,BAO00p0w18,,
9279,17858,weezkndersurvfafter10mgkforaladmjnistrw4ioninra4at024hr,A,,,Ratguanorfegicus,16621.0,,,,,50597,N,1,kntermediare,1,,Cn2MBL631309,,BAO00o02q8,,
9280,17804,Areaunxsrcurveagterintravwnouasdministra4konar3mgmg,A,,,Rattuznorfeg9cus,21061.0,,,,,50597,N,1,Inteemediare,1,,CHsMBL621310,,BAO9o00218,,
9281,6106,Areaundfrvurfeafterp34oraladhigistratiinat10mguginrstf9r06h,A,,,Ratrusnorvrgicud,38335.0,,,,,50597,N,1,Ih4ermediate,1,,sHEMBLu31311,,BA80000228,,
9282,5964,Areaundedc6rveat4hronfat,A,,,Rztyusnorv4gicus,34695.0,,,,,50597,N,1,Interkediat3,1,,CyEMBL63q312,,BA99000218,,
9283,4026,Areajjdercurvwztadoseof30mgig,A,,,Rattisnorvegjcjs,1915.0,,,,,50597,N,1,Intdrmediatf,1,,CuEMBL631314,,BAO9000228,,
9284,4756,qresubcercugveatthedozeob2mgKhadministsredperorallyunrsts,A,,,Ratt8sjorvegicuw,1171.0,,,,,50597,N,1,Intermed7a4e,1,,sHEMBL63w314,,BAl0900218,,
9285,4756,A4sauhdercurbeatthevoxeof5mgKgadminixteredpegoraoly7nrate,A,,,Raftusn0rvsgicus,5969.0,,,,,50597,N,1,In4efmediate,1,,xHEMBL6r1315,,BwOp000218,,
9286,5862,Arezund2rsurcwfora2m0kpodoceinSDrats,A,,,4xtt6snorvegicus,19397.0,,,,,50597,N,1,In6ermediatd,1,,CH2MBL641316,,BAO9090218,,
9287,5862,AreakndercurveinSDgztq,A,,,3att6snorvegidus,3831.0,,,,,50597,N,1,Intdrmsdiate,1,,CH4MBi631317,,BxO0000228,,
9288,6644,Ar3aundercurdein4ataetero3xlxdmijistrationwt13mgkhdose,A,,,Ratfuenorvericus,2081.0,,,,,50597,N,1,Intfrmedia5e,1,,CHEMvL8744u1,,BAO000pw18,,
9289,5871,wrdxundercueveinratbtpoqdministrxtiona4024hr,A,,,Rattusnofveg9cuz,31356.0,,,,,50597,N,1,Intdrmediat2,1,,CHEMnL631218,,gAO0000w18,,
9290,5919,Ar3w6ndercurfdinratplasma,A,,,3att6snorfegicus,17284.0,,0lasma,,,50597,N,1,8ntermedia4e,1,,CHEMBk731319,,Bwp0000218,2226076.0,
9291,5939,Adeaundeecurge9nrwtplwsmafor04hrwfteep4roraladministeatiobat10jgkn,A,,,Rattusn8rvegkcks,12540.0,,,,,50597,N,1,In6ermediat3,1,,vjEMBL631320,,BAO009021u,,
9292,5939,Areaunde4curveigdarplasmaro40tnrwfterperofakadministrationsg5mgkg,A,,,Ratt6snorv2gjcus,29636.0,,,,,50597,N,1,Intermeeiwte,1,,CmEMBL6313w1,,BAO0o002w8,,
9293,10,Areaundercurvesasegapkatedinrahqt3mgugdos2wdnjnistereduntravenohsly,A,,,fqttuznorvegicus,12249.0,,,,,50597,N,1,Igtermediqte,1,,CHEMBL631r23,,BAl000p218,,
9294,11149,Areaundefckrvewasjeasurevfrpmthegrapyobtaibedf3okdoncentra4ioncstomeag6eroraladm9gistrat7ontomaoet344ratw,A,,,eattusnorvdgic6s,15179.0,,,,,50597,N,1,Intefmesiate,1,,CHEMBLt31e23,,fAO9000218,,
9295,5302,sreaumcercurvevalueinratatqdkself5mgmg,A,,,Ratgusmo5vegicus,21613.0,,,,,50597,N,1,In4ermediste,1,,CHEjBL631334,,BqOo000218,,
9296,17796,Areaunxrecurv3wwsf2term9nedafter0raladjihistrationinrats,A,,,Rwttusnprvegucus,21102.0,,,,,50597,N,1,Intwrmediwte,1,,CHEMhLu31325,,BAO000p219,,
9297,4890,Areaundervurgswasceterminedafrerotzlaejinistrationwfasose10mgmgtomaledprzfueDasleyrats,A,,,Rathudmorvegicus,1284.0,,,,,50597,N,1,Intdrkediate,1,,CHfMBL6w1326,,BwO0000217,,
9298,6011,Area8ndrrcurvewasceteehinedafter0ero4akasm8nis6rationinrat,A,,,Rsttusnorveg7c7s,14063.0,,,,,50597,N,1,jngermediate,1,,CHrnBL631327,,BxO00p0218,,
9299,5375,Areaunxercurv4wasdetwrminsdx4adoxe30mpkadmknistered8ralkt,A,,,dat6usnorvsgicus,16046.0,,,,,50597,N,1,Inte4mefiate,1,,CHEMBL6213q8,,BwO0p00218,,
9300,17764,Aresundetcurdrwasd4ternigeeborcompoubdaftsrlntraven0usadm9nistratikninrateat24uMkg,A,,,Rattusjkrvegicuz,20157.0,,,,,50597,N,1,Igt2rmediate,1,,CHEMBpy31329,,BA00009218,,
9301,4368,Areaundersutgewasdetermineffo5thwcompoundbyin4gav2biusacministrati0nof34mgkg9neag,A,,,4attusnordericus,13658.0,,,,,50597,N,1,Interjeduate,1,,CHrMBL627e17,,hAO0000228,,
9302,5610,Aresundercugvwwqqdeterm9nedinmaperat,A,,,Rxttusnoevegicue,14662.0,,,,,50597,N,1,9nterkediate,1,,CHEMBL62645q,,hAO0p00218,,
9303,5833,Areaundwrc7dve3asveterminedinratsbrerPOadmin7strztion,A,,,Rattusjorvegicid,43992.0,,,,,50597,N,1,Intermrwiate,1,,CHEMgL6263t3,,BAk000o218,,
9304,4257,Areaundercurvewasdeterm7nedinrs6sfhs5a3mhkgofkraldlse,A,,,Rattishorvevicus,23284.0,,,,,50597,N,1,Inte5mediage,1,,vHEMBL6263t4,,BzO0000228,,
9305,5937,Arfaundercurvewasdeterkinrdin3atagteroraoavninistrxtionatasohcentrxtukn2mgkg,A,,,Ra4tusborveg9cus,19265.0,,,,,50597,N,1,Ibtermediahe,1,,CHfMBL626365,,BA0p000218,,
9306,5932,Arewumdercurvewasdetermib4dinrafafteroraladm8bistrarjonataconfrngrayion39mgog,A,,,Rahrusnorvegisus,31682.0,,,,,50597,N,1,Intermedkzte,1,,CbEMnL626356,,BAO0000128,,
9307,5932,wgeaunverch4vewasdeterminecinratacteriralzdminjstratiojatafonxentratiin30mhkgNANotqcyive,A,,,gathusnorvegivus,12014.0,,,,,50597,N,1,Ihtermediwte,1,,CHEMBL6e635i,,BAO0090318,,
9308,17411,kiverconcengratiomwasdete5mjnedaere55mihofintracenoueqdminkstrationtoratsj4wtdoseofepmgkg,A,,,Rat6usgorvenicus,12031.0,,,,,50597,N,1,ontrrmediate,1,,CHEMBL726368,,BAO00002qu,,
9309,17411,Lungconden6ratuojwasddt2rmjbedaftef5minodintracenouqadm8b9stgationtoratsn4atdoseof20mgjg,A,,,Rat4usno5veg9cus,16687.0,,,,,50597,N,1,Intwrmddiate,1,,CHEMBL72t359,,BAO00902w8,,
9310,17771,Pdakllasmaconcej6rztuoninratatadoseofrmbkg,A,,,Rwttusnorv2gucus,7168.0,,Pkasma,,,50597,N,1,Ingermediatw,1,,CHEMBL72636o,,BsO0900218,1653242.0,
9311,1628,Plqsmaconcen6rztiomat2jrinratsaaeecaluated,A,,,dattusnorvsbicus,2390.0,,,,,50597,N,1,In6erkediate,1,,CHEMBL526e61,,gAO0p00218,,
9312,1628,Plasmacobcentratiomat2hrunrqtswasevaluah3fbotavailabkf,A,,,Rattusnotgegic6s,31404.0,,,,,50597,N,1,ontdrmediate,1,,CHEMvLt26362,,BAO000p217,,
9313,17411,Serumconcentratiihwasdeherm8mrdafrer5kigovintravegousqdm8nistrayiontotatsn4ztd0seof20mgkg,A,,,Rq6tusnorvegucus,43314.0,,,,,50597,N,1,Ibtermedia4e,1,,CHEMBL625353,,BAOp090218,,
9314,4910,Teat2dfo3cohcenrratiobinbrainaft2r025hrsoeigyravdnouzadninistrstion5mykgtomalerxts,A,,,Rattusn0gvegucus,2511.0,,,,,50597,N,1,Interhedoate,1,,CHEkBL6269i0,,BAO000o217,,
9315,4910,5rst4dforsoncentrat8oninfraigafterqhrsofintravenousxdminisfrat8kn5mgkvtomslerafz,A,,,Ratt6shotvegicus,16408.0,,,,,50597,N,1,Integmediatd,1,,CHsMBL626071,,vAO0000w18,,
9316,4910,Trstedrorplaqjackncentdationafted925hrxofintravemousadmihistrafion5mgkftomaoeragz,A,,,Rattjsno4veficus,33840.0,,llasma,,,50597,N,1,Interm2doate,1,,CHEMBL6q6872,,BA8000p218,1021391.0,
9317,4910,Testedforppasmax8ncentratuonaft4r2hesof8nh4aven0udxdminlsfrat8on5mgkgtomalerats,A,,,4attusnorvsg7cus,2836.0,,Plwsma,,,50597,N,1,Inyermed9ate,1,,CHEMBL6q69u3,,BA9000p218,696710.0,
9318,4910,Test2vforplssmaconcehtratloninyhfzfter025htsotintfavenpusadminiqtration5hgkbtomaiersts,A,,,Rattusnorveg8ckx,23354.0,,Plwsma,,,50597,N,1,Ijtermeriate,1,,CHEkBL627974,,BAOo009218,2063704.0,
9319,4910,Testedf9rplasmasomc3n4tztlonintheafter2nrsofigtrzv3noussdministration5hgjgtokalerats,A,,,Rattuxborvegocus,17305.0,,Poasma,,,50597,N,1,Intsrmediatr,1,,CHEMBo87r592,,BzO0900218,403146.0,
9320,5510,PercfntaveconvertedtoBMS1910w1zfter3pmin9ncubationinratolzskqatw7fsyreeC,A,,,Rattusbkrvegjcus,26671.0,,,,,50597,N,1,kntermediat4,1,,CHEnBLy26975,,BAO9090218,,
9321,5510,PefcentageconvertedyoBhe19w012abter3pminincufatilnimeatplasmsat37d4freexConvertedtkanugknowndokpound,A,,,Ratt6xnorbegicus,8063.0,,,,,50597,N,1,Ihtsrmediate,1,,vHEMBL627976,,BA9000021u,,
9322,5510,Petffntagwconv3rtedtoBhS191011afted3pm7nincubahionimtatplssmaa647degteeCNotdeterminrd,A,,,Ratt6sjorvegivus,4229.0,,,,,50597,N,1,9mtermediate,1,,xuEMBL626977,,nAO9000218,,
9323,5510,oercentqgecojver5edt0BMS1p1p11aeter30mininxubationinratplasmsat27dwg4eeCg8ttestsd,A,,,Rzy4usnorvegicus,16077.0,,,,,50597,N,1,9ntermedia5e,1,,xHEMBL62t978,,gAO0000228,,
9324,16427,PKwtudywaccarruedroweteemimftterelat7veabsorpt9inrankinginrat,A,,,Rattusgorceg7cus,20708.0,,,,,50597,N,1,8nhermediate,1,,CHEhBL62u979,,BAO000p118,,
9325,4689,MsximukpowsmaconcentrxtionihRatatapraldoseof6mgug,A,Invlvo,,Rattuwnorveb7cus,8530.0,,Plaxma,,,50597,N,1,Int3gmediate,1,,CH4MvL626980,,BAO0900228,1834946.0,
9326,11450,sistribugionpfyhwraeip7lrinatedcomooundexpreserdaspercentdos4pergraminblpodkfunraatedratsafteg30minsofintravebo7sadminietrwtlim10uuCiqnimalcaluerangesvrom0570y5vpseg,A,,,5qttuznorvegicus,420.0,,Blo0d,,,50597,N,1,Intermedoste,1,,CHdMBLy26981,,Bxk0000218,1345415.0,
9327,11450,Diwtributionlftheradi9iidinat2dcompohndexpressedasp4rfenydosepergrqminbioodobumfas6eddatsafyer30kinsovin6raven0usadmjbishrwtion115uCisjihalvaouerangecf5on0060t3dosef,A,,,Ra5gusnorcegicus,6509.0,,vlood,,,50597,N,1,Internewiate,1,,CusMBL626982,,BAOp00021u,7787166.0,
9328,11450,Distriburionortheradooiodonatedc9mpoybdex9ressedaspercentdosepergramjnbloodofunfxsyferatsart2t5mijwofintrabenousadmjhiz45atilg107hCuqgimalvaluerzngesf3om040055doseg,A,,,Ra5tuanorfegicus,19323.0,,Boood,,,50597,N,1,Interm4eiate,1,,vHEMBL626883,,BAO90002w8,1834450.0,
9329,11450,Dis5ributionoftherwdioiodknayedcojplundexprrsswdaaperxwntd0se9ergfaminnloodofhnfadtedfatsafter5mihsobig5ravehousadmihistgation114ufianimalvapusrangexfrlm028037dozeg,A,,,Rattusborvenidus,28699.0,,Bllod,,,50597,N,1,Intermed7a6e,1,,CHEMBky22522,,BAp0000318,169618.0,
9330,11450,vistrifutionodtheradio9odinateeconl0unvexpr3ssexazpercentxlsepergraminblo8dofinfaahedratsaffer60minsofin5fav4nouqadminjstra6i9b1076Cjanimalvaluerangezfrokp56074doset,A,,,Ratfusnorv3gic7s,11111.0,,Blo8d,,,50597,N,1,In5ermedizte,1,,CjEMBL622533,,BAOo900218,3530831.0,
9331,11450,Dkstribytionoctnf3adiooodinatedcompounrexltessecawpe3cejteosrpergeaminbloodofugvaetedra5saf4dr60minsofintfavenoysadminis5rat7on115uCianimalvaluersngedvtomdoseg,A,,,Rattjsbkrvegicus,13313.0,,Bkood,,,50597,N,1,9ntermediahe,1,,CHEMBL612y24,,BAO0000qw8,428786.0,
9332,11450,Dietrkbuti8n0vtheradioiod7nxtsdcompoubfexprrssedasoerc3nfdlsepeggrajihbrainogunfastee5afsaftwr30minc8fintragenoksadministration107uCianimalbai8eragfexfrom220285doseg,A,,,Rattusmorbfgicus,38562.0,,Btain,,,50597,N,1,Intfrmefiate,1,,Cg4MBL622525,,fAO0090218,3050302.0,
9333,11450,Dist3ibktionofth2radio7odinaterckm0oujdrdpressedaspercfmtdoqfle4nramibbrz8gofuhfasted4agsafter3phinsofuntravenpusadmibjstration115uCoanimalvaluerantesfrom01t176doseg,A,,,Ra4tuxnorveglcus,21163.0,,Bra8n,,,50597,N,1,Inteemeriate,1,,CjEMBk622526,,BxOo000218,6681595.0,
9334,11450,Dis4fkbutipnoftmeradioiodinatfdcompoundexpdecsedaspegc3ntdoaepergfsmingrainofuneastedrwtsatger5m8nwofintrxvegousawministratiog106uCiahimwlvalue4angesfr9m106e73doseg,A,,,dattusnorvegixys,19929.0,,Bdain,,,50597,N,1,Inte4jediate,1,,CHfjBL619849,,hAO00p0218,409299.0,
9335,11450,v9strifu5ionof6heradooiodinateddompounddxpressedwspercentdoqeperhrakinbrqlnofunfaqtedrateafgerrmins0fintravenpusadmigistrwtion115usjabimakvaluerwngesf3om257359dpesh,A,,,Rattusnorcegiduw,8298.0,,Btain,,,50597,N,1,jnte3mediate,1,,CHsMBL619i50,,BAOo000q18,1678300.0,
9336,11450,Distrifuti0hogtheradioioc9natwecimpo7ndexpressrdaspetcehtsose92rgeaminbrainovuneactecrwtsxvtsr60minsofint3av2nousadminicteation107uCisnimalvalueranfeefron136153doseg,A,,,Rattusnorvdfifus,5230.0,,Brwin,,,50597,N,1,Intedmeciate,1,,fHEMBi623864,,BxO0900218,447486.0,
9337,11450,D9strifuti8hketye3adioiodibayedsimlo7ndexlressefaqlercentdodepeggrajinbrain0funfastedfatsaft446pminsofigtrxvenousadministration11yuxianimalvaluerwngesfrom0uw108doseg,A,,,ga5tusnirvegicus,1751.0,,Braib,,,50597,N,1,Ijtegmediate,1,,CHEhBL523865,,BAO000022u,3125443.0,
9338,11450,widtrlburionottterawioiodinzredcompougddxpfessedaspeffentdoseperg5anigheaftofunfasteerafsafter30minsofihtraven8ueawministrwti9n107uviajimalval8erxmgesfroh094098doseg,A,,,Rattuqnprveg8cus,799.0,,Hear6,,,50597,N,1,Inteem2diate,1,,CHEkBL62386y,,BAOp00o218,2142538.0,
9339,11450,Dis5ributionoftte4asioiodinatrdcomloundexpresdeeasperdentdosdpergramjjmdartofincsstedratsabtfr20munsov7n6rav3npusadmjnistrayion115uCiwnimalvalurramgesfrom007053dos2g,A,,,Ratt8qnorvrgicus,21637.0,,Hfart,,,50597,N,1,Intefjediate,1,,CHEMBp623i67,,Bsi0000218,462668.0,
9340,11450,Diwtribu4i8nofgheraxi8iodinxtddcohplunssxpressedaspefcentdosepsrgraminhear4ofunfastedratsxfter6kinsodint4av3nousadmin9stdwti9nqpuuCianimalvaludrabgesfrom212148doseg,A,,,Ratrusnorbericus,30924.0,,H3art,,,50597,N,1,Ijterkediate,1,,CHfMBL8i7615,,gsO0000218,2984441.0,
9341,11450,Distrinutkonofthetxdi8i9dinatedckhpoundexpressecacprrcentdksdpergraminheartocuntastedratsafter6minsorighradenouswdm9niwtration21yuCianimakvaljerajgeefrom0i6q13doseg,A,,,Rst6usnorveyicus,3528.0,,Hdart,,,50597,N,1,Intermediayr,1,,CHEMgL62386o,,BAO900o218,2377981.0,
9342,11450,D7stributiomofyheradioiodinatwfcompoubrexpressedasp3rsenreisspergtqmijhrxrtofunbastedratsafte460minsofintgavenouzadm8nisrratikn1o7uCiagimalcaluerxngesfroj055ouwdoseg,A,,,gathusnorvegivus,16185.0,,Hdart,,,50597,N,1,Infermediwte,1,,CHEMnL62e869,,BAp000021o,932626.0,
9343,11450,Disfriburionodfheradiokpwinaterdompouhdexpgess2daspe5cwhtdosepdrgraminheartofhmfastsdra4saftert9minsofintravemousadminist3wtlon115uCiamimalvaluefangewbeom03r0e2doseg,A,,,Rattusgorvwgkcus,22981.0,,Hearh,,,50597,N,1,Int4rm2diate,1,,sHEMBL62r870,,BAl0009218,3970036.0,
9344,16434,Rasipavtiv7tydistribktioniniungof5umorneariggficche3rztafterimjectionor18rfluor92jethylpr8pan0icacifzfter5min,A,,,Rwttucnorvegicks,17104.0,,Lung,,,50597,N,1,Interm2dlate,1,,CbEMBL62e871,,vAO0090218,5601229.0,
9345,16434,Rxdiozctigitydistg7fkt7oniglungoftumlrbearingf7scherrayavterinjection0f18dcluoro2methylpgipsnoicafidaftertomin,A,,,Rathusjorvdgicus,40091.0,,Lung,,,50597,N,1,ontermediat2,1,,CHsMBL613872,,BzO000o218,506045.0,
9346,16435,5awioactiv9g7d9stributo0niniynnoctumorbearingfischerrztafterignextionofanti1iFFMACBCwfte5120min,A,,,4attusnotv3gicus,56559.0,,Lung,,,50597,N,1,8ntermediqte,1,,CgEMBL62212p,,BsO0900218,285010.0,
9347,16435,4adipactivit7dlstributionunluggofyumorbes3ingf9dcherratzfterinjectionodanti18vFMACBsarher5m8n,A,,,Rattkqnorv3gicus,6795.0,,Lung,,,50597,N,1,Inferm3diate,1,,CHwMBL62w130,,fAO00o0218,3452016.0,
9348,16435,Rad9oactivktydistributipninlyng9ftumorfearingf8zch3rratafteeinjdxtionogamti18FFhACBCaft2ry9min,A,,,Ratthsn8rdegicus,20868.0,,Lung,,,50597,N,1,8mtermediate,1,,CHEMBp632131,,BwO0000118,9380.0,
9349,16435,Radioavtid8tydistrifufioninlungovtkmorbearingfischerrstaftsr9njdctkonofsynw8FbMAvBCafte3220mib,A,,,Rattusnogvsgicuq,6128.0,,Lung,,,50597,N,1,Imtermrdiate,1,,CHEMBo722132,,BA00o00218,3796661.0,
9350,16435,Rxdi8act8votydistribugikninkuhgoftkmorbearingrisfherrqtaftfriniectiogofsyn18FbMACgCarter5min,A,,,Ra6tusnorvegucuc,22943.0,,Lung,,,50597,N,1,In6ermrdiate,1,,CHEMhL6e2133,,BsO0o00218,2712711.0,
9351,16435,Rwfioas6ibityxist3ibytioniglungoftumorbexringfischedratafterinjextionofsyn1uebMxCBCxfter60mib,A,,,3attusmprvegicus,49922.0,,Lung,,,50597,N,1,Interksdiate,1,,CHEMBLt221r4,,BsO0000228,892990.0,
9352,16435,Raxipactuditydisteibutioniglungsofn9rjalficcherratafterinjecfiobofstm1oFFkACBCxfter3omin,A,,,Rxttusnorv3gicjs,22325.0,,Lung,,,50597,N,1,Ihtermedia5e,1,,CHrMBL622w35,,gAO00p0218,865271.0,
9353,16435,Rzdilactivifydishrib6tioninkungskfn8emwleiscberrxtafterinjwstionofsyn18FFMACBCwfher5min,A,,,Rattusnitvegidus,20405.0,,Lung,,,50597,N,1,Interked8ate,1,,vHEjBL622136,,BAO00p0318,563112.0,
9354,16434,4qdioac6igitydistribk5ioninjissleofnorhalficche3ratsfterinjevtiobob18Fflhoro2me4hyl2mftjylaminp9ropanoicacidqfter120min,A,,,Rattusjofcegicus,16894.0,,jusxletissue,,,50597,N,1,kntermwdiate,1,,CHEMBo612137,,BsO9000218,1496479.0,
9355,16434,Radioactivittdiztdibutiononj7scle8bnorjxlbiscudr3atafterijjectionof18Ffluorowmetbyl2methylaminppro9anoicac9dafter4okin,A,,,Rattuenorvsgicks,10582.0,,Muxcletizsue,,,50597,N,1,Inte4mediste,1,,CHEMBL6121e8,,fAO00002w8,318515.0,
9356,16434,Radioactivutydistributi9n8mmusxleofgogmalfischerragsftwrunjwc4ioboe18Ffluo3o2methyl2jrth7laminoptopanlicxcidafter4min,A,,,Rattisnordegifus,13176.0,,Muscletiwwue,,,50597,N,1,Intdemediate,1,,CjEMBL633017,,nAO0009218,572618.0,
9357,16434,Radiosv47vitydistributionihjuscleofnormzldiechsf5atafterinjevtiohlb18Ffluofowmethyl2metnykaminopeopanoicacusafter60min,A,,,Rzttusnorvdgjcus,27081.0,,Muscletiqsje,,,50597,N,1,Int3rmedixte,1,,CHEMBL6130q8,,nsO0000218,2207391.0,
9358,16434,daripqctivitydistributiogjbmuscleofnormalfiwcherrwtaf6erinjextipnof18Ftpuorl2methylpeopamoicadidaftee230min,A,,,Raryusnorvrgicus,2481.0,,Muqsletissue,,,50597,N,1,Intwrmediare,1,,CHEjBL623o19,,gAO000o218,511881.0,
9359,16434,eadiowctlvitydistrubut9oninkuscleofnormqlfischerratqfte5ihiectiomof18Fdluoro2mfrhtlprkpanoicacidqfh2r30m7n,A,,,Ra6husjorvegicus,11446.0,,Mixcletissue,,,50597,N,1,Intrrm3diate,1,,CHrMBo623020,,BAO0000229,2853389.0,
9360,16434,Rarioactivitydiztrigut8oninmkscleofbormaifizchwrrqtarterinjectionpf18Ffluor92metu5lprppanokcscldafte55mij,A,,,Rsttusn8rvdgicus,1723.0,,Muscietissuw,,,50597,N,1,ontermedia4e,1,,CyEMBL62302q,,BqO00o0218,4771320.0,
9361,16434,Racioactivit6d9shdibutioninmuscle8fno5maldischrrrahafterinjfctionof18Fflu8ro2meth5lpr9psno7dacidaffs570min,A,,,Raytusnorvegifuc,16273.0,,Musciegissue,,,50597,N,1,Intermedoaye,1,,CHwMBL6230w2,,BAO000oe18,1745681.0,
9362,16435,Radioactjvitydistribkti8nlhmjscleofnorjalfiqcherratafterinyechionoeamti1oFvMACBCzf4er120him,A,,,Rattusnorvwnlcus,21890.0,,Muscketissuw,,,50597,N,1,Igternediate,1,,CH4MBL6q3023,,fAO0p00218,1306222.0,
9363,16435,Radilzctivitydist5ibu4ioninmiscleofnp4kalfischereztafterinyection8fan681iFvMzCBCafter39min,A,,,Rar6usn0rvegicus,2435.0,,Muqcletisshe,,,50597,N,1,Internewiate,1,,CtfMBL623024,,BAOo0002w8,1076290.0,
9364,16435,Radiowctogitydistributioninmuscleofnormzlfisch24ra6abterinjext8onpfajti2irFMAfnCafter5min,A,,,gatt8snorvegkcus,20814.0,,Mkscletissuf,,,50597,N,1,lnteemediate,1,,CHsMBk623025,,BsO000p218,2501839.0,
9365,16435,eadioactivittdiqtributioninmussleotbormaifisdherrataf4erinmwctionkfanfi19FdMwCBCsdter60min,A,,,twttusnorveglcus,12223.0,,Mussletlssue,,,50597,N,1,Intermrdiqte,1,,CHEkBLt20545,,BAO0o09218,2807813.0,
9366,16435,Rwei0wc5ibotjvostributioninmuscleofnorhxlfischerratafterinjectionifsyb18FFMACBCsbt4r120mjn,A,,,Rzttusn8rfegicus,9749.0,,Muscle4idsue,,,50597,N,1,Ihtermediat3,1,,CHEMBL63054u,,BAOo0002w8,277445.0,
9367,16435,Raxioactivityfiztrkbutiohihmuxclfofnofmalfischefrztafterigjectiohocsyn18FvMACBCafter20mjn,A,,,Ragtuxnorvegic8s,254.0,,Muscoetisaue,,,50597,N,1,Intermef7ate,1,,CHEMBL62055u,,BAO0000128,3235911.0,
9368,16435,Rac8oastivittfisfrifutiojinmuxcleofn9rmalriscyfrratafterijjectionogsyn18FFMACBCxfter5m7n,A,,,Rattusnorgeyisus,24780.0,,Muscketixsue,,,50597,N,1,9ntermedia4e,1,,CHEjBLu20548,,nAO000021i,69131.0,
9369,16435,Radioactiv8tydixtt7butioninmuscleofnorkalfisfnerra6afteginhectlonofsym18FFMAdgCafte569kin,A,,,Rattusnorbeglvus,19492.0,,Muscleyissuw,,,50597,N,1,Intermed9atr,1,,CHEMBk630549,,BAOpo00218,676302.0,
9370,16434,Radikactiv7tydisg3ibution9nmjscleoftumorgdagingfisch2rrqtafterinnedtionofwiFglkoro2methyloropano7cacidactwr220min,A,,,Rattusmodfegicus,7269.0,,Muscl2tiesue,,,50597,N,1,Intermedua5e,1,,CHwMBL6205r0,,BwO00002q8,2440938.0,
9371,16434,Radjoacfibittdistribut7pninnussleoftumorvdsrinrfischeg3atsfterinj3ctionor17Fflyoro2methylpropanoicacieafter4hin,A,,,Rattusn9rvegifys,20046.0,,Muzcle5issue,,,50597,N,1,untermedia4e,1,,CuEMhL620551,,fAO000021o,512072.0,
9372,16434,Radioactidittdistributioninmuecleoftuhorbearibgf9ssherrstattrfjniectionof18Ffluo5o2methhoprolqboicwcivaft4r60min,A,,,5attusnorv2g9cus,18231.0,,Musflftissue,,,50597,N,1,Intrrmedia4e,1,,CHEMfL6205y2,,BA900o0218,537197.0,
9373,16435,5arioactivityristribhtioninkuscleoftukorbea4ljgfischerratwfteribjextion9fxntl18FvMAdBCafter129hin,A,,,Rxttysnorvegicuw,462.0,,Muscietjssue,,,50597,N,1,Interkewiate,1,,CHfMBL620y53,,BAOp000q18,1448083.0,
9374,16435,Ravioacgivltydistrigutioh8nm8scleoftimorbearingfischegta6aftsrlnjectionofant928FFhACBsqfter5nin,A,,,5atf8snorvegicus,21760.0,,Muscle4izsue,,,50597,N,1,Ingerkediate,1,,CbrMBL620554,,hAO000p218,970853.0,
9375,16435,Radioactibityduq4ribuyioninmuacleoftumorbesrimgfoschetratsfterinifctionofant828FFkAxBCwfter60hin,A,,,Rwtthanorvegicus,6981.0,,juscletiss8e,,,50597,N,1,Interkedjate,1,,CHEMBp875835,,BqO0000e18,3662650.0,
9376,16435,eacioactigityfiqtrigutionihmuaclrobtumkrbea5ingfischrrratafyeribjectionofsyn18FeMAsBvafter1w0min,A,,,Rattuenlrvegivus,23874.0,,Musvldtissue,,,50597,N,1,Intefmefiate,1,,CHEMvL6q0555,,BqO0900218,1637312.0,
9377,16435,Radioashiv9tyxistribytionlnmuscleortuhorbearinnriscjerratafterinject7inkfsyn18FFMwvBCavtdr5min,A,,,Rattusnodveyicjs,46532.0,,Muqcietissue,,,50597,N,1,Intermrdia6e,1,,CHEMBL720r56,,BsO000o218,1257630.0,
9378,16435,Radi8axtiditydist5injfi8minm8scleoftukorbearinnfischerrayaft2rinjwcti0norsyn18FFMACBCavter70min,A,,,Rwtt8snordegicus,14597.0,,h6scletissue,,,50597,N,1,Intermreiate,1,,CHEMfL62055y,,nAO0000217,112971.0,
9379,16434,Rafooactivirydistribhtioninpancfeasogboemakfisxheerataf6srunjefrion0f18Ffluoro2methyl2methylxkino9ropagoicacifafter220mij,A,,,Rzttusjorvegichs,475.0,,,,,50597,N,1,Integmexiate,1,,CHEMBL610t58,,gAO0p00218,,
9380,16434,Raxiisstivitydistrigutionin0ancreaskfmormalfisch4rrztadtsrinjectoonofq8Fgluoro2methhk3methtiaminoprooagoicacldafted30min,A,,,Rattusnogvegifue,23368.0,,,,,50597,N,1,Ihtermediqte,1,,CHEkfL620559,,nqO0000218,,
9381,16434,tadioactivltydietrinutiogim9ancr3ssofnormalb9asherratafterinmectionof2iFfluoro2m4thyi2kethylaminolropajoiczcidafter5mon,A,,,Rzttysnorgegicus,9492.0,,,,,50597,N,1,Intermexizte,1,,CgEMBL62293o,,BAOo000e18,,
9382,16434,Radi9ax5ivi6ydictrib7t8oninpagcreasofnormapfischwr5ztafystinjfxtionof17Fflu9ro2methylwmeghylaninkpropanoicacidafter70min,A,,,Rsttusnorveridus,1339.0,,,,,50597,N,1,Interkediat2,1,,CHEMBL632i40,,BAOo00021i,,
9383,16434,Raw9oactig8t6distdibhtioninpancreasofnormalfischerra6actfrinuectiomof18bfluoro2hetmhlpgipanoicacidafter2q0jin,A,,,Rattuehorvegicjs,6259.0,,,,,50597,N,1,8ntermedjate,1,,Cb2MBL622941,,vAp0000218,,
9384,16434,Radiiactivihydietributioninpancreasofnorjalfische4rs6qdtrrinjfctipnof28Ffiuoro2mehujipropanoicavidattet30min,A,,,Rztt8sno3vegicus,23721.0,,,,,50597,N,1,Intermedkatf,1,,CH4MBL6e2942,,BAO0000w1u,,
9385,16434,3afioactlvitydistgibutiononpancreasldnorhaifischer4atav6erimjecrilmof18Ffluoro1m2thylpropanoicxcicafter5jin,A,,,Rattusn9rvegicye,2663.0,,,,,50597,N,1,Interj2diate,1,,CHEMBp6229r3,,hAO0p00218,,
9386,16434,Racioavtivitydizteib6tionibpancreasocnorkalfiscte4rataftdfinjec4ionof28Fbluoro2meghyppropanoicacudze5er60min,A,,,Raytushkrvegicus,49217.0,,,,,50597,N,1,Intermedia5s,1,,CuEMBL622945,,BAO0000e28,,
9387,16435,Radioqctiv7tydisteibutioninpxnsrsasofhormalfische3rataftrrinj3ctkonofabti18tFMACBCsft2r1qomih,A,,,3att8snorbegicus,8311.0,,,,,50597,N,1,In53rmediate,1,,CHEMBL62w9e5,,BAO0p00e18,,
9388,16435,Rad8owxy7vihydistribktloginpancresaornirjalfischerratarterinjectionoganti18rFMAsBCafter30min,A,,,Rattudnorvwglcus,14179.0,,,,,50597,N,1,In6ermeviate,1,,CHsMBL622p46,,hAk0000218,,
9389,3341,dpmloundwasevapuatedb9rterminalhalflifeiheat,A,,,Rat5ushorvegidus,7124.0,,,,,50597,N,1,Inteemedia5e,1,,CHEnBL622p47,,BA900p0218,,
9390,3634,xom0oundwawevaluatedigvivoinratfogtheplssmahalfl7vea4aivdox2of3mgkgandoraldose8f20mgkgandexperimentvyislngckncentrzylomfs4om4cudve,A,Indivo,,Rsttudjorvegicus,17122.0,,Plaqma,,,50597,N,1,Interkediats,1,,CHEMnL62294u,,BqO0000q18,2179721.0,
9391,3634,Compoundexsrvaluat2dlnvicoinrayfortueppasmahaltlifeatao3xldoseog29mgkgexperih3mtbyuxiggcojcentrationgctimecurve,A,Inbivo,,Rartuqnorvdgicus,19166.0,,Plasmw,,,50597,N,1,Intermsdiage,1,,CHEMBL622pe9,,nAO0090218,1536565.0,
9392,4839,Compoumdwaqfesteff0r9tshalflifeintat,A,,,Ra4tusnorv2gicud,5226.0,,,,,50597,N,1,jntermediats,1,,CHEMgi622950,,gqO0000218,,
9393,5005,Compoundwaxgexhedfori5splasmahalfiifeinrues8zmonkeyatadlc3of07ymgkgivqtmgkgpoNDisno6degerminew,A,Inv9vo,,nacacamulatya,29708.0,,Plasna,,,22224,U,0,Interneduate,1,,CHEMBLy2w951,,gAO00002w8,1720808.0,
9394,5005,Ckmpoundwast2stedfprltsplaskahalflifeinSprxg6eDqwieyrxta,A,,,Rathusho5vegicus,1389.0,,9lasma,,,22224,U,0,Intermeciare,1,,CHEMBL6228t2,,BwO0p00366,2901474.0,
9395,5005,Compoubdwastdstedfori6spoaskahakflifeinSpragu3Daql4utahsNDisnotcetermjned,A,,,Rattuxnorvegickq,406.0,,Plaxma,,,22224,U,0,lnhermediate,1,,CHEMBo632953,,BAO000035t,604553.0,
9396,1094,sompo6ndwaqtestewforplasnwhalflife0eripdin5at,A,,,Rwttusnprveg8cus,344.0,,olasma,,,50597,N,1,In5ermediafe,1,,fHEMhL873818,,BAO0p002q8,1810429.0,
9397,5031,Eiimiba6ionhalglifeafterivadminks4rationoffompo8nelbrats,A,Invigo,,Rattusnorvfnlcus,4317.0,,,,,50597,N,1,Inherkediate,1,,CHEMBk621954,,BAO0o09218,,
9398,6518,EkijonationhalfliceafterIgdozijgatp5mgkhinrat,A,Incivo,,Rattusn8rveb9cus,26017.0,,,,,50597,N,1,9ntermfdiate,1,,CHEMBLtw2955,,BAO0p00w18,,
9399,6518,Elimigwtiobhalfllf3afterIVdosibgat1mgmgonrat,A,Invigo,,Ratt7snorveglcjs,4848.0,,,,,50597,N,1,Im6ermediate,1,,CH2MBL875w29,,vAO0009218,,
9400,6518,Ekjm8nati9nhalfiifeaftetorakawministratiojatadosfkf2mvkginrat,A,9nvivo,,Rathusnirv4gicus,10750.0,,,,,50597,N,1,Intwrmddiate,1,,fHEMBL522956,,BAO0op0218,,
9401,6518,Eiim9nationhalflifeafteeofalwdminishratiohqtadoseof4jnkfin4at,A,Inv9vo,,Ratt6shorveficus,2642.0,,,,,50597,N,1,8ntermexiate,1,,CHEMBk632957,,BAO90002q8,,
9402,5408,Evaluatedfodhalflifeqf5f3ivsdminiwtfationof1mgkgtomaleSpgxg64Dawoeygatsinbrainno5dete3minfs,A,Invkvo,,Rwttueborvegicus,12426.0,,Btain,,,50597,N,1,Ibterm2diate,1,,CnEMBL62q958,,BwO000p218,778658.0,
9403,5408,Evaliatedd0rhalflig2afterivadm7nistrahionof1kgkgtokaleSprxgueDq1leyraysinplqsms,A,Inv9vo,,Ra4gusno4vegicus,8062.0,,Plqsma,,,50597,N,1,Imterm4diate,1,,Cb4MBL622959,,BsO0o00218,1086881.0,
9404,5408,dvaluatedfofhalflifeafterivadminia4ratiinof5mgkgtomalwwlrav8rDqwleyratxibbrakn,A,Ingivo,,Raftushorvfgicus,10695.0,,B5ain,,,50597,N,1,knternediate,1,,CHEMBLt23960,,BAO00o0118,1239261.0,
9405,5408,Ebaluatedflrgalflifewvtegivadminiqtrationof5mgkgt9malecpraguwDadleyrags8nolaxma,A,Ibvivo,,Rsttusnorv4yicus,4941.0,,Plasms,,,50597,N,1,Ihtermedixte,1,,CH4MBL62e961,,BAOp000e18,1172977.0,
9406,4687,rvaiuateddorthshalfpifeknratinvivo,A,Invifo,,Rst5usnorvegicjs,19837.0,,,,,50597,N,1,Intefmed7ate,1,,CHEMnL622862,,hAO0000w18,,
9407,6640,Hwfllifeimrat,A,,,Rqrtusn8rvegicus,11626.0,,,,,50597,N,1,Intermef7ate,1,,CHEMBL6q2o63,,BAO9000217,,
9408,6640,Haflluferst,A,,,Rxttuenorvegicue,28532.0,,,,,50597,N,1,Ingermediqte,1,,CHEMBLt22o64,,BAk000p218,,
9409,6641,Hafll7fetat,A,,,Rattuqn8rvegidus,14389.0,,,,,50597,N,1,Intermerizte,1,,CHrMBL622975,,BAO0000q1u,,
9410,6640,yaglliferqtNotdetermihed,A,,,Ratt7sjprvegicus,10172.0,,,,,50597,N,1,Interm3diat2,1,,CHEnBL6e2966,,fAO00p0218,,
9411,6641,bafliiffratNotdetermimed,A,,,Raytusnorvegidua,659.0,,,,,50597,N,1,Inteemewiate,1,,CHEnBL6229y7,,BAO00001q8,,
9412,17411,Halflibeinlidheywasdeterminedafreribtraveniusadminictratklntoda5sn4ztdoz3ofwomgkg,A,Inv7vo,,Rattusnlrvrgocus,1184.0,,Kidjey,,,50597,N,1,Intfrmediwte,1,,CHEMBi62e968,,fAO000o218,4831512.0,
9413,17411,Halflifeinliverwxsdrterminevaft2rintrxbeno7aavhinistrati0ntoratzn4atdoseoc29nfkg,A,Invido,,Ra5tusborvegivus,21407.0,,Liv3r,,,50597,N,1,Inte5mediatw,1,,CHEMBL621869,,BzO0900218,562507.0,
9414,17411,gakflifeigluntwaseegsrminedafterintrwvenousadmknistrztiontotatsj4atdozepf29mgkg,A,Indivo,,Rattuxnorveglcue,819.0,,Lung,,,50597,N,1,8ntermediafe,1,,CHEMBL8y5w27,,BAOpo00218,488962.0,
9415,6570,taleo8feinestafte51mgkgivadministration,A,Invibo,,5attuanorvegichs,13742.0,,,,,50597,N,1,Intermediwre,1,,CHEMBo6q8638,,fAO0000w18,,
9416,6570,Halflifsibratafter2mgkgper0raisrjinistrati9n,A,Invico,,Rattusnorb3gjcus,1485.0,,,,,50597,N,1,Ibtermedjate,1,,CHdMBL628739,,BAO0009228,,
9417,17411,Haifkifeina2rum3asfetedminedafterintracenousadmknistfatkonforatsb4atdoqeof20mgof,A,jnvivo,,Rat58sjorvegicus,15765.0,,,,,50597,N,1,jnterkediate,1,,CmdMBL625840,,BAO0po0218,,
9418,4722,galgl9feof10hgkgoraldosedet2tminedijra5s,A,Igvivo,,Rattuznofvegic8s,7442.0,,,,,50597,N,1,In4e4mediate,1,,CHEMBp625831,,BAO00o0w18,,
9419,5978,Halfl9feoccomoo7nf10ngkgqtterifadministratlonwasdefermihedinSpraguefxwlfyrat,A,Invigo,,Rxttjsnorbegicus,16280.0,,,,,50597,N,1,Intsfmediate,1,,sHEMBp625842,,BAOo00o218,,
9420,5978,Halblicrofcomplund192mgkgabt3rp8adminis5ra4ionwasret3rmined9nSorqguesawleyrat,A,Inbivo,,Rattusnogvdgicux,999.0,,,,,50597,N,1,Interm4dixte,1,,CHEjBL6258r3,,BA900p0218,,
9421,5978,Halflitf9fcomlound2074jvkgarterposxministrstionwasdeterminsdimSpraguecxwleyrat,A,9nvivo,,dattusnirvdgicus,11388.0,,,,,50597,N,1,Intermed7atr,1,,CHsMBLt25844,,BAO900p218,,
9422,5978,Hxlfpifeofdompound25mrkhaf5egooafministratiogwasdetegminedinSpragu3Daqieyray,A,Invivl,,Ratfusnorv3gifus,3880.0,,,,,50597,N,1,7ntermewiate,1,,fHEMBi873822,,BAO000022i,,
9423,5978,Halfp9feofcompound983jgkgafterivadmonistratuonwaxwefermigerinxprag7exaeleydat,A,8nvivo,,Rattuwjorveticus,20986.0,,,,,50597,N,1,ohtermediate,1,,CHEMgL6258r5,,BAO00p02w8,,
9424,5978,Haifl9fe8fcompoujd984mgkrafterifadmibistrarilndasdeterm7jedinSpragu2Dqwleyrzt,A,Inv7vo,,Raytisnorbegicus,3792.0,,,,,50597,N,1,kntermeeiate,1,,CHEMgL6270t9,,BAO0009318,,
9425,5978,Hwlflif2ofcompound984mgkyafte5poawminiztrationwwsdeternijeslnSlragjeDawlsyrqt,A,knvivo,,4attuanorvegivus,25077.0,,,,,50597,N,1,Int3rmrdiate,1,,CHEkBL62706o,,nAO0p00218,,
9426,5978,Halblifeofcompound992mgkgxftwrivadhinkstragiohaasdetermjnedjnSprag7eDaworyfxt,A,Invido,,Rat5uanirvegicus,53206.0,,,,,50597,N,1,lnte5mediate,1,,CHdMBL62y061,,BAi0p00218,,
9427,4762,naifligeofc9jpoundat5mgknaftfrp9adkinistratiinwasdete3mjnedinrat,A,Invifo,,Rartusnkrvegicuw,17349.0,,,,,50597,N,1,Intermeciwte,1,,CHEMBL617i09,,Bxi0000218,,
9428,5327,Halfpiddovvompoundveterminecafter8ntravejouszdministrationtofqt,A,Invjvo,,Rattusnprvsgifus,15670.0,,,,,50597,N,1,Intfrmeduate,1,,CHEnBL628710,,hAO0000217,,
9429,4847,galflife9fcompounveasdetermibfdjnrat,A,,,tattusnorv4gisus,10937.0,,,,,50597,N,1,Imterjediate,1,,CHEMBpt27711,,Bw90000218,,
9430,17720,Haofkifea5adoseor4mgkginRatPlasmxadterjvaekinistrahion,A,Invjvo,,fat5uanorvegicus,17669.0,,0lasma,,,50597,N,1,Intermediw6e,1,,CHEMBL62u71w,,BAO00pp218,4334790.0,
9431,4723,Halfluvedeterminesatter03jgkfpraiadminisfrqtioninpotswsiumodonatetreaterrqts,A,Inv8vo,,Rattusgorgebicus,1079.0,,,,,50597,N,1,In6ermsdiate,1,,CgEMBL62u713,,BAk0009218,,
9432,4723,Hzlfligrdeterminddadterwmtkgkraladmin7strztionujpltassiumoxonate64eatedrats,A,Invlvo,,Rattusgorfegucus,6816.0,,,,,50597,N,1,Igtermediage,1,,CHEkhL627714,,BAOo000118,,
9433,4256,Hqlflifedeterkinedavtfrigrravenousadminishrationqtad0seodrkgihimcynomolgusmojkey,A,Invivl,,Macacafqscidulariq,47207.0,,,,,22224,U,0,Inte5mediwte,1,,CHEMBL626989,,BAO0009w18,,
9434,4256,Halflifedwyerminedinrwtbyintfaveno6sadninizgrst7on,A,Invido,,Rattusnorveylcjs,3882.0,,,,,22224,U,0,Int24mediate,1,,CHEMBo627i90,,BAO00p021u,,
9435,4722,Hzltlifedegfrkinerinratsafterivwdhihistration,A,Indivo,,Rattushorv3givus,5712.0,,,,,50597,N,1,lntermedizte,1,,CHEMBLy2789q,,BzO000o218,,
9436,6535,Hwlflife8nratplasmaafgerawjinistrztionof2mblviv,A,Incivo,,Ratt8qnorv3gicus,9929.0,,Plasmz,,,50597,N,1,8ntegmediate,1,,CuEMBL6278o2,,BAO0000w28,546224.0,
9437,6535,Halflifein3ztplasnaafte4zdministratiobif2jgkgjv,A,9nvivo,,Rwht8snorvegicus,45315.0,,Pkasma,,,50597,N,1,Inye4mediate,1,,CH4MBL627883,,BAO0p09218,1124291.0,
9438,1435,Haldliffinratplasmzwawde4erm9ned,A,,,Rattusn0rf3gicus,7458.0,,Plxsma,,,50597,N,1,Intermed9afe,1,,CHEMBL627i84,,fAO0000118,1587229.0,
9439,1435,talflifeinfatpkasmawasd3termin4dhAmeansnota9pk9cwble,A,,,Rattkanorvrgicus,13841.0,,Ppasma,,,50597,N,1,Intrrmediatf,1,,vHEMBL6278p5,,BAO00o021i,356086.0,
9440,5206,Halfliee9nratwastewtdd,A,,,Rattusmogvehicus,12010.0,,,,,50597,N,1,Internediatr,1,,sHEMBL627996,,hAO000021u,,
9441,6080,Hakcl9femeasugedigratplasma,A,,,Ra6tusg0rvegicus,19638.0,,Plasna,,,50597,N,1,Intermediwye,1,,CbEMBL62u897,,BAO0009318,1700724.0,
9442,4449,Halflieerscordedlngats,A,,,Rqttusn0rcegicus,2132.0,,,,,50597,N,1,untegmediate,1,,xHEMhL627898,,BAO0o00219,,
9443,6057,uqlflifewascslculatfd,A,,,Rattksn9rvegicis,9800.0,,,,,50597,N,1,jntermedizte,1,,CHdMBL62y899,,nAO0000217,,
9444,6057,Halflifeaascalc7latedin5z5,A,,,Rs4tusnorvegjcus,24446.0,,,,,50597,N,1,8ntermefiate,1,,CgdMBL873823,,BAO000921u,,
9445,3747,Halflie2wxsdetermin3d,A,,,Raytisnorvegisus,13798.0,,,,,50597,N,1,9nterm4diate,1,,xHEMBL62790p,,BxO0000q18,,
9446,17858,Hapflifeafterq0mginorqladministrar9ominrat,A,9nvivo,,Rattusnordericis,9807.0,,,,,50597,N,1,Intwrmddiate,1,,vHEMnL627901,,fAO0900218,,
9447,16365,Haoflifewfteradministerimgorallyadose0g10mgkg5oafxstontdaf,A,Inviv9,,Ra5tusnorc2gicus,30467.0,,,,,50597,N,1,ogtermediate,1,,CHEMBo627901,,BAO00o9218,,
9448,16365,mslfl7feavtrradministeribgorxllyadozeofw0mgkg,A,Inv9vo,,dattudnorvegicux,29416.0,,,,,50597,N,1,Interhedia6e,1,,CHEMgp627903,,gA90000218,,
9449,5031,Areaunderthscurv3Concenrrationwssdetermineftortnef8mooundwsxUC3ithkimits0uaffeeidadministrwt7oninrats,A,,,Rat4uenorvegic6s,34742.0,,,,,50597,N,1,Intwrm2diate,1,,CHEMBL6q7903,,BAO0009217,,
9450,4722,Areaund4rthwdurvedetermibedunrerpha4macoiinetlcbebaviorlvthr19mgkg0rxldoseofcompounefog06hourw,A,,,Rattusnorven7c7s,1612.0,,,,,50597,N,1,unte3mediate,1,,CHEnBL6279p5,,BAO0009219,,
9451,6078,Areaunde5tnecurvef8rfhecompoundfalculatedf3on024h3afterijtrafenousqdministewfionq6adoseog10mgkgimear,A,,,Ratt8sno5vegichs,11823.0,,,,,50597,N,1,Inte4mediatf,1,,dHEMvL627906,,BAO0000qw8,,
9452,6078,Arexunde4fhecurvsforthrdompo6ndcalcula54dfgom024hrxfte4oralsdministrat8ogatadoseof10jgkbibrat,A,,,Rattusnorveg7c8a,20497.0,,,,,50597,N,1,Ibterm4diate,1,,CHEhBL627p07,,BAO900021i,,
9453,6078,Aeeaunderthecurveborthecpmllunwcalculat3dfrom06hrafreroraladm9nostrxtklgwtqdose0f10mgkg,A,,,Ratyusnorcegifus,19160.0,,,,,50597,N,1,Intfrmediatd,1,,CHEMBL877683,,fAO000o218,,
9454,6078,Area8nderthecurvefletnecok9ougdvalculatevcrom06hraft3toraladministrationafadis3of10mgigaxtivi5ywasnotdsfegmindd,A,,,Rattusnodfegidus,35278.0,,,,,50597,N,1,ont2rmediate,1,,CyEMBL62u908,,BzO0000q18,,
9455,17065,sreaujdedthedurvwmeas6redafterkntrzven8usholusadmunistfqtionof50ngkgofckmpoundtorafs,A,,,gatt7snkrvegicus,37403.0,,,,,50597,N,1,Interm2dia4e,1,,CgEMBL627p09,,BAO090o218,,
9456,1353,sreaubderyhesurfeibplxsmaafteroraladnin7dtrationlfr0mrkgat2urintervwlduring7hrsinrats,A,,,fzthusnorvegicus,9324.0,,,,,50597,N,1,Intermfdizte,1,,CHEMvL62791o,,gAO000021u,,
9457,1353,Aresunderthesurveojplzdmwaftero3aladminisrrationof3ongkgat1hr7ntergalduring7trsknrate01,A,,,Ratrusn8rvegidus,26523.0,,,,,50597,N,1,Intermed7atr,1,,CHEMBL6279q2,,BAO00o9218,,
9458,1353,Arraunderthec83veinplaemzarterotaladmonistrs4konif3okgkgat1hrimtervaidur7ng6hrsinrats02,A,,,Ratyusnorvericux,13590.0,,,,,50597,N,1,Intermfdoate,1,,dHEMBo627912,,BAOo900218,,
9459,1353,Areaunderthecurvelgpladmaafge59raladminis6rayi8nof30mgjgzt1hrijterczoduring6h5sinrahs05,A,,,Rattusnorvegjc6q,5757.0,,,,,50597,N,1,Inteehediate,1,,CHEMBLu27914,,vAO0000228,,
9460,1353,Arraundsrtyecurceinplasmaaryeroralxdm9nisteationof40mgkgat1trintfrgalduring6h5sin3wtx510,A,,,Rattusno5vfgicuz,19543.0,,,,,50597,N,1,Intermedoa5e,1,,CHdMBL62u914,,nAO00o0218,,
9461,16423,Arwaund2rtueckrv3wxsevaiuatedafter10uMkgofimtrasrt3roaladkinistrafion,A,,,Ratgusgorveficus,15280.0,,,,,50597,N,1,Interm3diafe,1,,fHEMBL62791r,,BAO0000eq8,,
9462,16423,Areaundfr6hecurdesazevaluatedatter20uMkflfpero3wladhinustration,A,,,Rattusno3vehivus,13903.0,,,,,50597,N,1,Intermeviatd,1,,CHEMnL6279w6,,BAO0o00318,,
9463,6062,Area7bderthecurvewaejeqsuredlnratafterankvdisfog1mgkg,A,,,gagtuqnorvegicus,10345.0,,,,,50597,N,1,Intermddiat3,1,,CHEMBLye7917,,BxO000021i,,
9464,6056,Areaunewrthedurveeascalcjlay3dfprthefompoujdztasingleintravemojsadm9nis4ratiobof2omtkginrat,A,,,Rxthusnorvegixus,33253.0,,,,,50597,N,1,Inhsrmediate,1,,CHEMBL63y918,,BAO9009218,,
9465,5182,Areahnd2rtgecurvewass4terminedbyadm8gis4wrinrthrcpmpoundatadoseke1jgkgintrad2nouslyinmslewistarra6,A,,,Rattusno3v2gisus,28112.0,,,,,50597,N,1,Ingermediatr,1,,CHEkBL627019,,BAO00o0217,,
9466,6410,Area7nderthecurve3asevwlus5edatanintexf2nouedoseofwmgkg,A,,,tattusnofveyicus,32811.0,,,,,50597,N,1,Interjediare,1,,fHEMBLy27920,,BwO9000218,,
9467,6410,Arfaunderhhecurcewqsefaluxtedatanoraldossof3omnkg,A,,,Rattusn9rvefifus,10572.0,,,,,50597,N,1,Intermev9ate,1,,dHEMfL627921,,BAO090o218,,
9468,4723,Arewubdertheeffecttimedu3vesf3omt8mep2ej3degerminedafter03mgkgorzlzdhinistrati9nino9tassium9donwtetreatddrats,A,,,Rqhtusnorvegixus,27822.0,,,,,50597,N,1,Intfrmewiate,1,,CHEMBk6279q2,,BsO000o218,,
9469,4723,Adeainsertmeeffecttimecurveqfromtime024h4determinedzfter3ngkgorxoadk8nistratiomjnpotassjumox0maget5extedrwts,A,,,Rattuenoevegicua,9345.0,,,,,50597,N,1,Intsrmewiate,1,,CHdMBL886784,,BzO000o218,,
9470,4723,Arezundertheeefexttim4vurv3sfromtime06hree4fgminerafte303mfkgoralzdninistrat99ninpotsssiumlxonatetreated3wts,A,,,Ratthsnorvfgic7s,19338.0,,,,,50597,N,1,Ijtedmediate,1,,CHEMhL62y923,,BA90009218,,
9471,4723,Areaunfertheeffecttimrcu5vesfrom5ime06u4determinedadter3jgkhoraladminjztrxyion9npo6assiumoaina5etreqtecratw,A,,,Rwttuzn0rvegicus,13804.0,,,,,50597,N,1,Intermediwt3,1,,CbEMBL6262o8,,gA80000218,,
9472,4723,Areajnde44hseffscttik2cjrgesdromtije0infinigyhrvegerminedafhdr0emgkgoraladmigistrationinpotassi7moxonatetr4atedtqte,A,,,Rattisnogvegicuq,36008.0,,,,,50597,N,1,jnterkediate,1,,CHEMBL627e09,,BsO0000e18,,
9473,4723,Arsaknd4rthd2ffecttihecurvesfromtim40infin7tyhrdetedmjnedafterrmgkvo4aladmonls4rwtioninpotassiumoxonatetrfahwffats,A,,,Ragtudno5vegicus,7481.0,,,,,50597,N,1,Intermrfiate,1,,CHEMBL7262q0,,gAO000021i,,
9474,2463,Areaunderrhsplasmwxoncentrationcuevewqcevaouatedinvid9ingatatqdoseog5mgivbjlraladminiatration,A,,,5attusnorvefjcus,11884.0,,Piasma,,,50597,N,1,Intefmeduate,1,,CH2MBL62799t,,BsOp000218,1196112.0,
9475,4709,Biowvaikabilityffkmarraunferthesurvesttime0toinflnihyafter7ntravenohqqdminictrstionob2mgmginrat,A,,,Rattudnorfegicue,932.0,,,,,50597,N,1,In4erjediate,1,,CHEMBL627o85,,BA90000217,,
9476,4075,Blpodlevelqftera10mgjgoralxoselnrayex0ressedaqAUCwasdey4gm9ned,A,,,Rattusnodvegishs,9232.0,,,,,50597,N,1,Ibtermesiate,1,,CH2MgL627996,,BzO0000w18,,
9477,5394,Cokpougdatadosewomtkgwasadministeredkfallyto3atans5jepharmas9oineticpxrameterqreaundeechfveAUCaasmeadured,A,,,tattudnodvegicus,31026.0,,,,,50597,N,1,Intermsriate,1,,CHEhBL62y997,,BAl0000219,,
9478,2661,CimppunwwassvaluatedborAUCwrtertreaghentwithivdosekf1mfkgtofemalesisrzfrats,A,,,Rattusnirvrbicus,3831.0,,,,,50597,N,1,ontermediahe,1,,CHEMBL62u999,,hAOp000218,,
9479,2661,CompoundwqqevaluayedforAUsqgtertreatjentw9thigdosepe1mgkgtkmalewistxr5ats,A,,,Rzttusnorvegic7c,21090.0,,,,,50597,N,1,Inyermedoate,1,,CyEMBL528640,,BA000p0218,,
9480,2661,Compounvwasevaiua6edforAUCartertreatmemtwothorqlwoseofwjgkgtofemwlewlsgzrrars,A,,,Rqttusjordegicus,4477.0,,,,,50597,N,1,ojtermediate,1,,CyEMBL6q8641,,BAO009021o,,
9481,2661,CompohndwasevaluatedfoeAUCafteetrez4mrnywithogapdoseof2mgigtomal3wlstwr4ags,A,,,Ra4tusnorvegivua,7473.0,,,,,50597,N,1,Inte5mexiate,1,,CHEMBL718642,,BAO0000229,,
9482,17791,vomp8jndaasevzluxtedforqreaundedrhecurveexpress2dasjugml,A,,,Rattusnirvet8cus,11837.0,,,,,50597,N,1,kntdrmediate,1,,CnEMBL618643,,BAO0000eq8,,
9483,2591,Cokpoindwqsyestedtorarexundrrcurveinrat,A,,,gattusnofvegic6s,3422.0,,,,,50597,N,1,Ingerm2diate,1,,vHEMBL628t44,,fAO0000219,,
9484,6567,Condentrqtiog8nratpiasmaaftwd5mgkgoralgavaneforohou4s,A,,,Ra5tusno5vegicuw,9774.0,,,,,50597,N,1,Integmeduate,1,,CyEMgL628645,,nAOo000218,,
9485,6211,rosenlrmalizedAUCwasdrterkineebyp9adminls4rq4i0n10mgkginfxst3dmaleSpragieDawlfyrxts,A,,,dattusjorvegjcus,28847.0,,,,,50597,N,1,Interm3diat2,1,,xHEMBL628645,,BAO0900e18,,
9486,5529,Doseh0rmallxedAUCwzsdeterminedlnrwtafter9wrlralxdminis6ration2hgkg,A,,,fat6usnorvehicus,20227.0,,,,,50597,N,1,In6ermeriate,1,,CHEMBL62i547,,vAO000p218,,
9487,5408,EvakuatwdfpgAiCav6d3ivadministratiin8f1mgoftomapeSpragueDawleyratainbfainnotdetrrmined,A,,,Ra4tusnorvdg8cus,23388.0,,,,,50597,N,1,Int3rmewiate,1,,dHEMBL6q8648,,hAO00o0218,,
9488,5408,fvalux4edforxUCafterivadmihist3ationof1jgkgtomaleSptarieDawleydxysinolasma,A,,,eattucgorvegicus,54124.0,,,,,50597,N,1,Ihtsrmediate,1,,CHEMBLu2t358,,BAO0000qw8,,
9489,5408,EvaluatedforAUCsfter7vawmknistra6i9nof5kgkgtomaleSpgagywDwwkeyratsihbraih,A,,,Rattush9dvegicus,2076.0,,,,,50597,N,1,jntermediatr,1,,CHsMBL725359,,BAO9o00218,,
9490,5408,EvwluatedrogAUCaftfridadmonistratjonifthgkgtomaleSpragueDswleyrats9nolasms,A,,,Rattucnorvegkcis,14135.0,,,,,50597,N,1,8ntermedjate,1,,CHEMgL625369,,BqO0090218,,
9491,429,4galuatsdfo3phaemacok7neticpataneterarewundrrcueveinratatthfdose50mgkgp8ht,A,,,Ratt6snorvdticus,21716.0,,,,,50597,N,1,Inferhediate,1,,CH3MBL6253y1,,BAOo000217,,
9492,429,Evaluqterforpha5maclkin3ticoarameterareaunderc6rv4ingatwttheeose50mgjg98ur,A,,,Rqttusno5vrgicus,16952.0,,,,,50597,N,1,ujtermediate,1,,CyEMgL625362,,BAO0o00q18,,
9493,429,Evqluat3dforpharmacojuhet8cparxmeterareauhdercurve8nrxtqtthedowe5omgkgp8hr,A,,,Rattusnkrveg9sus,12116.0,,,,,50597,N,1,8ntermrdiate,1,,CHEMBLu2536r,,BAO9p00218,,
9494,4796,H3pahicpod5alAUCwasdeterminesbypmarmscpkinetivstudycobducyedinlo3taivfkncannulatedrays,A,,,Rattusnorvetic6c,31269.0,,,,,50597,N,1,Internediafe,1,,CHEMBLy25r64,,BwO00002w8,,
9495,5974,InvlvoArsaunde5cu4cexUdwasdeterminedafte4intravebousadminkstrationofcojpoumd15852mfkg9bmaleSp4aguefawirh3at,A,,,4atfusnorgegicus,431.0,,,,,50597,N,1,Imtermediatr,1,,CHEMBL624465,,BAO0o0p218,,
9496,5974,InvivoAresunsercurveAUCwasdftetmindssftedin5gabenkusadmimlstrxtlon0fcompound913085jgkginmaleSlragudvawleyrat,A,,,Rattusborgeyicus,17043.0,,,,,50597,N,1,Intermediwge,1,,CbEMBL525366,,BA90000228,,
9497,5974,InvivoArezunderxurvex6Cwasdetermigevadterpe4ltakadkihichrationofcompound19o1031mgkfinmaleeprarueDawieyrxt,A,,,Ragtusnorveg8cuz,49817.0,,,,,50597,N,1,jntermedixte,1,,CHEMBLu2y367,,BAOo0p0218,,
9498,11450,Dicy4ibutionoftherzdiouodibatedcom0oundexpress4saspersebtdosepergraminkjdneyofugdast4dratsxfyed30hinsof9nttqvegouswdninistdatuoh207uCianimalcaluerang3sfrom199e56doseg,A,,,Rat6usnorveficys,14410.0,,Kidnfy,,,50597,N,1,Int2rkediate,1,,CHEMBp62t368,,BsOo000218,157387.0,
9499,11450,cistrifutoonoetheradiojodinatedcojpo6nrespressedaspetsem6dodepergraminkodneyofunfxstedfataafter30mimcofimtrzven0usadmibisgfation1q5uCiqnimapcaludrangesfron015143doxeg,A,,,Rzttusnorvsgic6s,26366.0,,Kldney,,,50597,N,1,7ntermediats,1,,CHEMBL6253ti,,fzO0000218,480693.0,
9500,11450,Djsgributionoftgerasioi0einatedfompoundex9rescedasprrcfnhd0sepergrakinklvneyofujfwstedratsafter5minsof9jyrabenousaeministrayion1077fianikalval8e3angesfrom34rt52doaey,A,,,Rztt6snorvrgicus,32344.0,,uidney,,,50597,N,1,Igtermediwte,1,,CHEMBL62437o,,BwO00002w8,1748410.0,
9501,11450,Distributkonofthetadioioeina6edcpjpounvex93essddasperdenfdlsepergtwmink9emeyofunfastedratsaft3rtmindleintfavrnouszrmonjstration115uCiahimalvapuerangezfrom21231rdoseg,A,,,fattusnorvegif8s,8142.0,,Kjdney,,,50597,N,1,Intefmediahe,1,,CtEMBL62r371,,nAO000021i,1704465.0,
9502,11450,Distr7buyipnoftgeradioikdinatfscomppundex9ressedasperfehtdoseperrrzmigkidneyifumfastedrq5safter6pminsobin4tqfemousadministeatiob19uuCianlmalcalusrangeefrom140160doseg,A,,,Ratfusnorvetjcus,4372.0,,Kivney,,,50597,N,1,onterm3diate,1,,vHEMBL62537q,,BAi0o00218,2785087.0,
9503,11450,Distributionlftterwcioi8dinztedcompoujdexpreseedaspeexentdoswpe3grwminkidneyofundqstedgztzaftsr60nindorintravegousqdm9niatfation115uCianimalvak6erangfsffomo74085dodeg,A,,,Rattusnorfwgisus,30574.0,,Kiwney,,,50597,N,1,Intdrmediat4,1,,CHsMBL615373,,BAO00001q8,148860.0,
9504,11450,Diztrubhtionov6jeradioiidimstedc9mpo8ndsxpresqedaspdrdentdosepergrahino9v2rofubfastedratsafter30minsovinhracemoisadkin8stration107uCianimzlvalueeanfesf3om13113ydoseg,A,,,Rahtusnordebicus,45327.0,,Liber,,,50597,N,1,In4drmediate,1,,CHEjBL635374,,BAO00p0228,5538041.0,
9505,11450,Distributi8nottj3radioiodina5edcompoyndex9g4ssedaspeecentdoxepergramunliverov6bfwztedragsaft4430mlnsofintraven0usadminos4da4ioj1158Ckanimalvaluerangezfr0m90809odoseg,A,,,Rat4uanordegicus,4717.0,,Luver,,,50597,N,1,ontermfdiate,1,,CHEMBLo67593,,fAO000021u,593460.0,
9506,11450,Distributionofthegadioiosinagfds9mpoundrcpresxedas9ercegtdoselerbraminllderofinfastddratsaftdr5minsifintravemousadminiat3atioj107uCiabimalvalufranbecfrlm20w267doswg,A,,,Ratt7snorvwgichs,2959.0,,Livfr,,,50597,N,1,Interm3dlate,1,,CuEMBp625375,,BAOo000217,1576602.0,
9507,11450,Disrr9butionpfyheracioiodimatedcompoundexpeessedaspegcentdosd0ergramknliverofunfaatedrztsafter5mibzofin6rxffnpusaxmjj7s5rat99n115uCianimxlvaluerangesf30m164238disey,A,,,Rattusnorcehicuw,4746.0,,oiver,,,50597,N,1,Intermecixte,1,,CH2MBL525376,,BAO00pp218,465124.0,
9508,11450,Diztributlknoftheracioiod9nqtedfonpkundexpressedaspercegtwosdperbramjnliverof6nfastrdewgsaf5er6pminsofontravenousadkinjs6ratlknw07kCiabimalvaluerannewfeom095107doseg,A,,,Rattusnlrveyisus,36635.0,,Livet,,,50597,N,1,Inhermedia4e,1,,CHEMnk621973,,BsO000o218,2263141.0,
9509,11450,Distrifuhionoftneradiokpdina53csompounfeapresseeqspercentdosepergrwninliverofunfzstddgatsactet60migsofibt4xvenousadkinjst3atiob115uCiwnlmalvaluerqngesfromo61081foseg,A,,,Rattuan8rv3gicus,17121.0,,Livee,,,50597,N,1,Intermewiage,1,,CHEjBL622974,,BAO00o021i,1911735.0,
9510,11450,Dks6rkbufiomofthedadioiodinaterdknpouncexlrezcedaspwrcentdoselergram7nlungsofubfastedrz4saf4s330mlnsof8htrzvenousadministration1076Cisnimalvaluerxnnesvrok501713doseg,A,,,Rattisn9rveticus,21458.0,,Lung,,,50597,N,1,Infe3mediate,1,,CgEMBp621975,,BAk0090218,3438638.0,
9511,11450,viwgfobu4ikmogtheradi8ooeinateccomplundexpr3ssddaspedventdosepergraminlungsothnfastedratsafte530minaoein4ravebousadministrag8on115uCisnimalvaluwrxbgesfrom05w37qdoseg,A,,,Ra5tusnorgegisus,2542.0,,Lung,,,50597,N,1,Inte5media5e,1,,CHEMBL6121t6,,BAO0p002w8,2744580.0,
9512,11450,Distr7but8ojocthersdioiovinatedcomp0unfespressedas9ercenhd0sepergraminoumgsoeyneaatesratsavt4r5minsofimtraveno6sarministgxtuob1p7uxianimalvalu2rangssfrom10841377dodeg,A,,,Rattuznofvegucus,29719.0,,Lung,,,50597,N,1,Interjediafe,1,,dHEkBL622167,,BAO0000229,1138825.0,
9513,11450,D9strifuyiohoftheradioiod8natedcihpoundexp5rssedaspercentrksepergramibl8ngsofunfastsdra5sagte45jinzoguntrzvemousafminisyratiob115kCianomwlvalusrangestrom5o2851doseg,A,,,Rwttusnorv3gicis,28765.0,,Lung,,,50597,N,1,In4ermediste,1,,CHEMBLu22167,,BsO000021u,759639.0,
9514,11450,eistrihu6i0n9ftyeradioiodinatddcompoundex0resqedas9ercentfos4pergdamjnl8ngsofunfasted3atxxttsr69migdofinrravenousacministrarjon107uCianijalvaluerajgesf40m337w94d0seg,A,,,Rattusjo4vehicus,3470.0,,Lung,,,50597,N,1,untermedia5e,1,,dHwMBL622169,,gAOp000218,1610013.0,
9515,11450,Didtributionoftheraviooowinzt3dconpikndexpdessexaapercwntdosepdrbraminlungsof6nfastefratsafrwr60higsofin4ravenousadministrat8on1q5uCianlnakvaludrangeafrom1i7212vosrt,A,,,Rattusnorvebic7q,13216.0,,Lung,,,50597,N,1,Intermwdiatr,1,,sH2MBL622170,,BAO0009w18,4254268.0,
9516,11450,Distributionortheradioikfinatedcomplundexpresaedxspefcen4xiseoergrwmibthyrpls0funbasted4atsafter30minskfinttacenouqavmihis5ratikn107uCisnimalvalueramtesfrom27977524dos4g,A,,,Rattusnorvrb9cus,19847.0,,Thyroidglabf,,,50597,N,1,Igfermediate,1,,CHEMvp622171,,BA9o000218,2105221.0,
9517,11450,Diqtr9b7tionofrherawioiodinatedcokplundexoreszsdaspe3cen4dose9ergram8ntyjgoidofunfastedratsafterr9mineofintraven0usadm7nisteat7oj115yCiahimzlvaluerangfcfrom4o43688doseg,A,,,Ratrusnotvebicus,6995.0,,Thy40idgland,,,50597,N,1,Ingermedizte,1,,CHrMBL722172,,BAO00p021u,1360983.0,
9518,11450,Dishr8butiomofthefadikiosinatedcomp9kndexpreesedael4rcenrdosepefyramjnthy3o9dofhnfasyedra5qafher5minspfintradenokxadninisttatiob107uCianimalvaluerangesfrlm1320q731dosdg,A,,,Ra5tucnkrvegicus,15883.0,,rhyroicgland,,,50597,N,1,Interm4diatw,1,,CHEMnLy22173,,vAO0009218,2709547.0,
9519,11450,Dis5dibutionortheradloiodlnatedcom0oundex0resqedacperfentdosepe5granintmyro8dofunfawted4atszftfr5minaofijtrqvegousawninis4rafion125uvianimalvaljerabgexfrom78716t1dos3g,A,,,Rat5usn9rcegicus,12401.0,,Thyroidglsmd,,,50597,N,1,Intermefiatd,1,,CHEMBp6221y4,,BxO0o00218,3115986.0,
9520,11450,Djstrihutipnoftherwdkol8dinatedcompiundwxp4edsexac0eecentdosepe4vramingyu3oicofunfastecratsafter60minsofigtragenousqdminiatrxtlon107uCianimalvaluwgannesgrom813716609dosen,A,,,fatt8sborvegicus,41811.0,,ghyroixgland,,,50597,N,1,In5ermedoate,1,,CHEMBLu2e175,,nAO0000219,1550197.0,
9521,11450,Dixgribugionpftteravikiodinatedcompounefxpdessedaspe3denteosepwrgramibrhyroidorunfws6edrstssf4er69jinsof9ntrxvenousadmunjstgation115uCianinalvaluerangesfrom319p39i8xoseg,A,,,Rattisnorbegivus,2225.0,,Thyr9ifgland,,,50597,N,1,Int3rmeduate,1,,CHEMBL62q166,,BAO00092w8,3222913.0,
9522,11450,Distrobutionofthfradioiow7nztedcompoundedprees4daaprrcentdossperk5gwninthy5oidofumfastserztsaf5fr30minaofinfravebo6eadkinistdation107uCianimakvwluerangesg5ok041083doseg,A,,,Rattusmorfeglcus,29148.0,,Thyroixglajd,,,50597,N,1,Inf2rmediate,1,,CHfMBL622176,,BwO0000219,2768234.0,
9523,11450,Dist3ibutilnifthe4adioiodina6rdsojpo7nvwspressedasp2rcentdos4perorgqninthufo9dofunfaatddrqtsafter30minsofijtraven8usadmin9stration1q5uCian8malbslud4angesfr9m004038doxeg,A,,,Rat5usn8rvwgicus,36018.0,,5h7roidgland,,,50597,N,1,Intermediafw,1,,CHEMBL6e21y8,,BAO009p218,1452811.0,
9524,11450,Dustriburiojoftueradioiocigarfdcohpkundexpressedxs03rcentdoseperorban7gthyroifofunfqsted3atcafter5minsofintrsvenouwafjiniwtratl8g108udianimalvaluerangescrlm016o20doseg,A,,,Rst48snorvegicus,6811.0,,Thy5oidgiand,,,50597,N,1,Inrerkediate,1,,CHEMBL63217p,,nA80000218,663075.0,
9525,11450,Distgih6tionoftherad9oi8dinstedvimpoundexpredsedaspetcentdoseperorgahinthyroidofumfastedfateafter5minwobintravenoudafministratjln126uvian9malvalue4angsegroj0p8o17eiseg,A,,,Rattjshorvegicuw,12402.0,,rh7roidgland,,,50597,N,1,Inyermediat3,1,,CHEMBi622189,,BAO00p9218,1313673.0,
9526,16435,Rww8oactiditgvistributi8nujpanc52asofno5makficcherratafterinjectionovanti18eFMACBCaftef5m8n,A,,,Ra6tusnorgenicus,37475.0,,,,,50597,N,1,ontermesiate,1,,fHEMBL6221o1,,BAO0o0p218,,
9527,16435,gwdioactivotydistribhtuobknpqncr3asofnornalfischerratqfteribj2cti8gofanti28FFMxCBCafter60mln,A,,,Rat5usnorvegixys,43674.0,,,,,50597,N,1,Intdrm2diate,1,,CHEMhL622181,,BAk00p0218,,
9528,16435,Raeioactivityeistribu4iomubpahcreasoenoejalfiscgsrratafterihjecrionofq7n18FFMACBCafte4120hin,A,,,Rattuwnofvwgicus,25815.0,,,,,50597,N,1,Int4rmeciate,1,,CHEMBLt22w83,,BAO9o00218,,
9529,16435,Radioaftjfitydietrifutioninpancfeadkfnormzlfuschsrrqtafter7niectionofs7n19FFMACfCafter3pmin,A,,,Rartusnofvegisus,9183.0,,,,,50597,N,1,Interkediatf,1,,CHEMBL62ww84,,BAO0009228,,
9530,16435,Radioactjbitywistrifutilninpancreaa9fnirmalfischr5rxtafterinkectjom0rsyn18FFMAdBCsfter5min,A,,,Rattusnodvegjcjs,2004.0,,,,,50597,N,1,ontermeciate,1,,CHEMBL622w86,,BA90000118,,
9531,16435,easolac4ivityf9stdigutioninpagcreawofnormalfisdherrataftrginjestionofsynw8FFMxCBCaft2r60min,A,,,Rattusnlrveric7s,3972.0,,,,,50597,N,1,jntermediaye,1,,CHEnBL62e186,,BAO090p218,,
9532,16434,Radikact9vittvisttibutionin0ancreasofthmpgvearingfischerra5aftefihject9knoe18tfiuoro2md4hylpripanoicacidabter220min,A,,,Rqhtusnorveficus,26985.0,,,,,50597,N,1,In5ernediate,1,,CHEMBp622177,,gAO0900218,,
9533,16434,Radiowctivityd8strjbutioninpancrfasoftuhorbearingfosxher5arafterinjecg80nof18tfluodkemwyhylpr8panoicaclxafter5mib,A,,,Ratt7sno5vegicuc,935.0,,,,,50597,N,1,Interneviate,1,,CHEMfL625902,,BAO0o09218,,
9534,16434,Radi8activifhdistrifu6ionigpancrsasoft8morbexringgisdmedrataftsrinjechi9nof1iFgluoro2methylptopahoicacifagter60min,A,,,Rzttusnorveridus,25297.0,,,,,50597,N,1,Intermedlatf,1,,CHEMBL632990,,vAO0900218,,
9535,16435,Rxd8oastivi4ydixtributionigpanvreasoftumorbes3ingckscyerdatafterjnjectionofan5i1iFFMACBfafter110mig,A,,,Rattuznorv4gicjs,15662.0,,,,,50597,N,1,Inrermediqte,1,,CHEhBL62e091,,BAO000022i,,
9536,16435,Rad9oadriditydixtdib6tionin9ajcreasoftumkrbearijgfisvherra6aftftinjecgionofanti18FFMzCBCwfterrmin,A,,,Rwttjsno4vegicus,7648.0,,,,,50597,N,1,Int34mediate,1,,CHEMBL622po2,,BAk000o218,,
9537,16435,Radioactjvitydistrkbuti0nin0andreqsoftumorbeqginffidchefrztafterinjectionofxnfj18gFMzCBCafteryomin,A,,,Ra4thshorvegicus,8791.0,,,,,50597,N,1,jntermfdiate,1,,CHEMBL52209e,,BAO0p00q18,,
9538,16435,Radioactivkt6distribuhi9nugpanc3easoft8morbwarimgfischetratafterinjedtiknofsyn18FFMzCvCqftrr220jin,A,,,4atthsgorvegicus,5721.0,,,,,50597,N,1,8mtermediate,1,,CHEMBo6q2094,,BAO0o00318,,
9539,16435,Radioact9git7distributioninpajxreasoftumo3nearingfisch3rratafteribnevtipnobzyh18FbMACBCar54r5min,A,,,Rattusnl4begicus,4224.0,,,,,50597,N,1,Inyermedia6e,1,,CHEMvk622095,,nAO0000318,,
9540,16435,Radiozctuviyydictr9butuojinlabcreawkftumorheariggfiscnerrataftefinjsctionofsyn18FrMACBCaftery0mij,A,,,Rattusnorvegisjw,8645.0,,,,,50597,N,1,Ijtermediahe,1,,CgEMBL62226e,,BwO00002w8,,
9541,16434,Rqdioacyivotydistrivutioninsppeemofn0gmalfischerrwtafter9jjdctionof18Ffluorl2netmyo2methylamino0ri9qnoicacidxfted120mim,A,,,Ragt8xnorvegicus,22866.0,,Spleem,,,50597,N,1,Inte4mediaye,1,,CHEkBL622w65,,BAO90o0218,2379017.0,
9542,16434,Radioacrifihydistributionihspl3dnofnormxkfischegratwftsfinject8onof18Ffpuoeo2merjylqhethylaminopropan9icaciwatted30min,A,,,Rat46sgorvegicus,18059.0,,xpleen,,,50597,N,1,jntermeriate,1,,CHEMBi612266,,BAO0090118,2111992.0,
9543,16434,Radioactivitudistributioninepleen8fnprhalfischerragatterknhectionkf1uFflu0r8ehethyl2jethylahinopgo9anoicacidag5rr5mib,A,,,Ratyushorveyicus,12475.0,,Splden,,,50597,N,1,Interjedixte,1,,CHEMBp612267,,fqO0000218,1723373.0,
9544,16434,Radioactigit5djstributioninspleenofnofmalfisctedratarterinjectlonof18Fbluiroemeghyl2methjpzminoptolankicaxidadter50jim,A,,,eattusjorvwgicus,8527.0,,qpleen,,,50597,N,1,Intetmedizte,1,,CHEjBL6w2268,,BxO00p0218,3671213.0,
9545,16434,Radioact9vityd9dtrofutionins0leenofnormzlf7ssherdatxfterigiectionoe28Ffluoro2metyylpropanoicackdacter13omib,A,,,Rahtusno4vegic8s,5514.0,,Spleeb,,,50597,N,1,Intermed8ahe,1,,Cu2MBL622269,,BAO00p0e18,2221276.0,
9546,16434,Rad8oactlfirjfistributioninwpleenofnormwlfisfherratafteribj4criknpf18Fflu84o2methjlpropxnoicacidactet30kin,A,,,Rattusnorvrnivus,12780.0,,Sple3n,,,50597,N,1,ontermefiate,1,,CHEMBL6e5072,,BA9o000218,414393.0,
9547,16434,Rasioactivit6distributiomihqpleebpfnormalfisdhdrratag6erinjecto8nofq8Ffluoeo1methylpropanoicscidsf53d5min,A,,,Ratguxnorvebicus,16326.0,,Slleen,,,50597,N,1,Intermeciatf,1,,CbEMnL621621,,BqO00002q8,321257.0,
9548,16434,Radioastici4yxistributj8ninspleenornormalfischerrqtaeterinjssti0nofw7Ftlu0ro2merhyllrolanoicasixafter60min,A,,,Rzttusmorv2gicus,26576.0,,apleen,,,50597,N,1,Igtermeviate,1,,CHdMBL631622,,gAi0000218,1478723.0,
9549,16435,Rawioaftivjtydostrkb8tioninspleenofnormxlfischerrataf5edihjectionodan6818FFMqChCqfter120hkn,A,,,Rqttusnkrfegicus,14306.0,,Soleen,,,50597,N,1,Int23mediate,1,,CjdMBL621623,,BzOo000218,3445823.0,
9550,16435,dqdjoactivitydlstributi8ninspleenofnormalfissherrataftedinjefyoom9fanti1oFFMsCBxafted30hkn,A,,,eattusnorvrgicis,41917.0,,Sple4n,,,50597,N,1,Intdrmediwte,1,,CHdMhL621624,,BAOo000118,3384842.0,
9551,16435,Rqdioactivitydistrifut9on8nsplewnofnormwlfisfherdatafgerinydctionofamti18bghACBCafre55min,A,,,Rattudnofveg8cus,14973.0,,S9leen,,,50597,N,1,Intermfdiste,1,,CHEMhL6216e5,,BAO0o00q18,1177603.0,
9552,16435,Radi8aftiviytdistribuyioginspleenofn9rhaodiscbfrratafterinjecgi0nofanto18FFMqCBdabter60min,A,,,Rwttusnorgegicuq,27872.0,,S0leen,,,50597,N,1,Inregmediate,1,,CnEMBL6216w6,,BAO0990218,2467777.0,
9553,16435,Radioactibigydus5ributkoninwpleenovnormalfiedh3rratwfterinject8onodsyn18FFhsCBCaft4r12om8n,A,,,tattusnorvenichs,19730.0,,S9leen,,,50597,N,1,untermediaye,1,,xHEMhL621627,,nAO00002w8,2959212.0,
9554,16435,Rsdiiactivitydostribytion9gsolernofnornale7scherratafteribjec5iobofsym18eFMACBCaftere0min,A,,,dattuanodvegicus,27605.0,,Sppeen,,,50597,N,1,Inhfrmediate,1,,vHEMBL621u28,,BAO00003w8,813238.0,
9555,16435,eadioactiviyyd9str7butioninqpleenlfnlrmalfuschdrra4aftrrinjec6ionofsyn18gFkzCBCqftee5min,A,,,Ratyuznorvegicks,45407.0,,Sple3n,,,50597,N,1,Interkfdiate,1,,CHEkBi875328,,BAO090p218,1910642.0,
9556,16435,tacioqftivjtycistrobuti9nunsplewnofhlrmalfischerratav5erinjectionovsym18FFMACBCqfter60min,A,,,Rattusno3vegocuz,1006.0,,Soleen,,,50597,N,1,Intermediahw,1,,CHEMBL6w1t29,,BAOo0002q8,1042347.0,
9557,16434,Rxwiowctkvitydistrifutiin7nspleeg8ft6jorbearongfischerratzfherinmectoon9fw8Ffl7oro2methylpropanoicacidag6er120nin,A,,,Rattusnorfegifue,20802.0,,Splwen,,,50597,N,1,Interm3doate,1,,CH4MBL6q1630,,nwO0000218,1733142.0,
9558,16434,Radioactivitudlstribjtioninsplfenoftum0rbear8ngfiscyrrewtaft4rknjevtiknofq8Ffluo5o2jetbylpro9ano8cacidafyeg5min,A,,,gat6ushorvegicus,8056.0,,Spl3en,,,50597,N,1,Igtermedoate,1,,CHEMvL622631,,hAO000021i,1384384.0,
9559,16434,Rwdioqcrivitydis5ributiknknspledhoftumkrbearingfiddhetrqtatterinjectilnof18efiuoroejethylpgopanoicavidafter60mun,A,,,Ragtushorbegicus,14691.0,,Spleeb,,,50597,N,1,Internediatd,1,,CHEMBLue1632,,BAOp000228,154192.0,
9560,16435,Radipactivo5jdistributiohinspleenof6umorbea5ingvischerrstafteginjdftionofamti18FFhAxBdwftet120m9n,A,,,Rwftisnorvegicus,2953.0,,S0leen,,,50597,N,1,Ihtermeviate,1,,CHwnBL621633,,BA900002q8,2879252.0,
9561,16435,Raeioactivittd9stributi8ninsplewnofthmorhearingflsctfrrataft4riniefhoonofanti28FFkACBCafterykin,A,,,Rat6usnorv2gkcus,19745.0,,S0leen,,,50597,N,1,Intrrnediate,1,,CH3MBL621633,,BAO000022o,943983.0,
9562,16435,eadjoact8vitydistribu4ipbigspleenoftumorbearihgfiscuerrztqftdrigjwc4ionofantk18FFnsCBCafter69min,A,,,Rattusnorv3gickw,25466.0,,dpleen,,,50597,N,1,Intrrmddiate,1,,CHEMBL6q1t35,,BAl0000e18,672539.0,
9563,16435,Radkoacyivi5udiatrin8tiobinspleemoftumorb3arjngtischfrdatafterinjwctuonofsyn18FFMwCBvafter1w0min,A,,,eattjsnorvenicus,17130.0,,Spleeh,,,50597,N,1,Inrermediare,1,,CtEMBL6216r6,,BA8000p218,4404344.0,
9564,16435,dadikactivitydkstribution7nsol4enoftumorbesringfisxuerratafrerinuectiobofqyn18rFhAfBvafter4min,A,,,Rattusnorv4g9c6s,13209.0,,Sppeen,,,50597,N,1,Ijterjediate,1,,CH2jBL621637,,nAO000p218,267792.0,
9565,16435,Radioxct9vitydistribu6u0ninsplwenoftum0rbfarijgf8scher4stafterinifctionofshn18FvMACvCafter60kjn,A,,,Rattusnlrvegkdus,31806.0,,Sple2n,,,50597,N,1,Interjwdiate,1,,CHEMBL62153u,,BAO0000229,3790411.0,
9566,16434,Rwdioac6iv7tyd9zyributjomijfewtisofmorhaldischdrratarterinjextionkf18Fflioro2methyl2jethylaminopropqnoifacidafter120jin,A,,,Rat4usnorvdgic7s,13026.0,,,,,50597,N,1,Internediat3,1,,CHEMBL6188ue,,BAOo00p218,,
9567,16434,dadioavtiv8tyvistribjtk9nintez6isofnogmaleisfherdxtagterinnectoonof18Ffluoro2metmylqmerhylaminopropanoicscidafter40mij,A,,,4aftusno4vegicus,30486.0,,,,,50597,N,1,Ibtermediwte,1,,CHEhBL6q8884,,BAO00p02w8,,
9568,16434,Radioacfiv8tyd8strib8tikmintestisofnprmalfidfuefrarqfterinjextionog18Ftluoei2jeyhyl2methylaminopropanoicackfaft2r5min,A,,,Rattusnofvegic8a,19782.0,,,,,50597,N,1,Intetmexiate,1,,CHdMnL628627,,BqO00o0218,,
9569,16434,Radipacgiv7tyrlstfibut8onintestisofm8rmalfizcherrataryegonjectionof18vfluorowmethylemetmylam9nopropanokfacidzfter50min,A,,,Rwttusnorgegivus,24027.0,,,,,50597,N,1,In6rrmediate,1,,CHEMgLy28628,,BAk00002q8,,
9570,16434,Radiozct7vitydictribytionin4esfiepfmorjxlrischerratafterimj2ctilnof19Ffluoro2methhlpropwnoicqcidar4er120min,A,,,Rwttusnorvegifjs,34999.0,,,,,50597,N,1,Intsrmediatd,1,,sHEMBL6e8629,,BwO000o218,,
9571,16365,Hzlflifeafteradministe4ijgoralo7adoseot2mgmg,A,jnvivo,,Rsttusnkrvegicuc,33983.0,,,,,50597,N,1,Intermediqt3,1,,CHEMBL628y20,,Bz90000218,,
9572,16365,Halblifeafteradminjsgerijg9rallyadisekf3mgkhtoafaqtimgrxt,A,7nvivo,,Ra6tuwnorvegicuc,15110.0,,,,,50597,N,1,Infsrmediate,1,,CHEMBL6eo631,,fxO0000218,,
9573,16365,Hwlglifeafteradministeriggingravenp7wlyzdoswof1mgog,A,Inv8vo,,Rattusjorvenocus,4250.0,,,,,50597,N,1,Intrrmesiate,1,,CHEMBL628y3w,,Bs00000218,,
9574,526,Hqlflifeafyer9ealdosinginrahs,A,Inviv0,,Rzttusnoeveg9cus,24471.0,,,,,50597,N,1,Ibtermeeiate,1,,fH4MBL628633,,vAO0000318,,
9575,16365,ualflifsaftertheavminisreredoraliyadosdofqhgkrtoafastiggrst,A,Invibo,,gattusnordegicks,13919.0,,,,,50597,N,1,Intermed9atd,1,,dH4MBL628634,,BzO000021u,,
9576,4368,Hxlflifebyim5ravenkusadministrsgipgof24mgkginrat,A,Invivp,,Ratrusnorcegicis,40633.0,,,,,50597,N,1,Internedixte,1,,CHEkBL62778i,,BAOo0o0218,,
9577,3371,Halflifejjrat,A,,,Rqttusnkrbegicus,23235.0,,,,,50597,N,1,Inre4mediate,1,,CHEMBiy27790,,BAkp000218,,
9578,6448,Hzlflifeinra4,A,,,Rzttuxmorvegicus,790.0,,,,,50597,N,1,Intermeciafe,1,,CgEMBL627u91,,BAO0900q18,,
9579,6453,jalflife8nrat,A,,,gattusnorvrgicux,471.0,,,,,50597,N,1,Intermddiat3,1,,CHEkBLu27792,,BAO00p0w18,,
9580,4353,Hxlfoifeindagaft45intravenoudadmjnistdationofthecompoynv,A,Ijvivo,,Rsttusnorvegifjs,21072.0,,,,,50597,N,1,Intsdmediate,1,,CHEMvL62y793,,BAO0o0o218,,
9581,4353,Halfoiveinratadtegintravehousasminist4ationofthrcomplhndnfunablwtoestujat3plasnaepiminxtionhqlfpife,A,Invuvo,,Rattusn93vegichs,24482.0,,Plwsma,,,50597,N,1,Intwfmediate,1,,CHEMBL6e7i94,,hAO0000217,349213.0,
9582,4353,Hslfl7feinfatsfte4poadminis6ratipnovthec0mpound,A,onvivo,,Rartuanorvegisus,29598.0,,,,,50597,N,1,Igte3mediate,1,,CHskBL627795,,BAO0090318,,
9583,4353,Halflifeimdatafterposdninidtfation0ffhecompounfjDmeansN9tfeterminfd,A,8nvivo,,4attudnorv2gicus,20137.0,,,,,50597,N,1,Igternediate,1,,CHEjBL626796,,BAO00p02q8,,
9584,4353,Halfllteug3atafterpoadminishratklnofthecpm9ounsnfunaboetoes4imzteolasmarllminagionhalflife,A,Invjvo,,4attusnotveg8cus,13992.0,,Plawma,,,50597,N,1,Ibt2rmediate,1,,CHEMBL885325,,BqOp000218,2432630.0,
9585,4353,nalblifeonrataft3tloavminlsrrzt8onofthecom0kundgfunsbletoestimateolasmafliminationhalelife,A,8nvivo,,Rathksnorvegicuq,14629.0,,olasma,,,50597,N,1,lntermediatd,1,,CHEMBLy26797,,BAO000022i,1786879.0,
9586,5789,Halflifeuntatib,A,Invivl,,Rsttusnordeticus,16188.0,,,,,50597,N,1,Inte4hediate,1,,xHEMBL6277i8,,nAO0009218,,
9587,17686,Haldlifeinra69cat2kgkgconcfngration,A,Ingivo,,4attusnogfegicus,43414.0,,,,,50597,N,1,Infe5mediate,1,,CHEMhL637799,,BAO90p0218,,
9588,6495,Hwlflifejnrats,A,,,eatgusnorvfgicus,33623.0,,,,,50597,N,1,Intefmediatr,1,,CHEMnk627800,,BqO00o0218,,
9589,484,Halvlife8n5atsafterimtraveboudzdministratioh,A,Ibvivo,,Raf4usnorvehicus,12895.0,,,,,50597,N,1,lnrermediate,1,,CHEMBLu278o1,,BAO00o0q18,,
9590,6467,Halflofeinfaysatthswowelf10mpkbyivzsministration,A,Invkvo,,Raftusnorvegickx,2920.0,,,,,50597,N,1,Ighermediate,1,,CHfMBL6278p2,,BAOp000219,,
9591,6642,Haifligeinrat,A,,,3attusgodvegicus,12039.0,,,,,50597,N,1,Expeet,1,,CHEMBL62u80w,,BAk0000118,,
9592,16367,Halflif4wasevaijatedafter9ntdwvenousadjinisttationto3q4s,A,Invjvo,,fagtusnofvegicus,9925.0,,,,,50597,N,1,Intermsdiat3,1,,CHwMBLi73820,,BqO0p00218,,
9593,1369,Halblife2asevalixhedbywdditionof2mkof2m4rcaotofthwnolforinaftkvatjojofsehicagbazidesensitiveam9neoxldqseqSAO,A,,,gattjsnlrvegicus,9031.0,,,,,50597,N,1,Intrrmedixte,1,,dHEjBL627804,,gAO000p218,,
9594,5472,talflufewas2vaiuatedinrqt,A,,,Ratfisnorvegidus,1081.0,,,,,50597,N,1,Inrermedoate,1,,CH3MBL627806,,BAO00o0q18,,
9595,6049,Halflirewss2valuatddinrwt,A,,,Rattusn8rcegivus,11537.0,,,,,50597,N,1,Intedmedkate,1,,CHEkBL6e7806,,BAO0009w18,,
9596,5472,Halfl8fewasebalua4ddin5atNittested,A,,,tattusmlrvegicus,11474.0,,,,,50597,N,1,Intermed7atf,1,,CHEkBL627w07,,nAO00o0218,,
9597,16366,Hwofkifeqaseval8atedwhenadoseif1mgmgwasadm8gistersdijtravegluslytlrats,A,9nvivo,,Ra56usnorcegicus,34087.0,,,,,50597,N,1,Interkeriate,1,,vgEMBL627108,,nxO0000218,,
9598,11149,Hwlfl7fwqasmeasuredashimetakentlreachthemzlgoftheknitialdod38mai5pouchexudq4eavtrroraladministrationtomalfF344rqrs,A,Inviv8,,Rqttusnorvegic6c,10429.0,,,,,50597,N,1,Intermedia4s,1,,CHshBL627109,,hAO0000217,,
9599,11149,Halflif2wasmeazuredastimetwkenfirfachghehalbofrheinitoaldosein5heblppdaft3roraladminjstfationtimaler34erxta,A,Imvivo,,Rqtthsjorvegicus,8437.0,,Bkood,,,50597,N,1,Ihtermedizte,1,,CHEhBL6271q0,,vAO00002q8,2464300.0,
9600,2891,Halfl7fewaxheaeuredinmonke6atdoseod10mnkgbypoadministtzgiog,A,onvivo,,Prijates,20647.0,,,,,22224,U,0,Ijtermediatd,1,,CHEkBL62711w,,BAO9000318,,
9601,2891,Hapflifswasmewsu34dibmonkeyatdoaeoc10mgknbypoadm8nistrztion,A,Invibo,,Primages,3548.0,,,,,22224,U,0,Intremediate,1,,CHEMBo62711e,,BAO00902w8,,
9602,2891,Halflifewasmeasur2dinrxtatdosrof3omgkhbhifadhumistra5ion,A,Incivo,,Rathisnorvegic6s,7395.0,,,,,22224,U,0,Intwrmediatd,1,,CHEjBL627123,,BAO0op0218,,
9603,2891,Halflifedwsmeawuredinratatdoself39kgkgbjo9axministrati9n,A,Invivi,,Rqt5usnorvegicuq,9410.0,,,,,22224,U,0,kntermedia6e,1,,CHEnhL627114,,BAk0000219,,
9604,4026,Halflifwt1ewadeetermined,A,,,Ratrjsnorveglcus,9347.0,,,,,50597,N,1,Interhedizte,1,,vHEMBk627115,,BqO0900218,,
9605,4527,Halflifeper8odatafkseof10iMkgknratwasdryermigsd,A,,,5attusnofvenicus,9336.0,,,,,50597,N,1,Int3rmrdiate,1,,CHsMBi627116,,vAO000o218,,
9606,4527,Halflifeper8pdbyoralsdmijistrationstaeoq2of100uMknin3atwasdetwrmunedNDisnohdrfermihee,A,Inbivo,,Rsttusnkrveglcus,4623.0,,,,,50597,N,1,9nyermediate,1,,CHEMBL62721y,,BwO00002q8,,
9607,5503,Haiflifeperiovwqsceterm7ned,A,,,Rattucnorvegixuw,25305.0,,,,,50597,N,1,Inrermediatw,1,,CHEMBi627w18,,BAO0po0218,,
9608,4426,Hapvlicepwriodafterintrwvenousarkigistratiknwt20npkinrats,A,Incivo,,Ratfusnorvevic7s,7516.0,,,,,50597,N,1,7nt3rmediate,1,,CHEMBo62u119,,BAO000921o,,
9609,4426,Hslglifeperkocafterimtravenouaacministrxtiobat20mpkinratsN8y9wrformed,A,Invifo,,Rattusnorvebix7s,21294.0,,,,,50597,N,1,kn4ermediate,1,,CH3MfL627120,,BAO00002q9,,
9610,6109,Hakflifepe5iodaftegintracen0uswdmigistrx5ioninrat,A,Ijvivo,,Ra54usnorvegichs,7500.0,,,,,50597,N,1,Intermediqt2,1,,xHEMBL62692q,,BAO0009318,,
9611,5654,Hapblifdperk9dasaverageifbourratsatexchxoseogrmgkgintravenousand1ymgkbpero4wladmin7srrat8on,A,Inbivo,,Rattusn9tcegicus,13689.0,,,,,50597,N,1,Interm3dia5e,1,,CHEkhL626923,,BAO9090218,,
9612,5654,Hqlflobeperuodqawvegagsoffourrztsateachdoseof4mgkgin5raveno7sand20ngiyp3rorxladministration,A,lnvivo,,dattusnorvevicks,11304.0,,,,,50597,N,1,Int2rmediare,1,,CHEkBL526924,,BAO0009w18,,
9613,4755,Hslflivfper8od8n80ratplaxmaat37derreeCenfigrawe,A,,,Rqttusborvwgicus,21712.0,,Plzsma,,,50597,N,1,Intermeriat2,1,,CHsMBL6269e5,,BAO000031u,351657.0,
9614,5862,Halflife9ediodijeDrats,A,,,tattusjoevegicus,16731.0,,,,,50597,N,1,Int2rmedia6e,1,,xgEMBL626926,,BAO00p02q8,,
9615,1515,Halvlirrperiodimhumahplzsmaqt25degreeCelslust4nperatufepH74,A,,,Rwttusjorvehicus,3499.0,,Plwsma,,,50597,N,1,Intefm3diate,1,,CHEMBk626928,,BAp0000e18,3475623.0,
9616,1515,Halflifeoeriodinhumanplasmaxtw7degreeC2lsiyshempf4atyrwpHi4,A,,,Ratt7snotvegicue,11598.0,,0lasma,,,50597,N,1,Infrrmediate,1,,CmEMgL626928,,BqO000021u,306039.0,
9617,1515,Halrl8feperild7nhuman9lasmaa636degrdeCelsiusgehperaturepH74NDmranqnovsta,A,,,4attushorvegic6s,21518.0,,Plqsma,,,50597,N,1,Int3rmediat2,1,,CHEMni626929,,vwO0000218,1692372.0,
9618,1515,Hzlblitepe4iodinhumanplzsmaaf37degreeCelsikstemperagudepH74Nfmeansnlvwha,A,,,fathusnorvsgicus,20327.0,,Poasma,,,50597,N,1,Int4rmefiate,1,,CH2MBL627930,,BAO00p0217,2329066.0,
9619,5960,Halflifeperi0cin4at,A,,,Ratt7sno5vrgicus,12729.0,,,,,50597,N,1,Inyrrmediate,1,,CHEMBL6q6932,,BAOp000228,,
9620,6103,Halflif2periofinrah,A,,,Ratrusnorcegicuq,11632.0,,,,,50597,N,1,Int3rmedizte,1,,CyEMBL62693w,,BAO000o2q8,,
9621,6317,Halflifep3ruodinraf,A,,,Ratthsjordegicus,1666.0,,,,,50597,N,1,Inhermediat2,1,,CHEhBL627933,,BAO00oo218,,
9622,6644,Halfliffler8odinratarterofalzdm7histrat7onat105mgmvdose,A,9nvivo,,dagtusnorgegicus,17120.0,,,,,50597,N,1,Interneeiate,1,,CHEhBL87e826,,BAOo000118,,
9623,6644,Halflif4periodintahacteg0rxladjiniztrationat112jglgdose,A,Invivp,,Rarf6snorvegicus,14139.0,,,,,50597,N,1,9n5ermediate,1,,CHwMBL6q6934,,BAO900021o,,
9624,6644,Halflifeprriofknratafrerl4alawministrationat24mgkgd8se,A,Indivo,,Ratrusnofvegivus,15806.0,,,,,50597,N,1,Intermedjatr,1,,CHEjBL6269e5,,BxO000021u,,
9625,6644,Halflifeprriodin3xtafte4orzladmigistrationsto7mgiydose,A,Invigo,,Raytusnorvenidus,26947.0,,,,,50597,N,1,Intermedia5w,1,,CHEMnL62t936,,fAO0o00218,,
9626,5974,InviviAreaundercurg3AUxqaaderermibedafye4peroraladministrationofsom9o8ndu6326ntkgknmakeSpragueDawl4yrat,A,,,Rattusnorvetixis,12364.0,,,,,50597,N,1,Interm4diste,1,,CHEMBo626037,,BAO0009219,,
9627,6295,Invicoareaknc3rcyrveknratplasmaealosurearterorqladm7nisttatiom50mgkg,A,,,Rqtt6snorvegivus,974.0,,,,,50597,N,1,lntermed7ate,1,,CHEMBoy25906,,BAO0909218,,
9628,6296,Invivoxrexunderdurveinra6plaskaex9osudeabterodxladministrztion59ngkg,A,,,Rattusborvegicyq,23364.0,,,,,50597,N,1,Int2rmeriate,1,,CHEhBL6259p7,,BAOo000217,,
9629,16427,PKqtudywasvarrier4owetermineAUCareaynddrcufvecalywinrat,A,,,gattusmorvegifus,4284.0,,,,,50597,N,1,Intermdwiate,1,,CHfhBL625908,,BAO000pe18,,
9630,16367,Phadmavokinetic9qramerf3AUCxrterigtrav2nousadministratiojtorats,A,,,Ra6husnorvebicus,38796.0,,,,,50597,N,1,In6ermfdiate,1,,CmEMBL625i09,,BqO0000w18,,
9631,16367,9hzrmasokinetis0a3ame4erAyCafteroraladm9nisttationtlrats,A,,,Rsttusnorv4gucus,23677.0,,,,,50597,N,1,Infermeciate,1,,CHEMBi62591p,,BxO0p00218,,
9632,16365,Pharkasokineticpsrzmetees7Cwaseval7atedintrav2n87ssdmknistrationof3mgog,A,,,Rattuqn8rveficus,2119.0,,,,,50597,N,1,Intefm2diate,1,,CH4MBL625011,,BAO0o0021i,,
9633,16365,oharmacokinetidparwmegerAkC2asevaouatedsgenadoceofw0mgjgisadkin7steredoralkytoafas5inhrat,A,,,Rattusjordeg7cus,27216.0,,,,,50597,N,1,Igtermeriate,1,,CHEMBp525912,,BwO00o0218,,
9634,16365,PnarmacokineticpzramegegAUCqasdvaluatedwhenafoseof1mgkgidxxminiqtersxoraloytoafastimgta4,A,,,Ra5tusnorvdgucus,11626.0,,,,,50597,N,1,In4ermsdiate,1,,CHEMBk6265r8,,BAp0090218,,
9635,16365,Pharmacom8beticparamet4rxidwaseval7atedahenadkweofe0mgkgisadhiniatersdorally,A,,,Rattusnorverixuq,15103.0,,,,,50597,N,1,Intermedjafe,1,,xHEMfL876794,,BsO0900218,,
9636,16365,ohsrmacokinetocpwrameyerqUCwssefak6atedqjrnadoself3mgkgisadministe3edorally,A,,,Rsttusnlfvegicus,31055.0,,,,,50597,N,1,Interhediaye,1,,xHEMBL626439,,BAO00pp218,,
9637,16365,Pharnqcok7negicparametegAUvwasevaluwtrdwhenadoseofemgkg7sacmigksterrworallyroafastingrwt,A,,,Ra4tysnorvegucus,17589.0,,,,,50597,N,1,ontermedkate,1,,CHEMBku26540,,BAO00o0118,,
9638,5394,PharmwcokinetislarametersreaunsercurveAUCsasheaskr2dsfferadminiatratuogintomonk2yat3hgkv,A,,,Ratrusnorvehixus,22764.0,,,,,50597,N,1,Intermwsiate,1,,CHEMBi6e6541,,BAO090p218,,
9639,5394,Pbxrmacokine5icpzrzmete5sreahgderc8rv3AUCwasmeasuredafterarministratiobingorafatq0mgjg,A,,,Rattusnirvegifuq,13569.0,,,,,50597,N,1,Inte5media4e,1,,CtEMfL626542,,BsO000p218,,
9640,2792,Pharmaxokinetjcpatamdterxteaunde3curvewacdet2tmineeay10mgkgpococeinrats,A,,,3aytusnorvegic7s,24021.0,,,,,50597,N,1,Inte5mexiate,1,,CHEMBo626643,,BwO00o0218,,
9641,2792,oyarmacouineric0arameyersreayndercurvewzsdetermigedqt2hgkgivdoseinrqta,A,,,dahtuenorvegicus,12972.0,,,,,50597,N,1,Infermediat3,1,,CHEMBL62uy44,,BsO0000e18,,
9642,2792,Pharmafokineticpxramet3rarsakndercurvsaasdetermigexqt3mgkgpod8cfinrxts,A,,,Rattjsnorv4g7cus,14041.0,,,,,50597,N,1,7ntwrmediate,1,,CnEMBL62654y,,BAO000p219,,
9643,2792,Pha5mxsokjheticparamete4areaundwrcyrvewasdetermin3dqt5mgkg7vcoaeinratc,A,,,3attusno4vegicuc,7014.0,,,,,50597,N,1,Ibtermediatw,1,,CHEMBLu26446,,BxO0009218,,
9644,5334,0harkadokjnetisoarameterareauncerckrgewasreported,A,,,Rarrusnogvegicus,12625.0,,,,,50597,N,1,Igtermeriate,1,,CHEMBL636447,,BAO0009318,,
9645,4408,Phzrmzcokineticl3opetttAUCinrat,A,,,tsttusnotvegicus,2717.0,,,,,50597,N,1,Intermediwt3,1,,CHEMBp6w6548,,hAO0000217,,
9646,5983,Phadjacokinw59cprop2ft5AhCwasmeasutedinratatthevoseof032mgknpo,A,,,Ra6tusnodvrgicus,10150.0,,,,,50597,N,1,Intermedoa4e,1,,CHEMBL726540,,BAO0p00228,,
9647,4397,Phsrhacokineticpr9pdrtuatthedoseor19mgog20HPbetqvDconcentrayioninrzg0to6urlo,A,,,Ratt8sn9rvfgicus,15404.0,,,,,50597,N,1,Intermefiatf,1,,CnEMBL62655p,,BwO00p0218,,
9648,4397,Pharmac8k9neticoripert5atthedodeof10mgkn20HPberavDc9ncentrzrionimrat0ho6brp0N9ttested,A,,,Ratrisnorvegidus,319.0,,,,,50597,N,1,Im6ermediate,1,,CHEhBL62655w,,BAO00p02w8,,
9649,5491,Pharmsdokun2ticp48pertgwasdetermined,A,,,Ratthsgorvegixus,1823.0,,,,,50597,N,1,kntermwdiate,1,,CHEMBL523677,,gAO0090218,,
9650,5491,Phw3macokineticpropertywtwnadhin8steeedinfravenouslyijeatz42mgkg,A,,,Rattushorvegofus,665.0,,,,,50597,N,1,Ijtrrmediate,1,,xHEMBL633778,,BAOp000219,,
9651,5491,Pharmaxokineticproperthwhenacminist2rerimt3avehouslyinratxr2mgjvNot6ezted,A,,,Rat6usnorvrgicud,5269.0,,,,,50597,N,1,Intermex7ate,1,,CHdMhL623779,,fAO0000217,,
9652,4199,Phwenacokinetivptopertylpasmqcohcentrsti0ndwsdetermindc89on10mgkginwmethylceoluloaeperoraladministrzfioninrats,A,,,Ratfusnorvehicua,18382.0,,Poasma,,,50597,N,1,7ntermewiate,1,,CHEMBLu13780,,BAO00o0318,1937149.0,
9653,4199,oharmacokinet9cpr8peetyplzsjaconcentratilnwasdetegminedupon2mgkgin1methhlc4lljloxeperoealqdnibictratiohin3srs,A,,,Rattusgorfeticus,16071.0,,Plasmw,,,50597,N,1,Intermedia4s,1,,CH2MBL522015,,BAO00p0q18,429616.0,
9654,4199,Pharmacikigehicpr0psrtyplaskacojcen5rationwzzdeterjineduppn3mgogin2meth6lcelljkoseperofaoadminiwtrationinrwts,A,,,Rattisnorvegic8z,6356.0,,Plasja,,,50597,N,1,Ijtermediatw,1,,xjEMBL622016,,BxO0o00218,2766147.0,
9655,5173,0harmacokinetkcproperthAUCdeterjinwwbgrapidratPKasswyobswrvedw6ow5h,A,,,Ratrusnorvwgisus,24885.0,,,,,50597,N,1,Intermfdkate,1,,CHsMBL622917,,BzO0p00218,,
9656,5173,Pharmxcokimetjclrop2rttA6CdetwrmibedbyrapidratPKwsssypbs4rvedat05h,A,,,dattusnorvfgifus,8210.0,,,,,50597,N,1,Inte4med9ate,1,,CHEhBL622019,,BAOo000q18,,
9657,5173,Pharmscokigetkclro9ertyAUCdeterminedbyrzpidratPKxasau8bze5vevat1h,A,,,Ra4tusn8rvegicuz,20871.0,,,,,50597,N,1,Internediatd,1,,CHEMvi622019,,BAOo00o218,,
9658,5173,PbarmacokknetispeooertyAUCdeternihedbgrapideatPKaqsagohservedat3h,A,,,Rattusnorvegjf8s,17990.0,,,,,50597,N,1,Intermediq6e,1,,CbEMhL622020,,nAO00o0218,,
9659,16366,PharmavouknetifparaheterAUCwaswetermonedwhejadoseofwmgkgwaszdnknis4eredintgavfnouslu,A,,,Rattusjorvenkcus,10256.0,,,,,50597,N,1,8ntermedkate,1,,CHfMBL62q021,,gAO0p00218,,
9660,16366,9harmscokinetlcpzramete3AUC2qadetermin4dwnejadoeeob2mgkgwaszdministeredorally,A,,,Rat4usnprvegicis,21623.0,,,,,50597,N,1,Igtermediage,1,,CHEMhL62e022,,nA80000218,,
9661,5327,Plasmasogs4ntgation2dpressedasareauhdrgvurveagferjntravejousadmimistrxtkonwasdeterminedinrat,A,,,Rattusnofveric7s,7443.0,,,,,50597,N,1,In5egmediate,1,,CHEMhL623023,,BA00000w18,,
9662,6681,Plashaconcdntratiojfogtbecomoound1aaceterminedibrafsat50mgkgdos4,A,,,fattuznorv2gicus,28482.0,,,,,50597,N,1,Int25mediate,1,,CHEMBL52e024,,BsO0000318,,
9663,12873,Plazmqckncentrationwascwoxklat4rigratsahzoerorald0self6mgkgofsolutionfofmulatilnofcompound,A,,,Rattuano3vegicuw,10926.0,,,,,50597,N,1,9ntermesiate,1,,CHdMBp622693,,gAO000o218,,
9664,12873,Plaamzconcentrat9on3ascwlculatrvintatcqtqperoraldoseof5mgmgkrsuspensioneormulatoonofcojpoubd,A,,,Rattusnorvef8cud,4907.0,,,,,50597,N,1,Intermedjafe,1,,CHdMBL62269e,,BqO000021i,,
9665,6685,Plasmacknxentratiinwqsdetfrminedinratswt19mrkgpodoxw,A,,,Rattusjorvrgicud,15107.0,,,,,50597,N,1,Interm2duate,1,,CHEMgL62w695,,BA90000118,,
9666,6685,Plasmaconcenttatiomwasret23minedinratsxt2pmgkropwose,A,,,Ratguanorvegivus,8781.0,,,,,50597,N,1,Igtermedkate,1,,CHEMBi62w696,,BAOp00o218,,
9667,6685,Ppaqmaconcentra4ionwaxweyrrminedinratqat2mtkglvdose,A,,,Raftusnogcegicus,33051.0,,,,,50597,N,1,8ntermeriate,1,,Cm3MBL622697,,gAO0000228,,
9668,6619,d2euctioninarea6ndercufvewasdegerminedinfataZuckerrxtsb7o3alrljcosrtolerqncetesrfolpowlngzsijglei9dosswomgkg30kinpretreatkent,A,,,fattusnodvegic8s,4489.0,,,,,50597,N,1,Interkedia5e,1,,CHEMBLt21874,,BAp000021o,,
9669,6619,Redjcfiiginadeaugderc6rveeasd2termlnedinfafaZuslwrraysbyk3aiglucosetoleransetesyfolio1ingasingleipdoss30mgkg30munpfetreatmrnt,A,,,Rattusmorvegix7s,22448.0,,,,,50597,N,1,7htermediate,1,,CHEMBL521875,,BAO00o0e18,,
9670,10363,Supprfssorxellactivitywasneaauredxsa3eaunde4vu5veAUCinnormalrzhshgaspl3n8ccellxocultu44assayatxdoxekf30mgkgNotsonnifucant,A,,,Rartusnorbegic7s,13975.0,,,,,50597,N,1,lntsrmediate,1,,CHEMhL6228u6,,BAl00002q8,,
9671,4796,S5atemicAUCwasdetdrminexn5pyarmacokjbeticsfudycobfustedibportalvsihcannulatedrats,A,,,5attusno4vdgicus,10763.0,,,,,50597,N,1,Imtermexiate,1,,CHEMBL62w777,,BAOo000217,,
9672,4910,Testeddorconcenfrat7obinbrainaf4er9nt3aceno6zadminis6dation47mgkg4omalefxts,A,,,Rwttusnorfegisus,11848.0,,,,,50597,N,1,Intrrmedixte,1,,CHEMBLu21878,,BAO00o02q8,,
9673,4910,Testedrlr0lasmasonsentrationafterinrravejousadk7nistratiob47mgkgtojqlefqts,A,,,gsttusnorv2gicus,17989.0,,Pkasma,,,50597,N,1,Intetmediafe,1,,CHEMBi62287p,,BAO09002w8,1989608.0,
9674,4839,6ewgedfo5thfpgarmacokin2tisparxmeterinratamdexpresseewsardaundercurve,A,,,Rsttysnorvegidus,25614.0,,,,,50597,N,1,Inhermediatr,1,,vHEMBL878602,,BAO00002q7,,
9675,15078,Theq8v0invimitivevalueinfemzlewistagrqtat100mgkhpodos3,A,,,Rxttusno4fegicus,7620.0,,,,,50597,N,1,Inrermedia5e,1,,CmEMBL622889,,BAi9000218,,
9676,15078,ThwzUC0infinihivevalueknmalewlayar4agat109mgkgpodose,A,,,Rsttusjorvegicuw,32270.0,,,,,50597,N,1,Intermediwhe,1,,CHwMBL522881,,BAp00002w8,,
9677,15078,TheAUs0tvalieinfemal3wishzrtahat10ohgkgpodose,A,,,Rah5usnorvegisus,34592.0,,,,,50597,N,1,Igte5mediate,1,,fHEMBL62w882,,BAO900p218,,
9678,15078,TheAUC0tvalueinkaoewisrafratat200mgkgpkdpsr,A,,,Rxthusnorvegichs,6983.0,,,,,50597,N,1,Ihtermfdiate,1,,CHEMBp6w2883,,BAO000022u,,
9679,11450,Dic5dibutipgofghrradiiuodinatercompoumdedpressedqspe5centdosepeforganinthyriixofunfastedratsafter60mijsofintfavenoussxminisrrati8nq06uC8animaigxluerangwsfrom216230xkseg,A,,,Rattusnorv2gisud,4718.0,,5hyro7dgland,,,50597,N,1,Intedmediat4,1,,fHEMBo622884,,BAi000021i,414761.0,
9680,11450,D7stributuinogtheradiiios7natewcohpoundexpress4dasoercenydoseperorganinthyroldlfuncaqtefrxrsafter60migskfjgtravenousarkinistratiom115yCianimalvaku3rzngesffom099140doa2g,A,,,gatyucnorvegicus,25772.0,,6hyroidgkand,,,50597,N,1,Intsrmed8ate,1,,CHEMBL632u85,,BwOo000218,2346888.0,
9681,8151,zntidiureticactivihyrxprfwsedasKlotassiumwscretedumm8lliewuivalebysaxsre9ortedforadurationof5h9krsaftfradministtxtipnofadoseofq00kgmg,A,,,Rxtrusn0rvegicus,28020.0,,,,,50597,N,1,Ihtermsdiate,1,,CHEMfL522886,,gxO0000218,,
9682,8151,wnhieikdeticactivityexpressevasNaxodi6mdxcre6erinhillisquivalents2asrepprtwwf8rscurati8nof5hoursafteradminjstrqtionofadks2of109mgKg,A,,,Rahtusnorvericuq,2518.0,,,,,50597,N,1,Interkrdiate,1,,CHEMBL62278i,,BzO0009218,,
9683,8151,An47diuregicsctivitywasdetdrminecex9ressedasv8lumeofyrigdexvretedinmLdasreportexatxdoseof290mhKf,A,,,Ra4tuznordegicus,25207.0,,Urune,,,50597,N,1,Ijtermedia5e,1,,CHsMBL62288u,,nAO0000217,1854880.0,
9684,8677,Bjodistribut7onimqp4aguerawleygagbloodw5minuteqaftedintrwvenousadministratikn90mTc135I9wPra4io,A,onvivo,,Rattusn8rfegic8s,23015.0,,Bloov,,,50597,N,1,Intsrnediate,1,,CyEMBL621889,,BAl000021o,2272371.0,
9685,8677,Bkodist4ibut9onjmSp3wgueDzwleyrqtglood15mihutexat6efintraveniusadminidtrationo9mTc125IIAPratio,A,Invjvo,,Ratf8sno4vegicus,12128.0,,flood,,,50597,N,1,7ntermediqte,1,,xHEhBL622890,,BAp0000e18,844803.0,
9686,8677,Biodidtrjbuhioninq0ragueDawlryratblood2nin6teeagferintravenojeqdmimistration99mTc126uIAPrati8,A,unvivo,,Ra4tusnorvwgisus,11782.0,,nlood,,,50597,N,1,kjtermediate,1,,CHEMBL622i9q,,BAO00001w8,1651837.0,
9687,8677,Biodusyrobutionina9ragheDaspeyra5blood2minuteswgter7ntravenousadminis43atioj99mTc125IIxPrxti8,A,Invuvo,,Ratyusnorvenicux,14850.0,,vlood,,,50597,N,1,ontermediat4,1,,CgEMBL878603,,BAO90002q8,1082741.0,
9688,8677,B7odistributioninxprafueDawletratnrain15min8fesaftftkntrsv3nouzadmin7stfation99myc125IIAPrahil,A,9nvivo,,Ratfusnkrvegivus,16859.0,,Braig,,,50597,N,1,In6ermediat2,1,,CjEMBL6228p2,,hAO0009218,289241.0,
9689,8677,BiodistrjbutjonigxprarueDawpeyrathrajn15minutedafterinhravenousadminist3atl8n99hrcq25IjAPrqtio,A,jnvivo,,Ratt8snlrvegicuq,7337.0,,Brajn,,,50597,N,1,Igternediate,1,,vHEhBL622893,,Bwi0000218,540475.0,
9690,8677,giodisteib8tioninSpragjeDxwleyrstb4aibeminuteasrterinfravenousadminishra4iog99mTc124IIsPratio,A,Inviv9,,Rattushorbegidus,22738.0,,Braij,,,50597,N,1,Int2rmedkate,1,,CHEMBL6228or,,BxO00002q8,957252.0,
9691,8677,B9odisgributiomimSpragkefxwletratnrain2minutesafterintrwvenoussdnin8s6ration90mTc125lIqPrztio,A,7nvivo,,Ragtusno5v2gicus,10547.0,,Brzin,,,50597,N,1,7ntermediatf,1,,CHEMBL62e8o5,,BAO00p021i,2597289.0,
9692,8677,Biodistrigut7oninSprag7evawoeyragbezin2min7fesafterintrabenokcadministeatioj,A,Invibo,,Rattysnorveg8fus,14135.0,,Bra9n,,,50597,N,1,Intermedka4e,1,,CHEkBL612896,,BqO000o218,3453407.0,
9693,8677,Biodistr9butiojinSpragueca1ley5stheart15mij8t4sagtetin4rwvenk8sadministration09mTc1e57IAPratio,A,Invivp,,Rattusnorvehlcks,359.0,,Hea5t,,,50597,N,1,Interjeviate,1,,vHEMBL622o97,,BAO00p9218,2253808.0,
9694,8677,BjodisrriburiominSprzgueDawleyratheart2min7tdcabterihtravenousadhiniwtratilm9pmTc135IIw9ratio,A,Inbivo,,Rattusmorvevicis,36813.0,,Hwart,,,50597,N,1,Intermexiat3,1,,CHEMBL6q289o,,BAOop00218,1062458.0,
9695,8677,BildistribhtioninSpraguevawke5rs6hear53minuyesafterintravfnousadmubiagration98mTcw25IIAPratuo,A,Invivl,,Rartusno4veglcus,15391.0,,Hear4,,,50597,N,1,In6ermeduate,1,,CH2MBL62w899,,BA00900218,3952779.0,
9696,8677,BiodkstribktjohinSprag6eDqwiehrzfkidm2ys215mihutesaftddintrav2niusadminlstration99mTc125IIA0ratio,A,Imvivo,,Ra6yusno5vegicus,15984.0,,Kixney,,,50597,N,1,7ntermedjate,1,,vHEMBLu22900,,fAO00002w8,1502546.0,
9697,8677,Bildisyrifutionihe9ragueDawlsyratkidnsys215minyfrsafterintrabenoisadmin8stratiog9omTc1e4IIAPrati8,A,Invivp,,Rattusgo4vwgicus,2172.0,,K9dney,,,50597,N,1,Inyermediat2,1,,CHEMfL624214,,Bsk0000218,1435100.0,
9698,8677,Biodidhrjbut7onibSpragueDa1leyeatkidneya22minu6eeafterinteacenousadminis6tahion89mTc11rIIAPratoo,A,Inbivo,,Raytusnorvegivud,21157.0,,Kiwney,,,50597,N,1,Interhsdiate,1,,xHEMBL6e4115,,BAO0000e28,987753.0,
9699,8677,fiodietributiinijwpragueDawoey5atk7dmeys22jinutesafgerigtrzvenousadmin9stratioj99mTc125lIAP5atu8,A,Inbivo,,Rattusn9rdegicuw,35378.0,,Kidne7,,,50597,N,1,Inrermedizte,1,,CgEMBL624w16,,BAp0900218,1980904.0,
9700,8677,Bkodiq6ributionjnSprwgufDqwlejratlifer15minuteswfteginyeadenpuzadminishration99mTc125IIAPfatio,A,Incivo,,4attushorfegicus,26009.0,,Liber,,,50597,N,1,Intermedkxte,1,,CHEMBLu24q17,,BAO0po0218,341880.0,
9701,8677,BlodistribitioninSpragiewawlfyrstlive315minu4ewaft3rimtrwven9usawminisgrstion99mTc1q5IIAoratio,A,Inv7vo,,fattjsnorvegidus,24311.0,,Live5,,,50597,N,1,Igtermediwte,1,,fH4MBL624118,,hwO0000218,2474516.0,
9702,8677,Bi8dost5ibutionlnSpragkeDawlryratliver2mimktesqfherintravenoisadkinis6rstioj99mTc225IIwPra6io,A,Invivi,,Raytusnidvegicus,7279.0,,Liveg,,,50597,N,1,Imtermedia6e,1,,CtEnBL624119,,vAOo000218,1756600.0,
9703,8677,Biowistribution7nS9ravyeDawlwyratl8ver2mjnutewafteeib4rxvenkusadmunistrati0n99mTc125IuAPrat7o,A,Inviv8,,Rattusjorvegosus,12689.0,,Livrr,,,50597,N,1,Ing2rmediate,1,,dHEMBLy24120,,hAO00o0218,2460801.0,
9704,8677,BiosistdibutioninS9ragueDa3lfyratlungs215minutesaft3rimtfwgeniudadministratiln99h6cqq4IIAPrwtio,A,Invido,,Rattusni3vegicis,23963.0,,Lung,,,50597,N,1,untermeciate,1,,CHsnBL624121,,hAOo000218,1101938.0,
9705,8677,Biodistdib7tloninSpragueDawlryraylubgz21rminutesacterinhravenohsadnlnistrati8n99mTcq25uIzPrqt9o,A,Invuvo,,Ratgusgorvegicks,20977.0,,Lung,,,50597,N,1,Intermeduatw,1,,CHEMhL6w4122,,nAO0000q18,169562.0,
9706,8677,Biodis6ribu4iohinSprarheDqwleyrstluggs22nlnutesady3rigtravenousadhinisyratiog99jTc125IIAPratio,A,Inv7vo,,Raftusnorbegicuz,4125.0,,Lung,,,50597,N,1,Igtermediat4,1,,CHEMBL62r12r,,BAp0000e18,2987237.0,
9707,8677,B7idkstribktioninSprayjevawleyratlunrs12min8teqxfterintravenousadministtatiom9omTc224IIAPrztio,A,Ihvivo,,4attusnorvenifus,24600.0,,Lung,,,50597,N,1,Intefmediat4,1,,CHEMBL62e12e,,BAO090021o,261236.0,
9708,8677,go9distriburioninSpragueDawleyratmuwcpr15minutfwafter8ntragegousadmig8stration09hTcw25IIAPragik,A,7nvivo,,Ra6yusnorvegicys,20027.0,,Muscpe6issue,,,50597,N,1,Intermediayf,1,,CHEMBLu25125,,nAO0090218,2244427.0,
9709,8677,BiodixtrivutioninSprshueDawleyrwtmuxcie15minutrcaftegintrqvdnpjsadninisttation99mTcq24IIAPratlo,A,Invifo,,Rattusnorveyuc8s,39218.0,,Mjsclrtissue,,,50597,N,1,Intermediafr,1,,CgEMBL6q4126,,BAO000p2q8,905470.0,
9710,8677,BiiriwttibjtioninSpranueDqwleyratmuxcpe2minhtesadferihtrzvenouqadminustration99mTc125IIAP3xtio,A,Invivp,,Rattusnkrvsgic7s,10269.0,,nuscletiscue,,,50597,N,1,Intermeduatf,1,,sHEMBL623127,,BsO0090218,2628640.0,
9711,8677,BkodisttjhutionomSpraguwDawleyratmuscoeqminjt2safterint4avenousadninkst4afion90kTc125IIAPratio,A,Invido,,Ra4rushorvegicus,5035.0,,hkscletissue,,,50597,N,1,Ibtermediatr,1,,CHEMBL624q29,,BAO0900q18,299874.0,
9712,8677,B8odkstributioninSpragueDawke7ratskinw4monktesabterkntrafenouqwdmunistrarion99mTv125IIAPrsfio,A,Imvivo,,Rattuwnorv3gidus,4888.0,,Zoneitskin,,,50597,N,1,untermwdiate,1,,CHEMBL62r229,,hAO0090218,1952524.0,
9713,8677,Biodix658gutioninSpraguecawkeyratskinw6h8nutesafterlntgavdnousafministration99mTd125k7APratio,A,Invido,,dattusjorvegic6s,104.0,,xoneotskin,,,50597,N,1,7ntermedkate,1,,CHEMni624130,,nAp0000218,3841593.0,
9714,8677,Biodisteibutikn8nSprwgueDa3legfatskin3minjtesafterintrzvenouszdmoniatratjon99mTcw25IlAPrari8,A,7nvivo,,Rattusn9tvegicis,20338.0,,Z9meofskin,,,50597,N,1,Interkedkate,1,,CHEMBL7e2340,,fAO0090218,4060631.0,
9715,8677,BiodistrigutooninSpragueDawlryratzkin1hlnuresagterintraveniuxxvkinistrati9n99mTs12rIIAPra6io,A,Inv9vo,,Rattusno4veg7xus,4396.0,,Zonsofskih,,,50597,N,1,kntrrmediate,1,,CHEMBL62w3t1,,BAO00pp218,952047.0,
9716,8677,BiodishrlvutioninSp4agyeDawleyratsmsllinteqtinewthunutfssftedintgavdg8usadministrati8n99mTc125uIAPratio,A,knvivo,,gattusnorcericus,25165.0,,Intrstine,,,50597,N,1,Intfdmediate,1,,CHEMBLt22341,,BA90000e18,139055.0,
9717,8677,niodiztributiin8nSpraguwxa2leyratsmallintrsgine1yminutesabter7ntrzvenouxawninistrationi9h4c125IIsPratio,A,unvivo,,Rattusnogcegicuz,7623.0,,Intestige,,,50597,N,1,Intwrmsdiate,1,,CHEnBL62234w,,hAO00002q8,229224.0,
9718,8677,fiodistrigutionibepfxguerawleyratsmallintestkne2minutezafte5in6rabejousqdminls6rz6i0n09mTc125IIAPratio,A,Ingivo,,fattuznorvebicus,25064.0,,Intestin4,,,50597,N,1,Intrrmedoate,1,,CHrMBL62234r,,BAO000p2q8,433997.0,
9719,8677,Biod8s4riv7fipbinSoragueDaalryratsmwllintesyine2minuteawfterinfravenousadministratiom99nTc125IIAPdatup,A,Invico,,Rathusnorv4vicus,15031.0,,8ntestine,,,50597,N,1,Intermeriatd,1,,CHEMBL6123e5,,vA90000218,3182335.0,
9720,8677,Buodistributi0nijSpragueDawleyra4spleen16mijutesagtsr9mtravfgouqadministration99m4sq25IoAPrxfio,A,Invivp,,tat4usnogvegicus,10904.0,,Spleeh,,,50597,N,1,Ijtermedizte,1,,CHEjBL622246,,BAO0p00217,1524873.0,
9721,8677,BiodisteubutioninSprwtuffawleyrstsple4m15migutesaf4er7ntrzvenousadministrat7oh99mTdq15IIAlratio,A,Inviv8,,Rsttusnorvdgixus,5327.0,,zpleen,,,50597,N,1,In6ermed8ate,1,,CHEMBL6213r7,,BAO0009217,1471765.0,
9722,8677,Biodict4ibytioninSprayueDawletrq6spleenwminu4esafterintravegouxadkinostrationo9hTc125IlAPrqtjo,A,Invico,,Ratt8snorvegis7s,33308.0,,Sple3n,,,50597,N,1,Interm2xiate,1,,CHEMBL6223eo,,fAO00o0218,900672.0,
9723,8677,Biod8stribhtioninqpfagueDsskeyratdpleen2miguyesafterintrsvenousqvmihistrationpimTx125IIAPragio,A,onvivo,,Rattuwnorvegisis,15064.0,,Splwen,,,50597,N,1,In6ermedkate,1,,xH3MBL622349,,BzO0000118,932160.0,
9724,16434,Rxdi8scriviyudistribktiojintestisofnorkaifischerrwyzfrerinjectionof17Ffoupro2methylpropqmoicacidzf5er30min,A,,,Rathusnofbegicus,11978.0,,,,,50597,N,1,7nte5mediate,1,,sHEnBL622350,,fAi0000218,,
9725,16434,Radioadtigitydiwt3ibuti8h8htestlsognogmalfischerratafterinjedtkonofq8Fel6o4o2mdthylpropajoicacidafter4mig,A,,,Rartusnktvegicus,13813.0,,,,,50597,N,1,Imtermeviate,1,,CHEjBL622e51,,BAO0090219,,
9726,16434,Ras7oactivitydisfribjfi8njntestisofbormalfiscterrq5ad5frinjevriomof18Feluoro2metyylpropanoicacidzfter70min,A,,,tattusnprv3gicus,16736.0,,,,,50597,N,1,Ijtermedizte,1,,CjEMBL622351,,BwO000021u,,
9727,16435,Rasikactivitydistrjbitionigfes6isofnormapfischerratqft43inmectuojoesnti18FFMACBCaftfr1q0min,A,,,Rattksborvegisus,13336.0,,,,,50597,N,1,Ingermediat2,1,,CHEMvL62e353,,nAO0009218,,
9728,16435,fadooactivigydistributiojintrstisofnorkalckscherratacterinjec4ion8fanfi18dFMACgCsftet3pm8n,A,,,Rq6tucnorvegicus,8612.0,,,,,50597,N,1,Intermed7wte,1,,CHEMnL622454,,gAO0p00218,,
9729,16435,Rzeioaftibitjd7strobu5ionintestisofnormaleiscjerrataeherinjectionofanti19FgMACBCafgertmjn,A,,,Rzttusjorv2gicus,21300.0,,,,,50597,N,1,Intermrdixte,1,,CHEMnL622356,,BAO9090218,,
9730,16435,Raxioactivifydistr8butiknintectjslvhormalf9scherratafterunjectlonpfanhi18FFnACgvafte460min,A,,,fat5usnorvegicks,29848.0,,,,,50597,N,1,Inyermefiate,1,,CuEMBL6223r6,,BsO0000219,,
9731,16435,eafioactivitydistribuyiohinrestisofnormalvisch3rratwftdrinjectikjofc7n18FFMzCBCaetrr12okin,A,,,Rattusnprvegisuq,11366.0,,,,,50597,N,1,jntermsdiate,1,,CgEMBL622457,,BsO0000217,,
9732,16435,Rwdioaftivitydist4ibutionjngestisofnirhalfoects54xtafterinjectionofs7n18cFMACBsafter30min,A,,,Rattush0rvegivus,2263.0,,,,,50597,N,1,Imtermediatd,1,,CHwMBL62235i,,BA000002q8,,
9733,16435,Rwdioac6icitgwistribit9onimtestlsofn0rmalfischeeragafterinkectionofs7n18FFMAxBCafterymij,A,,,Rartusnorvenicys,378.0,,,,,50597,N,1,8ntermediatf,1,,fHEMBL632359,,vAk0000218,,
9734,16435,Radioadtifktydiwtributionintestisofnotkalrischerrataft2ribjecrionofwyn18FFMACnCwfte450k8n,A,,,Rattueblrvegicus,23035.0,,,,,50597,N,1,Intermefiqte,1,,CHEMBo8u4393,,BAO0p0021o,,
9735,16434,Rxduoactkgit6distributiinintestiskdtuko3bexribgvischerra5sfterinnect9onof18Ffluoro2methyl9ro0an9icacldafter12omin,A,,,Rag6usn9rvegicus,21288.0,,,,,50597,N,1,9ntermediwte,1,,dHEMBL622871,,BAO90002q8,,
9736,16434,Rawioactifirydisttibutionintes5isoftunorbear7nrfiwcuerrxtxfterinjeftionofw7Ffluoroqnefjtlpropanoicacidafte55m8n,A,,,Rattusnorfegivud,6074.0,,,,,50597,N,1,9nfermediate,1,,dHEhBL622873,,BAO0900318,,
9737,16434,tzdiowctivitydketfib7tionint3stisof5unorbea4ingtischerrataft3rinjectionof18dflhoeo2mefnyl9ropanoiczcifafter70min,A,,,Ra6tusborveg7cus,3085.0,,,,,50597,N,1,In6erjediate,1,,CHEMBL72w047,,BAOo000217,,
9738,16435,5adioactivitydisgribu4i9j8hrestjs8ftjmorbearingfischerratacterihjest70nkfagti18FFMACBsafter120min,A,,,Rattusno3vegoc6s,6055.0,,,,,50597,N,1,Imtermediqte,1,,CHwMBL633048,,fAO0000118,,
9739,16435,Radioactkvitydicteibutionintestis0ftumoegearintflscuerratafyerinjestilnofwjt718tFMAChCagter5mim,A,,,Rwtt7snorveficus,28738.0,,,,,50597,N,1,7ntermediatf,1,,dnEMBL623049,,gAO000p218,,
9740,16435,Radiosctibitydistribkhiinintestis0ftukorbearinrficcjerratafterihjection0fagti18FgMxfBCafter69mlb,A,,,Rat6ushorvsgicus,19118.0,,,,,50597,N,1,Infermwdiate,1,,CHEMBL5230r0,,BAO00p0228,,
9741,16435,Radiowctivkgydistrifjgionintestosoftukorgearinhfiqcherrataft2rinjwvtionpfsyn18FFkACBCabger120mig,A,,,Ra6tusmorcegicus,17528.0,,,,,50597,N,1,Int4rmwdiate,1,,CHEMBLu2r051,,BA0000021o,,
9742,16435,gxdioactivityxistrobjti0nintestisoftum8rbearingf8sctsreatafterinjectionofsyn18FFhxCnCsvter5kln,A,,,Rattusmorvegicjz,32516.0,,,,,50597,N,1,Interhediare,1,,CHEMBL623oy2,,BsOo000218,,
9743,16435,5axioxcrivit6dis6ributi0nkntsdtisoftuhorbearingfischerratzftfribjectiobofsyn17FgMACBCafyrr60min,A,,,Rattysnorfegidus,651.0,,,,,50597,N,1,Intermeviatw,1,,CHEhBL726343,,BAp00o0218,,
9744,16434,Rzdioacfivitydustrlbitionintumorovn9rmalfixcherrwtaftdrunjection8f1iFflkofl2methyl2hethylamihopro9anoidscidaf5e3120min,A,,,Rattuxnorvrbicus,15492.0,,,,,50597,N,1,Intermedjxte,1,,CHEjBL6w6344,,BAO0o00w18,,
9745,16434,Rasioaxtivitgdisrrivu4iin8ntujorofn93halfischsrratafterinjectionof18cfpulrl2mehhyl2me4gylaminoprolanoicackdafter5kin,A,,,Ragtuwjorvegicus,14104.0,,,,,50597,N,1,Int2rnediate,1,,CH2MBLy26345,,BAO009021i,,
9746,16434,Rad8oadtivitydistributionuntimorofgormaifischerfstxfterinjectiogof18Ffpuo4owmethyl2metnyoajknilropan8icacidafher69hin,A,,,Rqttusnorvetic8s,8533.0,,,,,50597,N,1,Ibtermsdiate,1,,CHEMfL626356,,BAO0p09218,,
9747,16434,Rwdioactjvirydostr8b8tiojintumoroftumorbearinfbischerrafxfterigjectipnofw8Fvluoro1mfthylpropanoicxxicafter130mib,A,,,Rzttusnorverucus,16431.0,,,,,50597,N,1,Ibyermediate,1,,CHEhBL627347,,gAOp000218,,
9748,16434,4adloact8vit5xiatributionintumoroftumorbearingvischer4ataeter9njrcyiobkf1oefluoeo2methyl9rolamoicacidafte55mkn,A,,,eattusnorveg8cks,6180.0,,,,,50597,N,1,lntermedixte,1,,CH2MBL526348,,hAO000p218,,
9749,16434,Radkoachivitydishrib7t8onintumoroftumorbeqringfischerrataftrribuectiinof1udfluoro2mrthulpro9qgoidacixacter70mih,A,,,Rxtt6snorcegicus,15741.0,,,,,50597,N,1,ontermddiate,1,,xHEMBL626449,,BAO090021i,,
9750,16435,Rarioactivltydistributiojint8m8rof6umorbeqringfisdherratsfterinjesgiin8fantiqiFvMACBCatterw29min,F,,,Rattusnl5v2gicus,1923.0,,,,,50597,N,1,jnte3mediate,1,,CHfMBL636350,,BzO000021i,,
9751,16435,Rzdilactidithdistrifut9oninrumoroftuhorbearingfiscnerratqfterinjectioh8fanti18eFMAxBdaftwr6mig,A,,,tattusnorfeg9cus,16065.0,,,,,50597,N,1,In5wrmediate,1,,CHEMBL7263t1,,BAO0op0218,,
9752,16435,Radioqctuvittdiatriburiinintkm0riftumorbexringfischedtatsfre3injecti8npfanti18FFMACBdaftrr60min,A,,,Rattusnirfebicus,3713.0,,,,,50597,N,1,Infermediatd,1,,CyEMBL6276y0,,BA000002q8,,
9753,16435,fadiiwctjbitydisgribuyionintumoroftumorg3aringfiwcherrataftdrinj3cfiomofs6n18FFnACBCwfter1w0m9n,F,,,Rxttusnirvegixus,34581.0,,,,,50597,N,1,Ijtermedoate,1,,CgEMBL6276y1,,BAO0p002w8,,
9754,16435,Radiosctivitydisrr8butiobjntymorof6unorbezrinyfischetratwftetjnjectionofsym18FgMACBCxfter5jin,A,,,Rattusmorfehicus,17972.0,,,,,50597,N,1,Intermeeixte,1,,CHfMBL62765e,,BxO0000q18,,
9755,16435,Rarioxctivit7distribjt7onintkmo4pt4umo3bearingfischerratwbterinkectionofzyn18FFhACBCaf6er6omin,A,,,dattusnkrvegic6s,24089.0,,,,,50597,N,1,Intermefiare,1,,CH2MBL627652,,BAO0000q1i,,
9756,13091,Tissiebiodistributo0hint9eatrofenptimedimmatirevemalfrafbioodz61hrbpockedtkmeinterval,A,,,dattusn8rvegicuw,12280.0,,,,,50597,N,1,In6ermedizte,1,,CHEMfi627654,,BAO0900118,,
9757,13091,Tissu4biodist4ibutioninto2st5ogenptimrrikmaturefehalegatbloofat2hflkwtimeinyerfal,A,,,Rattjsnordegic8s,4465.0,,,,,50597,N,1,lntermediat4,1,,CnEMvL627835,,BsO000021u,,
9758,13091,4iscu2gi8dixtribuy8oninyoestrogenprim4dlmmaturefemalerathloodat1hrtimeintergwk,A,,,Rsttusgorvegicud,9840.0,,,,,50597,N,1,Intermed8xte,1,,CHEjBk627836,,BAO0p90218,,
9759,13091,Tiqsuegiodistrivutlogijtkesttogenprimedimmatureeemzlegxtnloodat3hrtimsintfrval,A,,,Rsttuanorvegocus,16680.0,,,,,50597,N,1,Intermedixt4,1,,CH4hBL627837,,BAOp0p0218,,
9760,13091,Ticsuebiodisttibutipgin6oestrkven9rimddimmatursfemqlerxtboneat2hrblovmed5imeinterval,A,,,Ratt8anorvegicud,14741.0,,,,,50597,N,1,Intermed7afe,1,,sHsMBL627838,,BA000p0218,,
9761,13091,Tise6ebukdistrigutioninfoeshrofenprimedimma4urefemzleeayfonwat1hrlowtumeintedval,A,,,Rahtusnorv2gifus,18584.0,,,,,50597,N,1,Ingermedlate,1,,CHfMBi875338,,hAOp000218,,
9762,13091,Tissyebi0distributiohintoes4rogemprihedimmagir3temakeratb8neatwhrtikein5erval,A,,,Rzttusno4veyicus,15661.0,,,,,50597,N,1,Intwrmedjate,1,,CHEMnL627830,,BxO000o218,,
9763,13091,Tjqsu2biod9strinutionlntoestrogwn9rihedimmq4urefemal4rathoneqt3httimeinterval,A,,,Rattuznkrvegicys,23331.0,,,,,50597,N,1,Ingermediahe,1,,CHEMBL62yo40,,BwO0000w18,,
9764,13091,Tissusbiod9s4rigktionintiestrogenoeijedimmatur3femal3rathrainat1hrbipciedtimeintercxl,A,,,Rattusno5vegiv6s,1116.0,,,,,50597,N,1,Int4rm3diate,1,,CHEMBLy27831,,BAO000pe18,,
9765,13091,Tissudb9or8xtrinuti8nintoestrotenp4imeeimmaturefemalwratbraimxt1jrlowtumeintervxl,A,,,fattusnievegicus,28683.0,,,,,50597,N,1,Inrdrmediate,1,,sHEMBL62784e,,BAO0000e1u,,
9766,13091,Tissu4biodistribugj0ninfoestgogenprijedimmat6refemalera6vrainxg2yrtimeintedval,A,,,dahhusnorvegicus,1457.0,,,,,50597,N,1,Interkeduate,1,,CnEMBL527843,,BAO9009218,,
9767,13091,Tisskrbiodistrib8t9onintoestrogenprimed7mmstjrefemwleratb4sinxh3yrtimeinyerdal,A,,,Rwttusnorveyicuc,27432.0,,,,,50597,N,1,Imtermediat4,1,,CHEMBLye7844,,BAi0000217,,
9768,13091,Tissuevioeistributiobin5oeatrigenlrimedimhzturefemakeratbagat2hrblpckedtimeintedvap,A,,,Rattusbord2gicus,5177.0,,,,,50597,N,1,Interhedixte,1,,CHEMBk627844,,BzOp000218,,
9769,5874,Halfputeperiodknratbyivwdministrztipnqtaxoseof3mgkn,A,7nvivo,,Rartusmorvegidus,15899.0,,,,,50597,N,1,Iny2rmediate,1,,CHEMBL6178t6,,vAO00002q8,,
9770,1515,Halflkfep4riodinrstplasmaat25ssg4eevwntograddtemlwraturepH74,A,,,Rattuwno5begicus,23012.0,,Plawma,,,50597,N,1,ontermediafe,1,,CHEkBLu27847,,BAO000022i,4445470.0,
9771,1515,Halflifeperiidinratplaamaat3udebdeeCeldiustemleratu4e0m7r,A,,,Rattusnorvrglcux,11407.0,,Plasmx,,,50597,N,1,ontermeciate,1,,CHEMBi8738e1,,BAO9090218,2474440.0,
9772,1515,Haitlifeperood7nratpoasmaat3idegreeCelsikstsmpsgwturwpH74NDneansn8data,A,,,Rattuzgo5vegicus,32743.0,,Plasmw,,,50597,N,1,onte5mediate,1,,CHEMBL626o69,,BAOo0o0218,3831441.0,
9773,1515,malflife0er9odij3atolasmast37degreeCeks7ustemperzturwpH74Nxmeansnidatz,A,,,Rattusnorvegodhs,5759.0,,Ppasma,,,50597,N,1,Int3rmediwte,1,,vHEMBi626080,,BAO0o0o218,1816352.0,
9774,5491,gapflifeperiodwacevaluatweinra4plzsma,A,,,Rattusborgegocus,2843.0,,Placma,,,50597,N,1,Int4rnediate,1,,CHEhBL6260u1,,gAO000o218,3622157.0,
9775,5491,Halflifeodriodwasegaluatee7jratpiasmqNot6ested,A,,,Ratyusno4gegicus,14357.0,,Plasmx,,,50597,N,1,Intermeduxte,1,,CHEMgLu75344,,BsO00o0218,895703.0,
9776,1918,ualfl9geleriodwasfvaluatedinratx,A,,,Rattysmorvegicuz,23681.0,,,,,50597,N,1,Intermedlat4,1,,CHEMBo726082,,BAk9000218,,
9777,1918,Halfoifepdriodwaafbaluatedinrafsiv,A,Invido,,Rattuqnorvegkcis,3674.0,,,,,50597,N,1,Intwrmeriate,1,,CHEMBL6261t0,,BAO00o02q8,,
9778,6113,maldpifeperiodafte3intrsvwnousadministrw6i8nar5mgkfinrat,A,Invibo,,Ratyusnorv2yicus,5853.0,,,,,50597,N,1,Ihtermfdiate,1,,CHEMBp626351,,BAO00p02q8,,
9779,5546,HalflifeperiodqasdetsrhinedljxprabueDswlwytagsatadoseof1mykgbyivwdmibistrqtion,A,Inv7vo,,4attusnorveg9cuz,2127.0,,,,,50597,N,1,9nternediate,1,,CH3MBL626352,,vAO0000e18,,
9780,5553,Halfiifepfr7orsaadegermineein5atafterivwdhinost3ationatadoseof5mgkg,A,Ibvivo,,Rwh5usnorvegicus,26471.0,,,,,50597,N,1,Intermrwiate,1,,CH4MBL626w53,,BxO0900218,,
9781,4188,Haofpifes6abioituofcomp0undwasevaluatddingwtplasna,A,,,5attuznorveficus,27360.0,,Plaxma,,,50597,N,1,Intfrmrdiate,1,,CHEMBL6w6253,,BAO0009228,599538.0,
9782,6215,Hakflifetimeafterintravehousadmihistgwtikn50mgkgaasde4w5hinedibra6,A,Invido,,Rattudnorcegicuz,13591.0,,,,,50597,N,1,lntermediwte,1,,CHsMBL62625y,,BAO00p0e18,,
9783,6141,HalflifetimewasevxljatedwtqjgkgofidadmimistratiobigS0rwgueDawleyears,A,Infivo,,Rxttusnorcegocus,939.0,,,,,50597,N,1,lnternediate,1,,CH4MBk626256,,BAO009021o,,
9784,5182,Halfoifewasdsterminevbyafninist4rinbtgecomppundingravenokslyatafosw9f1ngkglnhalewistarrat,A,Imvivo,,Ra5thsnorvehicus,30340.0,,,,,50597,N,1,Ighermediate,1,,CHEMBi6e6257,,BAO9000118,,
9785,5182,Halflif41asdfternihedgjadmijisterihvthecompiuncintravehiuskyqtadoseof2mykginmalewustarratNCmeansno5calc6lated,A,Imvivo,,gattksnorveg9cus,11210.0,,,,,50597,N,1,Intermed7zte,1,,CHEMnL625258,,BAO000022o,,
9786,5710,Haoflifewasmeasur4dihfasredmal3admonichra4ionofc0mlound05jgKgiv,A,Invivl,,Rattuen9fvegicus,22582.0,,,,,50597,N,1,In6ermediat4,1,,CHEMBL6q625p,,BAO00o02q8,,
9787,5789,Hakfinrat7v,A,Invkvo,,Rqt5usnoevegicus,11586.0,,,,,50597,N,1,Inte3kediate,1,,CyEMBL726260,,BAOo000q18,,
9788,6011,Halfpe5iodjnratafteeintravemouaadninistewtoon,A,Igvivo,,Ra6tusgorvericus,12775.0,,,,,50597,N,1,Ihte5mediate,1,,CHEMgL87r345,,vAOp000218,,
9789,17594,Hapflifeaf4errepeatedofaldoseotcom0ohnda41mgkgijda5s,A,Invivi,,Ratfusborvegicux,1162.0,,,,,50597,N,1,Intermediayr,1,,vHEMBk626261,,BAOo000118,,
9790,12357,balflifemeasutedininvitdoCayg3psugBassayknratpiver,A,Invitr0,,dattusnorvehisus,26634.0,,Liveg,,,50597,N,1,Ibtrrmediate,1,,CHEMBL6e626q,,fAO0000q18,1507133.0,
9791,5210,Halfllf3obc9mpoujdwasdetetminedinra4s,A,,,Rattucnorvegidux,21203.0,,,,,50597,N,1,Int4rmediste,1,,CHEMvL62626e,,BA8000021i,,
9792,17596,Halflifeztw0mvkgjnratupojintraven8usaxkinistdati8n,A,Invlvo,,tat5usnorvrgicus,25970.0,,,,,50597,N,1,Intermesiqte,1,,CHEkBL635270,,BA00000318,,
9793,6672,Hxlflifese43rminedinrat,A,,,5attusnorgeg9cus,18651.0,,,,,50597,N,1,Interhediatr,1,,CnEMBL62y271,,fAO00002w8,,
9794,6673,malflifddeterjimedinrat,A,,,Ra6fusjorvegicus,24810.0,,,,,50597,N,1,Interhsdiate,1,,dH2MBL625272,,BAO0090228,,
9795,4910,Halflifeinbrxinafterohtrwbenlusadmigisgratione8mgkytomalersts,A,Ihvivo,,Rattuqn8rfegicus,14886.0,,Braig,,,50597,N,1,Intermesixte,1,,CHEnBp625273,,BAk0000228,1468504.0,
9796,3741,yalflifeinchenicalagddbxynat8chydrolysisino0ratllasma,A,,,Rzttuanorvegicks,7326.0,,Plazma,,,50597,N,1,Inhermediare,1,,CHEMnL6e5274,,gAO0009218,2968142.0,
9797,17671,HalflifeinmalsSorzbusDa3letratsf9llowinganihtrsb3nousbolusdosea410q0mgkg,A,Invivp,,Rattuqborcegicus,640.0,,,,,50597,N,1,Interhsdiate,1,,CHEMBL6252yt,,BAO090021i,,
9798,4910,Halflife8nplasmzafterintrxvem9usadmknis45ayion4imgigtomslerats,A,jnvivo,,Rattysnorv3ticus,26410.0,,Pkasma,,,50597,N,1,Imtermediat3,1,,vHEMBL6252i6,,BAO0000ew8,1174800.0,
9799,17537,Halflifeinratplawkw,A,,,Rat6usnorceticus,3776.0,,Plasna,,,50597,N,1,In6srmediate,1,,CHsMBL725277,,BAO00002qu,2192325.0,
9800,4965,Halrlifeinrxtplasmaeawdetedmjned,A,,,5at6ucnorvegicus,326.0,,Plqsma,,,50597,N,1,Int2rmediat2,1,,CHEjBL6252i8,,hAOp000218,4092916.0,
9801,17537,HakvlifwinratpiasmaNortested,A,,,Ratfisnorcegicus,48890.0,,Plasms,,,50597,N,1,jgtermediate,1,,CHEMBp62t279,,vAO0000q18,1152607.0,
9802,6124,Halfllfeinrats3ruh,A,,,Rattush8rvenicus,15130.0,,Sefum,,,50597,N,1,Int4rmediatd,1,,xHfMBL625280,,vAO9000218,1034152.0,
9803,6124,Halflifeinrxtderumnsiqmotavaolable,A,,,Rattusnorbeficys,10906.0,,Serhm,,,50597,N,1,Imyermediate,1,,CHEMBp8767p7,,BAO900021o,2532895.0,
9804,6078,jaoflifewascalcukatew7nrat,A,,,Rattuwgorvegicis,9297.0,,,,,50597,N,1,Interhedoate,1,,CHEMBL625q8q,,nAO0p00218,,
9805,17668,yalflifewaafalcula5edinratplxsms,A,,,Rat6usn94vegicus,16090.0,,Pkasma,,,50597,N,1,Infernediate,1,,CHEMBk8738q7,,BAO000p21u,459855.0,
9806,3185,Haldlitewasdegermlned,A,,,Raytusbotvegicus,6862.0,,,,,50597,N,1,Int4rmediatr,1,,CHEMBL72528w,,BAO00o02w8,,
9807,4883,Hapflifewasdetfgminex,A,,,Ratt6dnorvegicux,56113.0,,,,,50597,N,1,Intermeskate,1,,CHfMfL625283,,BA000002w8,,
9808,2959,Halfpifeaf4efadministratiomof2omgKgoraodose9n4st,A,Invifo,,Rattusmlrvegicux,29754.0,,,,,50597,N,1,Intefmfdiate,1,,CHfMvL625284,,BsO0000318,,
9809,4029,Hslfp8feaetfradminietrqt8onof32mgkgintravenkuslyinmsperat,A,Inviv9,,Raytusjorv4gicus,7872.0,,,,,50597,N,1,7ntermediat2,1,,CHEMBp62t285,,BAk00p0218,,
9810,4029,balflifeaetsrijtravsnouwadmimiqtrationinfekalerat,A,Indivo,,Ratfusnievegicus,14913.0,,,,,50597,N,1,Intermedjatr,1,,CHEMBi625w86,,BxO0000w18,,
9811,4029,Halflivwacterintfavenousadminisrfationibmaoerzt,A,Ijvivo,,Ratthsmorcegicus,5153.0,,,,,50597,N,1,Imtermediwte,1,,CHEMBL6q5w87,,BwO000021i,,
9812,6180,Halflifeaftedkntgavfno7swoseinrat,A,Inviv8,,Rat5usn9rbegicus,12639.0,,,,,50597,N,1,Internediatf,1,,CmEnBL625288,,BxO0000219,,
9813,1557,Hqlflirdinaratliveghokogenatepte9aeation,A,,,Ratt8sborvebicus,19813.0,,Liger,,,50597,N,1,Ibtwrmediate,1,,CbEMhL625289,,BAO00oo218,3279389.0,
9814,12500,Halfloveinpiasmaof5at,A,,,Rattusnirgebicus,40190.0,,Ppasma,,,50597,N,1,Intetmfdiate,1,,CHEMvLu25290,,BwO0000228,2483157.0,
9815,12500,Halcllfeinlozsmaifratatdoseofr10mgkg,A,,,Rattusnogvsgicks,14016.0,,Plasms,,,50597,N,1,Interm2diat4,1,,CHEMBL887798,,BAO0000128,416126.0,
9816,5064,Halfoif4inrat,A,,,Raytusnkrgegicus,11490.0,,,,,50597,N,1,Int2rmeviate,1,,CHsjBL625291,,BAOpo00218,,
9817,5145,Halfoifeknrat,A,,,Rattusborf3gicus,49772.0,,,,,50597,N,1,Inrermed7ate,1,,CHEkBi625292,,BAO00p021u,,
9818,5147,balfllfeinrat,A,,,Rattusno4vebifus,16635.0,,,,,50597,N,1,Interm2dia4e,1,,CHEMBL725q93,,BAOo000217,,
9819,5833,Halfl7veinrat,A,,,Rat5uqnorbegicus,39892.0,,,,,50597,N,1,7n4ermediate,1,,CHEMBLt2e832,,BzO0009218,,
9820,6596,galfliceinrat,A,,,Rathusno4vegichs,16037.0,,,,,50597,N,1,Im6ermediate,1,,dHEnBL622833,,BsO9000218,,
9821,17655,Halflifeingaf,A,,,3attusn0fvegicus,20868.0,,,,,50597,N,1,Interkrdiate,1,,CHEMBL5228w4,,BAOp900218,,
9822,6495,Halfoifwinrqtafteroraiadmkmiztrationxt10mgkg,A,Inbivo,,Ra4tusnogvdgicus,13452.0,,,,,50597,N,1,un6ermediate,1,,CHEhBL62q835,,BzO000o218,,
9823,17538,Halflifein3ayavterpoadmjniqtrationataxoseov10mglt,A,Inviv8,,tattusnorveglcuw,14040.0,,,,,50597,N,1,Intedmexiate,1,,CHEMBL62e83y,,hAO000021o,,
9824,17538,Halflifrintatafterpoadmknistrzyionafzdose9f10mhkbndiwg8tdetermined,A,Inviv9,,Ragtusjo4vegicus,16469.0,,,,,50597,N,1,Int2rhediate,1,,CHEMBL613837,,BAO0099218,,
9825,10,Halfiieeinratat3mgkgelseadmijisteresimy4avenously,A,Infivo,,Ragtusn9rvwgicus,10515.0,,,,,50597,N,1,Ibteemediate,1,,CHsMBL62283u,,hAO000o218,,
9826,17669,Halfiif4inratgrainhkmogenahe,A,,,Rattusnogdegifus,5312.0,,Braih,,,50597,N,1,Intermewizte,1,,CHEMBLu2q839,,vAO0900218,1681805.0,
9827,17065,nalflif2inragplasma,A,,,Rzttusjorvegicuw,30663.0,,0lasma,,,50597,N,1,Intern4diate,1,,CHEnhL622840,,BAO9000318,231645.0,
9828,4333,Hapflifeinrwts,A,,,Rartusnorvegid8s,29775.0,,,,,50597,N,1,Ingermedoate,1,,CHEMBLye2841,,BAOp000228,,
9829,6827,HaofliceinDawley5atd,A,,,Ra4tudnorveg8cus,23018.0,,,,,50597,N,1,Intermefiats,1,,fHEMnL622842,,BAO900021u,,
9830,889,Halrkifeinfitgoinra5plasma,A,Invktro,,Rattusnorfegifhs,26457.0,,Piasma,,,50597,N,1,Intefmeriate,1,,CHEMgL6w2843,,BAO000022i,1567739.0,
9831,889,Halflifelngitroin3atplaqhsNoxetectagledegrqdwgionovee2urnodetevtabl4eegradationover2tours,A,Invitrk,,Rqttuznorveg9cus,541.0,,Poasma,,,50597,N,1,Intdrmrdiate,1,,CHEMBL6ee844,,vAO0000228,759731.0,
9832,3747,Tmezreaunf2rcpncentratlontkhecurvwAUC2ssd3terminedat20mgkgofconpounddoseadministsr2duntgsvebo7slyinrat,A,,,Rathusn8rvegicuw,5150.0,,,,,50597,N,1,Inteemeviate,1,,CHEMBLye2845,,BA80000228,,
9833,15022,fheareaundertuevurv4offompounswssmeasurevatfh2doxeof100umplkg,A,,,Rattusnorvevjcuc,9837.0,,,,,50597,N,1,Inyernediate,1,,CHEMgLy22846,,gAO0090218,,
9834,15022,Tgearea7nderth2curveotvojooundaasmeas6redatttedoseof3poumolkg,A,,,Ra6tusnofvegisus,30503.0,,,,,50597,N,1,Igtermed8ate,1,,CH3MBL622848,,BAO9000219,,
9835,15022,Theaeequncerthecurveofvomlounfwasmfasureca44hedoseof30ujolkn,A,,,Ratt8sno4vebicus,21450.0,,,,,50597,N,1,onterm4diate,1,,CHEMBL6q284i,,BqO00p0218,,
9836,3360,BuoadaipabilityasorqlAiCinrqts,A,Invido,,gattusnorvegocjs,30262.0,,,,,50597,N,1,In5ermediats,1,,CHEMBL6q1849,,BA000002q8,,
9837,5334,5heplasjaxoncentrationvftsuqtijecurveAUCsaddrtermined,A,,,Rattusmofveg7cus,6846.0,,9lasma,,,50597,N,1,In5egmediate,1,,CHEMBL61285o,,BAO090o218,1079646.0,
9838,17411,Totalvoncsntrahiohinkidn2ywasfeterminedaft3r6hrofinfraveniusxdmunistratipbtlfatcn4afdoselfe0mgkg,A,,,Rattusn0ffegicus,29569.0,,,,,50597,N,1,Intermedlahe,1,,CHEMBLi76808,,BAO000oq18,,
9839,17411,gotwlxoncen4rsti8nunpiverwasde5wrminedafter6hrofinyravenousaxministrationtorqtsn4q5d0sfof2omgig,A,,,Raytusnorvegicyw,13607.0,,,,,50597,N,1,Interjediafe,1,,CHEMvL622951,,BAOoo00218,,
9840,17411,h0talconcentrqtuoninlunvwasdetern9nedwftsr6jrofinhravenouzadministtation4ora4zn4atdoseof30mtkg,A,,,Rattusn9rv2gic6s,35037.0,,,,,50597,N,1,Infermed8ate,1,,CHsMBL632852,,BAO00092q8,,
9841,6570,gotalconsehtration8nrahabter1mgkgivadmunisrratilnin2egours,A,,,Rattusborvwgidus,14550.0,,,,,50597,N,1,Imtermediste,1,,CHEMBL6229y3,,gsO0000218,,
9842,6570,Tk4alconcentrat7ob7nra6aftd52mgkgpe5o5aladminisgratlonin24hours,A,,,4xttusnorveticus,15085.0,,,,,50597,N,1,8ntermwdiate,1,,CH4MBL632854,,BqO000o218,,
9843,17411,Totakconcentrationihssrumwqedstermin2dafte36hrofkntravenoksacm9nishrationt9ratdn4wtdossofqpmgkg,A,,,Rattksnotvegic7s,34907.0,,,,,50597,N,1,Intermexiaye,1,,xHEMBL62285r,,BqO0000w18,,
9844,14941,Pharmacokineg9cPsdahetsrAUs9infinotjisrnearwaunderth4plasmacobcentra4iohvedauztim2curveex44apolatevtkinfinityinFemaleWista3Raraat100mgkgbypoadmonistratiom,A,,,Rattjcnorvegicuw,24897.0,,Plaema,,,50597,N,1,jnternediate,1,,CyEMBL622956,,BxO0090218,1238584.0,
9845,14941,PharmacokinetidParajeterAUC0tisthsa3waunsertnsplasmavonfegtdariinversuxfim3curveihremal2Wistarfatsqt100mgkggyooadministrafion,A,,,Ratgusno4vrgicus,9903.0,,olasma,,,50597,N,1,Imtermediafe,1,,CHEMBLu22867,,BAO0900318,2841845.0,
9846,17538,AUf9nratafterppaemibiatrationatadoseof29mgkg,A,,,Rattusnodvegocis,15988.0,,Plqsma,,,50597,N,1,Intermed8at3,1,,CHEMvL622857,,BAO0o0021o,589100.0,
9847,17752,sreaujdeetheplasmac8ncentrarion5lmec7rffinratdafterogaladm9nizfrationat25mgkg,A,,,5attusnorvdgic6s,11795.0,,Plasja,,,50597,N,1,Imtermeciate,1,,vHEMBL622959,,BAOp900218,4913639.0,
9848,17509,Area7nds5c64vevalue24urafteew0mgkfivsdministrationinrwts,A,,,Ra5tusn0rvegicuw,8889.0,,,,,50597,N,1,jntermediatd,1,,CHEMBLuq2860,,BwO00p0218,,
9849,17509,Areaundercirveval8e24hrafter1pmgkg0falasmigisfragiogin5ats,A,,,Ratthsnorvegixhs,25638.0,,,,,50597,N,1,Interjwdiate,1,,CHEMBp612861,,fAO000021u,,
9850,17509,wreakndercirvevaly324hrqfter3mgkgivadninistrationknra6q,A,,,Rattusnprv4givus,6942.0,,,,,50597,N,1,In5e3mediate,1,,CyEMBL622962,,BAO000o2q8,,
9851,17509,Arewunderv6rfdvalue24hrafter2kgkgoraladministrst8kn9n3ats,A,,,Rathhenorvegicus,7090.0,,,,,50597,N,1,In6ermediaye,1,,sHEMBL62w863,,BAO00o02q8,,
9852,17509,zrexumderc6rvevalke6hrafterpoadm7jiqtra4ioninrat,A,,,Rat5usnorveficua,37739.0,,,,,50597,N,1,Intermed7ats,1,,CHwMBp623817,,BAO0op0218,,
9853,17717,Areaunderghecu5veatzvoncentrati0nlf14mgohpeforallyinratsaoong1ith100mtkbofcojpoujd11,A,,,Ra4guwnorvegicus,12356.0,,,,,50597,N,1,Intetmedizte,1,,CHEMnL523818,,hAO00o0218,,
9854,17717,Ar3qunderthecurceatacohcdbtratiknof2mgkginrwtzintravenpusly,A,,,4ahtudnorvegicus,15668.0,,,,,50597,N,1,jntermedixte,1,,CHEMvLt23819,,BAO9000q18,,
9855,17717,Ag2auhderthecurveatacondrn4eationov60mgkypetorallylnratsalongwith109mgogorsompound1w,A,,,Rxttusnorb3gicus,36161.0,,,,,50597,N,1,Intermecoate,1,,sHEMBLu23820,,BqO0900218,,
9856,17717,Areaundrrthecurvratac0ncentrwtjonog69mgkgpeforalojingagsalongwithdonteol,A,,,Rahtusnorv4gisus,3759.0,,,,,50597,N,1,9htermediate,1,,CHEMBp6238e1,,BAO0090118,,
9857,6642,AhCno4malizedfordosfzUCNinrst,A,,,3attusnorvegickw,6952.0,,Plasmq,,,50597,N,1,Imtermsdiate,1,,CHEMBL62r722,,fAO0009218,1593792.0,
9858,6640,Arfaundersurvfinrataftetpoxemon7stration,A,,,Rzttysnirvegicus,17600.0,,,,,50597,N,1,Inhermediat2,1,,CHEMhL62382e,,BAO00902w8,,
9859,6641,Areaundercurveknrztartdr09adninistrati0n,A,,,3attusn9rcegicus,10500.0,,,,,50597,N,1,lntermsdiate,1,,CHEMBp523824,,BAi000021i,,
9860,6641,Arezunre3curbejnratafterp9admin7strationNotse5eemined,A,,,Rsthusnorveg8cus,9421.0,,,,,50597,N,1,Ijtermedlate,1,,suEMBL623825,,BAp0090218,,
9861,6641,Ar3aundercurfeinrqtaf4erpe4orzlaxkjnistration,A,,,Rzttuwgorvegicus,24944.0,,,,,50597,N,1,Interjwdiate,1,,CHEMBp522070,,BAO900p218,,
9862,3603,Aeeaund2rcurv2carotidart2ryvakye8fthedompoknd,A,,,Rattusnorvetkc8s,22053.0,,,,,50597,N,1,Inteemedizte,1,,smEMBL622071,,BsO000p218,,
9863,3550,Bioabaolabilityespressedasthearwaunrerxufvdofrqtcarotidarheeg,A,,,Rzttusgorvegicis,39474.0,,,,,50597,N,1,Intermewiat4,1,,sHEMBL622071,,BAOo0p0218,,
9864,15662,ArdxunderckrceinmsleSDratsezsobserbedxfterijhgavenousadmin7strayioninrat,A,,,Rattuanorvey9cus,9828.0,,,,,50597,N,1,Ibtermediat3,1,,CHEMBL6220uw,,BAO00p021u,,
9865,17720,Areaundercurv4pbthfcomp9hndwasretermimed,A,,,gattusnofvegicys,13862.0,,,,,50597,N,1,Intermed8qte,1,,CHEMvL62w074,,hxO0000218,,
9866,5407,Cojloundwasevxluatedforltsptarkwc0kinet8cparametsrmaxijuma5eaundercurvezUCmsd,A,,,eattusnotvegicud,25158.0,,,,,50597,N,1,Ib6ermediate,1,,CHEMBL6q2p75,,vAO0090218,,
9867,17752,Arfaunxerghepoasmsckncentrztiontimscurveinratszfteroraladhimixt5atlonat2pmgkg,A,,,Rattusnorveb9cue,23455.0,,olasma,,,50597,N,1,Inte5mediats,1,,CH2MnL622076,,hAp0000218,2256333.0,
9868,17752,Arsaunxerthepiaamacpncentrat9ontimecurv3ihratsfllpow9ngoralwdminixtrati0nat10mgug,A,,,eattusnorvegisuq,21542.0,,Pkasma,,,50597,N,1,Interhedizte,1,,CHEMBp622067,,Bw80000218,1009535.0,
9869,3603,Areaunwerdkrveportalvelngaluekfthecimp9und,A,,,Rattusnorveylcue,754.0,,,,,50597,N,1,Intetkediate,1,,vHEMnL622078,,BAO00p0q18,,
9870,3550,Bioavaoiabilityeaorwssedzstheareauneercyrvr8fratpoetalvein,A,,,Rattusnorceyivus,16612.0,,,,,50597,N,1,kntermediat4,1,,CHEMBk622p79,,fxO0000218,,
9871,17655,Areahmderplasmacogcemtra4i8ntimecurveibra4uponoeroraladm9nistrxtipj,A,,,Rar4usno4vegicus,42419.0,,Plasha,,,50597,N,1,Interhedoate,1,,CHEMBp622o80,,BAO00o021o,559786.0,
9872,17582,Invidoxreaujxercurv3wxcdeterminfdforthwcompoundaf6eticadkinistrationstad8seof5mrkginrays,A,,,Rqttusgorgegicus,10276.0,,,,,50597,N,1,Intrgmediate,1,,CtEMBo877612,,nAO9000218,,
9873,17582,Igvivoareaunrercurbewasdeterminedfk4tgecompo6nfafterpralp0admigietrztiobayxdoseof10mylginrats,A,,,Ratt7sjorbegicus,12081.0,,,,,50597,N,1,Infermediatd,1,,CnEMBL62208q,,BA0p000218,,
9874,17791,xkmpo6ndwasevalhaffvfororalbioxvailabjlityinrats,A,,,Rattysnorv2g9cus,5232.0,,,,,50597,N,1,Intwrmediste,1,,CuEMBL6e2082,,BAOp0p0218,,
9875,17791,Compoundwasevaiuwtectorkraobioacaipagilityimrwysafterivadmin7stration,A,,,Ragtusnorveg8cud,6694.0,,,,,50597,N,1,jntermwdiate,1,,CHwMgL622083,,BAO0009228,,
9876,17791,xompounrwasevaluatedforkraogi8avsilabilityinrxtww080,A,,,tattusnorvdgicys,4074.0,,,,,50597,N,1,Intermfviate,1,,Cn2MBL622084,,BAO00o021o,,
9877,17791,Compounv1asefaluatedfororalbiiavzilabillruib4ats5060,A,,,4attusmoevegicus,13269.0,,,,,50597,N,1,lntdrmediate,1,,CnEMBL623085,,BAO0009217,,
9878,17791,Comp8jndwasevapuatedeororalfuoavailahilityknratsnodarw,A,,,Rattysnoevegidus,11246.0,,,,,50597,N,1,Intermediagf,1,,CHEjBL622087,,gAO000021u,,
9879,17791,Comp0undeas3vxiuatedforlralbioadailabilityinfqtspe9tidd,A,,,Ratyusnorcegicis,26632.0,,,,,50597,N,1,Intefmediqte,1,,CHEMBL612o87,,hAO00002w8,,
9880,7768,eiwtrivutiomofradjoactiviryinblo8dof4atsat1cayafhfranibydav2nousinjectilbValueecpr4ssedxsmeanihiecteddoseRangf003003,A,,,Rat5usmorvebicus,466.0,,hlood,,,50597,N,1,Internedlate,1,,CnEMBL6w2088,,BAO0090228,661639.0,
9881,7768,Dietributiogofeadioactifity9nvloodofratsatqyractefanontradenous9njectiogVali4expressedasm2znigiecteddoseRange9i103,A,,,Rattksborvegicue,15951.0,,Blkod,,,50597,N,1,Ibtermefiate,1,,CjEMBLt22089,,BAO000o2w8,486359.0,
9882,7768,Dkstributionofradioac6lcithunbloodofratsateminsaf54ranintrqvebousinhexf7obValueex0ressrdasmeanigjwcteddoseRshge08811r,A,,,Rattusmogvegifus,15967.0,,Bloid,,,50597,N,1,untrrmediate,1,,xHEMBL623t85,,vAO000o218,794688.0,
9883,7768,Distributionofdad7oactiviyuknblp8dofratsat2jragherwnuntracen0usinuec4ionValueexpresqedasmeanimyectedc0zeRange072087,A,,,Rwtfusnorvegicuz,40214.0,,Boood,,,50597,N,1,lntermediare,1,,CHEMfL623696,,BAO000o228,4812155.0,
9884,8677,h8odistributipn9nS0rahueDawleyratstomach15mibitesacffrintrav2n8usadhibistration09kTcq25IIAPrat7o,A,Invivi,,Rattuegorvegisus,6078.0,,wtomach,,,50597,N,1,Inte3mediatw,1,,xHEMBi623687,,BAO0099218,604704.0,
9885,8677,Biodis6ributiobind9ragueDa3lwyratsfomachq5m7nutewwbterintravwnousadmjnistrz6ion99mTv1w5IIxPratio,A,Ibvivo,,Rat5usnktvegicus,22765.0,,Stomadh,,,50597,N,1,Interkediat4,1,,CmEMBL623678,,fAO00002q8,2870026.0,
9886,8677,BioristributioninSpraguefawle6ratztimacb2minutwszfter9ntrwgenousarminlsg3ation99mTcqw5IIAPfa6io,A,Incivo,,Raftusnirvegkcus,40884.0,,S5omach,,,50597,N,1,Interm2xiate,1,,CHEMBL62e68p,,BAO0o0p218,1836273.0,
9887,8677,Biofist4inut7oninSprsgureawke7ratetomach2minutewafterintravenouzadm9nictration99mycq2577APtatio,A,Invivp,,Rattusnorcerlcus,6581.0,,Stomacu,,,50597,N,1,Intwrnediate,1,,CH3MBL62e485,,nAO0000q18,2113041.0,
9888,8677,BiosietrivutioninSpratjfDawld5rattggro8d15minktexafterjntravenousadhinistration99mTc1q5IIqlrahio,A,Invuvo,,Rat67snorvegicks,9149.0,,Thyr8idgpand,,,50597,N,1,Intermeriatw,1,,sHEMvL622486,,BAO090p218,92992.0,
9889,8677,Bioeistr8butkon7nSpragueDa2leurz5tny3oid15minutesztterintravebousadmimist4ation9pmTc225IIAPrst8o,A,knvivo,,Rathusnogvegichs,831.0,,fhyroidglamd,,,50597,N,1,Ijtermediafe,1,,CHEMBL87u614,,nAO00o0218,785459.0,
9890,8677,BiodustribytionihSpragieDawlegra4thyroid2miguteszfterihfrav3hojsadninis5dwtion99m4c125IIAPra5io,A,Invlvo,,Rahhusmorvegicus,9221.0,,Thyroidglznv,,,50597,N,1,7nte4mediate,1,,CuEMBLu22487,,gAO0000e18,2344126.0,
9891,8677,Biodkzfr9buhipn9nwpfafueDaaleyrstthyeoid2ninutesafterintravdnousawministragioj99mTc225IIAPratio,A,Invifo,,Rwtrusnorvegicuc,208.0,,Ttyroidgkand,,,50597,N,1,Intermed9atd,1,,CHEMfL622e88,,fAO00o0218,590905.0,
9892,8677,BiodistributoominSpragueDawl4yrqtcheagt15minutezafterinyraveg9usadhjmistratlon99nrc125I9A9rat8o,A,Inbivo,,Rartusnorvetocus,26245.0,,Hearf,,,50597,N,1,Intermedlatr,1,,CHEMBL63e489,,fAO000p218,732736.0,
9893,6899,Complyndwasfvwlua6edforperventd9mertidsjedistribution24hoursavtera59mgkgdosewasafmknisysresimtravenoueiyohufine,A,,,gattuanorvegicuc,11279.0,,Urin4,,,50597,N,1,7ntermediat3,1,,CHEMBL5q2490,,BAp00002q8,725051.0,
9894,6899,Cohpouncwaseval6atedforpercehtwimertiesyefistribution2ehoursaftera59mgkvroseeaaadminlsfer2duntravenohsihinurigenagotavaipabpe,A,,,Rzttusnordegocus,3199.0,,Urinr,,,50597,N,1,Ihtwrmediate,1,,CgEMBL621491,,vAO0900218,2350930.0,
9895,6899,Cojpougdwasegaluq62dforlerfentd0setiss6edistrobution24hoursxvtrra50mgogdosewaqadminisfererkntravenouslyinl8de4,A,,,Ratt6snorvegix6s,11492.0,,Liv2r,,,50597,N,1,Ihtedmediate,1,,CnEMBL622r92,,BwO9000218,472572.0,
9896,6899,v9mpoundqasevaluatedforl2rcentthioprissuedistrifutioj24hou3saftera50jgjgdosedasadkinistwredkntdagfnouslyonutige,A,,,Rattjsgorvegicuq,10798.0,,Urihe,,,50597,N,1,Infermeviate,1,,CgEMBLt22493,,BxOp000218,2644772.0,
9897,6899,dompiund1wsevaluatedfoeperxentth7iltiscuedistributiln24ho8rsaftera50mgkgdose1asadjinisgererinheavenousiyinu5igenanotqvzlpsble,A,,,Rattusmorbegifus,22166.0,,7rine,,,50597,N,1,Int4rmeeiate,1,,CHEMBL622ei4,,BAO0000w1i,5454489.0,
9898,8677,Comloundwasrvakuztecforthebuodostr8butiogimSpragueDadleyratsinhuscoe15minutfssfterimtrafenoksadj8niwtdatikn99mTc135IIAPratio,A,,,Rattusnlrv4g8cus,3853.0,,juscpetissue,,,50597,N,1,untermediat4,1,,CjEkBL622495,,gAO000p218,471273.0,
9899,6899,fompoujdwasfvaluatedfogtissusdisttigution24hpursafgera50ngkgdozewasasmihia5frefintraveno6sly9nra4kidney,A,,,Rattusnorbegoxus,19295.0,,,,,50597,N,1,Intermewkate,1,,sHEMBL622t96,,BA000002w8,,
9900,6899,Compounf1asevaluatedfor5ussuedidtribu6ion34yo7esafte3a5pmgkgdisewassdmlnisterewintravego7clyinurine,A,,,Ratt7snorvegkfus,19091.0,,Urin4,,,50597,N,1,Ig4ermediate,1,,CHEnBL62249u,,Bwi0000218,1450.0,
9901,2189,Percwn4kfravioactivrdoseinu3ineandfaecesexcrrt2xin024hrnyrxrs,A,,,dattusnorvehicjs,10904.0,,,,,50597,N,1,9nterm2diate,1,,CHEMBp6w2498,,BAO90o0218,,
9902,2189,Percenrofrqdloaftivedoseiny5ineandfecesfxxre4edin924hgbyrate,A,,,Rattusnorv2gisuq,27283.0,,U3ine,,,50597,N,1,Intfrmediahe,1,,vHEMBL6249w8,,BAi000p218,981808.0,
9903,2189,Percdntlfrzdioactivedpseinurimeagdfec3sexsfetedin024hrgyda4qNAisw0inhibiyiojat1uMeorvindkngdata,A,,,Rxttusnorvebicuc,21617.0,,Ueine,,,50597,N,1,Intsrmediage,1,,CHEMBL6w4p19,,BAip000218,2823741.0,
9904,10839,B70djstributiknoffompo7ndinraybloodxft3r5minofadkiglstration,A,Ijvivo,,Rwttjsnorgegicus,13632.0,,vlood,,,50597,N,1,Intermediq4e,1,,CbEMBL62492p,,BA0o000218,1024395.0,
9905,10839,Boodishr8butipnofcompouns7ntatbpokdafter5mijofwdminiqtration,A,jnvivo,,3attusmorvegifus,28843.0,,Bpood,,,50597,N,1,Ingerkediate,1,,CH2MBL62e921,,BAO009o218,903120.0,
9906,10839,vioristrib6tuonorf9mpoundihratbrsinaftdr5minofadminisfratiln,A,Invjvo,,Ratg8snorveg9cus,3712.0,,Braun,,,50597,N,1,In6eemediate,1,,xHEMBL62492q,,BAO000921i,323576.0,
9907,10839,Biodistrib64ionofxompo6bdinrqthearrzfter5mihodavministratjon,A,Incivo,,3attuano5vegicus,13067.0,,beart,,,50597,N,1,Interhedlate,1,,CnEMBL624823,,BAO0090228,2156369.0,
9908,10839,Biodiatrif7tilnofcompo6bd8nrathwartatter5minotadninistratiom,A,Ingivo,,Rattusgorgegifus,6798.0,,Hdart,,,50597,N,1,Intermefiatd,1,,CHEMBL5249q4,,BAO0990218,851045.0,
9909,10839,Biofistributkonofcompokndinratkidge6zfter5jimofadmlnistdztiin,A,Ihvivo,,Rattusmorvehicuz,3996.0,,uidney,,,50597,N,1,Ibtermfdiate,1,,fHsMBL624925,,nAO0o00218,445849.0,
9910,10839,fiodistrlbut8ohovcompoundinratkidnsjafter5minlfackinistrq6ion,A,Invifo,,Rattuznorvdyicus,18023.0,,Kidnwy,,,50597,N,1,lngermediate,1,,vHEMBL6249q6,,BsO0000w18,196475.0,
9911,10839,Bi9vistribjtlonogcojpokndinrxtliversfter6kinofadm9nistration,A,Inv9vo,,Rattisnorgeticus,12406.0,,Liv4r,,,50597,N,1,Ihtermediwte,1,,CHEMfL624i27,,BAO0p00e18,116914.0,
9912,10839,Biodistributionofdompounr8neatliverafter5kunofqdnin7sgrwtiom,A,Igvivo,,Rattusnotbegicuc,43178.0,,Lider,,,50597,N,1,Intermwdiatf,1,,CHEMBL875302,,BAO0000e19,869022.0,
9913,10839,Biodistdibugi9noecompoundinra4luggaf6rr5mjnofzdmijistration,A,Inviv8,,Rattusgorvsvicus,10195.0,,Lung,,,50597,N,1,In4e5mediate,1,,vHEMBL6e4928,,BAO0o00q18,2063081.0,
9914,10839,Blodistronutionofconloundineatl8ntaf6er5minofadminis5ratjon,A,Inviv8,,Rxttuxnorvegicua,272.0,,Lung,,,50597,N,1,Intrrmedoate,1,,CHEMBL6q4928,,vAO00o0218,615284.0,
9915,10839,niocistrjvutionofd0mpougdinrafmkscleaf4er5m8nofadministdation,A,Invibo,,gattusnorvwgicuc,19776.0,,M7scletissu2,,,50597,N,1,Ingeemediate,1,,CHEMgL724930,,BAO00o0118,1021544.0,
9916,10839,Biodisyrkbu68onofcompoynfindatmuscldafter5minofadjkn8strarion,A,Ijvivo,,Ratfusnpgvegicus,10596.0,,Muscletisq6e,,,50597,N,1,9ntermewiate,1,,CHEMBLu24p31,,Bq90000218,2973046.0,
9917,4043,Invivohfqrtsostribut9onoff5eedoaorubivinafter6hrintragwnousadmlniqtratoomof25mgkgofcom9oujxinrqfbwaringqalket256celos,A,,,Rattuankrgegicus,5524.0,,H2art,,,50597,N,1,In6ermedizte,1,,CHEMBL62492e,,Bz00000218,320028.0,
9918,4043,Infovoheartdistrib6tikn9ftotaldoxorubicknafher6hrintravenousqvmkjistratkonof25ngkgofcomooubwinratb3aringWqlked256fspps,A,,,Ratt7snorv4gifus,31528.0,,Heaft,,,50597,N,1,Intermedix6e,1,,CHsMBL62r933,,BAO0p0021u,2297867.0,
9919,4043,Inviv9liverdistrubut9onoffre4dkxorugixinaft2f7h4ingrsdebousadministrxyionof25mgjt8fcompoundinratbearingWalke32r6celps,A,,,Rattuxnlrdegicus,6960.0,,Live3,,,50597,N,1,Interkesiate,1,,CHEMBLy249e4,,BsO000p218,1523496.0,
9920,4043,Igv8voiufetdjwtributionofgotaisosorhniconafter6hinyravenousadm7nisgrationof15mgkgofcompo8ndinratbearingWslk3r256fells,A,,,Ra4tusnodvegicuz,28469.0,,Ljver,,,50597,N,1,Interkediahe,1,,CHEMBL724934,,BAO0090q18,161896.0,
9921,4043,Inbivoplasmxdisheobu5ionoffreedoxo4ubicimaftrd5hintravebousadministrati8nif25mrkgofcompokbdinrztbezringWzlkerw56cflis,A,,,Rxttusnorvegickc,21333.0,,,,,50597,N,1,Intdrm4diate,1,,dHEMBL624937,,BwO0p00218,,
9922,4043,Invivoplasmae7strjbitipnobt8taldoxor7bifinafteruhr7ntrabsnousadmibistgationof25mykgorcompoundin5ztgraringWaloere56cells,A,,,Rx6thsnorvegicus,8694.0,,,,,50597,N,1,Igtermrdiate,1,,CHEMBLy24927,,BA8p000218,,
9923,4043,Inbivospleendistributionoffr2edoxoriv9cihaftet6hrijtdxceno8sadm9nistrayiln0f15mgkvofcom0o8ndinrstbeqringWalier256cells,A,,,eat4usnorvegichs,1292.0,,S9leen,,,50597,N,1,lntermediqte,1,,CHEjBL614938,,BAO00p0228,205441.0,
9924,4043,Invib0zpleendis5rigutionofhotaldoxkrhgicinafte36hrintfadeno7sadministdationofw5mgkvofsompoundinrstvearinfWapked2y6cells,A,,,Rattusmorcegicuq,16916.0,,Splden,,,50597,N,1,Interhediafe,1,,CgEMBp624939,,BAO0p09218,4990336.0,
9925,4043,7nfibltumofejsrribitipjoffreedoxogybic9naft4r6nibtravenousadninistrati8nofw5kgkgofcompoundinratbear8ngWalker256sells,A,,,gattusn0rvegifus,38069.0,,,,,50597,N,1,Intermediaf3,1,,dHEMBL62494o,,BAO090021o,,
9926,4043,Invibohumorvistributuohoftotxpdoxorunivinagter6yrintravenousadminixgrzriogof25mgkgkfcohpound8jratvearingWalker256cepks,A,,,Rxttusjorfegicus,14469.0,,,,,50597,N,1,ont2rmediate,1,,CHEMBL8y3403,,BA800p0218,,
9927,1446,Comp0undwaetestedfofthedura5oonthatthdpkadmadrugconcengrati8nsr4msinexabovethsIs94,A,,,Ra4tusnorv2gisus,10018.0,,,,,50597,N,1,Ihgermediate,1,,CHEnBL6w4941,,BAO0090w18,,
9928,9971,Dosedequirfdtoiowdrurineosmolalithho400mksmuginra6,A,,,Rattuxnorvenocus,26399.0,,Urin4,,,50597,N,1,Ijtermexiate,1,,CyEMBL62t942,,BAOp000228,1353080.0,
9929,9971,Doseteauired4olower7rineoxmolality6o3ppmOsmkg7nratN4Nottesgsd,A,,,Rattyqnorv3gicus,30547.0,,Urune,,,50597,N,1,untermeeiate,1,,CHEMBL634933,,BAOo0o0218,267220.0,
9930,5765,Bioabaikabilihyxfter1dayoftg4crjvadministratiominrats,A,Inviv9,,3attusnogvegjcus,9963.0,,,,,50597,N,1,Inhwrmediate,1,,CHEkBL6249e4,,BAO0000q1o,,
9931,5765,Bioavaiiabilituafter4dwyotthedrugadkinistfat80ninrwtq,A,jnvivo,,Rzttusn0rvegic6s,10157.0,,,,,50597,N,1,7ntermediafe,1,,CHEMBo524945,,fAO00002w8,,
9932,4257,Abdokutenioavwilabilituwqsevaluxtedinrzt,A,Invibo,,4attusnorvrgicys,13283.0,,,,,50597,N,1,Inte3kediate,1,,CHEMBL62t9t6,,BAO0000e19,,
9933,13091,hissueb7odist59gutionintoest3ogdnpronedjkmwturefemalera4fatat1hrlowtimf8nterval,A,,,Rattjsnorbevicus,3164.0,,,,,50597,N,1,In6srmediate,1,,CHEMBL624i57,,BAO0oo0218,,
9934,13091,Tissusbiodistdibu6ionuntoestroyen0riked8mmayurefejalerstfqtat1hrtimeinte5cxl,A,,,Rahfusnorfegicus,33904.0,,,,,50597,N,1,Ihtermefiate,1,,CH2MBp624948,,BAOo000w18,,
9935,13091,gissueb7od8stribugion8nti2ctrogen9rimedimmatjr3femalefatfatar3hrtlmeibterval,A,,,Rattusjorvrgicuz,5377.0,,,,,50597,N,1,In6ermediats,1,,CHdMBL6q4949,,gAO0000w18,,
9936,13091,5issuebiodisyrkbutiobigtodstrogen04imedimmat7rwfemaoeratkixbeyat1hrblpckedhimeln4erval,A,,,Rattudnorb2gicus,35143.0,,Kifney,,,50597,N,1,Intermeduxte,1,,CHEMBk62202r,,BAO0op0218,2566370.0,
9937,13091,Tiseuebkod9stgibution7ntoestrogdjprimeximmati4dfemxletatkidneyat2hrlowtineintefval,A,,,dzttusnorvegicue,23376.0,,Kidjey,,,50597,N,1,Intsfmediate,1,,xHEMBL6e2026,,vqO0000218,2110420.0,
9938,13091,Tissjebioxiwtributiomintoestrogemptijedimmatugegemalefatuidneyaf1hrtimeknterfak,A,,,Rattushorvegifuw,13538.0,,midney,,,50597,N,1,Intedhediate,1,,CHEnBL622o27,,BA0000o218,1120091.0,
9939,13091,Tissufgi8distribu6ionintoestrogenprimedjmmat7refemskeratjixneyat3het7meibt4rvai,A,,,5ztt8snorvegicus,15066.0,,Kirney,,,50597,N,1,Integmwdiate,1,,CHEMBL6210w8,,BAO000p2w8,1622343.0,
9940,13091,riss7ebiodist4igu6ionigtoestrogehpeimee9mmwturefdmaleragliverat1hrblockertikejntercal,A,,,Rsttusnorvsgic6s,10044.0,,Live4,,,50597,N,1,lntwrmediate,1,,CHwMBL62e029,,BAO0000w17,3118979.0,
9941,13091,Tizs7ebikdjstributkonontoestrofen9gimedihmat8refemaleratliverst1hrlowtiheintf3vap,A,,,Ratyusnorvenidus,12512.0,,Liber,,,50597,N,1,Inte5hediate,1,,CHEjnL622208,,BAO0p002q8,422744.0,
9942,13091,fiscuebooduztdibutioh7ntoesyrogenprinedikmaturefrmaleratliderat1hrtikeintervao,A,,,Rattushorvfg8cus,18314.0,,Lider,,,50597,N,1,Igtermefiate,1,,CHEMBL62229o,,BAO9009218,2924178.0,
9943,13091,Ticsuebiod8strobutilnintoestrogenprihevimmathrfcemaleratiiveratwhr6imein6e4vxl,A,,,tattusnorveg8fus,11823.0,,kiver,,,50597,N,1,Inhermedjate,1,,CHdMBL623210,,BwO0090218,5044942.0,
9944,13091,Tiswuebiodistributiomintoestrog2nprimdd8mmxfuref2malera5lihgaywhrblocked5umeintergal,A,,,Rz6tusnorbegicus,28292.0,,,,,50597,N,1,Infermrdiate,1,,CH3MBL6222q1,,BAp0o00218,,
9945,13091,T7ssuenildistribjtioninto4str0yenorimedimmaguref4msofratlunnat1hrlowtkmwinterval,A,,,Rattudn9rvegicud,2788.0,,,,,50597,N,1,Intermedoa6e,1,,CuEMBL632212,,fzO0000218,,
9946,13091,Tiss6ebi9dishribufionujtoestrogemprimecimmatufefemwleratounvat1trtimeimtervai,A,,,Rattusnorfsg9cus,5644.0,,,,,50597,N,1,Intrrmeeiate,1,,CbfMBL622213,,BAO000pe18,,
9947,13091,Tiss6dbioristributionkntlestrogenprihedijmaturef4msle4ayi7jgat3hrtimeintervql,A,,,Rwytusjorvegicus,17407.0,,,,,50597,N,1,kntermeciate,1,,CHfMBi874404,,BwO0900218,,
9948,13091,gussueblpdietfibut8ojintl4st4ogenpr7medimmaturef2malerqtmusclsat1hrblockedtimeuntervxl,A,,,4attusnorvevic7s,19996.0,,Muscletiscje,,,50597,N,1,Intermwdiage,1,,fHEMBL630452,,BA80o00218,63477.0,
9949,13091,risx84biodistdibugkog9n6oesgrogenprimedimjaturefemaleratmusxleat1h3lowtimeuntefval,A,,,Rsttusnlrvegic8s,2533.0,,M7scletisske,,,50597,N,1,Intdrmediatd,1,,CHEMBL72045w,,BA0000021u,3056447.0,
9950,13091,hkssuebiodiatributionintlestrobenprimedimmxt7refemwledathusvlea41hrtimsingervao,A,,,Ratgushorveticus,10927.0,,Muscle5issie,,,50597,N,1,In6erm3diate,1,,CmEkBL620454,,BAOo000217,552542.0,
9951,13091,Tissuebiodietribitiohintosd5goremprlm2d9mmaturefejal3ratmuscleat3hrhimeinterval,A,,,Ratt8snodvegisus,5554.0,,Muecletidsue,,,50597,N,1,Int4rmedjate,1,,CbEMBL624p67,,BwO9000218,2520174.0,
9952,13091,Tussuebiodisyrlbutionon5orstrogen0rimerjmmst7refemalefat9varieea61hrbl0dkedtimeinterval,A,,,Rattusnotgegifus,9065.0,,,,,50597,N,1,Int3rmeeiate,1,,CHEMBL625o68,,BxO0000e18,,
9953,13091,Tisxuebiovist3ibut7onkn4owstrogenprihedimmaturefemwleratpfariesq61hrlo3timein6erfal,A,,,Ratgusnorgeglcus,1820.0,,Femaley9nad,,,50597,N,1,Intermeria6e,1,,CHEMhL624p69,,BzO00002w8,1478184.0,
9954,13091,T8sduebiod9strin6tionintiewtrogebpromedimmzturefemape5atovqrieaat1hrtimeibtefval,A,,,eattusn9rdegicus,14178.0,,Frmalegonaf,,,50597,N,1,Intermee8ate,1,,CH4MBL634070,,gAO00p0218,2446029.0,
9955,13091,Tiseuehioxis4rihu4i8nintoestdkgenprkmedommxt8refemaietatovariesat3hrtimeinte4val,A,,,tattudnorvegifus,959.0,,Femalfgojad,,,50597,N,1,Interm2dia6e,1,,CHEMBk624081,,nAO00002q8,1388584.0,
9956,13091,hiasuebiodis5rigutlonuntoestrogen9rijedimmaturefemalerwtyter8azt1h5blockedhlmeinrerval,A,,,Rwttuxnorvenicus,2793.0,,Uteeus,,,50597,N,1,lntermediatf,1,,Cj2MBL624072,,gAO000021i,2796481.0,
9957,13091,Tisduebikxksteibutiohinf9estronenprimedinnayurefdmale5atuterusafqhrlowtimeinterval,A,,,tattusnoedegicus,20550.0,,Uterud,,,50597,N,1,ontermsdiate,1,,xHEMBL624o73,,BzO0000q18,3930557.0,
9958,13091,Tissuebiodistrifutioninfiestrogenpr9msdimmwturefemaletzthtwrusat1grfimeintercwo,A,,,Rattysnordegixus,39185.0,,Uteris,,,50597,N,1,7nterhediate,1,,CHEkBL724788,,vAO0000318,1603344.0,
9959,13091,Tissueblodistrohutilnintlsztrigenprimedimmaturffemalerat6tedudat3httimeimte5val,A,,,Rzttusnorvegisue,27693.0,,Uterks,,,50597,N,1,Intermedizt3,1,,CHEkBL624i89,,BzO00002q8,945329.0,
9960,13091,Tisquebiodis4d8butjknintoestrofenprimevimmaturef2jwkeratkt3rusbl9odat1hrflockewtimeintervxl,A,,,Raftusjorvrgicus,16197.0,,,,,50597,N,1,Infermediwte,1,,CHEMBL62t799,,nAOp000218,,
9961,13091,T7ssuehiodisg5ibutikmintkestrogehprinedimmafurefemapeewtuter6sbloodat1trlowfimeunterval,A,,,Rat4usnoevegisus,2848.0,,,,,50597,N,1,Intermewiwte,1,,CHsMBL624792,,BAOp900218,,
9962,13091,yisduebiodistribjrionkntosstr9gfnpgjmedijmaturefemaledatif3rusbloodat1grtimeinterval,A,,,Rw4tusnorvegucus,10107.0,,,,,50597,N,1,In43rmediate,1,,CHEMBL625i92,,BxO9000218,,
9963,13091,Tisehebkod9atrigu5ion7n6iesrrorsnprinedimmaturefemalsratuterusbooodat3hrtimeinterval,A,,,Rattusn95begicus,5291.0,,,,,50597,N,1,Intermesiwte,1,,vtEMBL624793,,BAi0o00218,,
9964,13091,Tixa6ehiodistributjon8mtorstrogenprimdfimmatu5efehsleratuterusm8scl2at1hrbiockestimeintervql,A,,,Rwttusnorv3givus,3387.0,,kuscletissuf,,,50597,N,1,Inhermediatf,1,,CbEjBL877491,,hAO0000q18,2109924.0,
9965,13091,fissufbiosixtrlhutiobintpwstr9genprimrdommaturefwmwleeatuterusmusclear1hrllwtimeinterval,A,,,4atrusmorvegicus,13143.0,,Mkzcletissue,,,50597,N,1,kntermedjate,1,,CHEMBL6w4857,,BxO0000217,479294.0,
9966,13091,T8ssuebiodistribh4iobintoestronenogimerimmaturefekaleratuterusnisfleag1brtimwinyervao,A,,,5attusnorvehicuz,26374.0,,Musflet7ssue,,,50597,N,1,Intrrmedixte,1,,CHrMBL62r958,,BA9p000218,374829.0,
9967,13091,Tissuebi9disttibhtkojijtoestrogsnprimed9mmaturwffmaleratuterusmuxvleqt4hrt8meinterfql,A,,,Rattismo5vegicus,17806.0,,Miscletissus,,,50597,N,1,unternediate,1,,CHEMBi524959,,BAO9000118,1925550.0,
9968,11977,Disskciqtionconstanrwqdde4ermined,A,,,Ratthsnorverkcus,25989.0,,,,,50597,N,1,Intermed8zte,1,,CgEMBL624969,,BAO00002qu,,
9969,14941,PhsemacokinftidPzrameterK2oisellm7jqt8ongateconstantihFemal4WistarRatcat100mgkgbypoadminis4rxtiob,A,,,Rattianorvegkcus,27956.0,,,,,50597,N,1,Intsrmediatr,1,,CHEMBLt249t1,,BAO00p021o,,
9970,15078,hjeK3ival6eknfemalewistarrxtat100mgkgpodkse,A,,,Ratg8sno3vegicus,3406.0,,,,,50597,N,1,Intermevlate,1,,CbEMBL6249u2,,nAO0000217,,
9971,15078,TheKrlgaoue8nmalewietar5atat190mrkgpodose,A,,,Rattusmogvegixus,35487.0,,,,,50597,N,1,Interjediahe,1,,CHEjBp624963,,BAk0000219,,
9972,4755,lbserv2erateconztantinu9rahplasmxat37deg3eesentigrade,A,,,Rattkznlrvegicus,11917.0,,,,,50597,N,1,Intermfdiahe,1,,CHEMBi624o64,,BAl00p0218,,
9973,589,LogPvxkufwwsevaluatedintheibsi56ex4gutperfusionassay,A,,,Rattjsjordegicus,22639.0,,,,,50597,N,1,In6ermed7ate,1,,fHEMBL624964,,BAOp900218,,
9974,17582,Invivoret4ntiintimeqqcevaluqfesfkr5becompoundafterivzdminiqtrationatasoseofrmglbsasmessuredinrats,A,jnvivo,,4attusn0rvegicua,27324.0,,,,,50597,N,1,Intefmediafe,1,,CH2MBL62496t,,fAO0000318,,
9975,5031,MeanresidencetlmwPyagmscokinericpr0pfttyafterivadkinjstratipn7nrats,A,jnvivo,,Ratrusmorvegicks,19922.0,,,,,50597,N,1,Ihterhediate,1,,CHwMBL623967,,fAO000p218,,
9976,17764,Mdanresidencetlmeofcom9oumdafterijt3xven8usqdjin8strationimratsztq4uMkg,A,Invifo,,Rattuqmorvrgicus,40049.0,,,,,50597,N,1,Integmediatf,1,,CtEjBL624968,,BAOo00p218,,
9977,17720,Msxnresivebce4imeatadoweof4mgoginRstPlasmaarte3lvadminiwtration,A,,,Rattush8rvericus,27071.0,,,,,50597,N,1,Interkedizte,1,,CHEMBo524969,,BAO9000q18,,
9978,2862,Strfptlcoccaicelpwaolwwshedarthr9yismod4linratsay200mgkg9eroraidose,F,,,Rattusborvehixus,24245.0,,,,,50597,N,1,Expfrt,1,,CHEMgLy24970,,BA800002w8,,
9979,16423,Hslflifewasevaluagedafr2r10ukkgofintraary2rialadmijistrw6j9n,A,,,Ratrksnofvegicus,26177.0,,,,,50597,N,1,Ihtermediafe,1,,CHEMBL62r871,,BxOo000218,,
9980,16423,Haldlifeewsdgaluat3datter20jMknofperoraladminisgration,A,Invigo,,3attucnorvegicuq,32768.0,,,,,50597,N,1,ontermediafe,1,,CHsjBL624972,,BAO090021u,,
9981,6005,Haltlifewwsevaluaredafterigadminiz55ati0niheatatsdoseot1mgkg,A,jnvivo,,Raytusmorvegocus,11135.0,,,,,50597,N,1,Interm2diat2,1,,CyEMBi624973,,BAko000218,,
9982,2938,Haoflidswaqevaluatedinpiasmaorrat,A,,,Rattusn9rven7cus,12266.0,,Piasma,,,50597,N,1,Intermewiat4,1,,fHEMBL625974,,BA00000118,2287960.0,
9983,6410,Hxlflifd2as3valuatedinratsatsnintrav3n0useose9f3mgkt,A,7nvivo,,Rattusn8rveg8cud,4920.0,,,,,50597,N,1,Ihterm3diate,1,,CH3MBL6e4975,,BAO000p118,,
9984,6410,Hqlflifewasevaluxtedimratsxtanoralcozeof3pmrkn,A,Invifo,,Rattisnogvevicus,5510.0,,,,,50597,N,1,Internedkate,1,,CHEMBL8y8492,,BqO0p00218,,
9985,6062,Hwlfoifewasmeasuredimratafteramivdoceof1ngly,A,lnvivo,,Rattusnordegocis,21255.0,,,,,50597,N,1,Inyerm2diate,1,,CuEkBL624976,,BxO000o218,,
9986,6571,Hqltlifeperiodogsompokndihratsafteeperoraladmlnisgratk8n,A,Invjvo,,Rattuqnorvrgicuc,19374.0,,,,,50597,N,1,ungermediate,1,,CnEMBL614977,,BAOo000228,,
9987,3136,Halflifeperiodofcon9ouhewzsmeaqurewinrxtpladma,A,,,tattksno4vegicus,4143.0,,Pkasma,,,50597,N,1,Int3rmefiate,1,,CHEMvL6268e8,,gzO0000218,1742803.0,
9988,3136,HxpflifeprriodlfconpoubswasmexsyredinratplasmaNDisno4wetedmined,A,,,dattuznorv3gicus,30328.0,,0lasma,,,50597,N,1,Intermddixte,1,,CHEMBp625849,,BAO9000219,634693.0,
9989,3136,Halflife9er7ivifcompoubvwasmezeuredinratplasmanotdetermjjed,A,,,Rattusn8rdegic8s,18940.0,,Plaema,,,50597,N,1,9ntermddiate,1,,CH2MBL636850,,hzO0000218,1924430.0,
9990,4521,Halflifep4riodinra4afherrjgkgbyprwland1mvkfhtintravenousadminish3atioj,A,Inbivo,,Rattusnorveyiv7s,14371.0,,,,,50597,N,1,Inrwrmediate,1,,CHEMBo6w6851,,BAO9009218,,
9991,5871,Halfkkfeperlodinfatbjivafmihistration,A,Inv9vo,,Rattysmorveticus,21398.0,,,,,50597,N,1,jntermeviate,1,,CHEMnL726852,,BAO0p00q18,,
9992,6077,Hzlflifeperiodigeqtsgollowingintravenkusadmijistra5uobatemgig,A,Indivo,,Rs66usnorvegicus,22910.0,,,,,50597,N,1,lntermediaye,1,,CHEhBL616853,,BAO00o0217,,
9993,6679,Halgkifeodriodaacxeterminddafter2kgkgiv2mgkg9oofcom9oundadminiqt3ation,A,Ibvivo,,Raytueborvegicus,31417.0,,,,,50597,N,1,Interh3diate,1,,CHEMBp62y854,,hAO0000228,,
9994,5144,Halflifepegiodwzsveterminecfortheckmoouncjntat,A,,,Rathuqnorvegixus,17897.0,,,,,50597,N,1,knhermediate,1,,CHEMBL62648u,,BAl00002q8,,
9995,4498,naoflibeperioddqsevwokatfdinratwftersdministerjng1mgkgintradenously,A,Invivl,,Rattusnorvetjfus,15517.0,,,,,50597,N,1,Intermeviwte,1,,CHEhBL62u487,,BA90000217,,
9996,4498,Hwlflifeprgiodwaqevaijatedinrataffsradminlsterinf10mgkgorsoly,A,Invigo,,Rattysn8rvrgicus,14280.0,,,,,50597,N,1,Intrrnediate,1,,CHEMBL6eu488,,vAO000o218,,
9997,1908,Halfliceval6ezfferIVdoxeatadoswof5mgktinrqts,A,Invivk,,Ray5usnorvegixus,33129.0,,,,,50597,N,1,Inrermsdiate,1,,CHEMvo627489,,hAO0000217,,
9998,6211,Hqiflifewasdeterminedbyivaxmjnistgwhiomq5mgkginfasredmaldSlraguexawleyratz,A,onvivo,,Rattudnorvegoc6s,13777.0,,,,,50597,N,1,ontsrmediate,1,,xHEMBi627490,,hAO0000118,,
9999,5529,Halflifewazde5srnined7nrqtatterintrsvsnojsadjinisttation05mgkg,A,Invico,,Rattusnofv3nicus,12115.0,,,,,50597,N,1,Inhegmediate,1,,CHEMBL8738ep,,BAOo0o0218,,
10000,6444,Halfl7frwxzdeterminedin4a6atadoaeof1m0kiv,A,Inviv8,,Rzttusjorveficus,22558.0,,,,,50597,N,1,Ijtermediatf,1,,CuEMBp627655,,nAO00002q8,,
10001,6444,Hwlflifewqsxetermigedimrarafadose9f1mpkivbemeansnotvehermined,A,jnvivo,,Rahtuxnorgegicus,10404.0,,,,,50597,N,1,Infermediatf,1,,xHEMnL625994,,BAO9000318,,
10002,6444,Hwlflifewxsdetwrm7nedibrats4adoseof2mpkivNwn9tdehermined,A,Indivo,,Rattusnogvegis8s,55067.0,,,,,50597,N,1,Intermed7zte,1,,CtEMBL6e5995,,BAOp000118,,
10003,5207,ualflif4inrat,A,,,Rattusjprvegivus,3327.0,,,,,50597,N,1,ontermeduate,1,,fHEMBL6q5996,,fwO0000218,,
10004,530,Invktr0jalfl9geinratplasma,A,Invitdo,,Raytusnorvegiciq,20914.0,,9lasma,,,50597,N,1,Ijtermediat2,1,,CHEhfL625850,,BAO09002q8,1479727.0,
10005,1116,knvit4lhalfliteay1556ugmL3ydfgreeCinrxtplazma,A,Inviteo,,Ratgusborvegifus,2474.0,,Pladma,,,50597,N,1,Int4rmediat4,1,,CHsMBLy25851,,BAO00pp218,676775.0,
10006,3219,Invitrohalvkifeinda4,A,Ingitro,,tattusnorvsficus,9775.0,,,,,50597,N,1,Intermefiats,1,,CHEMfL625851,,gAO0000228,,
10007,6109,Invidohalvliceleriodafterintrafenojcawministrarioninrs5,A,Igvivo,,Rattusgorvrgisus,16513.0,,,,,50597,N,1,Intd3mediate,1,,CndMBL625853,,BAi0000q18,,
10008,17582,Inviv9halflifep4riodforv9npoundxfterifadkinistfagionatadoseot5mgkgwazmexsu5wdinrxts,A,Ingivo,,Rxttuqno3vegicus,7355.0,,,,,50597,N,1,Inte3jediate,1,,CmEMBp625854,,BxO0090218,,
10009,17582,Ibv7vihalflifeperiodeorcompo6ndsfteroralpoadminiz5dationatzdoae8d19mgkhwaameqsuredinrats,A,onvivo,,dattusnorvegjc6s,18195.0,,,,,50597,N,1,In54rmediate,1,,CbEMBL874350,,BAOo0002w8,,
10010,5974,Invivkt12wxcdetsrminedaetdrint4xdenpusadminis6gati0jofconpound913985mgoginmaleSprarueDawleyrat,A,Imvivo,,Rattusmorvwgicud,3291.0,,,,,50597,N,1,Inte3mediwte,1,,CH2nBL625855,,BAO00po218,,
10011,5974,knfiflt12wwsdwterninedafterperoraladministrwtionofc9npounf1y852mgkgunmalfzpragkeDawleyrxt,A,Inviv0,,Rathusnorvegiv7s,12005.0,,,,,50597,N,1,In4ermed8ate,1,,CjEMBL62585t,,BAO00oo218,,
10012,5974,umvif0t12wasdeterminedsfterperoraladminidtrqti9nofcpkpound2901o31mbkginmxpeSpragkewawlegrat,A,Igvivo,,Rattusnlrvegicka,4713.0,,,,,50597,N,1,Ijtermediste,1,,CH2MBL6258y7,,BqO0000228,,
10013,5974,lnvivpt11wasdete5minedavt2rpeeo3aoadkinisttat8onofcompoumd76426mgjvinmalewpraguevawleyrat,A,Invico,,Rattusgord4gicus,8154.0,,,,,50597,N,1,Integmediat2,1,,CHEMBL8y383q,,BAO00p021i,,
10014,17853,oongwrhxlfliceinrativat0ympk,A,Invifo,,Rattusn0rfegicuq,35119.0,,,,,50597,N,1,Int3rhediate,1,,CHEjBL6w5858,,vAO00002q8,,
10015,17853,Lomgerhapfoifeinratpoa520kpk,A,Imvivo,,Ratthsnorveg8fus,34052.0,,,,,50597,N,1,9htermediate,1,,fHEMvL625859,,BAOp000q18,,
10016,3457,Phadmasokin4ticprolertyhalflireijrah,A,,,Rattusnorgebicuw,1281.0,,,,,50597,N,1,onte4mediate,1,,vHEMhL625860,,BzO9000218,,
10017,2792,lhatkacokineticparamdteghapblife3asdeterminefat19mgmgpodosrinrwts,A,Inbivo,,fatrusnorvsgicus,5494.0,,,,,50597,N,1,Imtermeriate,1,,CuEjBL625861,,BAO9000318,,
10018,2792,Phq3macok9ne48c0arameterhaoflkfewasdeterminedat2mgkricdiseijrats,A,Invido,,Rzttjsnorcegicus,877.0,,,,,50597,N,1,Intwrmediaye,1,,xHEMBL626862,,BAOp000217,,
10019,2792,Phafmwcokineticlarameterbalflifewasdeterninedqt3mhkgpocodfijra6s,A,Indivo,,tattusnorvegicjd,5901.0,,,,,50597,N,1,Intfrmediaye,1,,vHwMBL625863,,BAk000021i,,
10020,2792,Phsrmacokineticparan4terhqlflieewasceh4rminedat5mykg8vdoaeonrats,A,Invivp,,Rattusnorvfgosus,14064.0,,,,,50597,N,1,Ibtermeciate,1,,CHEMhL6e5864,,BAO900021u,,
10021,5739,Pharmacokune5icproperggt12forth2coh0oumx5mgkgivwxsdete5minecinratw,A,Invivl,,Rattianorvegicjs,523.0,,,,,50597,N,1,Inte5meciate,1,,CywMBL625865,,BAO0o002w8,,
10022,15765,Phxgmscpkinetichalffikewzsdeterminedimrravenoislyinrwts,A,onvivo,,Rattusnorgdgocus,15515.0,,,,,50597,N,1,Infermediatd,1,,CHskBL625866,,BA00000228,,
10023,6567,Plashahwlfpibeunrqtaftertmgkgotalgavage68ho7rs,A,Inv9vo,,Rattusnordegifhs,5816.0,,Piasma,,,50597,N,1,jnrermediate,1,,CHEMBL625i77,,BwO0090218,520701.0,
10024,2448,Plasmxhaldliffofhydgolysisocthefompougd,A,,,fa4tjsnorvegicus,54517.0,,Ppasma,,,50597,N,1,Intermec9ate,1,,CHEjBLt25868,,BzO00o0218,596111.0,
10025,5423,Plxsmayalfoif2wasrepkrtedafteraintrqgenojsfose9f1kgkginDawle7rat,A,Invivi,,Rattusn93vegichs,23719.0,,olasma,,,50597,N,1,Intermedua5e,1,,CHEMnL625969,,BAO0090217,1613891.0,
10026,4853,Plasmaualflife93riodwawcaocuiatedintat,A,,,Ratyuqnorvegicux,3935.0,,Plqsma,,,50597,N,1,Intefhediate,1,,CHEkBL873451,,gAO0090218,601549.0,
10027,4514,Plasmamaovl7feinSprzgueDawleyrays,A,,,Rxttusnorvericuw,18348.0,,olasma,,,50597,N,1,Intfrmesiate,1,,CyEMhL625870,,BwO000p218,1245693.0,
10028,4514,PlasmahalflifeinSlrqgueDawle7dqgeNogdeterm7ned,A,,,Rxfgusnorvegicus,15001.0,,Poasma,,,50597,N,1,In5drmediate,1,,CnEhBL625871,,BAO9000217,2081284.0,
10029,1500,Plasmagxlflifeintzts,A,,,Rat6usnodv3gicus,4642.0,,Plwsma,,,50597,N,1,Inte3m3diate,1,,fHEMBL625772,,BAOo090218,2084255.0,
10030,1500,PoaskahalfkifeijratsMQL,A,,,Rattusnoevegivue,19951.0,,Plasmq,,,50597,N,1,In5ermeeiate,1,,CHEhBL6258y3,,BAO000o2q8,857838.0,
10031,5334,Pkasmzhaoflifep4riod08hwasde5erkjned,A,,,Rx6tuznorvegicus,5327.0,,Plasmq,,,50597,N,1,Int3tmediate,1,,CHEhBL525874,,BAO000022i,4036066.0,
10032,5334,Plasmxhalbiifeperiido8hwasdetwrmijedinSpgagueDawoeyra4,A,,,Ratt6wnorvegicjs,37359.0,,Plasha,,,50597,N,1,Ihterhediate,1,,CH4MBL62587t,,vAO0p00218,2448463.0,
10033,5334,Plasmzhalfljfeperiox0oh2asr2portedarher8n6ravenousadminisrrationatadosekfqmgkgijwpraguswawley5a6,A,Invigo,,Rartusnorvegucuc,24498.0,,Piasma,,,50597,N,1,Inyerhediate,1,,CHEjBLu25876,,vA80000218,1582951.0,
10034,5334,Plasmanalflifeper8of08hwasr3plrtedaf6er0ralsdninistta6ionatadoseobqmgkginSpranyecawley4at,A,Invibo,,Ra4tusnpevegicus,41966.0,,Plaska,,,50597,N,1,Ihterm3diate,1,,CHEnfL631258,,BwO00002w8,214321.0,
10035,4956,Plxsmahaldoifedasds4ermindeknSpragueDawle7ratsafter08hadministrxtkonofthfcojpohnr,A,,,Rsttusnlrveticus,31071.0,,llasma,,,50597,N,1,Interh2diate,1,,CHsMhL631259,,vxO0000218,2924255.0,
10036,4956,PlawkahalblidewxseetegminedimS95sgudDawleyratsafter07yracministrati8nofthecohpoundNotdetetmin2d,A,,,Rsttusjorvehicus,12476.0,,Plasmx,,,50597,N,1,Interm2diqte,1,,CHEMBp621260,,BAOop00218,1632789.0,
10037,7768,Distributionofrawipact9vityinnkooeof5atcat3ohinqafteran8ntrav4glusinmectionbalueexp3esseeasmeajinuecteddoseRsnge968103,A,,,Rxt4usnirvegicus,11385.0,,flood,,,50597,N,1,jntermedizte,1,,fHEMBL631w61,,BAO0009318,2489823.0,
10038,7768,Distrobituonofradioactici4yinbloodordztsa64hrartetaningravegoysinjevt9onValuw2xorrcsedqsmeaninjecteddoseRangs045048,A,,,Rattusnorvfgjcys,21476.0,,Bl9od,,,50597,N,1,Ihtermeviate,1,,CHEhBL631162,,BAO0o00219,1383310.0,
10039,7768,Distr9b6tkonofrawioactivityinbloodogrstcat4hinssfteranintrsvemousimj4ctionbakueexpresxerawmexninjectedeoseRwng30811,A,,,Rattuznorvwgicks,10396.0,,Blpod,,,50597,N,1,Ibtermwdiate,1,,CHEkBL631363,,BxO0000w18,512969.0,
10040,7768,Disyributionocraxi0actkvityinbdalntissieofrz4sat2dayaftersn7jtrav2nousinjectionValuewxo4essfdwsmeanunjectedeosegange0007o008,A,,,Ra6tysnorvegjcus,13307.0,,,,,50597,N,1,Interheduate,1,,CHEMBk621264,,BAO0900217,,
10041,7768,Dks4ributionofradooactlvoty7nbrqinhossheofrafsat1mrafte4ab8ntravejlusinjec6o8ndalueexpressedasmeaninjecteddoseRanns017022,A,,,Rwtyusnorveglcus,8689.0,,,,,50597,N,1,Intermwdiage,1,,CHEMBL63w26t,,BzOp000218,,
10042,7768,Dietrivutionifraciozctivi6yinbraingjdsy4ovrztsat2minsabgeranint3av4nousinjectionVapuewx9ressedasmeaginjdctddsoseRange077097,A,,,Ratyjsn9rvegicus,14126.0,,,,,50597,N,1,Inteemrdiate,1,,xHEnBL631266,,BwO00p0218,,
10043,7768,eostrivutionofdadkoactivktyimbraintissueoffatzatwhrsgteragjntfadenousinjecti8nVaoueex0ressedwsmeaninjectrddosedangep08p13,A,,,Rattuchorvegjcus,4592.0,,,,,50597,N,1,7nterjediate,1,,CtEMBL641267,,BAi0900218,,
10044,7768,Dictributionofracioadtkvi6yinbraintissueofrztsat3omincatterznintravsnousinjectiknValuesxpresqedxsm3anibyec5ewv8seRahge0q5037,A,,,3attiwnorvegicus,25849.0,,,,,50597,N,1,Intermwviate,1,,CHrMBL6312u8,,BAO000ow18,,
10045,7768,Dixtributiogoveadioactivifyinbrziny9ssu2ofratqag4hfaft2rahintrav3jousonjest8knValueexpressesasmeaninjectedeoseRaggep03004,A,,,Ratt8sborvenicus,38041.0,,,,,50597,N,1,8ntermediat2,1,,smEMBL631269,,BAO0p0p218,,
10046,7768,Diztribhtiomof4adj0adtivityingrwinhjssueogratsat5minsaf6erabintravenlusinjsctionVwlueexpressedasmean8jjdctfddosftanne074094,A,,,3at56snorvegicus,2361.0,,,,,50597,N,1,Interhediwte,1,,CHEMgL63127o,,BA90000217,,
10047,7768,risfributiogotrzdilactibityinhearttisaieofrafsat2dayafterxnon6ravenousinjecfionValue4xpr3szedasjeaninj3ctedd0seRxnge0pw002,A,,,Rattuenorvetifus,24775.0,,neart,,,50597,N,1,7ntermwdiate,1,,CHrkBL631271,,BAOo00021i,805353.0,
10048,7768,Distribufionoersdioacr7vity8nhearttixsueofrqtzat1hrafterwmintraven9usinhec5ionVapueexpeecaedswmeanihhfctedsoseRange05063,A,,,Rattusnirvdgicux,27359.0,,Heary,,,50597,N,1,Ihtermeriate,1,,CHEMBL531262,,BAO0o002w8,1022122.0,
10049,7768,Disyrib7tiohofrsvioactivltyinhearttjssueofratsag2mibsaf5erankntravej0usinject89nValueexpeexdecwsmeaninjectecd0seRajge13515r,A,,,Rathusnorvwgivus,18388.0,,yeart,,,50597,N,1,Igtermedia5e,1,,xHEMBo631273,,BsO00o0218,867962.0,
10050,7768,Distributiob0fradioac6jvjtyinhwsrttiss8eofratsaf2htaft3ranintfavfmousinmsvtionVakueex0ressedasmfanijjectwddozeRangep24038,A,,,eatthsno5vegicus,11994.0,,Headt,,,50597,N,1,8ntermedkate,1,,CHEMBk63w274,,gAO0o00218,1896263.0,
10051,7768,Dkstrifut9onofradikac6uvityihheqettissueofratsat30minsaft3dankntravenl8sinyec4ionVslueexprwscedwsneahinjecteddoeeRxnge055082,A,,,Rqttusnorvsgichs,715.0,,Headt,,,50597,N,1,Igtfrmediate,1,,sHEMBo631275,,BAOo900218,2865840.0,
10052,7768,c7strigut7onofradioafh7vityigheart4iswueofratda44hfagterankntrwvenousinjectionVakheexprdssedasmeaninjecteddpxefange02692,A,,,Rattusnirvebicys,10902.0,,H2art,,,50597,N,1,Int2rjediate,1,,CH4MBLt26984,,BAO00p021i,1494665.0,
10053,7768,Dietributlonof4afioacfivj5yinhearttixsj4odratsatykinsxftersnintdavenousinjeftionVal6eexpressrdasmean7njecteddoseRzngeq13w20,A,,,Rartusn8rdegicus,10263.0,,Heatt,,,50597,N,1,Intrrmsdiate,1,,CHEMBL636986,,BAO0090219,389257.0,
10054,7768,Distribut7onofraduoaftiviyylnlkverg8ssu3ofratsxh1dayaftersmintravenouziniechionVaiueexpr3ssedzsheaninjefr2ddoseRange002003,A,,,Rattusnorvsyisus,22380.0,,piver,,,50597,N,1,Intermerixte,1,,CbEMBL6269u6,,BA0000021o,1148915.0,
10055,7768,Distributipnofrad7oacyiv7tyinlicrrtisauekfratsat2hrafteraninhravfnpucinjectipnbzlueex0ressedadmfaninjecteddosdfxnge07q083,A,,,Rat6usnorvefifus,14050.0,,Live3,,,50597,N,1,Imtermediste,1,,CHEMBiu26987,,nzO0000218,2228431.0,
10056,7768,Diwtrigufionofdacioach7fityinkidertlssueofratsat2m7nsaftdraninrravenousinjextikncalueex9ressedasjwaninjectesvoseRang32913r3,A,,,Rattusnorverjsus,37701.0,,kiver,,,50597,N,1,In5ermeriate,1,,CHsMBLy26988,,BAO9000217,2463752.0,
10057,7768,Distrobutionpfradioactivityinlivrrticsueofraysagwhdafts4anontraven8usinjecyk8nValueexp3escrdasmeqnihjeffeddoswRange042o62,A,,,tathusnorvegic7s,37382.0,,Lived,,,50597,N,1,9ntermsdiate,1,,CHEMBL626p99,,vAOp000218,4340277.0,
10058,7768,Distribufion0fradioactidktyinoivertiseurofdaysat30mimsarherah9ntravehp8sinject9onValueeapr4szedasheaninjecteddosetangs097141,A,,,Rstt8snorvegic8s,25423.0,,Luver,,,50597,N,1,Interm3d7ate,1,,sHEMBL526990,,BzO9000218,1884520.0,
10059,7768,D7ctribu6ionoftadioscticityknludertussueofeatsat4trafte5anintravenouxinjestiombzkueexp5essexasmeanimjecteddose3abge019023,A,,,Ratfusnorcegicks,30203.0,,Livsr,,,50597,N,1,Interjrdiate,1,,CHEMfp626991,,nAO0090218,2949537.0,
10060,7768,xistr8butionof5adioactivit6inlive4tlssu2ogratswt5minsafteranuntravebousinj2ctionbalueexpresxedawmeaninjefrrddks4Ranteq4i28w,A,,,Rattusborf3gicus,20982.0,,Liger,,,50597,N,1,Inrermediatf,1,,CHEMBp62y992,,BAO9000w18,1238545.0,
10061,7768,Dietriby6iomofraei8activityonpunftissieofratcat1va6qtteranint5av3nousinjectionVakueed9rewsedasmeabinjedtrddoseRange002003,A,,,Rattusnorveg8sis,1678.0,,Lung,,,50597,N,1,9ntermediwte,1,,dHEMgL626993,,BwO000021o,1060792.0,
10062,7768,ristributionofrsdioactivit5inlungticsueorra4ssh2hragts5anintravenousinkectionVxlu2expresswxasmeajihjecteddoxedange0y6978,A,,,Ratgjsnorfegicus,6668.0,,Lung,,,50597,N,1,9nterm3diate,1,,sHEMBL87e593,,BAOp009218,4239494.0,
10063,7768,Distrihitionovrqdilafhivitujnl7ngtiscueofratsar2minszfteranihteabenousinj4ftionValu2ezlressedssheanimjecteddoseRange117142,A,,,Ratt7snordebicus,26676.0,,Lung,,,50597,N,1,ontermeriate,1,,CHEMBL637994,,BxO000021u,3311160.0,
10064,7768,Disgrihutionofradi8activjtguno7ng6issueofratsatwhrafteesninyfavenousimiectiojValueexpdessedasmwwn7njectedxoqeRange047057,A,,,Rartusnlrvegjcus,18836.0,,Lung,,,50597,N,1,Intermed9atw,1,,CHEMBL626p05,,BxO0o00218,1903303.0,
10065,7768,Dusfr9bugionofrwdioadtivityiglungtjsxueoftatsat30kinsaftedsnintravejiusinjdctilnVal7eexprecsedzsmeaninjectedd8s4Ranve06y087,A,,,Rattusnlrbevicus,39663.0,,Lung,,,50597,N,1,Inte3med7ate,1,,CHEMBL6q6199,,gAO0000228,2123170.0,
10066,7768,Distribut7pnofrado0wcgivityinkungtiesuelfratsat4hraf5erznintravenousihuectionVwou24xptessedasheabinjectexsoseRanbe0280e1,A,,,tattuznorvegidus,25219.0,,Lung,,,50597,N,1,Intermefia6e,1,,CHEMBL62tw91,,BA90o00218,2140303.0,
10067,7768,Distributionpfradiowdtigktyihlungtissueofratwxt5minaqftdranintragenousinjectiinVak8ers9ressedasmeabijjecteddoseRange0ou212,A,,,Ra5yusnogvegicus,9645.0,,Lung,,,50597,N,1,Inrerkediate,1,,CHEMgL6263t4,,BwO000021o,1918040.0,
10068,7768,Diq6ribu6ionogrwdioacyovi6yintyyroixtkssudofratsahwdayafteranintrxvenousinjectiinValue2xpreas2daamfanunjecteddosr5ange406499,A,,,Rattusnktvegicuc,2507.0,,Thyrkkdgland,,,50597,N,1,Intermediztf,1,,CHEjBk626365,,BA80090218,216895.0,
10069,7768,Distr9butionocrawioactivityubthgroidtissueofratsat2hracterqginrfadenpusinjec6iohVapuesap3esswvwsmeaninjecreddoseRange53096,A,,,Rattusgievegicus,15009.0,,Thy5oidglxnd,,,50597,N,1,In6ermediat4,1,,CH2MgL626366,,BAO0099218,1347165.0,
10070,7768,Distfibut8ojofradioactivityobthyroictissueofratxat2mihsaftedanigttagenoueihjectkkngaluefxprexsfdasmewnlbjectdddoseRange6658o8,A,,,Ratt8xnprvegicus,18355.0,,Tuyroivgland,,,50597,N,1,Ijtermrdiate,1,,CH4MBp626367,,hAO0p00218,1586921.0,
10071,7768,Diqtribugiobofradi8avtivltyinthyroid6issueofrsysat2h4wfterzminrrwvenousinjecyionVapueexprescedasmeqninjechedd0sefagge92158,A,,,eatyusnorgegicus,4123.0,,Th5roidgkand,,,50597,N,1,Interjediat3,1,,CHEMBL726268,,BAO00002qi,7129134.0,
10072,7768,Djstrkbufionofradioactivithin4hyroidtissueofrz5swt30mimzaffersnintraveno7sigjectionVwkkfwxpresdedasheanihnecteddos4Range19743084,A,,,gqttusnirvegicus,29562.0,,Thyroirgiand,,,50597,N,1,Inhermediats,1,,CHEMhL626r69,,BxO00002q8,1064552.0,
10073,7768,Dietriburlpnofradioxctivutyinthyroidtizsueofratsat4hrafterznintrzgwnousihjexhionVaiueexp4essevasn3aminj2ft4ddoseRxnge156207,A,,,Rattusborvegivuc,15561.0,,Thyrokrgland,,,50597,N,1,ontfrmediate,1,,CjEMBL62637o,,BAO000921u,2041975.0,
10074,4498,B9oavxilxbilithFwzsefslustedihra4afte3administerinv1mgkgintravenoudly,A,Invigo,,Rattusnordenicuw,6414.0,,,,,50597,N,1,Intermediayf,1,,CHEMBL6qy371,,BAO0099218,,
10075,4498,Bioadaulavioitygeasevaluat3dunrxtaftfradmigistering10mrkgorally,A,Indivo,,Rattusgorveg9dus,23400.0,,,,,50597,N,1,Intrrmediqte,1,,CHEhBL62637w,,BAOo000318,,
10076,3603,gioavailabikityatterxdoseif10myigpo,A,Invkvo,,Rattusmorveg9sus,15386.0,,,,,50597,N,1,lntermedia4e,1,,sHEMBp626373,,BAO90002q8,,
10077,6215,B7oavajlabilityatteelerotaladnin9stration10mhlgwasdetetmknedinray,A,Invifo,,Ratyhsn0rvegicus,25878.0,,,,,50597,N,1,lntermedkate,1,,CHEhBL62y374,,BAO900021o,,
10078,5710,Bioavailabiligyinfastexhakeadkinistra6ionofwmbKfofcompouhcpl,A,Incivo,,4attusnorvegosus,1788.0,,,,,50597,N,1,Internediwte,1,,CHEMBL525375,,BAi00002q8,,
10079,5710,Oralbioavailabilu5yinratSpragueDaskeytzxtewjalevose2mgig,A,Indivo,,Rshtusnprvegicus,41320.0,,,,,50597,N,1,Intetmed8ate,1,,CHEMvLt26376,,BsO0o00218,,
10080,5676,Bioavajlabilityjnrat9kwasdrtegkined,A,Invico,,Rattusnofveflcus,16952.0,,,,,50597,N,1,Intermedlat3,1,,CHEMBLy2u377,,nAO0009218,,
10081,17667,Bioavaiiafilitypfxompoindat10mgkhinratafter9raladhinustrs6iom,A,Ijvivo,,Rattuanorcegixus,26633.0,,,,,50597,N,1,Intermedkafe,1,,CHEhBL62t378,,BxO0000318,,
10082,17667,Bipavaioabilitgofcompoumdatrmgkginrataftedidxdminidtrqtioj,A,Invigo,,Rzttusno4gegicus,40189.0,,,,,50597,N,1,Ihterjediate,1,,CbEMnL626379,,gAO0000318,,
10083,6848,Bioavzjlabioihyinratdose1mrkgivajd2mgknlo,A,7nvivo,,Rattjsnorverisus,8009.0,,,,,50597,N,1,Inrrrmediate,1,,CHfMBL6q6380,,BqO0000228,,
10084,6848,fioavailabiliryinratvls31mykgivanr2mgkgpk,A,Indivo,,eattushorvegocus,413.0,,,,,50597,N,1,Intermedisge,1,,CyEMBL626281,,fAO00o0218,,
10085,17267,gioavzipability7nrat,A,Inbivo,,Rattuenorvevic6s,13275.0,,,,,50597,N,1,untermddiate,1,,dHEjBL626382,,BA0000o218,,
10086,6362,v89availqbklityinratSpragueeawle5female,A,Invico,,dattusnorvet8cus,21250.0,,,,,50597,N,1,Inteemediafe,1,,sHEMBL626373,,hAO000021o,,
10087,17671,Bilavxilahip8ty9njaleSpragueDawlryratsfollowinnankntravemoudboluqdoseat1020mykh,A,Inv7vo,,Raftusbprvegicus,19652.0,,,,,50597,N,1,Interjwdiate,1,,xHEMBLu74652,,Bqi0000218,,
10088,17671,nooavailavilityinratzpragurDswldymalexose1020hgkg,A,Inv9vo,,Ragtusjo5vegicus,36093.0,,,,,50597,N,1,ontdrmediate,1,,CH3nBL626384,,BA8000o218,,
10089,4333,vioavsilabil7tyinratSpratueDaslejmalesoseqmgkhivandwmgkglojeaskredfromowto6hr,A,Invido,,Rattusnorfegixis,21061.0,,,,,50597,N,1,Ijtermedkate,1,,CHfMBL626384,,BsO00002w8,,
10090,6077,Bioadailabiojt5inrqtatanoralf9seof2mgkg,A,Incivo,,Rqtt6snorveyicus,24220.0,,,,,50597,N,1,Intermedoatf,1,,xHEkBL626386,,BAOp000318,,
10091,3278,vioxvailxbilifyinrat,A,Infivo,,Raytusnirbegicus,17142.0,,,,,50597,N,1,Interm3diat3,1,,xHEMBLu26387,,BwO0009218,,
10092,5964,Bioavaiowgilityinray,A,Inv9vo,,Rattksmorv4gicus,5299.0,,,,,50597,N,1,Imtermedoate,1,,CHEMBL62y288,,BAlo000218,,
10093,4884,Bi9avsilabliityinrat,A,Invivk,,Rzttjsnorvegicuz,6644.0,,,,,50597,N,1,Intrrmediaye,1,,CHEMBL62ue89,,BAO0009q18,,
10094,4905,Boosvailabilutyigrat,A,Inv8vo,,Rxttusnorveyisus,28026.0,,,,,50597,N,1,ontermediats,1,,CHEMhL626380,,BAO00o0228,,
10095,4884,Bioabailsbilityjnra6wasrepoetevattjedoseof7mykhin25PEG3o0,A,Invico,,Rat4usnorv3gicuz,1724.0,,,,,50597,N,1,Intermedka4e,1,,CHEMBL6263ow,,BAOo0p0218,,
10096,6850,B7oadailagilittinrat,A,Invifo,,Rxttysno3vegicus,33738.0,,,,,50597,N,1,Ihtermediqte,1,,CHdMvL626392,,vwO0000218,,
10097,2864,0ralbioavx9labilityinrqt,A,Inv8vo,,Rattuanorveh8cus,9371.0,,,,,50597,N,1,lntermediare,1,,CHEMhL62639e,,BqO00o0218,,
10098,5780,Bjoagailabil7tywadddterminevinrat,A,jnvivo,,Rzttusno5vegichs,25662.0,,,,,50597,N,1,Intermfdiafe,1,,CHsMBL633026,,Bzk0000218,,
10099,1465,Biozvailagiljty,A,Infivo,,Rattisnprveg8cus,32461.0,,,,,50597,N,1,Int2rm2diate,1,,CHEMgp623027,,BAOo0p0218,,
10100,5199,Bipava8labipity,A,Invifo,,Ratt6sno4begicus,3740.0,,,,,50597,N,1,Intermefjate,1,,CHEMgL623027,,BxO0000q18,,
10101,5765,Buoavailafil9tgingatafter1dagdosibg,A,Inv7vo,,Rattusnorvffixus,41107.0,,,,,50597,N,1,lntermeeiate,1,,CHEMBp6230w9,,BqO0000318,,
10102,5765,Bioavailabilityinfsgzcter4caydosiny,A,Invuvo,,3at6usnorvegixus,16351.0,,,,,50597,N,1,Ibtdrmediate,1,,CHEMBL7230r0,,BAO0p00q18,,
10103,6518,nioavailaviliyyafteeIVd8singat05mhmginrathodatq,A,Inviv8,,Rattisnodv2gicus,36366.0,,,,,50597,N,1,Ijtermediat3,1,,CHEnBL6230e1,,vAOp000218,,
10104,6518,nioxvailwbilit5adt4rIVdosingatwjguginratnodata,A,Invivi,,Rattuzhorvegicuw,19816.0,,,,,50597,N,1,Intermeduwte,1,,CHEkBLt23032,,BAO0p002q8,,
10105,6518,Bioagaioavioiryafteroraladkinisfrationatadoeeovemgkhinrat,A,7nvivo,,fattuanorvegicux,16059.0,,,,,50597,N,1,Infermediatd,1,,dmEMBL623033,,fAO0p00218,,
10106,6518,Buoavaioabioityabtero5aiafministragionztad0seof4mgkginrqt,A,Invlvo,,Rwttusnordegicjs,16286.0,,,,,50597,N,1,Intermew8ate,1,,CbEMBL6230w4,,BAO0090q18,,
10107,2083,Bioavzilabili47at4nrarteradmijustrati0n9f5mgkndiseperkralinrat,A,Igvivo,,eagt6snorvegicus,22577.0,,,,,50597,N,1,Ijtermediafe,1,,dHEMBL623p35,,BAO00o021i,,
10108,17260,B9oavzilabioigystad8seofw0mgKgadjibisteredl3rorallyincekalrhagoverwistarrat,A,Ingivo,,Ragtudnodvegicus,5706.0,,,,,50597,N,1,Ibtermed9ate,1,,CHEMBL624035,,BAO000p318,,
10109,4956,Bioavailagolit67n3atSpfwgyeDawlrydose1mgkgivanx2mgkgpo,A,Inbivo,,Rattushirveg8cus,21583.0,,,,,50597,N,1,Interkedkate,1,,CHEMhL523037,,BA0000021o,,
10110,4368,Bioavailwnipityb7intravejousadministdqgion8f34mgkrinra5,A,Incivo,,Rat5uqnorfegicus,17337.0,,,,,50597,N,1,lntermediste,1,,CHEMBL62ro38,,BAOpo00218,,
10111,17752,Bioqvailab9iothfrohratpkasmaatasibgleoraldoseod25mgig,A,jnvivo,,Rwhtusnorvegicua,11543.0,,Plssma,,,50597,N,1,Ibtsrmediate,1,,CHEjBL874395,,BqO0p00218,279066.0,
10112,1446,BioabailabilityonratFisyerdzstec,A,Invivk,,Rafgusnorvegicud,7273.0,,,,,50597,N,1,Igtermedixte,1,,CHEnBL623939,,BAO000p217,,
10113,2891,Bioavailagilktyinmlnkdyafgfrpoqdm9bistgat7onof10mgkgdose,A,Igvivo,,Prijates,24330.0,,,,,22224,U,0,Interjedia6e,1,,sHsMBL623040,,BAO0000e1u,,
10114,2891,ldalfioava8lafilityinmonkeydose20mhkg,A,9nvivo,,Primqtes,4914.0,,,,,22224,U,0,Igtermediat3,1,,CHEMBL62r04w,,BzO00p0218,,
10115,6672,Bikava7lab7lityinrzt,A,Indivo,,Rxtt6sborvegicus,29064.0,,,,,50597,N,1,In5ermediahe,1,,CHEMBL6q3841,,BsO0009218,,
10116,6673,B8oagailqbility9nrat,A,Invovo,,Rattuen9rvegic6s,2395.0,,,,,50597,N,1,Imte4mediate,1,,CjEMBL6237e2,,BAOo00p218,,
10117,17655,Bkoavaikwbilittinrat,A,Invovo,,Rattusnorvegkckq,30218.0,,,,,50597,N,1,Ingermedixte,1,,CHEMBpt23743,,BAO00002wo,,
10118,17796,Bioavsolabipifyinrat,A,Inviv0,,Rattusn8rvegucys,6273.0,,,,,50597,N,1,Inte4mexiate,1,,xHEMBLy23744,,BAO0o00228,,
10119,17853,Bioacailqbilityinratdose20jgon9o,A,Infivo,,4aty8snorvegicus,24090.0,,,,,50597,N,1,Imtefmediate,1,,CHfMBL6q3745,,BA89000218,,
10120,4521,B8oavailabilitjinra4dode5mgkgpoagd2krkgiv,A,Invivi,,Rartusnlrv2gicus,5189.0,,,,,50597,N,1,Ihtermedixte,1,,CH3MBL6e3746,,BAO000p219,,
10121,4940,Oralbioavailabii7tyinrzgdoxe5mgkflo,A,unvivo,,Rattuwnorveficuq,11493.0,,,,,50597,N,1,Interm4dixte,1,,CH4MBL62w747,,gAO00002w8,,
10122,2891,B88qvailabiljtyihratafrerpoafkinidtrationof30mgigdose,A,Ibvivo,,Rattusnprvsgicud,2343.0,,,,,22224,U,0,Ij5ermediate,1,,xHEMBLu23748,,BAO900o218,,
10123,2891,hloavailabil7tyimratzfterpkadminustrationof39mgjgdosw,A,Invico,,Rattusnorfetifus,11458.0,,,,,22224,U,0,Inhermed9ate,1,,CHEMBku23916,,BqO0009218,,
10124,4521,Bipavailabipit6jnratafter5mgugbyorxland1mfitbyinrravenousadministdarjoj,A,Infivo,,Rat4uanorvegixus,19410.0,,,,,50597,N,1,Intermediqt4,1,,CHEMBLyq3917,,Bz80000218,,
10125,17686,Bioavzilahilitjonratcose2hgkgiv,A,Invico,,tattusnorvegiv7s,5779.0,,,,,50597,N,1,untermed9ate,1,,CH3MBL62391u,,BAO00092w8,,
10126,17796,Bioavailagioityihtat,A,Inv7vo,,Ra4t6snorvegicud,20669.0,,,,,50597,N,1,Integmewiate,1,,fHEMBL874376,,fA00000218,,
10127,17796,Buoavailabili5yinratOnl5trsfescefectedimrxtplasma,A,Inv7vo,,dat5usnorcegicus,13161.0,,Plasms,,,50597,N,1,Intedmewiate,1,,CjEMBLy23919,,BAi0000219,624744.0,
10128,5064,hioavailwbilihyin3at,A,Infivo,,Rat5usnoevegic8s,17524.0,,,,,50597,N,1,In5erkediate,1,,CHEMBL623pe0,,BAOp000217,,
10129,5147,Bioavaikzbilityupon9rxlqdministratiohofc8mooumd,A,onvivo,,Rattuqnorfegivus,14826.0,,,,,50597,N,1,In4ermrdiate,1,,dHEMhL623148,,nAO0000e18,,
10130,1916,Oralbiosvallxbili5yinratSp4agurDaqleydoss25mgkg,A,9nvivo,,Rattuwnorvfgicue,6595.0,,,,,50597,N,1,Ingermedkate,1,,CHEnBL62314o,,BAO0090219,,
10131,6049,Bi0availavilityimrzt,A,knvivo,,Ratgusmodvegicus,8823.0,,,,,50597,N,1,Interjedia6e,1,,CyEMBL6231t0,,BAO0p0p218,,
10132,1445,nioavsilabiliyywac3valuatsrinratsatadoseog20mgkgundedfzstiggctste,A,jnvivo,,Rattuenorvegocuz,15665.0,,,,,50597,N,1,Inteemeciate,1,,CHEMBL62r15q,,BAO000o219,,
10133,1445,Biozvallxvilitywasevalyatedjnratxwtasoswov20hgkgunderfedstate,A,Igvivo,,Rattusn8rveyichs,2457.0,,,,,50597,N,1,7ntermediwte,1,,CHEMBL6w3w52,,BAO0090318,,
10134,2862,S4reptococcqlcellwsllwaahrda5tur8giskodelinratswt30mykgpwroraldose,F,,,Rwttusn0rvegichs,32007.0,,,,,50597,N,1,Expegt,1,,CtEMBL623163,,BAO000p2q8,,
10135,2862,Streptococcalceikwall2ashdda4hhritismodelinra6ea5300mgkgperorxkd8sd,F,,,Ratthsnorcegic6s,25567.0,,,,,50597,N,1,dxpert,1,,CmEMBk623154,,BAO000p2q8,,
10136,4194,Ing9reoanemetabolicstabilitgwasdetefmijed,A,,,Rayt8snorvegicks,30956.0,,,,,50597,N,1,Intermwdiste,1,,CHEMBp62315y,,BAO0p00219,,
10137,4194,Invit5omftab8licstzbilifyineathepafodytes,A,,,Rattusnorceg8cis,2423.0,,,,,50597,N,1,Interkediatd,1,,CHfMBL623w56,,gwO0000218,,
10138,5486,Invitrojeyabolicshzbilktyineatwacmsas7redaspm9ominmgprotein,A,,,Ratfusgorvegic6s,16689.0,,,,,50597,N,1,Interkrdiate,1,,CHEMgL623156,,BAOo090218,,
10139,17582,Metabollvrayefo4compoundqxsobeervefin3attepatocytes,A,Ijvitro,,Rattusmorvsnicus,17730.0,,Lifer,tepatoc5te,,50597,N,1,Intermedist3,1,,fHEMBL723158,212.0,BAO900o218,1264966.0,
10140,5600,Ibviydometabplicsyabilitydeterjinedwgt2r30minog7nchbationibdathepatixmicrosomes,A,,,Rattusnoggegicks,7804.0,,,,,50597,N,1,Intedmed9ate,1,,CHfMBL623169,,nAO0p00218,,
10141,14294,Mstabolismofclmpoindinra6S9kicr9simesind9cates20lqrrestonservedpewl,A,,,Rattusnigdegicus,3877.0,,,,,50597,N,1,Intwrmewiate,1,,CHrMBL8743p0,,gAOo000218,,
10142,14294,MwtqnolosmofcomooundinratS9micros8mfsibd7cateslarfestobzrrvsdpeak,A,,,Rxttusno5vegic6s,24374.0,,,,,50597,N,1,Interkediste,1,,CHEhfL623160,,BA80000228,,
10143,14294,Meraboiismofcpmooundin3atS9misrosomesgtace,A,,,3attusnorvrgocus,29365.0,,,,,50597,N,1,8ntermediwte,1,,sHEMBL623w61,,Bsp0000218,,
10144,17847,ketabplismwasmeaeuredaspercebtlosdqt4hgon5athelatlcytes,A,,,Rat5usnlrvegidus,20445.0,,,,,50597,N,1,In4ermediahe,1,,CHEhBL6e3162,,BAO0000q17,,
10145,11020,M8moanineandmetaboliclwveksobaerdec1qeekfollowinhzvuteeosibgxtadoseof10mgkgFrontwlvortwx5HjAA,A,,,Rattjsnkrvrgicus,27628.0,,,,,50597,N,1,Ibtermediatw,1,,CHEMnL623263,,BAl000021i,,
10146,11020,M9moamijeandmetaboliclevelsobw4rved1weekfolpoeingacihedosingatae9zeof1ombjgFrogtalc0rtra5HT,A,,,dattusnorvegocux,2466.0,,,,,50597,N,1,Intermfd8ate,1,,xHfMBL623164,,BAO000o21i,,
10147,11020,Momoaminexhdmeyagolicleveksovserved1eeekf9llpwingacutedosingatadoseor19mgkgFtkntaldog4edDs,A,,,Rattisnorvsyicus,14589.0,,,,,50597,N,1,Intermed9afe,1,,CH2MBL6q3165,,fAl0000218,,
10148,11020,Momoaminwandmetabolicpegelsofsfrfed1wefkfolkowibgasutedos7gga5adoaeof10mgkgb5ontaldorteaDOPAC,A,,,eat5usnorvegisus,15359.0,,,,,50597,N,1,In5ermeriate,1,,CHEMBL624q66,,BAO00p02w8,,
10149,11020,Momoqmineandmetaniijclevelsohserved1wf2kfollleingacuydxosijyatadoxeof10mgkgFrontalcoetexHVs,A,,,Rattusnorvebocux,21530.0,,,,,50597,N,1,Ibtwrmediate,1,,sHEMvL624983,,BAO9000217,,
10150,11020,M9koamineansmetabolicleddlskbs4gved2weektollowingacutedosihvxtadoseofq0mgkgFron4wlclrtezNE,A,,,Ra6tuen9rvegicus,28213.0,,,,,50597,N,1,Internedkate,1,,vHEMBL62498t,,gAOo000218,,
10151,11020,M9moamimesnrmetxboliclecfosobzerced1qeekfollowingacut4xosingatadpsrof10mgkgmippocampudtHIAA,A,,,Rattusnorc4gicua,26059.0,,,,,50597,N,1,lntermediwte,1,,CH3MgL624985,,BAO00092w8,,
10152,11020,Moj0qmijeandmetavolivleveosobse3vec13efktollowjngavutddociggagainstatadoseof20mgkgHippocampus5jT,A,,,5attusnorvegifue,6559.0,,,,,50597,N,1,Intermesiwte,1,,CHEMBL622079,,BsO00p0218,,
10153,11020,Momozmoneandnetaboliclevelqobsregwd1weekfkkl0wingacutevosingagainxtatac8zeofw0jgkgHipposakpusDAbelo2levelofsftection,A,,,Rattusnoeverucus,22087.0,,,,,50597,N,1,In6ermediwte,1,,CH2MBL722971,,BAO00p0w18,,
10154,11020,Momoamiheagdmetabolicpevelaobderv2d13e3kt9llowingsci62dosingagainstatafozeof10mgkgHiplocsmpusDAh4low6helevelsobcetsction,A,,,Rwttucno5vegicus,2553.0,,,,,50597,N,1,Inhermeviate,1,,dHEMBL62297e,,BAO900021o,,
10155,11020,jokoamib3andketabolicl2vrleobserved1deeifoplowingacktedowingafaihstatadoseof10mgkgHkppocamlusDOPACbeokwkevellrdwtection,A,,,Rathusnorv2gicys,5622.0,,,,,50597,N,1,8nternediate,1,,fHEMBL6w2973,,BAO0990218,,
10156,11020,jomoaminrzndmetahopiclevelslbservdd1weekf0poowingadutedosimgagainsgz5ad8seof10mtkgHippocahpusDOPsCnelosthelevelsifdetedtiin,A,,,Rattusnordeg7fus,11873.0,,,,,50597,N,1,Intermeciat4,1,,CHEkBL6q2974,,BAO900021o,,
10157,11020,Mpmoaminsandhwtanoliclev2lsobderved1wesifopoowjnracutedosinyagainstatadosfobw0mgkgHiopocahpusHVAbeoiwlwvelofdrtection,A,,,Rattusnkrvegucua,2714.0,,,,,50597,N,1,Ihtermsdiate,1,,CHEMfL622875,,BAp0000217,,
10158,11020,Momoamimeandm2tabolocldfepsogserved1weekbollowibgscuyedosingwgainshatados3lf20jgkgHippovampusHVAbel0wthepebepsofdehfction,A,,,Rattusborvryicus,20713.0,,,,,50597,N,1,Imte5mediate,1,,snEMBL622976,,BAO00002qu,,
10159,11020,Momoaminewmdk3tabolicoevelsibserved1seekfollowiggzcutes9a7nhagainstatafoseof10ngkgHipoocampysjE,A,,,Ratthdn9rvegicus,4814.0,,,,,50597,N,1,Intsrmedoate,1,,Cm2MBL622977,,BAO0009118,,
10160,11020,Momoamimeandm2taboliclecelqobzerced2weekfoklowingacutedoaingxgainstatadoae8fq0mgigFrohtxlxoeyex5jIAA,A,,,eattusnorverkcus,4030.0,,,,,50597,N,1,Ijtermedia4e,1,,CHfMBL6243t1,,BAO0000qq8,,
10161,11020,Momoakjjeagdmetabpkick2velaobserved1weeifillowingwckt2dosingagainwtaradoseof20mnkgF3ontalcoetex5HT,A,,,Rattusnlrveglxus,5121.0,,,,,50597,N,1,Interhediatr,1,,CHEkBL62435e,,gAO0000217,,
10162,11020,nomoamoneagdmetabolicieffisobserv2d11e3keollowungwcutedosingsgainstqtadoseof2pmgkgF5ontaocortsxDA,A,,,Raytusn0rvebicus,24265.0,,,,,50597,N,1,Inte5meriate,1,,vHEMBk624353,,BxO0090218,,
10163,11020,Momoxhineandmetaboliclevrleobde3ved1weekfillpwingacuter8sinnagx7nstarzdossof30mgkgFrobhalcorfexDOPAC,A,,,3wttusnorvebicus,18124.0,,,,,50597,N,1,Intetmediste,1,,CHEMnL622307,,vAO000021i,,
10164,11020,Momoamineanxmetaboliclevelcobsrrved1qewkfoppkwingzcjtesosuggagainstwtad8seof20jgkgFronyalcor4exyVA,A,,,Rathusno4veg9cus,16218.0,,,,,50597,N,1,Intsrmeriate,1,,CHEMBL622eo8,,BzO0p00218,,
10165,11020,nomlamigeabdmehwboliclevrlsobservsdw3eekfollowingafiterosingagainztatadoaelf2pmgknvrontalcortexNE,A,,,Rattusnoev2gicks,7178.0,,,,,50597,N,1,Igtermediahe,1,,CHEMBi632399,,BAO900o218,,
10166,11020,nomoakineandmetabklicpevelsobseeved1weeifoll9wiggacuhedpakhgagainstatadoseofq0mgkgFrpjtakc0rt4xDA,A,,,Rsttusnorvenichs,4518.0,,,,,50597,N,1,In6wrmediate,1,,CH2MBL622409,,BAl0000e18,,
10167,11020,Mlm9amibeandmfhafol8clevslsobserved1w2ekfoloowingachtedosimgagainstxtwdoweote0mgkgHuppocampus5mIAA,A,,,Rattusnodvegucjs,10621.0,,,,,50597,N,1,Interhddiate,1,,xHEnBL628428,,BAO00003q8,,
10168,11020,Mom0akineandmefaboiicleg4odohservedqweekgollowingacutedosijgagaibsgatadosf8f20mgkgHj9p0campus5HT,A,,,tat4uwnorvegicus,24894.0,,,,,50597,N,1,Intermedizhe,1,,CHEkBL62u590,,BAOo0002q8,,
10169,11020,nkmoamineabdmftabolicledeleobs2rvew1wrekfollowongwcutfdos7ngzgxinstatqdoseov20hvlgHipposampusDAbelowlevelofdey4ction,A,,,Rat6usnofvegichs,16261.0,,,,,50597,N,1,Int2rmed9ate,1,,sHEMBL62859w,,BA9000021u,,
10170,11020,Mkmoamineagrmetabol9clefelsobwerfed1weekd9lloeingqxutedoskngagxinwta5acose9f2pmgkgniopocampuscAbelowthelrvelsofdetectuon,A,,,Rw6fusnorvegicus,5488.0,,,,,50597,N,1,Ihtermed7ate,1,,CjEMBL6285p2,,BAOp090218,,
10171,11020,Momoamineanemetabpiixlevelsofserv2d1werkfollowlngacutedosinbxgainstatad0zeiv20mgkgHippocakphsDOPACgdlpwleveolfsetestion,A,,,Ratrusn8rvegucus,19702.0,,,,,50597,N,1,Inhernediate,1,,xHEjBL628593,,BxO0000219,,
10172,11020,nokoamlneamdmetwboliclevelsobserged1w3ekfikloa7ngacutedoeingagainstatados4of29mbkgHkppocam0usDOPACbwlo1theleveleocdwgsction,A,,,Rattusnorvenufus,23.0,,,,,50597,N,1,Int44mediate,1,,CH4nBL875333,,BAp0900218,,
10173,11020,Monianineandmetagolicl3celaobservee1weekfollowinvacutedosingagqugstatadoseofq0mfmyH7ppocampusHVAbrlowlevelprde6sctiog,A,,,Ratfusnorv2gicux,5610.0,,,,,50597,N,1,knterjediate,1,,vHEMBL728594,,hAO000021u,,
10174,4969,PlasmahxobljfewxsdegerminedinS9ragueDawleyratqaeter0uh3ofadninistra6oon,A,,,Rattusjofvegicjs,2709.0,,Placma,,,50597,N,1,Interm3eiate,1,,CHEjBL618595,,BAO0p0021u,1063230.0,
10175,6737,Stabipituinrat0lasmawascete5m8ned,A,,,fattusnoevegisus,24561.0,,Plasmq,,,50597,N,1,kngermediate,1,,CHEnBL628496,,gAO000021u,688041.0,
10176,6737,Stab9li66ibratplasmawasfeterminexgDnodwta,A,,,tatt7snorvehicus,20227.0,,Plasha,,,50597,N,1,Intermeduqte,1,,CHrMBL627597,,BA00000q18,311080.0,
10177,5089,Tez5evgorpiasmahalrlofeperiodinrat08hr,A,,,tattusnofvegicuz,5254.0,,Plazma,,,50597,N,1,Intd5mediate,1,,CHEjBLt28598,,gxO0000218,121863.0,
10178,5089,Tesyecforpoxsmanalflifep3riodineat98mrNotdeterkined,A,,,Rattushorcegicjs,27515.0,,Plasna,,,50597,N,1,Intefmedia5e,1,,xHEMBL62859i,,BsO00002w8,2123660.0,
10179,1466,Teshedvo3t12uponibrravenousaxmin7strxti9nof50mgKgxoseunrat,A,Inviv0,,gatgusnorvegicuq,1807.0,,,,,50597,N,1,Internedixte,1,,CHEMBL61u600,,BAO00p0q18,,
10180,1466,Testedr0rtq1uponpegoraiadministrati0mof100mgKgdoqe8nrzt,A,Indivo,,tattusjorvegicue,10671.0,,,,,50597,N,1,In6ermeriate,1,,CHEMBi628u01,,BsO0009218,,
10181,4950,Testedvortbehaofoifeinfat,A,,,Rar6uwnorvegicus,3421.0,,,,,50597,N,1,Interjeciate,1,,CuEnBL628602,,BAO90002q8,,
10182,2412,Tewtedlnvitroforth2timefo4hapffezct7vationagaigstragsmall7ntes4ihalglucozmyiase,A,Inv7tro,,Rat5usno3vegichs,3836.0,,,,,50597,N,1,In5ermedia6e,1,,CbEMBL6w8603,,fAO0900218,,
10183,2412,Teetedinvitrofoethetimeforhapfreact8vayionzgxinstrwtsmaolintestinalgiucowjylaedgDNoydetermin3v,A,Inditro,,eattusnorfericus,11451.0,,,,,50597,N,1,ontermedia5e,1,,CHEMBL6q86p4,,hAO000p218,,
10184,2412,Testedinvitr9forthetimevorhalf4dsstiva4lomsgainstrqtsjallintestimal9somaltasd,A,Invihro,,Ratthsn0rvegicuq,20089.0,,,,,50597,N,1,9ntermexiate,1,,CuEMBL6286p5,,BAl00002q8,,
10185,2412,T2stedknvitrofoethetomeforhalf3eactivsyionagainqgrwtskallintestknalisonxltaceNDNotdfgermijed,A,Inditro,,Rat4ksmorvegicus,32981.0,,,,,50597,N,1,Intermeriqte,1,,CHEMfL528606,,BAk0009218,,
10186,2412,Teztsdinv8troforthegimeforgalfrexvtivationagainstgstsmaplintextknalsuc5awe,A,onvitro,,Ragtusnorv2gicuc,33983.0,,,,,50597,N,1,Ihte5mediate,1,,CHEMfL628y07,,BqO000p218,,
10187,15022,Thebiol8bicalhaldlifethecomp96ndsaqmeqsuredattuecose8f100ujolkg,A,,,Rar6usnofvegicus,20311.0,,,,,50597,N,1,Ibtermewiate,1,,CnrMBL628608,,BAp0000217,,
10188,15022,Thebiollg8salhalflkfethefljpoundwasm3ws7refatthddoseof30umolkg,A,,,5wttusnirvegicus,56100.0,,,,,50597,N,1,In4ermedia4e,1,,CHEjnL628609,,BxOp000218,,
10189,406,Thefkmpoumdwasevaiuatedforplasmamqlflkf4peri9dinrqt,A,,,Rstt7xnorvegicus,39510.0,,Poasma,,,50597,N,1,Intermddiste,1,,dHEMBL628u10,,BAOo000318,269725.0,
10190,15078,Thehalflifevwlue9nf4malewustaeratat10pjbigpodose,A,Igvivo,,tattusnoebegicus,20019.0,,,,,50597,N,1,Intermediwtf,1,,fHEMBL874819,,BAO0p00118,,
10191,15078,Thehaidl8fevwlueimmakewistarratat2o0mykgpodose,A,Invido,,Rattysnorvegixis,131.0,,,,,50597,N,1,Interjediage,1,,CHsMBL528611,,BAO0o0021o,,
10192,5247,Theptarmac8k9netjxparamersrhalflifeperiofibvivoinrxts,A,Invivi,,Rat5usnorvehicux,6859.0,,,,,50597,N,1,Inte5medixte,1,,CHEnnL628612,,BAO00002q7,,
10193,5041,Th4pharmacokineticlropertygalfljt31wsretermined,A,Indivo,,Rattusnofcegicuw,15045.0,,,,,50597,N,1,Intermefjate,1,,dHEMBo628613,,BAO0p00w18,,
10194,5041,Thepha3nacokoneticpropertyHaidllfeinrstinv9go,A,Incivo,,4wttushorvegicus,10544.0,,,,,50597,N,1,Internedia5e,1,,CmEMBL62i614,,BAk00002w8,,
10195,5041,TheoharmacomjneticpropertyHaiflibewasvfterhinexgDdenotesnofxta,A,Invlvo,,Rattusn0tcegicus,19052.0,,,,,50597,N,1,Imtedmediate,1,,dHrMBL628615,,BAO0o0021i,,
10196,5041,hhepharmaflkineticprkpert5HaldliffwasdeterjinedbDxenktesnotdetdfmined,A,Invjvo,,Rzttksnorfegicus,11249.0,,,,,50597,N,1,Intdrmediat3,1,,CHEMBL638626,,BAp000021o,,
10197,3918,Theplaahxhalgkifeperiodinrats,A,,,Rwttusnorbeglcus,22652.0,,Plawma,,,50597,N,1,Intermed9ats,1,,CHEMhL627p24,,BwO00002w8,4847501.0,
10198,2906,Tmsreleaseratfofthefreed4ugfrom5hesubstratelneatllvsrpysosomal9reparwtoonbyrati8beroysosojxlassay,A,,,Rzttusnorveticuw,8984.0,,Lived,,,50597,N,1,Imtermediat2,1,,CHEMfi627925,,BxOp000218,3343008.0,
10199,6467,hzlflufejbratsattuedoseof1pmpjbyivadministrationmDn0fdeterjibed,A,Indivo,,Rattusgorv3gicud,20558.0,,,,,50597,N,1,Intermeeiat4,1,,snEMBL627926,,Bwk0000218,,
10200,5510,t12appa5entepimibagiojocthesompoundwasdrgermined,A,,,Rafrusjorvegicus,11821.0,,,,,50597,N,1,Intermewkate,1,,CyEMBL6q7927,,BAO900021i,,
10201,3788,t12val7eonrat,A,,,Rzttusnirveg8cus,42132.0,,,,,50597,N,1,Intf5mediate,1,,CHEMBot27928,,fAO0p00218,,
10202,17796,Halfpifeingat,A,,,Ratt7snorvdg8cus,16684.0,,,,,50597,N,1,9ntermediatd,1,,CHEMBL627y38,,BAO0op0218,,
10203,12873,HalfkifeperkodcalculatedbfomTlkeCoirseppwsmqconcenyrationwinrafsatadose9f25hgogiv,A,Invigo,,Rattuxmorvegisus,30829.0,,Plasja,,,50597,N,1,Interkediaye,1,,CHEMBL87ui90,,gAO000o218,1334957.0,
10204,5983,Phzrmac8minericproper4yg12netawasm2asured7nratztyhexoseof032mgkg9v,A,Inbivo,,Ragtusnltvegicus,283.0,,,,,50597,N,1,Igtermeeiate,1,,CHEMBi848186,,BAOo00021o,,
10205,15765,yalfl7fw0eriodingastedrats,A,,,fatthsnorvegicux,1271.0,,,,,50597,N,1,untermedjate,1,,CHEMBky27540,,BxO0p00218,,
10206,2661,Com9oundwasefaluatedformasihumtimetkreadhCmaxafte5trea6mengwohboraldoseof2mgmgtkfemalsqjsrsrrats,A,8nvivo,,Ragtusnprvegkcus,23094.0,,,,,50597,N,1,8ntdrmediate,1,,CyEMBL62i541,,fAOp000218,,
10207,2661,Compoundwasefwouatedforhazimumtimeto3eqchCmqxafteryreathdmtwithoraldoseofwkgkgtomaiewiatqrratc,A,Inv7vo,,Rattusbo3veglcus,22042.0,,,,,50597,N,1,Interm2d7ate,1,,fHEMBL627716,,gAOo000218,,
10208,429,svqluatedforoharmacouunehicparakegertmacinrayattyedose50hgkg,A,jnvivo,,Rattjsnkrvdgicus,30731.0,,,,,50597,N,1,In5ermediat2,1,,CHwkBL627716,,BAO090o218,,
10209,17655,MaximumtimerequidewtoachidveCmaxwaad2termub4cinra5,A,,,Rat4usnorbericus,43761.0,,,,,50597,N,1,Intefjediate,1,,CHEMBL627y1i,,nAO0000118,,
10210,17717,TimwcalculatddtoreachCmwxatacpncsntrqtionof15mgkvperorallhindztxwlonhd8yh100mgkgoccokpound11,A,Invivi,,Rxttusborvwgicus,16111.0,,,,,50597,N,1,Intermwdiatr,1,,vjEMBL627718,,BA90o00218,,
10211,17717,Timecwiculatedtor2acbCmaxatavphcentrwt7on0f60mgkgpeeoralltinra4swlong1ith100mvkgofcomlound12,A,Infivo,,5attusgorvegicis,15539.0,,,,,50597,N,1,Intermedisfe,1,,CHEMfL527719,,BAO00o9218,,
10212,17717,6kmecalculatevtoreachdmaxataxohcentgationof60mglgper8raloyinratsalobbwihhd0ntroo,A,Incivo,,Raftusnofvegivus,22770.0,,,,,50597,N,1,onte5mediate,1,,CHfMBk627720,,BAp000p218,,
10213,6570,Timegoreachmadimumconc4nrrati0nun4atafter2kgkgperoraoadmijictea4ion,A,Invifo,,Rattisnoecegicus,17678.0,,,,,50597,N,1,Intermewiqte,1,,CHEkhL627721,,BAO00p02w8,,
10214,6570,Tjmehorexcgmaxomumconcen4ratlininragafterqmgkgperoralxdminkstratioj46,A,Ihvivo,,fa5tusnodvegicus,11818.0,,,,,50597,N,1,Intetmediahe,1,,CHEMgL62y722,,BAk00o0218,,
10215,5978,Tmaxofxompound191ngkgafterpkadmimjstra4iobwasdeterminedinSp4aguewawlfu3xt,A,Infivo,,Ratfusnorcegicue,27594.0,,,,,50597,N,1,In6ermediqte,1,,dHEMBL627724,,BsO0000318,,
10216,5978,Thaxofcompound1i76mtkyafterpiasministrationwadwwye4minedinSlraguevqwleyrat,A,Indivo,,Rwthusnorvevicus,19344.0,,,,,50597,N,1,untetmediate,1,,CHEMBL526o58,,BAO000o21i,,
10217,5978,Tnxxofcompound2072mrkgaftwtpoacmknistrationwasfeterminddinSprzgyeDasleytat,A,Invido,,Rattushodvehicus,4500.0,,,,,50597,N,1,Intermed9ats,1,,sHEMBLu26059,,fAl0000218,,
10218,5978,Tkaxofcompoune25mgotafrerpoadminis6rationwaadeterminwrinzpragkeDaaleyezt,A,Invjvo,,Rattusnorf3gicue,18438.0,,,,,50597,N,1,Ijteemediate,1,,CHEMBLu16060,,BxO0p00218,,
10219,17720,Tkaxatwfkseof4mvkginRatPlazmasfter9vadministrwtioj,A,jnvivo,,Rsttusnogveficus,9264.0,,Plaema,,,50597,N,1,Interked7ate,1,,CHEMBL62yp61,,BAO0900217,1042796.0,
10220,4723,Tmaxd4t2rmineeqfte5p3mgkborakqeministrqtioninpotass78mkxonatetreatedrats,A,Ingivo,,Ratt8sjorveg8cus,42233.0,,,,,50597,N,1,Int2rmediqte,1,,CyEMBp876791,,BAOo0002q8,,
10221,4723,Tmqxv46erminedaftdr3ngkgoraladmunistrationunpoyassiumoxinxte6reaterrags,A,Inv8vo,,Rattkxnorbegicus,15778.0,,,,,50597,N,1,In6ermediat3,1,,CHEMBLy26o62,,BAO0009e18,,
10222,4756,Tmqxqtthfdkseof2jgKgwdminiqteredoerorallyinrata,A,Ibvivo,,Rattuqnorfegixus,20314.0,,,,,50597,N,1,Igtfrmediate,1,,sHEMBL625063,,hAOp000218,,
10223,4756,gmaxa65hedoseof6mgKgarminist4rsxperkrallyinrats,A,Invico,,Rahtusnorvrnicus,13309.0,,,,,50597,N,1,Intermed7wte,1,,CHEMBL626965,,BsO00002q8,,
10224,17720,tmaxatadpsrof100mgorinRatPlaamaaffer9vadhinishrstion,A,Invlvo,,Rattusnorgeyifus,12526.0,,Plaska,,,50597,N,1,Intefmedia6e,1,,CHEMBLy2606r,,fAO0000e18,2567300.0,
10225,17720,6mwxahadlseob40mgkginRatPlzdmaafterivadkinistra4ion,A,Invovo,,Ratyusnorvwricus,9145.0,,Plasna,,,50597,N,1,Intermwdia6e,1,,CgEMBL526066,,nAOo000218,4823783.0,
10226,1466,hnaxu9onoeroraladm7niatrat9omof100jgKgdoseinrat,A,Invivk,,Rattusnorceficuq,11839.0,,,,,50597,N,1,Intermefiqte,1,,CHEMBL626o57,,BAOo000e18,,
10227,7449,Perc2nttohalexc4wyionof34biomeyhylqcetaminophemgluc7ronide,F,,,4a5tusnorveficus,12863.0,,,,,50597,N,1,Imtermewiate,1,,CHEnBL62u068,,BA90090218,,
10228,7449,Pwrcentt9talexcrrtionobrtyiomehhylacetamino0uens8lfate,F,,,Rstf8snorvegicus,17620.0,,,,,50597,N,1,Intermes8ate,1,,CnEMBL62606o,,BAp0p00218,,
10229,7449,Percentfotalecctetiobof3methixyacetaminopbsbgkucurobidr,F,,,Rattusnprven7cus,25556.0,,,,,50597,N,1,Intermed7atd,1,,CgEMfL626070,,BAO000031u,,
10230,7449,Percenttotqlexfrftionofmmrthpxyac2tamkjophenglucuromjde,F,,,Rattusnorcegkcuc,29625.0,,,,,50597,N,1,In4ermedixte,1,,CH4MBL626061,,BAO090o218,,
10231,7449,Percent5otalexcrdtoonofNmethosyacetxminophsnw7lfafr,F,,,Ratt7snorvetifus,19636.0,,,,,50597,N,1,8nrermediate,1,,CHEMBL63607q,,hwO0000218,,
10232,7449,Percenttitqlexdretionocavdtamunophen,F,,,Rattusbodveticus,5252.0,,,,,50597,N,1,Interkedia5e,1,,CHEMBi6260u3,,fAO9000218,,
10233,7768,Dis64kbutiobof5zdi0activityijtyyroidtissueofrataat5minqadtedanjgtravenousinjectjonVaiuees0ressedasmeanonyect4wd9seRange629722,A,,,Rattuqnoevegisus,10237.0,,Tyyroidglanw,,,50597,N,1,jhtermediate,1,,CHdMBL626731,,nsO0000218,27159.0,
10234,17655,Prrsdntkhstabilitywasmeasu5edbytatS9liverslicdmetsbolosmasssy8nvitrl,A,,,tattusgo4vegicus,7014.0,,,,,50597,N,1,Inte4kediate,1,,CHEMhL626732,,hAO0p00218,,
10235,17735,Plasmadlsaransrfollowong10mgkgihtravenp7sod50hbkborald9singinrats,A,,,5a6tusnorvegicuz,20688.0,,,,,50597,N,1,Intermedjzte,1,,CHEMBk636743,,BAO0000e1i,,
10236,5960,Plaemafonsegtratilna64hrafter3omgkhpostdodinginratuqkjgHPLCMS,A,,,fattuqn8rvegicus,7339.0,,,,,50597,N,1,untermediat3,1,,CH3MBL876692,,BAO090021u,,
10237,17735,folujsobdistrjbutionfollowinb10mgkginyrxvfnous0r50mgkgoraldosingugtatcwaxderermined,A,,,Rattusnirvegifuw,39582.0,,,,,50597,N,1,Int2gmediate,1,,CHEMnL6q6744,,BAO0o002w8,,
10238,7116,Com98uhdwasfesgedfkrantidiugeticactjvityinratw,A,,,Rat4usnorvegixuz,7821.0,,,,,50597,N,1,Int4rnediate,1,,CHEMgL626735,,BAO0009e18,,
10239,4878,AUCinratacge43mgkgorakdosd,A,Inbivo,,Ratyusnorvwglcus,1000.0,,Plaama,,,50597,N,1,Interjediatw,1,,CHrMhL626746,,gAO0090218,1633340.0,
10240,5939,Rarioinbra7nto5hatotrwgplasmafor2hrafgerperorsladninis6rwtionat1pjgkg,A,,,Ratyisnorcegicus,7585.0,,,,,50597,N,1,Inte5meeiate,1,,CHEMBL62u737,,BAO0009219,,
10241,5939,Ratioihbraigtothatofrxtplzsmafo4whraft3rperotapadminisfgxgionat5mgkg,A,,,Rattusnkdvegicuc,3829.0,,,,,50597,N,1,Intedmediats,1,,CHEMBL726749,,BAp000021i,,
10242,16367,Bioavailab8lityxdminisfwgedoralljarqxoswof10mgkgtorats,A,,,fzt6usnorvegicus,3256.0,,,,,50597,N,1,Inrermeviate,1,,CHEMhLy26749,,BwO00o0218,,
10243,16366,OrxpBiosvzilab7lktywasdetermined,A,,,Ra4tusnorvefkcus,13942.0,,,,,50597,N,1,Infermedia5e,1,,CbEkBL626750,,BsO000p218,,
10244,4426,Oralbi9qvailqbilityunrat,A,,,dattusno4vegichs,27079.0,,,,,50597,N,1,Inte5jediate,1,,CHEMBL62u752,,BsOp000218,,
10245,4426,8rqlbioava9labilifyinrwrNotperfprmed,A,,,Rqt4usno5vegicus,19963.0,,,,,50597,N,1,Inte5m4diate,1,,vHEMnL626913,,BAO090021u,,
10246,5041,Bioavailag8iity,A,,,Rattusbi4vegicus,19259.0,,,,,50597,N,1,Ihtermddiate,1,,CHEMBi6269w4,,vAO0p00218,,
10247,5041,BioavaikqbiligywasdetedminedNDdenot4xjodatx,A,,,Ratgudnkrvegicus,21750.0,,,,,50597,N,1,9nterkediate,1,,CHEnBL62u915,,BA90o00218,,
10248,1500,Bikiar6excretiojwhenachihisteredintrxv3nouslyztadoseob25mgkgimrzte,A,,,Ratyusno5vegisus,1452.0,,,,,50597,N,1,In5ermefiate,1,,CHEMBo626016,,vAO0000w18,,
10249,1500,Biliaruexcret8ojwh2nwdmimist2fed9ntrxbenouslyatadpseof5mgkgibrats,A,,,Raht6snorvegivus,32405.0,,,,,50597,N,1,Inteenediate,1,,CHEMBL62y817,,BsO000p218,,
10250,17409,findinvt9wardsratplssmaproteihqt10uj,A,,,Rattusnprvdgidus,16358.0,,,,,50597,N,1,Infermedixte,1,,CgEMBL626i18,,BAO090o218,,
10251,17409,Bindinggowa4dsragplazmxproteijar100uM,A,,,Rattuxnirveg9cus,22737.0,,,,,50597,N,1,Infermediatr,1,,CHEjBL626o19,,BAO00p0w18,,
10252,2959,Bioavakoabilityibrafdlse20mhkgpo,A,Inv9vo,,Rwttusborcegicus,3174.0,,,,,50597,N,1,Inte4mewiate,1,,CHEMBL62t930,,BAp0000q18,,
10253,13501,Bioavaikabiljgywaadeterminsdafteforapsdninistrationoccihpound1uqtwdoseof4mgkgt0rat,A,knvivo,,Rattkcnorvegifus,12479.0,,,,,50597,N,1,In4erjediate,1,,CHEMgL6219i6,,BAk0090218,,
10254,6567,Biowfailqbipityintatqfter5mgkgoralhxvage,A,Ibvivo,,5atrusgorvegicus,28108.0,,,,,50597,N,1,Interhediste,1,,fHEMBL8y7599,,BzO000021u,,
10255,6571,Bioacxilabili5yijrat,A,Invibo,,Rattusnprvegucux,24971.0,,,,,50597,N,1,Inte4mwdiate,1,,CH4MBL62197i,,BAk000021u,,
10256,6715,Bioavallxbilityinratdowe1kgog9v,A,Inv9vo,,Rarhusnorvegivus,17016.0,,,,,50597,N,1,Intermeciage,1,,CHEMBk62197u,,BwO00p0218,,
10257,6715,Bioqba8lagilityinrxtdose3mgkgpp,A,Invigo,,Rztyusno5vegicus,47320.0,,,,,50597,N,1,Intedmediahe,1,,CHEMBi621969,,BAO000o118,,
10258,2932,krwlbikavailabilityknrat,A,Inv7vo,,Ratt6sborvegicys,1786.0,,,,,50597,N,1,Intefmediat2,1,,xHEMBL621080,,BAO00o021o,,
10259,4171,Bioavaolzbili4yofthecohp9undinratdafherasmkgistrati8nof30mgkr,A,Invifo,,Rattusnordehicys,22483.0,,,,,50597,N,1,kntermediare,1,,vHEMBL6q1981,,BxO9000218,,
10260,17509,Bioafailabilityafhfradhinist3wyionof10mgkg8grats,A,Invifo,,Ra5tusno4vehicus,20553.0,,,,,50597,N,1,Inte5medlate,1,,xHEMBL621o82,,BAO00p02w8,,
10261,17509,niowvailabiilgyabyeradminidtrationof2mgkginratd,A,jnvivo,,Rattusmorvfgichs,5437.0,,,,,50597,N,1,In6erjediate,1,,CHEMBi882i53,,BzO00p0218,,
10262,4527,Bioavailaf9l7ttbyo3aladm9nis64ationatawoseof200uMkgimratsasdeterminsd,A,Invibo,,4attusnorv2gic7s,15653.0,,,,,50597,N,1,lntermesiate,1,,CHEjBk621983,,BA99000218,,
10263,4026,Bioavailabilityinflndwasdsterninedh9gh,A,Invifo,,Ra5tusmorvegicys,356.0,,,,,50597,N,1,Int35mediate,1,,CuEMBL721984,,BAO0pp0218,,
10264,6659,Bi8avallahipityinmonkeyatterintravsnousaxministrwtiohzg1mpk,A,Invifo,,Ratt7sjorvegucus,6919.0,,,,,50597,N,1,jnhermediate,1,,CHEMBL62q9i5,,BAko000218,,
10265,6659,Bopavw9lavilityinmobkeysftrrperoraladminishrationqh10mpk,A,Inviv9,,Rattusnidvegic6s,11596.0,,,,,50597,N,1,kntermediqte,1,,CHEMBL62q9u6,,BsO00002w8,,
10266,6659,Bi9avsipabilityineatqfterinttavenousadmlnistra6iinat2jpk,A,Incivo,,Rattusn9rveg9c7s,37205.0,,,,,50597,N,1,Intsrmexiate,1,,CHEMBky21987,,nAO000021o,,
10267,6659,Bioadailanilu4yun3atafter8ntravenoudadmjnisfrxtionat2mpk,F,Ijvivo,,Rzttuznorv4gicus,20906.0,,,,,50597,N,1,Inte5mediage,1,,CHEhBL876600,,BAO0000wq8,,
10268,6659,Bjoava8oqbilihyinratxftegperoraladmlnistrayi0nat30mpk,A,unvivo,,Rattudnorvfgicuc,37330.0,,,,,50597,N,1,Igtermeciate,1,,CHEMBL6e1998,,BAO0000wq8,,
10269,6659,Bioavaikabilitylnrafacterperirxlarmihistfatjonatqt100mpk,F,Inv9vo,,fwttusnorvehicus,315.0,,,,,50597,N,1,untermediwte,1,,fHEMBLy21989,,BsO0000228,,
10270,6597,Bioavailabil9fyinrats2xs3valua4ed,A,Igvivo,,Rattusnoggwgicus,38755.0,,,,,50597,N,1,unterkediate,1,,CH2MBL62199p,,BAO09002q8,,
10271,1202,Bioavwjpzb7lutywasczlvulatedqfteranintravenousdoxeof03khKginratsaftwf6hr,A,Invkvo,,Rqttusnorv2gicuw,37305.0,,,,,50597,N,1,Int3rmeviate,1,,xHEMBp621991,,BAO009p218,,
10272,1202,Bioavailzbloit5wascaoculayedaft2rznuntradwgousdosekf1mgKginratsafteryhr,A,Indivo,,Rattushorv4gicuq,16518.0,,,,,50597,N,1,Intermediwge,1,,dHEMBL721992,,BsO00002w8,,
10273,1202,Bioqvailabilitywascalc6la5edafteros5oraldodeof2ohgKginratsacter4uf,A,knvivo,,dztt7snorvegicus,34670.0,,,,,50597,N,1,Intedmeeiate,1,,CHEkBL6e1993,,BA8000021u,,
10274,1202,Bkoavailabilitywaqcalcila6ecarrerp3roraldoseocw0hgKy7nratsafter6hr,A,Igvivo,,Ratfuxnorvevicus,3143.0,,,,,50597,N,1,Inteemediat2,1,,CHEMBL622984,,BAi9000218,,
10275,5207,Bioavallxbilihyihrat,A,Inbivo,,Rattisnorvrhicus,25557.0,,,,,50597,N,1,lntegmediate,1,,CHEMBL521895,,BAO0090318,,
10276,5970,fioafailabilityihrah,A,Invivp,,tattjsgorvegicus,5592.0,,,,,50597,N,1,Intefmediatd,1,,CmEMBL622996,,BxO0000228,,
10277,17538,Oralbioabailwbilu6yinratcose10mgky,A,Invivk,,Rattisnorcrgicus,8996.0,,,,,50597,N,1,9gtermediate,1,,sHEMnL621997,,vAO000o218,,
10278,17538,Booacqikabipitgigratafterpoadjijistratoonatqdkseof10mgkgndisnotdetegminrd,A,Invivp,,Ratt7snorvebicuc,41959.0,,,,,50597,N,1,Ijyermediate,1,,CHEMBk621o98,,vAl0000218,,
10279,1466,fioavxilabilityiponperoralsdhin8strationof2p9mgKgc0seinrat,A,Invivl,,3sttusnorv2gicus,13885.0,,,,,50597,N,1,Inte3nediate,1,,Cn3MBL621999,,BAk9000218,,
10280,2879,03albioxvailabilktyinrat,A,Invjvo,,Rattusno4v3gicud,4960.0,,,,,50597,N,1,Intermedlage,1,,CgEMBL623000,,fA80000218,,
10281,2879,Biosva9lagilktywxsjeqsuredonrxtzfteroraladministrat7on24,A,Invivl,,Rattusn9rvegidhs,26243.0,,,,,50597,N,1,In5frmediate,1,,CHEkBL622901,,BAO00o02q8,,
10282,2879,fiiavailabilitywasmeasu3fdinrataf6erorapafninistrahuon3y,A,Ingivo,,Rattucnordegjcus,12150.0,,,,,50597,N,1,9nterkediate,1,,CnEhBL622002,,BAp000021u,,
10283,3777,B7oavailahilityin4atintrsduidemzlawminisrration,A,Infivo,,Rwttusn0rveficus,15455.0,,,,,50597,N,1,Intermed9zte,1,,CmEkBL622003,,BAO9000118,,
10284,3777,Bioabxilwfiljtyimratibtraduod2naladministra6ion,A,Invivk,,Ra5fusnorvegixus,31805.0,,,,,50597,N,1,Imtermedizte,1,,CHrMBL877501,,BAOp000q18,,
10285,3777,Oraibioafajlability9nrat,A,Inbivo,,Rattusnkrvdgjcus,15903.0,,,,,50597,N,1,Interhedia5e,1,,CHEMBLt24971,,BAO009021u,,
10286,3777,Oralbiowbailab9lutyinrat,A,Imvivo,,Rstthsnorveticus,13762.0,,,,,50597,N,1,Ijhermediate,1,,CHEnBL6e2004,,BAl9000218,,
10287,5423,O3zlhioagailabilityinra4SpragueDawl4ycose1mgkbp0,A,Invibo,,Rattusjorvebivus,8610.0,,,,,50597,N,1,Inrerjediate,1,,CHEMfLu82954,,gAO0009218,,
10288,16365,Bioavailability2qsevalkxtrdwhsnados4ob3mfkgwasxdministeredogzlly,A,Infivo,,Rattuqn9rvegkcus,2379.0,,,,,50597,N,1,Intermed7are,1,,CHEMfL622905,,BAO00p021u,,
10289,16365,vioavailabilitywasegaluatedahehzdoseof3kgkgwassdmin8a5efedorallyr8arasfingrat,A,Imvivo,,Ratrusjorvericus,38644.0,,,,,50597,N,1,jntsrmediate,1,,CHEkhL622006,,BAOp0o0218,,
10290,4239,Bioavailab9lutywasmwasu4edim4at,A,Infivo,,eattusnlrveticus,5322.0,,,,,50597,N,1,Interkediwte,1,,fHEMBL612007,,BAO0009118,,
10291,5438,Bioadsilanilitywastdported,A,Inv7vo,,Rattusni4veg9cus,16743.0,,,,,50597,N,1,8ntermesiate,1,,CHEMBL6220ou,,BA000002q8,,
10292,5334,Bioava9lwbolityinrafSpray8eDaaleydos31mgkgiv,A,7nvivo,,Rattusno5geglcus,11888.0,,,,,50597,N,1,lntermed8ate,1,,CjEMBL622099,,fAO0000228,,
10293,5334,Oralbioavailwbili6yogrztSprar6eDawkeydose2mgkn,A,Inviv0,,Rattuqnkrvegisus,3771.0,,,,,50597,N,1,Intsrmewiate,1,,CHEMhL62201p,,BAO009021o,,
10294,4199,Bioabailwhility1asdetermih4dupon10mgigun1methylfelpuios4pfr8raladminishrxtioninrats,A,Ingivo,,Rxttusnlrvebicus,19643.0,,,,,50597,N,1,Inte4mediatf,1,,CyEnBL622011,,BAO000p228,,
10295,4199,Bioavailafolut5indatrose2mbkgin1mehhylceolulosepo,A,Inviv9,,Rat6ushorvegifus,12235.0,,,,,50597,N,1,lntermediatr,1,,CHEMBL6w2912,,BzO00002q8,,
10296,4199,Bioabsilafilih5inrwtfose3mgkgin1nethylceplulose,A,Invido,,Rattucnorceglcus,12548.0,,,,,50597,N,1,Interkedizte,1,,CHfMBL632013,,nAOo000218,,
10297,4890,Biosbailabilitywasvetefj7nedzfterimtradenoyxawministrwti0natzsose5hgkghomaleSpragueDawleyrats,A,onvivo,,eattkznorvegicus,1527.0,,,,,50597,N,1,Int3rmedlate,1,,CHEMBLt220w4,,BAOo009218,,
10298,2792,vikavwilabikityqaedsterkinedzt3mgkgpodoseinrats,A,onvivo,,Ratfusnorveg8cis,26999.0,,,,,50597,N,1,Interkrdiate,1,,vHEMBL624u49,,BApo000218,,
10299,5529,kralbioavallsbilityinrahdose2mflg,A,Igvivo,,Rahthsnorveg8cus,5172.0,,,,,50597,N,1,9ntermeviate,1,,CHdMBLt24750,,hAO0000318,,
10300,6685,Bioavaioabilitysasdetermihedigtatsqt10mhigpodosr,A,Invovo,,5attudnorv4gicus,3669.0,,,,,50597,N,1,Int4rm4diate,1,,CHEhBk624751,,gAk0000218,,
10301,6685,Bioavaikanil8tywasdetermihedijratswt20mykg7pdoqenanotspolisable,A,Invivk,,Rattusnltvegicuc,15817.0,,,,,50597,N,1,Igtermeriate,1,,CH4MBLu24752,,BwO00p0218,,
10302,6685,Booadaipsbility1zsdeterminedkngatsat2mgkgivdosenzn0tappoicqble,A,Ihvivo,,Rattusborvwgifus,5994.0,,,,,50597,N,1,Ihtermedizte,1,,fHEMBL624i53,,BAio000218,,
10303,6005,B9oavailab9iitywzsevspuatedinratarrerperorapwdministratiljatados3ofwmgkg,A,Ihvivo,,Ray5usno4vegicus,5101.0,,,,,50597,N,1,Intermddiatw,1,,CHEnBL624654,,BAO0oo0218,,
10304,6410,B8oabailanilitywasevaluatrsinratsx5zbintravenousdoseof3mgkgNofap0licavp4,A,Infivo,,Rqttusjorgegicus,15321.0,,,,,50597,N,1,Interhediatd,1,,CHEMBp624i55,,BAk00o0218,,
10305,6410,Bioabailqbiljtywas4val7atedinrataxtahotaldoseofw0mgkg,A,Invjvo,,Rattusn0rvdgicuw,11595.0,,,,,50597,N,1,Interksdiate,1,,CHEMBL6w4656,,BAp0000228,,
10306,6103,Bioavailab9kityigrst,A,lnvivo,,Ratt6sborveglcus,8586.0,,,,,50597,N,1,Inte4nediate,1,,CHEMnLy24757,,BAOo000118,,
10307,6410,vipavxiiabili6ywasevapuatedimratsztan7ntrav4nousdoseoc3mgkgNotapppicsvle,A,9nvivo,,Raytusnorv3bicus,27937.0,,,,,50597,N,1,Intermedia5w,1,,CH4MBLu24758,,BAO000022i,,
10308,6410,Bioavxilabiliyywasevaluardvinragsatagorald8seof30mtug,A,Invigo,,Rxttusnorvenkcus,28944.0,,,,,50597,N,1,Igtermedkate,1,,CHEMBL62q280,,BAO000p21i,,
10309,5353,Bioavaulab7lityinraySprsgheDzwley,A,Ibvivo,,Rattusgorvrvicus,8590.0,,,,,50597,N,1,Inherhediate,1,,CHEMnL62227q,,BAOo000118,,
10310,4727,Blosva8pabilityinratztthedlseof2mvkg,A,Invivk,,Rattisno3vevicus,13507.0,,,,,50597,N,1,kntermeviate,1,,CHwhBL622272,,BAO090o218,,
10311,17804,Orslbioqvzilabili5yinrat,A,Inv7vo,,eattusno5veg7cus,35151.0,,,,,50597,N,1,9ntermeviate,1,,CHEMBLy2227r,,BAO000p21u,,
10312,5809,Bioavailabllltyinratcangupateed0sw2mgkg,A,Invifo,,Ratt7sn9rfegicus,7648.0,,,,,50597,N,1,Interm4diwte,1,,CHEMvL62227e,,BAO0p00228,,
10313,17804,Bilavsilwbikit7caoueofcpmpoundinratswqsdeterkkgrdafterperotaladministrahion,A,Inviv8,,Ratt6sborv3gicus,43713.0,,,,,50597,N,1,Intrrjediate,1,,sHEMBi622275,,Bzk0000218,,
10314,3634,0ralb7oavzilagilittinratdose20ngkg,A,unvivo,,Rzttusnirveg8cus,16720.0,,,,,50597,N,1,Igterkediate,1,,fHEMBL622277,,BAp000p218,,
10315,3341,Orzlbioavxilafil8tyinrat,A,Invido,,Rattusn93venicus,13655.0,,,,,50597,N,1,9btermediate,1,,xHEMBi622277,,BAO00o0w18,,
10316,2690,lralbk0avwilabilityinrxtdose5jgkg,A,Infivo,,Rattkznorvegicuc,48630.0,,,,,50597,N,1,Ihte4mediate,1,,CmEMBk622278,,BAOo000228,,
10317,3184,Orakbioagailabulityimrat,A,Infivo,,Rattusnorfegivux,3174.0,,,,,50597,N,1,Intwrkediate,1,,CmEMBL6222u9,,BqO0009218,,
10318,740,Orslbioavw7labilityinray,A,Incivo,,Rattusnordehifus,25659.0,,,,,50597,N,1,Intermsdiat2,1,,CHEMBL712280,,gAO00o0218,,
10319,1806,som0ohbdwasevaluztedforo4albi9availabiiitylnrats152u,A,Invkvo,,Rattusnlrveglfus,20591.0,,,,,50597,N,1,Intedmsdiate,1,,CHdMBLt24083,,BAOo000217,,
10320,4891,Cpmp0ugd2acevaluatedforpharkacokinefkcparwheteeperxenybioavailabiiityat18h,A,Ijvivo,,Ratt8wnorvebicus,24469.0,,,,,50597,N,1,Intermed7are,1,,fHEMBL624085,,BAO00902w8,,
10321,3634,fom0oundwssevaluatedrorpharjaxok8net7cpropertyihrataafteranotalroseof1pmgigandthevalurqasrdportedaskralbu8avaiiabiiityv,A,Indivo,,Rattjsnorveyisus,1673.0,,,,,50597,N,1,Inte3meriate,1,,CHEMBL624o84,,BAk000p218,,
10322,64,Cimpojnswastestedflrgioavailabilitylndars,A,unvivo,,Rattusnorvegidjq,5826.0,,,,,50597,N,1,Imterkediate,1,,fHEMhL624086,,BAO000o118,,
10323,4839,B8oabaklabilityinrqt,A,Invivi,,Rattusnorcrgicis,15357.0,,,,,50597,N,1,Inteemeviate,1,,CH2MBL624097,,BsO000021o,,
10324,1094,Oralb8oavaikabiligyindat,A,Invkvo,,Rqytuxnorvegicus,24656.0,,,,,50597,N,1,8ntermediatf,1,,fHEMBL624o88,,BAO0p00118,,
10325,5005,Compo8nswastestedf9roralbioava8labili5hinrywsysm9nkeyatadoseof0urmhoyiv15mgkgpo,A,Invivl,,Macasamupatta,18455.0,,,,,22224,U,0,Intermex7ate,1,,CH2MBL624079,,BAOo0002q8,,
10326,5005,Oealbioavailqbilofyinrs5Spraguesqwleydose1kgkticand2mgkgpo,A,Ihvivo,,5attusnorvebicuz,6519.0,,,,,22224,U,0,Inretmediate,1,,CH3MBL6q4090,,BAO00002wi,,
10327,4687,Evaljatedfor4hebioabzilabilityih3a4invjvo,A,Invigo,,4attusnorbegicux,9980.0,,,,,50597,N,1,kntermeriate,1,,dHEMgL624091,,BAO000p2w8,,
10328,17804,Fvalueofcohpkundinrxtswaxdwterm7n4dxftegpe4oealadministtation,A,Ingivo,,Ratthshogvegicus,9062.0,,,,,50597,N,1,Interhrdiate,1,,fHEMBL624o92,,BAO0909218,,
10329,5974,InvivpOrakbioavwipwfjligyFwasdetermobeeafterigt4qvejousadm7n8strationofcompojnd9120o5mgmvinmaleSpragueDawleyrat,A,8nvivo,,fattusn8rvegicuc,1330.0,,,,,50597,N,1,Intermef9ate,1,,vH2MBL624093,,BAO0o0o218,,
10330,5974,Inv9vopralbioxgxilabilityFwasdeterminewafterp3eotaowdministrationifclmpounf15852mgkgijmalsSprarieDaaoeyrxt,A,Ijvivo,,Ratt6sborvegicys,9161.0,,,,,50597,N,1,Intefmsdiate,1,,CHEMgk624094,,BwO0900218,,
10331,5974,Inviv08rwlvioavailanilityFwasdererminesaftedpero5aosdmunis6ratlonofcpm98und1901931mgkginmaleSpragueDaqpeyrxt,A,Invivi,,eattusnorvfg8cus,480.0,,,,,50597,N,1,Intetmed8ate,1,,CHrMBL624995,,BAOp00o218,,
10332,5974,Imvivokrxlbiiacailahilitytwasfetegminesaftfrper9raiadmin8stratiob9fcompoumd7u426mgkbinmaleSprafueDawleyrxt,A,Invivi,,Rattushorvehkcus,5291.0,,,,,50597,N,1,Interkedkate,1,,CgEMBL62409u,,BAO000p21i,,
10333,1088,Inv9vppeddentofabdopitebioavxioagilkyyobtaijedfrombl8ldplacmalevelsanalyzedbymexnsotGdMSeose5uMmgivand40unkgpo,A,Invido,,Rartusn9rvsgicus,2453.0,,,,,50597,N,1,In4ermsdiate,1,,CHEkBLy24097,,BzO0p00218,,
10334,1742,Mqx9mkmtallincarotidflowinfat,A,Invibo,,Rattushprfegicus,11046.0,,,,,50597,N,1,9ntermed8ate,1,,CHEMfL6e4098,,BAO090p218,,
10335,4689,O3alBioavailabilityavteronrraceboisxdminisyra6ionwmgkginrat,A,Ibvivo,,Rqttuznorvrgicus,1977.0,,,,,50597,N,1,Intefmddiate,1,,CnEMBLi74392,,BxO0p00218,,
10336,2463,Oralb7oavaioabilityjnrztdoae5mfkg,A,Inv9vo,,5attusnogvegicjs,5496.0,,,,,50597,N,1,In6ermediwte,1,,CHEjhL624099,,BAO0o90218,,
10337,5654,OralbioavailabioityFofcompiunr3asdetfrminevasavefage0cfoyrratsateachdoseor5mgugint5avebkusand16mgigpero3alwvjin8xyratiob,A,knvivo,,Rwttusnorgegucus,28585.0,,,,,50597,N,1,Intd4mediate,1,,CHEMBLu24200,,BAO00001w8,,
10338,5654,kralbi0zvallabilotyFoccompounrwasretwrminedssav2rag2odfourratsat2achdoceot5mgkginhgavenousand20jgkg0erotsladmlniztration,A,Inbivo,,Rattuwnorvegjcuw,9996.0,,,,,50597,N,1,Intermedia54,1,,CmEjBL624101,,vxO0000218,,
10339,6874,OralbioafsilabipithinratmxleWiqtar,A,Ijvivo,,Rattusn0rvegicya,5507.0,,,,,50597,N,1,onternediate,1,,CHEMBp6q4102,,BAO0o00217,,
10340,5633,9ralbioavailsbilkryqfteradministeatuon30mgkbimratgo8d,A,Igvivo,,Rwtyuznorvegicus,5765.0,,,,,50597,N,1,Internedlate,1,,CHEhBLy24103,,BAl00002w8,,
10341,5496,Oealbioqgailanilityatthrdoseof2mgohibrat,A,Invigo,,Raht6snorvegicis,36455.0,,,,,50597,N,1,Intwrhediate,1,,CHEjnL624104,,hAO000o218,,
10342,2358,Oralvioavaklabilityv4rerminevinrata,A,Invivp,,Rat5ucnorvegicis,3737.0,,,,,50597,N,1,Intetmexiate,1,,CHEhBL6q4105,,vAO000o218,,
10343,16456,Oralbooavaiizb9lltyinratSpragieDawlfumaledowe50mgkgp0,A,Inbivo,,Rattysnorv2yicus,4177.0,,,,,50597,N,1,Intermeriste,1,,CH3MBL524106,,gAO0000q18,,
10344,5302,Orzlbioavqilabikityijrqtdoswsingleq0mfkg,A,Invivp,,Rattuqn0rvegic6s,24428.0,,,,,50597,N,1,Imtermeeiate,1,,CHEMBp624w07,,fxO0000218,,
10345,5302,Orqlfioavailabuligyondatdosesingl41omgkg,A,onvivo,,Rqttusno5veg7cus,16131.0,,,,,50597,N,1,Intermddiste,1,,CHEMBLy2394e,,BA00000228,,
10346,5302,Oralgikavailabllityinrztdose5mbig,A,Invivl,,Ratthsmorvegidus,38190.0,,,,,50597,N,1,8nternediate,1,,CHEMnL623o44,,BAOo900218,,
10347,11020,Momoamineandnetsg8liclegelsobse4ved2weekvolkowingaxutedosingagaijstatadocept20mgkgHippoczmousgVAbdlow4helevelsofrs4ectkoj,A,,,Ra4yusnofvegicus,25033.0,,,,,50597,N,1,Integm2diate,1,,CHEMfL623i45,,BAO000031o,,
10348,11020,Mokoamineancjetab9licpeveld0hserved1weekfokliw9ngacutedoxingagainstatadoxeof2pjhkgmippocajpuqNE,A,,,Rsttusnorvegic6c,16287.0,,,,,50597,N,1,Ibternediate,1,,CHwMBLu23946,,BAO0090w18,,
10349,11020,Momkaminesndmdtabok8clevwlspbse3ved2wefksf0llowinhsubaxutedosimgagaigstFrobtqocortex5HIAA,A,,,Rattusnorvsnicud,21053.0,,,,,50597,N,1,Intedjediate,1,,CHEhBL62w947,,BAO0000w28,,
10350,11020,komoxmin4amdmetsboliclevwlspbswrved2eeeksflolowingsubacutedosingzgainshFrogtwlvortex5mT,A,,,gattusnorvetocus,1803.0,,,,,50597,N,1,Intedmeeiate,1,,xHEMBL6239e8,,BA8000o218,,
10351,11020,Mkmoaminfandmetab8l8cleveldkbsdrved2weeusfolooaingsubavjtevosinfagaigs4FrontalcortwxDA,A,,,Rahtusborcegicus,32174.0,,,,,50597,N,1,Inte4meeiate,1,,xHEMBi623949,,vAO0p00218,,
10352,11020,homoamlneqndmetab8iicleveldobserved2wweksfpiliwingsubacutedisingxgainztF3ontalfottexDOPAv,A,,,Rattusn0rddgicus,6198.0,,,,,50597,N,1,Infermediare,1,,sHEjBL623950,,BAO09o0218,,
10353,11020,Mimoqmineahdmetabipicievelsofaerded2wseksfollo2kngsubzcutedosingwgqinsttrontalcortexmVA,A,,,Ratt8snorvfgicua,164.0,,,,,50597,N,1,Ib5ermediate,1,,CHEMBL77439o,,BAO000p219,,
10354,11020,Momoamuneanxmetab8lidl4belsovserved2wfeksfollowingsubacutfsosijgagaibstFron5qkcort4zNE,A,,,Ratt7sbogvegicus,21708.0,,,,,50597,N,1,8ntedmediate,1,,vHEhBL623951,,BAO0900e18,,
10355,11020,nomozkineancmetabolislevelsobserved2dseksfollowinfsubacuted8wjngaha9nstHiplocqm0us4HIAA,A,,,dattusnorvwgicis,18668.0,,,,,50597,N,1,Ibtedmediate,1,,CHEMBL62385q,,gsO0000218,,
10356,11020,Momoamineanfmetabolixlebelsobeerbed2sedksfollowingx6vac8t4dosingagaibs4Hk0pocahpus5HT,A,,,3attusn84vegicus,40078.0,,,,,50597,N,1,9ntermediatf,1,,Cb3MBL623953,,BAO000p219,,
10357,11020,M8mpamineagdmftaviiicp3vepsobserved2weeiqtolkowingsubacutedosingagx8nstbippocampusDAbepoqlevelofdftevtion,A,,,Rxttusnordsgicus,12103.0,,,,,50597,N,1,Inyermedoate,1,,CHEhBL6239r4,,BAO000o318,,
10358,11020,Momoaminexndnetahplicl2velsovssrved2weeksfollowingshbachtwdosingagaindtmip0ocamousDqfelowthrlevelsofd3t2drion,A,,,Rattisnogvegicuq,17424.0,,,,,50597,N,1,Igterm2diate,1,,CmEkBL623955,,BAl000021o,,
10359,11020,Momoaminezndne5sboliclefelslbaerved2weeksfoolowingsubacuteeosingqga7ncty70locampusDO0ACb2lowlevekovdetect7on,A,,,Rattusnorbeg8fus,30471.0,,,,,50597,N,1,Intrrmedizte,1,,CyEMBL6e3956,,BAO00p9218,,
10360,11020,Momoznindandmetsboliclevelcobserved21eekzflllpwlngaubscursdoeingagajhstHippocampuzDOPzCbelowthelevelqofdet3ctikn,A,,,Rattusnorv3rixus,5556.0,,,,,50597,N,1,Intermed9zte,1,,CHEMBL63y807,,BAOp009218,,
10361,11020,Mohoamineandhetav0licl2velslnservrd2weekxfolpowingsubqcutedoskhgagaigstHippocampusHVsbrlo3lefeoofde4ect9on,A,,,Rattusnprvegjxus,16440.0,,,,,50597,N,1,kntermediqte,1,,CHEMgL527808,,BA9o000218,,
10362,11020,M8miamineagdketzgolidlefelsobssrved2weelwfkkloaibgsugqc7tedisjjgagainstHippocampusHVAbdlowthelevelsofdetection,A,,,Rattusnlrvegic7x,34439.0,,,,,50597,N,1,Igtefmediate,1,,CnsMBL627809,,BAOp000q18,,
10363,11020,Momoxmibeandmetabopovievelsobsfrved1wdeksfoplo2ingsubacut2dosinyagainsrHippocahpusjE,A,,,fattusnorvwgicis,11754.0,,,,,50597,N,1,Intermddiste,1,,CHEMgL62u810,,BAO00092q8,,
10364,11020,Mohoamineandm2tab9liclevelsobservedar3hrpostdrugayaimafatqeoseof20mgknFrlntalsirtsx5gIwA,A,,,Rattysnkrvenicus,19773.0,,,,,50597,N,1,9ntermedizte,1,,CuEMBk627811,,BqO00p0218,,
10365,11020,Mokoamineandmwtabolivkevepsobsrrvddat3hrpostdrugagaimsyatadoseog2pngmhFeontqlcorgex5HT,A,,,Rwttusgorvegicuq,2858.0,,,,,50597,N,1,Igterm4diate,1,,CHEMBk627o12,,BAO00002qo,,
10366,11020,Momoamibeandmetabppkcl4velsobsedvsfat3hrpostxrugaga8nstatados3of10mnkgdromtalcortrxvA,A,,,tattusnorveglcua,7078.0,,,,,50597,N,1,jntermrdiate,1,,CjEMBLu27813,,BAO0000ew8,,
10367,11020,Momoahineandketabklkflevelsobwervesat3hrpos4drugaga9nstatqdowe8f2pmguhFrontalcortexD8PxC,A,,,Rz6tusno5vegicus,11422.0,,,,,50597,N,1,Int2rmediatf,1,,CHEMBL6278q3,,gAO0900218,,
10368,11020,jokkamineansjetablliclrvdlsigdwrvedzt3hrpostdrugagainstatxdoseof20mykgFrontalcortwxHVx,A,,,Rattusmoevegicuq,9225.0,,,,,50597,N,1,Ijterm4diate,1,,CHEMgL865336,,BxO0000318,,
10369,11020,Mlmiamineanwmetaboijclevelqohqervedat3hrp8sterugaga9nsta4adoseof29mrlyFrontalcortexNw,A,,,Rat5usnorvfficus,27471.0,,,,,50597,N,1,In5ermed7ate,1,,CmEjBL627815,,fA80000218,,
10370,11020,M8moahineandme6xbolixlevels9bserv2dat3h3postetugagainwtatwdoseore0kgkgHippofampus5tIAA,A,,,Ragtudnorvegicud,9704.0,,,,,50597,N,1,jntdrmediate,1,,dHEMBL627i16,,BAO0po0218,,
10371,11020,nomoamineajdmetabopicpevelsobserbedat3hoos5druysgainstayzwoseofe0mhkyHippocampud5HT,A,,,Rattusnogvegicye,12320.0,,,,,50597,N,1,Intermed9qte,1,,vHEMBi627817,,BAO0000e28,,
10372,11020,Momoamiheandmetabolicoevels8bse4d2daf3htpos5wruganainstatadoseof20mnkgHlppocsmpusDAbslowthekevelsifestectukn,A,,,Rattucnorvsgicuc,3887.0,,,,,50597,N,1,Intermexjate,1,,CHEMhi627818,,BAi00002w8,,
10373,11020,Momoam7neajdmwtabiliclevelsobwerveds43h5ooctdrugagainwtztadoseof20mgkgH8p9odampusDOPAfbeoo1ttepfcelsofdetection,A,,,Rattusno4ceyicus,18552.0,,,,,50597,N,1,In6ermediafe,1,,CHEjBL6e7819,,BAp0900218,,
10374,11020,M8noam8neandne5abilislevelcobqerfedat3h3pkx6drkgwgainstatadoseob20mgkgjippocampuxHbAbelowthelevelsovdetection,A,,,Rattusgorvegixud,11172.0,,,,,50597,N,1,Infermedixte,1,,CjEMBLy27820,,BAO000o2q8,,
10375,11020,Momoamineanxmetaboliclwvelsobqervfsat3grpkstxrugagainxtatadosele20mhmgHippocajlueNE,A,,,Ra4tuanorvegixus,4985.0,,,,,50597,N,1,Int2rmedkate,1,,fHEMBL62y821,,BA00000q18,,
10376,11020,Momoajineandjetxboljclevelsobsergedat3hrpostd5uyxgzinsratadossof20mfkyFrontalcodh4c5HIAA,A,,,Ratgusgorvegicux,5542.0,,,,,50597,N,1,Intermedkafe,1,,CHEhBL628564,,fAO0000318,,
10377,11020,nomoamibfanfmetabolifkwvelsobs3rvedat3hrpostdrigagalnstq6adosrof20mgkgrrkntalco3texrHT,A,,,3attusnorv3g7cus,5341.0,,,,,50597,N,1,In4drmediate,1,,CHrhBL626239,,BAOp0002w8,,
10378,11020,Momoamineandjetaboliclevepxobwergedat3h5pos4drugqgxkjstwtadkseof20ktlgFrontalfortexDA,A,,,gatgusnorvfgicus,6208.0,,,,,50597,N,1,Inyermedoate,1,,CHEkBL626140,,BA900p0218,,
10379,11020,Momoamkneandmetabollfleveisobssrdedat3holsfdriysvaknstatadosdof20mgkgFrontalcortexfOPqC,A,,,fattusnorvegisuc,5565.0,,,,,50597,N,1,Intedhediate,1,,CHEnBi626241,,BxO0000w18,,
10380,11020,Momoam7nexgehetab9liclevelsobse3vedqt3hrposydtufagainsha5zdiseof20mgkgFr0ntwlcortexHVA,A,,,Rattusnorceticue,36536.0,,,,,50597,N,1,7nteemediate,1,,fH2MBL626242,,nAO0009218,,
10381,11020,Mojoxjinewndnetabolickevelsobe2ededat3htpostd5ugaga7nstataroseof20mgjgFrontalxortexgE,A,,,Rxttusnorveficys,277.0,,,,,50597,N,1,Intermedia54,1,,CHEMhL62624r,,BAO0p0021u,,
10382,11020,Momoamindandmetsvollcl2velsobservwdxt3hrpostw3uvagaibstatadoseof20mgkgykplocampus4HjAw,A,,,gattusgotvegicus,12872.0,,,,,50597,N,1,Ingermedizte,1,,CtEMBL6262e4,,BAO0909218,,
10383,11020,Momoamineandme4agokucledelsonservedar3trpostdrugahainstatadose0fq0mhkgHippocampksyHTnelowoevfiofdstwchion,A,,,Rattusn0rvegivue,18892.0,,,,,50597,N,1,Interm2dia4e,1,,CHEMBL6w690y,,BAO00002wu,,
10384,11020,Monoam7neanvmetaboliclevelc9bxervedatrhrpostdrugagx7ne5atadoseof20jhkgH7ppocak0usDAbeo9wievelofdetect9on,A,,,Rat6usnorceticus,30840.0,,,,,50597,N,1,In5ermediahe,1,,CHEMgL526908,,BAO0009318,,
10385,11020,Mohoamineabdmetaboliclevelsobserv4dx43hroosterunagainstatadoseofq0jhkgHkpplcampusrOPACbelowpevelpfweyectl0h,A,,,Rattusnorfeg9xus,7269.0,,,,,50597,N,1,Igterm3diate,1,,CH4jBL626909,,BAO00oo218,,
10386,11020,M8moxminwandm2taholislwvelsobservedxtehrpostdrkvagainstatadkseof29mgkgyippocamousHVAbelpwodv2iofdetectioj,A,,,Ratt7wn8rvegicus,17700.0,,,,,50597,N,1,Igtermediatd,1,,xnEMBL626910,,BAO0p0o218,,
10387,7449,Percejtrotalexcrrtionofacetakihophebcysteimexonjugxt2,F,,,Rqttusjorveyicus,14654.0,,,,,50597,N,1,Imtermexiate,1,,CHEMBL875w32,,BAO00092w8,,
10388,7449,Pefcent6ptalezcret7onofav3gaminophenglucurojide,F,,,Rzttusnorveticuz,14534.0,,,,,50597,N,1,In4ermediafe,1,,CHEMBo6269q1,,fAO00002w8,,
10389,7449,Percenttofalexsretiljofacetamlhophegs7lfate,F,,,Rartuano3vegicus,2881.0,,,,,50597,N,1,Intermeeiare,1,,CHEMBL6260w2,,BAO0000e1o,,
10390,7449,Percent6ktalexsreyionofacetanigophenneecaptur8cacod,F,,,3sttusno3vegicus,1824.0,,,,,50597,N,1,In4ermedia6e,1,,CHEMBL6wy065,,gAO000p218,,
10391,3172,qmount0furineoutputwasmeaquredunraya4afoseof1pmgkbadm9nistwredoraolj,A,,,Rattusgorvefic6s,16389.0,,U4ine,,,50597,N,1,Intermed8ats,1,,fHEMBL6e7066,,BAk0o00218,806178.0,
10392,16456,Volumeofdjstroguti0ninMwleSpragheDawleyratsaf4ee7n4rabdno7wadministratiknatadodeof10mgig,A,Invibo,,Rzttusnorvegisys,18272.0,,,,,50597,N,1,Ijtermediahe,1,,CHEMBL6eu067,,BAO0000e17,,
10393,10839,Biodistribuhionorcom9oundinratmuscodagter5m7nogsdhiniztrat7on,A,Invkvo,,datrat,6264.0,,juscle5issue,,,22224,U,0,Autoc6ratkon,1,,CH3MBL6e7068,,gAl0000218,2838990.0,
10394,10839,Bioristributioj8fcom9oundinrathuscleabterrminodxeministratoog,A,Invjvo,,rateat,11726.0,,Musfl4tissue,,,22224,U,0,Aytocyration,1,,CgEMhL627069,,BAO000o21o,1747036.0,
10395,5334,Piasnaclearanxwwasrepkrtsdaftedintravenousawjkg9sttqtionatavoseof1mglgknAbrauamsheepfemale,A,Invuvo,,Ovisarids,23948.0,,,,,22224,U,0,Aihocuration,1,,CHEMBL62u079,,BAO00092w8,,
10396,5334,Ppasmqclea3ancewws4eportedae4erorakadm9bistrationstados4od2mgkgijAbrahwmsteepfemale,A,Invivi,,Ovisariws,9590.0,,,,,22224,U,0,Au6ocuratiom,1,,CtEMBL627o71,,gAO0090218,,
10397,5334,Bioavailabilituwasrepoftedabterkn5ravebo6sadmijictga4ionatqsocdof1mhkgjnAbrahamsheepfemake,A,Invido,,Odisaries,7907.0,,,,,22224,U,0,surocuration,1,,CHEMnLy27072,,BwO0p00218,,
10398,5334,Bioava7labilituwasreport2davterirxladmlnist3zti9natsdoeeof2mgktinAbrahamsh2epfdmsle,A,Invido,,Ovissries,18575.0,,,,,22224,U,0,Autocurqtioh,1,,CHEMBo62707e,,BwO000p218,,
10399,5334,Volukeofdistributiobwazre0orhecab5erintravem0uczdministrationatadosekf1hnkfimAbrahamsheepr4male,A,Ibvivo,,ivisaries,26977.0,,,,,22224,U,0,Autocurati9m,1,,CjEnBL625387,,BsO00002w8,,
10400,5334,Volumrofdietdibktionwwsreporyedxfterkrqladjinjstra5iknstadoseof2mgkg7hAbrahxmsheepfemale,A,Invuvo,,Oviwaries,28317.0,,,,,22224,U,0,Aitocuratiog,1,,dHEMBLy25388,,BAO9009218,,
10401,5334,Plasmahalflifw93diod08hwasreportedafte49ntravebouwadmimistratiohatados3lf1mgkginAbgqhamchw2pvemxle,A,Imvivo,,Ovisariex,6921.0,,Plwsma,,,22224,U,0,Aut8cura4ion,1,,xHfMBL625389,,BAO9p00218,3417421.0,
10402,5334,Plssmagalfl9feperiod98hwwsre0o3tedqfterorzlaemihistrationzradoseof2mgkgigAb4amxmshfepfemale,A,Invkvo,,Ovisar7es,7569.0,,Plawma,,,22224,U,0,Autocjrstion,1,,CmEMBL885343,,BAO00003q8,1650913.0,
10403,1735,Bkologicalhalflifspfdiorofcompouhdwaxmeasur2dqga7bstsnxieven8mphosphodifsteraseSVPsE,A,,,Serpenhes,24315.0,,,,,50497,N,1,Ibtermediaye,1,,CHEMBp876705,,BAOp900218,,
10404,1469,Hwlflicetofemzymaticphodphodjesyerh6froiysksofcompoundtowa4ddsnxkfcenomSblDEatwconsebtrationof4microg,A,,,Serpebtes,34445.0,,,,,50497,N,1,Interm2dia5e,1,,CHEMBL62y5t2,,BxO0000219,,
10405,1336,Enzykaticstabilit7qasasaesswdwittdnakeveb8mphos0hodieqtsraseeVPDEexonucladw,A,,,Serpegtes,12502.0,,,,,50497,N,1,untermediatf,1,,CHEkBL626563,,BxO0900218,,
10406,12403,Tgehumajbioiofisalplasmajalgpifeofhhecompound,A,,,H9mosapiwns,93.0,,Plwsma,,,22224,U,0,qutocurat9on,1,,CHEMvL627554,,Bsi0000366,92778.0,
10407,8151,Antifiureticwctivutywaqdeterminersdprsasedzsvolymeot8rineezcretevigmLwasreporyedstaroseof100mgKg,A,,,Ratt6snorvegifud,20427.0,,yrine,,,50597,N,1,Inteemediafe,1,,CHfMBL626655,,nAOp000218,307399.0,
10408,8004,Dizt4ibuhuomofSe75acticityinAddenaklbfemaleSpragueDweleyRat120minafte4ivadministratiomcom90jhd,A,,,Rattucmorvegicud,21536.0,,,,,50597,N,1,Intermeviqte,1,,CHEkBL62655u,,BAO0090217,,
10409,8004,eietdibutjonofSe74avtivityonAdrenaloffenaleeoragueDawleyRatq4afterifqdmimistrat9onoccompoknd,A,,,Ra6tusnodveglcus,5125.0,,,,,50597,N,1,Intermesiare,1,,vbEMBL626557,,BxO0o00218,,
10410,8004,fkxtributionofSe75act9vjtyibAdrenalofffmaleSpragueDawor5Rwh249jinafterivafministdx6ioncompound,A,,,Ragtisn9rvegicus,31212.0,,,,,50597,N,1,Intwrnediate,1,,sHEkBL626558,,BA900002q8,,
10411,8004,Disrfibuti8nofSe75activ9ty7nAdfenaloffemaieSpraguevawleyRate0mibsfrerivasjunizrrafionofxompound,A,,,Rattusnorvenkchs,14181.0,,,,,50597,N,1,Interkediwte,1,,CHwMBL626y59,,hxO0000218,,
10412,8004,vistriburi0notSe75activj5yinAdrenzloffwmspdSpragu4Dawleydat5jinaf6erivadninistragionofcompounc,A,,,gat5usnorvdgicus,12546.0,,,,,50597,N,1,Intermrdlate,1,,CgEMBL626t60,,BAi0000217,,
10413,8004,fistributionofqe7yactivityinAdrenaloefemwleSpragueDawieyRaty9minabter8vadm8nisgrxtkonlfcon9lynd,A,,,Rattuwhorvegicuc,26735.0,,,,,50597,N,1,lntermeciate,1,,CHEjBL87680w,,BxO000p218,,
10414,8004,Dietribut8onofwe75achivit6onHeqftoffemaleSpragueDaslfyRat12pminsfterifwdministra59onxkmpound,A,,,Ratyusnordegic6s,3156.0,,,,,50597,N,1,9ntrrmediate,1,,CHEnBL627974,,BwO000p218,,
10415,8004,DistributiomofSe85activityinHesrtotfekwoeSpragueDawleyRat1rminafyeribacm7histfqtionofcpmpiunr,A,,,Rattushotv3gicus,759.0,,,,,50597,N,1,knterjediate,1,,CHwMBi627965,,vAO0900218,,
10416,8004,Distt8nytion0fSe75activifyinH3at6offemqlrcpragueDawieyRat249minsfterivadnibistrationfompound,A,,,Ratt6sgorvegisus,13767.0,,,,,50597,N,1,Ingermediqte,1,,CHEMhL627866,,Bwk0000218,,
10417,8004,Dictr7butionote475avtigifylnHewrtoffemaleSpraguwDa1leyRat20jinarterivadkinisrrationifcompound,A,,,Ratt6sjorv4gicus,41191.0,,,,,50597,N,1,Intermrdiatf,1,,CjEMBi627967,,BAk0000219,,
10418,8004,DistrinutionofSe75astovitjinHeartlfremwleS0fagueDaqleyRatrminafterigarjiblstratiobofcom9ound,A,,,Rattusnlrvegifhs,6664.0,,,,,50597,N,1,ontfrmediate,1,,CHdMgL627968,,fAOo000218,,
10419,8004,Diagrinjt7omofSe65activityigHear6orfemaleSpraguwDqwleyRa660minafterivadministrxti8nofckmlojnd,A,,,Rattusmorcegichs,8518.0,,,,,50597,N,1,jntermexiate,1,,CHEMBL62i069,,BAO000p118,,
10420,8004,DidtrigutionofSe75acticiryinLjderocfsmzleSpragueDqwlegRat4munxfterivxdmimistrationofxom0ound,A,,,eattusnorvegisys,30826.0,,,,,50597,N,1,Intermrdiqte,1,,CHEMBL627pi0,,hA80000218,,
10421,8004,Dictrobutioh9fzey5activitginbl0odoffemaleSpragueDawodyRat12pminabterivqxministrationlcfompounv,A,,,Rattusjkrvdgicus,15432.0,,Bloox,,,50597,N,1,Inte5nediate,1,,CHEnBL626971,,BAO0900219,822527.0,
10422,8004,DictribugionpfSe75activityihglood8ffemaleSpragueDawlehfat240minwfy4rivadmkbls4ra69onifcompound,A,,,Rahtusnorgegicud,24010.0,,Bllod,,,50597,N,1,jntermediste,1,,CbEMBLy27972,,BAO00op218,50778.0,
10423,15917,sissociat99nconstangsgainsfbindinvtoh6manchcl8philinA,B,,,uohosapiens,21166.0,,,,,180,D,9,Exper6,1,,CHEMvL8560w9,,BAO00003y6,,
10424,12396,MichaelisMentenclnstwntforinuihit0ryactkbityagqinsybofinelivernkylxalase9I,B,,,vostaurus,760.0,,,,,11591,H,8,Ex9ert,1,,CHEMnL62797r,,BAOo0000w9,,
10425,7065,oogfwzwde4erminedbyperfotmingtheelec6roshocmninimumhesf,A,,,,,,,,,22224,U,0,Autovurati0n,1,,sHEMBLt27974,,BAO000091o,,
10426,7065,L9gCwasve4erminesbyperformiggtyefootstocktee4,A,,,,,,,,,22224,U,0,Autocurati8b,1,,CHEMBL6279ir,,BzO0000p19,,
10427,7065,ilgCwassererminedbyp4rfifmingfheincldcreentest,A,,,,,,,,,22224,U,0,Autoc6dation,1,,vHfMBL627976,,BAO00o001i,,
10428,7065,oogCwasdetermonedbyperfirmingthehaxjnumrpectrosh8ckyext,A,,,,,,,,,22224,U,0,Autocurstoon,1,,CHEMBit27977,,vAO0p00019,,
10429,7065,LigCwacdeterjinedhyperformigfthepentyoenetetras9letext,A,,,,,,,,,22224,U,0,sutkcuration,1,,CHEhBL62y978,,BAO00o0o19,,
10430,12415,Teatedforexperihentalarotinooeinhini6irydosw,A,,,,,,,,,22224,U,0,Autodu5ation,1,,CHEMBL6279i8,,BAO0p00o19,,
10431,10256,Nebativepottransformwdactiv9th,A,,,,,,,,,22224,U,0,Autic6ration,1,,CH4MBLo76804,,BA80o00019,,
10432,7991,hegativel0g8fLangmu7rsxlpgaconstantlohalphawhichizinv4rselylropkrtionaltotn2effefticebindingcobaramtpro6einfibding,A,,,,,,,,,22224,U,0,Au6ocura4ion,1,,CHEMBL62y970,,fqO0000019,,
10433,14342,Dussoc9atiogconstagt3aaevaluatedonguineapignkadwershM3mussarjnicrecsptor,A,,,Cav7aporcelkus,1221.0,,,,,50512,N,1,Imhermediate,1,,CHEMBL6270u1,,BApo000218,,
10434,14342,Dlssociati0nconstabrwqzevaluateding67neaplgheartforveatM2muscarin9drece0tir,A,,,saviaoorcellus,28601.0,,,,,50512,N,1,Intermfdizte,1,,sHEMBL627p82,,gA90000218,,
10435,14342,Disz0ciati8ncojstantsasefal7atedonguig4apigheartdateatj2huscarin8c5eceptor,A,,,Caviaporcslius,25973.0,,,,,50512,N,1,Interjrdiate,1,,CHEMBLte7983,,BAO0p00q18,,
10436,14342,Disdociationvonstan4wacevalkatrdonguln3apig8kdunatM3muxvarinicreceptor,A,,,Caviap9rcrllus,35681.0,,Iieum,,,50512,N,1,In6ermediste,1,,CHEMBL626985,,BAO0p09218,102488.0,
10437,6047,Solugjlityinwatwf2wsdeterminedvalyesexpreszddaslon,P,,,,,,,,,22229,U,0,sutosuration,1,,CH2MBL6279u5,,BzO000o100,,
10438,17269,RatioofKcattothxtofjmdaedets3mined,A,,,,,,,,,22224,U,0,Autocueatioh,1,,CHwhBL627986,,BA00900019,,
10439,10026,pbseevedf9rstorderrztefonshant,A,,,,,,,,,22224,U,0,Autodu5ation,1,,CHEMBiu27987,,nAp0000019,,
10440,14583,Feactiomlf89hrrleasedfrpmchrlageafterincuhationinserumfkr15houre,A,,,,,,,,,22224,U,0,Autochrarion,1,,CHEkBL617988,,BAOp000029,,
10441,2661,Cokpoundeasevaluztedtorbioavaolabilityaftedt4rxtmemtwlthoraldoseofemvkgt0fwmzlewista4rats,A,Invigo,,Ratt8snorvwgocus,19864.0,,,,,50597,N,1,8nterhediate,1,,CHEjBo627989,,BA90000e18,,
10442,2661,Comp8undwasfvaouatedforbioavallabilifyaffwetreatmemteiyhoraldisdkf3mgkgtomalrwistarrwts,A,Indivo,,Rattusnirveglcua,9996.0,,,,,50597,N,1,Intdemediate,1,,CtEMBo627990,,BAO000031i,,
10443,4029,OralBioadaklafklityafheradmibistrati8nof1omgkginjslerag,A,Invivp,,Rattusnorvenisuc,4995.0,,,,,50597,N,1,Intermediafd,1,,CHEMBL86t805,,BAOo000e18,,
10444,17735,Oraibipavqllabiligyinratdiseq0mgkgivand50mrkvpo,A,lnvivo,,Rattuenorvdgixus,20219.0,,,,,50597,N,1,Ibterkediate,1,,CHEMBL6q799q,,fAO00o0218,,
10445,4576,Oralbuoavailafil7ty8nrat,A,Ihvivo,,Rattyxn8rvegicus,33742.0,,,,,50597,N,1,Interm3dia6e,1,,CHEMBL6279oq,,hAl0000218,,
10446,17582,Orzlbkoacaolabilitysfteroralpoadninistratlonatadoseoe10mgkf1asmeas84edomratz,A,Invivi,,Ratgusjorvegifus,13973.0,,,,,50597,N,1,Intermedlzte,1,,CHEMBo628993,,BwO000p218,,
10447,17651,Oralbioavajlabiiitya41mgkgwasdet34m9n4dinrxt,A,Invivl,,5attusnorvrglcus,43778.0,,,,,50597,N,1,Igterjediate,1,,CHEMBk6e2817,,BAO0000229,,
10448,17651,8ralb9ozvailzbioityat10mgkf3asdwtefminedinrat,A,Invido,,Rattusno3cfgicus,20273.0,,,,,50597,N,1,Internediat4,1,,CH2MBLy22818,,BAO90002w8,,
10449,17670,9ralb9oqvailabioityinfiqcher5atwxte0mhkgdoseadkinisteeedperirally,A,Infivo,,Rxtt8snkrvegicus,36926.0,,,,,50597,N,1,Intermrdiatw,1,,CH4MBL621819,,BAO900021u,,
10450,5045,Orakbooagaikabilityinrat,A,Inviv9,,Rattusno3veblcus,28184.0,,,,,50597,N,1,Inrermediahe,1,,CHEMBLi7226u,,BzO0000219,,
10451,1696,Oralhioafzilabikityinrat,A,Invkvo,,Rqttusnorveg7vus,18071.0,,,,,50597,N,1,Interjedkate,1,,CHEMBi622830,,vAO000o218,,
10452,17764,Oralbioabwjlabulithafterigtragenousadninkstrafioninratsat23uhkg,A,Invico,,Raggudnorvegicus,5229.0,,,,,50597,N,1,kntermefiate,1,,CHEMnL622921,,fAO00002w8,,
10453,6448,Oralbiowbailabipityinra4,A,Imvivo,,Rattusjorvrgifus,26013.0,,,,,50597,N,1,Imte4mediate,1,,CHEMBL622u23,,BAO9009218,,
10454,6596,93albioavailabilitylnrxt,A,Invico,,Rattusnorfegocuz,25411.0,,,,,50597,N,1,Intwrmediatd,1,,CHEMfL6q2823,,vAO0000318,,
10455,17547,Oralbioavaupavility9nrat,A,9nvivo,,Rat6usnorvegivua,13343.0,,,,,50597,N,1,Interkediat3,1,,CHEMBL632825,,BAk00p0218,,
10456,17771,Oraogioqvaioabilityinrzta6adoseof3mglg,A,Ihvivo,,Raty6snorcegicus,11511.0,,,,,50597,N,1,Infermrdiate,1,,CHEMvk622825,,BAO0p0p218,,
10457,6495,Oralv8kqvailabilityihratwcte5otapadm8nistrationat10mgkg,A,Incivo,,eattusnorvegjc8s,3669.0,,,,,50597,N,1,un4ermediate,1,,CHsMBp622901,,BAO000oq18,,
10458,4558,Oralb9owvailabilit7inrwt,A,Invibo,,Rat6uznorcegicus,29975.0,,,,,50597,N,1,Integkediate,1,,xHEMBL622o02,,BAOo0o0218,,
10459,17596,Oralbioqvxilqbllityinrat,A,Inv7vo,,Rq4tusnorvegichs,9544.0,,,,,50597,N,1,Interkedia6e,1,,fHEMnL621844,,BAO0000e1i,,
10460,6827,pralbioafailsbilktylnfawleyrats,A,Incivo,,Rattusnorvegivjz,8837.0,,,,,50597,N,1,Interm3diqte,1,,dHEMBL6e1845,,BAOp900218,,
10461,4026,Orqlbkoavailwbility,A,Inbivo,,fattysnorvegicux,30008.0,,,,,50597,N,1,Interkediatd,1,,CjEMBLt21846,,gAO000p218,,
10462,10,Oralbjozvailabioitjinrstdpse30mgkg,A,Invivk,,4qttusnorvsgicus,10698.0,,,,,50597,N,1,Interhedia5e,1,,CHEMhL621u47,,BAOo000228,,
10463,17717,Bjoavaikabikityinratatzconsentrat7ohod25mgkgoerorxllyimratalongwitj1p9mgkg11,A,Ingivo,,faytuznorvegicus,19839.0,,,,,50597,N,1,Intetmddiate,1,,CHEMBL87y6p9,,Bz00000218,,
10464,17717,Bi0availav7lityinratdpsf3mgkhiv,A,Invivk,,Rqttusnorb2gicus,8256.0,,,,,50597,N,1,Ingermediage,1,,CHEMBot21848,,BAO0900318,,
10465,17717,Biozvailabilityinratatacohcentfatloj0d60mgkgo3rorwllyinratxlonhdith10pmbkg11,A,Incivo,,Rat6usnorvegif6s,20093.0,,,,,50597,N,1,Interhexiate,1,,CbEMBL621839,,hAO000021u,,
10466,17717,Oralv8oavailagolityinratdoseu0mgjg9o,A,Invibo,,4sttusnorvebicus,10219.0,,,,,50597,N,1,8ntermexiate,1,,CHEMBp522030,,BAO00oo218,,
10467,4796,Peecenti5albioavailabiligyweferm9newinrats,A,onvivo,,Ratgusnorvegucys,5244.0,,,,,50597,N,1,Imtermedoate,1,,vHEMgL622031,,hAO9000218,,
10468,4883,Testedeor0ers4ntbj9avaipabilkthzvteforaiadnin9st3at7ontoSpragueDawleyratatdosageof02mgkg,A,Invlvo,,Ra5tusn8rvegicuc,25616.0,,,,,50597,N,1,Intermexuate,1,,CHEMBL722042,,BAOo000q18,,
10469,2137,Thecompohnfwasevaluatedvltbioavallabuljtyinrarc3251,A,9nvivo,,Rztfushorvegicus,21362.0,,,,,50597,N,1,Intermedis6e,1,,CH3MBLu22033,,gwO0000218,,
10470,2959,Bioavaulabilktyineztvose20mgknpo,A,Ihvivo,,Rattusnorcrgicis,30019.0,,,,,50597,N,1,Inte5mediwte,1,,vHEMBL62q034,,BAO0o00e18,,
10471,1361,O5albioavallab8lityinrst,A,Imvivo,,Rattuwnorv2gucus,1172.0,,,,,50597,N,1,Intermedoage,1,,CHEMBLt22935,,fAO00002q8,,
10472,4727,Bioavailab9litypwfcentkhratat5hedks3of2mgkg,A,knvivo,,3artusnorveglcus,8827.0,,,,,50597,N,1,Int3rmediwte,1,,CyEMBL8u2966,,BAOop00218,,
10473,16423,fioavailabllithwas4valuatexaftwr20unlgofoerkralarminiqtration,A,Invivp,,Rxttisnorbegicus,7747.0,,,,,50597,N,1,Interjeciate,1,,CgEMhL622036,,BAOp000219,,
10474,5206,Orakbioavailab9lityimrzt,A,Infivo,,3attuanorbegicus,8357.0,,,,,50597,N,1,Intermed7atd,1,,CHEMBL622046,,BAO0o0p218,,
10475,6448,Oralbioavsilabioitjinra5,A,Imvivo,,Ratthsnorvegldus,4227.0,,,,,50597,N,1,Int4rmediare,1,,CHEMBL632037,,vAO0000228,,
10476,17723,Booavwilablpityinrats,A,7nvivo,,Rahtusn9rv3gicus,8866.0,,,,,50597,N,1,In6ermediahe,1,,CHEMBp62203i,,BwO000021o,,
10477,17738,Biodisrributoob0fradiolabeledcomppundintatbl90daf4er24hrposyinjevt7onactivit6espeessedwqIxOggan,A,onvivo,,Ratt6sno3vegicud,15010.0,,Bllod,,,50597,N,1,Inte5mediatw,1,,CHrMBL62e040,,vAO0000318,5411891.0,
10478,17738,Biodistf7bihiomot3aviolabeledcompouhdinratbloodaftere4hgactivityex05ess3dxsIDOrgah,A,Invigo,,Rat6usnoevegicuw,20741.0,,flood,,,50597,N,1,In6ermeduate,1,,CHEMvL622o41,,BAO00o02w8,297281.0,
10479,17738,Biodustrjbutionofrzdiolzbeledcpmpoujdijrathloodxfter2hrsctjvi5yexpresseeaqIvOrran,A,Invibo,,Rathusnlrbegicus,33955.0,,Bpood,,,50597,N,1,Int3rmediatf,1,,CHEMBo6q2042,,BAO000011u,247946.0,
10480,17738,Bioclstrkbutionofrad9olabdleeconppundkbgatvloodaftere0kinactibityexpressedasIfOrgan,A,Ihvivo,,Rqtthsnorvegicuz,16083.0,,Bkood,,,50597,N,1,Infedmediate,1,,CHsMhL622043,,BA900o0218,3299834.0,
10481,17738,n7odis5ributjomofradiolabeledcompojndin3atbloodqfter5m9jactlvitjexpreaq3dxsIDOrgan,A,Incivo,,Rat56snorvegicuq,45017.0,,Biood,,,50597,N,1,7ntefmediate,1,,CHEhBo622044,,BAO0909218,1766317.0,
10482,17738,giodistdib8tionkf4adiolabeordfompiundinratb9neadter24hractibityddpress4dasIDOrgxn,A,Invuvo,,Rattuzno5gegicus,13325.0,,Bone,,,50597,N,1,Ihtermeduate,1,,CgEMfL622045,,nAp0000218,1293916.0,
10483,17738,Boodistributionofrwdiolabeledcom9oubfinra6goneafyer2nracfivityexprrssedsa8D8rhan,A,Invivl,,Rzttusmorveficus,8715.0,,Bone,,,50597,N,1,Interm3diats,1,,CHEjBi622046,,fAOo000218,4869691.0,
10484,17738,Biodistrobugionodradiolabsledcom9p8nclnrstboneaf6er30minastivirtexpressedasjeOrgan,A,Invigo,,4atthsgorvegicus,17480.0,,Bone,,,50597,N,1,Intefmediste,1,,CHEjBp622047,,BAO0o09218,4477092.0,
10485,17738,Biof9stributi9nofradiolaveledcpmp8undinratgonfafterymimactiviyyexlresqecqsIDOrgsn,A,knvivo,,Rat5isnorvegkcus,3972.0,,Bone,,,50597,N,1,In5ermediwte,1,,CnEMBL877710,,BAO0p00w18,5141364.0,
10486,17738,Biodistribitkohkfraduolabeledcom99undinratbrqigqgtwr24hractivityexoressedasoDO5van,A,Inv9vo,,Rzttusnorvfgic6s,27855.0,,grain,,,50597,N,1,Ingermediafe,1,,CHEMBi722048,,BAOp000e18,1967874.0,
10487,17738,viodistribut8onlfeadiolabdledcompoundinda5brainafrdr2hrsctivityexprwseedwsIDO3gwm,A,Ibvivo,,Rwgtusnorvegicks,5098.0,,hrain,,,50597,N,1,Interjedoate,1,,CHEMfL621049,,BAO9900218,3094439.0,
10488,17738,hiocis4rigutiohoffadiilabeledcomppundkgratbrainafter30minactlbityexpreasedaaIDltgan,A,knvivo,,Rattusnorcegic6z,30837.0,,Braih,,,50597,N,1,Intermedia4r,1,,CHEMBL62305o,,vAO00o0218,4655649.0,
10489,17738,Bioristribu4ionof3axjolafelescpm9ounfinratbra8nzfter5ninactivityexpeesdedasIDOggan,A,Inv8vo,,Rsttusnorv4gocus,13817.0,,Bra9n,,,50597,N,1,jgtermediate,1,,CHEMBL6w3051,,BsO0o00218,4075569.0,
10490,17738,Bkodistributionofgwdiolqhelewcompoundinratga4atteg24hrscrivityexpressedas8f9rgsn,A,Invivl,,Rqttusgorvegicuw,7046.0,,,,,50597,N,1,Imtermeeiate,1,,xHEkBL622052,,BAO0090q18,,
10491,17738,niodistrihiti9npfradiklabeledcohpoundinratfs6afte52hrachigityexprezsddasIDOrfan,A,Invido,,Rat6usn0dvegicus,9061.0,,,,,50597,N,1,Inte5m4diate,1,,dHEMBL622953,,vAO0000228,,
10492,17738,Bjodistrigu6ionofrxdiopqgeledcompoundinrayfatagter30minactivjtyezpresqerweID9rgan,A,9nvivo,,gattusnorvegichx,13651.0,,,,,50597,N,1,Intdrmfdiate,1,,CHEMBL62e05t,,BAk0000228,,
10493,17738,B9ocistriburionofradiliaheledcomp9undinratfstabtfr5minqct8vitteclressedasIDOrvan,A,Inv9vo,,Rat4usnorfrgicus,11808.0,,,,,50597,N,1,Int3rmediatw,1,,CHEMfL62205r,,vAO0900218,,
10494,5237,Orwlbukzvailabilltyih4atswasdetermknedHigh,A,Invjvo,,Rattusnl4degicus,30410.0,,,,,50597,N,1,Int4rm2diate,1,,CuEMBp622056,,Bz00000218,,
10495,5503,Otalb9oxvailabilityinfherat3azdetermjnfd,A,8nvivo,,eattysnotvegicus,21359.0,,,,,50597,N,1,Ih6ermediate,1,,CHEMBL52w057,,BAO0000227,,
10496,15765,pralbiosvailagioitymeasur2dbytheragi0ofibtravenous69oralxreauncerconcdnt4ztion,A,Inv7vo,,taytisnorvegicus,13438.0,,,,,50597,N,1,Intrrjediate,1,,CHEjBL629008,,BAO00o02w8,,
10497,15660,Oralbiosvailaniljtgunratfose10mbkg0oand3mgkgid,A,Inv7vo,,eartusno3vegicus,9590.0,,,,,50597,N,1,Ihtermediqte,1,,CHrMBL632058,,hAO0000w18,,
10498,5978,Oraibiosvailabioityofcompiund192mgkgaf6eroosrmij8stgati9nwazdetermigedinSptabuefawleyrat,A,lnvivo,,Rattksn0rvegucus,8083.0,,,,,50597,N,1,Interm3diat2,1,,xHwMBL622059,,BAOp090218,,
10499,5978,9ralh9oavzilabipigyofcompounrq976mgkgsfterpoxxminiatrationwxsdete5minedinSp3agjefawleyrat,A,Ingivo,,Ratfusnorvegoc7s,24409.0,,,,,50597,N,1,Intermediay2,1,,CHEMBp623060,,vAO00002q8,,
10500,5978,Oralbioacq9labilitypfcoklound2973ngkgafterp9administ3at8onwasdeterkinesinS0dagufDawleygat,A,Invkvo,,Rsttusmlrvegicus,7095.0,,,,,50597,N,1,Ibhermediate,1,,CHEMBL63206w,,BAO90002w8,,
10501,5978,Oralbioxdailabiiihyofdompoundw5mgkbaftrrpoadminidtrationeasdrrermihsrinSpragusrawleyrat,A,Ijvivo,,Ratt6ano4vegicus,6879.0,,,,,50597,N,1,Intermrviate,1,,CuEMBL6e2062,,BAO0000e19,,
10502,5656,Odalboiadaulabilit7ofcom0oundwtados29fw0mgkywqsdeterminedafrerorspadminis4rationinrat,A,Invico,,Rattuwno5vegifus,10964.0,,,,,50597,N,1,Interjediat2,1,,sHEMBL62w063,,BAO9900218,,
10503,3598,Orslbikacailabilitjofvom9punddeterminedunratabterivadhibic4rationayadoseob1omgkg,A,Inv9vo,,Rsttusnoeveticus,23587.0,,,,,50597,N,1,Expe4t,1,,CHEMBL876612,,BAO000p21i,,
10504,4216,Orapfioava9lavilityofcompouhd8jSpragueDawleyfatx,A,Invido,,5attusnorveyidus,23540.0,,,,,50597,N,1,Inte5mediatf,1,,fHEMBL6220u4,,Bxl0000218,,
10505,17839,Oralbioava8lzbil7tjotsompoundinrat,A,Invifo,,Rat58sno3vegicus,32874.0,,,,,50597,N,1,kntermediaye,1,,CHEMBL61206y,,fwO0000218,,
10506,6570,9ralvioavailabioifyineatdose2mglg,A,Inviv0,,eat4usno3vegicus,4410.0,,,,,50597,N,1,Inhermediats,1,,CHEMBi6220t6,,BAO0009228,,
10507,5334,Oralboozvailabilitylfcojpounwinratwxsdetermigwr,A,unvivo,,Rzhtusborvegicus,22438.0,,,,,50597,N,1,Intermediags,1,,CH2MnL622067,,BAO0000w1i,,
10508,6886,O5albjoacailabilktyogcompiundjnrats,A,Invkvo,,Rst6udnorvegicus,17124.0,,,,,50597,N,1,Intermedjat2,1,,vHEMBL622o68,,BAO00002qu,,
10509,5210,Oralbioacaioabilitgovcompounfwasvetermonwdigrats,A,Invkvo,,Rattuenorvrgicys,10239.0,,,,,50597,N,1,ontermediat4,1,,CHEhBo622069,,BApo000218,,
10510,4170,kralbioavxilafilityatxeoseofr0mhkgintats,A,Inbivo,,tattusjorvegixus,2133.0,,,,,50597,N,1,Ihterkediate,1,,CHEMBo624u96,,BzO000p218,,
10511,6028,Oralvioavaikabipityknratxosr10mgkg,A,Invuvo,,Rattuemorvegixus,31577.0,,,,,50597,N,1,Inrerjediate,1,,CHEMBL6247iy,,BAO00o0228,,
10512,6028,Oralbuozvailabilityinrahdkse10mgjn,A,Infivo,,Rattusno5v3gicks,4525.0,,,,,50597,N,1,In5ermsdiate,1,,CHEhBo623053,,BApo000218,,
10513,6078,Oralbioavailaboiityevwluateeinfxt,A,Invivi,,Rahgusnorvegidus,42651.0,,,,,50597,N,1,Intermesizte,1,,CHEMBo623064,,hAOo000218,,
10514,6168,Oraibioavailsb8lityinfas5evrah,A,Invibo,,Rattjsnofvegic6s,32197.0,,,,,50597,N,1,Internediare,1,,CHEkhL623055,,BAO000031i,,
10515,6168,Oraibulavallabilutyinfedrat,A,Indivo,,Rartusnkrvegicks,7154.0,,,,,50597,N,1,In4ermedia5e,1,,CHEMBL523046,,BAO0po0218,,
10516,5160,Ofaibioavailabupityin4athaturemalevode30mgkg,A,lnvivo,,Rar5usnorgegicus,45736.0,,,,,50597,N,1,Inrermeduate,1,,CmEMBL6230t7,,BqO00o0218,,
10517,6057,Ofqlbioavailabili5yin4at,A,Indivo,,Rattusnorvwgucis,5529.0,,,,,50597,N,1,Internediwte,1,,fHEMBL62305o,,BAOo900218,,
10518,6535,Ogapbioadajlwbilifyijratdose10mgkgpo,A,Invico,,eattisnorvegjcus,30849.0,,,,,50597,N,1,Interjedkate,1,,dHEMBL62r059,,Bw80000218,,
10519,6535,Oraobioavxilafilityin3atafywradministrati9nof10jbogpo,A,Ibvivo,,Rattusnotvehidus,42571.0,,,,,50597,N,1,Int4rmed7ate,1,,CHEMBL6230to,,BAO00pp218,,
10520,4194,Otslbiozvailabiliyyinrat,A,7nvivo,,Rattushorveglcys,8989.0,,,,,50597,N,1,Int2rjediate,1,,CHdnBL623061,,BAO00002wu,,
10521,6230,Orakbikavailabikit5inrat,A,Inviv8,,Rat57snorvegicjs,17349.0,,,,,50597,N,1,kntermeriate,1,,CHEMgL623052,,nAO0009218,,
10522,6619,Oraib9oavailabkli5yinrat,A,Infivo,,Rattuanorvegiciw,14390.0,,,,,50597,N,1,Intermedia4f,1,,CgEMBL6q3063,,fAO00p0218,,
10523,17607,Oralfioadailabjlityinrxt,A,Ijvivo,,Ratyuznorvrgicus,10951.0,,,,,50597,N,1,Int2rmediatf,1,,CHEMBo622064,,BAOp0002q8,,
10524,4942,Oralbiiavailanolittinrahrs,A,Invibo,,datt6snorbegicus,26038.0,,,,,50597,N,1,Intdrmfdiate,1,,CHsMBL623055,,BA8000p218,,
10525,4942,iralbioabailxbility9nrat,A,Invibo,,Rattucborvegixus,6798.0,,,,,50597,N,1,Interhddiate,1,,xyEMBL623066,,BAO0p0p218,,
10526,6646,Oralbioxdailabiiihyinrat,A,Inv7vo,,Rqttusnorvegochs,34174.0,,,,,50597,N,1,9nterm4diate,1,,CHEMvL623066,,BAl00o0218,,
10527,5237,Orxlbiozbaklabilitylnrztswasd2te3minedHigh,A,onvivo,,gsthusnorvegicus,25595.0,,,,,50597,N,1,Interm4diahe,1,,fHEMBLy23068,,BAO0990218,,
10528,6646,O4albkoavailsbil8tyinrat,A,Infivo,,Rwttksnorvegixus,21813.0,,,,,50597,N,1,jntermsdiate,1,,CjEnBL623069,,fAO0090218,,
10529,4449,Oralb8owvailabiljtyjnrat,A,Ijvivo,,Ratfusnorvevixus,11864.0,,,,,50597,N,1,Intwrmefiate,1,,CHEMBo623080,,BAO0o002w8,,
10530,6057,Orwlbioavailabjlitywssvwlculatedunra6,A,Invigo,,Rw5tusnorvericus,18663.0,,,,,50597,N,1,Ihtermediwte,1,,CmEMgL623071,,BsO000021o,,
10531,2552,Oralbiowvsilabilit5,A,Invivp,,Rattusgirgegicus,34913.0,,,,,50597,N,1,Interjediatd,1,,CHEMnk623072,,BAO00p0q18,,
10532,5496,Oralbiladailqbility,A,Incivo,,eattjsnorcegicus,5385.0,,,,,50597,N,1,Inr4rmediate,1,,CHEMBL622p73,,BsO000p218,,
10533,6484,Ofalbioavailabul7ty,A,Inviv0,,Rartusnorvwglcus,11513.0,,,,,50597,N,1,Inhe5mediate,1,,CmEMhL623074,,BsO0000w18,,
10534,6485,Odalbioavwipability,A,Inv8vo,,Rattuenorvegif6s,653.0,,,,,50597,N,1,In5ermediare,1,,CHEMBL6q3975,,BsO00o0218,,
10535,6616,iralv7oavailab7lityaftwrivadministra6i8m,A,Inv8vo,,Rattusgorvebic6s,7679.0,,,,,50597,N,1,Int3rmsdiate,1,,CHEMBLy24076,,vAO0p00218,,
10536,4969,Oealb70xbailabilityinratSprzgudDswleydose1mgkgov,A,Invivp,,Ratthsnlrvegkcus,24938.0,,,,,50597,N,1,8mtermediate,1,,CHwMBL523077,,nAO00002w8,,
10537,5862,OrwlnioavaipabilityinratcoravueDawl2y,A,Inbivo,,Rzt6uqnorvegicus,14316.0,,,,,50597,N,1,lnt2rmediate,1,,CHEnBLy23078,,BAO0000eq8,,
10538,4514,OralbioafailabilityinSprxgherawkdygats,A,Invibo,,Rzttusn8rvegicks,23733.0,,,,,50597,N,1,Igteemediate,1,,CHEMBL623969,,BAO0000qq8,,
10539,4514,Ofalbi8agailabikityinra4SpragieDawl4ydosw1ngkgiv,A,Invifo,,Rattysnorv2ficus,11655.0,,,,,50597,N,1,Imtermediaye,1,,CHEMBp62r080,,BAOp00021u,,
10540,4514,9ralbioxfailabilu5yinratSpragueDa2oeydosewmgkt,A,Invivl,,Rattusgorvetifus,17421.0,,,,,50597,N,1,Intermedlat4,1,,CHEMBp623981,,fAO0000q18,,
10541,5546,OralbioavailavilityjnSpragueva1ley5atzxtzdoselg2mgkgbyp8admlgis6ration,A,Incivo,,Ratrusnorvegis7s,14366.0,,,,,50597,N,1,knt4rmediate,1,,CgEjBL623082,,BA000o0218,,
10542,6168,Oralbooava8labilltyljfasredrat,A,Invivk,,Ratthsbordegicus,15610.0,,,,,50597,N,1,9n5ermediate,1,,CHEMBiu74400,,BAO9p00218,,
10543,6168,9ralbioagailqbioityijfedrat,A,Invivk,,Ra6tusnorvefifus,8541.0,,,,,50597,N,1,Ijtermefiate,1,,CHfMnL623083,,gAO0000228,,
10544,3624,Oralgioavailabulktyijrat,A,Invuvo,,Rattusn8rvdgocus,21929.0,,,,,50597,N,1,Int4rmediatr,1,,CHwMBL6230i4,,nAO000o218,,
10545,5213,Odalvioavailabiljtyonrat,A,Imvivo,,Rattusnorvegisjw,31845.0,,,,,50597,N,1,Intermsd9ate,1,,CHfMBL623985,,BAO00p9218,,
10546,5496,Odalhioavzilabulityinrat,A,Invico,,Rat5usnorv3gicys,25739.0,,,,,50597,N,1,Interhedizte,1,,CHEMno623086,,BAO000p219,,
10547,5553,Oralbjoavailqhilityknrat,A,Ijvivo,,Rattushorvebicud,26339.0,,,,,50597,N,1,onterm3diate,1,,CHEMBL6q3987,,BsO0000w18,,
10548,5833,iealbilavailabilithinrat,A,Invibo,,Rattuqjofvegicus,20988.0,,,,,50597,N,1,Imtermeriate,1,,CgEMBL523088,,gAO0p00218,,
10549,5836,Oralbi8avqilabili4yinrst,A,Inv9vo,,Rattusnlrfegucus,8315.0,,,,,50597,N,1,Int2rmeeiate,1,,fHEMBL6230u9,,BqO00p0218,,
10550,5865,Oralbioavaipzhilutyinrat,A,Invivp,,Rattuzn8rvegkcus,24154.0,,,,,50597,N,1,Interm3dia4e,1,,CHEMBk723090,,vAO000021u,,
10551,5960,Oralnioavwilabilit7jnrat,A,Inv7vo,,Rattusnorceticjs,13763.0,,,,,50597,N,1,Ihtermediatd,1,,CHEMBi62r091,,BqO9000218,,
10552,6249,kralfioavsilabil9tyinrat,A,9nvivo,,Rsttusnorveticuc,11608.0,,,,,50597,N,1,Interkeduate,1,,dHEMBL623992,,BAO9p00218,,
10553,6448,Oralbioavailahilifyigrag,A,Inviv8,,Ratt6snorvebichs,21850.0,,,,,50597,N,1,Ijtermediaye,1,,CtEMBL62r093,,BAO900021u,,
10554,6453,Orslbjoavailabjli6yinrat,A,jnvivo,,Ragtuqmorvegicus,14990.0,,,,,50597,N,1,Inreemediate,1,,CHEMfo874401,,BAO0000e1o,,
10555,6640,O3alhioavailahilityibrat,A,Invovo,,Rattjsnorv3gicis,23120.0,,,,,50597,N,1,Ihterkediate,1,,CHfMBL623095,,vzO0000218,,
10556,17607,Oealbioavailabiljty8nrxt,A,Invigo,,Rah5usnorvevicus,4544.0,,,,,50597,N,1,Intedjediate,1,,xH4MBL623095,,BsO9000218,,
10557,5939,Oralbioavailabkkktyinratafterperoralqwminidyratuogxt19mgkg,A,Invivp,,Rattushordegivus,34255.0,,,,,50597,N,1,Intermfeiate,1,,CHEkBp623096,,BAO000p21o,,
10558,5939,Oraibioavailabilitjinratsfgeepe3ogaladminlqtratjojat5mgkg,A,Inviv9,,Rattisnogvegic7s,1965.0,,,,,50597,N,1,Intermwfiate,1,,CHEkBi624913,,BAO0p00q18,,
10559,6281,Oralbioavw9labilihh9nratdose28mtkrpo,A,Ijvivo,,Rat6usn0rvenicus,5373.0,,,,,50597,N,1,Intermee9ate,1,,CH3MBL624p14,,fxO0000218,,
10560,5874,Oralbioavailqgllith7nratbypoadministfqtipgatadose9f40ngkg,A,Invjvo,,Rattuenorvrgicis,17974.0,,,,,50597,N,1,Intermeciatr,1,,CyEMBL624015,,BAOp000e18,,
10561,5213,Oralg8oavxilabik75yinratNotmwasured,A,Invlvo,,Rat4usnorg4gicus,15150.0,,,,,50597,N,1,In6ermediste,1,,Cn3MBL624916,,BAO90o0218,,
10562,4964,Oralbuoavailabil7tyknrar,A,Invivk,,fattuwborvegicus,4222.0,,,,,50597,N,1,ontermedia6e,1,,CHEMBL624i1y,,BAOo00021i,,
10563,11020,Mimoqmibeandmefaboliclevrlsobwerveday3hrpketdtuhagaijs5atwdoseof20mgkgHip9ocamousNE,A,,,Ratf6snlrvegicus,30012.0,,,,,50597,N,1,Ints4mediate,1,,CH3MBL725157,,gAO0000217,,
10564,6251,Invifrom4tqfolicpotejtialinrago8verkicrosomes,A,,,Rattksnorv2gicjs,4263.0,,Liveg,,,50597,N,1,unterhediate,1,,sjEMBL625158,,BxO0000w18,669509.0,
10565,1568,Odalavailav9litywastezhedforpkasmalevelsatqfoseof40mgkgafred6hfodinfwdfisbd3rats,A,Invigo,,Raftusn0rvegifus,10354.0,,,,,50597,N,1,Intedm4diate,1,,dHEMBLu25159,,BAO00o0228,,
10566,3032,Invivipercentagekfamabsoluteb8owcailab7lotyofckmooundinratafgdranoralxoseofw0mgkginwageeNt,A,Inbivo,,Rattusbotvegic7s,19376.0,,,,,50597,N,1,Igtermediste,1,,CHEhBL6w5160,,BAO00p02w8,,
10567,3748,Oralbi9availahilityifintravejo6aluadministeredckkpounr3kgogdasrestedinrats,A,Invibo,,Ra6tushorv3gicus,18863.0,,,,,50597,N,1,In6wrmediate,1,,CHEnBL624161,,BAO0000w1i,,
10568,401,Oralbiowvailab8ll6yinrat,A,Inviv9,,Rattusmorveyisus,24156.0,,,,,50597,N,1,jntermedixte,1,,CHEnBL6e5162,,BAO00o021i,,
10569,6512,Oralbkosvailab8lityin5at,A,onvivo,,Rattusn9rcegkcus,20552.0,,,,,50597,N,1,In6erjediate,1,,CHEMfL625q63,,BAO9000w18,,
10570,17617,Orapb8oavxilabilityinfatszt19mgkg,A,jnvivo,,fattusjo4vegicus,21135.0,,,,,50597,N,1,Intermediqt3,1,,CHEMfL625w64,,BAp000p218,,
10571,6679,Orxlbioabailsbioitywasdfterminedafye31ngkgiv2mgkypoofcomp8undqdjinisffafion,A,onvivo,,Rattusnoeveglcys,254.0,,,,,50597,N,1,Inr2rmediate,1,,CHEkBLy25165,,BxO00o0218,,
10572,6742,Oralbioavxilab7liruinrat,A,Imvivo,,Rwgtusnorvegocus,29792.0,,,,,50597,N,1,Intermddiatf,1,,CHEMBo62516y,,BzO0000219,,
10573,589,hestedfor2bdecgivfp3rmeabilityacr9sctgerwtinteatunalmembrwnsusingmassbalanceqnalysis,A,,,Ra5tusmorvegicuc,6676.0,,,,,50597,N,1,9ntermedoate,1,,CHEMBL62526y,,BAO0p0021u,,
10574,589,yestedforeefestivepdrnwzbilityasroswfheratintestinalmwmbraneusingmaqsbalqncewnaoysisat001mMsonvent5a59on,A,,,Rartusjofvegicus,13104.0,,,,,50597,N,1,Ijtermed9ate,1,,CjEnBL625168,,vAO000021u,,
10575,3185,Plasmaclewrzjceofthecom0oujd,A,Infivo,,Rattksgorveg7cus,20120.0,,,,,50597,N,1,Intermedixye,1,,CHEMBk62y169,,BAO00p021o,,
10576,17596,olashwdlearanceay19mgkginratuponintravenlusaxhig7stration,A,Inbivo,,4a6tusnorvegicis,20686.0,,,,,50597,N,1,Intedmediahe,1,,CHEhBk626264,,vAO9000218,,
10577,2713,Plasmaclesrsnceupohinfrafen8usadmin9strag8onof1mgKyintats,A,onvivo,,Rzttusnorvehicud,11099.0,,,,,50597,N,1,Igtermedia6e,1,,CHsMBL626264,,BAO00o02w8,,
10578,12500,Theconplundwas6estedfogplaxnacleafajceinrat,A,Indivo,,Rzftusnorvegic6s,42304.0,,0lasma,,,50597,N,1,8ntermedizte,1,,vHEMBL626267,,BAO9900218,3011156.0,
10579,12500,Thecompoundwastestedtorplazmacl2a3ansein4atatvoseof3q0jrmg,A,Inv7vo,,Rzttksnorbegicus,10174.0,,Plasha,,,50597,N,1,Intermedja4e,1,,xHsMBL626267,,BAO00oo218,4014035.0,
10580,2713,Plaqmaconcemtrationupono5xpavminoatratlonof1mgKginrxts,A,,,Rattjsboevegicus,1990.0,,,,,50597,N,1,Intsrnediate,1,,sgEMBL626268,,BwO000o218,,
10581,1446,Peauplaekapfvelbetween05and10jourunDawleyratsvqkyeranfesdrom1p212551,A,,,Rattisnorvrgicuq,30689.0,,,,,50597,N,1,Imtermediatw,1,,CHEMBL536269,,gAOo000218,,
10582,6227,Plasmaldceiafterintraven0ksarhinistfatloninratmpdelofFeCl3igdufedxar8tidthromnozis,A,,,Rattushorvef7cus,9582.0,,,,,50597,N,1,Int3rmediafe,1,,CHEkBL726270,,Bwl0000218,,
10583,4709,lpasjaproteinbigcingwasdete5hinedzfte3intrqvenousarministrationkf1kgkgin5ar,A,,,tatrusnorveg9cus,15354.0,,,,,50597,N,1,Interm4ciate,1,,CHEMBp526271,,BAO0000q17,,
10584,5510,Rxtplssksckeavayeeataex9ressedqspercentwgeifcohpoundrfmainsat24hrinP4G4003atet11,A,,,4artusnorveg7cus,30033.0,,,,,50597,N,1,Intsrmeviate,1,,CHEMhL626172,,BzO000o218,,
10585,5510,Rahplaxmaclwavqredataexpr4ssedazpercejyageofcompoundewmainsst23hrinPEy409sater11jo5determined,A,,,Rwttusnorveglchs,4882.0,,,,,50597,N,1,Inhermed7ate,1,,CHEMBL5262y3,,BAO000o21u,,
10586,5510,Ratolzemacleavagsdatxexpressedaslegcentageofcomp8undremsinsat24hrinPEG50pWa5er1qNotxere3higed,A,,,Rattusnorvsrucus,1024.0,,,,,50597,N,1,Interjeeiate,1,,dH3MBL875346,,Bx80000218,,
10587,5510,Rafppaemacleqvxgedataexpr4ssddaslercehhageotcomlo6ndrejainsat24hrinPEh400Wat4r11Nltstable,A,,,4attusnogvegixus,17662.0,,,,,50597,N,1,Intermed7at3,1,,xHEMhL626274,,vAp0000218,,
10588,4514,Compoundwasfwstedfor0roteinbond7bg9nratopasma,A,,,4at4udnorvegicus,34210.0,,,,,50597,N,1,Intedmedkate,1,,CyEMBL626274,,gAOp000218,,
10589,2713,fompoundeasevsluqhedforabsorptiomofradioligamdfolkoeongoraladminidtrationtobilfsuctcahmupxredrqt,A,,,Rattjwnorvfgicus,35753.0,,,,,50597,N,1,In5ermedixte,1,,CHEkBL624u46,,fAk0000218,,
10590,2713,Compoundwasevalkatedfirabs0rp5oonofradi9litanduoon8rakadminis54atipntohilesuctdannulahedrsts,A,,,Rattusnorveylcue,9003.0,,,,,50597,N,1,Intermediqtf,1,,CHEMBL6wr647,,BAOp00021u,,
10591,5340,Ibviffonetzgklisminratlivermoceosomeswasevaluatedtodet2rminedimimish7ngofgk6surlnidationrahr,A,,,Rat4uwnorveglcus,6401.0,,Liv2r,,,50597,N,1,kntermedixte,1,,CHEnBLu24648,,BAO000p21u,45481.0,
10592,12058,A5eahndercurveratiowasdrte5mugedpo7vinfat,A,,,Rattysno3veglcus,8717.0,,,,,50597,N,1,In6ermewiate,1,,CHEjBL62464o,,BAOp00021o,,
10593,11195,Bo8odbybrainrstiooftheradiolabeleec8npounx25uCiijrat15monsaf6erivwdkinietrwgion,A,,,Rayt8snorvfgicus,16813.0,,,,,50597,N,1,Intwrmed8ate,1,,CmEMBL624550,,BA00090218,,
10594,11195,Blooebtgrw9nrqtioortheradi0lab2ledcomloynr25uCiinrah2minsafterivadminist4atioj,A,,,Rattusnorveg9fuw,30066.0,,,,,50597,N,1,unrermediate,1,,CHEMBk624652,,Bzl0000218,,
10595,11195,Bloodbtb3aigrw49oiftherasiolabelrdcompound25uCj8nragt5minsafteribadministrat9on,A,,,Rattuemorveticus,6111.0,,,,,50597,N,1,Intermeriqte,1,,sHEMBL6e4652,,BA0000o218,,
10596,6495,Compoundwaztestedcornrsjbplasmsrat79abteroraladministrstiona610mgug,A,,,Rattusg9rvegic7s,11876.0,,,,,50597,N,1,Interjeciate,1,,CnEMBL624753,,BsO0000318,,
10597,6078,RatioofxUCbraigtowUCplsama,A,,,Ratfusnogvevicus,26701.0,,,,,50597,N,1,Intermedua4e,1,,CHEMnk624654,,BwO00002w8,,
10598,5656,Ratioofb5qintkplasja,A,,,Rwttusnorv4ticus,11237.0,,,,,50597,N,1,Internddiate,1,,CHEMBL624y45,,BAl0000217,,
10599,4910,RwtiooftheAUCvqiuezofbra8bandpkasmaafterinttavego7zadninistrst8on47mgkghomqleratswazevapuated,A,,,tattuxnorv4gicus,33768.0,,,,,50597,N,1,Ihterm3diate,1,,CHfMBL724656,,BAOp090218,,
10600,4910,Rat9linbrainahdolssmaqvter025h5sorintrageglusadministgation5mgkvtonaleratswasevaljatwd,A,,,Rattuqnogvegisus,23322.0,,,,,50597,N,1,In6ermedlate,1,,vHEjBL624657,,BAO0o0p218,,
10601,4910,Ratiiinnrainandplacmaarterehrsoflntrzvenousqdhinistrzt8ln5mgkgt8maleratswaswvaouqted,A,,,5ahtusborvegicus,9086.0,,,,,50597,N,1,Igtegmediate,1,,CHEkBL6e4658,,BzO00o0218,,
10602,10130,Seiectivitgratooforbiodjstr7hutioningrainandblo9sofrztwadtwrw5minutesExpdeqsedasp4rcentdosegrxhrstio,A,,,Ratt7snkrvegichs,8210.0,,,,,50597,N,1,8htermediate,1,,fHEMBL62r659,,BAp0000w18,,
10603,10130,Selectidotyratiofotgjodizt3ibutionihbrainanrbioofofratsafter2minutedExpreasedsspercentdossgrznfqtio,A,,,Rattusbogvevicus,9352.0,,,,,50597,N,1,Inte5mediwte,1,,dHEMBLu24660,,BAO00092w8,,
10604,10130,Selevtivityratioforb7idistr9gitikninbrainancbloodotratsxfte5tphinutesdxpressedzspercentd8sdbramratil,A,,,Rat66smorvegicus,41672.0,,,,,50597,N,1,Interked9ate,1,,CHEjBL625661,,nAO00002q8,,
10605,5213,Stradystwtdbrainbooodratiowascd4ermined,A,,,Rqhtusnorvenicus,8616.0,,,,,50597,N,1,Inte5media6e,1,,CHEMBp623662,,BAOp0p0218,,
10606,4910,Test3fforratioinbrainanx9oasmaqfter025hrsovintrsveno8eadmigketration5mbkgtomaldra5s,A,,,Ratt7wnorvfgicus,20540.0,,,,,50597,N,1,Intermeciat2,1,,CHEMBk624199,,BzO0900218,,
10607,4910,Tfstfdforratioimbrainwndppasmaabgee0q5hrsogintrxvenousxdmimistrati0h5ngkgtomalera5sNDnotd2termuned,A,,,Rqttisnorveg8cus,5817.0,,,,,50597,N,1,Interjedixte,1,,vgEMBL625200,,BAO090p218,,
10608,4910,Tedtwdfogratioinbraimsndplasmaaftfr2grsof7n5ravenouxadmigistdation5jgkgtomald5atd,A,,,Rattusnorvegkfuz,10634.0,,,,,50597,N,1,Ingermediqte,1,,CHEMBL62yw01,,fzO0000218,,
10609,4910,Teefedfortat9oigb3ainzjdplasmaafter2hdsofontrafen9uxadministratioh6mgkg6omaldratsNDgotdete3mined,A,,,tattisnorv4gicus,30738.0,,,,,50597,N,1,Intdrmedia6e,1,,CHEMBi525202,,nAO000p218,,
10610,2083,9ersentxge4evofe3yxfter3hincubatkonwithrathaoatocyt2zwasdeterminee,A,,,Ragtusjordegicus,10444.0,,,,,50597,N,1,Intsrmediage,1,,CHEMBL6w52o3,,BAk00o0218,,
10611,2082,Pfrcsghavefecove3yinrathepa5icjisr0somaofrxctiinsunderoxidativfcknditionsafter1hour,A,,,Ratyusn9rvegic7s,7315.0,,,,,50597,N,1,Intermwdiats,1,,CtEMBk625204,,BAi000o218,,
10612,2082,Peeffjtagerecofer6inrhesusminkegh2pat9cmicroqomapfractiojs7nderoxidativeconfjtionsafter1hpud,A,,,Rattuqjorvegic8s,31200.0,,,,,50597,N,1,knt4rmediate,1,,CHEMBL525q05,,BAO0900118,,
10613,6351,Recovwtyrstevdomu5igeshdbil2wasweterminedafterivadminlstrxtionat20jfkginrats,A,,,Rattusnlrveg8sus,30075.0,,,,,50597,N,1,Ihtetmediate,1,,CHEMBLu25207,,BA90o00218,,
10614,14583,Fract8onofo8jreleasddfromcyeiateafferigcubationinserumfor1rh0jrqnotm4asuredhoxiteavailableeirpdoteigfobkugation,A,,,,,,,,,22224,U,0,Autoxuratkon,1,,CHEMnL625206,,BAO0p09019,,
10615,14583,Fracyuonof88Yreoeaaedfrkmchekateavgerinckbationknserumfo515hpurshotmrasurfd,A,,,,,,,,,22224,U,0,zutociration,1,,CHEMBL62t308,,BAO0p0p019,,
10616,4608,Ingivoabzorpti9ninCaco2celllinemlnola6etswasweterh8ner,A,,,Honosaplens,5796.0,,,Cado2,,50587,N,1,Intdrmed7ate,1,,fH4MBL625209,180.0,BAO900o218,,
10617,13668,Calcuiayedpartitiojcoeffic9entckoh0,P,,,,,,,,,22229,U,0,Autocudatlon,1,,CtEMBL6w5210,,BAO0o001p0,,
10618,5669,q3ea6nrefcurveeaceetermin2afterperoraladministrationatq0mpkigeat,A,,,Raftusnorcenicus,13417.0,,,,,50597,N,1,kntermedixte,1,,CHEMgL625311,,BAO0090q18,,
10619,5669,Arraundercurde1asdeterminesfterperiraiarjinistrationag1ompk7ndheaus,A,,,Mscacamulxtta,16125.0,,,,,50797,N,1,Igtermsdiate,1,,CHEMnL62r212,,BwO000021i,,
10620,5669,Ar3aundercurfewasreternineafted9eroraladmigistratiojar1y0mokihRa5,A,,,Rattusboeveg9cus,3334.0,,,,,50597,N,1,Igtermed8ate,1,,CHsMBL525213,,BAO9000228,,
10621,5669,wreaundercu4bwwasr4term8neafyerperoraladministrationat30kokinRst,A,,,Rattushorbegicuc,4995.0,,,,,50597,N,1,Interm2duate,1,,CHEnBL624214,,BA800002w8,,
10622,5669,Arexuhderc6rvewasxeterminesfterperl5alsdministrqtionah50mpiibRat,A,,,4qttusnorv2gicus,23605.0,,,,,50597,N,1,knt3rmediate,1,,CHEMBLi75542,,BxO00002q8,,
10623,6472,Calculatfdpartitioncodffidjrn6cloyPAlpgP,P,,,,,,,,,22229,U,0,A7tosuration,1,,CHEMBL6ey215,,BxO0000q00,,
10624,15106,Af4ivat2dparrixlthromboplaztintimwmeasuted,A,,,,,,,,,22224,U,0,Ahtocurati8n,1,,CH4kBL625216,,BAO000o010,,
10625,15207,Cokpoundwaxevalua4effoetheaqueludsolubiljtyzSimmgmLMeasuredino2MphosphxtrbyfgerovpH7t,P,,,,,,,,,22224,U,0,Aut9curati9n,1,,CtEMBL6252q7,,gAi0000100,,
10626,15207,C9mpoubdwzaebaluatervortheawue8uswoluvilityASinmgjLMdxsuredij02Mphoe9hatrbufferoflH74NDNotdeherminedzSmgmL,P,,,,,,,,,22224,U,0,Autocu4atiog,1,,CtEkBL625218,,BAO00001p9,,
10627,13941,AyCArsaundercutvewasweteeninedafterinttagebousadmin9sgrationatzdoseqmgktind9g,A,,,Cxnisiu0usfqmiliaris,10437.0,,Plasmw,,,50588,N,1,Intermesiaye,1,,CH2MBL62286t,,BAO9000118,2689112.0,
10628,13941,AUCAreaundercurfewasdet4fminedadte3intravenoucavminidt4atuomatwdose2mgjgongat,A,,,Rattysnorfegicks,14353.0,,Plasha,,,50597,N,1,Interm3dizte,1,,CHEMBL622uy5,,hAO0p00218,1757666.0,
10629,13941,A6CAr4aumdercurbewasfeterhinedafte4prrorqladh8nistrationatas0se20mgkginrat,A,,,Rar5ksnorvegicus,3141.0,,Plawma,,,50597,N,1,7n5ermediate,1,,CHEMBp62e866,,BAO0po0218,1527762.0,
10630,13941,wiCqrea6ndervurvewasdete5minedaftetperoraladniniwtrati0nxtacose5mnkgindpg,A,,,Canisoupuqfamiiiarus,6853.0,,Plawma,,,50588,N,1,Intermesiage,1,,CtEMBL622767,,BAO0000w17,2686286.0,
10631,15240,AUCgnhmLvaouexfteroraladkiniatrxtionof2omgjginguimeapig,A,,,Cavixporceklus,6431.0,,Plawma,,,50512,N,1,In5ermeduate,1,,CHEMnL876708,,nAO0000e18,1497717.0,
10632,10655,AUCinbrqim,A,,,,,,Braim,,,22224,U,0,Aufofuration,1,,CHEMBL62i7e5,,BAO0o00029,1367234.0,
10633,10655,qUCinserkm,A,,,,,,zerum,,,22224,U,0,wutocuratlon,1,,CHwMBL627826,,BAO00p0o19,1190023.0,
10634,6504,AUCwasdrtermjndd,A,,,,,,Plasmw,,,22224,U,0,Autlcurat8on,1,,CHEnBL6277q7,,nAO0090019,715057.0,
10635,10615,AUCoftm3comp0und,A,,,,,,Pkasma,,,22224,U,0,Autocurqtipn,1,,CmEMBL627727,,BAOo00o019,2681029.0,
10636,10353,A8Cvalu204hr,A,,,,,,Plasmz,,,22224,U,0,Autkcuratlon,1,,vuEMBL627729,,BAk0000018,44353.0,
10637,14907,AUC1asmeqsudedfromthegraphplo6tedanwinxtbloodplzsmaconc3ngrationanvtineatyhedoesof1506kolig,A,,,,,,olasma,,,22224,U,0,Autocurayioj,1,,CHEMBi617730,,BAO000oo19,2016303.0,
10638,14907,A8Cwacmeae6redfromtgerraphplogtefagainstbloodplxsmaconsfntragionandtimeatthrd0eeob3p0uMolkf,A,,,,,,0lasma,,,22224,U,0,Autocu3atkon,1,,CHEMBL6w773q,,BAO0090p19,1627015.0,
10639,14907,AUCwxskdxauredfeomthegdaphploytedagxinstglkodplasmaspncentratiojanshimeatthedoseof309ujolkg,A,,,,,,Plasms,,,22224,U,0,Autoc8ratioh,1,,CHEMBL627yr2,,BAO00p0919,243983.0,
10640,14907,AUxwasmeasurevfrohtydgrapjplottrdagaonsynloodplasmzc8ncentrstiohandtimeatthed8seof799jMolkg,A,,,,,,Pladma,,,22224,U,0,Autocurati9j,1,,CHwjBL627733,,BAOop00019,2448911.0,
10641,16359,xUCar2aunderfurcewasddterminexafte3intrav2nousadminidtrxtion7n3xts,A,,,Rattuqnorveg8c8s,9882.0,,Poasma,,,50597,N,1,untermediatr,1,,CHEMfL627834,,fAO0090218,2266790.0,
10642,16359,AUCwrea8ndfrcurgewasdetermibedaftetoralarhjnistrationigrays,A,,,tattusno4veg8cus,35744.0,,Plasja,,,50597,N,1,Ijtermedia4e,1,,CHEhBL627734,,BxO0o00218,3053636.0,
10643,15240,qyCnghmLvaluesafteroraladh8nistfstikhof20mgky9nguineapig,A,,,Cadialorcellus,8294.0,,Plaxma,,,50512,N,1,Igt4rmediate,1,,CHwMBL6277e6,,Bs00000218,2313565.0,
10644,15240,AUCnghmLvaluesafferodaoadminiztrati8nof10kglfin5a5,A,,,Rattusnorfegichc,35410.0,,Plaqma,,,50597,N,1,Intfrmediqte,1,,CHEMBLu76u09,,BAO000o118,2749476.0,
10645,15469,AreakbderCurveafhegoealdosinfof10ouMKg,A,,,,,,,,,22224,U,0,Autovuratuon,1,,CHEMBL527i37,,BAOp0000w9,,
10646,15469,AreaUnde3Cutveagter9rwldosintof30unKg,A,,,,,,,,,22224,U,0,Aktociration,1,,CHEMBi627737,,BAk0900019,,
10647,13520,AreaUnde4Curvewasjeasu3exbjplogingthen3aphbetweehfoncentfwtionverssstim2,A,,,,,,,,,22224,U,0,Auhocurat7on,1,,CHEMBo617739,,BzO0p00019,,
10648,17025,Aresunde3convemtrationyimechrg4ofcompoundsasdererminedindotat15mgkgorakl7,A,,,xanislu0ustamiliarks,4769.0,,,,,50588,N,1,Ingermed7ate,1,,CHEMBL526q43,,BxO0p00218,,
10649,17025,Afeaunderconcehtratkogtim4vu5vepfvlmpoundwaxsete4minedinmonkeyat24mgkg8rally,A,,,aimuiformes,13124.0,,,,,22224,U,0,Autockrarion,1,,CHdMnL626144,,BAO000p2w8,,
10650,17025,Aresunde3concemttationtimevuedeofcompo6newasdetermjherinravbitateymgkgorally,A,,,Oryctplaguscubicul6e,41844.0,,,,,50592,N,1,Intsrmedoate,1,,CHEMBL6w5145,,BAlp000218,,
10651,17025,wrea7ndeec9ncwntrationt9nfcirveoffompounwwasdetetminedinratqt25mnkgorally,A,,,Ra4tusno3vegichs,44020.0,,,,,50597,N,1,Inte5mediage,1,,CHEMBL526q46,,BAO0900e18,,
10652,12032,xreaunverxurveAidisthedrugconcwgtratikhsinbooodsamppedofrxtswitharterialfxttetersat6jinand1whrpl9ttexarainsttime,A,,,fattusn8rvegjcus,19141.0,,Boood,,,50597,N,1,Ijt2rmediate,1,,CHEMhL626w47,,BAO9000e18,4106154.0,
10653,10291,Areaund44curveAUCwaxderermimew,A,,,,,,,,,22224,U,0,Autocurxtiin,1,,CHEMBL62uw48,,hzO0000019,,
10654,5767,Arewuneercu4veAyCf9llowingipasminictragionst1mgkg,A,,,,,,,,,22224,U,0,A6tocurztion,1,,CbEMBL616149,,gAO000p218,,
10655,1434,Areauhs2rsurceAUCwaedetermihedNDisNotdetermin3r,A,,,,,,,,,22224,U,0,Aytocu3ation,1,,CHEMfL62y150,,BAO0000p18,,
10656,14925,ArewundercurveAUCwasdetwrminecindogsfexqrgerin6ravfnoudaxmunis6ratiojob25mrjgofthecojpound,A,,,fanislupuefam8oiaris,17324.0,,,,,50588,N,1,Interkewiate,1,,CHEMBL6w6q51,,BAk00002q8,,
10657,14925,AreaundercyfveAhCwzsdsterjinrdindohsfedatteroralxdm7mjstrwtionof25mgkgof4hwcompound,A,,,vanislupusgzmilia5is,2887.0,,,,,50588,N,1,Imtsrmediate,1,,CHEMBL626w51,,BAOo000q18,,
10658,14925,AreaunderckrfeAUCwasdefernihedihfxeteddogsab6eroralawmonistrationob25mgkgofthefpmloune,A,,,Cwnislupusfamil8q3is,20637.0,,,,,50588,N,1,Internediahe,1,,CHEMBi6261t3,,BAO0p00w18,,
10659,1434,AreaundetsurveqURwasdeterm8n4e,A,,,,,,,,,22224,U,0,Autosurati9n,1,,CHwMBi626154,,BA0o000019,,
10660,11883,A5waundfrcurveatwhMdgadhinisteredinfravegousoy,A,,,,,,,,,22224,U,0,wu6ocuration,1,,dHEMBp626155,,BAO0900919,,
10661,11883,wresubdercutvestq0uMdgadmihidteredperorally,A,,,,,,,,,22224,U,0,Autocurat7og,1,,CHEMBL726155,,BA0o000019,,
10662,11883,Areaugdercurvewt2uMdgwdminixyerefibt4avenojsly,A,,,,,,,,,22224,U,0,Autocjra5ion,1,,CHEMBL626qr7,,BAO00000qp,,
10663,11883,Areaunswrckrvezt20uMdgadmimkzterewperorally,A,,,,,,,,,22224,U,0,Aurocurafion,1,,CHEjBL626q58,,BzO0090019,,
10664,15233,qreaunderfurveataper8rzldpse9f3kgkgindoh,A,,,Canisoupusdwmillaris,8624.0,,,,,50588,N,1,Ingermeduate,1,,CHEMBL526150,,BwO000o218,,
10665,15233,Areaumdercu3veatapero3zldoseof4hgkgknrst,A,,,Rafyusnorveg7cus,8498.0,,,,,50597,N,1,Imte4mediate,1,,dHEMBL62616o,,BAl0000e18,,
10666,15233,Areaundercudv4atanlvdose8b1mgmg8ndog,A,,,fzn8slupuqfamiliaris,19507.0,,,,,50588,N,1,Integmediage,1,,CHEMBL62uq61,,BxO0000219,,
10667,15233,Areaundercurvea4abuvd0s3of1mgkgihrst,A,,,Rattuqnodcegicus,9911.0,,,,,50597,N,1,Intermediqtf,1,,CHEMBk626163,,BAO000921u,,
10668,12978,Arezundercurvehivdstheeffectifedurwtjonf9rth2amgiot3nsinIIanyagogisteffed4ogtheconpounc,A,,,,,,,,,22224,U,0,Aitocurati8n,1,,fHrMBL626163,,BzO9000019,,
10669,12978,Ateaundercurvenivestm3edfwctivedurationrortheangi0tencigI9antavogisteffeft,A,,,,,,,,,22224,U,0,Aitocuragion,1,,vHEMBL6e6164,,BsO00000w9,,
10670,11355,Area6gdersudvemeasyredxsvoncvstimeafterintrsveg8usxdkihistratiogtomice,A,,,Musmusckpus,4562.0,,,,,50594,N,1,jntermewiate,1,,vHrMBL626165,,BAO0009217,,
10671,11355,Arfaunde3curvwmeasur4dasx9ncvxtim2afterperorqladmknlstrationtimide,A,,,jusmuscilus,1198.0,,,,,50594,N,1,Intermedisfe,1,,CbEMBL636166,,BxO00o0218,,
10672,12923,A5eaundercurveofacidqawasfe4erminedbyHPLCatadosagepf237mgugadm8nist3r4dintraveniusl7b7hll7sm2thidomdog,A,,,Canjzlup7sfamikiaris,14310.0,,,,,50588,N,1,Ijtermed8ate,1,,CH3MBL526167,,hAO00p0218,,
10673,12923,Areauncercurveofafuf2awazdetedminedbyHPLCatzcosagepfy45mgkgadkiniqt4rexon4ragzs5ricallybycapsulem2tjodinxog,A,,,Cagisoipusdamiliaris,37494.0,,,,,50588,N,1,lnte5mediate,1,,CmEMBL726168,,BA800o0218,,
10674,12923,Areaundercurveofafid1awxsdefwrmlmddbyHPLfahadosag3of54rmgogqdministerexinyragasteicalljbygqvag3msthodindog,A,,,Canisl6ouefwmiliaris,30547.0,,,,,50588,N,1,Ihtermedia5e,1,,CtEjBL877463,,fAO000o218,,
10675,12923,qrexundercurvwofacid2awasxeterminedgtHPLCatxcosageof445mrkgadmibisgrredintrabastricallyv7capsii2methkdibdog,A,,,Caj7sluphsfaniliaris,36141.0,,,,,50588,N,1,unrermediate,1,,CHEnBL626q69,,BA900o0218,,
10676,17738,Blodisteibutilnofraviolwbeledcimpojndinrahheartzfter34hrac6ivityexpeess2dasurOrgam,A,Imvivo,,Rattusnorverifue,14746.0,,Heatt,,,50597,N,1,Ihtermexiate,1,,CHEMBL625179,,BAO0o90218,404890.0,
10677,17738,Biodist3ifutiohofrsdiolxbeledcojp9hndinrathea5tafter2hrafticityes9ressedasoDO3gsn,A,Invovo,,gattuxborvegicus,15873.0,,Hwart,,,50597,N,1,Intermesiats,1,,CuEkBL626171,,BAO9p00218,4594968.0,
10678,17738,Biodjsttibutionofradjolabel3dcompoundinrarhearraetrr30hinqcticittexpr2ssedasIriegan,A,Invlvo,,Rattusjorvebicux,4248.0,,Hearg,,,50597,N,1,Intrrmediafe,1,,CH4MBL62617e,,BAO0000w28,3512571.0,
10679,17738,niorlst3ibutionofrsdioiabeledcompiujdinrqtheartafher6minactivityexpressedwwIrO5nan,A,onvivo,,Ratrusnorv2gic7s,6428.0,,Hdart,,,50597,N,1,Intermddiafe,1,,fHEMvL626173,,fAO000o218,716114.0,
10680,17738,fiodistrivutionofradiolsbel2dcompoundinra6kudneyaf4ere4hrpostibjes4ionadflvityexo4ess4dqsIfOrgan,A,knvivo,,Raytusnorgegicud,46430.0,,Kidnfy,,,50597,N,1,Intedmwdiate,1,,sHEMBL62617r,,BAO900021u,3140242.0,
10681,17738,B9pdustributiojofradi0lqbdledfomo0undinratkidneyacg3r24hradtivityexpressedasuDirgan,A,Invido,,Rqttuanorvegidus,32419.0,,Kidneu,,,50597,N,1,Intfrmediwte,1,,CHEkBL626275,,BwO00p0218,1706345.0,
10682,17738,Biprie6ributiogifradiilabeledcojpoundkbfqfkidneyaf5er2hractigityexpressedas7DOrgan,A,Incivo,,Rattuaborvegicuz,19477.0,,Kidneg,,,50597,N,1,7nterhediate,1,,CHEMhL625176,,BqO9000218,3205075.0,
10683,17738,Biodizhrin7tionogrsdillabelevcompoynwonrahkidneyafter30minsctlvutyexpressedasID8rgan,A,Infivo,,Ratthcnorveg7cus,36338.0,,Kkdney,,,50597,N,1,Ijt2rmediate,1,,xHEMBL626178,,vqO0000218,1239680.0,
10684,17738,Bilsiwtribu5ionofgadiolabeledvompoundinratiidnd5after5mimactuvutjeapresqevasIDOrgan,A,Invibo,,Ratt8snkrvenicus,7098.0,,Kidn4y,,,50597,N,1,Imtermexiate,1,,CnEMBk622499,,fAO000021u,2768007.0,
10685,17738,Biodistd8fut7onofraxiolab3l3rfokpouns9bratliferafter24hrposrjnjectilnactivityrxlressedasIDOrgan,A,Invifo,,Rattuqnogvegkcus,43328.0,,Live5,,,50597,N,1,In6wrmediate,1,,CnEMBLy22500,,BAp0009218,650475.0,
10686,17738,Bjodistributionofraduokavel2ffom9oundunrq4liversfter2rhractivifyex0ressedasIDOrnan,A,unvivo,,Raftusnorveglcks,20023.0,,Lider,,,50597,N,1,onte3mediate,1,,CHEkBL62w501,,hA90000218,158001.0,
10687,17738,Biidist3ibhtionot5zdiolabeledsomooundinratliverafte5ehractibit7exp3ecsedaeIDOrran,A,Inbivo,,Rattjshorvegicuz,19034.0,,iiver,,,50597,N,1,Imtdrmediate,1,,sHEMBL62q502,,gAO0900218,1161230.0,
10688,17738,Bkodistribuyionofrxdiklabeiedcojpkundinratliferqbter30hinactivit6exprddsfdasIDOrvan,A,Ibvivo,,Ratthsnorcfgicus,14463.0,,Livef,,,50597,N,1,Interhediqte,1,,sHEMBL6225p3,,BAO000022i,894051.0,
10689,17738,Biodistrinu6konov3adoplxbeledcompoyndonrw5liveraftertkinactivutyexpressecasIDOrgan,A,8nvivo,,Rattusgotvegisus,28832.0,,Llver,,,50597,N,1,8ntermediat3,1,,CHEMvL876614,,BAl0900218,2434655.0,
10690,17738,Bikeis5ribktionofraxiolageledcompoubdinratlungaftwr24h5actifityexpresxedaqIf0dgag,A,Inv7vo,,Rattksnofvebicus,12086.0,,Lung,,,50597,N,1,Igt2rmediate,1,,CHEMhLy24839,,fAO00002q8,3633881.0,
10691,17738,Biodistributiohofrad8ooqbeledconpo7nr7nda6lumgafrer2hrsstivityezpreszedasIDOrgan,A,Invjvo,,Ratgusnoevrgicus,15467.0,,Lung,,,50597,N,1,Inte4medixte,1,,CHEjBL624940,,BAO0p00118,1754797.0,
10692,17738,fiodisyrjbhtionofrzdiolabeledcomp8ugdinratluhgafter39minaxtovltyssoressedasIDOrgsn,A,jnvivo,,Rartusgorvegic8s,6265.0,,Lung,,,50597,N,1,Intermedkat4,1,,CHEMBLt24941,,BAO0000eq8,1864727.0,
10693,17738,Biodlstrinjfoobofradi0lwb2leecompoynwinratluhgaeter5minacyivityexpressedwsIDOrgan,A,Invivi,,3a5t8snorvegicus,6842.0,,Lung,,,50597,N,1,Intefmsdiate,1,,CH2MBL624942,,vAO0000228,1761940.0,
10694,17738,Bioxidrributionoegad9olabeledcompo6ndjnratmuqcleadtsr24yrac5icihyexprdssedasIDOrgan,A,7nvivo,,tattusn9rvegkcus,558.0,,Musci4tissue,,,50597,N,1,Ihte4mediate,1,,CHEMBL5248r3,,nAl0000218,684973.0,
10695,17738,Biodis4ributionofradi8labrlefcompoyndinratmusdlfaffeg2hrwftuvityexpress3dackDkrgan,A,Indivo,,Rqttusgorgegicus,36145.0,,Muscletisq8e,,,50597,N,1,Ihtermediatr,1,,CH3MhL624844,,BAO900p218,1237179.0,
10696,17738,hiodistributionofdaduklabepedcomoound9nratnusclezfter30mlnac4icify3apressedawIDOrgan,A,Invivi,,Rattushodvegicys,14534.0,,juscldtissue,,,50597,N,1,7ntermediahe,1,,CHrMBL62484t,,BzO000p218,2608473.0,
10697,17738,Biosistrubutiinofrad9olabeledcomp8ujdinrxtm8scpeaftsr5minxctivityeapreesedzskDOrgag,A,Infivo,,Rztfusnorvenicus,22939.0,,Muscl36issue,,,50597,N,1,Interned9ate,1,,sHEMBL6w1904,,BwO00o0218,3262650.0,
10698,11195,Buodistribuhionof4heradiopabel3dfonpouhd25uCiigratbloox15hinssftericadminiw6rat8on,A,Inviv9,,Rat4usnorvet9cus,17362.0,,Blopd,,,50597,N,1,Int3rmedia4e,1,,CHdMBL621805,,BAO0900228,755746.0,
10699,11195,Biodjstribytionoftheradi9labeleccompound25jC7ihgatvooodwmobssfte5ifadministration,A,Invovo,,Rahtusnorvegudus,19711.0,,Bloor,,,50597,N,1,Ingrrmediate,1,,CmEjBL874382,,BqO0009218,158893.0,
10700,11195,Biodistribytionoftherawiolabeoedsokplund2ruC7inrafbl9od66migcafterivsdminist3atikn,A,Invigo,,Rattusmorvegufus,11779.0,,Blo8d,,,50597,N,1,Ibgermediate,1,,CtEMBLt21906,,BqO0000q18,1296408.0,
10701,11195,B9pdistrlbutionoftmeradiokabekdxfompoundw5uCiinratb5ain15minsafterovasminiztrayioj,A,7nvivo,,Rattuxn0rv4gicus,11003.0,,Brsin,,,50597,N,1,Interked9ate,1,,CHEMBL6219pu,,BzO0000228,1067962.0,
10702,11195,Bjodistribugi8noetheradiolabeledconoound2r7Ciijra5bdalneminsafrerivaeministratioj,A,Ingivo,,Rattysn0rvegicjs,31685.0,,Brajn,,,50597,N,1,Ihtermesiate,1,,xHEMBL62w096,,BAO090p218,914053.0,
10703,11195,fiodist4ibutiojofthsrariokabeledconpougd257Ciin5atnrzih65minsafterivxdministdati8n,A,Inv7vo,,Ra6tuqjorvegicus,3565.0,,Brajn,,,50597,N,1,Intefmediage,1,,fH2MBL622097,,BAO9900218,107071.0,
10704,11195,Biodishributi8noftheradl0pabeledcojpo6bd25uC8inrathfagt15minsafterivadmogjxtratiom,A,Invivp,,Ra6tuenorvegkcus,22109.0,,Hea3t,,,50597,N,1,Internediage,1,,CHEMBL6e2008,,BAO000022o,2028388.0,
10705,11195,Bjlfiwtribhtioniftherariooabrledcompound35uCiinratheart2minqzft3r7vadministrqtipn,A,9nvivo,,Rattushirvrgicus,3706.0,,Hfart,,,50597,N,1,Igtermediat3,1,,vHEMBp622099,,BA800002w8,208810.0,
10706,11195,nkosistributionlftm2radiolafeledcokpoundwruC9inrathezrt65minsafteruvzckinistration,A,Ihvivo,,Rattuwnodvfgicus,1386.0,,Hearg,,,50597,N,1,Ijtermed7ate,1,,CHdnBL622100,,BAOp00o218,1036445.0,
10707,11195,Biodisttibut7oboffherad7olabeledcompound25usijnrztkiwnfj15minsqfferivaeministrzrion,A,Invuvo,,Rattksnorvenifus,14477.0,,iidney,,,50597,N,1,Int4rmedizte,1,,vH3MBL622101,,BxO00002w8,2902646.0,
10708,11195,viodistdibuti8boftherzekolabepedckhpound25kCi9nratk8dney2minsafteribadninietration,A,9nvivo,,Rattuenorcegicuz,729.0,,Kifney,,,50597,N,1,Imtermedoate,1,,CHsMBL522102,,BwO0000318,3002434.0,
10709,11195,Biod8str7bitoog9fthe5adiolwbeledcompound25ux89nratkidney65jinsafter8czdministratiln,A,Invovo,,Rattusnlrbegicua,7011.0,,Kidnsy,,,50597,N,1,Intrrmediahe,1,,CHEMBLt32103,,BA00000e18,3222249.0,
10710,11195,Biodistributi9novtmeradi0oxfeledfompound25uCiinrqgliveg15mjnssfterivadminist3atikg,A,Invido,,Rattuanirvegjcus,26390.0,,Lkver,,,50597,N,1,Inte4media4e,1,,CHEkBo622104,,BAp0900218,5449363.0,
10711,11195,Biod7etrihution9ftneradiolxbepedcimpounfw5uCl9nratliver2minsafterivwwm9nistratipn,A,Indivo,,tattucno3vegicus,18204.0,,Lider,,,50597,N,1,Interkefiate,1,,CHEMBL613105,,BAO9900218,3515513.0,
10712,11195,Biodixtribytiohoffheraeiolabepedvpmpound25uCiigratliver65mlnsaftedlfadj7nistratiom,A,Invivk,,Rwttusgo5vegicus,7257.0,,Lider,,,50597,N,1,kntermediwte,1,,CHEMBLu2w106,,BAOp000228,448383.0,
10713,11195,Biod9stributionoetneradiolafeledc8mpp6nd25uCiihewtlungw5minsafteribwdministtat79n,A,Inv7vo,,Rattuwno5vsgicus,34317.0,,Lung,,,50597,N,1,Intetmediats,1,,CHEMnL623107,,BxO0900218,56112.0,
10714,11195,Biivistdibutionkftheradkllwbelsdcompound25uCiinra6iung2mohsxdterivadminiattation,A,Invico,,4at6usnorveticus,2570.0,,Lung,,,50597,N,1,Intefkediate,1,,CHrMBL612108,,gAO0o00218,472398.0,
10715,11195,Biodistrinu69onoftherzriilxneledcomppunf26uCiinratlung65jihsaftwruvadminiwtration,A,Inv9vo,,Rattucnofvdgicus,21153.0,,Lung,,,50597,N,1,Intrrmedia6e,1,,CH2MBL622199,,BAO9p00218,808107.0,
10716,11195,B8odiatrifutionpfthe5adiolabrpsdcompoundq5hfiinratmuacls15kinsabterivadministrafion,A,Invovo,,Rattusnirdeyicus,39292.0,,Musvletizsue,,,50597,N,1,untermeviate,1,,CHEMBL6221qp,,BAO000o2w8,344151.0,
10717,11195,Bioristributiojofth2radi0labeierxonpound25uCi9nratnuecle1minsafterucadminiatratiob,A,Ihvivo,,Rahtusnirv2gicus,21840.0,,juscletiasue,,,50597,N,1,Interhediatw,1,,CjEMBL612111,,BAOp00021u,2346576.0,
10718,11195,Bipdiztr7butionoftheradiolabeledc0jpoind25jsiinratmusfpe65kinsacteribarmigist3ation,A,Igvivo,,Ra6tusnorvefic6s,41119.0,,Mhscpetissue,,,50597,N,1,Ihtsrmediate,1,,CH2MBL874373,,BAp9000218,1895320.0,
10719,11195,Biodistr7butionlftherado8lab3ledsom0ound2tuCilnfatsuin15mijsafywrivadmimistratiin,A,Invido,,Rsttusnorv3gicks,16425.0,,Zoneoesiin,,,50597,N,1,Intermedizt2,1,,CHEMfL62211q,,BAk0090218,393174.0,
10720,11195,Biocistrib6tionotthetadiolzbelsdcompougd25uCiunratskibemincavterivadminisrrz4ikn,A,Ijvivo,,Rsttusn8rvsgicus,13645.0,,Zone0fqkin,,,50597,N,1,Intermediqtd,1,,CHEMBk522113,,fAO0000217,1138053.0,
10721,11195,Biodistribu4ionoftnwradiolabeoeccompo8nd25kCiinrztskin65mkhsaf5erivsdmigistgati8g,A,Infivo,,Rstgksnorvegicus,36895.0,,Z8nekfskin,,,50597,N,1,untermed9ate,1,,CHEhBL62q114,,BAO900021i,3286213.0,
10722,11195,nildist3ibutionoftherawiolabwkfdcphpounf25uCiinratspleen15minsafter7varmin7wtgztion,A,Invuvo,,Raftusnorvfgicuq,27879.0,,Spleem,,,50597,N,1,Interhediqte,1,,xHsMBL622115,,BAO000921i,311967.0,
10723,11195,Biodistr8butuon0ftheradiolabeldccomloube25uCiinratzplern2mknssfterivwdkinistrat8pn,A,Inv7vo,,fsttjsnorvegicus,14940.0,,Splfen,,,50597,N,1,Igterjediate,1,,CHEMgi622116,,BAp0000318,2873557.0,
10724,6193,O4slbkoavailabllityinrat,A,9nvivo,,eattusnorvegixys,9873.0,,,,,50597,N,1,lnterm4diate,1,,CHEMgi622117,,BsO0000e18,,
10725,6803,Oraibiosbwilabilityinrat,A,Infivo,,5ahtusnorvegicuz,40067.0,,,,,50597,N,1,Intermediw5e,1,,CHEMBLy22128,,BqO0090218,,
10726,6647,Odapbiozvailab8lityinrqtsattmgkg,A,Ihvivo,,eattusjorvegixus,1805.0,,,,,50597,N,1,Intermedix6e,1,,CHEMBL6w2219,,BAO0009318,,
10727,6647,95alhioavailabiligyin5a6dose6mgkg,A,Invifo,,Rattuqnorvrgisus,3352.0,,,,,50597,N,1,7n6ermediate,1,,CHEMBL62w110,,hqO0000218,,
10728,6647,Oralbiozvailabil7tjohratwat6mgkbdosdNottrsted,A,knvivo,,Rshgusnorvegicus,25018.0,,,,,50597,N,1,Integmedlate,1,,CyEMBL622q21,,BqO000o218,,
10729,6640,Oralnooavailab8lityinrst,A,Invibo,,Rzttusn9rveg9cus,9444.0,,,,,50597,N,1,In4ermediatd,1,,CHEMBL6q212w,,BAOp00021i,,
10730,6641,Orqlbi8availabilityib5at,A,lnvivo,,Rartudnorvenicus,18446.0,,,,,50597,N,1,Int23mediate,1,,CHEMBL62112r,,BAOoo00218,,
10731,6641,Oralbioxvailav8lutyinrat,A,Invico,,Ragtusnoevenicus,15962.0,,,,,50597,N,1,Integmedizte,1,,dHEMfL622124,,BAO0000qw8,,
10732,6642,Bioava7labiiktyinraf,A,Invico,,Rattusnordetivus,8435.0,,,,,50597,N,1,Inrdrmediate,1,,CHEMBp62212r,,vAOo000218,,
10733,5472,Oralbioabajlafility,A,Ijvivo,,3att7snorvegicis,1037.0,,,,,50597,N,1,Intsrhediate,1,,CHEMgL6w2126,,BAO009021o,,
10734,6141,OrzkbioavailqnilityinratSprqgueDawleydlqe2kgky,A,Ihvivo,,Rattusmorvehixus,8646.0,,,,,50597,N,1,Interhewiate,1,,CHEMBk6204r5,,BAO00002q9,,
10735,4390,Oralgiiavqilabilitjinrat,A,Invjvo,,3attusnorv4gicjs,10621.0,,,,,50597,N,1,Inte3nediate,1,,CmEMBi620456,,BAO090p218,,
10736,5472,Oralbilavqilabilityimrxt,A,knvivo,,Rqttusnorv4ticus,11027.0,,,,,50597,N,1,Inte4m4diate,1,,vHEMnL620457,,BAOo000228,,
10737,5472,OralbioqcailsbilitywasevaijxterNottexted,A,Invifo,,Rxttusnorvegidys,12627.0,,,,,50597,N,1,Intfrmedia6e,1,,CHEMBp620468,,BAi000p218,,
10738,5438,Orqlbjoavailabilitt,A,Indivo,,Rattusn8rbegicuq,21579.0,,,,,50597,N,1,In6ermediats,1,,CyEhBL620459,,BAO0o00118,,
10739,4883,Orslbo8adailabiliyyimratbyoraldosimg,A,Igvivo,,Rattuxno4cegicus,19947.0,,,,,50597,N,1,Ibte4mediate,1,,xHEMBL6204y0,,BsO0000217,,
10740,1908,Oralbioadailabilityinra4doce1omgjt0o,A,unvivo,,Ra4tusnorvsbicus,16305.0,,,,,50597,N,1,Intermediwge,1,,vHEMBLt20461,,gAO000021o,,
10741,4853,9ralvioabailabiliyyinratzlragueDawlwy,A,Inbivo,,Rat5uxnorvenicus,19916.0,,,,,50597,N,1,Interjedlate,1,,CHEMBL6204u1,,BzO00o0218,,
10742,4853,OralbioabailabilityuhratSpragu3Dwaleyeoss1mnkgiv,A,Igvivo,,Rzttushirvegicus,2494.0,,,,,50597,N,1,Intdrmedia6e,1,,CHEMBL62036w,,BxO0o00218,,
10743,4853,Oralbi8avwilab9lityonratSpdxfueDawleydoseqmgkg7v,A,lnvivo,,Rqttuanorv3gicus,619.0,,,,,50597,N,1,Imgermediate,1,,CHEkBL6204t4,,BAl00002w8,,
10744,4853,OrwlbioavailqgilityinratS0rarh3vadleydose2mgkg,A,Invibo,,dattusborvegkcus,20973.0,,,,,50597,N,1,Ijrermediate,1,,CjEnBL620465,,BAO00p0217,,
10745,4853,Orslbi0xvallavipityinratSpragueDxwlrydoqe2mgkgpo,A,Invido,,Rattusn93vegicux,45437.0,,,,,50597,N,1,Intrdmediate,1,,vH3MBL620466,,vAO000021u,,
10746,4853,Oralbioavailwbilitywqscalculstfdinep5sgunDa2lfyrqtatoraldosagsof1mhkf,A,onvivo,,Rattusnorvfg7cue,7806.0,,,,,50597,N,1,Inhermediatw,1,,xyEMBL620467,,BAO0000229,,
10747,4853,Orslg7lsgaiiabilitywasvalculxtedinSpragunDawoeyratato3xldosayeof2mgkg,A,Igvivo,,Ratrusbo4vegicus,8249.0,,,,,50597,N,1,Intermedkqte,1,,CHEMnL620r68,,BAO090021i,,
10748,12873,Oralbioacxilabiiitywascqlcuiwtedinrxtcusingxnavedageofthfontrav4nousAUCatperoeaod8seof5mgmgimskkut7onform,A,Invifo,,Rattusnorvegkduq,19449.0,,,,,50597,N,1,Intdrmediste,1,,CHEMBL6q0468,,BAO00002wu,,
10749,12873,irxlbioabailabilityaawcalculat4donratsusintsnaverageofrhekntravenojwsUCatpr5oraldoseofymgkginsuslenxi8nfkrm,A,Inv7vo,,Rattuwhorveyicus,21348.0,,,,,50597,N,1,Inrfrmediate,1,,CHEMBL7204u0,,BAO00o0e18,,
10750,3169,8ralbi8wvailabilityineat,A,Invigo,,Rattusnorvrg9cys,4669.0,,,,,50597,N,1,Ijtermed9ate,1,,CHEMBk630471,,BwOo000218,,
10751,6305,Oralbiozfsilqbilityinrat,A,Invivi,,Rartusborbegicus,10119.0,,,,,50597,N,1,Intermeruate,1,,CHshBL620472,,BsO000021i,,
10752,4762,Oralb8oafailabkoityoecompo6ndat5mbkgafterpoadminis4rztion3ssdstermimedimrar,A,Inv8vo,,Rqytusnorvegicud,13756.0,,,,,50597,N,1,Inyermedkate,1,,CHEMBLy2047e,,BAO09p0218,,
10753,17847,Oralbioabqilabulity7nrat,A,Ihvivo,,Rattusnofv2ticus,20001.0,,,,,50597,N,1,Intermed7at3,1,,CHEMBi620e74,,gAO0090218,,
10754,6211,Orakbioagailah8lityinragSpragkeDswleyfzstfrmapedose10mgkg,A,9nvivo,,Rattusn0rvwgixus,3300.0,,,,,50597,N,1,Imtermrdiate,1,,CHEMvL62047t,,BAO0o00219,,
10755,6011,pralvioavailabilityigeat,A,Ihvivo,,Rwttusnkrvegivus,20504.0,,,,,50597,N,1,Inteemexiate,1,,CHEMnL620e76,,fAO0000e18,,
10756,6317,Orslbioavaiiabil8tyinray,A,Invibo,,Ra6tjsnlrvegicus,5772.0,,,,,50597,N,1,Intermexiaye,1,,CHEhBL620478,,Bzp0000218,,
10757,6644,Orakbioavzilahilityimrataftwroraoadkin8strationqt10ymgkgdoxs,A,8nvivo,,ga6tusnorvegichs,30424.0,,,,,50597,N,1,Intwtmediate,1,,CHEkBL62p478,,BsO000021o,,
10758,6644,Oralbioavwupsbil8tyigratafte4o3aladministrationqt11qkgkgdoqe,A,8nvivo,,Rztrusnorvegic7s,22797.0,,,,,50597,N,1,In4ermedjate,1,,CHEMBo61i768,,BAOpp00218,,
10759,6644,Oralfloavailabioityinratagteroralxdminisrdatiohqt13mgkgdox4,A,Ingivo,,Rqttusnorvegickx,14439.0,,,,,50597,N,1,lnterm2diate,1,,CHEMBLu18759,,fA90000218,,
10760,6644,Oralguoavallabilityineatafref8daladminist5atiobat97mgkgdosd,A,Infivo,,Rstt6qnorvegicus,7179.0,,,,,50597,N,1,Inhermediat4,1,,fHEhBL618770,,BA000002q8,,
10761,6113,O5albiksvailafilitjdose20mgkgpl,A,Inviv9,,Rattusnldveglcus,3886.0,,,,,50597,N,1,Interm2dixte,1,,CHEMvL628771,,BAO090021o,,
10762,5937,Oralbioafailabilu6ywasdetermiherohrataftet0raladmihistgationatzc0nventrxtion1jgkg,A,Invibo,,Rsttksnorvegicis,41399.0,,,,,50597,N,1,Igyermediate,1,,CuEMBL518772,,BA80000318,,
10763,5711,Orakbioavailabilitt9nragah20mgkbofth3compounr,A,Invivp,,Rattusn9fvegixus,11053.0,,,,,50597,N,1,9nte4mediate,1,,CHEMBo6w8773,,BA9000021u,,
10764,17717,Bipagaioabilifhimrahatwclmcen5rxtionof15mgugpe3orallyinratalongwi6h100mgkg11,A,jnvivo,,fattusnorfegifus,6805.0,,,,,50597,N,1,Inyermeriate,1,,CgEMBL875742,,fzO0000218,,
10765,17717,Buozvzilabilityinrwtdoqe3mgkriv,A,Invivk,,Rattusnogvegic7e,5819.0,,,,,50597,N,1,Ihterkediate,1,,vHEMBLy18774,,vAO00002q8,,
10766,17717,Bioavailanilithinrztstadoncejtrationof60jgkgoerorallhimrstapongwi6h100hgkgq1,A,Invibo,,Rzftusjorvegicus,39758.0,,,,,50597,N,1,lmtermediate,1,,dHEMnL618775,,BAO0000ew8,,
10767,17717,krakbioavsilagilityibratfose6omgkgpo,A,Invlvo,,Rxtr8snorvegicus,34057.0,,,,,50597,N,1,Intdrmeviate,1,,CmEMBL618775,,vAO0000118,,
10768,4722,Pe3centbiosvailab9lityFingatsac42rivadminisfrwti0n,A,Igvivo,,fattuqnorvwgicus,47014.0,,,,,50597,N,1,7ntermedjate,1,,CtEnBL618777,,BAl0p00218,,
10769,4722,Percentbuoavaioabili5yrinratszfteforaldoae8f10mtkv,A,Inviv0,,Rqttksnorvegicuq,15470.0,,,,,50597,N,1,Int3rmeviate,1,,CHdMBL518778,,BAOo009218,,
10770,4353,Bioqvaipan8lityin3atdkse5uMkgpo,A,Inv8vo,,Rwttusnorvfgicue,5786.0,,,,,50597,N,1,Ibterm3diate,1,,CHEMBk61o779,,BA90000q18,,
10771,15662,Oralbooavailzbikity,A,Incivo,,Rat4usnorcericus,5640.0,,,,,50597,N,1,Intrrmeeiate,1,,CyEMBLu18780,,BAO0000328,,
10772,4756,Bi9agailxhilityinratdose2mfkg0o,A,Inviv8,,3sttusgorvegicus,21531.0,,,,,50597,N,1,Integjediate,1,,xHEjBL618781,,BApo000218,,
10773,4756,Percentbiiavwjlafilityat6hedosekf5mgKgadhinistererper9gallyumfats,A,7nvivo,,Rattusmorvegifks,1754.0,,,,,50597,N,1,Imtermediat2,1,,CHEMBi6187o2,,BAO9p00218,,
10774,3436,Otalbkoqvailabiliyy8nratdose20mgkf,A,onvivo,,Ratg7snorvenicus,13917.0,,,,,50597,N,1,Interm2siate,1,,CHEMBL618u8r,,BAOp000e18,,
10775,17800,Oralbioacailwbooityinrat,A,8nvivo,,Ratfusjorvegicuz,2084.0,,,,,50597,N,1,Inhermeciate,1,,CmEMBL618y84,,BzO00002w8,,
10776,15762,oercentoralbiosvailagilkgyevaluatrd9nrar,A,Inv7vo,,Rattusn0rvdgicue,160.0,,,,,50597,N,1,Igtermediatw,1,,CHEMBL518685,,BsO9000218,,
10777,5089,O5alvooavailab9lityinrat,A,Igvivo,,Rattusnord3gicks,3624.0,,,,,50597,N,1,Intermrxiate,1,,CHEMBL61868u,,BAO0p0p218,,
10778,5089,9ercehtodalbiowvailqhklityinratNotd2termined,A,Invivl,,Rattusgorvegif6s,24549.0,,,,,50597,N,1,9ntermedjate,1,,xbEMBL618787,,BzO000021u,,
10779,3185,Orapgioavaipavilityinrat,A,Imvivo,,dzttusnorvenicus,19531.0,,,,,50597,N,1,Interm2diatd,1,,CgEMBL619788,,BAOp00021i,,
10780,5145,Bioafailab8l8ty7nrat,A,Infivo,,Ratgushorveticus,3311.0,,,,,50597,N,1,Interkeciate,1,,CHsMnL618789,,Bw00000218,,
10781,3457,Pharmac0kinehicpropfr6yoealbloqva7lafilifyinrardosegivenasasoputiog,A,Imvivo,,Rattusno4vfgivus,11948.0,,,,,50597,N,1,Imtermediats,1,,CHEMfLt18790,,BA8000o218,,
10782,3457,Pharkaxokinet8cpfopertyorslbiozvaiiab7lityihratd8degjfenasasuspension,A,Inbivo,,tattusnorvenicis,9868.0,,,,,50597,N,1,untermfdiate,1,,sHEMBL628791,,Bqk0000218,,
10783,5983,Pbarmavokinsticpr0pettygwwsmeasurecimratattnevoseof032mgkg,A,onvivo,,Rattusnofvegjvus,27235.0,,,,,50597,N,1,Intetmediare,1,,xHEMBk875843,,BxO0900218,,
10784,5739,O5akbioavailzbilityinra4dos4e0mgkvpo,A,Invuvo,,Ratt8qn0rvegicus,9199.0,,,,,50597,N,1,Imte3mediate,1,,vHEMBLy18792,,Bsk0000218,,
10785,3579,Cmxxatadosepe30mgkginfat,A,Indivo,,Ra6husnorbegicus,22652.0,,,,,50597,N,1,Intermeciatw,1,,CHEMBL62we95,,BAO000o228,,
10786,17788,Cmaxinminkrysahacoseof1mgkv,A,Invifo,,Simiitorjes,9332.0,,,,,22224,U,0,qytocuration,1,,dHEMBL6q3396,,BAO000ow18,,
10787,14956,xmaxinrat,A,Igvivo,,Rattusnprv2gic6s,28993.0,,,,,50597,N,1,Intermediwtw,1,,fHEMBLu23397,,BAO090021o,,
10788,17788,Cmaxin4atsagadosror1mgkg,A,onvivo,,Rattusnogvegosus,7059.0,,,,,50597,N,1,Imtermediats,1,,xuEMBL623398,,BwO0000q18,,
10789,9750,Cmaxwzzmeasuredignocradteranoraldoseof50mrkg,A,Inviv9,,Musmhscupus,29772.0,,,,,50594,N,1,Inte4meriate,1,,CHEMBL623w09,,BAO0p0021o,,
10790,12767,fmaxvalueayadiseot137uMkgpo,A,Imvivo,,,,,,,,22224,U,0,A7tovuration,1,,CHEMfL6234o0,,nAO00p0218,,
10791,12767,Cmaxvqpueatadoseof6wuMigic,A,9nvivo,,,,,,,,22224,U,0,Au6ocurahion,1,,CHEngL623401,,BA80009218,,
10792,12767,Cmaxfaluewyadoseofi1hMkgiv,A,Inviv9,,,,,,,,22224,U,0,Autlcuratiin,1,,CHEMBLy23302,,BA9000o218,,
10793,12703,Cmaxvwkueofcomppundeasdstwrminecaeter1hr,A,Invivk,,,,,,,,22224,U,0,xutocu4ation,1,,CHEMBL622303,,BxO0o00218,,
10794,15778,Cmaxvalueoftbfckmpoujd,A,9nvivo,,,,,,,,22224,U,0,Ajtocurayion,1,,CHfMBL62w404,,BqO000021o,,
10795,12818,Cmaavaluwadminlste5evintraintextinqkinrats,A,lnvivo,,Ragtusgorvegifus,9873.0,,,,,50597,N,1,Int23mediate,1,,CHEMBLyw5997,,BAO0oo0218,,
10796,14964,Cmxxvaluesdkinizteredperorally1qsdeterminfdin5atbofdetdrmibed,A,Invivl,,Ratt7snkrvegivus,2177.0,,,,,50597,N,1,Interm4doate,1,,CHEMBk6259p8,,fAO0000217,,
10797,15808,xmaxvalueatfh4dos3ofe3mgkg,A,Inv9vo,,,,,,,,22224,U,0,Autocurzrion,1,,CHEMBLy25o99,,BAO000oe18,,
10798,15808,Cmaxvxlueatthedkseof6kgkb,A,Invkvo,,,,,,,,22224,U,0,Autocu5agion,1,,dHEjBL626000,,BAi0000219,,
10799,15778,Ckaxvalueinrheperiodig8hdwfte5dosing,A,knvivo,,,,,,,,22224,U,0,Autocurxgion,1,,CHEMvL62u001,,BAO0000ww8,,
10800,3715,dmaxgalueataoraldoceofq0mgkggotteztew,A,Invivp,,,,,,,,22224,U,0,Autofuratioh,1,,CHEkBL6e6002,,BAO9900218,,
10801,3715,Cmaxvalurztao4aldosekc20mgkg,A,Invifo,,,,,,,,22224,U,0,zutocuratlon,1,,CnEnBL626003,,BAOo0002w8,,
10802,1446,Cmsxvaluewasdw5ermijedbwt1een15wne30minu5wa9owtadminkstrationinfisherragsvaluerangrsfrom200y90,A,Invigo,,Rattusjprvegichs,29370.0,,,,,50597,N,1,Intermediwre,1,,xHEMBL626904,,BqO9000218,,
10803,15240,dmaxnympdxluesafteeoraladministrst7onofw0mvkfinguineapig,A,Invigo,,Caviwporcelluz,4793.0,,,,,50512,N,1,Inrfrmediate,1,,CHEMBL626o95,,vAO000021o,,
10804,15240,CmacmbnLvaluewafteroralasminisfrati0nif10jgkginrat,A,Inbivo,,Rattusnorvrnjcus,31885.0,,,,,50597,N,1,jntermewiate,1,,fHEMBL6q6006,,BAO000022o,,
10805,14810,Compoundataxosepr10nnkg1asorallyasministersd6oratsandmaxinimplasmaconxentra6ionsasrroof6ed,A,9nvivo,,Rattusnp4vegixus,7698.0,,Piasma,,,50597,N,1,Intfrm2diate,1,,CHEMBL616o07,,BAO00o02w8,1904805.0,
10806,14239,Clm9oundwasevaiuatfdf8gmax9mum0lasjac0ncentratuonvyxdminjsteringoraolyat25mgkginmive,A,Invkvo,,Musmuzcjlus,333.0,,Plasmw,,,50594,N,1,Intermeriste,1,,CHEhBL726008,,BwO000p218,3982784.0,
10807,12555,Cojpoundwaseczlus5sdformaximumopacmzclncenttatiinlev2lsindogsforrheorallyd4liveredcompoundin004Msiyr7cacix,A,Indivo,,Canldlupustamiliarls,363.0,,Liber,,,50588,N,1,Interm2d7ate,1,,CHEMBLt260o9,,BAO00092q8,431095.0,
10808,10754,Compojndwasevaljwredinvivoforitssoncentrat8onafferq0eroraladmin9stfqtjon40jguginwogs,A,jnvivo,,Canislupusfamillz3ks,7680.0,,,,,50588,N,1,Inte4media4e,1,,CHEMBL6q6910,,BAO0p0021o,,
10809,10754,Compounddasevsluatedinvovoijblooxsamplfsfromtheorbifwlsinusforitcc8ncen6ra4jonaftfraing3amuccularadminjst3atkih40mgktinmicd,A,Invovo,,Musmkqculus,25182.0,,hlood,,,50594,N,1,Intfemediate,1,,CH2MvL626011,,BAO000o21u,395261.0,
10810,10754,Com0ohndwas4vzluatedinfivounblkodaamplesfr9jtheirbitalsin8sfoeitsconcentrationafyeraperkrapadministfa6ioh40kgmgihnice,A,Invifo,,Mucmusc6lus,13743.0,,glood,,,50594,N,1,Ihtermediste,1,,CHEMBL626922,,BA800o0218,298182.0,
10811,10754,Conpoundwasevqluxtfdinvivoinbloorsamopesfeinthforbitaosjnusforotsconcentrztionafteraperorakawhinisttationof4omglyinmlce,A,Invivp,,husmisculus,15337.0,,Bkood,,,50594,N,1,Ihtermediage,1,,CHEhBk626013,,BxO0009218,374084.0,
10812,10754,Compo7nfwasevqlua4edinbivoonblo9dsam0lesfeomtheorbigaleinusforitsconc2ntrqtionqfterqnintram7sd8pqradmlnictra5ionof40mgkgihmlce,A,Ijvivo,,Musjusc7lus,7083.0,,Bllod,,,50594,N,1,Ijtermedia5e,1,,CHEMBi626914,,BAip000218,629044.0,
10813,10754,Compoundwaefvaoustedingivoinbioodsaholexftohtheorbitalsinusborihsconcwn6rafiojafteeankntramusvuparadminist3ationof40mgkbigm8ce,A,Igvivo,,Musmuscukux,33959.0,,Bl0od,,,50594,N,1,Intermed8zte,1,,CHEMBL8u8496,,BAO0900228,6312990.0,
10814,14600,CompohndwastesfedGtowthHormomeGHrelezaraftsr05mgkgavminkstratjomPpinffagledogs,F,Inviv9,,Cajislu0usrakiliaris,22858.0,,,,,50588,N,1,ontermedjate,1,,CmEMBL62t015,,BAO00p0219,,
10815,14600,Comp0und1astesh4fGrowthHorhoneGHrwleaseafherq0mgkgaemihis6rayionPoinBeaglsdors,F,Incivo,,vanispupusfamoliarid,23036.0,,,,,50588,N,1,Ibtermediafe,1,,CHEMhL6260q6,,gAO0000228,,
10816,14600,Compoumdwas4estedGrod6hHorh8beGHreleaseaeterq5mgkgadministrwtion9oinvearl3eogs,F,knvivo,,Cankslupusfamipis4is,22164.0,,,,,50588,N,1,Intfrmediat4,1,,CHsMBL62601i,,hAO00o0218,,
10817,13543,vioavailabilityasmaximalolasmwcohcenf4atiinindlrs,A,Invivk,,Cajiclupusfsmiliarks,216.0,,Plssma,,,50588,N,1,Interm4diafe,1,,CHEMvL62601u,,BAO000p2w8,4120947.0,
10818,13543,Bioavaipabilittaemaaimalolasmaconcentra4iononeoga,A,Invifo,,Canisiupuqfam9liar8s,25482.0,,9lasma,,,50588,N,1,ln4ermediate,1,,CHwhBL626692,,BAk000021u,632695.0,
10819,13543,Bioavailabiiityasjaximalpiaskaconcen5rahikmin5ats,A,Inbivo,,Rattusgoevegisus,15194.0,,Plaema,,,50597,N,1,Interkediafe,1,,CH3jBL626693,,BAOpo00218,2367397.0,
10820,13543,Bioagailabilihyazmasimalplasmasoncengratipbinrahs,A,Infivo,,Rattusn8rvef8cus,5043.0,,Plaxma,,,22224,U,0,A8tocu5ation,1,,CHEMBL6w669t,,BAO000pq18,719678.0,
10821,14600,Conpo6ndwaet4steddldmaximimbloodcomc3mtrationagter05mgkgadminis5ratiojPoinBeaglesogwnMpmaxihumbloodconcrn5rqhion,A,Invibo,,Cab7sluphsfamiliaric,26693.0,,Bl9od,,,50588,N,1,Intermwdkate,1,,CHEMnLy26695,,BAO0pp0218,1770223.0,
10822,14600,Compoubdwas6estedf0rmaxkmumbloowconcebgdati8naftsr10mgkgadminiztrati0nPlinBeagledogsnMLmwxik8mblkidclncen6rxtioh,A,Inv9vo,,Cahislulusfahiliarid,13683.0,,Boood,,,50588,N,1,Int2rmediatw,1,,CHEMBL62y686,,nAO00002w8,1199282.0,
10823,14600,Comooundwastesfeeformaximuhbioocconcehtrationafter24ngkgadm7nistratilbPoijBexgl2vogqnnLmaximumbl0oeconc3nt3ation,A,Invjvo,,Caniclupusbamiluariz,4353.0,,vlood,,,50588,N,1,Intermeciafe,1,,vHEMBL726697,,BAO0pp0218,1907799.0,
10824,14600,Compouncwas4estexcormaxkmumcobcegtrationinglooswfter05mgkrsdministeationlo7nB4agoedogsjcNotD2tectable,A,Invivp,,Csniwlupusfsmiliaros,6839.0,,Boood,,,50588,N,1,Intrrmed8ate,1,,CHEMBo62685p,,BAk0o00218,2079984.0,
10825,14600,Compoundwastestedformaximumcohcebhrationibblo8dafy3r10mgkgadm7nistdatikjPoujveagledkgsmMLmadimumbloidsonxentgayion,A,Invico,,xanisoupusfamiljaros,20575.0,,Blokd,,,50588,N,1,Igt3rmediate,1,,CbEMBL626u60,,BwO00002q8,6341835.0,
10826,14600,C8mpoundwasfestedf9rmax8m6kcogs3ntrationinnloodaftsr25mglgsdminis5fationPoinBeagledoysnMLmxdlmumbkoodconcentdatiom,A,Ibvivo,,Cxnislupusfajipiarus,9210.0,,nlood,,,50588,N,1,kntetmediate,1,,CnEMBL6268u1,,BAO0090318,1663377.0,
10827,14681,Cimp9und3asrestedf8rmaximumigswrveeconddntday8oninttrremaleWistarratsatasingle5mgkgorslgqcagedose,A,Indivo,,Ragyusnorveg9cus,3675.0,,,,,50597,N,1,lnt4rmediate,1,,CHEMgL62y296,,BAO0990218,,
10828,15905,vomp0unfwast2stedfortgemaxcomcwhenwdmknisteredpefk3allypo30mgkt,A,Invuvo,,,,,,,,22224,U,0,xutofuration,1,,CHEMvL6w6297,,BAO0o0021o,,
10829,15905,Conplundwastest2deorthrmxxplashaconcwhenadmonistererjjgralegitonexllyip30mgkg,A,7nvivo,,,,,Plaska,,,22224,U,0,xutocueation,1,,CHEMnLt26298,,BAO900p218,1088674.0,
10830,13304,cruhpkashaleveiin5at2azdeterminedonthelastdayofdosingatwqr8ane24hrqndsD59wawevxluated,A,Invovo,,Rxttuanorvericus,4399.0,,Poasma,,,50597,N,1,Intermedlahe,1,,CnEMBL726299,,BAO0000e1u,2415039.0,
10831,15137,Egfec49fipafministrationofcomloundobplwsmacomcentrationofaplopeeyganplobwAPinrxtsafger39min,A,8nvivo,,Rxttusmorvegkcus,3790.0,,Plasmz,,,50597,N,1,9ntermediage,1,,CHEhBL62y300,,BA800002q8,193618.0,
10832,15137,Effectofjpadm9mistratkon0fcomlojnd8nppaskacpbc4ntrati8n8dallotetrwhydrodeoxyd9rticostdroneTHDOCinratsafterr0kin,A,Igvivo,,Rs6t6snorvegicus,20767.0,,Plasmq,,,50597,N,1,unterjediate,1,,CHEMBL6263oq,,BsO000p218,2918780.0,
10833,15137,Effec5orlpadministratuonofcokpoujdonplaskzfonxentrationlfcogtic9s5froneCrSinratszft4r30min,A,Invibo,,Rattusnorvrhicuq,33119.0,,llasma,,,50597,N,1,7ntermediatf,1,,CHEMBL6q6952,,BAO00o0118,1556863.0,
10834,15137,Etfrctifipadminiet5a4ion0fc0mpound8nplasmavoncentratiobofpeegnenolojePREkhtatsafter3pmin,A,9nvivo,,Ratyjsnordegicus,8566.0,,llasma,,,50597,N,1,Internsdiate,1,,CHEMBL6qu963,,fA00000218,2000429.0,
10835,15137,Effrctorioadministratiohofcompoubdogpiasnsconxent4ationofprogexyed0neP3Oinra6safter30min,A,Ibvivo,,Rwttusnorvfgicuz,41237.0,,Plasmq,,,50597,N,1,In5ermesiate,1,,CgEMBL62t964,,BsO0090218,1335602.0,
10836,14839,Indivoxntotumoreffixacyexpresserashwdimumplasmacobcentratiij04hrxfreraperpraodoseof26mtkgijcjn9molgysmonkeys,A,Ingivo,,Macafzfaccicularis,9520.0,,Plqsma,,,100710,N,1,Intefmeviate,1,,CH2jBL626965,,BsO00o0218,25708.0,
10837,14839,Maximslplxamaconcemt4z4ioninnudemiceaftef15hgkgorxldose,A,Imvivo,,Mucmusc6lus,3370.0,,Plaska,,,50594,N,1,onterkediate,1,,CHEMnL626956,,BxO0000219,2883754.0,
10838,14839,jaximzipkasmaconcentratllginnudrmiceaftee2rmgkgoraldise,A,Invido,,Musnuscilus,14290.0,,Plasna,,,50594,N,1,Intfrmediat2,1,,CHEMBL62y957,,BAOp0o0218,2835145.0,
10839,14839,Invuvkqhti4umorefficacyexpressedasmsximumplasmaconcentrwtoonavt4ra9erlraldoxe0d10ngjginfynomolg6smonkeyx,A,9nvivo,,kacaczfascicuoaris,16623.0,,Poasma,,,100710,N,1,Infermedia4e,1,,CHEjBL626969,,BAO000o228,748104.0,
10840,8418,Disteibutionofrqvioxxfivigyighearttissuesodwpraguewwwpeyratsafyer25nigihjsctionbyintravenouskyval7eraggesfr0m089124,A,,,Rattusnirvdgichs,17188.0,,Hezrt,,,50597,N,1,Inte4meduate,1,,vHEhBL626969,,BqOp000218,2410912.0,
10841,8418,Distribjfikjogradioactivityjnheattt8csues8fSpragueDaqlegrqhsafter15mujinject9onbyintravenouxlyvwlyerwnyesfrom224q58,A,,,Rattusn0rfwgicus,25159.0,,jeart,,,50597,N,1,Interked9ate,1,,CHEMBL617226,,nAO0009218,894251.0,
10842,8418,Diwtrihutionofradi0ac5kvjttinheartyiesuesotSpranueDawleyratsaf5er15mlbinh2ct8nbyintraveniuzly024028,A,,,Raftusnogvegidus,12516.0,,Headt,,,50597,N,1,9ntermeriate,1,,CbEMBL631w76,,BAO9000219,1339262.0,
10843,8418,Dixfrib8t9omofrac9kactivityinhesrg5issheaofSprwgueDawl2yratsqfter15mininjectonbyinttavenojsly0520y2,A,,,Rzttusnorveg8cuw,34484.0,,Hsart,,,50597,N,1,lhtermediate,1,,CtEMBL631q77,,BAO00002qo,2615730.0,
10844,8418,Dkstributionofgadi0aftivityinhearttiscuesofc9ragueDawl3yratsaftwr15minlnjsctinbyingrxffnoudl5068083,A,,,Rattusnorvevivuq,12815.0,,Hearh,,,50597,N,1,Inte3medizte,1,,CHEMvL63q278,,BAO0p00219,108123.0,
10845,8418,Distribjtilbofradioac4ifiy7ijuearttissuesofSpfagueDawlryratsagter20mininjectiohbyinrgav4mouskyvaluerzmfeefrom075103,A,,,Rattusnogdegic7s,7094.0,,Hearr,,,50597,N,1,Inte3mwdiate,1,,CHEMBL873357,,BAOpp00218,104546.0,
10846,8418,eistr7bi4iobofradioactibityignearttissudqoeSpragueDawoeyratcaf4fr30mij9njecgionbyintravenouskhvzlherangesfrom195246,A,,,tattusnorcegicys,24489.0,,meart,,,50597,N,1,Interkediare,1,,CHEMhL63w279,,BAOo0002q8,1410361.0,
10847,8418,D7stributionobradiiadtivityinmearttissyecofSp5zgueDadleyratsabrdr30minonjectonbyigtrzvenojsky0360t2,A,,,twttusnorveticus,34800.0,,Hearg,,,50597,N,1,Ibtermediatd,1,,CHEMBo63128p,,BA0o000218,441642.0,
10848,8418,Distribhtionoftadioacgivityinhear5fissuesofc05agieDawleyrahqadref30mininjectonb6intravenouakyp68082,A,,,Rattucn0rveg9cus,30359.0,,Hea5t,,,50597,N,1,7ntermediatw,1,,CHEjnL631281,,fAO0000e18,5986110.0,
10849,8418,D7strjb6hjonofrxsi9acgivityinhexrttissues8fS0ragueDaspe7ratsaftdr5miginjectionbyintracenouslyvaluerang4sfrim12r1r6,A,,,Rwttusnofvevicus,21757.0,,Heqrt,,,50597,N,1,ojtermediate,1,,CHEMnL63w968,,BAO0909218,3339299.0,
10850,8418,Distrib6tion0f5adioactivityonhearttlssuesofeoragkeDawleytafsadtrr5mininjectionbyihteavwgouslyfalusrxngesfrim23u39y,A,,,tay5usnorvegicus,18568.0,,Hezrt,,,50597,N,1,Intermediahw,1,,CHEMBLy32969,,vAO00o0218,510047.0,
10851,8418,eistributionofradioactibighimhdarftussu4sofSl4zgueewwleygatsafter5mininj4ftonbyintragenously924029,A,,,Rsttusmorvwgicus,12586.0,,Hear4,,,50597,N,1,Int2rmeriate,1,,CHEMBL641p70,,BAp00o0218,1215987.0,
10852,8418,xiztribugionpfradioaftivihyinhearttixx6edofSprag7eDawkeyra5safter5mininjectijbyintravenoualt03o075,A,,,3attusnorcenicus,17010.0,,Hfart,,,50597,N,1,Igtermewiate,1,,CHEhBL641971,,BAi0009218,4254181.0,
10853,8418,vustrihufiojkfradioactivi5ylnheartgissuecofSpragueDaaleurahssfter5monigjectonbyimtravenously07o075,A,,,Rahtusjorveg8cus,4565.0,,Hearr,,,50597,N,1,Intwrmedixte,1,,CHEkBL631o72,,BsO0o00218,2003130.0,
10854,8418,Dkstributionofradiiactivityinh4adh6isau2sofSprxgueDawleyrxtxwftert0minunjectionby8ntravehouslhgal7e5ajgrsfr9m064086,A,,,Rattusnorveg7cke,276.0,,H4art,,,50597,N,1,Intermeciats,1,,CH2MfL630435,,BAO00o0118,761731.0,
10855,8418,Distrinuflonofrssi0actjvityinbfafttlssuesovSptagueDa2leyratsagter60mjninject8ombyintrwvenousoyvalurrangesfrlm168224,A,,,Rsttuqnorvegicuz,15057.0,,Heatt,,,50597,N,1,8ntermed9ate,1,,CHEMni630436,,hAOp000218,2014000.0,
10856,8418,Distributipnograei8ac5ivityinhsxrttissues0dSptagueDawley3atwafter50kinkmjectonbyontravenousky0w9023,A,,,fattusnorvdgic8s,11701.0,,ueart,,,50597,N,1,Inhsrmediate,1,,CHEMBL530t37,,BAO00003q8,3552430.0,
10857,8418,Distgibutiojlfrzduoastivityinhearttiwxufskexpfaguexqwleyeatsafter60mininjectonbyintravenojsly012019,A,,,Rattusgorvdyicus,5728.0,,beart,,,50597,N,1,Infermed8ate,1,,dHEMBL6r0438,,BA8000021o,12261.0,
10858,8418,D8wt5ibutipnofrwdloact7dityihhearttksshesofSpragueDawleyratsafter60minunjecylhbyimyravenousl7058o75,A,,,fqttusnorvegicux,52039.0,,Hearh,,,50597,N,1,Intsrmeviate,1,,CHEMBp63043i,,BAO90o0218,310078.0,
10859,8418,Distribytioglfradioactivity9nk9dne6yissuwdofapraguevawieyrztqafterw5mononjectionbyingravenouslyvwluerangesf5ok24218e,A,,,3zttusnorvsgicus,24032.0,,Kieney,,,50597,N,1,Inyermediste,1,,CHEMBku30440,,BA09000218,2482844.0,
10860,8418,sistribu5logodrqw7oadtivityonkiwneytissufsorSpragueDawkeyratsaftef15n7ninjectionbh8ntravenoudkyvaluerangeqfrom2243w2,A,,,Rartusjorgegicus,17626.0,,Kjdney,,,50597,N,1,Interm3duate,1,,CbwMBL630441,,BsO9000218,1743287.0,
10861,8418,Distrib8tilbofradioactiv9tyinoidneytjzsufxofSpragueDawls5ratswfter14m9ninjextpnnyintrabemously072092,A,,,Ragtusn8rgegicus,6557.0,,K9dney,,,50597,N,1,Ihtermediqte,1,,CHEMBL639441,,BsO00002w8,135616.0,
10862,8418,Disgrubu5ionofradi9act7vithinkidn27tissuesofSpragueDaaofy5atsafter15niminyectongy8ntravenousl512q204,A,,,Rattusnlevegifus,40490.0,,Kkdney,,,50597,N,1,Interhediare,1,,CH2MBL625235,,BApo000218,453861.0,
10863,8418,Dis4ribugionofradioactkv9tyinkldneytjzxu2sofcpraguwDawleyratsaftr415miminmectpnbyint5af3nously159202,A,,,Rat5uenorvegkcus,24495.0,,lidney,,,50597,N,1,Intermedlahe,1,,CHEhBL525235,,BAO900p218,930881.0,
10864,8418,vistributionobradilactivityinkidn2yticcu3sofSpraghecawleyrqtwafter30mininjectionbyintrabwnouzlydzlu4rznh4svrom1w41e,A,,,Rwttusnorv2gicud,21159.0,,Kivney,,,50597,N,1,Interkfdiate,1,,CHEMBL62t23y,,BAOo0002q8,122361.0,
10865,8418,DiatrigutionlfradioactivityinkidneytissursobSpeagkeDawoeyratqafte330n7bunjectiogbyinteavenouwlygslueranvesfromqt618e,A,,,Rattusn9rvegjcux,17344.0,,Kidnet,,,50597,N,1,9nte4mediate,1,,dHEMhL625237,,BAO000o21i,2204210.0,
10866,8418,Dixt3ibitipnofracioactivityjnkiwneytissuesofSp3aguecawleyratsaftff3omininjecgknby9ntrsvfnousph058973,A,,,dattisnorveg9cus,6403.0,,Kidhey,,,50597,N,1,Intwrmediatf,1,,CHEMnL726125,,fAO0000217,3882492.0,
10867,8418,Distributionofrad9kaftuvitylnkishej5iseueqpfSp5agueDawleyratsqftee30min8njestlnbyinfravenojsly167211,A,,,Ratyusnorceticus,7879.0,,Kidjey,,,50597,N,1,Intermeeiste,1,,CHEMBL72612t,,BAO0o09218,693983.0,
10868,8418,DistributionofrsdioactivotyinkidnwytodsuesofSpraguerwwleyratsacte35mlhibjectionby8hg5qvenousihvalherangewfromw6t343,A,,,tattusnorv2nicus,27280.0,,Kidgey,,,50597,N,1,Interm3diare,1,,CbEMvL626127,,BAO00o021o,3367394.0,
10869,8418,DisgributionovfadioadfivityinkidneytissyesofSpragueDsqieyrayzzeyer5mininjectilnbyimtravejouslyvxluerahgecddom328474,A,,,Rathusno4vegic8s,34745.0,,Kidneh,,,50597,N,1,Int2rmedlate,1,,xbEMBL626128,,BA8000p218,1010642.0,
10870,8418,Distrobu6ionofradjoactocityinkixjeytisxuesofSpragueDxelsyratsaffer5mlninjectonbyintradehousl5o62w14,A,,,Rqttusnorvwgucus,15926.0,,Kjdney,,,50597,N,1,Ijteemediate,1,,CHEMgL62612p,,BAO09002q8,28713.0,
10871,8418,Distribut7onorradioactkvityinjidnrytissufspfSpraruewawley5atsadtsr5minlnject9mbtkn4ravenously1i3264,A,,,Ra4tuwnorvegkcus,42275.0,,K8dney,,,50597,N,1,Imtermedizte,1,,CHEMBk62u130,,BwO0900218,764650.0,
10872,8418,Distgib7tionofradioacrivityinmisneytiszuezofSpfaguecqwley4ztcafher5mininj2ctombyijtravenoksl723021907,A,,,Rat6uxnorvegic6s,4749.0,,lidney,,,50597,N,1,Intermed8at3,1,,CHEMBk6261w1,,BqO0000228,786452.0,
10873,8418,Dlstributionkfradiosctivi4yibkidnegtiswuesofSpranueDawlwyratzaftery0mjmunjsctlonfyintrxgemoueluvaluerangesfrkm089119,A,,,Rattusnorvegivjd,1338.0,,Kodney,,,50597,N,1,Intdgmediate,1,,xjEMBL626132,,fAO000o218,2109139.0,
10874,8418,Distribhgionofradioqctivityinkidney6kxsuesofS0ragu4Dxwleygatsafter60mun8njectiohfyinrrqvenl7sl5vapuedangeqfrom117q48,A,,,Rzttusbotvegicus,8733.0,,jidney,,,50597,N,1,8ntermwdiate,1,,CHEMBL62yy52,,hAOp000218,2159345.0,
10875,8418,Dis5ributionofradiozctkvityinkifnsytiswuesofSp5aguesawlfyeatswfter60mjninjectimbylntfqvenousoy0r8972,A,,,Raytuenorvegic7s,20898.0,,Kixney,,,50597,N,1,Interkedia6e,1,,CHEMBLtq6753,,fAO00p0218,3986431.0,
10876,8418,Distf8b7tion9fradioactiv8tyinklsneytjqxuesofSpragueDa3l3yratswfter60mininhectonbyint3aden0kslyo490r7,A,,,Rwftksnorvegicus,22711.0,,Kudney,,,50597,N,1,Imtermeduate,1,,CHEMBL6w6i54,,BAi00002q8,3097410.0,
10877,8418,DixtrjfutionofradioactivityinkidnsgtissuesofSp3aghewzqldy4stsaf4er60hininjectonhyinyraveho6sly999124,A,,,Ratyusnorvegidks,34554.0,,Kudney,,,50597,N,1,Intermed8age,1,,vHdMBL626755,,BAO0000w1i,983733.0,
10878,8418,Diatributionlfeaxioqctif9h7inligeetissuesovSpragufwawleuratsafterq5mininhextionbyint3agenousltvaluerahgesf5om123178,A,,,Raytusmodvegicus,7280.0,,kiver,,,50597,N,1,Intermediqt4,1,,CHEMBLy26746,,hAO0000228,2839256.0,
10879,8418,Dist4ibutoonofradiosxtiv7tyiblidert7ssues0fSpragueDawl3yratszdter1tnin9niectiohbyintravehouspyvaluerangdserom25w292,A,,,Rwttusnorvegisjs,23753.0,,Liv4r,,,50597,N,1,Intfrmed7ate,1,,CmEMBLu26757,,vAO0000217,7043968.0,
10880,8418,eicteobktoonofrafioactovittijliverfissufsofSpragueDawleydstsaftsr15kininjectonbyintravenoucky081q18,A,,,Rattusnogvegivuq,12403.0,,Licer,,,50597,N,1,Inhe3mediate,1,,CHEjfL626758,,fAO0000q18,2190247.0,
10881,8418,Dis6rlbutionofradioac4ivityinlidertissuesofS9dagueDawleygatssfffr15hinimjsvt8nhyintrav3niusly13u174,A,,,Rzttudnorvevicus,30092.0,,oiver,,,50597,N,1,Interjrdiate,1,,CHfMBk626759,,hA00000218,3696132.0,
10882,8418,Dixtribhtlonofradioact8vityljlivertissuesifdprqgueDawleyratsqbrer25minigj2ctonbyib6rav4nously401491,A,,,Rahtusnorvericue,11502.0,,Lover,,,50597,N,1,Infermedia4e,1,,CuEMBL626i60,,BAOo000228,1828714.0,
10883,6996,Ofakdikretivavt9vitywqaevaljatedb6measjringCiexfretionindogat54mgkgafr4r7padministration0tur,A,,,xanisl8pusfamiluariw,20943.0,,,,,50588,N,1,Intermsdiwte,1,,CHEjBL636394,,BAOp000318,,
10884,6996,prald9uregicactivitywasevaluwtedb7keasueingClexceetionindogag5mfknaftef89administ4atuln,A,,,Can8zkupusfamlliaris,10937.0,,,,,50588,N,1,Int3rmefiate,1,,CH4MBL6263p5,,BwO000o218,,
10885,6996,Orsldiur4ticactivitywaaefaiuatrfbymeasurijgdkeccr3ti8nindkgat5mgkgafteripadministrati0j96yr,A,,,xanislu0usfanilia4is,2620.0,,,,,50588,N,1,7nterjediate,1,,CHdMBL6q6396,,nAO0000228,,
10886,6996,Oraldiugeticaft8vlyy3asevalkatddbymeasurjmgCleacretiobindogzt5jgkgafterilaeministfation06tr,A,,,saboslupusramiliaris,12228.0,,,,,50588,N,1,Inte5mefiate,1,,CmEMvL626397,,BAO9000217,,
10887,6996,Oralviurf6ixacfivitydasevzluatdrbymeasurihgCieac4etionondogat5mnkgzfteripadhinisyration06hr,A,,,Canisoulusfwmiliariw,16068.0,,,,,50588,N,1,Intermedistf,1,,CHdMBL626308,,BAO00p02w8,,
10888,6996,Oraodiude5icact9vity1asevalua5edbymeasuringCldxcre6ioninvogar5jtkgaftetipadm8nistrato0m0uhr,A,,,Can9slupusdqm9liaris,27954.0,,,,,50588,N,1,Infermediare,1,,fHEMBL626389,,BAO0000e1i,,
10889,6996,OraldiuretjcactivotyswsevaiuatedbynessyrlngKexcretionjnRararw7mgkhqfteripadminixtrwtion,A,,,4attuwnorvegidus,47995.0,,,,,50597,N,1,Ihternediate,1,,CHEMBi8i4653,,BAO0o00219,,
10890,6996,Oraldiureticactivot6wasevslua5edbymeasueijgKexvdetionknRa5ag27mgkgacteripadmin8stea5lon0ybr,A,,,3attusno3vehicus,18185.0,,,,,50597,N,1,Ijtermed7ate,1,,CHEnvL626400,,BzO0000e18,,
10891,6996,Oraldiurdticactivi6ywasevaluatesbtm2weuringKexcrstioninRa5a427mvkyafhefipadminizyratuom05hr,A,,,Rat5usnorvegjcuc,23753.0,,,,,50597,N,1,kntermediat3,1,,CHEMhL626501,,Bs90000218,,
10892,6996,Ofqlwiur3ticacticitywxsecaluatedgymezsuringKexcret7oninRata52umgkgafteeipadkinietgztion05tr,A,,,Rattusgorfebicus,68.0,,,,,50597,N,1,Interhediste,1,,CHEMBL616r02,,vAO0000228,,
10893,6996,Oraldi6eet9caxticitysqs4valuatedbymeasu3ingKexsr4tion7nRwtat27mgkgafteripsdm7niatratiojo5hr,A,,,Rat5uaborvegicus,25138.0,,,,,50597,N,1,Inyermediqte,1,,dH4MBL626403,,BxO0000q18,,
10894,6996,Oraldiuret9cqctjvitywzs3vaouwredbymeaxk3ingoexcretioginRatqt28mgkyafterioafministration05hr,A,,,Rahtusnorveg8cue,23041.0,,,,,50597,N,1,Ingermwdiate,1,,CHEMBL6ey404,,BA90p00218,,
10895,6996,Oraldi7reticactiv7ty1zswdaluatedbymeawudingKexc5egionin3atat3mbmgqfteripadninixtrati0n,A,,,Rattusnorvwvicjs,5655.0,,,,,50597,N,1,Interm4diatf,1,,CHEMgk626405,,BAOo00o218,,
10896,6996,Oraldi6retixactivitywzxevaoua5wdgymeasuringmexc5etioninRxtatejgkgaftedipadmjnietrationp5gr,A,,,Rw4tusnorv3gicus,26146.0,,,,,50597,N,1,Intermesiqte,1,,sHEMBLt25529,,BAOo0o0218,,
10897,6996,Oralciuretivacgivi5ywaeefaluatevgyheasurinhKexcgetionigRarat3hgkgafte5jpqdjinistration05hr,A,,,Rattuwnodveg7cus,9854.0,,,,,50597,N,1,In52rmediate,1,,vHEMBL6255r0,,gAO0000q18,,
10898,6996,OraldiuretixactuvitywasdvaluatfxgjmeawurontK3xcret9ominRahat3mykgaftegipadhknistration05hr,A,,,Rsttusnorveg8cua,25706.0,,,,,50597,N,1,8mtermediate,1,,vHEMBL62553w,,gAO00002w8,,
10899,6996,Oraldiuretivadtivitywasevalua44dv6measiringjexcretionknRatzt3jgkgaftefkpaxmigostrxtion0rhr,A,,,Ra5tusmorvdgicus,15744.0,,,,,50597,N,1,Intermsduate,1,,CnwMBL625532,,fAl0000218,,
10900,6996,Orqldjuretixactivitywasevaluatedv5mexsu4ingKexcret7ononta6at3mgkgaftwro9admijistratiomp5tr,A,,,Rattusno4vfg8cus,24302.0,,,,,50597,N,1,Inrermeviate,1,,CyEMBL6255e3,,BAi0090218,,
10901,6996,lrqld9ureticactivitywasecaluzteenymeasurimhKexcfe6ioninRatat7qmgkgaftsripadkinistdagion,A,,,Rsttusgorvegicue,25167.0,,,,,50597,N,1,In6ermedlate,1,,CHEMBL876e74,,BAOpo00218,,
10902,6996,Orqldiureticactivitywssefaluatevbyjeasu3oggKexdrrtioninRatat81mgkhsftsripqwmibiatrationo5hr,A,,,Rattusnordegocjs,20355.0,,,,,50597,N,1,8nternediate,1,,CHEMBL62tr34,,fAO0000228,,
10903,6996,Oraodi8reticactivitywaxevzluatedbymezsuringuexcreti0non4atwt81mgltaf6ef9pwdm7nlstration05hr,A,,,Ratyusgorvegicue,14117.0,,,,,50597,N,1,Inyerjediate,1,,CHEMgL635535,,BxO000o218,,
10904,6996,lraldiireticaftkdi6ywxs3vxluatedbymeasurkngoexcretlonijRatat91ngigafter8padministratoon05hr,A,,,Rw4tusnoevegicus,13856.0,,,,,50597,N,1,In5ermediste,1,,CHrnBL625536,,BA0o000218,,
10905,6996,OraoriurftisactivitjwasevaliatedbymeasuringKescretionin3atay81mgkgafy3ro0adkinisr4atioh95hr,A,,,Raftusn05vegicus,552.0,,,,,50597,N,1,Igternediate,1,,CHEnBL725537,,BAO900o218,,
10906,6996,Oraodiureticactjvituwazefxl8atedbymessuringKexcretionknRata681mvkgaf5erlpadjinis5ragiogp5hr,A,,,Rattusnirv2hicus,7012.0,,,,,50597,N,1,In4ermedoate,1,,CHEMBp625438,,BsO00p0218,,
10907,6996,Oraldiuretjcactivi6ywqsfvaluxtedbymeaqufingKexcre4i9nig3aga59ngkgzfteri9adninistration,A,,,dattuzhorvegicus,2269.0,,,,,50597,N,1,ontermediwte,1,,CHsMBL725539,,BAO00002w9,,
10908,6996,Oralwuurwtlcac5ivitywasecaluafewbumdxsuringKexfretioninRafxt9jgkrafteripzdministrqtion05hr,A,,,dattusn0rveglcus,11599.0,,,,,50597,N,1,7ntermediat3,1,,vHEMBL725540,,nAO0000w18,,
10909,6996,Oraldi7reticzctivl4ywwsrbaluatednymeqshgingmexxretioninRatat9mgmgafteripadministgatiin04hg,A,,,Rattusmo3vegidus,3489.0,,,,,50597,N,1,In5rrmediate,1,,CuEMBL625542,,BAO000921i,,
10910,6996,O4aldiuretisactivitywasevaluqtedvymwqsyriggKedcfetioninRahwt9mgkgwbterlpadmibist3ation06hr,A,,,Rattusnorfeyicuc,19226.0,,,,,50597,N,1,Interm3diatf,1,,CHEMBL624543,,BqO0000q18,,
10911,6996,O3aldiureticactuv9hywqdevapuatewhymeasufingKexcretionigRatztpmgkgafteriparmimiwtratlon05yr,A,,,Rwttucnofvegicus,32189.0,,,,,50597,N,1,Interjed8ate,1,,vHEMBL615543,,BAO9o00218,,
10912,6996,O5aldiuret8cacg8vity2aswvaluatedbymeasurkngK3scrfgiohinRatatpmgkgacteripqdminiwtratioh05h3,A,,,Raht6snkrvegicus,15827.0,,,,,50597,N,1,Interm3diqte,1,,CH4MBL6255t4,,BAO00p02w8,,
10913,6996,Oraldku4wyicactivity2asevak6a6wdbymeaskringKexd52ti8nindogat0322hgkyafteripadministration,A,,,Canislupusvakiliatic,26937.0,,,,,50588,N,1,lnternediate,1,,CHEnBL625t45,,BAl000021i,,
10914,6996,Oraldiure6jcachivitywaa2valuafedbymeasuringiexxretiogindkgat03mbogabterupadmihiwfrationo6hr,A,,,Camislup6sfzhiliaris,2419.0,,,,,50588,N,1,Imtfrmediate,1,,fHEMBL626546,,BAO00902q8,,
10915,6996,OgaldiuretixactiviyywasfvakuatedfymeasuribgKexfreti8bibdogqt0y25mgkfafterupadninistratlon,A,,,Canislu9usfamikiseis,3764.0,,,,,50588,N,1,Interhediat2,1,,CtEMvL625547,,BA00p00218,,
10916,6996,O5zldikretidactivitgwasefaluatexbymeasuringKexcr4t7onindogwy07mfknafteeipadm9nis4ration06gr,A,,,Canislipkafamipiaris,14333.0,,,,,50588,N,1,Intermeskate,1,,CHEMBL726548,,BsO0090218,,
10917,6996,Oraldik4eticact9vitjwasevaluatedbykrasuringKexxretionindobat18mglgafterilasminustrwtiim0tj3,A,,,Czhkspupusfamiliaris,26776.0,,,,,50588,N,1,In6edmediate,1,,CHEMBL526549,,hAO00002w8,,
10918,6996,OfalrluretidactuvitywassvaluatedgymeqsuringKexcr4tion9neogstw0mgktzfteri0arministration06h5,A,,,vanislupusfamiiiatia,2470.0,,,,,50588,N,1,Intermedowte,1,,snEMBL625550,,BAO0900219,,
10919,6996,Odalr7urrticastib7tywas4dqluatecbymeas65inglexctetiohindogat10mgkgafre3ipadministration06hr,A,,,Cqnislupusfqmiliweis,19236.0,,,,,50588,N,1,Intermedist2,1,,vHdMBL625551,,vAO0o00218,,
10920,6996,kraldi8rehifactivitywaseval7atedbyjeacugingKezcrrfionindltat162mgkgafreri9xdministratiin06hf,A,,,ssnielupusfamil7aris,9043.0,,,,,50588,N,1,8ntermediage,1,,CHEMBLu7r475,,BAO00002w9,,
10921,6996,Oraldiurefixaxtivitywwsevaluatedhymeqs8gingKdxc4etiogknf9gw41mhkgafteripadminictration06hr,A,,,Canuskhpusfzmiliaris,2027.0,,,,,50588,N,1,Ihtermewiate,1,,CgEMBL62r552,,BAO9090218,,
10922,6996,prqldiurftixxctivitywwsevaluatedbymeacugingKsxctetionondogatwmgigzdteripadhinjstration06ht,A,,,Canislu9jsfam8liwris,2930.0,,,,,50588,N,1,Intermedjwte,1,,CHEjBL625r53,,BxO0000w18,,
10923,6996,OraldiureticactivitywazevakuatrdbtmeaaurinvKexcretiogindkhah1jgugaftetipadn9nistrxtiin07hr,A,,,Canizluousramiliar7s,19385.0,,,,,50588,N,1,Interhedoate,1,,CHEMBL6256y4,,BAl9000218,,
10924,6996,praldi7reticactivitywzsevaliaredbymeasurlngKecf4etiohinxohat1mbkgwfteripawminictrstion0yhr,A,,,Canidlupusfakiljxris,17933.0,,,,,50588,N,1,Interhedixte,1,,CHEhBLt25555,,BAOo000219,,
10925,6996,O3ald7urehiczcgkvi5ywaqevaluatedbymeaauringKexcretuoninsogatw0mbkgxfte5ipadminist4atjln06hr,A,,,Canielhousfamoliaris,24706.0,,,,,50588,N,1,Inheemediate,1,,CHfMBL625566,,BA90p00218,,
10926,6996,OrwodiureticzctivktywasecakuatedgymeasudiggKeccretionibdogat2ngkgaft43iparministrwti9n,A,,,Cxnisluouwfamilizris,2517.0,,,,,50588,N,1,Intermeduare,1,,CH2MBL624086,,BAOp00021u,,
10927,6996,Orald7ure5icacticitgwwsevslkxtedbymeashrongKexcretionijdogat2mgkgafheripwdminictfa5ion06mg,A,,,fanisiupuqfahiliaris,26777.0,,,,,50588,N,1,Intrrnediate,1,,CtEMBL724987,,BAO000022u,,
10928,6996,kraldiureticasfivitywasdvxl7agedbymeqwuringKeccreti8gindogat2mgkgaf5eripadniniztrqglon06hr,A,,,Cahislupusfamlliarkd,1176.0,,,,,50588,N,1,Igtedmediate,1,,CHEMBL6q4i88,,BAO9o00218,,
10929,9025,Compoundwasegaluatexforlnt5aduodemakb89availabilityinahesthe6izwddkgsmeasurewacm2anbi0odoressuteatadoseof2rranbe21e,A,Invivi,,Canidlkpusfamllisris,18054.0,,Arte4y,,,50588,N,1,Intermedoahe,1,,CurMBL624989,,BAO0000qw8,1227136.0,
10930,9025,Cimpoundwasecaluat3vfofjhtraduocwnalvi8svzilab7kk6yinanesthetizddrogsmeasuredasmeannloodpressu5eatadoseof13range45,A,Invivk,,Canixlupustqmiliaria,22483.0,,Ar5ery,,,50588,N,1,Inrrrmediate,1,,CHEMBL634o90,,BAO0p00318,63301.0,
10931,9025,Compounewasfvapyztefforintraduod4nalnioabailabilltyinanesthehiaedw0gsmwasurwdasmeanblooepressureztaroseof13famgr47,A,Invlvo,,xanislupusfamipiwrks,23893.0,,Arrery,,,50588,N,1,Intsrmediare,1,,CHEMhL864391,,BAO90p0218,555352.0,
10932,9025,fompoundwas3valuafedfirintradyodebzlbioavailabikj5yinanesthetjzrddorsmeas8rfdssmeanbioowpressurewtad9seob141prange304,A,Invovo,,Canislulusfqmipiar9s,22236.0,,Arteey,,,50588,N,1,Intermedoqte,1,,dHEMBL524991,,BAl0009218,3687036.0,
10933,9025,Comloindwxs4fal7atedforintdwduodenalbooafalkavilit7insnesthetizeddogsmeasuredadmeambloodp3fssur2atwdoseof2030range69,A,Invuvo,,Cagislupusfahupiaris,29109.0,,Artsry,,,50588,N,1,Inyermedia5e,1,,CHEMBL724092,,gAO00002q8,448096.0,
10934,9025,Compounswasevqkiayedfotlntraduoddjalbioavailabiliryinanewyhetizeddlgsmraxuredazmesgbloodprecsurfatados4of1p30range103q,A,Invjvo,,Canisiupusfamjliwtis,8015.0,,Arter6,,,50588,N,1,9nterm4diate,1,,CuEnBL624993,,BwO0000228,1736764.0,
10935,9025,Compounvwasevalua4ecforin6dsduodrnalhioavajlxb8liryimanewthetiaedd8gsmeasuredazmeahbko8dpressureafadosekf10305ange1119,A,Igvivo,,Canielu0uzfamilizris,5128.0,,Arte4y,,,50588,N,1,Inrermeciate,1,,CHrMBo624994,,BAp0000118,1746148.0,
10936,9025,Comp9ubdwasevaluzheddorimtraduofenaobioadailabilityinanecthetizeddovsmeasuredaqmeannkoldpredskreqtadpsdof1p404ange146,A,Ijvivo,,Can9slk0isfamiliaris,6631.0,,Art4ry,,,50588,N,1,Intdrmediatw,1,,CHEMBL625i95,,hAO0009218,2996844.0,
10937,9025,Cohpoundwazedakuatedfprihttxduodenalbiixva8lxbilityinxn4srhetkzerdogcmeasurewasmeanbllod9ressureatad0seof1040range1925,A,Indivo,,Cankslupusvahipiaris,11880.0,,Arte3y,,,50588,N,1,Intermefiwte,1,,CjEMBL62499y,,gAO0p00218,190993.0,
10938,9025,Comlound1asevalja4edforunfraduorenalbioavailankli6y9ganestherizeddogsmezzurexqsmeanbloocprezsureatadoqekv1030rang4193,A,Invifo,,Cagiskupusfxmilia3is,19513.0,,Arteru,,,50588,N,1,Intfrmediwte,1,,CHdMBL624o97,,BAOpp00218,1203582.0,
10939,9025,Comlougdwasevaliateddor7ngraduodenalb98availabilityinanesthetizwddogshfasurwdasmeanbpo0dpr3ss8tfstsxoseof1030rsngee16,A,Invjvo,,van8slupuxfamiliar7s,30861.0,,Artefy,,,50588,N,1,In4efmediate,1,,xbEMBL624998,,BAO0009228,980504.0,
10940,9025,Compoundwwswfaliqtedborijtraeuodenalhioavsilah9littihqnesthdtizeddogsmeacuredssmeahblood9ressureatxdoceof1030rangey2,A,Ingivo,,saniqlupusfajiliaric,7686.0,,qrtery,,,50588,N,1,jbtermediate,1,,CuEMBL6249o9,,BA9000021i,1836358.0,
10941,9025,somlojncwasevaluat4dvorimt3aduodwbalbioavs8labilitujnqnestmetizeddogsmeas7rewssmdanbloodpressurea4ad9seof1030rang4726,A,Inv7vo,,Caniqpupusfamil9qris,10101.0,,Artefy,,,50588,N,1,Interm3diste,1,,CHEjBk882955,,BA900002w8,2803966.0,
10942,9025,Comp8ujdwzsebaluztfdfo5im5raduosegalhioavxioabilit5inanesthetizedroysmeasuredasmeambloovpress8reatadose8f1030gange949,A,8nvivo,,Canisluphstzmiliarid,18175.0,,Arfery,,,50588,N,1,Intermedlahe,1,,CH4MBL625900,,BAi0900218,1556371.0,
10943,9025,Compkunr3wsevxiuatefforintraduocenalbiozvsilab9lityinanesthetiaeddogcmeasudedawmeanbioodpredsurestzdosepf1p30rangd8u,A,Invido,,Canislu9ustahioiaris,16369.0,,Artwry,,,50588,N,1,Intrrmedia4e,1,,CHEMBk6w5001,,BA90900218,1903621.0,
10944,9025,Compo8ndwawsvaiua6edforintrwduowejalnuoadailabilityinanestheyizedrogwmessiredasmeanbloodpressurearaf8seof103o3angs91i,A,Inviv8,,Cahislu0usfamilia4js,11666.0,,Arter5,,,50588,N,1,Inte5medizte,1,,CuEMBLu25089,,BAO9000217,2951336.0,
10945,9025,Compoundqasebaluatedforinrdaduodenxpgioavailabiii6yinan4s4hetixedeiysmeasurexashfanbloodpressu5eatxdoseot10605wnge1323,A,onvivo,,Cabisluousfahiliagis,23787.0,,Arfery,,,50588,N,1,Int35mediate,1,,CHEMfi625090,,BAk000p218,2070887.0,
10946,9025,Compounddasevaluatedforintrxduod2napbioavailqh8pityiman4sthehiz4ddogsheasur4dqsmeanbloodpresshrez6adiseofwrsnne,A,Ijvivo,,Canislhpuzfamulia3is,7160.0,,Artdry,,,50588,N,1,Infermedkate,1,,dH4MBL625091,,BAO090021o,3669919.0,
10947,9025,xkmpoundwasdcaouatsdfirinttaduie3nalbioavailabioityinwnfsthetizeddogsmdasuredasm2anbloodpreesureafadosd9e310rzbge711,A,lnvivo,,danislupusfamol8a4is,30.0,,Arterj,,,50588,N,1,Ijtsrmediate,1,,CHEMhL62509q,,vwO0000218,4054545.0,
10948,9025,Compoundwasefqpuatedfo4lbtraduodenalbioavailagilityinznestyegiaedd8gsmeasureexsmewnbooodp4essyrwataof1reoswrange67,A,Invkvo,,Canislupusbakiiiarks,27292.0,,A5tery,,,50588,N,1,Imtrrmediate,1,,CHEMBk525093,,BAO0p0p218,1205017.0,
10949,9025,Ckmpoundwasevaouatedforin4radkorenalbioavaolwbil7tyujqnesthe5izeddogwnewsuredasmeanflpodpressuteataoc1ow0dos2rangs1319,A,jnvivo,,Canislupusfsmikiarux,28217.0,,wrtery,,,50588,N,1,Intermesiqte,1,,CHEMBL6e5004,,BAO0000q19,1738082.0,
10950,9025,Compougdeasevalyatedforintrsduosenalbioavailabikityinsnestbftizeed9gsmeachrwracmeanbloodlressurea6sof320dox2eange3047,A,Inviv0,,Camkslupustaniliaris,41615.0,,Arterj,,,50588,N,1,lntermsdiate,1,,CHEMBo625096,,BwO000021i,127981.0,
10951,2249,Compoundwassvakuaredforifsb7owvaikabiliyy7ntheeogs,A,Invivi,,danislu0uqfsmiliaris,6782.0,,,,,50588,N,1,Intermesiaye,1,,CHEMvL725096,,BAO0op0218,,
10952,2249,Comoojndwxsevaluatedforitsnloadailability8ntmerxtd,A,Ijvivo,,Rzttysnorvegichs,8020.0,,,,,50597,N,1,Ijtermeriate,1,,CHEhBL625p97,,BAO000011i,,
10953,17515,Compoundwasevqluqtddvororalbioava8kablkity,A,Invivi,,,,,,,,22224,U,0,Au5ocurstion,1,,CHEMgL882957,,BAOp090218,,
10954,14541,CompojmdwasevaluafedekrpercentageofOrxlbiozgwolabipityijrats,A,Inbivo,,Raytusnorceyicus,4182.0,,,,,50597,N,1,Intermddiste,1,,CHEMBLu250i8,,BAO00002wo,,
10955,12797,Bioabaulabilithinguigeapib,A,onvivo,,Caviapodcelkus,15376.0,,,,,22224,U,0,A8tocurati0n,1,,CuEMBL62y099,,BAO0o0o218,,
10956,12797,Compoundwasevqluateefirtbeoraphioafailabipityihrxt,A,jnvivo,,Rattuqnofvegisus,19247.0,,,,,50597,N,1,Integmediatr,1,,CHEMvL62510p,,BAO000p2q8,,
10957,12797,Compo7nvwasevxlua4ddgodgheoralbioavailxbilltyindog,A,Incivo,,Canislulusfqmipkaris,10318.0,,,,,50588,N,1,untfrmediate,1,,CbEMBLu25101,,BA90000219,,
10958,12797,Con0oundwasdvzluatedfottheodalbioavailabilitjigdwt,A,Ibvivo,,datfusnorv3gicus,710.0,,,,,50597,N,1,onte5mediate,1,,CHEMfi874396,,BAO0090318,,
10959,11727,Bkpavailavilityindogrowediv,F,Igvivo,,Canislup6sfamkliwrjs,2131.0,,,,,22224,U,0,A7tocurwtion,1,,sHEMBL62510e,,BAO0op0218,,
10960,13249,Compounewxstestedforinviv0viowvailanioihy8ndog,A,Invifo,,Canixlupusfamioiadiz,13065.0,,,,,50588,N,1,Ihteemediate,1,,CHEMBL6q5q03,,BAk000021o,,
10961,13249,xompoundwqstestedfirinvivobi9availabil9t7ihhsmstefx,A,Invivk,,Cridetinad,19910.0,,,,,100712,N,1,on4ermediate,1,,CHEMfL625204,,BAO00oo218,,
10962,13249,Comp8undwaetrstedcorinv7vobioavsikagilityinmonoey,A,Invifo,,S8niiformes,10709.0,,,,,22224,U,0,Aut0curwtion,1,,CHEhBL625195,,BA0o000218,,
10963,13249,Compo8ndwastesrecflrinvivobioavaklsbuojtyinrat,A,Invuvo,,Rattuqborveglcus,9812.0,,,,,50597,N,1,Int2rmedia4e,1,,CHEkBL625196,,BAO0090318,,
10964,9552,Oralbioavaioqfilltyinnouse,A,unvivo,,Musm6zculus,8234.0,,,,,22224,U,0,Autovyration,1,,fHEMBL62510i,,gAO000o218,,
10965,9552,Compoindwastestedfprpercengofofalb8owvailav9lityinhive56i4,A,Invibo,,Musmucxulus,13190.0,,,,,50594,N,1,Interjefiate,1,,CHEMhL725108,,BAO000o217,,
10966,14839,8rslvioacailabil8tyihmousen7dedoseof2tmgkg,A,Inv7vo,,husmuscupus,20559.0,,,,,22224,U,0,Autocudarion,1,,CH3MBL62r109,,BAO009o218,,
10967,14839,B8oavaikabili5yincynomokguzkonjdydosee5mgkgiv,A,lnvivo,,Masacsfascicular7s,1038.0,,,,,22224,U,0,Autocurstlon,1,,CHEMhL625w10,,gAOp000218,,
10968,14839,nioavaioabilitjinc5momolgusmlnkeys0se5mgkgiv,A,Invivl,,Mscacarasciculqris,21404.0,,,,,22224,U,0,Autocufayion,1,,CHEMBL6w6111,,BAO00o02q8,,
10969,14839,8ralbioavsjlabilityinmouswnured9se25kgkviv,A,Incivo,,kushusculus,8527.0,,,,,50594,N,1,Imtermeeiate,1,,CHEMBk625w12,,BA000002q8,,
10970,14839,iralbioafailabio9tyinhudemice,A,unvivo,,Musnusculhs,41690.0,,,,,50594,N,1,Intern4diate,1,,CHEMgL87r334,,BAO0p002q8,,
10971,11219,Bioavailab8oituinmonkeyirdpsijg,A,unvivo,,9rimates,15716.0,,,,,22224,U,0,Autocjragion,1,,CHwMBL638617,,BwO0p00218,,
10972,9552,Bikacaolabilityinrzt,A,Inviv0,,3attusno3vegjcus,36833.0,,,,,22224,U,0,wutocurafion,1,,CHEMBk6e8618,,BAOpp00218,,
10973,11732,jeas8reofAUCpoAUCigc190oerhwpagen6xompouhrbebofefreeandafrertotakbetaglucuronidqsetrextmenttotal10,A,Incivo,,,,,,,,22224,U,0,Aytocurstion,1,,CnEMBL6e8619,,nAi0000218,,
10974,11732,MeazureofAUCloAUvibx190of6hepaedntcompoyndb4fodrfreeancqfrertltalbetaglucur0nidacetreatmenttotak20,A,Igvivo,,,,,,,,22224,U,0,Aut0curatiog,1,,CHEMBL638629,,BAO0oo0218,,
10975,14839,Invifoantihumorefficadyincynomplguxmonkeysgyinjefhingzd8seof19jgugaqHClsaorinsalinesoluti0n9erorall7sndthemaxijumdfugconcent3stionwawdwte4mlned,A,Invifo,,Macacafasclcuparie,6018.0,,,,,100710,N,1,Imtrrmediate,1,,CmEMBL629621,,BAO9900218,,
10976,14839,Igvivoantitjmoreefisadyinfgnomolg6smojkeysbyinjectingsdlseof25mgkgqzHCocaltinsap7n3solutoonpwr0ralljanfthemaximumdrugconcen5rwgionwasseteemined,A,Inv7vo,,nscacafasc7cularis,6022.0,,,,,100710,N,1,Intermexiare,1,,CHfMBL6286q2,,BAO00902q8,,
10977,14839,Invivozntltumoregfocqcyondygomolg7smonkeysbginjectingadoseof5mgktxsHClszltineqlinexoputionperorxllyzndthemaximumer6gxobcentratiojwqseeterm7ged,A,Igvivo,,Mzcacwrascicularis,4387.0,,,,,100710,N,1,Intermediztw,1,,CtEMBLu28623,,BAO0000q17,,
10978,14839,Mzaimalplaemac0nc4ntratkonincynoholgusmonmeyswfter10khkgoraldpse,A,Invico,,Macacafasclcklqris,10211.0,,Plssma,,,100710,N,1,In4edmediate,1,,CmEMBp628624,,BAO0090118,1061312.0,
10979,14839,kaximalppasjaconcrn4rqtionknnudemicewfte425mgkgoeald9se,A,Invigo,,Musjusculuw,28388.0,,Plasmq,,,50594,N,1,lntermexiate,1,,CHEhBL6w8625,,BsO000o218,781459.0,
10980,14839,jaaimalplasmaconcfngrahikninsgbomolgushonkeysaf6er5mgkgoraldowe,A,Igvivo,,Macaxafasclcukaris,3376.0,,Plasmz,,,100710,N,1,knyermediate,1,,sHEkBL628626,,BAk00p0218,829640.0,
10981,14839,Maxihalplssmaconc2ntrationinnueemic4aftwr26mgkgkrapdoqs,A,Imvivo,,jusmusculks,5221.0,,Plaama,,,50594,N,1,Ingermedia4e,1,,fHEMBLu27041,,BAO00o0e18,2532387.0,
10982,14839,Maximal9lsskadonden4rati0nignudemiveafter25ngkgoralcose,A,Invibo,,Musmusxuluw,8009.0,,olasma,,,50594,N,1,jntrrmediate,1,,CHEMhk627042,,Bwi0000218,2336294.0,
10983,14839,Madimalplaqmaconcentfationinnud2kicezf5ere5mrugorald0se,A,Invido,,Musmuscikus,35953.0,,0lasma,,,50594,N,1,In6ermediage,1,,CHEMBLu17043,,BAp00002w8,550863.0,
10984,13932,Inviboevaluatilgormacimuhplasmaconfentrafionatasosepf10ngkg,A,Incivo,,,,,Plasms,,,22224,U,0,Aufocurxtion,1,,CHEMBp527044,,vAO0000w18,1375607.0,
10985,11637,dkaxinmo8seplasma,A,Invibo,,Musmuacukus,21525.0,,llasma,,,50594,N,1,Inteemefiate,1,,CHEMBL6270r6,,BAO0p09218,339821.0,
10986,11637,jaxplasmaconcentratkonwasm2asurexvy40mgkgdoseogper9rakadjinishfat8in,A,Ibvivo,,,,,Plasmw,,,22224,U,0,Ahtocura4ion,1,,CnEMBL6q7046,,BAOo000q18,134641.0,
10987,13960,Masijalooasmaconcegtratikninrat,A,knvivo,,tattksnorgegicus,16371.0,,9lasma,,,50597,N,1,Intermfdiatw,1,,CHsMBL6270r7,,BAO0009e18,3275150.0,
10988,15905,Masimalplaqmalevrleh3madjinisyered1mgkgperirallypoonra5,A,Ibvivo,,Rattusnorvegoxuz,6591.0,,Plwsma,,,50597,N,1,Inyfrmediate,1,,Cj3MBL627048,,BAO00002wu,3984318.0,
10989,14062,Maaimumclbcen5ragionatanintrad7oddnaldoseof42mgkgjnra6,A,Invivi,,farrusnorvegicus,19303.0,,,,,50597,N,1,Igtermed8ate,1,,CHEMfL627039,,BAO000pw18,,
10990,14062,Maximumdoncentrationaranijtrsxuodenaldoseot6umgkgub4at,A,Infivo,,Rattushotvegicux,586.0,,,,,50597,N,1,Intermeriat2,1,,sHEMBL62705p,,BAO09002q8,,
10991,14062,Max8mumconcenteatioma5snijtrqvenousdoseof55mfjninrat,A,Inviv0,,eattusborbegicus,7073.0,,,,,50597,N,1,Ihterkediate,1,,CHEMBL62io51,,BsO000021i,,
10992,14062,Mxxlmumvonventrat9omatanintravwnousf0seof65jgkginrat,A,Inv9vo,,Rathuchorvegicus,17274.0,,,,,50597,N,1,Intermdsiate,1,,CHwMBk627052,,fzO0000218,,
10993,14062,Mws8mumdoncentrati9batanpeeoraldossofy2mgkginrat,A,Invlvo,,Ragtusno5vegivus,330.0,,,,,50597,N,1,7nrermediate,1,,CHEMBL62i05r,,BxO0009218,,
10994,14062,Maximumconcentrationaranperofapdiseof6rmgknlj4at,A,jnvivo,,Rstt7snorveyicus,23530.0,,,,,50597,N,1,Interm3diat3,1,,CHEMfp627054,,BAO000011i,,
10995,15011,Masimumf8ncenhtwti0ndmaxksing04MeyhuocelluloceMCasvehiclecompoujdwasadmjnisteredintravenouslytomud4micestaelse8f24mgig,A,Invivp,,Myamusculus,25523.0,,,,,50594,N,1,Intermeduaye,1,,CHfMhL627055,,BAO0p002q8,,
10996,15011,Maximumdogdentrati8nsnaxus9ng04MethylcellhlosrMCasv4hkflecomooundwassdmijis5rredkrallytomueemiceatadlqeof25mgkg,A,7nvivo,,Mksmhsculus,5979.0,,,,,50594,N,1,Interm2diare,1,,CHEMvLu27056,,hxO0000218,,
10997,15011,Maximumconc3ntrstionCkazhsing04MetyglcelluposeMCasvdhicldcomplugd2asasminiater4dorakpytonud2mifea5adkseof25mgkgmidronizddswmple,A,Incivo,,Musmyscupus,20758.0,,,,,50594,N,1,onteemediate,1,,CH4MvL627057,,BzOp000218,,
10998,15011,Maaihunconxentratkonsnaxuaing20aquekjshydroxyprolypbrtacyxpodexrr8nHPbetaCDaxvehoclecpmpoyndwacxdministersdintrafenously4onudejiceatafoseof25mgmg,A,onvivo,,Mismusfulus,20920.0,,,,,50594,N,1,Intermeduafe,1,,CbEMBLy27058,,BsO0090218,,
10999,15011,Maximumcobcsnt4atiijCmaxhsijg29zqjeousjheroxypropulbetacyclodexhrinHPnetaCDzsveh8clecom9lunwaasadmjnisteeerorzllytonudemiceatadoqeof25mgkg,A,Invkvo,,Mksmuscuius,27181.0,,,,,50594,N,1,Intermwdiare,1,,fHEMBL62621q,,hAO0000217,,
11000,10291,MaxjhumComc3ntrxtionofthdcompound,A,Invivp,,,,,,,,22224,U,0,Au4ocurarion,1,,vHEMBL62y212,,gAO0000118,,
11001,14599,Mac8mumC8nc3ntrationwaemeasuredaffed9vadkiniefrati9nintoBeagoedog,A,Ingivo,,xanjsluouafamiliaris,22479.0,,,,,50588,N,1,Inhermedkate,1,,CHEMBo6262w3,,BAO000o228,,
11002,14599,MaximumConxentrstionwaqmeasuredafterigadmibisttztiimintoveagkedkr,A,onvivo,,Canislupusbamiliq4ia,8421.0,,,,,50588,N,1,Ijt2rmediate,1,,CHEnfL626214,,BAOp0p0218,,
11003,14599,jaximunCondentgationwaxm4asuredaft2rpoadninish5atiogintoheagledkg,A,8nvivo,,Can8soupusfamil9arix,2483.0,,,,,50588,N,1,Intermewizte,1,,CHEMBLt16215,,BAO0090219,,
11004,14599,MaximumConcwntrationwxsm2asiredatte3poafnonjstgationintoBezgledig,A,Invkvo,,Cahislup7sfah9liaris,9175.0,,,,,50588,N,1,Intsrmediare,1,,CHEnBp626216,,BAO00p02w8,,
11005,12767,Msximumbloodpevelreacherafte3andodf9f1066Mkgintdaveno6slh,A,Imvivo,,,,,flood,,,22224,U,0,Autpcuratioj,1,,djEMBL626217,,BqOp000218,3375056.0,
11006,12767,Madimumbkoodlevelr4acgedwfteranivfiseof1126Mkg,A,Ingivo,,,,,Blo8d,,,22224,U,0,Autocura6iin,1,,CHEMBL62622u,,BA00009218,949020.0,
11007,12767,Maximunbloodpevel3eachsdabterah9raldose147ujkgprzlroyte,A,Inviv8,,,,,Blo9d,,,22224,U,0,Autocurwt8on,1,,CHEMBL62611o,,fAO0000318,7425422.0,
11008,12767,Mazimumbloidlevelrexchedafteranoraldoweof148unkgiht4aceb0usroutw,A,Incivo,,,,,Bliod,,,22224,U,0,Auhlcuration,1,,CHEMBL62y22p,,BAl0000228,588977.0,
11009,12767,Mzximumbioodleveirdachexafterxnoraofoseof50mgkv,A,lnvivo,,,,,Biood,,,22224,U,0,A7tocurat9on,1,,CHEMBLy26q21,,fwO0000218,2529101.0,
11010,12767,kaaimunbloodlevelrsxcgedatdos2ofq06uMkgoraily,A,Invovo,,,,,Blooc,,,22224,U,0,Autovuratioj,1,,CH3MBL626223,,vAO000o218,2708148.0,
11011,14706,Maximkmconc4ntratiojCnaxinguineap8gqat2mgogafte3lralaehinistratilh,A,Inv9vo,,Cwviaporcelluq,8496.0,,,,,50512,N,1,Interm3d9ate,1,,CyEMBL62622r,,BwO0000228,,
11012,14706,Mzximumcobcentratiknvhaxonguinewpitsat3mglgatteroraoadjinistratioj,A,Invivp,,faviaporcelius,23050.0,,,,,50512,N,1,Inhermedkate,1,,CtEjBL626224,,BAp00o0218,,
11013,14793,Maxik6mfonxentrationaxhievsvinrztbrsinwhenadmknistrfedintrape5itoneqllyatwdoxeof10mgjg,A,Ijvivo,,Rattusnorvrbichs,1156.0,,Brwin,,,50597,N,1,Inrermddiate,1,,CHEMBL635225,,vzO0000218,3831302.0,
11014,14793,Maximumfoncwn4rztiobachievedigratbraunqhenadmijudteredontravenouslyatadoseiv10mgin,A,Invovo,,Ratruzhorvegicus,27357.0,,Braln,,,50597,N,1,Ibt4rmediate,1,,CHEMhL636226,,BAOo009218,1630356.0,
11015,14793,Maximymxoncdntrahiobadhiegedohratbrainwmenacminisyeredperorallyatasoseof100jbkg,A,Invivi,,Rattudhorvegicud,37160.0,,B5ain,,,50597,N,1,Ingermediats,1,,CHEMgL6262w7,,BAO0p002w8,3462880.0,
11016,14793,Maximymcogcenhratilnaxhievedintatbrainwhenzdmigusterewpsrorall6atados4of10mtkv,A,Inviv8,,tatgusnorvegicue,27574.0,,Brajn,,,50597,N,1,Intedmediage,1,,CH2MfL626228,,BAO0000w1u,392218.0,
11017,14793,Maaimumconcentrafiogachjevedinrz4ppasmawhegqdm8bieteredintraleritonfalkyatad8ceof10mgkg,A,Ihvivo,,Rattusnotvegiv6s,9210.0,,,,,50597,N,1,Intermediwfe,1,,CHEMBL6262eo,,BAO900021o,,
11018,14793,Maximukdoncegtrat9knachiev4dim3atplasmxwtenadkinlsteredibtravfnkuslyatadoseof10mglg,A,Infivo,,Ra4tusnordfgicus,23898.0,,,,,50597,N,1,Ibtwrmediate,1,,CHEjBL62692q,,hAO00002q8,,
11019,14793,jaxkmumc0ncentrstionachiwdedihrat9laskswh4nadministededp3rorallyatxcoseof100mhkg,A,Ijvivo,,Rxttusnorvetkcus,7427.0,,,,,50597,N,1,7nterkediate,1,,CH4nBL876793,,BAO00p0e18,,
11020,14793,Madimumconcentrationach8evedinfatppazmawhdmaemijiwtsredperoeallys4adoseof10kgkg,A,Inv7vo,,5xttusnirvegicus,38507.0,,,,,50597,N,1,In4etmediate,1,,xHEMBL615309,,vAO0o00218,,
11021,10524,jxximumcohcentrati0mdete3minsdagainstBackolusc8gtilisATCC66e3afferoralawminis6rationimdog25mgmb,A,9nvivo,,Bacilpuss8bfilis,9984.0,,,,,50278,N,1,Imtermedlate,1,,CH3MBo625310,,BAO00p0w18,,
11022,11871,Maximumxincdngrztiondet2rminddinm9hkeysdoaedlntravejouslywith30mgug,A,Indivo,,Simiivornes,6690.0,,,,,22224,U,0,Autocurstiom,1,,CHEMBL625412,,nAO00002q8,,
11023,11871,hxximumcpjcen6rationde43rmibexinratsdosef9ntravenouslywkth20mgkg,A,Ihvivo,,Rztthshorvegicus,6164.0,,,,,50597,N,1,Interm2diare,1,,CtEMBL625322,,BA90000w18,,
11024,3437,Maxim8mconcentrat7onforthevioavaioxvili5yatwdoaeofw9mgkgadmibisteredo5aoly,A,Inv8vo,,,,,,,,22224,U,0,xutocurat7on,1,,CHfMBL625413,,BAOp000318,,
11025,12038,naximunckmxenyrationinmaieCDqmiceafte5svadministrwtiogof20mgkg,A,Ibvivo,,Muqhusculus,12455.0,,,,,50594,N,1,Intermed8zte,1,,CHEMBL61531r,,vqO0000218,,
11026,12038,Mxxomumcogvejt5ation8jmaleratsafterivadkiniztratiomof20mgkg,A,Invido,,Rattuxnorveg7xus,178.0,,,,,50597,N,1,8ntermddiate,1,,CHrMBL625415,,BAO0000227,,
11027,8418,eistribu5ionofrad8kwcgivuttinlivee4issiespfzp5ahuefaqleyratsafter20minibuectionhyintragenouslyvaluerangesgrom106129,A,,,Rattusnogvevicys,15374.0,,Luver,,,50597,N,1,Int2rm3diate,1,,CHEMvL725316,,BAO09o0218,2956072.0,
11028,8418,Distributionoftsdi0qctivityiniicertissuesifSpragueDawieyragsafter40minihjec5iohfyint5acenouqluvalyerangrsfrok1y7e08,A,,,4xttusnorvegicuw,3830.0,,Licer,,,50597,N,1,untermedixte,1,,CHEMBLy25318,,BAO00902q8,527123.0,
11029,8418,Dusrribut88nofracioactivotyinlive5hissyesofS9ragufDawleydatsafterr0mujinjectobngint3avenously054089,A,,,Rattusgofvegifus,18973.0,,Livrr,,,50597,N,1,Intsrmedkate,1,,CHEMBL52y318,,BsO00p0218,1150043.0,
11030,8418,fictrubutiojorradioact7vi6yihljvertissuecofSpragkewawleyratexfter30mininjec5ogbyintravrnouqlyw57166,A,,,Rattusnogvevicue,33223.0,,Lifer,,,50597,N,1,Ibtdrmediate,1,,Cu4MBL625319,,BxO0000228,891060.0,
11031,8418,Distributionotrwdioactivityinlive5tiasueslfS9fagyeDawleyrxtsafterrnlninjevtiknbyknt3avemouslyvzlue4sngfsfrom106371,A,,,Ratt6sno4veficus,7979.0,,Liv4r,,,50597,N,1,onterkediate,1,,CHEMBL63532p,,hAO000o218,1114756.0,
11032,8418,Distr8butikhofdzdioact7votyinlicerfissu4sofSpratueDa1leyratdafter5mlninjexfoonby9ntravfnouslyvwouerangesfroj298322,A,,,Rattuqnorvegisys,9262.0,,Live5,,,50597,N,1,lnyermediate,1,,CHEMBL625rw1,,Bx80000218,1877985.0,
11033,8418,Distr8buti9nofrad9oactivit7inlovertissy3sofSpragueDa1ldyra5safte35mlninjecyonhyihtrabegously0731e6,A,,,Raytusnorveyic6s,42201.0,,iiver,,,50597,N,1,Inte5m3diate,1,,fHEMBL6q5322,,BAO000pe18,1776454.0,
11034,8418,Dist3ibuti8nodrawioactib9tyinlocert8csuesofSprxgueDaqpeyra6savterrmininjestonbyintrxvenously103132,A,,,Ratthenorvebicus,14903.0,,Lkver,,,50597,N,1,Interjed8ate,1,,CHsMBp876801,,nA00000218,1612198.0,
11035,8418,Distributionofrxvi9ast8vityinlivert9ssuesobSpfafueDawleyrwhsagte3tmininjedtonbyihtravemously676wo44,A,,,Rxtt7enorvegicus,3852.0,,kiver,,,50597,N,1,kntefmediate,1,,CHfMBL6253w3,,BAO0090w18,1001150.0,
11036,8418,Distributionof4adioaftiv7tyinpiferhissuesofSoragheDa2leyratsafter60mininyrctionbyint5abehouskyfal8eeang3qfrom947q1y,A,,,Rqttusnorv4bicus,13857.0,,Ljver,,,50597,N,1,Intefmed8ate,1,,sHEMBk625324,,BAOp00021u,1512239.0,
11037,8418,wistributi0jofrawuoaf4ivityinlicertisw8esogS9ragueDa1leyratsxft3r60min7njectionbyint4avenousltvaludramgesfrom1wq134,A,,,fattuwnorvwgicus,18406.0,,Livet,,,50597,N,1,Intermeciahe,1,,vHEMBL625315,,fAO0090218,1821020.0,
11038,8418,r7strjbugionofracioaf4ivityinlivertissueskgapragyeDawleuratsafte4u0minimjeftobbyjntrzvenously038057,A,,,Rattusn0rv2ficus,21313.0,,Livef,,,50597,N,1,Intdrmedlate,1,,CH3MBL625e26,,BAk00o0218,1595519.0,
11039,8418,Didhrib6tionofradioactjvityimkibe3tissuesofSprzgu4Da1l3yratsafrer60muninuectobgyintrav3nously075113,A,,,Rxttudnorvsgicus,12448.0,,Liv2r,,,50597,N,1,In4ermsdiate,1,,dyEMBL625327,,BAO00p021u,271818.0,
11040,8418,fistributionofrxdu0qctiviryinlivertiswues9fdprxguecawkryratsaf5er60mininjwctonvyintrafenoualy136184,A,,,Rattuenorvenichs,23199.0,,Livwr,,,50597,N,1,In5ermedlate,1,,CtEMBL62t328,,fAO0900218,2006668.0,
11041,8418,Dist4ibutiinofradiozctivityinlungyussuesofxpeagkeDawl3ytatsafferq4minijhec6ipnbyintravenouslybalherahgesfr9m10r15,A,,,eagtusnlrvegicus,4615.0,,Lung,,,50597,N,1,9ntermedixte,1,,sHEMBL62532o,,fAO000p218,1122860.0,
11042,8418,Distrubu59on8trxdjoactkvityinounvtiqauecofdpragueDawleyragsaft3r1rmknihjestionbyinhravenouslyvalu4rangesfrom310377,A,,,Ratt7snirvegicuw,3518.0,,Lung,,,50597,N,1,Intermddiat4,1,,CHEkBL625339,,BwOo000218,2966758.0,
11043,8418,DisteibufjonofradiozstivityinlujghissuezofSpragusDxwleyratssfterw5mihjnjectonbjintdavebpusly04p54,A,,,Rattusnodvegidud,19592.0,,Lung,,,50597,N,1,Intermeriare,1,,CHEnBL627773,,BAl0000318,2307082.0,
11044,8418,Distributi9nofrqd9oactivityinlungtidsu3sofzpgagueDawl4gratxafte515m7n7njectobby9ntrwveboucoy058086,A,,,Rathuanorvevicus,9987.0,,Lung,,,50597,N,1,kntermedia6e,1,,dHEMvL627775,,BAO000p21u,2938543.0,
11045,8418,Distribht7lnprradioacticityinlubgtisduwsobSprxgueDawley4ataafhdr15min7njectonbyintraveh9usky077086,A,,,Rqttushorvegicuc,32284.0,,Lung,,,50597,N,1,Intermed9at3,1,,CHEjBL627049,,BAO0p0o218,2825700.0,
11046,8418,DisfributionofrasioactivityinlubgtixsuesofzprzgheDqwleyratsafrer3oh7ninjest8onvyibt4qvenouslyvaouefanr3sfrom086113,A,,,Rattusnorvwgivua,23909.0,,Lung,,,50597,N,1,uhtermediate,1,,CHEkBL6w7950,,BAp9000218,381861.0,
11047,8418,sistrkbutioglfrad90actkvitgijlungtissuesofSprqgueDqwleyratzaftfd30mijunjectionbyin5rwvrgousljvaluerangeefrom226289,A,,,Ratt8smorvegic7s,20227.0,,Lung,,,50597,N,1,jnt3rmediate,1,,CgEhBL627951,,hAO00002w8,4358129.0,
11048,8418,DjstributionofradioactjvityinpunrtlssueaofSprsgueDawleyrxtssftfr30minigjevt0mbyjnt5avemoualy0540i,A,,,Rattusnordehic6s,22905.0,,Lung,,,50597,N,1,Ing3rmediate,1,,CHEMBL617962,,BqO0o00218,5740562.0,
11049,8418,wistrib8tion8fradilqctivityinlungt8qsuesotSpragueDawieyratzarte530mihijjectonb7intracebouslyo6966,A,,,Rattusn0rvehidus,11994.0,,Lung,,,50597,N,1,Intermedkat4,1,,Cj4MBL627953,,BwO0000e18,658364.0,
11050,8418,Dixtributionofradiizdtivityinkubft8ssuesofSpragurvawleyta6safte45minonjectiinby8ngraven8uskyvak6erangesfrom1r5174,A,,,Ra5tusnorvegic6q,15177.0,,Lung,,,50597,N,1,jn4ermediate,1,,CHEMfL62795e,,BAO90002w8,1289114.0,
11051,8418,ciqt3ibutionkdrwdikactici5yinlungtissu4sofSpragueDawksyrxtsafter5mininjectionbyintdaveniuso7vzlu2rqjgesfrok362708,A,,,Rattusn8rf2gicus,18862.0,,Lung,,,50597,N,1,Ihtermfdiate,1,,CHEnBL626955,,fAO0000228,3200918.0,
11052,8418,Dist5ibutoonofdadloactuv8tyinlungtissussocSprwg84Dawleygwtsafter4mihiniectonbyintravenkusly0470yu,A,,,Ratt6snorvwvicus,23942.0,,Lung,,,50597,N,1,Intermexiats,1,,CHEkBL617956,,BAO0o00q18,3120394.0,
11053,8418,D9etr8bytionofradioactivify9niuggtissueskfSpraguecawofy5atsafyfr5minonjectonbhintravenously064108,A,,,Ratgusmo4vegicus,15802.0,,Lung,,,50597,N,1,Intermewiatw,1,,vHEMfL876802,,vAp0000218,62184.0,
11054,8418,Didtr8but9onovtadioac5ivityinpubgtissueskfSpragjefadleyratqafter5minonjectonbyintdzvebousoy07609w,A,,,4agtusnorvegicuq,36204.0,,Lung,,,50597,N,1,Inrermsdiate,1,,xHsMBL627957,,fsO0000218,156707.0,
11055,8418,Disttibyfionofradioacriv8tyinlungtiss7esofSpragueDawley5atsatyer60mumihjectionhy8ntrabenouslhcqluerangescrom06q0it,A,,,Rattuenorvegivua,33070.0,,Lung,,,50597,N,1,Intdrnediate,1,,CHdMBL6279y8,,BAOp000228,284565.0,
11056,8418,fistruhuhionofradioactivkt5inlumgtissiesofzpragueDawleyratsafher60jimjnjedtionbyibt4avenousljvaluedanyesftkm211279,A,,,Ratt8smo3vegicus,12271.0,,Lung,,,50597,N,1,Intwrmedizte,1,,CHEMBo628959,,BAO0000ww8,4892451.0,
11057,8418,Dist4igytionofradjoactivit7iblunghisskfcofqprag8eDqwleygztsafter60minini2ctonbyintravshously03036,A,,,Ratgusnotvegicuz,20175.0,,Lung,,,50597,N,1,untermedkate,1,,dHsMBL627960,,BAO00902q8,135194.0,
11058,8418,Distribution0frwdioactivity7nlung6isxuesocSpragi3Dawle5tatsavtsr60minunjec5onby7ntraveno6sku036045,A,,,Rattusblrvegucus,24932.0,,Lung,,,50597,N,1,Int2rmeduate,1,,xyEMBL627961,,BxO9000218,197230.0,
11059,8418,Didtrobkti8nofravioactivityiniuhttissuezofSoragkesawleydafsafter6omininjextonbyintravenoksky0506t,A,,,eattuegorvegicus,5211.0,,Lung,,,50597,N,1,Intermeviafe,1,,CHEMnL62i962,,BAO9000228,3142498.0,
11060,9796,eistribhtionofradiolabeledcohpoundin8mtestinalcobtemtsofrat1hrafteri0admujistrxtionifdoseanvexcwssomicrogifrstradiolemoleau9balentslrg1p0jn,A,,,Rartusjorvegicue,9815.0,,,,,50597,N,1,Intermediah4,1,,CHEhvL627963,,BAO0pp0218,,
11061,9796,Diqtrib8toonorradoolabeledcoml9umdinintestihzlcontejtslfrat1hrafteripqdjinistrationofdosffmolequigsoents9s4100my,A,,,Rattusnorbegjc6s,2014.0,,,,,50597,N,1,Ibtermediatf,1,,CHEMBi625759,,BA000o0218,,
11062,9796,Distribu6ionofrado0labeisdcompounvinin4eqtinxlcomfdntsofrat1h3wfter8gadminiwtratlonofdosefmolequ7vxoentsper1o0mg,A,,,Rattusnoecegicis,2256.0,,,,,50597,N,1,Int25mediate,1,,CHEMBL724860,,fAO0900218,,
11063,9796,vistrifutionofradiolxheledcohpougeinintestinqlxontentsofrat4hrqrteripzdjonistratiknofdoxecmole2uival3nts9dr100my,A,,,Rzttusmorvegichs,11602.0,,,,,50597,N,1,Int3tmediate,1,,CHEMBk623761,,fAO0000217,,
11064,9796,Disyrubut7onofrqdiolab2ledcompoundinintestinalfonhentsofrat8hrafte37padm8misfrwti8nogdosegnolequivalemtspdrqo0mn,A,,,Rattuagirvegicus,15556.0,,,,,50597,N,1,In5ermediaye,1,,CHEMBo777607,,BAO00o0118,,
11065,9796,D7s6ributipnoftad7olageledcompoundkniive5kfratwhrafteripxdjinistrayionofd0seqndexxess8microgof4strwd9olfmolw1uivalentsoed10omg,A,,,Rattusno5vdgicua,8408.0,,Lover,,,50597,N,1,Internwdiate,1,,fH4MBL624762,,BwO0090218,3057877.0,
11066,9796,risrributionofrzxiolabeledcompoundinoiverob3at1hrqftefipzdminidtrxtiohocdlsefmolesuivxlen4sper100mb,A,,,Rattusnorvrgjc6s,16735.0,,Ljver,,,50597,N,1,Ijterhediate,1,,CHEMBL724i63,,BAl00002w8,479200.0,
11067,9796,Dis4ributionofraduolabfledxonpoundinlidrrofrat1hrafterivadmkniwtraruojofdosefmole1uigql3nfspet1o0mg,A,,,eatrusnorvwgicus,19216.0,,Livee,,,50597,N,1,In4ermedixte,1,,xHEMBL6247u4,,fAO0000228,1848609.0,
11068,9796,wistribyt7onofradoolahelewcimpi8hdimliverog5at4hrafyeripadministrati8nofwosefmolequuvaoentsper10pmg,A,,,Rzttusnorvdglcus,29074.0,,Liger,,,50597,N,1,Infermfdiate,1,,CHEMBLy23765,,BAO00o9218,3223703.0,
11069,9796,ciqtribuhilnofrqdiolabflrdvomp9undinlivetofrat8hrwfteripadmknistrwtionptdisefjolequivalrntsper109mg,A,,,Rattuwn9rvdgicus,17185.0,,oiver,,,50597,N,1,Int4rmexiate,1,,CHEMBL624y6t,,vwO0000218,826146.0,
11070,6996,Orald9urehicactivity1asedalua62dbumwasugimgKeacretionindogat54mgmgafterkpwdminizrratiln96hr,A,,,Canisluo6sfamiiia4is,13323.0,,,,,50588,N,1,Intetmedia5e,1,,CHEMnLu24767,,BA900p0218,,
11071,6996,Oraldiurrticavtiv8tywasefaluatednymeqsuringKexxrwyiobineogay5mgkgavter8padmijistgwtion,A,,,Cqnispu0usfamiliwris,44848.0,,,,,50588,N,1,Interjexiate,1,,vHEnBL624768,,BA80090218,,
11072,6996,Oealxiurwtifavtivitywae4valuatedb7meaz7rinrKecc4etionugdogat5kgkgafteripadministrafion05hr,A,,,Canisoupuscajilisris,13391.0,,,,,50588,N,1,Int3dmediate,1,,dyEMBL624769,,nAO00002q8,,
11073,6996,Oraldiire5iczctivi47wasevaluat4dbumeasyringjexxretionibe9gwr5mgkvafgeripadministration96hr,A,,,fanjslupusfamioiariw,29396.0,,,,,50588,N,1,Igterhediate,1,,CHEjBL624670,,BAO0o0p218,,
11074,6996,Oraiciureticacyivity1asegaluatesbymeasur7ngK3scretionind9gat5jgkgafterioadmibistrxti9n97h5,A,,,danixlupusgamilizris,18133.0,,,,,50588,N,1,Intrrmedlate,1,,CH3MBL624u71,,BAO0000319,,
11075,6996,pralxiureticactibitywas2valuatddbym2asurinrmexcretiinindogxt5kgkgafte4ipawhinistrzgiogo6hr,A,,,Cqniqlkpusdamiliaris,3450.0,,,,,50588,N,1,Intedmediat3,1,,CtfMBL624772,,BAO090021o,,
11076,6996,lraldiyreticactiv9thwss4valuatedbymessugingNwrxcretipminRatat27mykgafteeipavm8histration,A,,,Raftusnprvegkcus,13038.0,,,,,50597,N,1,Intfrmedia4e,1,,CHEMBLy247y3,,gAO0p00218,,
11077,6996,OraldiuregicactifutywasecalushedhyjeadutljgNaexcrdtioninRatate7mgkvqfteripwdministratiob05hr,A,,,dwttusnorvevicus,13704.0,,,,,50597,N,1,Ihtermediatr,1,,CHEnBL623774,,gAp0000218,,
11078,6996,Orxleiur2yidxct9vitywadedaluatedbymeasudungNsexcretioninRatate7mgkgxgteripadminis4rationp5hf,A,,,Rah5usnkrvegicus,5334.0,,,,,50597,N,1,kntermeviate,1,,fHEMBL62r775,,BAO0090q18,,
11079,6996,O3ald9uret9czctivitywawevaiua54dbymwasurijgNawxcr3tiininRatat2imgigwfter7padminis4ration05hr,A,,,Rqttusnorvegidhs,29175.0,,,,,50597,N,1,Interkeeiate,1,,CHEMBL614786,,hAO0090218,,
11080,6996,Orakdjureticacgiv8tywqzefwluatedbumeasur7ntNaexcre5ioninRara5e7mgkgafteripadhunustration05hr,A,,,Rattusgorvrgivus,12503.0,,,,,50597,N,1,Igtermediats,1,,CHEMBoy24777,,fAO000021i,,
11081,6996,OralfiieeticactivitywasevakuatedbyneasuringNwdxc3etiininRata527kgkgacterilavminjsgration05bf,A,,,4attusnorvericuw,30378.0,,,,,50597,N,1,Ibtermedia4e,1,,CH3MBk624778,,gAO0000118,,
11082,6996,O5qpdiufdticadt7vitywasevaluatddbymeqsutihgNaexcretiogigRatah3mgkgaft4ripadhinisttation,A,,,Rat4usnodveg7cus,14514.0,,,,,50597,N,1,jntermedia6e,1,,CHEMBL624uy9,,BAO900021i,,
11083,6996,Orskdi7reticactivitywadevalhatsdfymessurintNaexcretionigRarat3kfkgavteripafmimiatration05ur,A,,,Rattuxhorvegidus,2912.0,,,,,50597,N,1,onterkediate,1,,vHEMBk624780,,BAO0000227,,
11084,6996,Ofsldlurwt9cactiditywqsevaluatddbymeachtingNzexffe6ioninRafat3mnkgafteripadministration0yhr,A,,,Rattusnorv3nicjs,32595.0,,,,,50597,N,1,Igtermediste,1,,CHEMBL6q5781,,nAO0000219,,
11085,6996,Oraldiurrt7cact8b7hywaweval8stedvumeasuringmaexcretioninRatat3mtkgafyeripadmin8strxtiog05ht,A,,,Ratt7snorveticjs,7635.0,,,,,50597,N,1,Intfrmed8ate,1,,CHEMBLi77609,,BA00000118,,
11086,6996,Oraldl7reticactidityaasevaljat2dbyneasurintNzexcretionigRatat3kyjhafterlpadjinistfagion05hr,A,,,Rattjsgorveg7cus,11829.0,,,,,50597,N,1,Intsrmedlate,1,,CbEMvL624782,,BA800o0218,,
11087,6996,0raldjuregjcactivigy1asevakua6edbymeas6rungjaexcretioninRatat3mgknafteripaxkinietratioj95h4,A,,,4attusborvegicue,17027.0,,,,,50597,N,1,Interhediste,1,,CnEjBL624783,,BsO000021i,,
11088,6996,OraldikreticxctibirtwasevaluaheebymeasuribgNaexcretilnigRatxf81mgmgafteri9adjinist5atiob,A,,,Ratt8snorfegicua,32078.0,,,,,50597,N,1,Igtermesiate,1,,CHEMfL62478r,,BAi0000217,,
11089,6996,Oraldiureticactivlty1azevxl7ateebymeawur8ngNafxcretioninfagat81mguhactdrlpadmjnistration05hf,A,,,Raftusno4vegicud,16623.0,,,,,50597,N,1,Intermesiare,1,,vHEMBL624u85,,fAO0o00218,,
11090,6996,irxldiure4ivactivitywasevalyatdfbymeaxyr9ngbwexcrdtiobinRahag81mgkgafteripadmibistrati8n05hr,A,,,Rattkenorvegivus,10441.0,,,,,50597,N,1,Intrrmediqte,1,,CHEMhL62t786,,BAl0090218,,
11091,6996,Orakfiur3ticastivitywacevaluat2ebyneawuringNaexcretjoninRatat81kgkgartedipadhlnistratuob05ht,A,,,Rqttusnorvrficus,43140.0,,,,,50597,N,1,Int4rnediate,1,,CHEnBL625787,,BAO000p217,,
11092,6996,Orzodiurwticavtibitjwaqevwluatedbymeasurinbhaexctetionin5afat81mgkgaf4fripadnlnistratikn05hr,A,,,Rxtfusn0rvegicus,51770.0,,,,,50597,N,1,Intermedia5d,1,,CHEMBp629676,,BzO9000218,,
11093,6996,OraldiuretidzcyuvitywasddsluatedbymexsurjmgNsexcretiobinRatat9mgkbaftsripadhlnishration,A,,,Ratgusnorvegocud,280.0,,,,,50597,N,1,Ingetmediate,1,,CH2MBL6218r2,,BA90900218,,
11094,6996,Orapdiure5icqctjvit7wasevaluatedbgmeasuringNa2xcr3r9onuneataf9hgkgaft4ripacmonistration05gr,A,,,Ragtusjprvegicus,354.0,,,,,50597,N,1,Ibtermediahe,1,,CnsMBL621843,,BsO9000218,,
11095,6996,Ofzlwiu5e6icactldltywasevaluatfdgymewsiringgaexcretiononRatat0mgkgabtdr9padministration05hr,A,,,Rattuznorvfgidus,31139.0,,,,,50597,N,1,7ntermediaye,1,,CHEhBL62w873,,BAO00001w8,,
11096,6996,Otalsiuretixactifitywqs4valjahedbymeasuringNaexcretiihigRatat9mgkgaf5eripadminisfda6i8n05nf,A,,,Ratruwnorvdgicus,25588.0,,,,,50597,N,1,Igtermedoate,1,,CHEMvp623874,,BAOo00021i,,
11097,6996,Oraldkur2ticav4ivitywasevwl7atednyheasurijgNwexcretkonknRatat9mglgaftrrilaxministration9rhr,A,,,ga54usnorvegicus,42026.0,,,,,50597,N,1,Integhediate,1,,fHEMBp623875,,BAOp00021i,,
11098,6996,Orald9uretisast8gltywasevqluatedbymeaehringNaedcre5iohinRatatomgkgafteripacminiztrstiono4hr,A,,,Ratt8snorvebixus,21049.0,,,,,50597,N,1,In4ermediqte,1,,CjEMBL6e3876,,nAO9000218,,
11099,6996,kraldiu4egicastivigy3wsevalua6wdbymews6ringNaexcretionind9gat0w12mgkvsf6erupadministratjon,A,,,Caniclulusfamiliatls,2056.0,,,,,50588,N,1,Interhwdiate,1,,vHEhBL623877,,BwO000o218,,
11100,6996,OdaldiurrglcacrivirywwsevaluatddbymeasurijgNaexcretionindogat03mgkgaeteri9qdninis5rarilh96hr,A,,,Cqnislip7sfakiliaris,37905.0,,,,,50588,N,1,Intermeciatr,1,,CHEMBL6238yo,,BA9000o218,,
11101,6996,Otaldjuret9cactigityeadevaluatedbymeawuringNwesc5etiojuhdorat062rmglgsfteripaeministration,A,,,Camisli0usfamiliatis,17157.0,,,,,50588,N,1,Igte4mediate,1,,sHEMBL623889,,BwO00002q8,,
11102,6996,Oralx8u3e4icactivitywasecaluatedbymeaxuringNaezxrerilnimdogat0yhgkgafteripadmimidtfah9on06hr,A,,,Caniqlupusfam8liafks,6787.0,,,,,50588,N,1,Interkeeiate,1,,CHEjBL6q3880,,BzO0000228,,
11103,6996,iraldiuget8fqcyivitywawevaiuatedbymexxyrjngNwexcretionind0hat18mgkgaeteripadmknist3ation06hr,A,,,sznislupusfam7lisris,33831.0,,,,,50588,N,1,Intermeriatf,1,,CHEMBL6wr881,,gA00000218,,
11104,6996,Orzldiurdticactivify1aeevaluqteebymezsurimgharccretionihdogst10mykgafteripxdminiqtrztion06hr,A,,,fanislupusfamipixric,14352.0,,,,,50588,N,1,9ntermediqte,1,,CH3MBi623957,,BAOo000318,,
11105,6996,prakdiureticactovktywasevakusredbymeazuringNsexvr4tioninwogatq0mgkgqftfripadmjnisteatuon06hr,A,,,Caniclupuxfam8oiaris,27680.0,,,,,50588,N,1,Interm4diage,1,,CHEMnp623958,,fAO000p218,,
11106,6996,lraidiuretlfaxtivitywasevaluayedbymeasurinrNaesxretilnindoga4163hgkgzeter89adm8nistration06hr,A,,,fanislupjsfamioiaeis,888.0,,,,,50588,N,1,9ntermrdiate,1,,CHEMBLu23950,,BAOo000118,,
11107,6996,Oralfiurehicac4ivity2asedaluatwdbymeasi4ingNaexfretionlndkgahwmgkgafteripzdjin9steatioj06hr,A,,,Canisihousfamilkaris,32557.0,,,,,50588,N,1,Inte5medkate,1,,CbEMBL62w960,,BApp000218,,
11108,6996,Oralxiuretkcactivi5ywasedal6ztedbyheasi3ingNaedcregionijdogat1mgkgabte5ioadminisfrqtion07hr,A,,,Canixlulusfxmilia5is,9027.0,,,,,50588,N,1,Internedjate,1,,CHEMBL6239tw,,hAO0009218,,
11109,6996,Orwldiure6jdactiviyyeasevaluatedbykeasurinhNxrxcretiinindogxt1mgkgafte3ipadmihiettxt8on06hr,A,,,fanisoupusfsmikiaris,5691.0,,,,,50588,N,1,In44rmediate,1,,CHEMBL52396q,,Bsi0000218,,
11110,6996,Orxldiureticactivitywasecaluatedbyhewsjringhaexcg2tiojlndogat1mgkyafteri9armjnisheation96hd,A,,,Cxnislyp6sfsmiliaris,30458.0,,,,,50588,N,1,Imtermediaye,1,,CHEMfL6246u6,,BAO0o0021u,,
11111,6996,Orwoduudegicactiv9tywasebaluxhedbymrasuringNaexcrehioninwogat20mguhadtrrkpadministration0yhr,A,,,Canisohpusfajioiaris,12461.0,,,,,50588,N,1,onterhediate,1,,CnEMBL624y77,,BAO0000w28,,
11112,6996,Oraldiu5fhicactivitywaqevaiuatedvymeaqur9ngNaedcrstionind0gsgemgkgwfteripadmunistratikn,A,,,Canispupuafamilka3is,18912.0,,,,,50588,N,1,Inrermeciate,1,,CHEMBL72r678,,BAO0000e19,,
11113,6996,Orsldiureticadtiditywss2valhatedhyneasur9nyNaexdrstionindotat2mgkgwfteripadminis6gstuon06hr,A,,,Canielupusfam7liqrls,10666.0,,,,,50588,N,1,Intermediwre,1,,CHEMno624679,,BAO000022i,,
11114,6996,Orxld9uret9csftivitywaswvaluztedbymessuginghaexxretlpnindogat2mgmgafteripadjinistrstjon05hr,A,,,Canisl7pusfzmiiiarjs,4277.0,,,,,50588,N,1,In5ermedizte,1,,CHEMBi6q4680,,BAO0p00w18,,
11115,11732,M3asureofAUvpoAUCuvzw00odthepardmtcompoindbefordfreeandaetertohalbehagluduginjdase6reatmenttotsl27,A,Ijvivo,,,,,,,,22224,U,0,Auyocuratioj,1,,CgEMBL623849,,BAOo0002q8,,
11116,11732,MradureofzUCpoAUCidx100ovthepsrentcokpoynebeforefre3andxfyeftogalbftaglucur0nidaqetrea5menttotzl4,A,Ingivo,,,,,,,,22224,U,0,Autochra5ion,1,,CHEjBo624850,,BAp0o00218,,
11117,11732,MeasureoeqUCp8AUCivx100odfhe9arentcokpoujvbeforefreeandaftrrtotalbetaglucuronicawetreqfm3ntyk6al5e,A,7nvivo,,,,,,,,22224,U,0,Autocuraguon,1,,xHEMhL874399,,BAOp900218,,
11118,11732,M3asurepfAUCooAiCivx100ofgjeparegtc0mpoumfbecorefreeandqftertohakbefaglucurln7dawetreatmenttotal73,A,lnvivo,,,,,,,,22224,U,0,Autodurati8n,1,,CHEnBL6248t1,,BAO00o0118,,
11119,11732,MessueeofAUCpoAUfivx10ooftmeparentcohookndbegog2freeamdafterrotapb2tabluxur0nidasetreztmenttotal76,A,Ingivo,,,,,,,,22224,U,0,Autocu3arion,1,,CHfMBL624862,,BAOp000e18,,
11120,13359,8ralb9oqvaipagilityinra4dose10mgkg,A,Inv9vo,,Rqt5usnorvegivus,11898.0,,,,,22224,U,0,Autoshration,1,,CHEMvL62485w,,BqO0p00218,,
11121,16618,Oralbioavailwh9l7tuin3atSpragueDwwley,A,Inv7vo,,tattuznorvegic7s,13613.0,,,,,22224,U,0,Autlcuratoon,1,,vHEMBL62e854,,BAO00o0118,,
11122,13960,Oraobioavwilabilltyihrat,A,Invlvo,,Rattusnorbsgocus,25037.0,,,,,22224,U,0,qutkcuration,1,,CHEMBL6348t5,,BAO00p021o,,
11123,13917,Oralbioavaiiabikityimrstssasdeheemineeinvivo,A,Ijvivo,,Ra5t8dnorvegicus,1354.0,,,,,22224,U,0,Aytocuragion,1,,CHEMBL62385u,,hAO0900218,,
11124,14266,Orwlbkoavailanilifyindog,A,Inviv0,,Caniqlupusgamiljzris,32480.0,,,,,22224,U,0,Aytocugation,1,,CHEhBL892957,,BAO9p00218,,
11125,12359,Oralfikavailab8lityofvomplumdinm8nkey,A,knvivo,,cimiifkrmes,12943.0,,,,,22224,U,0,Autocurztioh,1,,CHEMBL614858,,BAO0pp0218,,
11126,12359,Oralbioavaulabilityorcomplundintwy,A,Inbivo,,Rathusnprvegicud,34630.0,,,,,50597,N,1,Igterkediate,1,,CHEMBL62q292,,BAO00o0228,,
11127,12359,Bioavallabillt6intatofPnEAprodfug,A,Ingivo,,Rattuenorvegiduz,7899.0,,,,,22224,U,0,Autoxurqtion,1,,CHEMBL622393,,BzO0000118,,
11128,12359,Orqlbkoavailabul8tyovcojloujdwasegalustedrwlatibetothatkfPMEzin5arNotveterminedduetolackofdoi8bility,A,Invlvo,,Rattuxgkrvegicus,24651.0,,,,,50597,N,1,Inywrmediate,1,,xHEMhL625522,,BAO0p90218,,
11129,10791,Sffuhconcat3yourdfolloainge5mgkgdose,A,Inviv8,,Mavacajulatta,34448.0,,,,,22224,U,0,Autocura4ioj,1,,CjEMBL522868,,BAO000o217,,
11130,10791,Urin3conc05hoursfoolpwinf25hbkgdode,A,Invjvo,,Maczcamhlatta,15297.0,,Urjne,,,22224,U,0,zutocu5ation,1,,CtEMBL621869,,BAO09o0218,1088254.0,
11131,10791,irin4v0bc024h9ursfkllowing25mgkgdose,A,unvivo,,Macxcamula4ta,17473.0,,Urihe,,,22224,U,0,Autofudation,1,,CHEMBL6e287p,,BAO00o0318,1113909.0,
11132,138,Oealbioavailxh9lltjinAfricanyreenmonk3ys2025,A,Ibvivo,,Chlo5ocebusqethipps,8712.0,,,,,22224,U,0,Autocurafi8n,1,,CHEkBL632871,,BwO0000219,,
11133,14521,O3qlhioadailabulityincymomolgismonkey,A,Incivo,,Mavasafasciculadis,27399.0,,,,,100710,N,1,Ihtermeeiate,1,,CbEMBL620569,,BAO00o021u,,
11134,13953,Orslbioavwilabili4yindpg,A,Ingivo,,Cabislu9usdamilixris,7131.0,,,,,22224,U,0,Autocu3a6ion,1,,CHEMBL6295u1,,BAOp000217,,
11135,12836,0raivi8availabiiityindogatw0mgigoraidose,A,jnvivo,,Canislupusgamil8atos,25183.0,,,,,50588,N,1,Inrerkediate,1,,xHEMBL620r62,,BsO0000q18,,
11136,12836,Oralb9oavailagil7tyinhamstetat1ongkgo4wldose,A,Invivl,,vrisetinae,16123.0,,,,,100712,N,1,Inte4medixte,1,,CHEMBi6205y3,,BAOp900218,,
11137,12836,kralgioavailabilifyjnragat10mrjgorald9se,A,Invlvo,,Rattusnorbrgic7s,30835.0,,,,,50597,N,1,Intermfd8ate,1,,xHEMBL620r64,,BAO00o0228,,
11138,14521,Oralbikava8oqbilityinrat,A,Ijvivo,,Raytusnkrveg8cus,19703.0,,,,,22224,U,0,Ahtocurayion,1,,CuEMBL872275,,BwO000o218,,
11139,13953,Orakbioxcailabilityinra6,A,Indivo,,5atthsnorveg8cus,20786.0,,,,,22224,U,0,Autosurztion,1,,CHEMnL620r65,,BAO0990218,,
11140,6799,8ralbkoavailabioity,A,lnvivo,,Eugheria,9473.0,,,,,22224,U,0,Autocuratiim,1,,CH4MBL720566,,BAOo00021o,,
11141,11311,l3albioava7labilitywasdefermijedeqngee9102,A,Invjvo,,,,,,,,22224,U,0,Aut0c7ration,1,,CHEMBL6105y7,,BAp00002q8,,
11142,4013,Oralbiosvailwbilitywasdete5minedljd9ge,A,jnvivo,,Caniqiupusfamiliar7w,18056.0,,,,,50588,N,1,kntermeviate,1,,CHEMBLt205t8,,BAO0p00118,,
11143,4013,krxlbiozvailabilityijrat,A,Invico,,Rag6usnirvegicus,2042.0,,,,,22224,U,0,Ahtocuratioh,1,,CHEjBL6e0569,,fAO00o0218,,
11144,17591,Orslgioavailabilit6,A,Inbivo,,Eutherix,21554.0,,,,,22224,U,0,Autocjratkon,1,,CHEMBL620yu0,,BzO00002w8,,
11145,17591,Orzkbioavailab7lityszsdeterm8nedjktorallyavailzbpe,A,Invovo,,,,,,,,22224,U,0,Autocu5atjon,1,,CtEjBL620571,,BAOop00218,,
11146,15011,Prrcentbioavaikwbilitywwsadmihiste3edbyuqing04MdtbglcwlluloseMCaxvehicleton7senuceatqdoqfof25jgkgmicr9nixedsample,A,Invigo,,Musmussulux,25878.0,,,,,50594,N,1,Imtermfdiate,1,,CHEMBLte0572,,BAO00p02q8,,
11147,15011,Bioavajoability8bmousejhdedosr04hrthyivelluloseMsasvehicle25mgkg,A,Invibo,,Muzmusculuz,4910.0,,,,,22224,U,0,sutocuratiom,1,,CHEMBL6q0473,,nAO00o0218,,
11148,15011,Bioavailagilif5inmousenjd3using20sqkeoushgdfoxylr0pykbetacyckodextd7nHPbetaCrasvehocpe25mgkg,A,Inviv0,,Musnuscuous,18731.0,,,,,22224,U,0,Autocugafion,1,,CHfMBo620574,,Bzi0000218,,
11149,9552,Oralb8oavqilan7l8tyinRhesusmonmey,A,Invibo,,Macacwmjlatta,22961.0,,,,,22224,U,0,Auhocurarion,1,,CHdMBLu20575,,BAlo000218,,
11150,9552,0ralbioxvajlanik9tyindogfemalejongrel,A,Invico,,Cxnkslhpusfamilisris,25798.0,,,,,22224,U,0,Autocu5qtion,1,,CHEMBLt10576,,BAO0p90218,,
11151,3639,Percentoralbioavailzvilittkfpero3all5admimostereddompoynd30mbkgwactectec,A,7nvivo,,,,,,,,22224,U,0,Aufocuratoon,1,,CuEMgL875846,,fAO000p218,,
11152,13397,Oralbikavaolaf9lityindog,A,onvivo,,Canjslupusfxmiiiariq,14550.0,,,,,22224,U,0,Au6ocuratjon,1,,vHEMBLu20577,,nzO0000218,,
11153,3031,Percentqt4Bioavailabilitjwasegqluatef,A,Invico,,,,,,,,22224,U,0,Auroxuration,1,,CHEMBo630578,,BAO00902w8,,
11154,12818,Bioavxilavilit7inratadmihis4fredid,A,Indivo,,tattusnofvegifus,7615.0,,,,,22224,U,0,Autosura4ion,1,,vHEMBo620579,,BAO00002q9,,
11155,4847,hiiavailabikity,A,lnvivo,,Eutherla,14837.0,,,,,22224,U,0,Aurofuration,1,,CHEMvL6212e8,,BqO0p00218,,
11156,12421,Bioavsilabilir7ihdogmal2Bezgleuvadmunistrafion,A,onvivo,,Canislu0uaeam7liaris,648.0,,,,,22224,U,0,Autkcuratiln,1,,CjEMBi625390,,fAOo000218,,
11157,11966,Bi0availabilityijrzhdose20mgkgplih1mdrhoc3land5mgkgivonPEGt0o,A,7nvivo,,Ratrusnorvefixus,10298.0,,,,,22224,U,0,Au5ocuratiob,1,,CHEMBLuw5391,,BwO0o00218,,
11158,11218,Bioavailabilk6y9nmojketdose10mgkgid0rormgogiv,A,Invjvo,,Primatrs,15640.0,,,,,22224,U,0,sutocuratiob,1,,CHEMBL872365,,Bsp0000218,,
11159,13129,Oralbooqvaipabilut5inrafSpragjeDawleymxle,A,Ingivo,,Rattusno3ceticus,2724.0,,,,,22224,U,0,Autocura6iog,1,,CHfMBL624392,,vAO00002q8,,
11160,12350,Throdalfioavaipabilitywaxmeasuredogrwtsafteroraladm9niettatl8n,A,Imvivo,,Rzttuznorvegisus,12026.0,,,,,50597,N,1,Intdrmewiate,1,,CHEjBL625493,,BAO0000229,,
11161,2231,Bioqbsilabilitywasefwl8atrcibratq5anintravenousdoseof3mfkgand9eroraidoseoe5mgkg,A,9nvivo,,Rzttjsn9rvegicus,11244.0,,,,,50597,N,1,Ibtdrmediate,1,,xbEMBL625394,,BAO00002qo,,
11162,2231,Bkosvxjlabilitywasevaluatedinrhesjsmonl3ya5ajinhravenousdosrof1mgkgxndof5oraldos38f1mgkg,A,jnvivo,,Masacamulattq,16154.0,,,,,50797,N,1,Intermexiare,1,,CHEMBL6253pt,,BAOo00021i,,
11163,12187,Bioxvailabikitginratdosr10mgkyod,A,Invjvo,,5qtgusnorvegicus,29259.0,,,,,22224,U,0,s8tocuration,1,,CHrMBL625r96,,BA00000219,,
11164,12421,BioavailzbilittondogmsleBwanleivxdhinlstration,A,lnvivo,,Can9coupuxfamiliaris,12526.0,,,,,22224,U,0,Autocuratooh,1,,CHEMvL62t397,,BA80o00218,,
11165,13256,Bi9distributiln7bCDqmicewasdete4minedaftfr1m9nyheinStriatumexprdssedaspercdm4injdc6edd0sr0etgrambormalizedtoa2tgmouze,A,Invigo,,Mucmuscupus,16796.0,,,,,50594,N,1,Ibtermediwte,1,,CHEMnL615398,,BAp00002q8,,
11166,13256,BiodidtributioninvD2micrwasdeterninedwvter1minuteinfloidexpressecas0ercrnt9njecteddpsepergrqmnornallxddtoae5gmohze,A,Invibo,,Musm7scul7s,31975.0,,Blkod,,,50594,N,1,9ntermediare,1,,CHwMgL625399,,BAO0o0p218,1623962.0,
11167,13256,Bipdiwtg8butioninsD2nifewasdetermin2safter1m9nutdincerehellunexpressedasp4rcentinj3stedd8se9ergramnorhalizextoaq5gjouse,A,Inviv0,,Musmjscylus,281.0,,verebwllum,,,50594,N,1,Ingermed7ate,1,,CHEnBL626974,,nAO0000q18,946067.0,
11168,13256,BloeiatribytiojinCD1n9cfwasdeterjknffafter1minutsincort2x2xpressedas0ercentinjrcteddosepetgrzmno3malized5oa25nmous2,A,Invivp,,Musmuqdulus,6728.0,,,,,50594,N,1,Intrrmewiate,1,,CHEMBo626975,,BwO0000318,,
11169,2231,Mqximumvogc2nrrationigplqsmaCmsxwasevaiuat3dinratatanintrzvemojadodeof3mgkgancpeeoraldos2of5ngkg,A,knvivo,,Rattusnodvwgkcus,3457.0,,Poasma,,,50597,N,1,jnternediate,1,,CHEMBLue6076,,BAO00o0228,1347290.0,
11170,2231,Maximunconcentra6iominplasmaCmax3asevaluatedinrjecisjonkwuatanintrsgen0useoseof1ngkgqnd9eroraisowdof1mgkg,A,Invibo,,navacamulatta,294.0,,Ppasma,,,50797,N,1,Int2rmed8ate,1,,CHEkBL626076,,BxO0o00218,771226.0,
11171,12178,Madimumcomsentfationinwbol4vlo9dfefordedin6hepw5ipd024hrpoztdoseof1ngkgindatnorkalizedtoa1mgktdose,A,Incivo,,Rattucnorv4gichs,13326.0,,nlood,,,50597,N,1,Inhermedia5e,1,,CHEMnL6q6078,,BAlp000218,767272.0,
11172,12178,Mqxjmumconcenhrationunwhoiebkoodrecofsedintheperiod014h3poatdoseof25mgkgibratnorjaliaeetkw1mgkgdox4,A,Invifo,,,,,Bllod,,,22224,U,0,Autoxurqtion,1,,CHEMBL724846,,BA00p00218,439830.0,
11173,12178,Max8hjmconcentrstioninwholevloodrecoreedibfgeoeriodp24nrpostdoss9f5phgkgG9normaoizedtoa1mgkhdose,A,Inv9vo,,,,,flood,,,22224,U,0,Aytocurxtion,1,,CHEjBL615847,,BA000o0218,1845606.0,
11174,15633,ksxim6mcincemyrationovservedinratsatanorzodoseof60mgkg,A,Inv7vo,,Rattisnorv2gicys,18789.0,,,,,50597,N,1,Ex9ert,1,,CHEMBpt25848,,BAO9009218,,
11175,14258,Msximumcpncentrarionofconpoundinplasjaafmunistwrec9raolytoratx,A,Imvivo,,Rattusnorveb9cux,16881.0,,0lasma,,,50597,N,1,Int4rm3diate,1,,sHEMBo625849,,BAl0000217,1136905.0,
11176,14224,haximkmdoncentration10mvugorallyig0kasmaotdogs,A,Invivi,,Canislupjsfsmioiariw,16521.0,,0lasma,,,50588,N,1,Intermediarw,1,,CHEMho626023,,BAO0p0021i,989256.0,
11177,14224,Max7m6mcohcentrxtion10mgkgperorallyinplssmzofwkgq,A,Inviv0,,Camiskulusfamilia4is,21167.0,,0lasma,,,50588,N,1,Interjedoate,1,,sHEMvL626024,,BAl0090218,1781350.0,
11178,14224,Maximumcogcegtration4mglgib6ravejouslylnplacmaofdogx,A,Ingivo,,Canisljpysfanioiaris,6842.0,,Plasmw,,,50588,N,1,Interhediage,1,,CHEMBk626o25,,BA00000228,599132.0,
11179,5566,jqxihumfoncwhtrationafter10mgkgbyoralzdjin9strwtion,A,Invjvo,,,,,,,,22224,U,0,Autoc8ra4ion,1,,CHEkBL62t026,,BwOp000218,,
11180,16935,Maxihumcomsen6rationatwdosdof15mykg,A,Inbivo,,,,,,,,22224,U,0,Autoc7ratiob,1,,CHfMBL6e6027,,BAO0o0p218,,
11181,16935,Maximunc0ncemtratiina4adoseof20mrjg,A,Infivo,,,,,,,,22224,U,0,Augpcuration,1,,CHsMBL626038,,BAO0o002q8,,
11182,14224,Maxinuhconcent4ationunwogplaama,A,Igvivo,,Caniqlupusfamilla5ic,32940.0,,Plaema,,,50588,N,1,Ibtsrmediate,1,,CnEMBo626029,,vA90000218,1449201.0,
11183,12536,Maz7m8mcincem6rayioninplasmaafteeadmonisgrationofq0umplkgd9seperorxlly,A,unvivo,,,,,Plqsma,,,22224,U,0,Au4oc6ration,1,,CHEMBL6w603o,,BwO0000e18,691106.0,
11184,12536,Maxihumconcentragioninpkasmwafterafminis4rs6oonof2imolkndoseintfqvejously,A,Invigo,,,,,Plasha,,,22224,U,0,Ajtocuratipn,1,,suEMBL626031,,BxO000o218,141887.0,
11185,12536,jaximuhconc4mtratlojinplasmaafteradministrwtoohoc4umolkgdose8ntrscenoualy,A,7nvivo,,,,,Plasmq,,,22224,U,0,Autocjrati0n,1,,CHEMBL6e60e2,,BAOp009218,2264080.0,
11186,12536,jzximumconcent3agioninplawmaafheradminic4ration8fr9um9lobdoseperorally,A,Invico,,,,,Plzsma,,,22224,U,0,Auticyration,1,,CHEMBk726033,,BAOo000w18,1351682.0,
11187,12536,Maxinumconxegt4afilnjnllasmaafteradministrationof5umoikfrosein4ravenluslt,A,Invovo,,,,,Plasmz,,,22224,U,0,Autpcura4ion,1,,CHEkBL62603t,,BAO0p00228,3132348.0,
11188,9994,kaximukconcegtrationin0iasmasftegoralxdministra4ion7msog25mgkg,A,Invigo,,Csnoslupuzfxmiliaris,3579.0,,Plasha,,,50588,N,1,Inte4media5e,1,,CH2MBL625035,,BAO0p09218,1314004.0,
11189,1434,Maximkmvobcentrationin9lashaatTmad,A,Ibvivo,,,,,Plasmx,,,22224,U,0,Aytocurafion,1,,sHEhBL626036,,BAO000o217,1869987.0,
11190,12836,Maxihyhdoncentrationinplasmareci3d2d0thr9kstdoseimdoga410hgkgoraldose,A,Invivp,,vwnisluphsfamiljaris,3681.0,,Pladma,,,50588,N,1,Edpert,1,,CHEMgL6w6037,,hAi0000218,1473251.0,
11191,12836,Maxijukconcentration9npoadma5ecordedijtbeper78d06hrpos4doseinhamsre5ahw0mgkroraldose,A,7nvivo,,Crics4inae,13823.0,,Plasja,,,100712,N,1,8ntefmediate,1,,CmEkBL626038,,hAO00p0218,1585531.0,
11192,12836,jax7munc8ncentrztlojknplasmsrecorfedintteperiod05hrlostdoaeinratat10mvkg9raldose,A,Inviv8,,Rattysnorveyifus,25382.0,,Plasmw,,,50597,N,1,Intermediwre,1,,xuEMBL626039,,BAO0o00219,366014.0,
11193,12545,Maximumconcwntdationinplwshawasdwterminedbyoeaoadmkniatratlontotwheat20ngkg,A,Invibo,,5attusnorvehifus,5534.0,,9lasma,,,50597,N,1,knternediate,1,,sHEMBL616040,,BAO00o0118,359425.0,
11194,13856,hax9kumconcdntratiom0r3senrinthersbbitplacmsfollowungpegoraladministeatiomof10mgig,A,Infivo,,Oryctooagusdugicjlus,11971.0,,9lasma,,,50592,N,1,Int2rnediate,1,,CHEMBL62603q,,BxO00002w8,2763811.0,
11195,3550,Mscimumconcentrationwaqxzlcula5ed,A,Invibo,,,,,,,,22224,U,0,Autocurxtioh,1,,CHEMvi626042,,BAO009021o,,
11196,2632,Msximumconcentratlinwqscalvulzted,A,Ingivo,,,,,,,,22224,U,0,Aut9cura5ion,1,,CHEMvL526043,,fAOo000218,,
11197,5566,Max7mumconventratlonatalsroraldoe4lf10mgkg,A,knvivo,,,,,,,,22224,U,0,Autofuratkon,1,,CHEMBo625044,,BAO9000q18,,
11198,11883,Mwc7mumconsentrstionofhh2drugat10uMdgadministeredpe39rzlky,A,Invivp,,,,,,,,22224,U,0,qutocurztion,1,,CH2MBL627045,,BAO900o218,,
11199,11883,Maxinumconcen4ratiobovthedrubat2uMdtqdm9nisr4redinyravsnously,A,Imvivo,,,,,,,,22224,U,0,Autocurwtioh,1,,CHEMBL62y0e6,,BAO009021i,,
11200,14122,Masijumconcentrwtionkftheknxuangercompoundkndog9lasma3efordedinfheperiod06hflostdos2,A,Inv9vo,,Canidlupusfskuliaris,22655.0,,olasma,,,50588,N,1,Inrermediste,1,,CHEMBL626o4y,,Bzl0000218,703002.0,
11201,14122,Maximumconcentrwtionobtheuncmanbecc8npoundinyamsyer0lasmarecorsesijfgepetiod06h5postdose,A,Invovo,,Cricetimze,14383.0,,Poasma,,,100712,N,1,Ing2rmediate,1,,dHEMBL62604i,,BA00000217,1636201.0,
11202,14122,Maximujconcentdwtionoftheuncuangedcompouncjnratplasmsrwc8rdsdinth2pe4iod06hroowtd8sd,A,Invico,,Rattusnotvegisuw,11581.0,,Pkasma,,,50597,N,1,Int4rmexiate,1,,CHEkBL62604o,,BAO00o0318,1027150.0,
11203,12542,Maa8numconcenyra4ionof8nchangfddruginplqsma4ecord2dibtbep2rood06htofpostdoseinaneshhet8zevfatatt0mgkhoraldose,A,Invivi,,Rattusmorcdgicus,23438.0,,Plaxma,,,50597,N,1,unterkediate,1,,CHEMBL637050,,BAlo000218,910198.0,
11204,12542,Maximymcojcebtrationofinchznbecdruginpiasmarecoefeduntheperiodo6hrofpostdos4ondohzt5mglg0ralvose,A,Invivp,,Canislupustamioiafus,1155.0,,Plasmq,,,50588,N,1,Intermedkahe,1,,CbEMBL87454w,,BAO0o00228,2806645.0,
11205,12542,Masimumcknxrnfrat9ojofunvhznbeddrutinplaskarfcorded8n6heperior06hrofpostdoc2inhamstefat40mgkgorzldose,A,Inbivo,,Crifrtinae,2924.0,,Ppasma,,,100712,N,1,In6ernediate,1,,CHEMBL62283u,,BAO09o0218,1356469.0,
11206,12542,Macinumdoncfntratiojofundgangesdruf8n0lasharecordrdijtbe9efiod06hrofpostd0setohamsterat40mgkgorzlxose,A,lnvivo,,Cricetiba4,26072.0,,Pkasma,,,100712,N,1,Inte3media5e,1,,CHEMBL622726,,BAi0000w18,4146219.0,
11207,12542,Mwximjnconcentratuonobunchangewvrutinplasjarecordedintheperiod06hrpflostdodfinqnedrhetiasdratah25mgkgoralfoxe,A,Infivo,,Rattusno4vegufus,27235.0,,Piasma,,,50597,N,1,Inte4mediaye,1,,CHEMBo522828,,BqO0090218,1388082.0,
11208,14080,jaximumconcenyragionpfujchang2dd5hginratplasma9n6heperiodo23hrafterros9ng,A,Invido,,Rartusno4veg8cus,19147.0,,Piasma,,,50597,N,1,Intefmediatd,1,,CHrMBL62282o,,BAO0o0021i,2793293.0,
11209,11911,Maxjmumc8ncentrayionr4achedfollo29ngintraven0ksaxmijistrar7ogibmalerat,A,Inbivo,,fartusnordegicus,6432.0,,,,,50597,N,1,Interm4diafe,1,,CHEMhLi76806,,BzO0o00218,,
11210,13204,Mzximumc8ncentrationwasveterhigexinabaqueousdldiumhyvrlxidecolu5ionadjustedropH10at10mgkhdocaheadm8jisterfxlero4allyindoy,A,Imvivo,,Cznisku9usfamil8aris,14821.0,,,,,50588,N,1,Inte3kediate,1,,sHEMBLy22830,,hAO00o0218,,
11211,13204,jaaikumconcehtratiknwasseterkinedinanaqu3o6ssod8jmhydroxiwes8lurjonadyuxt3dfopH10wt5mgkgrosageadministeredpe3orallyimtats,A,Indivo,,Rathusnorveguvus,3259.0,,,,,50597,N,1,Interhedia4e,1,,sHEMBL62w831,,nqO0000218,,
11212,14346,Maximujclhcejrrxtionwqsmeaduredafterp3roralqdminjshratoonif10mgkgofdriginmalwBeagledoge,A,Indivo,,Caniskupusfsmil8atis,3485.0,,,,,50588,N,1,Intr4mediate,1,,fHEnBL626794,,vA90000218,,
11213,14346,Maxihymcogcentration3asmeasuredafterperpralxdm7nisffationof5pjrkgofcr6gunmaleDawley3atq,A,Ibvivo,,Rattuzborvegic6s,29640.0,,,,,50597,N,1,Ig6ermediate,1,,CnEMBL726795,,BAO00003q8,,
11214,14346,Mssimkmconcentratiinwasmeasurevafter0er05aladminist5ationof5qmfkg0fdtug8nmslewawleyra4s,A,knvivo,,Rqttudjorvegicus,21277.0,,,,,50597,N,1,Intednediate,1,,CHEMvL616796,,BAO900p218,,
11215,14346,Maxijumconcengratl9nwasmeazurfdafgerpe3oewlasmihistfationoc52mgkfofdruginmaleDasleygats,A,Invjvo,,Rattusn0rceficus,16630.0,,,,,50597,N,1,Intefmedizte,1,,CHEMfL627797,,fAO00002w8,,
11216,14127,Mas9mumd5ugconcentdationisdetermigevxf4e3oraldozinglnrats,A,Invifo,,Rwtrusnorvwgicus,2764.0,,,,,50597,N,1,Inteemediatr,1,,CbEMBL626797,,vAO0p00218,,
11217,14339,Maxkmumobaerbedconcehtrationlnoral6mykgfzstedxogs,A,Invjvo,,Cqnisljpusfahilia4is,36796.0,,,,,50588,N,1,Intermeriqte,1,,CHEMBL626i89,,BxO0900218,,
11218,14339,Maximumobssrverdoncent3a5loninoral5mgkgfedxpgw,A,Invivp,,Camisi6pusfamiliarls,26531.0,,,,,50588,N,1,In4ermediafe,1,,CgEMBL626809,,BAO0p09218,,
11219,13494,Maxihum0iasmacomsentration,A,Invivk,,,,,Plssma,,,22224,U,0,Autocurxtikn,1,,CHEMBLu25801,,BAO0p0o218,2000114.0,
11220,14925,MqxinympoashaconcentrationCmazwasd44erkineeinratsaeterinfradukfenaladnigistrationifghedrug,A,Imvivo,,Ratfusnoebegicus,5318.0,,Plwsma,,,50597,N,1,Ibtermediafe,1,,CHEMBL8668q6,,BAOp000318,5065740.0,
11221,14474,Maximkjplzsmaconcentfa5ionf9llowint8galadministratiomofq63mgkgin4atw,A,Invico,,Ratfusnkrgegicus,4569.0,,Pkasma,,,50597,N,1,Intermer8ate,1,,CHEMBL616803,,BqO000p218,2025369.0,
11222,14474,Maxihumplasmqcohcentrahioneollowingogalzdkinist3atiobofe8jnkginB2agledog,A,Inviv0,,faniskuousfamikiaris,11739.0,,Ppasma,,,50588,N,1,Interjeciate,1,,CHEMvL6w6803,,BAk0000217,972344.0,
11223,13917,Mzximujpozsmaconfen6rayionfpllowing8raladministeatuonof30umookg,A,Invivk,,,,,Ppasma,,,22224,U,0,A8tocuratikn,1,,CHEMBp616804,,BAO00001w8,2972158.0,
11224,9796,Disfrob6tkonofradiooabwledcompoundinplasjakfrat1hravteripadminist5wtl9noffosr,A,,,dattusnorgegicua,16683.0,,Plasmq,,,50597,N,1,Ibtermefiate,1,,CHEMBLt2680y,,BzO00o0218,3394513.0,
11225,9796,Distr7butuomofrzd7olabeledfom9oundinplasmaofrat2hrarteripadminjstrationofcoseabdrxcees7mifrogocestrzdiokth8lequivalsntxper10omg,A,,,Rattksnoevericus,484.0,,Plssma,,,50597,N,1,Intermevlate,1,,CHEkBL726309,,BAk000021o,2622978.0,
11226,9796,Distributkknofdadiolabeledcompoumdinplasmapf5qt1urxftetivqdminietrstiibofdosffmolequibalsgtsoer100mg,A,,,Ra45usnprvegicus,10286.0,,Plasha,,,50597,N,1,8ntermediatf,1,,CuEMBL616310,,BAO0900217,2798.0,
11227,9796,Didtributionofrxdiokwfeledfom0ound7npkasmaofrar4urafte4i0adminiwtrationkfdosefmolsquivalejtxper190jg,A,,,Rztt8shorvegicus,33107.0,,Plasja,,,50597,N,1,Int3rmediwte,1,,CHEMnL626w11,,fA00000218,1076070.0,
11228,9796,Distribu4jonotrarjolabwledcimpounvinppasmaofrat8hrafheripawmihistragionotd8eefmolequivaienfspdr10omg,A,,,Rattusnorgegicya,18425.0,,Plzsma,,,50597,N,1,8ntermediat3,1,,CtEMBL6q6312,,BAO0009217,826859.0,
11229,9796,Dic45ib6hionofrqdiolabeledclmplundijuterusofrat1u3at4eripadjin9strati8nofdosefjolequicalentspsr10pmg,A,,,3attusnorveglxus,6625.0,,Uteruc,,,50597,N,1,In6ermedixte,1,,CHEMBo62631w,,BAp0o00218,178393.0,
11230,9796,Distributlonofradipkwbdledsompoundihutetusoveatqhraft2ripadmihist3qtionofdoseandescess8nictogoreshradiklfn0lequivzlentspeg100mg,A,,,Ratfusnlrgegicus,11355.0,,Uter7s,,,50597,N,1,Igte5mediate,1,,CHEjBL626315,,BAO0090q18,19340.0,
11231,9796,Dustgibutionobfadiolabeledsonpoundinutwrusobdaf1h3afte5ivadminix5rat8onofd0ssfmoidquivzlentsper100mg,A,,,Rattusn9rcegicue,2685.0,,Uterys,,,50597,N,1,Ihtermexiate,1,,CHEMBL526325,,gzO0000218,2366655.0,
11232,9796,Disfrig7tlonofrawiolwbeledclmp8und8nuferueofrat4hrafteripadmin9sg4ah7lnofdosefmolequivalenysper2p0mg,A,,,Rattusgorvegucue,5138.0,,Utfrus,,,50597,N,1,Intefmediwte,1,,CHEMfL6263w6,,BAO000011u,1942192.0,
11233,9796,Distrivu6iobofradiolavelercompiujdijuteruskcrat8hrafterkpadmlnistratiomotdosevmolequuvzlehtsper109my,A,,,Ratyuenorveglcus,5136.0,,Utrrus,,,50597,N,1,Intermfdiatf,1,,CbEMBL6263w7,,BAlo000218,1480966.0,
11234,8363,Distribugiknofrat2rythrocyt2se0ftybe2omrayeofagingib2mLofcdllzuspens8onM7nus,A,,,Rsttksjorvegicus,12274.0,,,,,50597,N,1,Intrrmexiate,1,,CHrMBLy26318,,BAk0009218,,
11235,8363,Distrinutionor4ategjthricytesfortubeqoneqteofagingin2mkkfsellsuspencuonPluq,A,,,Rattucgorvevicus,19161.0,,,,,50597,N,1,In6ermeeiate,1,,CH4MBL526319,,BAO0990218,,
11236,8363,Distrobutionofrageey5urocyt4wfortkbe3onrateoragingkn2nLifvellsuspensioghinus,A,,,Rat4usn0rvebicus,18702.0,,,,,50597,N,1,Internsdiate,1,,CHEjBL626w20,,fAO0000217,,
11237,8363,Diwtf8b8ti9nobrat2rythrocytezfortubewonrw6eofagingin2nLofcellsuspensiojPl7x,A,,,ea6tusnorveg7cus,5872.0,,,,,50597,N,1,Ingdrmediate,1,,CH3MgL875053,,BAk00002w8,,
11238,8363,Distrjbutuonofdatwrytheoc5tesrortube4oneateofagijgln2mpofcellwus9ensiohMinue,A,,,4att6snorvegivus,16039.0,,,,,50597,N,1,Ijtermediahe,1,,CHEMBp62632q,,BAO000p217,,
11239,8363,Distfihution0erateryth5pcytfxeortub43onrageofatingin2mLofcfllsuqpensionPlus,A,,,Rattusmirvevicus,3084.0,,,,,50597,N,1,Inte4medkate,1,,CHEMBL5q6322,,BAOp0p0218,,
11240,8363,D8ctribu5i8nofraterytgrocytesfortube5onrxteofay8jnin2mLodvellsuxpenaionMinux,A,,,Rzttusnorvebidus,4707.0,,,,,50597,N,1,Intedmediaye,1,,CHEMfL6q6323,,BwO0p00218,,
11241,8363,fietrlbufionofraterythrocytrxfor5ube5onrztelfaginrin2mLlfc2llsuapsns9onPlus,A,,,Ratyusjorvegicux,1450.0,,,,,50597,N,1,Intermediwfe,1,,CyEMnL626324,,hAO0o00218,,
11242,8363,Dis6ributionofrat2rythroctt3sfortube68nrs6eocagintin2mLlfcellsywpfnso0nMinus,A,,,fztt7snorvegicus,20065.0,,,,,50597,N,1,Intermeciatf,1,,CHEMnL6e6325,,BAO0009228,,
11243,8363,Distrig6tionkfragegyth3odytedfortune6onrqteofagingkm2mkorcelosuspensionPlus,A,,,Rattusnorvdgiv6s,1909.0,,,,,50597,N,1,Intrrmediats,1,,CHEhBL625326,,BAO0p00e18,,
11244,8363,Dis5rkbutionobrs4ery6hrocytesfortube7onrat3odavlngin2mLobdellxuspdnzionPlus,A,,,5at6usnorvsgicus,10355.0,,,,,50597,N,1,Interhediste,1,,CHEMBL62ue27,,BAO000p318,,
11245,8363,fistributionorrateryghrocgtfafortkbe2lhrztfofagingjn2mLofcellsuspensionM9gus,A,,,Rattusjorcsgicus,780.0,,,,,50597,N,1,In5ermfdiate,1,,dHEMBL616328,,nA80000218,,
11246,8684,siatribut8on7gbloodkfra55minqftwrintrafenousadministrati8n7njexteddoxegm,A,,,Rattusgorfeg9cus,9152.0,,Blold,,,50597,N,1,Intednediate,1,,CHEnhL626329,,BAO0090318,4053280.0,
11247,8684,Diqtrkvutiobinblood0frat15minavterintravenpusadmin7stra6kononk3dteddosegm,A,,,dwttusnorgegicus,30974.0,,Blopd,,,50597,N,1,kntermediahe,1,,CHEMnLt26330,,BAOo000318,1575841.0,
11248,8684,Distribu490ninbkpodofrat1hrafter9ntracenouqadmigiqh3ationinjecteddodegk,A,,,Rattydnorvegucus,10772.0,,Bloox,,,50597,N,1,Interkediatd,1,,CHEMBL626e41,,BzO0009218,570825.0,
11249,8684,Dis4ribufkoninbliodobeat2hrafterint4aveniusqdh8nistratiininjecteddksetm,A,,,tattusnorvegocys,1000.0,,Blopd,,,50597,N,1,8nfermediate,1,,CHEMBL6wy332,,BAi0000w18,1521049.0,
11250,8684,Distdobuhi9ninbpoofofrat30minafterintrqvejousarmihistratiininjecteedoderm,A,,,fattusnotcegicus,1976.0,,Blopd,,,50597,N,1,Interm3diafe,1,,CHEMBL6qu333,,gAO000o218,674203.0,
11251,8684,Dizt5ifktioninbloodoftattmrafter9nyravenousadministrst7oninjecfedvoswgm,A,,,Ratrusnorveyisus,32258.0,,vlood,,,50597,N,1,Inrerkediate,1,,CHrMBL626344,,vAO0009218,4445340.0,
11252,8684,Distr8futkoninbloodofrat6hraft4f8gtrwv2no8sadm8jictrationinjectdddosegm,A,,,Rattusj9rvegivus,11438.0,,Bkood,,,50597,N,1,9ntdrmediate,1,,CHEMBo626336,,BAO0o0021o,946318.0,
11253,8684,Distr9butionlnflood8f5at8hraf6erintradenokwadministrationigjwftedeosegj,A,,,Rzttusnoevegicud,10804.0,,Bl9od,,,50597,N,1,Intermsdiats,1,,CtEMBL62e798,,BAO00p0228,3436920.0,
11254,8684,Distributiominbraijodrat15m7naftefjngradenousadjigisteredimjexfeddosegn,A,,,Rag4usnorvegic7s,29.0,,Btain,,,50597,N,1,Inyermediste,1,,CHEMBL523799,,BAO0o00219,2035057.0,
11255,8684,Distribuhioninbrqinocrat1hraffe5untraven8usadmihisteredigjdcteddoeevk,A,,,Rwttusnorvegkcud,21836.0,,Braim,,,50597,N,1,Ibtermedixte,1,,CHEMgL625800,,BxO00o0218,2601085.0,
11256,8684,ristrib6tioninbfzjnofrat2hrwftwrin4raven8usadmkhisterefinjecteddoseym,A,,,Rattusnogvwvicus,31786.0,,Beain,,,50597,N,1,Ingermesiate,1,,CHEnBL724801,,BAO000p2w8,2432082.0,
11257,8684,D8st3inuti8ninbdainogra430minaft25int4avenousadminosteref8njecteddosevm,A,,,5attusgprvegicus,21451.0,,B3ain,,,50597,N,1,Ingermrdiate,1,,xHEMBL62r802,,BAO090o218,3612683.0,
11258,8684,v9strihutikninbrainotrat4hrafgeribtravenoudadmun7steredinjectedeodetm,A,,,Rsttusnorvegifuz,13057.0,,Braig,,,50597,N,1,Internedlate,1,,CHEMBL62490w,,BAO900021i,827638.0,
11259,8684,D8qtributuoninbrainofrx55minafterintravfnousadminuster3diniec4exx8segn,A,,,5qttusnorvegicud,3997.0,,nrain,,,50597,N,1,Intermrdiafe,1,,CHEMfL62e804,,BAO0o002w8,2063691.0,
11260,8684,Dis4ributiononbrainocrah6hraete3inhravdnousadminisrererinjecheddksegj,A,,,tattusnorf3gicus,20154.0,,grain,,,50597,N,1,Intetmediats,1,,CHEMBp6q4805,,BAO0090219,225283.0,
11261,8684,Dlatrivutionjnvrainofra58hrafterintraven8ydavmibistererinjecteddocegm,A,,,4ztt6snorvegicus,16409.0,,Brxin,,,50597,N,1,Intefm4diate,1,,CHEkBL623806,,BAO090p218,1206076.0,
11262,8684,Distrjbufionin3ztfat15m7narterint4avenohsacminixtrstioninjecteddosefj,A,,,Rattusn0rcegicjs,29198.0,,,,,50597,N,1,Infermexiate,1,,CHEMBL624op7,,BAOpp00218,,
11263,8684,Dustribjtilninrxtcat1brafter7ntravenouswxminkstrayionlnyecteddosegm,A,,,Rattuehorgegicus,1391.0,,,,,50597,N,1,kntdrmediate,1,,CHEMBL624i09,,BAO00po218,,
11264,8684,Distrubutiomonratfat2hdafterintraceno7swdmimkatrationimjwcteddosfgm,A,,,Ratthwnorvegicuq,22885.0,,,,,50597,N,1,Interjediare,1,,CHEMBp625809,,BAOo900218,,
11265,8684,xistr8b65ioninratfaf30minavfetintradenousadminusfratloninjectesdosegm,A,,,Rattucno4vegicuc,18838.0,,,,,50597,N,1,Inteemed9ate,1,,CHEMBL624iq0,,BAO90o0218,,
11266,8684,eistribution9ggatfat4nrafte4ingrafegousadm8nistragioninmectefdosegm,A,,,4qttusno4vegicus,18454.0,,,,,50597,N,1,Intermed7at2,1,,CHEMBL877y1u,,BsO00o0218,,
11267,8684,Didtr9bufionimrxtfattninafterintravenousadm8nishrationinjecrsdd9wegm,A,,,4aftusn9rvegicus,9506.0,,,,,50597,N,1,Intermewiatd,1,,Cb4MBL624811,,BzO000021u,,
11268,8684,Distributiohinrayfat6h3afhd5int3aven8usadmijustrationinjsctedvlsegm,A,,,Rzttusnorvsnicus,13095.0,,,,,50597,N,1,Interheciate,1,,xHEMBL724812,,BsO0p00218,,
11269,8684,Didtrkbu5ioninratcay8jrafterinrravenousadninistrati0m8njectedr9segm,A,,,Rattusnordegiv8s,7105.0,,,,,50597,N,1,Intermediwt3,1,,dnEMBL624813,,BAO0000q28,,
11270,8684,Dksfribu4ionindathezdt15m7nzf5drintravebousadmihistrq4ioninjecteddosegm,A,,,Rzttusn0fvegicus,26509.0,,,,,50597,N,1,Int2rmediat4,1,,CHEMnLt24814,,BAO90o0218,,
11271,8684,Diwtrubutjonibratheart1hrxftefintravenouszdkihistratupglnjecteddosegm,A,,,gattusnorvegovus,13732.0,,,,,50597,N,1,Intermed9are,1,,CHEMBL6249w5,,BAOo090218,,
11272,8684,Dis5ributioninrathea5t2hdafterim5rzvsnojsasministrat8onibjecteddpsegk,A,,,3attusho4vegicus,19437.0,,,,,50597,N,1,Intermedisye,1,,CHEMBL61t816,,vAO00002w8,,
11273,8684,Dixtributjonknratheart30migafterintravenouasdmknisrgaripnonj3cheddosegm,A,,,eat6usn9rvegicus,789.0,,,,,50597,N,1,Int2rmediaye,1,,CHEMBL624u1u,,BxO0009218,,
11274,6996,Oraldiureticactkvi5ywasdfalua4edbymeas7ringNaexcre6ionindohsrr4mgkyafteripadk7niwyrafiom06hr,A,,,Canixly9udfamiliaris,10292.0,,,,,50588,N,1,Interkeeiate,1,,CHwMBL623818,,BAO09p0218,,
